PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Montero, JC; Seoane, S; Ocana, A; Pandiella, A				Montero, J. C.; Seoane, S.; Ocana, A.; Pandiella, A.			P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancer	ONCOGENE			English	Article						P-Rex; ErbB; tyrosine kinases; breast cancer	NUCLEOTIDE EXCHANGE FACTOR; GROWTH-FACTOR RECEPTOR; BETA-GAMMA-SUBUNITS; HEREGULIN; RAC; METASTASIS; (3,4,5)-TRISPHOSPHATE; TUMORIGENICITY; ACTIVATION; KINASE	The Neuregulins and their receptors, the ErbB/HER subfamily of receptor tyrosine kinases, have critical roles in animal physiology, and their deregulation is frequent in cancer. Here we report the identification of the guanine nucleotide exchange factor, phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 (P-Rex1), as a novel mediator in signalling by ErbB/HER receptors. P-Rex1 was formerly described as a phosphoinositide 3-kinase and G beta gamma activated protein that regulates Rac function. We define how ErbB/HER receptors regulate P-Rex1 function, which involves dephosphorylation of inhibitory residues, and phosphorylation of activating residues of P-Rex. The net balance resulting from activation of this phosphorylation/dephosphorylation cycle of P-Rex1 favours Rac activation. Molecular and biological studies indicated that P-Rex1 phosphorylation regulated the proliferation of breast cancer cells, and P-Rex1 knockdown affected their migration or invasiveness, as well as their in vivo tumourigenic potential. Moreover, as we found correlation between high P-Rex1 expression and poor patient outcome in breast cancer, P-Rex1 targeting may be therapeutically relevant in cancer. Oncogene (2011) 30, 1059-1071; doi:10.1038/onc.2010.489; published online 1 November 2010	[Montero, J. C.; Seoane, S.; Pandiella, A.] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Salamanca 37007, Spain; [Ocana, A.] Complejo Hosp Univ Albacete, Med Oncol Serv, Albacete, Spain; [Ocana, A.] AECC Unit, Albacete, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Pandiella, A (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Campus Miguel de Unamuno,Ave Univ Coimbra, Salamanca 37007, Spain.	atanasio@usal.es	Seoane, Samuel/H-6299-2015; Seoane, Samuel/L-1309-2014; Montero, Juan Carlos/AAO-1780-2020; Pandiella, Atanasio/O-5180-2014	Seoane, Samuel/0000-0002-9178-0887; Montero, Juan Carlos/0000-0003-4773-053X; Pandiella, Atanasio/0000-0002-4704-8971; Ocana, Alberto/0000-0002-1067-9630	Ministry of Science and Innovation of Spain [BFU2006-01813/BMC, BFU2009-07728/BMC]; Consejeria de Sanidad de la JCYL; ISCIII [RD06/0020/0041]; Juan de la Cierva Program; European Community; Fundacion Ramon Areces	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Sanidad de la JCYL; ISCIII(Instituto de Salud Carlos III); Juan de la Cierva Program; European Community(European Commission); Fundacion Ramon Areces	This work was supported by grants from the Ministry of Science and Innovation of Spain (BFU2006-01813/BMC and BFU2009-07728/BMC) and by the Consejeria de Sanidad de la JCYL. JCM receives support from the Cancer Center Network Program from the ISCIII (RD06/0020/0041), and SS from the Juan de la Cierva Program. Our Cancer Research Institute, and the work carried out at our laboratory receive support from the European Community through the regional development funding program (FEDER), and from the Fundacion Ramon Areces. We thank Drs Heidi CE Welch and Mikio Hoshino for providing the myc-tagged P-Rex1 and an anti-P-Rex antibody, respectively.	Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Atlas E, 2003, MOL CANCER RES, V1, P165; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Baselga J, 2005, J CLIN ONCOL, V23, P2445, DOI 10.1200/JCO.2005.11.890; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Cabrera N, 1996, J CELL BIOL, V132, P427, DOI 10.1083/jcb.132.3.427; CARRAWAY KL, 1994, J BIOL CHEM, V269, P14303; de Alava E, 2007, J CLIN ONCOL, V25, P2656, DOI 10.1200/JCO.2006.08.6850; Donald S, 2004, FEBS LETT, V572, P172, DOI 10.1016/j.febslet.2004.06.096; Esparis-Ogando A, 2002, MOL CELL BIOL, V22, P270, DOI 10.1128/MCB.22.1.270-285.2002; Esteva FJ, 2010, NAT REV CLIN ONCOL, V7, P98, DOI 10.1038/nrclinonc.2009.216; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Joseph RE, 2005, J BIOL CHEM, V280, P27508, DOI 10.1074/jbc.M412495200; Krane IM, 1996, ONCOGENE, V12, P1781; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; Mayeenuddin LH, 2006, J BIOL CHEM, V281, P1921, DOI 10.1074/jbc.M506035200; Montero JC, 2007, MOL BIOL CELL, V18, P380, DOI 10.1091/mbc.E06-06-0511; Montero JC, 2008, CLIN CANCER RES, V14, P3237, DOI 10.1158/1078-0432.CCR-07-5133; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; Rosenfeldt H, 2004, FEBS LETT, V572, P167, DOI 10.1016/j.febslet.2004.06.097; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Tsai MS, 2003, ONCOGENE, V22, P761, DOI 10.1038/sj.onc.1206130; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Yang CF, 2006, MOL CELL BIOL, V26, P831, DOI 10.1128/MCB.26.3.831-842.2006; Yang C, 2008, BIOCHEM J, V410, P167, DOI 10.1042/BJ20070781; Yuste L, 2005, CANCER RES, V65, P6801, DOI 10.1158/0008-5472.CAN-04-4023	31	68	70	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	9					1059	1071		10.1038/onc.2010.489	http://dx.doi.org/10.1038/onc.2010.489			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	729PX	21042280				2022-12-25	WOS:000287964100005
J	Huang, YL; Zhang, WW; Gunst, SJ				Huang, Youliang; Zhang, Wenwu; Gunst, Susan J.			Activation of Vinculin Induced by Cholinergic Stimulation Regulates Contraction of Tracheal Smooth Muscle Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLING MEMBRANE PROTRUSION; ACTIN POLYMERIZATION; TENSION DEVELOPMENT; ALPHA-ACTININ; INTRAMOLECULAR ASSOCIATION; BINDING PROTEINS; STRUCTURAL BASIS; FOCAL ADHESIONS; ARP2/3 COMPLEX; CELL-ADHESION	Vinculin localizes to membrane adhesion junctions where it links actin filaments to the extracellular matrix by binding to the integrin-binding protein talin at its head domain (Vh) and to actin filaments at its tail domain (Vt). Vinculin can assume an inactive (closed) conformation in which Vh and Vt bind to each other, masking the binding sites for actin and talin, and an active (open) conformation in which the binding sites for talin and actin are exposed. We hypothesized that the contractile activation of smooth muscle tissues might regulate the activation of vinculin and thereby contribute to the regulation of contractile tension. Stimulation of tracheal smooth muscle tissues with acetylcholine (ACh) induced the recruitment of vinculin to cell membrane and its interaction with talin and increased the phosphorylation of membrane-localized vinculin at the C-terminal Tyr-1065. Expression of recombinant vinculin head domain peptide (Vh) in smooth muscle tissues, but not the talin-binding deficient mutant head domain, VhA50I, inhibited the ACh-induced recruitment of endogenous vinculin to the membrane and the interaction of vinculin with talin and also inhibited vinculin phosphorylation. Expression of Vh peptide also inhibited ACh-induced smooth muscle contraction and inhibited ACh-induced actin polymerization; however, it did not affect myosin light chain phosphorylation, which is necessary for cross-bridge cycling. Inactivation of RhoA inhibited vinculin activation in response to ACh. We conclude that ACh stimulation regulates vinculin activation in tracheal smooth muscle via RhoA and that vinculin activation contributes to the regulation of active tension by facilitating connections between actin filaments and talin-integrin adhesion complexes and by mediating the initiation of actin polymerization.	[Huang, Youliang; Zhang, Wenwu; Gunst, Susan J.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Gunst, SJ (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	sgunst@iupui.edu		Gunst, Susan/0000-0001-9836-4782	National Institutes of Health [HL29289, HL074099]; American Heart Association; American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R23HL029289, R01HL074099, R01HL029289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL29289 and HL074099. This work was also supported by an American Heart Association post-doctoral fellowship (to Y. H.) and an American Lung Association post-doctoral fellowship (to W. Z.).	Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bass MD, 1999, BIOCHEM J, V341, P257, DOI 10.1042/0264-6021:3410257; Bois PRJ, 2005, MOL CELL BIOL, V25, P6112, DOI 10.1128/MCB.25.14.6112-6122.2005; Bubeck P, 1997, J CELL SCI, V110, P1361; Chen H, 2005, J CELL BIOL, V169, P459, DOI 10.1083/jcb.200410100; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Chen XL, 2006, AM J PHYSIOL-HEART C, V290, pH1862, DOI 10.1152/ajpheart.00651.2005; Cipolla MJ, 2002, FASEB J, V16, P72, DOI 10.1096/cj.01-0104hyp; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; Delanoe-Ayari H, 2004, P NATL ACAD SCI USA, V101, P2229, DOI 10.1073/pnas.0304297101; DeMali KA, 2003, J CELL SCI, V116, P2389, DOI 10.1242/jcs.00605; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; GEIGER B, 1981, J CELL BIOL, V91, P614, DOI 10.1083/jcb.91.3.614; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; HATHAWAY DR, 1985, AM J PHYSIOL, V249, pC345; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; Kim HR, 2008, AM J PHYSIOL-CELL PH, V295, pC768, DOI 10.1152/ajpcell.00174.2008; Kim HR, 2004, AM J PHYSIOL-CELL PH, V287, pC1375, DOI 10.1152/ajpcell.00100.2004; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; MURPHY RA, 1989, ANNU REV PHYSIOL, V51, P275, DOI 10.1146/annurev.ph.51.030189.001423; MURPHY RA, 1994, FASEB J, V8, P311, DOI 10.1096/fasebj.8.3.8143937; NORTH AJ, 1993, J CELL BIOL, V120, P1159, DOI 10.1083/jcb.120.5.1159; OPAZO SA, 2004, AM J PHYSIOL-CELL PH, V286, pC433; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; Rembold CM, 2007, AM J PHYSIOL-CELL PH, V293, pC993, DOI 10.1152/ajpcell.00090.2007; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Saito Shin-Ya, 1996, Journal of Smooth Muscle Research, V32, P51; SMALL JV, 1985, EMBO J, V4, P45, DOI 10.1002/j.1460-2075.1985.tb02315.x; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Strassheim D, 1999, J BIOL CHEM, V274, P18675, DOI 10.1074/jbc.274.26.18675; Tang DD, 2005, J BIOL CHEM, V280, P23380, DOI 10.1074/jbc.M413390200; Tang DD, 2004, J BIOL CHEM, V279, P51722, DOI 10.1074/jbc.M408351200; Tang DD, 2003, J PHYSIOL-LONDON, V553, P21, DOI 10.1113/jphysiol.2003.045047; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; TURNER CE, 1991, EXP CELL RES, V192, P651, DOI 10.1016/0014-4827(91)90090-H; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Wang ZL, 1996, AM J PHYSIOL-CELL PH, V271, pC1594, DOI 10.1152/ajpcell.1996.271.5.C1594; WOOD CK, 1994, J CELL SCI, V107, P709; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zhang Wenwu, 2008, Proc Am Thorac Soc, V5, P32, DOI 10.1513/pats.200704-048VS; Zhang WW, 2006, J PHYSIOL-LONDON, V572, P659, DOI 10.1113/jphysiol.2006.106518; Zhang WW, 2010, AM J PHYSIOL-CELL PH, V299, pC298, DOI 10.1152/ajpcell.00118.2010; Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004; Zhang ZY, 2004, MOL BIOL CELL, V15, P4234, DOI 10.1091/mbc.E04-03-0264; Zhao R, 2008, J BIOL CHEM, V283, P36522, DOI 10.1074/jbc.M805294200; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	55	39	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3630	3644		10.1074/jbc.M110.139923	http://dx.doi.org/10.1074/jbc.M110.139923			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21071443	hybrid, Green Published			2022-12-25	WOS:000286653200047
J	Stark, M; Bram, EE; Akerman, M; Mandel-Gutfreund, Y; Assaraf, YG				Stark, Michal; Bram, Eran E.; Akerman, Martin; Mandel-Gutfreund, Yael; Assaraf, Yehuda G.			Heterogeneous Nuclear Ribonucleoprotein H1/H2-dependent Unsplicing of Thymidine Phosphorylase Results in Anticancer Drug Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR/THYMIDINE PHOSPHORYLASE; HELIX-UNWINDING PROTEINS; SPLICE-SITE SELECTION; MESSENGER-RNA; HNRNP-F; U937 CELLS; MACROPHAGE DIFFERENTIATION; SUBCELLULAR-LOCALIZATION; ANTITUMOR-ACTIVITY; BINDING-PROTEINS	Thymidine phosphorylase (TP) catalyzes the conversion of thymidine to thymine and 2-deoxyribose-1-phosphate. The latter plays an important role in induction of angiogenesis. As such, many human malignancies exhibit TP overexpression that correlates with increased microvessel density, formation of aggressive tumors, and dismal prognosis. Because TP is frequently overexpressed in cancer, pro-drugs were developed that utilize TP activity for their bioactivation to cytotoxic drugs. In this respect, TP is indispensable for the pharmacologic activity of the chemotherapeutic drug capecitabine, as it converts its intermediary metabolite 5'-deoxyfluorouridine to 5-fluorouracil. Thus, loss of TP function confers resistance to the prodrug capecitabine, currently used for the treatment of metastatic colorectal cancer and breast cancer. However, drug resistance phenomena may frequently emerge that compromise the pharmacologic activity of capecitabine. Deciphering the molecular mechanisms underlying resistance to TP-activated prodrugs is an important goal toward the overcoming of such drug resistance phenomena. Here, we discovered that lack of TP protein in drug-resistant tumor cells is due to unsplicing of its pre-mRNA. Advanced bioinformatics identified the family of heterogeneous nuclear ribonucleoproteins (hnRNP) H/F as candidate splicing factors potentially responsible for impaired TP splicing. Indeed, whereas parental cells lacked nuclear localization of hnRNPs H1/H2 and F, drug-resistant cells harbored marked levels of these splicing factors. Nuclear RNA immunoprecipitation experiments established a strong binding of hnRNP H1/H2 to TP pre-mRNA, hence implicating them in TP splicing. Moreover, introduction of hnRNP H2 into drug-sensitive parental cells recapitulated aberrant TP splicing and 5'-deoxyfluorouridine resistance. Thus, this is the first study identifying altered function of hnRNP H1/H2 in tumor cells as a novel determinant of aberrant TP splicing thereby resulting in acquired chemoresistance to TP-activated fluoropyrimidine anticancer drugs.	[Stark, Michal; Bram, Eran E.; Assaraf, Yehuda G.] Technion Israel Inst Technol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel; [Akerman, Martin; Mandel-Gutfreund, Yael] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology	Assaraf, YG (corresponding author), Technion Israel Inst Technol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel.	assaraf@tx.technion.ac.il	Mandel-Gutfreund, Yael/AAI-4365-2021; Akerman, Martin/E-6248-2012; Stark, Michal/AAH-1763-2022; Stark, Michal/AFL-9651-2022	Mandel-Gutfreund, Yael/0000-0002-8946-8237; Stark, Michal/0000-0002-4712-7696; Stark, Michal/0000-0002-4712-7696; Assaraf, Yehuda G./0000-0001-6692-8221; Bram, Eran/0000-0002-7213-5321				Ackland SP, 1999, DRUG RESIST UPDATE, V2, P205, DOI 10.1054/drup.1999.0089; Akerman M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r30; Alkan SA, 2006, BIOCHEM J, V393, P361, DOI 10.1042/BJ20050538; Arhin GK, 2002, NUCLEIC ACIDS RES, V30, P1842, DOI 10.1093/nar/30.8.1842; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Bagga PS, 1998, NUCLEIC ACIDS RES, V26, P5343, DOI 10.1093/nar/26.23.5343; Besnault-Mascard L, 2005, ONCOGENE, V24, P3268, DOI 10.1038/sj.onc.1208448; Buratti E, 2004, NUCLEIC ACIDS RES, V32, P4224, DOI 10.1093/nar/gkh752; Caputi M, 2001, J BIOL CHEM, V276, P43850, DOI 10.1074/jbc.M102861200; Cathelin S, 2006, J BIOL CHEM, V281, P17779, DOI 10.1074/jbc.M600537200; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chou MY, 1999, MOL CELL BIOL, V19, P69; Ciccolini Joseph, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P71, DOI 10.2174/1568011043482089; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P620, DOI 10.1038/nsmb1260; de Bruin M, 2004, MOL PHARMACOL, V66, P1054, DOI 10.1124/mol.104.000315; de Bruin M, 2003, BRIT J CANCER, V88, P957, DOI 10.1038/sj.bjc.6600808; Droin N, 2008, BIOCHIMIE, V90, P416, DOI 10.1016/j.biochi.2007.08.007; Endo M, 1999, INT J CANCER, V83, P127, DOI 10.1002/(SICI)1097-0215(19990924)83:1<127::AID-IJC22>3.0.CO;2-6; FRIEDKIN M, 1954, J BIOL CHEM, V207, P245; Gamberi C, 1997, MOL CELL BIOL, V17, P2587, DOI 10.1128/MCB.17.5.2587; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; HARAGUCHI M, 1994, NATURE, V368, P198, DOI 10.1038/368198a0; HASS R, 1990, EUR J CELL BIOL, V51, P265; HASS R, 1989, EUR J CELL BIOL, V48, P282; HERRICK G, 1976, J BIOL CHEM, V251, P2142; HERRICK G, 1976, J BIOL CHEM, V251, P2133; Honore B, 2004, EXP CELL RES, V294, P199, DOI 10.1016/j.yexcr.2003.11.011; Honore B, 1999, FEBS LETT, V456, P274, DOI 10.1016/S0014-5793(99)00911-4; HONORE B, 1995, J BIOL CHEM, V270, P28780; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; JAMISON SF, 1995, NUCLEIC ACIDS RES, V23, P3260, DOI 10.1093/nar/23.16.3260; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; Lara MC, 2007, BIOSCIENCE REP, V27, P151, DOI 10.1007/s10540-007-9043-2; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lu HY, 2009, CLIN CANCER RES, V15, P5136, DOI 10.1158/1078-0432.CCR-08-3203; Mahe D, 1997, J BIOL CHEM, V272, P1827, DOI 10.1074/jbc.272.3.1827; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Matsuura T, 1999, CANCER RES, V59, P5037; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; MIN HS, 1995, GENE DEV, V9, P2659, DOI 10.1101/gad.9.21.2659; MINN AJ, 1995, BLOOD, V86, P1903, DOI 10.1182/blood.V86.5.1903.bloodjournal8651903; Morita T., 2001, Current Pharmaceutical Biotechnology, V2, P257, DOI 10.2174/1389201013378662; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Phillips Roderick J, 2005, J Inflamm (Lond), V2, P14, DOI 10.1186/1476-9255-2-14; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Sanford JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003369; Sawada N, 1998, CLIN CANCER RES, V4, P1013; Schmid M, 2008, CHROMOSOMA, V117, P419, DOI 10.1007/s00412-008-0166-4; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCHWARTZ EL, 1994, CANCER RES, V54, P1472; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Sironi M, 2004, NUCLEIC ACIDS RES, V32, P1783, DOI 10.1093/nar/gkh341; Stark M, 2009, BLOOD, V113, P4362, DOI 10.1182/blood-2008-08-173799; Takebayashi Y, 1996, EUR J CANCER, V32A, P1227, DOI 10.1016/0959-8049(96)00061-5; Tian B, 2007, GENOME RES, V17, P156, DOI 10.1101/gr.5532707; Ueda M, 1998, CANCER RES, V58, P2343; Van Cutsem E, 2001, ONCOLOGIST, V6, P1, DOI 10.1634/theoncologist.6-suppl_4-1; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Yonenaga F, 1998, PATHOL INT, V48, P850, DOI 10.1111/j.1440-1827.1998.tb03851.x; Zhang DH, 2008, PROTEOM CLIN APPL, V2, P99, DOI 10.1002/prca.200780099; Zhu J, 2000, GENE DEV, V14, P3166, DOI 10.1101/gad.189500	64	38	38	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3741	3754		10.1074/jbc.M110.163444	http://dx.doi.org/10.1074/jbc.M110.163444			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21068389	Green Published, hybrid			2022-12-25	WOS:000286653200056
J	Lelie, HL; Liba, A; Bourassa, MW; Chattopadhyay, M; Chan, PK; Gralla, EB; Miller, LM; Borchelt, DR; Valentine, JS; Whitelegge, JP				Lelie, Herman L.; Liba, Amir; Bourassa, Megan W.; Chattopadhyay, Madhuri; Chan, Pik K.; Gralla, Edith B.; Miller, Lisa M.; Borchelt, David R.; Valentine, Joan Selverstone; Whitelegge, Julian P.			Copper and Zinc Metallation Status of Copper-Zinc Superoxide Dismutase from Amyotrophic Lateral Sclerosis Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRON-ACTIVATION ANALYSIS; DIFFERENTIAL SCANNING CALORIMETRY; MOLECULAR-WEIGHT COMPLEXES; MOTOR-NEURON DISEASE; X-RAY-FLUORESCENCE; CU,ZN-SUPEROXIDE DISMUTASE; SPINAL-CORDS; FAMILIAL ALS; MOUSE MODEL; CEREBROSPINAL-FLUID	Mutations in the metalloenzyme copper-zinc superoxide dismutase (SOD1) cause one form of familial amyotrophic lateral sclerosis (ALS), and metals are suspected to play a pivotal role in ALS pathology. To learn more about metals in ALS, we determined the metallation states of human wild-type or mutant (G37R, G93A, and H46R/H48Q) SOD1 proteins from SOD1-ALS transgenic mice spinal cords. SOD1 was gently extracted from spinal cord and separated into insoluble (aggregated) and soluble (supernatant) fractions, and then metallation states were determined by HPLC inductively coupled plasma MS. Insoluble SOD1-rich fractions were not enriched in copper and zinc. However, the soluble mutant and WT SOD1s were highly metallated except for the metal-binding-region mutant H46R/H48Q, which did not bind any copper. Due to the stability conferred by high metallation of G37R and G93A, it is unlikely that these soluble SOD1s are prone to aggregation in vivo, supporting the hypothesis that immature nascent SOD1 is the substrate for aggregation. We also investigated the effect of SOD1 overexpression and disease on metal homeostasis in spinal cord cross-sections of SOD1-ALS mice using synchrotron-based x-ray fluorescence microscopy. In each mouse genotype, except for the H46R/H48Q mouse, we found a redistribution of copper between gray and white matters correlated to areas of high SOD1. Interestingly, a disease-specific increase of zinc was observed in the white matter for all mutant SOD1 mice. Together these data provide a picture of copper and zinc in the cell as well as highlight the importance of these metals in understanding SOD1-ALS pathology.	[Valentine, Joan Selverstone] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Whitelegge, Julian P.] Univ Calif Los Angeles, Pasarow Mass Spectrometry Lab, NPI Semel Inst, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Borchelt, David R.] Univ Florida, Dept Neurosci, Santa Fe Hlth Care Alzheimers Dis Res Ctr, McKnight Brain Inst, Gainesville, FL 32610 USA; [Bourassa, Megan W.; Miller, Lisa M.] Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA; [Bourassa, Megan W.; Miller, Lisa M.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; State University System of Florida; University of Florida; State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Valentine, JS (corresponding author), Box 951569,607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	jsv@chem.ucla.edu; jpw@chem.ucla.edu	Valentine, Joan S/B-6665-2008	Valentine, Joan S/0000-0002-7174-925X	National Institutes of Health, NINDS [P01 NS049134-01]; United States Department of Energy [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049134] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 NS049134-01 (NINDS).; We thank Alvin Acerbo, Dr. Antonio Lanzirotti, Dr. Andreana Leskovjan, Randy Smith, and Dr. Ryan Tappero for help with beamline X27A and with data analysis on tissue cross-sections and Dr. Sadaf Sehati for editing and proofreading the manuscript. The National Synchrotron Light Source is supported by the United States Department of Energy under Contract DE-AC02-98CH10886.	ARMON C, 1991, NEUROLOGY, V41, P1077, DOI 10.1212/WNL.41.7.1077; Aschner M, 2009, NEUROMOL MED, V11, P252, DOI 10.1007/s12017-009-8083-0; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2007, BIOCHEMISTRY-US, V46, P9953, DOI 10.1021/bi700620r; BANKS TE, 1954, NATURE, V173, P348, DOI 10.1038/173348a0; Bertoni-Freddari C, 2008, EXP GERONTOL, V43, P389, DOI 10.1016/j.exger.2007.11.001; BORCHELT DR, 1995, J BIOL CHEM, V270, P3234, DOI 10.1074/jbc.270.7.3234; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Broniatowski M, 2009, J PHYS CHEM B, V113, P4275, DOI 10.1021/jp810339e; Bruns CK, 2007, EMBO J, V26, P855, DOI 10.1038/sj.emboj.7601528; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; FORMAN HJ, 1973, J BIOL CHEM, V248, P2645; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Gellein K, 2003, BIOL TRACE ELEM RES, V96, P39, DOI 10.1385/BTER:96:1-3:39; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; GREENE BDD, 1990, MICROBIAL OXYGENIC P, P280; Guatteo E, 2007, NEUROBIOL DIS, V28, P90, DOI 10.1016/j.nbd.2007.07.002; Ihara Y, 2005, NEUROL RES, V27, P105, DOI 10.1179/016164105X18430; Johnson FO, 2009, NEUROTOXICOLOGY, V30, P761, DOI 10.1016/j.neuro.2009.07.010; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jou MY, 2009, J NUTR, V139, P835, DOI 10.3945/jn.108.100974; Jusic A, 1992, Neurol Croat, V41, P213; Kamel F, 2002, EPIDEMIOLOGY, V13, P311, DOI 10.1097/00001648-200205000-00012; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; KHANDEKAR RN, 1987, SCI TOTAL ENVIRON, V66, P185, DOI 10.1016/0048-9697(87)90086-6; Kiaei M, 2004, J NEUROSCI, V24, P7945, DOI 10.1523/JNEUROSCI.2000-04.2004; KIHIRA T, 1990, J NEUROL SCI, V98, P251, DOI 10.1016/0022-510X(90)90266-P; Kim J, 2009, NEUROBIOL DIS, V34, P221, DOI 10.1016/j.nbd.2009.01.004; LEPOCK JR, 1985, ARCH BIOCHEM BIOPHYS, V241, P243, DOI 10.1016/0003-9861(85)90380-7; Levenson CW, 2005, PHYSIOL BEHAV, V86, P399, DOI 10.1016/j.physbeh.2005.08.010; Linder Maria C., 1996, American Journal of Clinical Nutrition, V63, p797S; Liu HB, 2000, BIOCHEMISTRY-US, V39, P8125, DOI 10.1021/bi000846f; Lopez-Alonso M, 2007, FOOD ADDIT CONTAM A, V24, P943, DOI 10.1080/02652030701216719; Markesbery WR, 1995, NEURODEGENERATION, V4, P383, DOI 10.1006/neur.1995.0046; NAGATA H, 1985, J NEUROL SCI, V67, P173, DOI 10.1016/0022-510X(85)90113-3; Nordlund A, 2009, P NATL ACAD SCI USA, V106, P9667, DOI 10.1073/pnas.0812046106; Ostachowicz B, 2006, SPECTROCHIM ACTA B, V61, P1210, DOI 10.1016/j.sab.2006.08.008; Pamphlett R, 2001, NEUROTOXICOLOGY, V22, P401, DOI 10.1016/S0161-813X(01)00029-8; PARDO CA, 1995, P NATL ACAD SCI USA, V92, P954, DOI 10.1073/pnas.92.4.954; Popescu BFG, 2009, CEREBELLUM, V8, P74, DOI 10.1007/s12311-008-0091-3; Praline J, 2007, CLIN NEUROL NEUROSUR, V109, P880, DOI 10.1016/j.clineuro.2007.07.008; Qureshi Muddasir, 2008, Open Neurol J, V2, P51, DOI 10.2174/1874205X00802010051; Rajan MT, 1997, J NEUROL SCI, V146, P153, DOI 10.1016/S0022-510X(96)00300-0; Ray SS, 2004, BIOCHEMISTRY-US, V43, P4899, DOI 10.1021/bi030246r; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; ROE JA, 1988, BIOCHEMISTRY-US, V27, P950, DOI 10.1021/bi00403a017; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Sahawneh MA, 2010, J BIOL CHEM, V285, P33885, DOI 10.1074/jbc.M110.118901; SHAFIQURREHMAN, 1984, B ENVIRON CONTAM TOX, V32, P157, DOI 10.1007/BF01607479; Shaw BF, 2008, J BIOL CHEM, V283, P8340, DOI 10.1074/jbc.M707751200; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Sillevis Smitt Peter A. E., 1994, Biological Signals, V3, P193; Smith AP, 2007, AMYOTROPH LATERAL SC, V8, P131, DOI 10.1080/17482960701249241; SPENCER PS, 1992, ANN NY ACAD SCI, V648, P154, DOI 10.1111/j.1749-6632.1992.tb24533.x; Strange RW, 2006, J MOL BIOL, V356, P1152, DOI 10.1016/j.jmb.2005.11.081; Tokuda E, 2009, J NEUROCHEM, V111, P181, DOI 10.1111/j.1471-4159.2009.06310.x; Tomik B, 2006, NEUROCHEM RES, V31, P321, DOI 10.1007/s11064-005-9030-6; Traynor BJ, 2000, ARCH NEUROL-CHICAGO, V57, P1171, DOI 10.1001/archneur.57.8.1171; Trumbull KA, 2009, ANTIOXID REDOX SIGN, V11, P1627, DOI 10.1089/ARS.2009.2574; Ukeda H, 1997, ANAL BIOCHEM, V251, P206, DOI 10.1006/abio.1997.2273; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2005, HUM MOL GENET, V14, P2335, DOI 10.1093/hmg/ddi236; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Winkler DD, 2009, BIOCHEMISTRY-US, V48, P3436, DOI 10.1021/bi8021735; Yao XM, 2009, NEUROTOXICOLOGY, V30, P121, DOI 10.1016/j.neuro.2008.11.002; YOSHIMASU F, 1980, FOLIA PSYCHIAT NEU J, V34, P75; YOSHIMASU F, 1982, FOLIA PSYCHIAT NEU J, V36, P173; Zetterstrom P, 2007, P NATL ACAD SCI USA, V104, P14157, DOI 10.1073/pnas.0700477104	77	102	103	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2795	2806		10.1074/jbc.M110.186999	http://dx.doi.org/10.1074/jbc.M110.186999			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21068388	Green Published, hybrid			2022-12-25	WOS:000286464300045
J	Zhou, XE; Suino-Powell, KM; Xu, Y; Chan, CW; Tanabe, O; Kruse, SW; Reynolds, R; Engel, JD; Xu, HE				Zhou, X. Edward; Suino-Powell, Kelly M.; Xu, Yong; Chan, Cee-Wah; Tanabe, Osamu; Kruse, Schoen W.; Reynolds, Ross; Engel, James Douglas; Xu, H. Eric			The Orphan Nuclear Receptor TR4 Is a Vitamin A-activated Nuclear Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; CRYSTAL-STRUCTURE; GLOBIN GENE; COUP-TF; ALPHA; RXR; EXPRESSION; HETERODIMERIZATION; IDENTIFICATION; PROMOTER	Testicular receptors 2 and 4 (TR2/4) constitute a subgroup of orphan nuclear receptors that play important roles in spermatogenesis, lipid and lipoprotein regulation, and the development of the central nervous system. Currently, little is known about the structural features and the ligand regulation of these receptors. Here we report the crystal structure of the ligand-free TR4 ligand binding domain, which reveals an autorepressed conformation. The ligand binding pocket of TR4 is filled by the C-terminal half of helix 10, and the cofactor binding site is occupied by the AF-2 helix, thus preventing ligand-independent activation of the receptor. However, TR4 exhibits constitutive transcriptional activity on multiple promoters, which can be further potentiated by nuclear receptor coactivators. Mutations designed to disrupt cofactor binding, dimerization, or ligand binding substantially reduce the transcriptional activity of this receptor. Importantly, both retinol and retinoic acid are able to promote TR4 to recruit coactivators and to activate a TR4-regulated reporter. These findings demonstrate that TR4 is a ligand-regulated nuclear receptor and suggest that retinoids might have a much wider regulatory role via activation of orphan receptors such as TR4.	[Reynolds, Ross; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci & Drug Discovery, Grand Rapids, MI 49503 USA; [Tanabe, Osamu; Engel, James Douglas] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Reynolds, Ross] Grand Valley State Univ, Dept Phys, Allendale, MI 49401 USA	Van Andel Institute; University of Michigan System; University of Michigan; Grand Valley State University		edward.zhou@vai.org; eric.xu@vai.org	Xu, H. Eric/ABD-7487-2021	Xu, H. Eric/0000-0002-6829-8144	National Institutes of Health [DK071662, DK066202, HL089301]; Jay and Betty Van Andel Foundation; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor [085P1000817]; Office of Science of the United States Department of Energy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662, R01DK066202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jay and Betty Van Andel Foundation; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor; Office of Science of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071662 and DK066202 and HL089301 (to H. E. X.). This work was also supported in part by the Jay and Betty Van Andel Foundation.; We thank D. Nadziejka for editing the manuscript, M. Tsai for cDNAs of the SRC coactivators, and Z. Wawrzak and J. S. Brunzelle for assistance in data collection at the beamlines of sector 21 (Life Sciences Collaborative Access Team), which is in part funded by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor (Grant 085P1000817). Use of the Advanced Photon Source was supported by the Office of Science of the United States Department of Energy.	[Anonymous], PYMOL MOL GRAPH SYST; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baleato RM, 2005, DEV BIOL, V286, P78, DOI 10.1016/j.ydbio.2005.07.009; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHANG CS, 1994, P NATL ACAD SCI USA, V91, P6040, DOI 10.1073/pnas.91.13.6040; Chen L, 2008, STEM CELLS, V26, P1858, DOI 10.1634/stemcells.2008-0050; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; Desvergne B, 2007, VITAM HORM, V75, P1, DOI 10.1016/S0083-6729(06)75001-4; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Escriva H, 2000, BIOESSAYS, V22, P717; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gampe RT, 2000, GENE DEV, V14, P2229, DOI 10.1101/gad.802300; Glass CK, 2000, GENE DEV, V14, P121; Helvering LM, 2000, GENE, V256, P123, DOI 10.1016/S0378-1119(00)00364-4; Jakel H, 2006, DRUG NEWS PERSPECT, V19, P91, DOI 10.1358/dnp.2006.19.2.977445; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Lee CH, 1998, J BIOL CHEM, V273, P25209, DOI 10.1074/jbc.273.39.25209; Lee YF, 2002, J STEROID BIOCHEM, V81, P291, DOI 10.1016/S0960-0760(02)00118-8; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; Li Y, 2003, STRUCTURE, V11, P741, DOI 10.1016/S0969-2126(03)00133-3; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Liu NC, 2007, DIABETES, V56, P2901, DOI 10.2337/db07-0359; Mu XM, 2004, MOL CELL BIOL, V24, P5887, DOI 10.1128/MCB.24.13.5887-5899.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; Pipaon C, 1999, MOL CELL BIOL, V19, P2734; Rizzo Giovanni, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P289, DOI 10.2174/1568008054863781; Sablin EP, 2008, P NATL ACAD SCI USA, V105, P18390, DOI 10.1073/pnas.0808936105; Stein RA, 2008, CANCER RES, V68, P8805, DOI 10.1158/0008-5472.CAN-08-1594; Tanabe O, 2002, EMBO J, V21, P3434, DOI 10.1093/emboj/cdf340; Tanimoto K, 2000, GENE DEV, V14, P2778, DOI 10.1101/gad.822500; Wada T, 2008, EXP BIOL MED, V233, P1191, DOI 10.3181/0802-MR-50; Waltner-Law M, 2003, J BIOL CHEM, V278, P10427, DOI 10.1074/jbc.M211846200; Wang CP, 2006, BIOCHEM BIOPH RES CO, V351, P204, DOI 10.1016/j.bbrc.2006.10.021; Woo EJ, 2007, J MOL BIOL, V373, P735, DOI 10.1016/j.jmb.2007.08.037; Zhou XE, 2010, J BIOL CHEM, V285, P9161, DOI 10.1074/jbc.M109.085779	39	59	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2877	2885		10.1074/jbc.M110.168740	http://dx.doi.org/10.1074/jbc.M110.168740			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21068381	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000286464300053
J	Hwang, SM; Koo, NY; Jin, MH; Davies, AJ; Chun, GS; Choi, SY; Kim, JS; Park, K				Hwang, Sung-Min; Koo, Na-Youn; Jin, Meihong; Davies, Alexander J.; Chun, Gae-Sig; Choi, Se-Young; Kim, Joong-Soo; Park, Kyungpyo			Intracellular Acidification Is Associated with Changes in Free Cytosolic Calcium and Inhibition of Action Potentials in Rat Trigeminal Ganglion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-BICARBONATE COTRANSPORTER; FUNCTIONAL EXPRESSION; SENSORY NEURONS; PH REGULATION; NA+-HCO3-COTRANSPORTER; CULTURED ASTROCYTES; MOLECULAR-CLONING; PH(I) REGULATION; SALIVARY-GLANDS; ACINAR-CELLS	The effect of intracellular acidification and subsequent pH recovery in sensory neurons has not been well characterized. We have studied the mechanisms underlying Ca2+-induced acidification and subsequent recovery of intracellular pH (pH(i)) in rat trigeminal ganglion neurons and report their effects on neuronal excitability. Glutamate (500 mu M) and capsaicin (1 mu M) increased intracellular Ca2+ concentration ([Ca2+](i)) with a following decrease in pH(i). The recovery of [Ca2+](i) to the prestimulus level was inhibited by LaCl3 (1 mM) and o-vanadate (10 mM), a plasma membrane Ca2+/ATPase (PMCA) inhibitor. Removal of extracellular Ca2+ also completely inhibited the acidification induced by capsaicin. TRPV1 was expressed only in small and medium sized trigeminal ganglion neurons. mRNAs for Na+/H+ exchanger type 1 (NHE1), pancreatic Na+-HCO3- cotransporter type 1 (pNBC1), NBC3, NBC4, and PMCA types 1-3 were detected by RT-PCR. pH(i) recovery was significantly inhibited by pretreatment with NHE1 or pNBC1 siRNA. We found that the frequency of action potentials (APs) was dependent on pH(i). Application of the NHE1 inhibitor 5'-(N-ethyl-N-isopropyl) amiloride (5 mu M) or the pNBC1 inhibitor 4',4'-di-isothiocyanostilbene-2',2'-sulfonic acid (500 mu M) delayed pH(i) recovery and decreased AP frequency. Simultaneous application of 5'-(N-ethyl-N-isopropyl) amiloride and 4',4'-di-isothiocyanostilbene-2',2'-sulfonic acid almost completely inhibited APs. In summary, our results demonstrate that the rise in [Ca2+](i) in sensory neurons by glutamate and capsaicin causes intracellular acidification by activation of PMCA type 3, that the pH(i) recovery from acidification is mediated by membrane transporters NHE1 and pNBC1 specifically, and that the activity of these transporters has direct consequences for neuronal excitability.	[Hwang, Sung-Min; Koo, Na-Youn; Jin, Meihong; Davies, Alexander J.; Choi, Se-Young; Kim, Joong-Soo; Park, Kyungpyo] Seoul Natl Univ, Sch Dent, Dept Physiol, Seoul 110749, South Korea; [Hwang, Sung-Min; Koo, Na-Youn; Jin, Meihong; Davies, Alexander J.; Choi, Se-Young; Kim, Joong-Soo; Park, Kyungpyo] Dent Res Inst, Seoul 110749, South Korea; [Chun, Gae-Sig] Dankook Univ, Sch Dent, Dept Oral Physiol, Cheonan 330714, South Korea	Seoul National University (SNU); Dankook University	Park, K (corresponding author), Seoul Natl Univ, Sch Dent, Dept Physiol, Seoul 110749, South Korea.	kppark@snu.ac.kr		Davies, Alexander/0000-0003-0072-1708; Choi, Se-Young/0000-0001-7534-5167	Korean Government through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University in Korea [2010-0029479]	Korean Government through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University in Korea	This work was supported by National Research Foundation of Korea Grant 2010-0029479 funded by the Korean Government through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University in Korea.	Abuladze N, 1998, J BIOL CHEM, V273, P17689, DOI 10.1074/jbc.273.28.17689; Bevensee MO, 1997, J GEN PHYSIOL, V110, P453, DOI 10.1085/jgp.110.4.453; Bevensee MO, 1997, J GEN PHYSIOL, V110, P467, DOI 10.1085/jgp.110.4.467; Bonnet U, 1999, BRAIN RES, V840, P16, DOI 10.1016/S0006-8993(99)01687-X; BRUNE T, 1995, GLIA, V14, P153, DOI 10.1002/glia.440140210; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; DAUGIRDAS JT, 1995, J CLIN INVEST, V95, P1480, DOI 10.1172/JCI117819; Dhaka A, 2009, J NEUROSCI, V29, P153, DOI 10.1523/JNEUROSCI.4901-08.2009; Douglas RM, 2003, J APPL PHYSIOL, V95, P292, DOI 10.1152/japplphysiol.01089.2002; Eckert SP, 1997, J NEUROSCI METH, V77, P183, DOI 10.1016/S0165-0270(97)00125-8; Fujita F, 2008, J CLIN INVEST, V118, P4049, DOI 10.1172/JCI35957; Gonzalez A, 1997, BIOCHEM BIOPH RES CO, V230, P652, DOI 10.1006/bbrc.1996.6026; Gonzalez A, 1997, PFLUG ARCH EUR J PHY, V434, P609, DOI 10.1007/s004240050443; Gover TD, 2007, CELL CALCIUM, V41, P389, DOI 10.1016/j.ceca.2006.08.014; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hellwig N, 2004, J BIOL CHEM, V279, P34553, DOI 10.1074/jbc.M402966200; Kim YB, 2003, BIOCHEM BIOPH RES CO, V304, P593, DOI 10.1016/S0006-291X(03)00632-6; Kiss L, 1999, J NEUROPHYSIOL, V81, P1839, DOI 10.1152/jn.1999.81.4.1839; Koo NY, 2006, BIOCHEM BIOPH RES CO, V342, P1114, DOI 10.1016/j.bbrc.2006.02.064; Kostyuk P, 2003, NEUROCHEM RES, V28, P1543, DOI 10.1023/A:1025626526410; Lam DK, 2009, BRAIN RES, V1251, P130, DOI 10.1016/j.brainres.2008.11.029; LAX D, 1994, AM J PHYSIOL, V267, pH734, DOI 10.1152/ajpheart.1994.267.2.H734; Li J, 2006, AM J PHYSIOL-GASTR L, V291, pG1031, DOI 10.1152/ajpgi.00483.2005; Liu CN, 2008, TOXICOL SCI, V103, P346, DOI 10.1093/toxsci/kfn045; Liu L, 2000, PHYSIOL BEHAV, V69, P363, DOI 10.1016/S0031-9384(00)00209-2; Matsumoto Y, 2004, STROKE, V35, P185, DOI 10.1161/01.STR.0000106910.42815.C2; Park CK, 2006, J BIOL CHEM, V281, P17304, DOI 10.1074/jbc.M511072200; Park K, 2002, ARCH ORAL BIOL, V47, P1, DOI 10.1016/S0003-9969(01)00098-X; Partosoedarso ER, 2000, AUTON NEUROSCI-BASIC, V83, P37, DOI 10.1016/S0165-1838(00)00109-0; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Pedersen SF, 1998, J NEUROSCI RES, V51, P431, DOI 10.1002/(SICI)1097-4547(19980215)51:4<431::AID-JNR3>3.3.CO;2-C; Phillis JW, 1999, BRAIN RES, V839, P199, DOI 10.1016/S0006-8993(99)01705-9; Praetorius J, 2004, AM J PHYSIOL-RENAL, V286, pF903, DOI 10.1152/ajprenal.00437.2002; Prentice HM, 2008, AM J PHYSIOL-REG I, V294, pR448, DOI 10.1152/ajpregu.00846.2007; Roussa E, 2004, BIOCHEM BIOPH RES CO, V314, P382, DOI 10.1016/j.bbrc.2003.12.099; Shimizu T, 2009, PFLUG ARCH EUR J PHY, V457, P795, DOI 10.1007/s00424-008-0558-6; Takahashi KI, 1996, NEUROSCI RES, V24, P109, DOI 10.1016/0168-0102(95)00989-2; Taylor CJ, 2006, J PHYSIOL-LONDON, V576, P769, DOI 10.1113/jphysiol.2006.117374; Taylor-Clark TE, 2005, J ALLERGY CLIN IMMUN, V116, P1282, DOI 10.1016/j.jaci.2005.08.043; Vale-Gonzalez C, 2006, J NEUROSCI RES, V84, P326, DOI 10.1002/jnr.20878; Vincent AM, 1999, J NEUROBIOL, V40, P171, DOI 10.1002/(SICI)1097-4695(199908)40:2<171::AID-NEU4>3.0.CO;2-F; Wu ML, 1999, AM J PHYSIOL-CELL PH, V277, pC717, DOI 10.1152/ajpcell.1999.277.4.C717; Yamada H, 2003, BIOCHEM BIOPH RES CO, V310, P1213, DOI 10.1016/j.bbrc.2003.09.147	44	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1719	1729		10.1074/jbc.M109.090951	http://dx.doi.org/10.1074/jbc.M109.090951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21068392	hybrid, Green Published			2022-12-25	WOS:000286191500011
J	Pillai, R; Huypens, P; Huang, M; Schaefer, S; Sheinin, T; Wettig, SD; Joseph, JW				Pillai, Renjitha; Huypens, Peter; Huang, Mei; Schaefer, Stephanie; Sheinin, Tanya; Wettig, Shawn D.; Joseph, Jamie W.			Aryl Hydrocarbon Receptor Nuclear Translocator/Hypoxia-inducible Factor-1 beta Plays a Critical Role in Maintaining Glucose-stimulated Anaplerosis and Insulin Release from Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE K+ CHANNELS; ATP-CITRATE LYASE; MALIC ENZYME; MOUSE ISLETS; MALONYL-COA; PYRUVATE-CARBOXYLASE; COUPLING FACTORS; REGULATORY ROLE; SECRETION; EXOCYTOSIS	The metabolic pathways that are involved in regulating insulin secretion from pancreatic beta-cells are still incompletely understood. One potential regulator of the metabolic phenotype of beta-cells is the transcription factor aryl hydrocarbon receptor nuclear translocator (ARNT)/hypoxia-inducible factor (HIF)-1 beta. ARNT/HIF-1 beta levels are profoundly reduced in islets obtained from type 2 diabetic patients. However, no study to date has investigated key pathways involved in regulating insulin release in beta-cells that lack ARNT/HIF-1 beta. In this study, we confirm that siRNA-mediated knockdown of ARNT/HIF-1 beta inhibits glucose-stimulated insulin secretion. We next investigated the metabolic consequence of the loss of ARNT/HIF-1 beta knockdown. We demonstrate that beta-cells with reduced ARNT/HIF-1 beta expression levels exhibit a 31% reduction in glycolytic flux without significant changes in glucose oxidation or the ATP:ADP ratio. Metabolic profiling of beta-cells treated with siRNAs against the ARNT/HIF-1 beta gene revealed that glycolysis, anaplerosis, and glucose-induced fatty acid production were down-regulated, and all are key events involved in glucose-stimulated insulin secretion. In addition, both first and second phase insulin secretion in islets were significantly reduced after ARNT/HIF-1 beta knockdown. Together, our data suggest an important role for ARNT/HIF-1 beta in anaplerosis, and it may play a critical role in maintaining normal secretion competence of beta-cells.	[Pillai, Renjitha; Huypens, Peter; Huang, Mei; Schaefer, Stephanie; Sheinin, Tanya; Wettig, Shawn D.; Joseph, Jamie W.] Univ Waterloo, Sch Pharm, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Joseph, JW (corresponding author), Univ Waterloo, Sch Pharm, Hlth Sci Campus,Rm 3008,10 Victoria St S, Kitchener, ON N2G 1C5, Canada.	j3joseph@uwaterloo.ca	Huypens, Peter/B-3617-2010; Wettig, Shawn/ABE-5382-2020	Huypens, Peter/0000-0001-7922-5787; Wettig, Shawn/0000-0002-6490-264X	Canadian Institutes of Health Research; Canada Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by Canadian Institutes of Health Research and Canada Foundation for Innovation grants (to J. W. J.).	ANTONSSON C, 1995, J BIOL CHEM, V270, P13968, DOI 10.1074/jbc.270.23.13968; Arpiainen S, 2007, J MOL BIOL, V369, P640, DOI 10.1016/j.jmb.2007.03.075; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Broca C, 2003, FEBS LETT, V545, P167, DOI 10.1016/S0014-5793(03)00526-X; Brown LJ, 2009, J BIOL CHEM, V284, P35359, DOI 10.1074/jbc.M109.040394; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Furness SGB, 2007, FEBS LETT, V581, P3616, DOI 10.1016/j.febslet.2007.04.011; GEMBAL M, 1992, J CLIN INVEST, V89, P1288, DOI 10.1172/JCI115714; GERMAN MS, 1993, P NATL ACAD SCI USA, V90, P1781, DOI 10.1073/pnas.90.5.1781; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Gunawardana SC, 2004, AM J PHYSIOL-ENDOC M, V287, pE828, DOI 10.1152/ajpendo.00381.2003; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Henquin JC, 2009, DIABETES OBES METAB, V11, P168, DOI 10.1111/j.1463-1326.2009.01109.x; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hoy M, 2002, FEBS LETT, V531, P199, DOI 10.1016/S0014-5793(02)03500-7; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Khan A, 1996, J BIOL CHEM, V271, P2539, DOI 10.1074/jbc.271.5.2539; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2008, MOL CELL BIOCHEM, V313, P195, DOI 10.1007/s11010-008-9757-x; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1993, METABOLISM, V42, P1229, DOI 10.1016/0026-0495(93)90118-8; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P205, DOI 10.1006/abbi.1993.1413; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Maechler P, 2000, IUBMB LIFE, V50, P27, DOI 10.1080/15216540050176557; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maechler P, 1997, EMBO J, V16, P3833, DOI 10.1093/emboj/16.13.3833; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; MEREDITH M, 1995, J CLIN INVEST, V96, P811, DOI 10.1172/JCI118127; Nenquin M, 2004, J BIOL CHEM, V279, P32316, DOI 10.1074/jbc.M402076200; Newgard CB, 2002, DIABETES, V51, pS389, DOI 10.2337/diabetes.51.2007.S389; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Quoix N, 2009, DIABETES, V58, P412, DOI 10.2337/db07-1298; Ravier MA, 2009, ENDOCRINOLOGY, V150, P33, DOI 10.1210/en.2008-0617; Ronnebaum SM, 2008, J BIOL CHEM, V283, P28909, DOI 10.1074/jbc.M804665200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; SATO Y, 1992, DIABETES, V41, P438, DOI 10.2337/diabetes.41.4.438; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Szollosi A, 2010, BRIT J PHARMACOL, V159, P669, DOI 10.1111/j.1476-5381.2009.00588.x; Vaxillaire M, 2008, ENDOCR REV, V29, P254, DOI 10.1210/er.2007-0024; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Xu J, 2008, DIABETOLOGIA, V51, P2281, DOI 10.1007/s00125-008-1155-0	56	30	31	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1014	1024		10.1074/jbc.M110.149062	http://dx.doi.org/10.1074/jbc.M110.149062			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059654	hybrid, Green Published			2022-12-25	WOS:000286005000012
J	Resnik, N; Sepcic, K; Plemenitas, A; Windoffer, R; Leube, R; Veranic, P				Resnik, Natasa; Sepcic, Kristina; Plemenitas, Ana; Windoffer, Reinhard; Leube, Rudolf; Veranic, Peter			Desmosome Assembly and Cell-Cell Adhesion Are Membrane Raft-dependent Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERGENT-RESISTANT MEMBRANES; LIPID RAFTS; CAVEOLAE MEMBRANE; TIGHT JUNCTIONS; CHOLESTEROL; DOMAINS; PROTEINS; LOCALIZATION; MICRODOMAINS; CYCLODEXTRINS	The aim of our study was to investigate the association of desmosomal proteins with cholesterol-enriched membrane domains, commonly called membrane rafts, and the influence of cholesterol on desmosome assembly in epithelial Madin-Darby canine kidney cells (clone MDc-2). Biochemical analysis proved an association of desmosomal cadherin desmocollin 2 (Dsc2) in cholesterol-enriched fractions that contain membrane raft markers caveolin-1 and flotillin-1 and the novel raft marker ostreolysin. Cold detergent extraction of biotinylated plasma membranes revealed that similar to 60% of Dsc2 associates with membrane rafts while the remainder is present in nonraft and cholesterol-poor membranes. The results of immunofluorescence microscopy confirmed colocalization of Dsc2 and ostreolysin. Partial depletion of cholesterol with methyl-beta-cyclodextrin disturbs desmosome assembly, as revealed by sequential recordings of live cells. Moreover, cholesterol depletion significantly reduces the strength of cell-cell junctions and partially releases Dsc2 from membrane rafts. Our data indicate that a pool of Dsc2 is associated with membrane rafts, particularly with the ostreolysin type of membrane raft, and that intact membrane rafts are necessary for desmosome assembly. Taken together, these data suggest cholesterol as a potential regulator that promotes desmosome assembly.	[Resnik, Natasa; Veranic, Peter] Univ Ljubljana, Fac Med, Inst Cell Biol, SI-1000 Ljubljana, Slovenia; [Sepcic, Kristina] Univ Ljubljana, Dept Biol, Biotech Fac, SI-1000 Ljubljana, Slovenia; [Plemenitas, Ana] Univ Ljubljana, Fac Med, Inst Biochem, SI-1000 Ljubljana, Slovenia; [Windoffer, Reinhard; Leube, Rudolf] Rhein Westfal TH Aachen, Inst Mol & Cellular Anat, D-52062 Aachen, Germany	University of Ljubljana; University of Ljubljana; University of Ljubljana; RWTH Aachen University	Veranic, P (corresponding author), Univ Ljubljana, Fac Med, Inst Cell Biol, SI-1000 Ljubljana, Slovenia.	peter.veranic@mf.uni-lj.si	Veranic, Peter/I-6276-2015; Sepcic, Kristina/S-5533-2018	Veranic, Peter/0000-0003-1999-9988; Sepcic, Kristina/0000-0002-4023-5379; Leube, Rudolf/0000-0002-5519-7379; Windoffer, Reinhard/0000-0003-1403-5880				Baumgartner W, 2008, J MOL BIOL, V378, P44, DOI 10.1016/j.jmb.2008.02.023; Berne S, 2002, BBA-GEN SUBJECTS, V1570, P153, DOI 10.1016/S0304-4165(02)00190-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Causeret M, 2005, MOL BIOL CELL, V16, P2168, DOI 10.1091/mbc.E04-09-0829; Chowdhury HH, 2008, TOXICON, V51, P1345, DOI 10.1016/j.toxicon.2008.03.010; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Huen AC, 2002, J CELL BIOL, V159, P1005, DOI 10.1083/jcb.200206098; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Kahya N, 2005, BIOCHEMISTRY-US, V44, P7479, DOI 10.1021/bi047429d; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Lambert D, 2005, BIOCHEM J, V387, P553, DOI 10.1042/BJ20041377; Lambert D, 2007, CELL PHYSIOL BIOCHEM, V20, P495, DOI 10.1159/000107533; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Locke D, 2005, BIOCHEMISTRY-US, V44, P13027, DOI 10.1021/bi050495a; Marwali MR, 2003, BLOOD, V102, P215, DOI 10.1182/blood-2002-10-3195; MATTEY DL, 1990, J CELL SCI, V97, P689; MATTEY DL, 1986, J CELL SCI, V85, P113; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; Morel E, 2004, J BIOL CHEM, V279, P1499, DOI 10.1074/jbc.M308578200; Nakai Y, 2002, J CELL BIOL, V159, P1097, DOI 10.1083/jcb.200209077; Nava P, 2007, MOL BIOL CELL, V18, P4565, DOI 10.1091/mbc.E07-05-0426; NUBER UA, 1995, EUR J CELL BIOL, V66, P69; Nusrat A, 2000, J CELL SCI, V113, P1771; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Sepcic K, 2004, FEBS LETT, V575, P81, DOI 10.1016/j.febslet.2004.07.093; Shah Mehul B., 2007, V398, P21, DOI 10.1007/978-1-59745-513-8_3; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; SKERROW CJ, 1974, J CELL BIOL, V63, P524, DOI 10.1083/jcb.63.2.524; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Suzuki T, 2006, ACTA HISTOCHEM CYTOC, V39, P155, DOI 10.1267/ahc.06024; Windoffer R, 2002, J CELL SCI, V115, P1717; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	42	62	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1499	1507		10.1074/jbc.M110.189464	http://dx.doi.org/10.1074/jbc.M110.189464			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21071449	Green Published, hybrid			2022-12-25	WOS:000286005000062
J	Daigo, K; Kawamura, T; Ohta, Y; Ohashi, R; Katayose, S; Tanaka, T; Aburatani, H; Naito, M; Kodama, T; Ihara, S; Hamakubo, T				Daigo, Kenji; Kawamura, Takeshi; Ohta, Yoshihiro; Ohashi, Riuko; Katayose, Satoshi; Tanaka, Toshiya; Aburatani, Hiroyuki; Naito, Makoto; Kodama, Tatsuhiko; Ihara, Sigeo; Hamakubo, Takao			Proteomic Analysis of Native Hepatocyte Nuclear Factor-4 alpha (HNF4 alpha) Isoforms, Phosphorylation Status, and Interactive Cofactors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED TRANSCRIPTION; CELL-SPECIFIC EXPRESSION; GENE-EXPRESSION; PROTEIN-KINASE; FACTOR (HNF)-4-ALPHA/GAMMA; COOPERATIVE INTERACTION; CENTRAL REGULATOR; HORMONE RECEPTOR; BINDING-SITES; MESSENGER-RNA	Hepatocyte nuclear factor-4 alpha (HNF4 alpha, NR2A1) is a nuclear receptor that has a critical role in hepatocyte differentiation and the maintenance of homeostasis in the adult liver. However, a detailed understanding of native HNF4 alpha in the steady-state remains to be elucidated. Here we report the native HNF4 alpha isoform, phosphorylation status, and complexes in the steady-state, as shown by shotgun proteomics in HepG2 hepatocarcinoma cells. Shotgun proteomic analysis revealed the complexity of native HNF4 alpha, including multiple phosphorylation sites and inter-isoform heterodimerization. The associating complexes identified by label-free semiquantitative proteomic analysis include the following: the DNA-dependent protein kinase catalytic subunit, histone acetyltransferase complexes, mRNA splicing complex, other nuclear receptor coactivator complexes, the chromatin remodeling complex, and the nucleosome remodeling and histone deacetylation complex. Among the associating proteins, GRB10 interacting GYF protein 2 (GIGYF2, PERQ2) is a new candidate cofactor in metabolic regulation. Moreover, an unexpected heterodimerization of HNF4 alpha and hepatocyte nuclear factor-4 alpha was found. A biochemical and genomewide analysis of transcriptional regulation showed that this heterodimerization activates gene transcription. The genes thus transcribed include the cell death-inducing DEF45-like effector b (CIDEB) gene, which is an important regulator of lipid metabolism in the liver. This suggests that the analysis of the distinctive stoichiometric balance of native HNF4 alpha and its cofactor complexes described here are important for an accurate understanding of transcriptional regulation.	[Daigo, Kenji; Kawamura, Takeshi; Ohta, Yoshihiro; Tanaka, Toshiya; Aburatani, Hiroyuki; Kodama, Tatsuhiko; Ihara, Sigeo; Hamakubo, Takao] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan; [Ohashi, Riuko; Naito, Makoto] Niigata Univ, Div Cellular & Mol Pathol, Grad Sch Med & Dent Sci, Niigata 9518510, Japan; [Katayose, Satoshi] JSR Corp, Tsukuba Res Labs, Ibaraki 3050841, Japan	University of Tokyo; Niigata University; Eisai Co Ltd; JSR Corporation	Hamakubo, T (corresponding author), Univ Tokyo, Adv Sci & Technol Res Ctr, 4-6-1 Komaba, Tokyo 1538904, Japan.	hamakubo@lsbm.org	Ohashi, Riuko/AAH-1415-2019; Daigo, Kenji/S-8915-2016	Ohashi, Riuko/0000-0001-5820-7870; Daigo, Kenji/0000-0001-6398-3356	National Institute of Biomedical Innovation (NIBIO), Japan; New Energy and Industrial Technology Development Organization (NEDO), Japan; Ministry of Education, Culture, Sports, Science and Technology [19319129, 19800009, 20221010]	National Institute of Biomedical Innovation (NIBIO), Japan(National Institute of Biomedical Innovation); New Energy and Industrial Technology Development Organization (NEDO), Japan(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), Japan, Development of New Functional Antibody Technologies of the New Energy and Industrial Technology Development Organization (NEDO), Japan, and Japan Grants-in-Aid for Scientific Research 19319129, 19800009, and 20221010 from the Ministry of Education, Culture, Sports, Science and Technology.	America AHP, 2008, PROTEOMICS, V8, P731, DOI 10.1002/pmic.200700694; Araya N, 2005, BIOCHEM BIOPH RES CO, V329, P653, DOI 10.1016/j.bbrc.2005.02.018; Araya N, 2003, J BIOL CHEM, V278, P5427, DOI 10.1074/jbc.M210234200; Archer A, 2005, MOL ENDOCRINOL, V19, P2320, DOI 10.1210/me.2004-0462; Bogan AA, 2000, J MOL BIOL, V302, P831, DOI 10.1006/jmbi.2000.4099; Brann DW, 2008, MOL CELL ENDOCRINOL, V290, P2, DOI 10.1016/j.mce.2008.04.019; Briancon N, 2006, EMBO J, V25, P1253, DOI 10.1038/sj.emboj.7601021; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chan SW, 2001, J BIOL CHEM, V276, P28402, DOI 10.1074/jbc.M100313200; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Da L, 2006, BIOCHEM J, V393, P779, DOI 10.1042/BJ20051027; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Drewes T, 1996, MOL CELL BIOL, V16, P925; Eeckhoute J, 2003, ENDOCRINOLOGY, V144, P1686, DOI 10.1210/en.2002-0024; Ellard S, 2006, HUM MUTAT, V27, P854, DOI 10.1002/humu.20357; FernandezCanon JM, 1996, NAT GENET, V14, P19, DOI 10.1038/ng0996-19; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Giovannone B, 2003, J BIOL CHEM, V278, P31564, DOI 10.1074/jbc.M211572200; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Guo HT, 2006, BIOCHEM J, V394, P379, DOI 10.1042/BJ20051730; Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507; HATA S, 1992, BIOCHIM BIOPHYS ACTA, V1131, P211, DOI 10.1016/0167-4781(92)90080-J; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hertz R, 1998, NATURE, V392, P512, DOI 10.1038/33185; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kim HJ, 1998, MOL ENDOCRINOL, V12, P1038, DOI 10.1210/me.12.7.1038; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Kritis AA, 1996, GENE, V173, P275, DOI 10.1016/0378-1119(96)00183-7; KTISTAKI E, 1995, P NATL ACAD SCI USA, V92, P9876, DOI 10.1073/pnas.92.21.9876; Kulkarni RN, 2004, SCIENCE, V303, P1311, DOI 10.1126/science.1095486; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Mathivanan S, 2008, NAT BIOTECHNOL, V26, P164, DOI 10.1038/nbt0208-164; Mayeur GL, 2005, J BIOL CHEM, V280, P10827, DOI 10.1074/jbc.M413336200; Nakhei H, 1998, NUCLEIC ACIDS RES, V26, P497, DOI 10.1093/nar/26.2.497; Navas MA, 1999, DIABETES, V48, P1459, DOI 10.2337/diabetes.48.7.1459; Nock A, 2009, J BIOL CHEM, V284, P19915, DOI 10.1074/jbc.M109.016295; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Odom DT, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100059; Ozeki T, 2003, PHARMACOGENETICS, V13, P49, DOI 10.1097/00008571-200301000-00007; Ozeki T, 2002, ARCH BIOCHEM BIOPHYS, V405, P185, DOI 10.1016/S0003-9861(02)00384-3; Ozeki T, 2001, BIOCHEM J, V355, P537, DOI 10.1042/0264-6021:3550537; Pascussi JM, 2007, HEPATOLOGY, V45, P1146, DOI 10.1002/hep.21592; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Petrescu AD, 2005, J BIOL CHEM, V280, P16714, DOI 10.1074/jbc.M405906200; Plengvidhya N, 1999, DIABETES, V48, pA186; Rada-Iglesias A, 2005, HUM MOL GENET, V14, P3435, DOI 10.1093/hmg/ddi378; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sakamoto A, 2007, J HISTOCHEM CYTOCHEM, V55, P641, DOI 10.1369/jhc.6A7120.2007; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Sladek FM, 1999, MOL CELL BIOL, V19, P6509; Song HH, 2009, J BIOL CHEM, V284, P29109, DOI 10.1074/jbc.M109.041145; Stegmann A, 2006, PHYSIOL GENOMICS, V27, P141, DOI 10.1152/physiolgenomics.00314.2005; Sumi K, 2007, MOL CELL BIOL, V27, P4248, DOI 10.1128/MCB.01894-06; Takegoshi S, 2009, PATHOL INT, V59, P61, DOI 10.1111/j.1440-1827.2008.02330.x; Tanaka T, 2006, J PATHOL, V208, P662, DOI 10.1002/path.1928; Viollet B, 1997, MOL CELL BIOL, V17, P4208, DOI 10.1128/MCB.17.8.4208; Wagner N, 2007, INT REV CYTOL, V261, P1, DOI 10.1016/S0074-7696(07)61001-8; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Wolfertstetter F, 1996, COMPUT APPL BIOSCI, V12, P71; Xu ZM, 2007, J BIOL CHEM, V282, P24607, DOI 10.1074/jbc.M611481200; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011	73	37	37	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					674	686		10.1074/jbc.M110.154732	http://dx.doi.org/10.1074/jbc.M110.154732			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21047794	Green Published, hybrid			2022-12-25	WOS:000285782800068
J	Kaustov, L; Hui, OY; Amaya, M; Lemak, A; Nady, N; Duan, SL; Wasney, GA; Li, ZH; Vedadi, M; Schapira, M; Min, JR; Arrowsmith, CH				Kaustov, Lilia; Hui Ouyang; Amaya, Maria; Lemak, Alexander; Nady, Nataliya; Duan, Shili; Wasney, Gregory A.; Li, Zhihong; Vedadi, Masoud; Schapira, Matthieu; Min, Jinrong; Arrowsmith, Cheryl H.			Recognition and Specificity Determinants of the Human Cbx Chromodomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE LYSINE METHYLATION; 3-WAY DECOMPOSITION; STRUCTURAL BASIS; H3; BINDING; NMR; PROTEINS; LOCUS; RNA; REPRESSION	The eight mammalian Cbx proteins are chromodomain-containing proteins involved in regulation of heterochromatin, gene expression, and developmental programs. They are evolutionarily related to the Drosophila HP1 (dHP1) and Pc (dPc) proteins that are key components of chromatin-associated complexes capable of recognizing repressive marks such as trimethylated Lys-9 and Lys-27, respectively, on histone H3. However, the binding specificity and function of the human homologs, Cbx1-8, remain unclear. To this end we employed structural, biophysical, and mutagenic approaches to characterize the molecular determinants of sequence contextual methyllysine binding to human Cbx1-8 proteins. Although all three human HP1 homologs (Cbx1, -3, -5) replicate the structural and binding features of their dHP counterparts, the five Pc homologs (Cbx2, -4, -6, -7, -8) bind with lower affinity to H3K9me3 or H3K27me3 peptides and are unable to distinguish between these two marks. Additionally, peptide permutation arrays revealed a greater sequence tolerance within the Pc family and suggest alternative nonhistone sequences as potential binding targets for this class of chromodomains. Our structures explain the divergence of peptide binding selectivity in the Pc subfamily and highlight previously unrecognized features of the chromodomain that influence binding and specificity.	[Kaustov, Lilia; Lemak, Alexander; Nady, Nataliya; Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 1L7, Canada; [Kaustov, Lilia; Lemak, Alexander; Nady, Nataliya; Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Hui Ouyang; Amaya, Maria; Wasney, Gregory A.; Li, Zhihong; Vedadi, Masoud; Schapira, Matthieu; Min, Jinrong; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada; [Schapira, Matthieu] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5G 1L5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Structural Genomics Consortium; University of Toronto	Arrowsmith, CH (corresponding author), Univ Toronto, Ontario Canc Inst, Campbell Family Canc Res Inst, 101 Coll St, Toronto, ON M5G 1L7, Canada.	carrow@uhnres.utoronto.ca	Min, Jinrong/G-3449-2011	Min, Jinrong/0000-0001-5210-3130; Arrowsmith, Cheryl/0000-0002-4971-3250; Kaustov, Lilia/0000-0002-8474-559X	Canadian Institutes of Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; Genome Canada through GlaxoSmithKline; Genome Canada through Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Ontario Ministry of Health and Long Term Care; Canadian Cancer Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); Genome Canada through GlaxoSmithKline; Genome Canada through Karolinska Institutet; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Cancer Society(Canadian Cancer Society (CCS))	We are grateful to Antoine Peters for fruitful discussions. We thank Chen Chen, Brett Larsen, and Andrew James (Dr. Pawson laboratory, University of Toronto) for help with MS data acquisition and analysis. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes of Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.; This work was supported in part by the Ontario Ministry of Health and Long Term Care. This work was also supported by the Canadian Cancer Society.; Supported by a Doctoral Research Award from the Canadian Institutes of Health Research.	Bernard D, 2005, ONCOGENE, V24, P5543, DOI 10.1038/sj.onc.1208735; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Biason-Lauber A, 2009, AM J HUM GENET, V84, P658, DOI 10.1016/j.ajhg.2009.03.016; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chin HG, 2007, NUCLEIC ACIDS RES, V35, P7313, DOI 10.1093/nar/gkm726; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Gutmanas A, 2002, J BIOMOL NMR, V24, P191, DOI 10.1023/A:1021609314308; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lemak A, 2008, J BIOMOL NMR, V41, P29, DOI 10.1007/s10858-008-9238-2; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Nady N, 2008, TRENDS BIOCHEM SCI, V33, P305, DOI 10.1016/j.tibs.2008.04.014; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Orekhov VY, 2003, J BIOMOL NMR, V27, P165, DOI 10.1023/A:1024944720653; Raush E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007394; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Scott CL, 2007, P NATL ACAD SCI USA, V104, P5389, DOI 10.1073/pnas.0608721104; Senthilkumar R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-549; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vincenz C, 2008, P NATL ACAD SCI USA, V105, P16572, DOI 10.1073/pnas.0805317105; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	39	197	211	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					521	529		10.1074/jbc.M110.191411	http://dx.doi.org/10.1074/jbc.M110.191411			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21047797	Green Published, hybrid			2022-12-25	WOS:000285782800055
J	Popova, TG; Turell, MJ; Espina, V; Kehn-Hall, K; Kidd, J; Narayanan, A; Liotta, L; Petricoin, EF; Kashanchi, F; Bailey, C; Popov, SG				Popova, Taissia G.; Turell, Michael J.; Espina, Virginia; Kehn-Hall, Kylene; Kidd, Jessica; Narayanan, Aarthi; Liotta, Lance; Petricoin, Emanuel F., III; Kashanchi, Fatah; Bailey, Charles; Popov, Serguei G.			Reverse-Phase Phosphoproteome Analysis of Signaling Pathways Induced by Rift Valley Fever Virus in Human Small Airway Epithelial Cells	PLOS ONE			English	Article							PROTEIN-KINASE PATHWAY; MAP KINASES; APOPTOSIS; ACTIVATION; EXPRESSION; TARGET; DEATH; TRANSCRIPTION; TRANSDUCTION; INHIBITOR	Rift valley fever virus (RVFV) infection is an emerging zoonotic disease endemic in many countries of sub-Saharan Africa and in Egypt. In this study we show that human small airway epithelial cells are highly susceptible to RVFV virulent strain ZH-501 and the attenuated strain MP-12. We used the reverse-phase protein arrays technology to identify phosphoprotein signaling pathways modulated during infection of cultured airway epithelium. ZH-501 infection induced activation of MAP kinases (p38, JNK and ERK) and downstream transcriptional factors [STAT1 (Y701), ATF2 (T69/71), MSK1 (S360) and CREB (S133)]. NF-kappa B phosphorylation was also increased. Activation of p53 (S15, S46) correlated with the increased levels of cleaved effector caspase-3, -6 and -7, indicating activation of the extrinsic apoptotic pathway. RVFV infection downregulated phosphorylation of a major anti-apoptotic regulator of survival pathways, AKT (S473), along with phosphorylation of FOX 01/03 (T24/31) which controls cell cycle arrest downstream from AKT. Consistent with this, the level of apoptosis inhibitor XIAP was decreased. However, the intrinsic apoptotic pathway marker, caspase-9, demonstrated only a marginal activation accompanied by an increased level of the inhibitor of apoptosome formation, HSP27. Concentration of the autophagy marker, LC3B, which often accompanies the pro-survival signaling, was decreased. Cumulatively, our analysis of RVFV infection in lung epithelium indicated a viral strategy directed toward the control of cell apoptosis through a number of transcriptional factors. Analyses of MP-12 titers in challenged cells in the presence of MAPK inhibitors indicated that activation of p38 represents a protective cell response while ERK activation controls viral replication.	[Popova, Taissia G.; Kehn-Hall, Kylene; Kidd, Jessica; Narayanan, Aarthi; Kashanchi, Fatah; Bailey, Charles; Popov, Serguei G.] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA; [Turell, Michael J.] US Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD USA; [Espina, Virginia; Liotta, Lance; Petricoin, Emanuel F., III] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA	George Mason University; George Mason University	Popova, TG (corresponding author), George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA.	spopov@gmu.edu	Turell, Michael/ABE-1826-2020; Kehn-Hall, Kylene/I-5752-2013	Turell, Michael/0000-0003-1902-7740; Espina, Virginia/0000-0001-5080-5972; Kehn-Hall, Kylene/0000-0001-8036-7213	Department of Energy [DE-FC52- FC04NA25455]	Department of Energy(United States Department of Energy (DOE))	This work was supported by the Department of Energy grant DE-FC52- FC04NA25455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 1999, LAB INVEST, V79, P1327; Balachandran S, 2000, J VIROL, V74, P1513, DOI 10.1128/JVI.74.3.1513-1523.2000; Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P153, DOI 10.1016/S0924-8579(02)00295-9; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; BROWN JL, 1981, INFECT IMMUN, V33, P848, DOI 10.1128/IAI.33.3.848-853.1981; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cain K, 2002, BIOCHIMIE, V84, P203, DOI 10.1016/S0300-9084(02)01376-7; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Easterday B C, 1965, Adv Vet Sci, V10, P65; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; ELLIOTT RM, 2000, VIRUS TAXONOMY CLASS; Flick R, 2005, CURR MOL MED, V5, P827, DOI 10.2174/156652405774962263; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Garrido C, 1999, FASEB J, V13, P2061, DOI 10.1096/fasebj.13.14.2061; Gauthier ML, 2005, CANCER RES, V65, P1792, DOI 10.1158/0008-5472.CAN-04-3507; Gerdes GH, 2002, VET CLIN N AM-FOOD A, V18, P549, DOI 10.1016/S0749-0720(02)00029-4; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; Ji Wen-Tsai, 2008, Recent Pat Biotechnol, V2, P218, DOI 10.2174/187220808786241042; Kasof GM, 2001, J BIOL CHEM, V276, P3238, DOI 10.1074/jbc.M003670200; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Li SP, 2003, CANCER RES, V63, P3473; Ludwig S, 2009, J ANTIMICROB CHEMOTH, V64, P1, DOI 10.1093/jac/dkp161; MEEGAN JM, 1979, T ROY SOC TROP MED H, V73, P618, DOI 10.1016/0035-9203(79)90004-X; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PETERS CJ, 1989, RIFT VALLEY FEVER; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Sandhu KS, 2009, BIOTECHNOL BIOENG, V104, P752, DOI 10.1002/bit.22439; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Won SY, 2007, J VIROL, V81, P13335, DOI 10.1128/JVI.01238-07; Wulfkuhle JD, 2006, NAT CLIN PRACT ONCOL, V3, P256, DOI 10.1038/ncponc0485; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	44	44	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13805	10.1371/journal.pone.0013805	http://dx.doi.org/10.1371/journal.pone.0013805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072193	Green Published, Green Submitted, gold			2022-12-25	WOS:000283780800008
J	Angel, TE; Luft, BJ; Yang, XH; Nicora, CD; Camp, DG; Jacobs, JM; Smith, RD				Angel, Thomas E.; Luft, Benjamin J.; Yang, Xiaohua; Nicora, Carrie D.; Camp, David G., II; Jacobs, Jon M.; Smith, Richard D.			Proteome Analysis of Borrelia burgdorferi Response to Environmental Change	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; OUTER SURFACE PROTEIN; HOST-SPECIFIC SIGNALS; GENE-EXPRESSION; MAMMALIAN HOST; INFECTIOUS CYCLE; FACTOR-H; BINDING; TRANSCRIPTOME; REGULATOR	We examined global changes in protein expression in the B31 strain of Borrelia burgdorferi, in response to two environmental cues (pH and temperature) chosen for their reported similarity to those encountered at different stages of the organism's life cycle. Multidimensional nano-liquid chromatographic separations coupled with tandem mass spectrometry were used to examine the array of proteins (i.e., the proteome) of B. burgdorferi for different pH and temperature culture conditions. Changes in pH and temperature elicited in vitro adaptations of this spirochete known to cause Lyme disease and led to alterations in protein expression that are associated with increased microbial pathogenesis. We identified 1,031 proteins that represent 59% of the annotated genome of B. burgdorferi and elucidated a core proteome of 414 proteins that were present in all environmental conditions investigated. Observed changes in protein abundances indicated varied replicon usage, as well as proteome functional distributions between the in vitro cell culture conditions. Surprisingly, the pH and temperature conditions that mimicked B. burgdorferi residing in the gut of a fed tick showed a marked reduction in protein diversity. Additionally, the results provide us with leading candidates for exploring how B. burgdorferi adapts to and is able to survive in a wide variety of environmental conditions and lay a foundation for planned in situ studies of B. burgdorferi isolated from the tick midgut and infected animals.	[Angel, Thomas E.; Nicora, Carrie D.; Camp, David G., II; Jacobs, Jon M.; Smith, Richard D.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Luft, Benjamin J.; Yang, Xiaohua] SUNY Stony Brook, Sch Med, Div Infect Dis, Stony Brook, NY 11794 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Angel, TE (corresponding author), Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA.	rds@pnl.gov	Smith, Richard D/J-3664-2012	Smith, Richard D/0000-0002-2381-2349; Luft, Benjamin/0000-0001-9008-7004	National Institutes of Health (NIH) [U01-AI56480]; National Center for Research Resources [RR18522]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI056480] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Portions of this research were supported by National Institutes of Health (NIH) grant U01-AI56480 (to BJL) and the National Center for Research Resources (RR18522 to RDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boardman BK, 2008, INFECT IMMUN, V76, P3844, DOI 10.1128/IAI.00467-08; Brooks CS, 2003, INFECT IMMUN, V71, P3371, DOI 10.1128/IAI.71.6.3371-3383.2003; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Byram R, 2004, J BACTERIOL, V186, P3561, DOI 10.1128/JB.186.11.3561-3569.2004; Carroll JA, 2000, INFECT IMMUN, V68, P6677, DOI 10.1128/IAI.68.12.6677-6684.2000; Carroll JA, 1999, INFECT IMMUN, V67, P3181, DOI 10.1128/IAI.67.7.3181-3187.1999; Feng SL, 1998, INFECT IMMUN, V66, P2827, DOI 10.1128/IAI.66.6.2827-2835.1998; Fischer JR, 2003, P NATL ACAD SCI USA, V100, P7307, DOI 10.1073/pnas.1231043100; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gilmore RD, 2010, P NATL ACAD SCI USA, V107, P7515, DOI 10.1073/pnas.1000268107; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Hughes JL, 2008, INFECT IMMUN, V76, P2498, DOI 10.1128/IAI.01583-07; Jacobs JM, 2005, PROTEOMICS, V5, P1446, DOI 10.1002/pmic.200401052; Kraiczy P, 2004, J BIOL CHEM, V279, P2421, DOI 10.1074/jbc.M308343200; Liang FT, 2002, INFECT IMMUN, V70, P3300, DOI 10.1128/IAI.70.6.3300-3303.2002; Mulay V, 2007, J BACTERIOL, V189, P2063, DOI 10.1128/JB.01239-06; Mulay VB, 2009, J BACTERIOL, V191, P2783, DOI 10.1128/JB.01802-08; Narasimhan S, 2003, P NATL ACAD SCI USA, V100, P15953, DOI 10.1073/pnas.2432412100; Narasimhan S, 2002, J BACTERIOL, V184, P3122, DOI 10.1128/JB.184.11.3122-3125.2002; Norris SJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-209; Nowalk AJ, 2006, PROTEOMICS, V6, P2121, DOI 10.1002/pmic.200500187; Ojaimi C, 2003, INFECT IMMUN, V71, P1689, DOI 10.1128/IAI.71.4.1689-1705.2003; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Scheckelhoff MR, 2007, P NATL ACAD SCI USA, V104, P7247, DOI 10.1073/pnas.0607263104; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; Stevenson B, 2002, INFECT IMMUN, V70, P491, DOI 10.1128/IAI.70.2.491-497.2002; Stevenson B, 2006, WIEN KLIN WOCHENSCHR, V118, P643, DOI 10.1007/s00508-006-0690-2; Stewart PE, 2008, INFECT IMMUN, V76, P1970, DOI 10.1128/IAI.00714-07; Tokarz R, 2004, INFECT IMMUN, V72, P5419, DOI 10.1128/IAI.72.9.5419-5432.2004; Xu Y, 2008, MICROB PATHOGENESIS, V45, P403, DOI 10.1016/j.micpath.2008.09.006; Yang XF, 2008, INFECT IMMUN, V76, P4439, DOI 10.1128/IAI.00740-08; Yang XF, 2000, MOL MICROBIOL, V37, P1470, DOI 10.1046/j.1365-2958.2000.02104.x; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zhiming OY, 2008, MICROBIOL-SGM, V154, P2641, DOI 10.1099/mic.0.2008/019992-0	38	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13800	10.1371/journal.pone.0013800	http://dx.doi.org/10.1371/journal.pone.0013800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072190	gold, Green Published, Green Submitted			2022-12-25	WOS:000283779700012
J	Niesen, FH; Schultz, L; Jadhav, A; Bhatia, C; Guo, KD; Maloney, DJ; Pilka, ES; Wang, MH; Oppermann, U; Heightman, TD; Simeonov, A				Niesen, Frank H.; Schultz, Lena; Jadhav, Ajit; Bhatia, Chitra; Guo, Kunde; Maloney, David J.; Pilka, Ewa S.; Wang, Minghua; Oppermann, Udo; Heightman, Tom D.; Simeonov, Anton			High-Affinity Inhibitors of Human NAD(+)-Dependent 15-Hydroxyprostaglandin Dehydrogenase: Mechanisms of Inhibition and Structure-Activity Relationships	PLOS ONE			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; PROSTAGLANDIN-E SYNTHASE; ALCOHOL-DEHYDROGENASE; STATISTICAL PARAMETER; SEQUENCE-ANALYSIS; CRYSTAL-STRUCTURE; CRITICAL RESIDUES; EXPRESSION; ENZYME; LIGAND	Background: 15-hydroxyprostaglandin dehydrogenase (15-PGDH, EC 1.1.1.141) is the key enzyme for the inactivation of prostaglandins, regulating processes such as inflammation or proliferation. The anabolic pathways of prostaglandins, especially with respect to regulation of the cyclooxygenase (COX) enzymes have been studied in detail; however, little is known about downstream events including functional interaction of prostaglandin-processing and -metabolizing enzymes. High-affinity probes for 15-PGDH will, therefore, represent important tools for further studies. Principal Findings: To identify novel high-affinity inhibitors of 15-PGDH we performed a quantitative high-throughput screen (qHTS) by testing > 160 thousand compounds in a concentration-response format and identified compounds that act as noncompetitive inhibitors as well as a competitive inhibitor, with nanomolar affinity. Both types of inhibitors caused strong thermal stabilization of the enzyme, with cofactor dependencies correlating with their mechanism of action. We solved the structure of human 15-PGDH and explored the binding modes of the inhibitors to the enzyme in silico. We found binding modes that are consistent with the observed mechanisms of action. Conclusions: Low cross-reactivity in screens of over 320 targets, including three other human dehydrogenases/reductases, suggest selectivity of the present inhibitors for 15-PGDH. The high potencies and different mechanisms of action of these chemotypes make them a useful set of complementary chemical probes for functional studies of prostaglandin-signaling pathways.	[Niesen, Frank H.; Bhatia, Chitra; Guo, Kunde; Pilka, Ewa S.; Wang, Minghua; Heightman, Tom D.] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford, England; [Schultz, Lena; Jadhav, Ajit; Maloney, David J.; Oppermann, Udo; Simeonov, Anton] NHGRI, NIH Chem Genom Ctr, NIH, Bethesda, MD 20892 USA; [Oppermann, Udo] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthoped Surg Rheumatol & Musculosk, Biomed Res Unit, Oxford, England	University of Oxford; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); NIH National Human Genome Research Institute (NHGRI); University of Oxford	Niesen, FH (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford, England.	asimeono@mail.nih.gov		Jadhav, Ajit/0000-0001-7955-1451; Seewooruthun, Chitra/0000-0002-9047-188X	Molecular Libraries Initiative of the NIH Roadmap for Medical Research; NHGRI, NIH; Oxford Biomedical Research Unit; Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG200319] Funding Source: NIH RePORTER	Molecular Libraries Initiative of the NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Oxford Biomedical Research Unit; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported in part by the Molecular Libraries Initiative of the NIH Roadmap for Medical Research, the Intramural Research Program of the NHGRI, NIH, and the Oxford Biomedical Research Unit. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERRY CN, 1983, BIOCHEM PHARMACOL, V32, P2863, DOI 10.1016/0006-2952(83)90390-8; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Cho H, 2002, PROSTAG LEUKOTR ESS, V67, P461, DOI 10.1054/plef.2002.0457; Cho H, 2005, ARCH BIOCHEM BIOPHYS, V433, P447, DOI 10.1016/j.abb.2004.09.036; Cho H, 2002, ARCH BIOCHEM BIOPHYS, V405, P247, DOI 10.1016/S0003-9861(02)00352-1; Cohen EG, 2003, CLIN CANCER RES, V9, P3425; DEKOK PMT, 1988, EUR J BIOCHEM, V175, P581; Dubinett SM, 2008, CANCER PREV RES, V1, P223, DOI 10.1158/1940-6207.CAPR-08-0148; Eastwood BJ, 2006, J BIOMOL SCREEN, V11, P253, DOI 10.1177/1087057105285611; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENSOR CM, 1994, BBA-PROTEIN STRUCT M, V1208, P151, DOI 10.1016/0167-4838(94)90172-4; ENSOR CM, 1990, J BIOL CHEM, V265, P14888; FEDOROV O, METHODS BIO IN PRESS; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; FitzGerald G, 2003, NAT REV DRUG DISCOV, V2, P879, DOI 10.1038/nrd1225; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Ito K, 2006, J MOL BIOL, V355, P722, DOI 10.1016/j.jmb.2005.10.072; Jadhav A, 2010, J MED CHEM, V53, P37, DOI 10.1021/jm901070c; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kallberg Y, 2002, PROTEIN SCI, V11, P636, DOI 10.1110/ps.26902; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kim EH, 2008, BIOCHEM PHARMACOL, V76, P1544, DOI 10.1016/j.bcp.2008.07.043; Kroe RR, 2003, J MED CHEM, V46, P4669, DOI 10.1021/jm030120s; KROOK M, 1990, BIOCHEMISTRY-US, V29, P738, DOI 10.1021/bi00455a021; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michael S, 2008, ASSAY DRUG DEV TECHN, V6, P637, DOI 10.1089/adt.2008.150; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Rizzo G, 2006, CURR OPIN PHARMACOL, V6, P421, DOI 10.1016/j.coph.2006.03.012; Rudolph F B, 1979, Methods Enzymol, V63, P411; Samuelsson B, 2000, AM J RESP CRIT CARE, V161, pS2, DOI 10.1164/ajrccm.161.supplement_1.ltta-1; SAMUELSSON B, 1983, BIOSCIENCE REP, V3, P791, DOI 10.1007/BF01133779; SAMUELSSON B, 1986, PROG LIPID RES, V25, P13, DOI 10.1016/0163-7827(86)90006-8; Schlieben NH, 2005, J MOL BIOL, V349, P801, DOI 10.1016/j.jmb.2005.04.029; Segel IH., 1993, ENZYME KINETICS BEHA; Sheng HM, 1998, CANCER RES, V58, P362; Simeonov A, 2008, J MED CHEM, V51, P2363, DOI 10.1021/jm701301m; Sogabe S, 2003, J BIOL CHEM, V278, P19387, DOI 10.1074/jbc.M208146200; Tai HH, 2002, PROSTAG OTH LIPID M, V68-9, P483, DOI 10.1016/S0090-6980(02)00050-3; Tai HH, 2007, PROSTAG OTH LIPID M, V83, P203, DOI 10.1016/j.prostaglandins.2007.01.007; Tong M, 2000, BIOCHEM BIOPH RES CO, V276, P77, DOI 10.1006/bbrc.2000.3437; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; WERMUTH B, 1988, J BIOL CHEM, V263, P16185; Yasgar Adam, 2008, JALA Charlottesv Va, V13, P79, DOI 10.1016/j.jala.2007.12.004; Yoshimatsu K, 2001, CLIN CANCER RES, V7, P3971; Yoshimatsu K, 2001, CLIN CANCER RES, V7, P2669; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhou HP, 2001, EUR J BIOCHEM, V268, P3368, DOI 10.1046/j.1432-1327.2001.02218.x	58	22	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13719	10.1371/journal.pone.0013719	http://dx.doi.org/10.1371/journal.pone.0013719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072165	Green Submitted, Green Published, gold			2022-12-25	WOS:000283779700002
J	Chan, KH; Zhang, AJX; To, KKW; Chan, CCS; Poon, VKM; Guo, KY; Ng, F; Zhang, QW; Leung, VHC; Cheung, ANY; Lau, CCY; Woo, PCY; Tse, H; Wu, WL; Chen, HL; Zheng, BJ; Yuen, KY				Chan, Kwok-Hung; Zhang, Anna J. X.; To, Kelvin K. W.; Chan, Chris C. S.; Poon, Vincent K. M.; Guo, Kunyuan; Ng, Fai; Zhang, Qi-Wei; Leung, Virtual H. C.; Cheung, Annie N. Y.; Lau, Candy C. Y.; Woo, Patrick C. Y.; Tse, Herman; Wu, Wailan; Chen, Honglin; Zheng, Bo-Jian; Yuen, Kwok-Yung			Wild Type and Mutant 2009 Pandemic Influenza A (H1N1) Viruses Cause More Severe Disease and Higher Mortality in Pregnant BALB/c Mice	PLOS ONE			English	Article							HONG-KONG; HEMAGGLUTININ; SUBSTITUTION; INFECTION	Background: Pregnant women infected by the pandemic influenza A (H1N1) 2009 virus had more severe disease and higher mortality but its pathogenesis is still unclear. Principal Findings: We showed that higher mortality, more severe pneumonitis, higher pulmonary viral load, lower peripheral blood T lymphocytes and antibody responses, higher levels of proinflammatory cytokines and chemokines, and worse fetal development occurred in pregnant mice than non-pregnant controls infected by either wild type (clinical isolate) or mouse-adapted mutant virus with D222G substitution in hemagglutinin. These disease-associated changes and the lower respiratory tract involvement were worse in pregnant mice challenged by mutant virus. Though human placental origin JEG-3 cell line could be infected and proinflammatory cytokines or chemokines were elevated in amniotic fluid of some mice, no placental or fetal involvement by virus were detected by culture, real-time reverse transcription polymerase chain reaction or histopathological changes. Dual immunofluorescent staining of viral nucleoprotein and type II alveolar cell marker SP-C protein suggested that the majority of infected alveolar epithelial cells were type II pneumocytes. Conclusion: The adverse effect of this pandemic virus on maternal and fetal outcome is largely related to the severe pulmonary disease and the indirect effect of inflammatory cytokine spillover into the systemic circulation.	[Chan, Kwok-Hung; Zhang, Anna J. X.; To, Kelvin K. W.; Chan, Chris C. S.; Poon, Vincent K. M.; Guo, Kunyuan; Ng, Fai; Zhang, Qi-Wei; Leung, Virtual H. C.; Lau, Candy C. Y.; Woo, Patrick C. Y.; Tse, Herman; Wu, Wailan; Chen, Honglin; Zheng, Bo-Jian; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Cheung, Annie N. Y.] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Anna J. X.; To, Kelvin K. W.; Woo, Patrick C. Y.; Tse, Herman; Chen, Honglin; Zheng, Bo-Jian; Yuen, Kwok-Yung] Univ Hong Kong, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Anna J. X.; To, Kelvin K. W.; Woo, Patrick C. Y.; Tse, Herman; Chen, Honglin; Zheng, Bo-Jian; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Chan, KH (corresponding author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	kyyuen@hkucc.hku.hk	Chan, Kwok Hung/ABD-5399-2021; Tse, Herman/C-4425-2009; Chen, Honglin/C-4224-2009; To, Kelvin/AAV-7007-2020; Zhang, Qiwei/AAX-1977-2020; Zhang, Qiwei/D-9110-2012; Woo, Patrick Chiu Yat/C-4449-2009; Cheung, Annie Nga Yin/C-4231-2009; Zhang, Jinxia/C-4470-2009	Chen, Honglin/0000-0001-5108-8338; To, Kelvin/0000-0002-1921-5824; Zhang, Qiwei/0000-0002-2770-111X; Poon, Vincent kwok-man/0000-0002-7737-8912; Woo, Patrick Chiu Yat/0000-0001-9401-1832; Cheung, Annie Nga Yin/0000-0002-1584-7568; Yuen, Kwok-yung/0000-0002-2083-1552; Zhang, Jinxia/0000-0002-5087-3614	Ted Sun Foundation; Ms. Teresa Wong On Yik, Research Fund for the Control of Infectious Diseases of the Food and Health Bureau; Research Grants Council of the Hong Kong Special Administrative Region, China	Ted Sun Foundation; Ms. Teresa Wong On Yik, Research Fund for the Control of Infectious Diseases of the Food and Health Bureau; Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	The authors are grateful to the support from the Ted Sun Foundation, the Clinical Infectious Diseases Research Endowment Fund from Ms. Teresa Wong On Yik, Research Fund for the Control of Infectious Diseases of the Food and Health Bureau, and the Research Grants Council of the Hong Kong Special Administrative Region, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs N, 2005, BIRTH DEFECTS RES A, V73, P989, DOI 10.1002/bdra.20195; Chen BY, 2009, MOL VIS, V15, P2821; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Gordon CL, 2010, CLIN INFECT DIS, V50, P672, DOI 10.1086/650462; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kilander A, 2010, EURO SURVEILL, V15; Lau SKP, 2009, J CLIN MICROBIOL, V47, P2344, DOI 10.1128/JCM.00924-09; Li IWS, 2009, J CLIN VIROL, V46, P325, DOI 10.1016/j.jcv.2009.09.013; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; Melidou A, 2010, VIRUS RES, V151, P192, DOI 10.1016/j.virusres.2010.05.005; MILLER RR, 2010, EURO SURVEILL, V15; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; SHORT SJ, 2010, BIOL PSYCHIAT; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; TO KK, 2010, POSTGRAD MED J; Tunbridge AJ, 2008, J INFECTION, V57, P95, DOI 10.1016/j.jinf.2008.03.004; Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P21; YAWN DH, 1971, J AMER MED ASSOC, V216, P1022, DOI 10.1001/jama.216.6.1022; ZHENG BJ, 2010, EXP BIOL MED; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105	33	57	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13757	10.1371/journal.pone.0013757	http://dx.doi.org/10.1371/journal.pone.0013757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060798	Green Published, Green Submitted, gold			2022-12-25	WOS:000283645300036
J	Li, QA; Wang, XH; Lu, ZM; Zhang, BZ; Guan, ZP; Liu, ZJ; Zhong, QM; Gu, LK; Zhou, J; Zhu, BD; Ji, JF; Deng, DJ				Li, Qiang; Wang, Xiuhong; Lu, Zheming; Zhang, Baozhen; Guan, Zhenpo; Liu, Zhaojun; Zhong, Qiming; Gu, Liankun; Zhou, Jing; Zhu, Budong; Ji, Jiafu; Deng, Dajun			Polycomb CBX7 Directly Controls Trimethylation of Histone H3 at Lysine 9 at the p16 Locus	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; CHROMOBOX PROTEIN; GENE-EXPRESSION; INK4A-ARF LOCUS; DNA METHYLATION; HUMAN CANCERS; CELLS; ISLAND; HETEROCHROMATIN; PROGRESSION	Background: H3K9 trimethylation (H3K9me3) and binding of PcG repressor complex-1 (PRC1) may play crucial roles in the epigenetic silencing of the p16 gene. However, the mechanism of the initiation of this trimethylation is unknown. Methodology/Principal Findings: In the present study, we found that upregulating the expression of PRC1 component Cbx7 in gastric cancer cell lines MGC803 and BGC823 led to significantly suppress the expression of genes within the p16-Arf-p15 locus. H3K9me3 formation was observed at the p16 promoter and Regulatory Domain (RD). CBX7 and SUV39H2 binding to these regions were also detectable in the CBX7-stably upregulated cells. CBX7-SUV39H2 complexes were observed within nucleus in bimolecular fluorescence complementation assay (BiFC). Mutations of the chromodomain or deletion of Pc-box abolished the CBX7-binding and H3K9me3 formation, and thus partially repressed the function of CBX7. SiRNA-knockdown of Suv39h2 blocked the repressive effect of CBX7 on p16 transcription. Moreover, we found that expression of CBX7 in gastric carcinoma tissues with p16 methylation was significantly lower than that in their corresponding normal tissues, which showed a negative correlation with transcription of p16 in gastric mucosa. Conclusion/Significance: These results demonstrated for the first time, to our knowledge, that CBX7 could initiate H3K9me3 formation at the p16 promoter.	[Li, Qiang; Wang, Xiuhong; Lu, Zheming; Zhang, Baozhen; Guan, Zhenpo; Liu, Zhaojun; Zhong, Qiming; Gu, Liankun; Zhou, Jing; Deng, Dajun] Peking Univ, Canc Hosp & Inst, Dept Etiol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China; [Zhu, Budong] Peking Univ, Canc Hosp & Inst, Dept Internal Med, Beijing 100871, Peoples R China; [Ji, Jiafu] Peking Univ, Canc Hosp & Inst, Dept Surg, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Li, QA (corresponding author), Peking Univ, Canc Hosp & Inst, Dept Etiol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China.	dengdajun@bjmu.edu.cn	Deng, Dajun/D-4605-2009; liu, zhao/GXV-6141-2022	Deng, Dajun/0000-0001-5161-5943; JI, JIAFU/0000-0001-6878-5543	National Basic Research Program of China (973 Program) [2005CB522403, 2011CB504201]; Natural Science Foundation of China [30571056, 90919015, 30921140311]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Basic Research Program of China (973 Program 2005CB522403 and 2011CB504201) and Natural Science Foundation of China (30571056, 90919015, and 30921140311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernard D, 2005, ONCOGENE, V24, P5543, DOI 10.1038/sj.onc.1208735; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Cao J, 2009, CLIN CANCER RES, V15, P5178, DOI 10.1158/1078-0432.CCR-09-0580; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Eads C, 2002, METHOD MOL BIOL, V200, P53; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Federico A, 2009, CANCER RES, V69, P7079, DOI 10.1158/0008-5472.CAN-09-1542; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585; GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Hahn MA, 2008, CANCER RES, V68, P10280, DOI 10.1158/0008-5472.CAN-08-1957; HERMAN JG, 1995, CANCER RES, V55, P4525; Hinz S, 2008, TUMOR BIOL, V29, P323, DOI 10.1159/000170879; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Luo DY, 2006, LAB INVEST, V86, P591, DOI 10.1038/labinvest.3700415; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Mohammad HP, 2009, CANCER RES, V69, P6322, DOI 10.1158/0008-5472.CAN-09-0065; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; Pallante P, 2008, CANCER RES, V68, P6770, DOI 10.1158/0008-5472.CAN-08-0695; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Scott CL, 2007, P NATL ACAD SCI USA, V104, P5389, DOI 10.1073/pnas.0608721104; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Vincenz C, 2008, P NATL ACAD SCI USA, V105, P16572, DOI 10.1073/pnas.0805317105; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Zhang BZ, 2008, CANCER EPIDEM BIOMAR, V17, P2402, DOI 10.1158/1055-9965.EPI-08-0315	35	24	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13732	10.1371/journal.pone.0013732	http://dx.doi.org/10.1371/journal.pone.0013732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060834	Green Submitted, Green Published, gold			2022-12-25	WOS:000283645300013
J	Mittapalli, O; Bai, XD; Mamidala, P; Rajarapu, SP; Bonello, P; Herms, DA				Mittapalli, Omprakash; Bai, Xiaodong; Mamidala, Praveen; Rajarapu, Swapna Priya; Bonello, Pierluigi; Herms, Daniel A.			Tissue-Specific Transcriptomics of the Exotic Invasive Insect Pest Emerald Ash Borer (Agrilus planipennis)	PLOS ONE			English	Article							CYTOCHROME-P450 GENES; NORTH-AMERICAN; WOLBACHIA INFECTION; TOBACCO HORNWORM; CYP4 FAMILY; EXPRESSION; RESISTANCE; ANNOTATION; PROTEIN; MIDGUT	Background: The insect midgut and fat body represent major tissue interfaces that deal with several important physiological functions including digestion, detoxification and immune response. The emerald ash borer (Agrilus planipennis), is an exotic invasive insect pest that has killed millions of ash trees (Fraxinus spp.) primarily in the Midwestern United States and Ontario, Canada. However, despite its high impact status little knowledge exists for A. planipennis at the molecular level. Methodology and Principal Findings: Newer-generation Roche-454 pyrosequencing was used to obtain 126,185 reads for the midgut and 240,848 reads for the fat body, which were assembled into 25,173 and 37,661 high quality expressed sequence tags (ESTs) for the midgut and the fat body of A. planipennis larvae, respectively. Among these ESTs, 36% of the midgut and 38% of the fat body sequences showed similarity to proteins in the GenBank nr database. A high number of the midgut sequences contained chitin-binding peritrophin (248) and trypsin (98) domains; while the fat body sequences showed high occurrence of cytochrome P450s (85) and protein kinase (123) domains. Further, the midgut transcriptome of A. planipennis revealed putative microbial transcripts encoding for cell-wall degrading enzymes such as polygalacturonases and endoglucanases. A significant number of SNPs (137 in midgut and 347 in fat body) and microsatellite loci (317 in midgut and 571 in fat body) were predicted in the A. planipennis transcripts. An initial assessment of cytochrome P450s belonging to various CYP clades revealed distinct expression patterns at the tissue level. Conclusions and Significance: To our knowledge this study is one of the first to illuminate tissue-specific gene expression in an invasive insect of high ecological and economic consequence. These findings will lay the foundation for future gene expression and functional studies in A. planipennis.	[Mittapalli, Omprakash; Bai, Xiaodong; Mamidala, Praveen; Rajarapu, Swapna Priya; Herms, Daniel A.] Ohio State Univ, Ohio Agr & Res Dev Ctr, Dept Entomol, Wooster, OH USA; [Bonello, Pierluigi] Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Mittapalli, O (corresponding author), Ohio State Univ, Ohio Agr & Res Dev Ctr, Dept Entomol, Wooster, OH USA.	mittapalli.1@osu.edu	Rajarapu, Swapna Priya/H-3514-2019; Bonello, Pierluigi/E-2776-2011	Bonello, Pierluigi/0000-0002-7207-7651; Mamidala, Praveen/0000-0001-8587-0635	USDA APHIS/USDA Forest Service [GRT00011769/60016270]; Ohio Agricultural Research and Development Center, The Ohio State University	USDA APHIS/USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Ohio Agricultural Research and Development Center, The Ohio State University(Ohio State University)	The research was supported by a grant from the USDA APHIS/USDA Forest Service Accelerated Emerald Ash Borer Research Program (GRT00011769/60016270), and by State and Federal funds appropriated to the Ohio Agricultural Research and Development Center, The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA K, 2000, ICONIC SERIES INSECT, V4; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anulewicz Andrea C., 2007, Arboriculture & Urban Forestry, V33, P338; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Bauer LS, 2005, P EM ASH BOR RES TEC, P71; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; BERENBAUM MR, 1992, ACS SYM SER, V505, P114; Bhandary Binny, 2010, J Vis Exp, DOI 10.3791/1974; Bishop JG, 2005, GENETICS, V169, P1009, DOI 10.1534/genetics.103.025098; Bogwitz MR, 2005, P NATL ACAD SCI USA, V102, P12807, DOI 10.1073/pnas.0503709102; Bourtzis K, 1996, GENETICS, V144, P1063; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cappaert David, 2005, American Entomologist, V51, P152; Chuma S, 2006, P NATL ACAD SCI USA, V103, P15894, DOI 10.1073/pnas.0601878103; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davies L, 2006, INSECT BIOCHEM MOLEC, V36, P801, DOI 10.1016/j.ibmb.2006.08.001; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elvin CM, 1996, J BIOL CHEM, V271, P8925, DOI 10.1074/jbc.271.15.8925; Eyles A, 2007, J CHEM ECOL, V33, P1430, DOI 10.1007/s10886-007-9312-3; FELTON GW, 1991, J CHEM ECOL, V17, P1715, DOI 10.1007/BF00993724; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gandhi KJK, 2010, BIOL INVASIONS, V12, P1839, DOI 10.1007/s10530-009-9594-1; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; GOULD J, 2004, USDA FOREST HLTH TEC, P73; Haack R. A., 2002, NEWSLETTER MICHIGAN, V47, P1; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Hemingway J, 1998, MED VET ENTOMOL, V12, P1, DOI 10.1046/j.1365-2915.1998.00082.x; Herms D. A., 2004, Special Circular - Ohio Agricultural Research and Development Center, P62; HOU Y, 2007, SHENG WU GONG CHENG, V5, P867; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Liebherr J.K., 2003, ENCY INSECTS, P209; LIEBHOLD AM, 1995, FOREST SCI, V41, P1; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mittapalli O, 2005, INSECT BIOCHEM MOLEC, V35, P981, DOI 10.1016/j.ibmb.2005.03.011; Mittapalli O, 2007, P NATL ACAD SCI USA, V104, P1889, DOI 10.1073/pnas.0604722104; Mittapalli O, 2006, J INSECT PHYSIOL, V52, P1143, DOI 10.1016/j.jinsphys.2006.08.007; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Nakabachi A, 2005, P NATL ACAD SCI USA, V102, P5477, DOI 10.1073/pnas.0409034102; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poland TM, 2006, J FOREST, V104, P118; Rebek EJ, 2008, ENVIRON ENTOMOL, V37, P242, DOI 10.1603/0046-225X(2008)37[242:IVIRTE]2.0.CO;2; Rewitz KF, 2006, INSECT BIOCHEM MOLEC, V36, P188, DOI 10.1016/j.ibmb.2005.12.002; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Rogers R., 1990, SILVICS N AM, V2; Salzberg S. L., 2005, GENOME BIOL, V6; SCHAEFER PW, 2005, USDA FOREST HLTH TEC, P67; Scharf ME, 2001, INSECT MOL BIOL, V10, P139, DOI 10.1046/j.1365-2583.2001.00248.x; Smith A., 2006, THESIS OHIO STATE U, P122; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; SNYDER MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P13, DOI 10.1006/abbi.1995.1362; THURSTON MI, 2005, MSATFINDER DETECTION; Tittiger C, 2005, RECENT ADV PHYTOCHEM, V39, P57; Vasanthakumar A, 2008, ENVIRON ENTOMOL, V37, P1344, DOI 10.1603/0046-225X(2008)37[1344:GMOAIS]2.0.CO;2; Vasemagi A, 2005, MOL BIOL EVOL, V22, P1067, DOI 10.1093/molbev/msi093; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Wang G, 2008, CURR BIOL, V18, P861, DOI 10.1016/j.cub.2008.05.009; WERCKREICHHART, 2000, GENOME BIOL, V1; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Yang YH, 2006, J ECON ENTOMOL, V99, P1784, DOI 10.1603/0022-0493-99.5.1784; Yu C., 1992, FOREST INSECTS CHINA, V2nd, P400; Yu QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-553; Zimmer C, 2001, SCIENCE, V292, P1093, DOI 10.1126/science.292.5519.1093	76	68	75	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13708	10.1371/journal.pone.0013708	http://dx.doi.org/10.1371/journal.pone.0013708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060843	gold, Green Published, Green Submitted			2022-12-25	WOS:000283573800009
J	Albert, E; Walker, J; Thiesen, A; Churchill, T; Madsen, K				Albert, Eric; Walker, John; Thiesen, Aducio; Churchill, Thomas; Madsen, Karen			cis-Urocanic Acid Attenuates Acute Dextran Sodium Sulphate-Induced Intestinal Inflammation	PLOS ONE			English	Article							DELTA-T-CELL; BOWEL-DISEASE; INTERLEUKIN-10-DEFICIENT MICE; ULTRAVIOLET-RADIATION; INDUCED COLITIS; SUPPRESSES; GENE; SUSCEPTIBILITY; DEFICIENT; RESPONSES	On exposure to sunlight, urocanic acid (UCA) in the skin is converted from trans to the cis form and distributed systemically where it confers systemic immunosuppression. The aim of this study was to determine if administration of cis-UCA would be effective in attenuating colitis and the possible role of IL-10. Colitis was induced in 129/SvEv mice by administering 5% dextran sodium sulfate (DSS) for 7 days in drinking water. During this period mice received daily subcutaneously injections of cis-UCA or vehicle. To examine a role for IL-10, 129/SvEv IL-10(-/-) mice were injected for 24 days with cis-UCA or vehicle. Clinical disease was assessed by measurement of body weight, stool consistency, and presence of blood. At sacrifice, colonic tissue was collected for histology and measurement of myeloperoxidase and cytokines. Splenocytes were analyzed for CD4+CD25+FoxP3+ T-regulatory cells via flow cytometry. Murine bone-marrow derived antigen-presenting cells were treated with lipopolysaccharide (LPS) +/- UCA and cytokine secretion measured. Our results demonstrated that cis-UCA at a dose of 50 mu g was effective in ameliorating DSS-induced colitis as evidenced by reduced weight loss and attenuated changes in colon weight/length. This protection was associated with reduced colonic expression of CXCL1, an increased expression of IL-17A and a significant preservation of splenic CD4+CD25+FoxP3+ T-regulatory cells. cis-UCA decreased LPS induced CXCL1, but not TNF alpha secretion, from antigen-presenting cells in vitro. UCA reduced colonic levels of IFN gamma in IL-10(-/-) mice but did not attenuate colitis. In conclusion, this study demonstrates that cis-urocanic acid is effective in reducing the severity of colitis in a chemically-induced mouse model, indicating that pathways induced by ultraviolet radiation to the skin can influence distal sites of inflammation. This provides further evidence for a possible role for sunlight exposure in modulating inflammatory disorders.	[Albert, Eric; Walker, John; Madsen, Karen] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Thiesen, Aducio] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Churchill, Thomas] Univ Alberta, Dept Surg, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Albert, E (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	karen.madsen@ualberta.ca	Madsen, Karen L/H-5898-2011		Alberta Heritage Foundation for Medical Research; Canadian Institutes for Health Research; Alberta IBD Consortium; Crohns and Colitis Foundation of Canada	Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta IBD Consortium; Crohns and Colitis Foundation of Canada	These studies were supported by the Alberta Heritage Foundation for Medical Research, Canadian Institutes for Health Research, Alberta IBD Consortium, and Crohns and Colitis Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Beissert S, 1997, J IMMUNOL, V159, P92; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Buanne P, 2007, J LEUKOCYTE BIOL, V82, P1239, DOI 10.1189/jlb.0207118; Danese S, 2004, AUTOIMMUN REV, V3, P394, DOI 10.1016/j.autrev.2004.03.002; DEFABO EC, 1983, J EXP MED, V158, P84, DOI 10.1084/jem.158.1.84; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Freitas A, 2009, J IMMUNOL, V182, P7846, DOI 10.4049/jimmunol.0803039; Garssen J, 1999, IMMUNOLOGY, V96, P298, DOI 10.1046/j.1365-2567.1999.00698.x; Gibbs NK, 2008, PHOTOCH PHOTOBIO SCI, V7, P655, DOI 10.1039/b717398a; HART PH, 1993, J IMMUNOL, V150, P4514; Henry T, 2010, J IMMUNOL, V184, P3755, DOI 10.4049/jimmunol.0902065; Holan V, 1998, J IMMUNOL, V161, P3237; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Kaneko K, 2008, J IMMUNOL, V181, P217, DOI 10.4049/jimmunol.181.1.217; Kapp JA, 2004, IMMUNOLOGY, V111, P155, DOI 10.1111/j.0019-2805.2003.01793.x; Kivisto K, 1996, INFLAMMATION, V20, P451, DOI 10.1007/BF01487038; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Madsen KL, 1999, GASTROENTEROLOGY, V116, P1107, DOI 10.1016/S0016-5085(99)70013-2; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; MAZZUCCHELLI L, 1994, AM J PATHOL, V144, P997; MORA JR, 2008, NAT REV IMMUNOL; Nerich V, 2006, INFLAMM BOWEL DIS, V12, P218, DOI 10.1097/01.MIB.0000206540.38834.8c; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Peyrin-Biroulet L, 2009, MED HYPOTHESES, V73, P94, DOI 10.1016/j.mehy.2009.01.022; Ponsoby AL, 2002, TOXICOLOGY, V181, P71, DOI 10.1016/S0300-483X(02)00257-3; Prater MR, 2003, PHOTODERMATOL PHOTO, V19, P287, DOI 10.1046/j.1600-0781.2003.00058.x; Rhodes KA, 2008, EUR J IMMUNOL, V38, P2274, DOI 10.1002/eji.200838354; Rinaldi M, 2006, J DAIRY SCI, V89, P4188, DOI 10.3168/jds.S0022-0302(06)72464-X; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Schwarz A, 2004, J IMMUNOL, V172, P1036, DOI 10.4049/jimmunol.172.2.1036; Shea-Donohue T, 2008, INNATE IMMUN-LONDON, V14, P117, DOI 10.1177/1753425908088724; Shreedhar VK, 1998, J IMMUNOL, V161, P1327; SONNENBERG A, 1991, GASTROENTEROLOGY, V100, P143, DOI 10.1016/0016-5085(91)90594-B; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xu S, 2010, CELL MOL IMMUNOL, V7, P164, DOI 10.1038/cmi.2010.21	40	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13676	10.1371/journal.pone.0013676	http://dx.doi.org/10.1371/journal.pone.0013676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060867	gold, Green Published, Green Submitted			2022-12-25	WOS:000283537000042
J	Pardini, R; Bueno, AD; Gardner, TA; Prado, PI; Metzger, JP				Pardini, Renata; Bueno, Adriana de Arruda; Gardner, Toby A.; Prado, Paulo Inacio; Metzger, Jean Paul			Beyond the Fragmentation Threshold Hypothesis: Regime Shifts in Biodiversity Across Fragmented Landscapes	PLOS ONE			English	Article							ATLANTIC-FOREST; HABITAT FRAGMENTATION; SPECIES-DIVERSITY; SMALL MAMMALS; STABLE STATES; CONSERVATION; RESPONSES; RESILIENCE; COVER; TIME	Ecological systems are vulnerable to irreversible change when key system properties are pushed over thresholds, resulting in the loss of resilience and the precipitation of a regime shift. Perhaps the most important of such properties in human-modified landscapes is the total amount of remnant native vegetation. In a seminal study Andren proposed the existence of a fragmentation threshold in the total amount of remnant vegetation, below which landscape-scale connectivity is eroded and local species richness and abundance become dependent on patch size. Despite the fact that species patch-area effects have been a mainstay of conservation science there has yet to be a robust empirical evaluation of this hypothesis. Here we present and test a new conceptual model describing the mechanisms and consequences of biodiversity change in fragmented landscapes, identifying the fragmentation threshold as a first step in a positive feedback mechanism that has the capacity to impair ecological resilience, and drive a regime shift in biodiversity. The model considers that local extinction risk is defined by patch size, and immigration rates by landscape vegetation cover, and that the recovery from local species losses depends upon the landscape species pool. Using a unique dataset on the distribution of non-volant small mammals across replicate landscapes in the Atlantic forest of Brazil, we found strong evidence for our model predictions - that patch-area effects are evident only at intermediate levels of total forest cover, where landscape diversity is still high and opportunities for enhancing biodiversity through local management are greatest. Furthermore, high levels of forest loss can push native biota through an extinction filter, and result in the abrupt, landscape-wide loss of forest-specialist taxa, ecological resilience and management effectiveness. The proposed model links hitherto distinct theoretical approaches within a single framework, providing a powerful tool for analysing the potential effectiveness of management interventions.	[Pardini, Renata; Bueno, Adriana de Arruda] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil; [Gardner, Toby A.] Univ Cambridge, Dept Zool, Cambridge, England; [Prado, Paulo Inacio; Metzger, Jean Paul] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, Brazil	Universidade de Sao Paulo; University of Cambridge; Universidade de Sao Paulo	Pardini, R (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil.	renatapardini@uol.com.br	Gardner, Toby/B-7516-2008; Prado, Paulo I/G-3353-2012; Prado, Paulo Inácio/AAN-6512-2021; Metzger, Jean Paul/C-2514-2012; Pardini, Renata/C-4095-2012; McLean, Laurence JA/C-7367-2014	Prado, Paulo Inácio/0000-0002-7174-5005; Metzger, Jean Paul/0000-0002-0087-5240; Pardini, Renata/0000-0002-3769-8401; 	FAPESP - Fundacao de Amaparo a Pesquisa do Estado de Sao Paulo [05/56555-4]; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; BMBF - Bundesministerium fur Bildung und Forschung [690144/01-6]; CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; NERC - Natural Environment Research Council [NE/F01614X/1]; NERC [NE/F01614X/1] Funding Source: UKRI; Natural Environment Research Council [NE/F01614X/1] Funding Source: researchfish	FAPESP - Fundacao de Amaparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); BMBF - Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NERC - Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by FAPESP - Fundacao de Amaparo a Pesquisa do Estado de Sao Paulo - http://www.fapesp.br (05/56555-4); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - http://www.cnpq.br/BMBF - Bundesministerium fur Bildung und Forschung - http://www.bmbf.de (690144/01-6); CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - http://www.capes.gov.br; and NERC - Natural Environment Research Council - http://www.nerc.ac.uk (NE/F01614X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren H, 1997, OIKOS, V80, P193, DOI 10.2307/3546534; Andren H, 1996, OIKOS, V76, P235, DOI 10.2307/3546195; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Arroyo-Rodriguez V, 2009, CONSERV BIOL, V23, P729, DOI 10.1111/j.1523-1739.2008.01120.x; Bengtsson J, 2003, AMBIO, V32, P389, DOI 10.1639/0044-7447(2003)032[0389:RRADL]2.0.CO;2; Bennett AF, 2006, BIOL CONSERV, V133, P250, DOI 10.1016/j.biocon.2006.06.008; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; BOLKER B, 2008, PACKAGE BBMLE TOOLS; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Brewer SW, 1999, J VEG SCI, V10, P165, DOI 10.2307/3237138; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Charrette NA, 2006, ECOLOGY, V87, P2330, DOI 10.1890/0012-9658(2006)87[2330:RSBBAL]2.0.CO;2; Colles A, 2009, ECOL LETT, V12, P849, DOI 10.1111/j.1461-0248.2009.01336.x; DeLonge M, 2008, GLOBAL CHANGE BIOL, V14, P154, DOI 10.1111/j.1365-2486.2007.01470.x; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Devictor V, 2009, DIVERS DISTRIB, V15, P122, DOI 10.1111/j.1472-4642.2008.00510.x; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Figueiredo LTM, 2009, EMERG INFECT DIS, V15, P561, DOI 10.3201/eid1504.080289; Filippi-Codaccioni O, 2010, BIOL CONSERV, V143, P1493, DOI 10.1016/j.biocon.2010.03.031; Fischer J, 2007, CONSERV SCI PRACT, V1, P229, DOI 10.1002/9780470692400.ch20; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Gaggiotti Oscar E., 2004, P337, DOI 10.1016/B978-012323448-3/50016-7; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Glazier DS, 2002, J BIOGEOGR, V29, P81, DOI 10.1046/j.1365-2699.2002.00646.x; Griffen BD, 2008, J ANIM ECOL, V77, P1274, DOI 10.1111/j.1365-2656.2008.01426.x; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; Isaac JL, 2009, DIVERS DISTRIB, V15, P280, DOI 10.1111/j.1472-4642.2008.00531.x; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Lawrence D, 2007, P NATL ACAD SCI USA, V104, P20696, DOI 10.1073/pnas.0705005104; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Lindenmayer DB, 2005, BIOL CONSERV, V124, P351, DOI 10.1016/j.biocon.2005.01.041; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Metzger JP, 2009, BIOL CONSERV, V142, P1138, DOI 10.1016/j.biocon.2008.10.012; Metzger JP, 1997, ACTA OECOL, V18, P1, DOI 10.1016/S1146-609X(97)80075-6; NAXARA L, 2008, THESIS U SAO PAULO S; Oliveira de Filho FJB, 2006, LANDSCAPE ECOL, V21, P1061, DOI 10.1007/s10980-006-6913-0; Pardini R, 2004, BIODIVERS CONSERV, V13, P2567, DOI 10.1023/B:BIOC.0000048452.18878.2d; Pardini R, 2005, BIOL CONSERV, V124, P253, DOI 10.1016/j.biocon.2005.01.033; Pardini R, 2009, BIOL CONSERV, V142, P1178, DOI 10.1016/j.biocon.2009.02.010; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; R Core Team, 2022, R LANG ENV STAT COMP; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schroder A, 2005, OIKOS, V110, P3, DOI 10.1111/j.0030-1299.2005.13962.x; Stenseth NC, 2003, FRONT ECOL ENVIRON, V1, P367, DOI 10.2307/3868189; Suding KN, 2009, TRENDS ECOL EVOL, V24, P271, DOI 10.1016/j.tree.2008.11.012; Suzan G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005461; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2008, ECOLOGY, V89, P944, DOI 10.1890/07-0455.1; Umetsu F, 2007, LANDSCAPE ECOL, V22, P517, DOI 10.1007/s10980-006-9041-y; Umetsu F, 2006, J MAMMAL, V87, P757, DOI 10.1644/05-MAMM-A-285R2.1; Walker B, 2004, ECOL SOC, V9; With KA, 1999, LANDSCAPE ECOL, V14, P73, DOI 10.1023/A:1008030215600; WITH KA, 1995, ECOLOGY, V76, P2446, DOI 10.2307/2265819; Zurita GA, 2010, LANDSCAPE ECOL, V25, P147, DOI 10.1007/s10980-009-9410-4	61	377	385	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13666	10.1371/journal.pone.0013666	http://dx.doi.org/10.1371/journal.pone.0013666			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060870	Green Published, gold			2022-12-25	WOS:000283537000035
J	Bender, JA; Simpson, EM; Ritzmann, RE				Bender, John A.; Simpson, Elaine M.; Ritzmann, Roy E.			Computer-Assisted 3D Kinematic Analysis of All Leg Joints in Walking Insects	PLOS ONE			English	Article							COCKROACH PERIPLANETA-AMERICANA; COXAL DEPRESSOR MUSCLES; HUMAN MOTION CAPTURE; BLABERUS-DISCOIDALIS; MOTOR-ACTIVITY; MULTIJOINT COORDINATION; TETHERED WALKING; SLIPPERY SURFACE; STICK INSECTS; LOCOMOTION	High-speed video can provide fine-scaled analysis of animal behavior. However, extracting behavioral data from video sequences is a time-consuming, tedious, subjective task. These issues are exacerbated where accurate behavioral descriptions require analysis of multiple points in three dimensions. We describe a new computer program written to assist a user in simultaneously extracting three-dimensional kinematics of multiple points on each of an insect's six legs. Digital video of a walking cockroach was collected in grayscale at 500 fps from two synchronized, calibrated cameras. We improved the legs' visibility by painting white dots on the joints, similar to techniques used for digitizing human motion. Compared to manual digitization of 26 points on the legs over a single, 8-second bout of walking (or 106,496 individual 3D points), our software achieved approximately 90% of the accuracy with 10% of the labor. Our experimental design reduced the complexity of the tracking problem by tethering the insect and allowing it to walk in place on a lightly oiled glass surface, but in principle, the algorithms implemented are extensible to free walking. Our software is free and open-source, written in the free language Python and including a graphical user interface for configuration and control. We encourage collaborative enhancements to make this tool both better and widely utilized.	[Bender, John A.; Simpson, Elaine M.; Ritzmann, Roy E.] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA	Case Western Reserve University	Bender, JA (corresponding author), Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA.	jbender@case.edu			National Science Foundation [IOS-0845417]; Air Force Office of Sponsored Research [FA9550-07-1-0149]	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Sponsored Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This material is based upon work supported by the National Science Foundation under Grant No. IOS-0845417 and the Air Force Office of Sponsored Research under grant FA9550-07-1-0149. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baden T, 2008, J EXP BIOL, V211, P2123, DOI 10.1242/jeb.019125; Buschges A, 2005, J NEUROPHYSIOL, V93, P1127, DOI 10.1152/jn.00615.2004; Carbonell C. S., 1947, SMITHSONIAN MISC COLL, V107, P1; Card G, 2008, CURR BIOL, V18, P1300, DOI 10.1016/j.cub.2008.07.094; DELCOMYN F, 1973, J EXP BIOL, V59, P643; DELCOMYN F, 1971, J EXP BIOL, V54, P443; DELCOMYN F, 1973, J EXP BIOL, V59, P629; EPSTEIN S, 1983, J EXP BIOL, V105, P215; Frantsevich L, 2009, ARTHROPOD STRUCT DEV, V38, P16, DOI 10.1016/j.asd.2008.06.002; Fry SN, 2005, J EXP BIOL, V208, P2303, DOI 10.1242/jeb.01612; Fry SN, 2004, J NEUROSCI METH, V135, P149, DOI 10.1016/j.jneumeth.2003.12.012; FULL RJ, 1990, J EXP BIOL, V148, P129; GRAHAM D, 1981, J EXP BIOL, V92, P229; Gruhn M, 2006, J NEUROSCI METH, V158, P195, DOI 10.1016/j.jneumeth.2006.05.029; Harley CM, 2009, J EXP BIOL, V212, P1463, DOI 10.1242/jeb.028381; HUGHES GM, 1952, J EXP BIOL, V29, P267; ILES JF, 1971, J EXP BIOL, V55, P151; Kram R, 1997, J EXP BIOL, V200, P1919; Krupczynski P, 2008, CURR BIOL, V18, P1961, DOI 10.1016/j.cub.2008.10.066; LAURENT G, 1986, J EXP BIOL, V123, P285; Moeslund TB, 2001, COMPUT VIS IMAGE UND, V81, P231, DOI 10.1006/cviu.2000.0897; Moeslund TB, 2006, COMPUT VIS IMAGE UND, V104, P90, DOI 10.1016/j.cviu.2006.08.002; Mu LY, 2005, J COMP PHYSIOL A, V191, P1037, DOI 10.1007/s00359-005-0029-x; NYE SW, 1992, J COMP PHYSIOL A, V171, P183, DOI 10.1007/BF00188926; PEARSON KG, 1970, J EXP BIOL, V52, P139; PEARSON KG, 1971, J EXP BIOL, V54, P215; PEARSON KG, 1973, J EXP BIOL, V58, P725; Pringle JWS, 1938, J EXP BIOL, V15, P114; Rosano H, 2007, BIOL CYBERN, V97, P229, DOI 10.1007/s00422-007-0170-4; SPIRITO CP, 1979, J EXP BIOL, V78, P233; Tryba AK, 2000, J NEUROPHYSIOL, V83, P3337, DOI 10.1152/jn.2000.83.6.3337; Tryba AK, 2000, J NEUROPHYSIOL, V83, P3323, DOI 10.1152/jn.2000.83.6.3323; Watson JT, 1998, J COMP PHYSIOL A, V182, P23, DOI 10.1007/s003590050154; Watson JT, 1998, J COMP PHYSIOL A, V182, P11, DOI 10.1007/s003590050153; Watson JT, 2002, J COMP PHYSIOL A, V188, P39, DOI 10.1007/s00359-002-0277-y; Zakotnik J, 2004, J NEUROSCI METH, V135, P43, DOI 10.1016/j.jneumeth.2003.11.013; Zhang ZY, 2000, IEEE T PATTERN ANAL, V22, P1330, DOI 10.1109/34.888718	37	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13617	10.1371/journal.pone.0013617	http://dx.doi.org/10.1371/journal.pone.0013617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049024	Green Submitted, Green Published, gold			2022-12-25	WOS:000283487400012
J	Sherman, CDH; Sagvik, J; Olsson, M				Sherman, Craig D. H.; Sagvik, Jorgen; Olsson, Mats			Female Choice for Males with Greater Fertilization Success in the Swedish Moor Frog, Rana arvalis	PLOS ONE			English	Article							PERONS TREE FROG; SPERM DNA-DAMAGE; REPRODUCTIVE SUCCESS; MULTIPLE PATERNITY; SEXUAL SELECTION; MATE SELECTION; TOAD; SKELETOCHRONOLOGY; POPULATIONS; COLORATION	Background: Studies of mate choice in anuran amphibians have shown female preference for a wide range of male traits despite females gaining no direct resources from males (i.e. non-resource based mating system). Nevertheless, theoretical and empirical studies have shown that females may still gain indirect genetic benefits from choosing males of higher genetic quality and thereby increase their reproductive success. Methodology/Principal Findings: We investigated two components of sexual selection in the Moor frog (Rana arvalis), precopulatory female choice between two males of different size ('large' vs. 'small'), and their fertilization success in sperm competition and in isolation. Females' showed no significant preference for male size (13 small and six large male preferences) but associated preferentially with the male that subsequently was the most successful at fertilizing her eggs in isolation. Siring success of males in competitive fertilizations was unrelated to genetic similarity with the female and we detected no effect of sperm viability on fertilization success. There was, however, a strong positive association between a male's innate fertilization ability with a female and his siring success in sperm competition. We also detected a strong negative effect of a male's thumb length on his competitive siring success. Conclusions/Significance: Our results show that females show no preference for male size but are still able to choose males which have greater fertilization success. Genetic similarity and differences in the proportion of viable sperm within a males ejaculate do not appear to affect siring success. These results could be explained through pre- and/or postcopulatory choice for genetic benefits and suggest that females are able to perceive the genetic quality of males, possibly basing their choice on multiple phenotypic male traits.	[Sherman, Craig D. H.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Waurn Ponds, Vic, Australia; [Sherman, Craig D. H.; Olsson, Mats] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Sagvik, Jorgen] Univ Gothenburg, Dept Zool, Gothenburg, Sweden; [Olsson, Mats] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Deakin University; University of Wollongong; University of Gothenburg; University of Sydney	Sherman, CDH (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Waurn Ponds, Vic, Australia.	craig.sherman@deakin.edu.au	Sherman, Craig/A-2484-2010; Olsson, Mats/AAK-5565-2021	Sherman, Craig/0000-0003-2099-0462; Olsson, Mats/0000-0002-4130-1323	Collianders Stiftelse and Helge Ax:son Johnsson's Stiftelse foundations; Australian Research Council	Collianders Stiftelse and Helge Ax:son Johnsson's Stiftelse foundations; Australian Research Council(Australian Research Council)	This study was funded by the Collianders Stiftelse and Helge Ax:son Johnsson's Stiftelse foundations and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; ARAK A, 1988, BEHAV ECOL SOCIOBIOL, V22, P317; BARBAULT R, 1980, B SOC ZOOL FR, V105, P347; Bosch J, 2001, COPEIA, P169, DOI 10.1643/0045-8511(2001)001[0169:CTIMMA]2.0.CO;2; Byrne PG, 2000, EVOLUTION, V54, P968; Chandler CH, 2008, MOL ECOL, V17, P1564, DOI 10.1111/j.1365-294X.2007.03614.x; Cho C, 2003, BIOL REPROD, V69, P211, DOI 10.1095/biolreprod.102.015115; Dziminski MA, 2008, EVOLUTION, V62, P879, DOI 10.1111/j.1558-5646.2008.00328.x; Dziminski MA, 2010, REPROD FERT DEVELOP, V22, P516, DOI 10.1071/RD09124; Eden CJ, 2007, COPEIA, P471, DOI 10.1643/0045-8511(2007)7[471:AAOSIT]2.0.CO;2; Fatehi AN, 2006, J ANDROL, V27, P176, DOI 10.2164/jandrol.04152; Fog K, 1997, NORDENS PADDER KRYBD; Garner TWJ, 2001, CONSERV GENET, V2, P77, DOI 10.1023/A:1011546712741; Greene AE, 2009, J HERPETOL, V43, P244, DOI 10.1670/08-112R.1; Hettyey A, 2006, BEHAV ECOL SOCIOBIOL, V59, P389, DOI 10.1007/s00265-005-0062-3; Hettyey A, 2009, AMPHIBIA-REPTILIA, V30, P37, DOI 10.1163/156853809787392784; Knopp T, 2008, MOL ECOL, V17, P2522, DOI 10.1111/j.1365-294X.2008.03748.x; Knopp T, 2007, CONSERV GENET, V8, P45, DOI 10.1007/s10592-006-9147-4; Knopp T, 2009, AMPHIBIA-REPTILIA, V30, P515, DOI 10.1163/156853809789647112; Kupfer A, 2008, J EXP ZOOL PART A, V309A, P460, DOI 10.1002/jez.475; Lee JC, 2002, J HERPETOL, V36, P502, DOI 10.2307/1566198; Marangoni F, 2009, J HERPETOL, V43, P546, DOI 10.1670/08-230R1.1; Morrison C, 2004, HERPETOLOGICA, V60, P34, DOI 10.1655/02-68; Morrison C, 2001, AUSTRAL ECOL, V26, P223, DOI 10.1046/j.1442-9993.2001.01107.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pryke SR, 2009, EVOLUTION, V63, P793, DOI 10.1111/j.1558-5646.2008.00584.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenthal GG, 2004, ANIM BEHAV, V68, P55, DOI 10.1016/j.anbehav.2003.07.013; RYAN MJ, 1992, TUNGARA FROG STUDY S; Sagvik J, 2008, EVOL ECOL, V22, P193, DOI 10.1007/s10682-007-9168-6; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; Sherman CDH, 2008, P R SOC B, V275, P971, DOI 10.1098/rspb.2007.1626; Sherman CDH, 2008, NATURWISSENSCHAFTEN, V95, P1055, DOI 10.1007/s00114-008-0423-7; Sherman CDH, 2008, AUSTRAL ECOL, V33, P348, DOI 10.1111/j.1442-9993.2007.01823.x; Sherman CDH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008252; Sherman CDH, 2009, BIOL LETTERS, V5, P232, DOI 10.1098/rsbl.2008.0796; Taylor RC, 2007, ANIM BEHAV, V74, P1753, DOI 10.1016/j.anbehav.2007.03.010; Uller T, 2006, BIOL J LINN SOC, V89, P189, DOI 10.1111/j.1095-8312.2006.00673.x; Vasquez T, 2007, BEHAV ECOL SOCIOBIOL, V62, P127, DOI 10.1007/s00265-007-0446-7; Vieites DR, 2004, NATURE, V431, P305, DOI 10.1038/nature02879; Welch AM, 1998, SCIENCE, V280, P1928, DOI 10.1126/science.280.5371.1928; Zini A, 2006, CAN MED ASSOC J, V175, P495, DOI 10.1503/cmaj.060218	42	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13634	10.1371/journal.pone.0013634	http://dx.doi.org/10.1371/journal.pone.0013634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049015	Green Published, Green Submitted, gold			2022-12-25	WOS:000283487400024
J	Chae, KS; Kang, MJ; Lee, JH; Ryu, BK; Lee, MG; Her, NG; Ha, TK; Han, J; Kim, YK; Chi, SG				Chae, K. S.; Kang, M. J.; Lee, J. H.; Ryu, B. K.; Lee, M. G.; Her, N. G.; Ha, T. K.; Han, J.; Kim, Y. K.; Chi, S. G.			Opposite functions of HIF-alpha isoforms in VEGF induction by TGF-beta 1 under non-hypoxic conditions	ONCOGENE			English	Article						TGF-beta 1; VEGF; Smad3; HIF-2 alpha; HuR; prostate cancer	ENDOTHELIAL GROWTH-FACTOR; HUMAN PROSTATE-CANCER; HYPOXIA-INDUCIBLE FACTOR-1; MESSENGER-RNA STABILITY; FACTOR GENE-EXPRESSION; RENAL-CELL CARCINOMA; FACTOR-BETA; CYCLOOXYGENASE-2 EXPRESSION; HIF-2-ALPHA EXPRESSION; FACTOR (HIF)-1-ALPHA	Transforming growth factor (TGF)-beta 1 has biphasic functions in prostate tumorigenesis, having a growth-inhibitory effect in the early stages, but in the late stages promoting tumor angiogenesis and metastasis. We demonstrate here that tumor-producing TGF-beta 1 induces vascular endothelial growth factor (VEGF) in prostate cancer cells, and hypoxia-inducible factor (HIF)-1 alpha and HIF-2 alpha has opposite functions in TGF-beta 1 regulation of VEGF expression under non-hypoxic conditions. The promoter response of VEGF to TGF-beta 1 was upregulated by the transfection of HIF-2 alpha or siHIF-1 alpha but downregulated by HIF-1 alpha and siHIF-2 alpha. Both HIF-1 alpha and HIF-2 alpha were induced by TGF-beta 1 at mRNA and protein levels, however, their nuclear translocation was differentially regulated by TGF-beta 1, suggesting its association with their opposite effects. VEGF induction by TGF-beta 1 occurred in a Smad3-dependent manner, and the Smad-binding element 2 (SBE2, -992 to -986) and hypoxia response element (-975 to -968) in the VEGF promoter were required for the promoter response to TGF-beta 1. Smad3 cooperated with HIF-2 alpha in TGF-beta 1 activation of VEGF transcription and Smad3 binding to the SBE2 site was greatly impaired by knockdown of HIF-2 alpha expression. Moreover, the VEGF promoter response to TGF-beta 1 was synergistically elevated by co-transfection of Smad3 and HIF-2 alpha but attenuated by HIF-1 alpha in a dose-dependent manner. Additionally, TGF-beta 1 was found to increase the stability of VEGF transcript by facilitating the cytoplasmic translocation of a RNA-stabilizing factor HuR. Collectively, our data show that tumor-producing TGF-beta 1 induces VEGF at the both transcription and post-transcriptional levels through multiple routes including Smad3, HIF-2 alpha and HuR. This study thus suggests that autocrine TGF-beta 1 production may contribute to tumor angiogenesis via HIF-2 alpha signaling under non-hypoxic conditions, providing a selective growth advantage for prostate tumor cells. Oncogene (2011) 30, 1213-1228; doi:10.1038/onc.2010.498; published online 8 November 2010	[Chae, K. S.; Kang, M. J.; Lee, J. H.; Ryu, B. K.; Lee, M. G.; Her, N. G.; Ha, T. K.; Han, J.; Kim, Y. K.; Chi, S. G.] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [Chae, K. S.] Kyungpook Natl Univ, Dept Biol Educ, Teachers Coll, Taegu, South Korea	Korea University; Kyungpook National University	Chi, SG (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea.	chi6302@korea.ac.kr	Han, Jikhyon/L-7891-2014; Her, Nam-Gu/AGY-5470-2022; Kang, Min-Ju/AAY-8706-2021	Han, Jikhyon/0000-0002-7767-3305; Kim, Yoon Ki/0000-0003-1303-072X; KANG, MIN-JU/0000-0001-5040-1388	National Research Foundation of Korea [0000794, 0001197]; Korea Research Foundation [2008-314-C00247]; National Cancer Center, Republic of Korea [0820070]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Research Foundation(National Research Foundation of Korea); National Cancer Center, Republic of Korea	This work was supported in part by grants from National Research Foundation of Korea (0000794 and 0001197), the Korea Research Foundation (2008-314-C00247) and the National Cancer Center (0820070), Republic of Korea.	Benckert C, 2003, CANCER RES, V63, P1083; Benjamin D, 2007, EXPERT OPIN BIOL TH, V7, P1515, DOI 10.1517/14712598.7.10.1515; Blancher C, 2000, CANCER RES, V60, P7106; Boddy JL, 2005, CLIN CANCER RES, V11, P7658, DOI 10.1158/1078-0432.CCR-05-0460; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Fukuda R, 2003, CANCER RES, V63, P2330; Giatromanolaki A, 2003, MELANOMA RES, V13, P493, DOI 10.1097/00008390-200310000-00008; Goodyear SM, 2009, PROSTATE, V69, P982, DOI 10.1002/pros.20945; Helczynska K, 2008, CANCER RES, V68, P9212, DOI 10.1158/0008-5472.CAN-08-1135; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Jackson MW, 2002, CANCER RES, V62, P854; Jeon SH, 2007, J LEUKOCYTE BIOL, V81, P557, DOI 10.1189/jlb.0806517; Kang MJ, 2008, GASTROENTEROLOGY, V135, P2030, DOI 10.1053/j.gastro.2008.08.009; Kim IY, 1996, CLIN CANCER RES, V2, P1255; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; Loureiro RMB, 2005, CYTOKINE GROWTH F R, V16, P77, DOI 10.1016/j.cytogfr.2005.01.005; Lu S, 2007, CLIN CANCER RES, V13, P5692, DOI 10.1158/1078-0432.CCR-07-1078; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; McMahon S, 2006, J BIOL CHEM, V281, P24171, DOI 10.1074/jbc.M604507200; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; Nabors LB, 2001, CANCER RES, V61, P2154; Noguera R, 2009, CLIN CANCER RES, V15, P7130, DOI 10.1158/1078-0432.CCR-09-0223; Pallares J, 2006, HISTOL HISTOPATHOL, V21, P857, DOI 10.14670/HH-21.857; Park BJ, 2000, CANCER RES, V60, P3031; Park JI, 2003, ONCOGENE, V22, P4314, DOI 10.1038/sj.onc.1206478; Pietras A, 2008, J PATHOL, V214, P482, DOI 10.1002/path.2304; Pu H, 2009, CANCER RES, V69, P7366, DOI 10.1158/0008-5472.CAN-09-0758; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Sanchez-Elsner T, 2001, J BIOL CHEM, V276, P38527, DOI 10.1074/jbc.M104536200; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Stearns ME, 1999, CLIN CANCER RES, V5, P711; Sugano Y, 2003, ONCOGENE, V22, P2309, DOI 10.1038/sj.onc.1206305; Tran H, 2003, MOL CELL BIOL, V23, P7177, DOI 10.1128/MCB.23.20.7177-7188.2003; TRUONG LD, 1993, HUM PATHOL, V24, P4, DOI 10.1016/0046-8177(93)90055-L; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang L, 2004, J BIOL CHEM, V279, P33213, DOI 10.1074/jbc.M403758200; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Wang WG, 2001, MOL CELL BIOL, V21, P5889, DOI 10.1128/MCB.21.17.5889-5898.2001; Williams RH, 1996, CLIN CANCER RES, V2, P635; Yoshimura H, 2004, CLIN CANCER RES, V10, P8554, DOI 10.1158/1078-0432.CCR-0946-03; Zhong H, 2004, CANCER DETECT PREV, V28, P88, DOI 10.1016/j.cdp.2003.12.009; Zhong H, 2000, CANCER RES, V60, P1541; Zhu B, 2005, CANC TREAT, V126, P157, DOI 10.1007/0-387-24361-5_7	55	44	46	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	10					1213	1228		10.1038/onc.2010.498	http://dx.doi.org/10.1038/onc.2010.498			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	732QD	21057546				2022-12-25	WOS:000288202400008
J	Lui, VWY; Wong, EYL; Ho, K; Ng, PKS; Lau, CPY; Tsui, SKW; Tsang, CM; Tsao, SW; Cheng, SH; Ng, MHL; Ng, YK; Lam, EKY; Hong, B; Lo, KW; Mok, TSK; Chan, ATC; Mills, GB				Lui, V. W. Y.; Wong, E. Y. L.; Ho, K.; Ng, P. K. S.; Lau, C. P. Y.; Tsui, S. K. W.; Tsang, C-M; Tsao, S-W; Cheng, S. H.; Ng, M. H. L.; Ng, Y. K.; Lam, E. K. Y.; Hong, B.; Lo, K. W.; Mok, T. S. K.; Chan, A. T. C.; Mills, G. B.			Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death	ONCOGENE			English	Article						c-Met tyrosine kinase inhibitor; TIGAR; NADPH	NASOPHARYNGEAL CARCINOMA; ACTIVATION; RECEPTOR; INVASION; CANCER	c-Met represents an important emerging therapeutic target in cancer. In this study, we demonstrate the mechanism by which c-Met tyrosine kinase inhibition inhibits tumor growth in a highly invasive Asian-prevalent head and neck cancer, nasopharyngeal cancer (NPC). c-Met tyrosine kinase inhibitors (TKIs; AM7 and c-Met TKI tool compound SU11274) downregulated c-Met phosphorylation, resulting in marked inhibition of NPC cell growth and invasion. Strikingly, inhibition of c-Met resulted in significant downregulation of TP53-induced Glycolysis and Apoptosis Regulator (TIGAR) and subsequent depletion of intracellular NADPH. Importantly, overexpression of TIGAR ameliorated the effects of c-Met kinase inhibition, confirming the importance of TIGAR downregulation in the growth inhibitory activity of c-Met TKI. The effects of c-Met inhibition on TIGAR and NADPH levels were observed with two different c-Met TKIs (AM7 and SU11274) and with multiple cell lines. As NADPH provides a crucial reducing power required for cell survival and proliferation, our findings reveal a novel mechanistic action of c-Met TKI, which may represent a key effect of c-Met kinase inhibition. Our data provide the first evidence linking c-Met, TIGAR and NADPH regulation in human cancer cells suggesting that inhibition of a tyrosine kinase/TIGAR/NADPH cascade may have therapeutic applicability in human cancers. Oncogene (2011) 30, 1127-1134; doi:10.1038/onc.2010.490; published online 8 November 2010	[Lui, V. W. Y.; Wong, E. Y. L.; Ho, K.; Lau, C. P. Y.; Lam, E. K. Y.; Hong, B.; Mok, T. S. K.; Chan, A. T. C.] Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, State Key Lab Oncol S China, Canc Signaling Lab,Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Ng, P. K. S.; Tsui, S. K. W.] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Tsang, C-M; Tsao, S-W] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Cheng, S. H.; Ng, M. H. L.; Lo, K. W.] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Ng, Y. K.] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Mills, G. B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	Chinese University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Texas System; UTMD Anderson Cancer Center	Chan, ATC (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Sha Tin, Hong Kong, Peoples R China.	anthony@clo.cuhk.edu.hk	Chan, Anthony Tak Cheung/R-3940-2018; Lui, Vivian W. Y./I-5458-2016; Cheng, Suk Hang/A-6177-2009; Mok, Tony Shu Kam/B-2310-2019; Tsui, Stephen Kwok-Wing/E-4385-2015; Hong, Bo/ABA-3687-2021; Ng, Yuen-Keng/ABC-3906-2020	Chan, Anthony Tak Cheung/0000-0002-6912-8091; Lui, Vivian W. Y./0000-0001-6918-1573; Cheng, Suk Hang/0000-0002-2880-2289; Mok, Tony Shu Kam/0000-0002-8251-0551; Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; Hong, Bo/0000-0001-8117-5029; Ng, Yuen-Keng/0000-0003-4491-5221; Lo, Kwok Wai/0000-0002-3488-6124	Research Grant Council, Hong Kong Government [471607]; Head and Neck SPORE [P50 CA097007]; CCSG [P30CA16672];  [2006.1.027];  [2007.1.025];  [2009.1.012]; NATIONAL CANCER INSTITUTE [P50CA098258, P50CA097007, P30CA016672] Funding Source: NIH RePORTER	Research Grant Council, Hong Kong Government(Hong Kong Research Grants Council); Head and Neck SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCSG; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Amgen, Inc. (USA) for the kind provision of the novel c-Met tyrosine kinase inhibitor, AM7. This study was supported by Research Grant Council, Hong Kong Government (471607) and Direct Grants for Research (2006.1.027; 2007.1.025; 2009.1.012) to VWYL. GBM is supported by Head and Neck SPORE P50 CA097007 and CCSG grant P30CA16672.	Anderson KE, 2006, CANC EPIDEMIOLOGY PR, P721; Bellon SF, 2008, J BIOL CHEM, V283, P2675, DOI 10.1074/jbc.M705774200; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; Horikawa T, 2001, AM J PATHOL, V159, P27, DOI 10.1016/S0002-9440(10)61669-0; Lui VWY, 2009, CARCINOGENESIS, V30, P2085, DOI 10.1093/carcin/bgp253; Lui VWY, 2007, MOL PHARMACOL, V71, P1435, DOI 10.1124/mol.106.032284; Lui VWY, 2010, BIOCHEM PHARMACOL, V79, P1772, DOI 10.1016/j.bcp.2010.02.012; Lui VWY, 2009, INT J CANCER, V125, P1884, DOI 10.1002/ijc.24567; Ma PC, 2007, BRIT J CANCER, V97, P368, DOI 10.1038/sj.bjc.6603884; Nakamura Y, 2008, CANCER SCI, V99, P14, DOI 10.1111/j.1349-7006.2007.00640.x; Qian CN, 2002, CANCER RES, V62, P589; Stabile LP, 2004, GENE THER, V11, P325, DOI 10.1038/sj.gt.3302169; Tulasne D, 2008, CELL DEATH DIFFER, V15, P427, DOI 10.1038/sj.cdd.4402229; Wang R, 2001, J CELL BIOL, V153, P1023, DOI 10.1083/jcb.153.5.1023; WONG JH, 2009, CANC LETT; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103	19	51	53	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	9					1127	1134		10.1038/onc.2010.490	http://dx.doi.org/10.1038/onc.2010.490			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	729PX	21057531	Green Accepted			2022-12-25	WOS:000287964100011
J	Asciutti, S; Akiri, G; Grumolato, L; Vijayakumar, S; Aaronson, SA				Asciutti, S.; Akiri, G.; Grumolato, L.; Vijayakumar, S.; Aaronson, S. A.			Diverse mechanisms of Wnt activation and effects of pathway inhibition on proliferation of human gastric carcinoma cells	ONCOGENE			English	Article						beta-catenin; DNTCF4; c-Myc; gastric cancer	BETA-CATENIN; SIGNALING PATHWAY; CANCER-CELLS; MAMMARY TUMORIGENESIS; EPITHELIAL-CELLS; GAMMA-CATENIN; C-MYC; APC; MUTATIONS; TRANSCRIPTION	Human gastric carcinomas are among the most treatment-refractory epithelial malignancies. Increased understanding of the underlying molecular aberrations in such tumors could provide insights leading to improved therapeutic approaches. In this study, we characterized diverse genetic aberrations leading to constitutive Wnt signaling activation in a series of human gastric carcinoma cell lines. Downregulation of TCF signaling by stable transduction of dominant negative TCF4 (DNTCF4) resulted in inhibition of proliferation in Wnt-activated AGS tumor cells. c-Myc downregulation and the associated upregulation of its repression target, p21 observed in these tumor cells, as well as the profound growth inhibition induced by c-Myc small hairpin RNA (shRNA) implied their c-Myc addiction. In striking contrast, Wnt-activated MKN-28 and MKN-74 tumor cells appeared refractory to DNTCF4 inhibition of proliferation despite comparably decreased c-Myc expression levels. The resistance of these same tumor cells to growth inhibition by c-Myc shRNA established that their refractoriness to DNTCF was because of their independence from c-Myc for proliferation. There was no correlation between this resistance phenotype and the presence or absence of constitutive mitogen-activated protein kinase (MAPK) and/or AKT pathway activation, commonly observed in gastrointestinal tumors. However, in both DNTCF-sensitive and -resistant tumor cells with MAPK and/or AKT pathway activation, the ability of small molecule antagonists directed against either pathway to inhibit tumor cell growth was enhanced by Wnt pathway inhibition. These findings support the concept that although certain Wnt-activated tumors may escape c-Myc dependence for proliferation, disruption of other oncogenic pathways can unmask cooperative antiproliferative effects for Wnt pathway downregulation. Oncogene (2011) 30, 956-966; doi:10.1038/onc.2010.475; published online 1 November 2010	[Asciutti, S.; Akiri, G.; Grumolato, L.; Vijayakumar, S.; Aaronson, S. A.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Aaronson, SA (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, Box 1130,1 Gustave L Levy Pl, New York, NY 10029 USA.	stuart.aaronson@mssm.edu	Grumolato, Luca/A-1697-2015	Grumolato, Luca/0000-0001-8231-3032	American Urological Association; National Cancer Institute [5R01CA071672]; NATIONAL CANCER INSTITUTE [R01CA071672] Funding Source: NIH RePORTER	American Urological Association; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Dr Yoshio Yamaoka (Baylor College of Medicine, Houston, TX, USA) for MKN-7 and MKN-28 cells; Dr Gary Schwartz (Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA) for MKN-74 cells and Dr Reuben Lotan (MD Anderson Cancer Center, Houston, TX, USA) for KATO-II cells. SV is a recipient of a post-doctoral fellowship award from the American Urological Association. Grant support: This work was supported by grant number 5R01CA071672 from the National Cancer Institute.	Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Bafico A, 1998, ONCOGENE, V16, P2819, DOI 10.1038/sj.onc.1201797; BAS PLW, 2000, INT J CANCER, V86, P533; Bechard M, 2009, MOL CELL BIOL, V29, P2092, DOI 10.1128/MCB.01405-08; Caca K, 1999, CELL GROWTH DIFFER, V10, P369; Clements WM, 2002, CANCER RES, V62, P3503; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; GIARDIELLO FM, 1993, GUT, V34, P1394, DOI 10.1136/gut.34.10.1394; Grabsch H, 2001, HISTOPATHOLOGY, V39, P141, DOI 10.1046/j.1365-2559.2001.01177.x; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ikenoue T, 2002, JPN J CANCER RES, V93, P1213, DOI 10.1111/j.1349-7006.2002.tb01226.x; Jang JW, 2006, MOL CELL BIOL, V26, P8109, DOI 10.1128/MCB.00404-06; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kim JS, 2002, CANCER RES, V62, P2744; Kim SE, 2007, CELL SIGNAL, V19, P511, DOI 10.1016/j.cellsig.2006.08.008; Kolligs FT, 2000, GENE DEV, V14, P1319; Michl P, 2005, Z GASTROENTEROL, V43, P1133, DOI 10.1055/s-2005-858638; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Overman Michael J, 2009, Gastrointest Cancer Res, V3, P90; Park KS, 2006, J CELL SCI, V119, P819, DOI 10.1242/jcs.02779; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Shimizu M, 2008, MOL CELL BIOL, V28, P825, DOI 10.1128/MCB.02375-06; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; STAMPFER MR, 1985, P NATL ACAD SCI USA, V82, P2394, DOI 10.1073/pnas.82.8.2394; Sunaga N, 2001, GENE CHROMOSOME CANC, V30, P316, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1097>3.0.CO;2-9; Suriano G, 2005, GENE CHROMOSOME CANC, V42, P238, DOI 10.1002/gcc.20135; Teuliere J, 2004, MOL CELL BIOL, V24, P8649, DOI 10.1128/MCB.24.19.8649-8661.2004; Tomita H, 2007, CANCER RES, V67, P4079, DOI 10.1158/0008-5472.CAN-06-4025; Van Cutsem E, 2006, ANN ONCOL, V17, P13, DOI 10.1093/annonc/mdl976; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Woo DK, 2001, INT J CANCER, V95, P108, DOI 10.1002/1097-0215(20010320)95:2<108::AID-IJC1019>3.0.CO;2-#; Zhurinsky J, 2000, MOL CELL BIOL, V20, P4238, DOI 10.1128/MCB.20.12.4238-4252.2000	39	15	16	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	8					956	966		10.1038/onc.2010.475	http://dx.doi.org/10.1038/onc.2010.475			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	726CJ	21042278	Green Accepted			2022-12-25	WOS:000287695900007
J	Marjenberg, ZR; Ellis, IR; Hagan, RM; Prabhakaran, S; Hook, M; Talay, SR; Potts, JR; Staunton, D; Schwarz-Linek, U				Marjenberg, Zoe R.; Ellis, Ian R.; Hagan, Robert M.; Prabhakaran, Sabitha; Hoeoek, Magnus; Talay, Susanne R.; Potts, Jennifer R.; Staunton, David; Schwarz-Linek, Ulrich			Cooperative Binding and Activation of Fibronectin by a Bacterial Surface Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION-STIMULATING FACTOR; STAPHYLOCOCCUS-AUREUS FNBPA; GROUP-A STREPTOCOCCI; TANDEM BETA-ZIPPER; EPITHELIAL-CELLS; GELATIN-BINDING; HOST-CELLS; PYOGENES; DOMAIN; ENTRY	Integrin-dependent cell invasion of some pathogenic bacteria is mediated by surface proteins targeting the extracellular matrix protein fibronectin (FN). Although the structural basis for bacterial FN recognition is well understood, it has been unclear why proteins such as streptococcal SfbI contain several FN-binding sites. We used microcalorimetry to reveal cooperative binding of FN fragments to arrays of binding sites in SfbI. In combination with thermodynamic analyses, functional cell-based assays show that SfbI induces conformational changes in the N-terminal 100-kDa region of FN (FN100kDa), most likely by competition with intramolecular interactions defining an inactive state of FN100kDa. This study provides insights into how long range conformational changes resulting in FN activation may be triggered by bacterial pathogens.	[Schwarz-Linek, Ulrich] Univ St Andrews, St Andrews KY16 9ST, Fife, Scotland; [Ellis, Ian R.] Univ Dundee, Sch Dent, Unit Cell & Mol Biol, Dundee DD1 4HR, Scotland; [Prabhakaran, Sabitha; Hoeoek, Magnus] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, Houston, TX 77030 USA; [Talay, Susanne R.] Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, D-38124 Braunschweig, Germany; [Potts, Jennifer R.] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; [Potts, Jennifer R.] Univ York, Dept Chem, York YO10 5YW, N Yorkshire, England; [Staunton, David] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of St Andrews; University of Dundee; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Helmholtz Association; Helmholtz-Center for Infection Research; University of York - UK; University of York - UK; University of Oxford	Schwarz-Linek, U (corresponding author), Univ St Andrews, Biomed Sci Res Complex, St Andrews KY16 9ST, Fife, Scotland.	us6@st-andrews.ac.uk	Ellis, Ian/AAM-9833-2021	Ellis, Ian/0000-0001-8035-6012; Schwarz-Linek, Ulrich/0000-0003-0526-223X	E. P. Abraham Cephalosporin Fund (Oxford, United Kingdom); BBSRC [BB/D010608/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D010608/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055449] Funding Source: NIH RePORTER	E. P. Abraham Cephalosporin Fund (Oxford, United Kingdom); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the E. P. Abraham Cephalosporin Fund (Oxford, United Kingdom).	Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Atkin KE, 2010, J BIOL CHEM, V285, P36977, DOI 10.1074/jbc.M110.156935; Beer C, 2007, J VIROL, V81, P8247, DOI 10.1128/JVI.00312-07; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730; CLARK RAF, 1988, J BIOL CHEM, V263, P12115; Cooper A, 2001, BIOPHYS CHEM, V93, P215, DOI 10.1016/S0301-4622(01)00222-8; Dziewanowska K, 1999, INFECT IMMUN, V67, P4673, DOI 10.1128/IAI.67.9.4673-4678.1999; Edwards AM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000964; Ellis IR, 2010, EXP CELL RES, V316, P2465, DOI 10.1016/j.yexcr.2010.04.003; Ensenberger MG, 2004, BIOPHYS CHEM, V112, P201, DOI 10.1016/j.bpc.2004.07.020; FUKAI F, 1995, BIOCHEMISTRY-US, V34, P11453, DOI 10.1021/bi00036a018; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; Liu XY, 2003, MATRIX BIOL, V22, P393, DOI 10.1016/S0945-053X(03)00071-4; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Millard CJ, 2007, J BIOL CHEM, V282, P35530, DOI 10.1074/jbc.M707532200; NATANSON S, 1995, J INFECT DIS, V171, P871, DOI 10.1093/infdis/171.4.871; Nitsche-Schmitz DP, 2007, THROMB HAEMOSTASIS, V98, P488, DOI 10.1160/TH07-03-0179; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Penkett CJ, 1998, BIOCHEMISTRY-US, V37, P17054, DOI 10.1021/bi9814080; Pickford AR, 2001, EMBO J, V20, P1519, DOI 10.1093/emboj/20.7.1519; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Potts JR, 1999, BIOCHEMISTRY-US, V38, P8304, DOI 10.1021/bi990202b; Rohde M, 2003, CELL MICROBIOL, V5, P323, DOI 10.1046/j.1462-5822.2003.00279.x; Schor SL, 2003, CANCER RES, V63, P8827; Schor SL, 1999, J CELL SCI, V112, P3879; SCHOR SL, 1980, J CELL SCI, V41, P159; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Shi F, 2008, J CELL SCI, V121, P2360, DOI 10.1242/jcs.014977; Staunton David, 2009, V522, P73, DOI 10.1007/978-1-59745-413-1_5; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; TALAY SR, 1992, INFECT IMMUN, V60, P3837, DOI 10.1128/IAI.60.9.3837-3844.1992; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Towers RJ, 2003, J CLIN MICROBIOL, V41, P5398, DOI 10.1128/JCM.41.12.5398-5406.2003; UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Zhao QS, 2001, EXP CELL RES, V268, P211, DOI 10.1006/excr.2001.5291	45	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1884	1894		10.1074/jbc.M110.183053	http://dx.doi.org/10.1074/jbc.M110.183053			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21059652	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000286191500029
J	Ainle, FN; O'Donnell, JS; Johnson, JA; Brown, L; Gleeson, EM; Smith, OP; Preston, RJS				Ainle, Fionnuala Ni; O'Donnell, James S.; Johnson, Jennifer A.; Brown, Laura; Gleeson, Eimear M.; Smith, Owen P.; Preston, Roger J. S.			Activated Protein C N-Linked Glycans Modulate Cytoprotective Signaling Function on Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FACTOR-VIII; ANTICOAGULANT ACTIVITY; GLA DOMAIN; RECEPTOR-1; GLYCOSYLATION; THROMBIN; COFACTOR; CLEAVAGE; SEPSIS; IDENTIFICATION	Activated protein C (APC) has potent anticoagulant and anti-inflammatory properties that limit clot formation, inhibit apoptosis, and protect vascular endothelial cell barrier integrity. In this study, the role of N-linked glycans in modulating APC endothelial cytoprotective signaling via endothelial cell protein C receptor/protease-activated receptor 1 (PAR1) was investigated. Enzymatic digestion of APC N-linked glycans (PNG-APC) decreased the APC concentration required to achieve half-maximal inhibition of thrombin-induced endothelial cell barrier permeability by 6-fold. Furthermore, PNG-APC exhibited increased protection against staurosporine-induced endothelial cell apoptosis when compared with untreated APC. To investigate the specific N-linked glycans responsible, recombinant APC variants were generated in which each N-linked glycan attachment site was eliminated. Of these, APC-N329Q was up to 5-fold more efficient in protecting endothelial barrier function when compared with wild type APC. Based on these findings, an APC variant (APC-L38D/N329Q) was generated with minimal anticoagulant activity, but 5-fold enhanced endothelial barrier protective function and 30-fold improved anti-apoptotic function when compared with wild type APC. These data highlight the previously unidentified role of APC N-linked glycosylation in modulating endothelial cell protein C receptor-dependent cytoprotective signaling via PAR1. Furthermore, our data suggest that plasma beta-protein C, characterized by aberrant N-linked glycosylation at Asn-329, may be particularly important for maintenance of APC cytoprotective functions in vivo.	[Preston, Roger J. S.] Trinity Coll Dublin, Inst Mol Med, Haemostasis Res Grp, Dublin 2, Ireland; [O'Donnell, James S.] St James Hosp, Natl Ctr Hereditary Coagulat Disorders, Dublin 8, Ireland; [Smith, Owen P.] Our Ladys Hosp Sick Children, Dept Haematol, Dublin 12, Ireland	Trinity College Dublin; Trinity College Dublin; Our Ladys Children Hospital Crumlin	O'Donnell, JS (corresponding author), Trinity Coll Dublin, St Jamess Hosp, Inst Mol Med, Haemostasis Res Grp, Dublin 8, Ireland.	jodonne@tcd.ie	O'Donnell, James/A-6171-2009; Smith, Owen/AAU-8929-2020	O'Donnell, James/0000-0003-0309-3313; Ni Ainle, Fionnuala/0000-0003-0163-792X; Preston, Roger/0000-0003-0108-4077	Molecular Medicine Ireland; Science Foundation Ireland (SFI)	Molecular Medicine Ireland; Science Foundation Ireland (SFI)(Science Foundation Ireland)	This work was supported by a Molecular Medicine Ireland Clinician Scientist Fellowship (to F. N. A.), a Science Foundation Ireland (SFI) Starting Investigator Research Grant (to R. J. S. P. and E. M. G.), and SFI PIYRA (J. S. O'D.).	Bae JS, 2007, BLOOD, V110, p520A; Bae JS, 2007, J BIOL CHEM, V282, P9251, DOI 10.1074/jbc.M610547200; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Cohen J, 2001, CRIT CARE MED, V29, P880, DOI 10.1097/00003246-200104000-00039; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; FAY PJ, 1991, J BIOL CHEM, V266, P20139; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Finigan JH, 2005, J BIOL CHEM, V280, P17286, DOI 10.1074/jbc.M412427200; FOSTER D, 1984, P NATL ACAD SCI-BIOL, V81, P4766, DOI 10.1073/pnas.81.15.4766; Gil GC, 2009, PROTEOMICS, V9, P2555, DOI 10.1002/pmic.200800775; GRINNELL BW, 1991, J BIOL CHEM, V266, P9778; Harmon S, 2008, J BIOL CHEM, V283, P30531, DOI 10.1074/jbc.M802338200; Iba T, 2005, CRIT CARE MED, V33, P368, DOI 10.1097/01.CCM.0000153415.04995.88; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Ludeman MJ, 2005, J BIOL CHEM, V280, P13122, DOI 10.1074/jbc.M410381200; Mather T, 1996, EMBO J, V15, P6822, DOI 10.1002/j.1460-2075.1996.tb01073.x; MILETICH JP, 1990, J BIOL CHEM, V265, P11397; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Mosnier LO, 2004, BLOOD, V104, P1740, DOI 10.1182/blood-2004-01-0110; Mosnier LO, 2003, BIOCHEM J, V373, P65, DOI 10.1042/BJ20030341; Niessen F, 2009, BLOOD, V113, P2859, DOI 10.1182/blood-2008-12-192385; OWEN WG, 1981, J BIOL CHEM, V256, P5532; Preston RJS, 2005, FEBS J, V272, P97, DOI 10.1111/j.1432-1033.2004.04401.x; Preston RJS, 2006, J BIOL CHEM, V281, P28850, DOI 10.1074/jbc.M604966200; Preston RJS, 2009, J BIOL CHEM, V284, P5869, DOI 10.1074/jbc.M804703200; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Simioni P, 1996, BLOOD, V88, P2101, DOI 10.1182/blood.V88.6.2101.bloodjournal8862101; Soto AG, 2010, J BIOL CHEM, V285, P18781, DOI 10.1074/jbc.M110.111088; WALKER FJ, 1979, BIOCHIM BIOPHYS ACTA, V571, P333, DOI 10.1016/0005-2744(79)90103-7; White B, 2000, BRIT J HAEMATOL, V110, P130, DOI 10.1046/j.1365-2141.2000.02128.x; YAN SCB, 1990, BIO-TECHNOL, V8, P655, DOI 10.1038/nbt0790-655; Yang LK, 2007, J BIOL CHEM, V282, P25493, DOI 10.1074/jbc.M702131200; Yang XV, 2009, P NATL ACAD SCI USA, V106, P274, DOI 10.1073/pnas.0807594106	36	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1323	1330		10.1074/jbc.M110.159475	http://dx.doi.org/10.1074/jbc.M110.159475			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21044954	Green Published, hybrid			2022-12-25	WOS:000286005000044
J	Griesser, M; Pistis, V; Suzuki, T; Tejera, N; Pratt, DA; Schneider, C				Griesser, Markus; Pistis, Valentina; Suzuki, Takashi; Tejera, Noemi; Pratt, Derek A.; Schneider, Claus			Autoxidative and Cyclooxygenase-2 Catalyzed Transformation of the Dietary Chemopreventive Agent Curcumin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUINONE METHIDE FORMATION; KAPPA-B ACTIVATION; ANTIOXIDANT MECHANISM; DEGRADATION-PRODUCTS; ANTICANCER ACTIVITY; DNA-ADDUCTS; CANCER; INHIBITION; LIPOXYGENASE; CELLS	The efficacy of the diphenol curcumin as a cancer chemopreventive agent is limited by its chemical and metabolic instability. Non-enzymatic degradation has been described to yield vanillin, ferulic acid, and feruloylmethane through cleavage of the heptadienone chain connecting the phenolic rings. Here we provide evidence for an alternative mechanism, resulting in autoxidative cyclization of the heptadienone moiety as a major pathway of degradation. Autoxidative transformation of curcumin was pH-dependent with the highest rate at pH 8 (2.2 mu M/min) and associated with stoichiometric uptake of O-2. Oxidation was also catalyzed by recombinant cyclooxygenase-2 (COX-2) (50 nM; 7.5 mu M/min), and the rate was increased approximate to 10-fold by the addition of 300 mu M H2O2. The COX-2 catalyzed transformation was inhibited by acetaminophen but not indomethacin, suggesting catalysis occurred by the peroxidase activity. We propose a mechanism of enzymatic or autoxidative hydrogen abstraction from a phenolic hydroxyl to give a quinone methide and a delocalized radical in the heptadienone chain that undergoes 5-exo cyclization and oxygenation. Hydration of the quinone methide (measured by the incorporation of O-18 from H-2 O-18) and rearrangement under loss of water gives the final dioxygenated bicyclopentadione product. When curcumin was added to RAW264.7 cells, the bicyclopentadione was increased 1.8-fold in cells activated by LPS; vanillin and other putative cleavage products were negligible. Oxidation to a reactive quinone methide is the mechanistic basis of many phenolic anti-cancer drugs. It is possible, therefore, that oxidative transformation of curcumin, a prominent but previously unrecognized reaction, contributes to its cancer chemopreventive activity.	[Griesser, Markus; Pistis, Valentina; Suzuki, Takashi; Tejera, Noemi; Schneider, Claus] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; [Griesser, Markus; Pistis, Valentina; Suzuki, Takashi; Tejera, Noemi; Schneider, Claus] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Pratt, Derek A.] Queens Univ, Dept Chem, Kingston, ON KL7 3N6, Canada	Vanderbilt University; Vanderbilt University; Queens University - Canada	Schneider, C (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, 23rd Ave S Pierce, Nashville, TN 37232 USA.	claus.schneider@vanderbilt.edu	Pratt, Derek A/A-1453-2011; Suzuki, Takashi/B-7656-2014; Tejera, Noemi/O-1558-2016	Suzuki, Takashi/0000-0002-2058-3333; Tejera, Noemi/0000-0001-8100-6022	National Institutes of Health, Center of Molecular Toxicology [P30 ES000267]; NIGMS [R01GM076592]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076592] Funding Source: NIH RePORTER	National Institutes of Health, Center of Molecular Toxicology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Pilot and Feasibility Grant P30 ES000267 from the Center of Molecular Toxicology and Grant R01GM076592 from the NIGMS.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Appiah-Opong R, 2007, TOXICOLOGY, V235, P83, DOI 10.1016/j.tox.2007.03.007; Aronoff DM, 2006, CLIN PHARMACOL THER, V79, P9, DOI 10.1016/j.clpt.2005.09.009; Barclay LRC, 2000, ORG LETT, V2, P2841, DOI 10.1021/ol000173t; Bernard K, 2009, J BIOL CHEM, V284, P30754, DOI 10.1074/jbc.M109.056010; Bodell WJ, 1998, CARCINOGENESIS, V19, P437, DOI 10.1093/carcin/19.3.437; BOLTON JL, 1995, CHEM-BIOL INTERACT, V95, P279, DOI 10.1016/0009-2797(94)03566-Q; Dempe JS, 2008, MOL NUTR FOOD RES, V52, P1074, DOI 10.1002/mnfr.200800029; Deters M, 2008, PHARM RES-DORDR, V25, P1822, DOI 10.1007/s11095-008-9579-2; Dhillon N, 2009, CLIN CANCER RES, V15, P7108, DOI 10.1158/1078-0432.CCR-09-2362; Fang JG, 2005, J BIOL CHEM, V280, P25284, DOI 10.1074/jbc.M414645200; Galano A, 2009, CHEM PHYS, V363, P13, DOI 10.1016/j.chemphys.2009.07.003; Garcea G, 2005, CANCER EPIDEM BIOMAR, V14, P120; Goel A, 2001, CANCER LETT, V172, P111, DOI 10.1016/S0304-3835(01)00655-3; HAIM N, 1987, CANCER RES, V47, P5835; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; HUANG MT, 1991, CANCER RES, V51, P813; Ireson C, 2001, CANCER RES, V61, P1058; Jovanovic SV, 1999, J AM CHEM SOC, V121, P9677, DOI 10.1021/ja991446m; KHURANA A, 1988, J LIQ CHROMATOGR, V11, P2295, DOI 10.1080/01483918808067200; KLASING SA, 1985, P SOC EXP BIOL MED, V179, P529; KLEGERIS A, 1995, FREE RADICAL BIO MED, V18, P215, DOI 10.1016/0891-5849(94)00141-6; Koeberle A, 2009, MOL CANCER THER, V8, P2348, DOI 10.1158/1535-7163.MCT-09-0290; Litwinienko G, 2004, J ORG CHEM, V69, P5888, DOI 10.1021/jo049254j; Liu ZF, 2009, BIOORG MED CHEM LETT, V19, P706, DOI 10.1016/j.bmcl.2008.12.041; MARKEY CM, 1987, J BIOL CHEM, V262, P6266; Marnett LJ, 2002, ANNU REV PHARMACOL, V42, P55, DOI 10.1146/annurev.pharmtox.42.082301.164620; MOORE HW, 1986, DRUG EXP CLIN RES, V12, P475; Murakami A, 2007, INT J CANCER, V121, P2357, DOI 10.1002/ijc.23161; PABON HJJ, 1964, RECL TRAV CHIM PAY B, V83, P379; Pan MH, 2000, BIOCHEM PHARMACOL, V60, P1665, DOI 10.1016/S0006-2952(00)00489-5; PETERSON DM, 1986, BIOCHEMISTRY-US, V25, P4077, DOI 10.1021/bi00362a014; Pfeiffer E, 2003, J FOOD ENG, V56, P257, DOI 10.1016/S0260-8774(02)00264-9; Plummer SM, 1999, ONCOGENE, V18, P6013, DOI 10.1038/sj.onc.1202980; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Prasad NS, 2004, PROSTAG LEUKOTR ESS, V70, P521, DOI 10.1016/j.plefa.2003.11.006; Ramsewak RS, 2000, PHYTOMEDICINE, V7, P303, DOI 10.1016/S0944-7113(00)80048-3; Rao CV, 2007, ADV EXP MED BIOL, V595, P213; Reddy Bandaru S., 2002, Journal of Environmental Pathology Toxicology and Oncology, V21, P155; Schneider C, 2004, J BIOL CHEM, V279, P4404, DOI 10.1074/jbc.M307431200; Schneider C, 1998, J MOL CATAL B-ENZYM, V4, P219, DOI 10.1016/S1381-1177(98)00002-2; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Sharma RA, 2001, CLIN CANCER RES, V7, P1894; Shen L, 2009, CLIN CANCER RES, V15, P7108, DOI 10.1158/1078-0432.CCR-09-1749; Skrzypczak-Jankun E, 2003, INT J MOL MED, V12, P17; Szewczuk LM, 2005, J NAT PROD, V68, P36, DOI 10.1021/np049702i; THOMPSON D, 1989, CHEM RES TOXICOL, V2, P186, DOI 10.1021/tx00009a011; THOMPSON DC, 1995, CHEM RES TOXICOL, V8, P323, DOI 10.1021/tx00045a001; THOMPSON DC, 1993, CHEM-BIOL INTERACT, V86, P129, DOI 10.1016/0009-2797(93)90117-H; TONNESEN HH, 1986, Z LEBENSM UNTERS FOR, V183, P116, DOI 10.1007/BF01041928; TONNESEN HH, 1985, Z LEBENSM UNTERS FOR, V180, P132, DOI 10.1007/BF01042637; Toth G, 2000, MAGN RESON CHEM, V38, P51, DOI 10.1002/(SICI)1097-458X(200001)38:1<51::AID-MRC593>3.3.CO;2-U; van der Woude H, 2005, CHEM RES TOXICOL, V18, P1907, DOI 10.1021/tx050201m; Wang YJ, 1997, J PHARMACEUT BIOMED, V15, P1867, DOI 10.1016/S0731-7085(96)02024-9; Werz O, 2007, PLANTA MED, V73, P1331, DOI 10.1055/s-2007-990242	56	110	111	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1114	1124		10.1074/jbc.M110.178806	http://dx.doi.org/10.1074/jbc.M110.178806			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21071447	Green Published, hybrid			2022-12-25	WOS:000286005000022
J	Rong, JA; Chen, LL; Toth, JI; Tcherpakov, M; Petroski, MD; Reed, JC				Rong, Juan; Chen, Lili; Toth, Julia I.; Tcherpakov, Marianna; Petroski, Matthew D.; Reed, John C.			Bifunctional Apoptosis Regulator (BAR), an Endoplasmic Reticulum (ER)-associated E3 Ubiquitin Ligase, Modulates BI-1 Protein Stability and Function in ER Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY PROTEINS; CELL-DEATH; NEGATIVE REGULATOR; PROAPOPTOTIC BAX; INHIBITOR-1; DEGRADATION; IRE1-ALPHA; CHAINS; IRE1; ACTIVATION	Accumulation of misfolded proteins in the endoplasmic reticulum (ER) causes ER stress and activates inositol-requiring protein-1 (IRE1), among other ER-associated signaling proteins of the unfolded protein response (UPR) in mammalian cells. IRE1 signaling becomes attenuated under prolonged ER stress. The mechanisms by which this occurs are not well understood. An ER resident protein, Bax inhibitor-1 (BI-1), interacts with IRE1 and directly inhibits IRE1 activity. However, little is known about regulation of the BI-1 protein. We show here that bifunctional apoptosis regulator (BAR) functions as an ER-associated RING-type E3 ligase, interacts with BI-1, and promotes proteasomal degradation of BI-1. Overexpression of BAR reduced BI-1 protein levels in a RING-dependent manner. Conversely, knockdown of endogenous BAR increased BI-1 protein levels and enhanced inhibition of IRE1 signaling during ER stress. We also found that the levels of endogenous BAR were reduced under prolonged ER stress. Our findings suggest that post-translational regulation of the BI-1 protein by E3 ligase BAR contributes to the dynamic control of IRE1 signaling during ER stress.	[Rong, Juan; Chen, Lili; Toth, Julia I.; Tcherpakov, Marianna; Petroski, Matthew D.; Reed, John C.] Sanford Burnham Med Res Inst, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	reedoffice@sanfordburnham.org			National Institutes of Health [AG-15393]; American Heart Association [0825021F]; NATIONAL INSTITUTE ON AGING [R01AG015393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG-15393 (to J.C.R.) and American Heart Association Western States Affiliate Postdoctoral Fellowship 0825021F (to J.R.).	Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Bailly-Maitre B, 2010, J BIOL CHEM, V285, P6198, DOI 10.1074/jbc.M109.056648; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bolduc N, 2003, PLANTA, V216, P377, DOI 10.1007/s00425-002-0879-1; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Chae HJ, 2003, GENE, V323, P101, DOI 10.1016/j.gene.2003.09.011; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Grzmil M, 2006, J PATHOL, V208, P340, DOI 10.1002/path.1902; Grzmil M, 2003, AM J PATHOL, V163, P543, DOI 10.1016/S0002-9440(10)63682-6; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Isbat M, 2009, J PLANT PHYSIOL, V166, P1685, DOI 10.1016/j.jplph.2009.04.017; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kawai-Yamada M, 2004, PLANT CELL, V16, P21, DOI 10.1105/tpc.014613; Kim HR, 2008, J BIOL CHEM, V283, P15946, DOI 10.1074/jbc.M800075200; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Lee GH, 2007, J BIOL CHEM, V282, P21618, DOI 10.1074/jbc.M700053200; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Mukasa T, 2007, ACTA CRYSTALLOGR F, V63, P297, DOI 10.1107/S1744309107008925; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roth W, 2003, CELL DEATH DIFFER, V10, P1178, DOI 10.1038/sj.cdd.4401287; Schmidt SM, 2009, LEUKEMIA, V23, P1818, DOI 10.1038/leu.2009.138; Tcherpakov M, 2008, MOL BIOL CELL, V19, P5019, DOI 10.1091/mbc.E08-08-0839; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang ZL, 2004, J BIOL CHEM, V279, P48168, DOI 10.1074/jbc.M405022200; Watanabe N, 2008, PLANT SIGNAL BEHAV, V3, P564, DOI 10.4161/psb.3.8.5709; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xia Z. P., 2005, SCI STKE, V2005, ppe7; Xu CY, 2008, J BIOL CHEM, V283, P11477, DOI 10.1074/jbc.M708385200; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Zapata JM, 2001, J BIOL CHEM, V276, P24242, DOI 10.1074/jbc.M100354200; Zhang H, 2000, P NATL ACAD SCI USA, V97, P2597, DOI 10.1073/pnas.97.6.2597	45	29	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1453	1463		10.1074/jbc.M110.175232	http://dx.doi.org/10.1074/jbc.M110.175232			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21068390	Green Published, hybrid			2022-12-25	WOS:000286005000058
J	Koshiba, T; Holman, HA; Kubara, K; Yasukawa, K; Kawabata, S; Okamoto, K; Macfarlane, J; Shaw, JM				Koshiba, Takumi; Holman, Holly A.; Kubara, Kenji; Yasukawa, Kai; Kawabata, Shun-ichiro; Okamoto, Koji; Macfarlane, Jane; Shaw, Janet M.			Structure-Function Analysis of the Yeast Mitochondrial Rho GTPase, Gem1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINESIN HEAVY-CHAIN; AXONAL-TRANSPORT; MIRO GTPASE; ACTIVATING PROTEINS; ESCHERICHIA-COLI; BUDDING YEAST; BINDING; MORPHOLOGY; SYNAPSES; IDENTIFICATION	Mitochondria undergo continuous cycles of homotypic fusion and fission, which play an important role in controlling organelle morphology, copy number, and mitochondrial DNA maintenance. Because mitochondria cannot be generated de novo, the motility and distribution of these organelles are essential for their inheritance by daughter cells during division. Mitochondrial Rho (Miro) GTPases are outer mitochondrial membrane proteins with two GTPase domains and two EF-hand motifs, which act as receptors to regulate mitochondrial motility and inheritance. Here we report that although all of these domains are biochemically active, only the GTPase domains are required for the mitochondrial inheritance function of Gem1p (the yeast Miro ortholog). Mutations in either of the Gem1p GTPase domains completely abrogated mitochondrial inheritance, although the mutant proteins retained half the GTPase activity of the wild-type protein. Although mitochondrial inheritance was not dependent upon Ca2+ binding by the two EF-hands of Gem1p, a functional N-terminal EF-hand I motif was critical for stable expression of Gem1p in vivo. Our results suggest that basic features of Miro protein function are conserved from yeast to humans, despite differences in the cellular machinery mediating mitochondrial distribution in these organisms.	[Koshiba, Takumi; Kubara, Kenji; Yasukawa, Kai; Kawabata, Shun-ichiro] Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, Fukuoka 8128581, Japan; [Holman, Holly A.; Macfarlane, Jane; Shaw, Janet M.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Okamoto, Koji] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Kyushu University; Utah System of Higher Education; University of Utah; Osaka University	Koshiba, T (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	koshiba@kyudai.jp	Koshiba, Takumi/A-3996-2013	Koshiba, Takumi/0000-0001-8535-5043	National Institutes of Health [5T32HL007576, R01GM84970]; Kyushu University; Kanae Foundation for the Promotion of Medical Science; Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation; Takeda Science Foundation; NCRR, National Institutes of Health [Grant M01-RR00064]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kyushu University; Kanae Foundation for the Promotion of Medical Science; Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); NCRR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5T32HL007576 (to H. A. H.) and R01GM84970 (to J. M. S.). This work was also supported by the Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (P & P type D; 20301), Kanae Foundation for the Promotion of Medical Science, Astellas Foundation for Research on Metabolic Disorders, Uehara Memorial Foundation, and Takeda Science Foundation (to T. K.). Support for sequencing and oligonucleotide services at the University of Utah was provided by NCRR, National Institutes of Health, Grant M01-RR00064 (to L. Betz).	Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; [Anonymous], 1991, Methods Enzymol, V194, P1; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Frederick RL, 2008, GENETICS, V178, P825, DOI 10.1534/genetics.107.083055; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; Fukushima NH, 2001, MOL BIOL CELL, V12, P2756, DOI 10.1091/mbc.12.9.2756; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Itoh T, 2004, EMBO J, V23, P2520, DOI 10.1038/sj.emboj.7600271; Itoh T, 2002, MOL CELL BIOL, V22, P7744, DOI 10.1128/MCB.22.22.7744-7757.2002; Jagath JR, 1998, BIOCHEMISTRY-US, V37, P15408, DOI 10.1021/bi981523a; Jeyaraju DV, 2009, BBA-BIOENERGETICS, V1787, P1363, DOI 10.1016/j.bbabio.2008.12.005; Koutsopoulos OS, 2010, BBA-MOL CELL RES, V1803, P564, DOI 10.1016/j.bbamcr.2010.03.006; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lehoux IE, 2003, PROTEIN EXPRES PURIF, V30, P203, DOI 10.1016/S1046-5928(03)00107-4; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Maniatis T., 1982, MOL CLONING LAB MANU; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Reis K, 2009, FEBS LETT, V583, P1391, DOI 10.1016/j.febslet.2009.04.015; Rutter GA, 2000, TRENDS BIOCHEM SCI, V25, P215, DOI 10.1016/S0968-0004(00)01585-1; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sherman F., 1986, METHODS YEAST GENETI; Sienaert I, 1996, J BIOL CHEM, V271, P27005, DOI 10.1074/jbc.271.43.27005; Solomaha E, 2005, BIOCHEM J, V391, P601, DOI 10.1042/BJ20050707; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Wang XD, 2001, GENE DEV, V15, P2922; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Yamaoka S, 2008, PLANT CELL, V20, P589, DOI 10.1105/tpc.107.055756; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Zhang BL, 1997, J BIOL CHEM, V272, P21999, DOI 10.1074/jbc.272.35.21999	44	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					354	362		10.1074/jbc.M110.180034	http://dx.doi.org/10.1074/jbc.M110.180034			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21036903	Green Published, hybrid			2022-12-25	WOS:000285782800038
J	Chittka, A				Chittka, Alexandra			Dynamic Distribution of Histone H4 Arginine 3 Methylation Marks in the Developing Murine Cortex	PLOS ONE			English	Article							CELL FATE; OLIGODENDROCYTE LINEAGE; PROTEIN METHYLATION; EPIGENETIC CONTROL; SPINAL-CORD; RADIAL GLIA; SPECIFICATION; ORIGIN; DIFFERENTIATION; TELENCEPHALON	Background: Epigenetic modifications regulate key transitions in cell fate during development of the central nervous system (CNS). During cortical development the initial population of proliferative neuroepithelial precursor cells give rise to neurons and then glia in a strict temporal order. Neurogenesis and gliogenesis are accompanied by a switch from symmetric to asymmetric divisions of the neural precursor cells generating another precursor and a differentiated progeny. To investigate whether specific post-translational histone modifications define specific stages of neural precursor differentiation during cortical development I focussed on the appearance of two different types of histone arginine methylation, the dimethyl symmetric H4R3 (H4R3me2s) and dimethyl asymmetric H4R3 (H4R3me2a) in the developing mouse cortex. Methodology/Principal Findings: An immunohistochemical study of the developing cortex at different developmental stages was performed to detect the distribution of H4R3me2s and H4R3me2a modifications. I analysed the distribution of these modifications in: 1) undifferentiated neural precursors, 2) post-mitotic neurons and 3) developing oligodendrocyte precursors (OLPs) using lineage-specific and histone modification-specific antibodies to co-label the cells. I found that the proliferative neuroepithelium during the stage of mainly symmetric expansive divisions is characterised by the prevalence of H4R3me2s modification and almost no detectable H4R3me2a modification. However, at a later stage, when the cortical layers with post-mitotic neurons have begun forming, both H4R3me2a and H4R3me2s modifications are detected in the post-mitotic neurons and in the developing OLPs. Conclusions/Significance: I propose that the H4R3me2s modification forms part of the "histone code" of undifferentiated neural precursors. The later appearance of the H4R3me2a modifications specifies the onset of neurogenesis and gliogenesis and the commitment of the NSCs to differentiate. Thus, the sequential appearance of the two different H4R3 methylation marks may define a particular cellular state of the NSCs during their development and differentiation demonstrating the role of histone arginine methylation in cortical development.	UCL, Wolfson Inst Biomed Res, London, England	University of London; University College London	Chittka, A (corresponding author), UCL, Wolfson Inst Biomed Res, London, England.	a.chittka@ucl.ac.uk	Chittka, Alexandra/AAR-9370-2021; Messier, Claude/A-2322-2008	Chittka, Alexandra/0000-0002-3495-270X; Messier, Claude/0000-0002-4791-1763	Wellcome Trust [WT076656MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust Career Re-entry Fellowship WT076656MA to Alexandra Chittka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Bayer S.A., 1991, NEOCORTICAL DEV; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Berthet C, 2002, GENES CELLS, V7, P29, DOI 10.1046/j.1356-9597.2001.00497.x; Chen SL, 2002, J BIOL CHEM, V277, P4324, DOI 10.1074/jbc.M109835200; Chittka A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000532; CHOI BH, 1983, DEV BRAIN RES, V8, P119, DOI 10.1016/0165-3806(83)90163-3; Cimato TR, 1997, J CELL BIOL, V138, P1089, DOI 10.1083/jcb.138.5.1089; Cimato TR, 2002, J NEUROSCI RES, V67, P435, DOI 10.1002/jnr.10123; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Fogarty M, 2005, DEVELOPMENT, V132, P1951, DOI 10.1242/dev.01777; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Guillemot F, 2007, PROG NEUROBIOL, V83, P37, DOI 10.1016/j.pneurobio.2007.02.009; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; HIRANO M, 1988, J NEUROSCI RES, V21, P155, DOI 10.1002/jnr.490210208; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kessaris N, 2008, PHILOS T R SOC B, V363, P71, DOI 10.1098/rstb.2006.2013; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Okano H, 2009, CURR OPIN NEUROBIOL, V19, P112, DOI 10.1016/j.conb.2009.04.003; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; Sarmento OF, 2004, J CELL SCI, V117, P4449, DOI 10.1242/jcs.01328; Spassky N, 1998, J NEUROSCI, V18, P8331; Tekki-Kessaris N, 2001, DEVELOPMENT, V128, P2545; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	28	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13807	10.1371/journal.pone.0013807	http://dx.doi.org/10.1371/journal.pone.0013807			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072194	Green Published, gold			2022-12-25	WOS:000283780800010
J	Karenina, K; Giljov, A; Baranov, V; Osipova, L; Krasnova, V; Malashichev, Y				Karenina, Karina; Giljov, Andrey; Baranov, Vladimir; Osipova, Ludmila; Krasnova, Vera; Malashichev, Yegor			Visual Laterality of Calf-Mother Interactions in Wild Whales	PLOS ONE			English	Article							INFANT SPATIAL RELATIONS; BOTTLE-NOSED DOLPHINS; SOCIAL-STIMULI; HEMISPHERIC-SPECIALIZATION; DELPHINAPTERUS-LEUCAS; BEHAVIORAL ASYMMETRY; DOMESTIC CHICK; BUFO-MARINUS; EYE USE; RESPONSES	Background: Behavioral laterality is known for a variety of vertebrate and invertebrate animals. Laterality in social interactions has been described for a wide range of species including humans. Although evidence and theoretical predictions indicate that in social species the degree of population level laterality is greater than in solitary ones, the origin of these unilateral biases is not fully understood. It is especially poorly studied in the wild animals. Little is known about the role, which laterality in social interactions plays in natural populations. A number of brain characteristics make cetaceans most suitable for investigation of lateralization in social contacts. Methodology/Principal Findings: Observations were made on wild beluga whales (Delphinapterus leucas) in the greatest breeding aggregation in the White Sea. Here we show that young calves (in 29 individually identified and in over a hundred of individually not recognized mother-calf pairs) swim and rest significantly longer on a mother's right side. Further observations along with the data from other cetaceans indicate that found laterality is a result of the calves' preference to observe their mothers with the left eye, i.e., to analyze the information on a socially significant object in the right brain hemisphere. Conclusions/Significance: Data from our and previous work on cetacean laterality suggest that basic brain lateralizations are expressed in the same way in cetaceans and other vertebrates. While the information on social partners and novel objects is analyzed in the right brain hemisphere, the control of feeding behavior is performed by the left brain hemisphere. Continuous unilateral visual contacts of calves to mothers with the left eye may influence social development of the young by activation of the contralateral (right) brain hemisphere, indicating a possible mechanism on how behavioral lateralization may influence species life and welfare. This hypothesis is supported by evidence from other vertebrates.	[Karenina, Karina; Giljov, Andrey; Osipova, Ludmila; Malashichev, Yegor] St Petersburg State Univ, Fac Biol & Soil Sci, Dept Vertebrate Zool, St Petersburg, Russia; [Baranov, Vladimir; Krasnova, Vera] PP Shirshov Oceanol Inst, Lab Marine Mammals, Moscow, Russia; [Malashichev, Yegor] St Petersburg State Univ, Fac Biol & Soil Sci, Dept Embryol, St Petersburg, Russia	Saint Petersburg State University; Russian Academy of Sciences; Shirshov Institute of Oceanology; Saint Petersburg State University	Karenina, K (corresponding author), St Petersburg State Univ, Fac Biol & Soil Sci, Dept Vertebrate Zool, St Petersburg, Russia.	malashichev@embryo.pu.ru	Giljov, Andrey/O-4755-2014; Karenina, Karina/B-9781-2012; Malashichev, Yegor/D-3511-2013	Giljov, Andrey/0000-0002-7533-1600; Karenina, Karina/0000-0001-8200-6876; Malashichev, Yegor/0000-0003-3813-5712	Federal Grant-in-Aid Program "Human Capital for Science and Education in Innovative Russia" [P2379]	Federal Grant-in-Aid Program "Human Capital for Science and Education in Innovative Russia"	This work was supported by the Federal Grant-in-Aid Program "Human Capital for Science and Education in Innovative Russia" (Governmental Contract No. P2379). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfora G, 2010, BEHAV BRAIN RES, V206, P236, DOI 10.1016/j.bbr.2009.09.023; Bel'kovich V. M., 2002, MORSKIE MLEKOPITAYUS, P53; Bisazza A, 2000, LATERALITY, V5, P269, DOI 10.1080/135765000406111; Bisazza A, 2003, BEHAV BRAIN RES, V141, P131, DOI 10.1016/S0166-4328(02)00344-3; Bisazza A, 2002, BEHAV BRAIN RES, V134, P417, DOI 10.1016/S0166-4328(02)00055-4; Cantalupo C, 1995, NEUROPSYCHOLOGIA, V33, P1637, DOI 10.1016/0028-3932(95)00043-7; Casperd JM, 1996, BEHAV PROCESS, V37, P57, DOI 10.1016/0376-6357(95)00075-5; Daisley JN, 2009, PHILOS T R SOC B, V364, P965, DOI 10.1098/rstb.2008.0229; Damerose E., 2002, P306, DOI 10.1017/CBO9780511546372.011; DECKEL AW, 1995, J EXP ZOOL, V272, P194, DOI 10.1002/jez.1402720304; Gero S, 2007, MAR MAMMAL SCI, V23, P398, DOI 10.1111/j.1748-7692.2007.00113.x; Ghirlanda S, 2004, P ROY SOC B-BIOL SCI, V271, P853, DOI 10.1098/rspb.2003.2669; Ghirlanda S, 2009, PHILOS T R SOC B, V364, P861, DOI 10.1098/rstb.2008.0227; Giljov AN, 2009, LATERALITY, V14, P273, DOI 10.1080/13576500802379665; Gouchie GM, 2008, BEHAV ECOL SOCIOBIOL, V62, P1821, DOI 10.1007/s00265-008-0611-7; Gubbins C, 1999, MAR MAMMAL SCI, V15, P751, DOI 10.1111/j.1748-7692.1999.tb00841.x; HAMILTON CR, 1988, SCIENCE, V242, P1691, DOI 10.1126/science.3201258; Harris LJ, 2010, LATERALITY, V15, P15, DOI 10.1080/13576500701650430; Harris LJ, 2009, LATERALITY, V14, P590, DOI 10.1080/13576500902745781; Harris LJ, 2001, BRAIN COGNITION, V46, P159, DOI 10.1016/S0278-2626(01)80056-7; Karenina KA., 2010, J ASYMM, V4, P3; Kilian A, 2000, BEHAV BRAIN RES, V116, P211, DOI 10.1016/S0166-4328(00)00273-4; Kilian A, 2005, BEHAV PROCESS, V68, P179, DOI 10.1016/j.beproc.2004.11.003; Krasnova VV, 2009, RUSS J MAR BIOL +, V35, P53, DOI 10.1134/S1063074009010088; Krasnova VV, 2006, BIOL BULL+, V33, P53, DOI 10.1134/S1062359006010079; Lippolis G, 2005, LATERALITY, V10, P457, DOI 10.1080/13576500442000210; Lippolis G, 2002, LATERALITY, V7, P163, DOI 10.1080/13576500143000221; Lyamin O, 2007, PHYSIOL BEHAV, V92, P725, DOI 10.1016/j.physbeh.2007.05.064; MacNeilage PF, 2009, SCI AM, V301, P60, DOI 10.1038/scientificamerican0709-60; Malashichev Y, 2002, LATERALITY, V7, P195, DOI 10.1080/13576500244000094; Malashichev YB, 2006, MOL B INT U, P33; Malashichev YB, 2006, J COMP PSYCHOL, V120, P401, DOI 10.1037/0735-7036.120.4.401; Maleashichev YB, 2006; Mann J, 1999, BEHAVIOUR, V136, P529, DOI 10.1163/156853999501469; MANN J, 1997, FAMILY SYSTEMS, V4, P35; Marino L, 2004, ANAT REC PART A, V281A, P1256, DOI 10.1002/ar.a.20075; MENCH JA, 1986, BEHAV NEURAL BIOL, V46, P107, DOI 10.1016/S0163-1047(86)90570-4; Miklosi A, 2001, BEHAV BRAIN RES, V122, P57, DOI 10.1016/S0166-4328(01)00167-X; Miklosi A, 1999, BEHAV BRAIN RES, V105, P199, DOI 10.1016/S0166-4328(99)00071-6; Peirce JW, 2000, NEUROPSYCHOLOGIA, V38, P475, DOI 10.1016/S0028-3932(99)00088-3; Poliakova EC., 1978, ELECTROPHYSIOLOGICAL; Reddon AR, 2010, BEHAV PROCESS, V85, P68, DOI 10.1016/j.beproc.2010.06.008; Regolin L, 1996, BEHAV PROCESS, V37, P67, DOI 10.1016/0376-6357(95)00076-3; REGOLIN L, 1995, ANIM BEHAV, V50, P203, DOI 10.1006/anbe.1995.0232; Ridgway S.H., 1986, P31; Rizhova LY, 2006, MOL BIOL INTELL UNIT, P160; Rizhova LY, 2005, BEHAV BRAIN RES, V161, P75, DOI 10.1016/j.bbr.2005.01.007; Robins A, 2005, NEUROREPORT, V16, P849, DOI 10.1097/00001756-200505310-00014; Robins A, 2004, ANIM BEHAV, V68, P767, DOI 10.1016/j.anbehav.2003.12.014; Robins A, 2006, NEUROBIOL LEARN MEM, V86, P214, DOI 10.1016/j.nlm.2006.03.002; Rogers Lesley J., 1989, INT J COMP PSYCHOL, V3, P5; Rogers LJ, 2000, BRAIN LANG, V73, P236, DOI 10.1006/brln.2000.2305; Rogers LJ, 2002, ADV STUD BEHAV, V31, P107, DOI 10.1016/S0065-3454(02)80007-9; Rogers LJ., 2002, COMP VERTEBRATE LATE; Rot-Nikcevic I, 2006, BEHAV ECOL SOCIOBIOL, V60, P19, DOI 10.1007/s00265-005-0133-5; Sakai M, 2006, BEHAV BRAIN RES, V170, P204, DOI 10.1016/j.bbr.2006.02.018; SALK L, 1973, SCI AM, V228, P24, DOI 10.1038/scientificamerican0573-24; SALK L, 1970, Diseases of the Nervous System, V31, P110; Salk L., 1960, WORLD MENT HLTH, V12, P168; Sieratzki JS, 1996, LANCET, V347, P1746, DOI 10.1016/S0140-6736(96)90813-2; Silber Gregory K., 1995, Aquatic Mammals, V21, P183; Siniscalchi M, 2010, BEHAV BRAIN RES, V208, P516, DOI 10.1016/j.bbr.2009.12.042; Sovrano VA, 1999, BEHAV BRAIN RES, V106, P175, DOI 10.1016/S0166-4328(99)00105-9; Sovrano VA, 2004, BEHAV BRAIN RES, V152, P385, DOI 10.1016/j.bbr.2003.10.022; Sovrano VA, 2001, PHYSIOL BEHAV, V74, P237, DOI 10.1016/S0031-9384(01)00552-2; TARPLEY RJ, 1994, BRAIN BEHAV EVOLUT, V44, P156, DOI 10.1159/000113587; Tommasi L, 2009, PHILOS T R SOC B, V364, P855, DOI 10.1098/rstb.2008.0293; VALLORTIGARA G, 1992, NEUROPSYCHOLOGIA, V30, P761, DOI 10.1016/0028-3932(92)90080-6; Vallortigara G, 1998, NEUROREPORT, V9, P3341, DOI 10.1097/00001756-199810050-00035; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Vallortigara G, 2001, CURR BIOL, V11, P29, DOI 10.1016/S0960-9822(00)00027-0; VALLORTIGARA G, 1994, BEHAV PROCESS, V33, P41, DOI 10.1016/0376-6357(94)90059-0; Vallortigara G, 2006, DEV PSYCHOBIOL, V48, P418, DOI 10.1002/dev.20166; von Fersen L, 2000, BEHAV BRAIN RES, V107, P177, DOI 10.1016/S0166-4328(99)00142-4; Woodward BL, 2006, MAR MAMMAL SCI, V22, P64, DOI 10.1111/j.1748-7692.2006.00006.x	75	48	51	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13787	10.1371/journal.pone.0013787	http://dx.doi.org/10.1371/journal.pone.0013787			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072179	Green Published, Green Submitted, gold			2022-12-25	WOS:000283780800004
J	Chow, HY; Stepanova, D; Koch, J; Chernoff, J				Chow, Hoi Yee; Stepanova, Dina; Koch, Jennifer; Chernoff, Jonathan			p21-Activated Kinases Are Required for Transformation in a Cell-Based Model of Neurofibromatosis Type 2	PLOS ONE			English	Article							NF2 TUMOR-SUPPRESSOR; HUMAN SCHWANNOMA CELLS; PAK PROTEIN-KINASES; REGULATED KINASE; GENE-PRODUCT; FERM DOMAIN; MERLIN; GROWTH; RAC; ACTIVATION	Background: NF2 is an autosomal dominant disease characterized by development of bilateral vestibular schwannomas and other benign tumors in central nervous system. Loss of the NF2 gene product, Merlin, leads to aberrant Schwann cell proliferation, motility, and survival, but the mechanisms by which this tumor suppressor functions remain unclear. One well-defined target of Merlin is the group I family of p21-activated kinases, which are allosterically inhibited by Merlin and which, when activated, stimulate cell cycle progression, motility, and increased survival. Here, we examine the effect of Pak inhibition on cells with diminished Merlin function. Methodology/Principal Findings: Using a specific peptide inhibitor of group I Paks, we show that loss of Pak activity restores normal cell movement in cells lacking Merlin function. In addition, xenografts of such cells form fewer and smaller tumors than do cells without Pak inhibition. However, in tumors, loss of Pak activity does not reduce Erk or Akt activity, two signaling proteins that are thought to mediate Pak function in growth factor pathways. Conclusions/Significance: These results suggest that Pak functions in novel signaling pathways in NF2, and may serve as a useful therapeutic target in this disease.	[Chow, Hoi Yee; Stepanova, Dina; Koch, Jennifer; Chernoff, Jonathan] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Chow, HY (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	J_Chernoff@fccc.edu	Chernoff, Jonathan/I-7631-2014; Stepanova, Dina/T-3999-2019	Chernoff, Jonathan/0000-0002-4803-7836; Stepanova, Dina/0000-0001-6138-8502	Department of Defense [W81XWH-06-1-0213, W81XWH-10-1-0092]; National Institutes of Health [CA117884]; Fox Chase Cancer Center [P30 CA006927]; State of Pennsylvania; NATIONAL CANCER INSTITUTE [R01CA117884, P30CA006927] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fox Chase Cancer Center; State of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Department of Defense to JC (W81XWH-06-1-0213) and H-CC (W81XWH-10-1-0092) and from the National Institutes of Health to JC (CA117884) and to the Fox Chase Cancer Center (P30 CA006927), as well as by an appropriation from the state of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammoun S, 2008, CANCER RES, V68, P5236, DOI 10.1158/0008-5472.CAN-07-5849; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Bashour AM, 2002, MOL CELL BIOL, V22, P1150, DOI 10.1128/MCB.22.4.1150-1157.2002; Beeser A, 2005, J BIOL CHEM, V280, P36609, DOI 10.1074/jbc.M502306200; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Chadee DN, 2006, P NATL ACAD SCI USA, V103, P4463, DOI 10.1073/pnas.0510651103; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Evans DGR, 2000, J MED GENET, V37, P897, DOI 10.1136/jmg.37.12.897; Flaiz C, 2009, EXP NEUROL, V218, P137, DOI 10.1016/j.expneurol.2009.04.019; Hage B, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-23; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; James MF, 2009, MOL CELL BIOL, V29, P4250, DOI 10.1128/MCB.01581-08; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Johnson KC, 2002, ONCOGENE, V21, P5990, DOI 10.1038/sj.onc.1205693; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Kiosses WB, 2002, CIRC RES, V90, P697, DOI 10.1161/01.RES.0000014227.76102.5D; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; KUMAR A, 2009, J CELL BIOCH; LaJeunesse DR, 1998, J CELL BIOL, V141, P1589, DOI 10.1083/jcb.141.7.1589; Lopez-Lago MA, 2009, MOL CELL BIOL, V29, P4235, DOI 10.1128/MCB.01578-08; Lozano E, 2008, J CELL SCI, V121, P933, DOI 10.1242/jcs.016121; Maksimoska J, 2008, J AM CHEM SOC, V130, P15764, DOI 10.1021/ja805555a; Maroto B, 2008, ONCOGENE, V27, P4900, DOI 10.1038/onc.2008.131; McLaughlin ME, 2007, P NATL ACAD SCI USA, V104, P3261, DOI 10.1073/pnas.0700044104; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; Obermeier A, 1998, EMBO J, V17, P4328, DOI 10.1093/emboj/17.15.4328; Okada T, 2005, J CELL BIOL, V171, P361, DOI 10.1083/jcb.200503165; Pelton PD, 1998, ONCOGENE, V17, P2195, DOI 10.1038/sj.onc.1202141; Ray RM, 2007, CELL MOTIL CYTOSKEL, V64, P143, DOI 10.1002/cm.20172; Reed N, 2001, TRENDS MOL MED, V7, P157, DOI 10.1016/S1471-4914(01)01955-4; Say E, 2010, MOL CELL, V38, P236, DOI 10.1016/j.molcel.2010.04.004; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Sherman L, 1997, ONCOGENE, V15, P2505, DOI 10.1038/sj.onc.1201418; Shimizu T, 2002, J BIOL CHEM, V277, P10332, DOI 10.1074/jbc.M109979200; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Stokowski RP, 2000, AM J HUM GENET, V66, P873, DOI 10.1086/302812; Tang Y, 1998, P NATL ACAD SCI USA, V95, P5139, DOI 10.1073/pnas.95.9.5139; Tang Y, 1997, MOL CELL BIOL, V17, P4454, DOI 10.1128/MCB.17.8.4454; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200; Yi CL, 2008, CANCER RES, V68, P7932, DOI 10.1158/0008-5472.CAN-08-0866; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035	45	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13791	10.1371/journal.pone.0013791	http://dx.doi.org/10.1371/journal.pone.0013791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072183	Green Published, gold, Green Submitted			2022-12-25	WOS:000283779700007
J	Sanz-Arigita, EJ; Schoonheim, MM; Damoiseaux, JS; Rombouts, SARB; Maris, E; Barkhof, F; Scheltens, P; Stam, CJ				Sanz-Arigita, Ernesto J.; Schoonheim, Menno M.; Damoiseaux, Jessica S.; Rombouts, Serge A. R. B.; Maris, Erik; Barkhof, Frederik; Scheltens, Philip; Stam, Cornelis J.			Loss of 'Small-World' Networks in Alzheimer's Disease: Graph Analysis of fMRI Resting-State Functional Connectivity	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; THEORETICAL ANALYSIS; DEFAULT-MODE; SYNCHRONIZATION LIKELIHOOD; HIPPOCAMPAL ATROPHY; NEURAL MECHANISMS; BRAIN; DEMENTIA; PATTERNS; AGE	Background: Local network connectivity disruptions in Alzheimer's disease patients have been found using graph analysis in BOLD fMRI. Other studies using MEG and cortical thickness measures, however, show more global long distance connectivity changes, both in functional and structural imaging data. The form and role of functional connectivity changes thus remains ambiguous. The current study shows more conclusive data on connectivity changes in early AD using graph analysis on resting-state condition fMRI data. Methodology/Principal Findings: 18 mild AD patients and 21 healthy age-matched control subjects without memory complaints were investigated in resting-state condition with MRI at 1.5 Tesla. Functional coupling between brain regions was calculated on the basis of pair-wise synchronizations between regional time-series. Local (cluster coefficient) and global (path length) network measures were quantitatively defined. Compared to controls, the characteristic path length of AD functional networks is closer to the theoretical values of random networks, while no significant differences were found in cluster coefficient. The whole-brain average synchronization does not differ between Alzheimer and healthy control groups. Post-hoc analysis of the regional synchronization reveals increased AD synchronization involving the frontal cortices and generalized decreases located at the parietal and occipital regions. This effectively translates in a global reduction of functional long-distance links between frontal and caudal brain regions. Conclusions/Significance: We present evidence of AD-induced changes in global brain functional connectivity specifically affecting long-distance connectivity. This finding is highly relevant for it supports the anterior-posterior disconnection theory and its role in AD. Our results can be interpreted as reflecting the randomization of the brain functional networks in AD, further suggesting a loss of global information integration in disease.	[Sanz-Arigita, Ernesto J.; Schoonheim, Menno M.; Barkhof, Frederik] Vrije Univ Amsterdam Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Sanz-Arigita, Ernesto J.] CITA Alzheimer Fdn, Dept Radiol, San Sebastian, Spain; [Damoiseaux, Jessica S.] Stanford Univ, Stanford Cognit & Syst Neurosci Lab, Palo Alto, CA 94304 USA; [Rombouts, Serge A. R. B.] Leiden Univ, Leiden Inst Brain & Cognit LIBC, Dept Radiol, Med Ctr,Inst Psycholog Res, Leiden, Netherlands; [Maris, Erik] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Stam, Cornelis J.] Vrije Univ Amsterdam Med Ctr, Clin Neurophysiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Stanford University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Sanz-Arigita, EJ (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Radiol, Amsterdam, Netherlands.	e.sanz.arigita@gmail.com	Schoonheim, Menno/AAI-6853-2021; Damoiseaux, Jessica/G-3228-2012; Barkhof, Frederik/AAJ-6226-2020; Schoonheim, Menno M/X-5398-2018; Rombouts, Serge A./AAL-7691-2021; Maris, Eric/E-4876-2012; Scheltens, Philip/E-1205-2012; Scheltens, Philip/AAL-9631-2020	Schoonheim, Menno/0000-0002-2504-6959; Barkhof, Frederik/0000-0003-3543-3706; Schoonheim, Menno M/0000-0002-2504-6959; Rombouts, Serge A./0000-0001-6351-4779; Maris, Eric/0000-0001-5166-1800; Scheltens, Philip/0000-0002-1046-6408; Stam, Cornelis/0000-0001-9163-7274; Sanz-Arigita, Ernesto J./0000-0001-9858-9666	Institute for the Study of Aging [231002]; Netherlands Organization for Scientific Research [916.36.117]	Institute for the Study of Aging; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The data acquisition was supported by the Institute for the Study of Aging (http://www.alzdiscovery.org; grant 231002) and Netherlands Organization for Scientific Research (http://www.nwo.nl; grant 916.36.117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Alsop DC, 2000, ANN NEUROL, V47, P93, DOI 10.1002/1531-8249(200001)47:1<93::AID-ANA15>3.0.CO;2-8; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Block F, 2005, PROG NEUROBIOL, V75, P342, DOI 10.1016/j.pneurobio.2005.03.004; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; DAMOISEAUX J, 2008, NEUROIMAGE, V41, pS144; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Leeuw FE, 2004, NEUROLOGY, V62, P310, DOI 10.1212/01.WNL.0000103289.03648.AD; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fein G, 2000, NEUROLOGY, V55, P1626, DOI 10.1212/WNL.55.11.1626; Ferri R, 2007, CLIN NEUROPHYSIOL, V118, P449, DOI 10.1016/j.clinph.2006.10.021; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston KJ, 2002, PROG NEUROBIOL, V68, P113, DOI 10.1016/S0301-0082(02)00076-X; Grady CL, 2007, NEUROPSYCHOLOGY, V21, P371, DOI 10.1037/0894-4105.21.3.371; Grady CL, 2003, J NEUROSCI, V23, P986, DOI 10.1523/jneurosci.23-03-00986.2003; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hao J, 2005, NEUROSCI LETT, V385, P18, DOI 10.1016/j.neulet.2005.05.028; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Honey CJ, 2008, HUM BRAIN MAPP, V29, P802, DOI 10.1002/hbm.20579; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Horwitz B, 1995, NEUROREPORT, V6, P2287, DOI 10.1097/00001756-199511270-00005; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kaiser M, 2007, PHILOS T R SOC A, V365, P3033, DOI 10.1098/rsta.2007.0007; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Karas GB, 2003, NEUROIMAGE, V18, P895, DOI 10.1016/S1053-8119(03)00041-7; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; Lindeboom J, 2004, EUR J PHARMACOL, V490, P83, DOI 10.1016/j.ejphar.2004.02.046; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mason Isobel, 2007, Nurs Stand, V22, P43; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Montez T, 2006, NEUROIMAGE, V33, P1117, DOI 10.1016/j.neuroimage.2006.06.066; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026121; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Prvulovic D, 2002, NEUROIMAGE, V17, P1403, DOI 10.1006/nimg.2002.1271; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sole-Padulles C, 2009, NEUROBIOL AGING, V30, P1114, DOI 10.1016/j.neurobiolaging.2007.10.008; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Villain N, 2008, J NEUROSCI, V28, P6174, DOI 10.1523/JNEUROSCI.1392-08.2008; Wang HY, 2008, LUPUS, V17, P638, DOI 10.1177/0961203308089408; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Woodard JL, 1998, NEUROPSYCHOLOGY, V12, P491, DOI 10.1037/0894-4105.12.4.491	71	420	437	5	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2010	5	11							e13788	10.1371/journal.pone.0013788	http://dx.doi.org/10.1371/journal.pone.0013788			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FY	21072180	Green Submitted, gold, Green Published			2022-12-25	WOS:000283645700010
J	Lahiri, A; Lahiri, A; Das, P; Vani, J; Shaila, MS; Chakravortty, D				Lahiri, Amit; Lahiri, Ayan; Das, Priyanka; Vani, Janakiraman; Shaila, M. S.; Chakravortty, Dipshikha			TLR 9 Activation in Dendritic Cells Enhances Salmonella Killing and Antigen Presentation via Involvement of the Reactive Oxygen Species	PLOS ONE			English	Article							CONTROLS PHAGOSOMAL PH; CROSS-PRESENTATION; NADPH OXIDASE; SURFACE EXPRESSION; OLIGONUCLEOTIDES; PHAGOCYTOSIS; MACROPHAGES; INHIBITION; GROWTH	Synthetic CpG containing oligodeoxynucleotide Toll like receptor-9 agonist (CpG DNA) activates innate immunity and can stimulate antigen presentation against numerous intracellular pathogens. It was observed that Salmonella Typhimurium growth can be inhibited by the CpG DNA treatment in the murine dendritic cells. This inhibitory effect was mediated by an increased reactive oxygen species production. In addition, it was noted that CpG DNA treatment of dendritic cells during Salmonella infection leads to an increased antigen presentation. Further this increased antigen presentation was dependent on the enhanced reactive oxygen species production elicited by Toll like receptor-9 activation. With the help of an exogenous antigen it was shown that Salmonella antigen could also be cross-presented in a better way by CpG induction. These data collectively indicate that CpG DNA enhance the ability of murine dendritic cells to contain the growth of virulent Salmonella through reactive oxygen species dependent killing.	[Lahiri, Amit] Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India; Indian Inst Sci, Dept Microbiol & Cell Biol, Biosafety Labs, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Lahiri, A (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India.	dipa@mcbl.iisc.ernet.in	Chakravortty, Dipshikha/AAI-4448-2020; J, Vani/B-4882-2013	Lahiri, Ayan/0000-0003-1621-2051; LAHIRI, AMIT/0000-0003-0307-3478; Chakravortty, Dipshikha/0000-0002-7838-5145	Indian Institute of Science, Bangalore, India [191/MCB]; Department of Biotechnology, India [DBT 197, DBT 172]	Indian Institute of Science, Bangalore, India; Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by the grant, Provision (2A) Tenth Plan (191/MCB) from the Director of Indian Institute of Science, Bangalore, India, and Department of Biotechnology (DBT 197 and DBT 172), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Cheminay C, 2005, J IMMUNOL, V174, P2892, DOI 10.4049/jimmunol.174.5.2892; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; Eguchi M, 2007, FEMS IMMUNOL MED MIC, V50, P411, DOI 10.1111/j.1574-695X.2007.00275.x; Ewaschuk JB, 2007, INFECT IMMUN, V75, P2572, DOI 10.1128/IAI.01662-06; Gong J, 2003, INT IMMUNOPHARMACOL, V3, P1841, DOI 10.1016/j.intimp.2003.08.010; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Halici S, 2008, INFECT IMMUN, V76, P4924, DOI 10.1128/IAI.00531-08; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Kaisho T, 2004, MICROBES INFECT, V6, P1388, DOI 10.1016/j.micinf.2004.08.019; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kirby AC, 2001, J IMMUNOL, V166, P6802, DOI 10.4049/jimmunol.166.11.6802; Lahiri A, 2008, VACCINE, V26, P6777, DOI 10.1016/j.vaccine.2008.09.045; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Lapaque N, 2009, P NATL ACAD SCI USA, V106, P14052, DOI 10.1073/pnas.0906735106; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Maemura K, 2005, IMMUNOL CELL BIOL, V83, P336, DOI 10.1111/j.1440-1711.2005.01323.x; Mantegazza AR, 2008, BLOOD, V112, P4712, DOI 10.1182/blood-2008-01-134791; Matsue H, 2003, J IMMUNOL, V171, P3010, DOI 10.4049/jimmunol.171.6.3010; McPhail L C, 1992, Immunol Ser, V57, P47; MCPHAIL LC, 1994, J EXP MED, V180, P2011, DOI 10.1084/jem.180.6.2011; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Riezman H, 1997, CELL, V91, P731, DOI 10.1016/S0092-8674(00)80461-4; Rock KL, 2003, NAT IMMUNOL, V4, P941, DOI 10.1038/ni1003-941; Sanchez-Campillo M, 2004, MICROBES INFECT, V6, P813, DOI 10.1016/j.micinf.2004.04.010; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Sousa CRE, 2001, IMMUNITY, V14, P495; Trieu A, 2009, IMMUNOL CELL BIOL, V87, P218, DOI 10.1038/icb.2008.95; Turpaev KT, 2002, BIOCHEMISTRY-MOSCOW+, V67, P281, DOI 10.1023/A:1014819832003; Vani J, 2007, CELL IMMUNOL, V246, P17, DOI 10.1016/j.cellimm.2007.05.001; Vani J, 2007, IMMUNOLOGY, V120, P486, DOI 10.1111/j.1365-2567.2006.02519.x; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Vulcano M, 2004, J IMMUNOL, V173, P5749, DOI 10.4049/jimmunol.173.9.5749; Wang JP, 2005, FEMS IMMUNOL MED MIC, V45, P303, DOI 10.1016/j.femsim.2005.05.007; Watson JL, 2006, CLIN CHIM ACTA, V364, P1, DOI 10.1016/j.cca.2005.05.017; Xiang SD, 2006, METHODS, V40, P1, DOI 10.1016/j.ymeth.2006.05.016; Yrlid U, 2001, MICROBES INFECT, V3, P1239, DOI 10.1016/S1286-4579(01)01484-8; Yrlid U, 2000, FEMS IMMUNOL MED MIC, V27, P313, DOI 10.1111/j.1574-695X.2000.tb01445.x; Zenk SF, 2009, J IMMUNOL, V183, P2697, DOI 10.4049/jimmunol.0900937	44	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13772	10.1371/journal.pone.0013772	http://dx.doi.org/10.1371/journal.pone.0013772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048937	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000283645300046
J	Roll, P; Sanlaville, D; Cillario, J; Labalme, A; Bruneau, N; Massacrier, A; Delepine, M; Dessen, P; Lazar, V; Robaglia-Schlupp, A; Lesca, G; Jouve, E; Rudolf, G; Rochette, J; Lathrop, GM; Szepetowski, P				Roll, Patrice; Sanlaville, Damien; Cillario, Jennifer; Labalme, Audrey; Bruneau, Nadine; Massacrier, Annick; Delepine, Marc; Dessen, Philippe; Lazar, Vladimir; Robaglia-Schlupp, Andree; Lesca, Gaetan; Jouve, Elisabeth; Rudolf, Gabrielle; Rochette, Jacques; Lathrop, G. Mark; Szepetowski, Pierre			Infantile Convulsions with Paroxysmal Dyskinesia (ICCA Syndrome) and Copy Number Variation at Human Chromosome 16p11	PLOS ONE			English	Article							KINESIGENIC DYSKINESIA; HUMAN GENOME; CHOREOATHETOSIS SYNDROME; LINKAGE; GENE; ASSOCIATION; SEIZURES; MUTATIONS; 16P12-Q12; FAMILIES	Background: Benign infantile convulsions and paroxysmal dyskinesia are episodic cerebral disorders that can share common genetic bases. They can be co-inherited as one single autosomal dominant trait (ICCA syndrome); the disease ICCA gene maps at chromosome 16p12-q12. Despite intensive and conventional mutation screening, the ICCA gene remains unknown to date. The critical area displays highly complicated genomic architecture and is the site of deletions and duplications associated with various diseases. The possibility that the ICCA syndrome is related to the existence of large-scale genomic alterations was addressed in the present study. Methodology/Principal Findings: A combination of whole genome and dedicated oligonucleotide array comparative genomic hybridization coupled with quantitative polymerase chain reaction was used. Low copy number of a region corresponding to a genomic variant (Variation_7105) located at 16p11 nearby the centromere was detected with statistical significance at much higher frequency in patients from ICCA families than in ethnically matched controls. The genomic variant showed no apparent difference in size and copy number between patients and controls, making it very unlikely that the genomic alteration detected here is ICCA-specific. Furthermore, no other genomic alteration that would directly cause the ICCA syndrome in those nine families was detected in the ICCA critical area. Conclusions/Significance: Our data excluded that inherited genomic deletion or duplication events directly cause the ICCA syndrome; rather, they help narrowing down the critical ICCA region dramatically and indicate that the disease ICCA genetic defect lies very close to or within Variation_7105 and hence should now be searched in the corresponding genomic area and its surrounding regions.	[Roll, Patrice; Robaglia-Schlupp, Andree] INSERM, U910, F-13258 Marseille, France; [Roll, Patrice; Cillario, Jennifer; Bruneau, Nadine; Massacrier, Annick; Robaglia-Schlupp, Andree; Szepetowski, Pierre] Univ Aix Marseille 2, Aix En Provence, France; [Sanlaville, Damien; Labalme, Audrey; Lesca, Gaetan] Hosp Civils Lyon, Serv Cytogenet Constitut, Lyon, France; [Sanlaville, Damien] Univ Lyon 1, EA 4171, F-69365 Lyon, France; [Cillario, Jennifer; Bruneau, Nadine; Massacrier, Annick; Szepetowski, Pierre] INSERM, U901, F-13258 Marseille, France; [Cillario, Jennifer; Bruneau, Nadine; Massacrier, Annick; Szepetowski, Pierre] INMED, Marseille, France; [Delepine, Marc; Lathrop, G. Mark] Univ Evry, CNG, Evry, France; [Dessen, Philippe] Inst Cancerol Gustave Roussy IGR, Unite Genom Fonct, Villejuif, France; [Jouve, Elisabeth] AP HM, CIC UPCET, Marseille, France; [Rudolf, Gabrielle] Hop Univ Strasbourg, Neurol Clin, Strasbourg, France; [Rochette, Jacques] INSERM, UMR925, Amiens, France; [Rochette, Jacques] Univ Picardie Jules Verne, Unite Neuropediat, Amiens, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Roll, P (corresponding author), INSERM, U910, F-13258 Marseille, France.	szepetowski@inmed.univ-mrs.fr	Sanlaville, Damien/M-4716-2014; Jouve, Elisabeth/GSN-9120-2022; Lazar, Vladimir/AAV-2087-2020; ROLL, Patrice/I-4355-2016; ROLL, Patrice/GLS-4467-2022; Lazar, Vladimir/AAQ-2086-2020; Lesca, Gaetan/C-6111-2019; Bruneau, Nadine/O-2100-2016	Sanlaville, Damien/0000-0001-9939-2849; Jouve, Elisabeth/0000-0002-4873-6522; ROLL, Patrice/0000-0002-0045-5641; ROLL, Patrice/0000-0002-0045-5641; Bruneau, Nadine/0000-0002-1523-3128; Rudolf, Gabrielle/0000-0002-2050-3911; Lesca, Gaetan/0000-0001-7691-9492	Institut National de la Sante Et de la Recherche Medicale (INSERM); Groupement d' Interet Scientifique (GIS)/Institut des Maladies Rares; French Ministere de la Recherche et de la Technologie (MRT)	Institut National de la Sante Et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Groupement d' Interet Scientifique (GIS)/Institut des Maladies Rares; French Ministere de la Recherche et de la Technologie (MRT)	This work was supported by Institut National de la Sante Et de la Recherche Medicale (INSERM) and by a grant from Groupement d' Interet Scientifique (GIS)/Institut des Maladies Rares. JC is a recipient of a French Ministere de la Recherche et de la Technologie (MRT) PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballif BC, 2007, NAT GENET, V39, P1071, DOI 10.1038/ng2107; Bayou N, 2008, COMP FUNCT GENOM, DOI 10.1155/2008/609684; Bennett LB, 2000, NEUROLOGY, V54, P125, DOI 10.1212/WNL.54.1.125; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Callenbach PMC, 2005, CLIN GENET, V67, P517, DOI 10.1111/j.1399-0004.2005.00445.x; Caraballo R, 2001, AM J HUM GENET, V68, P788, DOI 10.1086/318805; Caraballo RH, 2007, BENIGN FOCAL EPILEPS, P31; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Eichler EE, 1996, HUM MOL GENET, V5, P899, DOI 10.1093/hmg/5.7.899; Hahn KA, 2002, AM J HUM GENET, V70, P1349, DOI 10.1086/340092; HO G, 2005, BIOCHEM BIOPH RES CO, V336, P175; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kikuchi T, 2007, J HUM GENET, V52, P334, DOI 10.1007/s10038-007-0116-7; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lee HY, 2004, HUM MOL GENET, V13, P3161, DOI 10.1093/hmg/ddh330; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lee WL, 1998, HUM GENET, V103, P608, DOI 10.1007/s004390050876; Lipton J, 2009, NEUROLOGY, V73, P479, DOI 10.1212/WNL.0b013e3181b16393; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Loftus BJ, 1999, GENOMICS, V60, P295, DOI 10.1006/geno.1999.5927; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Martin J, 2004, NATURE, V432, P988, DOI 10.1038/nature03187; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Ng CC, 1999, GENE CHROMOSOME CANC, V26, P329, DOI 10.1002/(SICI)1098-2264(199912)26:4<329::AID-GCC7>3.0.CO;2-C; Rainier S, 2004, ARCH NEUROL-CHICAGO, V61, P1025, DOI 10.1001/archneur.61.7.1025; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rochette J, 2008, J MED GENET, V45, P773, DOI 10.1136/jmg.2008.059519; Rochette J, 2010, EPILEPTIC DISORD, V12, P199, DOI 10.1684/epd.2010.0328; Sadamatsu M, 1999, EPILEPSIA, V40, P942, DOI 10.1111/j.1528-1157.1999.tb00801.x; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Striano P, 2006, EPILEPSIA, V47, P1029, DOI 10.1111/j.1528-1167.2006.00521.x; Swoboda KJ, 2000, NEUROLOGY, V55, P224, DOI 10.1212/WNL.55.2.224; Szepetowski P, 1997, AM J HUM GENET, V61, P889, DOI 10.1086/514877; SZEPETOWSKI P, 2007, BENIGN FOCAL EPILEPS, P51; Thiriaux A, 2002, MOVEMENT DISORD, V17, P98, DOI 10.1002/mds.1195; Tomita H, 1999, AM J HUM GENET, V65, P1688, DOI 10.1086/302682; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Weber YG, 2004, EPILEPSIA, V45, P601, DOI 10.1111/j.0013-9580.2004.48203.x; Weber YG, 2008, J CLIN INVEST, V118, P2157, DOI 10.1172/JCI34438; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	43	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13750	10.1371/journal.pone.0013750	http://dx.doi.org/10.1371/journal.pone.0013750			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060786	Green Published, Green Submitted, gold			2022-12-25	WOS:000283645300029
J	Harris, GM; Dodelzon, K; Gong, LJ; Gonzalez-Alegre, P; Paulson, HL				Harris, Ginny Marie; Dodelzon, Katerina; Gong, Lijie; Gonzalez-Alegre, Pedro; Paulson, Henry L.			Splice Isoforms of the Polyglutamine Disease Protein Ataxin-3 Exhibit Similar Enzymatic yet Different Aggregation Properties	PLOS ONE			English	Article							MACHADO-JOSEPH-DISEASE; MESSENGER-RNA DECAY; NUCLEAR-LOCALIZATION; GENOMIC STRUCTURE; TRANSGENIC MICE; GENE; IDENTIFICATION; PATHWAY; CELLS; EXPANSIONS	Protein context clearly influences neurotoxicity in polyglutamine diseases, but the contribution of alternative splicing to this phenomenon has rarely been investigated. Ataxin-3, a deubiquitinating enzyme and the disease protein in SCA3, is alternatively spliced to encode either a C-terminal hydrophobic stretch or a third ubiquitin interacting motif (termed 2UIM and 3UIM isoforms, respectively). In light of emerging insights into ataxin-3 function, we examined the significance of this splice variation. We confirmed neural expression of several minor 5' variants and both of the known 3' ataxin-3 splice variants. Regardless of polyglutamine expansion, 3UIM ataxin-3 is the predominant isoform in brain. Although 2UIM and 3UIM ataxin-3 display similar in vitro deubiquitinating activity, 2UIM ataxin-3 is more prone to aggregate and more rapidly degraded by the proteasome. Our data demonstrate how alternative splicing of sequences distinct from the trinucleotide repeat can alter properties of the encoded polyglutamine disease protein and thereby perhaps contribute to selective neurotoxicity.	[Harris, Ginny Marie] Univ Iowa, Grad Program Mol & Cellular Biol, Iowa City, IA 52242 USA; [Harris, Ginny Marie] Univ Iowa, Med Sci Training Program, Iowa City, IA USA; [Dodelzon, Katerina] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Gong, Lijie; Paulson, Henry L.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Gonzalez-Alegre, Pedro] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Michigan System; University of Michigan; University of Iowa	Harris, GM (corresponding author), Univ Iowa, Grad Program Mol & Cellular Biol, Iowa City, IA 52242 USA.	henryp@umich.edu			NIH (NIND) [RO1 38712]; University of Iowa; Glenn Labs	NIH (NIND)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Iowa; Glenn Labs	We thank Sue Travis for invaluable advice on recombinant protein expression and in vitro DUB assays, Fredrick Oakley for his generous gifts of time and expertise in 2D-PAGE, Sokol Todi and Edgar Rodriguez for their insights into experimental design and interpretation, and Tina Knudson for preliminary management of the transgenic lines. We are grateful to Charles Brenner and Matthew Wean for providing the equipment and technical expertise necessary to complete the Ub-AMC assays. We also are grateful to all members of the Paulson, Gonzalez-Alegre, and Glenn Labs for their support and comments.; This work was funded by the NIH (NIND RO1 38712 to HLP), the University of Iowa Molecular and Cellular Biology Training Grant, and the University of Iowa Medical Scientist Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affaitati A, 2001, GENE, V267, P89, DOI 10.1016/S0378-1119(01)00402-4; BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Bettencourt C, 2010, NEUROGENETICS, V11, P193, DOI 10.1007/s10048-009-0216-y; Bichelmeier U, 2007, J NEUROSCI, V27, P7418, DOI 10.1523/JNEUROSCI.4540-06.2007; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Cemal CK, 2002, HUM MOL GENET, V11, P1075, DOI 10.1093/hmg/11.9.1075; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Costa MD, 2002, J HUM GENET, V47, P205; Einum DD, 2003, ARCH NEUROL-CHICAGO, V60, P97, DOI 10.1001/archneur.60.1.97; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Goto J, 1997, NEUROSCI RES, V28, P373, DOI 10.1016/S0168-0102(97)00056-4; Hirata S, 2003, TRENDS ENDOCRIN MET, V14, P124, DOI 10.1016/S1043-2760(03)00028-6; Ichikawa Y, 2001, J HUM GENET, V46, P413, DOI 10.1007/s100380170060; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kanumilli S, 2006, PHYSIOL GENOMICS, V24, P86, DOI 10.1152/physiolgenomics.00149.2005; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; Matsuyama Z, 2004, NEUROBIOL DIS, V17, P198, DOI 10.1016/j.nbd.2004.07.013; Mueller T, 2009, HUM MOL GENET, V18, P3334, DOI 10.1093/hmg/ddp274; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Paulson HL, 1997, ANN NEUROL, V41, P453, DOI 10.1002/ana.410410408; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; Reid SJ, 2009, BRAIN RES, V1268, P190, DOI 10.1016/j.brainres.2009.03.004; Sahba S, 1998, GENOMICS, V47, P359, DOI 10.1006/geno.1997.5131; Saunders HM, 2009, PROTEIN ENG DES SEL, V22, P447, DOI 10.1093/protein/gzp033; Schmidt T, 1998, BRAIN PATHOL, V8, P669, DOI 10.1111/j.1750-3639.1998.tb00193.x; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Silva AL, 2009, FEBS LETT, V583, P499, DOI 10.1016/j.febslet.2008.12.058; Tadokoro K, 2005, J HUM GENET, V50, P382, DOI 10.1007/s10038-005-0261-9; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Tsunemi T, 2008, NEUROSCI LETT, V447, P78, DOI 10.1016/j.neulet.2008.09.065; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Williams AJ, 2009, NEUROBIOL DIS, V33, P342, DOI 10.1016/j.nbd.2008.10.016; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Yang F, 2009, NEUROSCI LETT, V454, P203, DOI 10.1016/j.neulet.2009.03.027; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	42	46	46	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13695	10.1371/journal.pone.0013695	http://dx.doi.org/10.1371/journal.pone.0013695			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060878	Green Published, Green Submitted, gold			2022-12-25	WOS:000283537000056
J	Rosen, DB; Minden, MD; Kornblau, SM; Cohen, A; Gayko, U; Putta, S; Woronicz, J; Evensen, E; Fantl, WJ; Cesano, A				Rosen, David B.; Minden, Mark D.; Kornblau, Steven M.; Cohen, Aileen; Gayko, Urte; Putta, Santosh; Woronicz, John; Evensen, Erik; Fantl, Wendy J.; Cesano, Alessandra			Functional Characterization of FLT3 Receptor Signaling Deregulation in Acute Myeloid Leukemia by Single Cell Network Profiling (SCNP)	PLOS ONE			English	Article							INTERNAL TANDEM DUPLICATION; ACUTE MYELOGENOUS LEUKEMIA; OPERATING CHARACTERISTIC CURVES; HEMATOPOIETIC STEM-CELLS; NORMAL CYTOGENETICS; PROGNOSTIC-SIGNIFICANCE; GENE-MUTATIONS; NUCLEOPHOSMIN NPM1; TYROSINE KINASE; FAVORABLE PROGNOSIS	Background: Molecular characterization of the FMS-like tyrosine kinase 3 receptor (FLT3) in cytogenetically normal acute myeloid leukemia (AML) has recently been incorporated into clinical guidelines based on correlations between FLT3 internal tandem duplications (FLT3-ITD) and decreased disease-free and overall survival. These mutations result in constitutive activation of FLT3, and FLT3 inhibitors are currently undergoing trials in AML patients selected on FLT3 molecular status. However, the transient and partial responses observed suggest that FLT3 mutational status alone does not provide complete information on FLT3 biological activity at the individual patient level. Examination of variation in cellular responsiveness to signaling modulation may be more informative. Methodology/Principal Findings: Using single cell network profiling (SCNP), cells were treated with extracellular modulators and their functional responses were quantified by multiparametric flow cytometry. Intracellular signaling responses were compared between healthy bone marrow myeloblasts (BMMb) and AML leukemic blasts characterized as FLT3 wild type (FLT3-WT) or FLT3-ITD. Compared to healthy BMMb, FLT3-WT leukemic blasts demonstrated a wide range of signaling responses to FLT3 ligand (FLT3L), including elevated and sustained PI3K and Ras/Raf/Erk signaling. Distinct signaling and apoptosis profiles were observed in FLT3-WT and FLT3-ITD AML samples, with more uniform signaling observed in FLT3-ITD AML samples. Specifically, increased basal p-Stat5 levels, decreased FLT3L induced activation of the PI3K and Ras/Raf/Erk pathways, decreased IL-27 induced activation of the Jak/Stat pathway, and heightened apoptotic responses to agents inducing DNA damage were observed in FLT3-ITD AML samples. Preliminary analysis correlating these findings with clinical outcomes suggests that classification of patient samples based on signaling profiles may more accurately reflect FLT3 signaling deregulation and provide additional information for disease characterization and management. Conclusions/Significance: These studies show the feasibility of SCNP to assess modulated intracellular signaling pathways and characterize the biology of individual AML samples in the context of genetic alterations.	[Rosen, David B.; Cohen, Aileen; Gayko, Urte; Putta, Santosh; Woronicz, John; Evensen, Erik; Fantl, Wendy J.; Cesano, Alessandra] Nodality Inc, San Francisco, CA USA; [Minden, Mark D.] Univ Toronto, Princess Margaret Hosp, Dept Med Oncol Hematol, Toronto, ON, Canada; [Kornblau, Steven M.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Texas System; UTMD Anderson Cancer Center	Rosen, DB (corresponding author), Nodality Inc, San Francisco, CA USA.	Alessandra.Cesano@Nodality.com			Nodality, Inc.	Nodality, Inc.	Funding for these studies was provided by Nodality, Inc.. Employees and stockholders of Nodality, Inc., participated in all aspects of the manuscript.	Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Baldus CD, 2006, J CLIN ONCOL, V24, P790, DOI 10.1200/JCO.2005.01.6253; Beran M, 2004, LEUKEMIA RES, V28, P547, DOI 10.1016/j.leukres.2003.09.016; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Bruserud O, 1998, CYTOKINES CELL MOL T, V4, P187; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Choudhary C, 2005, BLOOD, V106, P265, DOI 10.1182/blood-2004-07-2942; Choudhary C, 2007, BLOOD, V110, P370, DOI 10.1182/blood-2006-05-024018; Covey TM, 2010, ASSAY DRUG DEV TECHN, V8, P321, DOI 10.1089/adt.2009.0251; de Jonge-Peeters SDPWM, 2007, CRIT REV ONCOL HEMAT, V62, P214, DOI 10.1016/j.critrevonc.2007.02.003; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; DOSIL M, 1993, MOL CELL BIOL, V13, P6572, DOI 10.1128/MCB.13.10.6572; Frohling S, 2002, BLOOD, V100, P4372, DOI 10.1182/blood-2002-05-1440; Gale RE, 2005, BLOOD, V106, P3658, DOI 10.1182/blood-2005-03-1323; Gale RE, 2008, BLOOD, V111, P2776, DOI 10.1182/blood-2007-08-109090; Gorello P, 2006, LEUKEMIA, V20, P1103, DOI 10.1038/sj.leu.2404149; Green CL, 2010, J CLIN ONCOL, V28, P2739, DOI 10.1200/JCO.2009.26.2501; Grundler R, 2005, BLOOD, V105, P4792, DOI 10.1182/blood-2004-11-4430; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hayakawa F, 2000, ONCOGENE, V19, P624, DOI 10.1038/sj.onc.1203354; Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Iwai T, 1999, LEUKEMIA, V13, P38, DOI 10.1038/sj.leu.2401241; Kayser S, 2009, BLOOD, V114, P2386, DOI 10.1182/blood-2009-03-209999; Kikushige Y, 2008, J IMMUNOL, V180, P7358, DOI 10.4049/jimmunol.180.11.7358; Kiyoi H, 1999, BLOOD, V93, P3074; Kondo M, 1999, MED PEDIATR ONCOL, V33, P525; Kornblau SM, 2010, CLIN CANCER RES, V16, P3721, DOI 10.1158/1078-0432.CCR-10-0093; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Lavagna-Sevenier C, 1998, LEUKEMIA, V12, P301, DOI 10.1038/sj.leu.2400921; Lyman SD, 1998, BLOOD, V91, P1101, DOI 10.1182/blood.V91.4.1101; Marcucci G, 2005, CURR OPIN HEMATOL, V12, P68, DOI 10.1097/01.moh.0000149608.29685.d1; Meshinchi S, 2001, BLOOD, V97, P89, DOI 10.1182/blood.V97.1.89; Meshinchi S, 2008, BLOOD, V111, P4930, DOI 10.1182/blood-2008-01-117770; Meshinchi S, 2009, CLIN CANCER RES, V15, P4263, DOI 10.1158/1078-0432.CCR-08-1123; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Moreno I, 2003, HAEMATOLOGICA, V88, P19; OBERMANN EC, 2010, ANN HEMATOL; Pradhan A, 2007, P NATL ACAD SCI USA, V104, P18502, DOI 10.1073/pnas.0702388104; Rosnet O, 1996, ACTA HAEMATOL-BASEL, V95, P218; Rusten LS, 1996, BLOOD, V87, P1317, DOI 10.1182/blood.V87.4.1317.bloodjournal8741317; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schnittger S, 2005, BLOOD, V106, P3733, DOI 10.1182/blood-2005-06-2248; Scholl C, 2008, SEMIN ONCOL, V35, P336, DOI 10.1053/j.seminoncol.2008.04.004; Seedhouse C, 2009, CLIN CANCER RES, V15, P7291, DOI 10.1158/1078-0432.CCR-09-1222; Seita J, 2008, BLOOD, V111, P1903, DOI 10.1182/blood-2007-06-093328; Shah AJ, 1996, BLOOD, V87, P3563, DOI 10.1182/blood.V87.9.3563.bloodjournal8793563; Sheikhha Mohammad Hasan, 2003, Hematol J, V4, P41, DOI 10.1038/sj.thj.6200224; Srinivasa SP, 2002, LEUKEMIA, V16, P244, DOI 10.1038/sj.leu.2402367; Stelzer GT, 2000, IMMUNOPHENOTYPING, P215; Stirewalt DL, 2006, BLOOD, V107, P3724, DOI 10.1182/blood-2005-08-3453; Svirnovski AI, 2009, HEMATOLOGY, V14, P204, DOI 10.1179/102453309X426218; Tang JL, 2009, BLOOD, V114, P5352, DOI 10.1182/blood-2009-05-223784; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Touw IP, 2007, FRONT BIOSCI-LANDMRK, V12, P800, DOI 10.2741/2103; Verhaak RGW, 2005, BLOOD, V106, P3747, DOI 10.1182/blood-2005-05-2168; Whitman SP, 2001, CANCER RES, V61, P7233; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Zhang SL, 2000, BIOCHEM BIOPH RES CO, V277, P195, DOI 10.1006/bbrc.2000.3662; Zhang SL, 1999, J LEUKOCYTE BIOL, V65, P372, DOI 10.1002/jlb.65.3.372	68	22	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13543	10.1371/journal.pone.0013543	http://dx.doi.org/10.1371/journal.pone.0013543			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048955	Green Published, gold, Green Submitted			2022-12-25	WOS:000283537000005
J	Wang, YW; Devkota, S; Musch, MW; Jabri, B; Nagler, C; Antonopoulos, DA; Chervonsky, A; Chang, EB				Wang, Yunwei; Devkota, Suzanne; Musch, Mark W.; Jabri, Bana; Nagler, Cathryn; Antonopoulos, Dionysios A.; Chervonsky, Alexander; Chang, Eugene B.			Regional Mucosa-Associated Microbiota Determine Physiological Expression of TLR2 and TLR4 in Murine Colon	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; VITAMIN-D-RECEPTOR; INNATE IMMUNITY; DISTAL COLON; GUT; INTESTINE; FLORA; DIVERSITY; COLONIZATION; BACTERIA	Many colonic mucosal genes that are highly regulated by microbial signals are differentially expressed along the rostral-caudal axis. This would suggest that differences in regional microbiota exist, particularly mucosa-associated microbes that are less likely to be transient. We therefore explored this possibility by examining the bacterial populations associated with the normal proximal and distal colonic mucosa in context of host Toll-like receptors (TLR) expression in C57BL/6J mice housed in specific pathogen-free (SPF) and germ-free (GF) environments. 16S rRNA gene-based terminal restriction fragment length polymorphism (T-RFLP) and clone library analysis revealed significant differences in the community structure and diversity of the mucosa-associated microbiota located in the distal colon compared to proximal colon and stool, the latter two clustering closely. Differential expression of colonic TLR2 and TLR4 along the proximal-distal axis was also found in SPF mice, but not in GF mice, suggesting that enteric microbes are essential in maintaining the regional expression of these TLRs. TLR2 is more highly expressed in proximal colon and decreases in a gradient to distal while TLR4 expression is highest in distal colon and a gradient of decreased expression to proximal colon is observed. After transfaunation in GF mice, both regional colonization of mucosa-associated microbes and expression of TLRs in the mouse colon were reestablished. In addition, exposure of the distal colon to cecal (proximal) microbiota induced TLR2 expression. These results demonstrate that regional colonic mucosa-associated microbiota determine the region-specific expression of TLR2 and TLR4. Conversely, region-specific host assembly rules are essential in determining the structure and function of mucosa-associated microbial populations. We believe this type of host-microbial mutualism is pivotal to the maintenance of intestinal and immune homeostasis.	[Wang, Yunwei; Devkota, Suzanne; Musch, Mark W.; Jabri, Bana; Antonopoulos, Dionysios A.; Chang, Eugene B.] Univ Chicago, Knapp Ctr Biomed Discovery, Dept Med, Chicago, IL 60637 USA; [Nagler, Cathryn; Chervonsky, Alexander] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Antonopoulos, Dionysios A.] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA	University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Wang, YW (corresponding author), Univ Chicago, Knapp Ctr Biomed Discovery, Dept Med, Chicago, IL 60637 USA.	echang@medicine.bsd.uchicago.edu	Devkota, Suzanne/AAG-1958-2021; Antonopoulos, Dionysios/ABE-6212-2020	Devkota, Suzanne/0000-0001-5575-9362; Antonopoulos, Dionysios/0000-0002-2238-5031; Chervonsky, Alexander/0000-0001-7547-871X	Human Microbiome Project [DK083993, HG004858]; Digestive Disease Research Core Center of the University of Chicago [DK-42086]; Crohns and Colitis Foundation of America;  [R37 DK47722];  [F31 AT006073-01]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [F31AT006073] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083993, UH3DK083993, P30DK042086, R37DK047722] Funding Source: NIH RePORTER	Human Microbiome Project; Digestive Disease Research Core Center of the University of Chicago(University of Chicago); Crohns and Colitis Foundation of America; ; ; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Human Microbiome Project (DK083993, HG004858), R37 DK47722 (EBC), the Digestive Disease Research Core Center DK-42086 of the University of Chicago, F31 AT006073-01 (SD), and Research Fellowship Award (YW) from the Crohns and Colitis Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelbaqi M, 2006, LAB INVEST, V86, P380, DOI 10.1038/labinvest.3700398; Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Arvans DL, 2005, AM J PHYSIOL-GASTR L, V288, pG696, DOI 10.1152/ajpgi.00206.2004; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BAUER H, 1963, AM J PATHOL, V42, P471; Bogunovic M, 2007, AM J PHYSIOL-GASTR L, V292, pG1770, DOI 10.1152/ajpgi.00249.2006; Chowdhury Shankar R, 2007, BMC Genomics, V8, P215, DOI 10.1186/1471-2164-8-215; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Comelli EM, 2008, GENOMICS, V91, P70, DOI 10.1016/j.ygeno.2007.09.006; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; He WM, 2003, GASTROENTEROLOGY, V125, P1388, DOI 10.1016/j.gastro.2003.07.009; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hu SE, 2009, AM J PHYSIOL-GASTR L, V296, pG1003, DOI 10.1152/ajpgi.00027.2009; Kong J, 2008, AM J PHYSIOL-GASTR L, V294, pG208, DOI 10.1152/ajpgi.00398.2007; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Love W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010739; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lundin A, 2008, CELL MICROBIOL, V10, P1093, DOI 10.1111/j.1462-5822.2007.01108.x; MICHIE MG, 1982, J INT ASS MATH GEOL, V14, P661, DOI 10.1007/BF01033886; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; Rijcken E, 2007, AM J PHYSIOL-GASTR L, V293, pG446, DOI 10.1152/ajpgi.00097.2007; Sodir NM, 2006, CANCER RES, V66, P8430, DOI 10.1158/0008-5472.CAN-06-1437; Su WD, 2007, PHYSIOL GENOMICS, V30, P342, DOI 10.1152/physiolgenomics.00042.2007; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Voltan S, 2007, CLIN VACCINE IMMUNOL, V14, P1138, DOI 10.1128/CVI.00079-07; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Waterhouse JC, 2009, ANN NY ACAD SCI, V1173, P757, DOI 10.1111/j.1749-6632.2009.04637.x; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	31	101	104	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13607	10.1371/journal.pone.0013607	http://dx.doi.org/10.1371/journal.pone.0013607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042588	Green Published, Green Submitted, gold			2022-12-25	WOS:000283419100025
J	Prykhozhij, SV				Prykhozhij, Sergey V.			In the Absence of Sonic Hedgehog, p53 Induces Apoptosis and Inhibits Retinal Cell Proliferation, Cell-Cycle Exit and Differentiation in Zebrafish	PLOS ONE			English	Article							PROTEIN-KINASE-A; STEM-CELL; REGULATES PROLIFERATION; FATE DETERMINATION; SIGNALING PATHWAY; TUMOR SUPPRESSION; CDK INHIBITOR; NEURAL-TUBE; EXPRESSION; GROWTH	Background: Sonic hedgehog (Shh) signaling regulates cell proliferation during vertebrate development via induction of cell-cycle regulator gene expression or activation of other signalling pathways, prevents cell death by an as yet unclear mechanism and is required for differentiation of retinal cell types. Thus, an unsolved question is how the same signalling molecule can regulate such distinct cell processes as proliferation, cell survival and differentiation. Methodology/Principal Findings: Analysis of the zebrafish shh(-/-) mutant revealed that in this context p53 mediates elevated apoptosis during nervous system and retina development and interferes with retinal proliferation and differentiation. While in shh(-/-) mutants there is activation of p53 target genes and p53-mediated apoptosis, an increase in Hedgehog (Hh) signalling by over-expression of dominant-negative Protein Kinase A strongly decreased p53 target gene expression and apoptosis levels in shh(-/-) mutants. Using a novel p53 reporter transgene, I confirm that p53 is active in tissues that require Shh for cell survival. Proliferation assays revealed that loss of p53 can rescue normal cell-cycle exit and the mitotic indices in the shh(-/-) mutant retina at 24, 36 and 48 hpf. Moreover, generation of amacrine cells and photoreceptors was strongly enhanced in the double p53(-/-) shh(-/-) mutant retina suggesting the effect of p53 on retinal differentiation. Conclusions: Loss of Shh signalling leads to the p53-dependent apoptosis in the developing nervous system and retina. Moreover, Shh-mediated control of p53 activity is required for proliferation and cell cycle exit of retinal cells as well as differentiation of amacrine cells and photoreceptors.	[Prykhozhij, Sergey V.] European Mol Biol Lab, Dev Biol Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Prykhozhij, SV (corresponding author), Max Planck Inst Mol Genet, Berlin, Germany.	rykhozh@embl.de			European Molecular Biology Laboratory (EMBL); EMBL; EMBL Heidelberg	European Molecular Biology Laboratory (EMBL); EMBL; EMBL Heidelberg	The study was supported by laboratory budget funds from European Molecular Biology Laboratory (EMBL) Heidelberg in the labs of Carl Neumann and Francesca Peri. The author was supported by a fellowship from EMBL International PhD Program and later by a post-doctoral fellowship from EMBL Heidelberg, web address: http://www.embl.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2008, P NATL ACAD SCI USA, V105, P4838, DOI 10.1073/pnas.0712216105; Ahlgren SC, 1999, CURR BIOL, V9, P1304, DOI 10.1016/S0960-9822(00)80052-4; Altaba AR, 2003, CURR OPIN GENET DEV, V13, P513, DOI 10.1016/j.gde.2003.08.005; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Bilitou A, 2010, DEV DYNAM, V239, P727, DOI 10.1002/dvdy.22223; Borycki AG, 1999, DEVELOPMENT, V126, P4053; Britto J, 2002, NAT NEUROSCI, V5, P103, DOI 10.1038/nn797; Burke R, 1996, DEVELOPMENT, V122, P2261; Cai C, 2008, STEM CELLS, V26, P1097, DOI 10.1634/stemcells.2007-0684; Cayuso J, 2006, DEVELOPMENT, V133, P517, DOI 10.1242/dev.02228; CHAO MV, 2003, SCI STKE, pPE38; Charrier JB, 2001, DEVELOPMENT, V128, P4011; Chen HY, 2007, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2007/03/005; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Dorak M.T., 2006, REAL TIME PCR, P89; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Dyer MA, 2001, J COMP NEUROL, V429, P601; Fan HR, 1999, J CELL BIOL, V147, P71, DOI 10.1083/jcb.147.1.71; Fischer S, 2007, CELL CYCLE, V6, P2962, DOI 10.4161/cc.6.23.4950; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Guerrero I, 2003, SCIENCE, V301, P774, DOI 10.1126/science.1088625; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jensen AM, 1997, DEVELOPMENT, V124, P363; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Jia JL, 2007, MOL CELL BIOL, V27, P7236, DOI 10.1128/MCB.00780-07; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jowett T, 2001, METHODS, V23, P345, DOI 10.1006/meth.2000.1147; Katoh Y, 2008, INT J ONCOL, V33, P881, DOI 10.3892/ijo_00000076; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Kok FO, 2007, DEV BIOL, V307, P214, DOI 10.1016/j.ydbio.2007.04.039; Kratz E, 2006, CELL DEATH DIFFER, V13, P1631, DOI 10.1038/sj.cdd.4402016; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Langenau DM, 2005, BLOOD, V105, P3278, DOI 10.1182/blood-2004-08-3073; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lee KC, 2008, ONCOGENE, V27, P629, DOI 10.1038/sj.onc.1210695; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Levine EM, 1997, J NEUROSCI, V17, P6277; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Locker M, 2006, GENE DEV, V20, P3036, DOI 10.1101/gad.391106; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; Masai I, 2005, DEVELOPMENT, V132, P1539, DOI 10.1242/dev.01714; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Michalak E, 2005, BIOCHEM BIOPH RES CO, V331, P786, DOI 10.1016/j.bbrc.2005.03.183; Moshiri A, 2005, DEV DYNAM, V233, P66, DOI 10.1002/dvdy.20299; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Neumann CJ, 2000, SCIENCE, V289, P2137, DOI 10.1126/science.289.5487.2137; Neumann CJ, 2005, CELL CYCLE, V4, P1139, DOI 10.4161/cc.4.9.1999; Ohnuma S, 2002, DEVELOPMENT, V129, P2435; Ohnuma S, 1999, CELL, V99, P499, DOI 10.1016/S0092-8674(00)81538-X; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Park HC, 2005, J NEUROSCI, V25, P6836, DOI 10.1523/JNEUROSCI.0981-05.2005; Plaster N, 2006, CELL DEATH DIFFER, V13, P223, DOI 10.1038/sj.cdd.4401747; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; SECCHIERO P, 2009, BLOOD; SHKUMATAVA A, 2005, EMBO REPORTS, P563; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Stenkamp DL, 2003, DEV BIOL, V258, P349, DOI 10.1016/S0012-1606(03)00121-0; Stenkamp DL, 2002, DEV DYNAM, V225, P344, DOI 10.1002/dvdy.10165; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Ungar AR, 1996, DEV BIOL, V178, P186, DOI 10.1006/dbio.1996.0209; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Vernon AE, 2006, EMBO REP, V7, P643, DOI 10.1038/sj.embor.7400691; Wang YP, 2005, DEVELOPMENT, V132, P5103, DOI 10.1242/dev.02096; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Yamaguchi M, 2008, DEVELOPMENT, V135, P1247, DOI 10.1242/dev.011015; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zhang JK, 2004, NAT GENET, V36, P351, DOI 10.1038/ng1318; Zhang WW, 2000, J BIOTECHNOL, V84, P79, DOI 10.1016/S0168-1656(00)00330-8	82	26	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13549	10.1371/journal.pone.0013549	http://dx.doi.org/10.1371/journal.pone.0013549			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042410	Green Published, gold, Green Submitted			2022-12-25	WOS:000283293800016
J	Acehan, D; Vaz, F; Houtkooper, RH; James, J; Moore, V; Tokunaga, C; Kulik, W; Wansapura, J; Toth, MJ; Strauss, A; Khuchua, Z				Acehan, Devrim; Vaz, Frederic; Houtkooper, Riekelt H.; James, Jeanne; Moore, Vicky; Tokunaga, Chonan; Kulik, Willem; Wansapura, Janaka; Toth, Matthew J.; Strauss, Arnold; Khuchua, Zaza			Cardiac and Skeletal Muscle Defects in a Mouse Model of Human Barth Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT PHOSPHOLIPASE A(2); MASS-SPECTROMETRY; HEART-FAILURE; GENE KNOCKDOWN; CARDIOLIPIN; MITOCHONDRIA; MICE; LIPIDOMICS; BRAIN; CARDIOMYOPATHY	Barth syndrome is an X-linked genetic disorder caused by mutations in the tafazzin (taz) gene and characterized by dilated cardiomyopathy, exercise intolerance, chronic fatigue, delayed growth, and neutropenia. Tafazzin is a mitochondrial transacylase required for cardiolipin remodeling. Although tafazzin function has been studied in non-mammalian model organisms, mammalian genetic loss of function approaches have not been used. We examined the consequences of tafazzin knockdown on sarcomeric mitochondria and cardiac function in mice. Tafazzin knockdown resulted in a dramatic decrease of tetralinoleoyl cardiolipin in cardiac and skeletal muscles and accumulation of monolysocardiolipins and cardiolipin molecular species with aberrant acyl groups. Electron microscopy revealed pathological changes in mitochondria, myofibrils, and mitochondrion-associated membranes in skeletal and cardiac muscles. Echocardiography and magnetic resonance imaging revealed severe cardiac abnormalities, including left ventricular dilation, left ventricular mass reduction, and depression of fractional shortening and ejection fraction in tafazzin-deficient mice. Tafazzin knockdown mice provide the first mammalian model system for Barth syndrome in which the pathophysiological relationships between altered content of mitochondrial phospholipids, ultrastructural abnormalities, myocardial and mitochondrial dysfunction, and clinical outcome can be completely investigated.	[James, Jeanne; Moore, Vicky; Tokunaga, Chonan; Wansapura, Janaka; Strauss, Arnold; Khuchua, Zaza] Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [James, Jeanne; Moore, Vicky; Tokunaga, Chonan; Wansapura, Janaka; Strauss, Arnold; Khuchua, Zaza] Univ Cincinnati, Cincinnati, OH 45229 USA; [Vaz, Frederic; Kulik, Willem] Univ Amsterdam, Acad Med Ctr, NL-1100 DE Amsterdam, Netherlands; [Houtkooper, Riekelt H.] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland; [Acehan, Devrim] NYU, Langone Med Ctr, Skirball Inst, New York, NY 10016 USA; [Toth, Matthew J.] Barth Syndrome Fdn Inc, Iselin, NJ 08830 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Amsterdam; Academic Medical Center Amsterdam; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; New York University; NYU Langone Medical Center	Khuchua, Z (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, MLC 7020, Cincinnati, OH 45229 USA.	zaza.khuchua@cchmc.org	Khuchua, Zaza/J-6536-2016; Houtkooper, Riekelt H/E-1602-2011; Houtkooper, Riekelt/P-5001-2019	Khuchua, Zaza/0000-0003-3582-5670; Houtkooper, Riekelt H/0000-0001-9961-0842; Vaz, Frederic/0000-0002-9048-1041	Barth Syndrome Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108867, K25HL102244] Funding Source: NIH RePORTER	Barth Syndrome Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the Barth Syndrome Foundation (to Z. K.).	Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480; Acehan D, 2009, MITOCHONDRION, V9, P86, DOI 10.1016/j.mito.2008.12.001; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Bissler JJ, 2002, LAB INVEST, V82, P335, DOI 10.1038/labinvest.3780427; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486; Cheng H, 2008, BIOCHEMISTRY-US, V47, P5869, DOI 10.1021/bi7023282; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; EILERS M, 1989, J BIOL CHEM, V264, P2945; Exil VJ, 2003, CIRC RES, V93, P448, DOI 10.1161/01.RES.0000088786.19197.E4; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Haiens TH, 2002, FEBS LETT, V528, P35, DOI 10.1016/S0014-5793(02)03292-1; Han XL, 2005, BIOCHEMISTRY-US, V44, P16684, DOI 10.1021/bi051908a; HAWKINS WE, 1980, CELL TISSUE RES, V209, P87; Heerdt PM, 2002, ANN THORAC SURG, V73, P1216, DOI 10.1016/S0003-4975(01)03621-9; Hinton RB, 2008, AM J PHYSIOL-HEART C, V294, pH2480, DOI 10.1152/ajpheart.91431.2007; Houtkooper RH, 2006, FEBS LETT, V580, P3059, DOI 10.1016/j.febslet.2006.04.054; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032; Jagerstrom S, 2009, CELL BIOL INT, V33, P934, DOI 10.1016/j.cellbi.2009.06.011; KELLEY RI, 1991, J PEDIATR-US, V119, P738, DOI 10.1016/S0022-3476(05)80289-6; Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200; Kiebish MA, 2008, LIPIDS, V43, P951, DOI 10.1007/s11745-008-3197-y; Kiebish MA, 2010, J LIPID RES, V51, P2153, DOI 10.1194/jlr.M004796; Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007; Kulik W, 2008, CLIN CHEM, V54, P371, DOI 10.1373/clinchem.2007.095711; Lacombe ML, 2009, BIOCHIMIE, V91, P779, DOI 10.1016/j.biochi.2009.02.006; Lee HJ, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-2; Lesnefsky EJ, 2008, BBA-BIOENERGETICS, V1777, P1020, DOI 10.1016/j.bbabio.2008.05.444; Lesnefsky EJ, 2009, J MOL CELL CARDIOL, V46, P1008, DOI 10.1016/j.yjmcc.2009.03.007; Lesnefsky EJ, 2004, AM J PHYSIOL-HEART C, V287, pH258, DOI 10.1152/ajpheart.00348.2003; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; Sandra F, 2005, CANCER RES, V65, P8286, DOI 10.1158/0008-5472.CAN-04-1913; SCHLAME M, 1993, EUR J BIOCHEM, V212, P727, DOI 10.1111/j.1432-1033.1993.tb17711.x; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; SCHLAME M, 1991, EUR J BIOCHEM, V199, P459, DOI 10.1111/j.1432-1033.1991.tb16144.x; Schlattner U, 2009, BBA-BIOMEMBRANES, V1788, P2032, DOI 10.1016/j.bbamem.2009.04.018; Seibler J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni065; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; Sparagna GC, 2005, J LIPID RES, V46, P1196, DOI 10.1194/jlr.M500031-JLR200; Sparagna GC, 2007, J LIPID RES, V48, P1559, DOI 10.1194/jlr.M600551-JLR200; SVOBODA DJ, 1964, AM J PATHOL, V44, P645; Valianpour F, 2002, J PEDIATR-US, V141, P729, DOI 10.1067/mpd.2002.129174; van Gestel RA, 2010, J PROTEOMICS, V73, P806, DOI 10.1016/j.jprot.2009.11.009; Wada J, 1998, P NATL ACAD SCI USA, V95, P144, DOI 10.1073/pnas.95.1.144; Zachman DK, 2010, J LIPID RES, V51, P525, DOI 10.1194/jlr.M000646	50	184	196	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					899	908		10.1074/jbc.M110.171439	http://dx.doi.org/10.1074/jbc.M110.171439			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21068380	hybrid, Green Published			2022-12-25	WOS:000286005000001
J	Homma, D; Sumi-Ichinose, C; Tokuoka, H; Ikemoto, K; Nomura, T; Kondo, K; Katoh, S; Ichinose, H				Homma, Daigo; Sumi-Ichinose, Chiho; Tokuoka, Hirofumi; Ikemoto, Kazuhisa; Nomura, Takahide; Kondo, Kazunao; Katoh, Setsuko; Ichinose, Hiroshi			Partial Biopterin Deficiency Disturbs Postnatal Development of the Dopaminergic System in the Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPA-RESPONSIVE DYSTONIA; GTP CYCLOHYDROLASE-I; SEPIAPTERIN-REDUCTASE DEFICIENCY; TYROSINE-HYDROXYLASE ACTIVITY; MOUSE MODEL; TETRAHYDROBIOPTERIN BIOSYNTHESIS; PHENYLALANINE-HYDROXYLASE; MICE; HYPERPHENYLALANINEMIA; MUTATIONS	Postnatal development of dopaminergic system is closely related to the development of psychomotor function. Tyrosine hydroxylase (TH) is the rate-limiting enzyme in the biosynthesis of dopamine and requires tetrahydrobiopterin (BH4) as a cofactor. To clarify the effect of partial BH4 deficiency on postnatal development of the dopaminergic system, we examined two lines of mutant mice lacking a BH4-biosynthesizing enzyme, including sepiapterin reductase knock-out (Spr(-/-)) mice and genetically rescued 6-pyruvoyltetrahydropterin synthase knock-out (DPS-Pts(-/-)) mice. We found that biopterin contents in the brains of these knock-out mice were moderately decreased from postnatal day 0 (P0) and remained constant up to P21. In contrast, the effects of BH4 deficiency on dopamine and TH protein levels were more manifested during the postnatal development. Both of dopamine and TH protein levels were greatly increased from P0 to P21 in wild-type mice but not in those mutant mice. Serotonin levels in those mutant mice were also severely suppressed after P7. Moreover, striatal TH immunoreactivity in Spr(-/-) mice showed a drop in the late developmental stage, when those mice exhibited hind-limb clasping behavior, a type of motor dysfunction. Our results demonstrate a critical role of biopterin in the augmentation of TH protein in the postnatal period. The developmental manifestation of psychomotor symptoms in BH4 deficiency might be attributable at least partially to high dependence of dopaminergic development on BH4 availability.	[Ichinose, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Sumi-Ichinose, Chiho; Ikemoto, Kazuhisa; Nomura, Takahide; Kondo, Kazunao] Fujita Hlth Univ, Sch Med, Dept Pharmacol, Toyoake, Aichi 4701192, Japan; [Katoh, Setsuko] Meikai Univ, Sch Dent, Sakado, Saitama 3500283, Japan	Tokyo Institute of Technology; Fujita Health University; Meikai University	Ichinose, H (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, 4259-B7, Yokohama, Kanagawa 2268501, Japan.	hichinos@bio.titech.ac.jp	Ichinose, Hiroshi/D-8986-2015	Ichinose, Hiroshi/0000-0001-6008-6860; Sumi-Ichinose, Chiho/0000-0001-5261-0853	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; Japan Science and Technology Agency, CREST [21500305, 22090250]; Grants-in-Aid for Scientific Research [21500305] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by Health and Labor Sciences Research Grants for Research on Intractable Diseases from the Ministry of Health, Labor, and Welfare of Japan, and by the Japan Science and Technology Agency, CREST (21500305 and 22090250).	Blau N, 2001, MOL GENET METAB, V74, P172, DOI 10.1006/mgme.2001.3213; Elzaouk L, 2003, J BIOL CHEM, V278, P28303, DOI 10.1074/jbc.M303986200; Fujisawa H, 2005, BIOCHEM BIOPH RES CO, V338, P271, DOI 10.1016/j.bbrc.2005.07.183; Furukawa Y, 1999, NEUROLOGY, V53, P1032, DOI 10.1212/WNL.53.5.1032; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; Iino T, 2003, ARCH BIOCHEM BIOPHYS, V416, P180, DOI 10.1016/S0003-9861(03)00295-9; JAEGER CB, 1983, SCIENCE, V219, P1233, DOI 10.1126/science.6131537; KAPATOS G, 1983, BRAIN RES, V258, P351, DOI 10.1016/0006-8993(83)91165-4; Knudsen GM, 1995, J INHERIT METAB DIS, V18, P653, DOI 10.1007/BF02436753; Nagatsu I, 1995, J NEURAL TRANSM-GEN, V102, P175, DOI 10.1007/BF01281153; Oades RD, 2002, BEHAV BRAIN RES, V130, P97, DOI 10.1016/S0166-4328(01)00440-5; Ogawa S, 2006, NEUROSCI LETT, V401, P261, DOI 10.1016/j.neulet.2006.03.031; OKUNO S, 1985, J BIOL CHEM, V260, P2633; PARK YS, 1991, BIOCHEM BIOPH RES CO, V175, P738, DOI 10.1016/0006-291X(91)91628-P; Pascucci T, 2008, BRAIN RES, V1217, P232, DOI 10.1016/j.brainres.2008.04.006; Perez B, 2005, MOL GENET METAB, V86, pS11, DOI 10.1016/j.ymgme.2005.06.009; RAJPUT AH, 1994, ANN NEUROL, V35, P396, DOI 10.1002/ana.410350405; Sato K, 2008, P NATL ACAD SCI USA, V105, P12551, DOI 10.1073/pnas.0806065105; Segawa M, 2003, ANN NEUROL, V54, pS32, DOI 10.1002/ana.10630; Shashidharan P, 2005, HUM MOL GENET, V14, P125, DOI 10.1093/hmg/ddi012; Sumi-Ichinose C, 2005, J NEUROCHEM, V95, P703, DOI 10.1111/j.1471-4159.2005.03402.x; Sumi-Ichinose C, 2001, J BIOL CHEM, V276, P41150, DOI 10.1074/jbc.M102237200; Takazawa C, 2008, BIOCHEM BIOPH RES CO, V367, P787, DOI 10.1016/j.bbrc.2008.01.028; Thony B, 2008, J NEUROCHEM, V106, P672, DOI 10.1111/j.1471-4159.2008.05423.x; Thony B, 2006, HUM MUTAT, V27, P870, DOI 10.1002/humu.20366; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Thony B, 2004, FEBS LETT, V577, P507, DOI 10.1016/j.febslet.2004.10.056; Urano F, 2006, J BIOCHEM, V139, P625, DOI 10.1093/jb/mvj073; Yang S, 2006, AM J HUM GENET, V78, P575, DOI 10.1086/501372; YEOH GCT, 1988, DIFFERENTIATION, V38, P42, DOI 10.1111/j.1432-0436.1988.tb00590.x	30	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1445	1452		10.1074/jbc.M110.159426	http://dx.doi.org/10.1074/jbc.M110.159426			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21062748	hybrid, Green Published			2022-12-25	WOS:000286005000057
J	Hua, SS; Wang, ZK; Jiang, K; Huang, YJ; Ward, T; Zhao, LL; Dou, Z; Yao, XBA				Hua, Shasha; Wang, Zhikai; Jiang, Kai; Huang, Yuejia; Ward, Tarsha; Zhao, Lingli; Dou, Zhen; Yao, Xuebiao			CENP-U Cooperates with Hec1 to Orchestrate Kinetochore-Microtubule Attachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE CHECKPOINT; NDC80 COMPLEX; MITOTIC CHECKPOINT; CHROMOSOME SEGREGATION; CENTROMERE COMPLEX; OUTER KINETOCHORE; PROTEIN E; COMPONENT; CELLS; ARCHITECTURE	Mitosis is an orchestration of dynamic interaction between chromosomes and spindle microtubules by which genomic materials are equally distributed into two daughter cells. Previous studies showed that CENP-U is a constitutive centromere component essential for proper chromosome segregation. However, the precise molecular mechanism has remained elusive. Here, we identified CENP-U as a novel interacting partner of Hec1, an evolutionarily conserved kinetochore core component essential for chromosome plasticity. Suppression of CENP-U by shRNA resulted in mitotic defects with an impaired kinetochore-microtubule attachment. Interestingly, CENP-U not only binds microtubules directly but also displays a cooperative microtubule binding activity with Hec1 in vitro. Furthermore, we showed that CENP-U is a substrate of Aurora-B. Importantly, phosphorylation of CENP-U leads to reduced kinetochore-microtubule interaction, which contributes to the error-correcting function of Aurora-B. Taken together, our results indicate that CENP-U is a novel microtubule binding protein and plays an important role in kinetochore-microtubule attachment through its interaction with Hec1.	[Hua, Shasha; Wang, Zhikai; Jiang, Kai; Huang, Yuejia; Zhao, Lingli; Dou, Zhen; Yao, Xuebiao] Hefei Natl Lab Phys Sci Nanoscale, Anhui Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Wang, Zhikai; Jiang, Kai; Huang, Yuejia; Ward, Tarsha; Dou, Zhen] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA	Morehouse School of Medicine	Dou, Z (corresponding author), Hefei Natl Lab Phys Sci Nanoscale, Anhui Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China.	douzhen@ustc.edu.cn; yaoxb@ustc.edu.cn	Yao, Xuebiao/P-5771-2014; DOU, ZHEN/N-2022-2013	DOU, ZHEN/0000-0003-3303-9393	National Institutes of Health [K-56292, CA132389]; National Center for Research Resources [UL1 RR025008]; Chinese Natural Science Foundation [31071184, 31000602, 90508002, 90913016]; Chinese Academy of Science [KSCX1-YW-R-65, KSCX2-YW-H-10, KSCX2-YW-R-195]; Chinese 973 Project [2006CB943603, 2007CB914503, 2010CB912103]; China National Key Projects for Infectious Disease [2008ZX10002-021]; Georgia Cancer Coalition; Atlanta Clinical and Translational Science Award [P20RR011104]; Anhui Province Key Project [08040102005]; NATIONAL CANCER INSTITUTE [P20CA132389] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034, UL1RR025008, P20RR011104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058268] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); Chinese 973 Project(National Basic Research Program of China); China National Key Projects for Infectious Disease; Georgia Cancer Coalition; Atlanta Clinical and Translational Science Award; Anhui Province Key Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-56292 and CA132389 and National Center for Research Resources Grant UL1 RR025008 from the Clinical and Translational Science Award program. This work was also supported by Chinese Natural Science Foundation Grants 31071184 (to Z.D.), 31000602 (to L.Z.), and 90508002 and 90913016 (to X.Y.), Chinese Academy of Science Grants KSCX1-YW-R-65, KSCX2-YW-H-10, and KSCX2-YW-R-195, Chinese 973 Project Grants 2006CB943603, 2007CB914503, and 2010CB912103, China National Key Projects for Infectious Disease Grant 2008ZX10002-021, a Georgia Cancer Coalition breast cancer research grant, Atlanta Clinical and Translational Science Award Chemical Biology Grant P20RR011104, and Anhui Province Key Project Grant 08040102005.	Amaro AC, 2010, NAT CELL BIOL, V12, P319, DOI 10.1038/ncb2033; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; BRINKLEY BR, 1966, CHROMOSOMA, V19, P28, DOI 10.1007/BF00332792; Cao XW, 2005, J BIOL CHEM, V280, P13584, DOI 10.1074/jbc.M411941200; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Du J, 2008, ONCOGENE, V27, P4107, DOI 10.1038/onc.2008.34; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Hori T, 2003, J CELL SCI, V116, P3347, DOI 10.1242/jcs.00645; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Liu D, 2007, J BIOL CHEM, V282, P21415, DOI 10.1074/jbc.M609026200; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; Minoshima Y, 2005, MOL CELL BIOL, V25, P10315, DOI 10.1128/MCB.25.23.10315-10328.2005; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wei RR, 2006, STRUCTURE, V14, P1003, DOI 10.1016/j.str.2006.04.007; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349; Yang Y, 2008, J BIOL CHEM, V283, P26726, DOI 10.1074/jbc.M804207200; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435	44	47	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1627	1638		10.1074/jbc.M110.174946	http://dx.doi.org/10.1074/jbc.M110.174946			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21056971	hybrid, Green Published			2022-12-25	WOS:000286005000075
J	Suen, JY; Gardiner, B; Grimmond, S; Fairlie, DP				Suen, Jacky Y.; Gardiner, Brooke; Grimmond, Sean; Fairlie, David P.			Profiling Gene Expression Induced by Protease-Activated Receptor 2 (PAR2) Activation in Human Kidney Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; PROINFLAMMATORY ROLE; COUPLED RECEPTORS; UP-REGULATION; MOUSE MODEL; INFLAMMATION; CANCER; PROLIFERATION; AGONISTS; TRYPSIN	Protease-Activated Receptor-2 (PAR2) has been implicated through genetic knockout mice with cytokine regulation and arthritis development. Many studies have associated PAR2 with inflammatory conditions (arthritis, airways inflammation, IBD) and key events in tumor progression (angiogenesis, metastasis), but they have relied heavily on the use of single agonists to identify physiological roles for PAR2. However such probes are now known not to be highly selective for PAR2, and thus precisely what PAR2 does and what mechanisms of downstream regulation are truly affected remain obscure. Effects of PAR2 activation on gene expression in Human Embryonic Kidney cells (HEK293), a commonly studied cell line in PAR2 research, were investigated here by comparing 19,000 human genes for intersecting up-or down-regulation by both trypsin (an endogenous protease that activates PAR2) and a PAR2 activating hexapeptide (2f-LIGRLO-NH2). Among 2,500 human genes regulated similarly by both agonists, there were clear associations between PAR2 activation and cellular metabolism (1,000 genes), the cell cycle, the MAPK pathway, HDAC and sirtuin enzymes, inflammatory cytokines, and anticomplement function. PAR-2 activation up-regulated four genes more than 5 fold (DUSP6, WWOX, AREG, SERPINB2) and down-regulated another six genes more than 3 fold (TXNIP, RARG, ITGB4, CTSD, MSC and TM4SF15). Both PAR2 and PAR1 activation resulted in up-regulated expression of several genes (CD44, FOSL1, TNFRSF12A, RAB3A, COPEB, CORO1C, THBS1, SDC4) known to be important in cancer. This is the first widespread profiling of specific activation of PAR2 and provides a valuable platform for better understanding key mechanistic roles of PAR2 in human physiology. Results clearly support the development of both antagonists and agonists of human PAR2 as potential disease modifying therapeutic agents.	[Suen, Jacky Y.; Gardiner, Brooke; Grimmond, Sean; Fairlie, David P.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	University of Queensland	Suen, JY (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	d.fairlie@imb.uq.edu.au	Fairlie, David P/F-8865-2014; Gardiner, Brooke B/C-7773-2011; Grimmond, Sean/K-3246-2019; Grimmond, Sean M/J-5304-2016; Suen, Jacky/G-4077-2015	Fairlie, David P/0000-0002-7856-8566; Gardiner, Brooke B/0000-0003-3740-3244; Grimmond, Sean/0000-0002-8102-7998; Grimmond, Sean M/0000-0002-8102-7998; Suen, Jacky/0000-0002-0309-2524	National Health and Medical Research Council of Australia [NHMRC569595]; Australian Research Council [FF0668733]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	Research funding is from the National Health and Medical Research Council of Australia (NHMRC569595; www.nhmrc.gov.au) and the Australian Research Council for a Federation Fellowship to DPF (FF0668733; www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abey HT, 2006, J PHARMACOL EXP THER, V317, P598, DOI 10.1124/jpet.105.097121; Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099; Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; Barry GD, 2006, CURR MED CHEM, V13, P243, DOI 10.2174/092986706775476070; Blanchard F, 2005, DRUG DISCOV TODAY, V10, P197, DOI 10.1016/S1359-6446(04)03309-4; Buddenkotte J, 2005, J INVEST DERMATOL, V124, P38, DOI 10.1111/j.0022-202X.2004.23539.x; Camelo S, 2005, J NEUROIMMUNOL, V164, P10, DOI 10.1016/j.jneuroim.2005.02.022; CAMPO BAD, 2005, BRIT J PHARMACOL, V144, P1100; Challen G, 2005, PHYSIOL GENOMICS, V23, P159, DOI 10.1152/physiolgenomics.00043.2005; Choi JH, 2005, CLIN EXP ALLERGY, V35, P89, DOI 10.1111/j.1365-2222.2004.02006.x; Chokki M, 2005, FEBS J, V272, P6387, DOI 10.1111/j.1742-4658.2005.05035.x; Chung CD, 2003, J IMMUNOL, V170, P581, DOI 10.4049/jimmunol.170.1.581; Cicala C, 2002, BRIT J PHARMACOL, V135, P14, DOI 10.1038/sj.bjp.0704438; Coates PJ, 2006, J PATHOL, V210, P385, DOI 10.1002/path.2080; Darmoul D, 2004, J BIOL CHEM, V279, P20927, DOI 10.1074/jbc.M401430200; Elefsinioti AL, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-208; Fiorucci S, 2001, P NATL ACAD SCI USA, V98, P13936, DOI 10.1073/pnas.241377298; Fiorucci S, 2004, HEPATOLOGY, V39, P365, DOI 10.1002/hep.20054; Gaca MDA, 2002, J HEPATOL, V36, P362, DOI 10.1016/S0168-8278(01)00285-9; Giancotti FG, 2007, TRENDS PHARMACOL SCI, V28, P506, DOI 10.1016/j.tips.2007.08.004; Grandaliano G, 2003, J AM SOC NEPHROL, V14, P2072, DOI 10.1097/01.ASN.0000080315.37254.A1; Halili MA, 2009, CURR TOP MED CHEM, V9, P309, DOI 10.2174/156802609788085250; Hansen KK, 2005, P NATL ACAD SCI USA, V102, P8363, DOI 10.1073/pnas.0409535102; Hill SJ, 2006, BRIT J PHARMACOL, V147, pS27, DOI 10.1038/sj.bjp.0706455; Hjortoe GM, 2004, BLOOD, V103, P3029, DOI 10.1182/blood-2003-10-3417; Holzhausen M, 2005, MEM I OSWALDO CRUZ, V100, P177, DOI 10.1590/S0074-02762005000900030; JACOB C, 2005, J BIOL CHEM; Johansson U, 2005, J LEUKOCYTE BIOL, V78, P967, DOI 10.1189/jlb.0704422; Kanke T, 2005, BRIT J PHARMACOL, V145, P255, DOI 10.1038/sj.bjp.0706189; Kawabata A, 2005, BRIT J PHARMACOL, V144, P212, DOI 10.1038/sj.bjp.0706059; Kawabata A, 2003, LIFE SCI, V74, P247, DOI 10.1016/j.lfs.2003.09.011; Kelso EB, 2007, ARTHRITIS RHEUM, V56, P765, DOI 10.1002/art.22423; Lee YCG, 2005, AM J PHYSIOL-LUNG C, V288, pL734, DOI 10.1152/ajplung.00173.2004; Lindner JR, 2000, J IMMUNOL, V165, P6504, DOI 10.4049/jimmunol.165.11.6504; Maeda K, 2005, PANCREAS, V31, P54, DOI 10.1097/01.mpa.0000163178.37050.0d; Marwick JA, 2007, EXPERT OPIN THER TAR, V11, P745, DOI 10.1517/14728222.11.6.745; Masamune A, 2005, J PHARMACOL EXP THER, V312, P651, DOI 10.1124/jpet.104.076232; McGuire JJ, 2004, J PHARMACOL EXP THER, V309, P1124, DOI 10.1124/jpet.103.064584; McLaughlin JN, 2005, J BIOL CHEM, V280, P22172, DOI 10.1074/jbc.M500721200; Moffatt JD, 2007, N-S ARCH PHARMACOL, V375, P1, DOI 10.1007/s00210-007-0139-9; Nishida K, 2004, ARTHRITIS RHEUM-US, V50, P3365, DOI 10.1002/art.20709; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Reilly CM, 2004, J IMMUNOL, V173, P4171, DOI 10.4049/jimmunol.173.6.4171; Schioth HB, 2005, GEN COMP ENDOCR, V142, P94, DOI 10.1016/j.ygcen.2004.12.018; Schmidlin F, 2001, AM J RESP CRIT CARE, V164, P1276, DOI 10.1164/ajrccm.164.7.2101157; Shichijo Michitaka, 2006, Allergol Int, V55, P271, DOI 10.2332/allergolint.55.271; Shimamoto R, 2004, INT J ONCOL, V24, P1401; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Stenton GR, 2002, J PHARMACOL EXP THER, V302, P466, DOI 10.1124/jpet.302.2.466; Takizawa T, 2005, J PHARMACOL SCI, V98, P99, DOI 10.1254/jphs.SCZ050138; Tanaka M, 2005, KIDNEY INT, V67, P2123, DOI 10.1111/j.1523-1755.2005.00317.x; Vesey DA, 2007, NEPHROLOGY, V12, P36, DOI 10.1111/j.1440-1797.2006.00746.x; Wilson S, 2005, BIOCHEM J, V388, P967, DOI 10.1042/BJ20041066; Yada K, 2005, J SURG ONCOL, V89, P79, DOI 10.1002/jso.20197; Zhao AP, 2003, AM J PHYSIOL-GASTR L, V285, pG696, DOI 10.1152/ajpgi.00064.2003	56	40	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13809	10.1371/journal.pone.0013809	http://dx.doi.org/10.1371/journal.pone.0013809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072196	Green Published, gold, Green Submitted			2022-12-25	WOS:000283779700016
J	Derycke, S; Vanaverbeke, J; Rigaux, A; Backeljau, T; Moens, T				Derycke, Sofie; Vanaverbeke, Jan; Rigaux, Annelien; Backeljau, Thierry; Moens, Tom			Exploring the Use of Cytochrome Oxidase c Subunit 1 (COI) for DNA Barcoding of Free-Living Marine Nematodes	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; MITOCHONDRIAL-DNA; SEQUENCE ALIGNMENT; FEEDING ECOLOGY; IDENTIFICATION; PHYLOGENY; PSEUDOGENES; WOLBACHIA	Background: The identification of free-living marine nematodes is difficult because of the paucity of easily scorable diagnostic morphological characters. Consequently, molecular identification tools could solve this problem. Unfortunately, hitherto most of these tools relied on 18S rDNA and 28S rDNA sequences, which often lack sufficient resolution at the species level. In contrast, only a few mitochondrial COI data are available for free-living marine nematodes. Therefore, we investigate the amplification and sequencing success of two partitions of the COI gene, the M1-M6 barcoding region and the I3-M11 partition. Methodology: Both partitions were analysed in 41 nematode species from a wide phylogenetic range. The taxon specific primers for the I3-M11 partition outperformed the universal M1-M6 primers in terms of amplification success (87.8% vs. 65.8%, respectively) and produced a higher number of bidirectional COI sequences (65.8% vs 39.0%, respectively). A threshold value of 5% K2P genetic divergence marked a clear DNA barcoding gap separating intra-and interspecific distances: 99.3% of all interspecific comparisons were >0.05, while 99.5% of all intraspecific comparisons were <0.05 K2P distance. Conclusion: The I3-M11 partition reliably identifies a wide range of marine nematodes, and our data show the need for a strict scrutiny of the obtained sequences, since contamination, nuclear pseudogenes and endosymbionts may confuse nematode species identification by COI sequences.	[Derycke, Sofie; Vanaverbeke, Jan; Rigaux, Annelien; Moens, Tom] Univ Ghent, Dept Biol, Marine Biol Res Grp, B-9000 Ghent, Belgium; [Derycke, Sofie; Rigaux, Annelien] Univ Ghent, Ctr Mol Phylogeny & Evolut, B-9000 Ghent, Belgium; [Backeljau, Thierry] Royal Belgian Inst Nat Sci, Joint Expt Mol Unit, Brussels, Belgium; [Backeljau, Thierry] Univ Antwerp, Evolutionary Biol Grp, Dept Biol, B-2020 Antwerp, Belgium	Ghent University; Ghent University; Royal Belgian Institute of Natural Sciences; University of Antwerp	Derycke, S (corresponding author), Univ Ghent, Dept Biol, Marine Biol Res Grp, B-9000 Ghent, Belgium.	s.derycke@ugent.be	Vanaverbeke, jan/A-1118-2012; Moens, Tom/AAB-8701-2019		Flemish Fund for Scientific Research (F.W.O.) [3G040407, 1507709]; Ghent University [B/07778/02]	Flemish Fund for Scientific Research (F.W.O.)(FWO); Ghent University(Ghent University)	This research was financially supported by the Flemish Fund for Scientific Research (F.W.O.) through the project 3G040407 and the research grant 1507709, and by Ghent University through the Special Research Fund (B.O.F.) project B/07778/02. S.D. acknowledges a postdoctoral fellowship from the F.W.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISE J, 1994, NATURAL HIST EVOLUTI; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bhadury P, 2006, MAR ECOL PROG SER, V320, P1, DOI 10.3354/meps320001; Bhadury P, 2009, AQUAT BIOL, V5, P149, DOI 10.3354/ab00145; Blouin MS, 2002, INT J PARASITOL, V32, P527, DOI 10.1016/S0020-7519(01)00357-5; Bordenstein SR, 2003, J NEMATOL, V35, P266; BOWLES J, 1992, MOL BIOCHEM PARASIT, V54, P165, DOI 10.1016/0166-6851(92)90109-W; Casiraghi M, 2001, PARASITOLOGY, V122, P93, DOI 10.1017/S0031182000007149; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; De Ley P, 2005, PHILOS T R SOC B, V360, P1945, DOI 10.1098/rstb.2005.1726; DEMESE, 2003, J EXP MAR BIOL ECOL, V296, P227; DEMESE, 2004, ENVIRON MICROBIOL, V6, P733; DEMESE, 2006, MAR ECOL PROG SER, V321, P157; Derycke S, 2008, MOL ECOL, V17, P3306, DOI 10.1111/j.1365-294X.2008.03846.x; Derycke S, 2007, MAR BIOL, V151, P1799, DOI 10.1007/s00227-007-0609-0; Derycke S, 2005, MAR ECOL PROG SER, V300, P91, DOI 10.3354/meps300091; Derycke S, 2010, ZOOL SCR, V39, P276, DOI 10.1111/j.1463-6409.2009.00420.x; dos Santos GAP, 2008, J EXP MAR BIOL ECOL, V355, P27, DOI 10.1016/j.jembe.2007.11.015; dos Santos GAP, 2009, MAR BIOL, V156, P629, DOI 10.1007/s00227-008-1114-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elsasser SC, 2009, MOL ECOL RESOUR, V9, P707, DOI 10.1111/j.1755-0998.2008.02393.x; Erpenbeck D, 2006, MOL ECOL NOTES, V6, P550, DOI 10.1111/j.1471-8286.2005.01259.x; Ferri E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1; FITCH DHA, 1995, MOL BIOL EVOL, V12, P346; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Hamels I, 2001, AQUAT MICROB ECOL, V26, P61, DOI 10.3354/ame026061; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Hu M, 2002, ELECTROPHORESIS, V23, P27, DOI [10.1002/1522-2683(200201)23:1<27::AID-ELPS27>3.0.CO;2-7, 10.1002/1522-2683(200201)23:1&lt;27::AID-ELPS27&gt;3.0.CO;2-7]; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Jacob Joachim E M, 2009, BMC Res Notes, V2, P192, DOI 10.1186/1756-0500-2-192; Jansen G, 2009, ZOOL SCR, V38, P527, DOI 10.1111/j.1463-6409.2009.00386.x; Leduc D, 2009, J MAR BIOL ASSOC UK, V89, P337, DOI 10.1017/S0025315408002464; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meldal BHM, 2007, MOL PHYLOGENET EVOL, V42, P622, DOI 10.1016/j.ympev.2006.08.025; Moens T, 1997, J MAR BIOL ASSOC UK, V77, P211, DOI 10.1017/S0025315400033889; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Postma-Blaauw MB, 2005, OECOLOGIA, V142, P428, DOI 10.1007/s00442-004-1741-x; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8	48	144	158	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13716	10.1371/journal.pone.0013716	http://dx.doi.org/10.1371/journal.pone.0013716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060838	Green Published, gold			2022-12-25	WOS:000283573800015
J	Mohammed, H; Ramos, M; Armstrong, J; Munoz-Jordan, J; Arnold-Lewis, KO; Ayala, A; Clark, GG; Tull, ES; Beatty, ME				Mohammed, Hamish; Ramos, Mary; Armstrong, Julie; Munoz-Jordan, Jorge; Arnold-Lewis, Kathleen O.; Ayala, Aurimar; Clark, Gary G.; Tull, Eugene S.; Beatty, Mark E.			An Outbreak of Dengue Fever in St. Croix (US Virgin Islands), 2005	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; VIRUSES; DISEASE; CUBA; TRANSMISSION; PATHOGENESIS; INFECTIONS; ANTIBODIES; EPIDEMIC; SEROTYPE	Background: Periodic outbreaks of dengue fever occur in the United States Virgin Islands. In June 2005, an outbreak of dengue virus (DENV) serotype-2 with cases of dengue hemorrhagic fever (DHF) was detected in St. Croix, US Virgin Islands. The objective of this report is to describe this outbreak of DENV-2 and the findings of a case-control study examining risk factors for DHF. Methodology/Principal Findings: This is the largest dengue outbreak ever recorded in St. Croix, with 331 suspected dengue cases reported island-wide during 2005 (62.2 cases/10,000 population); 54% were hospitalized, 21% had at least one hemorrhagic manifestation, 28% had thrombocytopenia, 5% had DHF and 1 patient died. Eighty-nine laboratory-positive hospitalized patients were identified. Of these, there were 15 (17%) who met the WHO criteria for DHF (cases) and 74 (83%) who did not (controls). The only variable significantly associated with DHF on bivariate or multivariable analysis was age, with an adjusted odds ratio (95% confidence interval) of 1.033 (1.003, 1.064). Conclusions/Significance: During this outbreak of DENV-2, a high proportion of cases developed DHF and increasing age was significantly associated with DHF.	[Mohammed, Hamish; Ramos, Mary; Munoz-Jordan, Jorge; Ayala, Aurimar] Ctr Dis Control & Prevent, Dengue Branch, Div Vector Borne Infect Dis, San Juan, PR USA; [Ramos, Mary] Univ New Mexico, Dept Pediat, Albuquerque, NM 87131 USA; [Armstrong, Julie; Tull, Eugene S.] US Virgin Islands, Dept Hlth, St Croix, VI USA; [Armstrong, Julie] Ctr Dis Control & Prevent, Off Director, Atlanta, GA USA; [Arnold-Lewis, Kathleen O.] Governor Juan F Luis Hosp, St Croix, VI USA; [Clark, Gary G.] USDA, Mosquito & Fly Res Unit, Gainesville, FL USA; [Beatty, Mark E.] Pediat Dengue Vaccine Initiat, Seoul, South Korea	Centers for Disease Control & Prevention - USA; University of New Mexico; University of the Virgin Islands; Centers for Disease Control & Prevention - USA; United States Department of Agriculture (USDA)	Mohammed, H (corresponding author), Ctr Dis Control & Prevent, Dengue Branch, Div Vector Borne Infect Dis, San Juan, PR USA.	hamohammed@rossvet.edu.kn		beatty, mark/0000-0002-9614-5938; Mohammed, Hamish/0000-0002-2060-7286; Tull, Eugene S./0000-0002-6825-0511				Acioli-Santos B, 2008, HUM IMMUNOL, V69, P122, DOI 10.1016/j.humimm.2008.01.005; Beal AC, 2006, PEDIATRICS, V117, P1618, DOI 10.1542/peds.2005-1203; Blanton RE, 2008, EUR J HUM GENET, V16, P762, DOI 10.1038/ejhg.2008.4; BURKE DS, 1982, J CLIN MICROBIOL, V16, P1034, DOI 10.1128/JCM.16.6.1034-1042.1982; Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006; GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; GUBLER DJ, 1983, MMWR-MORBID MORTAL W, V32, P23; GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179; Halstead SB, 2001, AM J TROP MED HYG, V65, P180, DOI 10.4269/ajtmh.2001.65.180; HALSTEAD SB, 1981, AM J EPIDEMIOL, V114, P632, DOI 10.1093/oxfordjournals.aje.a113235; Kalayanarooj S, 2007, J INFECT DIS, V195, P1014, DOI 10.1086/512244; Kouri G, 1998, EMERG INFECT DIS, V4, P89; KOURI GP, 1987, T ROY SOC TROP MED H, V81, P821, DOI 10.1016/0035-9203(87)90042-3; MCELROY K, 2010, EMERG INFEC IN PRESS; Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1; Nagao Y, 2008, P NATL ACAD SCI USA, V105, P2238, DOI 10.1073/pnas.0709029105; Nguyen TL, 1997, RES VIROLOGY, V148, P273, DOI 10.1016/S0923-2516(97)88364-1; *PAN AM HLTH ORG, 2008, NUM REP CAS DENG DEN; Pelaez O, 2004, EMERG INFECT DIS, V10, P719, DOI 10.3201/eid1004.030271; Restrepo BN, 2008, AM J TROP MED HYG, V79, P673, DOI 10.4269/ajtmh.2008.79.673; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Rigau-Perez Jose G., 1994, Morbidity and Mortality Weekly Report, V43, P7; ROSEN L, 1977, AM J TROP MED HYG, V26, P337, DOI 10.4269/ajtmh.1977.26.337; ROSEN L, 1974, AM J TROP MED HYG, V23, P1153, DOI 10.4269/ajtmh.1974.23.1153; Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091; Soldin SJ., 1997, PEDIAT REFERENCE RAN; Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x; Tomashek KM, 2009, AM J TROP MED HYG, V81, P467, DOI 10.4269/ajtmh.2009.81.467; *US BUR CENS, 2003, US VIRG ISL 2000 SOC; WHO, 1997, DENG HAEM FEV DIAGN; [No title captured]	32	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13729	10.1371/journal.pone.0013729	http://dx.doi.org/10.1371/journal.pone.0013729			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060852	Green Published, Green Submitted, gold			2022-12-25	WOS:000283573800023
J	Al-Shami, A; Jhaver, KG; Vogel, P; Wilkins, C; Humphries, J; Davis, JJ; Xu, NH; Potter, DG; Gerhardt, B; Mullinax, R; Shirley, CR; Anderson, SJ; Oravecz, T				Al-Shami, Amin; Jhaver, Kanchan G.; Vogel, Peter; Wilkins, Carrie; Humphries, Juliane; Davis, John J.; Xu, Nianhua; Potter, David G.; Gerhardt, Brenda; Mullinax, Robert; Shirley, Cynthia R.; Anderson, Stephen J.; Oravecz, Tamas			Regulators of the Proteasome Pathway, Uch37 and Rpn13, Play Distinct Roles in Mouse Development	PLOS ONE			English	Article							GROWTH-HORMONE RECEPTOR; DEUBIQUITINATING ENZYME; GAMMA-INTERFERON; PROTEIN; CELLS; MICE; GENE; ACTIVATOR; SUBUNIT; COMPLEX	Rpn13 is a novel mammalian proteasomal receptor that has recently been identified as an amplification target in ovarian cancer. It can interact with ubiquitin and activate the deubiquitinating enzyme Uch37 at the 26S proteasome. Since neither Rpn13 nor Uch37 is an integral proteasomal subunit, we explored whether either protein is essential for mammalian development and survival. Deletion of Uch37 resulted in prenatal lethality in mice associated with severe defect in embryonic brain development. In contrast, the majority of Rpn13-deficient mice survived to adulthood, although they were smaller at birth and fewer in number than wild-type littermates. Absence of Rpn13 produced tissue-specific effects on proteasomal function: increased proteasome activity in adrenal gland and lymphoid organs, and decreased activity in testes and brain. Adult Rpn13(-/-) mice reached normal body weight but had increased body fat content and were infertile due to defective gametogenesis. Additionally, Rpn13(-/-) mice showed increased T-cell numbers, resembling growth hormone-mediated effects. Indeed, serum growth hormone and follicular stimulating hormone levels were significantly increased in Rpn13(-/-) mice, while growth hormone receptor expression was reduced in the testes. In conclusion, this is the first report characterizing the physiological roles of Uch37 and Rpn13 in murine development and implicating a non-ATPase proteasomal protein, Rpn13, in the process of gametogenesis.	[Al-Shami, Amin; Jhaver, Kanchan G.; Vogel, Peter; Wilkins, Carrie; Humphries, Juliane; Davis, John J.; Xu, Nianhua; Potter, David G.; Gerhardt, Brenda; Mullinax, Robert; Shirley, Cynthia R.; Anderson, Stephen J.; Oravecz, Tamas] Lexicon Pharmaceut Inc, The Woodlands, TX USA	Lexicon Pharmaceuticals	Al-Shami, A (corresponding author), Lexicon Pharmaceut Inc, The Woodlands, TX USA.	aalshami@lexpharma.com	Vogel, Peter/N-2490-2018	Vogel, Peter/0000-0002-7535-0545	Lexicon Pharmaceuticals, Inc.	Lexicon Pharmaceuticals, Inc.	The work described in this paper was funded by Lexicon Pharmaceuticals, Inc. The authors designed the study, conducted data collection and analysis, and prepared the manuscript. Lexicon Pharmaceuticals approved the decision to publish this manuscript.	AHN JY, 1995, FEBS LETT, V366, P37, DOI 10.1016/0014-5793(95)00492-R; Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Burns KH, 2002, ENDOCRINOLOGY, V143, P2823, DOI 10.1210/en.143.8.2823; Carvalho B, 2009, GUT, V58, P79, DOI 10.1136/gut.2007.143065; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374; Fejzo MS, 2008, GENE CHROMOSOME CANC, V47, P873, DOI 10.1002/gcc.20592; Hamazaki J, 2007, MOL CELL BIOL, V27, P6629, DOI 10.1128/MCB.00509-07; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hasegawa K, 2001, DEV GROWTH DIFFER, V43, P25; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Jorgensen JP, 2006, J MOL BIOL, V360, P1043, DOI 10.1016/j.jmb.2006.06.011; Keene DE, 2002, J ANDROL, V23, P661; Khor B, 2006, MOL CELL BIOL, V26, P2999, DOI 10.1128/MCB.26.8.2999-3007.2006; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Lamerant N, 2005, FEBS J, V272, P1833, DOI 10.1111/j.1742-4658.2005.04613.x; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Mazumdar T, 2010, P NATL ACAD SCI USA, V107, P13854, DOI 10.1073/pnas.0913495107; Montecino-Rodriguez E, 1998, ENDOCRINOLOGY, V139, P4120, DOI 10.1210/en.139.10.4120; Napolitano LA, 2002, AIDS, V16, P1103, DOI 10.1097/00002030-200205240-00003; Olsen NJ, 1998, ENDOCRINOLOGY, V139, P748, DOI 10.1210/en.139.2.748; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Schrick JJ, 2006, AM J PATHOL, V168, P1288, DOI 10.2353/ajpath.2006.050941; SHIMADA S, 1994, CANCER RES, V54, P3831; Shimada Shinya, 1993, In Vivo (Attiki), V7, P1; Simins AB, 1999, CLIN EXP METASTAS, V17, P641, DOI 10.1023/A:1006790912877; Stone M, 2004, J MOL BIOL, V344, P697, DOI 10.1016/j.jmb.2004.09.057; Tansey WP, 2004, NEW ENGL J MED, V351, P393, DOI 10.1056/NEJMcibr041505; UTSUYAMA M, 1989, MECH AGEING DEV, V47, P175, DOI 10.1016/0047-6374(89)90030-4; van Kerkhof P, 2000, J BIOL CHEM, V275, P1575, DOI 10.1074/jbc.275.3.1575; Velasco-Velazquez MA, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-8; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wang X, 1998, J IMMUNOL, V160, P788; Wang X, 1997, EUR J IMMUNOL, V27, P2781, DOI 10.1002/eji.1830271106; Wicks SJ, 2006, BIOCHEM SOC T, V34, P761, DOI 10.1042/BST0340761; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Zambrowicz BP, 1998, INT J DEV BIOL, V42, P1025; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	45	70	73	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13654	10.1371/journal.pone.0013654	http://dx.doi.org/10.1371/journal.pone.0013654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048919	Green Submitted, Green Published, gold			2022-12-25	WOS:000283537000025
J	Giraudeau, M; Czirjak, GA; Duval, C; Bretagnolle, V; Eraud, C; McGraw, KJ; Heeb, P				Giraudeau, Mathieu; Czirjak, Gabor A.; Duval, Camille; Bretagnolle, Vincent; Eraud, Cyril; McGraw, Kevin J.; Heeb, Philipp			Effect of Restricted Preen-Gland Access on Maternal Self Maintenance and Reproductive Investment in Mallards	PLOS ONE			English	Article							EGG-SIZE; CHICK SURVIVAL; CAROTENOIDS; ATTRACTIVENESS; SECRETIONS; INFECTION; PARASITES; LYSOZYME; BACTERIA; SUCCESS	Background: As egg production and offspring care are costly, females should invest resources adaptively into their eggs to optimize current offspring quality and their own lifetime reproductive success. Parasite infections can influence maternal investment decisions due to their multiple negative physiological effects. The act of preening - applying oils with antimicrobial properties to feathers - is thought to be a means by which birds combat pathogens and parasites, but little is known of how preening during the reproductive period (and its expected disease-protecting effects) influences maternal investment decisions at the level of the egg. Methodology/Principal Findings: Here, we experimentally prevented female mallards (Anas platyrhynchos) from accessing their preen gland during breeding and monitored female immunoresponsiveness (e.g., plasma lysozyme concentration) as well as some egg traits linked to offspring quality (e.g., egg mass, yolk carotenoid content, and albumen lysozyme levels). Females with no access to their preen gland showed an increase in plasma lysozyme level compared to control, normally preening females. In addition, preen-gland-restricted females laid significantly lighter eggs and deposited higher carotenoid concentrations in the yolk compared to control females. Albumen lysozyme activity did not differ significantly between eggs laid by females with or without preen gland access. Conclusion/Significance: Our results establish a new link between an important avian self-maintenance behaviour and aspects of maternal health and reproduction. We suggest that higher yolk carotenoid levels in eggs laid by preen-gland-restricted females may serve to boost health of offspring that would hatch in a comparatively microbe-rich environment.	[Giraudeau, Mathieu; McGraw, Kevin J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Giraudeau, Mathieu; Czirjak, Gabor A.; Duval, Camille; Heeb, Philipp] Univ Toulouse 3, CNRS, Lab Evolut & Divers Biol, UMR 5174, F-31062 Toulouse, France; [Czirjak, Gabor A.] Univ Agr Sci & Vet Med, Fac Vet Med, Dept Infect Dis, Cluj Napoca, Romania; [Bretagnolle, Vincent] CNRS, Ctr Etud Biol Chize, UPR 1934, Beauvoir Sur Niort, France; [Eraud, Cyril] Ctr Natl Etude & Rech Appl Avifaune Migratrice, Direct Etud & Rech, Off Natl Chasse & Faune Sauvage, Villiers En Bois, France	Arizona State University; Arizona State University-Tempe; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; Centre National de la Recherche Scientifique (CNRS)	Giraudeau, M (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	giraudeau.mathieu@gmail.com	Czirják, Gábor Árpád/F-5440-2011	Czirják, Gábor Árpád/0000-0001-9488-0069	French government; Romanian Ministry of Education and Research; French Ministry of Foreign Affairs; French research grant [ANR-05, NT05-3_42075]; National Science Foundation [IOS-0746364]	French government; Romanian Ministry of Education and Research(Ministry of Education and Research - Romania); French Ministry of Foreign Affairs; French research grant; National Science Foundation(National Science Foundation (NSF))	MG was supported by a PhD scholarship of the French government. GAC was supported by a PhD scholarship of the Romanian Ministry of Education and Research and by an Eiffel grant from the French Ministry of Foreign Affairs. This project was supported by a French research grant (ANR-05, NT05-3_42075) to PH. During this study, KJM was supported by the National Science Foundation (grant # IOS-0746364). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexan A. F., 2009, Global Veterinaria, V3, P465; Berger S, 2003, J ORNITHOL, V144, P317, DOI 10.1007/BF02465631; Biard C, 2005, OECOLOGIA, V144, P32, DOI 10.1007/s00442-005-0048-x; Biard C, 2007, J EVOLUTION BIOL, V20, P326, DOI 10.1111/j.1420-9101.2006.01194.x; Blomqvist D, 1997, OECOLOGIA, V110, P18, DOI 10.1007/s004420050128; Blount Jonathan D., 2008, V4, P213, DOI 10.1007/978-3-7643-7499-0_11; BOLTON M, 1991, J ANIM ECOL, V60, P949, DOI 10.2307/5424; Bonisoli-Alquati A, 2010, BEHAV ECOL SOCIOBIOL, V64, P845, DOI 10.1007/s00265-010-0901-8; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Burtt EH, 1999, AUK, V116, P364, DOI 10.2307/4089371; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; CLAYTON DH, 1997, HOST PARASITE EVOLUT; COOK ME, 1993, POULTRY SCI, V72, P1301, DOI 10.3382/ps.0721301; Cook MI, 2003, P ROY SOC B-BIOL SCI, V270, P2233, DOI 10.1098/rspb.2003.2508; CROXALL JP, 1992, IBIS, V134, P219, DOI 10.1111/j.1474-919X.1992.tb03803.x; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; CURRIE GA, 1976, BRIT J CANCER, V33, P51, DOI 10.1038/bjc.1976.6; Dufva R, 1996, J AVIAN BIOL, V27, P83, DOI 10.2307/3676964; Eraud C, 2007, J EXP BIOL, V210, P3571, DOI 10.1242/jeb.005496; FEINGOLD KR, 1992, DIABETES, V41, P97, DOI 10.2337/diab.41.2.S97; GALBRAITH H, 1988, J ZOOL, V214, P383, DOI 10.1111/j.1469-7998.1988.tb03747.x; Giraudeau M, 2010, NATURWISSENSCHAFTEN, V97, P577, DOI 10.1007/s00114-010-0673-z; Gunderson AR, 2008, AUK, V125, P972, DOI 10.1525/auk.2008.91008; Haribal M, 2009, BIOCHEM SYST ECOL, V37, P80, DOI 10.1016/j.bse.2008.12.005; Jacob J., 1982, AVIAN BIOL, DOI [10.1016/B978-0-12-249406-2.50013-7, DOI 10.1016/B978-0-12-249406-2.50013-7]; KOLATTUKUDY PE, 1978, ARCH BIOCHEM BIOPHYS, V191, P244, DOI 10.1016/0003-9861(78)90087-5; Kulkarni S, 2007, BEHAV PROCESS, V74, P88, DOI 10.1016/j.beproc.2006.10.005; MAGRATH RD, 1992, J ZOOL, V227, P639, DOI 10.1111/j.1469-7998.1992.tb04420.x; Martin-Vivaldi M, 2010, P ROY SOC B-BIOL SCI, V277, P123, DOI 10.1098/rspb.2009.1377; McGraw KJ, 2005, NATURWISSENSCHAFTEN, V92, P375, DOI 10.1007/s00114-005-0003-z; McGraw KJ, 2003, AM NAT, V162, P704, DOI 10.1086/378904; Mennerat A, 2009, OECOLOGIA, V161, P849, DOI 10.1007/s00442-009-1418-6; Mougeot F, 2010, J EVOLUTION BIOL, V23, P643, DOI 10.1111/j.1420-9101.2009.01926.x; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Moyer BR, 2003, AUK, V120, P490, DOI 10.1642/0004-8038(2003)120[0490:ETOTIO]2.0.CO;2; OSSERMAN EF, 1966, J EXP MED, V124, P921, DOI 10.1084/jem.124.5.921; Parmentier HK, 1998, POULTRY SCI, V77, P248, DOI 10.1093/ps/77.2.248; POTTI J, 1993, CAN J ZOOL, V71, P1534, DOI 10.1139/z93-217; Reneerkens J, 2008, AUK, V125, P285, DOI 10.1525/auk.2008.06217; RHYMER JM, 1988, OECOLOGIA, V75, P20, DOI 10.1007/BF00378809; Romano M, 2008, J EVOLUTION BIOL, V21, P1626, DOI 10.1111/j.1420-9101.2008.01599.x; Saino N, 2002, P ROY SOC B-BIOL SCI, V269, P1005, DOI 10.1098/rspb.2002.1992; Saino N, 2002, J EVOLUTION BIOL, V15, P735, DOI 10.1046/j.1420-9101.2002.00448.x; Saino N, 2002, P ROY SOC B-BIOL SCI, V269, P1729, DOI 10.1098/rspb.2002.2088; Shawkey MD, 2005, MICROB ECOL, V50, P40, DOI 10.1007/s00248-004-0089-4; Shawkey MD, 2003, J AVIAN BIOL, V34, P345, DOI 10.1111/j.0908-8857.2003.03193.x; Stearns S.C., 1992, pi; Surai P.F., 2002, NATURAL ANTIOXIDANTS; Tschirren B, 2004, P ROY SOC B-BIOL SCI, V271, P1371, DOI 10.1098/rspb.2004.2730; vanHeugten E, 1996, J ANIM SCI, V74, P2431; Wellman-Labadie O, 2007, WORLD POULTRY SCI J, V63, P421, DOI 10.1017/S0043933907001559; WIGGINS DA, 1990, ORNIS SCAND, V21, P157, DOI 10.2307/3676812; WILLIAMS TD, 1994, BIOL REV, V69, P35, DOI 10.1111/j.1469-185X.1994.tb01485.x	54	25	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13555	10.1371/journal.pone.0013555	http://dx.doi.org/10.1371/journal.pone.0013555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048952	Green Published, gold			2022-12-25	WOS:000283537000009
J	Hoang, MV; Nagy, JA; Fox, JEB; Senger, DR				Hoang, Mien V.; Nagy, Janice A.; Fox, Joan E. B.; Senger, Donald R.			Moderation of Calpain Activity Promotes Neovascular Integration and Lumen Formation during VEGF-Induced Pathological Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL-MIGRATION; INHIBITOR-I; RETINAL NEOVASCULARIZATION; TUBE FORMATION; KAPPA-B; RHO; ORGANIZATION; ACTIVATION; MECHANISM	Background: Successful neovascularization requires that sprouting endothelial cells (ECs) integrate to form new vascular networks. However, architecturally defective, poorly integrated vessels with blind ends are typical of pathological angiogenesis induced by vascular endothelial growth factor-A (VEGF), thereby limiting the utility of VEGF for therapeutic angiogenesis and aggravating ischemia-related pathologies. Here we investigated the possibility that over-exuberant calpain activity is responsible for aberrant VEGF neovessel architecture and integration. Calpains are a family of intracellular calcium-dependent, non-lysosomal cysteine proteases that regulate cellular functions through proteolysis of numerous substrates. Methodology/Principal Findings: In a mouse skin model of VEGF-driven angiogenesis, retroviral transduction with dominant-negative (DN) calpain-I promoted neovessel integration and lumen formation, reduced blind ends, and improved vascular perfusion. Moderate doses of calpain inhibitor-I improved VEGF-driven angiogenesis similarly to DN calpain-I. Conversely, retroviral transduction with wild-type (WT) calpain-I abolished neovessel integration and lumen formation. In vitro, moderate suppression of calpain activity with DN calpain-I or calpain inhibitor-I increased the microtubule-stabilizing protein tau in endothelial cells (ECs), increased the average length of microtubules, increased actin cable length, and increased the interconnectivity of vascular cords. Conversely, WT calpain-I diminished tau, collapsed microtubules, disrupted actin cables, and inhibited integration of cord networks. Consistent with the critical importance of microtubules for vascular network integration, the microtubule-stabilizing agent taxol supported vascular cord integration whereas microtubule dissolution with nocodazole collapsed cord networks. Conclusions/Significance: These findings implicate VEGF-induction of calpain activity and impairment of cytoskeletal dynamics in the failure of VEGF-induced neovessels to form and integrate properly. Accordingly, calpain represents an important target for rectifying key vascular defects associated with pathological angiogenesis and for improving therapeutic angiogenesis with VEGF.	[Hoang, Mien V.; Nagy, Janice A.; Senger, Donald R.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Hoang, Mien V.; Nagy, Janice A.; Senger, Donald R.] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Hoang, Mien V.; Nagy, Janice A.; Senger, Donald R.] Harvard Univ, Sch Med, Boston, MA USA; [Fox, Joan E. B.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Cleveland Clinic Foundation	Hoang, MV (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	dsenger@bidmc.harvard.edu	Hoang, Mien V/H-8270-2012	Hoang, Mien V/0000-0003-0859-2170	National Cancer Institute [CA129339]; NATIONAL CANCER INSTITUTE [R01CA129339] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by NIH grant CA129339 from the National Cancer Institute (to D.R.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayless KJ, 2004, J BIOL CHEM, V279, P11686, DOI 10.1074/jbc.M308373200; Bhatt A, 2002, J CELL SCI, V115, P3415; Bodnar RJ, 2006, CIRC RES, V98, P617, DOI 10.1161/01.RES.0000209968.66606.10; Boodhwani M, 2009, ANTIOXID REDOX SIGN, V11, P1945, DOI 10.1089/ARS.2009.2439; BROCK TA, 1991, AM J PATHOL, V138, P213; Chae JK, 2000, ARTERIOSCL THROM VAS, V20, P2573, DOI 10.1161/01.ATV.20.12.2573; Cuzzocrea S, 2000, AM J PATHOL, V157, P2065, DOI 10.1016/S0002-9440(10)64845-6; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; DAVIS GE, 1995, EXP CELL RES, V216, P113, DOI 10.1006/excr.1995.1015; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Drake CJ, 1999, J HISTOCHEM CYTOCHEM, V47, P1351, DOI 10.1177/002215549904701101; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; ESMAELIAZAD B, 1994, J CELL SCI, V107, P869; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Fujitani K, 1997, J CELL BIOCHEM, V66, P197, DOI 10.1002/(SICI)1097-4644(19970801)66:2<197::AID-JCB7>3.0.CO;2-L; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gonscherowski V, 2006, AM J PHYSIOL-HEART C, V290, pH2035, DOI 10.1152/ajpheart.00772.2004; Grant DS, 2003, INT J CANCER, V104, P121, DOI 10.1002/ijc.10907; Hoang MV, 2004, P NATL ACAD SCI USA, V101, P1874, DOI 10.1073/pnas.0308525100; Hoang V., 2004, V294, P269; HORWITZ SB, 1992, TRENDS PHARMACOL SCI, V13, P134; Hotchkiss KA, 2002, MOL CANCER THER, V1, P1191; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Kulkarni S, 1999, J BIOL CHEM, V274, P21265, DOI 10.1074/jbc.274.30.21265; Kulkarni S, 2002, J BIOL CHEM, V277, P24435, DOI 10.1074/jbc.M203457200; Le Doux JM, 2001, HUM GENE THER, V12, P1611, DOI 10.1089/10430340152528110; Lovestone S, 1996, NEUROSCIENCE, V73, P1145, DOI 10.1016/0306-4522(96)00126-1; MAKI M, 1989, J BIOL CHEM, V264, P18866; McDonald MC, 2001, FASEB J, V15, P171, DOI 10.1096/fj.99-0645com; Nagy JA, 2006, EXP CELL RES, V312, P538, DOI 10.1016/j.yexcr.2005.10.017; NAGY JA, 1995, CANCER RES, V55, P376; Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420; Pocock TM, 2004, AM J PHYSIOL-HEART C, V286, pH1015, DOI 10.1152/ajpheart.00826.2003; Potter DA, 1998, J CELL BIOL, V141, P647, DOI 10.1083/jcb.141.3.647; RAMI A, 1993, BRAIN RES, V609, P67, DOI 10.1016/0006-8993(93)90856-I; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Richard L, 1998, EXP CELL RES, V240, P1, DOI 10.1006/excr.1998.3936; Robinson GS, 1996, P NATL ACAD SCI USA, V93, P4851, DOI 10.1073/pnas.93.10.4851; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Rosser BG, 2000, METH MOL B, V144, P245; Ruetten H, 1997, BRIT J PHARMACOL, V121, P695, DOI 10.1038/sj.bjp.0701180; SENGER DR, 1990, CANCER RES, V50, P1774; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Senger DR, 1997, P NATL ACAD SCI USA, V94, P13612, DOI 10.1073/pnas.94.25.13612; Shannon KB, 2005, MOL BIOL CELL, V16, P4423, DOI 10.1091/mbc.E04-11-0974; SIOUSSAT TM, 1993, ARCH BIOCHEM BIOPHYS, V301, P15, DOI 10.1006/abbi.1993.1109; Smith LEH, 1999, NAT MED, V5, P1390, DOI 10.1038/70963; Su YC, 2006, FASEB J, V20, P1443, DOI 10.1096/fj.05-5354com; TAKEMURA R, 1992, J CELL SCI, V103, P953; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; VERNON RB, 1995, AM J PATHOL, V147, P873; Voisine P, 2004, SURGERY, V136, P407, DOI 10.1016/j.surg.2004.05.017; Wang ZY, 2003, CHINESE CHEM LETT, V14, P13; Whelan MC, 2003, J BIOL CHEM, V278, P327, DOI 10.1074/jbc.M207554200; Wilson MT, 2000, J NEUROBIOL, V43, P159, DOI 10.1002/(SICI)1097-4695(200005)43:2<159::AID-NEU6>3.0.CO;2-N; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; Xie HQ, 1998, BRAIN RES, V798, P173, DOI 10.1016/S0006-8993(98)00407-7; Zeng HY, 2006, J EXP MED, V203, P719, DOI 10.1084/jem.20051523	66	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13612	10.1371/journal.pone.0013612	http://dx.doi.org/10.1371/journal.pone.0013612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049044	Green Published, Green Submitted, gold			2022-12-25	WOS:000283422100017
J	Kang, Y; Zarzycki-Siek, J; Walton, CB; Norris, MH; Hoang, TT				Kang, Yun; Zarzycki-Siek, Jan; Walton, Chad B.; Norris, Michael H.; Hoang, Tung T.			Multiple FadD Acyl-CoA Synthetases Contribute to Differential Fatty Acid Degradation and Virulence in Pseudomonas aeruginosa	PLOS ONE			English	Article							COENZYME-A SYNTHETASE; TRANSCRIPTION FACTOR FADR; III SECRETION SYSTEM; ESCHERICHIA-COLI; BETA-OXIDATION; CYSTIC-FIBROSIS; MYCOBACTERIUM-TUBERCULOSIS; NOSOCOMIAL PNEUMONIA; NUTRIENT ACQUISITION; MULTIENZYME COMPLEX	A close interconnection between nutrient metabolism and virulence factor expression contributes to the pathophysiology of Pseudomonas aeruginosa as a successful pathogen. P. aeruginosa fatty acid (FA) degradation is complicated with multiple acyl-CoA synthetase homologs (FadDs) expressed in vivo in lung tissue during cystic fibrosis infections. The promoters of two genetically linked P. aeruginosa fadD genes (fadD1 and fadD2) were mapped and northern blot analysis indicated they could exist on two different transcripts. These FadDs contain ATP/AMP signature and FA-binding motifs highly homologous to those of the Escherichia coli FadD. Upon introduction into an E. coli fadD(-)/fadR(-) double mutant, both P. aeruginosa fadDs functionally complemented the E. coli fadD(-)/fadR(-) mutant, allowing degradation of different chain-length FAs. Chromosomal mutagenesis, growth analysis, induction studies, and determination of kinetic parameters suggested that FadD1 has a substrate preference for long-chain FAs while FadD2 prefers shorter-chain FAs. When compared to the wild type strain, the fadD2 mutant exhibited decreased production of lipase, protease, rhamnolipid and phospholipase, and retardation of both swimming and swarming motilities. Interestingly, fadD1 mutant showed only increased swarming motility. Growth analysis of the fadD mutants showed noticeable deficiencies in utilizing FAs and phosphatidylcholine (major components of lung surfactant) as the sole carbon source. This defect translated into decreased in vivo fitness of P. aeruginosa in a BALB/c mouse lung infection model, supporting the role of lipids as a significant nutrient source for this bacterium in vivo.	[Kang, Yun; Norris, Michael H.; Hoang, Tung T.] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Zarzycki-Siek, Jan; Hoang, Tung T.] Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA; [Walton, Chad B.] Univ Hawaii Manoa, Dept Med, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Kang, Y (corresponding author), Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA.	tongh@hawaii.edu	Heacock-Kang, Yun/O-9767-2016	Heacock-Kang, Yun/0000-0002-7304-9687; Norris, Michael/0000-0002-5285-0432	National Institutes of Health (NIH) [R21-AI073816, G12RR003061]; National Center for Research Resources (NCRR) [P20RR01872]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073816] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by a National Institutes of Health (NIH) grant R21-AI073816 and in parts by NIH grant numbers G12RR003061 and P20RR01872 from the National Center for Research Resources (NCRR), a component of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd H, 2008, J EUKARYOT MICROBIOL, V55, P235, DOI 10.1111/j.1550-7408.2008.00311.x; Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x; BALTCH AL, 1977, AM J MED SCI, V274, P119, DOI 10.1097/00000441-197709000-00002; Barber CE, 1997, MOL MICROBIOL, V24, P555, DOI 10.1046/j.1365-2958.1997.3721736.x; BARTANA J, 1971, BIOCHEM J, V122, P353, DOI 10.1042/bj1220353; Bernhard W, 2001, AM J RESP CELL MOL, V25, P725, DOI 10.1165/ajrcmb.25.6.4616; BLACK PN, 1991, J BACTERIOL, V173, P435, DOI 10.1128/jb.173.2.435-442.1991; BLACK PN, 1994, BBA-LIPID LIPID MET, V1210, P123, DOI 10.1016/0005-2760(94)90113-9; BLACK PN, 1992, J BIOL CHEM, V267, P25513; Black PN, 1997, J BIOL CHEM, V272, P4896, DOI 10.1074/jbc.272.8.4896; BLACK PN, 1988, J BACTERIOL, V170, P2850, DOI 10.1128/jb.170.6.2850-2854.1988; Bowton DL, 1999, CHEST, V115, p28S, DOI 10.1378/chest.115.suppl_1.28S; Brickman TJ, 2006, INFECT IMMUN, V74, P1741, DOI 10.1128/IAI.74.3.1741-1744.2006; Caiazza NC, 2005, J BACTERIOL, V187, P7351, DOI 10.1128/JB.187.21.7351-7361.2005; Campbell JW, 2003, MOL MICROBIOL, V47, P793, DOI 10.1046/j.1365-2958.2003.03341.x; Campbell JW, 2002, J BACTERIOL, V184, P3759, DOI 10.1128/JB.184.13.3759-3764.2002; Clark D. P., 1996, ESCHERICHIA COLI SAL, P343; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; Doring G, 1997, Monaldi Arch Chest Dis, V52, P363; DOWD JE, 1965, J BIOL CHEM, V240, P863; FERNANDEZVALVERDE M, 1993, APPL ENVIRON MICROB, V59, P1149; Garcia B, 1999, J BIOL CHEM, V274, P29228, DOI 10.1074/jbc.274.41.29228; Greenberger PA, 1997, JAMA-J AM MED ASSOC, V278, P1924, DOI 10.1001/jama.278.22.1924; Groot P H, 1976, Adv Lipid Res, V14, P75; Hoang TT, 2002, MICROBIOL-SGM, V148, P3849, DOI 10.1099/00221287-148-12-3849; Hoang TT, 1997, J BACTERIOL, V179, P5326, DOI 10.1128/jb.179.17.5326-5332.1997; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hoffmann N, 2005, INFECT IMMUN, V73, P2504, DOI 10.1128/IAI.73.4.2504-2514.2005; HOLLOWAY BW, 1994, MICROBIOL-UK, V140, P2907, DOI 10.1099/13500872-140-11-2907; ICHIHARA K, 1991, J LIPID RES, V32, P1709; IMAMURA S, 1990, J BIOCHEM, V107, P184, DOI 10.1093/oxfordjournals.jbchem.a123023; Iram SH, 2006, J BACTERIOL, V188, P599, DOI 10.1128/JB.188.2.599-608.2006; Kang Y, 2008, MICROBIOL-SGM, V154, P1584, DOI 10.1099/mic.0.2008/018135-0; Kang Y, 2009, MOL MICROBIOL, V73, P120, DOI 10.1111/j.1365-2958.2009.06757.x; Kazakov AE, 2009, J BACTERIOL, V191, P52, DOI 10.1128/JB.01175-08; KOUKER G, 1987, APPL ENVIRON MICROB, V53, P211, DOI 10.1128/AEM.53.1.211-213.1987; KRIEG DP, 1988, INFECT IMMUN, V56, P864, DOI 10.1128/IAI.56.4.864-873.1988; KUMAR GB, 1993, J BIOL CHEM, V268, P15469; Lode H, 2000, CURR OPIN INFECT DIS, V13, P377, DOI 10.1097/00001432-200008000-00009; Lucas RL, 2000, J BACTERIOL, V182, P1872, DOI 10.1128/JB.182.7.1872-1882.2000; Matz C, 2008, ISME J, V2, P843, DOI 10.1038/ismej.2008.47; Miller JH., 1992, SHORT COURSE BACTERI, P72; Miller RM, 2008, J BACTERIOL, V190, P4038, DOI 10.1128/JB.00129-08; Mulcahy H, 2010, ENVIRON MICROBIOL, V12, P1621, DOI 10.1111/j.1462-2920.2010.02208.x; Olivera ER, 2001, MOL MICROBIOL, V39, P863, DOI 10.1046/j.1365-2958.2001.02296.x; OVERATH P, 1969, EUR J BIOCHEM, V7, P559; Overhage J, 2007, J BACTERIOL, V189, P2164, DOI 10.1128/JB.01623-06; Pinzon NM, 2009, APPL MICROBIOL BIOT, V82, P975, DOI 10.1007/s00253-009-1896-9; Postle AD, 1999, AM J RESP CELL MOL, V20, P90, DOI 10.1165/ajrcmb.20.1.3253; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Raman N, 1997, J BIOL CHEM, V272, P30645, DOI 10.1074/jbc.272.49.30645; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; Rindi L, 2002, MICROBIOL-SGM, V148, P3873, DOI 10.1099/00221287-148-12-3873; SATO S, 1992, J BIOCHEM-TOKYO, V111, P8, DOI 10.1093/oxfordjournals.jbchem.a123722; SATO S, 1992, J BIOCHEM, V111, P16, DOI 10.1093/oxfordjournals.jbchem.a123711; Son MS, 2008, PLASMID, V59, P111, DOI 10.1016/j.plasmid.2007.12.002; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; Soto MJ, 2002, MOL MICROBIOL, V43, P371, DOI 10.1046/j.1365-2958.2002.02749.x; STANIER RY, 1966, J GEN MICROBIOL, V43, P159, DOI 10.1099/00221287-43-2-159; van Aalten DMF, 2001, EMBO J, V20, P2041, DOI 10.1093/emboj/20.8.2041; van den Berg B, 2004, SCIENCE, V304, P1506, DOI 10.1126/science.1097524; Wargo MJ, 2008, J BACTERIOL, V190, P2690, DOI 10.1128/JB.01393-07; Wehrmann A, 1996, NAT BIOTECHNOL, V14, P1274, DOI 10.1038/nbt1096-1274; Weimar JD, 2002, J BIOL CHEM, V277, P29369, DOI 10.1074/jbc.M107022200; Weir TL, 2008, APPL ENVIRON MICROB, V74, P5784, DOI 10.1128/AEM.00860-08; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	69	56	61	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13557	10.1371/journal.pone.0013557	http://dx.doi.org/10.1371/journal.pone.0013557			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042406	Green Published, Green Submitted, gold			2022-12-25	WOS:000283293800021
J	Malik, AK; Khaldoyanidi, S; Auci, DL; Miller, SC; Ahlem, CN; Reading, CL; Page, T; Frincke, JM				Malik, Ajay K.; Khaldoyanidi, Sophia; Auci, Dominick L.; Miller, Scott C.; Ahlem, Clarence N.; Reading, Christopher L.; Page, Theodore; Frincke, James M.			5-Androstene-3 beta,7 beta,17 beta-triol (beta-AET) Slows Thermal Injury Induced Osteopenia in Mice: Relation to Aging and Osteoporosis	PLOS ONE			English	Article							BONE-MINERAL DENSITY; MESENCHYMAL STEM-CELLS; DEHYDROEPIANDROSTERONE DHEA; PROGENITOR CELLS; RECEPTOR-ALPHA; STROMAL CELLS; SELF-RENEWAL; IN-VITRO; GLUCOCORTICOIDS; METABOLISM	5-androstene-3 beta, 7 beta, 17 beta-triol (beta-AET), an active metabolite of dehydroepiandrosterone ( DHEA), reversed glucocorticoid ( GC)induced suppression of IL-6, IL-8 and osteoprotegerin production by human osteoblast-like MG-63 cells and promoted osteoblast differentiation of human mesenchymal stem cells (MSCs). In a murine thermal injury model that includes glucocorticoid-induced osteopenia, beta-AET significantly (p<0.05) preserved bone mineral content, restored whole body bone mineral content and endochondral growth, suggesting reversal of GC-mediated decreases in chondrocyte proliferation, maturation and osteogenesis in the growth plate. In men and women, levels of beta-AET decline with age, consistent with a role for beta-AET relevant to diseases associated with aging. beta-AET, related compounds or synthetic derivatives may be part of effective therapeutic strategies to accelerate tissue regeneration and prevent or treat diseases associated with aging such as osteoporosis.	[Malik, Ajay K.; Auci, Dominick L.; Ahlem, Clarence N.; Reading, Christopher L.; Page, Theodore; Frincke, James M.] Harbor Biosci Inc, San Diego, CA USA; [Khaldoyanidi, Sophia] Torrey Pines Inst Mol Studies, San Diego, CA USA; [Miller, Scott C.] Univ Utah, Div Radiobiol, Salt Lake City, UT 84112 USA	Torrey Pines Institute for Molecular Studies, California; Utah System of Higher Education; University of Utah	Malik, AK (corresponding author), Harbor Biosci Inc, San Diego, CA USA.	Dauci@harborbiosciences.com		MALIK, AJAY/0000-0002-4831-3597; Miller, Scott/0000-0002-2127-1243	Harbor Biosciences	Harbor Biosciences	This study was funded by Harbor Biosciences. The funders participated in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abu EO, 2000, J CLIN ENDOCR METAB, V85, P883, DOI 10.1210/jc.85.2.883; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; ARANEO BA, 1993, J INFECT DIS, V167, P830, DOI 10.1093/infdis/167.4.830; AUCI DL, 2003, MOD ASP IMMUNOBIOL, V3, P64; Auci DL, 2009, AUTOIMMUN REV, V8, P369, DOI 10.1016/j.autrev.2008.11.011; Balazs Z, 2008, J AM SOC NEPHROL, V19, P92, DOI 10.1681/ASN.2007030263; Benten WPM, 2001, ENDOCRINOLOGY, V142, P1669, DOI 10.1210/en.142.4.1669; Bovenberg SA, 2005, NETH J MED, V63, P300; BOWMAN BM, 2001, COMP INJURY STRESS R; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; Buxton EC, 2004, J CLIN ENDOCR METAB, V89, P3332, DOI 10.1210/jc.2003-032066; Canning MO, 2000, EUR J ENDOCRINOL, V143, P687, DOI 10.1530/eje.0.1430687; CERMAK K, 2009, CLIN ORTHOP RELAT RE; CLEARY MP, 1991, P SOC EXP BIOL MED, V196, P8; Clerici M, 1997, PSYCHONEUROENDOCRINO, V22, pS27, DOI 10.1016/S0306-4530(97)00019-X; Cock TA, 2004, EMBO REP, V5, P1007, DOI 10.1038/sj.embor.7400254; Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835; CROISILLE L, 1994, BLOOD, V84, P4116, DOI 10.1182/blood.V84.12.4116.bloodjournal84124116; Cui H, 2003, MOL CELL ENDOCRINOL, V203, P13, DOI 10.1016/S0303-7207(03)00121-7; Davidson M, 2000, CLIN INVEST MED, V23, P300; DAVIDSON MH, 1998, FASEB J         0418, pA764; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Dovio A, 2004, CLIN EXP RHEUMATOL, V22, P79; Dovio A, 2006, EUR J ENDOCRINOL, V154, P745, DOI 10.1530/eje.1.02147; Edelman Linda S., 1997, Journal of Burn Care and Rehabilitation, V18, P483, DOI 10.1097/00004630-199711000-00003; Eijken M, 2005, MOL ENDOCRINOL, V19, P621, DOI 10.1210/me.2004-0212; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Feldman BJ, 2009, PEDIATR RES, V65, P249, DOI 10.1203/PDR.0b013e3181989667; Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005; GODDARD MS, 2009, ORTHOPEDICS, V32; Gunther T, 2007, NAT CELL BIOL, V9, P1229, DOI 10.1038/ncb1107-1229; Hammer F, 2005, J CLIN ENDOCR METAB, V90, P3600, DOI 10.1210/jc.2004-2386; Harding G, 2006, CYTOKINE, V36, P57, DOI 10.1016/j.cyto.2006.10.012; Hartkamp A, 2004, ARTHRITIS RHEUM-US, V50, P3591, DOI 10.1002/art.20610; Jankowski CM, 2006, J CLIN ENDOCR METAB, V91, P2986, DOI 10.1210/jc.2005-2484; Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270; KALAK R, 2009, BONE; Klein Gordon L, 2006, J Burns Wounds, V5, pe5; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Korczowska Izabela, 2003, Yale Journal of Biology and Medicine, V76, P45; Labrie F, 2005, J ENDOCRINOL, V187, P169, DOI 10.1677/joe.1.06264; Lardy H, 2005, VITAM HORM, V71, P263, DOI 10.1016/S0083-6729(05)71009-8; Lardy H, 2002, LIPIDS, V37, P1187, DOI 10.1007/s11745-002-1019-7; Lardy H, 2003, J BIOL CHEM, V278, P3499, DOI 10.1074/jbc.X200003200; Liu DM, 2004, STEROIDS, V69, P279, DOI 10.1016/j.steroids.2004.02.004; Loria RM, 1997, PSYCHONEUROENDOCRINO, V22, pS103, DOI 10.1016/S0306-4530(97)00005-X; Loria RM, 1996, J ENDOCRINOL, V150, pS209; Marks SC, 2000, INT J DEV BIOL, V44, P309; Martin C, 2001, BIOCHEM J, V355, P509, DOI 10.1042/0264-6021:3550509; Marwah A, 2002, J CHROMATOGR B, V767, P285, DOI 10.1016/S1570-0232(01)00570-0; McDonough AK, 2008, NAT CLIN PRACT ENDOC, V4, P507, DOI 10.1038/ncpendmet0920; Meier C, 2008, ARCH INTERN MED, V168, P820, DOI 10.1001/archinte.168.8.820; Miller SC, 2002, CALCIFIED TISSUE INT, V71, P429, DOI 10.1007/s00223-001-1139-2; Mushtaq T, 2002, J ENDOCRINOL, V175, P705, DOI 10.1677/joe.0.1750705; Nashev LG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000561; Padgett DA, 1998, J NEUROIMMUNOL, V84, P61, DOI 10.1016/S0165-5728(97)00244-0; Padgett DA, 1995, ANN NY ACAD SCI, V774, P323; PADGETT DA, 1994, J IMMUNOL, V153, P1544; Przkora R, 2007, BONE, V41, P297, DOI 10.1016/j.bone.2007.04.195; Reyes M, 2001, ANN NY ACAD SCI, V938, P231; Rose KA, 1997, P NATL ACAD SCI USA, V94, P4925, DOI 10.1073/pnas.94.10.4925; Sahin Gunsah, 2002, SMJ Singapore Medical Journal, V43, P576; Sanchez-Guerrero J, 2008, J RHEUMATOL, V35, P1567; Sher LB, 2006, CALCIFIED TISSUE INT, V79, P118, DOI 10.1007/s00223-005-0297-z; Sher LB, 2004, ENDOCRINOLOGY, V145, P922, DOI 10.1210/en.2003-0655; STEWART PM, 1995, STEROIDS, V60, P143, DOI 10.1016/0039-128X(94)00024-7; Svec F, 1998, P SOC EXP BIOL MED, V218, P174; Takayanagi R, 2002, MECH AGEING DEV, V123, P1107, DOI 10.1016/S0047-6374(01)00394-3; Tamasi V, 2008, MOL PHARMACOL, V73, P968, DOI 10.1124/mol.107.036780; Urban NH, 2008, J STEROID BIOCHEM, V110, P223, DOI 10.1016/j.jsbmb.2008.04.005; Vicent GP, 2008, J STEROID BIOCHEM, V109, P344, DOI 10.1016/j.jsbmb.2008.03.015; VONMUHLE, 2008, OSTEOPOROSIS INT, V19, P699; Wang L, 2007, J MOL ENDOCRINOL, V38, P467, DOI 10.1677/jme.1.02173; WANG T, J PHARM EXP THER; Webb SJ, 2006, DRUG METAB REV, V38, P89, DOI 10.1080/03602530600569877; Wolf OT, 1999, BRAIN RES REV, V30, P264, DOI 10.1016/S0165-0173(99)00021-1; Yaturu S, 2007, DIABETES CARE, V30, P1574, DOI 10.2337/dc06-2606; Zhou H, 2008, J BIOL CHEM, V283, P1936, DOI 10.1074/jbc.M702687200	80	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13566	10.1371/journal.pone.0013566	http://dx.doi.org/10.1371/journal.pone.0013566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042414	Green Published, Green Submitted, gold			2022-12-25	WOS:000283293800024
J	Dangi-Garimella, S; Strouch, MJ; Grippo, PJ; Bentrem, DJ; Munshi, HG				Dangi-Garimella, S.; Strouch, M. J.; Grippo, P. J.; Bentrem, D. J.; Munshi, H. G.			Collagen regulation of let-7 in pancreatic cancer involves TGF-beta 1-mediated membrane type 1-matrix metalloproteinase expression	ONCOGENE			English	Article						TGF-beta 1; collagen; ERK1/2; MT1-MMP; let-7; fibrosis	EXTRACELLULAR-MATRIX; TRANSFORMING GROWTH-FACTOR-BETA-1; DUCTAL ADENOCARCINOMA; MICRORNA EXPRESSION; CELL-PROLIFERATION; TUMOR-DEVELOPMENT; INVASION; MT1-MMP; FAMILY; RAS	Pancreatic ductal adenocarcinoma (PDAC) is associated with a pronounced collagen-rich fibrosis known as desmoplastic reaction; however, the role of fibrosis in PDAC is poorly understood. In this report we show that collagen can regulate the tumor suppressive let-7 family of microRNAs in pancreatic cancer cells. PDAC cells growing in 3D collagen gels repress mature let-7 without affecting the precursor form of let-7 in part through increased expression of membrane type 1-matrix metallo-proteinase (MT1-MMP, MMP-14) and ERK1/2 activation. PDAC cells in collagen also demonstrate increased TGF-beta 1 signaling, and blocking TGF-beta 1 signaling attenuated collagen-induced MT1-MMP expression, ERK1/2 activation and repression of let-7 levels. Although MT1-MMP overexpression was not sufficient to inhibit let-7 on 2D tissue culture plastic, overexpression of MT1-MMP in PDAC cells embedded in 3D collagen gels or grown in vivo repressed let-7 levels. Importantly, MT1-MMP expression significantly correlated with decreased levels of let-7 in human PDAC tumor specimens. Overall, our study emphasizes the interplay between the key proteinase MT1-MMP and its substrate type I collagen in modulating microRNA expression, and identifies an additional mechanism by which fibrosis may contribute to PDAC progression. Oncogene (2011) 30, 1002-1008; doi:10.1038/onc.2010.485; published online 8 November 2010	[Dangi-Garimella, S.; Munshi, H. G.] Northwestern Univ, Sch Med, Dept Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Strouch, M. J.; Grippo, P. J.; Bentrem, D. J.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Div Surg Oncol, Chicago, IL 60611 USA; [Grippo, P. J.; Bentrem, D. J.; Munshi, H. G.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Bentrem, D. J.; Munshi, H. G.] Jesse Brown VA Med Ctr, Chicago, IL USA	Northwestern University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Dangi-Garimella, S (corresponding author), Northwestern Univ, Sch Med, Dept Med, Div Hematol Oncol, 303 E Super Ave,Lurie 3-117, Chicago, IL 60611 USA.	s-dangi-garimella@northwestern.edu; h-munshi@northwestern.edu			NCI [R01CA126888]; Elsa U Pardee Foundation; National Pancreas Foundation; NATIONAL CANCER INSTITUTE [R01CA126888] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Elsa U Pardee Foundation; National Pancreas Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by Grant R01CA126888 (HGM) from the NCI, and funding from the Elsa U Pardee Foundation (HGM) and the National Pancreas Foundation (HGM).	Aoyagi Y, 2004, BRIT J CANCER, V91, P1316, DOI 10.1038/sj.bjc.6602141; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Dangi-Garimella S, 2010, J BIOL CHEM, V285, P28363, DOI 10.1074/jbc.M110.146019; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Erkan M, 2007, GASTROENTEROLOGY, V132, P1447, DOI 10.1053/j.gastro.2007.01.031; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; IMAMURA T, 1995, PANCREAS, V11, P357, DOI 10.1097/00006676-199511000-00007; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lohr M, 2001, CANCER RES, V61, P550; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; MORRIS JP, 2005, SCI STKE, pPE41; Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028; Ottaviano AJ, 2006, CANCER RES, V66, P7032, DOI 10.1158/0008-5472.CAN-05-4421; Park JK, 2009, PANCREAS, V38, pE190, DOI 10.1097/MPA.0b013e3181ba82e1; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Qian BY, 2009, BREAST CANCER RES TR, V117, P131, DOI 10.1007/s10549-008-0219-7; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sounnil NE, 2010, INT J CANCER, V126, P1067, DOI 10.1002/ijc.24690; Torrisani J, 2009, HUM GENE THER, V20, P831, DOI 10.1089/hum.2008.134; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	33	61	62	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2011	30	8					1002	1008		10.1038/onc.2010.485	http://dx.doi.org/10.1038/onc.2010.485			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	726CJ	21057545	Green Accepted			2022-12-25	WOS:000287695900011
J	Bryant, KJ; Bidgood, MJ; Lei, PW; Taberner, M; Salom, C; Kumar, V; Lee, L; Church, WB; Courtenay, B; Smart, BP; Gelb, MH; Cahill, MA; Graham, GG; McNeil, HP; Scott, KF				Bryant, Katherine J.; Bidgood, Matthew J.; Lei, Pei-Wen; Taberner, Megan; Salom, Caroline; Kumar, Vinod; Lee, Lawrence; Church, W. Bret; Courtenay, Brett; Smart, Brian P.; Gelb, Michael H.; Cahill, Michael A.; Graham, Garry G.; McNeil, H. Patrick; Scott, Kieran F.			A Bifunctional Role for Group IIA Secreted Phospholipase A(2) in Human Rheumatoid Fibroblast-like Synoviocyte Arachidonic Acid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M-TYPE RECEPTOR; FACTOR-KAPPA-B; PROSTAGLANDIN PRODUCTION; MAMMALIAN-CELLS; CYCLOOXYGENASE-2 EXPRESSION; PYRROLIDINE INHIBITORS; SYNOVIAL FIBROBLASTS; GROUP IB; ARTHRITIS; RELEASE	Human group IIA-secreted phospholipase A(2) (sPLA(2)-IIA) is an important regulator of cytokine-mediated inflammatory responses in both in vitro and in vivo models of rheumatoid arthritis (RA). However, treatment of RA patients with sPLA(2)-IIA inhibitors shows only transient benefit. Using an activityimpaired sPLA(2)-IIA mutant protein (H48Q), we show that up-regulation of TNF-dependent PGE(2) production and cyclooxygenase-2 (COX-2) induction by exogenous sPLA(2)-IIA in RA fibroblast-like synoviocytes (FLSs) is independent of its enzyme function. Selective cytosolic phospholipase A(2)-alpha (cPLA(2)-alpha) inhibitors abrogate TNF/sPLA(2)-IIA-mediated PGE(2) production without affecting COX-2 levels, indicating arachidonic acid (AA) flux to COX-2 occurs exclusively through TNF-mediated activation of cPLA(2)-alpha. Nonetheless, exogenous sPLA(2)-IIA, but not H48Q, stimulates both AA mobilization from FLSs and microparticle-derived AA release that is not used for COX-2-dependent PGE(2) production. sPLA(2)-IIA-mediated AA production is inhibited by pharmacological blockade of sPLA(2)-IIA but not cPLA(2)-alpha. Exogenous H48Q alone, like sPLA(2)-IIA, increases COX-2 protein levels without inducing PGE(2) production. Unlike TNF, sPLA(2)-IIA alone does not rapidly mobilize NF-kappa B or activate phosphorylation of p38 MAPK, two key regulators of COX-2 protein expression, but does activate the ERK1/2 pathway. Thus, sPLA(2)-IIA regulates AA flux through the cPLA(2)-alpha/COX-2 pathway in RA FLSs by up-regulating steady state levels of these biosynthetic enzymes through an indirect mechanism, rather than direct provision of substrate to the pathway. Inhibitors that have been optimized for their potency in enzyme activity inhibition alone may not adequately block the activity-independent function of sPLA(2)-IIA.	[Courtenay, Brett] St Vincents Private Hosp, Sydney, NSW 2010, Australia; [Kumar, Vinod; Graham, Garry G.] Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW 2052, Australia; [Bryant, Katherine J.; Bidgood, Matthew J.; Lei, Pei-Wen; Taberner, Megan; Salom, Caroline; Scott, Kieran F.] Univ New S Wales, St Vincents Hosp, Sch Clin, Sydney, NSW 2052, Australia; [Bryant, Katherine J.; McNeil, H. Patrick] Univ New S Wales, S Western Sydney Clin Sch, Sydney, NSW 2052, Australia; [Lee, Lawrence; Church, W. Bret] Univ Sydney, Sydney, NSW 2006, Australia; [Cahill, Michael A.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2678, Australia; [Smart, Brian P.; Gelb, Michael H.] Univ Washington, Dept Chem & Biochem, Seattle, WA 98195 USA	University of New South Wales Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; Charles Sturt University; University of Washington; University of Washington Seattle	Scott, KF (corresponding author), Univ New S Wales, St Vincents Hosp, Sch Clin, Inflammat Res Lab, Darlinghurst, NSW 2010, Australia.	kieran.scott@unsw.edu.au	Church, William/H-6040-2013; CAHILL, Michael/J-8035-2012; Kumar, Vinod/AAM-3705-2020; Salom, Caroline/C-1761-2014; Bryant, Katherine/E-8574-2010	Church, William/0000-0002-8033-5518; CAHILL, Michael/0000-0002-8593-8844; Kumar, Vinod/0000-0002-7263-9917; Salom, Caroline/0000-0002-8986-9735; Bryant, Katherine/0000-0002-8686-623X; McNeil, Hugh Patrick/0000-0003-4336-2960; Lee, Lawrence/0000-0002-4453-4886; gelb, michael/0000-0001-7000-5219; Scott, Kieran/0000-0002-6012-4107	National Institutes of Health [HL50040, HL3625]; National Health and Medical Research Council [980263, 222870]; Cancer Council NSW [RG07-17]; Rebecca Cooper Foundation, Australia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003625, R01HL050040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW(Cancer Council New South Wales); Rebecca Cooper Foundation, Australia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL50040 and HL3625 (to M.H.G.), National Health and Medical Research Council Grants 980263 (to K.F.S. and P.M. Brooks) and 222870 (to K.F.S., G.G.G., and H.P.McN), Cancer Council NSW Grant RG07-17 (to K.F.S., G.G.G., Q.Dong, and P.J. Russell), and a grant from the Rebecca Cooper Foundation (to K.F.S.), Australia.	ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; ANCIAN P, 1995, J BIOL CHEM, V270, P8963, DOI 10.1074/jbc.270.15.8963; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Bidgood MJ, 2000, J IMMUNOL, V165, P2790, DOI 10.4049/jimmunol.165.5.2790; Boilard E, 2006, BIOCHEMISTRY-US, V45, P13203, DOI 10.1021/bi061376d; Boilard E, 2010, EMBO MOL MED, V2, P172, DOI 10.1002/emmm.201000072; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Bradbury DA, 2003, J BIOL CHEM, V278, P49954, DOI 10.1074/jbc.M307964200; Bradley JD, 2005, J RHEUMATOL, V32, P417; Chapdelaine Joan M., 1995, Arthritis and Rheumatism, V38, pS293; Church WB, 2001, J BIOL CHEM, V276, P33156, DOI 10.1074/jbc.M101272200; CISAR LA, 1993, CELL SIGNAL, V5, P463, DOI 10.1016/0898-6568(93)90086-2; Crofford LJ, 2005, J GENE MED, V7, P288, DOI 10.1002/jgm.661; Crofford LJ, 1997, ARTHRITIS RHEUM-US, V40, P226, DOI 10.1002/art.1780400207; Cupillard L, 1999, J BIOL CHEM, V274, P7043, DOI 10.1074/jbc.274.11.7043; Edwards SH, 2002, BIOCHEMISTRY-US, V41, P15468, DOI 10.1021/bi020485z; Faour WH, 2003, J BIOL CHEM, V278, P26897, DOI 10.1074/jbc.M212790200; Fitzpatrick FA, 2001, J CLIN INVEST, V107, P1347, DOI 10.1172/JCI13241; Ghomashchi F, 2001, BBA-BIOMEMBRANES, V1513, P160, DOI 10.1016/S0005-2736(01)00349-2; Ghosh M, 2007, J BIOL CHEM, V282, P11676, DOI 10.1074/jbc.M608458200; Grass DS, 1996, J CLIN INVEST, V97, P2233, DOI 10.1172/JCI118664; GREEN JA, 1991, INFLAMMATION, V15, P355, DOI 10.1007/BF00917352; Han WK, 2003, J BIOL CHEM, V278, P24153, DOI 10.1074/jbc.M300424200; Hanasaki K, 2004, BIOL PHARM BULL, V27, P1165, DOI 10.1248/bpb.27.1165; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Hirabayashi T, 2004, BIOL PHARM BULL, V27, P1168, DOI 10.1248/bpb.27.1168; Hughes-Fulford M, 2005, CARCINOGENESIS, V26, P1520, DOI 10.1093/carcin/bgi112; Ivandic B, 1999, ARTERIOSCL THROM VAS, V19, P1284, DOI 10.1161/01.ATV.19.5.1284; Jamal OS, 1998, ANN RHEUM DIS, V57, P550, DOI 10.1136/ard.57.9.550; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; KUSHNER PJ, 1990, MOL ENDOCRINOL, V4, P1465, DOI 10.1210/mend-4-10-1465; Lehmann T, 2002, J RHEUMATOL, V29, P787; Lin MKS, 1996, J RHEUMATOL, V23, P1162; Masuda S, 2005, FEBS J, V272, P655, DOI 10.1111/j.1742-4658.2004.04489.x; Min SY, 2004, J RHEUMATOL, V31, P875; Mounier CM, 2004, J BIOL CHEM, V279, P25024, DOI 10.1074/jbc.M313019200; Murakami M, 2004, BIOL PHARM BULL, V27, P1158, DOI 10.1248/bpb.27.1158; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; Murakami M, 1999, J BIOL CHEM, V274, P29927, DOI 10.1074/jbc.274.42.29927; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; Nevalainen TJ, 2000, BBA-MOL CELL BIOL L, V1488, P83, DOI 10.1016/S1388-1981(00)00112-8; Ni Z, 2006, J BIOL CHEM, V281, P16245, DOI 10.1074/jbc.M513874200; NUGTEREN DH, 1973, BIOCHIM BIOPHYS ACTA, V326, P448, DOI 10.1016/0005-2760(73)90145-8; Ono T, 2002, BIOCHEM J, V363, P727, DOI 10.1042/0264-6021:3630727; Pasztoi M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2697; REYNOLDS LJ, 1992, ANAL BIOCHEM, V204, P190, DOI 10.1016/0003-2697(92)90160-9; Santos LL, 2004, J RHEUMATOL, V31, P1038; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Sawada H, 1999, EUR J BIOCHEM, V263, P826, DOI 10.1046/j.1432-1327.1999.00565.x; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Scott KF, 2010, BIOCHIMIE, V92, P601, DOI 10.1016/j.biochi.2010.03.019; SEILHAMER JJ, 1989, J BIOL CHEM, V264, P5335; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; Seno K, 2001, BIOORG MED CHEM LETT, V11, P587, DOI 10.1016/S0960-894X(01)00003-8; SMITH GM, 1992, BRIT J RHEUMATOL, V31, P175; Sved P, 2004, CANCER RES, V64, P6934, DOI 10.1158/0008-5472.CAN-03-3018; Tada K, 1998, J IMMUNOL, V161, P5008; Tietge UJF, 2005, J LIPID RES, V46, P1604, DOI 10.1194/jlr.M400469-JLR200	61	27	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2492	2503		10.1074/jbc.M110.123927	http://dx.doi.org/10.1074/jbc.M110.123927			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21068383	Green Published, hybrid			2022-12-25	WOS:000286464300014
J	Frick, IM; Shannon, O; Akesson, P; Morgelin, M; Collin, M; Schmidtchen, A; Bjorck, L				Frick, Inga-Maria; Shannon, Oonagh; Akesson, Per; Morgelin, Matthias; Collin, Mattias; Schmidtchen, Artur; Bjorck, Lars			Antibacterial Activity of the Contact and Complement Systems Is Blocked by SIC, a Protein Secreted by Streptococcus pyogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; INNATE IMMUNITY; ANTIMICROBIAL PEPTIDES; INHIBITING PROTEIN; SURFACE PROTEIN; BINDING; IDENTIFICATION; ACTIVATION; COMPONENTS; KININOGENS	Recent studies have shown that activation of complement and contact systems results in the generation of antibacterial peptides. Streptococcus pyogenes, a major bacterial pathogen in humans, exists in > 100 different serotypes due to sequence variation in the surface-associated M protein. Cases of invasive and life-threatening S. pyogenes infections are commonly associated with isolates of the M1 serotype, and in contrast to the large majority of M serotypes, M1 isolates all secrete the SIC protein. Here, we show that SIC interferes with the activation of the contact system and blocks the activity of antibacterial peptides generated through complement and contact activation. This effect promotes the growth of S. pyogenes in human plasma, and in a mouse model of S. pyogenes sepsis, SIC enhances bacterial dissemination, results which help explain the high frequency of severe S. pyogenes infections caused by isolates of the M1 serotype.	[Frick, Inga-Maria; Shannon, Oonagh; Akesson, Per; Morgelin, Matthias; Collin, Mattias; Bjorck, Lars] Lund Univ, Dept Clin Sci, Div Infect Med, SE-22184 Lund, Sweden; [Schmidtchen, Artur] Lund Univ, Dept Clin Sci, Div Dermatol & Venereol, SE-22184 Lund, Sweden	Lund University; Lund University	Frick, IM (corresponding author), BMC B14,Tornavagen 10, SE-22184 Lund, Sweden.	Inga-Maria.Frick@med.lu.se	Collin, Mattias/C-6398-2009; Schmidtchen, Artur/F-9507-2015	Collin, Mattias/0000-0002-6166-7410; Shannon, Oonagh/0000-0001-8291-8189	Swedish Research Council [7480]; Foundations of Crafoord, Kock, Bergvall, and Osterlund; Royal Physiographic Society; Hansa Medical AB	Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundations of Crafoord, Kock, Bergvall, and Osterlund; Royal Physiographic Society; Hansa Medical AB	This work was supported by the Swedish Research Council (Project 7480), the Foundations of Crafoord, Kock, Bergvall, and Osterlund, the Royal Physiographic Society, and Hansa Medical AB.	Akesson P, 1996, J BIOL CHEM, V271, P1081, DOI 10.1074/jbc.271.2.1081; AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877; Akesson P., 2010, MICROBIOLOGY    0812, DOI [10.1099/mic.0.039578-0, DOI 10.1099/MIC.0.039578-0]; Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; BENNASR A, 1995, BIOCHEM J, V305, P173, DOI 10.1042/bj3050173; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; BJORCK L, 1984, J IMMUNOL, V133, P969; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; CHANG NS, 1992, BLOOD, V79, P2973; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Egesten A, 2007, J INFECT DIS, V195, P684, DOI 10.1086/510857; Facklam RF, 2002, CLIN INFECT DIS, V34, P28, DOI 10.1086/324621; Fernie-King BA, 2004, IMMUNOLOGY, V111, P444, DOI 10.1111/j.0019-2805.2004.01837.x; Fernie-King BA, 2002, INFECT IMMUN, V70, P4908, DOI 10.1128/IAI.70.9.4908-4916.2002; Fernie-King BA, 2001, IMMUNOLOGY, V103, P390, DOI 10.1046/j.1365-2567.2001.01249.x; Fernie-King BA, 2007, MICROBES INFECT, V9, P300, DOI 10.1016/j.micinf.2006.12.006; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; FRICK IM, 1994, MOL MICROBIOL, V12, P143, DOI 10.1111/j.1365-2958.1994.tb01003.x; Frick IM, 2003, J BIOL CHEM, V278, P16561, DOI 10.1074/jbc.M301995200; Frick IM, 2006, EMBO J, V25, P5569, DOI 10.1038/sj.emboj.7601422; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Haas PJ, 2007, IMMUNOL RES, V37, P161, DOI 10.1007/BF02697367; Hartas J, 1999, MICROB PATHOGENESIS, V26, P25, DOI 10.1006/mpat.1998.0244; HERWALD H, 1995, J BIOL CHEM, V270, P14634; Hoe NP, 1999, NAT MED, V5, P924, DOI 10.1038/11369; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imohl M, 2010, FEMS IMMUNOL MED MIC, V58, P389, DOI 10.1111/j.1574-695X.2010.00652.x; Joseph K, 2005, ADV IMMUNOL, V86, P159, DOI 10.1016/S0065-2776(04)86005-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lauth X, 2009, J INNATE IMMUN, V1, P202, DOI 10.1159/000203645; Luca-Harari B, 2009, J CLIN MICROBIOL, V47, P1155, DOI 10.1128/JCM.02155-08; Lukomski S, 2000, INFECT IMMUN, V68, P535, DOI 10.1128/IAI.68.2.535-542.2000; Minami M, 2009, FEMS MICROBIOL LETT, V298, P67, DOI 10.1111/j.1574-6968.2009.01696.x; Morgan BP, 2005, IMMUNOL LETT, V97, P171, DOI 10.1016/j.imlet.2004.11.010; Musser JM, 1998, BIOMED RES REP, P185; Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101; Nordahl EA, 2005, J BIOL CHEM, V280, P34832, DOI 10.1074/jbc.M507249200; Oehmcke S, 2009, J INNATE IMMUN, V1, P225, DOI 10.1159/000203700; Oehmcke S, 2009, BLOOD, V114, P444, DOI 10.1182/blood-2008-10-182527; Olsen RJ, 2009, CELL MICROBIOL, V11, P1, DOI 10.1111/j.1462-5822.2008.01225.x; Pasupuleti M, 2007, J BIOL CHEM, V282, P2520, DOI 10.1074/jbc.M607848200; Pence MA, 2010, J INNATE IMMUN, V2, P587, DOI 10.1159/000317672; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; ROTH J, 1978, J HISTOCHEM CYTOCHEM, V26, P1074, DOI 10.1177/26.12.366014; Rus H, 2005, IMMUNOL RES, V33, P103, DOI 10.1385/IR:33:2:103; Rydengard V, 2007, FEBS J, V274, P377, DOI 10.1111/j.1742-4658.2006.05586.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schuttelkopf AW, 2006, J BIOL CHEM, V281, P16570, DOI 10.1074/jbc.M601033200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shannon O, 2010, BLOOD, V116, P2365, DOI 10.1182/blood-2010-02-271858; Shelburne SA, 2005, INFECT IMMUN, V73, P4723, DOI 10.1128/IAI.73.8.4723-4731.2005; Sonesson A, 2007, BBA-BIOMEMBRANES, V1768, P346, DOI 10.1016/j.bbamem.2006.10.017; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Stockbauer KE, 1998, P NATL ACAD SCI USA, V95, P3128, DOI 10.1073/pnas.95.6.3128; Stone J. E., 1998, THESIS MISSOURI U SC; Vikerfors A, 2009, SCAND J INFECT DIS, V41, P823, DOI 10.3109/00365540903179749; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	61	18	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1331	1340		10.1074/jbc.M110.178350	http://dx.doi.org/10.1074/jbc.M110.178350			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21068386	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000286005000045
J	Komati, H; Maharsy, W; Beauregard, J; Hayek, S; Nemer, M				Komati, Hiba; Maharsy, Wael; Beauregard, Janie; Hayek, Salim; Nemer, Mona			ZFP260 Is an Inducer of Cardiac Hypertrophy and a Nuclear Mediator of Endothelin-1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGESTIVE-HEART-FAILURE; SERUM RESPONSE FACTOR; GENE-EXPRESSION; TRANSCRIPTION FACTORS; CARDIOMYOCYTE HYPERTROPHY; VENTRICULAR MYOCYTES; RAT CARDIOMYOCYTES; HYPERTENSIVE-RATS; NEURAL CREST; CELL-GROWTH	Pressure and volume overload induce hypertrophic growth of postnatal cardiomyocytes and genetic reprogramming characterized by reactivation of a subset of fetal genes. Despite intense efforts, the nuclear effectors of cardiomyocyte hypertrophy remain incompletely defined. Endothelin-1 (ET-1) plays an important role in cardiomyocyte growth and is involved in mediating the neurohormonal effects of mechanical stress. Here, we show that the phenylephrine-induced complex-1 (PEX1), also known as zinc finger transcription factor ZFP260, is essential for cardiomyocyte response to ET-1 as evidenced in cardiomyocytes with PEX1 knockdown. We found that ET-1 enhances PEX1 transcriptional activity via a PKC-dependent pathway which phosphorylates the protein and further potentiates its synergy with GATA4. Consistent with a role for PEX1 in cardiomyocyte hypertrophy, overexpression of PEX1 is sufficient to induce cardiomyocyte hypertrophy in vitro and in vivo. Importantly, transgenic mice with inducible PEX1 expression in the adult heart develop cardiac hypertrophy with preserved heart function. Together, the results identify a novel nuclear effector of ET-1 signaling and suggest that PEX1 may be a regulator of the early stages of cardiac hypertrophy.	[Komati, Hiba; Maharsy, Wael; Beauregard, Janie; Hayek, Salim; Nemer, Mona] Univ Ottawa, Lab Cardiac Dev & Differentiat, Dept Biochem Microbiol & Immunol, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Nemer, M (corresponding author), Univ Ottawa, Lab Cardiac Dev & Differentiat, Dept Biochem Microbiol & Immunol, 550 Rue Cumberland 246, Ottawa, ON K1N 6N5, Canada.	mona.nemer@uottawa.ca	Hayek, Salim S./E-6932-2013	Hayek, Salim S./0000-0003-0180-349X	Canadian Institutes of Health Research; Ottawa studentship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ottawa studentship	This work was supported by grants from the Canadian Institutes of Health Research.; Supported in part by a University of Ottawa studentship.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Ammarguellat FZ, 2002, HYPERTENSION, V39, P679, DOI 10.1161/hy0202.103481; ARDATI A, 1993, EMBO J, V12, P5131, DOI 10.1002/j.1460-2075.1993.tb06208.x; Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; Bisping E, 2006, P NATL ACAD SCI USA, V103, P14471, DOI 10.1073/pnas.0602543103; Charron F, 1999, MOL CELL BIOL, V19, P4355; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Clerk A, 2007, J CELL PHYSIOL, V212, P311, DOI 10.1002/jcp.21094; Clouthier DE, 1998, DEVELOPMENT, V125, P813; Debrus S, 2005, MOL CELL BIOL, V25, P8669, DOI 10.1128/MCB.25.19.8669-8682.2005; Dhaun N, 2008, HYPERTENSION, V52, P452, DOI 10.1161/HYPERTENSIONAHA.108.117366; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Georges R, 2008, MOL CELL BIOL, V28, P4052, DOI 10.1128/MCB.02100-07; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Houser SR, 2000, TRENDS CARDIOVAS MED, V10, P101, DOI 10.1016/S1050-1738(00)00057-8; ITO H, 1993, J CLIN INVEST, V92, P398, DOI 10.1172/JCI116579; ITO H, 1991, CIRC RES, V69, P209, DOI 10.1161/01.RES.69.1.209; Iwanaga Y, 1998, CIRCULATION, V98, P2065, DOI 10.1161/01.CIR.98.19.2065; Keijzer R, 2001, DEVELOPMENT, V128, P503; KURIHARA Y, 1995, J CLIN INVEST, V96, P293, DOI 10.1172/JCI118033; Lepore JJ, 2005, ARTERIOSCL THROM VAS, V25, P309, DOI 10.1161/01.ATV.0000152725.76020.3c; Lepore JJ, 2006, J CLIN INVEST, V116, P929, DOI 10.1172/JCi27363; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liang QR, 2002, J MOL CELL CARDIOL, V34, P611, DOI 10.1006/jmcc.2002.2011; Liang QR, 2001, MOL CELL BIOL, V21, P7460, DOI 10.1128/MCB.21.21.7460-7469.2001; MacLellan WR, 2000, ANNU REV PHYSIOL, V62, P289, DOI 10.1146/annurev.physiol.62.1.289; McMullen JR, 2004, MOL CELL BIOL, V24, P6231, DOI 10.1128/MCB.24.14.6231-6240.2004; Miyauchi T, 1999, ANNU REV PHYSIOL, V61, P391, DOI 10.1146/annurev.physiol.61.1.391; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Morimoto T, 2000, J BIOL CHEM, V275, P13721, DOI 10.1074/jbc.275.18.13721; Morin S, 2001, MOL CELL BIOL, V21, P1036, DOI 10.1128/MCB.21.4.1036-1044.2001; Nelson TJ, 2005, J MOL CELL CARDIOL, V39, P479, DOI 10.1016/j.yjmcc.2005.05.004; Oh J, 2004, MOL CELL BIOL, V24, P8519, DOI 10.1128/MCB.24.19.8519-8528.2004; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Oudit GY, 2004, J MOL CELL CARDIOL, V37, P449, DOI 10.1016/j.yjmcc.2004.05.015; Petrich BG, 2003, FASEB J, V17, P749, DOI 10.1096/fj.02-0438fje; Sakai S, 1996, NATURE, V384, P353, DOI 10.1038/384353a0; Sakai S, 1996, CIRCULATION, V93, P1214, DOI 10.1161/01.CIR.93.6.1214; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Spieker L E, 2001, Heart Fail Rev, V6, P301, DOI 10.1023/A:1011456309039; Sugden PH, 2003, J MOL CELL CARDIOL, V35, P871, DOI 10.1016/S0022-2828(03)00153-6; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang J, 2005, MOL CELL BIOL, V25, P9829, DOI 10.1128/MCB.25.22.9829-9844.2005; WEI CM, 1994, CIRCULATION, V89, P1580, DOI 10.1161/01.CIR.89.4.1580; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Yanazume T, 2003, MOL CELL BIOL, V23, P3593, DOI 10.1128/MCB.23.10.3593-3606.2003; Yang HH, 2002, DEVELOPMENT, V129, P2233; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115; Zhang T, 2004, CARDIOVASC RES, V63, P476, DOI 10.1016/j.cardiores.2004.04.026; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	54	11	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1508	1516		10.1074/jbc.M110.162966	http://dx.doi.org/10.1074/jbc.M110.162966			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21051538	hybrid, Green Published			2022-12-25	WOS:000286005000063
J	Loyer, P; Busson, A; Trembley, JH; Hyle, J; Grenet, J; Zhao, W; Ribault, C; Montier, T; Kidd, VJ; Lahti, JM				Loyer, Pascal; Busson, Adeline; Trembley, Janeen H.; Hyle, Judith; Grenet, Jose; Zhao, Wei; Ribault, Catherine; Montier, Tristan; Kidd, Vincent J.; Lahti, Jill M.			The RNA Binding Motif Protein 15B (RBM15B/OTT3) Is a Functional Competitor of Serine-Arginine (SR) Proteins and Antagonizes the Positive Effect of the CDK11(p110)-Cyclin L2 alpha Complex on Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; SIGNALING PATHWAY; SPLIT-ENDS; SPEN PROTEINS; CYCLIN L1; RS DOMAIN; IN-VIVO; KINASE; CELLS; NUCLEAR	Here, we report the identification of the RNA binding motif protein RBM15B/OTT3 as a new CDK11(p110) binding partner that alters the effects of CDK11 on splicing. RBM15B was initially identified as a binding partner of the Epstein-Barr virus mRNA export factor and, more recently, as a cofactor of the nuclear export receptor NXF1. In this study, we found that RBM15B co-elutes with CDK11(p110), cyclin L2 alpha, and serine-arginine (SR) proteins, including SF2/ASF, in a large nuclear complex of similar to 1-MDa molecular mass following size exclusion chromatography. Using co-immunoprecipitation experiments and in vitro pulldown assays, we mapped two distinct domains of RBM15B that are essential for its direct interaction with the N-terminal extension of CDK11(p110), cyclin L2 alpha, and SR proteins such as 9G8 and SF2/ASF. Finally, we established that RBM15B is a functional competitor of the SR proteins SF2/ASF and 9G8, inhibits formation of the functional spliceosomal E complex, and antagonizes the positive effect of the CDK11(p110)-cyclin L2 alpha complex on splicing both in vitro and in vivo.	[Loyer, Pascal; Trembley, Janeen H.; Hyle, Judith; Grenet, Jose; Kidd, Vincent J.; Lahti, Jill M.] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Zhao, Wei] St Jude Childrens Hosp, Dept Biostat, Memphis, TN 38105 USA; [Montier, Tristan] Univ Bretagne Occidentale, INSERM, Sci & Ingn Biol Sante IFR148, U613, F-29218 Brest 2, France; [Loyer, Pascal; Busson, Adeline; Ribault, Catherine] Univ Rennes 1, Hop Pontchaillou, INSERM, UMR Foie 991, F-35033 Rennes, France	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Lahti, JM (corresponding author), St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	Jill.Lahti@stjude.org	LOYER, Pascal/K-1838-2019	LOYER, PASCAL/0000-0002-5656-2673; Trembley, Janeen/0000-0003-3597-2611	National Institutes of Health [R01GM044088]; Cancer Center [P30CA021765]; American Lebanese Syrian Associated Charities; INSERM; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM044088 and Cancer Center Support Grant P30CA021765. This work was also supported by the American Lebanese Syrian Associated Charities and INSERM.	Ariyoshi M, 2003, GENE DEV, V17, P1909, DOI 10.1101/gad.266203; Berke JD, 2001, NEURON, V32, P277, DOI 10.1016/S0896-6273(01)00465-2; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Chen FL, 2000, CURR BIOL, V10, P943, DOI 10.1016/S0960-9822(00)00625-4; Chen HH, 2006, MOL CELL BIOL, V26, P2736, DOI 10.1128/MCB.26.7.2736-2745.2006; Chen HH, 2007, BIOCHEM BIOPH RES CO, V354, P735, DOI 10.1016/j.bbrc.2007.01.049; Colley SM, 2008, IUBMB LIFE, V60, P159, DOI 10.1002/iub.22; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Das R, 1999, RNA, V5, P1504, DOI 10.1017/S1355838299991501; de Graaf K, 2004, J BIOL CHEM, V279, P4612, DOI 10.1074/jbc.M310794200; Dickinson LA, 2002, J BIOL CHEM, V277, P25465, DOI 10.1074/jbc.M202266200; Evangelista M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162925; Even Y, 2006, J CELL BIOCHEM, V99, P890, DOI 10.1002/jcb.20986; Feng Y, 2007, CANCER RES, V67, P482, DOI 10.1158/0008-5472.CAN-06-2314; Herrmann A, 2007, FASEB J, V21, P3142, DOI 10.1096/fj.07-8377com; Hiriart E, 2005, J BIOL CHEM, V280, P36935, DOI 10.1074/jbc.M501725200; Hu DL, 2003, J BIOL CHEM, V278, P8623, DOI 10.1074/jbc.M210057200; Hu DL, 2007, J CELL SCI, V120, P2424, DOI 10.1242/jcs.007963; Juillard F, 2009, J VIROL, V83, P12759, DOI 10.1128/JVI.01276-09; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Laurent V, 2010, BIOTECHNOL J, V5, P314, DOI 10.1002/biot.200900255; Lee C. S., 2003, CURRENT PROTOCOL MOL, V63, P2711; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lindtner S, 2006, J BIOL CHEM, V281, P36915, DOI 10.1074/jbc.M608745200; Loyer P, 1998, J CELL SCI, V111, P1495; Loyer P, 2008, J BIOL CHEM, V283, P7721, DOI 10.1074/jbc.M708188200; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Mayeda A, 1999, MOL CELL BIOL, V19, P1853; Mayeda A, 1999, METH MOL B, V118, P309; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Naik S, 2009, CLIN CANCER RES, V15, P7529, DOI 10.1158/1078-0432.CCR-09-0336; Nasim MT, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf108; Niu C, 2009, BLOOD, V114, P2087, DOI 10.1182/blood-2009-01-197921; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; Petretti C, 2006, EMBO REP, V7, P418, DOI 10.1038/sj.embor.7400639; Rebay I, 2000, GENETICS, V154, P695; Sawada T, 2008, J BIOL CHEM, V283, P26820, DOI 10.1074/jbc.M802315200; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Trembley JH, 2005, MOL CELL BIOL, V25, P1446, DOI 10.1128/MCB.25.4.1446-1457.2005; Trembley JH, 2004, PROG NUCLEIC ACID RE, V77, P263, DOI 10.1016/S0079-6603(04)77007-5; Trembley JH, 2002, J BIOL CHEM, V277, P2589, DOI 10.1074/jbc.M109755200; Uranishi H, 2009, J BIOL CHEM, V284, P26106, DOI 10.1074/jbc.M109.040113; Valente ST, 2009, MOL CELL, V36, P279, DOI 10.1016/j.molcel.2009.10.004; Wiellette EL, 1999, DEVELOPMENT, V126, P5373; XIANG JL, 1994, J BIOL CHEM, V269, P15786; Yang LJ, 2004, J BIOL CHEM, V279, P11639, DOI 10.1074/jbc.M312895200; Zolotukhin AS, 2009, NUCLEIC ACIDS RES, V37, P7151, DOI 10.1093/nar/gkp782	49	14	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					147	159		10.1074/jbc.M110.192518	http://dx.doi.org/10.1074/jbc.M110.192518			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21044963	Green Published, hybrid			2022-12-25	WOS:000285782800016
J	Ushakov, DS; Caorsi, V; Ibanez-Garcia, D; Manning, HB; Konitsiotis, AD; West, TG; Dunsby, C; French, PM; Ferenczi, MA				Ushakov, Dmitry S.; Caorsi, Valentina; Ibanez-Garcia, Delisa; Manning, Hugh B.; Konitsiotis, Antonios D.; West, Timothy G.; Dunsby, Christopher; French, Paul M.; Ferenczi, Michael A.			Response of Rigor Cross-bridges to Stretch Detected by Fluorescence Lifetime Imaging Microscopy of Myosin Essential Light Chain in Skeletal Muscle Fibers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY DOMAIN; CONTRACTION; ORIENTATION; SUBFRAGMENT-1; GENERATION; RESOLUTION; RELEASE; COMPLEX; BINDING; REGION	We applied fluorescence lifetime imaging microscopy to map the microenvironment of the myosin essential light chain (ELC) in permeabilized skeletal muscle fibers. Four ELC mutants containing a single cysteine residue at different positions in the C-terminal half of the protein (ELC-127, ELC-142, ELC-160, and ELC-180) were generated by site-directed mutagenesis, labeled with 7-diethylamino-3-((((2-iodoacetamido)ethyl)amino)carbonyl)coumarin, and introduced into permeabilized rabbit psoas fibers. Binding to the myosin heavy chain was associated with a large conformational change in the ELC. When the fibers were moved from relaxation to rigor, the fluorescence lifetime increased for all label positions. However, when 1% stretch was applied to the rigor fibers, the lifetime decreased for ELC-127 and ELC-180 but did not change for ELC-142 and ELC-160. The differential change of fluorescence lifetime demonstrates the shift in position of the C-terminal domain of ELC with respect to the heavy chain and reveals specific locations in the lever arm region sensitive to the mechanical strain propagating from the actin-binding site to the lever arm.	[Ushakov, Dmitry S.; Caorsi, Valentina; Ibanez-Garcia, Delisa; Konitsiotis, Antonios D.; West, Timothy G.; Ferenczi, Michael A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Manning, Hugh B.; Dunsby, Christopher; French, Paul M.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2AZ, England	Imperial College London; Imperial College London	Ushakov, DS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	d.ushakov@imperial.ac.uk	Ferenczi, Michael/F-9510-2015; French, Paul/E-8649-2011; Ushakov, Dmitry/AAF-7914-2020	Ferenczi, Michael/0000-0002-0349-331X; Ushakov, Dmitry/0000-0001-7109-4217; French, Paul/0000-0002-0478-6755	Biotechnology and Biological Sciences Research Council [BB/E02/573/1]; Royal Society; UK Technology Strategy Board [CHBT/007/00030]; BBSRC [BB/I019448/1, BB/E021573/1] Funding Source: UKRI; MRC [G0601747] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E021573/1, BB/I019448/1] Funding Source: researchfish; Medical Research Council [G0601747] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); UK Technology Strategy Board; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BB/E02/573/1), by a Royal Society Wolfson Research Merit Award (to P. M. F.) and by the UK Technology Strategy Board (Technology Award CHBT/007/00030).	Baumann BAJ, 2001, BIOCHEMISTRY-US, V40, P7868, DOI 10.1021/bi002731h; Borejdo J, 2002, BIOPHYS J, V82, p362A; Borejdo J, 2001, BIOCHEMISTRY-US, V40, P3796, DOI 10.1021/bi002527u; Corrie JET, 1999, NATURE, V400, P425, DOI 10.1038/22704; Dobbie I, 1998, NATURE, V396, P383, DOI 10.1038/24647; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Dowling K, 1998, OPT LETT, V23, P810, DOI 10.1364/OL.23.000810; Garcia DI, 2007, BIOPHYS J, V93, P2091, DOI 10.1529/biophysj.106.096479; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; GOLDMAN YE, 1984, J PHYSIOL-LONDON, V350, P497, DOI 10.1113/jphysiol.1984.sp015215; He ZH, 1999, J PHYSIOL-LONDON, V517, P839, DOI 10.1111/j.1469-7793.1999.0839s.x; Hopkins SC, 2002, J MOL BIOL, V318, P1275, DOI 10.1016/S0022-2836(02)00189-4; Houdusse A, 1996, STRUCTURE, V4, P21, DOI 10.1016/S0969-2126(96)00006-8; Huang W, 1998, EUR J BIOCHEM, V257, P457, DOI 10.1046/j.1432-1327.1998.2570457.x; IRVING M, 1995, NATURE, V375, P688, DOI 10.1038/375688a0; Knowles AC, 2008, BIOPHYS J, V95, P3882, DOI 10.1529/biophysj.108.131508; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P9; Manning HB, 2008, J BIOPHOTONICS, V1, P494, DOI 10.1002/jbio.200810051; MARSH DJ, 1982, BIOCHEMISTRY-US, V21, P1925, DOI 10.1021/bi00537a035; Nelson MR, 1998, PROTEIN SCI, V7, P270; Palm T, 1999, BIOCHEMISTRY-US, V38, P13026, DOI 10.1021/bi991164z; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Smyczynski C, 1997, BIOCHEMISTRY-US, V36, P13201, DOI 10.1021/bi970746i; Sweeney H. L., 1995, BIOPHYS J, V68, p112S; THIRLWELL H, 1994, BIOPHYS J, V67, P2436, DOI 10.1016/S0006-3495(94)80730-1; Ushakov D. S., 2008, Biofizika, V53, P950; WAGNER PD, 1977, J MOL BIOL, V109, P455, DOI 10.1016/S0022-2836(77)80023-5; West TG, 2009, BIOPHYS J, V96, P3281, DOI 10.1016/j.bpj.2009.01.016	29	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					842	850		10.1074/jbc.M110.149526	http://dx.doi.org/10.1074/jbc.M110.149526			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21056977	Green Published, hybrid			2022-12-25	WOS:000285782800083
J	Lee, HJ; Finkelstein, D; Li, XF; Wu, DQ; Shi, DL; Zheng, JJ				Lee, Ho-Jin; Finkelstein, David; Li, Xiaofeng; Wu, Dianqing; Shi, De-Li; Zheng, Jie J.			Identification of Transmembrane Protein 88 (TMEM88) as a Dishevelled-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT SIGNALING PATHWAY; PDZ DOMAIN; SUBCELLULAR-LOCALIZATION; CONVERGENT EXTENSION; CHROMOSOME 17P13.1; DEP DOMAIN; SYSTEM; INHIBITION; MEMBRANE; ADJACENT	Wnt signaling pathways are involved in embryonic development and adult tissue maintenance and have been implicated in tumorigenesis. Dishevelled (Dvl/Dsh) protein is one of key components in Wnt signaling and plays essential roles in regulating these pathways through protein-protein interactions. Identifying and characterizing Dvl-binding proteins are key steps toward understanding biological functions. Given that the tripeptide VWV (Val-Trp-Val) binds to the PDZ domain of Dvl, we searched publically available databases to identify proteins containing the VWV motif at the C terminus that could be novel Dvl-binding partners. On the basis of the cellular localization and expression patterns of the candidates, we selected for further study the TMEM88 (target protein transmembrane 88), a two-transmembrane-type protein. The interaction between the PDZ domain of Dvl and the C-terminal tail of TMEM88 was confirmed by using NMR and fluorescence spectroscopy. Furthermore, in HEK293 cells, TMEM88 attenuated the Wnt/beta-catenin signaling induced by Wnt-1 ligand in a dose-dependent manner, and TMEM88 knockdown by RNAi increased Wnt activity. In Xenopus, TMEM88 protein is sublocalized at the cell membrane and inhibits Wnt signaling induced by Xdsh but not beta-catenin. In addition, TMEM88 protein inhibits the formation of a secondary axis normally induced by Xdsh. The findings suggest that TMEM88 plays a role in regulating Wnt signaling. Indeed, analysis of microarray data revealed that the expression of the Tmem88 gene was strongly correlated with that of Wnt signaling-related genes in embryonic mouse intestines. Together, we propose that TMEM88 associates with Dvl proteins and regulates Wnt signaling in a context-dependent manner.	[Lee, Ho-Jin; Zheng, Jie J.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Finkelstein, David] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Li, Xiaofeng; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Li, Xiaofeng] ENZO Biochem Inc, Farmingdale, NY 11735 USA; [Shi, De-Li] CNRS, Dev Biol Lab, UMR7622, F-75005 Paris, France	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Yale University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Zheng, JJ (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, Mail Stop 311,262 Danny Thomas Blvd, Memphis, TN 38105 USA.	jie.zheng@stjude.org	Lee, Ho-Jin/N-1973-2015; Shi, De-Li/AAG-1807-2021; Lee, Ho-Jin/O-9944-2014	Lee, Ho-Jin/0000-0002-3251-4984; Zheng, Jie/0000-0001-6524-6800	National Institutes of Health [GM081492]; National Institutes of Health, NCI Cancer Center [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA139395, P30CA021765, R01CA132317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM081492 and by National Institutes of Health, NCI Cancer Center Support Grant CA21765. This work was also supported by the American Lebanese Syrian Associated Charities.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Chang H, 2004, BRIT J HAEMATOL, V127, P280, DOI 10.1111/j.1365-2141.2004.05199.x; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Cousin P, 2000, GENOMICS, V63, P60, DOI 10.1006/geno.1999.6062; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dolan K, 1999, HUM PATHOL, V30, P1508, DOI 10.1016/S0046-8177(99)90175-2; Flavin RJ, 2009, MODERN PATHOL, V22, P197, DOI 10.1038/modpathol.2008.135; Grandy D, 2009, J BIOL CHEM, V284, P16256, DOI 10.1074/jbc.M109.009647; Gray RS, 2009, DEV DYNAM, V238, P2044, DOI 10.1002/dvdy.22028; Han K, 2004, BIOINFORMATICS, V20, P2466, DOI 10.1093/bioinformatics/bth253; Hino SI, 2001, MOL CELL BIOL, V21, P330, DOI 10.1128/MCB.21.1.330-342.2001; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Jenny A, 2005, NAT CELL BIOL, V7, P691, DOI 10.1038/ncb1271; Jung HL, 2004, J NEURO-ONCOL, V67, P41, DOI 10.1023/B:NEON.0000021773.71127.fb; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Lee HB, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.04C032; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Lee HJ, 2009, BIOORGAN MED CHEM, V17, P1701, DOI 10.1016/j.bmc.2008.12.060; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Pan WJ, 2008, SCIENCE, V321, P1350, DOI 10.1126/science.1160741; Pan WJ, 2004, CELL RES, V14, P324, DOI 10.1038/sj.cr.7290232; Park TJ, 2005, CURR BIOL, V15, P1039, DOI 10.1016/j.cub.2005.04.062; Pellecchia M, 2002, NAT REV DRUG DISCOV, V1, P211, DOI 10.1038/nrd748; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Semenov MV, 1997, GENOMICS, V42, P302, DOI 10.1006/geno.1997.4713; Shan JF, 2005, BIOCHEMISTRY-US, V44, P15495, DOI 10.1021/bi0512602; Simons M, 2009, NAT CELL BIOL, V11, P286, DOI 10.1038/ncb1836; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Suzuki H, 2003, GENOME RES, V13, P1534, DOI 10.1101/gr.956303; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang NX, 2008, DRUG NEWS PERSPECT, V21, P137, DOI 10.1358/dnp.2008.21.3.1203409; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152	48	35	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41549	41556		10.1074/jbc.M110.193383	http://dx.doi.org/10.1074/jbc.M110.193383			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21044957	Green Published, hybrid			2022-12-25	WOS:000285622600042
J	Hahn, P; Wegener, I; Burrells, A; Bose, J; Wolf, A; Erck, C; Butler, D; Schofield, CJ; Bottger, A; Lengeling, A				Hahn, Phillip; Wegener, Ivonne; Burrells, Alison; Boese, Jens; Wolf, Alexander; Erck, Christian; Butler, Danica; Schofield, Christopher J.; Boettger, Angelika; Lengeling, Andreas			Analysis of Jmjd6 Cellular Localization and Testing for Its Involvement in Histone Demethylation	PLOS ONE			English	Article							PHOSPHATIDYLSERINE RECEPTOR; NUCLEAR-LOCALIZATION; CHROMATIN REGULATION; PROTEIN; METHYLATION; GENE; 2-OXOGLUTARATE; CLEARANCE; LANGUAGE; HOMOLOG	Background: Methylation of residues in histone tails is part of a network that regulates gene expression. JmjC domain containing proteins catalyze the oxidative removal of methyl groups on histone lysine residues. Here, we report studies to test the involvement of Jumonji domain-containing protein 6 (Jmjd6) in histone lysine demethylation. Jmjd6 has recently been shown to hydroxylate RNA splicing factors and is known to be essential for the differentiation of multiple tissues and cells during embryogenesis. However, there have been conflicting reports as to whether Jmjd6 is a histone-modifying enzyme. Methodology/Principal Findings: Immunolocalization studies reveal that Jmjd6 is distributed throughout the nucleoplasm outside of regions containing heterochromatic DNA, with occasional localization in nucleoli. During mitosis, Jmjd6 is excluded from the nucleus and reappears in the telophase of the cell cycle. Western blot analyses confirmed that Jmjd6 forms homo-multimers of different molecular weights in the nucleus and cytoplasm. A comparison of mono-, di-, and trimethylation states of H3K4, H3K9, H3K27, H3K36, and H4K20 histone residues in wildtype and Jmjd6-knockout cells indicate that Jmjd6 is not involved in the demethylation of these histone lysine residues. This is further supported by overexpression of enzymatically active and inactive forms of Jmjd6 and subsequent analysis of histone methylation patterns by immunocytochemistry and western blot analysis. Finally, treatment of cells with RNase A and DNase I indicate that Jmjd6 may preferentially associate with RNA/RNA complexes and less likely with chromatin. Conclusions/Significance: Taken together, our results provide further evidence that Jmjd6 is unlikely to be involved in histone lysine demethylation. We confirmed that Jmjd6 forms multimers and showed that nuclear localization of the protein involves association with a nucleic acid matrix.	[Hahn, Phillip; Wegener, Ivonne; Boese, Jens; Lengeling, Andreas] Helmholtz Ctr Infect Res, Dept Expt Mouse Genet, Braunschweig, Germany; [Wolf, Alexander; Boettger, Angelika] Univ Munich, Dept Biol 2, Planeeg Martinsried, Germany; [Erck, Christian] Synapt Syst GmbH, Gottingen, Germany; [Butler, Danica; Schofield, Christopher J.] Univ Oxford, Chem Res Lab, Oxford, England; [Butler, Danica; Schofield, Christopher J.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford, England; [Lengeling, Andreas] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Lengeling, Andreas] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland	Helmholtz Association; Helmholtz-Center for Infection Research; University of Munich; University of Oxford; University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Hahn, P (corresponding author), Helmholtz Ctr Infect Res, Dept Expt Mouse Genet, Braunschweig, Germany.	Andreas.Lengeling@ed.ac.uk	Hahn, Phillip/A-4812-2012; Wolf, Alexander/K-2178-2013	Hahn, Phillip/0000-0002-8741-3603; Wolf, Alexander/0000-0003-0649-3363; Schofield, Christopher/0000-0002-0290-6565; Bottger, Angelika/0000-0003-3273-9558; Burrells, Alison/0000-0002-8608-8781	Deutsche Forschungsgemeinschaft [LE2130/2-1, BO1748-3]; UK Biotechnology and Biological Sciences Research Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Deutsche Forschungsgemeinschaft (A.L., LE2130/2-1; A.B., BO1748-3) and the UK Biotechnology and Biological Sciences Research Council (A.L. and C.J.S.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; BOSE J, 2004, J BIOL LONDON, V3, pNIL5; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cikala M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-26; Cui P, 2004, EXP CELL RES, V293, P154, DOI 10.1016/j.yexcr.2003.09.023; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dellaire G, 2003, NUCLEIC ACIDS RES, V31, P328, DOI 10.1093/nar/gkg018; Eissenberg JC, 2007, NAT STRUCT MOL BIOL, V14, P344, DOI 10.1038/nsmb1217; Hahn P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-293; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Hewitson KS, 2008, J BIOL CHEM, V283, P25971, DOI 10.1074/jbc.M804999200; Hong JR, 2004, DEVELOPMENT, V131, P5417, DOI 10.1242/dev.01409; Hong X, 2010, P NATL ACAD SCI USA, V107, P14568, DOI 10.1073/pnas.1008832107; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Krieser RJ, 2007, DEVELOPMENT, V134, P2407, DOI 10.1242/dev.02860; Kunisaki Y, 2004, BLOOD, V103, P3362, DOI 10.1182/blood-2003-09-3245; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Mantri M, 2010, J MOL BIOL, V401, P211, DOI 10.1016/j.jmb.2010.05.054; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mayer C, 2005, GENE DEV, V19, P933, DOI 10.1101/gad.333205; Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x; Mekhail K, 2004, NAT CELL BIOL, V6, P642, DOI 10.1038/ncb1144; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mitchell JE, 2006, J BIOL CHEM, V281, P5718, DOI 10.1074/jbc.M509775200; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Reinberg D, 2004, COLD SPRING HARB SYM, V69, P171, DOI 10.1101/sqb.2004.69.171; Schneider Juergen E., 2004, BMC Developmental Biology, V4, P1; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; Tibrewal N, 2007, MOL CELL BIOCHEM, V304, P119, DOI 10.1007/s11010-007-9492-8; TORRES RM, 1997, LAB PROTOCOLS CONDIT, P62; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tsukada YI, 2010, GENE DEV, V24, P432, DOI 10.1101/gad.1864410; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Wesierska-Gadek J, 2003, ANN NY ACAD SCI, V1010, P266, DOI 10.1196/annals.1299.046; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001	61	57	59	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13769	10.1371/journal.pone.0013769	http://dx.doi.org/10.1371/journal.pone.0013769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060799	Green Published, Green Submitted, gold			2022-12-25	WOS:000283645300044
J	Leignadier, J; Labrecque, N				Leignadier, Julie; Labrecque, Nathalie			Epitope Density Influences CD8(+) Memory T Cell Differentiation	PLOS ONE			English	Article							DENDRITIC CELLS; EFFECTOR; RECEPTOR; ANTIGEN; GENERATION; ACTIVATION; EXPRESSION; BET; EOMESODERMIN; CONTRIBUTE	Background: The generation of long-lived memory T cells is critical for successful vaccination but the factors controlling their differentiation are still poorly defined. We tested the hypothesis that the strength of T cell receptor (TCR) signaling contributed to memory CD8(+) T cell generation. Methodology/Principal Findings: We manipulated the density of antigenic epitope presented by dendritic cells to mouse naive CD8(+) T cells, without varying TCR affinity. Our results show that a two-fold decrease in antigen dose selectively affects memory CD8(+) T cell generation without influencing T cell expansion and acquisition of effector functions. Moreover, we show that low antigen dose alters the duration of the interaction between T cells and dendritic cells and finely tunes the expression level of the transcription factors Eomes and Bcl6. Furthermore, we demonstrate that priming with higher epitope density results in a 2-fold decrease in the expression of Neuron-derived orphan nuclear receptor 1 (Nor-1) and this correlates with a lower level of conversion of Bcl-2 into a pro-apoptotic molecule and an increased number of memory T cells. Conclusions: Our results show that the amount of antigen encountered by naive CD8(+) T cells following immunization with dendritic cells does not influence the generation of functional effector CD8(+) T cells but rather the number of CD8(+) memory T cells that persist in the host. Our data support a model where antigenic epitope density sensed by CD8(+) T cells at priming influences memory generation by modulating Bcl6, Eomes and Nor-1 expression.	[Leignadier, Julie; Labrecque, Nathalie] Univ Montreal, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada; [Leignadier, Julie; Labrecque, Nathalie] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Labrecque, Nathalie] Univ Montreal, Dept Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Leignadier, J (corresponding author), Univ Montreal, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada.	nathalie.labrecque@umontreal.ca	leignadier, julie/G-2701-2017	leignadier, julie/0000-0002-6546-1874	Canadian Institutes of Health Research (CIHR) [MOP-77545]; Department of Microbiology and Immunology of the University of Montreal	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Department of Microbiology and Immunology of the University of Montreal	This work was supported by a grant (MOP-77545) from the Canadian Institutes of Health Research (CIHR) to N.L. N.L. was supported by a CIHR New Investigator award and is currently a Senior Scholar of the FRSQ. J. L. received a studentship from the Department of Microbiology and Immunology of the University of Montreal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Benvenuti F, 2004, J IMMUNOL, V172, P292, DOI 10.4049/jimmunol.172.1.292; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; HEDVAT CV, 1995, MOL ENDOCRINOL, V9, P1692, DOI 10.1210/me.9.12.1692; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Ichii H, 2004, J IMMUNOL, V173, P883, DOI 10.4049/jimmunol.173.2.883; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Ichii H, 2007, INT IMMUNOL, V19, P427, DOI 10.1093/intimm/dxm007; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; La Gruta NL, 2006, P NATL ACAD SCI USA, V103, P994, DOI 10.1073/pnas.0510429103; Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4; Lacombe MH, 2005, J IMMUNOL, V175, P4400, DOI 10.4049/jimmunol.175.7.4400; LEIGNADIER J, IMMUNOL CELL BIOL; Lo WL, 2009, NAT IMMUNOL, V10, P1155, DOI 10.1038/ni.1796; Lozza L, 2008, EUR J IMMUNOL, V38, P30, DOI 10.1002/eji.200737852; Norbury CC, 2001, J IMMUNOL, V166, P4355, DOI 10.4049/jimmunol.166.7.4355; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Teixeiro E, 2009, SCIENCE, V323, P502, DOI 10.1126/science.1163612; Thompson J, 2008, J EXP MED, V205, P1029, DOI 10.1084/jem.20080101; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Wherry EJ, 2002, J IMMUNOL, V168, P4455, DOI 10.4049/jimmunol.168.9.4455; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	35	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13740	10.1371/journal.pone.0013740	http://dx.doi.org/10.1371/journal.pone.0013740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060788	Green Published, Green Submitted, gold			2022-12-25	WOS:000283645300020
J	Lucchi, NW; Demas, A; Narayanan, J; Sumari, D; Kabanywanyi, A; Kachur, SP; Barnwell, JW; Udhayakumar, V				Lucchi, Naomi W.; Demas, Allison; Narayanan, Jothikumar; Sumari, Deborah; Kabanywanyi, Abdunoor; Kachur, S. Patrick; Barnwell, John W.; Udhayakumar, Venkatachalam			Real-Time Fluorescence Loop Mediated Isothermal Amplification for the Diagnosis of Malaria	PLOS ONE			English	Article							FALCIPARUM-MALARIA; RAPID DETECTION; VIRUS; SYSTEM; ASSAY	Background: Molecular diagnostic methods can complement existing tools to improve the diagnosis of malaria. However, they require good laboratory infrastructure thereby restricting their use to reference laboratories and research studies. Therefore, adopting molecular tools for routine use in malaria endemic countries will require simpler molecular platforms. The recently developed loop-mediated isothermal amplification (LAMP) method is relatively simple and can be improved for better use in endemic countries. In this study, we attempted to improve this method for malaria diagnosis by using a simple and portable device capable of performing both the amplification and detection (by fluorescence) of LAMP in one platform. We refer to this as the RealAmp method. Methodology and Significant Findings: Published genus-specific primers were used to test the utility of this method. DNA derived from different species of malaria parasites was used for the initial characterization. Clinical samples of P. falciparum were used to determine the sensitivity and specificity of this system compared to microscopy and a nested PCR method. Additionally, directly boiled parasite preparations were compared with a conventional DNA isolation method. The RealAmp method was found to be simple and allowed real-time detection of DNA amplification. The time to amplification varied but was generally less than 60 minutes. All human-infecting Plasmodium species were detected. The sensitivity and specificity of RealAmp in detecting P. falciparum was 96.7% and 91.7% respectively, compared to microscopy and 98.9% and 100% respectively, compared to a standard nested PCR method. In addition, this method consistently detected P. falciparum from directly boiled blood samples. Conclusion: This RealAmp method has great potential as a field usable molecular tool for diagnosis of malaria. This tool can provide an alternative to conventional PCR based diagnostic methods for field use in clinical and operational programs.	[Lucchi, Naomi W.; Demas, Allison; Kachur, S. Patrick; Barnwell, John W.; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA; [Lucchi, Naomi W.; Udhayakumar, Venkatachalam] Atlanta Res & Educ Fdn, VA Med Ctr, Decatur, GA USA; [Narayanan, Jothikumar] Ctr Dis Control & Prevent, Waterborne Dis Prevent Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Sumari, Deborah; Kabanywanyi, Abdunoor] Ifakara Hlth Inst, Dar Es Salaam, Tanzania	Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Centers for Disease Control & Prevention - USA; Ifakara Health Institute	Lucchi, NW (corresponding author), Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, 4770 Buford Highway,Mail Stop F-12, Atlanta, GA 30333 USA.	NLucchi@cdc.gov	Kachur, Patrick/ABE-7220-2021	Lucchi, Naomi/0000-0001-8789-8041	Centers for Disease Control and Prevention - University of Georgia (CDC-UGA); Association of Public Health Laboratories/Emerging Infectious Disease; Atlanta Research and Education Foundation/VA Medical Center, Atlanta GA	Centers for Disease Control and Prevention - University of Georgia (CDC-UGA); Association of Public Health Laboratories/Emerging Infectious Disease; Atlanta Research and Education Foundation/VA Medical Center, Atlanta GA	Funding for this work was received from the Centers for Disease Control and Prevention - University of Georgia (CDC-UGA) collaborative Seed Award Program. Allison Demas was supported by the Association of Public Health Laboratories/Emerging Infectious Disease Fellowship. Naomi Lucchi is supported by Atlanta Research and Education Foundation/VA Medical Center, Atlanta GA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annaka Toshimitsu, 2003, Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi, V14, P25; Bronzan RN, 2008, MOL DIAGN THER, V12, P299, DOI 10.1007/BF03256295; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Fukuda S, 2006, J CLIN MICROBIOL, V44, P1376, DOI 10.1128/JCM.44.4.1376-1381.2006; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06; Imai M, 2006, VACCINE, V24, P6679, DOI 10.1016/j.vaccine.2006.05.046; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; Lin XA, 2009, DIAGN MICR INFEC DIS, V63, P237, DOI 10.1016/j.diagmicrobio.2008.10.012; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Njiru ZK, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000147; NJIRU ZK, 2010, EXP PARASITOL; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Parida M, 2004, J CLIN MICROBIOL, V42, P257, DOI 10.1128/JCM.42.1.257-263.2004; Paris DH, 2007, AM J TROP MED HYG, V77, P972, DOI 10.4269/ajtmh.2007.77.972; Poon LLM, 2006, CLIN CHEM, V52, P303; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; Thai HTC, 2004, J CLIN MICROBIOL, V42, P1956, DOI 10.1128/JCM.42.5.1956-1961.2004; Varga A, 2006, J VIROL METHODS, V138, P184, DOI 10.1016/j.jviromet.2006.08.014; WHO, 2010, GUID TREATM MAL, V2nd; World Health Organization, 2008, WORLD MAL REP; Yamamura M, 2009, JPN J INFECT DIS, V62, P20; Zheng CF, 2002, PARASITOL INT, V51, P1, DOI 10.1016/S1383-5769(01)00094-0	23	160	174	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13733	10.1371/journal.pone.0013733	http://dx.doi.org/10.1371/journal.pone.0013733			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060829	Green Published, Green Submitted, gold			2022-12-25	WOS:000283645300014
J	Verpelli, C; Bertani, G; Cea, V; Patti, M; Bikfalvi, A; Bello, L; Sala, C				Verpelli, Chiara; Bertani, Giulio; Cea, Valentina; Patti, Monica; Bikfalvi, Andreas; Bello, Lorenzo; Sala, Carlo			Anti-Angiogenic Therapy Induces Integrin-Linked Kinase 1 Up-Regulation in a Mouse Model of Glioblastoma	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; DEPENDENT PROTEIN-KINASE; MALIGNANT GLIOMA; ILK; CELLS; GROWTH; INHIBITION; ACTIVATION; TUMOR; MICROENVIRONMENT	Background: In order to improve our understanding of the molecular pathways that mediate tumor proliferation and angiogenesis, and to evaluate the biological response to anti-angiogenic therapy, we analyzed the changes in the protein profile of glioblastoma in response to treatment with recombinant human Platelet Factor 4-DLR mutated protein (PF4-DLR), an inhibitor of angiogenesis. Methodology/Principal Findings: U87-derived experimental glioblastomas were grown in the brain of xenografted nude mice, treated with PF4-DLR, and processed for proteomic analysis. More than fifty proteins were differentially expressed in response to PF4-DLR treatment. Among them, integrin-linked kinase 1 (ILK1) signaling pathway was first down-regulated but then up-regulated after treatment for prolonged period. The activity of PF4-DLR can be increased by simultaneously treating mice orthotopically implanted with glioblastomas, with ILK1-specific siRNA. As ILK1 is related to malignant progression and a poor prognosis in various types of tumors, we measured ILK1 expression in human glioblatomas, astrocytomas and oligodendrogliomas, and found that it varied widely; however, a high level of ILK1 expression was correlated to a poor prognosis. Conclusions/Significance: Our results suggest that identifying the molecular pathways induced by anti-angiogenic therapies may help the development of combinaatorial treatment strategies that increase the therapeutic efficacy of angiogenesis inhibitors by association with specific agents that disrupt signaling in tumor cells.	[Verpelli, Chiara; Bertani, Giulio; Cea, Valentina; Patti, Monica; Bikfalvi, Andreas; Bello, Lorenzo; Sala, Carlo] Univ Milan, ELAT European Lab Angiogenesis & Translat Res, Milan, Italy; [Verpelli, Chiara; Cea, Valentina; Patti, Monica; Sala, Carlo] Univ Milan, CNR, Inst Neurosci, Milan, Italy; [Verpelli, Chiara; Cea, Valentina; Patti, Monica; Sala, Carlo] Univ Milan, Dept Pharmacol, Milan, Italy; [Bikfalvi, Andreas] INSERM, U920 Ex E0113, Talence, France; [Bikfalvi, Andreas] Univ Bordeaux 1, F-33405 Talence, France; [Verpelli, Chiara; Bertani, Giulio; Bello, Lorenzo] Univ Milan, Dept Neurol Sci, Milan, Italy	University of Milan; Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Milan; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Milan	Verpelli, C (corresponding author), Univ Milan, ELAT European Lab Angiogenesis & Translat Res, Milan, Italy.	lorenzo.bello@unimi.it; c.sala@in.cnr.it	Sala, Carlo/A-2493-2009; Bello, Lorenzo/AAB-2884-2022; Verpelli, Chiara/AAH-1140-2020; Verpelli, Chiara/K-6673-2016; Bertani, Giulio/ABD-8401-2021	Sala, Carlo/0000-0003-0662-9523; Bello, Lorenzo/0000-0001-6797-7105; Verpelli, Chiara/0000-0003-2949-9725; Verpelli, Chiara/0000-0003-2949-9725; Bertani, Giulio/0000-0003-1470-3391	AIRC (the Italian Cancer Research Association); Fondazione Italo Monzino; Fondazione Berlucchi; Association sur la Recherche sur le Cancer (ARC); Ligue contre le Cancer; Fondazione CARIPLO [2009.264]; Regione Lombardia	AIRC (the Italian Cancer Research Association)(Fondazione AIRC per la ricerca sul cancro); Fondazione Italo Monzino; Fondazione Berlucchi; Association sur la Recherche sur le Cancer (ARC); Ligue contre le Cancer(Ligue nationale contre le cancer); Fondazione CARIPLO(Fondazione Cariplo); Regione Lombardia(Regione Lombardia)	This study was supported by grants from the AIRC (the Italian Cancer Research Association), Fondazione Italo Monzino and Fondazione Berlucchi (to LB), from "the Association sur la Recherche sur le Cancer (ARC)" and the "Ligue contre le Cancer" (to AB) and Fondazione CARIPLO (grant 2009.264) and Regione Lombardia (grant TERDISMENTAL) (to CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali-Osman F, 1997, CLIN CANCER RES, V3, P2253; Almond JB, 2002, LEUKEMIA, V16, P433, DOI 10.1038/sj.leu.2402417; Attwell S, 2000, ONCOGENE, V19, P3811, DOI 10.1038/sj.onc.1203711; Bello L, 2004, CLIN CANCER RES, V10, P4527, DOI 10.1158/1078-0432.CCR-04-0194; Bello L, 2001, CANCER RES, V61, P7501; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; BOYLAND E, 1969, ADV ENZYMOL RAMB, V32, P173; Dai DL, 2003, CLIN CANCER RES, V9, P4409; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Driver GA, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-12; Duxbury MS, 2005, CLIN CANCER RES, V11, P3433, DOI 10.1158/1078-0432.CCR-04-1510; Edwards LA, 2005, ONCOGENE, V24, P3596, DOI 10.1038/sj.onc.1208427; Edwards LA, 2006, MOL CANCER THER, V5, P645, DOI 10.1158/1535-7163.MCT-05-0099; Edwards LA, 2008, MOL CANCER THER, V7, P59, DOI 10.1158/1535-7163.MCT-07-0329; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; GROOTHUIS DR, 1983, CANCER RES, V43, P3362; Hagedorn M, 2002, CANCER RES, V62, P6884; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Jing RF, 2005, GLIA, V50, P107, DOI 10.1002/glia.20158; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Lo HW, 2004, CANCER RES, V64, P9131, DOI 10.1158/0008-5472.CAN-04-0283; Marotta A, 2001, ONCOGENE, V20, P6250, DOI 10.1038/sj.onc.1204791; Monferran S, 2008, INT J CANCER, V123, P357, DOI 10.1002/ijc.23498; Nagy JA, 2002, J EXP MED, V196, P1497, DOI 10.1084/jem.20021244; Obara S, 2004, CANCER LETT, V208, P115, DOI 10.1016/j.canlet.2003.11.020; Parmer TG, 1997, CELL GROWTH DIFFER, V8, P327; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Radeva G, 1997, J BIOL CHEM, V272, P13937, DOI 10.1074/jbc.272.21.13937; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Sundberg C, 2001, AM J PATHOL, V158, P1145, DOI 10.1016/S0002-9440(10)64062-X; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; TANNOCK I, 1982, CANCER RES, V42, P4921; Tong GM, 2000, IN VITRO CELL DEV-AN, V36, P493, DOI 10.1290/1071-2690(2000)036<0493:TDIOEI>2.0.CO;2; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Troussard AA, 2000, ONCOGENE, V19, P5444, DOI 10.1038/sj.onc.1203928; Vajkoczy P, 2004, CANC TREAT, V117, P249; Villafania A, 2000, ANN CLIN LAB SCI, V30, P57	39	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13710	10.1371/journal.pone.0013710	http://dx.doi.org/10.1371/journal.pone.0013710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060779	Green Published, gold			2022-12-25	WOS:000283645300008
J	Scerri, TS; Paracchini, S; Morris, A; MacPhie, IL; Talcott, J; Stein, J; Smith, SD; Pennington, BF; Olson, RK; DeFries, JC; Monaco, AP				Scerri, Thomas S.; Paracchini, Silvia; Morris, Andrew; MacPhie, I. Laurence; Talcott, Joel; Stein, John; Smith, Shelley D.; Pennington, Bruce F.; Olson, Richard K.; DeFries, John C.; Monaco, Anthony P.			Identification of Candidate Genes for Dyslexia Susceptibility on Chromosome 18	PLOS ONE			English	Article							MULTIPLE-REGRESSION ANALYSIS; QUANTITATIVE-TRAIT LOCUS; MULTILOCUS GENOTYPE DATA; GENOME-WIDE ASSOCIATION; MSH-ACTH 4-10; DEVELOPMENTAL DYSLEXIA; READING-DISABILITY; LINKAGE ANALYSES; BLOOD-PRESSURE; ENVIRONMENTAL-INFLUENCES	Background: Six independent studies have identified linkage to chromosome 18 for developmental dyslexia or general reading ability. Until now, no candidate genes have been identified to explain this linkage. Here, we set out to identify the gene(s) conferring susceptibility by a two stage strategy of linkage and association analysis. Methodology/Principal Findings: Linkage analysis: 264 UK families and 155 US families each containing at least one child diagnosed with dyslexia were genotyped with a dense set of microsatellite markers on chromosome 18. Association analysis: Using a discovery sample of 187 UK families, nearly 3000 SNPs were genotyped across the chromosome 18 dyslexia susceptibility candidate region. Following association analysis, the top ranking SNPs were then genotyped in the remaining samples. The linkage analysis revealed a broad signal that spans approximately 40 Mb from 18p11.2 to 18q12.2. Following the association analysis and subsequent replication attempts, we observed consistent association with the same SNPs in three genes; melanocortin 5 receptor (MC5R), dymeclin (DYM) and neural precursor cell expressed, developmentally down-regulated 4-like (NEDD4L). Conclusions: Along with already published biological evidence, MC5R, DYM and NEDD4L make attractive candidates for dyslexia susceptibility genes. However, further replication and functional studies are still required.	[Scerri, Thomas S.; Paracchini, Silvia; Morris, Andrew; MacPhie, I. Laurence; Monaco, Anthony P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Talcott, Joel] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Stein, John] Univ Oxford, Dept Physiol, Oxford, England; [Smith, Shelley D.] Univ Nebraska, Med Ctr, Dept Pediat, Omaha, NE USA; [Smith, Shelley D.] Univ Nebraska, Med Ctr, Munroe Meyer Inst, Omaha, NE USA; [Pennington, Bruce F.] Univ Denver, Dept Psychol, Denver, CO 80208 USA; [Olson, Richard K.; DeFries, John C.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA	University of Oxford; Wellcome Centre for Human Genetics; Aston University; University of Oxford; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Denver; University of Colorado System; University of Colorado Boulder	Scerri, TS (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	anthony.monaco@well.ox.ac.uk	Monaco, Anthony P/A-4495-2010; Paracchini, Silvia/AAU-6813-2021	Monaco, Anthony P/0000-0001-7480-3197; Paracchini, Silvia/0000-0001-9934-8602; Richardson, Alex/0000-0001-5650-4409; Stein, John/0000-0001-5843-8986	Wellcome Trust [075491/Z/04, 076566]; National Institute of Child Health and Human Development [HD-27802]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD027802] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Wellcome Trust grants [075491/Z/04] and [076566]. This support included all costs (staff and material) related to design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. In addition, the Colorado Learning Disabilities Research Center is supported by P50 grant HD-27802 (R.K. Olson, Director) from the National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Anthoni H, 2007, HUM MOL GENET, V16, P667, DOI 10.1093/hmg/ddm009; BAKWIN H, 1973, DEV MED CHILD NEUROL, V15, P184; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bates TC, 2007, EUR J HUM GENET, V15, P194, DOI 10.1038/sj.ejhg.5201739; BECKWITH BE, 1977, PHYSIOL BEHAV, V18, P63, DOI 10.1016/0031-9384(77)90095-6; Castles A, 1999, J EXP CHILD PSYCHOL, V72, P73, DOI 10.1006/jecp.1998.2482; Catania A, 2004, PHARMACOL REV, V56, P1, DOI 10.1124/pr.56.1.1; Chapman NH, 2004, AM J MED GENET B, V131B, P67, DOI 10.1002/ajmg.b.30018; Cohn DH, 2003, AM J HUM GENET, V72, P419, DOI 10.1086/346176; de Kovel CGF, 2008, AM J MED GENET B, V147B, P294, DOI 10.1002/ajmg.b.30598; de Kovel CGF, 2004, J MED GENET, V41, P652, DOI 10.1136/jmg.2003.012294; Defries J.C., 2015, DEV DISABIL RES REV, V2, P39, DOI [DOI 10.1002/(SICI)1098-2779(1996)2:1<39::AID-MRDD7>3.0.CO;2-S, 10.1002/(sici)1098-2779(1996)2:13.0.co;2-s, DOI 10.1002/(SICI)1098-2779(1996)2:13.0.CO;2-S]; DEFRIES JC, 1987, NATURE, V329, P537, DOI 10.1038/329537a0; Dennis MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000436; Falush D, 2003, GENETICS, V164, P1567; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fava C, 2006, KIDNEY INT, V70, P562, DOI 10.1038/sj.ki.5001590; Fiddy S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-210; Fisher SE, 2002, NAT GENET, V30, P86, DOI 10.1038/ng792; FULKER DW, 2004, READ WRIT, V3, P299; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GANTZ I, 1994, BIOCHEM BIOPH RES CO, V200, P1214, DOI 10.1006/bbrc.1994.1580; Gayan J, 2001, DEV NEUROPSYCHOL, V20, P483, DOI 10.1207/S15326942DN2002_3; Habib M, 2000, BRAIN, V123, P2373, DOI 10.1093/brain/123.12.2373; Hallgren B, 1950, ACTA PSYCH NEUROL SU, P1; Hannula-Jouppi K, 2005, PLOS GENET, V1, P467, DOI 10.1371/journal.pgen.0010050; Harvey KF, 2001, J BIOL CHEM, V276, P8597, DOI 10.1074/jbc.C000906200; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HASSLER M, 1992, INT J NEUROSCI, V65, P45, DOI 10.3109/00207459209003277; Hinshelwood J., 1907, BMJ-BRIT MED J, V1, P608; Igo RP, 2006, AM J MED GENET B, V141B, P15, DOI 10.1002/ajmg.b.30245; Kaminen N, 2003, J MED GENET, V40, P340, DOI 10.1136/jmg.40.5.340; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lasky-Su J, 2008, AM J MED GENET B, V147B, P1345, DOI 10.1002/ajmg.b.30867; Lessem JL, 2001, BIOINFORMATICS, V17, P371, DOI 10.1093/bioinformatics/17.4.371; Marlow AJ, 2003, AM J HUM GENET, V72, P561, DOI 10.1086/368201; Meng HY, 2005, P NATL ACAD SCI USA, V102, P17053, DOI 10.1073/pnas.0508591102; Nopola-Hemmi J, 2001, J MED GENET, V38, P658, DOI 10.1136/jmg.38.10.658; Norton N, 2000, AM J MED GENET, V96, P556; Pankow JS, 2005, AM J HYPERTENS, V18, P672, DOI 10.1016/j.amjhyper.2004.12.004; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Paracchini S, 2007, ANNU REV GENOM HUM G, V8, P57, DOI 10.1146/annurev.genom.8.080706.092312; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raskind WH, 2005, MOL PSYCHIATR, V10, P699, DOI 10.1038/sj.mp.4001657; Russo CJ, 2005, HYPERTENSION, V46, P488, DOI 10.1161/01.HYP.0000178594.63193.c0; Schumacher J, 2006, J NEURAL TRANSM, V113, P417, DOI 10.1007/s00702-005-0336-y; Schumacher J, 2007, J MED GENET, V44, P289, DOI 10.1136/jmg.2006.046516; Seshadri S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S15; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; Sile S, 2008, HUM HERED, V65, P33, DOI 10.1159/000106060; Smolnik R, 2000, J CLIN PSYCHOPHARM, V20, P445, DOI 10.1097/00004714-200008000-00009; Stephenson S., 1907, OPHTHALMOSCOPE, V5, P482; STEVENSON J, 1987, J CHILD PSYCHOL PSYC, V28, P229, DOI 10.1111/j.1469-7610.1987.tb00207.x; Storm Niels, 2003, Methods Mol Biol, V212, P241; Taipale M, 2003, P NATL ACAD SCI USA, V100, P11553, DOI 10.1073/pnas.1833911100; Tang K, 2003, INT J MASS SPECTROM, V226, P37, DOI 10.1016/S1387-3806(02)00980-6; Taylor K, 2002, ARCH DIS CHILD, V86, P30, DOI 10.1136/adc.86.1.30; THOMAS CJ, 2005, OPHTHALMOSCOPE, V3; VEITH JL, 1978, PHYSIOL BEHAV, V20, P43, DOI 10.1016/0031-9384(78)90201-9; VEITH JL, 1985, PSYCHONEUROENDOCRINO, V10, P33, DOI 10.1016/0306-4530(85)90037-X; WARD MM, 1979, PHYSIOL BEHAV, V22, P669, DOI 10.1016/0031-9384(79)90228-2; Wen H, 2008, CLIN EXP HYPERTENS, V30, P87, DOI 10.1080/10641960801949909; *WHO, 1993, ICD 10 CLASS MENT BE, pR12; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Willcutt EG, 2000, J LEARN DISABIL, V33, P179, DOI 10.1177/002221940003300206; Williams J, 2006, EUR J HUM GENET, V14, P681, DOI 10.1038/sj.ejhg.5201575	70	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13712	10.1371/journal.pone.0013712	http://dx.doi.org/10.1371/journal.pone.0013712			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060895	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000283573800012
J	Knowlton, ML; Selfors, LM; Wrobel, CN; Gu, TL; Ballif, BA; Gygi, SP; Polakiewicz, R; Brugge, JS				Knowlton, Melodie L.; Selfors, Laura M.; Wrobel, Carolyn N.; Gu, Ting-Lei; Ballif, Bryan A.; Gygi, Steven P.; Polakiewicz, Roberto; Brugge, Joan S.			Profiling Y561-Dependent and -Independent Substrates of CSF-1R in Epithelial Cells	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; SRC FAMILY KINASES; GROWTH-FACTOR RECEPTORS; ATP-CITRATE LYASE; BREAST-CANCER; SIGNAL-TRANSDUCTION; TYROSINE KINASES; LUNG-CANCER; E-CADHERIN; C-SRC	Receptor tyrosine kinases (RTKs) activate multiple downstream cytosolic tyrosine kinases following ligand stimulation. SRC family kinases (SFKs), which are recruited to activated RTKs through SH2 domain interactions with RTK autophosphorylation sites, are targets of many subfamilies of RTKs. To date, there has not been a systematic analysis of the downstream substrates of such receptor-activated SFKs. Here, we conducted quantitative mass spectrometry utilizing stable isotope labeling (SILAC) analysis to profile candidate SRC-substrates induced by the CSF-1R tyrosine kinase by comparing the phosphotyrosine-containing peptides from cells expressing either CSF-1R or a mutant form of this RTK that is unable to bind to SFKs. This analysis identified previously uncharacterized changes in tyrosine phosphorylation induced by CSF-1R in mammary epithelial cells as well as a set of candidate substrates dependent on SRC recruitment to CSF-1R. Many of these candidates may be direct SRC targets as the amino acids flanking the phosphorylation sites in these proteins are similar to known SRC kinase phosphorylation motifs. The putative SRC-dependent proteins include known SRC substrates as well as previously unrecognized SRC targets. The collection of substrates includes proteins involved in multiple cellular processes including cell-cell adhesion, endocytosis, and signal transduction. Analyses of phosphoproteomic data from breast and lung cancer patient samples identified a subset of the SRC-dependent phosphorylation sites as being strongly correlated with SRC activation, which represent candidate markers of SRC activation downstream of receptor tyrosine kinases in human tumors. In summary, our data reveal quantitative site-specific changes in tyrosine phosphorylation induced by CSF-1R activation in epithelial cells and identify many candidate SRC-dependent substrates phosphorylated downstream of an RTK.	[Knowlton, Melodie L.; Selfors, Laura M.; Wrobel, Carolyn N.; Ballif, Bryan A.; Gygi, Steven P.; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Gu, Ting-Lei; Polakiewicz, Roberto] Cell Signaling Technol Inc, Danvers, MA USA	Harvard University; Harvard Medical School	Knowlton, ML (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	joan_brugge@hms.harvard.edu		SELFORS, LAURA/0000-0002-1317-7353	NCI [CA CA089393]; NIH [HG3456]; Ford Foundation; National Center for Research Resources [P20 RR16462]; NATIONAL CANCER INSTITUTE [P50CA089393] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016462] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ford Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by an NCI SPORE grant to JSB (CA CA089393) and NIH grant HG3456 (S.P.G.), a Ford Foundation Predoctoral Fellowship (MLK), and funding from the Vermont Genetics Network through National Institutes of Health grant P20 RR16462 from the INBRE Program of the National Center for Research Resources (B.A.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work by Ting-Lei Gu and Roberto Polakiewicz in this study was funded by Cell Signaling Technology, Inc, who played a role in the design, data collection and analysis but not in the decision to publish, or the preparation of the first draft of the manuscript.	Alema S, 2007, BBA-MOL CELL RES, V1773, P47, DOI 10.1016/j.bbamcr.2006.06.001; ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; Alvarez RH, 2006, CANCER-AM CANCER SOC, V107, P1918, DOI 10.1002/cncr.22215; AMANCHY R, 2009, MOL ONCOL; Amanchy R, 2008, J PROTEOME RES, V7, P3900, DOI 10.1021/pr800198w; Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200; Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103; Brauer PM, 2009, CELL CYCLE, V8, P2728, DOI 10.4161/cc.8.17.9389; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Chambers SK, 1997, CLIN CANCER RES, V3, P999; Courtneidge SA, 2002, BIOCHEM SOC T, V30, P11, DOI 10.1042/bst0300011; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Douglass TG, 2008, INT IMMUNOPHARMACOL, V8, P1354, DOI 10.1016/j.intimp.2008.04.016; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Flick MB, 1997, ONCOGENE, V14, P2553, DOI 10.1038/sj.onc.1201092; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gunawardane RN, 2005, CANCER RES, V65, P11572, DOI 10.1158/0008-5472.CAN-05-1196; Hatzfeld M, 2003, J CELL SCI, V116, P1219, DOI 10.1242/jcs.00275; Heibeck TH, 2009, J PROTEOME RES, V8, P3852, DOI 10.1021/pr900044c; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Kacinski BM, 1997, MOL REPROD DEV, V46, P71, DOI 10.1002/(SICI)1098-2795(199701)46:1<71::AID-MRD11>3.0.CO;2-6; Leroy C, 2009, CANCER RES, V69, P2279, DOI 10.1158/0008-5472.CAN-08-2354; Luo W, 2008, J PROTEOME RES, V7, P3447, DOI 10.1021/pr800187n; Maher MG, 1998, CLIN CANCER RES, V4, P1851; Marks D C, 1999, Mol Cell Biol Res Commun, V1, P144, DOI 10.1006/mcbr.1999.0123; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Mosesson Y, 2004, SEMIN CANCER BIOL, V14, P262, DOI 10.1016/j.semcancer.2004.04.005; Mukherji M, 2006, BIOCHEMISTRY-US, V45, P15529, DOI 10.1021/bi060971c; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; PAN JG, 2007, SCI STKE, pPE14, DOI DOI 10.1126/STKE.3812007PE14; PATSIALOU A, 2009, CANC RES; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Pucharcos C, 2000, FEBS LETT, V478, P43, DOI 10.1016/S0014-5793(00)01793-2; Putignani L, 2008, BREAST CANCER RES TR, V110, P439, DOI 10.1007/s10549-007-9738-x; Raiborg C, 2002, CELL STRUCT FUNCT, V27, P403, DOI 10.1247/csf.27.403; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2001, BIOCHEM SOC T, V29, P472, DOI 10.1042/BST0290472; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rohde CM, 2004, J BIOL CHEM, V279, P43448, DOI 10.1074/jbc.M314170200; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Russello SV, 2004, FRONT BIOSCI-LANDMRK, V9, P139; Sapi E, 2004, EXP BIOL MED, V229, P1; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Toy EP, 2001, GYNECOL ONCOL, V80, P194, DOI 10.1006/gyno.2000.6070; Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x; Wrobel CN, 2004, J CELL BIOL, V165, P263, DOI 10.1083/jcb.200309102; Yancy Haile F, 2007, J Carcinog, V6, P8; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yeung YG, 2003, MOL CELL PROTEOMICS, V2, P1143, DOI 10.1074/mcp.R300009-MCP200; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012; Zimmerman B, 2009, CELL SIGNAL, V21, P103, DOI 10.1016/j.cellsig.2008.09.013	66	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13587	10.1371/journal.pone.0013587	http://dx.doi.org/10.1371/journal.pone.0013587			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049007	Green Published, Green Submitted, gold			2022-12-25	WOS:000283487400004
J	Roodveldt, C; Labrador-Garrido, A; Gonzalez-Rey, E; Fernandez-Montesinos, R; Caro, M; Lachaud, CC; Waudby, CA; Delgado, M; Dobson, CM; Pozo, D				Roodveldt, Cintia; Labrador-Garrido, Adahir; Gonzalez-Rey, Elena; Fernandez-Montesinos, Rafael; Caro, Marta; Lachaud, Christian C.; Waudby, Christopher A.; Delgado, Mario; Dobson, Christopher M.; Pozo, David			Glial Innate Immunity Generated by Non-Aggregated Alpha-Synuclein in Mouse: Differences between Wild-type and Parkinson's Disease-Linked Mutants	PLOS ONE			English	Article							NEURONAL CELL-DEATH; MICROGLIAL ACTIVATION; ALZHEIMERS-DISEASE; MATRIX METALLOPROTEINASES; DOPAMINERGIC-NEURONS; HUMAN PLASMA; MODEL; PROTEIN; PATHOGENESIS; MUTATION	Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized pathologically by the presence in the brain of intracellular protein inclusions highly enriched in aggregated alpha-synuclein (alpha-Syn). Although it has been established that progression of the disease is accompanied by sustained activation of microglia, the underlying molecules and factors involved in these immune-triggered mechanisms remain largely unexplored. Lately, accumulating evidence has shown the presence of extracellular alpha-Syn both in its aggregated and monomeric forms in cerebrospinal fluid and blood plasma. However, the effect of extracellular alpha-Syn on cellular activation and immune mediators, as well as the impact of familial PD-linked alpha-Syn mutants on this stimulation, are still largely unknown. Methods and Findings: In this work, we have compared the activation profiles of non-aggregated, extracellular wild-type and PD-linked mutant alpha-Syn variants on primary glial and microglial cell cultures. After stimulation of cells with alpha-Syn, we measured the release of Th1- and Th2-type cytokines as well as IP-10/CXCL10, RANTES/CCL5, MCP-1/CCL2 and MIP-1 alpha/CCL3 chemokines. Contrary to what had been observed using cell lines or for the case of aggregated alpha-Syn, we found strong differences in the immune response generated by wild-type alpha-Syn and the familial PD mutants (A30P, E46K and A53T). Conclusions: These findings might contribute to explain the differences in the onset and progression of this highly debilitating disease, which could be of value in the development of rational approaches towards effective control of immune responses that are associated with PD.	[Roodveldt, Cintia; Labrador-Garrido, Adahir; Fernandez-Montesinos, Rafael; Lachaud, Christian C.; Pozo, David] Univ Seville UPO Junta de Andalucia, Consejo Super Invest Cient, CABIMER Andalusian Ctr Mol Biol & Regenerat Med, Seville, Spain; [Gonzalez-Rey, Elena; Caro, Marta; Delgado, Mario] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Waudby, Christopher A.; Dobson, Christopher M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Waudby, Christopher A.] UCL, Dept Struct & Mol Biol, London, England	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Cambridge; University of London; University College London	Roodveldt, C (corresponding author), Univ Seville UPO Junta de Andalucia, Consejo Super Invest Cient, CABIMER Andalusian Ctr Mol Biol & Regenerat Med, Seville, Spain.	david.pozo@cabimer.es	Waudby, Christopher/AAT-1736-2021; Roodveldt, Cintia/I-9118-2014; GONZALEZ-REY, ELENA/L-3296-2014; Delgado, Mario/P-1524-2016; Caro, Marta/ABG-9963-2020; Lachaud, Christian Claude/C-2036-2017; Fernández-Montesinos, Rafael/ABG-1691-2021; Pozo Perez, PhD, David/C-2149-2017	Waudby, Christopher/0000-0001-7810-3753; Roodveldt, Cintia/0000-0003-4124-8769; GONZALEZ-REY, ELENA/0000-0003-3917-9020; Delgado, Mario/0000-0003-1893-5982; Lachaud, Christian Claude/0000-0001-8698-4589; Fernandez, Rafael/0000-0002-5062-4239; Pozo Perez, PhD, David/0000-0002-3732-4960; Caro, Marta/0000-0003-3385-4734; Labrador-Garrido, Adahir/0000-0001-5098-9601	Spanish Ministry of Science and Innovation; University of Seville Department of Normal and Pathological Cytology and Histology; Instituto de Salud Carlos III - Fund for Health of Spain; Junta de Andalucia [BIO-323, CTS-541]; Alicia Kloplowitz Foundation; Wellcome Trust; Leverhulme Trust	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University of Seville Department of Normal and Pathological Cytology and Histology; Instituto de Salud Carlos III - Fund for Health of Spain; Junta de Andalucia(Junta de Andalucia); Alicia Kloplowitz Foundation; Wellcome Trust(Wellcome Trust); Leverhulme Trust(Leverhulme Trust)	CR held a Federation of the Societies of Biochemistry and Molecular Biology Long-Term Fellowship during part of this work, and currently holds a postdoctoral fellowship by the Spanish Ministry of Science and Innovation (Juan de la Cierva Programme). RFM holds an FPI fellowship at the University of Seville Department of Normal and Pathological Cytology and Histology. This work was supported by Instituto de Salud Carlos III - Fund for Health of Spain (to MD and DP); Junta de Andalucia BIO-323 (DP) and CTS-541 (MD); Alicia Kloplowitz Foundation (to MD and DP); and Wellcome Trust and Leverhulme Trust grants (CMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin SA, 2006, J NEUROSCI, V26, P10558, DOI 10.1523/JNEUROSCI.1799-06.2006; Banati RB, 1998, MOVEMENT DISORD, V13, P221, DOI 10.1002/mds.870130205; Barreiro O, 2010, CARDIOVASC RES, V86, P174, DOI 10.1093/cvr/cvq001; Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Bonifati V, 2004, CELL MOL LIFE SCI, V61, P1729, DOI 10.1007/s00018-004-4104-1; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Bostantjopoulou S, 2001, MOVEMENT DISORD, V16, P1007, DOI 10.1002/mds.1221; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chung CY, 2009, J NEUROSCI, V29, P3365, DOI 10.1523/JNEUROSCI.5427-08.2009; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Croisier E, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-14; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Delgado M, 2003, FASEB J, V17, P944, DOI 10.1096/fj.02-0799fje; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Eriksen JL, 2005, ARCH NEUROL-CHICAGO, V62, P353, DOI 10.1001/archneur.62.3.353; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Gangemi S, 2003, MEDIAT INFLAMM, V12, P251, DOI 10.1080/09629350310001599701; Gasser T, 2005, CURR OPIN NEUROL, V18, P363, DOI 10.1097/01.wco.0000170951.08924.3d; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Golbe LI, 1996, ANN NEUROL, V40, P767, DOI 10.1002/ana.410400513; Gu XL, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-12; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Jensen PH, 1997, BIOCHEM J, V323, P539, DOI 10.1042/bj3230539; Joo SH, 2010, NEUROSCI LETT, V469, P352, DOI 10.1016/j.neulet.2009.12.026; Kim SH, 2004, PARKINSONISM RELAT D, V10, pS9, DOI 10.1016/j.parkreldis.2003.11.005; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Klegeris A, 2008, NEUROBIOL AGING, V29, P739, DOI 10.1016/j.neurobiolaging.2006.11.013; Klegeris A, 2006, FASEB J, V20, P2000, DOI 10.1096/fj.06-6183com; Knott C, 2000, MOL CELL NEUROSCI, V16, P724, DOI 10.1006/mcne.2000.0914; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee SJ, 2008, J MOL NEUROSCI, V34, P17, DOI 10.1007/s12031-007-0012-9; Liu J, 2007, J PROTEOME RES, V6, P3614, DOI 10.1021/pr0701512; Long-Smith CM, 2009, PROG NEUROBIOL, V89, P277, DOI 10.1016/j.pneurobio.2009.08.001; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mirza B, 2000, NEUROSCIENCE, V95, P425; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Mori F, 2002, EXP NEUROL, V176, P98, DOI 10.1006/exnr.2002.7929; Moussa CEH, 2004, NEUROSCI LETT, V371, P239, DOI 10.1016/j.neulet.2004.09.004; Papapetropoulos S, 2001, J NEUROL NEUROSUR PS, V70, P662, DOI 10.1136/jnnp.70.5.662; Park JY, 2008, GLIA, V56, P1215, DOI 10.1002/glia.20691; Perez RG, 2004, J NEUROCHEM, V89, P1318, DOI 10.1111/j.1471-4159.2004.02423.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Reale M, 2009, BRAIN BEHAV IMMUN, V23, P55, DOI 10.1016/j.bbi.2008.07.003; Rentzos M, 2007, ACTA NEUROL SCAND, V116, P374, DOI 10.1111/j.1600-0404.2007.00894.x; Reynolds AD, 2008, J NEUROCHEM, V104, P1504, DOI 10.1111/j.1471-4159.2007.05087.x; Reynolds AD, 2007, J LEUKOCYTE BIOL, V82, P1083, DOI 10.1189/jlb.0507296; Reynolds AD, 2009, J IMMUNOL, V182, P4137, DOI 10.4049/jimmunol.0803982; Rich RR., 2008, CLIN IMMUNOLOGY PRIN, piv; Richter-Landsberg C, 2000, J NEUROSCI RES, V62, P9, DOI 10.1002/1097-4547(20001001)62:1<9::AID-JNR2>3.0.CO;2-U; Roodveldt C, 2008, J CELL MOL MED, V12, P1820, DOI 10.1111/j.1582-4934.2008.00450.x; Sanchez-Guajardo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008784; Sanchez-Pernaute R, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-6; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schwartz M, 2010, BRAIN BEHAV IMMUN, V24, P1054, DOI 10.1016/j.bbi.2010.01.010; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spira PJ, 2001, ANN NEUROL, V49, P313, DOI 10.1002/ana.67; Stone DK, 2009, ANTIOXID REDOX SIGN, V11, P2151, DOI [10.1089/ars.2009.2460, 10.1089/ARS.2009.2460]; Su XM, 2008, NEUROBIOL AGING, V29, P1690, DOI 10.1016/j.neurobiolaging.2007.04.006; Su XM, 2009, NEUROTOX RES, V16, P238, DOI 10.1007/s12640-009-9053-x; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Sung JY, 2005, J BIOL CHEM, V280, P25216, DOI 10.1074/jbc.M503341200; Theodore S, 2008, J NEUROPATH EXP NEUR, V67, P1149, DOI 10.1097/NEN.0b013e31818e5e99; Thomas MP, 2007, J NEUROCHEM, V100, P503, DOI 10.1111/j.1471-4159.2006.04315.x; Vila M, 2001, CURR OPIN NEUROL, V14, P483, DOI 10.1097/00019052-200108000-00009; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhang W, 2007, GLIA, V55, P1178, DOI 10.1002/glia.20532	84	69	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13481	10.1371/journal.pone.0013481	http://dx.doi.org/10.1371/journal.pone.0013481			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21048992	Green Published, gold			2022-12-25	WOS:000283487400002
J	Tannour-Louet, M; Han, S; Corbett, ST; Louet, JF; Yatsenko, S; Meyers, L; Shaw, CA; Kang, SHL; Cheung, SW; Lamb, DJ				Tannour-Louet, Mounia; Han, Shuo; Corbett, Sean T.; Louet, Jean-Francois; Yatsenko, Svetlana; Meyers, Lindsay; Shaw, Chad A.; Kang, Sung-Hae L.; Cheung, Sau Wai; Lamb, Dolores J.			Identification of De Novo Copy Number Variants Associated with Human Disorders of Sexual Development	PLOS ONE			English	Article							CHROMOSOMAL MICROARRAY ANALYSIS; MICRODELETION SYNDROME; BETA-CATENIN; REVERSAL; CRYPTORCHIDISM; HYPOSPADIAS; DIFFERENTIATION; GENE; DUPLICATIONS; POLYMORPHISM	Disorders of sexual development (DSD), ranging in severity from genital abnormalities to complete sex reversal, are among the most common human birth defects with incidence rates reaching almost 3%. Although causative alterations in key genes controlling gonad development have been identified, the majority of DSD cases remain unexplained. To improve the diagnosis, we screened 116 children born with idiopathic DSD using a clinically validated array-based comparative genomic hybridization platform. 8951 controls without urogenital defects were used to compare with our cohort of affected patients. Clinically relevant imbalances were found in 21.5% of the analyzed patients. Most anomalies (74.2%) evaded detection by the routinely ordered karyotype and were scattered across the genome in gene-enriched subtelomeric loci. Among these defects, confirmed de novo duplication and deletion events were noted on 1p36.33, 9p24.3 and 19q12-q13.11 for ambiguous genitalia, 10p14 and Xq28 for cryptorchidism and 12p13 and 16p11.2 for hypospadias. These variants were significantly associated with genitourinary defects (P = 6.08 x 10(-12)). The causality of defects observed in 5p15.3, 9p24.3, 22q12.1 and Xq28 was supported by the presence of overlapping chromosomal rearrangements in several unrelated patients. In addition to known gonad determining genes including SRY and DMRT1, novel candidate genes such as FGFR2, KANK1, ADCY2 and ZEB2 were encompassed. The identification of risk germline rearrangements for urogenital birth defects may impact diagnosis and genetic counseling and contribute to the elucidation of the molecular mechanisms underlying the pathogenesis of human sexual development.	[Tannour-Louet, Mounia; Corbett, Sean T.; Lamb, Dolores J.] Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA; [Han, Shuo; Louet, Jean-Francois; Lamb, Dolores J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Yatsenko, Svetlana; Meyers, Lindsay; Shaw, Chad A.; Kang, Sung-Hae L.; Cheung, Sau Wai] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Tannour-Louet, M (corresponding author), Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA.	mlouet@bcm.edu; dlamb@bcm.edu	Mounia, TANNOUR LOUET/T-2622-2019; TANNOUR LOUET, Mounia/G-5413-2017	Mounia, TANNOUR LOUET/0000-0003-0614-063X; TANNOUR LOUET, Mounia/0000-0003-0614-063X; Shaw, Chad/0000-0001-7267-5398; Louet, Jean-Francois/0000-0002-1626-7098	National Institute of Kidney and Digestive Diseases [1R01DK078121]; American Urological Association Foundation; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01HD36289]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD036289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078121] Funding Source: NIH RePORTER	National Institute of Kidney and Digestive Diseases; American Urological Association Foundation; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grants 1R01DK078121 from the National Institute of Kidney and Digestive Diseases to DJL, the American Urological Association Foundation (SC and DJL), and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (P01HD36289) to DJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Bagheri-Fam S, 2008, DEV BIOL, V314, P71, DOI 10.1016/j.ydbio.2007.11.010; Ballif BC, 2007, NAT GENET, V39, P1071, DOI 10.1038/ng2107; BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; Beleza-Meireles A, 2007, EUR J HUM GENET, V15, P405, DOI 10.1038/sj.ejhg.5201777; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; Cox MJ, 2008, J UROLOGY, V180, P2649, DOI 10.1016/j.juro.2008.08.058; Foresta C, 2008, ENDOCR REV, V29, P560, DOI 10.1210/er.2007-0042; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Higashi Y, 2002, GENESIS, V32, P82, DOI 10.1002/gene.10048; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Hughes IA, 2007, ENDOCRIN DEV, V11, P47, DOI 10.1159/000111057; Jeays-Ward K, 2003, DEVELOPMENT, V130, P3663, DOI 10.1242/dev.00591; Jordan BK, 2001, AM J HUM GENET, V68, P1102, DOI 10.1086/320125; Kim Y, 2007, P NATL ACAD SCI USA, V104, P16558, DOI 10.1073/pnas.0702581104; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Lu XY, 2008, PEDIATRICS, V122, P1310, DOI 10.1542/peds.2008-0297; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Miquelajauregui A, 2007, P NATL ACAD SCI USA, V104, P12919, DOI 10.1073/pnas.0609863104; Moreno-Garcia M, 2002, J UROLOGY, V168, P2170, DOI 10.1016/S0022-5347(05)64346-7; Ou Z, 2008, GENET MED, V10, P278, DOI 10.1097/GIM.0b013e31816b4420; Pohl HG, 2007, J UROLOGY, V177, P1646, DOI 10.1016/j.juro.2007.01.058; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Shaffer LG, 1997, AM J MED GENET, V69, P325, DOI 10.1002/(SICI)1096-8628(19970331)69:3<325::AID-AJMG20>3.0.CO;2-S; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Smyk M, 2007, HUM GENET, V122, P63, DOI 10.1007/s00439-007-0373-8; Virtanen HE, 2007, ACTA PAEDIATR, V96, P611, DOI 10.1111/j.1651-2227.2007.00241.x; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wain LV, 2009, LANCET, V374, P340, DOI 10.1016/S0140-6736(09)60249-X; Wang MH, 2008, J ANDROL, V29, P499, DOI 10.2164/jandrol.108.004945; Wang Y, 2006, J CELL SCI, V119, P4002, DOI 10.1242/jcs.03169; Wilhelm D, 2006, NAT REV GENET, V7, P620, DOI 10.1038/nrg1903	36	110	117	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e15392	10.1371/journal.pone.0015392	http://dx.doi.org/10.1371/journal.pone.0015392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21048976	gold, Green Submitted, Green Published			2022-12-25	WOS:000283487400033
J	Voituron, N; Shvarev, Y; Menuet, C; Bevengut, M; Fasano, C; Vigneault, E; El Mestikawy, S; Hilaire, G				Voituron, Nicolas; Shvarev, Yuri; Menuet, Clement; Bevengut, Michelle; Fasano, Caroline; Vigneault, Erika; El Mestikawy, Salah; Hilaire, Gerard			Fluoxetine Treatment Abolishes the In Vitro Respiratory Response to Acidosis in Neonatal Mice	PLOS ONE			English	Article							INFANT-DEATH-SYNDROME; PHRENIC MOTONEURON ACTIVITY; RAT RETROTRAPEZOID NUCLEUS; BRAIN-STEM NEURONS; RHYTHM GENERATOR; SEROTONERGIC MODULATION; SPINAL-CORD; VENTRAL MEDULLA; MOUSE; CHEMOSENSITIVITY	Background: To secure pH homeostasis, the central respiratory network must permanently adapt its rhythmic motor drive to environment and behaviour. In neonates, it is commonly admitted that the retrotrapezoid/parafacial respiratory group of neurons of the ventral medulla plays the primary role in the respiratory response to acidosis, although the serotonergic system may also contribute to this response. Methodology/Principal Findings: Using en bloc medullary preparations from neonatal mice, we have shown for the first time that the respiratory response to acidosis is abolished after pre-treatment with the serotonin-transporter blocker fluoxetine (25-50 mu M, 20 min), a commonly used antidepressant. Using mRNA in situ hybridization and immunohistology, we have also shown the expression of the serotonin transporter mRNA and serotonin-containing neurons in the vicinity of the RTN/pFRG of neonatal mice. Conclusions: These results reveal that the serotonergic system plays a pivotal role in pH homeostasis. Although obtained in vitro in neonatal mice, they suggest that drugs targeting the serotonergic system should be used with caution in infants, pregnant women and breastfeeding mothers.	[Voituron, Nicolas; Shvarev, Yuri; Menuet, Clement; Bevengut, Michelle; Hilaire, Gerard] Univ Mediterranee Univ Paul Cezanne, CNRS, Unite Mixte Rech 6231, Marseille, France; [Shvarev, Yuri] Karolinska Inst, Dept Woman & Child Hlth, Stockholm, Sweden; [Shvarev, Yuri] Russian Acad Sci, Inst Cytol & Genet, Siberian Div, Novosibirsk 630090, Russia; [Fasano, Caroline; Vigneault, Erika; El Mestikawy, Salah] McGill Univ, Dept Psychiat, Douglas Hosp Res Ctr, Montreal, PQ H3A 2T5, Canada; [El Mestikawy, Salah] Inst Natl Sante & Rech Med, Unite 952, Paris, France; [El Mestikawy, Salah] CNRS, Unite Mixte Rech 7224, Paris, France; [El Mestikawy, Salah] Univ Paris 06, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Karolinska Institutet; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Voituron, N (corresponding author), Univ Mediterranee Univ Paul Cezanne, CNRS, Unite Mixte Rech 6231, Marseille, France.	gerard.hilaire@univ-cezanne.fr		voituron, nicolas/0000-0002-2092-4900; Menuet, Clement/0000-0002-7419-6427; el mestikawy, salah/0000-0002-6253-0002	International Rett Syndrome Foundation; Agence Nationale de la Recherche Prageder; Paul Cezanne University	International Rett Syndrome Foundation; Agence Nationale de la Recherche Prageder(French National Research Agency (ANR)); Paul Cezanne University	NV was supported by an International Rett Syndrome Foundation grant and Agence Nationale de la Recherche Prageder, YS by a Paul Cezanne University fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SBG, 2009, J NEUROSCI, V29, P5806, DOI 10.1523/JNEUROSCI.1106-09.2009; Amiel J, 2009, RESP PHYSIOL NEUROBI, V168, P125, DOI 10.1016/j.resp.2009.03.005; Belik J, 2008, SEMIN PERINATOL, V32, P350, DOI 10.1053/j.semperi.2008.08.001; Blanchi B, 2003, NAT NEUROSCI, V6, P1091, DOI 10.1038/nn1129; Bou-Flores C, 2001, J NEUROPHYSIOL, V85, P1543, DOI 10.1152/jn.2001.85.4.1543; Bou-Flores C, 2000, J NEUROSCI, V20, P4646, DOI 10.1523/JNEUROSCI.20-12-04646.2000; CAUBIT X, 2010, J NEUROSCI IN PRESS; Corcoran AE, 2009, RESP PHYSIOL NEUROBI, V168, P49, DOI 10.1016/j.resp.2009.04.014; DIPASQUALE E, 1994, DEV BRAIN RES, V80, P222, DOI 10.1016/0165-3806(94)90107-4; DIPASQUALE E, 1992, NEUROSCI LETT, V143, P91, DOI 10.1016/0304-3940(92)90240-8; DiPasquale E, 1997, NEUROSCI LETT, V230, P29, DOI 10.1016/S0304-3940(97)00469-2; Duncan JR, 2010, JAMA-J AM MED ASSOC, V303, P430, DOI 10.1001/jama.2010.45; Erickson JT, 2007, RESP PHYSIOL NEUROBI, V159, P85, DOI 10.1016/j.resp.2007.06.002; Erlichman JS, 2010, J APPL PHYSIOL, V108, P1803, DOI 10.1152/japplphysiol.01321.2009; Erlichman JS, 2009, J NEUROPHYSIOL, V102, P1577, DOI 10.1152/jn.00381.2009; Fortin G, 2009, RESP PHYSIOL NEUROBI, V168, P86, DOI 10.1016/j.resp.2009.06.013; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gras C, 2008, NAT NEUROSCI, V11, P292, DOI 10.1038/nn2052; Guyenet PG, 2009, RESP PHYSIOL NEUROBI, V168, P59, DOI 10.1016/j.resp.2009.02.001; GUYENET PG, 2010, RESP PHYSL IN PRESS; Hewitt A, 2004, AM J PHYSIOL-REG I, V287, pR1407, DOI 10.1152/ajpregu.00404.2004; Hilaire G, 2004, RESP PHYSIOL NEUROBI, V143, P187, DOI 10.1016/j.resp.2004.04.016; Hilaire G, 1997, EUR J PHARMACOL, V329, P115, DOI 10.1016/S0014-2999(97)10117-0; HILAIRE G, 2010, RESP PHYSL NEUROBIOL; Hodges MR, 2008, J NEUROSCI, V28, P2495, DOI 10.1523/JNEUROSCI.4729-07.2008; HODGES MR, 2010, RESP PHYSL IN PRESS; ISSA FG, 1992, J APPL PHYSIOL, V72, P439, DOI 10.1152/jappl.1992.72.2.439; Kawai A, 1996, J PHYSIOL-LONDON, V492, P277, DOI 10.1113/jphysiol.1996.sp021308; Kim DK, 2005, NEUROPHARMACOLOGY, V49, P798, DOI 10.1016/j.neuropharm.2005.08.010; Kinney HC, 2009, ANNU REV PATHOL-MECH, V4, P517, DOI 10.1146/annurev.pathol.4.110807.092322; Lanoir J, 2006, J COMP NEUROL, V495, P607, DOI 10.1002/cne.20916; Li AH, 2008, J PHYSIOL-LONDON, V586, P2321, DOI 10.1113/jphysiol.2008.152231; Liu QL, 2010, J COMP NEUROL, V518, P1082, DOI 10.1002/cne.22265; Moss BL, 2005, J NEUROPHYSIOL, V94, P2575, DOI 10.1152/jn.00322.2005; Mulkey DK, 2007, J NEUROSCI, V27, P14128, DOI 10.1523/JNEUROSCI.4167-07.2007; Nattie E, 1999, PROG NEUROBIOL, V59, P299, DOI 10.1016/S0301-0082(99)00008-8; Nichols NL, 2008, ADV EXP MED BIOL, V605, P348; Okada Y, 2007, EUR J NEUROSCI, V26, P2834, DOI 10.1111/j.1460-9568.2007.05891.x; Onimaru H, 2009, RESP PHYSIOL NEUROBI, V168, P13, DOI 10.1016/j.resp.2009.03.007; Onimaru H, 2008, J NEUROSCI, V28, P12845, DOI 10.1523/JNEUROSCI.3625-08.2008; Oyamada Y, 1998, J PHYSIOL-LONDON, V513, P381, DOI 10.1111/j.1469-7793.1998.381bb.x; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; Paterson DS, 2009, RESP PHYSIOL NEUROBI, V168, P133, DOI 10.1016/j.resp.2009.05.010; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; Ritucci NA, 2005, AM J PHYSIOL-REG I, V289, pR851, DOI 10.1152/ajpregu.00132.2005; Rorig B, 1996, EUR J NEUROSCI, V8, P1685, DOI 10.1111/j.1460-9568.1996.tb01312.x; Rosin DL, 2006, J COMP NEUROL, V499, P64, DOI 10.1002/cne.21105; Rudnick G, 2006, HANDB EXP PHARM, V175, P59; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; STEZHKA VV, 1995, EXP BRAIN RES, V105, P383; Stornetta RL, 2006, J NEUROSCI, V26, P10305, DOI 10.1523/JNEUROSCI.2917-06.2006; Thoby-Brisson M, 2009, NAT NEUROSCI, V12, P1028, DOI 10.1038/nn.2354; Yang L, 2008, RESP PHYSIOL NEUROBI, V160, P147, DOI 10.1016/j.resp.2007.09.006; Zanella S, 2008, J NEUROSCI, V28, P1745, DOI 10.1523/JNEUROSCI.4334-07.2008; Zanella S, 2006, RESP PHYSIOL NEUROBI, V153, P126, DOI 10.1016/j.resp.2005.09.009	55	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13644	10.1371/journal.pone.0013644	http://dx.doi.org/10.1371/journal.pone.0013644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21048979	Green Published, gold, Green Submitted			2022-12-25	WOS:000283487400031
J	Oba, S; Kumano, S; Suzuki, E; Nishimatsu, H; Takahashi, M; Takamori, H; Kasuya, M; Ogawa, Y; Sato, K; Kimura, K; Homma, Y; Hirata, Y; Fujita, T				Oba, Shigeyoshi; Kumano, Shintaro; Suzuki, Etsu; Nishimatsu, Hiroaki; Takahashi, Masao; Takamori, Hajime; Kasuya, Masatoshi; Ogawa, Yousuke; Sato, Kenichiro; Kimura, Kenjiro; Homma, Yukio; Hirata, Yasunobu; Fujita, Toshiro			miR-200b Precursor Can Ameliorate Renal Tubulointerstitial Fibrosis	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; INTERSTITIAL FIBROSIS; FAMILY; INFLAMMATION; EXPRESSION; ZEB1; EPITHELIUM	Members of the miR-200 family of micro RNAs (miRNAs) have been shown to inhibit epithelial-mesenchymal transition (EMT). EMT of tubular epithelial cells is the mechanism by which renal fibroblasts are generated. Here we show that miR-200 family members inhibit transforming growth factor-beta (TGF-beta)-induced EMT of tubular cells. Unilateral ureter obstruction (UUO) is a common model of EMT of tubular cells and subsequent tubulointerstitial fibrosis. In order to examine the role of miR-200 family members in tubulointerstitial fibrosis, their expression was investigated in the kidneys of UUO mice. The expression of miR-200 family miRNAs was increased in a time-dependent manner, with induction of miR-200b most pronounced. To clarify the effect of miR-200b on tubulointerstitial fibrosis, we injected miR-200b precursor intravenously. A single injection of 0.5 nM miR-200b precursor was sufficient to inhibit the increase of collagen types I, III and fibronectin in obstructed kidneys, and amelioration of fibrosis was confirmed by observation of the kidneys with Azan staining. miR-200 family members have been previously shown to inhibit EMT by reducing the expression of ZEB-1 and ZEB-2 which are known repressors of E-cadherin. We demonstrated that expression of ZEB-1 and ZEB-2 was increased after ureter obstruction and that administration of the miR-200b precursor reversed this effect. In summary, these results indicate that miR-200 family is up-regulated after ureter obstruction, miR-200b being strongly induced, and that miR-200b ameliorates tubulointerstitial fibrosis in obstructed kidneys. We suggest that members of the miR-200 family, and miR-200b specifically, might constitute novel therapeutic targets in kidney disease.	[Oba, Shigeyoshi; Takamori, Hajime; Kasuya, Masatoshi; Ogawa, Yousuke; Sato, Kenichiro; Fujita, Toshiro] Univ Tokyo, Sch Med, Dept Nephrol & Endocrinol, Tokyo 113, Japan; [Kumano, Shintaro; Nishimatsu, Hiroaki; Homma, Yukio] Univ Tokyo, Sch Med, Dept Urol, Tokyo 113, Japan; [Suzuki, Etsu] St Marianna Univ, Sch Med, Inst Med Sci, Kawasaki, Kanagawa, Japan; [Takahashi, Masao; Hirata, Yasunobu] Univ Tokyo, Sch Med, Dept Cardiovasc Dis, Tokyo 113, Japan; [Kimura, Kenjiro] St Marianna Univ, Sch Med, Dept Hypertens & Nephrol, Kawasaki, Kanagawa, Japan	University of Tokyo; University of Tokyo; Saint Marianna University; University of Tokyo; Saint Marianna University	Oba, S (corresponding author), Univ Tokyo, Sch Med, Dept Nephrol & Endocrinol, Tokyo 113, Japan.	OBA-2IM@h.u-tokyo.ac.jp		Takahashi, Masao/0000-0002-3799-2256				Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Duband JL, 1995, ACTA ANAT, V154, P63; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; KLAHR S, 1995, AM J KIDNEY DIS, V26, P141, DOI 10.1016/0272-6386(95)90167-1; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Leemans JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005704; Mukai H, 2008, BIOCHEM BIOPH RES CO, V372, P383, DOI 10.1016/j.bbrc.2008.04.097; MULLER GA, 1992, J AM SOC NEPHROL, V2, pS198; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Oba S, 1998, AM J KIDNEY DIS, V32, P419, DOI 10.1053/ajkd.1998.v32.pm9740158; SHARMA AK, 1993, KIDNEY INT, V44, P774, DOI 10.1038/ki.1993.312; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Tan XY, 2007, J STEROID BIOCHEM, V103, P491, DOI 10.1016/j.jsbmb.2006.11.011; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tian ZM, 2008, GENOME RES, V18, P404, DOI 10.1101/gr.6587008; Vieira JM, 2005, NEPHROL DIAL TRANSPL, V20, P1582, DOI 10.1093/ndt/gfh859; Vitalone MJ, 2008, J AM SOC NEPHROL, V19, P1571, DOI 10.1681/ASN.2007050580; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Yokoi H, 2002, AM J PHYSIOL-RENAL, V282, pF933, DOI 10.1152/ajprenal.00122.2001	24	108	118	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13614	10.1371/journal.pone.0013614	http://dx.doi.org/10.1371/journal.pone.0013614			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049046	Green Submitted, Green Published, gold			2022-12-25	WOS:000283422100019
J	Amarir, S; Marx, M; Calothy, G				Amarir, Samira; Marx, Maria; Calothy, Georges			Notch Signaling Activation Suppresses v-Src-Induced Transformation of Neural Cells by Restoring TGF-beta-Mediated Differentiation	PLOS ONE			English	Article							ROUS-SARCOMA-VIRUS; EMBRYO NEURORETINAL CELLS; GROWTH-FACTOR; RETINAL CELLS; IN-VITRO; EXPRESSION; CHICK; CANCER; INHIBITOR; INDUCTION	Background: We have been investigating how interruption of differentiation contributes to the oncogenic process and the possibility to reverse the transformed phenotype by restoring differentiation. In a previous report, we correlated the capacity of intracellular Notch (ICN) to suppress v-Src-mediated transformation of quail neuroretina (QNR/v-src(ts)) cells with the acquisition by these undifferentiated cells of glial differentiation markers. Methodology/Principal Findings: In this work, we have identified autocrine TGF-beta 3 signaling activation as a major effector of Notch-induced phenotypic changes, sufficient to induce transition in differentiation markers expression, suppress morphological transformation and significantly inhibit anchorage-independent growth. We also show that this signaling is constitutive of and contributes to ex-vivo autonomous QNR cell differentiation and that its down-regulation is essential to achieve v-Src-induced transformation. Conclusions/Significance: These results support the possibility that Notch signaling induces differentiation and suppresses transformation by a novel mechanism, involving secreted proteins. They also underline the importance of extracellular signals in controlling the balance between normal and transformed phenotypes.	[Amarir, Samira; Marx, Maria; Calothy, Georges] Inst Curie, CNRS UMR3347, INSERM U1021, Sect Rech, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay	Amarir, S (corresponding author), Inst Curie, CNRS UMR3347, INSERM U1021, Sect Rech, F-91405 Orsay, France.	georges.calothy@curie.u-psud.fr			Centre National de la Recherche Scientifique; Institut Curie; Ministere de la Recherche et de l'Enseignement Superieur; Association pour la Recherche sur le Cancer; Ligue Nationale contre le Cancer (Comite de l'Essonne)	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut Curie; Ministere de la Recherche et de l'Enseignement Superieur; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale contre le Cancer (Comite de l'Essonne)	This work was supported by the Centre National de la Recherche Scientifique and the Institut Curie. S.A was supported by fellowships from the Ministere de la Recherche et de l'Enseignement Superieur, the Association pour la Recherche sur le Cancer and Ligue Nationale contre le Cancer (Comite de l'Essonne). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANZANO MA, 1983, P NATL ACAD SCI-BIOL, V80, P6264, DOI 10.1073/pnas.80.20.6264; Bao ZZ, 1997, J NEUROSCI, V17, P1425; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; BIRCHENALLROBERTS MC, 1990, MOL CELL BIOL, V10, P4978, DOI 10.1128/MCB.10.9.4978; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Burnside J, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-13; CALOTHY G, 1976, VIROLOGY, V71, P336, DOI 10.1016/0042-6822(76)90117-3; CALOTHY G, 1980, COLD SPRING HARB SYM, V44, P983, DOI 10.1101/SQB.1980.044.01.106; COMBES PC, 1977, CELL TISSUE RES, V185, P159; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Douer D, 2002, INT J HEMATOL, V76, P179, DOI 10.1007/BF03165115; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Gronemeyer H, 2001, CELL MOL BIOL LETT, V6, P3; GUERMAH M, 1990, MOL CELL BIOL, V10, P3584, DOI 10.1128/MCB.10.7.3584; GUERMAH M, 1991, P NATL ACAD SCI USA, V88, P4503, DOI 10.1073/pnas.88.10.4503; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hansen LA, 2000, CARCINOGENESIS, V21, P1271, DOI 10.1093/carcin/21.7.1271; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jean D, 1998, MECH DEVELOP, V76, P3, DOI 10.1016/S0925-4773(98)00117-8; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; KRYCEVEMARTINERIE C, 1985, INT J CANCER, V35, P553, DOI 10.1002/ijc.2910350421; LAYER PG, 1989, CELL TISSUE RES, V258, P233; Liu GM, 2006, J BIOL CHEM, V281, P29479, DOI 10.1074/jbc.M600579200; Masker K, 2007, VIROLOGY, V364, P10, DOI 10.1016/j.virol.2007.03.026; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mateos S, 2007, ONCOGENE, V26, P3338, DOI 10.1038/sj.onc.1210124; Mey J, 2000, BRAIN RES REV, V32, P343, DOI 10.1016/S0165-0173(99)00022-3; Moustakas A, 2008, FEBS LETT, V582, P2051, DOI 10.1016/j.febslet.2008.03.027; Oren A, 1999, MOL CELL BIOL, V19, P1742; PESSAC B, 1983, NATURE, V302, P616, DOI 10.1038/302616a0; PESSAC B, 1974, SCIENCE, V185, P709, DOI 10.1126/science.185.4152.709; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Spira AI, 2003, CURR OPIN PHARMACOL, V3, P338, DOI 10.1016/S1471-4892(03)00081-X; Tanaka M, 1999, J NEUROBIOL, V41, P524, DOI 10.1002/(SICI)1097-4695(199912)41:4<524::AID-NEU8>3.3.CO;2-9; Wakamatsu Y, 2000, DEVELOPMENT, V127, P2811; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3	41	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13572	10.1371/journal.pone.0013572	http://dx.doi.org/10.1371/journal.pone.0013572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042581	gold, Green Published, Green Submitted			2022-12-25	WOS:000283419100012
J	Draheim, KM; Hermance, N; Yang, Y; Arous, E; Calvo, J; Kelliher, MA				Draheim, K. M.; Hermance, N.; Yang, Y.; Arous, E.; Calvo, J.; Kelliher, M. A.			A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice	ONCOGENE			English	Article						TAL1; Lmo2; E47; HEB; T cell acute lymphoblastic leukemia (T-ALL)	ACUTE LYMPHOBLASTIC-LEUKEMIA; LOOP-HELIX PROTEIN; C-KIT EXPRESSION; TRANSCRIPTION FACTOR; GENE-THERAPY; TRANSGENIC MICE; TRANSACTIVATION DOMAIN; HEMATOPOIETIC-CELLS; COMPLEX; SCL	The most common translocation in childhood T-cell acute lymphoblastic leukemia (T-ALL) involves the LMO2 locus, resulting in ectopic expression of the LMO2 gene in human thymocytes. The LMO2 gene was also activated in patients with X-linked Severe Combined Immune Deficiency treated with gene therapy because of retroviral insertion in the LMO2 locus. The LMO2 insertions predisposed these children to T-ALL, yet how LMO2 contributes to T cell transformation remains unclear. The LIM (Lin 11, Isl-1, Mec-3) domain containing LMO2 protein regulates erythropoiesis as part of a large transcriptional complex consisting of LMO2, TAL1, E47, GATA1 and LDB1 that recognizes bipartite E-box-GATA1 sites on target genes. Similarly, a TAL1/E47/LMO2/LDB1 complex is observed in human T-ALL and Tal1 and Lmo2 expression in mice results in disease acceleration. To address the mechanism(s) of Tal1/Lmo2 synergy in leukemia, we generated Lmo2 transgenic mice and mated them with mice that express wild-type Tal1 or a DNA-binding mutant of TAL1. Tal1/Lmo2 and MutTAL1/Lmo2 bitransgenic mice exhibit perturbations in thymocyte development due to reduced E47/HEB transcriptional activity and develop leukemia with identical kinetics. These data demonstrate that the DNA-binding activity of Tal1 is not required to cooperate with Lmo2 to cause leukemia in mice and suggest that Lmo2 may cooperate with Tal1 to interfere with E47/HEB function(s). Oncogene (2011) 30, 1252-1260; doi:10.1038/onc.2010.495; published online 8 November 2010	[Draheim, K. M.; Hermance, N.; Yang, Y.; Arous, E.; Kelliher, M. A.] UMass Med Sch, Dept Canc Biol, Worcester, MA USA; [Calvo, J.] MIT, Ctr Environm Hlth Sci, Dept Biol Engn, Cambridge, MA 02139 USA	University of Massachusetts System; University of Massachusetts Worcester; Massachusetts Institute of Technology (MIT)	Kelliher, MA (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, 364 Plantat St, Worcester, MA 01605 USA.	Michelle.Kelliher@umassmed.edu			NIH/NCI [CA096899]; Diabetes Endocrinology Research Center [DK32520]; NATIONAL CANCER INSTITUTE [R01CA096899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Diabetes Endocrinology Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by an NIH/NCI CA096899 Grant to MK. Core resources supported by the Diabetes Endocrinology Research Center Grant DK32520 were also used.	ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; Aoyama M, 2005, CANCER RES, V65, P4587, DOI 10.1158/0008-5472.CAN-04-4630; Aplan PD, 1997, EMBO J, V16, P2408, DOI 10.1093/emboj/16.9.2408; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; Berg T, 2002, P NATL ACAD SCI USA, V99, P3830, DOI 10.1073/pnas.062036999; BOEHM T, 1990, ONCOGENE, V5, P1103; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Davenport J, 2000, LEUKEMIA, V14, P1986, DOI 10.1038/sj.leu.2401913; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; FISCH P, 1992, ONCOGENE, V7, P2389; GARCIA IS, 1991, ONCOGENE, V6, P577; Goardon N, 2006, EMBO J, V25, P357, DOI 10.1038/sj.emboj.7600934; Greenbaum S, 2002, SEMIN IMMUNOL, V14, P405, DOI 10.1016/S1044532302000751; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Herblot S, 2000, NAT IMMUNOL, V1, P138, DOI 10.1038/77819; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; HSU HL, 1994, P NATL ACAD SCI USA, V91, P5947, DOI 10.1073/pnas.91.13.5947; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Huang EY, 2003, J IMMUNOL, V171, P2296, DOI 10.4049/jimmunol.171.5.2296; Huang S, 2000, MOL CELL BIOL, V20, P2248, DOI 10.1128/MCB.20.6.2248-2259.2000; Kelliher MA, 1996, EMBO J, V15, P5160, DOI 10.1002/j.1460-2075.1996.tb00900.x; Krosl G, 1998, J EXP MED, V188, P439, DOI 10.1084/jem.188.3.439; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lahlil R, 2004, MOL CELL BIOL, V24, P1439, DOI 10.1128/MCB.24.4.1439-1452.2004; Larson RC, 1996, EMBO J, V15, P1021, DOI 10.1002/j.1460-2075.1996.tb00439.x; Lecuyer E, 2002, BLOOD, V100, P2430, DOI 10.1182/blood-2002-02-0568; Nam CH, 2008, ONCOGENE, V27, P4962, DOI 10.1038/onc.2008.130; O'Neil J, 2004, CANCER CELL, V5, P587, DOI 10.1016/j.ccr.2004.05.023; O'Neil J, 2001, ONCOGENE, V20, P3897, DOI 10.1038/sj.onc.1204519; Ono Y, 1997, J BIOL CHEM, V272, P4576, DOI 10.1074/jbc.272.7.4576; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Ryan DP, 2008, PROTEINS, V70, P1461, DOI 10.1002/prot.21638; Schlaeger TM, 2004, MOL CELL BIOL, V24, P7491, DOI 10.1128/MCB.24.17.7491-7502.2004; Sharma VM, 2006, MOL CELL BIOL, V26, P8022, DOI 10.1128/MCB.01091-06; VALGEARCHER VE, 1994, P NATL ACAD SCI USA, V91, P8617, DOI 10.1073/pnas.91.18.8617; Visvader JE, 2001, P NATL ACAD SCI USA, V98, P14452, DOI 10.1073/pnas.251547698; WADMAN I, 1994, EMBO J, V13, P4831, DOI 10.1002/j.1460-2075.1994.tb06809.x; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wells JA, 1996, ANNU REV BIOCHEM, V65, P609, DOI 10.1146/annurev.bi.65.070196.003141; Wells JA, 1996, P NATL ACAD SCI USA, V93, P1, DOI 10.1073/pnas.93.1.1; Xu ZX, 2003, MOL CELL BIOL, V23, P7585, DOI 10.1128/MCB.23.21.7585-7599.2003; Yan W, 1997, MOL CELL BIOL, V17, P7317, DOI 10.1128/MCB.17.12.7317	44	24	26	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	10					1252	1260		10.1038/onc.2010.495	http://dx.doi.org/10.1038/onc.2010.495			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	732QD	21057528	Green Accepted			2022-12-25	WOS:000288202400011
J	Lee, MH; Padmashali, R; Koria, P; Andreadis, ST				Lee, Meng-Horng; Padmashali, Roshan; Koria, Piyush; Andreadis, Stelios T.			JNK regulates binding of alpha-catenin to adherens junctions and cell-cell adhesion	FASEB JOURNAL			English	Article						beta-catenin; junctional actin	HUMAN EPIDERMAL-CELLS; E-CADHERIN; BETA-CATENIN; ACTIN POLYMERIZATION; TUMOR-SUPPRESSOR; CONTACTS; MECHANISM; ACTIVATION; CAVEOLAE; CANCER	We recently reported that c-Jun N-terminal kinase (JNK) is associated with adherens junctions and phosphorylates beta-catenin at serine 33/37 and threonine 41. Here, we report that inhibition of JNK led to formation of adherens junctions, which was accompanied by dissociation of alpha-catenin from the beta-catenin/E-cadherin complex and increased association of alpha-catenin with the cytoskeleton. Conversely, activation of JNK increased binding of alpha-catenin to beta-catenin, which was blocked by the JNK inhibitor SP600125 or JNK siRNA. In addition, inhibition of JNK failed to lead to adherens junction formation in cells where alpha-catenin was absent or knocked down. Conversely, introduction of alpha-catenin restored the responsiveness of cells to JNK inhibition and led to cell-cell adhesion. Experiments with domain deletion mutants showed that binding of alpha-catenin to beta-catenin was required for transport of adherens junction complexes to the cell surface, while binding to actin was required for translocation to the cell-cell contact sites. Collectively, our results suggest that JNK affects the association of alpha-catenin with the adherens junction complex and regulates adherens junctions.-Lee, M.-H., Padmashali, R., Koria, P., Andreadis, S. T. JNK regulates binding of alpha-catenin to adherens junctions and cell-cell adhesion. FASEB J. 25, 613-623 (2011). www.fasebj.org	[Lee, Meng-Horng; Padmashali, Roshan; Koria, Piyush; Andreadis, Stelios T.] SUNY Buffalo, Bioengn Lab, Dept Chem & Biol Engn, Amherst, NY 14260 USA; [Andreadis, Stelios T.] SUNY Buffalo, Ctr Excellence Bioinformat & Life Sci, Amherst, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Andreadis, ST (corresponding author), SUNY Buffalo, Bioengn Lab, Dept Chem & Biol Engn, 908 Furnas Hall, Amherst, NY 14260 USA.	sandread@buffalo.edu			U.S. National Institutes of Health [R01 EB000876]; National Science Foundation [BES- 0354626]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000876] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by grants from the U.S. National Institutes of Health (R01 EB000876) and National Science Foundation (BES- 0354626) to S.T.A.	Atkinson SJ, 2004, J BIOL CHEM, V279, P5194, DOI 10.1074/jbc.M306973200; Avdi NJ, 2002, J BIOL CHEM, V277, P40687, DOI 10.1074/jbc.M204455200; Bajpai S, 2009, J BIOL CHEM, V284, P18252, DOI 10.1074/jbc.M109.000661; Bajpai S, 2008, P NATL ACAD SCI USA, V105, P18331, DOI 10.1073/pnas.0806783105; Bek S, 2002, J CELL SCI, V115, P4743, DOI 10.1242/jcs.00154; Brevier J, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/016005; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Koria P, 2006, J INVEST DERMATOL, V126, P1834, DOI 10.1038/sj.jid.5700325; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; Lee MH, 2008, J CELL SCI, V121, P1141, DOI 10.1242/jcs.016634; Liu JY, 2008, CARDIOVASC RES, V79, P24, DOI 10.1093/cvr/cvn059; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Orlichenko L, 2009, MOL BIOL CELL, V20, P4140, DOI 10.1091/mbc.E08-10-1043; Ozawa M, 1998, J BIOL CHEM, V273, P6166, DOI 10.1074/jbc.273.11.6166; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Pokutta S, 2008, BIOCHEM SOC T, V36, P141, DOI 10.1042/BST0360141; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Scott JA, 2006, MOL BIOL CELL, V17, P1085, DOI 10.1091/mbc.e05-07-0644; Serres M, 1997, EXP CELL RES, V231, P163, DOI 10.1006/excr.1996.3443; Stickney JT, 2004, CANCER RES, V64, P2717, DOI 10.1158/0008-5472.CAN-03-3798; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Tian J, 2008, MOL THER, V16, P1146, DOI 10.1038/mt.2008.79; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Zhang JK, 2005, J CELL SCI, V118, P5549, DOI 10.1242/jcs.02639; Zhu Y, 2003, BBA-MOL CELL BIOL L, V1635, P117, DOI 10.1016/j.bbalip.2003.10.011	29	31	31	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					613	623		10.1096/fj.10-161380	http://dx.doi.org/10.1096/fj.10-161380			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	21030692	Green Published			2022-12-25	WOS:000286724800019
J	Snider, NT; Weerasinghe, SVW; Iniguez-Lluhi, JA; Herrmann, H; Omary, MB				Snider, Natasha T.; Weerasinghe, Sujith V. W.; Iniguez-Lluhi, Jorge A.; Herrmann, Harald; Omary, M. Bishr			Keratin Hypersumoylation Alters Filament Dynamics and Is a Marker for Human Liver Disease and Keratin Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLE EPITHELIAL KERATINS; MODIFIER SUMO MODIFICATION; NUCLEAR-PORE COMPLEX; INTERMEDIATE-FILAMENTS; IN-VITRO; TRANSGENIC MICE; UBIQUITIN; PROTEIN; PHOSPHORYLATION; SUMOYLATION	Keratin polypeptide 8 (K8) associates noncovalently with its partners K18 and/or K19 to form the intermediate filament cytoskeleton of hepatocytes and other simple-type epithelial cells. Human K8, K18, and K19 variants predispose to liver disease, whereas site-specific keratin phosphorylation confers hepatoprotection. Because stress-induced protein phosphorylation regulates sumoylation, we hypothesized that keratins are sumoylated in an injury-dependent manner and that keratin sumoylation is an important regulatory modification. We demonstrate that K8/K18/K19, epidermal keratins, and vimentin are sumoylated in vitro. Upon transfection, K8, K18, and K19 are modified by poly-SUMO-2/3 chains on Lys-285/Lys-364 (K8), Lys-207/Lys-372 (K18), and Lys-208 (K19). Sumoylation affects filament organization and stimulus-induced keratin solubility and is partially inhibited upon mutation of one of three known K8 phosphorylation sites. Extensive sumoylation occurs in cells transfected with individual K8, K18, or K19 but is limited upon heterodimerization (K8/K18 or K8/K19) in the absence of stress. In contrast, keratin sumoylation is significantly augmented in cells and tissues during apoptosis, oxidative stress, and phosphatase inhibition. Poly-SUMO-2/3 conjugates are present in chronically injured but not normal, human, and mouse livers along with polyubiquitinated and large insoluble keratin-containing complexes. Notably, common human K8 liver disease-associated variants trigger keratin hypersumoylation with consequent diminished solubility. In contrast, modest sumoylation of wild type K8 promotes solubility. Hence, conformational changes induced by keratin natural mutations and extensive tissue injury result in K8/K18/K19 hypersumoylation, which retains keratins in an insoluble compartment, thereby limiting their cytoprotective function.	Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Iniguez-Lluhi, Jorge A.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Omary, M. Bishr] Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48109 USA; [Herrmann, Harald] German Canc Res Ctr, Funct Architecture Cell Grp, D-69120 Heidelberg, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Helmholtz Association; German Cancer Research Center (DKFZ)	Snider, NT (corresponding author), 7720 Med Sci 2,1301 E Catherine St, Ann Arbor, MI 48109 USA.	nsnider@umich.edu		Omary, Bishr/0000-0002-8624-2347; Iniguez-Lluhi, Jorge/0000-0001-7010-089X	National Institutes of Health [DK52951]; University of Michigan [UL1RR024986]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052951, R01DK052951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK52951 cells, respectively. Keratin post-translational modifications, (to M. B. O.) and by University of Michigan Postdoctoral Translational Scholars Program Award UL1RR024986 (to N. T. S.).	ABE M, 1990, J CELL BIOL, V111, P1197, DOI 10.1083/jcb.111.3.1197; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Carberry K, 2009, CELL MOTIL CYTOSKEL, V66, P852, DOI 10.1002/cm.20372; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dorval V, 2006, J BIOL CHEM, V281, P9919, DOI 10.1074/jbc.M510127200; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Hanada S, 2010, GASTROENTEROLOGY, V138, P1607, DOI 10.1053/j.gastro.2009.12.055; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Kaminsky R, 2009, DEV CELL, V17, P724, DOI 10.1016/j.devcel.2009.10.005; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 2010, NAT CELL BIOL, V12, P876, DOI 10.1038/ncb2091; Ku NO, 2004, METHOD CELL BIOL, V78, P489; Ku NO, 2005, GASTROENTEROLOGY, V129, P885, DOI 10.1053/j.gastro.2005.06.065; Ku NO, 1997, J BIOL CHEM, V272, P33197, DOI 10.1074/jbc.272.52.33197; Ku NO, 1998, J CELL BIOL, V143, P2023, DOI 10.1083/jcb.143.7.2023; Ku NO, 2002, P NATL ACAD SCI USA, V99, P4373, DOI 10.1073/pnas.072624299; Ku NO, 2001, J BIOL CHEM, V276, P26792, DOI 10.1074/jbc.M103315200; Ku NO, 2001, NEW ENGL J MED, V344, P1580, DOI 10.1056/NEJM200105243442103; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lapenta V, 1997, GENOMICS, V40, P362, DOI 10.1006/geno.1996.4556; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Marceau N, 2007, EXP CELL RES, V313, P2265, DOI 10.1016/j.yexcr.2007.03.038; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mukherjee S, 2009, J BIOL CHEM, V284, P21296, DOI 10.1074/jbc.M109.011494; Mukhopadhyay D, 2010, J CELL BIOL, V188, P681, DOI 10.1083/jcb.200909008; Omary M B, 1998, Subcell Biochem, V31, P105; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894; Riley BE, 2005, J BIOL CHEM, V280, P21942, DOI 10.1074/jbc.M501677200; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sarge KD, 2009, TRENDS BIOCHEM SCI, V34, P200, DOI 10.1016/j.tibs.2009.01.004; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Strnad P, 2010, GASTROENTEROLOGY, V139, P828, DOI 10.1053/j.gastro.2010.06.007; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Toivola DA, 2004, HEPATOLOGY, V40, P459, DOI 10.1002/hep.20277; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Yang ML, 2006, J BIOL CHEM, V281, P8264, DOI 10.1074/jbc.M510364200; Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503; Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhang YQ, 2008, J CELL BIOL, V182, P35, DOI 10.1083/jcb.200712124	54	53	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2273	2284		10.1074/jbc.M110.171314	http://dx.doi.org/10.1074/jbc.M110.171314			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21062750	Green Published, hybrid			2022-12-25	WOS:000286191500067
J	Wang, GY				Wang, Guangyu			The Inhibition Mechanism of Non-phosphorylated Ser(768) in the Regulatory Domain of Cystic Fibrosis Transmembrane Conductance Regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; R-DOMAIN; ABC TRANSPORTER; PHOSPHORYLATION SITES; CHLORIDE CHANNEL; ATP BINDING; CFTR; PROTEIN; ACTIVATION; DIMERIZATION	The cystic fibrosis transmembrane conductance regulator (CFTR) is a member of the ATP-binding cassette transporters but serves as a chloride channel dysfunctional in cystic fibrosis. The activity of CFTR is tightly controlled not only by ATP-driven dimerization of its nucleotide-binding domains but also by phosphorylation of a unique regulatory (R) domain by protein kinase A (PKA). The R domain has multiple excitatory phosphorylation sites, but Ser(737) and Ser(768) are inhibitory. The underlying mechanism is unclear. Here, sulfhydryl-specific cross-linking strategy was employed to demonstrate that Ser(768) or Ser(737) could interact with outwardly facing hydrophilic residues of cytoplasmic loop 3 regulating channel gating. Furthermore, mutation of these residues to alanines promoted channel opening by curcumin in an ATP-dependent manner even in the absence of PKA. However, mutation of Ser(768) and His(950) with different hydrogen bond donors or acceptors clearly changed ATP- and PKA-dependent channel activity no matter whether curcumin was present or not. More importantly, significant activation of a double mutant H950R/S768R needed only ATP. Finally, in vitro and in vivo single channel recordings suggest that Ser(768) may form a putative hydrogen bond with His950 of cytoplasmic loop 3 to prevent channel opening by ATP in the non-phosphorylated state and by subsequent cAMP-dependent phosphorylation. These observations support an electron cryomicroscopy-based structural model on which the R domain is closed to cytoplasmic loops regulating channel gating.	[Wang, Guangyu] Univ Nevada, Sch Med, Dept Pharmacol, Reno, NV 89557 USA; [Wang, Guangyu] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Wang, Guangyu] Univ Alabama, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wang, GY (corresponding author), Univ Nevada, Sch Med, Dept Pharmacol, 1664 N Virginia St MS 318,Manville Med Bldg Rm 9, Reno, NV 89557 USA.	wangg@medicine.nevada.edu		Wang, Guangyu/0000-0002-5581-6926	National Institutes of Health [2R56DK056796-10]; American Heart Association [10SDG4120011]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK056796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R56DK056796-10. This work was also supported by American Heart Association Grant 10SDG4120011 (to G. W.).	Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Baldursson O, 2001, J BIOL CHEM, V276, P1904, DOI 10.1074/jbc.M006934200; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Cotten JF, 1997, J BIOL CHEM, V272, P25617, DOI 10.1074/jbc.272.41.25617; Csanady L, 2005, J GEN PHYSIOL, V125, P171, DOI 10.1085/jgp.200409076; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DULHANTY AM, 1994, BIOCHEMISTRY-US, V33, P4072, DOI 10.1021/bi00179a036; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; Kongsuphol P, 2009, J BIOL CHEM, V284, P5645, DOI 10.1074/jbc.M806780200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Naren AP, 1999, SCIENCE, V286, P544, DOI 10.1126/science.286.5439.544; Ostedgaard LS, 2000, P NATL ACAD SCI USA, V97, P5657, DOI 10.1073/pnas.100588797; RICH DP, 1991, SCIENCE, V253, P205, DOI 10.1126/science.1712985; RIORDAN JR, 1989, SCIENCE, V245, P1066; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Vais H, 2004, AM J PHYSIOL-CELL PH, V287, pC737, DOI 10.1152/ajpcell.00504.2003; Vankeerberghen A, 1999, BIOCHEMISTRY-US, V38, P14988, DOI 10.1021/bi991520d; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang GY, 2007, J BIOL CHEM, V282, P13637, DOI 10.1074/jbc.M609182200; Wang GY, 2010, J BIOL CHEM, V285, P40438, DOI 10.1074/jbc.M110.161497; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; Xie JX, 2002, J BIOL CHEM, V277, P23019, DOI 10.1074/jbc.M201661200; Zhang L, 2009, J STRUCT BIOL, V167, P242, DOI 10.1016/j.jsb.2009.06.004	34	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2171	2182		10.1074/jbc.M110.145540	http://dx.doi.org/10.1074/jbc.M110.145540			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21059651	hybrid, Green Published			2022-12-25	WOS:000286191500058
J	Chae, H; Han, K; Kim, KS; Park, H; Lee, J; Lee, Y				Chae, Huiseok; Han, Kook; Kim, Kwang-sun; Park, Hongmarn; Lee, Jungmin; Lee, Younghoon			Rho-dependent Termination of ssrS (6S RNA) Transcription in Escherichia coli IMPLICATION FOR 3 ' PROCESSING OF 6S RNA AND EXPRESSION OF DOWNSTREAM ygfA (PUTATIVE 5-FORMYL-TETRAHYDROFOLATE CYCLO-LIGASE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI BIOFILMS; GENE-EXPRESSION; ARGININE TRNA(CCG); NONCODING RNAS; GROWTH DEFECT; STABLE RNAS; REGULATORS; PROTEIN; POLYMERASE; MUTATIONS	It is well known that 6S RNA, a global regulatory noncoding RNA that modulates gene expression in response to the cellular stresses in Escherichia coli, is generated by processing from primary ssrS (6S RNA) transcripts derived from two different promoters. The 5' processing of 6S RNA from primary transcripts has been well studied; however, it remains unclear how the 3'-end of this RNA is generated although previous studies have suggested that exoribonucleolytic trimming is necessary for 3' processing. Here, we describe several Rho-dependent termination sites located similar to 90 bases downstream of the mature 3'-end of 6S RNA. Our data suggest that the 3'-end of 6S RNA is generated via exoribonucleolytic trimming, rather than endoribonucleolytic cleavage, following the transcription termination events. The termination sites identified in this study are within the open reading frame of the downstream ygfA (putative 5-formyl-tetrahydrofolate cyclo-ligase) gene, a part of the highly conserved bacterial operon ssrS-ygfA, which is up-regulated during the biofilm formation. Our findings reveal that ygfA expression, which also aids the formation of multidrug-tolerant persister cells, could be regulated by Rho-dependent termination activity in the cell.	[Chae, Huiseok; Han, Kook; Park, Hongmarn; Lee, Jungmin; Lee, Younghoon] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; [Kim, Kwang-sun] Korea Res Inst Biosci & Biotechnol KRIBB, Taejon 305806, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, Y (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea.	Younghoon.Lee@kaist.ac.kr	Kim, Kwang-sun/AAB-6478-2020; Lee, Younghoon/C-1991-2011	Lee, Younghoon/0000-0002-3841-719X; Kim, Kwang-sun/0000-0003-3703-5461	21C Frontier Microbial Genomics and Application Center Program [MG08-0201-2-0]; Korea government (MEST) [2010-0000241, 2010-0029167]	21C Frontier Microbial Genomics and Application Center Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the 21C Frontier Microbial Genomics and Application Center Program (MG08-0201-2-0) and the National Research Foundation of Korea (NRF) Grant by the Korea government (MEST) (2010-0000241; 2010-0029167).	ALIFANO P, 1991, CELL, V64, P553; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; BROWNLEE GG, 1971, NATURE-NEW BIOL, V229, P147, DOI 10.1038/newbio229147a0; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Ciampi MS, 2006, MICROBIOL-SGM, V152, P2515, DOI 10.1099/mic.0.28982-0; Dasgupta S, 1998, MOL MICROBIOL, V28, P629, DOI 10.1046/j.1365-2958.1998.00828.x; Deutscher M. P., 1993, NUCLEASES; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Fozo EM, 2008, MOL MICROBIOL, V70, P1076, DOI 10.1111/j.1365-2958.2008.06394.x; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Graham JE, 2004, NUCLEIC ACIDS RES, V32, P3093, DOI 10.1093/nar/gkh630; Graham JE, 1998, J BIOL CHEM, V273, P20764, DOI 10.1074/jbc.273.33.20764; Han K, 2010, NUCLEIC ACIDS RES, V38, P5851, DOI 10.1093/nar/gkq292; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; HSU LM, 1985, J BACTERIOL, V161, P1162, DOI 10.1128/JB.161.3.1162-1170.1985; Ito A, 2009, BIOTECHNOL BIOENG, V103, P975, DOI 10.1002/bit.22305; Ito A, 2009, APPL ENVIRON MICROB, V75, P4093, DOI 10.1128/AEM.02949-08; KELLY KO, 1992, J BACTERIOL, V174, P6682, DOI 10.1128/JB.174.20.6682-6684.1992; Kim KS, 2004, NUCLEIC ACIDS RES, V32, P6057, DOI 10.1093/nar/gkh939; Kim MS, 1998, BIOCHEM MOL BIOL INT, V46, P1153; Kim MS, 1997, MOL GEN GENET, V254, P464, DOI 10.1007/s004380050440; Kim S, 1996, J BIOL CHEM, V271, P19330, DOI 10.1074/jbc.271.32.19330; Kim Y., 2009, THESIS KAIST; KIRSEBOM LA, 1988, J MOL BIOL, V204, P879, DOI 10.1016/0022-2836(88)90048-4; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; LEE SY, 1978, J BACTERIOL, V133, P1015, DOI 10.1128/JB.133.2.1015-1023.1978; Li ZW, 1998, P NATL ACAD SCI USA, V95, P2856, DOI 10.1073/pnas.95.6.2856; Park JW, 2002, BIOCHEM BIOPH RES CO, V290, P1183, DOI 10.1006/bbrc.2001.6331; Peters JM, 2009, P NATL ACAD SCI USA, V106, P15406, DOI 10.1073/pnas.0903846106; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; Storz G, 2004, CURR OPIN MICROBIOL, V7, P140, DOI 10.1016/j.mib.2004.02.015; Trotochaud AE, 2005, NAT STRUCT MOL BIOL, V12, P313, DOI 10.1038/nsmb917; Trotochaud AE, 2004, J BACTERIOL, V186, P4978, DOI 10.1128/JB.186.15.4978-4985.2004; Wachi M, 1997, MOL GEN GENET, V253, P515, DOI 10.1007/s004380050352; Wassarman KM, 2007, MOL MICROBIOL, V65, P1425, DOI 10.1111/j.1365-2958.2007.05894.x; Wassarman KM, 2006, SCIENCE, V314, P1601, DOI 10.1126/science.1134830; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Wassarman KM, 2002, CELL, V109, P141, DOI 10.1016/S0092-8674(02)00717-1; Willkomm DK, 2005, NUCLEIC ACIDS RES, V33, P1949, DOI 10.1093/nar/gki334; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	40	22	24	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					114	122		10.1074/jbc.M110.150201	http://dx.doi.org/10.1074/jbc.M110.150201			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21036909	Green Published, hybrid			2022-12-25	WOS:000285782800012
J	Dutta, AK; Khimji, AK; Kresge, C; Bugde, A; Dougherty, M; Esser, V; Ueno, Y; Glaser, SS; Alpini, G; Rockey, DC; Feranchak, AP				Dutta, Amal K.; Khimji, Al-karim; Kresge, Charles; Bugde, Abhijit; Dougherty, Michael; Esser, Victoria; Ueno, Yoshiyuki; Glaser, Shannon S.; Alpini, Gianfranco; Rockey, Don C.; Feranchak, Andrew P.			Identification and Functional Characterization of TMEM16A, a Ca2+-activated Cl- Channel Activated by Extracellular Nucleotides, in Biliary Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORMAL RAT-LIVER; CELL-LINE; CHLORIDE CHANNEL; CYSTIC-FIBROSIS; BICARBONATE SECRETION; UNANESTHETIZED DOG; PROTEIN-KINASE; CALCIUM; BILE; CHOLANGIOCYTES	Cl- channels in the apical membrane of biliary epithelial cells (BECs) provide the driving force for ductular bile formation. Although a cystic fibrosis transmembrane conductance regulator has been identified in BECs and contributes to secretion via secretin binding basolateral receptors and increasing [cAMP](i), an alternate Cl- secretory pathway has been identified that is activated via nucleotides (ATP, UTP) binding apical P2 receptors and increasing [Ca2+](i). The molecular identity of this Ca2+-activated Cl- channel is unknown. The present studies in human, mouse, and rat BECs provide evidence that TMEM16A is the operative channel and contributes to Ca2+-activated Cl- secretion in response to extracellular nucleotides. Furthermore, Cl- currents measured from BECs isolated from distinct areas of intrahepatic bile ducts revealed important functional differences. Large BECs, but not small BECs, exhibit cAMP-stimulated Cl- currents. However, both large and small BECs express TMEM16A and exhibit Ca2+-activated Cl- efflux in response to extracellular nucleotides. Incubation of polarized BEC monolayers with IL-4 increased TMEM16A protein expression, membrane localization, and transepithelial secretion (I-sc). These studies represent the first molecular identification of an alternate, noncystic fibrosis transmembrane conductance regulator, Cl- channel in BECs and suggest that TMEM16A may be a potential target to modulate bile formation in the treatment of cholestatic liver disorders.	[Dutta, Amal K.; Kresge, Charles; Feranchak, Andrew P.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Khimji, Al-karim; Esser, Victoria; Rockey, Don C.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Ueno, Yoshiyuki] Tohoku Univ, Sch Med, Sendai, Miyagi 980085, Japan; [Glaser, Shannon S.; Alpini, Gianfranco] Cent Texas Vet Hlth Care Syst, Dept Med, Div Res, Temple, TX 76504 USA; [Glaser, Shannon S.; Alpini, Gianfranco] Texas A&M Hlth Sci Ctr, Coll Med, Scott & White Digest Dis Res Ctr, Temple, TX 76504 USA; [Bugde, Abhijit] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Tohoku University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Feranchak, AP (corresponding author), UT SW Med Sch, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	drew.feranchak@UTSouthwestern.edu	Ueno, Yoshiyuki/R-9242-2019	Ueno, Yoshiyuki/0000-0001-5623-4250	NIDDK, National Institutes of Health [DK054811, DK 50574, DK078587]; American Association for the Study of Liver Diseases American Liver Foundation; Children's Medical Center Foundation; Cystic Fibrosis Foundation [FERANC08G0]; Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078587, R01DK050574, R01DK054811] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Association for the Study of Liver Diseases American Liver Foundation; Children's Medical Center Foundation; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by NIDDK, National Institutes of Health Grants DK054811 (to G. A.), DK 50574 (to D. C. R.), and DK078587 (to A. P. F.). This work was also supported by the American Association for the Study of Liver Diseases American Liver Foundation Liver Scholar award (to A. K. D.), the Children's Medical Center Foundation (to A. K. D.), Cystic Fibrosis Foundation Grant FERANC08G0 (to A. P. F.), and the Veterans Affairs Merit award (to G. A.).	Alpini G, 1997, AM J PHYSIOL-GASTR L, V272, pG289, DOI 10.1152/ajpgi.1997.272.2.G289; Alpini G, 1997, AM J PHYSIOL-GASTR L, V272, pG1064, DOI 10.1152/ajpgi.1997.272.5.G1064; Alpini G, 1996, GASTROENTEROLOGY, V110, P1636, DOI 10.1053/gast.1996.v110.pm8613073; BASAVAPPA S, 1993, GASTROENTEROLOGY, V104, pA874; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; CHANG D, 1988, COMPUT BIOL MED, V18, P351, DOI 10.1016/0010-4825(88)90022-4; Clarke LL, 2000, AM J PHYSIOL-GASTR L, V279, pG132, DOI 10.1152/ajpgi.2000.279.1.G132; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; Colombo C, 2002, HEPATOLOGY, V36, P1374, DOI 10.1053/jhep.2002.37136; Dutta AK, 2008, AM J PHYSIOL-GASTR L, V295, pG1004, DOI 10.1152/ajpgi.90382.2008; Dutta AK, 2009, AM J PHYSIOL-GASTR L, V297, pG1009, DOI 10.1152/ajpgi.00223.2009; Feranchak AP, 1999, J BIOL CHEM, V274, P30979, DOI 10.1074/jbc.274.43.30979; Feranchak AP, 2004, GASTROENTEROLOGY, V127, P903, DOI 10.1053/j.gastro.2004.06.047; Feranchak AP, 2001, J CLIN INVEST, V108, P1495, DOI 10.1172/JCI200112190; Feranchak AP, 2001, SEMIN LIVER DIS, V21, P471, DOI 10.1055/s-2001-19030; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Fiorotto R, 2007, GASTROENTEROLOGY, V133, P1603, DOI 10.1053/j.gastro.2007.08.071; FITZ JG, 1994, AM J PHYSIOL, V266, pG544, DOI 10.1152/ajpgi.1994.266.4.G544; Fitz JG, 2002, SEMIN LIVER DIS, V22, P241, DOI 10.1055/s-2002-34502; FITZ JG, 1993, J CLIN INVEST, V91, P319, DOI 10.1172/JCI116188; Francis H, 2008, AM J PHYSIOL-CELL PH, V295, pC499, DOI 10.1152/ajpcell.00369.2007; Glaser SS, 2009, LAB INVEST, V89, P456, DOI 10.1038/labinvest.2009.6; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; ISHII M, 1989, GASTROENTEROLOGY, V97, P1236, DOI 10.1016/0016-5085(89)91695-8; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; KUMAR U, 1986, LIVER, V6, P369; LIDOFSKY SD, 1993, J BIOL CHEM, V268, P14632; MCGILL JM, 1994, AM J PHYSIOL, V266, pG731, DOI 10.1152/ajpgi.1994.266.4.G731; McGill JM, 2001, AM J PHYSIOL-GASTR L, V280, pG738, DOI 10.1152/ajpgi.2001.280.4.G738; Minagawa N, 2007, GASTROENTEROLOGY, V133, P1592, DOI 10.1053/j.gastro.2007.08.020; Paradiso AM, 2001, J GEN PHYSIOL, V117, P53, DOI 10.1085/jgp.117.1.53; PREISIG R, 1962, J CLIN INVEST, V41, P1152, DOI 10.1172/JCI104568; Roman RM, 1996, AM J PHYSIOL-GASTR L, V271, pG239, DOI 10.1152/ajpgi.1996.271.2.G239; Salter KD, 2000, LAB INVEST, V80, P1775, DOI 10.1038/labinvest.3780187; Schlenker T, 1997, AM J PHYSIOL-GASTR L, V273, pG1108, DOI 10.1152/ajpgi.1997.273.5.G1108; Schlenker T, 1996, AM J PHYSIOL-GASTR L, V271, pG304, DOI 10.1152/ajpgi.1996.271.2.G304; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shibao K, 2003, GASTROENTEROLOGY, V125, P1175, DOI 10.1016/S0016-5085(03)01201-0; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Ueno Y, 2003, LIVER INT, V23, P449, DOI 10.1111/j.1478-3231.2003.00876.x; Vroman B, 1996, LAB INVEST, V74, P303; Wang Y, 1997, J CLIN INVEST, V99, P2890, DOI 10.1172/JCI119483; WHEELER HO, 1960, J CLIN INVEST, V39, P161, DOI 10.1172/JCI104015; Woo K, 2008, J PHYSIOL-LONDON, V586, P2779, DOI 10.1113/jphysiol.2008.153015; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	46	72	75	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					766	776		10.1074/jbc.M110.164970	http://dx.doi.org/10.1074/jbc.M110.164970			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21041307	hybrid, Green Published			2022-12-25	WOS:000285782800076
J	Pham, CTN; Mitchell, LM; Huang, JL; Lubniewski, CM; Schall, OF; Killgore, JK; Pan, DPJ; Wickline, SA; Lanza, GM; Hourcade, DE				Pham, Christine T. N.; Mitchell, Lynne M.; Huang, Jennifer L.; Lubniewski, Christopher M.; Schall, Otto F.; Killgore, J. Kendall; Pan, Dipanjan; Wickline, Samuel A.; Lanza, Gregory M.; Hourcade, Dennis E.			Variable Antibody-dependent Activation of Complement by Functionalized Phospholipid Nanoparticle Surfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LUNG INJURY; ALTERNATIVE PATHWAY; FUMAGILLIN NANOPARTICLES; TOXIC OXYGEN; IN-VIVO; 2 PARTS; LIPOSOMES; IMMUNOLOGY; CONVERTASE; MODEL	A wide variety of nanomaterials are currently being developed for use in the detection and treatment of human diseases. However, there is no systematic way to measure and predict the action of such materials in biological contexts. Lipid-encapsulated nanoparticles (NPs) are a class of nanomaterials that includes the liposomes, the most widely used and clinically proven type of NPs. Liposomes can, however, activate the complement system, an important branch of innate immunity, resulting in undesirable consequences. Here, we describe the complement response to lipid-encapsulated NPs that are functionalized on the surface with various lipid-anchored gadolinium chelates. We developed a quantitative approach to examine the interaction of NPs with the complement system using in vitro assays and correlating these results with those obtained in an in vivo mouse model. Our results indicate that surface functionalization of NPs with certain chemical structures elicits swift complement activation that is initiated by a natural IgM antibody and propagated via the classical pathway. The intensity of the response is dependent on the chemical structures of the lipid-anchored chelates and not zeta potential effects alone. Moreover, the extent of complement activation may be tempered by complement inhibiting regulatory proteins that bind to the surface of NPs. These findings represent a step forward in the understanding of the interactions between nanomaterials and the host innate immune response and provide the basis for a systematic structure-activity relationship study to establish guidelines that are critical to the future development of biocompatible nanotherapeutics.	[Hourcade, Dennis E.] Washington Univ, Sch Med, Div Rheumatol, St Louis, MO 63110 USA; [Pan, Dipanjan; Wickline, Samuel A.; Lanza, Gregory M.] Washington Univ, Sch Med, Div Cardiol, Dept Med, St Louis, MO 63110 USA; [Schall, Otto F.; Killgore, J. Kendall] Kereos Inc, St Louis, MO 63108 USA	Washington University (WUSTL); Washington University (WUSTL)	Pham, CTN (corresponding author), 660 S Euclid Ave,Box 8045, St Louis, MO 63110 USA.	cpham@dom.wustl.edu; dhourcad@dom.wustl.edu		Pan, Dipanjan/0000-0003-0175-4704	National Institutes of Health [AR056468, HL073646, CA119342, NS059302, HL094470, AI051436/AI051436S1]; National Institutes of Health/Food and Drug Administration [U01NS073457]; NATIONAL CANCER INSTITUTE [U54CA119342] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073646, R01HL094470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059302, U01NS073457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/Food and Drug Administration(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grants AR056468 (to C. T. N. P.), HL073646 (to S. A. W.), CA119342 (to G. M. L.), NS059302 (to G. M. L.), HL094470 (to G. M. L.), and AI051436/AI051436S1 (to D. E. H.) and National Institutes of Health/Food and Drug Administration Grant U01NS073457 (to D. E. H.). S. A. W. and G. M. L. are scientific founders of Kereos, Inc., and minority shareholders (less than 5%).	Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786; ATKINSON JP, 1980, J IMMUNOL METHODS, V33, P351, DOI 10.1016/0022-1759(80)90005-8; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Caruthers SD, 2007, CURR OPIN BIOTECH, V18, P26, DOI 10.1016/j.copbio.2007.01.006; CHONN A, 1991, J IMMUNOL, V146, P4234; CUNNINGHAM CM, 1979, J IMMUNOL, V122, P1237; Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223; Fischer HC, 2007, CURR OPIN BIOTECH, V18, P565, DOI 10.1016/j.copbio.2007.11.008; Fischer MB, 1996, J IMMUNOL, V157, P549; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Harris TD, 2003, [No title captured], Patent No. [US6511648, 6511648]; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Kraus D, 1998, INFECT IMMUN, V66, P399, DOI 10.1128/IAI.66.2.399-405.1998; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lanza GM, 1996, CIRCULATION, V94, P3334, DOI 10.1161/01.CIR.94.12.3334; Liszewski M.K., 1998, HUMAN COMPLEMENT SYS, P149; LUNDBERG C, 1987, AM J PATHOL, V128, P471; Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720; Niederbichler AD, 2006, J EXP MED, V203, P53, DOI 10.1084/jem.20051207; Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rihova B, 2002, ADV DRUG DELIVER REV, V54, P653; Sadeghi MM, 2004, CIRCULATION, V110, P84, DOI 10.1161/01.CIR.0000133319.84326.70; Szebeni J, 2005, TOXICOLOGY, V216, P106, DOI 10.1016/j.tox.2005.07.023; Szebeni J, 1999, CIRCULATION, V99, P2302, DOI 10.1161/01.CIR.99.17.2302; TILL GO, 1986, FASEB J, V45, P13; TILL GO, 1982, J CLIN INVEST, V69, P1126, DOI 10.1172/JCI110548; TVEDTEN HW, 1985, AM J PATHOL, V119, P92; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Whaley K, 1985, METHODS COMPLEMENT C, P77; Winter PM, 2008, FASEB J, V22, P2758, DOI 10.1096/fj.07-103929; Winter PM, 2008, JACC-CARDIOVASC IMAG, V1, P624, DOI 10.1016/j.jcmg.2008.06.003; WRIGHT SD, 1983, J EXP MED, V158, P2016, DOI 10.1084/jem.158.6.2016	37	55	58	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					123	130		10.1074/jbc.M110.180760	http://dx.doi.org/10.1074/jbc.M110.180760			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21047788	hybrid, Green Published			2022-12-25	WOS:000285782800013
J	Schorn, C; Frey, B; Lauber, K; Janko, C; Strysio, M; Keppeler, H; Gaipl, US; Voll, RE; Springer, E; Munoz, LE; Schett, G; Herrmann, M				Schorn, Christine; Frey, Benjamin; Lauber, Kirsten; Janko, Christina; Strysio, Moritz; Keppeler, Hildegard; Gaipl, Udo S.; Voll, Reinhard E.; Springer, Eva; Munoz, Luis E.; Schett, Georg; Herrmann, Martin			Sodium Overload and Water Influx Activate the NALP3 Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLS; GOUT; INTERLEUKIN-1-BETA; SYSTEM	The NALP3 inflammasome is activated by low intracellular potassium concentrations [K+](i), leading to the secretion of the proinflammatory cytokine IL-1 beta. However, the mechanism of [K+](i) lowering after phagocytosis of monosodium urate crystals is still elusive. Here, we propose that endosomes containing monosodium urate crystals fuse with acidic lysosomes. The low pH in the phagolysosome causes a massive release of sodium and raises the intracellular osmolarity. This process is balanced by passive water influx through aquaporins leading to cell swelling. This process dilutes [K+](i) to values below the threshold of 90 mM known to activate NALP3 inflammasomes without net loss of cytoplasmic potassium ions. In vitro, the inhibitors of lysosomal acidification (ammonium chloride, chloroquine) and of aquaporins (mercury chloride, phloretin) all significantly decreased the production of IL-1 beta. In vivo, only the pharmacological inhibitor of lysosome acidification chloroquine could be used which again significantly reduced the IL-1 beta production. As a translational aspect one may consider the use of chloroquine for the anti-inflammatory treatment of refractory gout.	[Voll, Reinhard E.; Munoz, Luis E.; Schett, Georg; Herrmann, Martin] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany; [Frey, Benjamin; Gaipl, Udo S.; Herrmann, Martin] Univ Erlangen Nurnberg, Dept Radiat Oncol, D-91054 Erlangen, Germany; [Springer, Eva] Univ Erlangen Nurnberg, Dept Mat Sci Glass & Ceram, D-91054 Erlangen, Germany; [Lauber, Kirsten] Univ Munich, Dept Radiat Oncol, D-81377 Munich, Germany; [Keppeler, Hildegard] Univ Tubingen, Dept Internal Med 1, D-72076 Tubingen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Munich; Eberhard Karls University of Tubingen	Herrmann, M (corresponding author), Univ Erlangen Nurnberg, Dept Internal Med 3, Krankenhausstr 12, D-91054 Erlangen, Germany.	Martin.Herrmann@uk-erlangen.de	Munoz, Luis E/E-7725-2010; herrmann, martin/AAT-9836-2020; Gaipl, Udo/AAE-1060-2020; Herrmann, Martin/A-9597-2013; Frey, Benjamin/D-9565-2017	Munoz, Luis E/0000-0002-5395-804X; Herrmann, Martin/0000-0002-0258-2484; Frey, Benjamin/0000-0001-6743-3351; Janko, Christina/0000-0001-5705-6329	Deutsche Forschungsgemeinschaft [GK SFB 643]; Interdisciplinary Center of Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg; University Clinic of Erlangen [09.10.15.1, 09.03.18.1]; K. und R. Wucherpfennigstiftung; Doktor Robert Pfleger Foundation; German Research Foundation [GA 1507/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisciplinary Center of Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg; University Clinic of Erlangen; K. und R. Wucherpfennigstiftung; Doktor Robert Pfleger Foundation; German Research Foundation(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft Grant GK SFB 643, the Interdisciplinary Center of Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg and by Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung (ELAN) Fond 09.10.15.1 of the University Clinic of Erlangen.; Supported by K. und R. Wucherpfennigstiftung.; Supported by the Doktor Robert Pfleger Foundation and by the German Research Foundation Grant GA 1507/1-1.; Supported by Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung (ELAN) Fond 09.03.18.1 of the University Clinic of Erlangen.	Bramley H, 2009, PLANT PHYSIOL, V150, P348, DOI 10.1104/pp.108.134098; Celsus A. C., 1906, AULUS CORNELIUS CELS; Colomar A, 2003, J BIOL CHEM, V278, P30732, DOI 10.1074/jbc.M304534200; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Figueiredo MD, 2009, VET IMMUNOL IMMUNOP, V127, P125, DOI 10.1016/j.vetimm.2008.09.028; FURUCHI T, 1993, J BIOL CHEM, V268, P27345; Haddoub Rose, 2009, Handb Exp Pharmacol, P385, DOI 10.1007/978-3-540-79885-9_19; Kloft N, 2009, BIOCHEM BIOPH RES CO, V385, P503, DOI 10.1016/j.bbrc.2009.05.121; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Lo CJ, 2006, BIOPHYS J, V90, P357, DOI 10.1529/biophysj.105.071332; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2006, J CLIN INVEST, V116, P2073, DOI 10.1172/JCI29404; Misinzo G, 2008, J VIROL, V82, P1128, DOI 10.1128/JVI.01229-07; Nilsson C, 2008, CLIN VACCINE IMMUNOL, V15, P585, DOI 10.1128/CVI.00161-07; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; Peng Liming, 2001, Journal of West China University of Medical Sciences, V32, P602; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Roddy E, 2007, ANN RHEUM DIS, V66, P1374, DOI 10.1136/ard.2006.063768; ROGERS SW, 1988, J BIOL CHEM, V263, P19843; Schorn C, 2009, AUTOIMMUNITY, V42, P314, DOI 10.1080/08916930902832058; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Stamp LK, 2007, INTERN MED J, V37, P258, DOI 10.1111/j.1445-5994.2007.01315.x; Takeuchi K, 2008, CHEM SENSES, V33, P425, DOI 10.1093/chemse/bjn009	24	120	127	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					35	41		10.1074/jbc.M110.139048	http://dx.doi.org/10.1074/jbc.M110.139048			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21051542	hybrid, Green Published			2022-12-25	WOS:000285782800004
J	Louafi, F; Martinez-Nunez, RT; Sanchez-Elsner, T				Louafi, Fethi; Martinez-Nunez, Rocio T.; Sanchez-Elsner, Tilman			MicroRNA-155 Targets SMAD2 and Modulates the Response of Macrophages to Transforming Growth Factor-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; PULMONARY-FIBROSIS; SIGNAL-TRANSDUCTION; DENDRITIC CELLS; EXPRESSION; TGF-BETA-1; PATHWAY; GENE; FIBROBLASTS; ACTIVATION	Transforming growth factor-beta (TGF-beta) is a pleiotropic cytokine with important effects on processes such as fibrosis, angiogenesis, and immunosupression. Using bioinformatics, we identified SMAD2, one of the mediators of TGF-beta signaling, as a predicted target for a microRNA, microRNA-155 (miR-155). MicroRNAs are a class of small non-coding RNAs that have emerged as an important class of gene expression regulators. miR-155 has been found to be involved in the regulation of the immune response in myeloid cells. Here, we provide direct evidence of binding of miR-155 to a predicted binding site and the ability of miR-155 to repress SMAD2 protein expression. We employed a lentivirally transduced monocyte cell line (THP1-155) containing an inducible miR-155 transgene to show that endogenous levels of SMAD2 protein were decreased after sustained overexpression of miR-155. This decrease in SMAD2 led to a reduction in both TGF-beta-induced SMAD-2 phosphorylation and SMAD-2-dependent activation of the expression of the CAGA(12)LUC reporter plasmid. Overexpression of miR-155 altered the cellular responses to TGF-beta by changing the expression of a set of genes that is involved in inflammation, fibrosis, and angiogenesis. Our study provides firm evidence of a role for miR-155 in directly repressing SMAD2 expression, and our results demonstrate the relevance of one of the two predicted target sites in SMAD2 3'-UTR. Altogether, our data uncover an important role for miR-155 in modulating the cellular response to TGF-beta with possible implications in several human diseases where homeostasis of TGF-beta might be altered.	[Louafi, Fethi; Martinez-Nunez, Rocio T.; Sanchez-Elsner, Tilman] Univ Southampton, Sch Med, Southampton Gen Hosp, JunkRNA Lab,Div Infect Inflammat & Immun, Southampton SO16 6YD, Hants, England	University of Southampton	Sanchez-Elsner, T (corresponding author), Gen Hosp MP 813, Tremona Rd, Southampton SO16 6YD, Hants, England.	Sanchez-Elsner@soton.ac.uk		Martinez-Nunez, Rocio Teresa/0000-0003-2507-4738; Sanchez-Elsner, Tilman/0000-0003-1915-2410	Medical Research Council [G0801984]; MRC [G0801984] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G0801984 (to T. S.-E.).	Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; Bosse Y, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-66; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Geissmann F, 1999, J IMMUNOL, V162, P4567; Gorelik L, 2001, NAT MED, V7, P1118, DOI 10.1038/nm1001-1118; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Khalil N, 2001, THORAX, V56, P907, DOI 10.1136/thorax.56.12.907; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; Martinez-Nunez RT, 2009, J BIOL CHEM, V284, P16334, DOI 10.1074/jbc.M109.011601; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Min AK, 2010, BIOCHEM BIOPH RES CO, V393, P536, DOI 10.1016/j.bbrc.2010.02.050; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Pottier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006718; Rai D, 2010, P NATL ACAD SCI USA, V107, P3111, DOI 10.1073/pnas.0910667107; Ralser M, 2006, BIOCHEM BIOPH RES CO, V347, P747, DOI 10.1016/j.bbrc.2006.06.151; Sanchez-Elsner T, 2001, J BIOL CHEM, V276, P38527, DOI 10.1074/jbc.M104536200; Senoo T, 2010, THORAX, V65, P334, DOI 10.1136/thx.2009.119974; Shih SC, 2001, GROWTH FACTORS, V19, P19, DOI 10.3109/08977190109001073; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796	35	154	168	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41328	41336		10.1074/jbc.M110.146852	http://dx.doi.org/10.1074/jbc.M110.146852			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21036908	Green Published, hybrid			2022-12-25	WOS:000285622600018
J	Mazar, J; DeYoung, K; Khaitan, D; Meister, E; Almodovar, A; Goydos, J; Ray, A; Perera, RJ				Mazar, Joseph; DeYoung, Katherine; Khaitan, Divya; Meister, Edward; Almodovar, Alvin; Goydos, James; Ray, Animesh; Perera, Ranjan J.			The Regulation of miRNA-211 Expression and Its Role in Melanoma Cell Invasiveness	PLOS ONE			English	Article							CUTANEOUS MALIGNANT-MELANOMA; SKIN-CANCER; TRANSCRIPTION FACTOR; TUMOR SUPPRESSORS; DNA-REPAIR; UV DAMAGE; MICRORNAS; GENE; METHYLATION; PROGRESSION	The immediate molecular mechanisms behind invasive melanoma are poorly understood. Recent studies implicate microRNAs (miRNAs) as important agents in melanoma and other cancers. To investigate the role of miRNAs in melanoma, we subjected human melanoma cell lines to miRNA expression profiling, and report a range of variations in several miRNAs. Specifically, compared with expression levels in melanocytes, levels of miR-211 were consistently reduced in all eight nonpigmented melanoma cell lines we examined; they were also reduced in 21 out of 30 distinct melanoma samples from patients, classified as primary in situ, regional metastatic, distant metastatic, and nodal metastatic. The levels of several predicted target mRNAs of miR-211 were reduced in melanoma cell lines that ectopically expressed miR-211. In vivo target cleavage assays confirmed one such target mRNA encoded by KCNMA1. Mutating the miR-211 binding site seed sequences at the KCNMA1 3'-UTR abolished target cleavage. KCNMA1 mRNA and protein expression levels varied inversely with miR211 levels. Two different melanoma cell lines ectopically expressing miR-211 exhibited significant growth inhibition and reduced invasiveness compared with the respective parental melanoma cell lines. An shRNA against KCNMA1 mRNA also demonstrated similar effects on melanoma cells. miR-211 is encoded within the sixth intron of TRPM1, a candidate suppressor of melanoma metastasis. The transcription factor MITF, important for melanocyte development and function, is needed for high TRPM1 expression. MITF is also needed for miR-211 expression, suggesting that the tumor-suppressor activities of MITF and/or TRPM1 may at least partially be due to miR-211's negative post transcriptional effects on the KCNMA1 transcript. Given previous reports of high KCNMA1 levels in metastasizing melanoma, prostate cancer and glioma, our findings that miR-211 is a direct posttranscriptional regulator of KCNMA1 expression as well as the dependence of this miRNA's expression on MITF activity, establishes miR-211 as an important regulatory agent in human melanoma.	[Mazar, Joseph; Khaitan, Divya; Almodovar, Alvin; Perera, Ranjan J.] Sanford Burnham Med Res Inst, Orlando, FL USA; [DeYoung, Katherine; Meister, Edward; Perera, Ranjan J.] Curtis & Elizabeth Anderson Canc Inst, Savannah, GA USA; [Goydos, James] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ USA; [Ray, Animesh] Keck Grad Inst, Claremont, CA USA	Sanford Burnham Prebys Medical Discovery Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Claremont Colleges; Keck Graduate Institute	Mazar, J (corresponding author), Sanford Burnham Med Res Inst, Orlando, FL USA.	rperera@sanfordburnham.org	Mazar, Joseph/AAQ-8199-2020; Goydos, James/AAR-8990-2020	Goydos, James/0000-0001-9811-939X; Mazar, Joseph/0000-0002-3713-4251; Ray, Animesh/0000-0002-0120-5820	National Institutes of Health [1R01GM084881-01]; National Science Foundation [FIBR 0527023]; Anderson Cancer Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084881] Funding Source: NIH RePORTER; Division of Computing and Communication Foundations [0941078] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Anderson Cancer Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by grants from the National Institutes of Health (1R01GM084881-01) and the National Science Foundation (FIBR 0527023) to AR, and the Anderson Cancer Institute support for RP's research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Aubert B, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.222001; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Bemis LT, 2008, CANCER RES, V68, P1362, DOI 10.1158/0008-5472.CAN-07-2912; Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; Carr KM, 2003, ONCOGENE, V22, P3076, DOI 10.1038/sj.onc.1206448; Chen AL, 2008, BIOTECHNOL LETT, V30, P2045, DOI 10.1007/s10529-008-9800-8; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Chen M, 2009, J BIOL CHEM, V284, P1484, DOI 10.1074/jbc.M803997200; Cleaver JE, 2002, FRONT BIOSCI-LANDMRK, V7, pD1024, DOI 10.2741/cleaver; Conn EM, 2008, J BIOL CHEM, V283, P26518, DOI 10.1074/jbc.M803337200; Cretnik M, 2009, INT J ONCOL, V34, P1045, DOI 10.3892/ijo_00000230; Crijns APG, 2007, EUR J CANCER, V43, P2495, DOI 10.1016/j.ejca.2007.08.025; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; de Gruijl FR, 2001, J PHOTOCH PHOTOBIO B, V63, P19, DOI 10.1016/S1011-1344(01)00199-3; Duncan LM, 2001, J CLIN ONCOL, V19, P568, DOI 10.1200/JCO.2001.19.2.568; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Felicetti F, 2008, EXPERT REV ANTICANC, V8, P1759, DOI 10.1586/14737140.8.11.1759; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Geerts D, 2003, CANCER LETT, V197, P87, DOI 10.1016/S0304-3835(03)00087-9; Geng J, 2008, J EUR ACAD DERMATOL, V22, P852, DOI 10.1111/j.1468-3083.2007.02574.x; Gonzalgo ML, 1997, CANCER RES, V57, P5336; Guan X, 2003, INT J CANCER, V107, P202, DOI 10.1002/ijc.11376; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Gyorffy B, 2006, MELANOMA RES, V16, P147; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hoon DSB, 2004, ONCOGENE, V23, P4014, DOI 10.1038/sj.onc.1207505; Houghton AN, 2002, CANCER CELL, V2, P275, DOI 10.1016/S1535-6108(02)00161-7; Igoucheva O, 2009, BIOCHEM BIOPH RES CO, V379, P790, DOI 10.1016/j.bbrc.2008.12.152; Jukic DM, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-27; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Lee WJ, 2002, CELL SIGNAL, V14, P1015, DOI 10.1016/S0898-6568(02)00049-9; Li G, 2001, CANCER RES, V61, P3819; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; von Zangen IL, 2007, ACTA NEUROPATHOL, V113, P325, DOI 10.1007/s00401-006-0190-5; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Mancuso M, 2009, CARCINOGENESIS, V30, P340, DOI 10.1093/carcin/bgn243; Massi D, 2006, MODERN PATHOL, V19, p85A; Matsumura Y, 2002, FRONT BIOSCI-LANDMRK, V7, pD765, DOI 10.2741/matsumur; Miller AJ, 2004, CANCER RES, V64, P509, DOI 10.1158/0008-5472.CAN-03-2440; MUELLER DW, 2009, J INVEST DERMATOL; Nashan D, 2007, J EUR ACAD DERMATOL, V21, P1305, DOI 10.1111/j.1468-3083.2007.02475.x; Oancea E, 2009, SCI SIGNAL, V2, pra21; Perera RF, 2007, BIODRUGS, V21, P97, DOI 10.2165/00063030-200721020-00004; Qi JF, 2005, MOL BIOL CELL, V16, P4386, DOI 10.1091/mbc.E05-03-0186; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rass K, 2008, ADV EXP MED BIOL, V624, P162, DOI 10.1007/978-0-387-77574-6_13; REPESH LA, 1989, INVAS METAST, V9, P192; Schmittgen TD, 2008, J CELL MOL MED, V12, P1811, DOI 10.1111/j.1582-4934.2008.00483.x; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Soehnge Holly, 1997, Frontiers in Bioscience, V2, pD538; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storey John D, 2003, Methods Mol Biol, V224, P149; Suarez-Martinez Edu B, 2007, P R Health Sci J, V26, P349; Tajima N, 2006, J PHYSIOL-LONDON, V571, P349, DOI 10.1113/jphysiol.2005.096818; Weaver AK, 2006, GLIA, V54, P223, DOI 10.1002/glia.20364; Worm J, 2000, ONCOGENE, V19, P5111, DOI 10.1038/sj.onc.1203891; Worm J, 2004, ONCOGENE, V23, P5215, DOI 10.1038/sj.onc.1207647; ZHANG B, 2006, DEV BIOL	67	160	167	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2010	5	11							e13779	10.1371/journal.pone.0013779	http://dx.doi.org/10.1371/journal.pone.0013779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FY	21072171	Green Submitted, Green Published, gold			2022-12-25	WOS:000283645700004
J	Trankenschuh, W; Puls, F; Christgen, M; Albat, C; Heim, A; Poczkaj, J; Fleming, P; Kreipe, H; Lehmann, U				Traenkenschuh, Wolfgang; Puls, Florian; Christgen, Matthias; Albat, Cord; Heim, Albert; Poczkaj, Jeanette; Fleming, Peer; Kreipe, Hans; Lehmann, Ulrich			Frequent and Distinct Aberrations of DNA Methylation Patterns in Fibrolamellar Carcinoma of the Liver	PLOS ONE			English	Article							CPG ISLAND HYPERMETHYLATION; EPIGENETIC INACTIVATION; RASSF1A GENE; CANCER; HYPOMETHYLATION; MICRORNA; INSTABILITY; PCR	Background: Gene silencing due to aberrant DNA methylation is a frequent event in hepatocellular carcinoma (HCC) and also in hepatocellular adenoma (HCA). However, very little is known about epigenetic defects in fibrolamellar carcinoma (FLC), a rare variant of hepatocellular carcinoma that displays distinct clinical and morphological features. Methodology/Principal Findings: We analyzed the methylation status of the APC, CDH1, cyclinD2, GST pi 1, hsa-mir-9-1, hsa-mir- 9-2, and RASSF1A gene in a series of 15 FLC and paired normal liver tissue specimens by quantitative high-resolution pyrosequencing. Results were compared with common HCC arising in non-cirrhotic liver (n = 10). Frequent aberrant hypermethylation was found for the cyclinD2 (19%) and the RASSF1A (38%) gene as well as for the microRNA genes mir-9-1 (13%) and mir-9-2 (33%). In contrast to common HCC the APC and CDH1 (E-cadherin) genes were found devoid of any DNA methylation in FLC, whereas the GSTp1 gene showed comparable DNA methylation in tumor and surrounding tissue at a moderate level. Changes in global DNA methylation level were measured by analyzing methylation status of the highly repetitive LINE-1 sequences. No evidence of global hypomethylation could be found in FLCs, whereas HCCs without cirrhosis showed a significant reduction in global methylation level as described previously. Conclusions: FLCs display frequent and distinct gene-specific hypermethylation in the absence of significant global hypomethylation indicating that these two epigenetic aberrations are induced by different pathways and that full-blown malignancy can develop in the absence of global loss of DNA methylation. Only quantitative DNA methylation detection methodology was able to identify these differences.	[Traenkenschuh, Wolfgang; Puls, Florian; Christgen, Matthias; Albat, Cord; Poczkaj, Jeanette; Fleming, Peer; Kreipe, Hans; Lehmann, Ulrich] Hannover Med Sch, Inst Pathol, D-30623 Hannover, Germany; [Heim, Albert] Hannover Med Sch, Inst Virol, D-30623 Hannover, Germany	Hannover Medical School; Hannover Medical School	Trankenschuh, W (corresponding author), Hannover Med Sch, Inst Pathol, D-30623 Hannover, Germany.	Lehmann.Ulrich@MH-Hannover.de		Puls, Florian/0000-0002-9841-4230	Deutsche Forschungsgemeinschaft (DFG) [SFB/TRR77, B1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by SFB/TRR77-"Liver cancer'' (Project B1) of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre X, 2009, CANCER RES, V69, P4443, DOI 10.1158/0008-5472.CAN-08-4025; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Brakensiek K, 2004, BLOOD, V104, P1586, DOI 10.1182/blood-2004-03-0898; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Chan AOO, 2006, CURR MOL MED, V6, P401, DOI 10.2174/156652406777435417; Cho NY, 2009, VIRCHOWS ARCH, V454, P17, DOI 10.1007/s00428-008-0706-6; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Dakubo GD, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-2; DATTA J, CANC RES, V68, P5049; De Smet C, 2010, EPIGENETICS-US, V5; Ehrlich M, 2006, CURR TOP MICROBIOL, V310, P251; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Huang J, 2009, SCI CHINA SER C, V52, P31, DOI 10.1007/s11427-009-0014-7; Kakar S, 2009, MODERN PATHOL, V22, P134, DOI 10.1038/modpathol.2008.178; Kim MJ, 2009, MODERN PATHOL, V22, P442, DOI 10.1038/modpathol.2008.203; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lee ES, 2008, CLIN CANCER RES, V14, P2664, DOI 10.1158/1078-0432.CCR-07-1232; Lee HS, 2009, CLIN CANCER RES, V15, P812, DOI 10.1158/1078-0432.CCR-08-0266; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Lehmann U, 2005, CLIN CANCER RES, V11, P3654, DOI 10.1158/1078-0432.CCR-04-2462; Liu S, 2009, AM J GASTROENTEROL, V104, P2617, DOI 10.1038/ajg.2009.440; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Park SY, 2009, J PATHOL, V219, P410, DOI 10.1002/path.2596; Pfeifer GP, 2002, BIOL CHEM, V383, P907, DOI 10.1515/BC.2002.097; Schagdarsurengin U, 2003, ONCOGENE, V22, P1866, DOI 10.1038/sj.onc.1206338; Simon R, 2007, CANCER INFORM, V3, P11; Torbenson M, 2007, ADV ANAT PATHOL, V14, P217, DOI 10.1097/PAP.0b013e3180504913; Vivekanandan P, 2008, MODERN PATHOL, V21, P670, DOI 10.1038/modpathol.2008.32; Wilkens L, 2000, AM J CLIN PATHOL, V114, P867, DOI 10.1309/BMTT-JBPD-D13H-1UVD; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032	31	27	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13688	10.1371/journal.pone.0013688	http://dx.doi.org/10.1371/journal.pone.0013688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060828	Green Submitted, gold, Green Published			2022-12-25	WOS:000283645300005
J	Walter, S; Kostpopoulos, P; Haass, A; Helwig, S; Keller, I; Licina, T; Schlechtriemen, T; Roth, C; Papanagiotou, P; Zimmer, A; Vierra, J; Korner, H; Schmidt, K; Romann, MS; Alexandrou, M; Yilmaz, U; Grunwald, I; Kubulus, D; Lesmeister, M; Ziegeler, S; Pattar, A; Golinski, M; Liu, Y; Volk, T; Bertsch, T; Reith, W; Fassbender, K				Walter, Silke; Kostpopoulos, Panagiotis; Haass, Anton; Helwig, Stefan; Keller, Isabel; Licina, Tamara; Schlechtriemen, Thomas; Roth, Christian; Papanagiotou, Panagiotis; Zimmer, Anna; Vierra, Julio; Koerner, Heiko; Schmidt, Kathrin; Romann, Marie-Sophie; Alexandrou, Maria; Yilmaz, Umut; Grunwald, Iris; Kubulus, Darius; Lesmeister, Martin; Ziegeler, Stephan; Pattar, Alexander; Golinski, Martin; Liu, Yang; Volk, Thomas; Bertsch, Thomas; Reith, Wolfgang; Fassbender, Klaus			Bringing the Hospital to the Patient: First Treatment of Stroke Patients at the Emergency Site	PLOS ONE			English	Article							GUIDELINES; MANAGEMENT; HEMORRHAGE; MORTALITY; PENUMBRA; OUTCOMES; COUNCIL; EVENTS; ADULTS	Background: Early treatment with rt-PA is critical for favorable outcome of acute stroke. However, only a very small proportion of stroke patients receive this treatment, as most arrive at hospital too late to be eligible for rt-PA therapy. Methods and Findings: We developed a "Mobile Stroke Unit'', consisting of an ambulance equipped with computed tomography, a point-of-care laboratory system for complete stroke laboratory work-up, and telemedicine capabilities for contact with hospital experts, to achieve delivery of etiology-specific and guideline-adherent stroke treatment at the site of the emergency, well before arrival at the hospital. In a departure from current practice, stroke patients could be differentially treated according to their ischemic or hemorrhagic etiology even in the prehospital phase of stroke management. Immediate diagnosis of cerebral ischemia and exclusion of thrombolysis contraindications enabled us to perform prehospital rt-PA thrombolysis as bridging to later intra-arterial recanalization in one patient. In a complementary patient with cerebral hemorrhage, prehospital diagnosis allowed immediate initiation of hemorrhage-specific blood pressure management and telemedicine consultation regarding surgery. Call-to-therapy-decision times were 35 minutes. Conclusion: This preliminary study proves the feasibility of guideline-adherent, etiology-specific and causal treatment of acute stroke directly at the emergency site.	[Walter, Silke; Kostpopoulos, Panagiotis; Haass, Anton; Helwig, Stefan; Keller, Isabel; Licina, Tamara; Lesmeister, Martin; Liu, Yang; Fassbender, Klaus] Univ Hosp Saarland, Dept Neurol, Homburg, Germany; [Schlechtriemen, Thomas] Zweckverband Rettungsdienst & Feuerwehralarmierun, Saarland, Germany; [Roth, Christian; Papanagiotou, Panagiotis; Zimmer, Anna; Vierra, Julio; Koerner, Heiko; Schmidt, Kathrin; Romann, Marie-Sophie; Alexandrou, Maria; Yilmaz, Umut; Grunwald, Iris; Reith, Wolfgang] Univ Hosp Saarland, Dept Neuroradiol, Homburg, Germany; [Kubulus, Darius; Ziegeler, Stephan; Pattar, Alexander; Golinski, Martin; Volk, Thomas] Univ Hosp Saarland, Dept Anaesthesiol & Intens Care, Homburg, Germany; [Bertsch, Thomas] Nurnberg Hosp, Dept Clin Chem, Nurnberg, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Walter, S (corresponding author), Univ Hosp Saarland, Dept Neurol, Homburg, Germany.	Klaus.Fassbender@uks.eu	Liu, Yang/GSD-5476-2022; Roth, Christian/B-6952-2015; Papanagiotou, Panagiotis/B-1434-2012; Grunwald, Iris/AAY-2521-2021; Romann, Michael/H-3571-2019; Yilmaz, Umut/A-9508-2012	Roth, Christian/0000-0001-5147-2241; Grunwald, Iris/0000-0002-3404-7590; Romann, Michael/0000-0003-4139-2955; Yilmaz, Umut/0000-0003-4940-3575; Lesmeister, Martin/0000-0001-5228-6483; Liu, Yang/0000-0002-7614-4233; Walter, Silke/0000-0002-1176-2911; Fassbender, Klaus/0000-0003-3596-868X	Ministry of Health of the Saarland, Germany; Jackstaedt-Foundation, Germany; Else Kroener-Fresenius Foundation, Germany; "Zweckverband fur Rettungsdienst und Feuerwehralarmierung Saar", Germany; German Red Cross, Saarland, Germany	Ministry of Health of the Saarland, Germany; Jackstaedt-Foundation, Germany; Else Kroener-Fresenius Foundation, Germany; "Zweckverband fur Rettungsdienst und Feuerwehralarmierung Saar", Germany; German Red Cross, Saarland, Germany	This study was funded by grants from the Ministry of Health of the Saarland, Germany; Jackstaedt-Foundation, Germany; Else Kroener-Fresenius Foundation, Germany; "Zweckverband fur Rettungsdienst und Feuerwehralarmierung Saar", Germany, and German Red Cross, Saarland, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; BOEHRINGER, 2009, SUMMARY PRODUCT CHAR; Bose A, 2008, AM J NEURORADIOL, V29, P1409, DOI 10.3174/ajnr.A1110; Broderick J, 2007, CIRCULATION, V116, pE391, DOI 10.1161/CIRCULATIONAHA.107.183689; *EUR STROK IN WORK, 2008, CEREBROVASC DIS, V22, P294; Fassbender K, 2003, STROKE, V34, pE44, DOI 10.1161/01.STR.0000075573.22885.3B; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Howells DW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000224; Katzan IL, 2004, ARCH NEUROL-CHICAGO, V61, P346, DOI 10.1001/archneur.61.3.346; Kleindorfer DO, 2008, STROKE, V39, pE43, DOI 10.1161/STROKEAHA.107.509109; Lichtman JH, 2009, STROKE, V40, pE127; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Marler JR, 2000, NEUROLOGY, V55, P1649, DOI 10.1212/WNL.55.11.1649; Mazighi M, 2009, LANCET NEUROL, V8, P802, DOI 10.1016/S1474-4422(09)70182-6; Nor AM, 2005, LANCET NEUROL, V4, P727, DOI 10.1016/S1474-4422(05)70201-5; Price CI, 2009, EXPERT REV NEUROTHER, V9, P211, DOI 10.1586/14737175.9.2.211; Qureshi AI, 2005, NEUROSURGERY, V57, P647, DOI 10.1227/01.NEU.0000175546.62088.D6; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; van der Worp HB, 2007, NEW ENGL J MED, V357, P572, DOI 10.1056/NEJMcp072057; VONKUMMER R, 1994, AM J NEURORADIOL, V15, P9; WEIR CJ, 1994, LANCET, V344, P999, DOI 10.1016/S0140-6736(94)91648-9	22	86	91	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13758	10.1371/journal.pone.0013758	http://dx.doi.org/10.1371/journal.pone.0013758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060800	Green Published, gold			2022-12-25	WOS:000283645300037
J	Looker, C; Carville, K; Grant, K; Kelly, H				Looker, Clare; Carville, Kylie; Grant, Kristina; Kelly, Heath			Influenza A (H1N1) in Victoria, Australia: A Community Case Series and Analysis of Household Transmission	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; SWINE INFLUENZA; UNITED-STATES; VIRUS; PREVENTION; EXPERIENCE; INFECTION; A(H1N1); LESSONS; HUMANS	Background: We characterise the clinical features and household transmission of pandemic influenza A (pH1N1) in community cases from Victoria, Australia in 2009. Methods: Questionnaires were used to collect information on epidemiological characteristics, illness features and comorbidities of cases identified in the 2009 Victorian Influenza Sentinel Surveillance program. Results: The median age of 132 index cases was 21 years, of whom 54 (41%) were under 18 years old and 28 (21%) had medical co-morbidities. The median symptom duration was significantly shorter for children who received antivirals than in those who did not (p = 0.03). Assumed influenza transmission was observed in 63 (51%) households. Influenza-like illness (ILI) developed in 115 of 351 household contacts, a crude secondary attack rate of 33%. Increased ILI rates were seen in households with larger numbers of children but not larger numbers of adults. Multivariate analysis indicated contacts of cases with cough and diarrhoea, and contacts in quarantined households were significantly more likely to develop influenza-like symptoms. Conclusion: Most cases of pH1N1 in our study were mild with similar clinical characteristics to seasonal influenza. Illness and case features relating to virus excretion, age and household quarantine may have influenced secondary ILI rates within households.	[Looker, Clare; Carville, Kylie; Grant, Kristina; Kelly, Heath] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia	Victorian Infectious Diseases Reference Laboratory	Looker, C (corresponding author), Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia.	heath.kelly@mh.org.au		Carville, Kylie/0000-0002-3663-8802	Australian National Health and Medical Research Council [604982]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Australian National Health and Medical Research Council Strategic Awards, Urgent Research - H1N1 Influenza grant number 604982. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Government Department of Health and Ageing, 2008, AUSTR HLTH MAN PLAN; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Cheng AC, 2009, MED J AUSTRALIA, V191, P142, DOI 10.5694/j.1326-5377.2009.tb02722.x; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; COWLING BJ, N ENGL J MED, V362, P2175; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Denholm JT, 2010, MED J AUSTRALIA, V192, P84, DOI 10.5694/j.1326-5377.2010.tb03424.x; Dixon GA, 2010, INFLUENZA OTHER RESP, V4, P231, DOI 10.1111/j.1750-2659.2010.00141.x; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Doshi P, 2010, J INFECT DIS, V201, P1444, DOI 10.1086/651701; Effler PV, 2010, EMERG INFECT DIS, V16, P205, DOI 10.3201/eid1602.091372; Eizenberg P, 2009, MED J AUSTRALIA, V191, P151, DOI 10.5694/j.1326-5377.2009.tb02725.x; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Grant KA, 2009, COMMUN DIS INTELL, V33, P328; Gubareva LV, 2002, J INFECT DIS, V186, P1575, DOI 10.1086/345372; Hayden FG, 2000, NEW ENGL J MED, V343, P1282, DOI 10.1056/NEJM200011023431801; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; KELLY H, 2009, EUROSURVEILL, V14; Kelly HA, 2009, MED J AUSTRALIA, V191, P146, DOI 10.5694/j.1326-5377.2009.tb02723.x; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Lum ME, 2009, MED J AUSTRALIA, V191, P502, DOI 10.5694/j.1326-5377.2009.tb02914.x; Miller N., 2009, AGE             0530; MONTO AS, 1994, EPIDEMIOL REV, V16, P351, DOI 10.1093/oxfordjournals.epirev.a036158; Mubareka S, 2009, J INFECT DIS, V199, P858, DOI 10.1086/597073; Nicoll A, 2010, PUBLIC HEALTH, V124, P14, DOI 10.1016/j.puhe.2009.12.001; O'Riordan S, 2010, CAN MED ASSOC J, V182, P39, DOI 10.1503/cmaj.091724; Patel M, 2009, ANAESTHESIA, V64, P1241, DOI 10.1111/j.1365-2044.2009.06128.x; Petrosillo N, 2009, ANN THORAC MED, V4, P163, DOI 10.4103/1817-1737.56008; *PROMEDMAIL, 2009, INFL A H1N1 WORLDW 4; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; *STAT GOV HLTH DEP, 2010, H1N1 INFL 09 HUM SWI; Thursky K, 2003, J CLIN VIROL, V27, P170, DOI 10.1016/S1386-6532(02)00172-5; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; *VICT INF DIS REF, 2010, VICT INFL VACC EFF A; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; WHO, 2009, WKLY EPIDEMIOL REC, V84, P185; Wilson N, 2009, EUROSURVEILLANCE, V14; 2009, STATELINE VICTORIA S	44	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13702	10.1371/journal.pone.0013702	http://dx.doi.org/10.1371/journal.pone.0013702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060887	Green Published, gold, Green Submitted			2022-12-25	WOS:000283573800005
J	Buttner, S; Delay, C; Franssens, V; Bammens, T; Ruli, D; Zaunschirm, S; de Oliveira, RM; Outeiro, TF; Madeo, F; Buee, L; Galas, MC; Winderickx, J				Buettner, Sabrina; Delay, Charlotte; Franssens, Vanessa; Bammens, Tine; Ruli, Doris; Zaunschirm, Sandra; de Oliveira, Rita Machado; Outeiro, Tiago Fleming; Madeo, Frank; Buee, Luc; Galas, Marie-Christine; Winderickx, Joris			Synphilin-1 Enhances alpha-Synuclein Aggregation in Yeast and Contributes to Cellular Stress and Cell Death in a Sir2-Dependent Manner	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; PARKINSONS-DISEASE; SACCHAROMYCES-CEREVISIAE; INTERACTING PROTEIN; INCLUSION FORMATION; PROMOTE LONGEVITY; TRANSGENIC MICE; BODY FORMATION; IN-VITRO; TOXICITY	Background: Parkinson's disease is characterized by the presence of cytoplasmic inclusions, known as Lewy bodies, containing both aggregated alpha-synuclein and its interaction partner, synphilin-1. While synphilin-1 is known to accelerate inclusion formation by alpha-synuclein in mammalian cells, its effect on cytotoxicity remains elusive. Methodology/Principal Findings: We expressed wild-type synphilin-1 or its R621C mutant either alone or in combination with alpha-synuclein in the yeast Saccharomyces cerevisiae and monitored the intracellular localization and inclusion formation of the proteins as well as the repercussions on growth, oxidative stress and cell death. We found that wild-type and mutant synphilin-1 formed inclusions and accelerated inclusion formation by alpha-synuclein in yeast cells, the latter being correlated to enhanced phosphorylation of serine-129. Synphilin-1 inclusions co-localized with lipid droplets and endomembranes. Consistently, we found that wild-type and mutant synphilin-1 interacts with detergent-resistant membrane domains, known as lipid rafts. The expression of synphilin-1 did not incite a marked growth defect in exponential cultures, which is likely due to the formation of aggresomes and the retrograde transport of inclusions from the daughter cells back to the mother cells. However, when the cultures approached stationary phase and during subsequent ageing of the yeast cells, both wild-type and mutant synphilin-1 reduced survival and triggered apoptotic and necrotic cell death, albeit to a different extent. Most interestingly, synphilin-1 did not trigger cytotoxicity in ageing cells lacking the sirtuin Sir2. This indicates that the expression of synphilin-1 in wild-type cells causes the deregulation of Sir2-dependent processes, such as the maintenance of the autophagic flux in response to nutrient starvation. Conclusions/Significance: Our findings demonstrate that wild-type and mutant synphilin-1 are lipid raft interacting proteins that form inclusions and accelerate inclusion formation of alpha-synuclein when expressed in yeast. Synphilin-1 thereby induces cytotoxicity, an effect most pronounced for the wild-type protein and mediated via Sir2-dependent processes.	[Buettner, Sabrina; Ruli, Doris; Zaunschirm, Sandra; Madeo, Frank] Graz Univ, Inst Mol Biosci, Graz, Austria; [Delay, Charlotte; Franssens, Vanessa; Bammens, Tine; Winderickx, Joris] Katholieke Univ Leuven, B-3001 Heverlee, Belgium; [Delay, Charlotte; Buee, Luc; Galas, Marie-Christine] INSERM, U837, F-59045 Lille, France; [Delay, Charlotte; Buee, Luc; Galas, Marie-Christine] Univ Lille Nord France, Jean Pierre Aubert Res Ctr, Lille, France; [Delay, Charlotte; Buee, Luc; Galas, Marie-Christine] Univ Lille 2, Fac Med Pole Rech, Lille, France; [Delay, Charlotte; Buee, Luc; Galas, Marie-Christine] CHU Lille, F-59037 Lille, France; [de Oliveira, Rita Machado; Outeiro, Tiago Fleming] Inst Mol Med, Cell & Mol Neurosci Unit, Lisbon, Portugal; [de Oliveira, Rita Machado; Outeiro, Tiago Fleming] Univ Lisbon, Inst Fisiol, P-1699 Lisbon, Portugal	University of Graz; KU Leuven; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universidade de Lisboa; Universidade de Lisboa	Buttner, S (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.	joris.winderickx@bio.kuleuven.be	de Oliveira, Rita M/E-9696-2015; Outeiro, Tiago F/C-1067-2008; Outeiro, Tiago/L-7351-2019; Galas, Marie-Christine/AAL-9812-2020; Outeiro, Tiago/M-8106-2019; Delay, Charlotte/F-3139-2011; BUEE, Luc/B-3126-2010	de Oliveira, Rita M/0000-0002-0970-4501; Outeiro, Tiago F/0000-0003-1679-1727; Outeiro, Tiago/0000-0003-1679-1727; BUEE, Luc/0000-0002-6261-4230; Galas, Marie-Christine/0000-0002-3766-7103; Madeo, Frank/0000-0002-5070-1329; Buttner, Sabrina/0000-0002-2786-8542	IWT-Vlaanderen; K.U.Leuven BOF-IOF; K.U.Leuven RD; Egide (Partenariat Hubert Curien) in France; Flemish Ministry of Education; Flanders (FWO) in Belgium; EU-Marie Curie PhD Graduate School NEURAD; Austrian Science Fund FWF (Austria) [S-9304-B05, T-414-B09]; EMBO; IRG; Fundacao para a Ciencia e Tecnologia [PTDC/SAU-NEU/105215/2008]	IWT-Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); K.U.Leuven BOF-IOF; K.U.Leuven RD(KU Leuven); Egide (Partenariat Hubert Curien) in France; Flemish Ministry of Education; Flanders (FWO) in Belgium(FWO); EU-Marie Curie PhD Graduate School NEURAD; Austrian Science Fund FWF (Austria)(Austrian Science Fund (FWF)); EMBO(European Molecular Biology Organization (EMBO)); IRG; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by grants from IWT-Vlaanderen (SBO NEURO-TARGET), the K.U.Leuven Research Fund (K.U.Leuven BOF-IOF) and K.U.Leuven R&D to JW, a Tournesol grant from Egide (Partenariat Hubert Curien) in France in collaboration with the Flemish Ministry of Education and the Fund of Scientific Research of Flanders (FWO) in Belgium to JW, MCG and LB, a shared PhD fellowship of the EU-Marie Curie PhD Graduate School NEURAD to JW, MCG and LB, grants of the Austrian Science Fund FWF (Austria) to FM and DR (S-9304-B05), to FM and SB (LIPOTOX), and to SB (T-414-B09; Hertha-Firnberg Fellowship) and an EMBO Installation Grant, a Marie Curie IRG, and a grant of the Fundacao para a Ciencia e Tecnologia (PTDC/SAU-NEU/105215/2008) to TFO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IR, 2000, TRENDS CELL BIOL, V10, P329, DOI 10.1016/S0962-8924(00)01798-0; Ahn M, 2006, BIOCHEM BIOPH RES CO, V346, P1142, DOI 10.1016/j.bbrc.2006.05.213; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; BORNIG H, 1974, ACTA HISTOCHEM, V50, P110; Buttner S, 2008, J BIOL CHEM, V283, P7554, DOI 10.1074/jbc.M708477200; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chen QH, 2005, J BIOL CHEM, V280, P30009, DOI 10.1074/jbc.M501308200; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; Dixon C, 2005, GENETICS, V170, P47, DOI 10.1534/genetics.104.035493; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Eyal A, 2006, CELL CYCLE, V5, P2082, DOI 10.4161/cc.5.18.3209; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fei WH, 2009, BIOCHEM J, V424, P61, DOI 10.1042/BJ20090785; Fleming J, 2008, METHOD ENZYMOL, V439, P339, DOI 10.1016/S0076-6879(07)00425-9; Franssens V, 2010, CELL DEATH DIFFER, V17, P746, DOI 10.1038/cdd.2009.203; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; Inoue Y, 2010, SEMIN CELL DEV BIOL, V21, P664, DOI 10.1016/j.semcdb.2010.03.009; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Jin HG, 2008, NEUROSCI LETT, V445, P12, DOI 10.1016/j.neulet.2008.08.073; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kanki T, 2010, MOL MICROBIOL, V75, P795, DOI 10.1111/j.1365-2958.2009.07035.x; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; Kim TD, 2000, PROTEIN SCI, V9, P2489, DOI 10.1110/ps.9.12.2489; Kim TD, 2004, BIOCHEM BIOPH RES CO, V324, P1352, DOI 10.1016/j.bbrc.2004.09.208; Krenz A, 2009, J NEUROCHEM, V108, P139, DOI 10.1111/j.1471-4159.2008.05755.x; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Kruger R, 2004, CELL TISSUE RES, V318, P195, DOI 10.1007/s00441-004-0953-z; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lee G, 2004, J BIOL CHEM, V279, P6834, DOI 10.1074/jbc.M312760200; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842; Marx FP, 2003, HUM MOL GENET, V12, P1223, DOI 10.1093/hmg/ddg134; Marx FP, 2007, FASEB J, V21, P1759, DOI 10.1096/fj.06-6734com; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; Morselli E, 2010, AUTOPHAGY, V6, P186, DOI 10.4161/auto.6.1.10817; Murray IVJ, 2003, ACTA NEUROPATHOL, V105, P177, DOI 10.1007/s00401-002-0629-2; Myhre R, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-19; Neystat M, 2002, NEUROSCI LETT, V325, P119, DOI 10.1016/S0304-3940(02)00253-7; Nishie M, 2004, ACTA NEUROPATHOL, V107, P292, DOI 10.1007/s00401-003-0811-1; Nuber S, 2010, NEUROGENETICS, V11, P107, DOI 10.1007/s10048-009-0212-2; O'Farrell C, 2001, MOL BRAIN RES, V97, P94, DOI 10.1016/S0169-328X(01)00292-3; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Palermo LM, 1997, CURR GENET, V32, P93, DOI 10.1007/s002940050252; Ribeiro CS, 2002, J BIOL CHEM, V277, P23927, DOI 10.1074/jbc.M201115200; Ron D, 2004, J CELL BIOL, V167, P23, DOI 10.1083/jcb.200408117; Salminen A, 2009, CELL SIGNAL, V21, P1356, DOI 10.1016/j.cellsig.2009.02.014; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Smith WW, 2010, HUM MOL GENET, V19, P2087, DOI 10.1093/hmg/ddq086; SU LJ, 2009, DIS MODEL MECH; Takahashi M, 2003, NEUROSCI LETT, V336, P155, DOI 10.1016/S0304-3940(02)01258-2; Takahashi T, 2006, FEBS LETT, V580, P4479, DOI 10.1016/j.febslet.2006.07.019; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Tang BL, 2008, MOL ASPECTS MED, V29, P187, DOI 10.1016/j.mam.2007.02.001; Tofaris GK, 2007, CELL MOL LIFE SCI, V64, P2194, DOI 10.1007/s00018-007-7217-5; Vamvaca K, 2009, J MOL BIOL, V389, P413, DOI 10.1016/j.jmb.2009.03.021; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Wakamatsu M, 2007, J NEUROSCI RES, V85, P1819, DOI 10.1002/jnr.21310; Wang YS, 2009, J EUR ACAD DERMATOL, V23, P451, DOI 10.1111/j.1468-3083.2008.02895.x; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Winderickx J, 2008, BBA-MOL CELL RES, V1783, P1381, DOI 10.1016/j.bbamcr.2008.01.020; Wong ESP, 2008, HUM MOL GENET, V17, P2570, DOI 10.1093/hmg/ddn157; Xie Xiao-jin, 2010, Zhongguo Shuidao Kexue, V24, P196, DOI 10.3969/j.issn.1001-7216.2010.02.15; Zaarur N, 2008, J BIOL CHEM, V283, P27575, DOI 10.1074/jbc.M802216200; Zabrocki P, 2005, FEBS J, V272, P1386, DOI 10.1111/j.1742-4658.2005.04571.x; Zabrocki P, 2008, BBA-MOL CELL RES, V1783, P1767, DOI 10.1016/j.bbamcr.2008.06.010	80	32	33	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13700	10.1371/journal.pone.0013700	http://dx.doi.org/10.1371/journal.pone.0013700			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060871	Green Published, gold, Green Submitted			2022-12-25	WOS:000283537000059
J	Dunn, MR; Connell, AM; Forman, J; Stevens, DW; Horn, PL				Dunn, Matthew R.; Connell, Amelia M.; Forman, Jeff; Stevens, Darren W.; Horn, Peter L.			Diet of Two Large Sympatric Teleosts, the Ling (Genypterus blacodes) and Hake (Merluccius australis)	PLOS ONE			English	Article							NEW-ZEALAND; CHATHAM RISE; SUBTROPICAL FRONT; FEEDING-HABITS; FISH; COMMUNITIES; VARIABILITY; OPHIDIIDAE; EVOLUTION; BIOMASS	Ling and hake are tertiary consumers, and as a result both may have an important structuring role in marine communities. The diets of 2064 ling and 913 hake from Chatham Rise, New Zealand, were determined from examination of stomach contents. Ling was a benthic generalist, and hake a demersal piscivore. The diet of ling was characterised by benthic crustaceans, mainly Munida gracilis and Metanephrops challengeri, and demersal fishes, mainly Macrourids and scavenged offal from fishing vessels. The diet of hake was characterised by teleost fishes, mainly macrourids and merlucciids. Multivariate analyses using distance-based linear models found the most important predictors of diet variability were depth, fish length, and vessel type (whether the sample was collected from a commercial or research vessel) for ling, and fish length and vessel type for hake. There was no interspecific predation between ling and hake, and resource competition was largely restricted to macrourid prey, although the dominant macrourid species predated by ling and hake were different. Cluster analysis of average diet of intraspecific groups of ling and hake confirmed the persistent diet separation. Although size is a central factor in determining ecological processes, similar sized ling and hake had distinctly different foraging ecology, and therefore could influence the ecosystem in different ways, and be unequally affected by ecosystem fluctuations.	[Dunn, Matthew R.; Connell, Amelia M.; Forman, Jeff; Stevens, Darren W.; Horn, Peter L.] Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Dunn, MR (corresponding author), Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand.	m.dunn@niwa.co.nz		Horn, Peter/0000-0003-4163-5064	New Zealand Ministry of Fisheries [ZBD2004-02, ENV2007-06]; New Zealand Foundation for Research, Science and Technology [C01X0501]	New Zealand Ministry of Fisheries; New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology)	This work was part-funded by the New Zealand Ministry of Fisheries (http://www.mfish.govt.nz) projects ZBD2004-02 and ENV2007-06, and the New Zealand Foundation for Research, Science and Technology (http://www.frst.govt.nz/) project C01X0501 (Coasts & Oceans OBI, IO2). The New Zealand Ministry of Fisheries had a role in determining the availability of the samples and scope of the study, and allowing the research to be published, but had no role in the design and completion of the data collection and analysis, or preparation of the manuscript. The New Zealand Foundation for Research, Science and Technology had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Hernandez M., 1995, HAKE FISHERIES ECOLO, P305; Alonso MK, 2002, ENVIRON BIOL FISH, V63, P193; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson OF, 1998, 42 NIWA; Arkhipkin A, 2003, J FISH BIOL, V63, P428, DOI 10.1046/j.1095-8649.2003.00164.x; BEZZI SI, 1995, HAKE FISHERIES ECOLO, P239; BLABER SJM, 1987, MAR BIOL, V95, P345, DOI 10.1007/BF00409564; Bradford-Grieve JM, 1999, J PLANKTON RES, V21, P405, DOI 10.1093/plankt/21.3.405; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Bull B, 2001, NEW ZEAL J MAR FRESH, V35, P795, DOI 10.1080/00288330.2001.9517043; Bulman C, 2001, MAR FRESHWATER RES, V52, P537, DOI 10.1071/MF99152; CLARK MR, 1985, NEW ZEAL J MAR FRESH, V19, P339, DOI 10.1080/00288330.1985.9516100; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR., 2006, CHANGE MARINE COMMUN; COLMAN JA, 1995, HAKE BIOL FISHERIES, P365; CONNELL AM, NZ J MAR FR IN PRESS; Cortes E, 1997, CAN J FISH AQUAT SCI, V54, P726, DOI 10.1139/cjfas-54-3-726; DEVINE J, 2009, 200921 MIN FISH; Dunn MR, 2009, NEW ZEAL J MAR FRESH, V43, P1103, DOI 10.1080/00288330.2009.9626533; Dunn MR, 2010, DEEP-SEA RES PT I, V57, P923, DOI 10.1016/j.dsr.2010.02.006; Dunn MR, 2010, MAR ECOL PROG SER, V407, P209, DOI 10.3354/meps08580; Franca FMG, 2007, OPER DENT, V32, P217, DOI 10.2341/06-61; Groenewold S, 2000, ICES J MAR SCI, V57, P1395, DOI 10.1006/jmsc.2000.0914; Haedrich RL, 1996, J FISH BIOL, V49, P40, DOI 10.1111/j.1095-8649.1996.tb06066.x; HEATH RA, 1985, NEW ZEAL J MAR FRESH, V19, P79, DOI 10.1080/00288330.1985.9516077; Horn P. L., 2005, 200559 MIN FISH; HORN PL, 1993, NEW ZEAL J MAR FRESH, V27, P385, DOI 10.1080/00288330.1993.9516580; Horn PL, 1997, MAR FRESHWATER RES, V48, P201, DOI 10.1071/MF96091; HORN PL, 2010, 201014 MIN FISH; HORN PL, 2008, 200824 MIN FISH; HUNTER MD, 1992, ECOLOGY, V73, P724; JAKSIC FM, 1990, OECOLOGIA, V82, P87, DOI 10.1007/BF00318537; Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267; LIVINGSTON ME, 2002, 113 NIWA; MACKENZIE K, 1995, CAN J FISH AQUAT SCI, V52, P213, DOI 10.1139/f95-529; Mahe K, 2007, ICES J MAR SCI, V64, P1210, DOI 10.1093/icesjms/fsm100; McClatchie S, 2003, DEEP-SEA RES PT I, V50, P1263, DOI 10.1016/S0967-0637(03)00128-6; McKnight DG, 1997, NEW ZEAL J MAR FRESH, V31, P505, DOI 10.1080/00288330.1997.9516784; Ministry of Fisheries, 2010, REP FISH ASS PLEN MA; MITCHELL SJ, 1984, NEW ZEAL J MAR FRESH, V18, P265, DOI 10.1080/00288330.1984.9516048; Mittelbach GG, 1998, CAN J FISH AQUAT SCI, V55, P1454, DOI 10.1139/f98-041; Murphy RJ, 2001, NEW ZEAL J MAR FRESH, V35, P343, DOI 10.1080/00288330.2001.9517005; Nodder SD, 2003, DEEP-SEA RES PT I, V50, P959, DOI 10.1016/S0967-0637(03)00094-3; Nyegaard M, 2004, J FISH BIOL, V65, P666, DOI 10.1111/j.0022-1112.2004.00476.x; PAYA I, 1992, S AFR J MARINE SCI, V12, P753; Pinkas L, 1971, FISH B CALIF DEP FIS; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Probert PK, 1996, INT REV GES HYDROBIO, V81, P577, DOI 10.1002/iroh.19960810411; ROBERTSON DA, 1978, NEW ZEAL J MAR FRESH, V12, P295, DOI 10.1080/00288330.1978.9515757; Ryer CH, 2004, ICES J MAR SCI, V61, P1157, DOI 10.1016/j.icesjms.2004.06.004; Stevens DW, 2011, MAR BIOL, V158, P59, DOI 10.1007/s00227-010-1542-1; STEVENS DW, 2009, 200918 MIN FISH; STOWASSER G, 2009, DEEP-SEA RES PT 1, V56, P182; Sutton P, 2001, J GEOPHYS RES-OCEANS, V106, P31045, DOI 10.1029/2000JC000562; Tirasin EM, 1999, MAR ECOL PROG SER, V182, P243; Uddstrom MJ, 1999, J GEOPHYS RES-OCEANS, V104, P20729, DOI 10.1029/1999JC900167; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Yamamura O, 1997, J FISH BIOL, V50, P919, DOI 10.1111/j.1095-8649.1997.tb01618.x	58	23	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13647	10.1371/journal.pone.0013647	http://dx.doi.org/10.1371/journal.pone.0013647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048962	Green Submitted, Green Published, gold			2022-12-25	WOS:000283537000019
J	Roy, S; Tyagi, A; Shukla, V; Kumar, A; Singh, UM; Chaudhary, LB; Datt, B; Bag, SK; Singh, PK; Nair, NK; Husain, T; Tuli, R				Roy, Sribash; Tyagi, Antariksh; Shukla, Virendra; Kumar, Anil; Singh, Uma M.; Chaudhary, Lal Babu; Datt, Bhaskar; Bag, Sumit K.; Singh, Pradhyumna K.; Nair, Narayanan K.; Husain, Tariq; Tuli, Rakesh			Universal Plant DNA Barcode Loci May Not Work in Complex Groups: A Case Study with Indian Berberis Species	PLOS ONE			English	Article							LAND PLANTS; PHYLOGENETIC-RELATIONSHIPS; DIVERSITY; SEQUENCES; TAXONOMY; GENUS; AFLP; POPULATIONS; RBCL	Background: The concept of DNA barcoding for species identification has gained considerable momentum in animals because of fairly successful species identification using cytochrome oxidase I (COI). In plants, matK and rbcL have been proposed as standard barcodes. However, barcoding in complex genera is a challenging task. Methodology and Principal Findings: We investigated the species discriminatory power of four reportedly most promising plant DNA barcoding loci (one from nuclear genome-ITS, and three from plastid genome- trnH-psbA, rbcL and matK) in species of Indian Berberis L. (Berberidaceae) and two other genera, Ficus L. (Moraceae) and Gossypium L. (Malvaceae). Berberis species were delineated using morphological characters. These characters resulted in a well resolved species tree. Applying both nucleotide distance and nucleotide character-based approaches, we found that none of the loci, either singly or in combinations, could discriminate the species of Berberis. ITS resolved all the tested species of Ficus and Gossypium and trnH-psbA resolved 82% of the tested species in Ficus. The highly regarded matK and rbcL could not resolve all the species. Finally, we employed amplified fragment length polymorphism test in species of Berberis to determine their relationships. Using ten primer pair combinations in AFLP, the data demonstrated incomplete species resolution. Further, AFLP analysis showed that there was a tendency of the Berberis accessions to cluster according to their geographic origin rather than species affiliation. Conclusions/Significance: We reconfirm the earlier reports that the concept of universal barcode in plants may not work in a number of genera. Our results also suggest that the matK and rbcL, recommended as universal barcode loci for plants, may not work in all the genera of land plants. Morphological, geographical and molecular data analyses of Indian species of Berberis suggest probable reticulate evolution and thus barcode markers may not work in this case.	[Roy, Sribash; Tyagi, Antariksh; Shukla, Virendra; Kumar, Anil; Singh, Uma M.; Bag, Sumit K.; Singh, Pradhyumna K.; Tuli, Rakesh] CSIR, Natl Bot Res Inst, Dept Plant Mol Biol & Genet Engn, Lucknow, Uttar Pradesh, India; [Chaudhary, Lal Babu; Datt, Bhaskar; Nair, Narayanan K.; Husain, Tariq] CSIR, Natl Bot Res Inst, Dept Plant Biodivers & Conservat Biol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI)	Roy, S (corresponding author), CSIR, Natl Bot Res Inst, Dept Plant Mol Biol & Genet Engn, Lucknow, Uttar Pradesh, India.	rakeshtuli@hotmail.com	Bag, Sumit/AAP-5728-2020; Bag, Sumit K/B-4010-2013; TULI, RAKESH/AAD-3047-2021; Tyagi, Antariksh/F-4367-2015	Bag, Sumit/0000-0001-8907-2841; Bag, Sumit K/0000-0001-8907-2841; Tyagi, Antariksh/0000-0002-4662-077X	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Funding from Department of Biotechnology, Government of India is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla AM, 2001, THEOR APPL GENET, V102, P222, DOI 10.1007/s001220051639; AHRENDT LESLIE WALTER ALLAM, 1961, JOUR LINNEAN SOC LONDON BOT, V57, P1; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Blaxter M, 2003, NATURE, V421, P122, DOI 10.1038/421122a; Bottini MCJ, 2007, BOT J LINN SOC, V153, P321, DOI 10.1111/j.1095-8339.2007.00586.x; BOTTINI MCJ, 1999, 16 INT BOT C ST LOUI; Cervera MT, 2005, THEOR APPL GENET, V111, P1440, DOI 10.1007/s00122-005-0076-2; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; CORNER E. J. H., 1958, REINWARDTIA, V4, P325; CORNER E. J. H., 1965, GARD BULL [SINGAPORE], V21, P1; DeSaille R, 2007, BIOESSAYS, V29, P1289, DOI 10.1002/bies.20667; Dodd RS, 2003, THEOR APPL GENET, V107, P884, DOI 10.1007/s00122-003-1290-4; Edwards D, 2008, TAXON, V57, P1317, DOI 10.1002/tax.574021; ERSTS PJ, GEOGRAPHIC DISTANCE; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; GAO T, 2010, J ETHNOPHARMACOL; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; HAWKES JG, 1990, POTATO EVOLUTION BIO; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HOOKER F, 1888, FLORA BRIT INDIA, P494; Jobes DV, 1997, PLANT MOL BIOL REP, V15, P326, DOI 10.1023/A:1007462330699; Kelly RP, 2007, MOL ECOL NOTES, V7, P177, DOI 10.1111/j.1471-8286.2006.01641.x; Kim YD, 2004, J PLANT RES, V117, P175, DOI 10.1007/s10265-004-0145-7; KING G, 1888, ANN ROYAL BOT GARDEN, P1; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Landrum LR, 1999, ANN MO BOT GARD, V86, P793, DOI 10.2307/2666170; LUBELL JD, 2008, J HORT SCI BIOTECHNO, V83; Lubell JD, 2008, AM J BOT, V95, P700, DOI 10.3732/ajb.2007336; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miura F, 2005, BIOINFORMATICS, V21, P4363, DOI 10.1093/bioinformatics/bti716; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Onodera K, 2004, MOL CELL PROBE, V18, P369, DOI 10.1016/j.mcp.2004.05.007; ORSI MC, 1984, BERBERIDACEAE, P325; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; PURI GS, 1946, J INDIAN BOT SOC, V25, P177; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; RAO RR, 1998, RHEEDEA, V3, P109; Rohlfs Marko, 2005, Front Zool, V2, P2, DOI 10.1186/1742-9994-2-2; Ronsted N, 2008, MOL PHYLOGENET EVOL, V48, P12, DOI 10.1016/j.ympev.2008.04.005; Rubinoff D, 2006, TRENDS ECOL EVOL, V21, P1, DOI 10.1016/j.tree.2005.10.019; Schmidt-Lebuhn AN, 2007, BOT J LINN SOC, V153, P9, DOI 10.1111/j.1095-8339.2007.00588.x; Schmidt-Lebuhn AN, 2006, SYST BOT, V31, P547, DOI 10.1600/036364406778388629; SCHNEIDER CK, 1905, B HERB BOISSIER 2, V5, P33; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Singer GAC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S14; SINGH PB, 1986, INJURY, V17, P228, DOI 10.1016/0020-1383(86)90225-1; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; SPOONER DM, 2006, STRUCTURE BIOSYSTEMA, P1; SPOONER DM, 2009, MOL ECOL RESOUR, V9, P1177; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; STOREY WB, 1975, FIGS ADV FRUIT BREED, P568; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tautz D, 2002, NATURE, V418, P479, DOI 10.1038/418479a; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Weiblen GD, 2000, AM J BOT, V87, P1342, DOI 10.2307/2656726; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x	69	124	143	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13674	10.1371/journal.pone.0013674	http://dx.doi.org/10.1371/journal.pone.0013674			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060687	gold, Green Published, Green Submitted			2022-12-25	WOS:000283537000041
J	Zhang, J; Zhang, Y				Zhang, Jian; Zhang, Yang			A Novel Side-Chain Orientation Dependent Potential Derived from Random-Walk Reference State for Protein Fold Selection and Structure Prediction	PLOS ONE			English	Article							FORCE-FIELD; STATISTICAL POTENTIALS; TERTIARY STRUCTURES; MOLECULAR-DYNAMICS; SCORING FUNCTION; MEAN FORCE; MODEL; REFINEMENT	Background: An accurate potential function is essential to attack protein folding and structure prediction problems. The key to developing efficient knowledge-based potential functions is to design reference states that can appropriately counteract generic interactions. The reference states of many knowledge-based distance-dependent atomic potential functions were derived from non-interacting particles such as ideal gas, however, which ignored the inherent sequence connectivity and entropic elasticity of proteins. Methodology: We developed a new pair-wise distance-dependent, atomic statistical potential function (RW), using an ideal random-walk chain as reference state, which was optimized on CASP models and then benchmarked on nine structural decoy sets. Second, we incorporated a new side-chain orientation-dependent energy term into RW (RWplus) and found that the side-chain packing orientation specificity can further improve the decoy recognition ability of the statistical potential. Significance: RW and RWplus demonstrate a significantly better ability than the best performing pair-wise distance-dependent atomic potential functions in both native and near-native model selections. It has higher energy-RMSD and energy TM-score correlations compared with other potentials of the same type in real-life structure assembly decoys. When benchmarked with a comprehensive list of publicly available potentials, RW and RWplus shows comparable performance to the state-of-the-art scoring functions, including those combining terms from multiple resources. These data demonstrate the usefulness of random-walk chain as reference states which correctly account for sequence connectivity and entropic elasticity of proteins. It shows potential usefulness in structure recognition and protein folding simulations. The RW and RWplus potentials, as well as the newly generated I-TASSER decoys, are freely available in http://zhanglab.ccmb.med.umich.edu/RW.	[Zhang, Jian; Zhang, Yang] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Zhang, J (corresponding author), Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	zhng@umich.edu	YZ, YZ/B-3243-2011; zhang, jian/B-9296-2011		Alfred P. Sloan Foundation; National Science Foundation [DBI 1027394]; National Institute of General Medical Sciences [GM083107, GM084222]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083107, R01GM084222] Funding Source: NIH RePORTER	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project is supported in part by the Alfred P. Sloan Foundation, National Science Foundation Career Award (DBI 1027394), and the National Institute of General Medical Sciences (GM083107, GM084222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-71; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bronshtein IN, 2003, HDB MATH; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen JH, 2007, PROTEINS, V67, P922, DOI 10.1002/prot.21345; Cheng J, 2007, BIOPHYS J, V92, P3868, DOI 10.1529/biophysj.106.102152; Das R, 2007, PROTEINS, V69, P118, DOI 10.1002/prot.21636; Doi M., 1986, THEORY POLYM DYNAMIC, V1st ed.; Fitzgerald JE, 2007, PROTEIN SCI, V16, P2123, DOI 10.1110/ps.072939707; FOGOLARI F, 2007, BMC STRUCTURAL BIOL, V7; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; John B, 2003, NUCLEIC ACIDS RES, V31, P3982, DOI 10.1093/nar/gkg460; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Kolinski A, 1999, PROTEINS, V37, P592, DOI 10.1002/(SICI)1097-0134(19991201)37:4<592::AID-PROT10>3.3.CO;2-U; Lee MR, 2001, J MOL BIOL, V313, P417, DOI 10.1006/jmbi.2001.5032; Li YQ, 2009, PROTEINS, V76, P665, DOI 10.1002/prot.22380; Lu H, 2001, PROTEINS, V44, P223, DOI 10.1002/prot.1087; Lu MY, 2008, J MOL BIOL, V376, P288, DOI 10.1016/j.jmb.2007.11.033; Ma JP, 2009, ACCOUNTS CHEM RES, V42, P1087, DOI 10.1021/ar900009e; Makino Y, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-46; Moult J, 2007, PROTEINS, V69, P3, DOI 10.1002/prot.21767; Moult J, 2009, PROTEINS, V77, P1, DOI 10.1002/prot.22589; Mukherjee A, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1940058; Panchenko AR, 2000, J MOL BIOL, V296, P1319, DOI 10.1006/jmbi.2000.3541; Park B, 1996, J MOL BIOL, V258, P367, DOI 10.1006/jmbi.1996.0256; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Rajgaria R, 2006, PROTEINS, V65, P726, DOI 10.1002/prot.21149; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1998, PHYS REV LETT, V81, P4764, DOI 10.1103/PhysRevLett.81.4764; Rykunov D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-128; Samudrala R, 2000, PROTEIN SCI, V9, P1399, DOI 10.1110/ps.9.7.1399; Samudrala R, 1998, J MOL BIOL, V275, P895, DOI 10.1006/jmbi.1997.1479; Schuler LD, 2001, J COMPUT CHEM, V22, P1205, DOI 10.1002/jcc.1078; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; Skolnick J, 2006, CURR OPIN STRUC BIOL, V16, P166, DOI 10.1016/j.sbi.2006.02.004; Skolnick J, 2000, PROTEINS, V38, P3, DOI 10.1002/(SICI)1097-0134(20000101)38:1<3::AID-PROT2>3.0.CO;2-S; Tobi D, 2000, PROTEINS, V40, P71, DOI 10.1002/(SICI)1097-0134(20000701)40:1<71::AID-PROT90>3.0.CO;2-3; Tobi D, 2000, PROTEINS, V41, P40, DOI 10.1002/1097-0134(20001001)41:1<40::AID-PROT70>3.0.CO;2-U; WANG G, 2002, BIOPOLYMERS UNPUB; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Xia Y, 2000, J MOL BIOL, V300, P171, DOI 10.1006/jmbi.2000.3835; XU JR, 2010, BIOINFORMAT IN PRESS; XU JR, 2010, BIOINFORMATICS; Yang CY, 2006, J MED CHEM, V49, P5903, DOI 10.1021/jm050043w; Yang YD, 2008, PROTEIN SCI, V17, P1212, DOI 10.1110/ps.033480.107; Zhang C, 1997, J MOL BIOL, V267, P707, DOI 10.1006/jmbi.1996.0859; Zhang Y, 2004, P NATL ACAD SCI USA, V101, P7594, DOI 10.1073/pnas.0305695101; Zhang Y, 2004, J COMPUT CHEM, V25, P865, DOI 10.1002/jcc.20011; Zhang Y, 2003, BIOPHYS J, V85, P1145, DOI 10.1016/S0006-3495(03)74551-2; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2001, BIOPHYS J, V81, P1133, DOI 10.1016/S0006-3495(01)75770-0; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zhang Y, 2009, CURR OPIN STRUC BIOL, V19, P145, DOI 10.1016/j.sbi.2009.02.005; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	61	155	157	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e15386	10.1371/journal.pone.0015386	http://dx.doi.org/10.1371/journal.pone.0015386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060880	gold, Green Published, Green Submitted			2022-12-25	WOS:000283537000063
J	Zughaier, SM; Svoboda, P; Pohl, J; Stephens, DS; Shafer, WM				Zughaier, Susu M.; Svoboda, Pavel; Pohl, Jan; Stephens, David S.; Shafer, William M.			The Human Host Defense Peptide LL-37 Interacts with Neisseria meningitidis Capsular Polysaccharides and Inhibits Inflammatory Mediators Release	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; ANTIMICROBIAL PEPTIDE; LIPOOLIGOSACCHARIDE STRUCTURE; ACTIN BUNDLES; INNATE; SUSCEPTIBILITY; RECOGNITION; GONORRHOEAE; CONTRIBUTE; RESISTANCE	Capsular polysaccharides (CPS) are a major virulence factor in meningococcal infections and form the basis for serogroup designation and protective vaccines. Our work has identified meningococcal CPS as a pro-inflammatory ligand that functions through TLR2 and TLR4-MD2-dependent activation. We hypothesized that human cationic host defense peptides interact with CPS and influence its biologic activity. Accordingly, the interaction of meningococcal CPS with the human-derived cationic peptide LL-37, which is expressed by phagocytic and epithelial cells that interface with meningococci during infection, was investigated. LL-37 neutralized the pro-inflammatory activity of endotoxin-free CPS as assessed by TLR2 and TLR4-MD-2-dependent release of TNF alpha, IL-6 and IL-8 from human and murine macrophages. The cationic and hydrophobic properties of LL-37 were crucial for this inhibition, which was due to binding of LL-37 to CPS. LL-37 also inhibited the ability of meningococcal CPS to induce nitric oxide release, as well as TNF alpha and CXCL10 (IP-10) release from TLR4-sufficient and TLR4-deficient murine macrophages. Truncated LL-37 analogs, especially those that retained the antibacterial domain, inhibited vaccine grade CPS and meningococcal CPS prepared from the major serogroups (A, B C, Y and W135). Thus, LL-37 interaction with CPS was independent of specific glucan structure. We conclude that the capacity of meningococcal CPS to activate macrophages via TLR2 and TLR4-MD-2 can be inhibited by the human cationic host defense peptide LL-37 and propose that this impacts CPS-based vaccine responses.	[Zughaier, Susu M.; Stephens, David S.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Zughaier, Susu M.; Svoboda, Pavel; Pohl, Jan; Stephens, David S.; Shafer, William M.] Labs Microbial Pathogenesis, Atlanta, GA USA; [Svoboda, Pavel; Pohl, Jan] Emory Univ, Sch Med, Microchem & Prote Facil, Atlanta, GA USA; [Stephens, David S.; Shafer, William M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Stephens, David S.; Shafer, William M.] Dept Vet Affairs Med Ctr, Atlanta, GA USA	Emory University; Emory University; Emory University	Zughaier, SM (corresponding author), Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.	szughai@emory.edu	Zughaier, Susu/GLQ-9288-2022; Stephens, David S/A-8788-2012; Zughaier, Susu/N-3185-2019	Zughaier, Susu/0000-0001-7487-8770	Georgia Research Alliance (GRA); National Institutes of Health (NIH) [R01 AI033517, R01 AI062755, S10RR022440]; VA Medical Research Services; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062755, R01AI033517] Funding Source: NIH RePORTER	Georgia Research Alliance (GRA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Medical Research Services; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant to Susu M. Zughaier from the Georgia Research Alliance (GRA), and National Institutes of Health (NIH) grants R01 AI033517 to David S. Stephens, R01 AI062755 to William M. Shafer, and S10RR022440 to Jan Pohl. William M. Shafer is the recipient of a Senior Research Career Scientist Award from the VA Medical Research Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Bucki R, 2007, EUR RESPIR J, V29, P624, DOI 10.1183/09031936.00080806; Castellheim A, 2009, SCAND J IMMUNOL, V69, P479, DOI 10.1111/j.1365-3083.2009.02255.x; Chennupati SK, 2009, AM J RHINOL ALLERGY, V23, P46, DOI 10.2500/ajra.2009.23.3261; Choudhury B, 2008, CARBOHYD RES, V343, P2971, DOI 10.1016/j.carres.2008.08.026; Cox DL, 2003, PEPTIDES, V24, P1741, DOI 10.1016/j.peptides.2003.07.026; Foschiatti M, 2009, MOL MICROBIOL, V72, P1137, DOI 10.1111/j.1365-2958.2009.06707.x; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Graveline R, 2007, INT IMMUNOL, V19, P375, DOI 10.1093/intimm/dxm003; Gudlavalleti SK, 2004, J BIOL CHEM, V279, P42765, DOI 10.1074/jbc.M313552200; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Hurtado P, 2010, J IMMUNOL, V184, P1425, DOI 10.4049/jimmunol.0902305; Jones A, 2009, J BACTERIOL, V191, P3861, DOI 10.1128/JB.01313-08; Kahler CM, 1998, INFECT IMMUN, V66, P5939, DOI 10.1128/IAI.66.12.5939-5947.1998; Kai-Larsen Y, 2007, PEDIATR RES, V61, P530, DOI 10.1203/pdr.0b013e318045be83; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; MELLY MA, 1979, J INFECT DIS, V140, P605, DOI 10.1093/infdis/140.4.605; Moal VLL, 2006, CLIN MICROBIOL REV, V19, P315, DOI 10.1128/CMR.19.2.315-337.2006; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; Rehaume LM, 2008, CRIT REV IMMUNOL, V28, P185, DOI 10.1615/CritRevImmunol.v28.i3.10; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Sandgren S, 2004, J BIOL CHEM, V279, P17951, DOI 10.1074/jbc.M311440200; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; Spinosa MR, 2007, INFECT IMMUN, V75, P3594, DOI 10.1128/IAI.01945-06; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271; Tzeng YL, 2005, J BACTERIOL, V187, P5387, DOI 10.1128/JB.187.15.5387-5396.2005; Tzeng YL, 2005, INFECT IMMUN, V73, P1491, DOI 10.1128/IAI.73.3.1491-1505.2005; Wang Q, 2006, J EXP MED, V203, P2853, DOI 10.1084/jem.20062008; Weiner DJ, 2003, AM J RESP CELL MOL, V28, P738, DOI 10.1165/rcmb.2002-0191OC; Zughaier SM, 2005, CELL MICROBIOL, V7, P1251, DOI 10.1111/j.1462-5822.2005.00549.x; Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004	34	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13627	10.1371/journal.pone.0013627	http://dx.doi.org/10.1371/journal.pone.0013627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049021	Green Published, Green Submitted, gold			2022-12-25	WOS:000283487400018
J	Colak, R; Moser, F; Chu, JSC; Schonhuth, A; Chen, NS; Ester, M				Colak, Recep; Moser, Flavia; Chu, Jeffrey Shih-Chieh; Schoenhuth, Alexander; Chen, Nansheng; Ester, Martin			Module Discovery by Exhaustive Search for Densely Connected, Co-Expressed Regions in Biomolecular Interaction Networks	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEIN COMPLEXES; BETA-CATENIN; MEDIATED TRANSCRIPTION; HIR PROTEINS; HISTONE H3; YEAST; HETEROCHROMATIN; IDENTIFICATION; CHROMATIN	Background: Computational prediction of functionally related groups of genes (functional modules) from large-scale data is an important issue in computational biology. Gene expression experiments and interaction networks are well studied largescale data sources, available for many not yet exhaustively annotated organisms. It has been well established, when analyzing these two data sources jointly, modules are often reflected by highly interconnected (dense) regions in the interaction networks whose participating genes are co-expressed. However, the tractability of the problem had remained unclear and methods by which to exhaustively search for such constellations had not been presented. Methodology/Principal Findings: We provide an algorithmic framework, referred to as Densely Connected Biclustering (DECOB), by which the aforementioned search problem becomes tractable. To benchmark the predictive power inherent to the approach, we computed all co-expressed, dense regions in physical protein and genetic interaction networks from human and yeast. An automatized filtering procedure reduces our output which results in smaller collections of modules, comparable to state-of-the-art approaches. Our results performed favorably in a fair benchmarking competition which adheres to standard criteria. We demonstrate the usefulness of an exhaustive module search, by using the unreduced output to more quickly perform GO term related function prediction tasks. We point out the advantages of our exhaustive output by predicting functional relationships using two examples. Conclusion/Significance: We demonstrate that the computation of all densely connected and co-expressed regions in interaction networks is an approach to module discovery of considerable value. Beyond confirming the well settled hypothesis that such co-expressed, densely connected interaction network regions reflect functional modules, we open up novel computational ways to comprehensively analyze the modular organization of an organism based on prevalent and largely available large-scale datasets.	[Colak, Recep; Ester, Martin] Simon Fraser Univ, Sch Comp Sci, Burnaby, BC V5A 1S6, Canada; [Moser, Flavia] Univ British Columbia, Ctr Dis Control, Burnaby, BC, Canada; [Chu, Jeffrey Shih-Chieh; Chen, Nansheng] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Schoenhuth, Alexander] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA	Simon Fraser University; University of British Columbia; Simon Fraser University; University of California System; University of California Berkeley	Colak, R (corresponding author), Simon Fraser Univ, Sch Comp Sci, Burnaby, BC V5A 1S6, Canada.	ester@cs.sfu.ca	Chen, Nansheng/E-6450-2012		Canadian Institute for Health Research (CIHR) /Michael Smith Foundation for Health Research (MSFHR); Simon Fraser University Community; Pacific Institute for the Mathematical Sciences (PIMS); National Sciences and Engineering Research Council (NSERC); Michael Smith Foundation for Health Research (MSFHR)	Canadian Institute for Health Research (CIHR) /Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health ResearchCanadian Institutes of Health Research (CIHR)); Simon Fraser University Community; Pacific Institute for the Mathematical Sciences (PIMS); National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	RC was funded by the Canadian Institute for Health Research (CIHR) /Michael Smith Foundation for Health Research (MSFHR) Bioinformatics Training Program for Health Research. RC, AS, ME and NC are members of the Bioinformatics for Combating Infectious Diseases (BCID) project, which is funded by the Simon Fraser University Community Trust Endowment Fund. AS is also funded by a postdoctoral stipend from the Pacific Institute for the Mathematical Sciences (PIMS). ME and NC are supported in part by a National Sciences and Engineering Research Council (NSERC) Discovery grant. NC is also a Michael Smith Foundation for Health Research (MSFHR) scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Alon N, 2008, BIOINFORMATICS, V24, pI241, DOI 10.1093/bioinformatics/btn163; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Ben-Dor A, 2003, J COMPUT BIOL, V10, P373, DOI 10.1089/10665270360688075; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Botstein D, 1997, SCIENCE, V277, P1259, DOI 10.1126/science.277.5330.1259; Bouck DC, 2008, ANNU REV GENET, V42, P335, DOI 10.1146/annurev.genet.42.110807.091620; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Caspi M, 2008, ONCOGENE, V27, P3546, DOI 10.1038/sj.onc.1211026; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; CHENG Y, 2000, ISMB, V8, P93; COLAK R, 2008, THESIS SIMON FRASER; Crasta K, 2008, NAT CELL BIOL, V10, P665, DOI 10.1038/ncb1729; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Gasch AP, 2002, GENOME BIOL, V3; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Georgii E, 2009, BIOINFORMATICS, V25, P933, DOI 10.1093/bioinformatics/btp080; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grigoriev A, 2001, NUCLEIC ACIDS RES, V29, P3513, DOI 10.1093/nar/29.17.3513; GROCHOW J, 2008, P RECOMB 92; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hanisch D., 2002, BIOINFORMATICS, V18, pS145, DOI [10.1093/bioinformatics/18.suppl_1.S145, DOI 10.1093/BI0INF0RMATICS/18.SUPPL_]; Hu HY, 2005, BIOINFORMATICS, V21, pI213, DOI 10.1093/bioinformatics/bti1049; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Karp R.M., 1972, PROC S COMPLEXITY CO, P85, DOI 10.1007/978-1-4684-2001-2_9.; King AD, 2004, BIOINFORMATICS, V20, P3013, DOI 10.1093/bioinformatics/bth351; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Koyuturk M, 2007, J COMPUT BIOL, V14, P747, DOI 10.1089/cmb.2007.R014; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Leung HCM, 2009, J COMPUT BIOL, V16, P133, DOI 10.1089/cmb.2008.01TT; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Mendez P, 2006, ENDOCRINOLOGY, V147, P3027, DOI 10.1210/en.2005-1224; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MOSER F, 2009, P 2009 SIAM INT C DA, P593; Pebernard S, 2004, MOL BIOL CELL, V15, P4866, DOI 10.1091/mbc.E04-05-0436; Pebernard S, 2008, EMBO J, V27, P3011, DOI 10.1038/emboj.2008.220; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Schliep A, 2005, IEEE ACM T COMPUT BI, V2, P179, DOI 10.1109/TCBB.2005.31; Schliep A, 2004, BIOINFORMATICS, V20, P283, DOI 10.1093/bioinformatics/bth937; Segal E, 2003, BIOINFORMATICS, V19, pi264, DOI 10.1093/bioinformatics/btg1037; Sharan R, 2005, J COMPUT BIOL, V12, P835, DOI 10.1089/cmb.2005.12.835; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Sharp JA, 2002, GENE DEV, V16, P85, DOI 10.1101/gad.925302; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Singer MS, 1998, GENETICS, V150, P613; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Talukder AH, 2003, J BIOL CHEM, V278, P11676, DOI 10.1074/jbc.M209570200; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Ulitsky I, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-8; Ulitsky I, 2009, BIOINFORMATICS, V25, P1158, DOI 10.1093/bioinformatics/btp118; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Yan XF, 2007, BIOINFORMATICS, V23, pI577, DOI 10.1093/bioinformatics/btm227; Yang B, 2008, MOL BIOL CELL, V19, P4993, DOI 10.1091/mbc.E08-05-0524; Zappulla DC, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-40; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	69	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13348	10.1371/journal.pone.0013348	http://dx.doi.org/10.1371/journal.pone.0013348			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049092	Green Submitted, Green Published, gold			2022-12-25	WOS:000283422100002
J	Lin, DD; Liu, CL; Xue, MX; Liu, RY; Jiang, L; Yu, XA; Bao, GM; Deng, F; Yu, MJ; Ao, JF; Zhou, YF; Wu, DP; Liu, HY				Lin, Dandan; Liu, Chunliang; Xue, Mengxing; Liu, Rengyun; Jiang, Lan; Yu, Xiao; Bao, Guangming; Deng, Fang; Yu, Mingjie; Ao, Jiafu; Zhou, Yifeng; Wu, Depei; Liu, Haiyan			The Role of Interleukin-15 Polymorphisms in Adult Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							LYMPHOID HOMEOSTASIS; RECEPTOR; IL-15; EXPRESSION; BIOLOGY; CELLS; STRATEGIES; CHILDREN; THERAPY; DISEASE	Background: Interleukin-15 (IL-15) plays important roles in the immune system and in the development of hematopoietic cells. Previous studies revealed that five SNPs in IL-15, rs10519612, rs10519613, rs35964658, rs17007695 and rs17015014, were significantly associated with childhood Acute Lymphoblastic Leukemia (ALL) treatment response. In adult ALL, the expression of IL-15 was also correlated with the immunophenotypes of ALL. Therefore, we hypothesize that SNPs of IL-15 might also be associated with adult ALL. Methods and Findings: We genotyped the above five SNPs of IL-15 gene by PCR-RFLP assays in adult ALL case-control studies. The current study included 121 adult ALL patients and 263 healthy controls. IL-15 genotypes and haplotypes were determined and the associations with the risk of ALL were analyzed by logistic regression. SNPs rs10519612 and rs17007695 were significantly associated with ALL (P = 0.013 and P = 0.001). We observed a 2-fold and 2.4-fold excess risk of developing ALL for the rs10519612 CC and rs17007695 TC genotype carriers compared with non-carriers, respectively. Haplotype analysis revealed that haplotypes ACAC, CAGT and CCAT were significantly associated with adult B-ALL, while haplotype CCAT conferred susceptibility to T-ALL. Conclusion: These findings suggest that IL-15 gene polymorphisms are significantly associated with ALL in adult Chinese population.	[Lin, Dandan; Xue, Mengxing; Jiang, Lan; Yu, Xiao; Bao, Guangming; Zhou, Yifeng; Wu, Depei; Liu, Haiyan] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Cyrus Tang Hematol Ctr,Dept Hematol,Lab Cellular, Suzhou, Peoples R China; [Lin, Dandan; Xue, Mengxing; Wu, Depei; Liu, Haiyan] Soochow Univ, Minist Hlth, Thrombosis & Hemostasis Key Lab, Suzhou, Peoples R China; [Liu, Chunliang] Soochow Univ, Coll Med, Dept Biochem & Mol Biol, Suzhou, Peoples R China; [Liu, Rengyun] Soochow Univ, Coll Med, Lab Canc Mol Genet, Suzhou, Jiangsu, Peoples R China; [Deng, Fang; Yu, Mingjie; Ao, Jiafu] Peoples Hosp Bozhou, Bozhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Lin, DD (corresponding author), Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Cyrus Tang Hematol Ctr,Dept Hematol,Lab Cellular, Suzhou, Peoples R China.	wudepei@medmail.com.cn; hliu@suda.edu.cn	Lin, Dandan/GRJ-2233-2022; Liu, Haiyan/ABD-8689-2021; Liu, Reng-Yun/C-4437-2011; Liu, Rengyun/O-4039-2018	Liu, Haiyan/0000-0002-4652-469X; Liu, Rengyun/0000-0002-1408-2372	Key Laboratory of Suzhou City; Soochow University	Key Laboratory of Suzhou City; Soochow University	This work has been supported by funds from the Key Laboratory of Suzhou City, startup funds and the Key Project in Science & Technology Cultivation Program from Soochow University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE RJ, 1995, J IMMUNOL, V154, P483; Bassan R, 2004, CRIT REV ONCOL HEMAT, V50, P223, DOI 10.1016/j.critrevonc.2003.11.003; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; Berman E, 2000, CURR OPIN HEMATOL, V7, P205, DOI 10.1097/00062752-200007000-00002; Blaser BW, 2005, BLOOD, V105, P894, DOI 10.1182/blood-2004-05-1687; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Bulfone-Paus S, 2006, BIOESSAYS, V28, P362, DOI 10.1002/bies.20380; Cario G, 2007, J CLIN ONCOL, V25, P4813, DOI 10.1200/JCO.2007.11.8166; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Faderl S, 2010, CANCER-AM CANCER SOC, V116, P1165, DOI 10.1002/cncr.24862; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Giron-Michel J, 2005, BLOOD, V106, P2302, DOI 10.1182/blood-2005-01-0064; Goldberg JM, 2003, J CLIN ONCOL, V21, P3616, DOI 10.1200/JCO.2003.10.116; GOLDSTONE AH, 2009, TRANSPLANTATION ADUL, P593; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; HOELZER D, 1992, LEUKEMIA, V6, P49; Hoelzer D, 2000, CRIT REV ONCOL HEMAT, V36, P49, DOI 10.1016/S1040-8428(00)00097-4; Irving JAE, 2005, CANCER RES, V65, P3053, DOI 10.1158/0008-5472.CAN-04-2604; Klebanoff CA, 2004, P NATL ACAD SCI USA, V101, P1969, DOI 10.1073/pnas.0307298101; KLUMPER E, 1995, BLOOD, V86, P3861, DOI 10.1182/blood.V86.10.3861.bloodjournal86103861; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Lodolce JP, 2002, CYTOKINE GROWTH F R, V13, P429, DOI 10.1016/S1359-6101(02)00029-1; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Maloney KW, 1999, BLOOD, V93, P2380, DOI 10.1182/blood.V93.7.2380.407k27_2380_2385; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; RAIMONDI SC, 1993, BLOOD, V82, P576; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Tinhofer I, 2000, BLOOD, V95, P610, DOI 10.1182/blood.V95.2.610; Trentin L, 1996, BLOOD, V87, P3327, DOI 10.1182/blood.V87.8.3327.bloodjournal8783327; VanBuskirk AM, 1997, JAMA-J AM MED ASSOC, V278, P1993, DOI 10.1001/jama.278.22.1993; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wu SL, 2010, CANCER, V116, P387, DOI 10.1002/cncr.24729; Yajima T, 2006, J IMMUNOL, V176, P507, DOI 10.4049/jimmunol.176.1.507; Yang JJ, 2009, JAMA-J AM MED ASSOC, V301, P393, DOI 10.1001/jama.2009.7; Zhang XJ, 2007, J INVEST DERMATOL, V127, P2544, DOI 10.1038/sj.jid.5700896	38	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13626	10.1371/journal.pone.0013626	http://dx.doi.org/10.1371/journal.pone.0013626			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049047	gold, Green Submitted, Green Published			2022-12-25	WOS:000283422100022
J	Unge, C; Sodergard, B; Marrone, G; Thorson, A; Lukhwaro, A; Carter, J; Ilako, F; Ekstrom, AM				Unge, Christian; Sodergard, Bjorn; Marrone, Gaetano; Thorson, Anna; Lukhwaro, Abigael; Carter, Jane; Ilako, Festus; Ekstrom, Anna Mia			Long-Term Adherence to Antiretroviral Treatment and Program Drop-Out in a High-Risk Urban Setting in Sub-Saharan Africa: A Prospective Cohort Study	PLOS ONE			English	Article							SELF-REPORTED ADHERENCE; FOLLOW-UP; PATIENTS LOST; INHIBITOR THERAPY; HIV-1 INFECTION; ART ADHERENCE; HEALTH-CARE; BASE-LINE; PROTEASE; OUTCOMES	Background: Seventy percent of urban populations in sub-Saharan Africa live in slums. Sustaining HIV patients in these high-risk and highly mobile settings is a major future challenge. This study seeks to assess program retention and to find determinants for low adherence to antiretroviral treatment (ART) and drop-out from an established HIV/ART program in Kibera, Nairobi, one of Africa's largest informal urban settlements. Methods and Findings: A prospective open cohort study of 800 patients was performed at the African Medical Research Foundation (AMREF) clinic in the Kibera slum. Adherence to ART and drop-out from the ART program were independent outcomes. Two different adherence measures were used: (1) "dose adherence" (the proportion of a prescribed dose taken over the past 4 days) and (2) "adherence index" (based on three adherence questions covering dosing, timing and special instructions). Drop-out from the program was calculated based on clinic appointment dates and number of prescribed doses, and a patient was defined as being lost to follow-up if over 90 days had expired since the last prescribed dose. More than one third of patients were non-adherent when all three aspects of adherence - dosing, timing and special instructions - were taken into account. Multivariate logistic regression revealed that not disclosing HIV status, having a low level of education, living below the poverty limit (US$ 2/day) and not having a treatment buddy were significant predictors for non-adherence. Additionally, one quarter of patients dropped out for more than 90 days after the last prescribed ART dose. Not having a treatment buddy was associated with increased risk for drop-out (hazard ratio 1.4, 95% CI = 1.0-1.9). Conclusion: These findings point to the dilemma of trying to sustain a growing number of people on life-long ART in conditions where prevailing stigma, poverty and food shortages threatens the long-term success of HIV treatment.	[Unge, Christian; Sodergard, Bjorn; Marrone, Gaetano; Thorson, Anna; Ekstrom, Anna Mia] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden; [Lukhwaro, Abigael; Carter, Jane; Ilako, Festus] African Med & Res Fdn, Kenya Country Program, Nairobi, Kenya	Karolinska Institutet; African Medical & Research Foundation (AMREF)	Unge, C (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden.	christianunge@gmail.com		Marrone, Gaetano/0000-0002-2991-1663; Thorson, Anna/0000-0002-8703-6561; Sodergard, Bjorn/0000-0002-7841-3396				Amberbir A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-265; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; BANGSBERG DR, ANN INT MED, V152; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Carrieri P, 2001, J ACQ IMMUN DEF SYND, V28, P232, DOI 10.1097/00042560-200111010-00005; CHALKER J, J ACQUIR IMMUNE DEFI, V53, P159; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Diabate S, 2007, AIDS, V21, P1799, DOI 10.1097/QAD.0b013e3282a5667b; Duong M, 2001, CLIN INFECT DIS, V33, P386, DOI 10.1086/321876; Flexner C, 1998, NEW ENGL J MED, V338, P1281, DOI 10.1056/NEJM199804303381808; Frick PA, 2001, INT J STD AIDS, V12, P329, DOI 10.1258/0956462011923048; GENG EH, 2009, J ACQ IMMUN DEF SYND, V53, P405; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Kyobutungi Catherine, 2008, Popul Health Metr, V6, P1, DOI 10.1186/1478-7954-6-1; Laurent C, 2005, CLIN INFECT DIS, V41, P108, DOI 10.1086/430712; Liu HH, 2001, ANN INTERN MED, V134, P968, DOI 10.7326/0003-4819-134-10-200105150-00011; Magadi MA, 2003, POP STUD-J DEMOG, V57, P347, DOI 10.1080/0032472032000137853; Mannheimer SB, 2006, AIDS CARE, V18, P853, DOI 10.1080/09540120500465160; Massaquoi M, 2009, T ROY SOC TROP MED H, V103, P594, DOI 10.1016/j.trstmh.2009.02.012; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Muhamadi L, 2010, HEALTH POLICY, V97, P187, DOI 10.1016/j.healthpol.2010.06.003; NACHEGA JB, ANN INT MED, V152, P18; Nieuwkerk PT, 2005, JAIDS-J ACQ IMM DEF, V38, P445, DOI 10.1097/01.qai.0000147522.34369.12; Nieuwkerk PT, 2001, ARCH INTERN MED, V161, P1962, DOI 10.1001/archinte.161.16.1962; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Panel on antiretroviral guidelines for adults and adolescents, 2009, GUID US ANT AG HIV 1, P1; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Schonnesson LN, 2006, AIDS CARE, V18, P246, DOI 10.1080/09540120500456631; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; Singh N, 1999, CLIN INFECT DIS, V29, P824, DOI 10.1086/520443; Taffa Negussie, 2003, Int J Adolesc Med Health, V15, P321; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; Unge C, 2008, AIDS CARE, V20, P146, DOI 10.1080/09540120701513677; Unge C, 2009, JAIDS-J ACQ IMM DEF, V50, P397, DOI 10.1097/QAI.0b013e318194618e; van Oosterhout JJ, 2005, TROP MED INT HEALTH, V10, P464, DOI 10.1111/j.1365-3156.2005.01409.x; WANG H, J CLIN NURS, V19, P380; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Zachariah R, 2008, T ROY SOC TROP MED H, V102, P288, DOI 10.1016/j.trstmh.2007.12.007	51	53	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13613	10.1371/journal.pone.0013613	http://dx.doi.org/10.1371/journal.pone.0013613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	670LB	21049045	Green Published, Green Submitted, gold			2022-12-25	WOS:000283422100018
J	Deng, YM; Edin, ML; Theken, KN; Schuck, RN; Flake, GP; Kannon, MA; DeGraff, LM; Lih, FB; Foley, J; Bradbury, JA; Graves, JP; Tomer, KB; Falck, JR; Zeldin, DC; Lee, CR				Deng, Yangmei; Edin, Matthew L.; Theken, Katherine N.; Schuck, Robert N.; Flake, Gordon P.; Kannon, M. Alison; DeGraff, Laura M.; Lih, Fred B.; Foley, Julie; Bradbury, J. Alyce; Graves, Joan P.; Tomer, Kenneth B.; Falck, John R.; Zeldin, Darryl C.; Lee, Craig R.			Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice	FASEB JOURNAL			English	Article						CYP2J2; CYP2C8; EPHX2; EETs; eicosanoids; inflammation	NF-KAPPA-B; ACUTE LUNG INJURY; ACUTE PSEUDOMONAS PNEUMONIA; BLOOD-PRESSURE REGULATION; ARACHIDONIC-ACID; CYTOCHROME-P450 EPOXYGENASES; CORONARY-ARTERIES; EPOXYEICOSATRIENOIC ACIDS; THERAPEUTIC TARGET; MOLECULAR-CLONING	Cytochrome P-450 (CYP)-derived epoxyeicosatrienoic acids (EETs) possess potent anti-inflammatory effects in vitro. However, the effect of increased CYP-mediated EET biosynthesis and decreased soluble epoxide hydrolase (sEH, Ephx2)-mediated EET hydrolysis on vascular inflammation in vivo has not been rigorously investigated. Consequently, we characterized acute vascular inflammatory responses to endotoxin in transgenic mice with endothelial expression of the human CYP2J2 and CYP2C8 epoxygenases and mice with targeted disruption of Ephx2. Compared to wild-type controls, CYP2J2 transgenic, CYP2C8 transgenic, and Ephx2(-/-) mice each exhibited a significant attenuation of endotoxin-induced activation of nuclear factor (NF)-kappa B signaling, cellular adhesion molecule, chemokine and cytokine expression, and neutrophil infiltration in lung in vivo. Furthermore, attenuation of endotoxin-induced NF-kappa B activation and cellular adhesion molecule and chemokine expression was observed in primary pulmonary endothelial cells isolated from CYP2J2 and CYP2C8 transgenic mice. This attenuation was inhibited by a putative EET receptor antagonist and CYP epoxygenase inhibitor, directly implicating CYP epoxygenase-derived EETs with the observed anti-inflammatory phenotype. Collectively, these data demonstrate that potentiation of the CYP epoxygenase pathway by either increased endothelial EET biosynthesis or globally decreased EET hydrolysis attenuates NF-kappa B-dependent vascular inflammatory responses in vivo and may serve as a viable anti-inflammatory therapeutic strategy.-Deng, Y., Edin, M. L., Theken, K. N., Schuck, R. N., Flake, G. P., Kannon, M. A., DeGraff, L. M., Lih, F. B., Foley, J., Bradbury, J. A., Graves, J. P., Tomer, K. B., Falck, J. R., Zeldin, D. C., Lee, C. R. Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice. FASEB J. 25, 703-713 (2011). www.fasebj.org	[Deng, Yangmei; Theken, Katherine N.; Schuck, Robert N.; Kannon, M. Alison; Lee, Craig R.] UNC, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27599 USA; [Edin, Matthew L.; Flake, Gordon P.; DeGraff, Laura M.; Lih, Fred B.; Foley, Julie; Bradbury, J. Alyce; Graves, Joan P.; Tomer, Kenneth B.; Zeldin, Darryl C.] Natl Inst Environm Hlth Sci, Natl Inst Hlth, Div Intramural Res, Res Triangle Pk, NC USA; [Falck, John R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Texas System; University of Texas Southwestern Medical Center Dallas	Lee, CR (corresponding author), UNC, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, CB 7569,Kerr Hall, Chapel Hill, NC 27599 USA.	craig_lee@unc.edu	Falck, John R/B-3030-2011; Theken, Katherine N/H-1098-2012; Theken, Katherine/AAD-7831-2022; Tomer, Kenneth B/E-8018-2013; Zeldin, Darryl C/Y-7091-2018; Edin, Matthew/AAI-1934-2019	Falck, John R/0000-0002-9219-7845; Zeldin, Darryl C/0000-0002-2087-7307; Theken, Katherine/0000-0001-9918-9170; Lee, Craig/0000-0003-3595-5301; Edin, Matthew/0000-0002-7042-500X	American Foundation for Pharmaceutical Education; NIH [GM31278, GM088199, P30 DK34987]; Robert A. Welch Foundation; NIH, NIEHS [Z01 ES050167, Z01 ES025034]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226, P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050167, Z01ES025034, ZIAES025034, Z01ES050167, ZIGES102505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088199, R01GM031278] Funding Source: NIH RePORTER	American Foundation for Pharmaceutical Education; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NIH, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This publication was made possible by a predoctoral fellowship from the American Foundation for Pharmaceutical Education to K.N.T., NIH grant GM31278 and support from the Robert A. Welch Foundation to J.R.F., funds from the Intramural Research Program of the NIH, NIEHS, to K. B. T. (Z01 ES050167) and D.C.Z. (Z01 ES025034), a Beginning Grant-in-Aid from the American Heart Association and NIH grant GM088199 to C. R. L., and NIH grant P30 DK34987. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the NIEHS, National Institute of General Medical Sciences, or NIH. D. C. Z. is a coinventor on U.S. Patent No. 6,531,506 B1 (issued March 11, 2003), Inhibition of Epoxide Hydrolases for the Treatment of Hypertension, and on U. S. Patent No. 6,916,843 B1 (issued July 12, 2005), Anti-inflammatory Actions of Cytochrome P450 Epoxygenase-Derived Eicosanoids. No other authors declare conflicts of interest.	Asti C, 2000, PULM PHARMACOL THER, V13, P61, DOI 10.1006/pupt.2000.0231; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Card JW, 2006, J IMMUNOL, V177, P621, DOI 10.4049/jimmunol.177.1.621; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; DeLozier TC, 2007, DRUG METAB DISPOS, V35, P682, DOI 10.1124/dmd.106.012823; Deng YM, 2010, J MOL CELL CARDIOL, V48, P331, DOI 10.1016/j.yjmcc.2009.10.022; Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995; Fang X, 2001, J BIOL CHEM, V276, P14867, DOI 10.1074/jbc.M011761200; Fisslthaler B, 1999, NATURE, V401, P493, DOI 10.1038/46816; Fleming I, 2001, CIRC RES, V88, P44, DOI 10.1161/01.RES.88.1.44; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Gauthier KM, 2002, CIRC RES, V90, P1028, DOI 10.1161/01.RES.0000018162.87285.F8; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Haegens A, 2009, J IMMUNOL, V182, P7990, DOI 10.4049/jimmunol.0800377; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Kabir K, 2002, SHOCK, V17, P300, DOI 10.1097/00024382-200204000-00010; Kerfoot SM, 2005, J LEUKOCYTE BIOL, V77, P862, DOI 10.1189/jlb.1004607; King LM, 2002, MOL PHARMACOL, V61, P840, DOI 10.1124/mol.61.4.840; Kiss L, 2010, EUR RESPIR J, V36, P1088, DOI 10.1183/09031936.00000309; Lau D, 2006, PHARMACOL THERAPEUT, V111, P16, DOI 10.1016/j.pharmthera.2005.06.023; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lee CR, 2007, PHARMACOGENET GENOM, V17, P145, DOI 10.1097/01.fpc.0000236340.87540.e3; Lee CR, 2010, FASEB J, V24, P3770, DOI 10.1096/fj.10-160119; Lim YC, 2003, AM J PATHOL, V162, P1591, DOI 10.1016/S0002-9440(10)64293-9; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; Michaelis UR, 2005, J CELL SCI, V118, P5489, DOI 10.1242/jcs.02674; Morin C, 2008, AM J RESP CELL MOL, V38, P192, DOI 10.1165/rcmb.2007-0232OC; Mosha KS, 2008, J CELL PHYSIOL, V215, P771, DOI 10.1002/jcp.21356; Newman JW, 2002, J LIPID RES, V43, P1563, DOI 10.1194/jlr.D200018-JLR200; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Rojas M, 2005, AM J PHYSIOL-LUNG C, V288, pL333, DOI 10.1152/ajplung.00334.2004; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Schmelzer KR, 2005, P NATL ACAD SCI USA, V102, P9772, DOI 10.1073/pnas.0503279102; Seubert JM, 2006, CIRC RES, V99, P442, DOI 10.1161/01.RES.0000237390.92932.37; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Smith KR, 2005, P NATL ACAD SCI USA, V102, P2186, DOI 10.1073/pnas.0409591102; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Theken KN, 2011, DRUG METAB DISPOS, V39, P22, DOI 10.1124/dmd.110.035287; Wang MH, 1998, J PHARMACOL EXP THER, V284, P966; Wu S, 1996, J BIOL CHEM, V271, P3460; Yaghi A, 2003, AM J PHYSIOL-LUNG C, V285, pL1099, DOI 10.1152/ajplung.00039.2003; Yaghi A, 2001, J PHARMACOL EXP THER, V297, P479; Yang BC, 2001, MOL PHARMACOL, V60, P310, DOI 10.1124/mol.60.2.310; Yang SL, 2007, AM J PHYSIOL-HEART C, V293, pH142, DOI 10.1152/ajpheart.00783.2006; Zeldin DC, 1996, ARCH BIOCHEM BIOPHYS, V330, P87, DOI 10.1006/abbi.1996.0229; ZELDIN DC, 1995, ARCH BIOCHEM BIOPHYS, V322, P76, DOI 10.1006/abbi.1995.1438	52	97	101	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					703	713		10.1096/fj.10-171488	http://dx.doi.org/10.1096/fj.10-171488			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	21059750	Green Published			2022-12-25	WOS:000286724800028
J	Lagerstedt, JO; Cavigiolio, G; Budamagunta, MS; Pagani, I; Voss, JC; Oda, MN				Lagerstedt, Jens O.; Cavigiolio, Giorgio; Budamagunta, Madhu S.; Pagani, Ioanna; Voss, John C.; Oda, Michael N.			Structure of Apolipoprotein A-I N Terminus on Nascent High Density Lipoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOA-I; CHOLESTEROL; DOMAIN; CONFORMATION; STABILITY; LECITHIN; PHOSPHATIDYLCHOLINE; FUNCTIONALITY; MORPHOLOGY; EXPRESSION	Apolipoprotein A-I (apoA-I) is the major protein component of high density lipoproteins (HDL) and a critical element of cholesterol metabolism. To better elucidate the role of the apoA-I structure-function in cholesterol metabolism, the conformation of the apoA-I N terminus (residues 6-98) on nascent HDL was examined by electron paramagnetic resonance (EPR) spectroscopic analysis. A series of 93 apoA-I variants bearing single nitroxide spin label at positions 6-98 was reconstituted onto 9.6-nm HDL particles (rHDL). These particles were subjected to EPR spectral analysis, measuring regional flexibility and side chain solvent accessibility. Secondary structure was elucidated from side-chain mobility and molecular accessibility, wherein two major alpha-helical domains were localized to residues 6-34 and 50-98. We identified an unstructured segment (residues 35-39) and a beta-strand (residues 40-49) between the two helices. Residues 14, 19, 34, 37, 41, and 58 were examined by EPR on 7.8, 8.4, and 9.6 nm rHDL to assess the effect of particle size on the N-terminal structure. Residues 14, 19, and 58 showed no significant rHDL size-dependent spectral or accessibility differences, whereas residues 34, 37, and 41 displayed moderate spectral changes along with substantial rHDL size-dependent differences in molecular accessibility. We have elucidated the secondary structure of the N-terminal domain of apoA-I on 9.6 nm rHDL (residues 6-98) and identified residues in this region that are affected by particle size. We conclude that the inter-helical segment (residues 35-49) plays a role in the adaptation of apoA-I to the particle size of HDL.	[Cavigiolio, Giorgio; Pagani, Ioanna; Oda, Michael N.] Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA; Lund Univ, Dept Expt Med Sci, S-22184 Lund, Sweden; [Budamagunta, Madhu S.; Voss, John C.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Lund University; University of California System; University of California Davis	Oda, MN (corresponding author), Childrens Hosp Oakland Res Inst, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	moda@chori.org	Budamagunta, Madhu S/C-4628-2011; Lagerstedt, Jens/AAF-9567-2021; Pagani, Ioanna/E-7390-2012	Cavigiolio, Giorgio/0000-0002-1622-0628; Lagerstedt, Jens/0000-0002-4313-2666; Voss, John/0000-0001-9279-209X	National Institutes of Health [HL77268, HL78615]; Swedish Research Council; Petrus and Augusta Hedlund Foundation; Crafoord Foundation; Carl Trygger Foundation for Scientific Research; American Heart Association Scientist Development [0235222N]; Tobacco-related Disease Research Program of California [8KT-0021]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078615, R01HL077268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Petrus and Augusta Hedlund Foundation; Crafoord Foundation; Carl Trygger Foundation for Scientific Research; American Heart Association Scientist Development(American Heart Association); Tobacco-related Disease Research Program of California(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL77268 and HL78615. This work was also supported by grants from the Swedish Research Council, the Petrus and Augusta Hedlund Foundation, the Crafoord Foundation, the Carl Trygger Foundation for Scientific Research, and American Heart Association Scientist Development Grant 0235222N.; Supported by New Investigator Award 8KT-0021 from the Tobacco-related Disease Research Program of California.	Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; Agree AKB, 2002, BBA-PROTEIN STRUCT M, V1594, P286, DOI 10.1016/S0167-4838(01)00317-X; ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; Bhat S, 2005, J BIOL CHEM, V280, P33015, DOI 10.1074/jbc.M505081200; Bhat S, 2007, BIOCHEMISTRY-US, V46, P7811, DOI 10.1021/bi700384t; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Catte A, 2006, BIOPHYS J, V90, P4345, DOI 10.1529/biophysj.105.071456; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Columbus L, 2001, BIOCHEMISTRY-US, V40, P3828, DOI 10.1021/bi002645h; Corsico B, 2001, J BIOL CHEM, V276, P16978, DOI 10.1074/jbc.M011533200; Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715; Davidson WS, 2007, J BIOL CHEM, V282, P22249, DOI 10.1074/jbc.R700014200; Davidson WS, 2003, J BIOL CHEM, V278, P27199, DOI 10.1074/jbc.M302764200; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Fang YL, 2003, BIOCHEMISTRY-US, V42, P6881, DOI 10.1021/bi034152t; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; FRONCISZ W, 1982, J MAGN RESON, V47, P515, DOI 10.1016/0022-2364(82)90221-9; GLOMSET JA, 1968, J LIPID RES, V9, P155; GLOMSET JA, 1962, BIOCHIM BIOPHYS ACTA, V65, P128, DOI 10.1016/0006-3002(62)90156-7; GOGONEA V, BIOCHEMISTRY, V49, P7323; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; HUBBELL WL, 1987, REV SCI INSTRUM, V58, P1879, DOI 10.1063/1.1139536; Jones MK, 2009, BIOCHEMISTRY-US, V48, P11196, DOI 10.1021/bi901242k; KAMMANN M, 1989, NUCLEIC ACIDS RES, V17, P5404, DOI 10.1093/nar/17.13.5404; Klug CS, 1997, BIOCHEMISTRY-US, V36, P13027, DOI 10.1021/bi971232m; Kono M, 2010, J LIPID RES, V51, P809, DOI 10.1194/jlr.M002113; Koyama M, 2009, BIOCHEMISTRY-US, V48, P2529, DOI 10.1021/bi802317v; Lagerstedt JO, 2007, BIOCHEMISTRY-US, V46, P9693, DOI 10.1021/bi7005493; Lagerstedt JO, 2007, J BIOL CHEM, V282, P9143, DOI 10.1074/jbc.M608717200; Li HH, 2000, J BIOL CHEM, V275, P37048, DOI 10.1074/jbc.M005336200; Li L, 2004, J MOL BIOL, V343, P1293, DOI 10.1016/j.jmb.2004.09.017; Martin DDO, 2006, J BIOL CHEM, V281, P20418, DOI 10.1074/jbc.M602077200; MILLER GJ, 1975, LANCET, V1, P16; Mulya A, 2007, ARTERIOSCL THROM VAS, V27, pE36; NICHOLS AV, 1983, BIOCHIM BIOPHYS ACTA, V750, P353, DOI 10.1016/0005-2760(83)90040-1; NICHOLS AV, 1987, J LIPID RES, V28, P719; Oda MN, 2003, NAT STRUCT BIOL, V10, P455, DOI 10.1038/nsb931; Oh KJ, 2000, METH MOL B, V145, P147; Panagotopulos SE, 2001, J BIOL CHEM, V276, P42965, DOI 10.1074/jbc.M106462200; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P11714, DOI 10.1021/bi973112k; Rogers DP, 1997, BIOCHEMISTRY-US, V36, P288, DOI 10.1021/bi961876e; Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; SEGREST JP, 1977, CHEM PHYS LIPIDS, V18, P7, DOI 10.1016/0009-3084(77)90023-8; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; SEGREST JP, 1992, J LIPID RES, V33, P141; Shao BH, 2010, J BIOL CHEM, V285, P18473, DOI 10.1074/jbc.M110.118182; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P8600, DOI 10.1021/bi050421z; Smith LE, 2010, BBA-MOL CELL BIOL L, V1801, P64, DOI 10.1016/j.bbalip.2009.09.012; Sorci-Thomas MG, 2002, TRENDS CARDIOVAS MED, V12, P121, DOI 10.1016/S1050-1738(01)00163-3; SUBBAIAH PV, 1994, BIOCHEMISTRY-US, V33, P13259, DOI 10.1021/bi00249a012; Sviridov D, 2008, J ATHEROSCLER THROMB, V15, P52, DOI 10.5551/jat.E571; Tabet F, 2009, CLIN SCI, V116, P87, DOI 10.1042/CS20080106; Tricerri MA, 2000, BIOCHEMISTRY-US, V39, P14682, DOI 10.1021/bi0014251; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537	58	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2966	2975		10.1074/jbc.M110.163097	http://dx.doi.org/10.1074/jbc.M110.163097			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21047795	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000286464300060
J	Ng, DCH; Ng, IHW; Yeap, YYC; Badrian, B; Tsoutsman, T; McMullen, JR; Semsarian, C; Bogoyevitch, MA				Ng, Dominic C. H.; Ng, Ivan H. W.; Yeap, Yvonne Y. C.; Badrian, Bahareh; Tsoutsman, Tatiana; McMullen, Julie R.; Semsarian, Christopher; Bogoyevitch, Marie A.			Opposing Actions of Extracellular Signal-regulated Kinase (ERK) and Signal Transducer and Activator of Transcription 3 (STAT3) in Regulating Microtubule Stabilization during Cardiac Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILE DYSFUNCTION; PRESSURE-OVERLOAD; PROTEIN-KINASES; HEART-FAILURE; MYOCARDIAL-INFARCTION; MYOCYTE MORPHOLOGY; PATHWAY; RAT; INHIBITION; DYNAMICS	Excessive proliferation and stabilization of the microtubule (MT) array in cardiac myocytes can accompany pathological cardiac hypertrophy, but the molecular control of these changes remains poorly characterized. In this study, we examined MT stabilization in two independent murine models of heart failure and revealed increases in the levels of post-translationally modified stable MTs, which were closely associated with STAT3 activation. To explore the molecular signaling events contributing to control of the cardiac MT network, we stimulated cardiac myocytes with an alpha-adrenergic agonist phenylephrine (PE), and observed increased tubulin content without changes in detyrosinated (glutubulin) stable MTs. In contrast, the hypertrophic interleukin-6 (IL6) family cytokines increased both the glu-tubulin content and glu-MT density. When we examined a role for ERK in regulating cardiac MTs, we showed that the MEK/ERK-inhibitor U0126 increased glu-MT density in either control cardiac myocytes or following exposure to hypertrophic agents. Conversely, expression of an activated MEK1 mutant reduced glu-tubulin levels. Thus, ERK signaling antagonizes stabilization of the cardiac MT array. In contrast, inhibiting either JAK2 with AG490, or STAT3 signaling with Stattic or siRNA knockdown, blocked cytokine-stimulated increases in glu-MT density. Furthermore, the expression of a constitutively active STAT3 mutant triggered increased glu-MT density in the absence of hypertrophic stimulation. Thus, STAT3 activation contributes substantially to cytokine-stimulated glu-MT changes. Taken together, our results highlight the opposing actions of STAT3 and ERK pathways in the regulation of MT changes associated with cardiac myocyte hypertrophy.	[Ng, Dominic C. H.; Ng, Ivan H. W.; Yeap, Yvonne Y. C.; Bogoyevitch, Marie A.] Univ Melbourne, Inst Bio21, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Badrian, Bahareh] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Nedlands, WA 6009, Australia; [Tsoutsman, Tatiana; Semsarian, Christopher] Centenary Inst, Agnes Ginges Ctr Mol Cardiol, Sydney, NSW 2042, Australia; [McMullen, Julie R.] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Tsoutsman, Tatiana; Semsarian, Christopher] Univ Sydney, Cent Clin Sch, Sydney, NSW 2050, Australia	University of Melbourne; University of Western Australia; University of Sydney; Centenary Institute; Baker Heart and Diabetes Institute; University of Sydney	Ng, DCH (corresponding author), Univ Melbourne, Inst Bio21, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia.	ngd@unimelb.edu.au	Ng, Dominic/C-7291-2015	Ng, Dominic/0000-0003-4657-159X; Badrian, Bahareh/0000-0001-5895-8498; Bogoyevitch, Marie/0000-0001-9745-3716	NHFA [G06P2517, G09M4435]; NHMRC [353592]	NHFA(National Heart Foundation of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported, in whole or in part, by NHFA Grants-in-aid (G06P2517, G09M4435; to D.C.H.N.) and NHMRC Project Grants (353592, to C.S. and 353592, to M.A.B.).	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Belmadani S, 2002, MOL CELL BIOCHEM, V237, P39, DOI 10.1023/A:1016554104209; Bogoyevitch MA, 1996, INT J BIOCHEM CELL B, V28, P1, DOI 10.1016/1357-2725(95)00142-5; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Cheng G, 2008, AM J PHYSIOL-HEART C, V294, pH2231, DOI 10.1152/ajpheart.91515.2007; Cooper G, 2006, AM J PHYSIOL-HEART C, V291, pH1003, DOI 10.1152/ajpheart.00132.2006; Drewes G, 1998, TRENDS BIOCHEM SCI, V23, P307, DOI 10.1016/S0968-0004(98)01245-6; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Fassett JT, 2009, AM J PHYSIOL-HEART C, V297, pH523, DOI 10.1152/ajpheart.00462.2009; Gao XM, 2006, J HYPERTENS, V24, P1663, DOI 10.1097/01.hjh.0000239304.01496.83; Grounds HR, 2005, J CELL BIOCHEM, V95, P529, DOI 10.1002/jcb.20441; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hilfiker-Kleiner D, 2005, PHARMACOL THERAPEUT, V107, P131, DOI 10.1016/j.pharmthera.2005.02.003; Hilfiker-Kleiner D, 2010, CIRCULATION, V122, P145, DOI 10.1161/CIRCULATIONAHA.109.933127; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Koide M, 2000, CIRCULATION, V102, P1045, DOI 10.1161/01.CIR.102.9.1045; Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315; Mascareno E, 2000, MOL CELL BIOCHEM, V212, P171, DOI 10.1023/A:1007157126806; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Miyamoto T, 2004, BASIC RES CARDIOL, V99, P328, DOI 10.1007/s00395-004-0482-7; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; Negoro S, 2000, CARDIOVASC RES, V47, P797, DOI 10.1016/S0008-6363(00)00138-3; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Ng DCH, 2003, CARDIOVASC RES, V57, P333, DOI 10.1016/S0008-6363(02)00664-8; Ng DCH, 2001, J BIOL CHEM, V276, P29490, DOI 10.1074/jbc.M100699200; Ng DCH, 2008, CELL MOTIL CYTOSKEL, V65, P40, DOI 10.1002/cm.20242; Rothen-Rutishauser BM, 1998, J MOL CELL CARDIOL, V30, P19, DOI 10.1006/jmcc.1997.0596; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Tsoutsman T, 2008, CIRCULATION, V117, P1820, DOI 10.1161/CIRCULATIONAHA.107.755777; TSUTSUI H, 1993, SCIENCE, V260, P682, DOI 10.1126/science.8097594; TSUTSUI H, 1994, CIRCULATION, V90, P533, DOI 10.1161/01.CIR.90.1.533; Vaillant AR, 2002, NEURON, V34, P985, DOI 10.1016/S0896-6273(02)00717-1; Verma NK, 2009, J BIOL CHEM, V284, P12349, DOI 10.1074/jbc.M807761200; WATKINS SC, 1987, CIRC RES, V60, P327, DOI 10.1161/01.RES.60.3.327; Webster Daniel R, 2002, Cardiovasc Toxicol, V2, P75, DOI 10.1385/CT:2:2:075; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; WEBSTER DR, 1989, J CELL SCI, V92, P57; Willey CD, 2008, INT J BIOL SCI, V4, P184; Yasukawa H, 2001, J CLIN INVEST, V108, P1459, DOI 10.1172/JCI13939; Yue H, 2010, CARDIOVASC RES, V85, P90, DOI 10.1093/cvr/cvp285	44	22	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1576	1587		10.1074/jbc.M110.128157	http://dx.doi.org/10.1074/jbc.M110.128157			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21056972	hybrid, Green Published			2022-12-25	WOS:000286005000070
J	Hochbaum, D; Barila, G; Ribeiro-Neto, F; Altschuler, DL				Hochbaum, Daniel; Barila, Guillermo; Ribeiro-Neto, Fernando; Altschuler, Daniel L.			Radixin Assembles cAMP Effectors Epac and PKA into a Functional cAMP Compartment ROLE IN cAMP-DEPENDENT CELL PROLIFERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE ANCHORING PROTEIN; A TYPE-I; CYCLIC-AMP; RAP1 ACTIVATION; TERMINAL DOMAIN; ERM PROTEINS; EZRIN; DIFFUSION; SITE; RAS	cAMP is an ubiquitous second messenger. Localized areas with high cAMP concentration, i.e. cAMP microdomains, provide an elegant mechanism to generate signaling specificity and transduction efficiency. However, the mechanisms underlying cAMP effector targeting into these compartments is still unclear. Here we report the identification of radixin as a scaffolding unit for both cAMP effectors, Epac and PKA. This complex localizes in a submembrane compartment where cAMP synthesis occurs. Compartment disruption by shRNA and dominant negative approaches negatively affects cAMP action. Inhibition can be rescued by expression of Rap1b, a substrate for both Epac1 and PKA, but only in its GTP-bound and phosphorylated state. We propose that radixin scaffolds both cAMP effectors in a functional cAMP-sensing compartment for efficient signal transduction, using Rap1 as a downstream signal integrator.	[Hochbaum, Daniel; Barila, Guillermo; Ribeiro-Neto, Fernando; Altschuler, Daniel L.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Altschuler, DL (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, 200 Lothrop St,W1346 BSTWR, Pittsburgh, PA 15261 USA.	altschul@pitt.edu		Hochbaum, Daniel/0000-0001-6387-7529	NCI, National Institutes of Health [CA071649]; NATIONAL CANCER INSTITUTE [R29CA071649, R01CA071649] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Public Health Service Grant CA071649 from the NCI, National Institutes of Health.	ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; Amieva MR, 1999, J CELL SCI, V112, P111; Barnes AP, 2005, J BIOL CHEM, V280, P7997, DOI 10.1074/jbc.M407521200; Borland G, 2006, MOL PHARMACOL, V69, P374, DOI 10.1124/mol.105.016337; BUXTON ILO, 1983, J BIOL CHEM, V258, P233; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Di Benedetto G, 2008, CIRC RES, V103, P836, DOI 10.1161/CIRCRESAHA.108.174813; Dodge-Kafka K. L., 2008, V186, P3, DOI 10.1007/978-3-540-72843-6_1; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Gloerich M, 2010, MOL CELL BIOL, V30, P5421, DOI 10.1128/MCB.00463-10; Hochbaum D, 2008, J BIOL CHEM, V283, P4464, DOI 10.1074/jbc.C700171200; Huston E, 2008, P NATL ACAD SCI USA, V105, P12791, DOI 10.1073/pnas.0805167105; Jurevicius J, 1996, P NATL ACAD SCI USA, V93, P295, DOI 10.1073/pnas.93.1.295; LEVITZKI A, 1988, SCIENCE, V241, P800, DOI 10.1126/science.2841758; Li Y, 2006, J BIOL CHEM, V281, P2506, DOI 10.1074/jbc.M508165200; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Liu C, 2010, MOL CELL BIOL, V30, P3956, DOI 10.1128/MCB.00242-10; Metrich M, 2010, CELL SIGNAL, V22, P1459, DOI 10.1016/j.cellsig.2010.05.014; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Ponsioen B, 2009, MOL CELL BIOL, V29, P2521, DOI 10.1128/MCB.01630-08; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rampersad SN, 2010, J BIOL CHEM, V285, P33614, DOI 10.1074/jbc.M110.140004; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; Ribeiro-Neto F, 2004, J BIOL CHEM, V279, P46868, DOI 10.1074/jbc.M406858200; Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Ruppelt A, 2007, J IMMUNOL, V179, P5159, DOI 10.4049/jimmunol.179.8.5159; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Vaiskunaite R, 2000, J BIOL CHEM, V275, P26206, DOI 10.1074/jbc.M001863200; Vijayaraghavan S, 1997, J BIOL CHEM, V272, P4747, DOI 10.1074/jbc.272.8.4747; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; Zaccolo M, 2006, BIOCHEM SOC T, V34, P495, DOI 10.1042/BST0340495; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982	39	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					859	866		10.1074/jbc.M110.163816	http://dx.doi.org/10.1074/jbc.M110.163816			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21047789	Green Published, hybrid			2022-12-25	WOS:000285782800085
J	Sumandea, CA; Garcia-Cazarin, ML; Bozio, CH; Sievert, GA; Balke, CW; Sumandea, MP				Sumandea, C. Amelia; Garcia-Cazarin, Mary L.; Bozio, Catherine H.; Sievert, Gail A.; Balke, C. William; Sumandea, Marius P.			Cardiac Troponin T, a Sarcomeric AKAP, Tethers Protein Kinase A at the Myofilaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORING PROTEINS; REGULATORY SUBUNIT; SIGNAL-TRANSDUCTION; C PHOSPHORYLATION; MOUSE MYOCARDIUM; THIN-FILAMENTS; IN-VIVO; HEART; BINDING; MYOCYTES	Efficient and specific phosphorylation of PKA substrates, elicited in response to beta-adrenergic stimulation, require spatially confined pools of PKA anchored in proximity of its substrates. PKA-dependent phosphorylation of cardiac sarcomeric proteins has been the subject of intense investigations. Yet, the identity, composition, and function of PKA complexes at the sarcomeres have remained elusive. Here we report the identification and characterization of a novel sarcomeric AKAP (A-kinase anchoring protein), cardiac troponin T (cTnT). Using yeast two-hybrid technology in screening two adult human heart cDNA libraries, we identified the regulatory subunit of PKA as interacting with human cTnT bait. Immunoprecipitation studies show that cTnT is a dual specificity AKAP, interacting with both PKA-regulatory subunits type I and II. The disruptor peptide Ht31, but not Ht31P (control), abolished cTnT/PKA-R association. Truncations and point mutations identified an amphipathic helix domain in cTnT as the PKA binding site. This was confirmed by a peptide SPOT assay in the presence of Ht31 or Ht31P (control). Gelsolin-dependent removal of thin filament proteins also reduced myofilament-bound PKA-type II. Using a cTn exchange procedure that substitutes the endogenous cTn complex with a recombinant cTn complex we show that PKA-type II is troponin-bound in the myofilament lattice. Displacement of PKA-cTnT complexes correlates with a significant decrease in myofibrillar PKA activity. Taken together, our data propose a novel role for cTnT as a dual-specificity sarcomeric AKAP.	[Sumandea, C. Amelia; Garcia-Cazarin, Mary L.; Bozio, Catherine H.; Sievert, Gail A.; Balke, C. William; Sumandea, Marius P.] Univ Kentucky, Dept Physiol, Ctr Muscle Biol, Lexington, KY 40536 USA	University of Kentucky	Sumandea, MP (corresponding author), 426 Sanders Brown Bldg,800 S Limestone St, Lexington, KY 40536 USA.	MariusSumandea@uky.edu			National Institutes of Health [HL071865, HL68733, AG032009]; Ruth L. Kirschstein National Research Service Award [HL82120]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068733, R01HL071865, F32HL082120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG032009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL071865, HL68733, and AG032009 and Ruth L. Kirschstein National Research Service Award HL82120 (to C. A. S.).	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Canaves JM, 2000, BIOCHEMISTRY-US, V39, P15022, DOI 10.1021/bi001563q; CARR DW, 1991, J BIOL CHEM, V266, P14188; Colson BA, 2007, J MOL BIOL, V367, P36, DOI 10.1016/j.jmb.2006.12.063; DAVID H, 1979, J MOL CELL CARDIOL, V11, P631, DOI 10.1016/0022-2828(79)90377-8; Di Benedetto G, 2008, CIRC RES, V103, P836, DOI 10.1161/CIRCRESAHA.108.174813; Diviani D, 2008, CURR OPIN PHARMACOL, V8, P166, DOI 10.1016/j.coph.2007.11.001; Dodge-Kafka K. L., 2008, V186, P3, DOI 10.1007/978-3-540-72843-6_1; DOSTMANN WRG, 1991, BIOCHEMISTRY-US, V30, P8710, DOI 10.1021/bi00099a032; El-Armouche A, 2009, HEART FAIL REV, V14, P225, DOI 10.1007/s10741-008-9132-8; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fink MA, 2001, CIRC RES, V88, P291, DOI 10.1161/01.RES.88.3.291; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Hamdani N, 2008, CARDIOVASC RES, V77, P649, DOI 10.1093/cvr/cvm079; Hinkle A, 1999, J BIOL CHEM, V274, P7157, DOI 10.1074/jbc.274.11.7157; Hoshijima M, 2006, AM J PHYSIOL-HEART C, V290, pH1313, DOI 10.1152/ajpheart.00816.2005; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Jarnaess E, 2008, J BIOL CHEM, V283, P33708, DOI 10.1074/jbc.M804807200; Kawai M, 2006, J MUSCLE RES CELL M, V27, P455, DOI 10.1007/s10974-006-9075-4; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; Mauban JRH, 2009, PHYSIOLOGY, V24, P78, DOI 10.1152/physiol.00041.2008; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; McConnell BK, 2009, J BIOL CHEM, V284, P1583, DOI 10.1074/jbc.M806321200; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Nagayama T, 2007, CIRCULATION, V116, P2399, DOI 10.1161/CIRCULATIONAHA.107.706523; Patel HH, 2010, J BIOL CHEM, V285, P27632, DOI 10.1074/jbc.M110.146589; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Ruehr ML, 2004, J MOL CELL CARDIOL, V37, P653, DOI 10.1016/j.yjmcc.2004.04.017; Russell MA, 2006, ARCH BIOCHEM BIOPHYS, V456, P204, DOI 10.1016/j.abb.2006.06.010; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sfichi-Duke L, 2010, J MOL CELL CARDIOL, V48, P934, DOI 10.1016/j.yjmcc.2010.01.005; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Solaro RJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/105648; Solaro RJ, 2009, IDRUGS, V12, P243; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; Stelzer JE, 2006, BIOPHYS J, V90, P4119, DOI 10.1529/biophysj.105.078147; Sumandea MP, 2009, BIOCHEMISTRY-US, V48, P7722, DOI 10.1021/bi900516n; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Trombitas K, 1997, AM J PHYSIOL-CELL PH, V273, pC662, DOI 10.1152/ajpcell.1997.273.2.C662; Trombitas K, 1997, J MUSCLE RES CELL M, V18, P345, DOI 10.1023/A:1018626210300; Wu SC, 2007, J BIOL CHEM, V282, P30691, DOI 10.1074/jbc.M703670200; Yamasaki R, 2002, CIRC RES, V90, P1181, DOI 10.1161/01.RES.0000021115.24712.99; Yuasa K, 1999, J BIOL CHEM, V274, P37429, DOI 10.1074/jbc.274.52.37429; Zaccolo M, 2009, BRIT J PHARMACOL, V158, P50, DOI 10.1111/j.1476-5381.2009.00185.x; Zakhary DR, 2000, J BIOL CHEM, V275, P41389, DOI 10.1074/jbc.M004212200	59	38	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					530	541		10.1074/jbc.M110.148684	http://dx.doi.org/10.1074/jbc.M110.148684			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21056973	Green Published, hybrid			2022-12-25	WOS:000285782800056
J	Koo, BH; Han, JH; Il Yeom, Y; Kim, DS				Koo, Bon-Hun; Han, Jung Ho; Il Yeom, Young; Kim, Doo-Sik			Thrombin-dependent MMP-2 Activity Is Regulated by Heparan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRO-MATRIX METALLOPROTEINASE-2; SMOOTH-MUSCLE-CELLS; HUMAN PROGELATINASE-A; GELATINASE-A; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; IV COLLAGENASE; EXOSITE-II; ALLOSTERIC LINKAGE; BINDING-PROPERTIES	Like most metalloproteases, matrix metalloprotease 2 (MMP-2) is synthesized as a zymogen. MMP-2 propeptide plays a role in inhibition of catalytic activity through a cysteine-zinc ion pairing, disruption of which results in full enzyme activation. A variety of proteases have been shown to be involved in the activation of pro-MMP-2, including metalloproteases and serine proteases. In the previous study we showed that MMP-2 activation occurred via specific cleavages of the propeptide by thrombin followed by intermolecular autoproteolytic processing for full enzymatic activity. Thrombin also degraded MMP-2, but this degradation was reduced greatly under cell-associated conditions with a concomitant increase in activation, prompting us to elucidate the molecular mechanisms underlying thrombin-mediated MMP-2 activation. In the present study we demonstrate that heparan sulfate is essential for thrombin-mediated activation of pro-MMP-2. Binding of heparan sulfate to thrombin is primarily responsible for this activation process, presumably through conformational changes at the active site. Furthermore, interaction of MMP-2 with exosites 1 and 2 of thrombin is crucial for thrombin-mediated MMP-2 degradation, and inhibition of this interaction by heparan sulfate or hirudin fragment results in a decrease in MMP-2 degradation. Finally, we demonstrated interaction between exosite 1 and hemopexin-like domain of MMP-2, suggesting a regulatory role of hemopexin-like domain in MMP-2 degradation. Taken together, our experimental data suggest a novel regulatory mechanism of thrombin-dependent MMP-2 enzymatic activity by heparan sulfate proteoglycans.	[Koo, Bon-Hun] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Han, Jung Ho] Seoul Natl Univ, Coll Med, Med Res Ctr, Seoul 110799, South Korea; [Il Yeom, Young] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon 305806, South Korea	Yonsei University; Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, DS (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, 134 Sinchon Dong, Seoul 120749, South Korea.	dskim@yonsei.ac.kr			Ministry of Education, Science, and Technology [2009-0081760]	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Future-based Technology Development Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (no. 2009-0081760).	Baramova EN, 1997, FEBS LETT, V405, P157, DOI 10.1016/S0014-5793(97)00175-0; Bescond A, 1999, BIOCHEM BIOPH RES CO, V263, P498, DOI 10.1006/bbrc.1999.1391; Bode W, 2006, SEMIN THROMB HEMOST, V32, P16, DOI 10.1055/s-2006-939551; Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; Callahan MK, 2004, J NEUROIMMUNOL, V153, P150, DOI 10.1016/j.jneuroim.2004.05.004; Chen DX, 2008, J EXP MED, V205, P1739, DOI 10.1084/jem.20071427; Chen JM, 2001, BIOL CHEM, V382, P777, DOI 10.1515/BC.2001.093; CRABBE T, 1994, FEBS LETT, V345, P14, DOI 10.1016/0014-5793(94)00412-9; CRABBE T, 1993, EUR J BIOCHEM, V218, P431, DOI 10.1111/j.1432-1033.1993.tb18393.x; Crawley JTB, 2005, BLOOD, V105, P1085, DOI 10.1182/blood-2004-03-1101; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; Fedarko NS, 2004, FASEB J, V18, P734, DOI 10.1096/fj.03-0966fje; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; Galis ZS, 1997, ARTERIOSCL THROM VAS, V17, P483, DOI 10.1161/01.ATV.17.3.483; Gioia M, 2009, J MOL BIOL, V386, P419, DOI 10.1016/j.jmb.2008.12.021; Henderson N, 2007, AM J PHYSIOL-LUNG C, V292, pL1030, DOI 10.1152/ajplung.00317.2006; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; Ikeda K, 2006, AM J PATHOL, V168, P856, DOI 10.2353/ajpath.2006.050384; Jackson MT, 2009, ARTHRITIS RHEUM-US, V60, P780, DOI 10.1002/art.24303; Jain A, 2008, BIOCHEMISTRY-US, V47, P10162, DOI 10.1021/bi801068p; KAHAN C, 1992, J BIOL CHEM, V267, P13369; Koo BH, 2009, J BIOL CHEM, V284, P23375, DOI 10.1074/jbc.M109.036848; Lafleur MA, 2001, BIOCHEM J, V357, P107, DOI 10.1042/0264-6021:3570107; Lazure C, 2002, CURR PHARM DESIGN, V8, P511, DOI 10.2174/1381612023395691; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; MCNAMARA CA, 1993, J CLIN INVEST, V91, P94, DOI 10.1172/JCI116206; Monea S, 2002, J CELL PHYSIOL, V192, P160, DOI 10.1002/jcp.10126; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Morrison CJ, 2001, J BIOL CHEM, V276, P47402, DOI 10.1074/jbc.M108643200; Munesue S, 2007, J BIOL CHEM, V282, P28164, DOI 10.1074/jbc.M609812200; MURPHY G, 1994, J BIOL CHEM, V269, P6632; Nakada M, 2001, CANCER RES, V61, P8896; Nguyen M, 1999, LAB INVEST, V79, P467; Nie J, 2003, CANCER RES, V63, P6758; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032; Pei DQ, 1999, J BIOL CHEM, V274, P8925, DOI 10.1074/jbc.274.13.8925; Pospisil CH, 2003, J BIOL CHEM, V278, P21584, DOI 10.1074/jbc.M300545200; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Rahgozar S, 2007, ARTHRITIS RHEUM-US, V56, P605, DOI 10.1002/art.22367; Rauch BH, 2002, CIRC RES, V90, P1122, DOI 10.1161/01.RES.0000019240.72809.76; Segers K, 2007, J BIOL CHEM, V282, P33915, DOI 10.1074/jbc.M701123200; SHIMADA K, 1985, J CLIN INVEST, V75, P1308, DOI 10.1172/JCI111831; Somerville RPT, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-216; Sorsa T, 1997, J BIOL CHEM, V272, P21067, DOI 10.1074/jbc.272.34.21067; STEFFENSEN B, 1995, J BIOL CHEM, V270, P11555, DOI 10.1074/jbc.270.19.11555; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; Wallon UM, 1997, J BIOL CHEM, V272, P7473, DOI 10.1074/jbc.272.11.7473; Wang ZB, 2009, NEUROSCI LETT, V451, P199, DOI 10.1016/j.neulet.2009.01.003; WOESSNER JF, 1994, ANN NY ACAD SCI, V732, P11; Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183	54	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41270	41279		10.1074/jbc.M110.171595	http://dx.doi.org/10.1074/jbc.M110.171595			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041295	Green Published, hybrid			2022-12-25	WOS:000285622600012
J	Styer, AM; Mirshahi, UL; Wang, CA; Girard, L; Jin, TH; Logothetis, DE; Mirshahi, T				Styer, Amanda M.; Mirshahi, Uyenlinh L.; Wang, Chuan; Girard, Laura; Jin, Taihao; Logothetis, Diomedes E.; Mirshahi, Tooraj			G Protein beta gamma Gating Confers Volatile Anesthetic Inhibition to Kir3 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING K+ CHANNELS; GATED POTASSIUM CHANNELS; HIPPOCAMPAL CA3 NEURONS; GENERAL-ANESTHESIA; INHALED ANESTHETICS; ANGSTROM RESOLUTION; MOLECULAR TARGETS; CRYSTAL-STRUCTURE; BINDING-SITES; GIRK CHANNELS	G protein-activated inwardly rectifying potassium (GIRK or Kir3) channels are directly gated by the beta gamma subunits of G proteins and contribute to inhibitory neurotransmitter signaling pathways. Paradoxically, volatile anesthetics such as halothane inhibit these channels. We find that neuronal Kir3 currents are highly sensitive to inhibition by halothane. Given that Kir3 currents result from increased G beta gamma available to the channels, we asked whether reducing available G beta gamma to the channel would adversely affect halothane inhibition. Remarkably, scavenging G beta gamma using the C-terminal domain of beta-adrenergic receptor kinase (c beta ARK) resulted in channel activation by halothane. Consistent with this effect, channel mutants that impair G beta gamma activation were also activated by halothane. A single residue, phenylalanine 192, occupies the putative G beta gamma gate of neuronal Kir3.2 channels. Mutation of Phe-192 at the gate to other residues rendered the channel non-responsive, either activated or inhibited by halothane. These data indicated that halothane predominantly interferes with G beta gamma-mediated Kir3 currents, such as those functioning during inhibitory synaptic activity. Our report identifies the molecular correlate for anesthetic inhibition of Kir3 channels and highlights the significance of these effects in modulating neurotransmitter-mediated inhibitory signaling.	[Mirshahi, Tooraj] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA; [Jin, Taihao; Logothetis, Diomedes E.] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Logothetis, Diomedes E.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA 23298 USA	Icahn School of Medicine at Mount Sinai; Virginia Commonwealth University	Mirshahi, T (corresponding author), Weis Ctr Res, Geisinger Clin, 100 N Acad Ave, Danville, PA 17822 USA.	tmirshahi@geisinger.edu			American Heart Association [0765275U]; Geisinger Clinic	American Heart Association(American Heart Association); Geisinger Clinic	This work was supported, in whole or in part, by American Heart Association-Great Rivers Affiliate Beginning Grant-in-Aid 0765275U and by funds from the Geisinger Clinic (to T. M.).	Andres-Enguix I, 2007, J BIOL CHEM, V282, P20977, DOI 10.1074/jbc.M610692200; Aryal P, 2009, NAT NEUROSCI, V12, P988, DOI 10.1038/nn.2358; Bertaccini EJ, 2007, ANESTH ANALG, V104, P318, DOI 10.1213/01.ane.0000253029.67331.8d; Blednow YA, 2003, P NATL ACAD SCI USA, V100, P277, DOI 10.1073/pnas.012682399; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Chen XD, 2006, P NATL ACAD SCI USA, V103, P3422, DOI 10.1073/pnas.0507710103; Chen XX, 2005, J NEUROSCI, V25, P3787, DOI 10.1523/JNEUROSCI.5312-04.2005; Chiara DC, 2003, BIOCHEMISTRY-US, V42, P13457, DOI 10.1021/bi0351561; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Eger EI, 2001, ANESTHESIOLOGY, V94, P915, DOI 10.1097/00000542-200105000-00032; Eger EI, 2004, AM J HEALTH-SYST PH, V61, pS3, DOI 10.1093/ajhp/61.suppl_4.S3; Finley M, 2004, J PHYSIOL-LONDON, V555, P643, DOI 10.1113/jphysiol.2003.056101; Franks NP, 2006, BRIT J PHARMACOL, V147, pS72, DOI 10.1038/sj.bjp.0706441; Franks NP, 2004, TRENDS PHARMACOL SCI, V25, P601, DOI 10.1016/j.tips.2004.09.003; Franks NP, 1998, TOXICOL LETT, V101, P1, DOI 10.1016/S0378-4274(98)00158-1; Goslin K., 1998, CULTURING NERVE CELL, P339; Guy-David L, 2007, NEURON, V55, P537, DOI 10.1016/j.neuron.2007.08.001; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Huang CL, 1997, FEBS LETT, V405, P291, DOI 10.1016/S0014-5793(97)00197-X; Ivanina T, 2003, J BIOL CHEM, V278, P29174, DOI 10.1074/jbc.M304518200; Jelacic TM, 2000, J BIOL CHEM, V275, P36211, DOI 10.1074/jbc.M007087200; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; Kulik A, 2006, J NEUROSCI, V26, P4289, DOI 10.1523/JNEUROSCI.4178-05.2006; Lazarenko RM, 2010, J NEUROSCI, V30, P9324, DOI 10.1523/JNEUROSCI.1956-10.2010; Leaney JL, 2003, EUR J NEUROSCI, V18, P2110, DOI 10.1046/j.1460-9568.2003.02933.x; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; Lewohl JM, 1999, NAT NEUROSCI, V2, P1084, DOI 10.1038/16012; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Lopes CMB, 1998, BRIT J PHARMACOL, V125, P309, DOI 10.1038/sj.bjp.0702069; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Luscher C, 1997, NEURON, V19, pU7; Marker CL, 2006, J NEUROSCI, V26, P12251, DOI 10.1523/JNEUROSCI.3693-06.2006; Marker CL, 2002, NEUROREPORT, V13, P2509, DOI 10.1097/00001756-200212200-00026; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Milovic S, 2004, J BIOL CHEM, V279, P34240, DOI 10.1074/jbc.M403448200; Minami K, 1998, J BIOL CHEM, V273, P8248, DOI 10.1074/jbc.273.14.8248; Mirshahi T, 2002, J BIOL CHEM, V277, P7348, DOI 10.1074/jbc.M109999200; MIRSHAHI T, 2003, SCI STKE, pPE32; Mitrovic I, 2003, P NATL ACAD SCI USA, V100, P271, DOI 10.1073/pnas.0136822100; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Ronald KM, 2001, J BIOL CHEM, V276, P44729, DOI 10.1074/jbc.M102800200; Sadja R, 2002, P NATL ACAD SCI USA, V99, P10783, DOI 10.1073/pnas.162346199; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P453, DOI 10.1007/BF00388310; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sodickson DL, 1996, J NEUROSCI, V16, P6374; Sodickson DL, 1998, J NEUROSCI, V18, P8153; Talley EM, 2002, J BIOL CHEM, V277, P17733, DOI 10.1074/jbc.M200502200; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Torrecilla M, 2002, J NEUROSCI, V22, P4328, DOI 10.1523/JNEUROSCI.22-11-04328.2002; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Weigl LG, 2001, MOL PHARMACOL, V60, P282, DOI 10.1124/mol.60.2.282; Yamakura T, 2001, ANESTHESIOLOGY, V95, P144, DOI 10.1097/00000542-200107000-00025; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	63	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41290	41299		10.1074/jbc.M110.178541	http://dx.doi.org/10.1074/jbc.M110.178541			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21044958	hybrid, Green Published			2022-12-25	WOS:000285622600014
J	Yan, ZH; Garg, SK; Banerjee, R				Yan, Zhonghua; Garg, Sanjay K.; Banerjee, Ruma			Regulatory T Cells Interfere with Glutathione Metabolism in Dendritic Cells and T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN-PRESENTING CELLS; IMMUNE-RESPONSES; TRYPTOPHAN CATABOLISM; SELF-TOLERANCE; CUTTING EDGE; REDOX; ACTIVATION; LYMPHOCYTES; SUPPRESSION; CYSTEINE	Naturally occurring CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) suppress proliferation of CD4(+)CD25(-) effector T cells (Teffs) by mechanisms that are not well understood. We have previously demonstrated a novel mechanism of Treg suppression, i.e. interference with extracellular redox remodeling that occurs during activation of T cells by dendritic cells. In this study, we demonstrate that Treg-mediated redox perturbation is antigen-dependent but not antigen-specific, is CTLA-4-dependent, and requires cell-cell contact. Furthermore, we show that Tregs use multiple strategies for extracellular redox remodeling, including diminished GSH synthesis in dendritic cells via decreased expression of gamma-glutamylcysteine synthetase, the limiting enzyme for GSH synthesis. Tregs also consume extracellular cysteine and partition it more proficiently to the oxidation product (sulfate), whereas Teffs divert more of the cysteine pool toward protein and GSH synthesis. Tregs appear to block GSH redistribution from the nucleus to the cytoplasm in Teffs, which is abrogated by the addition of exogenous cysteine. Together, these data provide novel insights into modulation of sulfur-based redox metabolism by Tregs, leading to suppression of T cell activation and proliferation.	[Yan, Zhonghua; Garg, Sanjay K.; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu			National Institutes of Health [HL58984, DK64959]; NIDDK [5P60 DK20572]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, R01DK064959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL58984 and DK64959. The work performed in the Morphology and Image Analysis Cores of the Michigan Diabetes Research and Training Center was supported by National Institutes of Health Grant 5P60 DK20572 from NIDDK.	Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Avval FZ, 2009, J BIOL CHEM, V284, P8233, DOI 10.1074/jbc.M809338200; Castellani P, 2008, EUR J IMMUNOL, V38, P2419, DOI 10.1002/eji.200838439; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; Corthay A, 2009, SCAND J IMMUNOL, V70, P326, DOI 10.1111/j.1365-3083.2009.02308.x; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; ECK HP, 1989, BIOL CHEM H-S, V370, P101, DOI 10.1515/bchm3.1989.370.1.101; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Foster DJ, 2009, J NEUROCHEM, V108, P437, DOI 10.1111/j.1471-4159.2008.05773.x; GAJEWSKI TF, 1989, IMMUNOL REV, V111, P79, DOI 10.1111/j.1600-065X.1989.tb00543.x; Garg S. K., 2010, ANTIOXID RE IN PRESS; Garg SK, 2008, J IMMUNOL, V180, P3866, DOI 10.4049/jimmunol.180.6.3866; Grimble RF, 2006, J NUTR, V136, p1660S, DOI 10.1093/jn/136.6.1660S; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Homann D, 1999, IMMUNITY, V11, P463, DOI 10.1016/S1074-7613(00)80121-1; ISHII T, 1981, J CELL PHYSIOL, V107, P283, DOI 10.1002/jcp.1041070215; ISHII T, 1987, J CELL PHYSIOL, V133, P330, DOI 10.1002/jcp.1041330217; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P14663, DOI 10.1073/pnas.0404842101; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mahnke K, 2007, CELL IMMUNOL, V250, P1, DOI 10.1016/j.cellimm.2008.01.004; Markovic J, 2007, J BIOL CHEM, V282, P20416, DOI 10.1074/jbc.M609582200; Menon SG, 2007, ONCOGENE, V26, P1101, DOI 10.1038/sj.onc.1209895; MESSINA JP, 1989, J IMMUNOL, V143, P1974; Misra N, 2004, J IMMUNOL, V172, P4676, DOI 10.4049/jimmunol.172.8.4676; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208; Pallardo FV, 2009, MOL ASPECTS MED, V30, P77, DOI 10.1016/j.mam.2009.01.001; Randolph DA, 2006, ANNU REV MED, V57, P381, DOI 10.1146/annurev.med.57.121304.131337; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Sido B, 2000, J EXP MED, V192, P907, DOI 10.1084/jem.192.6.907; Sido B, 2008, GASTROENTEROLOGY, V134, P179, DOI 10.1053/j.gastro.2007.11.001; Staal FJT, 1998, EUR J CLIN INVEST, V28, P194; STIPANUK MH, 1992, J NUTR, V122, P420, DOI 10.1093/jn/122.3.420; SUTHANTHIRAN M, 1990, P NATL ACAD SCI USA, V87, P3343, DOI 10.1073/pnas.87.9.3343; Szymczak-Workman AL, 2009, J IMMUNOL, V182, P5188, DOI 10.4049/jimmunol.0803123; Tanchot C, 2004, J IMMUNOL, V172, P4285, DOI 10.4049/jimmunol.172.7.4285; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Voehringer DW, 1998, P NATL ACAD SCI USA, V95, P2956, DOI 10.1073/pnas.95.6.2956; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Yan ZH, 2010, BIOCHEMISTRY-US, V49, P1059, DOI 10.1021/bi902022n; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; Yu P, 2005, J IMMUNOL, V174, P6772, DOI 10.4049/jimmunol.174.11.6772	47	73	73	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41525	41532		10.1074/jbc.M110.189944	http://dx.doi.org/10.1074/jbc.M110.189944			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21037289	Green Published, hybrid			2022-12-25	WOS:000285622600039
J	Vandewoestijne, S; Van Dyck, H				Vandewoestijne, Sofie; Van Dyck, Hans			Population Genetic Differences along a Latitudinal Cline between Original and Recently Colonized Habitat in a Butterfly	PLOS ONE			English	Article							MICROSATELLITE NULL ALLELES; MANIOLA-JURTINA LEPIDOPTERA; PARARGE-AEGERIA; PHENOTYPIC PLASTICITY; DISPERSAL; LANDSCAPE; BEHAVIOR; FRAGMENTATION; EVOLUTION; FLIGHT	Background: Past and current range or spatial expansions have important consequences on population genetic structure. Habitat-use expansion, i.e. changing habitat associations, may also influence genetic population parameters, but has been less studied. Here we examined the genetic population structure of a Palaeartic woodland butterfly Pararge aegeria (Nymphalidae) which has recently colonized agricultural landscapes in NW-Europe. Butterflies from woodland and agricultural landscapes differ in several phenotypic traits (including morphology, behavior and life history). We investigated whether phenotypic divergence is accompanied by genetic divergence between populations of different landscapes along a 700 km latitudinal gradient. Methodology/Principal Findings: Populations (23) along the latitudinal gradient in both landscape types were analyzed using microsatellite and allozyme markers. A general decrease in genetic diversity with latitude was detected, likely due to post-glacial colonization effects. Contrary to expectations, agricultural landscapes were not less diverse and no significant bottlenecks were detected. Nonetheless, a genetic signature of recent colonization is reflected in the absence of clinal genetic differentiation within the agricultural landscape, significantly lower gene flow between agricultural populations (3.494) than between woodland populations (4.183), and significantly higher genetic differentiation between agricultural (0.050) than woodland (0.034) pairwise comparisons, likely due to multiple founder events. Globally, the genetic data suggest multiple long distance dispersal/colonization events and subsequent high intra-and inter-landscape gene flow in this species. Phosphoglucomutase deviated from other enzymes and microsatellite markers, and hence may be under selection along the latitudinal gradient but not between landscape types. Phenotypic divergence was greater than genetic divergence, indicating directional selection on some flight morphology traits. Main Conclusions/Significance: Clinal differentiation characterizes the population structure within the original woodland habitat. Genetic signatures of recent habitat expansion remain, notwithstanding high gene flow. After differentiation through drift was excluded, both latitude and landscape were significant factors inducing spatially variable phenotypic variation.	[Vandewoestijne, Sofie; Van Dyck, Hans] Catholic Univ Louvain, Biodivers Res Ctr, Earth & Life Inst, B-1348 Louvain, Belgium	Universite Catholique Louvain	Vandewoestijne, S (corresponding author), Catholic Univ Louvain, Biodivers Res Ctr, Earth & Life Inst, B-1348 Louvain, Belgium.	Sofie.Vandewoestijne@uclouvain.be			Fund for Scientific Research FNRS (FRFC) [2.4595.07]; ARC (Actions de recherche concertees, Communaute francaise de Belgique/Academie Louvain) [10/15-031]	Fund for Scientific Research FNRS (FRFC)(Fonds de la Recherche Scientifique - FNRS); ARC (Actions de recherche concertees, Communaute francaise de Belgique/Academie Louvain)	This research was supported by a research grant of the Fund for Scientific Research FNRS (FRFC 2.4595.07) and an ARC research grant (Actions de recherche concertees, Communaute francaise de Belgique/Academie Louvain, Convention no10/15-031). S Vandewoestijne is postdoctoral researcher of the Fund for Scientific Research - FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoullaye D, 2010, MOL ECOL RESOUR, V10, P232, DOI 10.1111/j.1755-0998.2009.02796.x; Allendorf F., 2007, CONSERVATION GENETIC; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Austerlitz F, 1997, THEOR POPUL BIOL, V51, P148, DOI 10.1006/tpbi.1997.1302; Baguette M, 2007, LANDSCAPE ECOL, V22, P1117, DOI 10.1007/s10980-007-9108-4; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berwaerts K, 1998, NETH J ZOOL, V48, P241, DOI 10.1163/156854298X00093; Bialozyt R, 2006, J EVOLUTION BIOL, V19, P12, DOI 10.1111/j.1420-9101.2005.00995.x; Breuker C.J., 2010, MORPHOMETRICS NONMOR, P271; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Corander J, 2003, GENETICS, V163, P367; Corander J, 2008, COMPUTATION STAT, V23, P111, DOI 10.1007/s00180-007-0072-x; Cornuet JM, 1996, GENETICS, V144, P2001; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Darling JA, 2009, MOL ECOL, V18, P4827, DOI 10.1111/j.1365-294X.2009.04405.x; Dover J, 2000, J ENVIRON MANAGE, V60, P51, DOI 10.1006/jema.2000.0361; Edelaar P, 2008, EVOLUTION, V62, P2462, DOI 10.1111/j.1558-5646.2008.00459.x; Evans KL, 2009, P ROY SOC B-BIOL SCI, V276, P2403, DOI 10.1098/rspb.2008.1712; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Finger A, 2009, ECOGRAPHY, V32, P382, DOI 10.1111/j.1600-0587.2008.05766.x; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; GOULSON D, 1993, HEREDITY, V71, P386, DOI 10.1038/hdy.1993.153; Harper GL, 2003, MOL ECOL, V12, P3349, DOI 10.1046/j.1365-294X.2003.02012.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hill JK, 2006, BIOL LETTERS, V2, P152, DOI 10.1098/rsbl.2005.0401; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Karl I, 2009, ECOGRAPHY, V32, P488, DOI 10.1111/j.1600-0587.2008.05660.x; Karlsson B, 2005, P ROY SOC B-BIOL SCI, V272, P1257, DOI 10.1098/rspb.2005.3074; Kemp DJ, 2006, BEHAV ECOL SOCIOBIOL, V59, P403, DOI 10.1007/s00265-005-0064-1; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; Marrs RA, 2008, BIOL INVASIONS, V10, P561, DOI 10.1007/s10530-007-9153-6; Merckx T, 2005, ANIM BEHAV, V70, P411, DOI 10.1016/j.anbehav.2004.12.005; Merckx T, 2003, P ROY SOC B-BIOL SCI, V270, P1815, DOI 10.1098/rspb.2003.2459; Merckx T, 2008, BASIC APPL ECOL, V9, P433, DOI 10.1016/j.baae.2007.03.009; Merckx T, 2007, ANIM BEHAV, V74, P1029, DOI 10.1016/j.anbehav.2006.12.020; Merckx T, 2006, OIKOS, V113, P226, DOI 10.1111/j.2006.0030-1299.14501.x; NYLIN S, 1989, BIOL J LINN SOC, V38, P155, DOI 10.1111/j.1095-8312.1989.tb01571.x; Oliver T, 2009, ECOL LETT, V12, P1091, DOI 10.1111/j.1461-0248.2009.01367.x; Olivieri I, 2009, TRENDS ECOL EVOL, V24, P289, DOI 10.1016/j.tree.2009.01.015; Orsini L, 2008, MOL ECOL, V17, P2629, DOI 10.1111/j.1365-294X.2008.03782.x; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Raufaste N, 2000, THEOR POPUL BIOL, V57, P285, DOI 10.1006/tpbi.2000.1457; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Schmitt T, 2005, BIOL J LINN SOC, V85, P419, DOI 10.1111/j.1095-8312.2005.00504.x; Schneider S., 2000, ARLEQUIN VER 2 000 S; Settele Josef, 2008, BioRisk, V1, P1; Shreeve Tim, 2009, P171; Skrede I, 2009, HEREDITY, V102, P293, DOI 10.1038/hdy.2008.120; Stevens VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011123; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Travis JMJ, 2002, EVOL ECOL RES, V4, P1119; Van der Veken S, 2008, FRONT ECOL ENVIRON, V6, P212, DOI 10.1890/070063; Van Dyck H, 2002, J EVOLUTION BIOL, V15, P216, DOI 10.1046/j.1420-9101.2002.00384.x; Van Dyck H, 2005, BASIC APPL ECOL, V6, P535, DOI 10.1016/j.baae.2005.03.005; Van Dyck Hans, 2003, P353; Van Dyck H, 2009, CONSERV BIOL, V23, P957, DOI 10.1111/j.1523-1739.2009.01175.x; Vandewoestijne S, 1999, MOL ECOL, V8, P1539, DOI 10.1046/j.1365-294x.1999.00725.x; Vandewoestijne S, 2004, BASIC APPL ECOL, V5, P581, DOI 10.1016/j.baae.2004.07.004; VANDEWOESTIJNE S, FLIGHT MORPHOL UNPUB; WATT WB, 1977, GENETICS, V87, P177; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Williams BL, 2003, MOL ECOL, V12, P11, DOI 10.1046/j.1365-294X.2003.01700.x; Wilson GA, 2003, GENETICS, V163, P1177; Wood BC, 2002, BIODIVERS CONSERV, V11, P1451, DOI 10.1023/A:1016223907962; Wright S, 1943, GENETICS, V28, P114; Zakharov EV, 2008, MOL ECOL, V17, P3035, DOI 10.1111/j.1365-294X.2008.03825.x	74	31	31	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13810	10.1371/journal.pone.0013810	http://dx.doi.org/10.1371/journal.pone.0013810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072197	Green Published, gold, Green Submitted			2022-12-25	WOS:000283780800011
J	Wei, J; Ghosh, AK; Sargent, JL; Komura, K; Wu, MH; Huang, QQ; Jain, M; Whitfield, ML; Feghali-Bostwick, C; Varga, J				Wei, Jun; Ghosh, Asish K.; Sargent, Jennifer L.; Komura, Kazuhiro; Wu, Minghua; Huang, Qi-Quan; Jain, Manu; Whitfield, Michael L.; Feghali-Bostwick, Carol; Varga, John			PPAR gamma Downregulation by TGF beta in Fibroblast and Impaired Expression and Function in Systemic Sclerosis: A Novel Mechanism for Progressive Fibrogenesis	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; GROWTH-FACTOR-BETA; COLLAGEN GENE-EXPRESSION; HUMAN SKIN FIBROBLASTS; I COLLAGEN; PROFIBROTIC RESPONSES; MOUSE MODEL; ADIPOGENESIS; SCLERODERMA; INHIBITION	The nuclear orphan receptor peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is expressed in multiple cell types in addition to adipocytes. Upon its activation by natural ligands such as fatty acids and eicosanoids, or by synthetic agonists such as rosiglitazone, PPAR-gamma regulates adipogenesis, glucose uptake and inflammatory responses. Recent studies establish a novel role for PPAR-gamma signaling as an endogenous mechanism for regulating transforming growth factor-beta (TGF-beta)-dependent fibrogenesis. Here, we sought to characterize PPAR-gamma function in the prototypic fibrosing disorder systemic sclerosis (SSc), and delineate the factors governing PPAR-gamma expression. We report that PPAR-gamma levels were markedly diminished in skin and lung biopsies from patients with SSc, and in fibroblasts explanted from the lesional skin. In normal fibroblasts, treatment with TGF-beta resulted in a time- and dose-dependent down-regulation of PPAR-gamma expression. Inhibition occurred at the transcriptional level and was mediated via canonical Smad signal transduction. Genome-wide expression profiling of SSc skin biopsies revealed a marked attenuation of PPAR-gamma levels and transcriptional activity in a subset of patients with diffuse cutaneous SSc, which was correlated with the presence of a "TGF-beta responsive gene signature" in these biopsies. Together, these results demonstrate that the expression and function of PPAR-gamma are impaired in SSc, and reveal the existence of a reciprocal inhibitory cross-talk between TGF-beta activation and PPAR-gamma signaling in the context of fibrogenesis. In light of the potent anti-fibrotic effects attributed to PPAR-gamma, these observations lead us to propose that excessive TGF-beta activity in SSc accounts for impaired PPAR-gamma function, which in turn contributes to unchecked fibroblast activation and progressive fibrosis.	[Wei, Jun; Ghosh, Asish K.; Komura, Kazuhiro; Wu, Minghua; Huang, Qi-Quan; Varga, John] Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; [Jain, Manu] Northwestern Univ, Feinberg Sch Med, Div Resp & Crit Care Med, Chicago, IL 60611 USA; [Sargent, Jennifer L.; Whitfield, Michael L.] Dartmouth Med Coll, Dept Genet, Hanover, NH USA; [Feghali-Bostwick, Carol] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Dartmouth College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wei, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA.	j-varga@northwestern.edu	Wei, Jun/G-3295-2012; Komura, Kazuhiro/AAS-8380-2021; Varga, John/AAK-6472-2021; Whitfield, Michael/AAC-5010-2020	Komura, Kazuhiro/0000-0002-4775-7356; 	National Institutes of Health [AR-42309, AR-49025]; Scleroderma Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049025, R56AR042309, R01AR042309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by grants from the National Institutes of Health (AR-42309 and AR-49025) and the Scleroderma Research Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Beyer C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2598; Burgess HA, 2005, AM J PHYSIOL-LUNG C, V288, pL1146, DOI 10.1152/ajplung.00383.2004; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Culver DA, 2004, AM J RESP CELL MOL, V30, P1; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dong CM, 2002, P NATL ACAD SCI USA, V99, P3908, DOI 10.1073/pnas.062010399; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; Dudas M, 2004, DEV BIOL, V266, P96, DOI 10.1016/j.ydbio.2003.10.007; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; FLEISCHMAJER R, 1972, ARCH DERMATOL, V105, P59, DOI 10.1001/archderm.105.1.59; Galli A, 2002, GASTROENTEROLOGY, V122, pA488; Ghosh AK, 2004, ARTHRITIS RHEUM-US, V50, P1305, DOI 10.1002/art.20104; Ghosh AK, 2000, ONCOGENE, V19, P3546, DOI 10.1038/sj.onc.1203693; Ghosh A, 2009, FASEB J, V23; Ghosh AK, 2008, BIOCHEM BIOPH RES CO, V374, P231, DOI 10.1016/j.bbrc.2008.07.014; Gressner OA, 2008, J HEPATOL, V49, P758, DOI 10.1016/j.jhep.2008.03.029; Ha H, 2009, NAT REV NEPHROL, V5, P203, DOI 10.1038/nrneph.2009.15; Higgins LS, 2010, AM J CLIN NUTR, V91, p267S, DOI 10.3945/ajcn.2009.28449E; Hong KM, 2005, FASEB J, V19, pA1052; Kapoor M, 2007, PROSTAG LEUKOTR ESS, V76, P103, DOI 10.1016/j.plefa.2006.11.006; Kapoor M, 2009, ARTHRITIS RHEUM-US, V60, P2822, DOI 10.1002/art.24761; Karnik P, 2009, J INVEST DERMATOL, V129, P1243, DOI 10.1038/jid.2008.369; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; Kim S, 2007, P NATL ACAD SCI USA, V104, P16627, DOI 10.1073/pnas.0707797104; Kis A, 2009, EUR J HEART FAIL, V11, P533, DOI 10.1093/eurjhf/hfp048; Lakos G, 2004, AM J PATHOL, V165, P203, DOI 10.1016/S0002-9440(10)63289-0; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li X, 2007, NEPHROL DIAL TRANSPL, V22, P1041, DOI 10.1093/ndt/gfl766; LIU SH, CELL MOL LIFE SCI; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Milam JE, 2008, AM J PHYSIOL-LUNG C, V294, pL891, DOI 10.1152/ajplung.00333.2007; Milano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696; Miyahara T, 2000, J BIOL CHEM, V275, P35715, DOI 10.1074/jbc.M006577200; Mori Y, 2004, ARTHRITIS RHEUM-US, V50, P4008, DOI 10.1002/art.20658; Mori Y, 2003, ARTHRITIS RHEUM-US, V48, P1964, DOI 10.1002/art.11157; Park Y, 2003, DIABETOLOGIA, V46, P365, DOI 10.1007/s00125-003-1037-4; Psaty BM, 2007, NEW ENGL J MED, V356, P2522, DOI 10.1056/NEJMe078099; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; SARGENT JL, 2009, J INVEST DERMATOL; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shiomi T, 2002, CIRCULATION, V106, P3126, DOI 10.1161/01.CIR.0000039346.31538.2C; SHIWEN X, RHEUMATOLOGY OXFORD, V49, P259; Simon MF, 2005, J BIOL CHEM, V280, P14656, DOI 10.1074/jbc.M412585200; Sonnylal S, 2007, ARTHRITIS RHEUM-US, V56, P334, DOI 10.1002/art.22328; Tan JTM, 2008, AM J PHYSIOL-CELL PH, V295, pC740, DOI 10.1152/ajpcell.00333.2007; TAN X, RESP RES, V11, P21; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trojanowska M, 2007, CURR OPIN RHEUMATOL, V19, P568, DOI 10.1097/BOR.0b013e3282e6f495; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Varga J, 2009, NAT REV RHEUMATOL, V5, P200, DOI 10.1038/nrrheum.2009.26; Verrecchia F, 2007, RHEUMATOLOGY, V46, P833, DOI 10.1093/rheumatology/kel451; Wang YQ, 2006, ARTHRITIS RHEUM-US, V54, P2271, DOI 10.1002/art.21948; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wu MH, 2009, AM J PATHOL, V174, P519, DOI 10.2353/ajpath.2009.080574; Yang L, 2006, AM J PHYSIOL-GASTR L, V291, pG902, DOI 10.1152/ajpgi.00124.2006; Yuan WH, 2001, J BIOL CHEM, V276, P38502, DOI 10.1074/jbc.M107081200; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zheng F, 2002, AM J PHYSIOL-RENAL, V282, pF639, DOI 10.1152/ajprenal.00189.2001; Zheng SZ, 2007, AM J PHYSIOL-GASTR L, V292, pG113, DOI 10.1152/ajpgi.00200.2006; Vincent ZA, 2007, BBA-MOL CELL BIOL L, V1771, P915, DOI 10.1016/j.bbalip.2007.01.007	65	111	116	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13778	10.1371/journal.pone.0013778	http://dx.doi.org/10.1371/journal.pone.0013778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072170	Green Published, gold, Green Submitted			2022-12-25	WOS:000283779700003
J	Coelmont, L; Hanoulle, X; Chatterji, U; Berger, C; Snoeck, J; Bobardt, M; Lim, P; Vliegen, I; Paeshuyse, J; Vuagniaux, G; Vandamme, AM; Bartenschlager, R; Gallay, P; Lippens, G; Neyts, J				Coelmont, Lotte; Hanoulle, Xavier; Chatterji, Udayan; Berger, Carola; Snoeck, Joke; Bobardt, Michael; Lim, Precious; Vliegen, Inge; Paeshuyse, Jan; Vuagniaux, Gregoire; Vandamme, Anne-Mieke; Bartenschlager, Ralf; Gallay, Philippe; Lippens, Guy; Neyts, Johan			DEB025 (Alisporivir) Inhibits Hepatitis C Virus Replication by Preventing a Cyclophilin A Induced Cis-Trans Isomerisation in Domain II of NS5A	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN 5A; CYCLOSPORINE-A; ISOMERASE ACTIVITY; RNA REPLICATION; RESISTANCE; BINDING; DEBIO-025; IDENTIFICATION; COMBINATION; POLYMERASE	DEB025/Debio 025 (Alisporivir) is a cyclophilin (Cyp)-binding molecule with potent anti-hepatitis C virus (HCV) activity both in vitro and in vivo. It is currently being evaluated in phase II clinical trials. DEB025 binds to CypA, a peptidyl-prolyl cis-trans isomerase which is a crucial cofactor for HCV replication. Here we report that it was very difficult to select resistant replicons (genotype 1b) to DEB025, requiring an average of 20 weeks (four independent experiments), compared to the typically <2 weeks with protease or polymerase inhibitors. This indicates a high genetic barrier to resistance for DEB025. Mutation D320E in NS5A was the only mutation consistently selected in the replicon genome. This mutation alone conferred a low-level (3.9-fold) resistance. Replacing the NS5A gene (but not the NS5B gene) from the wild type (WT) genome with the corresponding sequence from the DEB025(res) replicon resulted in transfer of resistance. Cross-resistance with cyclosporine A (CsA) was observed, whereas NS3 protease and NS5B polymerase inhibitors retained WT-activity against DEB025(res) replicons. Unlike WT, DEB025(res) replicon replicated efficiently in CypA knock down cells. However, DEB025 disrupted the interaction between CypA and NS5A regardless of whether the NS5A protein was derived from WT or DEB025(res) replicon. NMR titration experiments with peptides derived from the WT or the DEB025(res) domain II of NS5A corroborated this observation in a quantitative manner. Interestingly, comparative NMR studies on two 20-mer NS5A peptides that contain D320 or E320 revealed a shift in population between the major and minor conformers. These data suggest that D320E conferred low-level resistance to DEB025 probably by reducing the need for CypA-dependent isomerisation of NS5A. Prolonged DEB025 treatment and multiple genotypic changes may be necessary to generate significant resistance to DEB025, underlying the high barrier to resistance.	[Coelmont, Lotte; Snoeck, Joke; Vliegen, Inge; Paeshuyse, Jan; Vandamme, Anne-Mieke; Neyts, Johan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Louvain, Belgium; [Hanoulle, Xavier; Lippens, Guy] Univ Lille 1, Ctr Natl Rech Sci, Unite Mixte Rech 8576, F-59655 Villeneuve Dascq, France; [Chatterji, Udayan; Bobardt, Michael; Lim, Precious; Gallay, Philippe] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Berger, Carola; Bartenschlager, Ralf] Heidelberg Univ, Dept Mol Virol, Heidelberg, Germany; [Vuagniaux, Gregoire] Debiopharm, Pharmacol & Screening Unit, Lausanne, Switzerland	KU Leuven; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Scripps Research Institute; Ruprecht Karls University Heidelberg; Debiopharm	Coelmont, L (corresponding author), Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Louvain, Belgium.	johan.neyts@rega.kuleuven.be	Hanoulle, Xavier/AAK-7236-2021; HANOULLE, Xavier/HHN-4815-2022; Neyts, Johan/U-8267-2017; Vandamme, Anne-Mieke/I-4127-2012; Bartenschlager, Ralf/L-2582-2015	Hanoulle, Xavier/0000-0002-3755-2680; Neyts, Johan/0000-0002-0033-7514; Vandamme, Anne-Mieke/0000-0002-6594-2766; Bartenschlager, Ralf/0000-0001-5601-9307; Lippens, Guy/0000-0002-8236-0901; Paeshuyse, Jan/0000-0003-2396-354X	Fonds voor Wetenschappelijk Onderzoek, Vlaanderen (FWO) [G.0728.09N]; Debiopharm (Lausanne, Switzerland); Deutsche Forschungsgemeinschaft [BA 1505/2]; U.S. Public Health Service [AI087746]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087746] Funding Source: NIH RePORTER	Fonds voor Wetenschappelijk Onderzoek, Vlaanderen (FWO)(FWO); Debiopharm (Lausanne, Switzerland); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported in part by grant G.0728.09N from the "Fonds voor Wetenschappelijk Onderzoek, Vlaanderen (FWO)". J. Paeshuyse and J. Snoeck are supported by a post-doctoral position of the FWO. Part of this study was sponsored by Debiopharm (Lausanne, Switzerland). G. Vuagniaux is an employee of Debiopharm. R. Bartenschlager is supported by a grant from the "Deutsche Forschungsgemeinschaft" (BA 1505/2). P. Gallay is supported by U.S. Public Health Service grants no. AI087746 (P.A.G.). The funder Debiopharm had a role in study design, decision to publish and preparation of the manuscript, but not in data collection and analysis.	Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Chatterji U, 2010, J HEPATOL, V53, P50, DOI 10.1016/j.jhep.2010.01.041; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; Coelmont L, 2009, ANTIMICROB AGENTS CH, V53, P967, DOI 10.1128/AAC.00939-08; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Craxi A, 2003, SEMIN LIVER DIS, V23, P35; Delang L, 2010, VIRUSES-BASEL, V2, P826, DOI 10.3390/v2040826; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Fernandes F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009815; Flisiak R, 2008, HEPATOLOGY, V47, P817, DOI 10.1002/hep.22131; Flisiak R, 2009, HEPATOLOGY, V49, P1460, DOI 10.1002/hep.22835; Foster TL, 2010, J VIROL, V84, P9267, DOI 10.1128/JVI.00616-10; Goto K, 2009, CANCER SCI, V100, P1943, DOI 10.1111/j.1349-7006.2009.01263.x; Hanoulle X, 2010, PROTEIN PEPTIDE LETT, V17, P1012, DOI 10.2174/092986610791498920; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; Hopkins S, 2010, ANTIMICROB AGENTS CH, V54, P660, DOI 10.1128/AAC.00660-09; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Huang LY, 2004, PROTEIN EXPRES PURIF, V37, P144, DOI 10.1016/j.pep.2004.05.005; Inoue K, 2005, TRANSPLANT P, V37, P1233, DOI 10.1016/j.transproceed.2004.11.041; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Landrieu I, 2010, BIOCHEMISTRY-US, V49, P4679, DOI 10.1021/bi1003266; Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09; Liang Y, 2007, BIOCHEMISTRY-US, V46, P11550, DOI 10.1021/bi700776e; Liu Z, 2009, J VIROL, V83, P6554, DOI 10.1128/JVI.02550-08; Liu Z, 2009, HEPATOLOGY, V50, P25, DOI 10.1002/hep.22987; Lohmann V, 2001, J VIROL, V75, P1437, DOI 10.1128/JVI.75.3.1437-1449.2001; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Ma S, 2006, ANTIMICROB AGENTS CH, V50, P2976, DOI 10.1128/AAC.00310-06; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Nakagawa M, 2005, GASTROENTEROLOGY, V129, P1031, DOI 10.1053/j.gastro.2005.06.031; Nakagawa M, 2004, BIOCHEM BIOPH RES CO, V313, P42, DOI 10.1016/j.bbrc.2003.11.080; Paeshuyse J, 2006, HEPATOLOGY, V43, P761, DOI 10.1002/hep.21102; Ptak RG, 2008, ANTIMICROB AGENTS CH, V52, P1302, DOI 10.1128/AAC.01324-07; Puyang XL, 2010, ANTIMICROB AGENTS CH, V54, P1981, DOI 10.1128/AAC.01236-09; QUINKERT D, 2008, 15 INT S HEP C VIR R; Reddy KR, 2009, J HEPATOL, V50, P402, DOI 10.1016/j.jhep.2008.11.006; Robida JM, 2007, J VIROL, V81, P5829, DOI 10.1128/JVI.02524-06; Saphire ACS, 1999, EMBO J, V18, P6771, DOI 10.1093/emboj/18.23.6771; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Targett-Adams P, 2005, J GEN VIROL, V86, P3075, DOI 10.1099/vir.0.81334-0; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; van den Hoff M J, 1995, Methods Mol Biol, V48, P185; Vrolijk JM, 2003, J VIROL METHODS, V110, P201, DOI 10.1016/S0166-0934(03)00134-4; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Zoulim F, 2003, REV MED VIROL, V13, P57, DOI 10.1002/rmv.371	54	138	142	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13687	10.1371/journal.pone.0013687	http://dx.doi.org/10.1371/journal.pone.0013687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060866	Green Published, gold, Green Submitted			2022-12-25	WOS:000283537000052
J	Langley, AR; Chambers, H; Christov, CP; Krude, T				Langley, Alexander R.; Chambers, Helen; Christov, Christo P.; Krude, Torsten			Ribonucleoprotein Particles Containing Non-Coding Y RNAs, Ro60, La and Nucleolin Are Not Required for Y RNA Function in DNA Replication	PLOS ONE			English	Article							SMALL CYTOPLASMIC RIBONUCLEOPROTEINS; PROTEIN-A; INTRACELLULAR-LOCALIZATION; SUBCELLULAR-DISTRIBUTION; CONSERVED FEATURES; QUALITY-CONTROL; IN-VITRO; AUTOANTIGEN; INITIATION; BINDING	Background: Ro ribonucleoprotein particles (Ro RNPs) consist of a non-coding Y RNA bound by Ro60, La and possibly other proteins. The physiological function of Ro RNPs is controversial as divergent functions have been reported for its different constituents. We have recently shown that Y RNAs are essential for the initiation of mammalian chromosomal DNA replication, whereas Ro RNPs are implicated in RNA stability and RNA quality control. Therefore, we investigate here the functional consequences of RNP formation between Ro60, La and nucleolin proteins with hY RNAs for human chromosomal DNA replication. Methodology/Principal Findings: We first immunoprecipitated Ro60, La and nucleolin together with associated hY RNAs from HeLa cytosolic cell extract, and analysed the protein and RNA compositions of these precipitated RNPs by Western blotting and quantitative RT-PCR. We found that Y RNAs exist in several RNP complexes. One RNP comprises Ro60, La and hY RNA, and a different RNP comprises nucleolin and hY RNA. In addition about 50% of the Y RNAs in the extract are present outside of these two RNPs. Next, we immunodepleted these RNP complexes from the cytosolic extract and tested the ability of the depleted extracts to reconstitute DNA replication in a human cell-free system. We found that depletion of these RNP complexes from the cytosolic extract does not inhibit DNA replication in vitro. Finally, we tested if an excess of recombinant pure Ro or La protein inhibits Y RNA-dependent DNA replication in this cell-free system. We found that Ro60 and La proteins do not inhibit DNA replication in vitro. Conclusions/Significance: We conclude that RNPs containing hY RNAs and Ro60, La or nucleolin are not required for the function of hY RNAs in chromosomal DNA replication in a human cell-free system, which can be mediated by Y RNAs outside of these RNPs. These data suggest that Y RNAs can support different cellular functions depending on associated proteins.	[Langley, Alexander R.; Chambers, Helen; Christov, Christo P.; Krude, Torsten] Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge	Langley, AR (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	tk1@mole.bio.cam.ac.uk		Krude, Torsten/0000-0002-1842-1933	Cancer Research UK [C1471/A8448]; Medical Research Council (MRC); Nuffield Foundation [URB/33112]	Cancer Research UK(Cancer Research UK); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Nuffield Foundation	This work was supported by Cancer Research UK (project grant C1471/A8448; URL: http://www.cancerresearchuk.org/). A.R.L was supported by a Research Studentship from the Medical Research Council (MRC; URL: http://www.mrc.ac.uk/index.htm), and H. C. was supported by an Undergraduate Research Bursary from the Nuffield Foundation (URB/33112; URL: http://www.nuffieldfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belisova A, 2005, RNA, V11, P1084, DOI 10.1261/rna.7263905; BOIRE G, 1990, J CLIN INVEST, V85, P1182, DOI 10.1172/JCI114551; Chen XG, 2004, J MOL MED, V82, P232, DOI 10.1007/s00109-004-0529-0; Chen XG, 2003, CURR BIOL, V13, P2206, DOI 10.1016/j.cub.2003.11.028; Christov CP, 2008, BRIT J CANCER, V98, P981, DOI 10.1038/sj.bjc.6604254; Christov CP, 2006, MOL CELL BIOL, V26, P6993, DOI 10.1128/MCB.01060-06; Daniely Y, 2000, J CELL BIOL, V149, P799, DOI 10.1083/jcb.149.4.799; Daniely Y, 2002, MOL CELL BIOL, V22, P6014, DOI 10.1128/MCB.22.16.6014-6022.2002; Fabini G, 2000, EUR J BIOCHEM, V267, P2778, DOI 10.1046/j.1432-1327.2000.01298.x; Fabini G, 2001, J BIOL CHEM, V276, P20711, DOI 10.1074/jbc.M101360200; Farris AD, 1999, NUCLEIC ACIDS RES, V27, P1070, DOI 10.1093/nar/27.4.1070; Fouraux MA, 2002, J MOL BIOL, V320, P475, DOI 10.1016/S0022-2836(02)00518-1; Fuchs G, 2006, NAT STRUCT MOL BIOL, V13, P1002, DOI 10.1038/nsmb1156; Garcia EL, 2009, J VIROL, V83, P12526, DOI 10.1128/JVI.01219-09; Gardiner TJ, 2009, RNA, V15, P1375, DOI 10.1261/rna.1472009; GOTTLIEB E, 1989, EMBO J, V8, P851, DOI 10.1002/j.1460-2075.1989.tb03446.x; GOTTLIEB EL, 1989, EMBO J, V8, P841, DOI 10.1002/j.1460-2075.1989.tb03445.x; Green CD, 1998, RNA, V4, P750, DOI 10.1017/S1355838298971667; HENDRICK JP, 1981, MOL CELL BIOL, V1, P1138, DOI 10.1128/MCB.1.12.1138; Kim K, 2005, MOL CELL BIOL, V25, P2463, DOI 10.1128/MCB.25.6.2463-2474.2005; Krude T, 2000, J BIOL CHEM, V275, P13699, DOI 10.1074/jbc.275.18.13699; Krude T, 1997, CELL, V88, P109, DOI 10.1016/S0092-8674(00)81863-2; Krude T, 1999, EXP CELL RES, V247, P148, DOI 10.1006/excr.1998.4342; Krude T, 2009, J CELL SCI, V122, P2836, DOI 10.1242/jcs.047563; LERNER MR, 1981, SCIENCE, V211, P400, DOI 10.1126/science.6164096; MATHEWS MB, 1984, MOL CELL BIOL, V4, P1134, DOI 10.1128/MCB.4.6.1134; Mosig A, 2007, THEOR BIOSCI, V126, P9, DOI 10.1007/s12064-007-0003-y; OBRIEN CA, 1994, GENE DEV, V8, P2891, DOI 10.1101/gad.8.23.2891; PEEK R, 1993, J CELL SCI, V106, P929; Perreault J, 2007, MOL BIOL EVOL, V24, P1678, DOI 10.1093/molbev/msm084; Pruijn GJM, 1997, EUR J CELL BIOL, V74, P123; PRUIJN GJM, 1991, NUCLEIC ACIDS RES, V19, P5173, DOI 10.1093/nar/19.19.5173; Sim S, 2009, MOL BIOL CELL, V20, P1555, DOI 10.1091/mbc.E08-11-1094; Simons FHM, 1996, RNA, V2, P264; SIMONS FHM, 1994, J CELL BIOL, V125, P981, DOI 10.1083/jcb.125.5.981; STEFANO JE, 1984, CELL, V36, P145, DOI 10.1016/0092-8674(84)90083-7; Stein AJ, 2005, CELL, V121, P529, DOI 10.1016/j.cell.2005.03.009; Szuts D, 2003, NUCLEIC ACIDS RES, V31, P1725, DOI 10.1093/nar/gkg269; Szuts D, 2005, EXP CELL RES, V311, P240, DOI 10.1016/j.yexcr.2005.09.009; Teunissen SWM, 2000, NUCLEIC ACIDS RES, V28, P610, DOI 10.1093/nar/28.2.610; Wang YZ, 2001, J BIOL CHEM, V276, P20579, DOI 10.1074/jbc.M100874200; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; WOLIN SL, 1984, P NATL ACAD SCI-BIOL, V81, P1996, DOI 10.1073/pnas.81.7.1996; Xue DH, 2003, P NATL ACAD SCI USA, V100, P7503, DOI 10.1073/pnas.0832411100	44	31	31	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13673	10.1371/journal.pone.0013673	http://dx.doi.org/10.1371/journal.pone.0013673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060685	Green Published, gold, Green Submitted			2022-12-25	WOS:000283537000040
J	Passannante, M; Marti, CO; Pfefferli, C; Moroni, PS; Kaeser-Pebernard, S; Puoti, A; Hunziker, P; Wicky, C; Muller, F				Passannante, Myriam; Marti, Claude-Olivier; Pfefferli, Catherine; Moroni, Paolo S.; Kaeser-Pebernard, Stephanie; Puoti, Alessandro; Hunziker, Peter; Wicky, Chantal; Mueller, Fritz			Different Mi-2 Complexes for Various Developmental Functions in Caenorhabditis elegans	PLOS ONE			English	Article							TANDEM AFFINITY PURIFICATION; NURD-COMPLEX; VULVAL DEVELOPMENT; LIN-35 RB; PROTEIN; GENES; HOMOLOG; BINDING; ANTAGONIZE; EXPRESSION	Biochemical purifications from mammalian cells and Xenopus oocytes revealed that vertebrate Mi-2 proteins reside in multisubunit NuRD (Nucleosome Remodeling and Deacetylase) complexes. Since all NuRD subunits are highly conserved in the genomes of C. elegans and Drosophila, it was suggested that NuRD complexes also exist in invertebrates. Recently, a novel dMec complex, composed of dMi-2 and dMEP-1 was identified in Drosophila. The genome of C. elegans encodes two highly homologous Mi-2 orthologues, LET-418 and CHD-3. Here we demonstrate that these proteins define at least three different protein complexes, two distinct NuRD complexes and one MEC complex. The two canonical NuRD complexes share the same core subunits HDA-1/HDAC, LIN-53/RbAp and LIN-40/MTA, but differ in their Mi-2 orthologues LET-418 or CHD-3. LET-418 but not CHD-3, interacts with the Kruppel-like protein MEP-1 in a distinct complex, the MEC complex. Based on microarrays analyses, we propose that MEC constitutes an important LET-418 containing regulatory complex during C. elegans embryonic and early larval development. It is required for the repression of germline potential in somatic cells and acts when blastomeres are still dividing and differentiating. The two NuRD complexes may not be important for the early development, but may act later during postembryonic development. Altogether, our data suggest a considerable complexity in the composition, the developmental function and the tissue-specificity of the different C. elegans Mi-2 complexes.	[Passannante, Myriam; Marti, Claude-Olivier; Pfefferli, Catherine; Moroni, Paolo S.; Kaeser-Pebernard, Stephanie; Puoti, Alessandro; Wicky, Chantal; Mueller, Fritz] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Hunziker, Peter] Univ ETH Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland	University of Fribourg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Passannante, M (corresponding author), Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland.	fritz.mueller@unifr.ch	Puoti, Alessandro/ABE-9963-2021; Käser-Pébernard, Stéphanie GM/C-4219-2014; Puoti, Alessandro/E-5700-2012; Müller, Fritz/C-9905-2015	Puoti, Alessandro/0000-0002-1396-7662; Käser-Pébernard, Stéphanie GM/0000-0002-6035-6979; Müller, Fritz/0000-0002-3275-7417; Wicky, Chantal/0000-0002-0034-4992	Swiss National Science Foundation [31003A-109938, 31003A-125577]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work is funded by the Swiss National Science Foundation (http://www.snf.ch/E/Pages/default.aspx) (SNF grants: 31003A-109938 and 31003A-125577). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Al-Shahrour F, 2006, NUCLEIC ACIDS RES, V34, pW472, DOI 10.1093/nar/gkl172; Andersen EC, 2006, DEVELOPMENT, V133, P2695, DOI 10.1242/dev.02444; Ballestar E, 2001, EUR J BIOCHEM, V268, P5397, DOI 10.1046/j.0014-2956.2001.02480.x; Belfiore M, 2002, RNA, V8, P725, DOI 10.1017/S1355838202028595; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berezikov E, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh033; Bettinger JC, 1996, DEVELOPMENT, V122, P2517; Bouazoune K, 2006, CHROMOSOME RES, V14, P433, DOI 10.1007/s10577-006-1067-0; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Brehm A, 2000, EMBO J, V19, P4332, DOI 10.1093/emboj/19.16.4332; BRENNER S, 1974, GENETICS, V77, P71; Chen Z, 2001, DEVELOPMENT, V128, P4911; Chen Z, 2001, CURR BIOL, V11, P1874, DOI 10.1016/S0960-9822(01)00596-6; Chuang PT, 1996, SCIENCE, V274, P1736, DOI 10.1126/science.274.5293.1736; Couteau F, 2005, GENE DEV, V19, P2744, DOI 10.1101/gad.1348205; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Dufourcq P, 2002, MOL CELL BIOL, V22, P3024, DOI 10.1128/MCB.22.9.3024-3034.2002; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; GE Q, 1995, J CLIN INVEST, V96, P1730, DOI 10.1172/JCI118218; Goodyer W, 2008, DEV CELL, V14, P263, DOI 10.1016/j.devcel.2007.11.016; Gould KL, 2004, METHODS, V33, P239, DOI 10.1016/j.ymeth.2003.11.019; Guerry F, 2007, DEV BIOL, V306, P469, DOI 10.1016/j.ydbio.2007.03.026; Gutierrez A, 2004, NUCLEIC ACIDS RES, V32, P6388, DOI 10.1093/nar/gkh982; Harrison MM, 2006, P NATL ACAD SCI USA, V103, P16782, DOI 10.1073/pnas.0608461103; HARRISON MM, 2007, GENETICS; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Herman MA, 1999, DEVELOPMENT, V126, P1055; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; KIEFER JC, 2006, DEV BIOL; KON C, 2005, GENETICS; KUNERT N, 2009, EMBO J; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Marhold J, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-20; Murawska M, 2008, MOL CELL BIOL, V28, P2745, DOI 10.1128/MCB.01839-07; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; POULIN G, 2005, EMBO J; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; SEELIG HP, 1995, ARTHRITIS RHEUM-US, V38, P1389, DOI 10.1002/art.1780381006; Shakhnovich BE, 2006, GENOME RES, V16, P1529, DOI 10.1101/gr.5346206; Shi Y, 1998, GENE DEV, V12, P943, DOI 10.1101/gad.12.7.943; Siegfried KR, 2002, DEVELOPMENT, V129, P443; Solari F, 2000, CURR BIOL, V10, P223, DOI 10.1016/S0960-9822(00)00343-2; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; Thomas JH, 2003, GENETICS, V164, P135; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; UPDIKE DL, 2009, J ANDROL; von Zelewsky T, 2000, DEVELOPMENT, V127, P5277; Wang X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-213; Wood WB, 1988, NEMATODE CAENORHABDI; Yuzyuk T, 2009, DEV CELL, V16, P699, DOI 10.1016/j.devcel.2009.03.008	56	24	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13681	10.1371/journal.pone.0013681	http://dx.doi.org/10.1371/journal.pone.0013681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060680	Green Published, gold, Green Submitted			2022-12-25	WOS:000283537000047
J	Xu, W; Cornel, AJ; Leal, WS				Xu, Wei; Cornel, Anthony J.; Leal, Walter S.			Odorant-Binding Proteins of the Malaria Mosquito Anopheles funestus sensu stricto	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; PHEROMONE-BINDING; AEDES-AEGYPTI; CRYSTAL-STRUCTURE; CARBON-DIOXIDE; RELEASE MECHANISM; CULEX MOSQUITOS; LIGAND-BINDING; NMR STRUCTURE; BOMBYX-MORI	Background: The mosquito Anopheles funestus is one of the major malaria vector species in sub-Saharan Africa. Olfaction is essential in guiding mosquito behaviors. Odorant-binding proteins (OBPs) are highly expressed in insect olfactory tissues and involved in the first step of odorant reception. An improved understanding of the function of malaria mosquito OBPs may contribute to identifying new attractants/repellents and assist in the development of more efficient and environmentally friendly mosquito controlling strategies. Methodology: In this study, a large screening of over 50 ecologically significant odorant compounds led to the identification of 12 ligands that elicit significant electroantennographic (EAG) responses from An. funestus female antennae. To compare the absolute efficiency/potency of these chemicals, corrections were made for differences in volatility by determining the exact amount in a stimulus puff. Fourteen AfunOBP genes were cloned and their expression patterns were analyzed. AfunOBP1, 3, 7, 20 and 66 showed olfactory tissue specificity by reverse transcriptase PCR (RT-PCR). Quantitative real-time PCR (qRT-PCR) analysis showed that among olfactory-specific OBPs, AfunOBP1 and 3 are the most enriched OBPs in female antennae. Binding assay experiments showed that at pH 7, AfunOBP1 significantly binds to 2-undecanone, nonyl acetate, octyl acetate and 1-octen-3-ol but AfunOBP3, which shares 68% identify with AfunOBP1 at amino acid level, showed nearly no binding activity to the selected 12 EAG-active odorant compounds. Conclusion: This work presents for the first time a study on the odorants and OBPs of the malaria vector mosquito An. funestus, which may provide insight into the An. funestus olfactory research, assist in a comparative study between major malaria mosquitoes An. gambiae and An. funestus olfactory system, and help developing new mosquito control strategies to reduce malaria transmission.	[Xu, Wei; Cornel, Anthony J.; Leal, Walter S.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	University of California System; University of California Davis	Xu, W (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021; Xu, Wei/G-4709-2010	Leal Filho, Walter/0000-0002-1241-5225; Leal, Walter/0000-0002-6800-1240; Xu, Wei/0000-0003-4019-5140	National Science Foundation [0918177]; USDA-AFRI [2010-65105-20582]; Bedoukian Research Incorporation; Fuji Flavor Co., Ltd.	National Science Foundation(National Science Foundation (NSF)); USDA-AFRI(United States Department of Agriculture (USDA)); Bedoukian Research Incorporation; Fuji Flavor Co., Ltd.	This work was supported by the National Science Foundation (0918177), USDA-AFRI grant 2010-65105-20582, and unrestricted research funds (defined per university policy as gifts) provided by Bedoukian Research Incorporation, and Fuji Flavor Co., Ltd. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, SUPPLEMENT ANOPHELIN; [Anonymous], 1968, ANOPHELINAE AFR S SA; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Biessmann H, 2002, INSECT MOL BIOL, V11, P123, DOI 10.1046/j.1365-2583.2002.00316.x; Biessmann H, 2005, INSECT MOL BIOL, V14, P575, DOI 10.1111/j.1365-2583.2005.00590.x; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Bissinger BW, 2009, AM J TROP MED HYG, V81, P685, DOI 10.4269/ajtmh.2009.09-0114; Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x; Costantini C, 2001, MED VET ENTOMOL, V15, P259, DOI 10.1046/j.0269-283x.2001.00297.x; Damberger F, 2000, PROTEIN SCI, V9, P1038, DOI 10.1110/ps.9.5.1038; Damberger FF, 2007, J MOL BIOL, V373, P811, DOI 10.1016/j.jmb.2007.07.078; FARRAR RR, 1987, ENTOMOL EXP APPL, V43, P17, DOI 10.1007/BF00350369; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; HALLETT MB, 1984, CELL CALCIUM, V5, P1, DOI 10.1016/0143-4160(84)90150-7; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Innocent E, 2008, Tanzan J Health Res, V10, P50; Ishida Y, 2004, NATURWISSENSCHAFTEN, V91, P426, DOI 10.1007/s00114-004-0551-7; Ishida Y, 2002, J CHEM ECOL, V28, P867, DOI 10.1023/A:1015253214273; KEIL TA, 1984, TISSUE CELL, V16, P705, DOI 10.1016/0040-8166(84)90004-1; Kline DL, 2003, J MED ENTOMOL, V40, P463, DOI 10.1603/0022-2585-40.4.463; KLINE DL, 1991, J MED ENTOMOL, V28, P254, DOI 10.1093/jmedent/28.2.254; KLINE DL, 1994, J AM MOSQUITO CONTR, V10, P280; KLINE DL, 1990, MED VET ENTOMOL, V4, P383, DOI 10.1111/j.1365-2915.1990.tb00455.x; Konate L, 2001, LANCET, V358, P336, DOI 10.1016/S0140-6736(01)05517-9; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Lartigue A, 2004, J BIOL CHEM, V279, P4459, DOI 10.1074/jbc.M311212200; Lartigue A, 2003, J BIOL CHEM, V278, P30213, DOI 10.1074/jbc.M304688200; LAURENCE BR, 1982, J CHEM SOC CHEM COMM, P59, DOI 10.1039/c39820000059; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Leal WS., 2003, INSECT PHEROMONE BIO; Leite NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008006; Li ZX, 2005, ARCH INSECT BIOCHEM, V58, P175, DOI 10.1002/arch.20047; Manga L, 1997, T ROY SOC TROP MED H, V91, P387, DOI 10.1016/S0035-9203(97)90249-2; Matsui M, 2007, EUR NEUROL, V57, P57, DOI 10.1159/000097120; Meijerink J, 1999, J INSECT PHYSIOL, V45, P365, DOI 10.1016/S0022-1910(98)00135-8; Muller GC, 2008, J AM MOSQUITO CONTR, V24, P150, DOI 10.2987/8756-971X(2008)24[150:IPAMAS]2.0.CO;2; Ndjemai HNM, 2009, T ROY SOC TROP MED H, V103, P1127, DOI 10.1016/j.trstmh.2008.11.018; Pelletier J, 2010, J CHEM ECOL, V36, P245, DOI 10.1007/s10886-010-9762-x; Pelletier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006237; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Sengul MS, 2010, INSECT MOL BIOL, V19, P49, DOI 10.1111/j.1365-2583.2009.00929.x; Sharakhov IV, 2002, SCIENCE, V298, P182, DOI 10.1126/science.1076803; Spillings BL, 2009, AM J TROP MED HYG, V81, P510, DOI 10.4269/ajtmh.2009.81.510; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Syed Z, 2009, P NATL ACAD SCI USA, V106, P18803, DOI 10.1073/pnas.0906932106; TAKKEN W, 1989, J AM MOSQUITO CONTR, V5, P311; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Witting-Bissinger BE, 2008, J MED ENTOMOL, V45, P891, DOI 10.1603/0022-2585(2008)45[891:NARBIA]2.0.CO;2; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108; World Health Organization, 2008, WORLD MAL REP; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x	63	37	42	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e15403	10.1371/journal.pone.0015403	http://dx.doi.org/10.1371/journal.pone.0015403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042539	gold, Green Submitted, Green Published			2022-12-25	WOS:000283419100029
J	Welti, JC; Gourlaouen, M; Powles, T; Kudahetti, SC; Wilson, P; Berney, DM; Reynolds, AR				Welti, J. C.; Gourlaouen, M.; Powles, T.; Kudahetti, S. C.; Wilson, P.; Berney, D. M.; Reynolds, A. R.			Fibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinib	ONCOGENE			English	Article						angiogenesis; growth factors; sunitinib; renal cancer; resistance	TYROSINE KINASE INHIBITOR; IN-VITRO; ANTITUMOR-ACTIVITY; TARGETED THERAPY; INTERFERON-ALPHA; TUMOR-GROWTH; ANGIOGENESIS; VEGF; RESISTANCE; EXPRESSION	The vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor sunitinib has been approved for first-line treatment of patients with metastatic renal cancer and is currently being trialled in other cancers. However, the effectiveness of this anti-angiogenic agent is limited by the presence of innate and acquired drug resistance. By screening a panel of candidate growth factors we identified fibroblast growth factor 2 (FGF2) as a potent regulator of endothelial cell sensitivity to sunitinib. We show that FGF2 supports endothelial proliferation and de novo tubule formation in the presence of sunitinib and that FGF2 can suppress sunitinib-induced retraction of tubules. Importantly, these effects of FGF2 were ablated by PD173074, a small molecule inhibitor of FGF receptor signalling. We also show that FGF2 can stimulate pro-angiogenic signalling pathways in endothelial cells despite the presence of sunitinib. Finally, analysis of clinical renal-cancer samples demonstrates that a large proportion of renal cancers strongly express FGF2. We suggest that therapeutic strategies designed to simultaneously target both VEGF and FGF2 signalling may prove more efficacious than sunitinib in renal cancer patients whose tumours express FGF2. Oncogene (2011) 30, 1183-1193; doi:10.1038/onc.2010.503; published online 8 November 2010	[Welti, J. C.; Gourlaouen, M.; Reynolds, A. R.] Inst Canc Res, Tumour Angiogenesis Grp, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Powles, T.; Kudahetti, S. C.; Berney, D. M.] Queen Mary Univ London, Ctr Mol Oncol, Barts & London Sch Med & Dent, John Vane Sci Ctr,Inst Canc, London, England; [Wilson, P.] Dept Med Oncol, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Queen Mary University London	Reynolds, AR (corresponding author), Inst Canc Res, Tumour Angiogenesis Grp, Breakthrough Breast Canc Res Ctr, 237 Fulham Rd, London SW3 6JB, England.	andrew.reynolds@icr.ac.uk		Berney, Daniel/0000-0001-5474-8696; Welti, Jonathan/0000-0002-9433-8138	Breakthrough Breast Cancer; Pfizer Global Pharmaceuticals	Breakthrough Breast Cancer; Pfizer Global Pharmaceuticals(Pfizer)	Thomas Powles is the recipient of an educational research grant from Pfizer Global Pharmaceuticals. The other authors declare no potential conflict of interest.; We would like to thank Alan Ashworth, Clare Isacke and Nicholas Turner for critical comments on the paper and Breakthrough Breast Cancer for research funding.	Abrams TJ, 2003, MOL CANCER THER, V2, P1011; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Britten CD, 2008, CANCER CHEMOTH PHARM, V61, P515, DOI 10.1007/s00280-007-0498-4; Bryant DM, 2005, TRAFFIC, V6, P947, DOI 10.1111/j.1600-0854.2005.00332.x; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Ebos JML, 2009, CLIN CANCER RES, V15, P5020, DOI 10.1158/1078-0432.CCR-09-0095; EGUCHI J, 1992, BIOCHEM BIOPH RES CO, V183, P937, DOI 10.1016/S0006-291X(05)80280-3; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Faivre S, 2006, J CLIN ONCOL, V24, P25, DOI 10.1200/JCO.2005.02.2194; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Fukata S, 2005, CANCER-AM CANCER SOC, V103, P931, DOI 10.1002/cncr.20887; Giavazzi R, 2003, AM J PATHOL, V162, P1913, DOI 10.1016/S0002-9440(10)64325-8; Gualandris A, 1996, CELL GROWTH DIFFER, V7, P147; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Huang D, 2010, CANCER RES, V70, P1053, DOI 10.1158/0008-5472.CAN-09-3722; Huang D, 2010, CANCER RES, V70, P1063, DOI 10.1158/0008-5472.CAN-09-3965; Joy A, 1997, ONCOGENE, V14, P171, DOI 10.1038/sj.onc.1200823; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Meyer RD, 2003, J BIOL CHEM, V278, P16347, DOI 10.1074/jbc.M300259200; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Nakatsu MN, 2008, METHOD ENZYMOL, V443, P65, DOI 10.1016/S0076-6879(08)02004-1; NANUS DM, 1993, J NATL CANCER I, V85, P1597, DOI 10.1093/jnci/85.19.1597; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pardo OE, 2009, CANCER RES, V69, P8645, DOI 10.1158/0008-5472.CAN-09-1576; PEPPER MS, 1992, BIOCHEM BIOPH RES CO, V189, P824, DOI 10.1016/0006-291X(92)92277-5; Pintucci G, 2002, FASEB J, V16, P598, DOI 10.1096/fj.01-0815fje; PRESTA M, 1991, CELL REGUL, V2, P719, DOI 10.1091/mbc.2.9.719; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Ravaud A, 2008, J CLIN ONCOL, V26, P2285, DOI 10.1200/JCO.2007.14.5029; Relf M, 1997, CANCER RES, V57, P963; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; SCHWEIGERER L, 1987, NATURE, V325, P257, DOI 10.1038/325257a0; Slaton JW, 2001, AM J PATHOL, V158, P735, DOI 10.1016/S0002-9440(10)64016-3; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780	51	101	103	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	10					1183	1193		10.1038/onc.2010.503	http://dx.doi.org/10.1038/onc.2010.503			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	732QD	21057538				2022-12-25	WOS:000288202400005
J	Morishita, D; Takami, M; Yoshikawa, S; Katayama, R; Sato, S; Kukimoto-Niino, M; Umehara, T; Shirouzu, M; Sekimizu, K; Yokoyama, S; Fujita, N				Morishita, Daisuke; Takami, Miho; Yoshikawa, Seiko; Katayama, Ryohei; Sato, Shigeo; Kukimoto-Niino, Mutsuko; Umehara, Takashi; Shirouzu, Mikako; Sekimizu, Kazuhisa; Yokoyama, Shigeyuki; Fujita, Naoya			Cell-permeable Carboxyl-terminal p27(Kip1) Peptide Exhibits Anti-tumor Activity by Inhibiting Pim-1 Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; CYTOPLASMIC LOCALIZATION; PROTEIN-KINASES; TUMOR-GROWTH; PHOSPHORYLATION; PROMOTES; BINDING; SPECIFICITY; OVEREXPRESSION; IDENTIFICATION	The incidence and death rate of prostate cancer is increasing rapidly. In addition, the low sensitivity of prostate cancer to chemotherapy makes it difficult to treat this condition. The serine/threonine kinase Pim-1 plays an important role in cell cycle progression and apoptosis inhibition, resulting in prostate tumorigenesis. Therefore, Pim-1 inhibition has been expected to be an attractive target for developing new anti-cancer drugs. However, no small compounds targeting Pim-1 have progressed to clinical use because of their lack of specificity. Here, we have reported a new cell-permeable Pim-1 inhibitory p27(Kip1) peptide that could interfere with the binding of Pim-1 to its substrates and act as an anti-cancer drug. The peptide could bind to Pim-1 and inhibit phosphorylation of endogenous p27(Kip1) and Bad by Pim-1. Treatment of prostate cancer with the peptide induces G(1) arrest and subsequently apoptosis in vitro. However, the peptide showed almost no growth inhibitory or apoptosis-inducing effects in normal cells. The peptide could inhibit tumor growth in in vivo prostate cancer xenograft models. Moreover, the peptide treatment could overcome resistance to taxol, one of the first line chemotherapeutic agents for prostate cancer, and a combination of the peptide with taxol synergistically inhibited prostate cancer growth in vivo. These results indicate that a Pim-1 inhibitory p27(Kip1) peptide could be developed as an anti-cancer drug against prostate cancer.	[Fujita, Naoya] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Koto Ku, Tokyo 1358550, Japan; [Yoshikawa, Seiko; Kukimoto-Niino, Mutsuko; Umehara, Takashi; Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Morishita, Daisuke; Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Tokyo 1130033, Japan	Japanese Foundation for Cancer Research; RIKEN; University of Tokyo; University of Tokyo	Fujita, N (corresponding author), Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	naoya.fujita@jfcr.or.jp	Katayama, Ryohei/K-8537-2014; Umehara, Takashi/AHB-1730-2022; Yokoyama, Shigeyuki/N-6911-2015; Shirouzu, Mikako/A-6521-2016; Kukimoto-Niino, Mutsuko/C-6704-2017; Fujita, Naoya/A-7349-2010; Umehara, Takashi/N-5683-2015	Katayama, Ryohei/0000-0001-7394-895X; Umehara, Takashi/0000-0003-3464-2960; Yokoyama, Shigeyuki/0000-0003-3133-7338; Kukimoto-Niino, Mutsuko/0000-0002-4178-1611; Fujita, Naoya/0000-0002-9631-9264; Umehara, Takashi/0000-0003-3464-2960	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan; National Institute of Biomedical Innovation, Japan; Grants-in-Aid for Scientific Research [22650238] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation, Japan(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for Challenging Exploratory Research from the Japan Society for the Promotion of Science, by Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology, Japan and by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan (to N. F.).	Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Bogoyevitch MA, 2007, DRUG DISCOV TODAY, V12, P622, DOI 10.1016/j.drudis.2007.06.008; Bullock AN, 2005, J MED CHEM, V48, P7604, DOI 10.1021/jm0504858; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Chen WW, 2005, MOL CANCER RES, V3, P443, DOI 10.1158/1541-7786.MCR-05-0007; Cheney IW, 2007, BIOORG MED CHEM LETT, V17, P1679, DOI 10.1016/j.bmcl.2006.12.086; CHENG HC, 1986, J BIOL CHEM, V261, P989; Cibull TL, 2006, J CLIN PATHOL, V59, P285, DOI 10.1136/jcp.2005.027672; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Fujita N, 2003, J BIOL CHEM, V278, P49254, DOI 10.1074/jbc.M306614200; GLASS DB, 1986, J BIOL CHEM, V261, P2166; Holder S, 2007, BIOORGAN MED CHEM, V15, P6463, DOI 10.1016/j.bmc.2007.06.025; Holder S, 2007, MOL CANCER THER, V6, P163, DOI 10.1158/1535-7163.MCT-06-0397; Hu XF, 2009, J CLIN INVEST, V119, P362, DOI 10.1172/JCI33216; Kaidanovich-Beilin O, 2006, PHYSIOLOGY, V21, P411, DOI 10.1152/physiol.00022.2006; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Peng C, 2007, J BIOCHEM, V141, P353, DOI 10.1093/jb/mvm040; Plotkin B, 2003, J PHARMACOL EXP THER, V305, P974, DOI 10.1124/jpet.102.047381; Pogacic V, 2007, CANCER RES, V67, P6916, DOI 10.1158/0008-5472.CAN-07-0320; Valdman A, 2004, PROSTATE, V60, P367, DOI 10.1002/pros.20064; Xu Y, 2005, J SURG ONCOL, V92, P326, DOI 10.1002/jso.20325; Yang LL, 2003, CANCER RES, V63, P831; Zemskova M, 2008, J BIOL CHEM, V283, P20635, DOI 10.1074/jbc.M709479200	25	26	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2681	2688		10.1074/jbc.M109.092452	http://dx.doi.org/10.1074/jbc.M109.092452			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21062737	Green Published, hybrid			2022-12-25	WOS:000286464300034
J	Sliter, DA; Aguiar, M; Gygi, SP; Wojcikiewicz, RJH				Sliter, Danielle A.; Aguiar, Mike; Gygi, Steven P.; Wojcikiewicz, Richard J. H.			Activated Inositol 1,4,5-Trisphosphate Receptors Are Modified by Homogeneous Lys-48-and Lys-63-linked Ubiquitin Chains, but Only Lys-48-linked Chains Are Required for Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ANAPHASE-PROMOTING COMPLEX; ENDOPLASMIC-RETICULUM; DOWN-REGULATION; POLYUBIQUITIN CHAINS; DEUBIQUITINATING ENZYMES; PROTEASOMAL DEGRADATION; PROTEIN UBIQUITINATION; CONJUGATING ENZYME; LIGASE	Inositol 1,4,5-trisphosphate (IP3) receptors (IP(3)Rs) are large, ubiquitously expressed, endoplasmic reticulum membrane proteins that form tetrameric IP3 and Ca2+-gated Ca2+ channels. Endogenous IP(3)Rs provide very appealing tools for studying the ubiquitin-proteasome pathway in intact mammalian cells because, upon activation, they are rapidly ubiquitinated and degraded. Using mass spectrometry, we previously examined the ubiquitination of IP(3)R1 in alpha T3-1 pituitary gonadotrophs and found that IP(3)R1 ubiquitination is highly complex, with receptors being modified at multiple sites by monoubiquitin and polyubiquitin chains formed through both Lys-48 and Lys-63 linkages (Sliter, D. A., Kubota, K., Kirkpatrick, D. S., Alzayady, K. J., Gygi, S. P., and Wojcikiewicz, R. J. H. (2008) J. Biol. Chem. 283, 35319-35328). Here, we have extended these studies to determine whether IP(3)R2 and IP(3)R3 are similarly modified and if ubiquitination is cell type-dependent. Using mass spectrometry and linkage-specific ubiquitin antibodies, we found that all IP3R types are subject to ubiquitination at approximately the same locations and that, independent of cell type, IP(3)Rs are modified by monoubiquitin and Lys-48- and Lys-63-linked ubiquitin chains, although in differing proportions. Remarkably, the attached Lys-48- and Lys-63-linked ubiquitin chains are homogeneous and are segregated to separate IP3R subunits, and Lys-48-linked ubiquitin chains, but not Lys-63-linked chains, are required for IP3R degradation. Together, these data provide unique insight into the complexities of ubiquitination of an endogenous ubiquitin-proteasome pathway substrate in unperturbed mammalian cells. Importantly, although Lys-48-linked ubiquitin chains appear to trigger proteasomal degradation, the presence of Lys-63-linked ubiquitin chains suggests that ubiquitination of IP(3)Rs may have physiological consequences beyond signaling for degradation.	[Sliter, Danielle A.; Wojcikiewicz, Richard J. H.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Aguiar, Mike; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Harvard University; Harvard Medical School	Wojcikiewicz, RJH (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	wojcikir@upstate.edu		Aguiar, Mike/0000-0001-8175-010X	National Institutes of Health [DK049194, GM67945]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK049194, R01DK049194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK049194 (to R. J. H. W.) and GM67945 (to S. P. G.). This work was also supported by the American Heart Association (to D. A. S.).	Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; Bokkala S, 1997, J BIOL CHEM, V272, P12454, DOI 10.1074/jbc.272.19.12454; Boname JM, 2010, TRAFFIC, V11, P210, DOI 10.1111/j.1600-0854.2009.01011.x; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Goto E, 2010, J BIOL CHEM, V285, P35311, DOI 10.1074/jbc.M110.112763; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Jung T, 2009, MOL ASPECTS MED, V30, P191, DOI 10.1016/j.mam.2009.04.001; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim HT, 2009, EMBO J, V28, P1867, DOI 10.1038/emboj.2009.115; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Maes K, 2001, J BIOL CHEM, V276, P3492, DOI 10.1074/jbc.M006082200; Marx C, 2010, CANCER RES, V70, P3709, DOI 10.1158/0008-5472.CAN-09-3768; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Oberdorf J, 1999, BIOCHEM J, V339, P453, DOI 10.1042/0264-6021:3390453; Pearce MMP, 2009, J BIOL CHEM, V284, P10433, DOI 10.1074/jbc.M809801200; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Serysheva II, 2003, J BIOL CHEM, V278, P21319, DOI 10.1074/jbc.C300148200; Sliter DA, 2008, J BIOL CHEM, V283, P35319, DOI 10.1074/jbc.M807288200; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Soulsby MD, 2005, BIOCHEM J, V392, P493, DOI 10.1042/BJ20051325; Taylor CW, 2004, TRENDS BIOCHEM SCI, V29, P210, DOI 10.1016/j.tibs.2004.02.010; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Webster JM, 2003, J BIOL CHEM, V278, P38238, DOI 10.1074/jbc.M305600200; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wojcikiewicz RJH, 2009, CELL CALCIUM, V46, P147, DOI 10.1016/j.ceca.2009.05.002; Wojcikiewicz RJH, 1999, GASTROENTEROLOGY, V116, P1194, DOI 10.1016/S0016-5085(99)70023-5; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 2003, J BIOL CHEM, V278, P940, DOI 10.1074/jbc.M206607200; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316; Yule DI, 2010, CELL CALCIUM, V47, P469, DOI 10.1016/j.ceca.2010.04.005	55	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1074	1082		10.1074/jbc.M110.188383	http://dx.doi.org/10.1074/jbc.M110.188383			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21071436	Green Published, hybrid			2022-12-25	WOS:000286005000018
J	Schmidt-Lucke, C; Fichtlscherer, S; Aicher, A; Tschope, C; Schultheiss, HP; Zeiher, AM; Dimmeler, S				Schmidt-Lucke, Caroline; Fichtlscherer, Stephan; Aicher, Alexandra; Tschoepe, Carsten; Schultheiss, Heinz-Peter; Zeiher, Andreas M.; Dimmeler, Stefanie			Quantification of Circulating Endothelial Progenitor Cells Using the Modified ISHAGE Protocol	PLOS ONE			English	Article							FLOW-CYTOMETRIC ENUMERATION; CORONARY-ARTERY DISEASE; CD34(+) HEMATOPOIETIC STEM; VASCULAR REPAIR; STATIN THERAPY; RISK-FACTORS; ANGIOGENESIS; PRECURSORS; INCREASE; NUMBER	Aims: Circulating endothelial progenitor cells (EPC), involved in endothelial regeneration, neovascularisation, and determination of prognosis in cardiovascular disease can be characterised with functional assays or using immunofluorescence and flow cytometry. Combinations of markers, including CD34+KDR+ or CD133+KDR+, are used. This approach, however may not consider all characteristics of EPC. The lack of a standardised protocol with regards to reagents and gating strategies may account for the widespread inter-laboratory variations in quantification of EPC. We, therefore developed a novel protocol adapted from the standardised so-called ISHAGE protocol for enumeration of haematopoietic stem cells to enable comparison of clinical and laboratory data. Methods and Results: In 25 control subjects, 65 patients with coronary artery disease (CAD; 40 stable CAD, 25 acute coronary syndrome/acute myocardial infarction (ACS)), EPC were quantified using the following approach: Whole blood was incubated with CD45, KDR, and CD34. The ISHAGE sequential strategy was used, and finally, CD45(dim)CD34(+) cells were quantified for KDR. A minimum of 100 CD34(+) events were collected. For comparison, CD45(+)CD34(+) and CD45(-)CD34(+) were analysed simultaneously. The number of CD45(dim)CD34(+)KDR(+) cells only were significantly higher in healthy controls compared to patients with CAD or ACS (p = 0.005 each, p<0.001 for trend). An inverse correlation of CD45(dim)CD34(+)KDR(+) with disease activity (r = -0.475, p<0.001) was confirmed. Only CD45(dim)CD34(+)KDR(+) correlated inversely with the number of diseased coronaries (r = -0.344; p<0.005). In a second study, a 4-week de-novo treatment of atorvastatin in stable CAD evoked an increase only of CD45(dim)CD34(+)KDR(+) EPC (p<0.05). CD45(+)CD34(+)KDR(+) and CD45(-)CD34(+)KDR(+) were indifferent between the three groups. Conclusion: Our newly established protocol adopted from the standardised ISHAGE protocol achieved higher accuracy in EPC enumeration confirming previous findings with respect to the correlation of EPC with disease activity and the increase of EPC during statin therapy. The data of this study show the CD45(dim) fraction to harbour EPC.	[Schmidt-Lucke, Caroline; Fichtlscherer, Stephan; Aicher, Alexandra; Zeiher, Andreas M.; Dimmeler, Stefanie] Goethe Univ Frankfurt, Dept Mol Cardiol, Frankfurt, Germany; [Schmidt-Lucke, Caroline; Tschoepe, Carsten; Schultheiss, Heinz-Peter] Charite, Dept Cardiol & Pulmonol, Berlin, Germany	Goethe University Frankfurt; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schmidt-Lucke, C (corresponding author), Goethe Univ Frankfurt, Dept Mol Cardiol, Frankfurt, Germany.	caroline.schmidt-lucke@charite.de	Aicher, Alexandra/GZK-8031-2022	Aicher, Alexandra/0000-0002-8920-9577; Tschope, Carsten/0000-0001-5243-8985; Dimmeler, Stefanie/0000-0002-1045-2436	Deutsche Forschungsgemeinschaft [Di 600/4-1, Exc 147/1]; "Rahel Hirsch"-grant; Berlin-Brandenburg Centre for Regenerative Therapies	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); "Rahel Hirsch"-grant; Berlin-Brandenburg Centre for Regenerative Therapies	This study was supported by the Deutsche Forschungsgemeinschaft Di 600/4-1 to S. D., Exc 147/1 to S. F., A.M.Z. and S. D., the "Rahel Hirsch''-grant to C.S.-L. and the Berlin-Brandenburg Centre for Regenerative Therapies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2006, CIRCULATION, V114, P2823, DOI 10.1161/CIRCULATIONAHA.106.628623; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Barnett D, 1999, CLIN LAB HAEMATOL, V21, P301, DOI 10.1046/j.1365-2257.1999.00253.x; De Backer G, 2004, ATHEROSCLEROSIS, V173, P379, DOI 10.1016/j.atherosclerosis.2004.02.014; Dimmeler S, 2004, J MOL MED, V82, P671, DOI 10.1007/s00109-004-0580-x; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Fadini GP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011488; Gratama JW, 2001, SEMIN HEMATOL, V38, P139, DOI 10.1053/shem.2001.21925; Gratama JW, 1998, CYTOMETRY, V34, P128, DOI 10.1002/(SICI)1097-0320(19980615)34:3<128::AID-CYTO3>3.0.CO;2-D; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; ROMAGNANI PAF, 2005, CIRC RES, V97, P299; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Shantsila E, 2008, J THROMB HAEMOST, V6, P1021, DOI 10.1111/j.1538-7836.2008.02985.x; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; Sutherland D R, 1996, J Hematother, V5, P213, DOI 10.1089/scd.1.1996.5.213; Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; VITA JA, 1990, CIRCULATION, V81, P491, DOI 10.1161/01.CIR.81.2.491; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814	23	120	125	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13790	10.1371/journal.pone.0013790	http://dx.doi.org/10.1371/journal.pone.0013790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072182	gold, Green Submitted, Green Published			2022-12-25	WOS:000283780800005
J	Van Simaeys, D; Lopez-Colon, D; Sefah, K; Sutphen, R; Jimenez, E; Tan, WH				Van Simaeys, Dimitri; Lopez-Colon, Dalia; Sefah, Kwame; Sutphen, Rebecca; Jimenez, Elizabeth; Tan, Weihong			Study of the Molecular Recognition of Aptamers Selected through Ovarian Cancer Cell-SELEX	PLOS ONE			English	Article							LIVE CELLS; PATTERNS; UPDATE; PROBES	Background: Ovarian cancer is the most lethal gynecological malignancy, and the ovarian clear cell carcinoma subtype (OCCA) demonstrates a particularly poor response to standard treatment. Improvements in ovarian cancer outcomes, especially for OCCA, could be expected from a clearer understanding of the molecular pathology that might guide strategies for earlier diagnosis and more effective treatment. Methodology/Principal Findings: Cell-SELEX technology was employed to develop new molecular probes for ovarian cancer cell surface markers. A total of thirteen aptamers with K-d's to ovarian cancer cells in the pico- to nanomolar range were obtained. Preliminary investigation of the targets of these aptamers and their binding characteristics was also performed. Conclusions/Significance: We have selected a series of aptamers that bind to different types of ovarian cancer, but not cervical cancer. Though binding to other cancer cell lines was observed, these aptamers could lead to identification of biomarkers that are related to cancer.	[Van Simaeys, Dimitri; Lopez-Colon, Dalia; Sefah, Kwame; Jimenez, Elizabeth; Tan, Weihong] Univ Florida, Dept Chem, Ctr Res Bio Nano Interface, Gainesville, FL 32611 USA; [Van Simaeys, Dimitri; Lopez-Colon, Dalia; Sefah, Kwame; Jimenez, Elizabeth; Tan, Weihong] Univ Florida, Shands Canc & Genet Res Ctr, Dept Physiol & Funct Gen, Gainesville, FL 32611 USA; [Sutphen, Rebecca] Univ S Florida, Coll Med, Dept Pediat, Tampa, FL 33612 USA; [Tan, Weihong] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute	Van Simaeys, D (corresponding author), Univ Florida, Dept Chem, Ctr Res Bio Nano Interface, Gainesville, FL 32611 USA.	tan@chem.ufl.edu	Jimenez, Elizabeth/GQB-5576-2022; Tan, Weihong/AAA-4536-2020; Tan, Weihong/A-5412-2008	Jimenez, Elizabeth/0000-0001-7798-2194; Tan, Weihong/0000-0002-8066-1524; Van Simaeys, Dimitri/0000-0003-3457-761X	National Institutes of Health (NIH) [R01GM079359, R01 CA133086, R01-CA106414]; NATIONAL CANCER INSTITUTE [R01CA106414, R01CA133086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079359] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank National Institutes of Health (NIH) for support (R01GM079359, R01 CA133086, R01-CA106414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAST RC, 1992, J NATL CANCER I, V84, P556, DOI 10.1093/jnci/84.8.556; BING T, 2010, BIOORG MED CHEM; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; Chen HW, 2008, CHEMMEDCHEM, V3, P991, DOI 10.1002/cmdc.200800030; Crotzer DR, 2007, GYNECOL ONCOL, V105, P404, DOI 10.1016/j.ygyno.2006.12.024; Faca VM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002425; Fang XH, 2010, ACCOUNTS CHEM RES, V43, P48, DOI 10.1021/ar900101s; Fitter S, 2005, J BIOL CHEM, V280, P34193, DOI 10.1074/jbc.M504772200; Hartge P, 2010, JNCI-J NATL CANCER I, V102, P3, DOI 10.1093/jnci/djp450; Jacobs IJ, 2004, MOL CELL PROTEOMICS, V3, P355, DOI 10.1074/mcp.R400006-MCP200; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jhaveri S, 2000, NAT BIOTECHNOL, V18, P1293, DOI 10.1038/82414; KURMAN RJ, 2010, AM J SURG PATHOL; LU C, 2010, CANC BIOL THER, V9; Maines-Bandiera S, 2010, INT J GYNECOL CANCER, V20, P16, DOI 10.1111/IGC.0b013e3181bcc96d; Mallikaratchy P, 2007, MOL CELL PROTEOMICS, V6, P2230, DOI 10.1074/mcp.M700026-MCP200; Munkarah A, 2007, CURR OPIN OBSTET GYN, V19, P22, DOI 10.1097/GCO.0b013e328011ec99; Nosov V, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.042; Oaknin A, 2010, INT J GYNECOL CANCER, V20, P87, DOI 10.1111/IGC.0b013e3181c16ba1; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Reynolds EA, 2006, CURR PROB CANCER, V30, P203, DOI 10.1016/j.currproblcancer.2006.06.001; Shangguan D, 2008, J PROTEOME RES, V7, P2133, DOI 10.1021/pr700894d; Shangguan DH, 2008, ANAL CHEM, V80, P721, DOI 10.1021/ac701962v; Shangguan DH, 2007, CLIN CHEM, V53, P1153, DOI 10.1373/clinchem.2006.083246; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Shirai T, 2009, J OBSTET GYNAECOL RE, V35, P926, DOI 10.1111/j.1447-0756.2009.01033.x; Tang ZW, 2009, CLIN CHEM, V55, P813, DOI 10.1373/clinchem.2008.113514; Ulrich H, 2009, CYTOM PART A, V75A, P727, DOI 10.1002/cyto.a.20766; Williams TI, 2007, J PROTEOME RES, V6, P2936, DOI 10.1021/pr070041v; Willmott LJ, 2010, J ONCOL, V2010, DOI 10.1155/2010/740472; Zhao ZL, 2009, ANALYST, V134, P1808, DOI 10.1039/b904476k	31	81	86	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2010	5	11							e13770	10.1371/journal.pone.0013770	http://dx.doi.org/10.1371/journal.pone.0013770			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FY	21072169	gold, Green Published, Green Submitted			2022-12-25	WOS:000283645700003
J	Gravitt, PE; Paul, P; Katki, HA; Vendantham, H; Ramakrishna, G; Sudula, M; Kalpana, B; Ronnett, BM; Vijayaraghavan, K; Shah, KV				Gravitt, Patti E.; Paul, Proma; Katki, Hormuzd A.; Vendantham, Haripriya; Ramakrishna, Gayatri; Sudula, Mrudula; Kalpana, Basany; Ronnett, Brigitte M.; Vijayaraghavan, K.; Shah, Keerti V.		CATCH Study Team	Effectiveness of VIA, Pap, and HPV DNA Testing in a Cervical Cancer Screening Program in a Peri-Urban Community in Andhra Pradesh, India	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; LOW-RESOURCE SETTINGS; LUGOLS IODINE VILI; VISUAL INSPECTION; ACETIC-ACID; HUMAN-PAPILLOMAVIRUS; DEVELOPING-COUNTRIES; RURAL INDIA; CYTOLOGY; ACCURACY	Background: While many studies have compared the efficacy of Pap cytology, visual inspection with acetic acid (VIA) and human papillomavirus (HPV) DNA assays for the detection cervical intraepithelial neoplasia and cancer, few have evaluated the program effectiveness. Methods and Findings: A population-based sample of 5603 women from Medchal Mandal in Andhra Pradesh, India were invited to participate in a study comparing Pap cytology, VIA, and HPV DNA screening for the detection of CIN3+. Participation in primary screening and all subsequent follow-up visits was rigorously tracked. A 20% random sample of all women screened, in addition to all women with a positive screening test result underwent colposcopy with directed biopsy for final diagnosis. Sensitivity, specificity, positive and negative predictive values were adjusted for verification bias. HPV testing had a higher sensitivity (100%) and specificity (90.6%) compared to Pap cytology (sensitivity = 78.2%; specificity = 86.0%) and VIA (sensitivity = 31.6%; specificity = 87.5%). Since 58% of the sample refused involvement and another 28% refused colposcopy or biopsy, we estimated that potentially 87.6% of the total underlying cases of CIN3 and cancer may have been missed due to program failures. Conclusions: We conclude that despite our use of available resources, infrastructure, and guidelines for cervical cancer screening implementation in resource limited areas, community participation and non-compliance remain the major obstacles to successful reduction in cervical cancer mortality in this Indian population. HPV DNA testing was both more sensitive and specific than Pap cytology and VIA. The use of a less invasive and more user-friendly primary screening strategy (such as self-collected swabs for HPV DNA testing) may be required to achieve the coverage necessary for effective reduction in cervical cancer mortality.	[Gravitt, Patti E.; Paul, Proma] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Gravitt, Patti E.; Shah, Keerti V.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Katki, Hormuzd A.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Vendantham, Haripriya; Sudula, Mrudula; Kalpana, Basany; Vijayaraghavan, K.] Mediciti Inst Med Sci, SHARE INDIA, Ghanpur, India; [Ramakrishna, Gayatri] Ctr DNA Fingerprinting & Diagnost, Hyderabad, Andhra Pradesh, India; [Ronnett, Brigitte M.] Johns Hopkins Univ, Sch Med & Hosp, Dept Pathol, Baltimore, MD USA; [Ronnett, Brigitte M.] Johns Hopkins Univ, Sch Med & Hosp, Dept Gynecol & Obstet, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Johns Hopkins University; Johns Hopkins University	Gravitt, PE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.	pgravitt@jhsph.edu	Katki, Hormuzd A/B-4003-2015		Department of Biotechnology, Ministry of Science and Technology, Government of India; NIH, USA [BT/IN/US/CRHR/PP/2002]; Research Excellence (SPORE) in Cervical Cancer [P50 CA98252]; NATIONAL CANCER INSTITUTE [P50CA098252] Funding Source: NIH RePORTER	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Excellence (SPORE) in Cervical Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	INDO-US collaborative program of Department of Biotechnology, Ministry of Science and Technology, Government of India and the NIH, USA (BT/IN/US/CRHR/PP/2002). NIH Specialized Programs of Research Excellence (SPORE) in Cervical Cancer P50 CA98252. Reagent discounts from Qiagen Corp (formerly Digene) and reagent gifts from Roche Molecular Systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hady ES, 2006, INT J GYNECOL OBSTET, V93, P118, DOI 10.1016/j.ijgo.2006.01.024; Almonte M, 2007, INT J CANCER, V121, P796, DOI 10.1002/ijc.22757; [Anonymous], 1999, LANCET, V353, P869; Arbyn M, 2008, INT J CANCER, V123, P153, DOI 10.1002/ijc.23489; Basu P, 2006, CANCER DETECT PREV, V30, P369, DOI 10.1016/j.cdp.2006.07.004; Basu PS, 2003, INT J GYNECOL CANCER, V13, P626, DOI 10.1046/j.1525-1438.2003.13394.x; Belinson J, 2001, GYNECOL ONCOL, V83, P439, DOI 10.1006/gyno.2001.6370; Belinson JL, 2003, INT J GYNECOL CANCER, V13, P819, DOI 10.1111/j.1525-1438.2003.13611.x; Blumenthal PD, 2005, INT J GYNECOL OBSTET, V89, pS30, DOI 10.1016/j.ijgo.2005.01.012; CAGLE AJ, INT J CANC, V126, P156; CASTLE PE, AM J EPIDEMIOL, V171, P155; Cronje HS, 2001, INT J GYNECOL OBSTET, V72, P151, DOI 10.1016/S0020-7292(00)00382-9; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; De Vuyst H, 2005, INT J GYNECOL OBSTET, V89, P120, DOI 10.1016/j.ijgo.2005.01.035; Denny L, 2000, CANCER-AM CANCER SOC, V89, P826, DOI 10.1002/1097-0142(20000815)89:4&lt;826::AID-CNCR15&gt;3.0.CO;2-5; Denny L, 2002, CANCER-AM CANCER SOC, V94, P1699, DOI 10.1002/cncr.10381; Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173; Denny L, 2006, VACCINE, V24, P71, DOI 10.1016/j.vaccine.2006.05.121; Gaffikin L, 2003, LANCET, V361, P814, DOI 10.1016/S0140-6736(03)12707-9; Gravitt PE, 1998, J CLIN MICROBIOL, V36, P3020, DOI 10.1128/JCM.36.10.3020-3027.1998; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; JERONIMO J, 2006, AM J OBSTET GYNECOL; Jonsson M, 1997, OBSTET GYNECOL, V90, P744, DOI 10.1016/S0029-7844(97)00418-3; Li N, 2009, BRIT J CANCER, V100, P532, DOI 10.1038/sj.bjc.6604840; Mahe C, 2005, CANCER CAUSE CONTROL, V16, P657, DOI 10.1007/s10552-005-0296-4; Nene BM, 1996, INT J CANCER, V68, P770, DOI 10.1002/(SICI)1097-0215(19961211)68:6<770::AID-IJC14>3.0.CO;2-4; Pretorius RG, 2007, INT J CANCER, V121, P2218, DOI 10.1002/ijc.22991; Pretorius Robert G, 2006, J Low Genit Tract Dis, V10, P5, DOI 10.1097/01.lgt.0000192694.85549.3d; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Sankaranarayanan R, 2003, INT J CANCER, V106, P404, DOI 10.1002/ijc.11245; Sankaranarayanan R, 2005, INT J CANCER, V116, P617, DOI 10.1002/ijc.21050; Sankaranarayanan R, 2004, INT J CANCER, V110, P907, DOI 10.1002/ijc.20190; Sankaranarayanan R, 2001, B WORLD HEALTH ORGAN, V79, P954; Sankaranarayanan R, 1998, CANCER-AM CANCER SOC, V83, P2150, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2150::AID-CNCR13>3.3.CO;2-S; Sankaranarayanan R, 1999, INT J CANCER, V80, P161, DOI 10.1002/(SICI)1097-0215(19990105)80:1<161::AID-IJC28>3.3.CO;2-#; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sarian LO, 2005, J MED SCREEN, V12, P142, DOI 10.1258/0969141054855328; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Sowjanya AP, 2009, CANCER EPIDEM BIOMAR, V18, P1373, DOI 10.1158/1055-9965.EPI-08-1171; Trimble CL, 2005, CLIN CANCER RES, V11, P4717, DOI 10.1158/1078-0432.CCR-04-2599; Vedantham H, 2010, CANCER EPIDEM BIOMAR, V19, P1373, DOI 10.1158/1055-9965.EPI-09-1282	41	74	74	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13711	10.1371/journal.pone.0013711	http://dx.doi.org/10.1371/journal.pone.0013711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060889	Green Published, gold, Green Accepted			2022-12-25	WOS:000283573800011
J	Mitrovic, D; Klanke, S; Osu, R; Kawato, M; Vijayakumar, S				Mitrovic, Djordje; Klanke, Stefan; Osu, Rieko; Kawato, Mitsuo; Vijayakumar, Sethu			A Computational Model of Limb Impedance Control Based on Principles of Internal Model Uncertainty	PLOS ONE			English	Article							OPTIMAL FEEDBACK-CONTROL; MULTIJOINT ARM MOVEMENT; SIGNAL-DEPENDENT NOISE; MOTOR ADAPTATION; ADAPTIVE-CONTROL; STIFFNESS; DYNAMICS; COACTIVATION; COCONTRACTION; VARIABILITY	Efficient human motor control is characterized by an extensive use of joint impedance modulation, which is achieved by co-contracting antagonistic muscles in a way that is beneficial to the specific task. While there is much experimental evidence available that the nervous system employs such strategies, no generally-valid computational model of impedance control derived from first principles has been proposed so far. Here we develop a new impedance control model for antagonistic limb systems which is based on a minimization of uncertainties in the internal model predictions. In contrast to previously proposed models, our framework predicts a wide range of impedance control patterns, during stationary and adaptive tasks. This indicates that many well-known impedance control phenomena naturally emerge from the first principles of a stochastic optimization process that minimizes for internal model prediction uncertainties, along with energy and accuracy demands. The insights from this computational model could be used to interpret existing experimental impedance control data from the viewpoint of optimality or could even govern the design of future experiments based on principles of internal model uncertainty.	[Mitrovic, Djordje; Klanke, Stefan; Vijayakumar, Sethu] Univ Edinburgh, Sch Informat, IPAB, Edinburgh, Midlothian, Scotland; [Osu, Rieko; Kawato, Mitsuo] ATR Computat Neurosci Labs, Keihanna Sci City, Kyoto, Japan; [Osu, Rieko] Natl Inst Informat & Commun, Kyoto, Japan	University of Edinburgh; National Institute of Information & Communications Technology (NICT) - Japan	Mitrovic, D (corresponding author), Univ Edinburgh, Sch Informat, IPAB, Edinburgh, Midlothian, Scotland.	d.mitrovic@ed.ac.uk			EU	EU(European Commission)	This work was supported by the funding from EU FP7 project STIFF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT DJ, 1993, EXP BRAIN RES, V95, P488; Burdet E, 2006, BIOL CYBERN, V94, P20, DOI 10.1007/s00422-005-0025-9; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Chhabra M, 2006, J NEUROSCI, V26, P10883, DOI 10.1523/JNEUROSCI.2238-06.2006; Davidson PR, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S11; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Franklin DW, 2008, J NEUROSCI, V28, P11165, DOI 10.1523/JNEUROSCI.3099-08.2008; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; Gribble PL, 2003, J NEUROPHYSIOL, V89, P2396, DOI 10.1152/jn.01020.2002; Gribble PL, 1998, EXP BRAIN RES, V123, P355, DOI 10.1007/s002210050580; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Haruno M, 2005, J NEUROPHYSIOL, V94, P4244, DOI 10.1152/jn.00404.2005; HOGAN N, 1984, IEEE T AUTOMAT CONTR, V29, P681, DOI 10.1109/TAC.1984.1103644; Izawa J, 2008, J NEUROSCI, V28, P2883, DOI 10.1523/JNEUROSCI.5359-07.2008; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; KATAYAMA M, 1993, BIOL CYBERN, V69, P353, DOI 10.1007/BF01185407; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Krutky MA, 2010, J NEUROPHYSIOL, V103, P429, DOI 10.1152/jn.00679.2009; Lametti DR, 2007, J NEUROPHYSIOL, V98, P3516, DOI 10.1152/jn.00970.2007; Laursen B, 1998, EUR J APPL PHYSIOL, V78, P544, DOI 10.1007/s004210050458; Li W, 2007, INT J CONTROL, V80, P1439, DOI 10.1080/00207170701364913; Li W., 2006, THESIS U CALIFORNIA; Lockhart DB, 2007, NAT NEUROSCI, V10, P1329, DOI 10.1038/nn1986; McIntyre J, 1996, EXP BRAIN RES, V110, P248; Milner TE, 2005, J PHYSIOL-LONDON, V567, P651, DOI 10.1113/jphysiol.2005.090449; MITROVIC D, 2008, P 10 INT C SIM AD BE; Osu R, 1999, J NEUROPHYSIOL, V81, P1458, DOI 10.1152/jn.1999.81.4.1458; Osu R, 2004, J NEUROPHYSIOL, V92, P1199, DOI 10.1152/jn.00519.2003; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Selen LPJ, 2005, BIOL CYBERN, V93, P373, DOI 10.1007/s00422-005-0015-y; SELEN LPJ, 2007, THESIS VRIJE U AMSTE; Selen LPJ, 2009, J NEUROSCI, V29, P12606, DOI 10.1523/JNEUROSCI.2826-09.2009; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Stengel R. F., 1994, OPTIMAL CONTROL ESTI; Suzuki M, 2001, EXP BRAIN RES, V140, P171, DOI 10.1007/s002210100797; Tee KP, 2004, BIOL CYBERN, V90, P368, DOI 10.1007/s00422-004-0484-4; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Todorov E, 2005, NEURAL COMPUT, V17, P1084, DOI 10.1162/0899766053491887; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Trumbower RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005411; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Valero-Cuevas FJ, 2009, ADV EXP MED BIOL, V629, P619, DOI 10.1007/978-0-387-77064-2_33; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; Vijayakumar S, 2005, NEURAL COMPUT, V17, P2602, DOI 10.1162/089976605774320557; Wang T, 2001, BIOL CYBERN, V85, P437, DOI 10.1007/s004220100277; WIERZBICKA MM, 1986, EXP BRAIN RES, V63, P331; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	52	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13601	10.1371/journal.pone.0013601	http://dx.doi.org/10.1371/journal.pone.0013601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049061	Green Published, Green Submitted, gold			2022-12-25	WOS:000283487400008
J	Starostik, MR; Rebello, MR; Cotter, KA; Kulik, A; Medler, KF				Starostik, Margaret R.; Rebello, Michelle R.; Cotter, Kellie A.; Kulik, Akos; Medler, Kathryn F.			Expression of GABAergic Receptors in Mouse Taste Receptor Cells	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; PLASMA-MEMBRANE TRANSPORTERS; GABA(B) RECEPTORS; IMMUNOCYTOCHEMICAL LOCALIZATION; COEXPRESSION PATTERNS; AIRWAY EPITHELIUM; RAT-BRAIN; BUDS; SEROTONIN; PHARMACOLOGY	Background: Multiple excitatory neurotransmitters have been identified in the mammalian taste transduction, with few studies focused on inhibitory neurotransmitters. Since the synthetic enzyme glutamate decarboxylase (GAD) for gamma-aminobutyric acid (GABA) is expressed in a subset of mouse taste cells, we hypothesized that other components of the GABA signaling pathway are likely expressed in this system. GABA signaling is initiated by the activation of either ionotropic receptors (GABA(A) and GABA(C)) or metabotropic receptors (GABA(B)) while it is terminated by the re-uptake of GABA through transporters (GATs). Methodology/Principal Findings: Using reverse transcriptase-PCR (RT-PCR) analysis, we investigated the expression of different GABA signaling molecules in the mouse taste system. Taste receptor cells (TRCs) in the circumvallate papillae express multiple subunits of the GABA(A) and GABA(B) receptors as well as multiple GATs. Immunocytochemical analyses examined the distribution of the GABA machinery in the circumvallate papillae. Both GABA(A)- and GABA(B)-immunoreactivity were detected in the peripheral taste receptor cells. We also used transgenic mice that express green fluorescent protein (GFP) in either the Type II taste cells, which can respond to bitter, sweet or umami taste stimuli, or in the Type III GAD67 expressing taste cells. Thus, we were able to identify that GABAergic receptors are expressed in some Type II and Type III taste cells. Mouse GAT4 labeling was concentrated in the cells surrounding the taste buds with a few positively labeled TRCs at the margins of the taste buds. Conclusions/Significance: The presence of GABAergic receptors localized on Type II and Type III taste cells suggests that GABA is likely modulating evoked taste responses in the mouse taste bud.	[Starostik, Margaret R.; Rebello, Michelle R.; Cotter, Kellie A.; Medler, Kathryn F.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Kulik, Akos] Univ Freiburg, Inst Anat & Cell Biol, Dept Neuroanat, Freiburg, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Freiburg	Starostik, MR (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	kmedler@buffalo.edu		Cotter, Kellie/0000-0002-2574-815X; Starostik, Margaret/0000-0002-5274-2765; Medler, Kathryn/0000-0001-9664-3606	NIH [DC006358]; NSF [0917893]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC006358] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH Grant DC006358 and NSF 0917893 to KM. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belenky MA, 2008, J COMP NEUROL, V506, P708, DOI 10.1002/cne.21553; Bettler B, 2006, PHARMACOL THERAPEUT, V110, P533, DOI 10.1016/j.pharmthera.2006.03.006; BORDEN LA, 1992, J BIOL CHEM, V267, P21098; BOWERY NG, 1980, NATURE, V283, P92, DOI 10.1038/283092a0; Cao Y, 2009, P NATL ACAD SCI USA, V106, P4006, DOI 10.1073/pnas.0808672106; Clapp TR, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-6; Clapp TR, 2004, J COMP NEUROL, V468, P311, DOI 10.1002/cne.10963; CLARK JA, 1992, NEURON, V9, P337, DOI 10.1016/0896-6273(92)90172-A; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; CURTIS DR, 1974, ERG PHYSIOL BIOL CH, V69, P97; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; DELAY RJ, 1988, J COMP NEUROL, V277, P268, DOI 10.1002/cne.902770208; Deriu D, 2005, BIOCHEM J, V386, P423, DOI 10.1042/BJ20040804; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Ernst M, 2005, MOL PHARMACOL, V68, P1291, DOI 10.1124/mol.105.015982; EWALD DA, 1994, J NEUROSCI, V14, P3791; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; Ferguson RE, 2005, PROTEOMICS, V5, P566, DOI 10.1002/pmic.200400941; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Guo C, 2009, J COMP NEUROL, V512, P6, DOI 10.1002/cne.21846; Hacker K, 2008, J NEUROPHYSIOL, V99, P1503, DOI 10.1152/jn.00892.2007; HALES TG, 1994, J NEUROSCI, V14, P5429; Herness S, 2002, J NEUROSCI, V22, P10018; Herness S, 2005, CHEM SENSES, V30, pI37, DOI 10.1093/chemse/bjh101; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; Hirota JA, 2010, CLIN EXP ALLERGY, V40, P820, DOI 10.1111/j.1365-2222.2010.03458.x; Huang YJ, 2005, J NEUROSCI, V25, P843, DOI 10.1523/JNEUROSCI.4446-04.2005; Huang ZJ, 2006, NEURON, V50, P521, DOI 10.1016/j.neuron.2006.05.005; IVERSEN LL, 1975, BIOCHEM PHARMACOL, V24, P933, DOI 10.1016/0006-2952(75)90422-0; JAIN S, 1991, J COMP NEUROL, V307, P675, DOI 10.1002/cne.903070412; Jin N, 2005, CELL TISSUE RES, V321, P173, DOI 10.1007/s00441-005-1130-8; Johnson J, 1996, J COMP NEUROL, V375, P212; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kaya N, 2004, AM J PHYSIOL-REG I, V286, pR649, DOI 10.1152/ajpregu.00572.2003; KIM DJ, 1995, J COMP NEUROL, V353, P364, DOI 10.1002/cne.903530304; KINNAMON JC, 1988, J COMP NEUROL, V270, P1, DOI 10.1002/cne.902700102; KROGSGAARDLARSEN P, 1979, J NEUROCHEM, V32, P1717, DOI 10.1111/j.1471-4159.1979.tb02284.x; Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x; Li JL, 2001, NEUROSCI LETT, V315, P93, DOI 10.1016/S0304-3940(01)02321-7; LIU QR, 1993, J BIOL CHEM, V268, P2106; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; Mukherjee RS, 2006, MOL PHARMACOL, V70, P1406, DOI 10.1124/mol.106.024463; NADA O, 1975, HISTOCHEMISTRY, V43, P237, DOI 10.1007/BF00499704; Nagai T, 1998, J COMP NEUROL, V392, P199, DOI 10.1002/(SICI)1096-9861(19980309)392:2<199::AID-CNE4>3.0.CO;2-Y; Nagai T, 1996, CHEM SENSES, V21, P353, DOI 10.1093/chemse/21.3.353; Nakamura Y, 2007, CHEM SENSES, V32, pJ19; Obata H, 1997, MOL BRAIN RES, V49, P29, DOI 10.1016/S0169-328X(97)00118-6; Ogura T, 2005, CHEM SENSES, V30, pI41, DOI 10.1093/chemse/bjh103; Ogura T, 2002, J NEUROPHYSIOL, V87, P2643, DOI 10.1152/jn.2002.87.6.2643; Ogura T, 2007, CELL TISSUE RES, V330, P17, DOI 10.1007/s00441-007-0470-y; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Queva S, 2003, BRIT J PHARMACOL, V140, P315, DOI 10.1038/sj.bjp.0705447; Ren Y, 1999, MOL BRAIN RES, V74, P221, DOI 10.1016/S0169-328X(99)00253-3; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; Ribak CE, 1996, J COMP NEUROL, V367, P595, DOI 10.1002/(SICI)1096-9861(19960415)367:4<595::AID-CNE9>3.0.CO;2-#; Roper SD, 2006, CELL MOL LIFE SCI, V63, P1494, DOI 10.1007/s00018-006-6112-9; Roper SD, 2007, PFLUG ARCH EUR J PHY, V454, P759, DOI 10.1007/s00424-007-0247-x; Rozzo A, 2002, EUR J NEUROSCI, V15, P1747, DOI 10.1046/j.1460-9568.2002.02013.x; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Shen T, 2005, NEUROSCIENCE, V130, P229, DOI 10.1016/j.neuroscience.2004.09.017; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Takanaga T, 2001, J CEREBR BLOOD F MET, V21, P1232, DOI 10.1097/00004647-200110000-00012; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; UCHIDA T, 1985, JAP J ORAL BIOL, V27, P132; Wagner DA, 2001, J NEUROSCI, V21, P67, DOI 10.1523/JNEUROSCI.21-01-00067.2001; Wegelius K, 1998, EUR J NEUROSCI, V10, P350, DOI 10.1046/j.1460-9568.1998.00023.x; Wu Y, 2006, ANN NEUROL, V59, P42, DOI 10.1002/ana.20686; Xiang YY, 2007, NAT MED, V13, P862, DOI 10.1038/nm1604; Yamamoto T, 1998, JPN J PHARMACOL, V76, P325, DOI 10.1254/jjp.76.325; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Zhao FL, 2005, P NATL ACAD SCI USA, V102, P11100, DOI 10.1073/pnas.0501988102	79	14	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13639	10.1371/journal.pone.0013639	http://dx.doi.org/10.1371/journal.pone.0013639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049022	Green Published, Green Submitted, gold			2022-12-25	WOS:000283487400027
J	Asikainen, S; Dogan, B; Turgut, Z; Paster, BJ; Bodur, A; Oscarsson, J				Asikainen, Sirkka; Dogan, Basak; Turgut, Zeynep; Paster, Bruce J.; Bodur, Aysen; Oscarsson, Jan			Specified Species in Gingival Crevicular Fluid Predict Bacterial Diversity	PLOS ONE			English	Article							PERIODONTAL-DISEASE; MICROFLORA; IDENTIFICATION; INFLAMMATION; COMPONENTS; MARKERS; CARIES	Background: Analysis of gingival crevicular fluid (GCF) samples may give information of unattached (planktonic) subgingival bacteria. Our study represents the first one targeting the identity of bacteria in GCF. Methodology/Principal Findings: We determined bacterial species diversity in GCF samples of a group of periodontitis patients and delineated contributing bacterial and host-associated factors. Subgingival paper point (PP) samples from the same sites were taken for comparison. After DNA extraction, 16S rRNA genes were PCR amplified and DNA-DNA hybridization was performed using a microarray for over 300 bacterial species or groups. Altogether 133 species from 41 genera and 8 phyla were detected with 9 to 62 and 18 to 64 species in GCF and PP samples, respectively, per patient. Projection to latent structures by means of partial least squares (PLS) was applied to the multivariate data analysis. PLS regression analysis showed that species of genera including Campylobacter, Selenomonas, Porphyromonas, Catonella, Tannerella, Dialister, Peptostreptococcus, Streptococcus and Eubacterium had significant positive correlations and the number of teeth with low-grade attachment loss a significant negative correlation to species diversity in GCF samples. OPLS/O2PLS discriminant analysis revealed significant positive correlations to GCF sample group membership for species of genera Campylobacter, Leptotrichia, Prevotella, Dialister, Tannerella, Haemophilus, Fusobacterium, Eubacterium, and Actinomyces. Conclusions/Significance: Among a variety of detected species those traditionally classified as Gram-negative anaerobes growing in mature subgingival biofilms were the main predictors for species diversity in GCF samples as well as responsible for distinguishing GCF samples from PP samples. GCF bacteria may provide new prospects for studying dynamic properties of subgingival biofilms.	[Asikainen, Sirkka; Oscarsson, Jan] Umea Univ, Inst Odontol, Sect Oral Microbiol, Umea, Sweden; [Dogan, Basak] Marmara Univ, Fac Dent, Dept Periodontol, Istanbul, Turkey; [Turgut, Zeynep; Bodur, Aysen] Gazi Univ, Dept Periodontol, Ankara, Turkey; [Paster, Bruce J.] Forsyth Inst, Dept Mol Genet, Boston, MA USA; [Paster, Bruce J.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	Umea University; Marmara University; Gazi University; Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine	Asikainen, S (corresponding author), Kuwait Univ, Fac Dent, Safat, Kuwait.	sirkka.asikainen@odont.umu.se	çankaya, zeynep turgut/AAF-3306-2020; Paster, Bruce J/AAP-8559-2021; Bodur, Ayşen/AAC-2762-2021	Dogan, Basak/0000-0002-3602-4886	Swedish Medical Research Council [2006-06X-14747-04-3/SA]; County Council of Vasterbotten, Sweden [VLL 1165-2005/SA]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); County Council of Vasterbotten, Sweden	This work was funded by grants from the Swedish Medical Research Council 2006-06X-14747-04-3/SA, County Council of Vasterbotten, Sweden VLL 1165-2005/SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Armitage GC, 2004, PERIODONTOL 2000, V34, P109, DOI 10.1046/j.0906-6713.2002.003427.x; Baelum V, 2007, J ORAL REHABIL, V34, P872, DOI 10.1111/j.1365-2842.2007.01799.x; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; de Lillo A, 2006, ORAL MICROBIOL IMMUN, V21, P61, DOI 10.1111/j.1399-302X.2005.00255.x; Dige I, 2009, ORAL MICROBIOL IMMUN, V24, P69, DOI 10.1111/j.1399-302X.2008.00482.x; Dogan B, 2005, J PERIODONTOL, V76, P740, DOI 10.1902/jop.2005.76.5.740; Dogan BA, 2003, J PERIODONTOL, V74, P803, DOI 10.1902/jop.2003.74.6.803; Downes J, 2002, INT J SYST EVOL MICR, V52, P1469, DOI 10.1099/00207713-52-5-1469; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eriksson L, 2004, ANAL BIOANAL CHEM, V380, P419, DOI 10.1007/s00216-004-2783-y; Faveri M, 2008, ORAL MICROBIOL IMMUN, V23, P112, DOI 10.1111/j.1399-302X.2007.00397.x; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; Kamma JJ, 2000, ORAL MICROBIOL IMMUN, V15, P103, DOI 10.1034/j.1399-302x.2000.150206.x; Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Karched M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-18; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; Lamster IB, 2007, ANN NY ACAD SCI, V1098, P216, DOI 10.1196/annals.1384.027; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Loos BG, 2005, J PERIODONTOL, V76, P2106, DOI 10.1902/jop.2005.76.11-S.2106; Marsh P D, 1994, Adv Dent Res, V8, P263; Nakashima K, 1996, J CLIN PERIODONTOL, V23, P832, DOI 10.1111/j.1600-051X.1996.tb00620.x; Oscarsson J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-206; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Preza D, 2009, EUR J CLIN MICROBIOL, V28, P509, DOI 10.1007/s10096-008-0662-8; Ridker PM, 2008, J PERIODONTOL, V79, P1544, DOI 10.1902/jop.2008.080249; SLOTS J, 1977, SCAND J DENT RES, V85, P247; SOCRANSKY SS, 1977, J PERIODONTAL RES, V12, P90, DOI 10.1111/j.1600-0765.1977.tb00112.x; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Willems A, 1996, INT J SYST BACTERIOL, V46, P1083, DOI 10.1099/00207713-46-4-1083	34	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13589	10.1371/journal.pone.0013589	http://dx.doi.org/10.1371/journal.pone.0013589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049043	Green Published, Green Submitted, gold			2022-12-25	WOS:000283422100009
J	Frost, JM; Monk, D; Stojilkovic-Mikic, T; Woodfine, K; Chitty, LS; Murrell, A; Stanier, P; Moore, GE				Frost, Jennifer M.; Monk, Dave; Stojilkovic-Mikic, Taita; Woodfine, Kathryn; Chitty, Lyn S.; Murrell, Adele; Stanier, Philip; Moore, Gudrun E.			Evaluation of Allelic Expression of Imprinted Genes in Adult Human Blood	PLOS ONE			English	Article							BECKWITH-WIEDEMANN-SYNDROME; COLORECTAL-CANCER; METHYLATION CHANGES; GROWTH DISORDERS; BLADDER-CANCER; FETAL-GROWTH; IGF2; H19; HYPOMETHYLATION; BRAIN	Background: Imprinted genes are expressed from only one allele in a parent-of-origin dependent manner. Loss of imprinted expression can result in a variety of human disorders and is frequently reported in cancer. Biallelic expression of imprinted genes in adult blood has been suggested as a useful biomarker and is currently being investigated in colorectal cancer. In general, the expression profiles of imprinted genes are well characterised during human and mouse fetal development, but not in human adults. Methodology/Principal Findings: We investigated quantitative expression of 36 imprinted genes in adult human peripheral blood leukocytes obtained from healthy individuals. Allelic expression was also investigated in B and T lymphocytes and myeloid cells. We found that 21 genes were essentially undetectable in adult blood. Only six genes were demonstrably monoallelic, and most importantly, we found that nine genes were either biallelic or showed variable expression in different individuals. Separated leukocyte populations showed the same expression patterns as whole blood. Differential methylation at each of the imprinting control loci analysed was maintained, including regions that contained biallelically expressed genes. This suggests in some cases methylation has become uncoupled from its role in regulating gene expression. Conclusions/Significance: We conclude that only a limited set of imprinted genes, including IGF2 and SNRPN, may be useful for LOI cancer biomarker studies. In addition, blood is not a good tissue to use for the discovery of new imprinted genes. Finally, lymphocyte DNA methylation status in the adult may not always be a reliable indicator of monoallelic gene expression.	[Frost, Jennifer M.; Monk, Dave; Stojilkovic-Mikic, Taita; Chitty, Lyn S.; Stanier, Philip; Moore, Gudrun E.] UCL, Inst Child Hlth, Clin & Mol Genet Unit, London, England; [Frost, Jennifer M.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Stojilkovic-Mikic, Taita; Chitty, Lyn S.] UCL, Acad Dept Obstet & Gynaecol, London, England; [Monk, Dave] Hosp Duran I Reynals, Catalan Inst Oncol, Canc Epigenet & Biol Program, Imprinting & Canc Grp, Barcelona, Spain; [Woodfine, Kathryn; Murrell, Adele] Cambridge Res Inst, Canc Res UK, Cambridge, England	University of London; University College London; Imperial College London; University of London; University College London; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Frost, JM (corresponding author), UCL, Inst Child Hlth, Clin & Mol Genet Unit, London, England.	j.frost@ich.ucl.ac.uk	Stanier, Philip/C-1593-2008; Moore, Gudrun/A-2092-2009; Frost, Jennifer/D-1867-2015	Stanier, Philip/0000-0001-9340-8117; chitty, lyn/0000-0002-4857-7138; Frost, Jennifer/0000-0002-3057-6313; Murrell, adele/0000-0003-2647-3511	Medical Research Council; March of Dimes and Wellbeing of Women; Cancer Research UK Senior Cancer Research Fellowship; Association for International Cancer Research; University of Cambridge, and Cancer Research UK; Great Ormond Street Hospital Childrens Charity [V0909] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); March of Dimes and Wellbeing of Women(March of Dimes); Cancer Research UK Senior Cancer Research Fellowship(Cancer Research UK); Association for International Cancer Research; University of Cambridge, and Cancer Research UK(University of Cambridge); Great Ormond Street Hospital Childrens Charity	This work was supported by grants from the Medical Research Council, the March of Dimes and Wellbeing of Women. AM and KW would like to acknowledge a Cancer Research UK Senior Cancer Research Fellowship and Association for International Cancer Research Project grant, as well as the support of The University of Cambridge, and Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (http://www.mrc.ac.uk/index.htm; http://www.marchofdimes.com/; http://www.wellbeingofwomen.org.uk/; http://www.cancerresearchuk.org/; http://www.aicr.org.uk/)	Abu-Amero S, 2008, J MED GENET, V45, P193, DOI 10.1136/jmg.2007.053017; Apostolidou S, 2007, J MOL MED, V85, P379, DOI 10.1007/s00109-006-0131-8; Arnaud P, 2003, HUM MOL GENET, V12, P1005, DOI 10.1093/hmg/ddg110; Azzi S, 2009, HUM MOL GENET, V18, P4724, DOI 10.1093/hmg/ddp435; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Byun HM, 2007, CANCER RES, V67, P10753, DOI 10.1158/0008-5472.CAN-07-0329; Choi JD, 2005, MOL CELL BIOL, V25, P5514, DOI 10.1128/MCB.25.13.5514-5522.2005; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Cui HM, 2002, CANCER RES, V62, P6442; DAVIES SM, 1994, CANCER RES, V54, P2560; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Diaz-Meyer N, 2003, J MED GENET, V40, P797, DOI 10.1136/jmg.40.11.797; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; FROST JM, 2011, EPIGENETICS, V6; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Ito Y, 2008, HUM MOL GENET, V17, P2633, DOI 10.1093/hmg/ddn163; Jelinic P, 2007, J PATHOL, V211, P261, DOI 10.1002/path.2116; Kosaki K, 2000, AM J HUM GENET, V66, P309, DOI 10.1086/302712; Liu J, 2003, J CLIN ENDOCR METAB, V88, P4336, DOI 10.1210/jc.2003-030393; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Murrell A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001849; Paulsen M, 1998, HUM MOL GENET, V7, P1149, DOI 10.1093/hmg/7.7.1149; Pham NV, 1998, BRAIN RES, V810, P1, DOI 10.1016/S0006-8993(98)00783-5; Pollard KS, 2008, HUM GENET, V122, P625, DOI 10.1007/s00439-007-0440-1; Sakatani T, 2001, BIOCHEM BIOPH RES CO, V283, P1124, DOI 10.1006/bbrc.2001.4916; Shin JY, 2008, EMBO J, V27, P168, DOI 10.1038/sj.emboj.7601960; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; TANIGUCHI T, 1995, P NATL ACAD SCI USA, V92, P2159, DOI 10.1073/pnas.92.6.2159; Ulaner GA, 2003, HUM MOL GENET, V12, P535, DOI 10.1093/hmg/ddg034; Valleley EM, 2007, HUM MOL GENET, V16, P972, DOI 10.1093/hmg/ddm041; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weksberg R, 2001, HUM MOL GENET, V10, P2989, DOI 10.1093/hmg/10.26.2989; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Wood AJ, 2007, PLOS GENET, V3, P192, DOI 10.1371/journal.pgen.0030020	42	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13556	10.1371/journal.pone.0013556	http://dx.doi.org/10.1371/journal.pone.0013556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042416	Green Published, Green Submitted, gold			2022-12-25	WOS:000283293800020
J	Rugo, RE; Mutamba, JT; Mohan, KN; Yee, T; Chaillet, JR; Greenberger, JS; Engelward, BP				Rugo, R. E.; Mutamba, J. T.; Mohan, K. N.; Yee, T.; Chaillet, J. R.; Greenberger, J. S.; Engelward, B. P.			Methyltransferases mediate cell memory of a genotoxic insult	ONCOGENE			English	Article						epigenetics; memory; genomic instability; methyltransferase; bystander effect; persistent effects	DELAYED GENOMIC INSTABILITY; IONIZING-RADIATION; IN-VIVO; CHROMOSOMAL INSTABILITY; UNIRRADIATED CELLS; ALPHA-PARTICLES; DNA METHYLATION; BYSTANDER CELLS; EXPOSURE; DNMT1	Characterization of the direct effects of DNA-damaging agents shows how DNA lesions lead to specific mutations. Yet, serum from Hiroshima survivors, Chernobyl liquidators and radiotherapy patients can induce a clastogenic effect on naive cells, showing indirect induction of genomic instability that persists years after exposure. Such indirect effects are not restricted to ionizing radiation, as chemical genotoxins also induce heritable and transmissible genomic instability phenotypes. Although such indirect induction of genomic instability is well described, the underlying mechanism has remained enigmatic. Here, we show that mouse embryonic stem cells exposed to gamma-radiation bear the effects of the insult for weeks. Specifically, conditioned media from the progeny of exposed cells can induce DNA damage and homologous recombination in naive cells. Notably, cells exposed to conditioned media also elicit a genome-destabilizing effect on their neighbouring cells, thus demonstrating transmission of genomic instability. Moreover, we show that the underlying basis for the memory of an insult is completely dependent on two of the major DNA cytosine methyltransferases, Dnmt1 and Dnmt3a. Targeted disruption of these genes in exposed cells completely eliminates transmission of genomic instability. Furthermore, transient inactivation of Dnmt1, using a tet-suppressible allele, clears the memory of the insult, thus protecting neighbouring cells from indirect induction of genomic instability. We have thus demonstrated that a single exposure can lead to long-term, genome-destabilizing effects that spread from cell to cell, and we provide a specific molecular mechanism for these persistent bystander effects. Collectively, our results impact the current understanding of risks from toxin exposures and suggest modes of intervention for suppressing genomic instability in people exposed to carcinogenic genotoxins. Oncogene (2011) 30, 751-756; doi:10.1038/onc.2010.480; published online 8 November 2010	[Rugo, R. E.; Mutamba, J. T.; Yee, T.; Engelward, B. P.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Mohan, K. N.; Chaillet, J. R.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Greenberger, J. S.] Univ Pittsburgh, Inst Canc, Dept Radiat Oncol, Pittsburgh, PA USA	Massachusetts Institute of Technology (MIT); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Engelward, BP (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave,16-743, Cambridge, MA 02139 USA.	bevin@mit.edu	Mohan, Kommu Naga/HIK-1746-2022		NIH [RO1-CA83876-8]; NIH/NIAID CMCR [U19 AI068021]; Department of Energy [DE-FG02-05ER64053]; NIEHS Center for Environmental Health Sciences [P30-ES002109]; TY; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044133] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA083876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAID CMCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NIEHS Center for Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); TY; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank M Okano and E Li for MTase-deficient ES cells. This work was supported primarily by NIH Grant RO1-CA83876-8, NIH/NIAID CMCR U19 AI068021, with partial support from the Department of Energy DE-FG02-05ER64053. We thank the NIEHS Center for Environmental Health Sciences (P30-ES002109), the Cancer Research Center Flow Cytometry Facility and Debby Pheasant for technical support. We thank Benjamin Greenberger, Paavni Komanduri and Werner Olipitz for their contributions.; RER designed and performed all experiments with support from TY; KNM and JRC engineered the dox controllable Dnmt1 system and performed western analysis; BPE prepared the paper with support from JTM; BPE and JSG oversaw the study design. All authors discussed the results and commented on the paper.	Azzam EI, 2002, CANCER RES, V62, P5436; BENDER MA, 1962, RADIAT RES, V16, P44, DOI 10.2307/3571128; Borowczyk E, 2009, P NATL ACAD SCI USA, V106, P20806, DOI 10.1073/pnas.0905668106; Burr KL, 2010, RADIAT RES, V173, P760, DOI 10.1667/RR1937.1; CHANG WP, 1992, CARCINOGENESIS, V13, P923, DOI 10.1093/carcin/13.6.923; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Dickey JS, 2009, CARCINOGENESIS, V30, P1686, DOI 10.1093/carcin/bgp192; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Engelward BP, 1996, EMBO J, V15, P945, DOI 10.1002/j.1460-2075.1996.tb00429.x; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Goldberg Z, 2002, INT J ONCOL, V21, P337; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Huang L, 2007, CANCER RES, V67, P1099, DOI 10.1158/0008-5472.CAN-06-3697; Huo LH, 2001, RADIAT RES, V156, P521, DOI 10.1667/0033-7587(2001)156[0521:HMIIBC]2.0.CO;2; KADHIM MA, 1992, NATURE, V355, P738, DOI 10.1038/355738a0; Kim M, 2004, NUCLEIC ACIDS RES, V32, P5742, DOI 10.1093/nar/gkh912; Koturbash I, 2006, ONCOGENE, V25, P4267, DOI 10.1038/sj.onc.1209467; Kovalchuk O, 2008, ENVIRON MOL MUTAGEN, V49, P16, DOI 10.1002/em.20361; Lei H, 1996, DEVELOPMENT, V122, P3195; Lewis DA, 2001, RADIAT RES, V156, P251, DOI 10.1667/0033-7587(2001)156[0251:PODDAN]2.0.CO;2; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Limoli CL, 1998, PHOTOCHEM PHOTOBIOL, V67, P233, DOI 10.1562/0031-8655(1998)067<0233:IOCAAD>2.3.CO;2; Little JB, 2003, ONCOGENE, V22, P6978, DOI 10.1038/sj.onc.1206988; LITTLE JB, 1990, INT J RADIAT ONCOL, V19, P1425, DOI 10.1016/0360-3016(90)90354-M; Lorimore SA, 2005, CANCER RES, V65, P5668, DOI 10.1158/0008-5472.CAN-05-0834; Lorimore SA, 2003, ONCOGENE, V22, P7058, DOI 10.1038/sj.onc.1207044; Maltseva DV, 2010, BIOCHEMISTRY-MOSCOW+, V75, P173, DOI 10.1134/S0006297910020070; Maxwell CA, 2008, CANCER RES, V68, P8304, DOI 10.1158/0008-5472.CAN-08-1212; Morgan WF, 2005, P NATL ACAD SCI USA, V102, P14127, DOI 10.1073/pnas.0507119102; Morgan WF, 2003, RADIAT RES, V159, P581, DOI 10.1667/0033-7587(2003)159[0581:NADEOE]2.0.CO;2; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Mothersill C, 1998, INT J RADIAT BIOL, V74, P673, DOI 10.1080/095530098140934; Mothersill C, 2004, NAT REV CANCER, V4, P158, DOI 10.1038/nrc1277; Mothersill C, 2002, RADIAT PROT DOSIM, V99, P163, DOI 10.1093/oxfordjournals.rpd.a006752; Mothersill C, 2001, RADIAT RES, V155, P759, DOI 10.1667/0033-7587(2001)155[0759:RIBEPH]2.0.CO;2; Mothersill Carmel, 2006, Dose-Response, V4, P283, DOI 10.2203/dose-response.06-111.Mothersill; Mothersill C, 2007, ENVIRON SCI TECHNOL, V41, P3382, DOI 10.1021/es062978n; Mothersill Carmel, 2005, Med Confl Surviv, V21, P101, DOI 10.1080/13623690500073398; Nagar S, 2003, CANCER RES, V63, P324; NAGASAWA H, 1992, CANCER RES, V52, P6394; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; PAMPFER S, 1989, INT J RADIAT BIOL, V55, P85, DOI 10.1080/09553008914550091; PANT GS, 1977, HIROSHIMA J MED SCI, V26, P149; Rodier F, 2009, NAT CELL BIOL, V11, P1272, DOI 10.1038/ncb1009-1272a; Rugo RE, 2005, ONCOGENE, V24, P5016, DOI 10.1038/sj.onc.1208690; STEIN R, 1982, P NATL ACAD SCI-BIOL, V79, P61, DOI 10.1073/pnas.79.1.61; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Watson GE, 2000, CANCER RES, V60, P5608; Yang G, 2008, RADIAT RES, V170, P372, DOI 10.1667/RR1324.1; Zhou HN, 2000, P NATL ACAD SCI USA, V97, P2099, DOI 10.1073/pnas.030420797	55	25	28	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	6					751	756		10.1038/onc.2010.480	http://dx.doi.org/10.1038/onc.2010.480			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	719GY	21057543	Green Accepted, Green Submitted			2022-12-25	WOS:000287192000011
J	Garcia, LL; Rivas-Marin, E; Floriano, B; Bernhardt, R; Ewen, KM; Reyes-Ramirez, F; Santero, E				Ledesma Garcia, Laura; Rivas-Marin, Elena; Floriano, Belen; Bernhardt, Rita; Ewen, Kerstin Maria; Reyes-Ramirez, Francisca; Santero, Eduardo			ThnY Is a Ferredoxin Reductase-like Iron-Sulfur Flavoprotein That Has Evolved to Function as a Regulator of Tetralin Biodegradation Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AZOTOBACTER-VINELANDII NIFL; SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; NITROGEN-FIXATION; CATABOLIC PATHWAY; NADP+ REDUCTASE; DIOXYGENASE; PURIFICATION; SYSTEM; STRAIN	Previous genetic studies in Sphingomonas macrogolitabida strain TFA have established that expression of genes involved in tetralin biodegradation (thn genes) requires the function of the LysR type activator ThnR and also ThnY. Sequence comparison indicated that ThnY is homologous to bacterial oxygenase-coupled NAD(P) H-dependent ferredoxin reductases. However, ThnY showed substitutions in highly conserved positions of the pyridine nucleotide binding domain of these ferredoxin reductases. ThnY expression is co-regulated with all other genes required for tetralin biodegradation, and presumably thnY is part of the thnCA3A4RY operon. ThnY has been purified, and its biochemical and functional properties were characterized. ThnY was found to be a monomeric orange-brown iron-sulfur flavoprotein (estimated mass of 37,000 Da) containing one non-covalently attached flavin adenine dinucleotide and one plant type ferredoxin 2Fe-2S cluster. It can be efficiently reduced by dithionite, but reduction by pyridine nucleotides was very poor. Consistently, ThnY-dependent reduction of cytochrome c, ferricyanide, or 2,6-dichloropheno-lindophenol using NAD(P) H as the electron donor was undetectable or very weak. The addition of ThnY to electrophoretic mobility shift assays containing ThnR and a probe bearing two thn divergent promoters resulted in a 3-fold increase in protein-DNA complex formation affinity, which indicates that ThnY directly promotes thn transcription activation by ThnR.	[Ledesma Garcia, Laura; Rivas-Marin, Elena; Floriano, Belen; Reyes-Ramirez, Francisca; Santero, Eduardo] Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville 41013, Spain; [Bernhardt, Rita; Ewen, Kerstin Maria] Univ Saarland, D-66123 Saarbrucken, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Saarland University	Reyes-Ramirez, F (corresponding author), Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Carretera Utrera Km 1, Seville 41013, Spain.	freyram@upo.es	Rivas-Marín, Elena/B-6508-2016; Garcia, Laura Ledesma/AAA-6524-2021; Reyes-Ramirez, Francisca/L-3314-2014; Rivas-Marin, Elena/AAU-4036-2020; Floriano, Belen/K-7644-2014; Santero, Eduardo/K-6510-2014	Rivas-Marín, Elena/0000-0002-8696-8113; Garcia, Laura Ledesma/0000-0003-3276-2192; Reyes-Ramirez, Francisca/0000-0002-5120-8931; Rivas-Marin, Elena/0000-0002-8696-8113; Floriano, Belen/0000-0002-5326-7601; Santero, Eduardo/0000-0002-6111-7160	Spanish Ministry of Science and Innovation [BIO2008-01805, CSD2007-00005]; Andalusian Government [P05-CVI-131, P07-CVI-2518]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Andalusian Government	This work was supported by Spanish Ministry of Science and Innovation Grants BIO2008-01805 and CSD2007-00005 and Andalusian Government Grants P05-CVI-131 and P07-CVI-2518 (to L.L.G.).	ALIVERTI A, 1993, BIOCHEMISTRY-US, V32, P6374, DOI 10.1021/bi00076a010; Aliverti A, 2008, ARCH BIOCHEM BIOPHYS, V474, P283, DOI 10.1016/j.abb.2008.02.014; Andujar E, 2003, MICROBIOL-SGM, V149, P1559, DOI 10.1099/mic.0.26034-0; Andujar E, 2000, J BACTERIOL, V182, P789, DOI 10.1128/JB.182.3.789-795.2000; Batie C. J., 1991, CHEM BIOCH FLAVOENZY, V3, P543; Bauer CE, 1999, ANNU REV MICROBIOL, V53, P495, DOI 10.1146/annurev.micro.53.1.495; Butler CS, 1997, ADV MICROB PHYSIOL, V38, P47; Ceccarelli EA, 2004, BBA-PROTEINS PROTEOM, V1698, P155, DOI 10.1016/j.bbapap.2003.12.005; CORRELL CC, 1993, PROTEIN SCI, V2, P2112, DOI 10.1002/pro.5560021212; DORN E, 1974, ARCH MICROBIOL, V99, P61, DOI 10.1007/BF00696222; Dubbs JM, 2004, FEMS MICROBIOL REV, V28, P353, DOI 10.1016/j.femsre.2004.01.002; Elsen S, 2005, MOL MICROBIOL, V57, P17, DOI 10.1111/j.1365-2958.2005.04655.x; Ewen KM, 2011, BBA-PROTEINS PROTEOM, V1814, P111, DOI 10.1016/j.bbapap.2010.06.003; Ferraro DJ, 2005, BIOCHEM BIOPH RES CO, V338, P175, DOI 10.1016/j.bbrc.2005.08.222; FETZNER S, 1992, J BACTERIOL, V174, P279, DOI 10.1128/jb.174.1.279-290.1992; Frago S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-160; Garcia-Gonzalez V, 2009, FEMS MICROBIOL LETT, V300, P222, DOI 10.1111/j.1574-6968.2009.01784.x; Govantes F, 1996, J BACTERIOL, V178, P6817, DOI 10.1128/jb.178.23.6817-6823.1996; HAIGLER BE, 1990, J BACTERIOL, V172, P457, DOI 10.1128/JB.172.1.457-464.1990; Hall DA, 2004, SCIENCE, V306, P482, DOI 10.1126/science.1096773; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Heil G, 2002, MICROBIOL-SGM, V148, P2203, DOI 10.1099/00221287-148-7-2203; Hernaez MJ, 2000, J BACTERIOL, V182, P5448, DOI 10.1128/JB.182.19.5448-5453.2000; Hernaez MJ, 1999, APPL ENVIRON MICROB, V65, P1806; Hill S, 1996, P NATL ACAD SCI USA, V93, P2143, DOI 10.1073/pnas.93.5.2143; Huang JZ, 1998, J BACTERIOL, V180, P2736, DOI 10.1128/JB.180.10.2736-2743.1998; Karlsson A, 2002, J MOL BIOL, V318, P261, DOI 10.1016/S0022-2836(02)00039-6; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; Kauppi B, 1998, STRUCTURE, V6, P571, DOI 10.1016/S0969-2126(98)00059-8; Kovacikova G, 2004, MOL MICROBIOL, V53, P129, DOI 10.1111/j.1365-2958.2004.04121.x; LANE D, 1994, J MOL BIOL, V242, P339, DOI 10.1006/jmbi.1994.1585; Little R, 2000, EMBO J, V19, P6041, DOI 10.1093/emboj/19.22.6041; Lopez-Sanchez A, 2010, APPL ENVIRON MICROB, V76, P110, DOI 10.1128/AEM.01846-09; Lopez-Sanchez A, 2009, MOL MICROBIOL, V73, P1086, DOI 10.1111/j.1365-2958.2009.06834.x; LOVENBERG W, 1973, IRON SULFUR PROTEINS, P214; MACHEROUX P, 1999, FLAVOPROTEIN PROTOCO, P1; Martinez-Perez O, 2004, J BACTERIOL, V186, P6101, DOI 10.1128/JB.186.18.6101-6109.2004; Martinez-Perez O, 2007, J BACTERIOL, V189, P3768, DOI 10.1128/JB.00057-07; MASON JR, 1992, ANNU REV MICROBIOL, V46, P277, DOI 10.1146/annurev.mi.46.100192.001425; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Moreno-Ruiz E, 2003, J BACTERIOL, V185, P2026, DOI 10.1128/JB.185.6.2026-2030.2003; Nam JW, 2002, APPL ENVIRON MICROB, V68, P5882, DOI 10.1128/AEM.68.12.5882-5890.2002; Porrua O, 2007, MOL MICROBIOL, V66, P410, DOI 10.1111/j.1365-2958.2007.05927.x; Sambrook J, 2001, MOL CLONING LAB MANU; Shi YJ, 2004, TRENDS GENET, V20, P445, DOI 10.1016/j.tig.2004.07.004; Unden G, 1997, MOL MICROBIOL, V25, P205, DOI 10.1046/j.1365-2958.1997.4731841.x; YAMAGUCHI M, 1980, J BIOL CHEM, V255, P5058; Zheng M, 2000, BIOCHEM PHARMACOL, V59, P1, DOI 10.1016/S0006-2952(99)00289-0; Zhou YZ, 2008, AMINO ACIDS, V35, P711, DOI 10.1007/s00726-008-0053-6	50	19	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1709	1718		10.1074/jbc.M110.184648	http://dx.doi.org/10.1074/jbc.M110.184648			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21068394	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000286191500010
J	Carriere, A; Romeo, Y; Acosta-Jaquez, HA; Moreau, J; Bonneil, E; Thibault, P; Fingar, DC; Roux, PP				Carriere, Audrey; Romeo, Yves; Acosta-Jaquez, Hugo A.; Moreau, Julie; Bonneil, Eric; Thibault, Pierre; Fingar, Diane C.; Roux, Philippe P.			ERK1/2 Phosphorylate Raptor to Promote Ras-dependent Activation of mTOR Complex 1 (mTORC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; TUMOR-SUPPRESSOR COMPLEX; INITIATION-FACTOR 4E; RIBOSOMAL S6 KINASE; CELL-GROWTH; TUBEROUS SCLEROSIS; PROTEIN-PHOSPHORYLATION; MAMMALIAN TARGET; DOWNSTREAM TARGETS; IN-VIVO	The Ras/mitogen-activated protein kinase (MAPK) pathway regulates a variety of cellular processes by activating specific transcriptional and translational programs. Ras/MAPK signaling promotes mRNA translation and protein synthesis, but the exact molecular mechanisms underlying this regulation remain poorly understood. Increasing evidence suggests that the mammalian target of rapamycin (mTOR) plays an essential role in this process. Here, we show that Raptor, an essential scaffolding protein of the mTOR complex 1 (mTORC1), becomes phosphorylated on proline-directed sites following activation of the Ras/MAPK pathway. We found that ERK1 and ERK2 interact with Raptor in cells and mediate its phosphorylation in vivo and in vitro. Using mass spectrometry and phosphospecific antibodies, we found three proline-directed residues within Raptor, Ser(8), Ser(696), and Ser(863), which are directly phosphorylated by ERK1/2. Expression of phosphorylation-deficient alleles of Raptor revealed that phosphorylation of these sites by ERK1/2 normally promotes mTORC1 activity and signaling to downstream substrates, such as 4E-BP1. Our data provide a novel regulatory mechanism by which mitogenic and oncogenic activation of the Ras/MAPK pathway promotes mTOR signaling.	[Romeo, Yves; Moreau, Julie; Bonneil, Eric; Thibault, Pierre; Roux, Philippe P.] Univ Montreal, IRIC, Montreal, PQ H3C 3J7, Canada; [Carriere, Audrey; Romeo, Yves; Roux, Philippe P.] Univ Montreal, Dept Pathol & Cell Biol, Fac Med, Montreal, PQ H3C 3J7, Canada; [Thibault, Pierre] Univ Montreal, Dept Chem, Fac Arts & Sci, Montreal, PQ H3C 3J7, Canada; [Acosta-Jaquez, Hugo A.; Fingar, Diane C.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Fingar, Diane C.] Univ Michigan, Sch Med, Dept Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA	Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Roux, PP (corresponding author), Univ Montreal, IRIC, POB 6128,Stn Ctr Ville, Montreal, PQ H3C 3J7, Canada.	philippe.roux@umontreal.ca	Romeo, Yves/AAC-1669-2021; Roux, Philippe P./J-3996-2012	Roux, Philippe P./0000-0002-5962-0250; Thibault, Pierre/0000-0001-5993-0331; Carriere, Audrey/0000-0002-4277-7905	Terry Fox Foundation, Canadian Cancer Society Research Institute [018311]; Fondation pour la recherche en sante du Quebec; Cole Foundation; National Institutes of Health [R01 (DK-078135)]; American Diabetes Association; Human Frontier Science Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078135] Funding Source: NIH RePORTER	Terry Fox Foundation, Canadian Cancer Society Research Institute; Fondation pour la recherche en sante du Quebec; Cole Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Terry Fox Foundation Grant 018311 from the Canadian Cancer Society Research Institute. IRIC core facilities are supported by the Fondation pour la recherche en sante du Quebec.; Recipient of a fellowship from the Cole Foundation.; Supported by National Institutes of Health Grant R01 (DK-078135) and an American Diabetes Association Junior Faculty Award.; Holds a Canada Research Chair in Signal Transduction and Proteomics and a Career Development Award from the Human Frontier Science Program.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Avruch J, 2009, BIOCHEM SOC T, V37, P223, DOI 10.1042/BST0370223; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Buxade M, 2008, FRONT BIOSCI-LANDMRK, V13, P5359, DOI 10.2741/3086; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jacinto E, 2008, IUBMB LIFE, V60, P483, DOI 10.1002/iub.56; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Proud CG, 2009, BIOCHEM SOC T, V37, P227, DOI 10.1042/BST0370227; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Ramirez-Valle F, 2010, MOL CELL BIOL, V30, P3151, DOI 10.1128/MCB.00322-09; Rolfe M, 2005, BIOCHEM J, V388, P973, DOI 10.1042/BJ20041888; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2009, BIOCHEM SOC T, V37, P289, DOI 10.1042/BST0370289; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Servant MJ, 1996, J BIOL CHEM, V271, P16047, DOI 10.1074/jbc.271.27.16047; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Urano J, 2005, MOL MICROBIOL, V58, P1074, DOI 10.1111/j.1365-2958.2005.04877.x; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang L, 2009, J BIOL CHEM, V284, P14693, DOI 10.1074/jbc.C109.002907; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	65	168	173	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					567	577		10.1074/jbc.M110.159046	http://dx.doi.org/10.1074/jbc.M110.159046			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21071439	Green Published, hybrid			2022-12-25	WOS:000285782800059
J	Billings, NA; Emerson, MM; Cepko, CL				Billings, Nathan A.; Emerson, Mark M.; Cepko, Constance L.			Analysis of Thyroid Response Element Activity during Retinal Development	PLOS ONE			English	Article							HORMONE RECEPTOR-ALPHA; TYPE-2 IODOTHYRONINE DEIODINASE; CONE OPSIN EXPRESSION; BRAIN-DEVELOPMENT; FUNCTIONAL-CHARACTERIZATION; NUCLEAR RECEPTORS; RNA INTERFERENCE; ORPHAN RECEPTORS; GENE-EXPRESSION; CEREBRAL-CORTEX	Thyroid hormone (TH) signaling components are expressed during retinal development in dynamic spatial and temporal patterns. To probe the competence of retinal cells to mount a transcriptional response to TH, reporters that included thyroid response elements (TREs) were introduced into developing retinal tissue. The TREs were placed upstream of a minimal TATA-box and two reporter genes, green fluorescent protein (GFP) and human placental alkaline phosphatase (PLAP). Six of the seven tested TREs were first tested in vitro where they were shown to drive TH-dependent expression. However, when introduced into the developing retina, the TREs reported in different cell types in both a TH-dependent and TH-independent manner, as well as revealed specific spatial patterns in their expression. The role of the known thyroid receptors (TR), TR alpha and TR beta, was probed using shRNAs, which were co-electroporated into the retina with the TREs. Some TREs were positively activated by TR+TH in the developing outer nuclear layer (ONL), where photoreceptors reside, as well as in the outer neuroblastic layer (ONBL) where cycling progenitor cells are located. Other TREs were actively repressed by TR+TH in cells of the ONBL. These data demonstrate that non-TRs can activate some TREs in a spatially regulated manner, whereas other TREs respond only to the known TRs, which also read out activity in a spatially regulated manner. The transcriptional response to even simple TREs provides a starting point for understanding the regulation of genes by TH, and highlights the complexity of transcriptional regulation within developing tissue.	[Billings, Nathan A.; Cepko, Constance L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Billings, NA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA.	cepko@genetics.med.harvard.edu			Howard Hughes Medical Institute; NIH [F32 EY018287-01]; NATIONAL EYE INSTITUTE [F32EY018287] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Howard Hughes Medical Institute (NAB) and by a NIH Kirschstein NRSA fellowship, F32 EY018287-01 (MME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison WT, 2006, J COMP NEUROL, V499, P702, DOI 10.1002/cne.21164; Applebury ML, 2007, DEV DYNAM, V236, P1203, DOI 10.1002/dvdy.21155; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Bernal J, 2003, THYROID, V13, P1005, DOI 10.1089/105072503770867174; Bernal J, 2005, VITAM HORM, V71, P95, DOI 10.1016/S0083-6729(05)71004-9; Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; BRENT GA, 1989, J BIOL CHEM, V264, P178; BRENT GA, 1989, MOL ENDOCRINOL, V3, P1996, DOI 10.1210/mend-3-12-1996; Bruhn SL, 1996, J NEUROSCI, V16, P1430; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cheng CL, 2009, INVEST OPHTH VIS SCI, V50, P3024, DOI 10.1167/iovs.08-2713; COONEY AJ, 1993, J BIOL CHEM, V268, P4152; CRANTZ FR, 1982, ENDOCRINOLOGY, V110, P367, DOI 10.1210/endo-110-2-367; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; Dentice M, 2005, NAT CELL BIOL, V7, P698, DOI 10.1038/ncb1272; Dentice M, 2007, P NATL ACAD SCI USA, V104, P14466, DOI 10.1073/pnas.0706754104; Desouza LA, 2005, MOL CELL NEUROSCI, V29, P414, DOI 10.1016/j.mcn.2005.03.010; DESVERGNE B, 1991, J BIOL CHEM, V266, P1008; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Dodd M.H.I., 1976, P467; DUNN JT, 1993, ANN N Y ACAD SCI, V678, P158; DUSSAULT JH, 1987, ANNU REV PHYSIOL, V49, P321, DOI 10.1146/annurev.ph.49.030187.001541; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FORREST D, 1994, SEMIN CANCER BIOL, V5, P167; Forrest D, 1996, NAT GENET, V13, P354, DOI 10.1038/ng0796-354; Freitas BCG, 2010, J CLIN INVEST, V120, P2206, DOI 10.1172/JCI41977; Galton VA, 2009, ENDOCRINOLOGY, V150, P2957, DOI 10.1210/en.2008-1572; Gereben B, 2008, CELL MOL LIFE SCI, V65, P570, DOI 10.1007/s00018-007-7396-0; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GuadanoFerraz A, 1997, P NATL ACAD SCI USA, V94, P10391, DOI 10.1073/pnas.94.19.10391; Heuer H, 2007, BEST PRACT RES CL EN, V21, P265, DOI 10.1016/j.beem.2007.03.003; HILFER SR, 1980, DEV BIOL, V79, P107, DOI 10.1016/0012-1606(80)90076-7; Hitoshi N., 1991, GENE, V108, P193; HO R, 1995, NATURE, V377, P397; Inoue M, 2010, EXP EYE RES, V90, P49, DOI 10.1016/j.exer.2009.09.009; Jones I, 2007, MOL ENDOCRINOL, V21, P1108, DOI 10.1210/me.2007-0037; KELLEY MW, 1995, DEVELOPMENT, V121, P3777; Kim DS, 2008, J COMP NEUROL, V507, P1795, DOI 10.1002/cne.21639; Kim DS, 2008, J NEUROSCI, V28, P7748, DOI 10.1523/JNEUROSCI.0397-08.2008; KLIEWER SA, 1992, P NATL ACAD SCI USA, V89, P1448, DOI 10.1073/pnas.89.4.1448; KOENIG RJ, 1988, P NATL ACAD SCI USA, V85, P5031, DOI 10.1073/pnas.85.14.5031; Mader M, 2006, MOL VIS, V12, P915; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Marsh-Armstrong N, 1999, NEURON, V24, P871, DOI 10.1016/S0896-6273(00)81034-X; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; McCaffery P, 1999, MECH DEVELOP, V82, P119, DOI 10.1016/S0925-4773(99)00022-2; McEwan Iain J., 2009, V505, P3, DOI 10.1007/978-1-60327-575-0_1; Mey J, 1997, J NEUROSCI, V17, P7441; Morte B, 2010, ENDOCRINOLOGY, V151, P2381, DOI 10.1210/en.2009-0944; Nagaya T, 1996, BIOCHEM BIOPH RES CO, V226, P426, DOI 10.1006/bbrc.1996.1372; Ng L, 2004, P NATL ACAD SCI USA, V101, P3474, DOI 10.1073/pnas.0307402101; Ng L, 2001, HUM MOL GENET, V10, P2701, DOI 10.1093/hmg/10.23.2701; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Ng L, 2009, NEUROREPORT, V20, P627, DOI 10.1097/WNR.0b013e32832a2c63; Ng L, 2009, ENDOCRINOLOGY, V150, P1952, DOI 10.1210/en.2008-1419; Nillni EA, 2010, FRONT NEUROENDOCRIN, V31, P134, DOI 10.1016/j.yfrne.2010.01.001; Oppenheimer JH, 1997, ENDOCR REV, V18, P462, DOI 10.1210/er.18.4.462; PARK HY, 1993, MOL ENDOCRINOL, V7, P319, DOI 10.1210/me.7.3.319; Pessoa CN, 2008, INVEST OPHTH VIS SCI, V49, P2039, DOI 10.1167/iovs.07-0908; PETTY KJ, 1990, J BIOL CHEM, V265, P7395; PRATI M, 1992, ENDOCRINOLOGY, V130, P2651, DOI 10.1210/en.130.5.2651; PROST E, 1988, NUCLEIC ACIDS RES, V16, P6248, DOI 10.1093/nar/16.13.6248; Raine JC, 2010, J EXP BIOL, V213, P493, DOI 10.1242/jeb.036301; Raine JC, 2009, J EXP BIOL, V212, P2781, DOI 10.1242/jeb.030866; Roberts MR, 2006, P NATL ACAD SCI USA, V103, P6218, DOI 10.1073/pnas.0509981103; Rusch A, 2001, J NEUROSCI, V21, P9792, DOI 10.1523/JNEUROSCI.21-24-09792.2001; Sakai Y, 2004, DEV BIOL, V276, P143, DOI 10.1016/j.ydbio.2004.08.032; SECHMAN A, 1988, GEN COMP ENDOCR, V69, P99, DOI 10.1016/0016-6480(88)90057-3; Simonides WS, 2008, J CLIN INVEST, V118, P975, DOI 10.1172/JCI32824; Sprecher SG, 2008, NATURE, V454, P533, DOI 10.1038/nature07062; TRAN P, 1992, MOL CELL BIOL, V12, P4666, DOI 10.1128/MCB.12.10.4666; Trimarchi JM, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-101; Tsui KH, 2008, PROSTATE, V68, P610, DOI 10.1002/pros.20725; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Visser W, 2007, BEST PRACT RES CL EN, V21, P223, DOI 10.1016/j.beem.2007.03.008; WEINBERGER C, 1990, ANNU REV PHYSIOL, V52, P823; Wilson CM, 1997, GEN COMP ENDOCR, V107, P153, DOI 10.1006/gcen.1997.6906; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; Zavacki AM, 1996, ENDOCRINOLOGY, V137, P2833, DOI 10.1210/en.137.7.2833; Zavacki AM, 1996, ENDOCRINOLOGY, V137, P1438, DOI 10.1210/en.137.4.1438; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	87	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13739	10.1371/journal.pone.0013739	http://dx.doi.org/10.1371/journal.pone.0013739			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060789	gold, Green Published, Green Submitted			2022-12-25	WOS:000283645300019
J	Haebig, K; Gloeckner, CJ; Miralles, MG; Gillardon, F; Schulte, C; Riess, O; Ueffing, M; Biskup, S; Bonin, M				Haebig, Karina; Gloeckner, Christian Johannes; Miralles, Marta Garcia; Gillardon, Frank; Schulte, Claudia; Riess, Olaf; Ueffing, Marius; Biskup, Saskia; Bonin, Michael			ARHGEF7 (BETA-PIX) Acts as Guanine Nucleotide Exchange Factor for Leucine-Rich Repeat Kinase 2	PLOS ONE			English	Article							FAMILIAL PARKINSONS-DISEASE; LEUCINE-RICH-REPEAT-KINASE-2 LRRK2; NEURONAL TOXICITY; SH-SY5Y CELLS; GTP-BINDING; MUTATIONS; GENE; PROTEIN; TANDEM; DOMAIN	Background: Mutations within the leucine-rich repeat kinase 2 (LRRK2) gene are a common cause of familial and sporadic Parkinson's disease. The multidomain protein LRRK2 exhibits overall low GTPase and kinase activity in vitro. Methodology/Principal Findings: Here, we show that the rho guanine nucleotide exchange factor ARHGEF7 and the small GTPase CDC42 are interacting with LRRK2 in vitro and in vivo. GTPase activity of full-length LRRK2 increases in the presence of recombinant ARHGEF7. Interestingly, LRRK2 phosphorylates ARHGEF7 in vitro at previously unknown phosphorylation sites. We provide evidence that ARHGEF7 might act as a guanine nucleotide exchange factor for LRRK2 and that R1441C mutant LRRK2 with reduced GTP hydrolysis activity also shows reduced binding to ARHGEF7. Conclusions/Significance: Downstream effects of phosphorylation of ARHGEF7 through LRRK2 could be (i) a feedback control mechanism for LRRK2 activity as well as (ii) an impact of LRRK2 on actin cytoskeleton regulation. A newly identified familial mutation N1437S, localized within the GTPase domain of LRRK2, further underlines the importance of the GTPase domain of LRRK2 in Parkinson's disease pathogenesis.	[Haebig, Karina; Riess, Olaf; Biskup, Saskia; Bonin, Michael] Univ Tubingen, Dept Med Genet, Inst Human Genet, Tubingen, Germany; [Gloeckner, Christian Johannes; Ueffing, Marius] Helmholtz Zentrum Munchen, Dept Prot Sci, Munich, Germany; [Gloeckner, Christian Johannes; Ueffing, Marius] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Tubingen, Germany; [Miralles, Marta Garcia; Schulte, Claudia; Biskup, Saskia] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Miralles, Marta Garcia; Schulte, Claudia; Biskup, Saskia] Univ Tubingen, German Ctr Neurodegenerat Dis, Tubingen, Germany; [Gillardon, Frank] Boehringer Ingelheim Pharma GmbH & Co KG, CNS Res, Biberach, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Boehringer Ingelheim	Haebig, K (corresponding author), Univ Tubingen, Dept Med Genet, Inst Human Genet, Tubingen, Germany.	saskia.biskup@medizin.uni-tuebingen.de; michael.bonin@med.uni-tuebingen.de	Gloeckner, Christian Johannes/R-5374-2019	Gloeckner, Christian Johannes/0000-0001-6494-6944; Garcia Miralles, Marta/0000-0001-7250-5778; Schulte, Claudia/0000-0003-4006-1265	Helmholtz Alliance for Mental Health in an Aging Society (HelMA) in Germany [FKZ: HA-215]; NGFNPlus [FKZ: 01GS08140]; University of Tuebingen	Helmholtz Alliance for Mental Health in an Aging Society (HelMA) in Germany; NGFNPlus; University of Tuebingen	CJG is supported by the Helmholtz Alliance for Mental Health in an Aging Society (HelMA, FKZ: HA-215) in Germany. SB is supported by IZKF Junior Group founding through the University of Tuebingen. This work was supported by the NGFNPlus grant to OR and MU (FKZ: 01GS08140). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasly JO, 2010, MOVEMENT DISORD, V25, P2156, DOI 10.1002/mds.23265; Anand VS, 2009, FEBS J, V276, P6428, DOI 10.1111/j.1742-4658.2009.07341.x; Bauer M, 2009, GENE THER, V16, P142, DOI 10.1038/gt.2008.123; Biskup S, 2009, BBA-MOL BASIS DIS, V1792, P625, DOI 10.1016/j.bbadis.2008.09.015; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Farrer M, 1999, HUM MOL GENET, V8, P81, DOI 10.1093/hmg/8.1.81; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; Gandhi PN, 2008, J NEUROSCI RES, V86, P1711, DOI 10.1002/jnr.21622; Gillardon F, 2009, NEUROSCIENCE, V163, P533, DOI 10.1016/j.neuroscience.2009.06.051; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Gloeckner Christian Johannes, 2009, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471140864.ps1920s57; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; GLOECKNER CJ, J PROTEOME RES, V9, P1738; GLOECKNER CJ, 2009, J NEUROCHEM; Gotthardt K, 2008, EMBO J, V27, P2239, DOI 10.1038/emboj.2008.150; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Habig K, 2008, NEUROGENETICS, V9, P83, DOI 10.1007/s10048-007-0114-0; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Jensen SS, 2007, RAPID COMMUN MASS SP, V21, P3635, DOI 10.1002/rcm.3254; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Klein CL, 2009, J NEUROCHEM, V111, P703, DOI 10.1111/j.1471-4159.2009.06358.x; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Luzon-Toro B, 2007, HUM MOL GENET, V16, P2031, DOI 10.1093/hmg/ddm151; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Sancho RM, 2009, HUM MOL GENET, V18, P3955, DOI 10.1093/hmg/ddp337; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tomasson MH, 1999, BLOOD, V93, P1707, DOI 10.1182/blood.V93.5.1707.405k24_1707_1714; van Egmond Wouter N, 2008, J Biol Chem, V283, P30412, DOI 10.1074/jbc.M804265200; Webber PJ, 2009, FEBS J, V276, P6436, DOI 10.1111/j.1742-4658.2009.07342.x; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Yue ZY, 2009, FEBS J, V276, P6445, DOI 10.1111/j.1742-4658.2009.07343.x; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	44	49	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13762	10.1371/journal.pone.0013762	http://dx.doi.org/10.1371/journal.pone.0013762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048939	Green Published, gold, Green Submitted			2022-12-25	WOS:000283645300040
J	Wang, JTH; Kerr, MC; Karunaratne, S; Jeanes, A; Yap, AS; Teasdale, RD				Wang, Jack T. H.; Kerr, Markus C.; Karunaratne, Seetha; Jeanes, Angela; Yap, Alpha S.; Teasdale, Rohan D.			The SNX-PX-BAR Family in Macropinocytosis: The Regulation of Macropinosome Formation by SNX-PX-BAR Proteins	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; EPITHELIAL-CELL INVASION; STIMULATED A431 CELLS; PLASMA-MEMBRANE; PHOSPHOINOSITIDE 3-KINASE; RECEPTOR DEGRADATION; SHIGELLA-FLEXNERI; SORTING NEXIN-1; COATED VESICLES; DOMAINS	Background: Macropinocytosis is an actin-driven endocytic process, whereby membrane ruffles fold back onto the plasma membrane to form large (> 0.2 mu m in diameter) endocytic organelles called macropinosomes. Relative to other endocytic pathways, little is known about the molecular mechanisms involved in macropinocytosis. Recently, members of the Sorting Nexin (SNX) family have been localized to the cell surface and early macropinosomes, and implicated in macropinosome formation. SNX-PX-BAR proteins form a subset of the SNX family and their lipid-binding (PX) and membrane-curvature sensing (BAR) domain architecture further implicates their functional involvement in macropinosome formation. Methodology/Principal Findings: We exploited the tractability of macropinosomes through image-based screening and systematic overexpression of SNX-PX-BAR proteins to quantitate their effect on macropinosome formation. SNX1 (40.9+/-3.19 macropinosomes), SNX5 (36.99+/-4.48 macropinosomes), SNX9 (37.55+/-2.4 macropinosomes), SNX18 (88.2+/-8 macropinosomes), SNX33 (65.25+/-6.95 macropinosomes) all exhibited statistically significant (p < 0.05) increases in average macropinosome numbers per 100 transfected cells as compared to control cells (24.44+/-1.81 macropinosomes). SNX1, SNX5, SNX9, and SNX18 were also found to associate with early-stage macropinosomes within 5 minutes following organelle formation. The modulation of intracellular PI(3,4,5)P-3 levels through overexpression of PTEN or a lipid phosphatase-deficient mutant PTEN(G129E) was also observed to significantly reduce or elevate macropinosome formation respectively; coexpression of PTEN(G129E) with SNX9 or SNX18 synergistically elevated macropinosome formation to 119.4+/-7.13 and 91.4+/-6.37 macropinosomes respectively (p < 0.05). Conclusions/Significance: SNX1, SNX5, SNX9, SNX18, and SNX33 were all found to elevate macropinosome formation and (with the exception of SNX33) associate with early-stage macropinosomes. Moreover the effects of SNX9 and SNX18 overexpression in elevating macropinocytosis is likely to be synergistic with the increase in PI(3,4,5)P-3 levels, which is known to accumulate on the cell surface and early-stage macropinocytic cups. Together these findings represent the first systematic functional study into the impact of the SNX-PX-BAR family on macropinocytosis.	[Wang, Jack T. H.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; Univ Queensland, ARC, Ctr Excellence Bioinformat, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Wang, JTH (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	R.Teasdale@imb.uq.edu.au	Kerr, Markus C/A-9864-2014; Jeanes, Angela/D-9770-2011; Wang, Jack T.H./B-4855-2013; Teasdale, Rohan D/B-2538-2009; Yap, Alpha S./J-1554-2014; Teasdale, Rohan/AAD-6698-2019	Jeanes, Angela/0000-0003-0717-6298; Teasdale, Rohan D/0000-0001-7455-5269; Yap, Alpha S./0000-0002-1038-8956; Teasdale, Rohan/0000-0001-7455-5269; Wang, Jack/0000-0002-9956-6041	National Health and Medical Research Council (NHMRC) of Australia [455824, 566727]; Australian Research Council [DP0771706]; Australian Postgraduate Award; NHMRC [351448, 511042]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funding from the National Health and Medical Research Council (NHMRC) of Australia (455824, 566727) and Australian Research Council (DP0771706). JTHW was supported by an Australian Postgraduate Award, AJ by an NHMRC Dora Lush scholarship, and AY and RDT are supported by NHMRC Senior Research Fellowships (351448 and 511042 respectively). Confocal microscopy was performed at the Australian Cancer Research Foundation (ACRF)/Institute for Molecular Bioscience Dynamic Imaging Facility for Cancer Biology, which was established with the support of the ACRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPUCHEARANDA CM, 1994, J EXP MED, V179, P601, DOI 10.1084/jem.179.2.601; Amyere M, 2002, INT J MED MICROBIOL, V291, P487; Amyere M, 2000, MOL BIOL CELL, V11, P3453, DOI 10.1091/mbc.11.10.3453; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Araki N, 2006, CELL STRUCT FUNCT, V31, P145, DOI 10.1247/csf.06029; Araki N, 2007, EXP CELL RES, V313, P1496, DOI 10.1016/j.yexcr.2007.02.012; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Coyne CB, 2007, CELL HOST MICROBE, V2, P181, DOI 10.1016/j.chom.2007.07.003; Cozier GE, 2002, J BIOL CHEM, V277, P48730, DOI 10.1074/jbc.M206986200; DOWRICK P, 1993, EUR J CELL BIOL, V61, P44; Ellson CD, 2001, NAT CELL BIOL, V3, P679, DOI 10.1038/35083076; Garcia-Perez BE, 2008, MICROB PATHOGENESIS, V45, P1, DOI 10.1016/j.micpath.2008.01.009; Evans TM, 2003, TRAFFIC, V4, P869, DOI 10.1046/j.1600-0854.2003.00141.x; FRANCIS CL, 1993, NATURE, V364, P639, DOI 10.1038/364639a0; GARCIADELPORTILLO F, 1994, INFECT IMMUN, V62, P4641, DOI 10.1128/IAI.62.10.4641-4645.1994; Haberg K, 2008, J CELL SCI, V121, P1495, DOI 10.1242/jcs.028530; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; HAIGLER HT, 1979, J CELL BIOL, V83, P82, DOI 10.1083/jcb.83.1.82; HAMILTON N, 2005, CURRENT PRO IN PRESS; HEWLETT LJ, 1994, J CELL BIOL, V124, P689, DOI 10.1083/jcb.124.5.689; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kasahara K, 2007, J CELL PHYSIOL, V211, P220, DOI 10.1002/jcp.20931; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kerr MC, 2006, J CELL SCI, V119, P3967, DOI 10.1242/jcs.03167; Kerr MC, 2010, EMBO J, V29, P1331, DOI 10.1038/emboj.2010.28; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Lanzavecchia A, 1996, CURR OPIN IMMUNOL, V8, P348, DOI 10.1016/S0952-7915(96)80124-5; Lim JP, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-58; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Liu H, 2006, BIOCHEM BIOPH RES CO, V342, P537, DOI 10.1016/j.bbrc.2006.01.179; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Merino-Trigo A, 2004, J CELL SCI, V117, P6413, DOI 10.1242/jcs.01561; Park J, 2010, J CELL SCI, V123, P1742, DOI 10.1242/jcs.064170; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; PEARSE BMF, 1976, P NATL ACAD SCI USA, V73, P1255, DOI 10.1073/pnas.73.4.1255; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; PORATSHLIOM N, 2007, MOL BIOL CELL; RACOOSIN EL, 1993, J CELL BIOL, V121, P1011, DOI 10.1083/jcb.121.5.1011; Roberts RL, 1999, J CELL SCI, V112, P3667; RUBENSTEIN JLR, 1981, J CELL BIOL, V89, P357, DOI 10.1083/jcb.89.2.357; Sansonetti PJ, 1998, ANTON LEEUW INT J G, V74, P191, DOI 10.1023/A:1001519806727; Sansonetti PJ, 1997, CR ACAD SCI III-VIE, V320, P729, DOI 10.1016/S0764-4469(97)84821-4; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; Shin N, 2008, J CELL SCI, V121, P1252, DOI 10.1242/jcs.016709; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Sun P, 2003, J BIOL CHEM, V278, P4063, DOI 10.1074/jbc.M208699200; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Tran Van Nhieu G., 1997, EMBO J, V16, P2717; Venkateswarlu K, 1999, J CELL SCI, V112, P1957; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; Xiao Y, 2007, CELL SIGNAL, V19, P1434, DOI 10.1016/j.cellsig.2007.01.021; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Yarar D, 2008, TRAFFIC, V9, P133, DOI 10.1111/j.1600-0854.2007.00675.x; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014; Yoshida S, 2009, J CELL SCI, V122, P3250, DOI 10.1242/jcs.053207; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang J, 2009, J BIOL CHEM, V284, P21659, DOI 10.1074/jbc.M109.007278; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	70	42	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13763	10.1371/journal.pone.0013763	http://dx.doi.org/10.1371/journal.pone.0013763			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048941	Green Published, Green Submitted, gold			2022-12-25	WOS:000283645300041
J	Hamilton, NK; Maizels, N				Hamilton, Nicolle K.; Maizels, Nancy			MRE11 Function in Response to Topoisomerase Poisons Is Independent of its Function in Double-Strand Break Repair in Saccharomyces cerevisiae	PLOS ONE			English	Article							DNA PHOSPHODIESTERASE TDP1; I COVALENT COMPLEXES; NUCLEASE ACTIVITY; MRE11-RAD50-XRS2 COMPLEX; BUDDING YEAST; DAMAGE; GENE; RECOMBINATION; MUTATIONS; PATHWAYS	Camptothecin (CPT) and etoposide (ETP) trap topoisomerase-DNA covalent intermediates, resulting in formation of DNA damage that can be cytotoxic if unrepaired. CPT and ETP are prototypes for molecules widely used in chemotherapy of cancer, so defining the mechanisms for repair of damage induced by treatment with these compounds is of great interest. In S. cerevisiae, deficiency in MRE11, which encodes a highly conserved factor, greatly enhances sensitivity to treatment with CPT or ETP. This has been thought to reflect the importance of double-strand break (DSB) repair pathways in the response to these to agents. Here we report that an S. cerevisiae strain expressing the mre11-H59A allele, mutant at a conserved active site histidine, is sensitive to hydroxyurea and also to ionizing radiation, which induces DSBs, but not to CPT or ETP. We show that TDP1, which encodes a tyrosyl-DNA phosphodiesterase activity able to release both 5'- and 3'-covalent topoisomerase-DNA complexes in vitro, contributes to ETP-resistance but not CPT-resistance in the mre11-H59A background. We further show that CPT- and ETP-resistance mediated by MRE11 is independent of SAE2, and thus independent of the coordinated functions of MRE11 and SAE2 in homology-directed repair and removal of Spo11 from DNA ends in meiosis. These results identify a function for MRE11 in the response to topoisomerase poisons that is distinct from its functions in DSB repair or meiotic DNA processing. They also establish that cellular proficiency in repair of DSBs may not correlate with resistance to topoisomerase poisons, a finding with potential implications for stratification of tumors with specific DNA repair deficiencies for treatment with these compounds.	[Hamilton, Nicolle K.; Maizels, Nancy] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA; [Maizels, Nancy] Univ Washington, Dept Biochem, Sch Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hamilton, NK (corresponding author), Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA.	maizels@u.washington.edu			National Institutes of Health [P01 CA77852, T32 GM07270]; NATIONAL CANCER INSTITUTE [P01CA077852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health P01 CA77852 to NM; National Institutes of Health T32 GM07270 to NKH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur LM, 2004, NUCLEIC ACIDS RES, V32, P1886, DOI 10.1093/nar/gkh343; Baldwin EL, 2005, NUCLEIC ACIDS RES, V33, P1021, DOI 10.1093/nar/gki246; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Ben Hassine S, 2009, EMBO J, V28, P632, DOI 10.1038/emboj.2009.9; Chamankhah M, 1999, NUCLEIC ACIDS RES, V27, P2072, DOI 10.1093/nar/27.10.2072; Deng CC, 2005, GENETICS, V170, P591, DOI 10.1534/genetics.104.028795; Farah JA, 2005, GENETICS, V169, P1261, DOI 10.1534/genetics.104.037515; Giannini G, 2004, ONCOGENE, V23, P2640, DOI 10.1038/sj.onc.1207409; Giannini G, 2002, EMBO REP, V3, P248, DOI 10.1093/embo-reports/kvf044; Hartsuiker E, 2009, MOL CELL BIOL, V29, P1671, DOI 10.1128/MCB.01182-08; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Interthal H, 2001, P NATL ACAD SCI USA, V98, P12009, DOI 10.1073/pnas.211429198; Krogh BO, 2005, GENETICS, V171, P1561, DOI 10.1534/genetics.105.049478; Larson ED, 2005, MOL CELL, V20, P367, DOI 10.1016/j.molcel.2005.09.018; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Liu CY, 2004, DNA REPAIR, V3, P593, DOI 10.1016/j.dnarep.2004.03.030; Liu CY, 2002, P NATL ACAD SCI USA, V99, P14970, DOI 10.1073/pnas.182557199; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nitiss KC, 2006, P NATL ACAD SCI USA, V103, P8953, DOI 10.1073/pnas.0603455103; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Pouliot JJ, 2001, GENES CELLS, V6, P677, DOI 10.1046/j.1365-2443.2001.00452.x; Stracker TH, 2008, CELL CYCLE, V7, P3618, DOI 10.4161/cc.7.23.7064; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; Vance JR, 2002, P NATL ACAD SCI USA, V99, P13669, DOI 10.1073/pnas.202242599; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534	33	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e15387	10.1371/journal.pone.0015387	http://dx.doi.org/10.1371/journal.pone.0015387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060845	gold, Green Published, Green Submitted			2022-12-25	WOS:000283573800025
J	Knight, CJ; Bailey, AM; Foster, GD				Knight, Claire J.; Bailey, Andy M.; Foster, Gary D.			Investigating Agrobacterium-Mediated Transformation of Verticillium albo-atrum on Plant Surfaces	PLOS ONE			English	Article							GENETIC-TRANSFORMATION; AGARICUS-BISPORUS; TUMEFACIENS; DNA; BIOLOGY; GROWTH; CELLS; TOOL	Background: Agrobacterium tumefaciens has long been known to transform plant tissue in nature as part of its infection process. This natural mechanism has been utilised over the last few decades in laboratories world wide to genetically manipulate many species of plants. More recently this technology has been successfully applied to non-plant organisms in the laboratory, including fungi, where the plant wound hormone acetosyringone, an inducer of transformation, is supplied exogenously. In the natural environment it is possible that Agrobacterium and fungi may encounter each other at plant wound sites, where acetosyringone would be present, raising the possibility of natural gene transfer from bacterium to fungus. Methodology/Principal Findings: We investigate this hypothesis through the development of experiments designed to replicate such a situation at a plant wound site. A. tumefaciens harbouring the plasmid pCAMDsRed was co-cultivated with the common plant pathogenic fungus Verticillium albo-atrum on a range of wounded plant tissues. Fungal transformants were obtained from co-cultivation on a range of plant tissue types, demonstrating that plant tissue provides sufficient vir gene inducers to allow A. tumefaciens to transform fungi in planta. Conclusions/Significance: This work raises interesting questions about whether A. tumefaciens may be able to transform organisms other than plants in nature, or indeed should be considered during GM risk assessments, with further investigations required to determine whether this phenomenon has already occurred in nature.	[Knight, Claire J.; Bailey, Andy M.; Foster, Gary D.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Bristol	Knight, CJ (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	Gary.Foster@bristol.ac.uk	Foster, Gary D/A-7985-2011	Foster, Gary D/0000-0002-1979-1397; Bailey, Andy/0000-0002-7594-3703	Natural Environment Research Council (NERC)	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a Natural Environment Research Council (NERC) PhD studentship awarded to CJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amey RC, 2002, MYCOL RES, V106, P4, DOI 10.1017/S0953756201005251; Barrett C, 1997, PLANT CELL TISS ORG, V47, P135, DOI 10.1007/BF02318949; BUNDOCK P, 1995, EMBO J, V14, P3206, DOI 10.1002/j.1460-2075.1995.tb07323.x; Burns C, 2006, MOL BIOTECHNOL, V32, P129, DOI 10.1385/MB:32:2:129; Chen X, 2000, APPL ENVIRON MICROB, V66, P4510, DOI 10.1128/AEM.66.10.4510-4513.2000; CHILTON MD, 1977, CELL, V11, P263, DOI 10.1016/0092-8674(77)90043-5; COLLINS C, 2010, J MICROBIOL IN PRESS; Covert SF, 2001, MYCOL RES, V105, P259, DOI 10.1017/S0953756201003872; [杨敏生 YANG MinSheng], 2006, [生态学报, Acta Ecologica Sinica], V26, P3555, DOI 10.1016/S1872-2032(06)60055-3; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; dos Reis MC, 2004, J MICROBIOL METH, V58, P197, DOI 10.1016/j.mimet.2004.03.012; Eckert M, 2005, FEMS MICROBIOL LETT, V253, P67, DOI 10.1016/j.femsle.2005.09.041; Gelvin SB, 2005, NATURE, V433, P583, DOI 10.1038/433583a; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Hartley AJ, 2009, FEMS MICROBIOL LETT, V297, P24, DOI 10.1111/j.1574-6968.2009.01656.x; Keon J, 1998, FEMS MICROBIOL LETT, V161, P337, DOI 10.1111/j.1574-6968.1998.tb12966.x; Kilaru S, 2009, APPL ENVIRON MICROB, V75, P7196, DOI 10.1128/AEM.01151-09; Kilaru S, 2009, CURR GENET, V55, P543, DOI 10.1007/s00294-009-0266-6; KNIGHT CJ, 2009, J PLANT PATHOL, V91, P637; Kunik T, 2001, P NATL ACAD SCI USA, V98, P1871, DOI 10.1073/pnas.041327598; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; McCullen CA, 2006, ANNU REV CELL DEV BI, V22, P101, DOI 10.1146/annurev.cellbio.22.011105.102022; Michielse CB, 2004, J BACTERIOL, V186, P2038, DOI 10.1128/JB.186.7.2038-2045.2004; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAZAR RN, 1991, PHYSIOL MOL PLANT P, V39, P1, DOI 10.1016/0885-5765(91)90027-F; Patel AD, 2008, PLANT SOIL ENVIRON, V54, P367, DOI 10.17221/407-PSE; Pegg GF, 2002, VERTICILLUM WILTS, DOI [DOI 10.1079/9780851995298.0000, 10.1079/9780851995298.0000]; Sambrook J., 2002, MOL CLONING LAB MANU; Tzfira T, 2003, PLANT PHYSIOL, V133, P943, DOI 10.1104/pp.103.032821	31	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13684	10.1371/journal.pone.0013684	http://dx.doi.org/10.1371/journal.pone.0013684			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060684	Green Published, gold, Green Submitted			2022-12-25	WOS:000283537000049
J	Verstraete, E; van den Heuvel, MP; Veldink, JH; Blanken, N; Mandl, RC; Pol, HEH; van den Berg, LH				Verstraete, Esther; van den Heuvel, Martijn P.; Veldink, Jan H.; Blanken, Niels; Mandl, Rene C.; Pol, Hilleke E. Hulshoff; van den Berg, Leonard H.			Motor Network Degeneration in Amyotrophic Lateral Sclerosis: A Structural and Functional Connectivity Study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; HUMAN CEREBRAL-CORTEX; GRAPH-THEORETICAL ANALYSIS; RESTING-STATE NETWORKS; DIFFUSION TENSOR MRI; HUMAN BRAIN; CORTICAL HYPEREXCITABILITY; TRACT DEGENERATION; MULTIPLE-SCLEROSIS; COMPONENT ANALYSIS	Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterised by motor neuron degeneration. How this disease affects the central motor network is largely unknown. Here, we combined for the first time structural and functional imaging measures on the motor network in patients with ALS and healthy controls. Methodology/Principal Findings: Structural measures included whole brain cortical thickness and diffusion tensor imaging (DTI) of crucial motor tracts. These structural measures were combined with functional connectivity analysis of the motor network based on resting state fMRI. Focal cortical thinning was observed in the primary motor area in patients with ALS compared to controls and was found to correlate with disease progression. DTI revealed reduced FA values in the corpus callosum and in the rostral part of the corticospinal tract. Overall functional organisation of the motor network was unchanged in patients with ALS compared to healthy controls, however the level of functional connectedness was significantly correlated with disease progression rate. Patients with increased connectedness appear to have a more progressive disease course. Conclusions/Significance: We demonstrate structural motor network deterioration in ALS with preserved functional connectivity measures. The positive correlation between functional connectedness of the motor network and disease progression rate could suggest spread of disease along functional connections of the motor network.	[Verstraete, Esther; Veldink, Jan H.; van den Berg, Leonard H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands; [van den Heuvel, Martijn P.; Mandl, Rene C.; Pol, Hilleke E. Hulshoff] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Blanken, Niels] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Verstraete, E (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands.	L.H.vandenBerg@umcutrecht.nl	van den Heuvel, Martijn/AFR-3213-2022; Hulshoff Pol, Hilleke Evertje/B-4795-2014; Mandl, René C.W./AAU-7037-2020	Hulshoff Pol, Hilleke Evertje/0000-0002-2038-5281; van den Heuvel, Martijn/0000-0003-1570-1195; Veldink, Jan/0000-0001-5572-9657	Netherlands Amyotrophic Lateral Sclerosis (ALS) foundation; 'Prinses Beatrix fonds'	Netherlands Amyotrophic Lateral Sclerosis (ALS) foundation; 'Prinses Beatrix fonds'	This study was funded by the Netherlands Amyotrophic Lateral Sclerosis (ALS) foundation and the 'Prinses Beatrix fonds'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Agosta F, 2007, HUM BRAIN MAPP, V28, P1430, DOI 10.1002/hbm.20364; AGOSTA F, 2010, AJNR AM J NEURO 0401; Bakkour A, 2009, NEUROLOGY, V72, P1048, DOI 10.1212/01.wnl.0000340981.97664.2f; Bartels C, 2008, NEUROMUSCULAR DISORD, V18, P398, DOI 10.1016/j.nmd.2008.02.005; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Budde MD, 2008, NMR BIOMED, V21, P589, DOI 10.1002/nbm.1229; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Ciccarelli O, 2009, HUM BRAIN MAPP, V30, P615, DOI 10.1002/hbm.20527; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Eisen A, 2009, MUSCLE NERVE, V40, P297, DOI 10.1002/mus.21404; Ellis CM, 2001, NEUROLOGY, V57, P1571, DOI 10.1212/WNL.57.9.1571; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Graham JM, 2004, NEUROLOGY, V63, P2111, DOI 10.1212/01.WNL.0000145766.03057.E7; Grossman M, 2008, NEUROLOGY, V71, P1396, DOI 10.1212/01.wnl.0000319701.50168.8c; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kahkonen S, 2004, J PSYCHOPHARMACOL, V18, P257, DOI 10.1177/0269881104042631; KIERNAN JA, 1991, BRAIN, V114, P843, DOI 10.1093/brain/114.2.843; Kim JH, 2007, MAGN RESON MED, V58, P253, DOI 10.1002/mrm.21316; Kunst CB, 2004, AM J HUM GENET, V75, P933, DOI 10.1086/426001; Lowe MJ, 2008, HUM BRAIN MAPP, V29, P818, DOI 10.1002/hbm.20576; Lowe MJ, 2000, NEUROIMAGE, V12, P582, DOI 10.1006/nimg.2000.0654; Mandl RC, 2008, SCHIZOPHR B, V36, P778; Mohammadi B, 2009, EXP NEUROL, V217, P147, DOI 10.1016/j.expneurol.2009.01.025; Morgan VL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006660; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Rivara CB, 2003, ANAT REC PART A, V270A, P137, DOI 10.1002/ar.a.10015; Rogers J, 2007, HUM BRAIN MAPP, V28, P576, DOI 10.1002/hbm.20407; Rohrer JD, 2009, NEUROLOGY, V72, P1562, DOI 10.1212/WNL.0b013e3181a4124e; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Sach M, 2004, BRAIN, V127, P340, DOI 10.1093/brain/awh041; Sage CA, 2007, NEUROIMAGE, V34, P486, DOI 10.1016/j.neuroimage.2006.09.025; Salvador R, 2007, NEUROIMAGE, V35, P83, DOI 10.1016/j.neuroimage.2006.12.001; Schoenfeld MA, 2005, J NEUROL, V252, P944, DOI 10.1007/s00415-005-0787-y; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Senda J, 2009, AMYOTROPH LATERAL SC, V10, P288, DOI 10.3109/17482960802651717; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Stanton BR, 2007, J NEUROL, V254, P1260, DOI 10.1007/s00415-006-0513-4; Tessitore A, 2006, BRAIN RES BULL, V69, P489, DOI 10.1016/j.brainresbull.2006.01.013; Thivard L, 2007, J NEUROL NEUROSUR PS, V78, P889, DOI 10.1136/jnnp.2006.101758; Turner MR, 2007, AMYOTROPH LATERAL SC, V8, P343, DOI 10.1080/17482960701538734; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel M, 2008, J NEUROSCI, V28, P10844, DOI 10.1523/JNEUROSCI.2964-08.2008; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; van der Schot AC, 2009, ARCH GEN PSYCHIAT, V66, P142, DOI 10.1001/archgenpsychiatry.2008.541; Vucic S, 2008, BRAIN, V131, P1540, DOI 10.1093/brain/awn071; Vucic S, 2009, EXP NEUROL, V220, P177, DOI 10.1016/j.expneurol.2009.08.017; Wahl M, 2007, J NEUROSCI, V27, P12132, DOI 10.1523/JNEUROSCI.2320-07.2007; Wittstock M, 2007, CLIN NEUROPHYSIOL, V118, P301, DOI 10.1016/j.clinph.2006.09.026; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	68	133	137	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13664	10.1371/journal.pone.0013664	http://dx.doi.org/10.1371/journal.pone.0013664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060689	Green Published, Green Submitted, gold			2022-12-25	WOS:000283537000033
J	Oude Griep, LM; Geleijnse, JM; Kromhout, D; Ocke, MC; Verschuren, WMM				Oude Griep, Linda M.; Geleijnse, Johanna M.; Kromhout, Daan; Ocke, Marga C.; Verschuren, W. M. Monique			Raw and Processed Fruit and Vegetable Consumption and 10-Year Coronary Heart Disease Incidence in a Population-Based Cohort Study in the Netherlands	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ANTIOXIDANT VITAMINS; BLOOD-PRESSURE; DIETARY FIBER; RELATIVE VALIDITY; POOLED ANALYSIS; METAANALYSIS; RISK; PREVENTION; MORTALITY	Background: Prospective cohort studies have shown that high fruit and vegetable consumption is inversely associated with coronary heart disease (CHD). Whether food processing affects this association is unknown. Therefore, we quantified the association of fruit and vegetable consumption with 10-year CHD incidence in a population-based study in the Netherlands and the effect of processing on these associations. Methods: Prospective population-based cohort study, including 20,069 men and women aged 20 to 65 years, enrolled between 1993 and 1997 and free of cardiovascular disease at baseline. Diet was assessed using a validated 178-item food frequency questionnaire. Hazard ratios (HR) were calculated for CHD incidence using multivariable Cox proportional hazards models. Results: During a mean follow-up time of 10.5y, 245 incident cases of CHD were documented, which comprised 211 non-fatal acute myocardial infarctions and 34 fatal CHD events. The risk of CHD incidence was 34% lower for participants with a high intake of total fruit and vegetables (>475 g/d; HR: 0.66; 95% CI: 0.45-0.99) compared to participants with a low total fruit and vegetable consumption (<= 241 g/d). Intake of raw fruit and vegetables (>262 g/d vs <= 92 g/d; HR: 0.70; 95% CI: 0.47-1.04) as well as processed fruit and vegetables (>234 g/d vs <= 113 g/d; HR: 0.79; 95% CI: 0.54-1.16) were inversely related with CHD incidence. Conclusion: Higher consumption of fruit and vegetables, whether consumed raw or processed, may protect against CHD incidence.	[Oude Griep, Linda M.; Geleijnse, Johanna M.; Kromhout, Daan] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Ocke, Marga C.; Verschuren, W. M. Monique] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Wageningen University & Research; Netherlands National Institute for Public Health & the Environment	Oude Griep, LM (corresponding author), Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.	Linda.oudegriep@wur.nl	Geleijnse, Johanna Marianna M/B-5749-2012; Kromhout, Daan/A-8566-2014; Oude Griep, Linda/M-5112-2013	Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Oude Griep, Linda/0000-0001-7697-7473	Product Board for Horticulture, Zoetermeer, the Netherlands [13281]; Ministry of Health, Welfare and Sport of the Netherlands; National Institute of Public Health and the Environment, Bilthoven, the Netherlands; European Union	Product Board for Horticulture, Zoetermeer, the Netherlands(Netherlands Government); Ministry of Health, Welfare and Sport of the Netherlands; National Institute of Public Health and the Environment, Bilthoven, the Netherlands(Netherlands Government); European Union(European Commission)	Dr. Geleijnse obtained an unrestricted grant (13281) from the Product Board for Horticulture, Zoetermeer, the Netherlands, to cover the costs of data-analysis for the present study. The other authors report no financial disclosures. The Monitoring Project on Risk Factors and chronic diseases in the Netherlands (MORGEN) Study was supported by the Ministry of Health, Welfare and Sport of the Netherlands, the National Institute of Public Health and the Environment, Bilthoven, the Netherlands and the Europe Against Cancer Program of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, INT CLASS DIS; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Brown L, 1999, AM J CLIN NUTR, V69, P30; Colin-Henrion M, 2009, FOOD CHEM, V117, P254, DOI 10.1016/j.foodchem.2009.03.109; Danesi F, 2008, J FOOD SCI, V73, pH109, DOI 10.1111/j.1750-3841.2008.00826.x; Dauchet L, 2004, BRIT J NUTR, V92, P963, DOI 10.1079/BJN20041286; Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588; DEBRUIN A, 2003, LINKING DATA NATL AM; Eichholzer M, 2001, INT J VITAM NUTR RES, V71, P5, DOI 10.1024/0300-9831.71.1.5; Flood-Obbagy JE, 2009, APPETITE, V52, P416, DOI 10.1016/j.appet.2008.12.001; Gartner C, 1997, AM J CLIN NUTR, V66, P116; Gaziano J. Michael, 1995, Annals of Epidemiology, V5, P255, DOI 10.1016/1047-2797(94)00090-G; He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212; HOEVENAARBLOM MP, 2010, EUR J CARDIOVASC PRE; Hof KHV, 2000, J NUTR, V130, P503; Homero-Mendez D, 2007, INNOV FOOD SCI EMERG, V8, P407, DOI 10.1016/j.ifset.2007.03.014; Hung HC, 2004, JNCI-J NATL CANCER I, V96, P1577, DOI 10.1093/jnci/djh296; Huxley RR, 2003, EUR J CLIN NUTR, V57, P904, DOI 10.1038/sj.ejcn.1601624; Jacobs DR, 2009, AM J CLIN NUTR, V89, pS1543, DOI 10.3945/ajcn.2009.26736B; Jansen MCJF, 2004, EUR J CLIN NUTR, V58, P1386, DOI 10.1038/sj.ejcn.1601981; Joshipura KJ, 2001, ANN INTERN MED, V134, P1106, DOI 10.7326/0003-4819-134-12-200106190-00010; Key TJA, 1996, BMJ-BRIT MED J, V313, P775, DOI 10.1136/bmj.313.7060.775; Knekt P, 2004, AM J CLIN NUTR, V80, P1508, DOI 10.1093/ajcn/80.6.1508; Kohlmeier L, 1997, AM J EPIDEMIOL, V146, P618, DOI 10.1093/oxfordjournals.aje.a009327; Melse-Boonstra A, 2004, AM J CLIN NUTR, V79, P424; Melse-Boonstra A, 2002, J AGR FOOD CHEM, V50, P3473, DOI 10.1021/jf0112318; Merry AHH, 2009, EUR J EPIDEMIOL, V24, P237, DOI 10.1007/s10654-009-9335-x; *NETH NUTR CTR, 1996, NETH FOOD COMP DAT; Obarzanek E, 2001, AM J CLIN NUTR, V74, P80; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS37, DOI 10.1093/ije/26.suppl_1.S37; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS49, DOI 10.1093/ije/26.suppl_1.S49; Paran E, 2009, CARDIOVASC DRUG THER, V23, P145, DOI 10.1007/s10557-008-6155-2; Pereira MA, 2004, ARCH INTERN MED, V164, P370, DOI 10.1001/archinte.164.4.370; Pols MA, 1997, INT J EPIDEMIOL, V26, pS181, DOI 10.1093/ije/26.suppl_1.S181; Rao AV, 1999, NUTR RES, V19, P305, DOI 10.1016/S0271-5317(98)00193-6; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Rickman JC, 2007, J SCI FOOD AGR, V87, P930, DOI 10.1002/jsfa.2825; Ruiz-Rodriguez Alejandro, 2008, Phytochemistry Reviews, V7, P345, DOI 10.1007/s11101-007-9073-1; Ruxton CHS, 2006, INT J FOOD SCI NUTR, V57, P249, DOI 10.1080/09637480600858134; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Streppel MT, 2005, ARCH INTERN MED, V165, P150, DOI 10.1001/archinte.165.2.150; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Verschuren WMM, 2008, INT J EPIDEMIOL, V37, P1236, DOI 10.1093/ije/dym292; Vivekananthan DP, 2003, LANCET, V361, P2017, DOI 10.1016/S0140-6736(03)13637-9; Whelton PK, 1997, JAMA-J AM MED ASSOC, V277, P1624, DOI 10.1001/jama.277.20.1624; World Health Organization, 1977, INT CLASS DIS; Ye Z, 2008, EUR J CARDIOV PREV R, V15, P26, DOI 10.1097/HJR.0b013e3282f11f95	47	66	68	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13609	10.1371/journal.pone.0013609	http://dx.doi.org/10.1371/journal.pone.0013609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049053	Green Submitted, Green Published, gold			2022-12-25	WOS:000283422100016
J	Lorenzetti, MA; De Matteo, E; Gass, H; Vazquez, PM; Lara, J; Gonzalez, P; Preciado, MV; Chabay, PA				Lorenzetti, Mario A.; De Matteo, Elena; Gass, Hugo; Martinez Vazquez, Paula; Lara, Julia; Gonzalez, Pedro; Victoria Preciado, Maria; Chabay, Paola A.			Characterization of Epstein Barr Virus Latency Pattern in Argentine Breast Carcinoma	PLOS ONE			English	Article							GENE-EXPRESSION; VIRAL CARCINOGENESIS; GASTRIC-CARCINOMA; EPITHELIAL-CELLS; EBV INFECTION; HUMAN CANCERS; RISK-FACTORS; ASSOCIATION; DISEASE; PROTEIN	Introduction: Epstein-Barr virus (EBV)-associated tumors show different expression patterns of latency genes. Since in breast carcinoma this pattern is not yet fully described, our aim was to characterize EBV latency pattern in our EBV positive breast carcinoma series. Methods: The study was conducted on 71 biopsies of breast carcinoma and in 48 non-neoplastic breast controls. EBNA1, LMP2A and LMP1 expression was assessed by immunohistochemistry with monoclonal antibodies, while viral genomic DNA and EBERs RNA transcripts expression was performed by in situ hybridization. EBV presence was confirmed by PCR. Results: EBV genomic DNA and EBNA1 expression were detected in 31% (22/71) of patients specifically restricted to tumor epithelial cells in breast carcinoma while all breast control samples were negative for both viral DNA and EBNA1 protein. LMP2A was detected in 73% of EBNA1 positive cases, none of which expressed either LMP1 protein or EBERs transcripts. Conclusions: These findings suggest that EBV expression pattern in the studied biopsies could be different from those previously observed in breast carcinoma cell lines and lead us to suggest a new, EBNA1, LMP2A positive and LMP1 and EBERs negative latency profile in breast carcinoma in our population.	[Lorenzetti, Mario A.; Lara, Julia; Victoria Preciado, Maria; Chabay, Paola A.] Ricardo Gutierrez Children Hosp, Mol Biol Lab, Div Pathol, Buenos Aires, Argentina; [De Matteo, Elena] Ricardo Gutierrez Children Hosp, Div Pathol, Buenos Aires, DF, Argentina; [Gass, Hugo; Martinez Vazquez, Paula] Magdalena Villegas de Martinez Hosp, Gynecol Div, Tigre, Prov Buenos Air, Argentina; [Gonzalez, Pedro] Magdalena Villegas de Martinez Hosp, Div Pathol, Tigre, Prov Buenos Air, Argentina	Hospital de Ninos Doctor Ricardo Gutierrez; Hospital de Ninos Doctor Ricardo Gutierrez	Lorenzetti, MA (corresponding author), Ricardo Gutierrez Children Hosp, Mol Biol Lab, Div Pathol, Buenos Aires, Argentina.	marioloren@yahoo.com.ar	Lorenzetti, Mario Alejandro/O-8976-2019	Lorenzetti, Mario Alejandro/0000-0002-9434-399X; Preciado, Maria Victoria/0000-0003-4082-0698	National Agency for Science and Technology Promotion [1071]; National Research Council (CONICET)	National Agency for Science and Technology Promotion; National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was partially supported by a grant from National Agency for Science and Technology Promotion (PICT 2007 No 1071). M.L. is supported by a fellowship from the National Research Council (CONICET), P.A.Ch. and M.V.P. are members of the National Research Council (CONICET), Research Career Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM JOINT COMM CAN, 2007, CANC STAG MAN; Arbach H, 2006, J VIROL, V80, P845, DOI 10.1128/JVI.80.2.845-853.2006; Bonnet M, 1999, J NATL CANCER I, V91, P1376, DOI 10.1093/jnci/91.16.1376; Brink AATP, 2000, J NATL CANCER I, V92, P655, DOI 10.1093/jnci/92.8.655; Butel JS, 2000, CARCINOGENESIS, V21, P405, DOI 10.1093/carcin/21.3.405; Chan KH, 2001, J CLIN VIROL, V21, P57, DOI 10.1016/S1386-6532(01)00149-4; Chu PGG, 2001, AM J PATHOL, V159, P571, DOI 10.1016/S0002-9440(10)61728-2; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Delecluse HJ, 2007, J CLIN PATHOL, V60, P1358, DOI 10.1136/jcp.2006.044586; Deshpande CG, 2002, LAB INVEST, V82, P1193, DOI 10.1097/01.LAB.0000029150.90532.24; Fawzy S, 2008, CLIN BIOCHEM, V41, P486, DOI 10.1016/j.clinbiochem.2007.12.017; Fukuda M, 2007, J VIROL, V81, P9299, DOI 10.1128/JVI.00537-07; Gan YJ, 2002, AM J PATHOL, V160, P781, DOI 10.1016/S0002-9440(10)64900-0; Glaser SL, 2004, CANCER EPIDEM BIOMAR, V13, P688; Grinstein S, 2002, CANCER RES, V62, P4876; Hennard C, 2006, J PATHOL, V209, P430, DOI 10.1002/path.1996; Herrmann K, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr561; IMAI S, 1994, P NATL ACAD SCI USA, V91, P9131, DOI 10.1073/pnas.91.19.9131; Joshi D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008180; Kuppers R, 2003, NAT REV IMMUNOL, V3, P801, DOI 10.1038/nri1201; LESPAGNARD L, 1995, AM J CLIN PATHOL, V103, P449; Lin JH, 2007, J VIROL, V81, P5705, DOI 10.1128/JVI.00076-07; LONGNECKER R, 1998, HUMAN TUMOR VIRUSES, P135; Lu J, 2006, J BIOL CHEM, V281, P8806, DOI 10.1074/jbc.M507305200; MADIGAN MP, 1995, J NATL CANCER I, V87, P1681, DOI 10.1093/jnci/87.22.1681; Martin AM, 2000, JNCI-J NATL CANCER I, V92, P1126, DOI 10.1093/jnci/92.14.1126; Morrison JA, 2003, J VIROL, V77, P12276, DOI 10.1128/JVI.77.22.12276-12284.2003; Murray PG, 2003, CANCER RES, V63, P2338; Preciado MV, 2005, ARCH PATHOL LAB MED, V129, P377; Ribeiro-Silva A, 2004, BRAZ J MED BIOL RES, V37, P89, DOI 10.1590/S0100-879X2004000100013; Rickinson AB, 2007, FIELDS VIROLOGY, V5, P2655; RIES L, 2002, CANC STAT REV BETHES, P1973; Rowe M, 2009, SEMIN CANCER BIOL, V19, P377, DOI 10.1016/j.semcancer.2009.07.004; Stewart S, 2004, P NATL ACAD SCI USA, V101, P15730, DOI 10.1073/pnas.0402135101; Sugiura M, 1996, BRIT J CANCER, V74, P625, DOI 10.1038/bjc.1996.412; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Thorley-Lawson DA, 2008, TRENDS IMMUNOL, V29, P195, DOI 10.1016/j.it.2008.01.006; Uozaki H, 2008, INT J CLIN EXP PATHO, V1, P198; Xue SA, 2003, BRIT J CANCER, V89, P113, DOI 10.1038/sj.bjc.6601027; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; zur Hausen A, 2000, CANCER RES, V60, P2745; zur Hausen H, 2009, VIROLOGY, V392, P1, DOI 10.1016/j.virol.2009.06.001	42	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13603	10.1371/journal.pone.0013603	http://dx.doi.org/10.1371/journal.pone.0013603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042577	Green Submitted, Green Published, gold			2022-12-25	WOS:000283419100023
J	Prazeres, H; Torres, J; Rodrigues, F; Pinto, M; Pastoriza, MC; Gomes, D; Cameselle-Teijeiro, J; Vidal, A; Martins, TC; Sobrinho-Simoes, M; Soares, P				Prazeres, H.; Torres, J.; Rodrigues, F.; Pinto, M.; Pastoriza, M. C.; Gomes, D.; Cameselle-Teijeiro, J.; Vidal, A.; Martins, T. C.; Sobrinho-Simoes, M.; Soares, P.			Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells	ONCOGENE			English	Article						tumor suppressor gene; low-density lipoprotein receptor family; EP300 histone-acetyltransferase; microRNA; matrix metalloproteinase 2; endocytosis and tumor microenvironment	RECEPTOR-RELATED PROTEIN; TUMOR-SUPPRESSOR GENE; LINKAGE ANALYSIS; SUSCEPTIBILITY LOCUS; DNA METHYLATION; LUNG-CANCER; UROKINASE; CARCINOMA; FAMILY; EXPRESSION	The low-density lipoprotein receptor-related protein (LRP1B), encoding an endocytic LDL-family receptor, is among the 10 most significantly deleted genes across 3312 human cancer specimens. However, currently the apparently crucial role of this lipoprotein receptor in carcinogenesis is not clear. Here we show that LRP1B inactivation (by chromosomal, epigenetic and microRNA (miR)-mediated mechanisms) results in changes to the tumor environment that confer cancer cells an increased growth and invasive capacity. LRP1B displays frequent DNA copy number loss and CpG island methylation, resulting in mRNA underexpression. By using CpG island reporters methylated in vitro, we found that DNA methylation disrupts a functional binding site for the histone-acetyltransferase p300 located at intron 1. We identified and validated an miR targeting LRP1B (miR-548a-5p), which is overexpressed in cancer cell lines as a result of 8q22 DNA gains. Restoration of LRP1B impaired in vitro and in vivo tumor growth, inhibited cell invasion and led to a reduction of matrix metalloproteinase 2 in the extracellular medium. We emphasized the role of an endocytic receptor acting as a tumor suppressor by modulating the extracellular environment composition in a way that constrains the invasive behavior of the cancer cells. Oncogene (2011) 30, 1302-1317; doi:10.1038/onc.2010.512; published online 8 November 2010	[Prazeres, H.; Torres, J.; Pinto, M.; Sobrinho-Simoes, M.; Soares, P.] Univ Porto IPATIMUP, Dept Canc Biol, Inst Mol Pathol & Immunol, P-4200465 Oporto, Portugal; [Prazeres, H.; Sobrinho-Simoes, M.; Soares, P.] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Prazeres, H.; Martins, T. C.] EPE, Dept Mol Pathol, Serv Portuguese Inst Oncol Coimbra, Coimbra, Portugal; [Rodrigues, F.] EPE, Dept Endocrinol, Serv Portuguese Inst Oncol Coimbra, Coimbra, Portugal; [Pastoriza, M. C.; Vidal, A.] Univ Santiago de Compostela, Inst Sanitary Res IDIS, Dept Physiol, Sch Med, Santiago De Compostela, Spain; [Gomes, D.] EPE, Anat Pathol Serv, Portuguese Inst Oncol Coimbra, Coimbra, Portugal; [Cameselle-Teijeiro, J.] Univ Santiago de Compostela, Dept Anat Pathol, Clin Univ Hosp CHUS, SERGAS, Santiago De Compostela, Spain	Universidade do Porto; Universidade do Porto; Universidade de Coimbra; Universidade de Coimbra; Universidade de Santiago de Compostela; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Santiago de Compostela	Soares, P (corresponding author), Univ Porto IPATIMUP, Dept Canc Biol, Inst Mol Pathol & Immunol, Rua Dr Roberto Frias S-N, P-4200465 Oporto, Portugal.	psoares@ipatimup.pt	Sobrinho-Simões, Manuel/J-8290-2013; Soares, Paula/B-6054-2008; Pinto, Marta T/J-2519-2013; Vidal, Anxo/B-5010-2015	Soares, Paula/0000-0001-9607-6998; Pinto, Marta T/0000-0002-8521-2904; Vidal, Anxo/0000-0002-0866-4202; Martins, Teresa/0000-0003-4271-2869; Rodrigues, Fernando/0000-0002-4913-3889; Torres, Joana/0000-0002-5651-4575; Sobrinho-Simoes, Manuel/0000-0003-1613-1235; Prazeres, Hugo/0000-0002-5504-6642	Portuguese Foundation for Science and Technology [SFRH/BD30041/2006, PTDC/SAU-OBD/101242/2008]; Portuguese Society of Endocrinology and Metabolism; Portuguese Ministry of Health [13/2007]; Ministry of Science and Innovation (Instituto de Salud Carlos III), Spain [PS09/02050-FEDER]; Portuguese Foundation for Science and Technology	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Portuguese Society of Endocrinology and Metabolism; Portuguese Ministry of Health; Ministry of Science and Innovation (Instituto de Salud Carlos III), Spain(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	We would like to acknowledge funding from grants from the Portuguese Foundation for Science and Technology (SFRH/BD30041/2006 and PTDC/SAU-OBD/101242/2008), the Portuguese Society of Endocrinology and Metabolism (Edward Limber Prize) and the Portuguese Ministry of Health (project 13/2007). Jose Cameselle-Teijeiro was supported by Grant PS09/02050-FEDER, from the Ministry of Science and Innovation (Instituto de Salud Carlos III), Spain. IPATIMUP is an associated laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by the Portuguese Foundation for Science and Technology.	ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; Asami Y, 2009, J ANTIBIOT, V62, P105, DOI 10.1038/ja.2008.17; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 1997, AM J HUM GENET, V61, P1123, DOI 10.1086/301610; Canzian F, 1998, AM J HUM GENET, V63, P1743, DOI 10.1086/302164; Cavaco BM, 2008, J CLIN ENDOCR METAB, V93, P4426, DOI 10.1210/jc.2008-0449; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; CLARK SJ, 1995, NAT GENET, V10, P20, DOI 10.1038/ng0595-20; Dedieu S, 2008, MOL CELL BIOL, V28, P2980, DOI 10.1128/MCB.02238-07; Desrosiers RR, 2006, PEDIATR BLOOD CANCER, V46, P40, DOI 10.1002/pbc.20566; Emonard H, 2005, BIOCHIMIE, V87, P369, DOI 10.1016/j.biochi.2004.11.013; Emonard H, 2004, J BIOL CHEM, V279, P54944, DOI 10.1074/jbc.M406792200; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Gustafsdottir SM, 2007, P NATL ACAD SCI USA, V104, P3067, DOI 10.1073/pnas.0611229104; Hagedorn M, 2005, P NATL ACAD SCI USA, V102, P1643, DOI 10.1073/pnas.0408622102; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; He HL, 2009, CANCER RES, V69, P625, DOI 10.1158/0008-5472.CAN-08-1071; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Horlings HM, 2010, CLIN CANCER RES, V16, P651, DOI 10.1158/1078-0432.CCR-09-0709; Ida K, 1997, BLOOD, V90, P4699, DOI 10.1182/blood.V90.12.4699.4699_4699_4704; Knisely JM, 2007, EXP CELL RES, V313, P3298, DOI 10.1016/j.yexcr.2007.05.026; Kohno T, 2010, GENE CHROMOSOME CANC, V49, P342, DOI 10.1002/gcc.20746; Li YH, 2002, J BIOL CHEM, V277, P42366, DOI 10.1074/jbc.M207705200; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu CX, 2007, J BIOL CHEM, V282, P7504, DOI 10.1074/jbc.M608088200; Liu CX, 2000, GENOMICS, V69, P271, DOI 10.1006/geno.2000.6331; Liu CX, 2000, CANCER RES, V60, P1961; Liu CX, 2001, J BIOL CHEM, V276, P28889, DOI 10.1074/jbc.M102727200; Malchoff CD, 2000, J CLIN ENDOCR METAB, V85, P1758, DOI 10.1210/jc.85.5.1758; Malone CS, 2001, P NATL ACAD SCI USA, V98, P10404, DOI 10.1073/pnas.181206898; Marschang P, 2004, MOL CELL BIOL, V24, P3782, DOI 10.1128/MCB.24.9.3782-3793.2004; Mateus AR, 2009, EXP CELL RES, V315, P1393, DOI 10.1016/j.yexcr.2009.02.020; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; McKay JD, 2001, AM J HUM GENET, V69, P440, DOI 10.1086/321979; Muraoka M, 1996, ONCOGENE, V12, P1565; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; Prazeres HJ, 2008, FAM CANCER, V7, P141, DOI 10.1007/s10689-007-9160-x; Ribeiro AS, 2010, ONCOGENE, V29, P392, DOI 10.1038/onc.2009.338; Ribeiro FR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-371; RIKITAKE Y, 1992, MOL CELL BIOL, V12, P2826, DOI 10.1128/MCB.12.6.2826; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Shiroshima T, 2009, FEBS LETT, V583, P43, DOI 10.1016/j.febslet.2008.11.045; Song H, 2009, CANCER RES, V69, P879, DOI 10.1158/0008-5472.CAN-08-3379; Stankov K, 2004, INT J CANCER, V111, P463, DOI 10.1002/ijc.20259; Suh I, 2009, SURGERY, V146, P1073, DOI 10.1016/j.surg.2009.09.012; Tanaga K, 2004, ARTERIOSCL THROM VAS, V24, P1422, DOI 10.1161/01.ATV.0000133607.80554.09; TOTH M, 1990, J MOL BIOL, V214, P673, DOI 10.1016/0022-2836(90)90285-T; Ulisse S, 2009, CURR CANCER DRUG TAR, V9, P32, DOI 10.2174/156800909787314002; Walker LC, 2008, GENE CHROMOSOME CANC, V47, P405, DOI 10.1002/gcc.20545; Woodcock DM, 1997, J BIOL CHEM, V272, P7810, DOI 10.1074/jbc.272.12.7810; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200	55	62	64	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	11					1302	1317		10.1038/onc.2010.512	http://dx.doi.org/10.1038/onc.2010.512			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	736JX	21057533	Green Published			2022-12-25	WOS:000288492100005
J	Lin, YP; Kuo, CJ; Koleci, X; McDonough, SP; Chang, YF				Lin, Yi-Pin; Kuo, Chih-Jung; Koleci, Xhelil; McDonough, Sean P.; Chang, Yung-Fu			Manganese Binds to Clostridium difficile Fbp68 and Is Essential for Fibronectin Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-LAYER PROTEINS; IMMUNOGLOBULIN-LIKE PROTEIN; TANDEM BETA-ZIPPER; STAPHYLOCOCCUS-AUREUS; MOLECULAR CHARACTERIZATION; PATHOGENIC LEPTOSPIRA; CALCIUM BINDS; GROEL HSP60; GENE; EXPRESSION	Clostridium difficile is an etiological agent of pseudomembranous colitis and antibiotic-associated diarrhea. Adhesion is the crucial first step in bacterial infection. Thus, in addition to toxins, the importance of colonization factors in C. difficile-associated disease is recognized. In this study, we identified Fbp68, one of the colonization factors that bind to fibronectin (Fn), as a manganese-binding protein (K-D = 52.70 +/- 1.97 nM). Furthermore, the conformation of Fbp68 changed dramatically upon manganese binding. Manganese binding can also stabilize the structure of Fbp68 as evidenced by the increased T-m measured by thermodenatured circular dichroism and differential scanning calorimetry (CD, T-m = 58-65 degrees C; differential scanning calorimetry, T-m = 59-66 degrees C). In addition, enhanced tolerance to protease K also suggests greatly improved stability of Fbp68 through manganese binding. Fn binding activity was found to be dependent on manganese due to the lack of binding by manganese-free Fbp68 to Fn. The C-terminal 194 amino acid residues of Fbp68 (Fbp68C) were discovered to bind to the N-terminal domain of Fn (Fbp68C-NTD, K-D = 233 +/- 10 nM, obtained from isothermal titration calorimetry). Moreover, adhesion of C. difficile to Caco-2 cells can be partially blocked if cells are pretreated with Fbp68C, and the binding of Fbp68C on Fn siRNA-transfected cells was significantly reduced. These results raise the possibility that Fbp68 plays a key role in C. difficile adherence on host cells to initiate infection.	[Lin, Yi-Pin; Kuo, Chih-Jung; Koleci, Xhelil; Chang, Yung-Fu] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [McDonough, Sean P.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Chang, YF (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	yc42@cornell.edu		Kuo, Chih-Jung/0000-0002-4988-5124	National Institutes of Health [N01-AI-30054]; NIAID, Department of Health and Human Services [ZC005-06, ZC008-09]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030054] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant N01-AI-30054, Project ZC005-06 and ZC008-09 from NIAID, Department of Health and Human Services.	AINSWORTH S, 1975, BIOCHEM J, V145, P63, DOI 10.1042/bj1450063; Barondeau DP, 2004, CURR OPIN STRUC BIOL, V14, P765, DOI 10.1016/j.sbi.2004.10.012; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; BORRIELLO SP, 1990, REV INFECT DIS, V12, pS185; Brown DR, 2000, EMBO J, V19, P1180, DOI 10.1093/emboj/19.6.1180; Calabi E, 2002, INFECT IMMUN, V70, P5770, DOI 10.1128/IAI.70.10.5770-5778.2002; Calabi E, 2001, MOL MICROBIOL, V40, P1187, DOI 10.1046/j.1365-2958.2001.02461.x; Cerquetti M, 2000, MICROB PATHOGENESIS, V28, P363, DOI 10.1006/mpat.2000.0356; Chessa D, 2008, MOL MICROBIOL, V68, P573, DOI 10.1111/j.1365-2958.2008.06185.x; Christie J, 2002, MICROBIOL-SGM, V148, P1615, DOI 10.1099/00221287-148-6-1615; Coburn J, 2005, MOL MICROBIOL, V57, P1182, DOI 10.1111/j.1365-2958.2005.04759.x; CORTHIER G, 1989, INFECT IMMUN, V57, P3922, DOI 10.1128/IAI.57.12.3922-3927.1989; Courtney HS, 1996, INFECT IMMUN, V64, P2415, DOI 10.1128/IAI.64.7.2415-2419.1996; DAVIES HA, 1990, MICROB PATHOGENESIS, V9, P141, DOI 10.1016/0882-4010(90)90088-8; Dugan TA, 2003, J BIOL CHEM, V278, P13655, DOI 10.1074/jbc.M300171200; EVEILLARD M, 1993, MOL MICROBIOL, V7, P371, DOI 10.1111/j.1365-2958.1993.tb01129.x; Giesemann T, 2008, J MED MICROBIOL, V57, P690, DOI 10.1099/jmm.0.47742-0; Hauk P, 2009, J MOL BIOL, V390, P722, DOI 10.1016/j.jmb.2009.05.034; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Hennequin C, 2003, MICROBIOL-SGM, V149, P2779, DOI 10.1099/mic.0.26145-0; Hennequin C, 2001, MICROB PATHOGENESIS, V31, P255, DOI 10.1006/mpat.2001.0468; Hennequin C, 2001, MICROBIOL-UK, V147, P87, DOI 10.1099/00221287-147-1-87; Hesketh S, 2008, MOL CELL NEUROSCI, V37, P590, DOI 10.1016/j.mcn.2007.12.008; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Jaffe J, 1996, MOL MICROBIOL, V21, P373, DOI 10.1046/j.1365-2958.1996.6331356.x; Janvilisri T, 2010, J INFECT DIS, V202, P282, DOI 10.1086/653484; Janvilisri T, 2009, J BACTERIOL, V191, P3881, DOI 10.1128/JB.00222-09; JOHNSON GS, 1979, J BIOL CHEM, V254, P5483; KARJALAINEN T, 1994, INFECT IMMUN, V62, P4347, DOI 10.1128/IAI.62.10.4347-4355.1994; Karjalainen T, 2002, J CLIN MICROBIOL, V40, P2452, DOI 10.1128/JCM.40.7.2452-2458.2002; Karjalainen T, 2001, INFECT IMMUN, V69, P3442, DOI 10.1128/IAI.69.5.3442-3446.2001; Kelly CP, 1998, ANNU REV MED, V49, P375; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lin XP, 2008, J VET SCI, V9, P133; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Mempel M, 2002, BRIT J DERMATOL, V146, P943, DOI 10.1046/j.1365-2133.2002.04752.x; Mizuno K, 2004, J BIOL CHEM, V279, P27339, DOI 10.1074/jbc.M400813200; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Peacock SJ, 1999, MICROBIOL-SGM, V145, P3477, DOI 10.1099/00221287-145-12-3477; Pechine S, 2005, J MED MICROBIOL, V54, P193, DOI 10.1099/jmm.0.45800-0; Poilane I, 1998, CAN J MICROBIOL, V44, P157, DOI 10.1139/cjm-44-2-157; Raibaud S, 2005, J BIOL CHEM, V280, P18803, DOI 10.1074/jbc.M501731200; Santos R, 2001, MOL PLANT MICROBE IN, V14, P758, DOI 10.1094/MPMI.2001.14.6.758; Schwan C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000626; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; SEDDON SV, 1992, J MED MICROBIOL, V36, P307, DOI 10.1099/00222615-36-5-307; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Shi L, 2001, J BACTERIOL, V183, P7053, DOI 10.1128/JB.183.24.7053-7057.2001; SILVA JJ, 2001, BIOL CHEM ELEMENTS I, P402; TAINER JA, 1983, NATURE, V306, P284, DOI 10.1038/306284a0; Tasteyre A, 2000, MICROBIOL-SGM, V146, P957, DOI 10.1099/00221287-146-4-957; Tasteyre A, 2001, INFECT IMMUN, V69, P7937, DOI 10.1128/IAI.69.12.7937-7940.2001; Tasteyre A, 2001, J CLIN MICROBIOL, V39, P1178, DOI 10.1128/JCM.39.3.1178-1183.2001; Tung JY, 2010, J BIOL CHEM, V285, P3245, DOI 10.1074/jbc.M109.006320; Vendrame F, 2006, J CLIN ENDOCR METAB, V91, P5064, DOI 10.1210/jc.2006-1358; Waligora AJ, 2001, INFECT IMMUN, V69, P2144, DOI 10.1128/IAI.69.4.2144-2153.2001	68	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3957	3969		10.1074/jbc.M110.184523	http://dx.doi.org/10.1074/jbc.M110.184523			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21062746	Green Published, hybrid			2022-12-25	WOS:000286653200076
J	Rybakova, IN; Greaser, ML; Moss, RL				Rybakova, Inna N.; Greaser, Marion L.; Moss, Richard L.			Myosin Binding Protein C Interaction with Actin CHARACTERIZATION AND MAPPING OF THE BINDING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; N-TERMINAL DOMAINS; MYBP-C; CARDIAC-MUSCLE; F-ACTIN; IN-VITRO; PHOSPHORYLATION; PURIFICATION; FILAMENTS; CRYSTALLIZATION	Myosin binding protein C (MyBPC) is a multidomain protein associated with the thick filaments of striated muscle. Although both structural and regulatory roles have been proposed for MyBPC, its interactions with other sarcomeric proteins remain obscure. The current study was designed to examine the actin-binding properties of MyBPC and to define MyBPC domain regions involved in actin interaction. Here, we have expressed full-length mouse cardiac MyBPC (cMyBPC) in a baculovirus system and shown that purified cMyBPC binds actin filaments with an affinity of 4.3 +/- 1.1 mu M and a 1: 1 molar ratio with regard to an actin protomer. The actin binding by cMyBPC is independent of protein phosphorylation status and is not significantly affected by the presence of tropomyosin and troponin on the actin filament. In addition, cMyBPC-actin interaction is not modulated by calmodulin. To determine the region of cMyBPC that is responsible for its interaction with actin, we have expressed and characterized five recombinant proteins encoding fragments of the cMyBPC sequence. Recombinant N-terminal fragments such as C0-C1, C0-C4, and C0-C5 cosediment with actin in a linear, nonsaturable manner. At the same time, MyBPC fragments lacking either the C0-C1 or C0-C4 region bind F-actin with essentially the same properties as full-length protein. Together, our results indicate that cMyBPC interacts with actin via a single, moderate affinity site localized to the C-terminal region of the protein. In contrast, certain basic regions of the N-terminal domains of MyBPC may act as small polycations and therefore bind actin via nonspecific electrostatic interactions.	[Rybakova, Inna N.; Moss, Richard L.] Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA; [Greaser, Marion L.] Univ Wisconsin, Muscle Biol Lab, Dept Anim Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Rybakova, IN (corresponding author), 601 Sci Dr, Madison, WI 53711 USA.	rybakova@physiology.wisc.edu	Greaser, Marion L/C-6147-2012	Greaser, Marion L/0000-0002-6583-9566	National Institutes of Health [R37HL82900]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL082900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R37HL82900 (to R. L. M.).	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; BROOKS SPJ, 1992, BIOTECHNIQUES, V13, P906; Chen PP, 2010, J GEN PHYSIOL, V136, P615, DOI 10.1085/jgp.201010448; Flashman E, 2004, CIRC RES, V94, P1279, DOI 10.1161/01.RES.0000127175.21818.C2; Fougerousse F, 1998, CIRC RES, V82, P130; Freiburg A, 1996, EUR J BIOCHEM, V235, P317, DOI 10.1111/j.1432-1033.1996.00317.x; Gautel M, 1998, CIRC RES, V82, P124; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Ge Y, 2009, P NATL ACAD SCI USA, V106, P12658, DOI 10.1073/pnas.0813369106; Gordon AM, 1997, BIOPHYS J, V72, pWP199; Govada L, 2008, J MOL BIOL, V378, P387, DOI 10.1016/j.jmb.2008.02.044; GREASER ML, 1971, J BIOL CHEM, V246, P4226; GREASER ML, 1973, J BIOL CHEM, V248, P2125; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; HARRIS SP, 2010, MYOFILAMENT CONTROL, P22; HARTZELL HC, 1984, J BIOL CHEM, V259, P5587; HARTZELL HC, 1985, J CELL BIOL, V100, P208, DOI 10.1083/jcb.100.1.208; Herron TJ, 2006, CIRC RES, V98, P1290, DOI 10.1161/01.RES.0000222059.54917.ef; Idowu SM, 2003, J MOL BIOL, V329, P745, DOI 10.1016/S0022-2836(03)00425-X; Jeffries CM, 2008, J MOL BIOL, V377, P1186, DOI 10.1016/j.jmb.2008.01.080; KENSLER RW, 2010, MYOFILAMENT CONTROL, P67; Kulikovskaya I, 2003, J GEN PHYSIOL, V122, P761, DOI 10.1085/jgp.200308941; Kunst G, 2000, CIRC RES, V86, P51, DOI 10.1161/01.RES.86.1.51; Kurasawa M, 1999, MUSCLE NERVE, V22, P196, DOI 10.1002/(SICI)1097-4598(199902)22:2<196::AID-MUS7>3.0.CO;2-E; LEAHY DJ, 1994, PROTEINS, V19, P48, DOI 10.1002/prot.340190107; Moolman-Smook J, 2002, CIRC RES, V91, P704, DOI 10.1161/01.RES.0000036750.81083.83; MOOS C, 1978, J MOL BIOL, V124, P571, DOI 10.1016/0022-2836(78)90172-9; Oakley CE, 2004, CELL RES, V14, P95, DOI 10.1038/sj.cr.7290208; OFFER G, 1973, J MOL BIOL, V74, P653, DOI 10.1016/0022-2836(73)90055-7; OKAGAKI T, 1993, J CELL BIOL, V123, P619, DOI 10.1083/jcb.123.3.619; Razumova MV, 2006, J BIOL CHEM, V281, P35846, DOI 10.1074/jbc.M606949200; Rybakova IN, 1996, J CELL BIOL, V135, P661, DOI 10.1083/jcb.135.3.661; Rybakova IN, 2002, MOL BIOL CELL, V13, P1512, DOI 10.1091/mbc.01-09-0446; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Squire JM, 2003, J MOL BIOL, V331, P713, DOI 10.1016/S0022-2836(03)00781-2; Tang JX, 1997, EUR J BIOCHEM, V247, P432, DOI 10.1111/j.1432-1033.1997.00432.x; Welikson RE, 2002, J CELL SCI, V115, P3517; Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105; YAMAMOTO K, 1983, J BIOL CHEM, V258, P8395; YAMAMOTO K, 1986, FEBS LETT, V208, P123, DOI 10.1016/0014-5793(86)81545-9; ZHUO S, 1993, J BIOL CHEM, V268, P17754; Zoghbi ME, 2008, P NATL ACAD SCI USA, V105, P2386, DOI 10.1073/pnas.0708912105	42	61	61	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2008	2016		10.1074/jbc.M110.170605	http://dx.doi.org/10.1074/jbc.M110.170605			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21071444	Green Published, hybrid			2022-12-25	WOS:000286191500042
J	Sephton, CF; Cenik, C; Kucukural, A; Dammer, EB; Cenik, B; Han, YH; Dewey, CM; Roth, FP; Herz, J; Peng, JM; Moore, MJ; Yu, G				Sephton, Chantelle F.; Cenik, Can; Kucukural, Alper; Dammer, Eric B.; Cenik, Basar; Han, YuHong; Dewey, Colleen M.; Roth, Frederick P.; Herz, Joachim; Peng, Junmin; Moore, Melissa J.; Yu, Gang			Identification of Neuronal RNA Targets of TDP-43-containing Ribonucleoprotein Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR FACTOR TDP-43; MESSENGER-RNA; BINDING-PROTEIN; GENE-EXPRESSION; CFTR EXON-9; MUTATIONS; ALS; DISEASE	TAR DNA-binding protein 43 (TDP-43) is associated with a spectrum of neurodegenerative diseases. Although TDP-43 resembles heterogeneous nuclear ribonucleoproteins, its RNA targets and physiological protein partners remain unknown. Here we identify RNA targets of TDP-43 from cortical neurons by RNA immunoprecipitation followed by deep sequencing (RIP-seq). The canonical TDP-43 binding site (TG)(n) is 55.1-fold enriched, and moreover, a variant with adenine in the middle, (TG)(n)TA(TG)(m), is highly abundant among reads in our TDP-43 RIP-seq library. TDP-43 RNA targets can be divided into three different groups: those primarily binding in introns, in exons, and across both introns and exons. TDP-43 RNA targets are particularly enriched for Gene Ontology terms related to synaptic function, RNA metabolism, and neuronal development. Furthermore, TDP-43 binds to a number of RNAs encoding for proteins implicated in neurodegeneration, including TDP-43 itself, FUS/TLS, progranulin, Tau, and ataxin 1 and -2. We also identify 25 proteins that co-purify with TDP-43 from rodent brain nuclear extracts. Prominent among them are nuclear proteins involved in pre-mRNA splicing and RNA stability and transport. Also notable are two neuron-enriched proteins, methyl CpG-binding protein 2 and polypyrimidine tract-binding protein 2 (PTBP2). A PTBP2 consensus RNA binding motif is enriched in the TDP-43 RIP-seq library, suggesting that PTBP2 may co-regulate TDP-43 RNA targets. This work thus reveals the protein and RNA components of the TDP-43-containing ribonucleoprotein complexes and provides a framework for understanding how dysregulation of TDP-43 in RNA metabolism contributes to neurodegeneration.	[Dewey, Colleen M.; Herz, Joachim; Yu, Gang] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Cenik, Can; Roth, Frederick P.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kucukural, Alper; Moore, Melissa J.] Univ Massachusetts, Sch Med, Dept Biol Chem & Mol Pharmacol, Worcester, MA 01655 USA; [Moore, Melissa J.] Howard Hughes Med Inst, Worcester, MA 01655 USA; [Dammer, Eric B.; Peng, Junmin] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; Emory University	Yu, G (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	Gang.Yu@UTSouthwestern.edu	Roth, Frederick P/H-6308-2011; Kucukural, Alper/AAJ-7758-2020; Dammer, Eric B/V-8652-2019; Kucukural, Alper/T-3563-2018; Han, YuHong/N-1461-2015; Peng, Junmin/N-2614-2018	Kucukural, Alper/0000-0001-9983-394X; Dammer, Eric B/0000-0003-2947-7606; Kucukural, Alper/0000-0001-9983-394X; Peng, Junmin/0000-0003-0472-7648; Roth, Frederick/0000-0002-6628-649X; Cenik, Can/0000-0001-6370-0889	National Institutes of Health [R01 AG029547, AG023104, HG004233, T32 NS007480, P30 NS055077]; Consortium for Frontotemporal Dementia Research; Welch Foundation; Ted Nash Long Life Foundation; Canadian Institute for Advanced Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007480, P30NS055077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029547, R01AG023104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Frontotemporal Dementia Research; Welch Foundation(The Welch Foundation); Ted Nash Long Life Foundation; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG029547 and AG023104 (to G. Y.), HG004233 (to F. P. R.), T32 NS007480 (to E. B. D.), and P30 NS055077 (to J. P.). This work was also supported by the Consortium for Frontotemporal Dementia Research (to G. Y. and J. H.), the Welch Foundation (to G. Y.), the Ted Nash Long Life Foundation (to G. Y.), and a fellowship from the Canadian Institute for Advanced Research (to F. P. R.). M. J. M. is an HHMI investigator.	Aizawa H, 2010, ACTA NEUROPATHOL, V120, P75, DOI 10.1007/s00401-010-0678-x; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Casafont I, 2009, J STRUCT BIOL, V167, P235, DOI 10.1016/j.jsb.2009.06.006; Cenik C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r29; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Gabut M, 2008, CELL, V133, P192, DOI 10.1016/j.cell.2008.03.010; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Keene JD, 2005, CHROMOSOME RES, V13, P327, DOI 10.1007/s10577-005-0848-1; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Lucking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Nelson PT, 2007, J NEUROPATH EXP NEUR, V66, P461, DOI 10.1097/01.jnen.0000240474.27791.f3; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Strong MJ, 2010, J NEUROL SCI, V288, P1, DOI 10.1016/j.jns.2009.09.029; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Zhang Y, 2009, ANAL CHEM, V81, P6317, DOI 10.1021/ac9004887	50	309	312	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1204	1215		10.1074/jbc.M110.190884	http://dx.doi.org/10.1074/jbc.M110.190884			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21051541	Green Published, hybrid			2022-12-25	WOS:000286005000032
J	Zhang, LY; Zheng, YC; Callahan, B; Belfort, M; Liu, YZ				Zhang, Liyun; Zheng, Yuchuan; Callahan, Brian; Belfort, Marlene; Liu, Yangzhong			Cisplatin Inhibits Protein Splicing, Suggesting Inteins as Therapeutic Targets in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC SYSTEM; IN-VITRO; PLATINUM; PLATINATION; INTRONS; AGENTS; DRUGS; BCG	Mycobacterium tuberculosis harbors three protein splicing elements, called inteins, in critical genes and their protein products. Post-translational removal of the inteins occurs autocatalytically and is required for function of the respective M. tuberculosis proteins. Inteins are therefore potential targets for antimycobacterial agents. In this work, we report that the splicing activity of the intein present in the RecA recombinase of M. tuberculosis is potently inhibited by the anticancer drug cisplatin (cis-diamminedichloro-platinum(II)). This previously unrecognized activity of cisplatin was established using both an in vitro intein splicing assay, which yielded an IC50 of similar to 2 mu M, and a genetic reporter for intein splicing in Escherichia coli. Testing of related platinum(II) complexes indicated that the inhibition activity is highly structure-dependent, with cisplatin exhibiting the best inhibitory effect. Finally, we report that cisplatin is toxic toward M. tuberculosis with a minimum inhibitory concentration of similar to 40 mu M, and in genetic experiments conducted with the related Mycobacterium bovis bacillus Calmette-Guerrin (BCG) strain, we show that cisplatin toxicity can be mitigated by intein overexpression. We propose that cisplatin inhibits intein activity by modifying at least one conserved cysteine residue that is required for splicing. Together these results identify a novel active site inhibitor of inteins and validate inteins as viable targets for small molecule inhibition in mycobacteria.	Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei 230026, Peoples R China; [Callahan, Brian; Belfort, Marlene] New York State Dept Hlth, Ctr Med Sci, Wadsworth Ctr, Albany, NY 12208 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; State University of New York (SUNY) System; Wadsworth Center	Liu, YZ (corresponding author), 96 Jinzhai Rd, Hefei 230026, Peoples R China.	liuyz@ustc.edu.cn	Zhang, Liyun/E-8123-2012; liu, yang/HHY-8583-2022; Liu, Yangzhong/D-5363-2009	Zhang, Liyun/0000-0003-1517-8808; Liu, Yangzhong/0000-0003-2891-7964; Belfort, Marlene/0000-0002-1592-5618; Callahan, Brian/0000-0003-4826-0162	Ministry of Education of China [707036]; National Science Foundation of China [20873135]; National Basic Research Program of China (973 Program) [2009CB918804]; National Institutes of Health [GM44844]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044844] Funding Source: NIH RePORTER	Ministry of Education of China(Ministry of Education, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by grants from the Cultivation Fund of the Key Scientific and Technical Innovation Project, Ministry of Education of China (Grant 707036), the National Science Foundation of China (Grant 20873135), the National Basic Research Program of China (973 Program, 2009CB918804), and by National Institutes of Health Grant GM44844 (to M. B.).	Barnham KJ, 2008, P NATL ACAD SCI USA, V105, P6813, DOI 10.1073/pnas.0800712105; BELFORT M, 1984, J BACTERIOL, V160, P371, DOI 10.1128/JB.160.1.371-378.1984; Belfort M., 1998, U. S. Patent, Patent No. [5,795,731, 5795731]; Bhattacharya SK, 2007, J INFECT DIS, V196, P591, DOI 10.1086/519690; Dassa B, 2007, BIOCHEMISTRY-US, V46, P322, DOI 10.1021/bi0611762; DAVIS EO, 1994, EMBO J, V13, P699, DOI 10.1002/j.1460-2075.1994.tb06309.x; Derbyshire V, 1997, P NATL ACAD SCI USA, V94, P11466, DOI 10.1073/pnas.94.21.11466; Du ZM, 2009, J AM CHEM SOC, V131, P11581, DOI 10.1021/ja904318w; Duncan K, 2004, CURR OPIN MICROBIOL, V7, P460, DOI 10.1016/j.mib.2004.08.011; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gangopadhyay JP, 2003, ANAL CHEM, V75, P2456, DOI 10.1021/ac020756b; Ghosh I, 2001, J BIOL CHEM, V276, P24051, DOI 10.1074/jbc.M011049200; Hiraga K, 2005, J MOL BIOL, V354, P916, DOI 10.1016/j.jmb.2005.09.088; Janin YL, 2007, BIOORGAN MED CHEM, V15, P2479, DOI 10.1016/j.bmc.2007.01.030; Kostova I, 2006, RECENT PAT ANTI-CANC, V1, P1, DOI 10.2174/157489206775246458; Li C, 2009, ANGEW CHEM INT EDIT, V48, P8497, DOI 10.1002/anie.200902948; Liu XQ, 2004, FEBS LETT, V572, P46, DOI 10.1016/j.febslet.2004.07.016; Miguel DC, 2009, J ANTIMICROB CHEMOTH, V63, P365, DOI 10.1093/jac/dkn509; Mills KV, 2001, J BIOL CHEM, V276, P10832, DOI 10.1074/jbc.M011149200; Mitchison DA, 2005, EUR RESPIR J, V25, P376, DOI 10.1183/09031936.05.00075704; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Naik PR, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-230; Paulus H, 1998, CHEM SOC REV, V27, P375, DOI 10.1039/a827375z; Paulus H, 2007, DRUG FUTURE, V32, P973, DOI 10.1358/dof.2007.032.11.1140690; Perez RP, 1998, EUR J CANCER, V34, P1535, DOI 10.1016/S0959-8049(98)00227-5; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Poehlsgaard J, 2005, NAT REV MICROBIOL, V3, P870, DOI 10.1038/nrmicro1265; Raghavan R, 2008, J BACTERIOL, V190, P5934, DOI 10.1128/JB.00602-08; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; Reedijk J, 1999, CHEM REV, V99, P2499, DOI 10.1021/cr980422f; Sander P, 2001, INFECT IMMUN, V69, P3562, DOI 10.1128/IAI.69.6.3562-3568.2001; Stordal B, 2007, CANCER TREAT REV, V33, P347, DOI 10.1016/j.ctrv.2007.01.009; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Thayer AM, 2010, CHEM ENG NEWS, V88, P24, DOI 10.1021/cen-v088n026.p024; Van Roey P, 2007, J MOL BIOL, V367, P162, DOI 10.1016/j.jmb.2006.12.050; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Weidt SK, 2007, CHEM COMMUN, P1719, DOI 10.1039/b701903c; Williams DS, 2007, INORG CHEM, V46, P2944, DOI 10.1021/ic062055t; Wood DW, 1999, NAT BIOTECHNOL, V17, P889, DOI 10.1038/12879; Xu MQ, 2005, CURR OPIN BIOTECH, V16, P440, DOI 10.1016/j.copbio.2005.06.012; Zhang LY, 2010, CHEM-EUR J, V16, P4297, DOI 10.1002/chem.200903584; Zhang LY, 2009, MOL BIOSYST, V5, P644, DOI 10.1039/b903144h	42	36	41	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1277	1282		10.1074/jbc.M110.171124	http://dx.doi.org/10.1074/jbc.M110.171124			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059649	Green Published, hybrid			2022-12-25	WOS:000286005000039
J	D'Adamo, MC; Shang, LJ; Imbrici, P; Brown, SDM; Pessia, M; Tucker, SJ				D'Adamo, M. Cristina; Shang, Lijun; Imbrici, Paola; Brown, Steve D. M.; Pessia, Mauro; Tucker, Stephen J.			Genetic Inactivation of Kcnj16 Identifies Kir5.1 as an Important Determinant of Neuronal PCO2/pH Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-COERULEUS NEURONS; HETEROMERIC KIR4.1-KIR5.1 CHANNELS; RECTIFIER K+ CHANNEL; POTASSIUM CHANNELS; CERULEUS NEURONS; FUNCTIONAL NEUROANATOMY; PH SENSITIVITY; KIR4.1; RAT; MODULATION	The molecular identity of ion channels which confer PCO2/pH sensitivity in the brain is unclear. Heteromeric Kir4.1/Kir5.1 channels are highly sensitive to inhibition by intracellular pH and are widely expressed in several brainstem nuclei involved in cardiorespiratory control, including the locus coeruleus. This has therefore led to a proposed role for these channels in neuronal CO2 chemosensitivity. To examine this, we generated mutant mice lacking the Kir5.1 (Kcnj16) gene. We show that although locus coeruleus neurons from Kcnj16((+/+)) mice rapidly respond to cytoplasmic alkalinization and acidification, those from Kcnj16((-/-)) mice display a dramatically reduced and delayed response. These results identify Kir5.1 as an important determinant of PCO2/pH sensitivity in locus coeruleus neurons and suggest that Kir5.1 may be involved in the response to hypercapnic acidosis.	[D'Adamo, M. Cristina; Imbrici, Paola; Pessia, Mauro] Univ Perugia, Sch Med, Sect Human Physiol, I-06100 Perugia, Italy; [Shang, Lijun; Tucker, Stephen J.] Univ Oxford, Clarendon Lab, Dept Phys, Oxford OX1 3PT, England; [Shang, Lijun; Brown, Steve D. M.; Tucker, Stephen J.] Univ Oxford, OXION Initiat, Oxford OX1 3PT, England; [Brown, Steve D. M.] Med Res Council Harwell, Med Res Council, Mammalian Genet Unit, Didcot OX11 ORD, Oxon, England	University of Perugia; University of Oxford; University of Oxford; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Pessia, M (corresponding author), Univ Perugia, Sch Med, Sect Human Physiol, I-06100 Perugia, Italy.	pessia@unipg.it	Shang, Lijun/AAT-8172-2020; Tucker, Stephen J./ABE-6741-2020; D'Adamo, Maria Cristina/AAD-3701-2022; imbrici, paola/J-6855-2018; Tucker, Stephen J./ABE-7468-2020	Shang, Lijun/0000-0001-5925-5903; Tucker, Stephen J./0000-0001-8996-2000; D'Adamo, Maria Cristina/0000-0002-6758-6064; imbrici, paola/0000-0001-9140-5350; Tucker, Stephen J./0000-0001-8996-2000; Pessia, Mauro/0000-0002-2857-6795	Royal Society; COMPAGNIA di San Paolo (Turin); Ministero dell'Istruzione dell'Universita e della Ricerca FIRB [RBAU01TJ93]; PRIN; Fondazione Cassa di Risparmio di Perugia; MRC [MC_U142684175, MC_U142684172] Funding Source: UKRI; Medical Research Council [MC_U142684175, MC_U142684172] Funding Source: researchfish	Royal Society(Royal Society of London); COMPAGNIA di San Paolo (Turin)(Compagnia di San Paolo); Ministero dell'Istruzione dell'Universita e della Ricerca FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Royal Society (to S. J. T.) and the COMPAGNIA di San Paolo (Turin) "Programma Neuroscienze," Ministero dell'Istruzione dell'Universita e della Ricerca FIRB (RBAU01TJ93) and PRIN (to M. P.).; Recipient of a fellowship from Fondazione Cassa di Risparmio di Perugia.	BOND CT, 1994, RECEPTOR CHANNEL, V2, pU2; Buckler KJ, 2010, ADV EXP MED BIOL, V661, P15, DOI 10.1007/978-1-60761-500-2_2; Cui N, 2001, J CELL PHYSIOL, V189, P229, DOI 10.1002/jcp.10021; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Filosa JA, 2003, AM J PHYSIOL-CELL PH, V284, pC145, DOI 10.1152/ajpcell.00346.2002; Filosa JA, 2002, J PHYSIOL-LONDON, V541, P493, DOI 10.1113/jphysiol.2001.014142; Gargaglioni LH, 2010, RESP PHYSIOL NEUROBI, V173, P264, DOI 10.1016/j.resp.2010.04.024; Gestreau C, 2010, P NATL ACAD SCI USA, V107, P2325, DOI 10.1073/pnas.0910059107; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Gourine AV, 2005, J PHYSIOL-LONDON, V568, P715, DOI 10.1113/jphysiol.2005.095968; Hibino H, 2004, J BIOL CHEM, V279, P44065, DOI 10.1074/jbc.M405985200; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Johnson SM, 2008, J APPL PHYSIOL, V105, P1301, DOI 10.1152/japplphysiol.90414.2008; Mulkey DK, 2007, J NEUROSCI, V27, P14049, DOI 10.1523/JNEUROSCI.4254-07.2007; Nagaraja TN, 1998, AM J PHYSIOL-CELL PH, V274, pC883, DOI 10.1152/ajpcell.1998.274.4.C883; Neusch C, 2001, J NEUROSCI, V21, P5429, DOI 10.1523/JNEUROSCI.21-15-05429.2001; Oyamada Y, 1998, J PHYSIOL-LONDON, V513, P381, DOI 10.1111/j.1469-7793.1998.381bb.x; Pearson WL, 1999, J PHYSIOL-LONDON, V514, P639, DOI 10.1111/j.1469-7793.1999.639ad.x; Pessia M, 2001, J PHYSIOL-LONDON, V532, P359, DOI 10.1111/j.1469-7793.2001.0359f.x; Pessia M, 1996, EMBO J, V15, P2980, DOI 10.1002/j.1460-2075.1996.tb00661.x; Pineda J, 1997, NEUROSCIENCE, V77, P723, DOI 10.1016/S0306-4522(96)00485-X; Putnam RW, 2010, J APPL PHYSIOL, V108, P1796, DOI 10.1152/japplphysiol.01169.2009; Salvatore L, 1999, FEBS LETT, V449, P146, DOI 10.1016/S0014-5793(99)00420-2; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P254, DOI 10.2174/157015908785777193; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; SHEN KZ, 1992, NEUROSCIENCE, V50, P345, DOI 10.1016/0306-4522(92)90428-5; SHEN KZ, 1992, J PHYSIOL-LONDON, V455, P471, DOI 10.1113/jphysiol.1992.sp019312; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; Tanemoto M, 2000, J PHYSIOL-LONDON, V525, P587, DOI 10.1111/j.1469-7793.2000.00587.x; THOMAS RC, 1984, J PHYSIOL-LONDON, V354, pP3; Trapp S, 1996, J PHYSIOL-LONDON, V496, P695, DOI 10.1113/jphysiol.1996.sp021720; Trapp S, 2008, J NEUROSCI, V28, P8844, DOI 10.1523/JNEUROSCI.1810-08.2008; Tucker SJ, 2000, J BIOL CHEM, V275, P16404, DOI 10.1074/jbc.C000127200; WILLIAMS JT, 1984, MOL PHARMACOL, V26, P489; Wu J, 2004, J MEMBRANE BIOL, V197, P179, DOI 10.1007/s00232-004-0652-4; Xu HX, 2000, J PHYSIOL-LONDON, V524, P725, DOI 10.1111/j.1469-7793.2000.00725.x; Yang ZJ, 2000, J GEN PHYSIOL, V116, P33, DOI 10.1085/jgp.116.1.33; Zhang XL, 2010, AM J PHYSIOL-CELL PH, V298, pC635, DOI 10.1152/ajpcell.00442.2009	39	37	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					192	198		10.1074/jbc.M110.189290	http://dx.doi.org/10.1074/jbc.M110.189290			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21047793	Green Published, hybrid			2022-12-25	WOS:000285782800021
J	Huang, ZY; Hunter, S; Chien, P; Kim, MK; Han-Kim, TH; Indik, ZK; Schreiber, AD				Huang, Zhen-Yu; Hunter, Sharon; Chien, Paul; Kim, Moo-Kyung; Han-Kim, Tae-Hee; Indik, Zena K.; Schreiber, Alan D.			Interaction of Two Phagocytic Host Defense Systems Fc gamma RECEPTORS AND COMPLEMENT RECEPTOR 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE SYK; CYTOPLASMIC DOMAIN; MEDIATED PHAGOCYTOSIS; NEUTROPHIL ADHESION; ESCHERICHIA-COLI; MAC-1 CD11B/CD18; COMPLEMENT; RECEPTORS; MACROPHAGES; CHAIN	Phagocytosis of foreign pathogens by cells of the immune system is a vitally important function of innate immunity. The phagocytic response is initiated when ligands on the surface of invading microorganisms come in contact with receptors on the surface of phagocytic cells such as neutrophils, monocytes/macrophages, and dendritic cells. The complement receptor CR3 (CD11b/CD18, Mac-1) mediates the phagocytosis of complement protein (C3bi)-coated particles. Fc gamma receptors (Fc gamma Rs) bind IgG-opsonized particles and provide a mechanism for immune clearance and phagocytosis of IgG-coated particles. We have observed that stimulation of Fc gamma Rs modulates CR3-mediated phagocytosis and that Fc gamma RIIA and Fc gamma RI exert opposite (stimulatory and inhibitory) effects. We have also determined that an intact Fc gamma R immunoreceptor tyrosine-based activation motif is required for these effects, and we have investigated the involvement of downstream effectors. The ability to up-regulate or down-regulate CR3 signaling has important implications for therapeutics in disorders involving the host defense system.	[Huang, Zhen-Yu; Hunter, Sharon; Chien, Paul; Kim, Moo-Kyung; Han-Kim, Tae-Hee; Indik, Zena K.; Schreiber, Alan D.] Univ Penn, Sch Med, Dept Hematol Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania	Huang, ZY (corresponding author), 421 Curie Blvd,BRB2-3,Rm 736, Philadelphia, PA 19104 USA.	zyh@mail.med.upenn.edu; schreibr@mail.med.upenn.edu						ARAUJOJORGE T, 1993, INFECT IMMUN, V61, P4925, DOI 10.1128/IAI.61.11.4925-4928.1993; Boekhoudt GH, 2007, J LEUKOCYTE BIOL, V81, P1086, DOI 10.1189/jlb.0906543; BROWN EJ, 1988, J CLIN INVEST, V81, P365, DOI 10.1172/JCI113328; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Caron E, 2000, CURR BIOL, V10, pR489, DOI 10.1016/S0960-9822(00)00555-8; CHACKO GW, 1994, J BIOL CHEM, V269, P32435; da Silva FP, 2007, NAT MED, V13, P1368, DOI 10.1038/nm1665; Edberg JC, 2002, J BIOL CHEM, V277, P41287, DOI 10.1074/jbc.M207835200; Edberg JC, 1999, J BIOL CHEM, V274, P30328, DOI 10.1074/jbc.274.42.30328; EHLENBERGER AG, 1977, J EXP MED, V145, P357, DOI 10.1084/jem.145.2.357; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; GHAZIZADEH S, 1995, BIOCHEM J, V305, P669, DOI 10.1042/bj3050669; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Huang ZY, 2006, J LEUKOCYTE BIOL, V80, P1553, DOI 10.1189/jlb.0106019; Huang ZY, 2004, J LEUKOCYTE BIOL, V76, P491, DOI 10.1189/jlb.1103562; Indik Z K, 1995, Semin Immunol, V7, P45, DOI 10.1016/1044-5323(95)90007-1; INDIK ZK, 1994, EXP HEMATOL, V22, P599; INDIK ZK, 1995, BLOOD, V85, P1175, DOI 10.1182/blood.V85.5.1175.bloodjournal8551175; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Isakov N, 1997, J LEUKOCYTE BIOL, V61, P6, DOI 10.1002/jlb.61.1.6; Jongstra-Bilen J, 2003, J BIOL CHEM, V278, P45720, DOI 10.1074/jbc.M303704200; Kavai M, 2007, AUTOIMMUN REV, V6, P497, DOI 10.1016/j.autrev.2007.01.017; Kiefer F, 1998, MOL CELL BIOL, V18, P4209, DOI 10.1128/MCB.18.7.4209; Kim MK, 2001, CLIN IMMUNOL, V98, P125, DOI 10.1006/clim.2000.4955; Kohl J, 2006, ADV EXP MED BIOL, V586, P71; Kruse K, 2010, APOPTOSIS, V15, P1098, DOI 10.1007/s10495-010-0478-8; KUSUNOKI T, 1994, J LEUKOCYTE BIOL, V55, P735, DOI 10.1002/jlb.55.6.735; Li Y, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2590; Lourenco EV, 2009, CURR MOL MED, V9, P242, DOI 10.2174/156652409787847263; McKenzie S E, 1998, Curr Opin Hematol, V5, P16, DOI 10.1097/00062752-199801000-00003; MITCHELL MA, 1994, BLOOD, V84, P1753; Morgan BP, 2003, MOL IMMUNOL, V40, P159, DOI 10.1016/S0161-5890(03)00111-1; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; PARK JG, 1993, J CLIN INVEST, V92, P2073, DOI 10.1172/JCI116804; Quigg RJ, 2004, CURR DIRECT AUTOIMMU, V7, P165; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Ross GD, 1999, IMMUNOPHARMACOLOGY, V42, P61, DOI 10.1016/S0162-3109(99)00013-2; SCHREIBER AD, 1975, J CLIN INVEST, V56, P1189, DOI 10.1172/JCI108196; Shi YH, 2006, BLOOD, V107, P4554, DOI 10.1182/blood-2005-09-3616; Strzelecka A, 1997, FEBS LETT, V400, P11, DOI 10.1016/S0014-5793(96)01359-2; SZUCS G, 1994, SCAND J IMMUNOL, V40, P481, DOI 10.1111/j.1365-3083.1994.tb03493.x; Tang T, 1997, J EXP MED, V186, P1853, DOI 10.1084/jem.186.11.1853; Tohyama Y, 2006, IUBMB LIFE, V58, P304, DOI 10.1080/15216540600746377; Tridandapani S, 2002, J BIOL CHEM, V277, P5082, DOI 10.1074/jbc.M110277200; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; van Spriel AB, 2003, BLOOD, V101, P253, DOI 10.1182/blood.V101.1.253; vanVugt MJ, 1996, BLOOD, V87, P3593, DOI 10.1182/blood.V87.9.3593.bloodjournal8793593; Wiedemann AS, 2006, J CELL BIOL, V172, P1069, DOI 10.1083/jcb.200508075; WRIGHT SD, 1986, J EXP MED, V164, P1876, DOI 10.1084/jem.164.6.1876	57	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					160	168		10.1074/jbc.M110.163030	http://dx.doi.org/10.1074/jbc.M110.163030			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21044955	hybrid, Green Published			2022-12-25	WOS:000285782800017
J	Liu, HL; Focia, PJ; He, XL				Liu, Heli; Focia, Pamela J.; He, Xiaolin			Homophilic Adhesion Mechanism of Neurofascin, a Member of the L1 Family of Neural Cell Adhesion Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING MODULE; IMMUNOGLOBULIN SUPERFAMILY; NEURITE OUTGROWTH; CRYSTAL-STRUCTURE; MENTAL-RETARDATION; STRUCTURAL BASIS; HUMAN-DISEASE; MUTATIONS; DOMAINS; SPECIFICITY	The L1 family neural cell adhesion molecules play key roles in specifying the formation and remodeling of the neural network, but their homophilic interaction that mediates adhesion is not well understood. We report two crystal structures of a dimeric form of the headpiece of neurofascin, an L1 family member. The four N-terminal Ig-like domains of neurofascin form a horseshoe shape, akin to several other immunoglobulin superfamily cell adhesion molecules such as hemolin, axonin, and Dscam. The neurofascin dimer, captured in two crystal forms with independent packing patterns, reveals a pair of horseshoes in trans-synaptic adhesion mode. The adhesion interaction is mediated mostly by the second Ig-like domain, which features an intermolecular beta-sheet formed by the joining of two individual GFC beta-sheets and a large but loosely packed hydrophobic cluster. Mutagenesis combined with gel filtration assays suggested that the side chain hydrogen bonds at the intermolecular beta-sheet are essential for the homophilic interaction and that the residues at the hydrophobic cluster play supplementary roles. Our structures reveal a conserved homophilic adhesion mode for the L1 family and also shed light on how the pathological mutations of L1 affect its structure and function.	[Liu, Heli; Focia, Pamela J.; He, Xiaolin] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	He, XL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA.	x-he@northwestern.edu			R. H. Lurie Comprehensive Cancer Center of Northwestern University; United States Department of Energy [W-31-109-Eng-38]	R. H. Lurie Comprehensive Cancer Center of Northwestern University; United States Department of Energy(United States Department of Energy (DOE))	We thank Xiaoyan Chen for assistance with cell culture and Zdzislaw Wawrzak for support with x-ray data collection. The Structural Biology Facility is supported by the R. H. Lurie Comprehensive Cancer Center of Northwestern University. Data were measured at the Life Sciences Collaborative Access Team beamline 21-ID-D at the Advanced Photon Source, Argonne National Laboratory, which is supported by United States Department of Energy Contract W-31-109-Eng-38.	Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng L, 2004, MOL CELL NEUROSCI, V27, P522, DOI 10.1016/j.mcn.2004.08.005; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Frints SGM, 2003, HUM MOL GENET, V12, P1463, DOI 10.1093/hmg/ddg165; Gouveia RM, 2008, J BIOL CHEM, V283, P28038, DOI 10.1074/jbc.M804991200; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Haspel J, 2000, J NEUROBIOL, V42, P287, DOI 10.1002/(SICI)1097-4695(20000215)42:3<287::AID-NEU1>3.3.CO;2-O; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; He YN, 2009, STRUCTURE, V17, P460, DOI 10.1016/j.str.2009.01.009; Hortsch M, 2000, MOL CELL NEUROSCI, V15, P1, DOI 10.1006/mcne.1999.0809; Katidou Markella, 2008, Biotechnology Journal, V3, P1564, DOI 10.1002/biot.200800281; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Koticha D, 2005, MOL CELL NEUROSCI, V30, P137, DOI 10.1016/j.mcn.2005.06.007; Kunz S, 1998, J CELL BIOL, V143, P1673, DOI 10.1083/jcb.143.6.1673; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Mortl M, 2007, PROTEIN SCI, V16, P2174, DOI 10.1110/ps.072802707; Nagem RAP, 2003, METHOD ENZYMOL, V374, P120, DOI 10.1016/S0076-6879(03)74005-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; Sawaya MR, 2008, CELL, V134, P1007, DOI 10.1016/j.cell.2008.07.042; Schurmann G, 2001, MOL BIOL CELL, V12, P1765, DOI 10.1091/mbc.12.6.1765; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; WONG EV, 1995, TRENDS NEUROSCI, V18, P168, DOI 10.1016/0166-2236(95)93896-6; ZHAO XO, 1995, J BIOL CHEM, V270, P29413, DOI 10.1074/jbc.270.49.29413	30	49	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					797	805		10.1074/jbc.M110.180281	http://dx.doi.org/10.1074/jbc.M110.180281			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21047790	Green Published, hybrid			2022-12-25	WOS:000285782800079
J	Dutta, D; Ray, S; Home, P; Saha, B; Wang, SJ; Sheibani, N; Tawfik, O; Cheng, NK; Paul, S				Dutta, Debasree; Ray, Soma; Home, Pratik; Saha, Biswarup; Wang, Shoujian; Sheibani, Nader; Tawfik, Osama; Cheng, Niki; Paul, Soumen			Regulation of Angiogenesis by Histone Chaperone HIRA-mediated Incorporation of Lysine 56-acetylated Histone H3.3 at Chromatin Domains of Endothelial Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VEGF RECEPTOR FLT-1; CHOROIDAL NEOVASCULARIZATION; TRANSCRIPTIONAL ACTIVATION; H3K56 ACETYLATION; GENOMIC REGIONS; DNA-REPLICATION; TYROSINE KINASE; GROWTH-FACTOR; BONE-MARROW; IN-VIVO	Angiogenesis is critically dependent on endothelial cell-specific transcriptional mechanisms. However, the molecular processes that regulate chromatin domains and thereby dictate transcription of key endothelial genes are poorly understood. Here, we report that, in endothelial cells, angiogenic signal-mediated transcriptional induction of Vegfr1 (vascular endothelial growth factor receptor 1) is dependent on the histone chaperone, HIRA (histone cell cycle regulation-defective homolog A). Our molecular analyses revealed that, in response to angiogenic signals, HIRA is induced in endothelial cells and mediates incorporation of lysine 56 acetylated histone H3.3 (H3acK56) at the chromatin domain of Vegfr1. HIRA-mediated incorporation of H3acK56 is a general mechanism associated with transcriptional induction of several angiogenic genes in endothelial cells. Depletion of HIRA inhibits H3acK56 incorporation and transcriptional induction of Vegfr1 and other angiogenic genes. Our functional analyses revealed that depletion of HIRA abrogates endothelial network formation on Matrigel and inhibits angiogenesis in an in vivo Matrigel plug assay. Furthermore, analysis in a laser-induced choroidal neovascularization model showed that depletion of HIRA significantly inhibits neovascularization. Our results for the first time decipher a histone chaperone (HIRA)-dependent molecular mechanism in endothelial gene regulation and indicate that histone chaperones could be new targets for angiogenesis therapy.	[Dutta, Debasree; Ray, Soma; Home, Pratik; Saha, Biswarup; Tawfik, Osama; Cheng, Niki; Paul, Soumen] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Div Canc & Dev Biol, Kansas City, KS 66160 USA; [Wang, Shoujian; Paul, Soumen] Univ Kansas, Med Ctr, Inst Reprod Hlth & Regenerat Med, Kansas City, KS 66160 USA; [Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53792 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Wisconsin System; University of Wisconsin Madison	Paul, S (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Div Canc & Dev Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	spaul2@kumc.edu	Home, Pratik/D-5061-2014; Sheibani, Nader/AAG-2379-2020; Saha, Biswarup/T-7341-2019	Sheibani, Nader/0000-0003-2723-9217; Saha, Biswarup/0000-0003-2797-7308	National Institutes of Health [HL094892, HD062546, P20 RRO24214, EY16995, EY18179, P30 EY16665]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD062546] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024214] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY016665, R01EY018179] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094892, R21HL106311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL094892, HD062546, P20 RRO24214, EY16995, EY18179, and P30 EY16665.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Dutta D, 2008, J BIOL CHEM, V283, P25404, DOI 10.1074/jbc.M804349200; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2007, ANNU REV MED, V58, P491, DOI 10.1146/annurev.med.58.061705.145635; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Geisberg JV, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh148; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Home P, 2009, J BIOL CHEM, V284, P28729, DOI 10.1074/jbc.M109.016840; Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; Kim HJ, 2007, EMBO J, V26, P4467, DOI 10.1038/sj.emboj.7601870; Lee HK, 2006, FEBS LETT, V580, P2253, DOI 10.1016/j.febslet.2006.03.033; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Mori K, 2001, J CELL PHYSIOL, V188, P253, DOI 10.1002/jcp.1114; Pal S, 2006, J CELL BIOL, V174, P1047, DOI 10.1083/jcb.200603152; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Roberts C, 2002, MOL CELL BIOL, V22, P2318, DOI 10.1128/MCB.22.7.2318-2328.2002; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Sengupta T, 2008, MOL CELL BIOL, V28, P6160, DOI 10.1128/MCB.00919-08; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Su XJ, 2003, MOL VIS, V9, P171; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Taylor DS, 1999, P NATL ACAD SCI USA, V96, P1633, DOI 10.1073/pnas.96.4.1633; Umeda N, 2006, MOL PHARMACOL, V69, P1820, DOI 10.1124/mol.105.020941; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011	54	43	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41567	41577		10.1074/jbc.M110.190025	http://dx.doi.org/10.1074/jbc.M110.190025			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041298	Green Published			2022-12-25	WOS:000285622600044
J	Pavlopoulou, A; Pampalakis, G; Michalopoulos, I; Sotiropoulou, G				Pavlopoulou, Athanasia; Pampalakis, Georgios; Michalopoulos, Ioannis; Sotiropoulou, Georgia			Evolutionary History of Tissue Kallikreins	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; MULTIPLE PROTEIN-SEQUENCE; SERINE PROTEASES; GENE FAMILY; PROTEOLYTIC CASCADE; NETHERTON-SYNDROME; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; WEB SERVER; E-CADHERIN	The gene family of human kallikrein-related peptidases (KLKs) encodes proteins with diverse and pleiotropic functions in normal physiology as well as in disease states. Currently, the most widely known KLK is KLK3 or prostate-specific antigen (PSA) that has applications in clinical diagnosis and monitoring of prostate cancer. The KLK gene family encompasses the largest contiguous cluster of serine proteases in humans which is not interrupted by non-KLK genes. This exceptional and unique characteristic of KLKs makes them ideal for evolutionary studies aiming to infer the direction and timing of gene duplication events. Previous studies on the evolution of KLKs were restricted to mammals and the emergence of KLKs was suggested about 150 million years ago (mya). In order to elucidate the evolutionary history of KLKs, we performed comprehensive phylogenetic analyses of KLK homologous proteins in multiple genomes including those that have been completed recently. Interestingly, we were able to identify novel reptilian, avian and amphibian KLK members which allowed us to trace the emergence of KLKs 330 mya. We suggest that a series of duplication and mutation events gave rise to the KLK gene family. The prominent feature of the KLK family is that it consists of tandemly and uninterruptedly arrayed genes in all species under investigation. The chromosomal co-localization in a single cluster distinguishes KLKs from trypsin and other trypsin-like proteases which are spread in different genetic loci. All the defining features of the KLKs were further found to be conserved in the novel KLK protein sequences. The study of this unique family will further assist in selecting new model organisms for functional studies of proteolytic pathways involving KLKs.	[Pavlopoulou, Athanasia; Pampalakis, Georgios; Sotiropoulou, Georgia] Univ Patras, Dept Pharm, Sch Hlth Sci, Rion, Greece; [Michalopoulos, Ioannis] Acad Athens, Biomed Res Fdn, Athens, Greece	University of Patras; Academy of Athens	Pavlopoulou, A (corresponding author), Univ Patras, Dept Pharm, Sch Hlth Sci, Rion, Greece.	gdsotiro@upatras.gr	, 0000-0001-8991-8712/S-4398-2016; Pavlopoulou, Athanasia/AAH-1204-2020; Pavlopoulou, Athanasia/ABB-3275-2021	, 0000-0001-8991-8712/0000-0001-8991-8712; Pavlopoulou, Athanasia/0000-0002-0815-3808	Research Committee (ELKE) of the University of Patras [C.186]	Research Committee (ELKE) of the University of Patras	The authors acknowledge financial support by K. Karatheodoris grant (C.186) funded by the Research Committee (ELKE) of the University of Patras (http://www.upatras.gr/index/page/id/70/lang/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hashimi N, 2009, J MOL EVOL, V69, P635, DOI 10.1007/s00239-009-9302-x; ALHASHIMI N, 2010, MOL BIOL EV IN PRESS; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aminetzach YT, 2009, CURR BIOL, V19, P1925, DOI 10.1016/j.cub.2009.09.022; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bernett MJ, 2002, J BIOL CHEM, V277, P24562, DOI 10.1074/jbc.M202392200; Bonnart C, 2010, J CLIN INVEST, V120, P871, DOI 10.1172/JCI41440; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Carvalho AL, 2002, J MOL BIOL, V322, P325, DOI 10.1016/S0022-2836(02)00705-2; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; CHAPDELAINE P, 1991, DNA CELL BIOL, V10, P49, DOI 10.1089/dna.1991.10.49; Cheng HT, 2007, BIOINFORMATICS, V23, P2628, DOI 10.1093/bioinformatics/btm379; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Clark NL, 2005, PLOS GENET, V1, P335, DOI 10.1371/journal.pgen.0010035; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Debela M, 2007, J MOL BIOL, V373, P1017, DOI 10.1016/j.jmb.2007.08.042; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Dong Y, 2010, CANCER RES, V70, P2624, DOI 10.1158/0008-5472.CAN-09-3415; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egelrud T, 2005, BRIT J DERMATOL, V153, P1200, DOI 10.1111/j.1365-2133.2005.06834.x; Elliott MB, 2006, GENOMICS, V88, P591, DOI 10.1016/j.ygeno.2006.06.001; EVANS BA, 1987, J BIOL CHEM, V262, P8027; FAHNESTOCK M, 1994, DNA CELL BIOL, V13, P293, DOI 10.1089/dna.1994.13.293; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Fernando SC, 2007, GENOMICS, V89, P429, DOI 10.1016/j.ygeno.2006.11.010; Fiedler F, 1999, BIOL CHEM, V380, P63, DOI 10.1515/BC.1999.008; Fong Jessica H, 2008, BMC Res Notes, V1, P114, DOI 10.1186/1756-0500-1-114; FORSGREN M, 1987, FEBS LETT, V213, P254, DOI 10.1016/0014-5793(87)81501-6; Fujimori H, 1986, Adv Exp Med Biol, V198 Pt A, P219; Galliano MF, 2005, GENOMICS, V85, P483, DOI 10.1016/j.ygeno.2005.01.001; GAUTHIER ER, 1993, BIOCHIM BIOPHYS ACTA, V1174, P207, DOI 10.1016/0167-4781(93)90118-W; GiovanniDeSimone S, 1997, J PROTEIN CHEM, V16, P809, DOI 10.1023/A:1026372018547; Gomis-Ruth FX, 2002, J BIOL CHEM, V277, P27273, DOI 10.1074/jbc.M201534200; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hallstrom BM, 2007, MOL BIOL EVOL, V24, P2059, DOI 10.1093/molbev/msm136; Hart PS, 2004, J MED GENET, V41, P545, DOI 10.1136/jmg.2003.017657; Harvey TJ, 2000, J BIOL CHEM, V275, P37397, DOI 10.1074/jbc.M004525200; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jensen-Seaman MI, 2003, J MOL EVOL, V57, P261, DOI 10.1007/s00239-003-2474-x; KARR JF, 1995, CANCER RES, V55, P2455; KIM WS, 1991, J BIOL CHEM, V266, P19283; Kita M, 2004, P NATL ACAD SCI USA, V101, P7542, DOI 10.1073/pnas.0402517101; Kita M, 2009, J AM CHEM SOC, V131, P18038, DOI 10.1021/ja908148z; Klucky B, 2007, CANCER RES, V67, P8198, DOI 10.1158/0008-5472.CAN-07-0607; Knudsen B, 2001, P NATL ACAD SCI USA, V98, P14512, DOI 10.1073/pnas.251526398; Komatsu N, 2002, J INVEST DERMATOL, V118, P436, DOI 10.1046/j.0022-202x.2001.01663.x; Kong HJ, 2009, FISH SHELLFISH IMMUN, V27, P486, DOI 10.1016/j.fsi.2009.06.022; Kroon Evert, 1997, Genes and Function, V1, P309; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LAWRENCE MG, 2010, ENDOCR REV IN PRESS; Laxmikanthan G, 2005, PROTEINS, V58, P802, DOI 10.1002/prot.20368; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lilja H, 2008, NAT REV CANCER, V8, P268, DOI 10.1038/nrc2351; Lillywhite HB, 2006, J EXP BIOL, V209, P202, DOI 10.1242/jeb.02007; LIN FK, 1993, BIOCHIM BIOPHYS ACTA, V1173, P325, DOI 10.1016/0167-4781(93)90131-V; Lovgren J, 1997, BIOCHEM BIOPH RES CO, V238, P549, DOI 10.1006/bbrc.1997.7333; Lundwall A, 2008, CELL MOL LIFE SCI, V65, P2019, DOI 10.1007/s00018-008-8024-3; Lundwall A, 2006, BIOL CHEM, V387, P637, DOI 10.1515/BC.2006.082; LUNDWALL A, 1995, FEBS LETT, V374, P53, DOI 10.1016/0014-5793(95)01076-Q; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Miriam F-F, 2010, BIOCHIM BIOPHYS ACTA, V1803, P3, DOI DOI 10.1016/J.BBAMCR.2009.07.004; Nikolaev S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030002; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Olsson AY, 2004, GENE, V343, P347, DOI 10.1016/j.gene.2004.09.020; Olsson AY, 2004, GENOMICS, V84, P147, DOI 10.1016/j.ygeno.2004.01.009; Olsson AY, 2002, BIOCHEM BIOPH RES CO, V299, P305; Pampalakis G, 2008, COMPUT BIOL CHEM, V32, P111, DOI 10.1016/j.compbiolchem.2007.11.002; Pampalakis G, 2007, BBA-REV CANCER, V1776, P22, DOI 10.1016/j.bbcan.2007.06.001; Pampalakis G, 2009, CANCER RES, V69, P3779, DOI 10.1158/0008-5472.CAN-08-1976; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; Puente XS, 2004, GENOME RES, V14, P609, DOI 10.1101/gr.1946304; Quaranta A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007699; Quesada V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-220; ROSEN BS, 1989, SCIENCE, V244, P1483, DOI 10.1126/science.2734615; Sales KU, 2010, NAT GENET, V42, P676, DOI 10.1038/ng.629; Schmidt AE, 2004, J BIOL CHEM, V279, P29485, DOI 10.1074/jbc.M402971200; Scordis P, 1999, BIOINFORMATICS, V15, P799, DOI 10.1093/bioinformatics/15.10.799; Shaw JLV, 2007, J PROTEOME RES, V6, P2859, DOI 10.1021/pr0701658; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Shaw JLV, 2008, BIOL CHEM, V389, P1513, DOI 10.1515/BC.2008.171; Simmer JP, 2009, J BIOL CHEM, V284, P19110, DOI 10.1074/jbc.M109.013623; Sotiropoulou G, 2003, ONCOL RES, V13, P381; Sotiropoulou G, 2009, J BIOL CHEM, V284, P32989, DOI 10.1074/jbc.R109.027946; Tian X, 2009, BIOL REPROD, V80, P616, DOI 10.1095/biolreprod.108.073684; Veveris-Lowe TL, 2005, ENDOCR-RELAT CANCER, V12, P631, DOI 10.1677/erc.1.00958; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; WINES DR, 1989, J BIOL CHEM, V264, P7653; WOLFSBERG TG, 2007, CURR PROTOC BIOINFOR, pCH1; Yoon H, 2009, BIOL CHEM, V390, P373, DOI 10.1515/BC.2009.026; Yousef GM, 2004, BRIT J CANCER, V90, P167, DOI 10.1038/sj.bjc.6601451; Yousef GM, 2003, CANCER RES, V63, P2223; Zhang P, 2005, SYST BIOL, V54, P391, DOI 10.1080/10635150590945278	106	52	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2010	5	11							e13781	10.1371/journal.pone.0013781	http://dx.doi.org/10.1371/journal.pone.0013781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FY	21072173	Green Published, gold, Green Submitted			2022-12-25	WOS:000283645700006
J	Barrio, RA; Hernandez-Machado, A; Varea, C; Romero-Arias, JR; Alvarez-Buylla, E				Angel Barrio, Rafael; Hernandez-Machado, Aurora; Varea, C.; Roberto Romero-Arias, Jose; Alvarez-Buylla, Elena			Flower Development as an Interplay between Dynamical Physical Fields and Genetic Networks	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; REGULATORY NETWORK; ROBUST; MODEL	In this paper we propose a model to describe the mechanisms by which undifferentiated cells attain gene configurations underlying cell fate determination during morphogenesis. Despite the complicated mechanisms that surely intervene in this process, it is clear that the fundamental fact is that cells obtain spatial and temporal information that bias their destiny. Our main hypothesis assumes that there is at least one macroscopic field that breaks the symmetry of space at a given time. This field provides the information required for the process of cell differentiation to occur by being dynamically coupled to a signal transduction mechanism that, in turn, acts directly upon the gene regulatory network (GRN) underlying cell-fate decisions within cells. We illustrate and test our proposal with a GRN model grounded on experimental data for cell fate specification during organ formation in early Arabidopsis thaliana flower development. We show that our model is able to recover the multigene configurations characteristic of sepal, petal, stamen and carpel primordial cells arranged in concentric rings, in a similar pattern to that observed during actual floral organ determination. Such pattern is robust to alterations of the model parameters and simulated failures predict altered spatio-temporal patterns that mimic those described for several mutants. Furthermore, simulated alterations in the physical fields predict a pattern equivalent to that found in Lacandonia schismatica, the only flowering species with central stamens surrounded by carpels.	[Angel Barrio, Rafael; Varea, C.; Roberto Romero-Arias, Jose] Univ Nacl Autonoma Mexico, Inst Fis, Dept Fis Qum, Mexico City, DF, Mexico; [Hernandez-Machado, Aurora] Univ Barcelona, Fac Fis, Dept Struct & Constituents Matter, E-08028 Barcelona, Spain; [Alvarez-Buylla, Elena] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; University of Barcelona; Universidad Nacional Autonoma de Mexico	Barrio, RA (corresponding author), Univ Nacl Autonoma Mexico, Inst Fis, Dept Fis Qum, Mexico City, DF, Mexico.	barrio@fisica.unam.mx; eabuylla@gmail.com	Hernandez-Machado, Aurora/N-3362-2019; Hernandez-Machado, Aurora/H-7425-2012; Romero-Arias, Jose Roberto/ABY-7195-2022	Hernandez-Machado, Aurora/0000-0002-0397-5255; Hernandez-Machado, Aurora/0000-0002-0397-5255; Alvarez-Buylla Roces, Maria Elena/0000-0002-7938-6473; Romero-Arias, Jose Roberto/0000-0002-3423-6455	Conacyt [79641]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Universidad Nacional Autonoma de Mexico [IN229009-3]; Consejo Nacional de Ciencia y Tecnologa [81542]; UNAM y a la Direccion General de Investigacion (Spain) [FIS2009-12964-C05-02]	Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Universidad Nacional Autonoma de Mexico(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologa(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UNAM y a la Direccion General de Investigacion (Spain)	This work was financed in part by: Conacyt (http://www.conacyt.mx) through project No. 79641. EAB akcnowledges financial support from: Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Universidad Nacional Autonoma de Mexico (http;//www.unam.mx) IN229009-3, Consejo Nacional de Ciencia y Tecnologa grant to E. A. B, 81542. JRRA akcnowledges the scholarship received from Conacyt. AHM agradece la hospitalidad de la UNAM y a la Direccion General de Investigacion (Spain) under project: FIS2009-12964-C05-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2004, BIOPHYS J, V86, P2650, DOI 10.1016/S0006-3495(04)74321-0; Alvarez-Buylla ER, 2010, SEMIN CELL DEV BIOL, V21, P108, DOI 10.1016/j.semcdb.2009.11.010; ALVAREZBULLYA ER, 2008, PLOS ONE; Benitez M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-98; Benitez-Alfonso Y, 2009, P NATL ACAD SCI USA, V106, P3615, DOI 10.1073/pnas.0808717106; Campelo F, 2007, EUR PHYS J-SPEC TOP, V143, P101, DOI 10.1140/epjst/e2007-00077-y; Campelo F, 2006, EUR PHYS J E, V20, P37, DOI 10.1140/epje/i2005-10079-5; CAMPELO F, 2005, THESIS U BARCELONA; CHAOS A, 2006, GENES FLOWER PATTERN; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Gonzalez-Cinca R., 2004, ADV CONDENSED MATTER, P203; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Jonsson H, 2005, BIOINFORMATICS, V21, pI232, DOI 10.1093/bioinformatics/bti1036; KOGI G, 1996, J BIOSCIENCE, V21, P369; Kwiatkowska D, 2006, J EXP BOT, V57, P571, DOI 10.1093/jxb/erj042; Kwiatkowska D, 2008, J EXP BOT, V59, P187, DOI 10.1093/jxb/erm290; Mattsson J, 2003, PLANT PHYSIOL, V131, P1327, DOI 10.1104/pp.013623; Mendoza L, 1998, J THEOR BIOL, V193, P307, DOI 10.1006/jtbi.1998.0701; Mendoza L, 1999, BIOINFORMATICS, V15, P593, DOI 10.1093/bioinformatics/15.7.593; Prunet N, 2009, PLANT PHYSIOL, V150, P1764, DOI 10.1104/pp.109.141812; Scheres B, 2001, PLANT PHYSIOL, V125, P112, DOI 10.1104/pp.125.1.112; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085	24	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13523	10.1371/journal.pone.0013523	http://dx.doi.org/10.1371/journal.pone.0013523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048956	Green Published, gold, Green Submitted			2022-12-25	WOS:000283537000004
J	Budding, AE; Vandenbroucke-Grauls, CMJE; Melles, DC; van Duijkeren, E; Kluytmans, JA; Savelkoul, PHM				Budding, Andries E.; Vandenbroucke-Grauls, Christina M. J. E.; Melles, Damian C.; van Duijkeren, Engeline; Kluytmans, Jan A.; Savelkoul, Paul H. M.			Binary IS Typing for Staphylococcus aureus	PLOS ONE			English	Article							SPACER SEQUENCES; PCR ANALYSIS; STRAINS; AMPLIFICATION; IDENTIFICATION	Background: We present an easily applicable test for rapid binary typing of Staphylococcus aureus: binary interspace (IS) typing. This test is a further development of a previously described molecular typing technique that is based on length polymorphisms of the 16S-23S rDNA interspace region of S. aureus. Methodology/Principal Findings: A novel approach of IS-typing was performed in which binary profiles are created. 424 human and animal derived MRSA and MSSA isolates were tested and a subset of these isolates was compared with multi locus sequence typing (MLST) and Amplified Fragment Length Polymorphism (AFLP). Binary IS typing had a high discriminatory potential and a good correlation with MLST and AFLP. Conclusions/Significance: Binary IS typing is easy to perform and binary profiles can be generated in a standardized fashion. These two features, combined with the high correlation with MLST clonal complexes, make the technique applicable for large-scale inter-laboratory molecular epidemiological comparisons.	[Budding, Andries E.; Vandenbroucke-Grauls, Christina M. J. E.; Kluytmans, Jan A.; Savelkoul, Paul H. M.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Melles, Damian C.] Erasmus MC, Dept Med Microbiol, Rotterdam, Netherlands; [van Duijkeren, Engeline] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Kluytmans, Jan A.] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Amphia Hospital	Budding, AE (corresponding author), Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands.	d.budding@vumc.nl	Vandenbroucke-Grauls, Christina/AAO-7953-2020	Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; Budding, Andries/0000-0001-5128-5411	Department of Medical Microbiology, VU University Medical Center	Department of Medical Microbiology, VU University Medical Center	The authors received internal funding from the Department of Medical Microbiology, VU University Medical Center. No external funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Deplano A, 2000, J CLIN MICROBIOL, V38, P3527, DOI 10.1128/JCM.38.10.3527-3533.2000; DOLZANI L, 1994, FEMS MICROBIOL LETT, V119, P167, DOI 10.1016/0378-1097(94)90409-X; GURTLER V, 1995, MICROBIOL-SGM, V141, P1255, DOI 10.1099/13500872-141-5-1255; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Kluytmans J, 2009, BMJ-BRIT MED J, V338, P532; Kumari DNP, 1997, J CLIN MICROBIOL, V35, P881, DOI 10.1128/JCM.35.4.881-885.1997; Meeniken D, 2008, DEUT TIERARZTL WOCH, V115, P132, DOI 10.2377/0341-6593-115-132; MELLES DC, 2007, J MICROBIOL METHODS; Mendoza M, 1998, INT J SYST BACTERIOL, V48, P1049, DOI 10.1099/00207713-48-3-1049; Saruta K, 1997, FEMS MICROBIOL LETT, V146, P271, DOI 10.1016/S0378-1097(96)00487-9; Schmitz FJ, 1998, J MED MICROBIOL, V47, P341, DOI 10.1099/00222615-47-4-341; Schmitz FJ, 1997, ZBL HYG UMWELTMED, V200, P172; Struelens MJ, 2009, CLIN MICROBIOL INFEC, V15, P112, DOI 10.1111/j.1469-0691.2009.02698.x; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Wulf M, 2008, CLIN MICROBIOL INFEC, V14, P519, DOI 10.1111/j.1469-0691.2008.01970.x; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x	16	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13671	10.1371/journal.pone.0013671	http://dx.doi.org/10.1371/journal.pone.0013671			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060683	Green Published, gold, Green Submitted			2022-12-25	WOS:000283537000038
J	Skoe, E; Kraus, N				Skoe, Erika; Kraus, Nina			Hearing It Again and Again: On-Line Subcortical Plasticity in Humans	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; FREQUENCY-FOLLOWING RESPONSES; CORTICOFUGAL MODULATION; INFERIOR COLLICULUS; SPEECH STREAM; PURE-TONE; ADAPTATION; LANGUAGE; PITCH; VARIABILITY	Background: Human brainstem activity is sensitive to local sound statistics, as reflected in an enhanced response in repetitive compared to pseudo-random stimulus conditions [1]. Here we probed the short-term time course of this enhancement using a paradigm that assessed how the local sound statistics (i.e., repetition within a five-note melody) interact with more global statistics (i.e., repetition of the melody). Methodology/Principal Findings: To test the hypothesis that subcortical repetition enhancement builds over time, we recorded auditory brainstem responses in young adults to a five-note melody containing a repeated note, and monitored how the response changed over the course of 1.5 hrs. By comparing response amplitudes over time, we found a robust time-dependent enhancement to the locally repeating note that was superimposed on a weaker enhancement of the globally repeating pattern. Conclusions/Significance: We provide the first demonstration of on-line subcortical plasticity in humans. This complements previous findings that experience-dependent subcortical plasticity can occur on a number of time scales, including life-long experiences with music and language, and short-term auditory training. Our results suggest that the incoming stimulus stream is constantly being monitored, even when the stimulus is physically invariant and attention is directed elsewhere, to augment the neural response to the most statistically salient features of the ongoing stimulus stream. These real-time transformations, which may subserve humans' strong disposition for grouping auditory objects, likely reflect a mix of local processes and corticofugal modulation arising from statistical regularities and the influences of expectation. Our results contribute to our understanding of the biological basis of statistical learning and initiate a new investigational approach relating to the time-course of subcortical plasticity. Although the reported time-dependent enhancements are believed to reflect universal neurophysiological processes, future experiments utilizing a larger array of stimuli are needed to establish the generalizability of our findings.	[Skoe, Erika; Kraus, Nina] Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA; [Skoe, Erika; Kraus, Nina] Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL USA; [Kraus, Nina] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Kraus, Nina] Northwestern Univ, Dept Otolaryngol, Evanston, IL USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University	Skoe, E (corresponding author), Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA.	eeskoe@northwestern.edu			NSF (National Science Foundation) [0842376]; NIH (National Institutes of Health) [R01 DC01510, F32 DC 008052]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC008052, R01DC001510] Funding Source: NIH RePORTER	NSF (National Science Foundation)(National Science Foundation (NSF)); NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Work was supported by NSF (National Science Foundation) 0842376 and NIH (National Institutes of Health) R01 DC01510, F32 DC 008052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abla D, 2008, J COGNITIVE NEUROSCI, V20, P952, DOI 10.1162/jocn.2008.20058; Aiken SJ, 2006, AUDIOL NEURO-OTOL, V11, P213, DOI 10.1159/000092589; Bajo VM, 2010, NAT NEUROSCI, V13, P253, DOI 10.1038/nn.2466; Baldwin D, 2008, COGNITION, V106, P1382, DOI 10.1016/j.cognition.2007.07.005; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Bregman A.S., 1994, AUDITORY SCENE ANAL; CARHART R, 1959, J SPEECH HEAR DISORD, V24, P330, DOI 10.1044/jshd.2404.330; Chandrasekaran B, 2009, NEURON, V64, P311, DOI 10.1016/j.neuron.2009.10.006; Chandrasekaran B, 2010, PSYCHOPHYSIOLOGY, V47, P236, DOI 10.1111/j.1469-8986.2009.00928.x; CHIAPPA KH, 1979, ARCH NEUROL-CHICAGO, V36, P81, DOI 10.1001/archneur.1979.00500380051005; Cunillera T, 2009, NEUROIMAGE, V48, P541, DOI 10.1016/j.neuroimage.2009.06.069; Dean I, 2005, NAT NEUROSCI, V8, P1684, DOI 10.1038/nn1541; Dean I, 2008, J NEUROSCI, V28, P6430, DOI 10.1523/JNEUROSCI.0470-08.2008; DON M, 1994, J ACOUST SOC AM, V96, P2746, DOI 10.1121/1.411281; Drake C, 2001, ANN NY ACAD SCI, V930, P17, DOI 10.1111/j.1749-6632.2001.tb05722.x; EDWARDS RM, 1982, ELECTROEN CLIN NEURO, V53, P125, DOI 10.1016/0013-4694(82)90018-9; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Evans JL, 2009, J SPEECH LANG HEAR R, V52, P321, DOI 10.1044/1092-4388(2009/07-0189); GALBRAITH GC, 1994, ELECTROEN CLIN NEURO, V92, P321, DOI 10.1016/0168-5597(94)90100-7; Gao E, 1998, P NATL ACAD SCI USA, V95, P12663, DOI 10.1073/pnas.95.21.12663; Gao EQ, 2000, P NATL ACAD SCI USA, V97, P8081, DOI 10.1073/pnas.97.14.8081; Garrido MI, 2009, NEUROIMAGE, V48, P269, DOI 10.1016/j.neuroimage.2009.06.034; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; GREENBERG S, 1987, HEARING RES, V25, P91, DOI 10.1016/0378-5955(87)90083-9; HALL JW, 1979, SCIENCE, V205, P1297, DOI 10.1126/science.472748; Hall JW III, 2015, EHANDBOOK AUDITORY E; Hauser MD, 2001, COGNITION, V78, pB53, DOI 10.1016/S0010-0277(00)00132-3; He C, 2009, J NEUROSCI, V29, P7718, DOI 10.1523/JNEUROSCI.0157-09.2009; HOORMANN J, 1992, HEARING RES, V59, P179, DOI 10.1016/0378-5955(92)90114-3; Koelsch S, 2008, BRAIN RES, V1212, P55, DOI 10.1016/j.brainres.2007.10.078; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Kraus N, 2009, ANN NY ACAD SCI, V1169, P543, DOI 10.1111/j.1749-6632.2009.04549.x; Krishnan A., 2007, AUDITORY EVOKED POTE, P313; Krishnan A, 2009, BRAIN LANG, V110, P135, DOI 10.1016/j.bandl.2009.03.005; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; LAUTER JL, 1986, SCAND AUDIOL, V15, P167, DOI 10.3109/01050398609070693; Luo F, 2008, J NEUROSCI, V28, P11615, DOI 10.1523/JNEUROSCI.3972-08.2008; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; Micheyl C, 2010, HEARING RES, V266, P36, DOI 10.1016/j.heares.2009.09.012; MOUSHEGIAN G, 1973, ELECTROEN CLIN NEURO, V35, P665, DOI 10.1016/0013-4694(73)90223-X; OSTERHAMMEL PA, 1985, SCAND AUDIOL, V14, P47, DOI 10.3109/01050398509045921; Perez-Gonzalez D, 2005, EUR J NEUROSCI, V22, P2879, DOI 10.1111/j.1460-9568.2005.04472.x; Pressnitzer D, 2008, CURR BIOL, V18, P1124, DOI 10.1016/j.cub.2008.06.053; Repp BH, 2007, COGNITION, V102, P434, DOI 10.1016/j.cognition.2006.02.003; ROSENHAMER H J, 1978, Scandinavian Audiology, V7, P193, DOI 10.3109/01050397809076287; Ross B, 2009, HEARING RES, V248, P48, DOI 10.1016/j.heares.2008.11.012; Russo N, 2004, CLIN NEUROPHYSIOL, V115, P2021, DOI 10.1016/j.clinph.2004.04.003; Russo NM, 2005, BEHAV BRAIN RES, V156, P95, DOI 10.1016/j.bbr.2004.05.012; Ruusuvirta T, 2007, CEREB CORTEX, V17, P2777, DOI 10.1093/cercor/bhm005; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Saffran JR, 2003, ANN NY ACAD SCI, V999, P397, DOI 10.1196/annals.1284.050; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; SCOTTVAN Z, 2010, BIOL PSYCHIAT, P345; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; SONG JH, 2010, CLIN NEUROPHYSIOL; Song JH, 2008, J COGNITIVE NEUROSCI, V20, P1892, DOI 10.1162/jocn.2008.20131; Suga N, 2002, NEURON, V36, P9, DOI 10.1016/S0896-6273(02)00933-9; Teinonen T, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-21; Toro JM, 2005, PERCEPT PSYCHOPHYS, V67, P867, DOI 10.3758/BF03193539; Tremblay KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010283; Turk-Browne NB, 2009, J COGNITIVE NEUROSCI, V21, P1934, DOI 10.1162/jocn.2009.21131; Tzounopoulos T, 2009, NEURON, V62, P463, DOI 10.1016/j.neuron.2009.05.002; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Wen B, 2009, J NEUROSCI, V29, P13797, DOI 10.1523/JNEUROSCI.5610-08.2009; Wible B, 2002, CLIN NEUROPHYSIOL, V113, P485, DOI 10.1016/S1388-2457(02)00017-2; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003; Winkler I, 2009, P NATL ACAD SCI USA, V106, P2468, DOI 10.1073/pnas.0809035106; Yan J, 2005, J NEUROPHYSIOL, V93, P71, DOI 10.1152/jn.00348.2004; Yan W, 1998, NAT NEUROSCI, V1, P54, DOI 10.1038/255; Yoshida KA, 2010, COGNITION, V115, P356, DOI 10.1016/j.cognition.2010.01.005	71	48	53	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13645	10.1371/journal.pone.0013645	http://dx.doi.org/10.1371/journal.pone.0013645			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049035	Green Published, gold, Green Submitted			2022-12-25	WOS:000283487400032
J	Bouligand, J; Delemer, B; Hecart, AC; Meduri, G; Viengchareun, S; Amazit, L; Trabado, S; Feve, B; Guiochon-Mantel, A; Young, J; Lombes, M				Bouligand, Jerome; Delemer, Brigitte; Hecart, Annie-Claude; Meduri, Geri; Viengchareun, Say; Amazit, Larbi; Trabado, Severine; Feve, Bruno; Guiochon-Mantel, Anne; Young, Jacques; Lombes, Marc			Familial Glucocorticoid Receptor Haploinsufficiency by Non-Sense Mediated mRNA Decay, Adrenal Hyperplasia and Apparent Mineralocorticoid Excess	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; SENSITIVITY; RESISTANCE; HORMONE; DEHYDROGENASE; EXPRESSION; PROMOTER; DOMAIN	Primary glucocorticoid resistance (OMIM 138040) is a rare hereditary disease that causes a generalized partial insensitivity to glucocorticoid action, due to genetic alterations of the glucocorticoid receptor (GR). Investigation of adrenal incidentalomas led to the discovery of a family (eight affected individuals spanning three generations), prone to cortisol resistance, bilateral adrenal hyperplasia, arterial hypertension and hypokalemia. This phenotype exacerbated over time, cosegregates with the first heterozygous nonsense mutation p.R469[R,X] reported to date for the GR, replacing an arginine (CGA) by a stop (TGA) at amino-acid 469 in the second zinc finger of the DNA-binding domain of the receptor. In vitro, this mutation leads to a truncated 50-kDa GR lacking hormone and DNA binding capacity, devoid of hormone-dependent nuclear translocation and transactivation properties. In the proband's fibroblasts, we provided evidence for the lack of expression of the defective allele in vivo. The absence of detectable mutated GR mRNA was accompanied by a 50% reduction in wild type GR transcript and protein. This reduced GR expression leads to a significantly below-normal induction of glucocorticoid-induced target genes, FKBP5 in fibroblasts. We demonstrated that the molecular mechanisms of glucocorticoid signaling dysfunction involved GR haploinsufficiency due to the selective degradation of the mutated GR transcript through a nonsense-mediated mRNA Decay that was experimentally validated on emetine-treated propositus' fibroblasts. GR haploinsufficiency leads to hypertension due to illicit occupation of renal mineralocorticoid receptor by elevated cortisol rather than to increased mineralocorticoid production reported in primary glucocorticoid resistance. Indeed, apparent mineralocorticoid excess was demonstrated by a decrease in urinary tetrahydrocortisone-tetrahydrocortisol ratio in affected patients, revealing reduced glucocorticoid degradation by renal activity of the 11 beta-hydroxysteroid dehydrogenase type 2, a GR regulated gene. We propose thus that GR haploinsufficiency compromises glucocorticoid sensitivity and may represent a novel genetic cause of subclinical hypercortisolism, incidentally revealed bilateral adrenal hyperplasia and mineralocorticoid-independent hypertension.	[Bouligand, Jerome; Meduri, Geri; Trabado, Severine; Feve, Bruno; Guiochon-Mantel, Anne; Young, Jacques; Lombes, Marc] Hop Bicetre, AP HP, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France; [Bouligand, Jerome; Meduri, Geri; Viengchareun, Say; Amazit, Larbi; Trabado, Severine; Feve, Bruno; Guiochon-Mantel, Anne; Young, Jacques; Lombes, Marc] INSERM, U693, F-94275 Le Kremlin Bicetre, France; [Bouligand, Jerome; Viengchareun, Say; Amazit, Larbi; Trabado, Severine; Guiochon-Mantel, Anne] Univ Paris Sud, Fac Med Paris Sud, UMR S693, F-94275 Le Kremlin Bicetre, France; [Delemer, Brigitte; Hecart, Annie-Claude] Ctr Hosp Robert Debre, Serv Endocrinol, Reims, France; [Feve, Bruno; Young, Jacques; Lombes, Marc] Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU de Reims; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Bouligand, J (corresponding author), Hop Bicetre, AP HP, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France.	marc.lombes@u-psud.fr	Viengchareun, Say/GOV-6812-2022; Viengchareun, Say/M-6612-2017; BOULIGAND, Jérôme/S-5716-2018; Lombes, Marc/L-5933-2018; Young, Jacques/T-2976-2018; Guiochon-Mantel, Anne S/S-8408-2018; Young, Jacques/N-5251-2019	Lombes, Marc/0000-0003-3189-023X; Young, Jacques/0000-0001-9286-5631; Guiochon-Mantel, Anne S/0000-0003-1737-1409; Young, Jacques/0000-0001-9286-5631; Feve, Bruno/0000-0001-6577-9009; viengchareun, say/0000-0003-4280-3250; Trabado, Severine/0000-0002-1925-1999	Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Paris-Sud 11	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris-Sud 11	This work has been supported by fundings from Institut National de la Sante et de la Recherche Medicale (INSERM), the Universite Paris-Sud 11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani-Koupaei R, 2007, FASEB J, V21, P3618, DOI 10.1096/fj.07-8140com; Caprio M, 2007, FASEB J, V21, P2185, DOI 10.1096/fj.06-7970com; Charmandari E, 2008, J CLIN ENDOCR METAB, V93, P1563, DOI 10.1210/jc.2008-0040; Frio TR, 2008, J CLIN INVEST, V118, P1519, DOI 10.1172/JCI34211; Gesina E, 2006, DIABETOLOGIA, V49, P2939, DOI 10.1007/s00125-006-0449-3; Gross KL, 2008, TRENDS ENDOCRIN MET, V19, P331, DOI 10.1016/j.tem.2008.07.009; Gross KL, 2009, MOL CELL ENDOCRINOL, V300, P7, DOI 10.1016/j.mce.2008.10.001; Gummow BM, 2006, MOL ENDOCRINOL, V20, P2711, DOI 10.1210/me.2005-0461; Kamenicky P, 2008, ENDOCRINOLOGY, V149, P3294, DOI 10.1210/en.2008-0143; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Lu NZ, 2006, PHARMACOL REV, V58, P782, DOI 10.1124/pr.58.4.9; Lu NZ, 2004, ANN NY ACAD SCI, V1024, P102, DOI 10.1196/annals.1321.008; Mansmann G, 2004, ENDOCR REV, V25, P309, DOI 10.1210/er.2002-0031; McMahon SK, 2010, J CLIN ENDOCR METAB, V95, P297, DOI 10.1210/jc.2009-1003; Michailidou Z, 2008, FASEB J, V22, P3896, DOI 10.1096/fj.08-111914; Nader N, 2010, J CLIN ENDOCR METAB, V95, P2281, DOI 10.1210/jc.2009-2463; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; Pascual-Le Tallec L, 2003, MOL ENDOCRINOL, V17, P2529, DOI 10.1210/me.2003-0299; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Stalder L, 2008, TRENDS CELL BIOL, V18, P315, DOI 10.1016/j.tcb.2008.04.005; Vermeer H, 2003, J CLIN ENDOCR METAB, V88, P277, DOI 10.1210/jc.2002-020354; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Watts LM, 2005, DIABETES, V54, P1846, DOI 10.2337/diabetes.54.6.1846; White PC, 1997, ENDOCR REV, V18, P135, DOI 10.1210/er.18.1.135	27	43	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13563	10.1371/journal.pone.0013563	http://dx.doi.org/10.1371/journal.pone.0013563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042587	Green Published, Green Submitted, gold			2022-12-25	WOS:000283419100007
J	Flynn, JM; Meadows, E; Fiorotto, M; Klein, WH				Flynn, Jesse M.; Meadows, Eric; Fiorotto, Marta; Klein, William H.			Myogenin Regulates Exercise Capacity and Skeletal Muscle Metabolism in the Adult Mouse	PLOS ONE			English	Article							PYRUVATE-CARBOXYLASE DEFICIENCY; LACTIC-ACID; LACTATE ACCUMULATION; SIGNALING PATHWAYS; ADAPTATIONS; MECHANISMS; DIVERSITY; HEAVY; MICE; FORM	Although skeletal muscle metabolism is a well-studied physiological process, little is known about how it is regulated at the transcriptional level. The myogenic transcription factor myogenin is required for skeletal muscle development during embryonic and fetal life, but myogenin's role in adult skeletal muscle is unclear. We sought to determine myogenin's function in adult muscle metabolism. A Myog conditional allele and Cre-ER transgene were used to delete Myog in adult mice. Mice were analyzed for exercise capacity by involuntary treadmill running. To assess oxidative and glycolytic metabolism, we performed indirect calorimetry, monitored blood glucose and lactate levels, and performed histochemical analyses on muscle fibers. Surprisingly, we found that Myog-deleted mice performed significantly better than controls in high-and low-intensity treadmill running. This enhanced exercise capacity was due to more efficient oxidative metabolism during low-and high-intensity exercise and more efficient glycolytic metabolism during high-intensity exercise. Furthermore, Myog-deleted mice had an enhanced response to long-term voluntary exercise training on running wheels. We identified several candidate genes whose expression was altered in exercise-stressed muscle of mice lacking myogenin. The results suggest that myogenin plays a critical role as a high-level transcriptional regulator to control the energy balance between aerobic and anaerobic metabolism in adult skeletal muscle.	[Flynn, Jesse M.; Meadows, Eric; Klein, William H.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Flynn, Jesse M.; Meadows, Eric; Klein, William H.] Univ Texas Sch Biomed Sci Houston, Grad Training Program Genes & Dev, Houston, TX USA; [Fiorotto, Marta] Baylor Coll Med, Childrens Nutr Res Ctr, USDA ARS, Dept Pediat, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; United States Department of Agriculture (USDA)	Flynn, JM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	whklein@mdanderson.org			National Cancer Institute Cancer Center [CA016672]; Muscular Dystrophy Association [MDA4289]; Robert A. Welch Foundation [G-0010]; USDA/Agricultural Research Service [58-6250-6001]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Muscular Dystrophy Association(Muscular Dystrophy Association); Robert A. Welch Foundation(The Welch Foundation); USDA/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Facilities are supported in part by a National Cancer Institute Cancer Center Core Grant (CA016672). The work was supported by grants to W. H. K. from the Muscular Dystrophy Association (MDA4289) and from the Robert A. Welch Foundation (G-0010). M. L. F. was supported with funds from USDA/Agricultural Research Service under Cooperative Agreement number 58-6250-6001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alapat DV, 2009, CELL SIGNAL, V21, P128, DOI 10.1016/j.cellsig.2008.09.020; BALDWIN KM, 1977, J APPL PHYSIOL, V42, P267, DOI 10.1152/jappl.1977.42.2.267; BALDWIN KM, 1972, AM J PHYSIOL, V222, P373, DOI 10.1152/ajplegacy.1972.222.2.373; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Carbone MA, 2002, HUM MUTAT, V20, P48, DOI 10.1002/humu.10093; DUDLEY GA, 1982, J APPL PHYSIOL, V53, P844, DOI 10.1152/jappl.1982.53.4.844; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FISCHER KF, 1986, NEW ENGL J MED, V315, P1245, DOI 10.1056/NEJM198611133152002; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; FITTS RH, 2004, MECH MUSCULAR FATIGU; Frey N, 2008, J CLIN INVEST, V118, P3598, DOI 10.1172/JCI36277; Gladden LB, 2000, MED SCI SPORT EXER, V32, P764, DOI 10.1097/00005768-200004000-00008; Gundersen K, 1998, ACTA PHYSIOL SCAND, V162, P333, DOI 10.1046/j.1365-201X.1998.0336e.x; Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003; HAGBERG H, 1985, PFLUG ARCH EUR J PHY, V404, P342, DOI 10.1007/BF00585346; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; HOLLOSZY JO, 1970, BIOCHEM BIOPH RES CO, V40, P1368, DOI 10.1016/0006-291X(70)90017-3; Hughes SM, 1999, J CELL BIOL, V145, P633, DOI 10.1083/jcb.145.3.633; HUGHES SM, 1993, DEVELOPMENT, V118, P1137; ISHIHARA A, 1991, EUR J APPL PHYSIOL, V62, P211, DOI 10.1007/BF00643744; Katz S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-464; Knapp JR, 2006, DEVELOPMENT, V133, P601, DOI 10.1242/dev.02249; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Meadows E, 2008, DEV BIOL, V322, P406, DOI 10.1016/j.ydbio.2008.07.024; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; MORESI V, 2010, MYOGENIN CLASS 2 HDA; Nabben M, 2008, PHYSIOL BEHAV, V94, P259, DOI 10.1016/j.physbeh.2007.11.039; Noakes TD, 1997, MED SCI SPORT EXER, V29, P571, DOI 10.1097/00005768-199705000-00001; PETTE D, 1983, J PHYSIOL-LONDON, V338, P1; Robergs RA, 2004, AM J PHYSIOL-REG I, V287, pR502, DOI 10.1152/ajpregu.00114.2004; ROBINSON BH, 1987, AM J HUM GENET, V40, P50; ROBINSON BH, 1984, AM J HUM GENET, V36, P283; Robinson BH, 2006, MOL GENET METAB, V89, P3, DOI 10.1016/j.ymgme.2006.05.015; RODNICK KJ, 1989, J APPL PHYSIOL, V66, P1250, DOI 10.1152/jappl.1989.66.3.1250; Sahlin K, 1998, ACTA PHYSIOL SCAND, V162, P261, DOI 10.1046/j.1365-201X.1998.0298f.x; SAHLIN K, 1987, BIOCHEM J, V245, P551, DOI 10.1042/bj2450551; SAHLIN K, 1981, AM J PHYSIOL, V240, pC121, DOI 10.1152/ajpcell.1981.240.3.C121; SAHLIN K, 1984, ACTA PHYSIOL SCAND, V122, P331, DOI 10.1111/j.1748-1716.1984.tb07517.x; SAHLIN K, 1976, PFLUG ARCH EUR J PHY, V367, P143, DOI 10.1007/BF00585150; Sahlin K., 1986, BIOCH EXERCISE, VVI, P323; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; SERVICE FJ, 1995, NEW ENGL J MED, V332, P1144, DOI 10.1056/NEJM199504273321707; SEXTON WL, 1995, J APPL PHYSIOL, V79, P287, DOI 10.1152/jappl.1995.79.1.287; Spangenburg EE, 2009, MOL CELL BIOCHEM, V332, P225, DOI 10.1007/s11010-009-0195-1; Stringer W, 1995, EUR J APPL PHYSIOL, V72, P25, DOI 10.1007/BF00964110; Tang HB, 2009, MOL BIOL CELL, V20, P1120, DOI 10.1091/mbc.E08-07-0759; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003	55	41	41	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13535	10.1371/journal.pone.0013535	http://dx.doi.org/10.1371/journal.pone.0013535			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042574	Green Published, gold, Green Submitted			2022-12-25	WOS:000283419100004
J	Caudron, F; Denarier, E; Thibout-Quintana, JC; Brocard, J; Andrieux, A; Fourest-Lieuvin, A				Caudron, Fabrice; Denarier, Eric; Thibout-Quintana, Jenny-Constanza; Brocard, Jacques; Andrieux, Annie; Fourest-Lieuvin, Anne			Mutation of Ser172 in Yeast beta Tubulin Induces Defects in Microtubule Dynamics and Cell Division	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; PLUS-END; BUDDING YEAST; SPINDLE ORIENTATION; CORTICAL SITES; CAPTURE; PROTEIN; TRACKING; CORTEX; DYNEIN	Ser172 of beta tubulin is an important residue that is mutated in a human brain disease and phosphorylated by the cyclin-dependent kinase Cdk1 in mammalian cells. To examine the role of this residue, we used the yeast S. cerevisiae as a model and produced two different mutations (S172A and S172E) of the conserved Ser172 in the yeast beta tubulin Tub2p. The two mutants showed impaired cell growth on benomyl-containing medium and at cold temperatures, altered microtubule (MT) dynamics, and altered nucleus positioning and segregation. When cytoplasmic MT effectors Dyn1p or Kar9p were deleted in S172A and S172E mutants, cells were viable but presented increased ploidy. Furthermore, the two beta tubulin mutations exhibited synthetic lethal interactions with Bik1p, Bim1p or Kar3p, which are effectors of cytoplasmic and spindle MTs. In the absence of Mad2p-dependent spindle checkpoint, both mutations are deleterious. These findings show the importance of Ser172 for the correct function of both cytoplasmic and spindle MTs and for normal cell division.	[Caudron, Fabrice] Swiss Fed Inst Technol, Inst Biochem, Zurich, Switzerland; [Denarier, Eric; Brocard, Jacques; Andrieux, Annie; Fourest-Lieuvin, Anne] Univ Grenoble 1, INSERM, Grenoble Inst Neurosci, U836, Grenoble, France; [Denarier, Eric; Andrieux, Annie; Fourest-Lieuvin, Anne] Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Rec Technol & Sci Vivant, Grp Physiopathol Cytosquelette, Grenoble, France; [Thibout-Quintana, Jenny-Constanza] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CHU Lyon	Caudron, F (corresponding author), Swiss Fed Inst Technol, Inst Biochem, Zurich, Switzerland.	anne.fourest-lieuvin@ujf-grenoble.fr	Fourest-Lieuvin, Anne/AGA-6504-2022; ANDRIEUX, ANNIE/B-2134-2017; Denarier, Eric/X-6137-2019; Denarier, Eric/H-3555-2017; Caudron, Fabrice/AAE-3039-2021; Brocard, Jacques/I-3135-2017	Fourest-Lieuvin, Anne/0000-0003-1325-6788; ANDRIEUX, ANNIE/0000-0002-4022-6405; Denarier, Eric/0000-0002-4169-397X; Denarier, Eric/0000-0002-4169-397X; Brocard, Jacques/0000-0002-0752-5737; Caudron, Fabrice/0000-0001-5159-1507	Agence Nationale Recherche Tyr-TIPs [Blan07-2_187328]; La Ligue contre le cancer [R07Job]; Association Recherche sur le Cancer [4892, 7927]	Agence Nationale Recherche Tyr-TIPs; La Ligue contre le cancer(Ligue nationale contre le cancer); Association Recherche sur le Cancer	This work was supported in part by grants from Agence Nationale Recherche Tyr-TIPs (Blan07-2_187328), La Ligue contre le cancer (R07Job), Association Recherche sur le Cancer (4892 and 7927) to AA team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Andersen SSL, 1999, BIOESSAYS, V21, P53, DOI 10.1002/(SICI)1521-1878(199901)21:1<53::AID-BIES7>3.0.CO;2-L; Badin-Larcon AC, 2004, P NATL ACAD SCI USA, V101, P5577, DOI 10.1073/pnas.0307917101; Burke D., 2000, METHODS YEAST GENETI; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Byers B, 1981, MOL BIOL YEAST SACCH, P59; Carvalho P, 2004, DEV CELL, V6, P815, DOI 10.1016/j.devcel.2004.05.001; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; Caudron F, 2008, J CELL SCI, V121, P1506, DOI 10.1242/jcs.023374; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Fourest-Lieuvin A, 2006, MOL BIOL CELL, V17, P1041, DOI 10.1091/mbc.E05-07-0621; Galjart N, 2003, CURR OPIN CELL BIOL, V15, P48, DOI 10.1016/S0955-0674(02)00007-8; Gardner MK, 2008, J CELL BIOL, V180, P91, DOI 10.1083/jcb.200710164; Grava S, 2006, DEV CELL, V10, P425, DOI 10.1016/j.devcel.2006.02.018; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Huang BY, 2006, J CELL BIOL, V175, P17, DOI 10.1083/jcb.200606021; Huisman SM, 2005, J CELL SCI, V118, P463, DOI 10.1242/jcs.01650; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; Kosco KA, 2001, MOL BIOL CELL, V12, P2870, DOI 10.1091/mbc.12.9.2870; Kusch J, 2003, TRENDS CELL BIOL, V13, P562, DOI 10.1016/j.tcb.2003.09.008; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3; LIEUVIN A, 1994, J CELL BIOL, V124, P985, DOI 10.1083/jcb.124.6.985; Lin HJ, 2001, J CELL BIOL, V155, P1173, DOI 10.1083/jcb.200108119; Maekawa H, 2004, GENE DEV, V18, P1709, DOI 10.1101/gad.298704; Maekawa H, 2003, EMBO J, V22, P438, DOI 10.1093/emboj/cdg063; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Moore JK, 2007, MOL BIOL CELL, V18, P1187, DOI 10.1091/mbc.E06-04-0360; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; REIJO RA, 1994, MOL BIOL CELL, V5, P29, DOI 10.1091/mbc.5.1.29; Schuyler SC, 2001, J CELL SCI, V114, P247; Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Wolyniak MJ, 2006, MOL BIOL CELL, V17, P2789, DOI 10.1091/mbc.E05-09-0892	38	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13553	10.1371/journal.pone.0013553	http://dx.doi.org/10.1371/journal.pone.0013553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042413	Green Published, gold			2022-12-25	WOS:000283293800019
J	Hellman, M; Arumae, U; Yu, LY; Lindholm, P; Peranen, J; Saarma, M; Permi, P				Hellman, Maarit; Arumae, Urmas; Yu, Li-ying; Lindholm, Paivi; Peranen, Johan; Saarma, Mart; Permi, Perttu			Mesencephalic Astrocyte-derived Neurotrophic Factor (MANF) Has a Unique Mechanism to Rescue Apoptotic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; RETRACTED ARTICLE. SEE; DOPAMINERGIC-NEURONS; PARKINSONS-DISEASE; PG 480; BINDING; BAX; DNA; DOMAIN; DYANA	Mesencephalic astrocyte-derived neurotrophic factor (MANF) protects neurons and repairs the Parkinson disease-like symptoms in a rat 6-hydroxydopamine model. We show a three-dimensional solution structure of human MANF that differs drastically from other neurotrophic factors. Remarkably, the C-terminal domain of MANF (C-MANF) is homologous to the SAP domain of Ku70, a well known inhibitor of proapoptotic Bax (Bcl-2-associated X protein). Cellular studies confirm that MANF and C-MANF protect neurons intracellularly as efficiently as Ku70.	[Hellman, Maarit; Permi, Perttu] Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, FI-00014 Helsinki, Finland; [Arumae, Urmas; Yu, Li-ying; Lindholm, Paivi; Peranen, Johan; Saarma, Mart] Univ Helsinki, Inst Biotechnol, Lab Mol Neurosci, FI-00014 Helsinki, Finland	University of Helsinki; University of Helsinki	Permi, P (corresponding author), Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, POB 65, FI-00014 Helsinki, Finland.	perttu.permi@helsinki.fi	Arumäe, Urmas/E-8290-2016	Arumäe, Urmas/0000-0003-3658-6464; Pulkkila, Paivi/0000-0003-3022-5035	Academy of Finland [122170, 131144]; Sigrid Juselius Foundation;  [11186236];  [1126735]	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); ; 	This work was supported by the Academy of Finland Grants 122170 and 131144 (to P. P.) and Grants 11186236 and 1126735 (to M. S.), and a Sigrid Juselius Foundation grant (to M. S.).	Airavaara M, 2009, J COMP NEUROL, V515, P116, DOI 10.1002/cne.22039; Amsel AD, 2008, P NATL ACAD SCI USA, V105, P5117, DOI 10.1073/pnas.0706700105; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Bruhn H, 2005, BIOCHEM J, V389, P249, DOI 10.1042/BJ20050051; Butte MJ, 2001, CELL MOL LIFE SCI, V58, P1003, DOI 10.1007/PL00000915; CASE DA, 2004, AMBER 8; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Gama V, 2009, CELL DEATH DIFFER, V16, P758, DOI 10.1038/cdd.2009.6; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hellman M, 2010, BIOMOL NMR ASSIGN, V4, P215, DOI 10.1007/s12104-010-9251-8; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Hoseki J, 2010, FEBS LETT, V584, P1536, DOI 10.1016/j.febslet.2010.03.008; Lindholm P, 2008, MOL CELL NEUROSCI, V39, P356, DOI 10.1016/j.mcn.2008.07.016; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; Mizobuchi N, 2007, CELL STRUCT FUNCT, V32, P41, DOI 10.1247/csf.07001; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Parkash V, 2009, PROTEIN ENG DES SEL, V22, P233, DOI 10.1093/protein/gzn080; Parkash V, 2008, J BIOL CHEM, V283, P35164, DOI 10.1074/jbc.M802543200; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Raaijmakers H, 2001, J MOL BIOL, V308, P311, DOI 10.1006/jmbi.2001.4592; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Sawada M, 2003, NAT CELL BIOL, V5, P352, DOI 10.1038/ncb955; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Tibbetts MD, 2004, STRUCTURE, V12, P2257, DOI 10.1016/j.str.2004.10.007; Vaughn AE, 2007, CELL DEATH DIFFER, V14, P973, DOI 10.1038/sj.cdd.4402084; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Yu LY, 2003, J CELL BIOL, V163, P987, DOI 10.1083/jcb.200305083	33	105	114	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2675	2680		10.1074/jbc.M110.146738	http://dx.doi.org/10.1074/jbc.M110.146738			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21047780	hybrid, Green Published			2022-12-25	WOS:000286464300033
J	Briknarova, K; Thomas, CJ; York, J; Nunberg, JH				Briknarova, Klara; Thomas, Celestine J.; York, Joanne; Nunberg, Jack H.			Structure of a Zinc-binding Domain in the Junin Virus Envelope Glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; STABLE SIGNAL PEPTIDE; RECOMBINANT VACCINIA VIRUS; PH-INDUCED ACTIVATION; MEMBRANE-FUSION; GP-C; IDENTIFICATION; RECEPTOR; ARENAVIRUSES; MECHANISMS	Arenaviruses cause acute hemorrhagic fevers with high mortality. Entry of the virus into the host cell is mediated by the viral envelope glycoprotein, GPC. In contrast to other class I viral envelope glycoproteins, the mature GPC complex contains a cleaved stable signal peptide (SSP) in addition to the canonical receptor-binding (G1) and transmembrane fusion (G2) subunits. SSP is critical for intracellular transport of the GPC complex to the cell surface and for its membrane-fusion activity. Previous studies have suggested that SSP is retained in GPC through interaction with a zinc-binding domain (ZBD) in the cytoplasmic tail of G2. Here we used NMR spectroscopy to determine the structure of Junin virus (JUNV) ZBD (G2 residues 445-485) and investigate its interaction with a conserved Cys residue (Cys-57) in SSP. We show that JUNV ZBD displays a novel fold containing two zinc ions. One zinc ion is coordinated by His-447, His-449, Cys-455, and His-485. The second zinc ion is coordinated by His-459, Cys-467, and Cys-469 and readily accepts Cys-57 from SSP as the fourth ligand. Our studies describe the structural basis for retention of the unique SSP subunit and suggest a mechanism whereby SSP is positioned in the GPC complex to modulate pH-dependent membrane fusion.	[Briknarova, Klara] Univ Montana, Dept Chem & Biochem, Missoula, MT 59812 USA; [Briknarova, Klara; Thomas, Celestine J.] Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA; [York, Joanne; Nunberg, Jack H.] Univ Montana, Montana Biotechnol Ctr, Missoula, MT 59812 USA	University of Montana System; University of Montana; University of Montana System; University of Montana; University of Montana System; University of Montana	Briknarova, K (corresponding author), Univ Montana, Dept Chem & Biochem, 32 Campus Dr, Missoula, MT 59812 USA.	klara.briknarova@umontana.edu			National Institutes of Health [R01 AI074818]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Research Grant R01 AI074818 (to J.H.N.).	Abraham J, 2010, NAT STRUCT MOL BIOL, V17, P438, DOI 10.1038/nsmb.1772; Agnihothram SS, 2007, J VIROL, V81, P4331, DOI 10.1128/JVI.02779-06; Agnihothram SS, 2006, J VIROL, V80, P5189, DOI 10.1128/JVI.00208-06; Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Beyer WR, 2003, J VIROL, V77, P2866, DOI 10.1128/JVI.77.5.2866-2872.2003; Bolken TC, 2006, ANTIVIR RES, V69, P86, DOI 10.1016/j.antiviral.2005.10.008; BORROW P, 1994, VIROLOGY, V198, P1, DOI 10.1006/viro.1994.1001; Bowden TA, 2009, J VIROL, V83, P8259, DOI 10.1128/JVI.00761-09; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchmeier MJ, 2007, ARENAVIRIDAE VIRUSES; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Charrel RN, 2002, BIOCHEM BIOPH RES CO, V296, P1118, DOI 10.1016/S0006-291X(02)02053-3; Delgado S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000047; DISIMONE C, 1994, VIROLOGY, V198, P455, DOI 10.1006/viro.1994.1057; Eichler R, 2003, EMBO REP, V4, P1084, DOI 10.1038/sj.embor.7400002; Eschli B, 2006, J VIROL, V80, P5897, DOI 10.1128/JVI.00008-06; Estrada DF, 2009, J BIOL CHEM, V284, P8645, DOI 10.1074/jbc.M808081200; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GHIRINGHELLI PD, 1991, J GEN VIROL, V72, P2129, DOI 10.1099/0022-1317-72-9-2129; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Harrison SC, 2005, ADV VIRUS RES, V64, P231, DOI 10.1016/S0065-3527(05)64007-9; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kunz S, 2003, VIROLOGY, V314, P168, DOI 10.1016/S0042-6822(03)00421-5; Larson RA, 2008, J VIROL, V82, P10768, DOI 10.1128/JVI.00941-08; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; Lesburg CA, 1997, BIOCHEMISTRY-US, V36, P15780, DOI 10.1021/bi971296x; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; MA L, 1995, PROTEIN SCI, V4, P1498, DOI 10.1002/pro.5560040807; McCormick JB, 2002, CURR TOP MICROBIOL, V262, P75; MCCORMICK JB, 1987, J INFECT DIS, V155, P437, DOI 10.1093/infdis/155.3.437; Meyer BJ, 2002, CURR TOP MICROBIOL, V262, P139; NUSSBAUM O, 1994, J VIROL, V68, P5411, DOI 10.1128/JVI.68.9.5411-5422.1994; Peters CJ, 2002, CURR TOP MICROBIOL, V262, P65; Radoshitzky SR, 2007, NATURE, V446, P92, DOI 10.1038/nature05539; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; SANCHEZ A, 1989, J GEN VIROL, V70, P1125, DOI 10.1099/0022-1317-70-5-1125; Saunders AA, 2007, J VIROL, V81, P5649, DOI 10.1128/JVI.02759-06; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wuthrich K, 1986, NMR PROTEINS NUCL AC; York J, 2005, VIROLOGY, V343, P267, DOI 10.1016/j.virol.2005.08.030; York J, 2004, J VIROL, V78, P10783, DOI 10.1128/JVI.78.19.10783-10792.2004; York J, 2008, J VIROL, V82, P10932, DOI 10.1128/JVI.01140-08; York J, 2007, J VIROL, V81, P13385, DOI 10.1128/JVI.01785-07; York J, 2007, VIROLOGY, V359, P72, DOI 10.1016/j.virol.2006.08.048; York J, 2006, J VIROL, V80, P7775, DOI 10.1128/JVI.00642-06; York J, 2010, J VIROL, V84, P6119, DOI 10.1128/JVI.02700-09; York J, 2009, J VIROL, V83, P4121, DOI 10.1128/JVI.02410-08	55	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1528	1536		10.1074/jbc.M110.166025	http://dx.doi.org/10.1074/jbc.M110.166025			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21068387	Green Published, hybrid			2022-12-25	WOS:000286005000065
J	Aiga, M; Levinson, JN; Bamji, SX				Aiga, Mytyl; Levinson, Joshua N.; Bamji, Shernaz X.			N-cadherin and Neuroligins Cooperate to Regulate Synapse Formation in Hippocampal Cultures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULES; SCAFFOLDING MOLECULE; INHIBITORY SYNAPSES; BETA-CATENIN; SYNAPTOGENESIS; PSD-95	Cadherins and neuroligins (NLs) represent two families of cell adhesion proteins that are essential for the establishment of synaptic connections in vitro; however, it remains unclear whether these proteins act in concert to regulate synapse density. Using a combination of overexpression and knockdown analyses in primary hippocampal neurons, we demonstrate that NL1 and N-cadherin promote the formation of glutamatergic synapses through a common functional pathway. Analysis of the spatial relationship between N-cadherin and NL1 indicates that in 14-day in vitro cultures, almost half of glutamatergic synapses are associated with both proteins, whereas only a subset of these synapses are associated with N-cadherin or NL1 alone. This suggests that NL1 and N-cadherin are spatially distributed in a manner that enables cooperation at synapses. In young cultures, N-cadherin clustering and its association with synaptic markers precede the clustering of NL1. Overexpression of N-cadherin at this time point enhances NL1 clustering and increases synapse density. Although N-cadherin is not sufficient to enhance NL1 clustering and synapse density in more mature cultures, knockdown of N-cadherin at later time points significantly attenuates the density of NL1 clusters and synapses. N-cadherin overexpression can partially rescue synapse loss in NL1 knockdown cells, possibly due to the ability of N-cadherin to recruit NL2 to glutamatergic synapses in these cells. We demonstrate that cadherins and NLs can act in concert to regulate synapse formation.	[Bamji, Shernaz X.] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Bamji, SX (corresponding author), Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	shernaz.bamji@ubc.ca						Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Benson DL, 1998, J NEUROSCI, V18, P6892; Biederer T, 2008, CURR OPIN NEUROBIOL, V18, P261, DOI 10.1016/j.conb.2008.07.014; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; Bruses JL, 2006, MOL NEUROBIOL, V33, P237, DOI 10.1385/MN:33:3:237; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Gerrow K, 2006, FRONT BIOSCI-LANDMRK, V11, P2400, DOI 10.2741/1978; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Jontes JD, 2004, J NEUROSCI, V24, P9027, DOI 10.1523/JNEUROSCI.5399-04.2004; Latefi NS, 2009, DEV NEUROBIOL, V69, P518, DOI 10.1002/dneu.20718; Levinson JN, 2010, NEUROSCIENCE, V165, P782, DOI 10.1016/j.neuroscience.2009.11.016; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Lida J, 2004, MOL CELL NEUROSCI, V27, P497, DOI 10.1016/j.mcn.2004.08.006; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Nishimura W, 2002, J NEUROSCI, V22, P757, DOI 10.1523/JNEUROSCI.22-03-00757.2002; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Stan A, 2010, P NATL ACAD SCI USA, V107, P11116, DOI 10.1073/pnas.0914233107; Sumita K, 2007, J NEUROCHEM, V100, P154, DOI 10.1111/j.1471-4159.2006.04170.x; Sun Y, 2009, MOL BIOL CELL, V20, P3390, DOI 10.1091/mbc.E08-12-1172; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Xie CS, 2000, FREE RADICAL BIO MED, V28, P665, DOI 10.1016/S0891-5849(99)00268-3; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	34	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					851	858		10.1074/jbc.M110.176305	http://dx.doi.org/10.1074/jbc.M110.176305			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21056983	Green Published, hybrid			2022-12-25	WOS:000285782800084
J	Hong, Y; Jang, SW; Ye, KQ				Hong, Yi; Jang, Sung-Wuk; Ye, Keqiang			The N-terminal Fragment from Caspase-cleaved Serine/Arginine Protein-specific Kinase2 (SRPK2) Translocates into the Nucleus and Promotes Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICING FACTORS; MESSENGER-RNA; SR PROTEINS; PROTEOMIC ANALYSIS; MAMMALIAN-CELLS; RS DOMAIN; LOCALIZATION; IMPORT; PHOSPHORYLATION; TRANSPORTIN-SR2	SRPK2 belongs to a family of serine/arginine (SR) protein-specific kinases (SRPKs), which phosphorylate SR domain-containing proteins in the nuclear speckles and mediate the pre-mRNA splicing. Previous studies have shown that SRPK2 plays a pivotal role in cell proliferation and apoptosis. However, how SRPK2 is regulated during the apoptosis is unclear. Here, we show that SRPK2 is cleaved by caspases at Asp-139 and -403 residues. Its N terminus cleaved product translocates into the nucleus and promotes VP16-induced apoptosis. Akt phosphorylation of SRPK2 prevents its apoptotic cleavage by caspases. 14-3-3 beta, the binding partner of Akt-phosphorylated SRPK2, further protects it from degradation. Hence, our results suggest that the N-terminal domain of SRPK2 cleaved by caspases translocates into the nucleus, where it promotes chromatin condensation and apoptotic cell death.	[Hong, Yi; Jang, Sung-Wuk; Ye, Keqiang] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University	Ye, KQ (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, 615 Michael St, Atlanta, GA 30322 USA.	kye@emory.edu			NCI, National Institutes of Health [NS060680]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060680] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by Grant NS060680 from NCI, National Institutes of Health (to K. Y.).	CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Ding JH, 2006, MOL BIOL CELL, V17, P876, DOI 10.1091/mbc.E05-10-0963; Gilbert W, 2004, MOL CELL, V13, P201, DOI 10.1016/S1097-2765(04)00030-9; Gilbert W, 2001, RNA, V7, P302, DOI 10.1017/S1355838201002369; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; Hayes GM, 2007, CANCER RES, V67, P2072, DOI 10.1158/0008-5472.CAN-06-2969; Jang SW, 2008, CANCER RES, V68, P4559, DOI 10.1158/0008-5472.CAN-08-0021; Jang SW, 2009, J BIOL CHEM, V284, P24512, DOI 10.1074/jbc.M109.026237; Jiang ZH, 1999, P SOC EXP BIOL MED, V220, P64, DOI 10.1046/j.1525-1373.1999.d01-11.x; Jiang ZH, 1998, P NATL ACAD SCI USA, V95, P9155, DOI 10.1073/pnas.95.16.9155; Kamachi M, 2002, J EXP MED, V196, P1213, DOI 10.1084/jem.20021167; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Sahara S, 1999, NATURE, V401, P168, DOI 10.1038/43678; Schwerk C, 2003, MOL CELL BIOL, V23, P2981, DOI 10.1128/MCB.23.8.2981-2990.2003; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; Wang HY, 1999, GENOMICS, V57, P310, DOI 10.1006/geno.1999.5770; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yun CY, 2003, J BIOL CHEM, V278, P18050, DOI 10.1074/jbc.M211714200; Yun CY, 2000, J CELL BIOL, V150, P707, DOI 10.1083/jcb.150.4.707; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	28	9	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					777	786		10.1074/jbc.M110.193441	http://dx.doi.org/10.1074/jbc.M110.193441			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21056976	Green Published, hybrid			2022-12-25	WOS:000285782800077
J	Qi, QA; Xia, MC; Bai, YT; Yu, SH; Cantorna, M; August, A				Qi, Qian; Xia, Mingcan; Bai, Yuting; Yu, Sanhong; Cantorna, Margherita; August, Avery			Interleukin-2-inducible T Cell Kinase (Itk) Network Edge Dependence for the Maturation of iNKT Cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; CUTTING EDGE; NKT CELLS; RECEPTOR; BET; HOMEOSTASIS; EFFECTOR; REQUIREMENTS; EXPRESSION; DEFICIENT	Invariant natural killer T (iNKT) cells are a unique subset of innate T lymphocytes that are selected by CD1d. They have diverse immune regulatory functions via the rapid production of interferon-gamma (IFN-gamma) and interleukin-4 (IL-4). In the absence of signaling nodes Itk and Txk, Tec family non-receptor tyrosine kinases, mice exhibit a significant block in iNKT cell development. We now show here that although the Itk node is required for iNKT cell maturation, the kinase domain edge of Itk is not required for continued maturation iNKT cells in the thymus compared with Itk-null mice. This rescue is dependent on the expression of the Txk node. Furthermore, this kinase domain independent edge rescue correlates with the increased expression of the transcription factors T-bet, the IL-2/IL-15 receptor beta chain CD122, and suppression of eomesodermin expression. By contrast, alpha-galactosyl ceramide induced cytokine secretion is dependent on the kinase domain edge of Itk. These findings indicate that the Itk node uses a kinase domain independent edge, a scaffolding function, in the signaling pathway leading to the maturation of iNKT cells. Furthermore, the findings indicate that phosphorylation of substrates by the Itk node is only partially required for maturation of iNKT cells, while functional activation of iNKT cells is dependent on the kinase domain/activity edge of Itk.	[August, Avery] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Qi, Qian; Xia, Mingcan; Bai, Yuting; Yu, Sanhong; Cantorna, Margherita; August, Avery] Penn State Univ, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Qi, Qian; Xia, Mingcan; Bai, Yuting; Yu, Sanhong; Cantorna, Margherita; August, Avery] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Qi, Qian; Xia, Mingcan; Yu, Sanhong; Cantorna, Margherita; August, Avery] Penn State Univ, Immunol & Infect Dis Grad Program, University Pk, PA 16802 USA	Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	August, A (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, C5 181 VMC, Ithaca, NY 14853 USA.	averyaugust@cornell.edu	Qi, Qian/E-7454-2012		National Institutes of Health [AI051626, AI065566]; Huck Institutes for the Life Sciences; Pennsylvania Department of Health; National Center for Complementary & Integrative Health [R01AT005378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051626, R56AI065566, R01AI065566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huck Institutes for the Life Sciences; Pennsylvania Department of Health; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI051626 and AI065566 (to A. A.).; Graduate Fellows of the Huck Institutes for the Life Sciences.; We thank members of the August Laboratory and the CMIID for feedback and discussion. We also thank E. Kunze, N. Bem, and S. Magargee in the Center for Quantitative Cell Analysis at Penn State. Work in the Center for Molecular Immunology & Infectious Disease is supported in part under a grant from the Pennsylvania Department of Health. There are no conflicts of interests to report.	Andreotti AH, 1997, NATURE, V385, P93, DOI 10.1038/385093a0; Au-Yeung BB, 2007, J IMMUNOL, V179, P111, DOI 10.4049/jimmunol.179.1.111; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Broussard C, 2006, IMMUNITY, V25, P93, DOI 10.1016/j.immuni.2006.05.011; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Colgan J, 2004, IMMUNITY, V21, P189, DOI 10.1016/j.immuni.2004.07.005; Dombroski D, 2005, J IMMUNOL, V174, P1385, DOI 10.4049/jimmunol.174.3.1385; Eberl G, 1999, J IMMUNOL, V163, P4091; Felices M, 2008, J IMMUNOL, V180, P3007, DOI 10.4049/jimmunol.180.5.3007; Gadue P, 1999, J EXP MED, V190, P1189, DOI 10.1084/jem.190.8.1189; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Gonzalez-Diaz H, 2008, PROTEOMICS, V8, P750, DOI 10.1002/pmic.200700638; Grasis JA, 2003, J IMMUNOL, V170, P3971, DOI 10.4049/jimmunol.170.8.3971; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Hao SL, 2006, FEBS LETT, V580, P2691, DOI 10.1016/j.febslet.2006.04.023; Horai R, 2007, IMMUNITY, V27, P775, DOI 10.1016/j.immuni.2007.09.012; Hu JF, 2008, J IMMUNOL, V180, P6544, DOI 10.4049/jimmunol.180.10.6544; Hu J, 2007, EUR J IMMUNOL, V37, P2892, DOI 10.1002/eji.200737311; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jordan MS, 2006, J IMMUNOL, V176, P2430, DOI 10.4049/jimmunol.176.4.2430; Kaiser M, 2004, BIOL CYBERN, V90, P311, DOI 10.1007/s00422-004-0479-1; Kishimoto H, 2007, BLOOD, V109, P3316, DOI 10.1182/blood-2006-07-038059; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Matsuda JL, 2007, J IMMUNOL, V178, P3457, DOI 10.4049/jimmunol.178.6.3457; Matsuda JL, 2006, BLOOD, V107, P2797, DOI 10.1182/blood-2005-08-3103; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; O Atherly L, 2006, IMMUNITY, V25, P79, DOI 10.1016/j.immuni.2006.05.012; Ohteki T, 1997, J IMMUNOL, V159, P5931; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Qi Q, 2006, J BIOL CHEM, V281, P38529, DOI 10.1074/jbc.M609180200; Qi Q, 2009, J BIOL CHEM, V284, P29882, DOI 10.1074/jbc.M109.003129; Raberger J, 2008, P NATL ACAD SCI USA, V105, P17919, DOI 10.1073/pnas.0805733105; Sahu N, 2008, J IMMUNOL, V181, P6125, DOI 10.4049/jimmunol.181.9.6125; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Stanic AK, 2004, J IMMUNOL, V172, P4667, DOI 10.4049/jimmunol.172.8.4667; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Yu SH, 2008, P NATL ACAD SCI USA, V105, P5207, DOI 10.1073/pnas.0711558105; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S; Zullo AJ, 2007, J IMMUNOL, V178, P58, DOI 10.4049/jimmunol.178.1.58	47	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					138	146		10.1074/jbc.M110.148205	http://dx.doi.org/10.1074/jbc.M110.148205			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21036902	Green Published, hybrid			2022-12-25	WOS:000285782800015
J	Tsuchiya, S; Fujiwara, T; Sato, F; Shimada, Y; Tanaka, E; Sakai, Y; Shimizu, K; Tsujimoto, G				Tsuchiya, Soken; Fujiwara, Takeshi; Sato, Fumiaki; Shimada, Yutaka; Tanaka, Eiji; Sakai, Yoshiharu; Shimizu, Kazuharu; Tsujimoto, Gozoh			MicroRNA-210 Regulates Cancer Cell Proliferation through Targeting Fibroblast Growth Factor Receptor-like 1 (FGFRL1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGNOSTIC-FACTOR; EPITHELIAL-CELLS; BREAST-CANCER; EXPRESSION; HYPOXIA; CARCINOMA; SURVIVAL; DIFFERENTIATION; HSA-MIR-210; ESOPHAGUS	The importance of microRNAs (miRNAs) in human malignancies has been well recognized. Here, we report that the expression of microRNA-210 (miR-210) is down-regulated in human esophageal squamous cell carcinoma and derived cell lines. Marked decreases in the level of miR-210 were observed especially in poorly differentiated carcinomas. We found that miR-210 inhibits cancer cell survival and proliferation by inducing cell death and cell cycle arrest in G(1)/G(0) and G(2)/M. Finally, we identified fibroblast growth factor receptor-like 1 (FGFRL1) as a target of miR-210 in esophageal squamous cell carcinoma and demonstrated that FGFRL1 accelerates cancer cell proliferation by preventing cell cycle arrest in G1/G0. Taken together, our findings show an important role for miR-210 as a tumor-suppressive microRNA with effects on cancer cell proliferation.	[Tsujimoto, Gozoh] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Sakyo Ku, Kyoto 6068501, Japan; [Tsuchiya, Soken; Fujiwara, Takeshi; Sato, Fumiaki; Shimizu, Kazuharu] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Nanobio Drug Discovery, Sakyo Ku, Kyoto 6068501, Japan; [Shimada, Yutaka] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Surg & Sci, Toyama 9300194, Japan; [Tanaka, Eiji; Sakai, Yoshiharu] Kyoto Univ, Grad Sch Med, Dept Surg, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University; Kyoto University; University of Toyama; Kyoto University	Tsujimoto, G (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Sakyo Ku, 46-29 Yoshida Shimoadachi, Kyoto 6068501, Japan.	gtsuji@pharm.kyoto-u.ac.jp			Kyoto University; Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan; New Energy and Industrial Technology Development Organization	Kyoto University; Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by grants from Kyoto University (to S. T.), the Takeda Science Foundation (to S. T.), the Ministry of Education, Culture, Sports, Science and Technology of Japan (to S. T. and G. T.), and the New Energy and Industrial Technology Development Organization (to G. T.).	Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Dow LE, 2008, ONCOGENE, V27, P5988, DOI 10.1038/onc.2008.219; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Gee HE, 2010, CANCER-AM CANCER SOC, V116, P2148, DOI 10.1002/cncr.25009; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Isohata N, 2009, INT J CANCER, V125, P1212, DOI 10.1002/ijc.24400; Ito T, 2008, CANCER RES, V68, P3214, DOI 10.1158/0008-5472.CAN-07-3043; Joshi J, 2008, EMBO J, V27, P2181, DOI 10.1038/emboj.2008.149; Karp CM, 2008, CANCER RES, V68, P4105, DOI 10.1158/0008-5472.CAN-07-6814; Kim HW, 2009, J BIOL CHEM, V284, P33161, DOI 10.1074/jbc.M109.020925; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Mathe EA, 2009, CLIN CANCER RES, V15, P6192, DOI 10.1158/1078-0432.CCR-09-1467; Ogawa R, 2009, MED MOL MORPHOL, V42, P102, DOI 10.1007/s00795-009-0443-1; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Sobin L H, 2002, TNM CLASSIFICATION M, P60; Tanaka E, 2007, CLIN CANCER RES, V13, P1331, DOI 10.1158/1078-0432.CCR-06-1192; Thepot A, 2010, INT J CANCER, V127, P2051, DOI 10.1002/ijc.25221; Tsuchiya S, 2006, J PHARMACOL SCI, V101, P267, DOI 10.1254/jphs.CPJ06013X; Tsuchiya S, 2009, NUCLEIC ACIDS RES, V37, P3821, DOI 10.1093/nar/gkp255; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Zavadil J, 2007, CELLS TISSUES ORGANS, V185, P157, DOI 10.1159/000101316; Zhang Z, 2009, CELL CYCLE, V8, P2756, DOI 10.4161/cc.8.17.9387	29	161	173	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					420	428		10.1074/jbc.M110.170852	http://dx.doi.org/10.1074/jbc.M110.170852			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21044961	hybrid, Green Published			2022-12-25	WOS:000285782800045
J	Adams-Cioaba, MA; Guo, YH; Bian, CB; Amaya, MF; Lam, R; Wasney, GA; Vedadi, M; Xu, C; Min, JR				Adams-Cioaba, Melanie A.; Guo, Yahong; Bian, ChuanBing; Amaya, Maria F.; Lam, Robert; Wasney, Gregory A.; Vedadi, Masoud; Xu, Chao; Min, Jinrong			Structural Studies of the Tandem Tudor Domains of Fragile X Mental Retardation Related Proteins FXR1 and FXR2	PLOS ONE			English	Article							HISTONE H3; FMRP; RECOGNITION; BINDING; PHENIX; MODEL; LOCALIZATION; TRANSLATION; REFINEMENT; LENGTH	Background: Expansion of the CGG trinucleotide repeat in the 5'-untranslated region of the FMR1, fragile X mental retardation 1, gene results in suppression of protein expression for this gene and is the underlying cause of Fragile X syndrome. In unaffected individuals, the FMRP protein, together with two additional paralogues (Fragile X Mental Retardation Syndrome-related Protein 1 and 2), associates with mRNA to form a ribonucleoprotein complex in the nucleus that is transported to dendrites and spines of neuronal cells. It is thought that the fragile X family of proteins contributes to the regulation of protein synthesis at sites where mRNAs are locally translated in response to stimuli. Methodology/Principal Findings: Here, we report the X-ray crystal structures of the non-canonical nuclear localization signals of the FXR1 and FXR2 autosomal paralogues of FMRP, which were determined at 2.50 and 1.92 angstrom, respectively. The nuclear localization signals of the FXR1 and FXR2 comprise tandem Tudor domain architectures, closely resembling that of UHRF1, which is proposed to bind methylated histone H3K9. Conclusions: The FMRP, FXR1 and FXR2 proteins comprise a small family of highly conserved proteins that appear to be important in translational regulation, particularly in neuronal cells. The crystal structures of the N-terminal tandem Tudor domains of FXR1 and FXR2 revealed a conserved architecture with that of FMRP. Biochemical analysis of the tandem Tudor doamins reveals their ability to preferentially recognize trimethylated peptides in a sequence-specific manner.	[Adams-Cioaba, Melanie A.; Guo, Yahong; Bian, ChuanBing; Amaya, Maria F.; Lam, Robert; Wasney, Gregory A.; Vedadi, Masoud; Xu, Chao; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto	Adams-Cioaba, MA (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	jr.min@utoronto.ca	Min, Jinrong/G-3449-2011; Xu, Chao/G-3885-2010	Min, Jinrong/0000-0001-5210-3130; Xu, Chao/0000-0003-0444-7080	Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co Inc.; Novartis Research Foundation; Swedish Agency for Innovationrefer Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovationrefer Systems; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co Inc., the Novartis Research Foundation, the Swedish Agency for Innovationrefer Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Bardoni B, 1997, NEUROBIOL DIS, V4, P329, DOI 10.1006/nbdi.1997.0142; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Blonden L, 2005, INT J DEV BIOL, V49, P437, DOI 10.1387/ijdb.051974lb; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eryilmaz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007274; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Fridell RA, 1996, EMBO J, V15, P5408, DOI 10.1002/j.1460-2075.1996.tb00924.x; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; Kenneson A, 2001, HUM MOL GENET, V10, P1449, DOI 10.1093/hmg/10.14.1449; Kim M, 2009, MOL CELL BIOL, V29, P214, DOI 10.1128/MCB.01377-08; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li XK, 2009, NEUROMOL MED, V11, P200, DOI 10.1007/s12017-009-8081-2; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Ramos A, 2006, STRUCTURE, V14, P21, DOI 10.1016/j.str.2005.09.018; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; SIOMI MC, 1995, EMBO J, V14, P2401, DOI 10.1002/j.1460-2075.1995.tb07237.x; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; van 't Padje S, 2005, DEV GENES EVOL, V215, P198, DOI 10.1007/s00427-005-0466-0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WARREN ST, 1994, JAMA-J AM MED ASSOC, V271, P536, DOI 10.1001/jama.271.7.536; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; ZOaW Minor, 1997, PROCESSING XRAY DIFF, P307	38	42	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13559	10.1371/journal.pone.0013559	http://dx.doi.org/10.1371/journal.pone.0013559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072162	Green Published, Green Submitted, gold			2022-12-25	WOS:000283779700001
J	Laukens, D; Georges, M; Libioulle, C; Sandor, C; Mni, M; Vander Cruyssen, B; Peeters, H; Elewaut, D; De Vos, M				Laukens, Debby; Georges, Michel; Libioulle, Cecile; Sandor, Cynthia; Mni, Myriam; Vander Cruyssen, Bert; Peeters, Harald; Elewaut, Dirk; De Vos, Martine			Evidence for Significant Overlap between Common Risk Variants for Crohn's Disease and Ankylosing Spondylitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; GENE; SUSCEPTIBILITY; EXPRESSION; CONTRIBUTE; ASTHMA; CELLS; JOINT; IL23R	Background: A multicenter genome-wide association scan for Crohn's Disease (CD) has recently reported 40 CD susceptibility loci, including 29 novel ones (19 significant and 10 putative). To gain insight into the genetic overlap between CD and ankylosing spondylitis (AS), these markers were tested for association in AS patients. Principal Findings: Two previously established associations, namely with the MHC and IL23R loci, were confirmed. In addition, rs2872507, which maps to a locus associated with asthma and influences the expression of the ORMDL3 gene in lymphoblastoid cells, showed a significant association with AS (p = 0.03). In gut biopsies of AS and CD patients, ORMDL3 expression was not significantly different from controls and no correlation was found with the rs2872507 genotype (Spearman's rho: -0.067). The distribution of p-values for the remaining 36 SNPs was significantly skewed towards low p-values unless the top 5 ranked SNPs (ORMDL3, NKX2-3, PTPN2, ICOSLG and MST1) were excluded from the analysis. Conclusions: Association analysis using risk variants for CD led to the identification of a new risk variant associated with AS (ORMDL3), underscoring a role for ER stress in AS. In addition, two known and five potentially relevant associations were detected, contributing to common susceptibility of CD and AS.	[Laukens, Debby; Peeters, Harald; De Vos, Martine] Univ Ghent, Dept Gastroenterol, B-9000 Ghent, Belgium; [Georges, Michel; Libioulle, Cecile; Sandor, Cynthia; Mni, Myriam] Univ Liege, GIGA R, Unit Anim Genom, Liege, Belgium; [Georges, Michel; Libioulle, Cecile; Sandor, Cynthia; Mni, Myriam] Univ Liege, Fac Vet Med, Liege, Belgium; [Vander Cruyssen, Bert; Elewaut, Dirk] Univ Ghent, Dept Rheumatol, B-9000 Ghent, Belgium	Ghent University; University of Liege; University of Liege; Ghent University	Laukens, D (corresponding author), Univ Ghent, Dept Gastroenterol, B-9000 Ghent, Belgium.	martine.devos@ugent.be	Elewaut, Dirk/K-6831-2014	Georges, Michel/0000-0003-4124-2375; Laukens, Debby/0000-0002-1984-5850; Elewaut, Dirk/0000-0002-7468-974X	La Direction Generale des Technologies de la Recherche et de l'Energie from the Walloon Region (DGTRE) [315422]; Walloon Region called CIBLES; Communaute Francaise de Belgique (Biomod ARC); Belgian Science Policy organization (SSTC Genefunc and Biomagnet PAI); Ghent University, Belgium [BOF07/GOA/002]	La Direction Generale des Technologies de la Recherche et de l'Energie from the Walloon Region (DGTRE); Walloon Region called CIBLES; Communaute Francaise de Belgique (Biomod ARC); Belgian Science Policy organization (SSTC Genefunc and Biomagnet PAI); Ghent University, Belgium(Ghent University)	This work was supported by grants from (i) La Direction Generale des Technologies de la Recherche et de l'Energie from the Walloon Region (DGTRE, nr 315422), (ii) The 2nd Excellence Programme from the Walloon Region called CIBLES, (iii) from the Communaute Francaise de Belgique (Biomod ARC), (iv) the Belgian Science Policy organization (SSTC Genefunc and Biomagnet PAI) and (v) by a concerted action grant BOF07/GOA/002 of Ghent University, Belgium. Cynthia Sandor is a fellow of the Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; BREWERTON DA, 1973, LANCET, V1, P904; Brown MA, 2002, CLIN EXP RHEUMATOL, V20, pS43; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; de Vlam K, 2000, J RHEUMATOL, V27, P2860; De Vos M, 2004, ALIMENT PHARM THER, V20, P36, DOI 10.1111/j.1365-2036.2004.02044.x; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Goyette P, 2008, MUCOSAL IMMUNOL, V1, P131, DOI 10.1038/mi.2007.15; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Laukens D, 2005, ANN RHEUM DIS, V64, P930, DOI 10.1136/ard.2004.028837; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Miceli-Richard C, 2002, ARTHRITIS RHEUM, V46, P1405, DOI 10.1002/art.10196; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Nakazawa A, 2004, GASTROENTEROLOGY, V126, P1347, DOI 10.1053/j.gastro.2004.02.004; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; TAUROG JD, 1993, J IMMUNOL, V150, P4168; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361	23	42	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13795	10.1371/journal.pone.0013795	http://dx.doi.org/10.1371/journal.pone.0013795			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072187	Green Published, gold			2022-12-25	WOS:000283779700009
J	Censi, F; Calcagnini, G; Bartolini, P; Giuliani, A				Censi, Federica; Calcagnini, Giovanni; Bartolini, Pietro; Giuliani, Alessandro			A Systems Biology Strategy on Differential Gene Expression Data Discloses Some Biological Features of Atrial Fibrillation	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; STROKE	Atrial fibrillation (AF), the most common cardiac arrhythmia, is associated with extensive structural, contractile, and electrophysiological remodeling. In this manuscript we re-analyzed gene expression data from a microarray experiment on AF patients and control tissues, using a new paradigm based on a posteriori unsupervised strategy in which the discrimination of patients comes out from purely syntactical premises. This paradigm, more adherent to biological reality where genes work in highly connected networks, allowed us to get both a very precise patients/control discrimination and the discovery of cell adhesion/tissue modeling and inflammation processes as the main dimensions of AF.	[Censi, Federica; Calcagnini, Giovanni; Bartolini, Pietro] Ist Super Sanita, Dept Technol & Hlth, I-00161 Rome, Italy; [Giuliani, Alessandro] Ist Super Sanita, Dept Environm & Hlth, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Censi, F (corresponding author), Ist Super Sanita, Dept Technol & Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.	federica.censi@iss.it	Giuliani, Alessandro/AAF-1740-2020; BARTOLINI, PIETRO/E-4619-2015; CALCAGNINI, GIOVANNI/E-3711-2015; Giuliani, Alessandro/K-7589-2016; CENSI, FEDERICA/E-3712-2015	Giuliani, Alessandro/0000-0002-4640-804X; Giuliani, Alessandro/0000-0002-4640-804X; 	Italian National Institute of Health	Italian National Institute of Health	The only funder is the authors' institution, Italian National Institute of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam O, 2010, J AM COLL CARDIOL, V55, P469, DOI 10.1016/j.jacc.2009.08.064; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Bar-Yam Y, 2009, SCIENCE, V323, P1016, DOI 10.1126/science.1163225; Barth AS, 2005, PFLUG ARCH EUR J PHY, V450, P201, DOI 10.1007/s00424-005-1404-8; Barth AS, 2005, CIRC RES, V96, P1022, DOI 10.1161/01.RES.0000165480.82737.33; Brundel BJJM, 2002, CARDIOVASC RES, V54, P315, DOI 10.1016/S0008-6363(02)00222-5; Centurion OA, 2009, INT J CARDIOL, V134, P6, DOI 10.1016/j.ijcard.2008.12.072; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Giuliani A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S2; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Kim YH, 2003, EXP MOL MED, V35, P336, DOI 10.1038/emm.2003.45; Lai LP, 2004, J CARDIOVASC ELECTR, V15, P214, DOI 10.1046/j.1540-8167.2004.03423.x; Lamirault G, 2006, J MOL CELL CARDIOL, V40, P173, DOI 10.1016/j.yjmcc.2005.09.004; MCBRIDE D, 2008, VALUE HLTH      0724; Noble D, 2008, PHILOS T R SOC A, V366, P3001, DOI 10.1098/rsta.2008.0086; Ohki-Kaneda R, 2004, BIOCHEM BIOPH RES CO, V320, P1328, DOI 10.1016/j.bbrc.2004.06.090; Patel P, 2010, J CARDIOVASC ELECTR, V21, P1064, DOI 10.1111/j.1540-8167.2010.01774.x; Podgoreanu MV, 2005, J AM COLL CARDIOL, V46, P1965, DOI 10.1016/j.jacc.2005.08.040; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Rencher AC, 2002, METHODS MULTIVARIATE; Romualdi C, 2009, OMICS, V13, P173, DOI 10.1089/omi.2009.0003; Surovyatkina E, 2010, PROG BIOPHYS MOL BIO, V103, P131, DOI 10.1016/j.pbiomolbio.2010.01.004; Van Regenmortel MHV, 2007, PROTEOMICS, V7, P965, DOI 10.1002/pmic.200600407; Wilkins AS, 2007, BIOESSAYS, V29, P1179, DOI 10.1002/bies.20685; Wolf PA, 1998, ARCH INTERN MED, V158, P229, DOI 10.1001/archinte.158.3.229; Yue LX, 1999, CIRC RES, V84, P776	27	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13668	10.1371/journal.pone.0013668	http://dx.doi.org/10.1371/journal.pone.0013668			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060823	Green Published, gold, Green Submitted			2022-12-25	WOS:000283645300003
J	Ouedraogo, R; Flaudrops, C; Ben Amara, A; Capo, C; Raoult, D; Mege, JL				Ouedraogo, Richard; Flaudrops, Christophe; Ben Amara, Amira; Capo, Christian; Raoult, Didier; Mege, Jean-Louis			Global Analysis of Circulating Immune Cells by Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry	PLOS ONE			English	Article							HUMAN PERIPHERAL-BLOOD; DENDRITIC CELLS; MALDI-TOF; IDENTIFICATION; PROTEOME; BACTERIA; DIFFERENTIATION; MACROPHAGES; LEUKOCYTES; INFECTION	Background: MALDI-TOF mass spectrometry is currently used in microbiological diagnosis to characterize bacterial populations. Our aim was to determine whether this technique could be applied to intact eukaryotic cells, and in particular, to cells involved in the immune response. Methodology/Principal Findings: A comparison of frozen monocytes, T lymphocytes and polymorphonuclear leukocytes revealed specific peak profiles. We also found that twenty cell types had specific profiles, permitting the establishment of a cell database. The circulating immune cells, namely monocytes, T lymphocytes and polymorphonuclear cells, were distinct from tissue immune cells such as monocyte-derived macrophages and dendritic cells. In addition, MALDI-TOF mass spectrometry was valuable to easily identify the signatures of monocytes and T lymphocytes in peripheral mononuclear cells. Conclusions/Significance: This method was rapid and easy to perform, and unlike flow cytometry, it did not require any additional components such as specific antibodies. The MALDI-TOF mass spectrometry approach could be extended to analyze the cell composition of tissues and the activation state of immune cells.	[Ouedraogo, Richard; Flaudrops, Christophe; Ben Amara, Amira; Capo, Christian; Raoult, Didier; Mege, Jean-Louis] Univ Aix Marseille 2, Fac Med, Unite Rech Malad Infect Trop & Emergentes, Ctr Natl Rech Sci,Inst Rech Dev Unite Mixte Rech, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Ouedraogo, R (corresponding author), Univ Aix Marseille 2, Fac Med, Unite Rech Malad Infect Trop & Emergentes, Ctr Natl Rech Sci,Inst Rech Dev Unite Mixte Rech, Marseille, France.	Jean-Louis.Mege@univmed.fr	RAOULT, Didier/A-8434-2008; MEGE, JEAN-LOUIS/O-6063-2016	RAOULT, Didier/0000-0002-0633-5974; 	Centre National de la Recherche Scientifique and Assistance Publique - Hopitaux de Marseille	Centre National de la Recherche Scientifique and Assistance Publique - Hopitaux de Marseille(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Centre National de la Recherche Scientifique and Assistance Publique - Hopitaux de Marseille. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Benoit M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000066; Degand N, 2008, J CLIN MICROBIOL, V46, P3361, DOI 10.1128/JCM.00569-08; Desnues B, 2005, J IMMUNOL, V175, P4575, DOI 10.4049/jimmunol.175.7.4575; Dieckmann R, 2008, APPL ENVIRON MICROB, V74, P7767, DOI 10.1128/AEM.01402-08; Drancourt M, 2002, APPL ENVIRON MICROB, V68, P6403, DOI 10.1128/AEM.68.12.6403-6404.2002; Dupont A, 2004, PROTEOMICS, V4, P1761, DOI 10.1002/pmic.200300691; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; Fournier PE, 2009, J MED MICROBIOL, V58, P1154, DOI 10.1099/jmm.0.009647-0; Greub G, 2002, APPL ENVIRON MICROB, V68, P3076, DOI 10.1128/AEM.68.6.3076-3084.2002; Hartman H, 2002, P NATL ACAD SCI USA, V99, P1420, DOI 10.1073/pnas.032658599; Horlock C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r30; Jiang Y, 2010, J PROTEOME RES, V9, P79, DOI 10.1021/pr900532r; Johnson RP, 2009, J BIOL CHEM, V284, P16562, DOI 10.1074/jbc.M109.010918; Karger A, 2010, J VIROL METHODS, V164, P116, DOI 10.1016/j.jviromet.2009.11.022; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Lay JO, 2000, METH MOL B, V146, P461, DOI 10.1385/1-59259-045-4:461; Lehtonen A, 2007, J LEUKOCYTE BIOL, V82, P710, DOI 10.1189/jlb.0307194; LEPIDI H, 1992, J CELL SCI, V103, P145; Li XY, 2009, MOL BIOCHEM PARASIT, V165, P162, DOI 10.1016/j.molbiopara.2009.02.001; Majcherczyk PA, 2006, FEMS MICROBIOL LETT, V255, P233, DOI 10.1111/j.1574-6968.2005.00060.x; Meghari S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040023; Mellmann A, 2008, J CLIN MICROBIOL, V46, P1946, DOI 10.1128/JCM.00157-08; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Petersen Catherine E., 2009, V492, P367, DOI 10.1007/978-1-59745-493-3_22; Robertson JWF, 2007, P NATL ACAD SCI USA, V104, P8207, DOI 10.1073/pnas.0611085104; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Srisomsap C, 2004, PROTEOMICS, V4, P1135, DOI 10.1002/pmic.200300651; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; Zhang X, 2006, J AM SOC MASS SPECTR, V17, P490, DOI 10.1016/j.jasms.2005.12.007; Zhao CQ, 2009, J PROTEOME RES, V8, P4028, DOI 10.1021/pr900364p	30	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13691	10.1371/journal.pone.0013691	http://dx.doi.org/10.1371/journal.pone.0013691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060873	Green Submitted, gold, Green Published			2022-12-25	WOS:000283537000054
J	Saederup, N; Cardona, AE; Croft, K; Mizutani, M; Cotleur, AC; Tsou, CL; Ransohoff, RM; Charo, IF				Saederup, Noah; Cardona, Astrid E.; Croft, Kelsey; Mizutani, Makiko; Cotleur, Anne C.; Tsou, Chia-Lin; Ransohoff, Richard M.; Charo, Israel F.			Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In Mice	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; BLOOD MONOCYTES; DENDRITIC CELLS; IMMUNE-RESPONSE; FRACTALKINE RECEPTOR; MULTIPLE-SCLEROSIS; MICROGLIAL CELLS; BONE-MARROW; SUBSETS	Background: Monocyte subpopulations distinguished by differential expression of chemokine receptors CCR2 and CX3CR1 are difficult to track in vivo, partly due to lack of CCR2 reagents. Methodology/Principal Findings: We created CCR2-red fluorescent protein (RFP) knock-in mice and crossed them with CX3CR1-GFP mice to investigate monocyte subset trafficking. In mice with experimental autoimmune encephalomyelitis, CCR2 was critical for efficient intrathecal accumulation and localization of Ly6C(hi)/CCR2(hi) monocytes. Surprisingly, neutrophils, not Ly6C(lo) monocytes, largely replaced Ly6C(hi) cells in the central nervous system of these mice. CCR2-RFP expression allowed the first unequivocal distinction between infiltrating monocytes/macrophages from resident microglia. Conclusion/Significance: These results refine the concept of monocyte subsets, provide mechanistic insight about monocyte entry into the central nervous system, and present a novel model for imaging and quantifying inflammatory myeloid populations.	[Saederup, Noah; Croft, Kelsey; Tsou, Chia-Lin; Charo, Israel F.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Cardona, Astrid E.; Mizutani, Makiko; Cotleur, Anne C.; Ransohoff, Richard M.] Cleveland Clin, Neuroinflammat Res Ctr, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44106 USA; [Charo, Israel F.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Cleveland Clinic Foundation; University of California System; University of California San Francisco	Saederup, N (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA USA.	ransohr@ccf.org; icharo@gladstone.ucsf.edu	Cardona, Astrid E/K-4749-2013	Cardona, Astrid E/0000-0002-5093-8078	National Institutes of Health [HL52773, HL63894, NIH R01NS32151]; Multiple Sclerosis Society [TA3121-A1/T]; National MS Society [RG3980]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063894, R01HL052773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Sclerosis Society(National Multiple Sclerosis Society); National MS Society(National Multiple Sclerosis Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sources of funding are: National Institutes of Health (HL52773 and HL63894 to IFC, NIH R01NS32151 to RMR), the Multiple Sclerosis Society (TA3121-A1/T to AEC), and the National MS Society (RG3980 to RMR).	Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cardona AE, 1999, J IMMUNOL, V162, P995; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Gaupp S, 2003, AM J PATHOL, V162, P139, DOI 10.1016/S0002-9440(10)63805-9; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Glabinski AR, 1997, METHOD ENZYMOL, V288, P182; Glabinski AR, 1997, AM J PATHOL, V150, P617; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Grace-Griebenow E, 2000, IMMUNOBIOLOGY, V202, P42, DOI 10.1016/S0171-2985(00)80051-0; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Huang D, 2006, FASEB J, V20, P896, DOI 10.1096/fj.05-5465com; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jung HS, 2009, J NEUROSCI, V29, P8051, DOI 10.1523/JNEUROSCI.0485-09.2009; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Mahad DJ, 2003, SEMIN IMMUNOL, V15, P23, DOI 10.1016/S1044-5323(02)00125-2; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Qu CF, 2004, J EXP MED, V200, P1231, DOI 10.1084/jem.20032152; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; RANSOHOFF RM, 1993, FASEB J, V7, P592, DOI 10.1096/fasebj.7.6.8472896; Rostene W, 2007, NAT REV NEUROSCI, V8, P895, DOI 10.1038/nrn2255; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Varol C, 2009, IMMUNOL CELL BIOL, V87, P30, DOI 10.1038/icb.2008.90; Weber C, 2000, J LEUKOCYTE BIOL, V67, P699, DOI 10.1002/jlb.67.5.699; Wong LM, 1997, J BIOL CHEM, V272, P1038, DOI 10.1074/jbc.272.2.1038; Ziegler-Heitbrock HWL, 2000, J LEUKOCYTE BIOL, V67, P603, DOI 10.1002/jlb.67.5.603	45	380	384	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13693	10.1371/journal.pone.0013693	http://dx.doi.org/10.1371/journal.pone.0013693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060874	Green Published, gold, Green Submitted			2022-12-25	WOS:000283537000055
J	Georgopoulos, NT; Kirkwood, LA; Walker, DC; Southgate, J				Georgopoulos, Nikolaos T.; Kirkwood, Lisa A.; Walker, Dawn C.; Southgate, Jennifer			Differential Regulation of Growth-Promoting Signalling Pathways by E-Cadherin	PLOS ONE			English	Article							HUMAN UROTHELIAL CELLS; LIGAND-INDEPENDENT ACTIVATION; HUMAN EPIDERMAL-KERATINOCYTES; FACTOR RECEPTOR; BLADDER-CANCER; IN-VITRO; PROTEIN-KINASE; TERMINAL DIFFERENTIATION; CARCINOMA-CELLS; ADHESION	Background: Despite the well-documented association between loss of E-cadherin and carcinogenesis, as well as the link between restoration of its expression and suppression of proliferation in carcinoma cells, the ability of E-cadherin to modulate growth-promoting cell signalling in normal epithelial cells is less well understood and frequently contradictory. The potential for E-cadherin to co-ordinate different proliferation-associated signalling pathways has yet to be fully explored. Methodology/Principal Findings: Using a normal human urothelial (NHU) cell culture system and following a calcium-switch approach, we demonstrate that the stability of NHU cell-cell contacts differentially regulates the Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-Regulated Kinase (ERK) and Phosphatidylinositol 3-Kinase (PI3-K)/AKT pathways. We show that stable cell contacts down-modulate the EGFR/ERK pathway, whilst inducing PI3-K/AKT activity, which transiently enhances cell growth at low density. Functional inactivation of E-cadherin interferes with the capacity of NHU cells to form stable calcium-mediated contacts, attenuates E-cadherin-mediated PI3-K/AKT induction and enhances NHU cell proliferation by allowing de-repression of the EGFR/ERK pathway and constitutive activation of beta-catenin-TCF signalling. Conclusions/Significance: Our findings provide evidence that E-cadherin can differentially and concurrently regulate specific growth-related signalling pathways in a context-specific fashion, with direct, functional consequences for cell proliferation and population growth. Our observations not only reveal a novel, complex role for E-cadherin in normal epithelial cell homeostasis and tissue regeneration, but also provide the basis for a more complete understanding of the consequences of E-cadherin loss on malignant transformation.	[Georgopoulos, Nikolaos T.; Kirkwood, Lisa A.; Southgate, Jennifer] Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England; [Walker, Dawn C.] Univ Sheffield, Dept Comp Sci, Kroto Res Inst, Sheffield S10 2TN, S Yorkshire, England	University of York - UK; University of Sheffield	Georgopoulos, NT (corresponding author), Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England.	js35@york.ac.uk	Southgate, Jennifer/AAJ-9089-2021	Southgate, Jennifer/0000-0002-0135-480X; Georgopoulos, Nik/0000-0002-6330-4947	Engineering and Physical Sciences Research Council (EPSRC) [GR/S62338/01]; RCUK; York Against Cancer; Engineering and Physical Sciences Research Council [GR/S62338/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); RCUK(UK Research & Innovation (UKRI)); York Against Cancer; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The study was funded by the Engineering and Physical Sciences Research Council (EPSRC; grant reference GR/S62338/01), on which NTG was employed. DCW is supported by an RCUK fellowship. LAC is a postgraduate student and JS holds a research chair supported by York Against Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Black PC, 2008, CLIN CANCER RES, V14, P1478, DOI 10.1158/1078-0432.CCR-07-1593; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bornman DM, 2001, AM J PATHOL, V159, P831, DOI 10.1016/S0002-9440(10)61758-0; Chopra B, 2009, CELL PROLIFERAT, V42, P688, DOI 10.1111/j.1365-2184.2009.00628.x; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; Crallan RA, 2006, CARCINOGENESIS, V27, P374, DOI 10.1093/carcin/bgi266; Cross WR, 2005, AM J PHYSIOL-RENAL, V289, pF459, DOI 10.1152/ajprenal.00040.2005; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Fadare Oluwole, 2005, World J Surg Oncol, V3, P38, DOI 10.1186/1477-7819-3-38; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Georgopoulos NT, 2007, INT J CANCER, V121, P1373, DOI 10.1002/ijc.22846; Liu WF, 2006, J CELL BIOL, V173, P431, DOI 10.1083/jcb.200510087; MacLaine NJ, 2008, MOL CANCER RES, V6, P53, DOI 10.1158/1541-7786.MCR-07-0134; Margulis A, 2005, CANCER RES, V65, P1783, DOI 10.1158/0008-5472.CAN-04-3399; Maruyama R, 2001, CANCER RES, V61, P8659; Masters, 2003, CULTURE EPITHELIAL C, V8, P381, DOI DOI 10.1002/0471221201.CH12; MOLL R, 1993, AM J PATHOL, V143, P1731; Nelson CM, 2002, FEBS LETT, V514, P238, DOI 10.1016/S0014-5793(02)02370-0; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Orsulic S, 1999, J CELL SCI, V112, P1237; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Perrais M, 2007, MOL BIOL CELL, V18, P2013, DOI 10.1091/mbc.E06-04-0348; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Reddy P, 2005, MOL ENDOCRINOL, V19, P2564, DOI 10.1210/me.2004-0342; Ribeiro LA, 2002, MOL CARCINOGEN, V34, P187, DOI 10.1002/mc.10064; RIEGER KM, 1995, BRIT J CANCER, V72, P683, DOI 10.1038/bjc.1995.394; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shaw NJ, 2005, INT J CANCER, V116, P634, DOI 10.1002/ijc.21114; Shen XD, 2004, AM J PATHOL, V165, P1315, DOI 10.1016/S0002-9440(10)63390-1; SOUTHGATE J, 1994, LAB INVEST, V71, P583; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; Stockinger A, 2001, J CELL BIOL, V154, P1185, DOI 10.1083/jcb.200104036; T Georgopoulos N, 2006, CELL DEATH DIFFER, V13, P1789, DOI 10.1038/sj.cdd.4401859; Takahashi K, 1996, EXP CELL RES, V226, P214, DOI 10.1006/excr.1996.0221; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Thievessen I, 2003, BRIT J CANCER, V88, P1932, DOI 10.1038/sj.bjc.6601031; Urakami S, 2006, CLIN CANCER RES, V12, P2109, DOI 10.1158/1078-0432.CCR-05-2468; Urakami S, 2006, CLIN CANCER RES, V12, P383, DOI 10.1158/1078-0432.CCR-05-1344; Varley C, 2005, EXP CELL RES, V306, P216, DOI 10.1016/j.yexcr.2005.02.004; Varley CL, 2004, J CELL SCI, V117, P2029, DOI 10.1242/jcs.01042; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Walker DC, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-102; Walker D, 2006, J THEOR BIOL, V242, P774, DOI 10.1016/j.jtbi.2006.04.020; Walker DC, 2004, BIOSYSTEMS, V76, P89, DOI 10.1016/j.biosystems.2004.05.025; Walker DC, 2004, IEEE T NANOBIOSCI, V3, P153, DOI 10.1109/TNB.2004.833680; Yates DR, 2007, CLIN CANCER RES, V13, P2046, DOI 10.1158/1078-0432.CCR-06-2476; Zhu AJ, 1999, DEVELOPMENT, V126, P2285; Zhu AJ, 1996, J CELL SCI, V109, P3013; Zhu AJ, 1999, P NATL ACAD SCI USA, V96, P6728, DOI 10.1073/pnas.96.12.6728	56	25	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13621	10.1371/journal.pone.0013621	http://dx.doi.org/10.1371/journal.pone.0013621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049033	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000283487400014
J	Hennigan, SL; Driskell, JD; Dluhy, RA; Zhao, YP; Tripp, RA; Waites, KB; Krause, DC				Hennigan, Suzanne L.; Driskell, Jeremy D.; Dluhy, Richard A.; Zhao, Yiping; Tripp, Ralph A.; Waites, Ken B.; Krause, Duncan C.			Detection of Mycoplasma pneumoniae in Simulated and True Clinical Throat Swab Specimens by Nanorod Array-Surface-Enhanced Raman Spectroscopy	PLOS ONE			English	Article							SENSITIVE DETECTION; LEAST-SQUARES; SCATTERING; PCR; IDENTIFICATION; DIAGNOSIS; PROTEIN; GENE; SERS; PATHOGENESIS	The prokaryote Mycoplasma pneumoniae is a major cause of respiratory disease in humans, accounting for 20% of all community-acquired pneumonia and the leading cause of pneumonia in older children and young adults. The limitations of existing options for mycoplasma diagnosis highlight a critical need for a new detection platform with high sensitivity, specificity, and expediency. Here we evaluated silver nanorod arrays (NA) as a biosensing platform for detection and differentiation of M. pneumoniae in culture and in spiked and true clinical throat swab samples by surface-enhanced Raman spectroscopy (SERS). Three M. pneumoniae strains were reproducibly differentiated by NA-SERS with 95%-100% specificity and 94-100% sensitivity, and with a lower detection limit exceeding standard PCR. Analysis of throat swab samples spiked with M. pneumoniae yielded detection in a complex, clinically relevant background with >90% accuracy and high sensitivity. In addition, NA-SERS correctly classified with >97% accuracy, ten true clinical throat swab samples previously established by real-time PCR and culture to be positive or negative for M. pneumoniae. Our findings suggest that the unique biochemical specificity of Raman spectroscopy, combined with reproducible spectral enhancement by silver NA, holds great promise as a superior platform for rapid and sensitive detection and identification of M. pneumoniae, with potential for point-of-care application.	[Hennigan, Suzanne L.; Krause, Duncan C.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Driskell, Jeremy D.; Tripp, Ralph A.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Dluhy, Richard A.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Zhao, Yiping] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA; [Waites, Ken B.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Waites, Ken B.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Hennigan, SL (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	dkrause@uga.edu	Tripp, Ralph/F-5218-2011; Zhao, Yiping/A-4968-2008	Tripp, Ralph/0000-0002-2924-9956; Zhao, Yiping/0000-0002-3710-4159; Hennigan, Suzanne/0000-0003-0551-6703; Driskell, Jeremy/0000-0001-5082-898X	U.S. Army Research Laboratory [W911NF-07-0065]; National Science Foundation [ECS-0701787]; Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI096364] Funding Source: NIH RePORTER	U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); National Science Foundation(National Science Foundation (NSF)); Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded in part by the U.S. Army Research Laboratory (http://www.arl.army.mil/www/default.htm) through contract number W911NF-07-0065, the National Science Foundation (http://www.nsf.gov) under contract ECS-0701787, and the Georgia Research Alliance (http://www.gra.org/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell JL, 2009, BIOSENS BIOELECTRON, V24, P3663, DOI 10.1016/j.bios.2009.05.039; Adams M. J., 2004, CHEMOMETRICS ANAL SP; Alfassi ZB, 2004, J AM SOC MASS SPECTR, V15, P385, DOI 10.1016/j.jasms.2003.11.008; Atkinson TP, 2008, FEMS MICROBIOL REV, V32, P956, DOI 10.1111/j.1574-6976.2008.00129.x; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Beebe K.R., 1998, CHEMOMETRICS PRACTIC, V1st; Chu HY, 2008, APPL SPECTROSC, V62, P922, DOI 10.1366/000370208785284330; Dallo SF, 1996, INFECT IMMUN, V64, P2595, DOI 10.1128/IAI.64.7.2595-2601.1996; Daxboeck F, 2003, CLIN MICROBIOL INFEC, V9, P263, DOI 10.1046/j.1469-0691.2003.00590.x; Demirel MC, 2009, BIOINTERPHASES, V4, P35, DOI 10.1116/1.3147962; Dorigo-Zetsma JW, 1999, J CLIN MICROBIOL, V37, P14, DOI 10.1128/JCM.37.1.14-17.1999; Driskell JD, 2008, J PHYS CHEM C, V112, P895, DOI 10.1021/jp075288u; Driskell JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010222; Dumke R, 2003, INT J MED MICROBIOL, V292, P513, DOI 10.1078/1438-4221-00231; Dumke R, 2007, J CLIN MICROBIOL, V45, P2726, DOI 10.1128/JCM.00321-07; Esbensen K.H, 2004, MULTIVARIATE DATA AN; Jacobs E, 1996, EUR J CLIN MICROBIOL, V15, P38, DOI 10.1007/BF01586183; Jarvis RM, 2004, ANAL CHEM, V76, P40, DOI 10.1021/ac034689c; Kenri T, 2008, J MED MICROBIOL, V57, P469, DOI 10.1099/jmm.0.47634-0; KRAUSE DC, 1982, INFECT IMMUN, V35, P809, DOI 10.1128/IAI.35.3.809-817.1982; Leverette CL, 2006, APPL SPECTROSC, V60, P906, DOI 10.1366/000370206778062084; LIPMAN RP, 1969, J BACTERIOL, V100, P1037, DOI 10.1128/JB.100.2.1037-1043.1969; Liu YJ, 2009, J PHYS CHEM C, V113, P9664, DOI 10.1021/jp902142y; Loens K, 2003, J CLIN MICROBIOL, V41, P4915, DOI 10.1128/JCM.41.11.4915-4923.2003; Loens K, 2010, EUR J CLIN MICROBIOL, V29, P1055, DOI 10.1007/s10096-010-0975-2; Maquelin K, 2009, MICROBIOL-SGM, V155, P2068, DOI 10.1099/mic.0.026724-0; Musumarra G, 2004, J CHEMOMETR, V18, P125, DOI 10.1002/cem.846; Naumann D, 2001, APPL SPECTROSC REV, V36, P239, DOI 10.1081/ASR-100106157; Patel IS, 2008, J RAMAN SPECTROSC, V39, P1660, DOI 10.1002/jrs.2064; Premasiri WR, 2005, J PHYS CHEM B, V109, P312, DOI 10.1021/jp040442n; PROFT T, 1995, J BACTERIOL, V177, P3370, DOI 10.1128/jb.177.12.3370-3378.1995; Romero-Arroyo CE, 1999, J BACTERIOL, V181, P1079, DOI 10.1128/JB.181.4.1079-1087.1999; RULAND K, 1994, J BACTERIOL, V176, P5202, DOI 10.1128/JB.176.17.5202-5209.1994; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Shanmukh S, 2006, NANO LETT, V6, P2630, DOI 10.1021/nl061666f; SU CJ, 1990, INFECT IMMUN, V58, P2669, DOI 10.1128/IAI.58.8.2669-2674.1990; TULLY JG, 1977, SCIENCE, V195, P892, DOI 10.1126/science.841314; Ursi D, 2003, J MICROBIOL METH, V55, P149, DOI 10.1016/S0167-7012(03)00131-3; VANKUPPEVELD FJM, 1992, APPL ENVIRON MICROB, V58, P2606, DOI 10.1128/AEM.58.8.2606-2615.1992; VO-DINH T, 1994, ANAL CHEM, V66, P3379, DOI 10.1021/ac00092a014; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Waitest KB, 2008, FUTURE MICROBIOL, V3, P635, DOI 10.2217/17460913.3.6.635; Waring AL, 2001, J CLIN MICROBIOL, V39, P1385, DOI 10.1128/JCM.39.4.1385-1390.2001; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Yakes BJ, 2008, CLIN VACCINE IMMUNOL, V15, P235, DOI 10.1128/CVI.00335-07; Zhao YP, 2006, J PHYS CHEM B, V110, P3153, DOI 10.1021/jp057406o	46	41	42	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13633	10.1371/journal.pone.0013633	http://dx.doi.org/10.1371/journal.pone.0013633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049032	gold, Green Published, Green Submitted			2022-12-25	WOS:000283487400023
J	Ng, WC; Wong, V; Muller, B; Rawlin, G; Brown, LE				Ng, Wy Ching; Wong, Victor; Muller, Brian; Rawlin, Grant; Brown, Lorena E.			Prevention and Treatment of Influenza with Hyperimmune Bovine Colostrum Antibody	PLOS ONE			English	Article							OSELTAMIVIR-RESISTANT INFLUENZA; A VIRUSES; PASSIVE IMMUNOTHERAPY; ADAMANTANE RESISTANCE; SCID MICE; INFECTION; HEMAGGLUTININ; FRAGMENTS; PROTECTION; PNEUMONIA	Background: Despite the availability of specific vaccines and antiviral drugs, influenza continues to impose a heavy toll on human health worldwide. Passive transfer of specific antibody (Ab) may provide a useful means of preventing or treating disease in unvaccinated individuals or those failing to adequately seroconvert, especially now that resistance to antiviral drugs is on the rise. However, preparation of appropriate Ab in large scale, quickly and on a yearly basis is viewed as a significant logistical hurdle for this approach to control seasonal influenza. Methodology/Principal Findings: In this study, bovine colostrum, which contains approximately 500 g of IgG per milking per animal, has been investigated as a source of polyclonal antibody for delivery to the respiratory tract. IgG and F(ab')2 were purified from the hyperimmune colostrum of cows vaccinated with influenza A/Puerto Rico/8/34 (PR8) vaccine and were shown to have high hemagglutination-inhibitory and virus-neutralizing titers. In BALB/c mice, a single administration of either IgG or F(ab')2 could prevent the establishment of infection with a sublethal dose of PR8 virus when given as early as 7 days prior to exposure to virus. Pre-treated mice also survived an otherwise lethal dose of virus, the IgG-but not the F(ab')2-treated mice showing no weight loss. Successful reduction of established infection with this highly virulent virus was also observed with a single treatment 24 hr after virus exposure. Conclusions/Significance: These data suggest that a novel and commercially-scalable technique for preparing Ab from hyperimmune bovine colostrum could allow production of a valuable substitute for antiviral drugs to control influenza with the advantage of eliminating the need for daily administration.	[Ng, Wy Ching; Brown, Lorena E.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Wong, Victor; Muller, Brian; Rawlin, Grant] Immuron Ltd, Melbourne, Vic, Australia	University of Melbourne	Ng, WC (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	lorena@unimelb.edu.au	Ng, Wy Ching/GQT-0056-2022	Brown, Lorena/0000-0001-9342-909X	National Health and Medical Research Council of Australia; Australian Research Council [LP0990420]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	The study was funded by grants from the National Health and Medical Research Council of Australia and the Australian Research Council (Linkage project LP0990420), who had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, and by Immuron Limited who had no role in data collection and analysis and decision to publish but provided input into study design and manuscript preparation.	BLEEKER WK, 1989, CLIN EXP IMMUNOL, V77, P338; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Casadevall A, 1999, CLIN IMMUNOL, V93, P5, DOI 10.1006/clim.1999.4768; DAVIES WL, 1964, SCIENCE, V144, P862, DOI 10.1126/science.144.3620.862; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;94::AID-JMV15&gt;3.0.CO;2-C; Dowdle W.A., 1979, DIAGNOSTIC PROCEDURE, V5th ed., P585; Hammarstrom L, 2008, ADV EXP MED BIOL, V606, P321, DOI 10.1007/978-0-387-74087-4_13; Hanson BJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-126; Hayden FG, 2001, PHILOS T R SOC B, V356, P1877, DOI 10.1098/rstb.2001.1007; HIRSCH RL, 1982, MICROBIOL REV, V46, P71, DOI 10.1128/MMBR.46.1.71-85.1982; Jackson LA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-71; Jones RGA, 2003, J IMMUNOL METHODS, V275, P239, DOI 10.1016/S0022-1759(03)00005-X; Kawai N, 2005, CLIN INFECT DIS, V40, P1309, DOI 10.1086/429241; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Korhonen H, 2000, BRIT J NUTR, V84, pS135; Lu JH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-43; Monto AS, 2008, PEDIATR INFECT DIS J, V27, pS110, DOI 10.1097/INF.0b013e318168b739; MORGAN EL, 1980, J EXP MED, V152, P113, DOI 10.1084/jem.152.1.113; Moscona A, 2004, LANCET, V364, P733, DOI 10.1016/S0140-6736(04)16947-X; Mozdzanowska K, 2003, J VIROL, V77, P8322, DOI 10.1128/JVI.77.15.8322-8328.2003; Nicoll A., 2008, EURO SURVEILL, V13; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; PALLADINO G, 1995, J VIROL, V69, P2075, DOI 10.1128/JVI.69.4.2075-2081.1995; Pejoski D, 2010, IMMUNOL CELL BIOL, V88, P605, DOI 10.1038/icb.2010.15; Ramisse F, 1998, CLIN EXP IMMUNOL, V111, P583; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Sawyer LA, 2000, ANTIVIR RES, V47, P57, DOI 10.1016/S0166-3542(00)00111-X; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Tamura D, 2009, J CLIN MICROBIOL, V47, P1424, DOI 10.1128/JCM.02396-08; TAMURA S, 1991, EUR J IMMUNOL, V21, P1337, DOI 10.1002/eji.1830210602; WONG JP, 1994, IMMUNOLOGY, V81, P280	33	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13622	10.1371/journal.pone.0013622	http://dx.doi.org/10.1371/journal.pone.0013622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049034	Green Published, gold			2022-12-25	WOS:000283487400015
J	Birts, CN; Bergman, LM; Blaydes, JP				Birts, C. N.; Bergman, L. M.; Blaydes, J. P.			CtBPs promote mitotic fidelity through their activities in the cell nucleus	ONCOGENE			English	Article						aurora B; CtBP proteins; BARS; mitosis; transcriptional repressor	HISTONE DEACETYLASE INHIBITORS; NEGATIVE MODULATION; GENE-EXPRESSION; BINDING CLEFT; PROTEIN; COREPRESSOR; PHOSPHOPROTEIN; SURVIVAL; FISSION; REGION	CtBPs form NADH-sensitive chromatin-modifying complexes, which link cellular metabolism to gene transcription. They also function in the cytoplasm to regulate Golgi fissioning; their inhibition can consequently cause a Golgi-dependent checkpoint in G(2). We have recently identified a novel role of CtBPs in the maintenance of mitotic fidelity; inhibition of CtBP synthesis resulting in reduced association of aurora B with mitotic chromatin and aberrant segregation of chromosomes. Here, we demonstrate that it is the interaction of CtBPs with transcriptional regulators and/or chromatin-modifying enzymes in the cell nucleus, rather than their role in Golgi fission, which is critical for the maintenance of mitotic fidelity. Oncogene (2011) 30, 1272-1280; doi:10.1038/onc.2010.507; published online 8 November 2010	[Birts, C. N.; Blaydes, J. P.] Univ Southampton, Sch Med, Southampton Canc Res UK Ctr, Southampton SO16 6YD, Hants, England; [Bergman, L. M.] Therapeut Goods Adm, Med Toxicol Evaluat Sect, Off Prescript Med, Woden, ACT, Australia	University of Southampton	Blaydes, JP (corresponding author), Univ Southampton, Sch Med, Southampton Gen Hosp, Southampton Canc Res UK Ctr, MP 824, Southampton SO16 6YD, Hants, England.	j.p.blaydes@soton.ac.uk	Blaydes, Jeremy/AAC-6939-2019; Birts, Charles N/N-9845-2013	Blaydes, Jeremy/0000-0001-8525-0209; Bergman, Lee/0000-0002-0111-411X; Birts, Charles/0000-0002-0368-8766	UK Breast Cancer Campaign	UK Breast Cancer Campaign	We are grateful to Matthew Darley for the generation of plasmid reagents, Patrick Duriez for the preparation of GST fusion proteins for microinjection, and the Southampton School of Medicine Bioimaging Unit for assistance with live cell imaging. Funding for the work was from the UK Breast Cancer Campaign.	Bergman LM, 2006, APOPTOSIS, V11, P879, DOI 10.1007/s10495-006-6651-4; Bergman LM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-35; Bergman LM, 2009, MOL CELL BIOL, V29, P4539, DOI 10.1128/MCB.00439-09; Blaydes JP, 1997, ONCOGENE, V14, P1859, DOI 10.1038/sj.onc.1201018; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Carcedo CH, 2004, SCIENCE, V305, P93, DOI 10.1126/science.1097775; Chen YW, 2008, CANCER RES, V68, P476, DOI 10.1158/0008-5472.CAN-07-1960; Cheok CF, 2010, CELL DEATH DIFFER, V17, P1486, DOI 10.1038/cdd.2010.18; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Colanzi A, 2007, EMBO J, V26, P2465, DOI 10.1038/sj.emboj.7601686; Ditchfield Claire, 2004, V296, P371; Eot-Houllier G, 2009, CANCER LETT, V274, P169, DOI 10.1016/j.canlet.2008.06.005; Grooteclaes M, 2003, P NATL ACAD SCI USA, V100, P4568, DOI 10.1073/pnas.0830998100; Kovi RC, 2010, CELL DEATH DIFFER, V17, P513, DOI 10.1038/cdd.2009.140; Kuppuswamy M, 2008, MOL CELL BIOL, V28, P269, DOI 10.1128/MCB.01077-07; Mirnezami AH, 2003, CURR BIOL, V13, P1234, DOI 10.1016/S0960-9822(03)00454-8; Mroz EA, 2008, CANCER RES, V68, P6049, DOI 10.1158/0008-5472.CAN-08-1279; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Paliwal S, 2006, MOL CELL BIOL, V26, P2360, DOI 10.1128/MCB.26.6.2360-2372.2006; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8202, DOI 10.1128/MCB.00445-06; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Stevens FE, 2008, ONCOGENE, V27, P1345, DOI 10.1038/sj.onc.1210779; Warrener R, 2003, FASEB J, V17, P1550, DOI 10.1096/fj.02-1003fje; Yang JS, 2008, NAT CELL BIOL, V10, P1146, DOI 10.1038/ncb1774; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zhang QH, 2002, SCIENCE, V295, P1895	29	8	8	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	11					1272	1280		10.1038/onc.2010.507	http://dx.doi.org/10.1038/onc.2010.507			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	736JX	21057548				2022-12-25	WOS:000288492100002
J	Qin, XH; Tan, Y; Wang, LL; Wang, ZF; Wang, BF; Wen, X; Yang, GF; Xi, Z; Shen, YQ				Qin, Xiaohong; Tan, Ying; Wang, Lele; Wang, Zhifang; Wang, Baifan; Wen, Xin; Yang, Guangfu; Xi, Zhen; Shen, Yuequan			Structural insight into human variegate porphyria disease	FASEB JOURNAL			English	Article						protoporphyrinogen IX oxidase; mitochondrial inner membrane protein; VP-causing mutations; FAD-containing enzyme	PROTOPORPHYRINOGEN OXIDASE GENE; CRYSTAL-STRUCTURE; TERMINAL STEPS; IX OXIDASE; HEME; MUTATIONS; ENZYME; IDENTIFICATION; EXPRESSION; PROTEINS	Human protoporphyrinogen IX oxidase (hPPO), a mitochondrial inner membrane protein, converts protoporphyrinogen IX to protoporphyrin IX in the heme biosynthetic pathway. Mutations in the hPPO gene cause the inherited human disease variegate porphyria (VP). In this study, we report the crystal structure of hPPO in complex with the coenzyme flavin adenine dinucleotide (FAD) and the inhibitor acifluorfen at a resolution of 1.9 angstrom. The structural and biochemical analyses revealed the molecular details of FAD and acifluorfen binding to hPPO as well as the interactions of the substrate with hPPO. Structural analysis and gel chromatography indicated that hPPO is a monomer rather than a homodimer in vitro. The founder-effect mutation R59W in VP patients is most likely caused by a severe electrostatic hindrance in the hydrophilic binding pocket involving the bulky, hydrophobic indolyl ring of the tryptophan. Forty-seven VP-causing mutations were purified by chromatography and kinetically characterized in vitro. The effect of each mutation was demonstrated in the high-resolution crystal structure.-Qin, X., Tan, Y., Wang, L., Wang, Z., Wang, B., Wen, X., Yang, G., Xi, Z., Shen, Y. Structural insight into human variegate porphyria disease. FASEB J. 25, 653-664 (2011). www.fasebj.org	[Qin, Xiaohong; Wang, Lele; Shen, Yuequan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Tan, Ying; Wang, Zhifang; Wang, Baifan; Wen, Xin; Xi, Zhen] Nankai Univ, State Key Lab Elementoorgan Chem, Dept Biol Chem, Coll Chem, Tianjin 300071, Peoples R China; [Tan, Ying; Yang, Guangfu] Cent China Normal Univ, Key Lab Pesticide & Chem Biol, Minist Educ, Coll Chem, Wuhan, Peoples R China	Nankai University; Nankai University; Central China Normal University	Shen, YQ (corresponding author), Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China.	zhenxi@nankai.edu.cn; yuequan74@yahoo.com	Wang, Baifan/J-3491-2014; Shen, Yuequan/C-8950-2013; TAN, YING/AAT-4671-2020	Wang, Baifan/0000-0003-0887-5795; Shen, Yuequan/0000-0002-3775-0900; TAN, YING/0000-0003-2957-0165	Ministry of Science and Technology [2007CB914301, 2009CB825504, 2006AA02A319, 2010CB126102, 2008DFA30770]; Tianjin Basic Research program [08QTPTJC28200, 08SYSYTC00200]; National Science Foundation of China [30940015, 20932005, 90713011, 30770428]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tianjin Basic Research program; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Ministry of Science and Technology (2007CB914301, 2009CB825504, 2006AA02A319, 2010CB126102, and 2008DFA30770), the Tianjin Basic Research program (08QTPTJC28200 and 08SYSYTC00200), and the National Science Foundation of China (30940015, 20932005, 90713011, and 30770428). The authors are grateful to the staff at beamline BL-17U1 in the Shanghai Synchrotron Radiation Facility and beamline 3W1A in the Beijing Synchrotron Radiation Facility for excellent technical assistance during data collection. The atomic coordinates and structure factors for the structure of hPPO in complex with acifluorfen have been deposited in the PDB (accession code 3NKS).	Bonnin A, 2009, J INHERIT METAB DIS, V32, pS59, DOI 10.1007/s10545-009-1059-2; BRENNER DA, 1980, NEW ENGL J MED, V302, P765, DOI 10.1056/NEJM198004033021401; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choi EJ, 2006, PROTEIN ENG DES SEL, V19, P285, DOI 10.1093/protein/gzl007; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; Corradi HR, 2006, J BIOL CHEM, V281, P38625, DOI 10.1074/jbc.M606640200; Dailey HA, 2002, BIOCHEM SOC T, V30, P590, DOI 10.1042/bst0300590; Dailey TA, 1998, J BIOL CHEM, V273, P13658, DOI 10.1074/jbc.273.22.13658; Dailey TA, 1996, PROTEIN SCI, V5, P98; DEYBACH JC, 1985, EUR J BIOCHEM, V149, P431, DOI 10.1111/j.1432-1033.1985.tb08943.x; Deybach JC, 1996, HUM MOL GENET, V5, P407, DOI 10.1093/hmg/5.3.407; Di Pierro E, 2009, CELL MOL BIOL, V55, P79, DOI 10.1170/T856; Elder GH, 1997, LANCET, V349, P1613, DOI 10.1016/S0140-6736(96)09070-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERREIRA GC, 1988, J BIOL CHEM, V263, P3835; Gill R, 2009, BIOCHEM J, V420, P17, DOI 10.1042/BJ20082077; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; Heinemann IU, 2007, BIOCHEM J, V402, P575, DOI 10.1042/BJ20061321; Hunte C., 2003, MEMBRANE PROTEIN PUR; Ilc G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011715; Kauppinen R, 2005, LANCET, V365, P241; Koch M, 2004, EMBO J, V23, P1720, DOI 10.1038/sj.emboj.7600189; Kunji ERS, 2008, METHODS, V46, P62, DOI 10.1016/j.ymeth.2008.10.020; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee DS, 2005, P NATL ACAD SCI USA, V102, P14232, DOI 10.1073/pnas.0506557102; MAIRE ML, 2008, NAT PROTOC, V3, P1782; Maneli MH, 2003, BBA-PROTEINS PROTEOM, V1650, P10, DOI 10.1016/S1570-9639(03)00186-9; Mathews MAA, 2001, EMBO J, V20, P5832, DOI 10.1093/emboj/20.21.5832; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meissner PN, 1996, NAT GENET, V13, P95, DOI 10.1038/ng0596-95; Morgan RR, 2002, CELL MOL BIOL, V48, P79; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MORTIER WJ, 1985, J AM CHEM SOC, V107, P829, DOI 10.1021/ja00290a017; NISHIMURA K, 1995, J BIOL CHEM, V270, P8076, DOI 10.1074/jbc.270.14.8076; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PROULX KL, 1993, PROTEIN SCI, V2, P1092, DOI 10.1002/pro.5560020703; Puy H, 1996, BIOCHEM BIOPH RES CO, V226, P226, DOI 10.1006/bbrc.1996.1337; Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5; Qin XH, 2010, J STRUCT BIOL, V170, P76, DOI 10.1016/j.jsb.2009.11.012; ROBERTS AG, 1995, HUM MOL GENET, V4, P2387, DOI 10.1093/hmg/4.12.2387; Rossetti MV, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-54; Sassa S, 2006, BRIT J HAEMATOL, V135, P281, DOI 10.1111/j.1365-2141.2006.06289.x; Schneider-Yin X, 2009, SWISS MED WKLY, V139, P198, DOI smw-12496; Shepherd M, 2005, ANAL BIOCHEM, V344, P115, DOI 10.1016/j.ab.2005.06.012; Song GJ, 2009, FASEB J, V23, P396, DOI 10.1096/fj.08-115469; Sun L, 2009, AMINO ACIDS, V37, P523, DOI 10.1007/s00726-009-0256-5; Warnich L, 1996, HUM MOL GENET, V5, P981, DOI 10.1093/hmg/5.7.981; Whitby FG, 1998, EMBO J, V17, P2463, DOI 10.1093/emboj/17.9.2463; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; Wu CK, 2001, NAT STRUCT BIOL, V8, P156, DOI 10.1038/84152	51	46	49	0	49	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					653	664		10.1096/fj.10-170811	http://dx.doi.org/10.1096/fj.10-170811			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	21048046				2022-12-25	WOS:000286724800023
J	Wang, XQ; Hawkins, BT; Miller, DS				Wang, Xueqian; Hawkins, Brian T.; Miller, David S.			Aryl hydrocarbon receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier	FASEB JOURNAL			English	Article						P-glycoprotein; multidrug resistance-associated protein 2; breast cancer resistance protein; dioxin; brain capillaries	CANCER RESISTANCE PROTEIN; P-GLYCOPROTEIN; IN-VITRO; DNA-BINDING; ALPHA-NAPHTHOFLAVONE; DRUG TRANSPORTER; ABC TRANSPORTERS; CYTOCHROMES P450; DIOXIN RECEPTOR; AH RECEPTOR	Many widespread and persistent organic pollutants, e.g., 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), activate the aryl hydrocarbon receptor (AhR), causing it to translocate to the cell nucleus, where it transactivates target genes. AhR's ability to target the blood-brain barrier is essentially unexplored. We show here that exposing isolated rat brain capillaries to 0.05-0.5 nM TCDD roughly doubled transport activity and protein expression of P-glycoprotein, an ATP-driven drug efflux pump and a critical determinant of drug entry into the CNS. These effects were abolished by actinomycin D or cycloheximide or by the AhR antagonists resveratrol and alpha-naphthoflavone. Brain capillaries from TCDD-dosed rats (1-5 mu g/kg, i.p.) exhibited increased transport activity and protein expression of 3 xenobiotic efflux pumps, P-glycoprotein, multidrug resistance-associated protein 2, and breast cancer resistance polypeptide, as well as expression of Cyp1a1 and Cyp1b1, both AhR target genes. Consistent with increased P-glycoprotein expression in capillaries from TCDD-dosed rats, in situ brain perfusion indicated significantly reduced brain accumulation of verapamil, a P-glycoprotein substrate. These findings suggest a new paradigm for the field of environmental toxicology: toxicants acting through AhR to target xenobiotic efflux transporters at the blood-brain barrier and thus reduce brain accumulation of CNS-acting therapeutic drugs.-Wang, X., Hawkins, B. T., Miller, D. S. Aryl hydrocarbon receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier. FASEB J. 25, 644-652 (2011). www.fasebj.org	[Wang, Xueqian; Hawkins, Brian T.; Miller, David S.] NIEHS, Lab Toxicol & Pharmacol, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Miller, DS (corresponding author), NIEHS, Lab Toxicol & Pharmacol, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	miller@niehs.nih.gov		Hawkins, Brian/0000-0001-6719-5402	National Institute of Environmental Health Sciences, National Institutes of Health	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Agarwal S, 2010, J PHARMACOL EXP THER, V334, P147, DOI 10.1124/jpet.110.167601; Allen JD, 2002, MOL CANCER THER, V1, P417; Bauer B, 2008, J CEREBR BLOOD F MET, V28, P1222, DOI 10.1038/jcbfm.2008.16; Bauer B, 2006, MOL PHARMACOL, V70, P1212, DOI 10.1124/mol.106.023796; Bertazzi PA, 1998, ENVIRON HEALTH PERSP, V106, P625, DOI 10.2307/3433813; Casper RF, 1999, MOL PHARMACOL, V56, P784; Chen Y, 2009, J PHARMACOL EXP THER, V330, P956, DOI 10.1124/jpet.109.154781; Collins LL, 2008, TOXICOL SCI, V103, P125, DOI 10.1093/toxsci/kfn017; Dagenais C, 2001, PHARMACEUT RES, V18, P957, DOI 10.1023/A:1010984110732; Dauchy S, 2009, BIOCHEM PHARMACOL, V77, P897, DOI 10.1016/j.bcp.2008.11.001; Dauchy S, 2008, J NEUROCHEM, V107, P1518, DOI 10.1111/j.1471-4159.2008.05720.x; de Klerk OL, 2010, J PSYCHOPHARMACOL, V24, P1237, DOI 10.1177/0269881109349840; Deng L, 2001, J BIOL CHEM, V276, P413, DOI 10.1074/jbc.M004551200; Drahushuk AT, 1996, TOXICOL APPL PHARM, V140, P393, DOI 10.1006/taap.1996.0236; Filbrandt CR, 2004, NEUROTOXICOLOGY, V25, P605, DOI 10.1016/j.neuro.2003.08.007; GASIEWICZ TA, 1987, J BIOL CHEM, V262, P2116; Geyer J, 2009, J VET PHARMACOL THER, V32, P87, DOI 10.1111/j.1365-2885.2008.01007.x; Granberg L, 2003, DRUG METAB DISPOS, V31, P259, DOI 10.1124/dmd.31.3.259; Han Y, 2006, BIOL PHARM BULL, V29, P1032, DOI 10.1248/bpb.29.1032; Harrigan JA, 2006, TOXICOL IN VITRO, V20, P426, DOI 10.1016/j.tiv.2005.08.015; HARTZ AM, MOL PHARM, V77, P715; Hartz AMS, 2004, MOL PHARMACOL, V66, P387, DOI 10.1124/mol.104.001503; Hawkins BT, 2010, J NEUROSCI, V30, P1417, DOI 10.1523/JNEUROSCI.5103-09.2010; Hong SJ, 1998, TOXICOL APPL PHARM, V148, P7, DOI 10.1006/taap.1997.8317; Jigorel E, 2006, DRUG METAB DISPOS, V34, P1756, DOI 10.1124/dmd.106.010033; Johnson DR, 2002, TOXICOL SCI, V67, P182, DOI 10.1093/toxsci/67.2.182; Joiakim A, 2003, DRUG METAB DISPOS, V31, P1279, DOI 10.1124/dmd.31.11.1279; Kainu T, 1995, NEUROREPORT, V6, P2557, DOI 10.1097/00001756-199512150-00026; Klaassen CD, PHARM REV, V62, P1; Ko HSP, 1996, MOL CELL BIOL, V16, P430; Mandal PK, 2005, J COMP PHYSIOL B, V175, P221, DOI 10.1007/s00360-005-0483-3; Mathieu MC, 2001, J BIOL CHEM, V276, P4819, DOI 10.1074/jbc.M008495200; Miller DS, 2010, TRENDS PHARMACOL SCI, V31, P246, DOI 10.1016/j.tips.2010.03.003; Miller DS, 2000, MOL PHARMACOL, V58, P1357, DOI 10.1124/mol.58.6.1357; Minsavage GD, 2004, J BIOL CHEM, V279, P20582, DOI 10.1074/jbc.M312977200; Nayyar T, 2002, EXP TOXICOL PATHOL, V53, P461, DOI 10.1078/0940-2993-00219; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Noguchi K, 2009, ADV DRUG DELIVER REV, V61, P26, DOI 10.1016/j.addr.2008.07.003; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; Rigor RR, 2010, J CEREBR BLOOD F MET, V30, P1373, DOI 10.1038/jcbfm.2010.21; SANTOSTEFANO M, 1993, MOL PHARMACOL, V43, P200; SCHRAMM U, 1995, AM J PHYSIOL-RENAL, V268, pF46, DOI 10.1152/ajprenal.1995.268.1.F46; Seelbach M, 2010, ENVIRON HEALTH PERSP, V118, P479, DOI 10.1289/ehp.0901334; Shukla S, 2009, PHARM RES-DORDR, V26, P480, DOI 10.1007/s11095-008-9735-8; Smith Quentin R, 2003, Methods Mol Med, V89, P209; Wang XQ, 2010, MOL PHARMACOL, V78, P376, DOI 10.1124/mol.110.063685; White SS, 2009, J ENVIRON SCI HEAL C, V27, P197, DOI 10.1080/10590500903310047; WILHELMSSON A, 1994, J BIOL CHEM, V269, P19028; Zhou SF, 2008, CURR MED CHEM, V15, P1981, DOI 10.2174/092986708785132870	50	78	80	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					644	652		10.1096/fj.10-169227	http://dx.doi.org/10.1096/fj.10-169227			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	21048045	Green Published			2022-12-25	WOS:000286724800022
J	Fontanesi, F; Clemente, P; Barrientos, A				Fontanesi, Flavia; Clemente, Paula; Barrientos, Antoni			Cox25 Teams Up with Mss51, Ssc1, and Cox14 to Regulate Mitochondrial Cytochrome c Oxidase Subunit 1 Expression and Assembly in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE SYSTEM; HUMAN-CELLS; YEAST; PROTEIN; TRANSLATION; BIOGENESIS; MUTANTS; PRODUCT; ENZYMES; DENITRIFICANS	In the yeast Saccharomyces cerevisiae, mitochondrial cytochrome c oxidase (COX) biogenesis is translationally regulated. Mss51, a specific COX1 mRNA translational activator and Cox1 chaperone, drives the regulatory mechanism. During translation and post-translationally, newly synthesized Cox1 physically interacts with a complex of proteins involving Ssc1, Mss51, and Cox14, which eventually hand over Cox1 to the assembly pathway. This step is probably catalyzed by assembly chaperones such as Shy1 in a process coupled to the release of Ssc1-Mss51 from the complex. Impaired COX assembly results in the trapping of Mss51 in the complex, thus limiting its availability for COX1 mRNA translation. An exception is a null mutation in COX14 that does not affect Cox1 synthesis because the Mss51 trapping complexes become unstable, and Mss51 is readily available for translation. Here we present evidence showing that Cox25 is a new essential COX assembly factor that plays some roles similar to Cox14. A null mutation in COX25 by itself or in combination with other COX mutations does not affect Cox1 synthesis. Cox25 is an inner mitochondrial membrane intrinsic protein with a hydrophilic C terminus protruding into the matrix. Cox25 is an essential component of the complexes containing newly synthesized Cox1, Ssc1, Mss51, and Cox14. In addition, Cox25 is also found to interact with Shy1 and Cox5 in a complex that does not contain Mss51. These results suggest that once Ssc1-Mss51 are released from the Cox1 stabilization complex, Cox25 continues to interact with Cox14 and Cox1 to facilitate the formation of multisubunit COX assembly intermediates.	[Fontanesi, Flavia; Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Clemente, Paula] Univ Autonoma Madrid, Fac Med, Dept Bioquim, Inst Invest Biomed,Alberto Sols Consejo Super Inv, E-28029 Madrid, Spain	University of Miami; University of Miami; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Barrientos, A (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol & Biochem Mol Biol, 1600 NW 10th Ave,RMSB 2067, Miami, FL 33136 USA.	abarrientos@med.miami.edu	Clemente, Paula/AAA-5768-2021	Clemente, Paula/0000-0002-6885-3750; Fontanesi, Flavia/0000-0003-0509-3835	National Institutes of Health [GM071775A]; Muscular Dystrophy Association; Consejeria de Educacion de la Comunidad de Madrid y Fondo Social Europeo; Universidad Autonoma de Madrid; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Consejeria de Educacion de la Comunidad de Madrid y Fondo Social Europeo; Universidad Autonoma de Madrid; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071775A (to A. B.). This work was also supported by a research grant from the Muscular Dystrophy Association (to A. B.) and a development grant from the Muscular Dystrophy Association (to F. F.).; Recipient of a research contract from the Consejeria de Educacion de la Comunidad de Madrid y Fondo Social Europeo and of a predoctoral fellowship for mobility from the Universidad Autonoma de Madrid (under the mentorship of Dr. Rafael Garesse).	Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Barros MH, 2002, FEBS LETT, V516, P119, DOI 10.1016/S0014-5793(02)02514-0; Carlson CG, 2003, J BIOL CHEM, V278, P3770, DOI 10.1074/jbc.M209893200; Choquet Y, 2001, BIOCHEM SOC T, V29, P421, DOI 10.1042/BST0290421; Church C, 2005, J BIOL CHEM, V280, P1854, DOI 10.1074/jbc.M410726200; FAYE G, 1974, J MOL BIOL, V88, P105, DOI 10.1016/0022-2836(74)90304-0; Fontanesi F, 2008, IUBMB LIFE, V60, P557, DOI 10.1002/iub.86; Fontanesi F, 2008, HUM MOL GENET, V17, P775, DOI 10.1093/hmg/ddm349; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; Glerum DM, 1997, J BIOL CHEM, V272, P19088, DOI 10.1074/jbc.272.30.19088; Glerum DM, 1997, FEBS LETT, V412, P410, DOI 10.1016/S0014-5793(97)00799-0; Glerum DM, 1996, J BIOL CHEM, V271, P20531, DOI 10.1074/jbc.271.34.20531; GLERUM DM, 1995, J BIOL CHEM, V270, P15585, DOI 10.1074/jbc.270.26.15585; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Hell K, 1997, FEBS LETT, V418, P367, DOI 10.1016/S0014-5793(97)01412-9; HERRMANN JM, 1994, J CELL BIOL, V127, P893, DOI 10.1083/jcb.127.4.893; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Horn D, 2010, J BIOL CHEM, V285, P15088, DOI 10.1074/jbc.M110.104786; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langer T, 2001, BIOCHEM SOC T, V29, P431, DOI 10.1042/BST0290431; Maniatis T., 1982, MOL CLONING LAB MANU; Manthey GM, 1998, EUR J BIOCHEM, V255, P156, DOI 10.1046/j.1432-1327.1998.2550156.x; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; NOBREGA MP, 1990, J BIOL CHEM, V265, P14220; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Shingu-Vazquez M, 2010, J BIOL CHEM, V285, P34382, DOI 10.1074/jbc.M110.161976; Soto IC, 2009, BBA-MOL CELL RES, V1793, P1776, DOI 10.1016/j.bbamcr.2009.09.002; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TZAGOLOFF A, 1990, EMBO J, V9, P2759, DOI 10.1002/j.1460-2075.1990.tb07463.x; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8228; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8236; Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200; Wollman FA, 1999, BBA-BIOENERGETICS, V1411, P21, DOI 10.1016/S0005-2728(99)00043-2; Wostrikoff K, 2007, P NATL ACAD SCI USA, V104, P6466, DOI 10.1073/pnas.0610586104; Zambrano A, 2007, MOL BIOL CELL, V18, P523, DOI 10.1091/mbc.E06-09-0803	47	62	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					555	566		10.1074/jbc.M110.188805	http://dx.doi.org/10.1074/jbc.M110.188805			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21068384	hybrid, Green Published			2022-12-25	WOS:000285782800058
J	Hu, G; Ren, G; Shi, Y				Hu, G.; Ren, G.; Shi, Y.			The putative cannabinoid receptor GPR55 promotes cancer cell proliferation	ONCOGENE			English	Editorial Material							LYSOPHOSPHATIDYLINOSITOL; LIGAND; BINDS	Cannabinoids, the active ingredients in marijuana, have dramatic effects on various organ systems. They exert their effects through two receptor types: CB1, primarily located in the brain, and CB2, primarily located in the immune system. Vertebrates also produce their own cannabinoid-like substances called endocannabinoids, including anandamide and 2-arachidonoylglyceral. Interestingly, some effects of endocannabinoids could not be explained by the signals through either CB1 or CB2. Recently, the orphan G protein-coupled receptor 55 (GPR55) was proposed to be an atypical cannabinoid receptor. In this issue of Oncogene, two groups demonstrated that GPR55 is expressed in various cancer types in an aggressiveness-related manner, suggesting a novel cancer biomarker and a potential therapeutic target. Oncogene (2011) 30, 139-141; doi:10.1038/onc.2010.502; published online 8 November 2010	[Hu, G.; Shi, Y.] Shanghai Jiao Tong Univ, Chinese Acad Sci, Key Lab Stem Cell Biol, Shanghai Inst Biol Sci,Sch Med,Inst Hlth Sci, Shanghai 200025, Peoples R China; [Ren, G.; Shi, Y.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Shi, Y (corresponding author), Shanghai Jiao Tong Univ, Chinese Acad Sci, Key Lab Stem Cell Biol, Shanghai Inst Biol Sci,Sch Med,Inst Hlth Sci, 225 S Chongqing Rd, Shanghai 200025, Peoples R China.	yufangshi@sibs.ac.cn	Ren, Gary/F-6724-2011; Shi, Yufang/AAE-4431-2020; Ren, Guangwen/D-8895-2012; Ren, Guangwen/H-5671-2011	Shi, Yufang/0000-0001-8964-319X; 				Alexander A, 2009, CANCER LETT, V285, P6, DOI 10.1016/j.canlet.2009.04.005; Andradas C, 2011, ONCOGENE, V30, P245, DOI 10.1038/onc.2010.402; DAS SK, 1995, P NATL ACAD SCI USA, V92, P4332, DOI 10.1073/pnas.92.10.4332; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Ford LA, 2010, BRIT J PHARMACOL, V160, P762, DOI 10.1111/j.1476-5381.2010.00743.x; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Oesch S, 2009, J PHARM PHARMACOL, V61, P839, DOI 10.1211/jpp/61.07.0002; Oka S, 2010, J BIOCHEM, V147, P671, DOI 10.1093/jb/mvp208; PINCIRO R, 2011, ONCOGENE, V30, P142; Sharir H, 2010, PHARMACOL THERAPEUT, V126, P301, DOI 10.1016/j.pharmthera.2010.02.004; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; Sugiura T, 1996, BIOCHEM BIOPH RES CO, V229, P58, DOI 10.1006/bbrc.1996.1757; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106	14	30	34	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	2					139	141		10.1038/onc.2010.502	http://dx.doi.org/10.1038/onc.2010.502			3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709LG	21057532				2022-12-25	WOS:000286438900002
J	Faisal, A; Stout, D; Apel, J; Bradley, B				Faisal, Aldo; Stout, Dietrich; Apel, Jan; Bradley, Bruce			The Manipulative Complexity of Lower Paleolithic Stone Toolmaking	PLOS ONE			English	Article							HAND; LANGUAGE; ORGANIZATION; TECHNOLOGY; EVOLUTION; BEHAVIOR; SPEECH; BRAIN; TOOL; ARTIFACTS	Background: Early stone tools provide direct evidence of human cognitive and behavioral evolution that is otherwise unavailable. Proper interpretation of these data requires a robust interpretive framework linking archaeological evidence to specific behavioral and cognitive actions. Methodology/Principal Findings: Here we employ a data glove to record manual joint angles in a modern experimental toolmaker (the 4(th) author) replicating ancient tool forms in order to characterize and compare the manipulative complexity of two major Lower Paleolithic technologies (Oldowan and Acheulean). To this end we used a principled and general measure of behavioral complexity based on the statistics of joint movements. Conclusions/Significance: This allowed us to confirm that previously observed differences in brain activation associated with Oldowan versus Acheulean technologies reflect higher-level behavior organization rather than lower-level differences in manipulative complexity. This conclusion is consistent with a scenario in which the earliest stages of human technological evolution depended on novel perceptual-motor capacities (such as the control of joint stiffness) whereas later developments increasingly relied on enhanced mechanisms for cognitive control. This further suggests possible links between toolmaking and language evolution.	[Faisal, Aldo] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Faisal, Aldo] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England; [Stout, Dietrich] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Apel, Jan] Gotland Univ Coll, Dept Archaeol & Osteol, Visby, Sweden; [Bradley, Bruce] Univ Exeter, Dept Archaeol, Exeter, Devon, England	Imperial College London; Imperial College London; Emory University; University of Exeter	Faisal, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.	aldo.faisal@imperial.ac.uk; dwstout@emory.edu	Faisal, Aldo/A-2367-2009	Faisal, Aldo/0000-0003-0813-7207; Stout, Dietrich/0000-0003-3555-7637	Commission of the European Communities Research Directorate [029065]	Commission of the European Communities Research Directorate	This work was supported by the Commission of the European Communities Research Directorate-General Specific Targeted Project number 029065, Hand to Mouth: A framework for understanding the archaeological and fossil records of human cognitive evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Bril B, 2005, STONE KNAPPING NECES, P353; Bril B., 2005, STONE KNAPPING NECES, P53; Bril B., 2000, PERLES CAMBAY PRACTI, P211; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Byrne Richard W., 2004, P31, DOI 10.1017/CBO9780511542299.005; Callahan E., 1979, ARCHAEOLOGY E N AM, V7, P1; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; CHASE PG, 1991, J ANTHROPOL ARCHAEOL, V10, P193, DOI 10.1016/0278-4165(91)90013-N; Clark J. D., 1994, INTEGRATIVE PATHS PA, P451; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; Deacon T., 1997, SYMBOLIC SPECIES COE; FAISAL A, 2009, COSYNE 2009; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Frey SH, 2006, J NEUROSCI, V26, P13194, DOI 10.1523/JNEUROSCI.3914-06.2006; Gowlett J. A. J., 1984, HOMINID EVOLUTION CO, P167; GOWLETT JAJ, 1996, MODELLING EARLY HUMA; GREENFIELD PM, 1991, BEHAV BRAIN SCI, V14, P531, DOI 10.1017/S0140525X00071235; GUIARD Y, 1987, J MOTOR BEHAV, V19, P486; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hartmann K, 2005, NEUROPSYCHOLOGIA, V43, P625, DOI 10.1016/j.neuropsychologia.2004.07.015; Higuchi S, 2009, NEUROREPORT, V20, P1376, DOI 10.1097/WNR.0b013e3283315570; HOLLOWAY RL, 1969, CURR ANTHROPOL, V10, P395, DOI 10.1086/201036; Ingram JN, 2008, EXP BRAIN RES, V188, P223, DOI 10.1007/s00221-008-1355-3; ISAAC GL, 1976, ANN NY ACAD SCI, V280, P275, DOI 10.1111/j.1749-6632.1976.tb25494.x; Jubault T, 2007, J NEUROSCI, V27, P11028, DOI 10.1523/JNEUROSCI.1986-07.2007; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Lang CE, 2004, J NEUROPHYSIOL, V92, P2802, DOI 10.1152/jn.00480.2004; Liberman AM, 2000, TRENDS COGN SCI, V4, P187, DOI 10.1016/S1364-6613(00)01471-6; Lieberman P, 2002, YEARB PHYS ANTHROPOL, V45, P36, DOI 10.1002/ajpa.10171; MACNEILAGE PF, 1991, BEHAV BRAIN SCI, V14, P568, DOI 10.1017/S0140525X00071405; Marzke MW, 1998, AM J PHYS ANTHROPOL, V105, P315, DOI 10.1002/(SICI)1096-8644(199803)105:3<315::AID-AJPA3>3.3.CO;2-D; MARZKE MW, 1986, J HUM EVOL, V15, P439, DOI 10.1016/S0047-2484(86)80027-6; Milner TE, 1998, IEEE T BIO-MED ENG, V45, P1363, DOI 10.1109/10.725333; MUNHALL KG, 1994, J ACOUST SOC AM, V95, P3605, DOI 10.1121/1.409929; Ottoni EB, 2000, BEHAV RES METH INS C, V32, P446, DOI 10.3758/BF03200814; Rearick MP, 2002, EXP BRAIN RES, V144, P38, DOI 10.1007/s00221-002-1024-x; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Ross ED, 2008, BRAIN LANG, V104, P51, DOI 10.1016/j.bandl.2007.04.007; ROUX V, 1995, WORLD ARCHAEOL, V27, P63, DOI 10.1080/00438243.1995.9980293; Roux V., 2005, STONE KNAPPING NECES, P243; Santello M, 1998, J NEUROSCI, V18, P10105; Sato M, 2009, BRAIN LANG, V111, P1, DOI 10.1016/j.bandl.2009.03.002; SAVAGERUMBAUGH S, 2006, OLDOWAN CASE STUDIES, P223; Schick K. D., 1993, MAKING SILENT STONES; Schieber MH, 2004, J APPL PHYSIOL, V96, P2293, DOI 10.1152/japplphysiol.01063.2003; Selen LPJ, 2009, J NEUROSCI, V29, P12606, DOI 10.1523/JNEUROSCI.2826-09.2009; Semaw S, 2000, J ARCHAEOL SCI, V27, P1197, DOI 10.1006/jasc.1999.0592; Shadmehr R., 2005, COMPUTATIONAL NEUROB; Stephan KE, 2003, SCIENCE, V301, P384, DOI 10.1126/science.1086025; Stout D, 2008, PHILOS T R SOC B, V363, P1939, DOI 10.1098/rstb.2008.0001; Stout D, 2007, NEUROPSYCHOLOGIA, V45, P1091, DOI 10.1016/j.neuropsychologia.2006.09.014; Stout D, 2010, J HUM EVOL, V58, P474, DOI 10.1016/j.jhevol.2010.02.005; Stout D, 2009, CAMB ARCHAEOL J, V19, P85, DOI 10.1017/S0959774309000055; Studdert-Kennedy M., 2003, STUDIES EVOLUTION LA, P235, DOI DOI 10.1093/ACPROF:OSO/9780199244843.003.0013; Tocheri MW, 2008, J ANAT, V212, P544, DOI 10.1111/j.1469-7580.2008.00865.x; Todorov E, 2004, P ANN INT IEEE EMBS, V26, P4637; Uomini NT, 2009, J HUM EVOL, V57, P411, DOI 10.1016/j.jhevol.2009.02.012; WYNN T, 1989, MAN, V24, P383, DOI 10.2307/2802697; [No title captured]	62	83	84	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13718	10.1371/journal.pone.0013718	http://dx.doi.org/10.1371/journal.pone.0013718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	674WJ	21072164	Green Submitted, Green Published, gold			2022-12-25	WOS:000283780800002
J	Brandariz-Nunez, A; Menaya-Vargas, R; Benavente, J; Martinez-Costas, J				Brandariz-Nunez, Alberto; Menaya-Vargas, Rebeca; Benavente, Javier; Martinez-Costas, Jose			IC-Tagging and Protein Relocation to ARV muNS Inclusions: A Method to Study Protein-Protein Interactions in the Cytoplasm or Nucleus of Living Cells	PLOS ONE			English	Article							AVIAN REOVIRUS MORPHOGENESIS; LARGE-T-ANTIGEN; SIGMA-NS; VIRUS; REPLICATION; FACTORIES; TRANSFORMATION; ASSOCIATIONS; PLATFORMS	Background: Characterization of protein-protein interactions is essential for understanding cellular functions. Although there are many published methods to analyze protein-protein interactions, most of them present serious limitations. In a different study we have characterized a novel avian reovirus muNS-based protein tagging and inclusion targeting method, and demonstrated its validity to purify free an immobilized protein. Methodology/Principal Findings: Here we present a method to identify protein-protein interactions inside living eukaryotic cells (tested in primate and avian cells). When p53 was tagged with Intercoil (IC; muNS residues 477-542), it not only got integrated into muNS cytoplasmic inclusions, but also attracted its known ligand SV40 large T antigen (TAg) to these structures. We have also adapted this system to work within the cell nucleus, by creating muNS-related protein chimeras that form nuclear inclusions. We show that nuclear muNS-derived inclusions are as efficient as cytoplasmic ones in capturing IC-tagged proteins, and that the proteins targeted to nuclear inclusions are able to interact with their known ligands. Conclusions/Significance: Our protein redistribution method does not present the architectural requirement of reconstructing a transcription factor as any of the two-hybrid systems do. The method is simple and requires only cell transfection and a fluorescence microscope. Our tagging method can be used either in the cytoplasm or the nucleus of living cells to test protein-protein interactions or to perform functional studies by protein ligand sequestration.	[Brandariz-Nunez, Alberto] Univ Santiago de Compostela, Fac Pharm, Dept Biochem & Mol Biol, Santiago De Compostela, Spain; Univ Santiago de Compostela, Ctr Res Biol Chem & Mol Mat, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; CiQUS	Brandariz-Nunez, A (corresponding author), Univ Santiago de Compostela, Fac Pharm, Dept Biochem & Mol Biol, Santiago De Compostela, Spain.	jose.martinez.costas@usc.es	Martinez-Costas, Jose/E-9005-2011; Brandariz, Alberto/S-2630-2016; Benavente, Javier/N-6475-2016	Martinez-Costas, Jose/0000-0002-8877-7775; Brandariz, Alberto/0000-0002-0640-1599; Benavente, Javier/0000-0003-4857-0312	European Commission [ERAS-CT-2003-980409]; Spanish Ministerio de Ciencia y Tecnologia [BFU2007-61330, BFU 205-24982-E]; Xunta de Galicia [08CSA009203PR]; Spanish Ministerio de Ciencia y Tecnologia	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from the European Commission under contracts ERAS-CT-2003-980409 (as part of the European Science Foundation EUROCORES Programme EuroSCOPE, web: http://www.esf.org/euroscope); the Spanish Ministerio de Ciencia y Tecnologia (BFU2007-61330, BFU 205-24982-E, web: http://www.mityc.es/) and Xunta de Galicia (08CSA009203PR, web: http://www.conselleriaiei.org/ga/dxidi/index.php). ABN was the recipient of a predoctoral FPI fellowship from the Spanish Ministerio de Ciencia y Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SH, 2001, SEMIN CANCER BIOL, V11, P15, DOI 10.1006/scbi.2000.0342; Attoui H, 2000, J GEN VIROL, V81, P1507, DOI 10.1099/0022-1317-81-6-1507; Benavente J, 2006, CURR TOP MICROBIOL, V309, P67; Benavente J, 2007, VIRUS RES, V123, P105, DOI 10.1016/j.virusres.2006.09.005; Brandariz-Nunez A, 2010, J VIROL, V84, P4289, DOI 10.1128/JVI.02534-09; BRANDARIZNUNEZ J, 2010, PLOS ONE IN PRESS; Costas C, 2005, J VIROL, V79, P2141, DOI 10.1128/JVI.79.4.2141-2150.2005; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Guan HT, 2008, ADV BIOCHEM ENG BIOT, V110, P1, DOI 10.1007/10_2007_092; Jones RC, 2000, REV SCI TECH OIE, V19, P614, DOI 10.20506/rst.19.2.1237; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Lievens S, 2009, TRENDS BIOCHEM SCI, V34, P579, DOI 10.1016/j.tibs.2009.06.009; MARTINEZCOSTAS J, 1995, VIROLOGY, V206, P1017, DOI 10.1006/viro.1995.1024; Mertens P, 2004, VIRUS RES, V101, P3, DOI 10.1016/j.virusres.2003.12.002; Miller CL, 2007, MOL CELL PROTEOMICS, V6, P1027, DOI 10.1074/mcp.M700056-MCP200; Netherton C, 2007, ADV VIRUS RES, V70, P101, DOI 10.1016/S0065-3527(07)70004-0; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Schmitz AM, 2009, NAT METHODS, V6, P500, DOI 10.1038/nmeth.1337; Touris-Otero F, 2004, J MOL BIOL, V341, P361, DOI 10.1016/j.jmb.2004.06.026; Touris-Otero F, 2004, VIROLOGY, V319, P94, DOI 10.1016/j.virol.2003.10.034; van der Heide L, 2000, AVIAN DIS, V44, P638, DOI 10.2307/1593104; Vazquez-Iglesias L, 2009, J VIROL, V83, P10163, DOI 10.1128/JVI.01080-09; ZALVIDE J, 1995, MOL CELL BIOL, V15, P5800; Zhang X, 2005, VIROLOGY, V343, P25, DOI 10.1016/j.virol.2005.08.002	25	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13785	10.1371/journal.pone.0013785	http://dx.doi.org/10.1371/journal.pone.0013785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072177	Green Submitted, gold, Green Published			2022-12-25	WOS:000283779700005
J	Chen, XY; Kim, P; Farinelli, B; Doukas, A; Yun, SH; Gelfand, JA; Anderson, RR; Wu, MX				Chen, Xinyuan; Kim, Pilhan; Farinelli, Bill; Doukas, Apostolos; Yun, Seok-Hyun; Gelfand, Jeffrey A.; Anderson, Richard R.; Wu, Mei X.			A Novel Laser Vaccine Adjuvant Increases the Motility of Antigen Presenting Cells	PLOS ONE			English	Article							ANTIBODIES; RESPONSES; DELIVERY; SQUALENE; THERAPY	Background: Development of a potent vaccine adjuvant without introduction of any side effects remains an unmet challenge in the field of the vaccine research. Methodology/Principal Findings: We found that laser at a specific setting increased the motility of antigen presenting cells (APCs) and immune responses, with few local or systemic side effects. This laser vaccine adjuvant (LVA) effect was induced by brief illumination of a small area of the skin or muscle with a nondestructive, 532 nm green laser prior to intradermal (i.d.) or intramuscular (i.m.) administration of vaccines at the site of laser illumination. The pre-illumination accelerated the motility of APCs as shown by intravital confocal microscopy, leading to sufficient antigen (Ag)-uptake at the site of vaccine injection and transportation of the Ag-captured APCs to the draining lymph nodes. As a result, the number of Ag+ dendritic cells (DCs) in draining lymph nodes was significantly higher in both the 1 degrees and 2 degrees draining lymph nodes in the presence than in the absence of LVA. Laser-mediated increases in the motility and lymphatic transportation of APCs augmented significantly humoral immune responses directed against a model vaccine ovalbumin (OVA) or influenza vaccine i.d. injected in both primary and booster vaccinations as compared to the vaccine itself. Strikingly, when the laser was delivered by a hair-like diffusing optical fiber into muscle, laser illumination greatly boosted not only humoral but also cell-mediated immune responses provoked by i.m. immunization with OVA relative to OVA alone. Conclusion/Significance: The results demonstrate the ability of this safe LVA to augment both humoral and cell-mediated immune responses. In comparison with all current vaccine adjuvants that are either chemical compounds or biological agents, LVA is novel in both its form and mechanism; it is risk-free and has distinct advantages over traditional vaccine adjuvants.	[Chen, Xinyuan; Kim, Pilhan; Farinelli, Bill; Doukas, Apostolos; Yun, Seok-Hyun; Anderson, Richard R.; Wu, Mei X.] Harvard Univ, Sch Med, Dept Dermatol, Wellman Ctr Photomed,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Gelfand, Jeffrey A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA USA; [Anderson, Richard R.; Wu, Mei X.] Harvard MIT Div Hlth Sci & Technol, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Chen, XY (corresponding author), Harvard Univ, Sch Med, Dept Dermatol, Wellman Ctr Photomed,Massachusetts Gen Hosp, Boston, MA 02115 USA.	mwu2@partners.org	Kim, Pilhan/C-1836-2011; Gelfand, Jeffrey A/G-1885-2018	Kim, Pilhan/0000-0001-8388-1840; Gelfand, Jeffrey A/0000-0002-4118-5676	National Institutes of Health [AI070785, RC1 DA028378]; Boston Biocom LLC. [2008A2565]; Bill and Melinda Gates Foundation [53273]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI070785, R01AI089779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA028378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Biocom LLC.; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported in part by the National Institutes of Health grants AI070785 and RC1 DA028378, Sponsored Research agreement grant #2008A25652 from Boston Biocom LLC., and Grand Challenges Explorations grant #53273 from the Bill and Melinda Gates Foundation (to M.X.W.). As Boston Biocom partially employed J.G., Boston Biocom did play a role in data analysis and preparation of the manuscript. Other funders had no role in the study design, data analysis, preparation of the manuscript and the decision to publish or preparation of the manuscript.	Aguilar JC, 2007, VACCINE, V25, P3752, DOI 10.1016/j.vaccine.2007.01.111; ALVING CR, 1993, ANN NY ACAD SCI, V690, P265; APRILE MA, 1966, C J PUBLIC HEALTH, V57, P343; Asa PB, 2000, EXP MOL PATHOL, V68, P55, DOI 10.1006/exmp.1999.2295; Asa PB, 2002, EXP MOL PATHOL, V73, P19, DOI 10.1006/exmp.2002.2429; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Castano AP, 2008, P NATL ACAD SCI USA, V105, P5495, DOI 10.1073/pnas.0709256105; Chen WR, 2006, J ENVIRON PATHOL TOX, V25, P281, DOI 10.1615/JEnvironPatholToxicolOncol.v25.i1-2.180; CLAESSON BA, 1988, J PEDIATR-US, V112, P695, DOI 10.1016/S0022-3476(88)80684-X; CVJETANOVIC B, 1965, ORGAN */* B WORLD HL, V32, P29; DAVENPORT FM, 1968, J IMMUNOL, V100, P1139; Doukas AG, 2004, ADV DRUG DELIVER REV, V56, P559, DOI 10.1016/j.addr.2003.10.031; Gherardi RK, 2001, BRAIN, V124, P1821, DOI 10.1093/brain/124.9.1821; GUPTA RK, 1995, VACCINE, V13, P1263, DOI 10.1016/0264-410X(95)00011-O; GUPTA RK, 1995, VACCINE, V13, P1623, DOI 10.1016/0264-410X(95)00112-E; Kandolf-Sekulovic L, 2003, PHOTODERMATOL PHOTO, V19, P203, DOI 10.1034/j.1600-0781.2003.00040.x; Kim P, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2839043; Klas SD, 2008, VACCINE, V26, P5494, DOI 10.1016/j.vaccine.2008.07.062; Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x; Ng CP, 2005, J CELL SCI, V118, P4731, DOI 10.1242/jcs.02605; Nishibu A, 2006, J INVEST DERMATOL, V126, P787, DOI 10.1038/sj.jid.5700107; Onikienko SB, 2006, DONOSOLOGIYA ST PETE, V1, P32; Ostberg JR, 2003, INT J HYPERTHER, V19, P520, DOI 10.1080/02656730310001607986; Posten W, 2005, DERMATOL SURG, V31, P334, DOI 10.1097/00042728-200503000-00016; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Satoh M, 2003, J AUTOIMMUN, V21, P1, DOI 10.1016/S0896-8411(03)00083-0; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Zeira E, 2007, FASEB J, V21, P3522, DOI 10.1096/fj.06-7528com	28	45	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13776	10.1371/journal.pone.0013776	http://dx.doi.org/10.1371/journal.pone.0013776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048884	Green Published, gold, Green Submitted			2022-12-25	WOS:000283645300050
J	den Besten, HMW; Arvind, A; Gaballo, HMS; Moezelaar, R; Zwietering, MH; Abee, T				den Besten, Heidy M. W.; Arvind, Aarathi; Gaballo, Heidi M. S.; Moezelaar, Roy; Zwietering, Marcel H.; Abee, Tjakko			Short- and Long-Term Biomarkers for Bacterial Robustness: A Framework for Quantifying Correlations between Cellular Indicators and Adaptive Behavior	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; GENERAL STRESS-RESPONSE; BACILLUS-CEREUS ATCC-14579; LISTERIA-MONOCYTOGENES; HYDROGEN-PEROXIDE; ENVIRONMENTAL-CHANGES; STAPHYLOCOCCUS-AUREUS; FOOD PRESERVATION; SIGMA(B) REGULON; SALT STRESS	The ability of microorganisms to adapt to changing environments challenges the prediction of their history-dependent behavior. Cellular biomarkers that are quantitatively correlated to stress adaptive behavior will facilitate our ability to predict the impact of these adaptive traits. Here, we present a framework for identifying cellular biomarkers for mild stress induced enhanced microbial robustness towards lethal stresses. Several candidate-biomarkers were selected by comparing the genome-wide transcriptome profiles of our model-organism Bacillus cereus upon exposure to four mild stress conditions (mild heat, acid, salt and oxidative stress). These candidate-biomarkers-a transcriptional regulator (activating general stress responses), enzymes (removing reactive oxygen species), and chaperones and proteases (maintaining protein quality)were quantitatively determined at transcript, protein and/or activity level upon exposure to mild heat, acid, salt and oxidative stress for various time intervals. Both unstressed and mild stress treated cells were also exposed to lethal stress conditions (severe heat, acid and oxidative stress) to quantify the robustness advantage provided by mild stress pretreatment. To evaluate whether the candidate-biomarkers could predict the robustness enhancement towards lethal stress elicited by mild stress pretreatment, the biomarker responses upon mild stress treatment were correlated to mild stress induced robustness towards lethal stress. Both short-and long-term biomarkers could be identified of which their induction levels were correlated to mild stress induced enhanced robustness towards lethal heat, acid and/ or oxidative stress, respectively, and are therefore predictive cellular indicators for mild stress induced enhanced robustness. The identified biomarkers are among the most consistently induced cellular components in stress responses and ubiquitous in biology, supporting extrapolation to other microorganisms than B. cereus. Our quantitative, systematic approach provides a framework to search for these biomarkers and to evaluate their predictive quality in order to select promising biomarkers that can serve to early detect and predict adaptive traits.	[den Besten, Heidy M. W.; Arvind, Aarathi; Gaballo, Heidi M. S.; Moezelaar, Roy; Abee, Tjakko] Top Inst Food & Nutr, Wageningen, Netherlands; [den Besten, Heidy M. W.; Arvind, Aarathi; Gaballo, Heidi M. S.; Zwietering, Marcel H.; Abee, Tjakko] Univ Wageningen & Res Ctr, Food Microbiol Lab, Wageningen, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research	den Besten, HMW (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	tjakko.abee@wur.nl	Zwietering, Marcel/C-2479-2008	Zwietering, Marcel/0000-0003-2704-5690				Abee T, 1999, INT J FOOD MICROBIOL, V50, P65, DOI 10.1016/S0168-1605(99)00078-1; Allen KJ, 2008, FOODBORNE PATHOG DIS, V5, P437, DOI 10.1089/fpd.2008.0100; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Browne N, 2002, J APPL MICROBIOL, V92, P404, DOI 10.1046/j.1365-2672.2002.01541.x; Browne N, 2001, J APPL MICROBIOL, V91, P1085, DOI 10.1046/j.1365-2672.2001.01478.x; Brul S, 2006, INT J FOOD MICROBIOL, V112, P195, DOI 10.1016/j.ijfoodmicro.2006.04.014; Bsat N, 1998, MOL MICROBIOL, V29, P189, DOI 10.1046/j.1365-2958.1998.00921.x; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Ceragioli M, 2010, APPL ENVIRON MICROB, V76, P3352, DOI 10.1128/AEM.03003-09; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Culligan EP, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-19; de Been M, 2010, ENVIRON MICROBIOL, V12, P730, DOI 10.1111/j.1462-2920.2009.02116.x; den Besten HMW, 2006, APPL ENVIRON MICROB, V72, P5884, DOI 10.1128/AEM.00780-06; den Besten HMW, 2009, APPL ENVIRON MICROB, V75, P4111, DOI 10.1128/AEM.02891-08; Derre I, 1999, MOL MICROBIOL, V31, P117, DOI 10.1046/j.1365-2958.1999.01152.x; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; Frees D, 2007, MOL MICROBIOL, V63, P1285, DOI 10.1111/j.1365-2958.2007.05598.x; Gahan CGM, 1999, INT J FOOD MICROBIOL, V50, P93, DOI 10.1016/S0168-1605(99)00079-3; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; Hain T, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-20; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Herbig AF, 2001, MOL MICROBIOL, V41, P849, DOI 10.1046/j.1365-2958.2001.02543.x; Hill C, 2002, INT DAIRY J, V12, P273, DOI 10.1016/S0958-6946(01)00125-X; Hols P, 2005, FEMS MICROBIOL REV, V29, P435, DOI 10.1016/j.femsre.2005.04.008; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Kazmierczak MJ, 2003, J BACTERIOL, V185, P5722, DOI 10.1128/JB.185.19.5722-5734.2003; Koburger T, 2005, MOL GENET GENOMICS, V274, P1, DOI 10.1007/s00438-005-1119-8; LEISTNER L, 1995, TRENDS FOOD SCI TECH, V6, P41, DOI 10.1016/S0924-2244(00)88941-4; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Mols M, 2010, INT J FOOD MICROBIOL, V137, P13, DOI 10.1016/j.ijfoodmicro.2009.09.027; PANE F, 2006, INT J MED MICROBIOL, V296, P237; Periago PM, 2002, APPL ENVIRON MICROB, V68, P3486, DOI 10.1128/AEM.68.7.3486-3495.2002; Petersohn A, 2001, J BACTERIOL, V183, P5617, DOI 10.1128/JB.183.19.5617-5631.2001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Price CW, 2001, MOL MICROBIOL, V41, P757, DOI 10.1046/j.1365-2958.2001.02534.x; Rea R, 2005, APPL ENVIRON MICROB, V71, P8314, DOI 10.1128/AEM.71.12.8314-8322.2005; Serrazanetti DI, 2009, FOOD MICROBIOL, V26, P700, DOI 10.1016/j.fm.2009.07.007; Skandamis PN, 2008, FOOD MICROBIOL, V25, P294, DOI 10.1016/j.fm.2007.10.008; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; van Schaik W, 2005, APPL ENVIRON MICROB, V71, P6427, DOI 10.1128/AEM.71.10.6427-6430.2005; van Schaik W, 2005, J BACTERIOL, V187, P5846, DOI 10.1128/JB.187.16.5846-5851.2005; van Schaik W, 2005, CURR OPIN BIOTECH, V16, P218, DOI 10.1016/j.copbio.2005.01.008; van Schaik W, 2004, J BACTERIOL, V186, P316, DOI 10.1128/JB.186.2.316-325.2004; van Schaik W, 2007, J BACTERIOL, V189, P4384, DOI 10.1128/JB.00313-07; VAND V, 2007, MICROBIOLOGY, V153, P3593; Wolf DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001700; WOODBURY W, 1971, ANAL BIOCHEM, V44, P301, DOI 10.1016/0003-2697(71)90375-7	49	44	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13746	10.1371/journal.pone.0013746	http://dx.doi.org/10.1371/journal.pone.0013746			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060783	Green Submitted, Green Published, gold			2022-12-25	WOS:000283645300026
J	Dou, ZH; Chen, RY; Wang, Z; Ji, GP; Peng, GP; Qiao, XC; Fu, JH; Meng, XD; Bulterys, M; Ma, Y; Zhao, Y; Wang, N; Zhang, FJ				Dou, Zhihui; Chen, Ray Y.; Wang, Zhe; Ji, Guoping; Peng, Guoping; Qiao, Xiaochun; Fu, Jihua; Meng, Xiangdong; Bulterys, Marc; Ma, Ye; Zhao, Yan; Wang, Ning; Zhang, Fujie			HIV-Infected Former Plasma Donors in Rural Central China: From Infection to Survival Outcomes, 1985-2008	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; MIDDLE-INCOME COUNTRIES; TREATMENT PROGRAM; BLOOD-DONORS; DRUG-USERS; FOLLOW-UP; SEROCONVERSION; MORTALITY	Background: The HIV epidemic among former plasma donors (FPDs) in rural Central China in the early-mid 1990s is likely the largest known HIV-infected cohort in the world related to commercial plasma donation but has never been fully described. The objectives of this study are to estimate the timing and geographic spread of HIV infection in this cohort and to demonstrate the impact of antiretroviral therapy on survival outcomes. Methodology/Principal Findings: HIV-infected FPDs were identified using the national HIV epidemiology and treatment databases. Locations of subjects were mapped. Dates of infection and survival were estimated using the midpoint date between initial-final plasma donation dates from 1985-2008 among those with plasma donation windows <= 2 years. Among 37084 FPDs in the two databases, 36110 were included. 95% were located in focal areas of Henan Province and adjacent areas of surrounding provinces. Midpoint year between initial-final plasma donation dates was 1994 among FPDs with known donation dates. Median survival from infection to AIDS was 11.8 years and, among those not treated, 1.6 years from AIDS to death. Among those on treatment, 71% were still alive after five years. Using Cox proportional hazard modeling, untreated AIDS patients were 4.9 times (95% confidence interval 4.6-5.2) more likely to die than those on treatment. Conclusions/Significance: The epidemic of HIV-infected FPD in China was not widespread throughout China but rather was centered in Henan Province and the adjacent areas of surrounding provinces. Even in these areas, infections were concentrated in focal locations. Overall, HIV infections in this cohort peaked in 1994, with median survival of 13.4 years from infection to death among those not treated. Among AIDS patients on treatment, 71% were still alive after five years.	[Dou, Zhihui; Ma, Ye; Zhao, Yan; Wang, Ning; Zhang, Fujie] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Chen, Ray Y.] US Natl Inst Hlth, Natl Inst Allergy & Infect Dis, Beijing, Peoples R China; [Wang, Zhe] Henan Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Ji, Guoping] Anhui Ctr Dis Control & Prevent, Hefei, Peoples R China; [Peng, Guoping] Hubei Ctr Dis Control & Prevent, Wuhan, Peoples R China; [Qiao, Xiaochun] Shanxi Ctr Dis Control & Prevent, Taiyuan, Peoples R China; [Fu, Jihua] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China; [Meng, Xiangdong] Jilin Ctr Dis Control & Prevent, Changchun, Peoples R China; [Bulterys, Marc] US Ctr Dis Control & Prevent, Global AIDS Program, Beijing, Peoples R China; [Zhang, Fujie] Beijing Ditan Hosp, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Capital Medical University	Dou, ZH (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wangnbj@163.com; treatment@chinaaids.cn	Chen, Ray/GRJ-6736-2022; Chen, Ray/T-5102-2019	Chen, Ray/0000-0001-6344-1442	China Ministry of Science and Technology [973:2006CB504201]	China Ministry of Science and Technology(Ministry of Science and Technology, China)	This work was supported in part by a grant from the China Ministry of Science and Technology Chinese National Basic Research Program (973:2006CB504201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Brettle RP, 1996, AIDS, V10, P419, DOI 10.1097/00002030-199604000-00011; Chinese Center for Disease Control and Prevention, 2005, CHIN FREE ART MAN; Ghys PD, 2007, AIDS, V21, pS1, DOI 10.1097/01.aids.0000299404.99033.bf; Glynn JR, 2007, AIDS, V21, P625, DOI 10.1097/QAD.0b013e328017f857; He N, 2005, CELL RES, V15, P825, DOI 10.1038/sj.cr.7290354; Ji GP, 2006, AIDS, V20, P585, DOI 10.1097/01.aids.0000210613.45212.c4; MA Y, 2009, INT J EPIDEMIOL; *MIN HLTH, 1987, PROV MON CONTR AIDS; PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508; PORTER K, 2004, AIDS S2, V2, pS9; PORTER K, 2004, AIDS S2, V2, pS17; Qian HZ, 2006, AIDS, V20, P1429, DOI 10.1097/01.aids.0000233577.33973.fa; Qian HZ, 2005, J INFECT DIS, V192, P1694, DOI 10.1086/497148; Sun XH, 2007, AIDS, V21, pS33, DOI 10.1097/01.aids.0000304694.54884.06; SUN YD, 1991, CHINESE MED J-PEKING, V104, P975; TODD J, 2007, AIDS S6, V6, pS55; Volkow P, 2001, LANCET, V358, P2001, DOI 10.1016/S0140-6736(01)06996-3; Wang N, 1991, Zhonghua Yi Xue Za Zhi, V71, P671; WANG N, 1991, ZHONGHUA YI XUE ZA Z, V71, P646; Wang S, 1991, Zhonghua Yi Xue Za Zhi, V71, P76; WARD JW, 1989, NEW ENGL J MED, V321, P947, DOI 10.1056/NEJM198910053211406; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; WU ZY, 1995, LANCET, V346, P61, DOI 10.1016/S0140-6736(95)92698-4; Wu ZY, 2001, HEALTH POLICY PLANN, V16, P41, DOI 10.1093/heapol/16.1.41; Xu JQ, 2006, CHINESE MED J-PEKING, V119, P1941, DOI 10.1097/00029330-200612010-00002; ZHANG FJ, 2008, DECADE HAART; Zhang FJ, 2008, CLIN INFECT DIS, V47, P825, DOI 10.1086/590945; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhang Xiao-fei, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P314; Zheng X, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P253; 2008, SEX TRANSM INFECT S1, V84, P31	35	58	72	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13737	10.1371/journal.pone.0013737	http://dx.doi.org/10.1371/journal.pone.0013737			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060835	Green Submitted, gold, Green Published			2022-12-25	WOS:000283645300017
J	Miller, MP; Haig, SM				Miller, Mark P.; Haig, Susan M.			Identifying Shared Genetic Structure Patterns among Pacific Northwest Forest Taxa: Insights from Use of Visualization Tools and Computer Simulations	PLOS ONE			English	Article							RANGE EXPANSION; INTRASPECIFIC PHYLOGEOGRAPHY; POPULATION; LANDSCAPE; FLOW; DIVERSITY; EVOLUTIONARY; HYPOTHESES; DIVERGENCE; DISPERSAL	Background: Identifying causal relationships in phylogeographic and landscape genetic investigations is notoriously difficult, but can be facilitated by use of multispecies comparisons. Methodology/Principal Findings: We used data visualizations to identify common spatial patterns within single lineages of four taxa inhabiting Pacific Northwest forests (northern spotted owl: Strix occidentalis caurina; red tree vole: Arborimus longicaudus; southern torrent salamander: Rhyacotriton variegatus; and western white pine: Pinus monticola). Visualizations suggested that, despite occupying the same geographical region and habitats, species responded differently to prevailing historical processes. S. o. caurina and P. monticola demonstrated directional patterns of spatial genetic structure where genetic distances and diversity were greater in southern versus northern locales. A. longicaudus and R. variegatus displayed opposite patterns where genetic distances were greater in northern versus southern regions. Statistical analyses of directional patterns subsequently confirmed observations from visualizations. Based upon regional climatological history, we hypothesized that observed latitudinal patterns may have been produced by range expansions. Subsequent computer simulations confirmed that directional patterns can be produced by expansion events. Conclusions/Significance: We discuss phylogeographic hypotheses regarding historical processes that may have produced observed patterns. Inferential methods used here may become increasingly powerful as detailed simulations of organisms and historical scenarios become plausible. We further suggest that inter-specific comparisons of historical patterns take place prior to drawing conclusions regarding effects of current anthropogenic change within landscapes.	[Miller, Mark P.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Miller, Mark P.] Utah State Univ, Ctr High Performance Comp, Logan, UT 84322 USA; [Miller, Mark P.; Haig, Susan M.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; United States Department of the Interior; United States Geological Survey	Miller, MP (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	mpmiller@usgs.gov	Miller, Mark/A-5488-2011	Miller, Mark/0000-0003-1045-1772	U.S. Geological Survey Forest; Rangeland Ecosystem Science Center	U.S. Geological Survey Forest(United States Geological Survey); Rangeland Ecosystem Science Center	This work was supported by the U.S. Geological Survey Forest and Rangeland Ecosystem Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen B. G., 1994, ICE AGE WORLD INTRO; Austerlitz F, 2001, GENETICS, V157, P851; Balkenhol N, 2009, LANDSCAPE ECOL, V24, P455, DOI 10.1007/s10980-009-9334-z; BONNICKSEN T. M., 2000, AM ANCIENT FORESTS I; Brunsfeld S., 2001, INTEGRATING ECOLOGY, V14, P319; Burns KJ, 2006, MOL PHYLOGENET EVOL, V38, P117, DOI 10.1016/j.ympev.2005.07.008; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Crida A, 2007, MOL ECOL NOTES, V7, P588, DOI 10.1111/j.1471-8286.2007.01753.x; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Epperson BK, 2010, MOL ECOL, V19, P3549, DOI 10.1111/j.1365-294X.2010.04678.x; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Excoffier L, 2006, NAT REV GENET, V7, P745, DOI 10.1038/nrg1904; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; FU YX, 1993, GENETICS, V133, P693; Funk WC, 2008, EVOL APPL, V1, P161, DOI 10.1111/j.1752-4571.2007.00002.x; FUYX, 1997, GENETICS, V147, P915; Garrick RC, 2008, MOL ECOL, V17, P1401, DOI 10.1111/j.1365-294X.2008.03675.x; GRAHAM RT, 2004, USDA HDB, V654, P775; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Haig SM, 2004, CONSERV GENET, V5, P683, DOI 10.1007/s10592-004-1864-y; Hartl D., 1989, PRINCIPLES POPULATIO; Irwin DE, 2002, EVOLUTION, V56, P2383; Johnson JA, 2008, J HERED, V99, P165, DOI 10.1093/jhered/esn002; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Manel S, 2007, MOL ECOL, V16, P2031, DOI 10.1111/j.1365-294X.2007.03293.x; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; MANTEL N, 1967, CANCER RES, V27, P209; Martin PR, 2004, EVOLUTION, V58, P938; Mila B, 2007, P R SOC B, V274, P2653, DOI 10.1098/rspb.2007.0852; Miller MP, 2006, J HERED, V97, P561, DOI 10.1093/jhered/esl038; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Miller MP, 2006, MOL ECOL, V15, P145, DOI 10.1111/j.1365-294X.2005.02765.x; NEI M, 1978, GENETICS, V89, P583; Nielsen R, 2009, MOL ECOL, V18, P1034, DOI 10.1111/j.1365-294X.2008.04059.x; Nielson M, 2001, EVOLUTION, V55, P147; Panchal M, 2007, EVOLUTION, V61, P1466, DOI 10.1111/j.1558-5646.2007.00124.x; Petit RJ, 2008, MOL ECOL, V17, P1404, DOI 10.1111/j.1365-294X.2008.03692.x; Petit RJ, 2008, MOL ECOL, V17, P516, DOI 10.1111/j.1365-294X.2007.03589.x; Petit RJ, 2002, GENETICS, V161, P469; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Rousset F, 1997, GENETICS, V145, P1219; Schneider S, 1999, GENETICS, V152, P1079; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; SOKAL RR, 1978, BIOL J LINN SOC, V10, P229, DOI 10.1111/j.1095-8312.1978.tb00014.x; Soltis DE, 1997, PLANT SYST EVOL, V206, P353, DOI 10.1007/BF00987957; STEINHOFF RJ, 1983, CAN J FOREST RES, V13, P1122, DOI 10.1139/x83-150; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; Templeton AR, 2008, MOL ECOL, V17, P1877, DOI 10.1111/j.1365-294X.2008.03731.x; Templeton AR, 2009, MOL ECOL, V18, P319, DOI 10.1111/j.1365-294X.2008.04026.x; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; Templeton AR, 2002, GENETICS, V161, P473; USDA/USDI [U.S.D.A. Forest Service; U.S.D.I. Bureau of Land Management], 2000, FIN SUPPL ENV IMP ST, V1; USFWS, 1990, FED REGISTER, V55, P26114; Vandergast AG, 2008, BIOL CONSERV, V141, P1648, DOI 10.1016/j.biocon.2008.04.009; Wilke T, 2004, MOL ECOL, V13, P2303, DOI 10.1111/j.1365-294X.2004.02234.x; WRIGHT S, 1946, GENETICS, V31, P39; 2000, FED REG, V65, P35951	63	6	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13683	10.1371/journal.pone.0013683	http://dx.doi.org/10.1371/journal.pone.0013683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060824	Green Published, gold, Green Submitted			2022-12-25	WOS:000283645300004
J	Ferret-Bernard, S; Remot, A; Lacroix-Lamande, S; Metton, C; Bernardet, N; Drouet, F; Laurent, F				Ferret-Bernard, Stephanie; Remot, Aude; Lacroix-Lamande, Sonia; Metton, Coralie; Bernardet, Nelly; Drouet, Francoise; Laurent, Fabrice			Cellular and Molecular Mechanisms Underlying the Strong Neonatal IL-12 Response of Lamb Mesenteric Lymph Node Cells to R-848	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; DENDRITIC CELLS; INNATE IMMUNITY; CYTOKINE PRODUCTION; BASIC MECHANISMS; IDENTIFICATION; MODULATION; AGONISTS; TH1	Background: Comparative studies on the response of neonates and adults to TLR stimulation have been almost exclusively limited to comparisons of human neonatal cord blood cells with peripheral blood from adults, and analyses of spleen cell responses in mice. We need to extend these studies and gain further information regarding such responses at mucosal sites. Methodology/Principal Findings: We used sheep as a large animal model to study TLR agonist responses in the lymph nodes draining the intestine, an organ that must adapt to profound changes after birth. In response to the imidazoquinoline compound R-848, neonatal mesenteric lymph node (MLN) and spleen cells produced more IL-12 and, consequently, more IFN gamma than their adult counterparts. This difference was age-related for both organs, but the preferential IL-12 response decreased more rapidly in the MLN, with young animals producing similar amounts of this cytokine to adults, from the age of 20 days onwards. Intracellular assays and depletion experiments identified CD14(+)CD11b(+)CD40(+) cells as the main producer of IL-12. These cells accounted for a greater proportion of neonatal than of adult MLN cells, and also produced, in direct response to R-848, more IL-12 after isolation. This strong IL-12 response in neonates occurred despite the production of larger amounts of the regulatory cytokine IL-10 and the stronger upregulation of SOCS-1 and SOCS-3 mRNA levels than in adult cells, and was correlated with an increase in p38/MAPK phosphorylation. Conclusions/Significance: This is the first attempt to decipher the mechanism by which neonatal MLN cells produce more IL-12 than adult cells in response to the TLR8 agonist R-848. CD14(+)CD11b(+)CD40(+) IL-12-producing cells were more numerous in neonate than in adult MLN cells and displayed higher intracellular responsiveness upon R-848 stimulation. This work provides relevant information for future vaccination or immunostimulation strategies targeting neonates.	[Ferret-Bernard, Stephanie; Remot, Aude; Lacroix-Lamande, Sonia; Metton, Coralie; Bernardet, Nelly; Drouet, Francoise; Laurent, Fabrice] INRA, Equipe Control & Immunol Malad Enter Nouveau Ne, Infectiol Anim & St Publ UR1282, F-37380 Nouzilly, France	INRAE	Ferret-Bernard, S (corresponding author), INRA, Equipe Control & Immunol Malad Enter Nouveau Ne, Infectiol Anim & St Publ UR1282, F-37380 Nouzilly, France.	fabrice.laurent@tours.inra.fr	Laurent, fabrice/AAC-2266-2019; Ferret-Bernard, Stéphanie/AAD-4465-2019	Laurent, fabrice/0000-0002-9687-7952; Ferret-Bernard, Stéphanie/0000-0002-1439-9206; Remot, Aude/0000-0001-9896-3216; LAMANDE, Sonia/0000-0002-7865-4587	French National Institute for Agricultural Research (INRA); Scottish Executive Environment and Rural Affairs Department (SEERAD)	French National Institute for Agricultural Research (INRA); Scottish Executive Environment and Rural Affairs Department (SEERAD)	This work was funded by The French National Institute for Agricultural Research (INRA). S.F.B. had a Postdoctoral Research Fellowship supported by INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank T. Chaumeil and E. Guitton for supplying us with animals and for helping us with the neonates in the animal facilities. We would also like to thank Y. Le Vern for expert technical assistance with cell sorting and P.Y. Sizaret for help with electron microscopy. We thank S. Wattegedera for providing recombinant ovine cytokines, which were produced at the Moredun Research Institute with funding from the Scottish Executive Environment and Rural Affairs Department (SEERAD) in collaboration with the BBSRC/SEERAD Immunological Toolbox initiative. The authors also thank J. Naessens for producing, and J. C. Hope and I. Schwartz-Cornil for supplying, the anti-ovine CD40. Finally, we would also like to thank L. Guzylack-Piriou for providing His<INF>6</INF>-tagged porcine Flt3 ligand.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; Barrier M, 2006, J INFECT DIS, V193, P1400, DOI 10.1086/503748; Bonneau M, 2006, J LEUKOCYTE BIOL, V79, P268, DOI 10.1189/jlb.0605288; Booth JS, 2009, MUCOSAL IMMUNOL, V2, P265, DOI 10.1038/mi.2009.6; Buza J, 2008, VET IMMUNOL IMMUNOP, V126, P273, DOI 10.1016/j.vetimm.2008.08.001; Caron JE, 2010, NEONATOLOGY, V97, P266, DOI 10.1159/000255165; Chelvarajan L, 2007, J LEUKOCYTE BIOL, V82, P403, DOI 10.1189/jlb.0107071; Chelvarajan RL, 2004, J LEUKOCYTE BIOL, V75, P982, DOI 10.1189/jlb.0403179; Elhmouzi-Younes J, 2009, VET RES, V40, DOI 10.1051/vetres/2009037; Fach SJ, 2006, VET IMMUNOL IMMUNOP, V112, P171, DOI 10.1016/j.vetimm.2006.02.012; Foulon E, 2008, J IMMUNOL METHODS, V339, P1, DOI 10.1016/j.jim.2008.07.012; Goriely S, 2004, J EXP MED, V199, P1011, DOI 10.1084/jem.20031272; Guzylack-Piriou L, 2010, DEV COMP IMMUNOL, V34, P455, DOI 10.1016/j.dci.2009.12.006; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hope JC, 2002, J IMMUNOL METHODS, V266, P117, DOI 10.1016/S0022-1759(02)00113-8; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Kwong LS, 2002, VET IMMUNOL IMMUNOP, V85, P213, DOI 10.1016/S0165-2427(02)00007-7; Lacroix-Lamande S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008291; Lahiri A, 2008, VACCINE, V26, P6777, DOI 10.1016/j.vaccine.2008.09.045; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Levy O, 2006, BLOOD, V108, P1284, DOI 10.1182/blood-2005-12-4821; Macpherson AJ, 2006, J EXP MED, V203, P497, DOI 10.1084/jem.20060227; Marodi L, 2002, CLIN EXP IMMUNOL, V128, P1, DOI 10.1046/j.1365-2249.2002.01873.x; Pascale F, 2008, J IMMUNOL, V180, P5963, DOI 10.4049/jimmunol.180.9.5963; Pedersen LG, 2002, VET IMMUNOL IMMUNOP, V88, P111, DOI 10.1016/S0165-2427(02)00139-3; Philbin VJ, 2007, BIOCHEM SOC T, V35, P1485, DOI 10.1042/BST0351485; Siegrist C A, 2000, Int Rev Immunol, V19, P195, DOI 10.3109/08830180009088505; Sun CM, 2005, IMMUNITY, V22, P467, DOI 10.1016/j.immuni.2005.02.008; Sun CM, 2003, BLOOD, V102, P585, DOI 10.1182/blood-2002-09-2966; Tourais-Esteves I, 2008, DEV COMP IMMUNOL, V32, P1231, DOI 10.1016/j.dci.2008.03.011; van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005; Vanden Eijnden S, 2006, EUR J IMMUNOL, V36, P21, DOI 10.1002/eji.200535467; Wagner TL, 1999, CELL IMMUNOL, V191, P10, DOI 10.1006/cimm.1998.1406; Wattegedera S, 2004, VET IMMUNOL IMMUNOP, V102, P67, DOI 10.1016/j.vetimm.2004.06.006; Wynn JL, 2008, BLOOD, V112, P1750, DOI 10.1182/blood-2008-01-130500; Zhao J, 2008, P NATL ACAD SCI USA, V105, P7528, DOI 10.1073/pnas.0800152105	39	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13705	10.1371/journal.pone.0013705	http://dx.doi.org/10.1371/journal.pone.0013705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060840	Green Published, gold, Green Submitted			2022-12-25	WOS:000283573800007
J	Vauchelles, R; Stalder, D; Botton, T; Arkowitz, RA; Bassilana, M				Vauchelles, Romain; Stalder, Daniele; Botton, Thomas; Arkowitz, Robert A.; Bassilana, Martine			Rac1 Dynamics in the Human Opportunistic Fungal Pathogen Candida albicans	PLOS ONE			English	Article							STAT TRANSCRIPTION FACTORS; GTPASE-ACTIVATING PROTEIN; RAS-LIKE GTPASES; RHO-FAMILY; NUCLEAR-LOCALIZATION; MEMBRANE ASSOCIATION; FILAMENTOUS GROWTH; POLYBASIC REGION; EXCHANGE FACTOR; HYPHAL GROWTH	The small Rho G-protein Rac1 is highly conserved from fungi to humans, with approximately 65% overall sequence identity in Candida albicans. As observed with human Rac1, we show that C. albicans Rac1 can accumulate in the nucleus, and fluorescence recovery after photobleaching ( FRAP) together with fluorescence loss in photobleaching ( FLIP) studies indicate that this Rho G-protein undergoes nucleo-cytoplasmic shuttling. Analyses of different chimeras revealed that nuclear accumulation of C. albicans Rac1 requires the NLS-motifs at its carboxyl-terminus, which are blocked by prenylation of the adjacent cysteine residue. Furthermore, we show that C. albicans Rac1 dynamics, both at the plasma membrane and in the nucleus, are dependent on its activation state and in particular that the inactive form accumulates faster in the nucleus. Heterologous expression of human Rac1 in C. albicans also results in nuclear accumulation, yet accumulation is more rapid than that of C. albicans Rac1. Taken together our results indicate that Rac1 nuclear accumulation is an inherent property of this G-protein and suggest that the requirements for its nucleo-cytoplasmic shuttling are conserved from fungi to humans.	[Vauchelles, Romain; Stalder, Daniele; Botton, Thomas; Arkowitz, Robert A.; Bassilana, Martine] Univ Nice, CNRS, Fac Sci Parc Valrose, Inst Dev Biol & Canc,UMR 6543, F-06034 Nice, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Vauchelles, R (corresponding author), Univ Nice, CNRS, Fac Sci Parc Valrose, Inst Dev Biol & Canc,UMR 6543, F-06034 Nice, France.	mbassila@unice.fr	arkowitz, robert/ABC-1860-2021; Botton, Thomas/AAA-9258-2020; Bassilana, Martine/AAS-5814-2021	arkowitz, robert/0000-0002-5216-5013; Botton, Thomas/0000-0001-9079-7014; Bassilana, Martine/0000-0001-9965-567X	Centre National de la Recherche Scientifique; Fondation pour la Recherche Medicale-BNP-Paribas	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale-BNP-Paribas	This work was supported by the Centre National de la Recherche Scientifique and Fondation pour la Recherche Medicale-BNP-Paribas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassilana M, 2006, EUKARYOT CELL, V5, P321, DOI 10.1128/EC.5.2.321-329.2006; Bassilana M, 2003, EUKARYOT CELL, V2, P9, DOI 10.1128/EC.2.1.9-18.2003; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Brown DH, 1999, MOL MICROBIOL, V34, P651, DOI 10.1046/j.1365-2958.1999.01619.x; Chen HJ, 2008, NUMER MATH-THEORY ME, V1, P1; Cole KC, 2007, EUKARYOT CELL, V6, P378, DOI 10.1128/EC.00368-06; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Court H, 2007, MOL BIOL CELL, V18, P265, DOI 10.1091/mbc.E06-05-0411; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; HOPE H, 2010, MOL MICROBIOL; Hope H, 2008, MOL BIOL CELL, V19, P3638, DOI 10.1091/mbc.E07-12-1272; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kawashima T, 2006, J CELL BIOL, V175, P937, DOI 10.1083/jcb.200604073; Kawashima T, 2009, MOL CELL BIOL, V29, P1796, DOI 10.1128/MCB.01423-08; Koster M, 2005, CURR OPIN BIOTECH, V16, P28, DOI 10.1016/j.copbio.2004.11.002; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Lin Q, 2003, CURR BIOL, V13, P1469, DOI 10.1016/S0960-9822(03)00613-4; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Mahlert M, 2006, MOL MICROBIOL, V59, P567, DOI 10.1111/j.1365-2958.2005.04952.x; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Michel S, 2002, MOL MICROBIOL, V46, P269, DOI 10.1046/j.1365-2958.2002.03167.x; Nern A, 2000, MOL CELL, V5, P853, DOI 10.1016/S1097-2765(00)80325-1; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sandrock K, 2010, TRAFFIC, V11, P198, DOI 10.1111/j.1600-0854.2009.01015.x; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; Slaughter BD, 2009, DEV CELL, V17, P823, DOI 10.1016/j.devcel.2009.10.022; Tiedje C, 2008, MOL BIOL CELL, V19, P2885, DOI 10.1091/mbc.E07-11-1152; Ushinsky SC, 2002, EUKARYOT CELL, V1, P95, DOI 10.1128/EC.1.1.95-104.2002; Vallim MA, 2005, EUKARYOT CELL, V4, P1066, DOI 10.1128/EC.4.6.1066-1078.2005; Virag A, 2007, MOL MICROBIOL, V66, P1579, DOI 10.1111/j.1365-2958.2007.06021.x; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Yin JH, 2004, ARCH BIOCHEM BIOPHYS, V429, P23, DOI 10.1016/j.abb.2004.05.014; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	40	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e15400	10.1371/journal.pone.0015400	http://dx.doi.org/10.1371/journal.pone.0015400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060846	Green Published, Green Submitted, gold			2022-12-25	WOS:000283573800026
J	Lafont, E; Milhas, D; Teissie, J; Therville, N; Andrieu-Abadie, N; Levade, T; Benoist, H; Segui, B				Lafont, Elodie; Milhas, Delphine; Teissie, Justin; Therville, Nicole; Andrieu-Abadie, Nathalie; Levade, Thierry; Benoist, Herve; Segui, Bruno			Caspase-10-Dependent Cell Death in Fas/CD95 Signalling Is Not Abrogated by Caspase Inhibitor zVAD-fmk	PLOS ONE			English	Article							AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; NF-KAPPA-B; INDUCED APOPTOSIS; EPITHELIAL-CELLS; FAS; DOMAIN; FADD; RECEPTOR; PATHWAY; PROTEIN	Background: Upon CD95/Fas ligation, the initiator caspase-8 is known to activate effector caspases leading to apoptosis. In the presence of zVAD-fmk, a broad-spectrum caspase inhibitor, Fas engagement can also trigger an alternative, nonapoptotic caspase-independent form of cell death, which is initiated by RIP1. Controversy exists as to the ability of caspase-10 to mediate cell death in response to FasL (CD95L or CD178). Herein, the role of caspase-10 in FasL-induced cell death has been re-evaluated. Methodology and Principal Findings: The present study shows that FasL-induced cell death was completely impaired in caspase-8- and caspase-10-doubly deficient (I9-2e) Jurkat leukaemia T-cell lines. Over-expressing of either caspase-8 or caspase-10 in I9-2e cells triggered cell death and restored sensitivity to FasL, further arguing for a role of both initiator caspases in Fas apoptotic signalling. In the presence of zVAD-fmk, FasL triggered an alternative form of cell death similarly in wild-type (A3) and in caspase-8-deficient Jurkat cells expressing endogenous caspase-10 (clone I9-2d). Cell death initiated by Fas stimulation in the presence of zVAD-fmk was abrogated in I9-2e cells as well as in HeLa cells, which did not express endogenous caspase-10, indicating that caspase-10 somewhat participates in this alternative form of cell death. Noteworthy, ectopic expression of caspase-10 in I9-2e and HeLa cells restored the ability of FasL to trigger cell death in the presence of zVAD-fmk. As a matter of fact, FasL-triggered caspase-10 processing still occurred in the presence of zVAD-fmk. Conclusions and Significance: Altogether, these data provide genetic evidence for the involvement of initiator caspase-10 in FasL-induced cell death and indicate that zVAD-fmk does not abrogate caspase-10 processing and cytotoxicity in Fas signalling. Our study also questions the existence of an alternative caspase-independent cell death pathway in Fas signalling.	[Lafont, Elodie; Milhas, Delphine; Therville, Nicole; Andrieu-Abadie, Nathalie; Levade, Thierry; Benoist, Herve; Segui, Bruno] U858 INSERM Inst Natl Sante & Rech Med, Equipe 14, Dept Canc, Toulouse, France; [Lafont, Elodie; Milhas, Delphine; Therville, Nicole; Andrieu-Abadie, Nathalie; Levade, Thierry; Benoist, Herve; Segui, Bruno] Inst Med Mol Rangueil, Inst Federatif Rech 150, Toulouse, France; [Lafont, Elodie; Benoist, Herve; Segui, Bruno] Univ Toulouse 3, Fac Pharmaceut Sci, F-31062 Toulouse, France; [Teissie, Justin] CNRS, IPBS, Inst Pharmacol & Biol Struct, Unite Mixte Rech 5089, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Lafont, E (corresponding author), U858 INSERM Inst Natl Sante & Rech Med, Equipe 14, Dept Canc, Toulouse, France.	bruno.segui@inserm.fr	Lafont, Elodie/L-3288-2019; Andrieu-Abadie, Nathalie/N-6793-2013; Therville, Nicole/P-2371-2014; Lafont, Elodie/GPS-9642-2022; Teissie, Justin/AAA-5697-2019; Benoist, Hervé/P-2927-2014; Levade, Thierry/O-8948-2014; Ségui, Bruno/O-8957-2014	Lafont, Elodie/0000-0003-1978-7491; Andrieu-Abadie, Nathalie/0000-0003-2698-1970; Therville, Nicole/0000-0002-7068-1361; Lafont, Elodie/0000-0003-1978-7491; Teissie, Justin/0000-0002-7588-8062; Ségui, Bruno/0000-0002-6119-1889	INSERM; Paul Sabatier University; Association pour la Recherche sur le Cancer (ARC) [3417]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paul Sabatier University; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	This study was supported by INSERM, Paul Sabatier University, and grant 3417 from the Association pour la Recherche sur le Cancer (ARC) (to BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcia RN, 2003, CELL IMMUNOL, V226, P78, DOI 10.1016/j.cellimm.2003.11.006; Boone E, 2000, J BIOL CHEM, V275, P37596, DOI 10.1074/jbc.M007166200; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cuvillier O, 2000, J BIOL CHEM, V275, P15691, DOI 10.1074/jbc.M000280200; Denecker G, 2001, CELL MOL LIFE SCI, V58, P356, DOI 10.1007/PL00000863; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Fischer U, 2006, ONCOGENE, V25, P152, DOI 10.1038/sj.onc.1209015; Gabriel B, 2003, EXP CELL RES, V289, P195, DOI 10.1016/S0014-4827(03)00255-6; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kadohara K, 2009, J BIOL CHEM, V284, P5478, DOI 10.1074/jbc.M808523200; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Lenardo MJ, 2003, IMMUNOL RES, V27, P387, DOI 10.1385/IR:27:2-3:387; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Maelfait J, 2008, BIOCHEM PHARMACOL, V76, P1365, DOI 10.1016/j.bcp.2008.07.034; Matsumura H, 2000, J CELL BIOL, V151, P1247, DOI 10.1083/jcb.151.6.1247; Milhas D, 2005, J BIOL CHEM, V280, P19836, DOI 10.1074/jbc.M414358200; Morgan MJ, 2001, CELL DEATH DIFFER, V8, P696, DOI 10.1038/sj.cdd.4400866; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Muzio M, 1997, J BIOL CHEM, V272, P2952, DOI 10.1074/jbc.272.5.2952; Rao VK, 2006, HEMATOLOGY, V11, P15, DOI 10.1080/10245330500329094; Rieux-Laucat F, 2006, CURR DIRECT AUTOIMMU, V9, P18; Shikama Y, 2003, EUR J IMMUNOL, V33, P1998, DOI 10.1002/eji.200324013; Shimizu M, 1999, J IMMUNOL, V162, P7350; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; Thorburn J, 2003, MOL BIOL CELL, V14, P67, DOI 10.1091/mbc.E02-04-0207; Vincenz C, 1997, J BIOL CHEM, V272, P6578, DOI 10.1074/jbc.272.10.6578; Wang H, 2007, BBA-GEN SUBJECTS, V1770, P1528, DOI 10.1016/j.bbagen.2007.07.010; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Worth A, 2006, BRIT J HAEMATOL, V133, P124, DOI 10.1111/j.1365-2141.2006.05993.x; Zhu SG, 2006, HUM GENET, V119, P284, DOI 10.1007/s00439-006-0138-9	35	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13638	10.1371/journal.pone.0013638	http://dx.doi.org/10.1371/journal.pone.0013638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049020	Green Submitted, Green Published, gold			2022-12-25	WOS:000283487400026
J	Liu, L; Vira, A; Friedman, E; Minas, J; Bolger, D; Bitan, T; Booth, J				Liu, Li; Vira, Amit; Friedman, Emma; Minas, Jennifer; Bolger, Donald; Bitan, Tali; Booth, James			Children with Reading Disability Show Brain Differences in Effective Connectivity for Visual, but Not Auditory Word Comprehension	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; DEVELOPMENTAL DYSLEXIA; ANGULAR GYRUS; DISSOCIATION; RECOGNITION; ACTIVATION; LANGUAGE; MODEL; DIFFICULTIES; ORGANIZATION	Background: Previous literature suggests that those with reading disability (RD) have more pronounced deficits during semantic processing in reading as compared to listening comprehension. This discrepancy has been supported by recent neuroimaging studies showing abnormal activity in RD during semantic processing in the visual but not in the auditory modality. Whether effective connectivity between brain regions in RD could also show this pattern of discrepancy has not been investigated. Methodology/Principal Findings: Children (8- to 14-year-olds) were given a semantic task in the visual and auditory modality that required an association judgment as to whether two sequentially presented words were associated. Effective connectivity was investigated using Dynamic Causal Modeling (DCM) on functional magnetic resonance imaging (fMRI) data. Bayesian Model Selection (BMS) was used separately for each modality to find a winning family of DCM models separately for typically developing (TD) and RD children. BMS yielded the same winning family with modulatory effects on bottom-up connections from the input regions to middle temporal gyrus (MTG) and inferior frontal gyrus(IFG) with inconclusive evidence regarding top-down modulations. Bayesian Model Averaging (BMA) was thus conducted across models in this winning family and compared across groups. The bottom-up effect from the fusiform gyrus (FG) to MTG rather than the top-down effect from IFG to MTG was stronger in TD compared to RD for the visual modality. The stronger bottom-up influence in TD was only evident for related word pairs but not for unrelated pairs. No group differences were noted in the auditory modality. Conclusions/Significance: This study revealed a modality-specific deficit for children with RD in bottom-up effective connectivity from orthographic to semantic processing regions. There were no group differences in connectivity from frontal regions, suggesting that the core deficit in RD is not in top-down modulation.	[Liu, Li] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Liu, Li; Vira, Amit; Friedman, Emma; Minas, Jennifer; Booth, James] Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL USA; [Bolger, Donald] Univ Maryland, Dept Human Dev, College Pk, MD 20742 USA; [Bitan, Tali] Univ Haifa, Dept Commun Disorders, IL-31999 Haifa, Israel	Beijing Normal University; Northwestern University; University System of Maryland; University of Maryland College Park; University of Haifa	Liu, L (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	lilyliu@bnu.edu.cn; j-booth@northwestern.edu	Bolger, Donald J/D-1748-2011	Bolger, Donald J/0000-0001-5114-8484; Bitan, Tali/0000-0001-6160-587X	National Institute of Child Health and Human Development [HD042049]; Beijing Natural Science Foundation [7102089]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042049] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R56HD042049] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by grants from the National Institute of Child Health and Human Development (HD042049, http://www.nichd.nih.gov/). This research was also supported by grants to the State Key Laboratory of Cognitive Neuroscience and Learning (Beijing Normal University), from Beijing Natural Science Foundation (7102089, http://www.bjnsf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron P.G., 1989, DYSLEXIA HYPERLEXIA; AARON PG, 1991, J LEARN DISABIL, V24, P178, DOI 10.1177/002221949102400306; [Anonymous], 1998, U S FLORIDA WORD ASS; Badian NA, 1999, J LEARN DISABIL, V32, P138, DOI 10.1177/002221949903200204; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Booth JR, 2007, NEUROPSYCHOLOGIA, V45, P775, DOI 10.1016/j.neuropsychologia.2006.08.015; Brambati SM, 2006, BRAIN RES, V1113, P174, DOI 10.1016/j.brainres.2006.06.099; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Cao F, 2008, BRAIN LANG, V107, P91, DOI 10.1016/j.bandl.2007.12.009; Chee MWL, 1999, HUM BRAIN MAPP, V7, P15, DOI 10.1002/(SICI)1097-0193(1999)7:1<15::AID-HBM2>3.3.CO;2-Y; Chou TL, 2006, HUM BRAIN MAPP, V27, P915, DOI 10.1002/hbm.20231; Chou TL, 2006, NEUROIMAGE, V29, P1141, DOI 10.1016/j.neuroimage.2005.09.064; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Helenius P, 1999, CEREB CORTEX, V9, P476, DOI 10.1093/cercor/9.5.476; Helenius P, 1999, J COGNITIVE NEUROSCI, V11, P535, DOI 10.1162/089892999563599; Hoeft F, 2007, P NATL ACAD SCI USA, V104, P4234, DOI 10.1073/pnas.0609399104; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Humphries C, 2006, J COGNITIVE NEUROSCI, V18, P665, DOI 10.1162/jocn.2006.18.4.665; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; McDermott KB, 2003, NEUROPSYCHOLOGIA, V41, P293, DOI 10.1016/S0028-3932(02)00162-8; Mechelli A, 2003, J COGNITIVE NEUROSCI, V15, P925, DOI 10.1162/089892903770007317; Mechelli A, 2007, HUM BRAIN MAPP, V28, P205, DOI 10.1002/hbm.20272; MILES J, 1994, J CLIN EXP NEUROPSYC, V16, P43, DOI 10.1080/01688639408402616; NELSON CA, 1995, DEV PSYCHOL, V31, P723, DOI 10.1037/0012-1649.31.5.723; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Penny WD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000709; Plante E, 2000, NEUROPSYCHOLOGIA, V38, P1669, DOI 10.1016/S0028-3932(00)00083-X; Pugh KR, 2000, PSYCHOL SCI, V11, P51, DOI 10.1111/1467-9280.00214; Quaglino V, 2008, NEUROPHYSIOL CLIN, V38, P73, DOI 10.1016/j.neucli.2007.12.007; RUMSEY JM, 1994, ARCH NEUROL-CHICAGO, V51, P27, DOI 10.1001/archneur.1994.00540130037011; Rumsey JM, 1997, ARCH NEUROL-CHICAGO, V54, P562, DOI 10.1001/archneur.1997.00550170042013; Sabisch B, 2006, J COGNITIVE NEUROSCI, V18, P1676, DOI 10.1162/jocn.2006.18.10.1676; Schulz E, 2009, NEUROPSYCHOLOGIA, V47, P2544, DOI 10.1016/j.neuropsychologia.2009.04.028; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; Shaywitz B., 1999, SCI STUD READ, V3, P95; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Shaywitz SE, 2003, BIOL PSYCHIAT, V54, P25, DOI 10.1016/S0006-3223(02)01836-X; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; Silva-Pereyra J, 2003, INT J PSYCHOPHYSIOL, V49, P187, DOI 10.1016/S0167-8760(03)00116-8; Snowling M, 1997, TRENDS COGN SCI, V1, P88, DOI 10.1016/S1364-6613(97)89053-5; Stephan KE, 2010, NEUROIMAGE, V49, P3099, DOI 10.1016/j.neuroimage.2009.11.015; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; STOTHARD SE, 1995, J CHILD PSYCHOL PSYC, V36, P399, DOI 10.1111/j.1469-7610.1995.tb01298.x; Torgesen J.K., 1999, COMPREHENSIVE TEST P; Torgeson J. K., 1999, TEST WORD READING EF; Wechsler D., 1999, WECHSLER ABBREVIATED; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME; Woodcock R. W., 2001, WOODCOCK JOHNSON 3 T	53	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13492	10.1371/journal.pone.0013492	http://dx.doi.org/10.1371/journal.pone.0013492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	670LB	21049093	gold, Green Published, Green Submitted			2022-12-25	WOS:000283422100004
J	Liang, L; Xu, B; Chen, YL; Liu, Y; Cao, WC; Fang, LQ; Feng, LM; Goodchild, MF; Gong, P				Liang, Lu; Xu, Bing; Chen, Yanlei; Liu, Yang; Cao, Wuchun; Fang, Liqun; Feng, Limin; Goodchild, Michael F.; Gong, Peng			Combining Spatial-Temporal and Phylogenetic Analysis Approaches for Improved Understanding on Global H5N1 Transmission	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUSES; WILD BIRDS; SPREAD; MODEL; ACCURATE	Background: Since late 2003, the highly pathogenic influenza A H5N1 had initiated several outbreak waves that swept across the Eurasia and Africa continents. Getting prepared for reassortment or mutation of H5N1 viruses has become a global priority. Although the spreading mechanism of H5N1 has been studied from different perspectives, its main transmission agents and spread route problems remain unsolved. Methodology/Principal Findings: Based on a compilation of the time and location of global H5N1 outbreaks from November 2003 to December 2006, we report an interdisciplinary effort that combines the geospatial informatics approach with a bioinformatics approach to form an improved understanding on the transmission mechanisms of H5N1 virus. Through a spherical coordinate based analysis, which is not conventionally done in geographical analyses, we reveal obvious spatial and temporal clusters of global H5N1 cases on different scales, which we consider to be associated with two different transmission modes of H5N1 viruses. Then through an interdisciplinary study of both geographic and phylogenetic analysis, we obtain a H5N1 spreading route map. Our results provide insight on competing hypotheses as to which avian hosts are responsible for the spread of H5N1. Conclusions/Significance: We found that although South China and Southeast Asia may be the virus pool of avian flu, East Siberia may be the source of the H5N1 epidemic. The concentration of migratory birds from different places increases the possibility of gene mutation. Special attention should be paid to East Siberia, Middle Siberia and South China for improved surveillance of H5N1 viruses and monitoring of migratory birds.	[Liang, Lu; Gong, Peng] Beijing Normal Univ, Chinese Acad Sci, Inst Remote Sensing Applicat, State Key Lab Remote Sensing Sci, Beijing 100875, Peoples R China; [Liang, Lu; Gong, Peng] Tsinghua Univ, Ctr Earth Syst Sci, Beijing 100084, Peoples R China; [Xu, Bing] Univ Utah, Dept Geog, Salt Lake City, UT USA; [Xu, Bing] Tsinghua Univ, Dept Environm Sci & Engn, Beijing 100084, Peoples R China; [Chen, Yanlei; Gong, Peng] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Liu, Yang] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Cao, Wuchun; Fang, Liqun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Feng, Limin] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China; [Goodchild, Michael F.] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA	Beijing Normal University; Chinese Academy of Sciences; Tsinghua University; Utah System of Higher Education; University of Utah; Tsinghua University; University of California System; University of California Berkeley; University of Bern; Beijing Institute of Microbiology & Epidemiology; Beijing Normal University; University of California System; University of California Santa Barbara	Liang, L (corresponding author), Beijing Normal Univ, Chinese Acad Sci, Inst Remote Sensing Applicat, State Key Lab Remote Sensing Sci, Beijing 100875, Peoples R China.	penggong@berkeley.edu	Liu, Yang/B-4877-2011; Xu, Bing/C-7732-2015; Gong, Peng/AAM-1516-2021; Feng, Limin/G-9539-2014; Fang, Li-Qun/GWD-0296-2022	Gong, Peng/0000-0003-1513-3765; Feng, Limin/0000-0001-9526-1681; liang, lu/0000-0002-9892-8346	National Natural Science Foundation of China [30590370]; National High Technology Research and Development Program of China [2009AA12200101]; National Basic Research Program of China [2010CB530304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China)	This research was partially supported by a major grant from the National Natural Science Foundation of China (Grant No 30590370), National High Technology Research and Development Program of China (Grant No 2009AA12200101), National Basic Research Program of China (Grant No 2010CB530304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; *AN HLTH AUSTR, 2006, DIS STRAT AV INFL VE, P27; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], GLOBAL LAND COVER FA; BAILEY TC, INTERACTIVE SPATIAL; Bunge J., J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Butler D., 2006, SPREAD AVIAN FLU TIM; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Duan L, 2008, VIROLOGY, V380, P243, DOI 10.1016/j.virol.2008.07.038; Feare CJ, 2007, AVIAN DIS, V51, P440, DOI 10.1637/7575-040106R1.1; FELSENSTEIN J, 2004, INFERRING PHYLOGENIE, V8, P85; Gaidet N, 2007, EMERG INFECT DIS, V13, P626, DOI 10.3201/eid1304.061011; Gatrell AC, 1996, T I BRIT GEOGR, V21, P256, DOI 10.2307/622936; GILBERT M, 2006, HPAI SPREAD W SIBERI; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Gu X, 1997, MOL BIOL EVOL, V14, P1106, DOI 10.1093/oxfordjournals.molbev.a025720; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Henderson M, 2003, INT J REMOTE SENS, V24, P595, DOI 10.1080/01431160304982; Janies D, 2007, SYST BIOL, V56, P321, DOI 10.1080/10635150701266848; *JOINT RES CTR EUR, 2003, GLOB LAND COV 2000 D; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kiselev OI, 2008, MOL BIOL+, V42, P70, DOI 10.1134/S002689330801010X; Kiss I, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-113; KULLDORFF M, 2005, SATSCAN V 703 SOFTWA; Le Gall-Recule G, 2008, AVIAN PATHOL, V37, P15, DOI 10.1080/03079450701774835; Li IWS, 2009, J CLIN VIROL, V46, P325, DOI 10.1016/j.jcv.2009.09.013; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Liu N, 2005, J ENVIRON INFORM, V5, P1, DOI 10.3808/jei.200500040; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RAMBAUT A, 2006, FIGTREE; Riede K., 2001, GLOBAL REGISTER MIGR; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; Si YL, 2009, GEOSPATIAL HEALTH, V4, P65, DOI 10.4081/gh.2009.211; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Sutton PC, 2003, REMOTE SENS ENVIRON, V86, P353, DOI 10.1016/S0034-4257(03)00078-6; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vijaykrishna D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000161; Waddell PJ, 1997, MOL PHYLOGENET EVOL, V8, P398, DOI 10.1006/mpev.1997.0452; Wang J, 2008, J Virol, V82, P3405, DOI 10.1128/JVI.02468-07; Weber S, 2007, J GEN VIROL, V88, P554, DOI 10.1099/vir.0.82300-0; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; *WHO WORLD ORG AN, 2008, UN NOM SYST HIGHL PA; IMAGE DATA PROCESSIN; 2004, FAOAIDE NEWS, V6	49	67	75	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13575	10.1371/journal.pone.0013575	http://dx.doi.org/10.1371/journal.pone.0013575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042591	gold, Green Submitted, Green Published			2022-12-25	WOS:000283419100015
J	Lodillinsky, C; Langle, Y; Guionet, A; Gongora, A; Baldi, A; Sandes, EO; Casabe, A; Eijan, AM				Lodillinsky, Catalina; Langle, Yanina; Guionet, Ariel; Gongora, Adrian; Baldi, Alberto; Sandes, Eduardo O.; Casabe, Alberto; Maria Eijan, Ana			Bacillus Calmette Guerin Induces Fibroblast Activation Both Directly and through Macrophages in a Mouse Bladder Cancer Model	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GROWTH-FACTOR; MECHANISMS; EXPRESSION; CARCINOMA; APOPTOSIS; CELLS; ANGIOGENESIS; SURVEILLANCE; PROGRESSION	Background: Bacillus Calmette-Guerin (BCG) is the most effective treatment for non-muscle invasive bladder cancer. However, a failure in the initial response or relapse within the first five years of treatment has been observed in 20% of patients. We have previously observed that in vivo administration of an inhibitor of nitric oxide improved the response to BCG of bladder tumor bearing mice. It was described that this effect was due to a replacement of tumor tissue by collagen depots. The aim of the present work was to clarify the mechanism involved in this process. Methodology/Principal Findings: We demonstrated that BCG induces NIH-3T3 fibroblast proliferation by activating the MAPK and PI3K signaling pathways and also differentiation determined by alpha-smooth muscle actin (alpha-SMA) expression. In vivo, intratumoral inoculation of BCG also increased alpha-SMA and collagen expression. Oral administration of L-NAME enhanced the pro-fibrotic effect of BCG. Peritoneal macrophages obtained from MB49 tumor-bearing mice treated in vivo with combined treatment of BCG with L-NAME also enhanced fibroblast proliferation. We observed that FGF-2 is one of the factors released by BCG-activated macrophages that is able to induce fibroblast proliferation. The involvement of FGF-2 was evidenced using an anti-FGF2 antibody. At the same time, this macrophage population improved wound healing rate in normal mice and FGF-2 expression was also increased in these wounds. Conclusions/Significance: Our findings suggest that fibroblasts are targeted by BCG both directly and through activated macrophages in an immunotherapy context of a bladder murine model. We also described, for the first time, that FGF-2 is involved in a dialog between fibroblasts and macrophages induced after BCG treatment. The fact that L-NAME administration improves the BCG effect on fibroblasts, NO inhibition, might represent a new approach to add to the conventional BCG therapy.	[Lodillinsky, Catalina; Langle, Yanina; Guionet, Ariel; Sandes, Eduardo O.; Casabe, Alberto; Maria Eijan, Ana] Univ Buenos Aires, Inst Oncol Angel H Roffo, Res Area, Buenos Aires, DF, Argentina; [Gongora, Adrian; Baldi, Alberto] Natl Res Council Argentina CONICET, Inst Biol & Expt Med IBYME, Mol Pathol & Pharmacol Lab, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Lodillinsky, C (corresponding author), Univ Buenos Aires, Inst Oncol Angel H Roffo, Res Area, Buenos Aires, DF, Argentina.	anamariaeijan@gmail.com	EIJAN, ANA MARIA/AAC-8849-2022		Consejo Nacional de Investigaciones Cientificas y Tecnicas; Consejo Nacional de Investigaciones Cientificas y Tecnicas-PIP; Universidad de Buenos Aires [UBACYT M017]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Consejo Nacional de Investigaciones Cientificas y Tecnicas-PIP(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires)	This study was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CL, YL, AB, AME), and grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas-PIP, and Universidad de Buenos Aires -UBACYT M017 (www.conicet.gov.ar.www.uba.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, IMMUNOL REV, V222, P155, DOI 10.1111/j.1600-065X.2008.00607.x; Alvarez V, 2005, INT J MOL MED, V16, P565; Amadeu TP, 2006, J CUTAN PATHOL, V33, P465, DOI 10.1111/j.1600-0560.2006.00472.x; Aoi Y, 2008, J PHYSIOL PHARMACOL, V59, P315; Babaei S, 1998, CIRC RES, V82, P1007, DOI 10.1161/01.RES.82.9.1007; Babjuk M, 2008, EUR UROL, V54, P303, DOI 10.1016/j.eururo.2008.04.051; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; BROSMAN SA, 1982, J UROLOGY, V128, P27, DOI 10.1016/S0022-5347(17)52736-6; Chen Fanghong, 2005, BMC Urol, V5, P8, DOI 10.1186/1471-2490-5-8; Chen Mingliang, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P705; Coleman AB, 2000, MOL PHARMACOL, V57, P324; Cristina C, 2007, AM J PHYSIOL-ENDOC M, V293, pE1341, DOI 10.1152/ajpendo.00260.2007; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Isenberg JS, 2004, MICROSURG, V24, P385, DOI 10.1002/micr.20051; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Malavaud B, 2004, ONCOGENE, V23, P6769, DOI 10.1038/sj.onc.1207135; Mitropoulos D, 2005, NITRIC OXIDE-BIOL CH, V13, P36, DOI 10.1016/j.niox.2005.04.012; MORALES A, 1976, J UROLOGY, V116, P180, DOI 10.1016/S0022-5347(17)58737-6; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murakami H, 2005, J ORTHOP SCI, V10, P84, DOI 10.1007/s00776-004-0858-4; Prescott S, 2000, CLIN INFECT DIS, V31, pS91, DOI 10.1086/314066; Riemensberger J, 2002, CLIN EXP IMMUNOL, V127, P20, DOI 10.1046/j.1365-2249.2002.01734.x; Saban MR, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-4; Sandes E, 2007, INT J MOL MED, V20, P823; Sandes EO, 2005, NITRIC OXIDE-BIOL CH, V12, P39, DOI 10.1016/j.niox.2004.11.003; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; SHELLEY MD, 2010, CANC TREAT REV; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787; Smaldone M C, 2009, Minerva Urol Nefrol, V61, P71; Strutz F, 2000, KIDNEY INT, V57, P1521, DOI 10.1046/j.1523-1755.2000.00997.x; Suttmann H, 2006, CANCER RES, V66, P8250, DOI 10.1158/0008-5472.CAN-06-1416; SYLVESTER RJ, 2009, EUR UROL; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; ZHANG S, 1995, ZHONGHUA JIE HE HE H, V18, P62; Zhang Shangming, 1995, Zhonghua Jiehe He Huxi Zazhi, V18, P26	40	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13571	10.1371/journal.pone.0013571	http://dx.doi.org/10.1371/journal.pone.0013571			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042580	Green Published, gold, Green Submitted			2022-12-25	WOS:000283419100011
J	Homaira, N; Rahman, M; Hossain, MJ; Nahar, N; Khan, R; Rahman, M; Podder, G; Nahar, K; Khan, D; Gurley, ES; Rollin, PE; Comer, JA; Ksiazek, TG; Luby, SP				Homaira, Nusrat; Rahman, Mahmudur; Hossain, M. Jahangir; Nahar, Nazmun; Khan, Rasheda; Rahman, Mostafizur; Podder, Goutam; Nahar, Kamrun; Khan, Dawlat; Gurley, Emily S.; Rollin, Pierre E.; Comer, James A.; Ksiazek, Thomas G.; Luby, Stephen P.			Cluster of Nipah Virus Infection, Kushtia District, Bangladesh, 2007	PLOS ONE			English	Article							TO-PERSON TRANSMISSION; OUTBREAK; ENCEPHALITIS	Objective: In March 2007, we investigated a cluster of Nipah encephalitis to identify risk factors for Nipah infection in Bangladesh. Methods: We defined confirmed Nipah cases by the presence of IgM and IgG antibodies against Nipah virus in serum. Case-patients, who resided in the same village during the outbreak period but died before serum could be collected, were classified as probable cases. Results: We identified three confirmed and five probable Nipah cases. There was a single index case. Five of the secondary cases came in close physical contact to the index case when she was ill. Case-patients were more likely to have physical contact with the index case (71% cases versus 0% controls, p = < 0.001). The index case, on her third day of illness, and all the subsequent cases attended the same religious gathering. For three probable cases including the index case, we could not identify any known risk factors for Nipah infection such as physical contact with Nipah case-patients, consumption of raw date palm juice, or contact with sick animals or fruit bats. Conclusion: Though person-to-person transmission remains an important mode of transmission for Nipah infection, we could not confirm the source of infection for three of the probable Nipah case-patients. Continued surveillance and outbreak investigations will help better understand the transmission of Nipah virus and develop preventive strategies.	[Homaira, Nusrat; Hossain, M. Jahangir; Nahar, Nazmun; Khan, Rasheda; Podder, Goutam; Nahar, Kamrun; Khan, Dawlat; Gurley, Emily S.; Luby, Stephen P.] Int Ctr Diarrhoeal Dis Res, Bangladesh ICDDRB, Dhaka 1000, Bangladesh; [Homaira, Nusrat; Rahman, Mahmudur; Rahman, Mostafizur] Inst Epidemiol Dis Control & Res, Dhaka, Bangladesh; [Rollin, Pierre E.; Comer, James A.; Ksiazek, Thomas G.; Luby, Stephen P.] Ctr Dis Control & Prevent, Special Pathogens Branch, Atlanta, GA USA	International Centre for Diarrhoeal Disease Research (ICDDR); Centers for Disease Control & Prevention - USA	Homaira, N (corresponding author), Int Ctr Diarrhoeal Dis Res, Bangladesh ICDDRB, GPO Box 128, Dhaka 1000, Bangladesh.	nhomaira@icddrb.org	Gurley, Emily S/B-7903-2010; Homaira, Nusrat/U-4526-2019	Gurley, Emily S/0000-0002-8648-9403; Homaira, Nusrat/0000-0003-3341-7964; Rollin, Pierre/0000-0002-4608-2641; Nahar, Nazmun/0000-0002-4530-6009	Centers for Disease Control and Prevention (CDC), Atlanta; U.S. National Institutes of Health, International Collaborations in Infectious Disease Research (ICIDR) Opportunity Pool; Government of Bangladesh (GoB) through IHP-HNPRP	Centers for Disease Control and Prevention (CDC), Atlanta(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); U.S. National Institutes of Health, International Collaborations in Infectious Disease Research (ICIDR) Opportunity Pool(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Government of Bangladesh (GoB) through IHP-HNPRP	This work was funded by the Centers for Disease Control and Prevention (CDC), Atlanta, the U.S. National Institutes of Health, International Collaborations in Infectious Disease Research (ICIDR) Opportunity Pool and the Government of Bangladesh (GoB) through IHP-HNPRP. Pierre E. Rollin, James A. Comer and Thomas G. Ksiazek from CDC and Mahmudur Rahman and Mostafizur Rahman from Government of Bangladesh (the two funding organizations) are also co-authors of this manuscript and were involved in study design and preparation of the manuscript.	Blum LS, 2009, AM J TROP MED HYG, V80, P96, DOI 10.4269/ajtmh.2009.80.96; Chua KB, 2003, J CLIN VIROL, V26, P265, DOI 10.1016/S1386-6532(02)00268-8; Chua KB, 2001, J INFECTION, V42, P40, DOI 10.1053/jinf.2000.0782; Daniels P, 2001, MICROBES INFECT, V3, P289, DOI 10.1016/S1286-4579(01)01382-X; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Harcourt BH, 2005, EMERG INFECT DIS, V11, P1594, DOI 10.3201/eid1110.050513; Harit AK, 2006, INDIAN J MED RES, V123, P553; Homaira N, 2010, EPIDEMIOL INFECT, V138, P1630, DOI 10.1017/S0950268810000695; Hossain MJ, 2008, CLIN INFECT DIS, V46, P977, DOI 10.1086/529147; LUBY SP, 2009, EMERGING INFECT DIS, V15; Luby SP, 2006, EMERG INFECT DIS, V12, P1888; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Montgomery JM, 2008, EMERG INFECT DIS, V14, P1526, DOI 10.3201/eid1410.060507	13	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13570	10.1371/journal.pone.0013570	http://dx.doi.org/10.1371/journal.pone.0013570			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042407	Green Published, gold			2022-12-25	WOS:000283293800027
J	Crawley, SW; Gharaei, MS; Ye, QL; Yang, YD; Raveh, B; London, N; Schueler-Furman, O; Jia, ZC; Cote, GP				Crawley, Scott W.; Gharaei, Mojdeh Samimi; Ye, Qilu; Yang, Yidai; Raveh, Barak; London, Nir; Schueler-Furman, Ora; Jia, Zongchao; Cote, Graham P.			Autophosphorylation Activates Dictyostelium Myosin II Heavy Chain Kinase A by Providing a Ligand for an Allosteric Binding Site in the alpha-Kinase Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL DOMAIN; PROTEIN-KINASE; CRYSTAL-STRUCTURE; ACTIN-BINDING; LOCALIZATION; PHOSPHORYLATION; IDENTIFICATION; DISCOIDEUM; FILAMENTS; TRPM7	Dictyostelium discoideum myosin II heavy chain kinase A (MHCK A), a member of the atypical alpha-kinase family, phosphorylates sites in the myosin II tail that block filament assembly. Here we show that the catalytic activity of A-CAT, the alpha-kinase domain of MHCKA (residues 552-841), is severely inhibited by the removal of a disordered C-terminal tail sequence (C-tail; residues 806-841). The key residue in the C-tail was identified as Thr(825), which was found to be constitutively autophosphorylated. Dephosphorylation of Thr(825) using shrimp alkaline phosphatase decreased A-CAT activity. The activity of a truncated A-CAT lacking Thr(825) could be rescued by Pi, phosphothreonine, and a phosphorylated peptide, but not by threonine, glutamic acid, aspartic acid, or an unphosphorylated peptide. These results focused attention on a Pi-binding pocket located in the C-terminal lobe of A-CAT. Mutational analysis demonstrated that the P-1-pocket was essential for A-CAT activity. Based on these results, it is proposed that autophosphorylation of Thr(825) activates ACAT by providing a covalently tethered ligand for the Pi-pocket. Ab initio modeling studies using the Rosetta FloppyTail and Flex-PepDock protocols showed that it is feasible for the phosphorylated Thr(825) to dock intramolecularly into the Pi-pocket. Allosteric activation is predicted to involve a conformational change in Arg(734), which bridges the bound Pi to Asp(762) in a key active site loop. Sequence alignments indicate that a comparable regulatory mechanism is likely to be conserved in Dictyostelium MHCKB-D and metazoan eukaryotic elongation factor-2 kinases.	[Crawley, Scott W.; Gharaei, Mojdeh Samimi; Ye, Qilu; Yang, Yidai; Jia, Zongchao; Cote, Graham P.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Raveh, Barak; London, Nir; Schueler-Furman, Ora] Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, Inst Med Res Israel Canada, Hadassah Med Sch, IL-91120 Jerusalem, Israel	Queens University - Canada; Hebrew University of Jerusalem	Cote, GP (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	coteg@queensu.ca	Schueler-Furman, Ora/AAC-5932-2020	Schueler-Furman, Ora/0000-0002-1624-0362; London, Nir/0000-0003-2687-0699	Canadian Institutes of Health Research [MOP8603]; Heart and Stroke Foundation of Ontario [T6054]; Natural Sciences and Engineering Research Council of Canada [203705]; Israel Academy of Science and Humanities ISF [306/6]; USA-Israel Bi-national Science Foundation [2009418]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Israel Academy of Science and Humanities ISF; USA-Israel Bi-national Science Foundation(US-Israel Binational Science Foundation)	This work was supported in part by Canadian Institutes of Health Research Grant MOP8603 and Heart and Stroke Foundation of Ontario Grant T6054 (to G. P. C.), Natural Sciences and Engineering Research Council of Canada Grant 203705 (to Z.J.), the Israel Science Foundation funded by Israel Academy of Science and Humanities ISF Grant 306/6, and USA-Israel Bi-national Science Foundation Grant 2009418 (to O.S.-F.).	Betapudi V, 2005, MOL BIOL CELL, V16, P2248, DOI 10.1091/mbc.e04-07-0639; Betapudi V, 2009, TRAFFIC, V10, P1773, DOI 10.1111/j.1600-0854.2009.00992.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CASNELLIE JE, 1991, METHOD ENZYMOL, V200, P115; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Clark K, 2008, J MOL BIOL, V378, P790, DOI 10.1016/j.jmb.2008.02.057; Cote GP, 1997, J BIOL CHEM, V272, P6846, DOI 10.1074/jbc.272.11.6846; COTE GP, 1987, J BIOL CHEM, V262, P1065; Crawley SW, 2008, BBA-PROTEINS PROTEOM, V1784, P908, DOI 10.1016/j.bbapap.2008.03.001; Crawley SW, 2009, BIOCHEM J, V420, P115, DOI 10.1042/BJ20081405; Crawley SW, 2006, J BIOL CHEM, V281, P6307, DOI 10.1074/jbc.M508670200; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; De la Roche MA, 2002, J MUSCLE RES CELL M, V23, P703, DOI 10.1023/A:1024467426244; Egelhoff TT, 2005, J BIOL CHEM, V280, P2879, DOI 10.1074/jbc.M410803200; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; FUTEY LM, 1995, J BIOL CHEM, V270, P523, DOI 10.1074/jbc.270.2.523; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; HADWIGER JA, 1992, GENE DEV, V6, P38, DOI 10.1101/gad.6.1.38; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; KNECHT DA, 1995, DEV BIOL, V170, P434, DOI 10.1006/dbio.1995.1227; Kolman MF, 1997, J BIOL CHEM, V272, P16904, DOI 10.1074/jbc.272.27.16904; Kolman MF, 1996, J CELL BIOL, V132, P101, DOI 10.1083/jcb.132.1.101; Kramer RH, 1998, NATURE, V395, P710, DOI 10.1038/27227; Levi S, 2000, PLASMID, V44, P231, DOI 10.1006/plas.2000.1487; Liang WC, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-19; Longenecker KL, 1996, J MOL BIOL, V257, P618, DOI 10.1006/jmbi.1996.0189; LUCKVIELMETTER D, 1990, FEBS LETT, V269, P239, DOI 10.1016/0014-5793(90)81163-I; Luo X, 2001, J BIOL CHEM, V276, P17836, DOI 10.1074/jbc.M009366200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MEDLEY QG, 1990, BIOCHEMISTRY-US, V29, P8992, DOI 10.1021/bi00490a016; MEDLEY QG, 1992, BIOCHIM BIOPHYS ACTA, V1175, P7, DOI 10.1016/0167-4889(92)90003-T; Middelbeek J, 2010, CELL MOL LIFE SCI, V67, P875, DOI 10.1007/s00018-009-0215-z; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nagasaki A, 2002, MOL BIOL CELL, V13, p447A; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; REDPATH NT, 1993, EUR J BIOCHEM, V212, P511, DOI 10.1111/j.1432-1033.1993.tb17688.x; Russ M, 2006, BIOCHEM J, V395, P373, DOI 10.1042/BJ20051376; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Steimle PA, 2002, FEBS LETT, V516, P58, DOI 10.1016/S0014-5793(02)02494-8; Steimle PA, 2001, J BIOL CHEM, V276, P6853, DOI 10.1074/jbc.M008992200; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; VAILLANCOURT JP, 1988, J BIOL CHEM, V263, P10082; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; XU RM, 1995, EMBO J, V14, P1015, DOI 10.1002/j.1460-2075.1995.tb07082.x; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Ye QL, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000525; Yumura S, 2005, MOL BIOL CELL, V16, P4256, DOI 10.1091/mbc.E05-03-0219	50	17	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2607	2616		10.1074/jbc.M110.177014	http://dx.doi.org/10.1074/jbc.M110.177014			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21071445	Green Published, hybrid			2022-12-25	WOS:000286464300026
J	Noben-Trauth, K; Latoche, JR				Noben-Trauth, Konrad; Latoche, Joseph R.			Ectopic Mineralization in the Middle Ear and Chronic Otitis Media with Effusion Caused by RPL38 Deficiency in the Tail-short (Ts) Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIAMOND-BLACKFAN ANEMIA; SENSORINEURAL HEARING-LOSS; RIBOSOMAL-PROTEIN S19; INNER-EAR; LABYRINTHITIS OSSIFICANS; CHOLESTEROL GRANULOMA; EXTRARIBOSOMAL FUNCTIONS; PLANAR POLARITY; EUSTACHIAN-TUBE; OTIC CAPSULE	Inflammation of the middle ear cavity (otitis media) and the abnormal deposition of bone at the otic capsule are common causes of conductive hearing impairment in children and adults. Although a host of environmental factors can contribute to these conditions, a genetic predisposition has an important role as well. Here, we analyze the Tail-short (Ts) mouse, which harbors a spontaneous semi-dominant mutation that causes skeletal defects and hearing loss. By genetic means, we show that the Ts phenotypes arise from an 18-kb deletion/insertion of the Rpl38 gene, encoding a ribosomal protein of the large subunit. We show that Ts mutants exhibit significantly elevated auditory-brain stem response thresholds and reduced distortion-product otoacoustic emissions, in the presence of normal endocochlear potentials and typical inner ear histology suggestive of a conductive hearing impairment. We locate the cause of the hearing impairment to the middle ear, demonstrating over-ossification at the round window ridge, ectopic deposition of cholesterol crystals in the middle ear cavity, enlarged Eustachian tube, and chronic otitis media with effusion all beginning at around 3 weeks after birth. Using specific antisera, we demonstrate that Rpl38 is an similar to 8-kDa protein that is predominantly expressed in mature erythrocytes. Finally, using an Rpl38 cDNA transgene, we rescue the Ts phenotypes. Together, these data present a previously uncharacterized combination of interrelated middle ear pathologies and suggest Rpl38 deficiency as a model to dissect the causative relationships between neo-ossification, cholesterol crystal deposition, and Eustachian tubes in the etiology of otitis media.	[Noben-Trauth, Konrad; Latoche, Joseph R.] NIDCD, Neurogenet Sect, Mol Biol Lab, NIH, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Noben-Trauth, K (corresponding author), 5 Res Ct, Rockville, MD 20850 USA.	nobentk@nidcd.nih.gov			National Institutes of Health Division of Intramural Research; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000056] Funding Source: NIH RePORTER	National Institutes of Health Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Division of Intramural Research.	Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; Benit L, 1997, J VIROL, V71, P5652; Bluestone CD, 1996, PEDIATR INFECT DIS J, V15, P281, DOI 10.1097/00006454-199604000-00002; BROOKHOUSER PE, 1993, LARYNGOSCOPE, V103, P371, DOI 10.1002/lary.5541030402; BROTHERTON TW, 1979, BLOOD, V54, P673; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Casselbrant ML, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-85; Casselbrant ML, 1999, JAMA-J AM MED ASSOC, V282, P2125, DOI 10.1001/jama.282.22.2125; Cureoglu S, 2006, AM J OTOLARYNG, V27, P334, DOI 10.1016/j.amjoto.2005.11.001; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Daly KA, 2004, AM J HUM GENET, V75, P988, DOI 10.1086/426061; DEOL MS, 1961, J EMBRYOL EXP MORPH, V6, P78; Depreux FFS, 2008, J CLIN INVEST, V118, P651, DOI 10.1172/JCI32899; Doherty L, 2010, AM J HUM GENET, V86, P222, DOI 10.1016/j.ajhg.2009.12.015; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Ealy M, 2010, HEARING RES, V266, P70, DOI 10.1016/j.heares.2009.07.002; Eriksson PO, 2006, INT J MED MICROBIOL, V296, P501, DOI 10.1016/j.ijmm.2006.04.002; Farrar JE, 2008, BLOOD, V112, P1582, DOI 10.1182/blood-2008-02-140012; Frisch T, 2000, ANN OTO RHINOL LARYN, V109, P33, DOI 10.1177/000348940010900106; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Gazda HT, 2006, BRIT J HAEMATOL, V135, P149, DOI 10.1111/j.1365-2141.2006.06268.x; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Grossi PM, 2008, J NEUROSURG, V108, P357, DOI 10.3171/JNS/2008/108/2/0357; Hardisty RE, 2003, JARO-J ASSOC RES OTO, V4, P130, DOI 10.1007/s10162-002-3015-9; Hardisty-Hughes RE, 2006, HUM MOL GENET, V15, P3273, DOI 10.1093/hmg/ddl403; HAWKE M, 1975, ARCH OTOLARYNGOL, V101, P462; Hustert E, 1996, MAMM GENOME, V7, P881, DOI 10.1007/s003359900261; Hwang CH, 2008, HUM MOL GENET, V17, P844, DOI 10.1093/hmg/ddm356; Ichimiya I, 1999, HEARING RES, V131, P128, DOI 10.1016/S0378-5955(99)00025-8; Ishijima J, 1998, GENOMICS, V49, P341, DOI 10.1006/geno.1998.5277; Jang CH, 2009, YONSEI MED J, V50, P585, DOI 10.3349/ymj.2009.50.4.585; Khan DC, 2000, HEARING RES, V142, P12, DOI 10.1016/S0378-5955(99)00221-X; KOTZIAS SA, 1985, AM J OTOL, V6, P490; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; Matsson H, 2004, MOL CELL BIOL, V24, P4032, DOI 10.1128/MCB.24.9.4032-4037.2004; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; MORGAN WC, 1950, J HERED, V41, P208, DOI 10.1093/oxfordjournals.jhered.a106131; Morris KA, 2005, JARO-J ASSOC RES OTO, V6, P75, DOI 10.1007/s10162-004-5046-x; Munker G, 1981, Adv Otorhinolaryngol, V27, P138; Nabili V, 1999, LARYNGOSCOPE, V109, P931, DOI 10.1097/00005537-199906000-00017; NAGER GT, 1976, ANN OTO RHINOL LARYN, V85, P204, DOI 10.1177/000348947608500204; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; PARK K, 1992, AM J OTOLARYNG, V13, P93, DOI 10.1016/0196-0709(92)90005-E; Parkinson N, 2006, PLOS GENET, V2, P1556, DOI 10.1371/journal.pgen.0020149; PATERSON HF, 1980, J EXP ZOOL, V211, P247, DOI 10.1002/jez.1402110214; Pau H, 2005, LARYNGOSCOPE, V115, P116, DOI 10.1097/01.mlg.0000150693.31130.a0; RIFKIND RA, 1974, ANN NY ACAD SCI, V241, P113; SADE J, 1982, AM J OTOL, V3, P203; Saeboe-Larssen S, 1998, GENETICS, V148, P1215; SHER AE, 1971, ACTA OTO-LARYNGOL, P1; STEEL KP, 1987, HEARING RES, V28, P227, DOI 10.1016/0378-5955(87)90051-7; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Thys M, 2009, OTOL NEUROTOL, V30, P1021, DOI 10.1097/MAO.0b013e3181a86509; Tinling SP, 2005, ANN OTO RHINOL LARYN, V114, P161, DOI 10.1177/000348940511400214; Tos M, 1989, Acta Otolaryngol Suppl, V457, P87; Uchida K, 1996, MAMM GENOME, V7, P481, DOI 10.1007/s003359900147; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Xu HX, 2009, OTOL NEUROTOL, V30, P579, DOI 10.1097/MAO.0b013e31819fe81c; Zheng QY, 2007, HEARING RES, V231, P23, DOI 10.1016/j.heares.2007.05.011; Zheng QY, 2006, BRAIN RES, V1091, P9, DOI 10.1016/j.brainres.2006.01.046	62	21	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3079	3093		10.1074/jbc.M110.184598	http://dx.doi.org/10.1074/jbc.M110.184598			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21062742	Green Published, hybrid			2022-12-25	WOS:000286464300070
J	Gibbings, S; Elkins, ND; Fitzgerald, H; Tiao, J; Weyman, ME; Shibao, G; Fini, MA; Wright, RM				Gibbings, Sophie; Elkins, Nancy D.; Fitzgerald, Hillary; Tiao, Janice; Weyman, Mari E.; Shibao, Gayle; Fini, Mehdi A.; Wright, Richard M.			Xanthine Oxidoreductase Promotes the Inflammatory State of Mononuclear Phagocytes through Effects on Chemokine Expression, Peroxisome Proliferator-activated Receptor-gamma Sumoylation, and HIF-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; CHRONIC HEART-FAILURE; ALVEOLAR AIR SPACE; PPAR-GAMMA; OXIDATIVE STRESS; TRANSCRIPTIONAL ACTIVITY; ENDOTHELIAL DYSFUNCTION; MACROPHAGE ACTIVATION; SUPEROXIDE-DISMUTASE	The protective effects of pharmacological inhibitors of xanthine oxidoreductase (XOR) have implicated XOR in many inflammatory diseases. Nonetheless, the role played by XOR during inflammation is poorly understood. We previously observed that inhibition of XOR within the inflammatory mononuclear phagocytes (MNP) prevented neutrophil recruitment during adoptive transfer demonstrating the role of XOR in MNP-mediated neutrophil recruitment. To further explore the role of XOR in the inflammatory state of MNP, we studied MNP isolated from inflammatory lungs combined with analyses of MNP cell lines. We demonstrated that XOR activity was increased in inflammatory MNP following insufflation of Th-1 cytokines in vivo and that activity was specifically increased by MNP differentiation. Inhibition of XOR reduced levels of CINC-1 secreted by MNP. Expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) in purified rat lung MNP and MNP cell lines reflected both the presence of PPAR gamma isoforms and PPAR gamma SUMOylation, and XOR inhibitors increased levels of SUMO-PPAR gamma in MNP cell lines. Both ectopic overexpression of XOR cDNA and uric acid supplementation reduced SUMO-PPAR gamma in MNP cells. Levels of the M2 markers CD36, CD206, and arginase-1 were modulated by uric acid and oxonic acid, whereas siRNA to SUMO-1 or PIAS-1 also reduced arginase-1 in RAW264.7 cells. We also observed that HIF-1 alpha was increased by XOR inhibitors in inflammatory MNP and in MNP cell lines. These data demonstrate that XOR promotes the inflammatory state of MNP through effects on chemokine expression, PPAR gamma SUMOylation, and HIF-1 alpha and suggest that strategies for inhibiting XOR may be valuable in modulating lung inflammatory disorders.	[Elkins, Nancy D.; Weyman, Mari E.; Shibao, Gayle; Fini, Mehdi A.; Wright, Richard M.] Univ Colorado Denver, Webb Waring Ctr, Aurora, CO 80045 USA; [Fini, Mehdi A.; Wright, Richard M.] Univ Colorado Denver, Dept Med, Div Pulm Sci, Aurora, CO 80045 USA; [Gibbings, Sophie] Univ Bath, Dept Biochem, Bath BA2 7AY, Avon, England; [Fitzgerald, Hillary; Tiao, Janice] Princeton Univ, Dept Biochem, Princeton, NJ 08544 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Bath; Princeton University	Wright, RM (corresponding author), Univ Colorado Denver, Webb Waring Ctr, Aurora, CO 80045 USA.	richard.m.wright@UCDenver.edu			National Institutes of Health [HL-45582]; Robert and Helen Kleberg Foundation; American Cancer Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert and Helen Kleberg Foundation; American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-45582. This work was also supported in part by grants from The Robert and Helen Kleberg Foundation, Brian Fitzgerald (in honor of his son), and the American Cancer Society.	ADKINS WK, 1990, J APPL PHYSIOL, V69, P2012, DOI 10.1152/jappl.1990.69.6.2012; Ansari A, 2008, ALIMENT PHARM THER, V28, P749, DOI 10.1111/j.1365-2036.2008.03768.x; Asada K, 2004, AM J RESP CRIT CARE, V169, P195, DOI 10.1164/rccm.200207-740OC; Ayoub SS, 2009, MOL CELL BIOCHEM, V327, P101, DOI 10.1007/s11010-009-0048-y; Beck-Schimmer B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-61; Becker J, 2006, FUND CLIN PHARMACOL, V20, P429, DOI 10.1111/j.1472-8206.2006.00425.x; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Berta MA, 2007, BIOCHEM BIOPH RES CO, V360, P646, DOI 10.1016/j.bbrc.2007.06.103; Berthiaume Y, 1999, THORAX, V54, P150, DOI 10.1136/thx.54.2.150; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bonomini F, 2008, HISTOL HISTOPATHOL, V23, P381, DOI 10.14670/HH-23.381; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Boueiz A, 2008, AM J PHYSIOL-LUNG C, V294, pL830, DOI 10.1152/ajplung.00007.2008; Butler R, 2000, HYPERTENSION, V35, P746, DOI 10.1161/01.HYP.35.3.746; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Chinnaiyan AM, 2001, AM J PATHOL, V159, P1199, DOI 10.1016/S0002-9440(10)62505-9; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Davies John Q, 2005, Methods Mol Biol, V290, P91; de Boer WI, 2000, J PATHOL, V190, P619, DOI 10.1002/(SICI)1096-9896(200004)190:5<619::AID-PATH555>3.0.CO;2-6; Desco MC, 2002, DIABETES, V51, P1118, DOI 10.2337/diabetes.51.4.1118; Desouza IA, 2005, BRIT J PHARMACOL, V146, P781, DOI 10.1038/sj.bjp.0706393; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Duan SZ, 2009, CURR OPIN NEPHROL HY, V18, P128, DOI 10.1097/MNH.0b013e328325803b; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Feig DI, 2008, JAMA-J AM MED ASSOC, V300, P924, DOI 10.1001/jama.300.8.924; Fini MA, 2008, J CELL BIOCHEM, V105, P1008, DOI 10.1002/jcb.21901; Frank JA, 2006, AM J PHYSIOL-LUNG C, V291, pL1191, DOI 10.1152/ajplung.00055.2006; Fukunari A, 2004, J PHARMACOL EXP THER, V311, P519, DOI 10.1124/jpet.104.070433; Gallardo-Soler A, 2008, MOL ENDOCRINOL, V22, P1394, DOI 10.1210/me.2007-0525; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; HELMKE RJ, 1989, IN VITRO CELL DEV B, V25, P44; Ichinose M, 2003, EUR RESPIR J, V22, P457, DOI 10.1183/09031936.03.00052002; Inkster ME, 2007, EUR J PHARMACOL, V561, P63, DOI 10.1016/j.ejphar.2006.12.029; Jaramillo M, 2004, J BIOL CHEM, V279, P52797, DOI 10.1074/jbc.M403823200; Jennewein C, 2008, J IMMUNOL, V181, P5646, DOI 10.4049/jimmunol.181.8.5646; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kovarik P, 1998, EMBO J, V17, P3660, DOI 10.1093/emboj/17.13.3660; Landmesser U, 2002, CIRCULATION, V106, P3073, DOI 10.1161/01.CIR.0000041431.57222.AF; Liu D, 2006, PHYSIOL RES, V55, P291, DOI 10.33549/physiolres.930822; Luciani A, 2009, J IMMUNOL, V183, P2775, DOI 10.4049/jimmunol.0900993; Malur A, 2009, J IMMUNOL, V182, P5816, DOI 10.4049/jimmunol.0803504; Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS; Maus U, 2001, AM J RESP CRIT CARE, V164, P406, DOI 10.1164/ajrccm.164.3.2009055; Maus U, 2001, AM J PHYSIOL-LUNG C, V280, pL58, DOI 10.1152/ajplung.2001.280.1.L58; Maus UA, 2005, AM J PHYSIOL-LUNG C, V288, pL350, DOI 10.1152/ajplung.00061.2004; Maus UA, 2003, J IMMUNOL, V170, P3273, DOI 10.4049/jimmunol.170.6.3273; Maus UA, 2002, AM J PHYSIOL-LUNG C, V282, pL1245, DOI 10.1152/ajplung.00453.2001; Moraes LA, 2006, PHARMACOL THERAPEUT, V110, P371, DOI 10.1016/j.pharmthera.2005.08.007; Ohshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200; Pacheco P, 2007, J IMMUNOL, V179, P8500, DOI 10.4049/jimmunol.179.12.8500; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Pan Z, 1999, J BIOL CHEM, V274, P23242, DOI 10.1074/jbc.274.33.23242; Parish RC, 2008, ANN PHARMACOTHER, V42, P1002, DOI 10.1345/aph.1K272; Parmley LA, 2007, BRIT J PHARMACOL, V152, P915, DOI 10.1038/sj.bjp.0707443; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pereda J, 2004, ANN SURG, V240, P108, DOI 10.1097/01.sla.0000129343.47774.89; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Prince Joseph E., 2003, Journal of Allergy and Clinical Immunology, V111, pS613; Puneet P, 2005, AM J PHYSIOL-LUNG C, V288, pL3, DOI 10.1152/ajplung.00405.2003; Qu J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001085; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Reddy RC, 2004, AM J PHYSIOL-LUNG C, V286, pL613, DOI 10.1152/ajplung.00206.2003; Riaz AA, 2003, FREE RADICAL BIO MED, V35, P782, DOI 10.1016/S0891-5849(03)00405-2; Riaz AA, 2002, BRIT J SURG, V89, P1572, DOI 10.1046/j.1365-2168.2002.02279.x; Rose CE, 2003, MICROCIRCULATION, V10, P273, DOI 10.1038/sj.mn.7800193; Rosseau S, 2000, AM J PHYSIOL-LUNG C, V279, pL25, DOI 10.1152/ajplung.2000.279.1.L25; Sekundo W, 2001, EUR J OPHTHALMOL, V11, P264, DOI 10.1177/112067210101100309; Seymour KJ, 2006, J BIOL CHEM, V281, P8545, DOI 10.1074/jbc.M507349200; Shi Y, 2006, J IMMUNOL, V176, P3905, DOI 10.4049/jimmunol.176.7.3905; Shibata K, 1998, AM J RESP CRIT CARE, V158, P1578, DOI 10.1164/ajrccm.158.5.9804039; SIEMS WG, 1992, CELL MOL BIOL, V38, P189; Smith MR, 2007, PPAR RES, V2007, DOI 10.1155/2007/23812; Smith SJ, 2006, BRIT J PHARMACOL, V149, P393, DOI 10.1038/sj.bjp.0706885; Standiford Theodore J, 2005, Proc Am Thorac Soc, V2, P226, DOI 10.1513/pats.200501-010AC; Steinmuller C, 2000, AM J RESP CELL MOL, V22, P481, DOI 10.1165/ajrcmb.22.4.3336; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Valledor AF, 1998, J LEUKOCYTE BIOL, V63, P405, DOI 10.1002/jlb.63.4.405; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; Vorbach C, 2003, TRENDS IMMUNOL, V24, P512, DOI 10.1016/S1471-4906(03)00237-0; Wang XD, 2009, PULM PHARMACOL THER, V22, P318, DOI 10.1016/j.pupt.2009.01.004; Wright RM, 2004, AM J RESP CELL MOL, V30, P479, DOI 10.1165/rcmb.2003-0309OC; Xiang L, 2003, INFLAMM RES, V52, P353, DOI 10.1007/s00011-003-1184-6; Yakabi K, 2003, DIGEST DIS SCI, V48, P1081, DOI 10.1023/A:1023708511116; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x; Yang J, 2008, HYPERTENS RES, V31, P931, DOI 10.1291/hypres.31.931; Zelcer N, 2005, CELL METAB, V2, P273, DOI 10.1016/j.cmet.2005.10.004; Zinkernagel AS, 2007, J MOL MED, V85, P1339, DOI 10.1007/s00109-007-0282-2	93	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					961	975		10.1074/jbc.M110.150847	http://dx.doi.org/10.1074/jbc.M110.150847			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059659	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000286005000007
J	Sun, QM; Zhang, J; Fan, WL; Wong, KN; Ding, XJ; Chen, S; Zhong, Q				Sun, Qiming; Zhang, Jing; Fan, Weiliang; Wong, Kwun Ngok; Ding, Xiaojun; Chen, She; Zhong, Qing			The RUN Domain of Rubicon Is Important for hVps34 Binding, Lipid Kinase Inhibition, and Autophagy Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE COMPLEXES; BECLIN 1; SACCHAROMYCES-CEREVISIAE; PROTEIN; VPS34; MATURATION; ENDOSOME; UVRAG; RECRUITMENT; EFFECTOR	The class III phosphatidylinositol 3-kinase (PI3KC3) plays a central role in autophagy. Rubicon, a RUN domain-containing protein, is newly identified as a PI3KC3 subunit through its association with Beclin 1. Rubicon serves as a negative regulator of PI3KC3 and autophagosome maturation. The molecular mechanism underlying the PI3KC3 and autophagy inhibition by Rubicon is largely unknown. Here, we demonstrate that Rubicon interacts with the PI3KC3 catalytic subunit hVps34 via its RUN domain. The RUN domain contributes to the efficient inhibition of PI3KC3 lipid kinase activity by Rubicon. Furthermore, a Rubicon RUN domain deletion mutant fails to complement the autophagy deficiency in Rubicon-depleted cells. Hence, these results reveal a critical role of the Rubicon RUN domain in PI3KC3 and autophagy regulation.	[Sun, Qiming; Zhang, Jing; Fan, Weiliang; Wong, Kwun Ngok; Zhong, Qing] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, Berkeley, CA 94720 USA; [Ding, Xiaojun; Chen, She] Natl Inst Biol Sci, Beijing 102206, Peoples R China	University of California System; University of California Berkeley; National Institute of Biological Sciences, Beijing	Zhong, Q (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, 316 Barker Hall, Berkeley, CA 94720 USA.	qingzhong@berkeley.edu	Zhong, Qing/GLT-4858-2022	Zhong, Qing/0000-0001-6979-955X; Sun, Qiming/0000-0003-4988-9886	National Institutes of Health [RO1 CA133228]; Ellison Medical Foundation; Hellman Family Fund; NATIONAL CANCER INSTITUTE [R01CA133228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Hellman Family Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA133228 (to Q. Z.). The work was also supported by a New Investigator Award for Aging from the Ellison Medical Foundation and the Hellman Family Fund (to Q. Z.).	Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Fan WL, 2010, AUTOPHAGY, V6, P614, DOI 10.4161/auto.6.5.12189; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kukimoto-Niino M, 2006, J BIOL CHEM, V281, P31843, DOI 10.1074/jbc.M604960200; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Mari M, 2001, J BIOL CHEM, V276, P42501, DOI 10.1074/jbc.M104885200; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Recacha R, 2009, STRUCTURE, V17, P21, DOI 10.1016/j.str.2008.10.014; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; Sun QM, 2010, P NATL ACAD SCI USA, V107, P19338, DOI 10.1073/pnas.1010554107; Sun QM, 2009, AUTOPHAGY, V5, P713, DOI 10.4161/auto.5.5.8524; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Wurmser AE, 2002, J CELL BIOL, V158, P761, DOI 10.1083/jcb.200112050; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	27	85	88	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					185	191		10.1074/jbc.M110.126425	http://dx.doi.org/10.1074/jbc.M110.126425			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21062745	Green Published, hybrid			2022-12-25	WOS:000285782800020
J	Aparicio, E; Parera, M; Franco, S; Perez-Alvarez, N; Tural, C; Clotet, B; Martinez, MA				Aparicio, Ester; Parera, Mariona; Franco, Sandra; Perez-Alvarez, Nuria; Tural, Cristina; Clotet, Bonaventura; Angel Martinez, Miguel			IL28B SNP rs8099917 Is Strongly Associated with Pegylated Interferon-alpha and Ribavirin Therapy Treatment Failure in HCV/HIV-1 Coinfected Patients	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; PLUS RIBAVIRIN; ANTIVIRAL THERAPY; GENETIC-VARIATION; RANDOMIZED-TRIAL; PEG-INTERFERON; HCV INFECTION; PEGINTERFERON; HIV	Recent genome-wide association studies report that the SNP rs8099917, located 8.9 kb upstream of the start codon of IL28B, is associated with both disease chronicity and therapeutic response to pegIFN-alpha and RBV in patients infected with genotype 1 HCV. To determine the effect of rs8099917 variation on the response of HCV to therapy, we genotyped this variant in a cohort of 160 HCV/HIV-1 coinfected patients in our clinic unit who received combined peg-IFN-alpha/RBV therapy. The rs8099917 T/G or G/G genotypes were observed in 56 patients (35%). Treatment failure occurred in 80% of G-allele carriers versus 48% of non-carriers (P < 0.0001). This result reveals that the G allele was strongly associated with treatment failure in this patient cohort. Importantly, a highly significant association was found between the G-allele and response to therapy in HCV genotype 1-infected patients (P < 0.0001) but not in HCV genotype 3-infected patients. Multivariate analysis (odds ratio; 95% confidence interval; P value) indicated that the rs8099917 TT genotype was a strong predictor of treatment success (5.83; 1.26-26.92; P = 0.021), independent of baseline plasma HCV-RNA load less than 500 000 IU/ml (4.85; 1.18-19.95; P = 0.025) and absence of advanced liver fibrosis (5.24; 1.20-22.91; P = 0.025). These results reveal the high prevalence of the rs8099917 G allele in HCV/HIV-1 coinfected patients as well as its strong association with treatment failure in HCV genotype 1-infected patients. rs8099917 SNP genotyping may be a valid pre-treatment predictor of which patients are likely to respond to treatment in this group of difficult-to-treat HCV/HIV-infected patients.	[Aparicio, Ester; Parera, Mariona; Franco, Sandra; Clotet, Bonaventura; Angel Martinez, Miguel] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Fundacio IrsiCaixa, E-08193 Barcelona, Spain; [Perez-Alvarez, Nuria; Tural, Cristina; Clotet, Bonaventura] Hosp Badalona Germans Trias & Pujol, Fundacio Lluita Sida, Badalona, Spain; [Perez-Alvarez, Nuria] Tech Univ Catalonia, Stat & Operat Res Dept, Barcelona, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Hospital Germans Trias i Pujol; Universitat Politecnica de Catalunya	Aparicio, E (corresponding author), Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Fundacio IrsiCaixa, E-08193 Barcelona, Spain.	mmartinez@irsicaixa.es	Franco, Sandra/S-6843-2019; Franco, Sandra/E-6114-2016; Martinez, Miguel Angel/K-6435-2014; Perez-Alvarez, Nuria/O-9244-2014	Franco, Sandra/0000-0003-4126-2202; Franco, Sandra/0000-0003-4126-2202; Martinez, Miguel Angel/0000-0002-6681-4950; Perez-Alvarez, Nuria/0000-0001-6582-1553; Parera Sallent, Mariona/0000-0002-0756-8307	Spanish Ministerio de Ciencia e Innovacion, Fondo de Investigaciones Sanitarias [PI07/0098]; Red Tematica de Investigacion Cooperativa en SIDA [RD06/0006]	Spanish Ministerio de Ciencia e Innovacion, Fondo de Investigaciones Sanitarias(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentInstituto de Salud Carlos III); Red Tematica de Investigacion Cooperativa en SIDA	This study was supported by the Spanish Ministerio de Ciencia e Innovacion, Fondo de Investigaciones Sanitarias project PI07/0098 and through "Red Tematica de Investigacion Cooperativa en SIDA" Grant RD06/0006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros AL, 2004, AIDS, V18, P59, DOI 10.1097/00002030-200401020-00007; Berenguer J, 2009, HEPATOLOGY, V50, P407, DOI 10.1002/hep.23020; Chen TY, 2009, CLIN INFECT DIS, V49, P1605, DOI 10.1086/644771; Chevaliez S, 2007, WORLD J GASTROENTERO, V13, P2461, DOI 10.3748/wjg.v13.i17.2461; Dodds MG, 2009, J HEPATOL, V50, pS342, DOI 10.1016/S0168-8278(09)60944-2; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Franco S, 2007, HEPATOLOGY, V45, P899, DOI 10.1002/hep.21623; Fried MW, 2000, AM J GASTROENTEROL, V95, P3225, DOI 10.1111/j.1572-0241.2000.03433.x; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gao B, 2004, HEPATOLOGY, V39, P880, DOI 10.1002/hep.20139; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Ibanez A, 1998, J MED VIROL, V55, P293, DOI 10.1002/(SICI)1096-9071(199808)55:4&lt;293::AID-JMV7&gt;3.0.CO;2-W; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kronenberger B, 2009, ANN HEPATOL, V8, P103, DOI 10.1016/S1665-2681(19)31786-7; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; MAS A, J MOL BIOL, V397, P865; Muir A, 2009, HEPATOLOGY, V50, p1039A; Pineda JA, 2010, CLIN INFECT DIS, V51, P788, DOI 10.1086/656235; RALLON NI, 1928, AIDS, V24, pF23; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rockstroh JK, 2008, HIV MED, V9, P82, DOI 10.1111/j.1468-1293.2007.00535.x; Rockstroh JK, 2004, LANCET INFECT DIS, V4, P437, DOI 10.1016/S1473-3099(04)01059-X; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Walsh MJ, 2006, GUT, V55, P529, DOI 10.1136/gut.2005.069674	30	66	72	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13771	10.1371/journal.pone.0013771	http://dx.doi.org/10.1371/journal.pone.0013771			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048934	Green Published, Green Submitted, gold			2022-12-25	WOS:000283645300045
J	Lard, M; Backman, J; Yakovleva, M; Danielsson, B; Hansson, LA				Lard, Mercy; Backman, Johan; Yakovleva, Maria; Danielsson, Bengt; Hansson, Lars-Anders			Tracking the Small with the Smallest - Using Nanotechnology in Tracking Zooplankton	PLOS ONE			English	Article							SEMICONDUCTOR QUANTUM DOTS; VERTICAL MIGRATION; DAPHNIA-MAGNA; NANOPARTICLES; UV; STREPTAVIDIN; PIGMENTATION; NANOCRYSTALS; THREATS	A major problem when studying behavior and migration of small organisms is that many of the questions addressed for larger animals are not possible to formulate due to constraints on tracking smaller animals. In aquatic ecosystems, this problem is particularly problematic for zoo- and phytoplankton, since tracking devices are too heavy to allow the organism to act naturally. However, recent advances in nanotechnology have made it possible to track individual animals and thereby to focus on important and urgent questions which previously have not been possible to address. Here we report on a novel approach to track movement and migratory behavior of millimeter sized aquatic animals, particularly Daphnia magna, using the commercially available nanometer sized fluorescent probes known as quantum dots. Experimental trials with and without quantum dots showed that they did not affect behavior, reproduction or mortality of the tested animals. Compared to previously used methods to label small animals, the nano-labeling method presented here offers considerable improvements including: 24 h fluorescence, studies in both light and darkness, much improved optical properties, potential to study large volumes and even track animals in semi-natural conditions. Hence, the suggested method, developed in close cooperation between biologists, chemists and physicists, offers new opportunities to routinely study zooplankton responses to light, food and predation, opening up advancements within research areas such as diel vertical/horizontal migration, partial migration and other differences in intra- and interspecific movements and migration.	[Lard, Mercy; Backman, Johan; Hansson, Lars-Anders] Lund Univ, Inst Biol, Lund, Sweden; [Yakovleva, Maria] Lund Univ, Dept Infect Dis & Med Microbiol, Lund, Sweden; [Danielsson, Bengt] Lund Univ, Dept Pure & Appl Biochem, Lund, Sweden	Lund University; Lund University; Lund University	Lard, M (corresponding author), Lund Univ, Inst Biol, Lund, Sweden.	lars-anders.hansson@limnol.lu.se	Lard, Mercy/C-4193-2011; Lard, Mercy/AAV-6577-2021; Hansson, Lars-Anders/HCI-2735-2022; Lard, Mercy/R-2035-2019	Lard, Mercy/0000-0001-9243-4735; Lard, Mercy/0000-0001-9243-4735; Hansson, Lars-Anders/0000-0002-3035-1317	Swedish Research Council; Linnean Grant	Swedish Research Council(Swedish Research CouncilEuropean Commission); Linnean Grant	The study was financed by the Swedish Research Council (VR) and the Linnean Grant to the Center for Animal Migration (CanMove). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivisatos AP, 1996, J PHYS CHEM-US, V100, P13226, DOI 10.1021/jp9535506; Ballou B, 2007, BIOCONJUGATE CHEM, V18, P389, DOI 10.1021/bc060261j; Biju V, 2008, ANAL BIOANAL CHEM, V391, P2469, DOI 10.1007/s00216-008-2185-7; BRO N, 2010, HYDROBIOLOGIA, V646, P91; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Galarza A., 2009, Animal Biodiversity and Conservation, V32, P117; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; GITLIN G, 1988, BIOCHEM J, V256, P279, DOI 10.1042/bj2560279; Hansson LA, 2000, ECOLOGY, V81, P842, DOI 10.2307/177381; Hansson LA, 2007, ECOLOGY, V88, P1932, DOI 10.1890/06-2038.1; Hansson LA, 2007, OIKOS, V116, P585, DOI 10.1111/j.2007.0030-1299.15754.x; Hansson LA, 2009, P R SOC B, V276, P331, DOI 10.1098/rspb.2008.1088; Hauck TS, 2010, SMALL, V6, P138, DOI 10.1002/smll.200900626; Hylander S, 2009, LIMNOL OCEANOGR, V54, P483, DOI 10.4319/lo.2009.54.2.0483; Jackson BP, 2009, ANAL BIOANAL CHEM, V394, P911, DOI 10.1007/s00216-009-2768-y; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt767; Liu W, 2008, J AM CHEM SOC, V130, P1274, DOI 10.1021/ja076069p; Morell V, 2009, SCIENCE, V323, P1284, DOI 10.1126/science.323.5919.1284; OBRIEN JJ, 1991, BIOL BULL, V181, P427, DOI 10.2307/1542363; Rogach A.L., 2008, SEMICONDUCTOR NANOCR; Smith AM, 2008, ADV DRUG DELIVER REV, V60, P1226, DOI 10.1016/j.addr.2008.03.015; SMITH KC, 1990, J COMP PHYSIOL A, V166, P597; Sperling RA, 2010, PHILOS T R SOC A, V368, P1333, DOI 10.1098/rsta.2009.0273; STICH HB, 1981, NATURE, V293, P396, DOI 10.1038/293396a0; Sun MM, 2010, STEROIDS, V75, P400, DOI 10.1016/j.steroids.2010.02.002	26	21	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13516	10.1371/journal.pone.0013516	http://dx.doi.org/10.1371/journal.pone.0013516			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060826	Green Submitted, Green Published, gold			2022-12-25	WOS:000283645300001
J	Zhao, H; Shen, J; Medico, L; Wang, D; Ambrosone, CB; Liu, S				Zhao, Hua; Shen, Jie; Medico, Leonard; Wang, Dan; Ambrosone, Christine B.; Liu, Song			A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer	PLOS ONE			English	Article							MICRORNA-21 TARGETS; TUMOR INVASION; METASTASIS; SERUM; MARKERS	Background: To date, there are no highly sensitive and specific minimally invasive biomarkers for detection of breast cancer at an early stage. The occurrence of circulating microRNAs (miRNAs) in blood components (including serum and plasma) has been repeatedly observed in cancer patients as well as healthy controls. Because of the significance of miRNA in carcinogenesis, circulating miRNAs in blood may be unique biomarkers for early and minimally invasive diagnosis of human cancers. The objective of this pilot study was to discover a panel of circulating miRNAs as potential novel breast cancer biomarkers. Methodology/Principal Findings: Using microarray-based expression profiling followed by Real-Time quantitative Polymerase Cycle Reaction (RT-qPCR) validation, we compared the levels of circulating miRNAs in plasma samples from 20 women with early stage breast cancer (10 Caucasian American (CA) and 10 African American (AA)) and 20 matched healthy controls (10 CAs and 10 AAs). Using the significance level of p<0.05 constrained by at least two-fold expression change as selection criteria, we found that 31 miRNAs were differentially expressed in CA study subjects (17 up and 14 down) and 18 miRNAs were differentially expressed in AA study subjects (9 up and 9 down). Interestingly, only 2 differentially expressed miRNAs overlapped between CA and AA study subjects. Using receiver operational curve (ROC) analysis, we show that not only up-regulated but also down-regulated miRNAs can discriminate patients with breast cancer from healthy controls with reasonable sensitivity and specificity. To further explore the potential roles of these circulating miRNAs in breast carcinogenesis, we applied pathway-based bioinformatics exploratory analysis and predicted a number of significantly enriched pathways which are predicted to be regulated by these circulating miRNAs, most of which are involved in critical cell functions, cancer development and progression. Conclusions: Our observations from this pilot study suggest that the altered levels of circulating miRNAs might have great potential to serve as novel, noninvasive biomarkers for early detection of breast cancer.	[Zhao, Hua; Shen, Jie; Medico, Leonard; Ambrosone, Christine B.] Roswell Pk Canc Inst, Dept Canc Prevent & Controls, Buffalo, NY 14263 USA; [Wang, Dan; Liu, Song] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Zhao, H (corresponding author), Roswell Pk Canc Inst, Dept Canc Prevent & Controls, Buffalo, NY 14263 USA.	hua.zhao@roswellpark.org; song.liu@roswellpark.org			NIH/NCI [5R01CA136483]; Congressionally directed Medical Research Program [BC074340]; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA136483] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Congressionally directed Medical Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study is supported by grants from NIH/NCI (5R01CA136483) www.nih.gov and Congressionally directed Medical Research Program (BC074340) http://cdmrp.army.mil/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosone CB, 2006, CANCER EPIDEM BIOMAR, V15, P1575, DOI 10.1158/1055-9965.EPI-06-0628; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Grinchuk OV, 2010, NUCLEIC ACIDS RES, V38, P534, DOI 10.1093/nar/gkp954; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; OHANLON DM, 1995, BRIT J CANCER, V71, P1288, DOI 10.1038/bjc.1995.249; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Selcuklu SD, 2009, CANCER GENET CYTOGEN, V189, P15, DOI 10.1016/j.cancergencyto.2008.09.009; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Smyth GK, 2004, STAT APPL GENET MOL, V5, pR3; Taplin S, 2008, J NATL CANCER I, V100, P876, DOI 10.1093/jnci/djn172; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thompson A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1983; Uehara M, 2008, INT J CLIN ONCOL, V13, P447, DOI 10.1007/s10147-008-0773-3; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Van der Auwera I, 2009, CANCER RES, V69, p862S; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; ZHAO Y, 2010, BREAST CANC RES 0610; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	40	304	331	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13735	10.1371/journal.pone.0013735	http://dx.doi.org/10.1371/journal.pone.0013735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060830	gold, Green Published, Green Submitted			2022-12-25	WOS:000283645300015
J	Graves, JA; Rothermund, K; Wang, T; Qian, W; Van Houten, B; Prochownik, EV				Graves, J. Anthony; Rothermund, Kristi; Wang, Tao; Qian, Wei; Van Houten, Bennett; Prochownik, Edward V.			Point Mutations in c-Myc Uncouple Neoplastic Transformation from Multiple Other Phenotypes in Rat Fibroblasts	PLOS ONE			English	Article							N-TERMINAL DOMAIN; GENOMIC INSTABILITY; GENE-EXPRESSION; GLUTAMATE EXCITOTOXICITY; TRANSACTIVATION DOMAIN; AEROBIC GLYCOLYSIS; TUMOR-SUPPRESSOR; BURKITT-LYMPHOMA; CANCER-CELLS; DNA-DAMAGE	Deregulation of c-Myc (Myc) occurs in many cancers. In addition to transforming various cell types, Myc also influences additional transformation-associated cellular phenotypes including proliferation, survival, genomic instability, reactive oxygen species production, and metabolism. Although Myc is wild type in most cancers (wtMyc), it occasionally acquires point mutations in certain lymphomas. Some of these mutations confer a survival advantage despite partially attenuating proliferation and transformation. Here, we have evaluated four naturally-occurring or synthetic point mutations of Myc for their ability to affect these phenotypes, as well as to promote genomic instability, to generate reactive oxygen species and to up-regulate aerobic glycolysis and oxidative phosphorylation. Our findings indicate that many of these phenotypes are genetically and functionally independent of one another and are not necessary for transformation. Specifically, the higher rate of glucose metabolism known to be associated with wtMyc deregulation was found to be independent of transformation. One mutation (Q131R) was greatly impaired for nearly all of the studied Myc phenotypes, yet was able to retain some ability to transform. These findings indicate that, while the Myc phenotypes examined here make additive contributions to transformation, none, with the possible exception of increased reliance on extracellular glutamine for survival, are necessary for achieving this state.	[Graves, J. Anthony; Rothermund, Kristi; Prochownik, Edward V.] Univ Pittsburgh, Dept Pediat, Div Hematol Oncol, Childrens Hosp Pittsburgh,Med Ctr, Pittsburgh, PA 15260 USA; [Wang, Tao; Qian, Wei; Van Houten, Bennett; Prochownik, Edward V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA; [Wang, Tao; Qian, Wei; Van Houten, Bennett] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Med Ctr, Pittsburgh, PA 15260 USA; [Prochownik, Edward V.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Med Ctr, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Graves, JA (corresponding author), Univ Pittsburgh, Dept Pediat, Div Hematol Oncol, Childrens Hosp Pittsburgh,Med Ctr, Pittsburgh, PA 15260 USA.	gravja@chp.edu	Van Houten, Bennett/K-2284-2019		National Institutes of Health (NIH) [CA140624, CA78259]; University of Pittsburgh Cancer Institute; Pennsylvania Settlement Fund; NIH [HD052892]; Robert Wood Johnson Foundation; Hyundai Hope on Wheels Scholarship; Commonwealth Universal Research Enhancement (C.U.R.E.); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052892] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA078259, R01CA140624] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh Cancer Institute; Pennsylvania Settlement Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Hyundai Hope on Wheels Scholarship; Commonwealth Universal Research Enhancement (C.U.R.E.); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grants CA140624 and CA78259 to EVP, by The University of Pittsburgh Cancer Institute and Commonwealth Universal Research Enhancement (C.U.R.E.) Program, Pennsylvania Settlement Fund to BVH, and by the K12 NIH Mentored Clinical Scientist Development Program Award HD052892, the Harold Amos Medical Faculty Development Program sponsored by the Robert Wood Johnson Foundation and the Hyundai Hope on Wheels Scholarship to JAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT T, 1994, ONCOGENE, V9, P759; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Barrett John F., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-7; BHATIA K, 1994, BLOOD, V84, P883; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; BROUGH DE, 1995, MOL CELL BIOL, V15, P1536; Chang DW, 2000, MOL CELL BIOL, V20, P4309, DOI 10.1128/MCB.20.12.4309-4319.2000; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104; Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; HOANG AT, 1995, MOL CELL BIOL, V15, P4031; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kuttler F, 2001, ONCOGENE, V20, P6084, DOI 10.1038/sj.onc.1204827; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li Y, 2008, ONCOGENE, V27, P1599, DOI 10.1038/sj.onc.1210794; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Morrish F, 2008, CELL CYCLE, V7, P1054, DOI 10.4161/cc.7.8.5739; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nesbit CE, 2000, ONCOGENE, V19, P3200, DOI 10.1038/sj.onc.1203636; Nicholls DG, 2007, J NEUROSCI RES, V85, P3206, DOI 10.1002/jnr.21290; Oster SK, 2003, ONCOGENE, V22, P1998, DOI 10.1038/sj.onc.1206228; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Papas KK, 1999, FEBS LETT, V446, P338, DOI 10.1016/S0014-5793(99)00240-9; Prochownik EV, 2008, CURR MOL MED, V8, P446, DOI 10.2174/156652408785747988; PULVERER BJ, 1994, ONCOGENE, V9, P59; RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; Rogulski K, 2005, ONCOGENE, V24, P7524, DOI 10.1038/sj.onc.1208897; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; SETH A, 1991, J BIOL CHEM, V266, P23521; Shim H, 1998, P NATL ACAD SCI USA, V95, P1511, DOI 10.1073/pnas.95.4.1511; STONE J, 1987, MOL CELL BIOL, V7, P1697, DOI 10.1128/MCB.7.5.1697; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; YANO T, 1993, ONCOGENE, V8, P2741; Yin XY, 1999, ONCOGENE, V18, P1177, DOI 10.1038/sj.onc.1202410; Yin XY, 2002, J BIOL CHEM, V277, P19998, DOI 10.1074/jbc.M200860200; Yin XY, 2001, CANCER RES, V61, P6487; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zhang H, 1997, J BIOL CHEM, V272, P17416, DOI 10.1074/jbc.272.28.17416	58	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13717	10.1371/journal.pone.0013717	http://dx.doi.org/10.1371/journal.pone.0013717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060841	Green Published, gold, Green Accepted			2022-12-25	WOS:000283573800016
J	Bao, F; Feng, LL; Gao, J; Tan, ZF; Xing, B; Ma, R; Yan, CJ				Bao, Feng; Feng, Lingling; Gao, Jie; Tan, Zhifang; Xing, Bin; Ma, Rui; Yan, Chunjie			New Cobalt-Mediated Radical Polymerization (CMRP) of Methyl Methacrylate Initiated by Two Single-Component Dinuclear beta-Diketone Cobalt (II) Catalysts	PLOS ONE			English	Article							ORGANOCOBALT PORPHYRIN COMPLEXES; VINYL-ACETATE; ACRYLATES; LIGANDS; STYRENE	Two dinuclear cobalt complexes based on bis-diketonate ligands (ligand 1: 3,3'-(1,3-phenylene)bis(1-phenylpropane-1,3-dione); ligand 2: 3,3'-(1,4-phenylene)bis(1-phenylpropane-1,3-dione)) were successfully synthesized. The two neutral catalysts all showed satisfactory activities in the cobalt-mediated radical polymerization (CMRP) of methyl methacrylate (MMA) with the common initiator of azodiisobutyronitrile (AIBN). The resulting polymerizations have all of the characteristics of a living polymerization and displayed linear semilogarithmic kinetic plots, a linear correlation between the number-average molecular weight and the monomer conversion, and low polydispersities. Mono-or dicomponent low polydispersity polymers could be obtained by using the two dinuclear catalysts under proper reaction conditions. All these improvements facilitate the implementation of the acrylate CMRP and open the door to the scale-up of the syntheses and applications of the multicomponent low polydispersity polymers.	[Bao, Feng; Feng, Lingling; Gao, Jie; Tan, Zhifang; Xing, Bin] Cent China Normal Univ, Coll Chem, Wuhan, Peoples R China; [Ma, Rui; Yan, Chunjie] China Univ Geosci, Dept Mat Sci & Chem Engn, Wuhan 430074, Peoples R China	Central China Normal University; China University of Geosciences	Bao, F (corresponding author), Cent China Normal Univ, Coll Chem, Wuhan, Peoples R China.	polymerbaofeng@yahoo.com.cn; marui.cug@gmail.com			Fundamental Research Funds for the Central Universities [CUGL100407]; National Natural Science Foundation of China [50903077, 20872044]; Natural Science Foundation of Hubei Province [2009CDB163, 2008CDZ065]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by the Fundamental Research Funds for the Central Universities (CUGL100407) and the National Natural Science Foundation of China (50903077, 20872044), the Natural Science Foundation of Hubei Province (2009CDB163, 2008CDZ065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARVANITOPOULOS LD, 1994, POLYM PREPR AM CHEM, V35, P549; Bassett AP, 2004, J AM CHEM SOC, V126, P9413, DOI 10.1021/ja048022z; Bryaskova R, 2006, MACROMOLECULES, V39, P8263, DOI 10.1021/ma060339r; Burgess J, 2000, ACTA CRYSTALLOGR C, V56, P649; Clegg JK, 2008, DALTON T, P1331, DOI 10.1039/b716653b; COTTON FA, 1964, INORG CHEM, V3, P1, DOI 10.1021/ic50011a001; Debuigne A, 2005, ANGEW CHEM INT EDIT, V44, P1101, DOI 10.1002/anie.200461333; Debuigne A, 2005, ANGEW CHEM INT EDIT, V44, P3439, DOI 10.1002/anie.200500112; Goto A, 2004, PROG POLYM SCI, V29, P329, DOI 10.1016/j.progpolymsci.2004.01.002; Hu T, 2005, ORGANOMETALLICS, V24, P2628, DOI 10.1021/om049223e; Huang YB, 2008, ORGANOMETALLICS, V27, P259, DOI 10.1021/om700901x; Kaneyoshi H, 2005, MACROMOLECULES, V38, P8163, DOI 10.1021/ma051433v; Lu Z, 2004, MACROMOLECULES, V37, P2686, DOI 10.1021/ma035924w; Maria S, 2007, CHEM-EUR J, V13, P2480, DOI 10.1002/chem.200601457; Matsubara K, 2006, J POLYM SCI POL CHEM, V44, P4222, DOI 10.1002/pola.21498; Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g; Patten TE, 1996, SCIENCE, V272, P866, DOI 10.1126/science.272.5263.866; Peng CH, 2008, MACROMOLECULES, V41, P2368, DOI 10.1021/ma702500b; PERCEC V, 1995, MACROMOLECULES, V28, P7970, DOI 10.1021/ma00127a057; Soldatov DV, 2003, CRYST GROWTH DES, V3, P1005, DOI 10.1021/cg030016b; Tang HD, 2006, J AM CHEM SOC, V128, P16277, DOI 10.1021/ja0653369; Wang BQ, 2003, MACROMOLECULES, V36, P9684, DOI 10.1021/ma035334y; Wang LC, 2002, J AM CHEM SOC, V124, P9448, DOI 10.1021/ja020223k; Wayland BB, 1997, MACROMOLECULES, V30, P8109, DOI 10.1021/ma9707493; WAYLAND BB, 1994, J AM CHEM SOC, V116, P7943, DOI 10.1021/ja00096a080; Weiser MS, 2005, J POLYM SCI POL CHEM, V43, P3804, DOI 10.1002/pola.20873; Zhang D, 2003, ORGANOMETALLICS, V22, P2851, DOI 10.1021/om030068y	27	6	6	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13629	10.1371/journal.pone.0013629	http://dx.doi.org/10.1371/journal.pone.0013629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049027	Green Published, Green Submitted, gold			2022-12-25	WOS:000283487400019
J	He, J; Zhang, JF; Yi, C; Lv, Q; Xie, WD; Li, JN; Wan, G; Cui, K; Kung, HF; Yang, J; Yang, BB; Zhang, YO				He, Jie; Zhang, Jin-fang; Yi, Can; Lv, Qing; Xie, Wei-dong; Li, Jian-na; Wan, Gang; Cui, Kai; Kung, Hsiang-fu; Yang, Jennifer; Yang, Burton B.; Zhang, Yaou			miRNA-Mediated Functional Changes through Co-Regulating Function Related Genes	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; OSTEOBLAST DIFFERENTIATION; MICRORNAS; EXPRESSION; GROWTH	Background: microRNAs play important roles in various biological processes involving fairly complex mechanism. Analysis of genome-wide miRNA microarray demonstrate that a single miRNA can regulate hundreds of genes, but the regulative extent on most individual genes is surprisingly mild so that it is difficult to understand how a miRNA provokes detectable functional changes with such mild regulation. Results: To explore the internal mechanism of miRNA-mediated regulation, we re-analyzed the data collected from genome-wide miRNA microarray with bioinformatics assay, and found that the transfection of miR-181b and miR-34a in Hela and HCT-116 tumor cells regulated large numbers of genes, among which, the genes related to cell growth and cell death demonstrated high Enrichment scores, suggesting that these miRNAs may be important in cell growth and cell death. MiR-181b induced changes in protein expression of most genes that were seemingly related to enhancing cell growth and decreasing cell death, while miR-34a mediated contrary changes of gene expression. Cell growth assays further confirmed this finding. In further study on miR-20b-mediated osteogenesis in hMSCs, miR-20b was found to enhance osteogenesis by activating BMPs/Runx2 signaling pathway in several stages by co-repressing of PPAR gamma, Bambi and Crim1. Conclusions: With its multi-target characteristics, miR-181b, miR-34a and miR-20b provoked detectable functional changes by co-regulating functionally-related gene groups or several genes in the same signaling pathway, and thus mild regulation from individual miRNA targeting genes could have contributed to an additive effect. This might also be one of the modes of miRNA-mediated gene regulation.	[He, Jie; Zhang, Jin-fang; Yi, Can; Lv, Qing; Wan, Gang; Cui, Kai] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [He, Jie; Zhang, Jin-fang; Yi, Can; Lv, Qing; Xie, Wei-dong; Li, Jian-na; Wan, Gang; Cui, Kai; Zhang, Yaou] Tsinghua Univ, Grad Sch Shenzhen, Div Life Sci, Shenzhen 518057, Peoples R China; [Kung, Hsiang-fu] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Yang, Burton B.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Lab Med & Pathol, Toronto, ON, Canada; [Yang, Jennifer] Univ Toronto, Dept Physiol, Toronto, ON, Canada	Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Chinese University of Hong Kong; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	He, J (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	byang@sri.utoronto.ca; zhangyo@sz.tsinghua.edu.cn	Lyu, Qing/AAF-5181-2021; Lyu, Qing/AAP-8387-2020	Lyu, Qing/0000-0002-1325-6828; 	National Natural Science and Foundation of China [30911120492]	National Natural Science and Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a China-Canada Joint Health Research Grant (from the National Natural Science and Foundation of China to Yaou Zhang) (No. 30911120492) http://www.nsfc.gov.cn/Portal0/default106.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Chen JQ, 2007, GENESIS, V45, P482, DOI 10.1002/dvg.20320; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gazzerro E, 2006, REV ENDOCR METAB DIS, V7, P51, DOI 10.1007/s11154-006-9000-6; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeon MJ, 2003, J BIOL CHEM, V278, P23270, DOI 10.1074/jbc.M211610200; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Pennisi DJ, 2007, DEV DYNAM, V236, P502, DOI 10.1002/dvdy.21015; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Shockley KR, 2009, J CELL BIOCHEM, V106, P232, DOI 10.1002/jcb.21994; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Wilkinson L, 2003, J BIOL CHEM, V278, P34181, DOI 10.1074/jbc.M301247200; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; ZHANG Y, ENCY LIFE SCI, DOI DOI 10.1002/9780470015902.A0021754	36	45	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13558	10.1371/journal.pone.0013558	http://dx.doi.org/10.1371/journal.pone.0013558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042576	Green Submitted, Green Published, gold			2022-12-25	WOS:000283419100006
J	Hong, Y; Kang, J; Lee, D; van Rossum, DB				Hong, Yoojin; Kang, Jaewoo; Lee, Dongwon; van Rossum, Damian B.			Adaptive GDDA-BLAST: Fast and Efficient Algorithm for Protein Sequence Embedding	PLOS ONE			English	Article							PHYLOGENETIC PROFILES; TWILIGHT ZONE; PSI-BLAST; DATABASE; DOMAIN; ALIGNMENTS; INFORMATION; SPACE	A major computational challenge in the genomic era is annotating structure/function to the vast quantities of sequence information that is now available. This problem is illustrated by the fact that most proteins lack comprehensive annotations, even when experimental evidence exists. We previously theorized that embedded-alignment profiles (simply "alignment profiles" hereafter) provide a quantitative method that is capable of relating the structural and functional properties of proteins, as well as their evolutionary relationships. A key feature of alignment profiles lies in the interoperability of data format (e.g., alignment information, physio-chemical information, genomic information, etc.). Indeed, we have demonstrated that the Position Specific Scoring Matrices (PSSMs) are an informative M-dimension that is scored by quantitatively measuring the embedded or unmodified sequence alignments. Moreover, the information obtained from these alignments is informative, and remains so even in the "twilight zone" of sequence similarity (<25% identity) [1-5]. Although our previous embedding strategy was powerful, it suffered from contaminating alignments (embedded AND unmodified) and high computational costs. Herein, we describe the logic and algorithmic process for a heuristic embedding strategy named "Adaptive GDDA-BLAST." Adaptive GDDA-BLAST is, on average, up to 19 times faster than, but has similar sensitivity to our previous method. Further, data are provided to demonstrate the benefits of embedded-alignment measurements in terms of detecting structural homology in highly divergent protein sequences and isolating secondary structural elements of transmembrane and ankyrin-repeat domains. Together, these advances allow further exploration of the embedded alignment data space within sufficiently large data sets to eventually induce relevant statistical inferences. We show that sequence embedding could serve as one of the vehicles for measurement of low-identity alignments and for incorporation thereof into high-performance PSSM-based alignment profiles.	[Hong, Yoojin; Lee, Dongwon] Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA; [Hong, Yoojin; van Rossum, Damian B.] Penn State Univ, Ctr Computat Prote, University Pk, PA 16802 USA; [Kang, Jaewoo] Korea Univ, Dept Comp Sci & Engn, Seoul, South Korea; [Kang, Jaewoo] Korea Univ, Coll Med, Dept Biostat, Seoul 136705, South Korea; [Lee, Dongwon] Penn State Univ, Coll Informat Sci & Technol, University Pk, PA 16802 USA; [van Rossum, Damian B.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Korea University; Korea University; Korea University Medicine (KU Medicine); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hong, Y (corresponding author), Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA.	kangj@korea.ac.kr; dbv10@psu.edu		van Rossum, Damian/0000-0003-1011-2586	NCSA [TG-MCB070027N]; The National Science Foundation [428-15 691M]; The National Institutes of Health [R01 GM087410-01]; Eberly College of Sciences and the Huck Institutes of the Life Sciences; Pennsylvania Department of Health; Brain Korea 21 Project; Microsoft; Korean Government (MOEHRD) [KRF-2008-331-D00481]; Korea government (MEST) [2009-0077688, 2009-0086140, R01-2008-000-20564-0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087410] Funding Source: NIH RePORTER	NCSA; The National Science Foundation(National Science Foundation (NSF)); The National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eberly College of Sciences and the Huck Institutes of the Life Sciences; Pennsylvania Department of Health; Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Microsoft(Microsoft); Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCSA grant TG-MCB070027N (DVR), The National Science Foundation 428-15 691M (DVR), and The National Institutes of Health R01 GM087410-01 (DVR). This project was also funded by a Fellowship from the Eberly College of Sciences and the Huck Institutes of the Life Sciences (DVR) and a grant from the Pennsylvania Department of Health using Tobacco Settlement Funds (DVR). The Department of Health specifically disclaims responsibility for any analyses, interpretations or conclusions. This work was also supported by the Second Brain Korea 21 Project Grant (JK), Microsoft Research Asia Grant (JK), the Korea Research Foundation Grant funded by the Korean Government (MOEHRD, Basic Research Promotion Fund) (KRF-2008-331-D00481) (JK), the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (2009-0077688, 2009-0086140) (JK), and the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) (R01-2008-000-20564-0) (JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baleanu-Gogonea C, 2006, J MOL MODEL, V12, P325, DOI 10.1007/s00894-005-0049-z; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Blake JD, 2001, J MOL BIOL, V307, P721, DOI 10.1006/jmbi.2001.4495; Caraveo G, 2006, SCIENCE, V314, P122, DOI 10.1126/science.1127815; Chakraborty A, 2008, P NATL ACAD SCI USA, V105, P1134, DOI 10.1073/pnas.0711168105; Chang GS, 2008, P NATL ACAD SCI USA, V105, P13474, DOI 10.1073/pnas.0803860105; Henikoff S, 1997, PROTEIN SCI, V6, P698; Hong Yoojin, 2009, J Proteomics Bioinform, V2, P139; Huang WC, 2006, BIOINFORMATICS, V22, P29, DOI 10.1093/bioinformatics/bti772; HUANG XQ, 1990, COMPUT APPL BIOSCI, V6, P373; Kim Y, 2006, PROTEINS, V62, P1115, DOI 10.1002/prot.20830; KO K, 2009, ARXIV09110652 PHYS A; KO KD, 2008, ARXIV0806239QBIOQ PH; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; MICHAELY P, CRYSTAL STRUCTURE 12; MUSTAFA A, 2009, P NATL ACAD IN PRESS; Nikolaidis N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000204; Park J, 1998, J MOL BIOL, V284, P1201, DOI 10.1006/jmbi.1998.2221; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Rognes T, 1998, BIOINFORMATICS, V14, P839, DOI 10.1093/bioinformatics/14.10.839; Schaffer AA, 1999, BIOINFORMATICS, V15, P1000; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; van Rossum DB, 2008, J BIOL CHEM, V283, P34384, DOI 10.1074/jbc.M804707200; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Van Walle I, 2005, BIOINFORMATICS, V21, P1267, DOI 10.1093/bioinformatics/bth493; Wu Jie, 2005, Genome Inform, V16, P142; Yona G, 2002, J MOL BIOL, V315, P1257, DOI 10.1006/jmbi.2001.5293; ZACHOS N, 2009, J BIOL CHEM IN PRESS	31	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13596	10.1371/journal.pone.0013596	http://dx.doi.org/10.1371/journal.pone.0013596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042584	Green Published, Green Submitted, gold			2022-12-25	WOS:000283419100022
J	Dong, LF; Jameson, VJA; Tilly, D; Cerny, J; Mahdavian, E; Marin-Hernandez, A; Hernandez-Esquivel, L; Rodriguez-Enriquez, S; Stursa, J; Witting, PK; Stantic, B; Rohlena, J; Truksa, J; Kluckova, K; Dyason, JC; Ledvina, M; Salvatore, BA; Moreno-Sanchez, R; Coster, MJ; Ralph, SJ; Smith, RAJ; Neuzil, J				Dong, Lan-Feng; Jameson, Victoria J. A.; Tilly, David; Cerny, Jiri; Mahdavian, Elahe; Marin-Hernandez, Alvaro; Hernandez-Esquivel, Luz; Rodriguez-Enriquez, Sara; Stursa, Jan; Witting, Paul K.; Stantic, Bela; Rohlena, Jakub; Truksa, Jaroslav; Kluckova, Katarina; Dyason, Jeffrey C.; Ledvina, Miroslav; Salvatore, Brian A.; Moreno-Sanchez, Rafael; Coster, Mark J.; Ralph, Stephen J.; Smith, Robin A. J.; Neuzil, Jiri			Mitochondrial Targeting of Vitamin E Succinate Enhances Its Pro-apoptotic and Anti-cancer Activity via Mitochondrial Complex II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TOCOPHERYL SUCCINATE; BREAST-CANCER CELLS; E ANALOGS; RESPIRATORY-CHAIN; OXIDATIVE STRESS; BINDING SITE; DEHYDROGENASE; UBIQUINONE; ANTIOXIDANT; GROWTH	Mitochondrial complex II (CII) has been recently identified as a novel target for anti-cancer drugs. Mitochondrially targeted vitamin E succinate (MitoVES) is modified so that it is preferentially localized to mitochondria, greatly enhancing its pro-apoptotic and anti-cancer activity. Using genetically manipulated cells, MitoVES caused apoptosis and generation of reactive oxygen species (ROS) in CII-proficient malignant cells but not their CII-dysfunctional counterparts. MitoVES inhibited the succinate dehydrogenase (SDH) activity of CII with IC50 of 80 mu M, whereas the electron transfer from CII to CIII was inhibited with IC50 of 1.5 mu M. The agent had no effect either on the enzymatic activity of CI or on electron transfer from CI to CIII. Over 24 h, MitoVES caused stabilization of the oxygen-dependent destruction domain of HIF1 alpha fused to GFP, indicating promotion of the state of pseudohypoxia. Molecular modeling predicted the succinyl group anchored into the proximal CII ubiquinone (UbQ)-binding site and successively reduced interaction energies for serially shorter phytyl chain homologs of MitoVES correlated with their lower effects on apoptosis induction, ROS generation, and SDH activity. Mutation of the UbQ-binding Ser(68) within the proximal site of the CII SDHC subunit (S68A or S68L) suppressed both ROS generation and apoptosis induction by MitoVES. In vivo studies indicated that MitoVES also acts by causing pseudohypoxia in the context of tumor suppression. We propose that mitochondrial targeting of VES with an 11-carbon chain localizes the agent into an ideal position across the interface of the mitochondrial inner membrane and matrix, optimizing its biological effects as an anti-cancer drug.	[Neuzil, Jiri] Griffith Univ, Sch Med Sci, Apoptosis Res Grp, Griffith Hlth Inst, Southport, Qld 4222, Australia; [Stantic, Bela] Griffith Univ, Inst Integrated & Intelligent Syst, Southport, Qld 4222, Australia; [Dyason, Jeffrey C.; Neuzil, Jiri] Griffith Univ, Inst Glyc, Southport, Qld 4222, Australia; [Jameson, Victoria J. A.; Smith, Robin A. J.] Univ Otago, Dept Chem, Dunedin 9016, New Zealand; [Tilly, David; Coster, Mark J.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [Cerny, Jiri; Rohlena, Jakub; Truksa, Jaroslav; Kluckova, Katarina] Acad Sci Czech Republ, Inst Biotechnol, Prague 14220, Czech Republic; [Stursa, Jan; Ledvina, Miroslav] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague 14220, Czech Republic; [Mahdavian, Elahe; Salvatore, Brian A.] Louisiana State Univ, Dept Chem & Phys, Shreveport, LA 71115 USA; [Marin-Hernandez, Alvaro; Hernandez-Esquivel, Luz; Rodriguez-Enriquez, Sara; Moreno-Sanchez, Rafael] Natl Inst Cardiol, Dept Biochem, Mexico City 14080, DF, Mexico; [Witting, Paul K.] Univ Sydney, Sydney Med Sch, Bosch Res Inst, Discipline Pathol, Sydney, NSW 2006, Australia	Griffith University; Menzies Health Institute Queensland; Griffith University; Griffith University; University of Otago; Griffith University; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; National Institute of Cardiology - Mexico; Bosch; University of Sydney	Neuzil, J (corresponding author), Griffith Univ, Sch Med Sci, Apoptosis Res Grp, Griffith Hlth Inst, Griffith Univ Gold Coast Campus,Parklands Av, Southport, Qld 4222, Australia.	j.neuzil@griffith.edu.au	Truksa, Jaroslav/G-9454-2014; Coster, Mark/C-4621-2008; Witting, Paul/ABD-2053-2020; DONG, LANFENG/S-8805-2019; Kluckova, Katarina/H-4802-2014; Rohlena, Jakub/H-6699-2014; Ralph, Stephen J./AAE-4888-2019; Dyason, Jeffrey C/L-5534-2014; Witting, Paul/L-9786-2019; Kluckova, Katarina/ABF-2155-2020; Truksa, Jaroslav/AAB-5089-2020; Černý, Jiří/I-4733-2012; Neuzil, Jiri/H-7204-2014; Moreno-Sanchez, Rafael/A-3158-2011; Stursa, Jan/J-4255-2014; RODRIGUEZ-ENRIQUEZ, SARA/I-8376-2017	Truksa, Jaroslav/0000-0002-8967-7354; Coster, Mark/0000-0002-0910-6819; Witting, Paul/0000-0003-2237-7004; Kluckova, Katarina/0000-0002-9693-7708; Rohlena, Jakub/0000-0001-5427-6502; Ralph, Stephen J./0000-0002-4335-092X; Truksa, Jaroslav/0000-0002-8967-7354; Černý, Jiří/0000-0002-1969-9304; Neuzil, Jiri/0000-0002-2478-2460; Moreno-Sanchez, Rafael/0000-0002-9587-7184; Dong, Lanfeng/0000-0002-9857-6352; RODRIGUEZ-ENRIQUEZ, SARA/0000-0002-0822-1233; Tilly, David/0000-0002-4859-961X; Marin-Hernandez, Alvaro/0000-0002-7968-7225	Australian Research Council; Cancer Council Queensland; National Breast Cancer Foundation; Grant Agency of the Czech Republic [204/08/0811, P301/10/1937]; Grant Agency of the Academy of Sciences of the Czech Republic [IAA500520702, KJB500970904, KAN200520703]; Griffith Health Institute; Otago University Research Grants Committee; Consejo Nacional de Ciencia y Tecnologia-Mexico [80534, 20675]; National Institutes of Health, NCRR [P20RR016456]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016456] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); Cancer Council Queensland(Cancer Council Queensland); National Breast Cancer Foundation; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Griffith Health Institute; Otago University Research Grants Committee; Consejo Nacional de Ciencia y Tecnologia-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the Australian Research Council, the Cancer Council Queensland, the National Breast Cancer Foundation, Grant Agency of the Czech Republic Grants 204/08/0811 and P301/10/1937, Grant Agency of the Academy of Sciences of the Czech Republic Grants IAA500520702, KJB500970904, and KAN200520703) (to J. N.), the Griffith Health Institute (to L.-F.D.), the Otago University Research Grants Committee (to R. A. J. S.), Consejo Nacional de Ciencia y Tecnologia-Mexico Grants 80534 and 20675 (to R.M.-S. and S. R.-E.), and National Institutes of Health, NCRR, Grant P20RR016456 (to E. M. and B. A. S.).	Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Adlam VJ, 2005, FASEB J, V19, P1088, DOI 10.1096/fj.05-3718com; Albayrak T, 2003, MOL BIOL CELL, V14, P3082, DOI 10.1091/mbc.e02-10-0631; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; BIASSUTTO L, 2010, MITOCHONDRI IN PRESS; Biasutto L, 2010, BBA-BIOENERGETICS, V1797, P189, DOI 10.1016/j.bbabio.2009.10.001; Cervera AM, 2008, CANCER RES, V68, P4058, DOI 10.1158/0008-5472.CAN-07-5580; Covian R, 2001, EUR J BIOCHEM, V268, P5783, DOI 10.1046/j.0014-2956.2001.02521.x; DAVIS S, 1985, J BIOL CHEM, V260, P3844; Dong LF, 2008, ONCOGENE, V27, P4324, DOI 10.1038/onc.2008.69; Dong LF, 2007, CANCER RES, V67, P11906, DOI 10.1158/0008-5472.CAN-07-3034; Dong LF, 2009, CLIN CANCER RES, V15, P1593, DOI 10.1158/1078-0432.CCR-08-2439; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Fantin VR, 2006, ONCOGENE, V25, P4787, DOI 10.1038/sj.onc.1209599; Fantin VR, 2002, CANCER CELL, V2, P29, DOI 10.1016/S1535-6108(02)00082-X; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Galluzzi L, 2010, MOL ASPECTS MED, V31, P1, DOI 10.1016/j.mam.2009.08.002; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; Hahn T, 2006, CANCER RES, V66, P9374, DOI 10.1158/0008-5472.CAN-06-2403; Hawkins BJ, 2010, J BIOL CHEM, V285, P26494, DOI 10.1074/jbc.M110.143164; Hayden EC, 2008, NATURE, V455, P158; Ishii T, 2005, CANCER RES, V65, P203; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; James AM, 2007, J BIOL CHEM, V282, P14708, DOI 10.1074/jbc.M611463200; Jasso-Chavez R, 2001, ARCH BIOCHEM BIOPHYS, V390, P295, DOI 10.1006/abbi.2001.2353; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Lawson KA, 2003, MOL CANCER THER, V2, P437; Lemarie A, 2009, MITOCHONDRION, V9, P254, DOI 10.1016/j.mito.2009.03.004; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; MAIOROV VN, 1994, J MOL BIOL, V235, P625, DOI 10.1006/jmbi.1994.1017; Malafa MP, 2002, SURGERY, V131, P85, DOI 10.1067/msy.2002.119191; Modica-Napolitano JS, 2001, ADV DRUG DELIVER REV, V49, P63, DOI 10.1016/S0169-409X(01)00125-9; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Neuzil J, 2001, FASEB J, V15, P403, DOI 10.1096/fj.00-0251com; Neuzil J, 2001, BRIT J CANCER, V84, P87, DOI 10.1054/bjoc.2000.1559; Neuzil J, 2007, MOL ASPECTS MED, V28, P607, DOI 10.1016/j.mam.2007.02.003; Neuzil J, 2007, REDOX REP, V12, P148, DOI 10.1179/135100007X200227; Neuzil J, 2007, MOL PHARMACOL, V71, P1185, DOI 10.1124/mol.106.030122; Neuzil J, 2006, FEBS LETT, V580, P5125, DOI 10.1016/j.febslet.2006.05.072; OOSTVEEN FG, 1995, J BIOL CHEM, V270, P26104, DOI 10.1074/jbc.270.44.26104; Peczkowska M, 2008, NAT CLIN PRACT ENDOC, V4, P111, DOI 10.1038/ncpendmet0726; Piantadosi CA, 2008, J BIOL CHEM, V283, P10967, DOI 10.1074/jbc.M709741200; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Prochazka L, 2010, APOPTOSIS, V15, P782, DOI 10.1007/s10495-010-0482-z; Rodriguez-Cuenca S, 2010, FREE RADICAL BIO MED, V48, P161, DOI 10.1016/j.freeradbiomed.2009.10.039; Rodriguez-Enriquez S, 2009, MOL NUTR FOOD RES, V53, P29, DOI 10.1002/mnfr.200700470; Schiavi F, 2005, JAMA-J AM MED ASSOC, V294, P2057, DOI 10.1001/jama.294.16.2057; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shiau CW, 2006, J BIOL CHEM, V281, P11819, DOI 10.1074/jbc.M511015200; Slane BG, 2006, CANCER RES, V66, P7615, DOI 10.1158/0008-5472.CAN-06-0833; Smith RAJ, 2003, P NATL ACAD SCI USA, V100, P5407, DOI 10.1073/pnas.0931245100; Stapelberg M, 2005, J BIOL CHEM, V280, P25369, DOI 10.1074/jbc.M414498200; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Szeto SSW, 2007, J BIOL CHEM, V282, P27518, DOI 10.1074/jbc.M700601200; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Twombly R, 2005, J NATL CANCER I, V97, P330, DOI 10.1093/jnci/97.5.330; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang XF, 2007, CANCER RES, V67, P3337, DOI 10.1158/0008-5472.CAN-06-2480; Weber T, 2003, BIOCHEMISTRY-US, V42, P4277, DOI 10.1021/bi020527j; Weber T, 2002, CLIN CANCER RES, V8, P863; Yang XD, 1998, J BIOL CHEM, V273, P31916, DOI 10.1074/jbc.273.48.31916; Yu WP, 2003, CANCER RES, V63, P2483	71	149	156	1	47	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3717	3728		10.1074/jbc.M110.186643	http://dx.doi.org/10.1074/jbc.M110.186643			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21059645	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000286653200054
J	Vanhees, K; Coort, S; Ruijters, EJB; Godschalk, RWL; van Schooten, FJ; van Doorn-Khosrovani, SBV				Vanhees, Kimberly; Coort, Susan; Ruijters, Erik J. B.; Godschalk, Roger W. L.; van Schooten, Frederik J.; van Doorn-Khosrovani, Sahar Barjesteh van Waalwijk			Epigenetics: prenatal exposure to genistein leaves a permanent signature on the hematopoietic lineage	FASEB JOURNAL			English	Article						flavonoid; in utero exposure; DNA methylation; gene expression; hematopoiesis	ARYL-HYDROCARBON RECEPTOR; STEM-CELL QUIESCENCE; BCL-X-L; MOLECULAR-IDENTIFICATION; MEGALOBLASTIC-ANEMIA; EXPRESSION; DIETARY; MICE; PROTEIN; PROGENITORS	Recent studies demonstrate that maternal diet during pregnancy results in long-lasting effects on the progeny. Supplementation of maternal diet with genistein, a phytoestrogen ubiquitous in the daily diet, altered coat color of agouti mice due to epigenetic changes. We studied hematopoiesis of mice prenatally exposed to genistein (270 mg/kg feed) compared with that of mice prenatally exposed to phytoestrogen-poor feed and observed a significant increase in granulopoiesis, erythropoiesis, and mild macrocytosis at the adult age of 12 wk. Genistein exposure was associated with hypermethylation of certain repetitive elements, which coincided with a significant down-regulation of estrogen-responsive genes and genes involved in hematopoiesis in bone marrow cells of genistein-exposed mice, as assessed by microarray technology. Although genistein exposure did not affect global methylation in fetal liver of fetuses at embryonic day 14.5, it accelerated the switch from primitive to definitive erythroid lineage. Taken together, our data demonstrate that prenatal exposure to genistein affects fetal erythropoiesis and exerts lifelong alterations in gene expression and DNA methylation of hematopoietic cells.-Vanhees, K., Coort, S., Ruitjers, E. J. B., Godschalk, R. W. L., van Schooten, F. J., Barjesteh van Waalwijk van Doorn-Khosrovani, S. Epigenetics: prenatal exposure to genistein leaves a permanent signature on the hematopoietic lineage. FASEB J. 25, 797-807 (2011). www.fasebj.org	[Vanhees, Kimberly; Ruijters, Erik J. B.; Godschalk, Roger W. L.; van Schooten, Frederik J.; van Doorn-Khosrovani, Sahar Barjesteh van Waalwijk] Maastricht Univ, Dept Hlth Risk Anal & Toxicol, Nutr & Toxicol Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Coort, Susan] Maastricht Univ, Dept Bioinformat, Bioinformat Grp, Cardiovasc Res Inst Maastrict CARIM, NL-6200 MD Maastricht, Netherlands; [Coort, Susan] Maastricht Univ, Tech Univ BiGCaT, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University	Vanhees, K (corresponding author), Maastricht Univ, Dept Hlth Risk Anal & Toxicol, Res Inst NUTRIM, POB 616, NL-6200 MD Maastricht, Netherlands.	kimberly.vanhees@maastrichtuniversity.nl	Coort, Susan/ABF-1021-2021	Coort, Susan/0000-0003-1224-9690	American Institute for Cancer Research [06A031]	American Institute for Cancer Research	This work was supported by grant 06A031 from the American Institute for Cancer Research. The authors sincerely thank Igor Pogribny and his laboratory staff (National Center for Toxicological Research) for their valuable support in setting up the DNA methylation assay and Ralph Gottschalk for the assistance during the microarray experiment. All of the authors declare no conflicts of interest.	Adlercreutz H, 1999, AM J OBSTET GYNECOL, V180, P737, DOI 10.1016/S0002-9378(99)70281-4; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Aslinia F, 2006, CLIN MED RES, V4, P236, DOI 10.3121/cmr.4.3.236; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; COWARD L, 1993, J AGR FOOD CHEM, V41, P1961, DOI 10.1021/jf00035a027; DAVIES KA, 1989, TRENDS GENET, V5, P222, DOI 10.1016/0168-9525(89)90086-3; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gaj S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-360; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; Gregoli PA, 1997, BLOOD, V90, P630, DOI 10.1182/blood.V90.2.630.630_630_640; Hanspal M, 1998, BLOOD, V92, P2940, DOI 10.1182/blood.V92.8.2940.420k31_2940_2950; He H, 2009, PHYTOTHER RES, V23, P868, DOI 10.1002/ptr.2715; Hertrampf T, 2009, TOXICOL LETT, V184, P198, DOI 10.1016/j.toxlet.2008.11.006; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; KAUSHANSKY K, 1995, J CLIN INVEST, V96, P1683, DOI 10.1172/JCI118210; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Kincade PW, 2006, NAT IMMUNOL, V7, P701, DOI 10.1038/ni0706-701; Kingsley PD, 2006, BLOOD, V107, P1665, DOI 10.1182/blood-2005-08-3097; Klausen P, 2004, J LEUKOCYTE BIOL, V75, P569, DOI 10.1189/jlb.1003474; Klein SL, 2002, MOL MED, V8, P742, DOI 10.1007/BF03402038; Kurzer MS, 1997, ANNU REV NUTR, V17, P353, DOI 10.1146/annurev.nutr.17.1.353; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Miodini P, 1999, BRIT J CANCER, V80, P1150, DOI 10.1038/sj.bjc.6690479; Moller FJ, 2009, J STEROID BIOCHEM, V113, P296, DOI 10.1016/j.jsbmb.2009.01.016; O'Donnell LC, 2002, J LEUKOCYTE BIOL, V72, P478; Ohta R, 2009, EXP ANIM TOKYO, V58, P471, DOI 10.1538/expanim.58.471; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2001, CELL, V104, P21, DOI 10.1016/S0092-8674(01)00188-X; Pellegrino CM, 1998, BLOOD CELL MOL DIS, V24, P31, DOI 10.1006/bcmd.1998.0168; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Pogribny IP, 2006, CARCINOGENESIS, V27, P1180, DOI 10.1093/carcin/bgi364; Pogribny IP, 2008, BRAIN RES, V1237, P25, DOI 10.1016/j.brainres.2008.07.077; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; SCOTT JM, 1980, CLIN HAEMATOL, V9, P587; SHALABY MR, 1995, CLIN IMMUNOL IMMUNOP, V74, P185, DOI 10.1006/clin.1995.1027; Singh KP, 2009, BIOCHEM PHARMACOL, V77, P577, DOI 10.1016/j.bcp.2008.10.001; Singh KP, 2009, CARCINOGENESIS, V30, P11, DOI 10.1093/carcin/bgn224; Skibola CF, 2000, FREE RADICAL BIO MED, V29, P375, DOI 10.1016/S0891-5849(00)00304-X; SLIGH JE, 1993, P NATL ACAD SCI USA, V90, P8529, DOI 10.1073/pnas.90.18.8529; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Takakuwa Y, 2001, CURR OPIN HEMATOL, V8, P80, DOI 10.1097/00062752-200103000-00004; Tam BYY, 2006, NAT MED, V12, P793, DOI 10.1038/nm1428; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Tanaka J, 2007, MOL CELL ENDOCRINOL, V272, P38, DOI 10.1016/j.mce.2007.04.008; TAURO GP, 1976, NEW ENGL J MED, V294, P466, DOI 10.1056/NEJM197602262940903; Tsantes AE, 2006, ANTIOXID REDOX SIGN, V8, P1205, DOI 10.1089/ars.2006.8.1205; van Doorn-Khosrovani SBV, 2007, CARCINOGENESIS, V28, P1703, DOI 10.1093/carcin/bgm102; Wang LC, 1998, GENE DEV, V12, P2392, DOI 10.1101/gad.12.15.2392; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; Williams WP, 2004, VIROLOGY, V327, P233, DOI 10.1016/j.virol.2004.06.040; Yasuda T, 2004, J EXP MED, V200, P1681, DOI 10.1084/jem.20041247; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang S, 2003, ENVIRON HEALTH PERSP, V111, P1877, DOI 10.1289/ehp.6322	60	64	67	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					797	807		10.1096/fj.10-172155	http://dx.doi.org/10.1096/fj.10-172155			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	21048042				2022-12-25	WOS:000286724800037
J	Lefevre, J; Chernov, KG; Joshi, V; Delga, S; Toma, F; Pastre, D; Curmi, PA; Savarin, P				Lefevre, Julien; Chernov, Konstantin G.; Joshi, Vandana; Delga, Stephanie; Toma, Flavio; Pastre, David; Curmi, Patrick A.; Savarin, Philippe			The C Terminus of Tubulin, a Versatile Partner for Cationic Molecules BINDING OF TAU, POLYAMINES, AND CALCIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; MICROTUBULE-ASSOCIATED PROTEINS; BETA-TUBULIN; STRUCTURAL BASIS; ALPHA-TUBULIN; IN-VITRO; SITES; NMR; POLYMERIZATION; DOMAIN	The C-terminal region of tubulin is involved in multiple aspects of the regulation of microtubule assembly. To elucidate the molecular mechanisms of this regulation, we study here, using different approaches, the interaction of Tau, spermine, and calcium, three representative partners of the tubulin C-terminal region, with a peptide composed of the last 42 residues of alpha 1a-tubulin. The results show that their binding involves overlapping amino acid stretches in the C-terminal tubulin region: amino acid residues 421-441 for Tau, 430-432 and 444-451 for spermine, and 421-443 for calcium. Isothermal titration calorimetry, NMR, and cosedimentation experiments show that Tau and spermine have similar micromolar binding affinities, whereas their binding stoichiometry differs (C-terminal tubulin peptide/spermine stoichiometry 1: 2, and C-terminal tubulin peptide/Tau stoichiometry 8: 1). Interestingly, calcium, known as a negative regulator of microtubule assembly, can compete with the binding of Tau and spermine with the C-terminal domain of tubulin and with the positive effect of these two partners on microtubule assembly in vitro. This observation opens up the possibility that calcium may participate in the regulation of microtubule assembly in vivo through direct (still unknown) or indirect mechanism (displacement of microtubule partners). The functional importance of this part of tubulin was also underlined by the observation that an alpha-tubulin mutant deleted from the last 23 amino acid residues does not incorporate properly into the microtubule network of HeLa cells. Together, these results provide a structural basis for a better understanding of the complex interactions and putative competition of tubulin cationic partners with the C-terminal region of tubulin.	[Lefevre, Julien; Chernov, Konstantin G.; Joshi, Vandana; Delga, Stephanie; Toma, Flavio; Pastre, David; Curmi, Patrick A.; Savarin, Philippe] Univ Evry Val dEssonne, INSERM, U829, Lab Struct Activite Biomol Normales & Pathol, F-91025 Evry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Curmi, PA (corresponding author), Univ Evry Val dEssonne, INSERM, U829, Lab Struct Activite Biomol Normales & Pathol, F-91025 Evry, France.	pcurmi@univ-evry.fr; philippe.savarin@univ-evry.fr	CURMI, Patrick/G-4036-2013; Pastre, David/B-2958-2014; joshi, vandana/GWR-3119-2022	Pastre, David/0000-0002-3348-9514; joshi, vandana/0000-0001-7853-6583; CURMI, Patrick A./0000-0001-5045-8501				Ackmann M, 2000, J BIOL CHEM, V275, P30335, DOI 10.1074/jbc.M002590200; Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; ANDERSON PJ, 1985, BIOCHEM BIOPH RES CO, V132, P147, DOI 10.1016/0006-291X(85)91000-9; BOUCHER D, 1994, BIOCHEMISTRY-US, V33, P12471, DOI 10.1021/bi00207a014; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chau MF, 1998, BIOCHEMISTRY-US, V37, P17692, DOI 10.1021/bi9812118; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; DETRICH HW, 1978, BIOCHEMISTRY-US, V17, P3900, DOI 10.1021/bi00612a002; Devred F, 2004, BIOCHEMISTRY-US, V43, P10520, DOI 10.1021/bi0493160; Doi H, 2003, BIOSCI BIOTECH BIOCH, V67, P1643, DOI 10.1271/bbb.67.1643; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; GUNDERSEN GG, 1987, J CELL BIOL, V105, P251, DOI 10.1083/jcb.105.1.251; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Jia J, 2001, STRUCTURE, V9, P267, DOI 10.1016/S0969-2126(01)00585-8; Jimenez MA, 1999, PROTEIN SCI, V8, P788; JOB D, 1985, J CELL BIOL, V101, P1680, DOI 10.1083/jcb.101.5.1680; JOB D, 1981, P NATL ACAD SCI-BIOL, V78, P4679, DOI 10.1073/pnas.78.8.4679; Joe PA, 2009, J BIOL CHEM, V284, P4283, DOI 10.1074/jbc.M807491200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kar S, 2003, FEBS LETT, V539, P34, DOI 10.1016/S0014-5793(03)00181-9; Knipling L, 1999, CELL MOTIL CYTOSKEL, V43, P63, DOI 10.1002/(SICI)1097-0169(1999)43:1<63::AID-CM7>3.0.CO;2-Z; KRAUHS E, 1981, P NATL ACAD SCI-BIOL, V78, P4156, DOI 10.1073/pnas.78.7.4156; KUZNETSOV SA, 1978, FEBS LETT, V95, P343, DOI 10.1016/0014-5793(78)81026-6; Landino LM, 2004, J BIOL CHEM, V279, P35101, DOI 10.1074/jbc.M405471200; Larcher JC, 1996, J BIOL CHEM, V271, P22117, DOI 10.1074/jbc.271.36.22117; LITTAUER UZ, 1986, P NATL ACAD SCI USA, V83, P7162, DOI 10.1073/pnas.83.19.7162; LITTLE M, 1988, COMP BIOCHEM PHYS B, V90, P655, DOI 10.1016/0305-0491(88)90320-3; LOBERT S, 1993, CELL MOTIL CYTOSKEL, V25, P282, DOI 10.1002/cm.970250308; Luchko T, 2008, BIOPHYS J, V94, P1971, DOI 10.1529/biophysj.107.115113; MACCIONI RB, 1988, EMBO J, V7, P1957, DOI 10.1002/j.1460-2075.1988.tb03033.x; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; MACCIONI RB, 1986, EUR J BIOCHEM, V156, P375, DOI 10.1111/j.1432-1033.1986.tb09593.x; Mechulam A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000255; Meier R, 2007, J BIOL CHEM, V282, P31477, DOI 10.1074/jbc.M704942200; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Osawa M, 2009, J BIOL CHEM, V284, P26117, DOI 10.1074/jbc.M109.029355; Ouameur AA, 2004, J BIOL CHEM, V279, P42041, DOI 10.1074/jbc.M406053200; Patel MM, 2005, BIOPHYS J, V88, P2089, DOI 10.1529/biophysj.104.052100; PONSTINGL H, 1981, P NATL ACAD SCI-BIOL, V78, P2757, DOI 10.1073/pnas.78.5.2757; PONSTINGL H, 1979, NATURE, V282, P423, DOI 10.1038/282423a0; PONSTINGL H, 1981, COLD SPRING HARB SYM, V46, P191; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Savarin P, 2010, BIOCHEM J, V430, P151, DOI 10.1042/BJ20091811; SCHLIWA M, 1981, P NATL ACAD SCI-BIOL, V78, P1037, DOI 10.1073/pnas.78.2.1037; SERRANO L, 1984, P NATL ACAD SCI-BIOL, V81, P5989, DOI 10.1073/pnas.81.19.5989; SERRANO L, 1984, BIOCHEMISTRY-US, V23, P4675, DOI 10.1021/bi00315a024; SERRANO L, 1986, J BIOL CHEM, V261, P7076; Sillen A, 2007, BIOCHEMISTRY-US, V46, P3055, DOI 10.1021/bi061920i; SOLOMON F, 1977, BIOCHEMISTRY-US, V16, P358, DOI 10.1021/bi00622a003; STROMBERG E, 1994, CELL MOTIL CYTOSKEL, V28, P59, DOI 10.1002/cm.970280106; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Wang ZH, 2000, BIOPHYS J, V78, P1955, DOI 10.1016/S0006-3495(00)76743-9; WEISENBERG RC, 1972, SCIENCE, V177, P1104, DOI 10.1126/science.177.4054.1104; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wolff J, 1998, BIOCHEMISTRY-US, V37, P10722, DOI 10.1021/bi980400n	66	42	43	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3065	3078		10.1074/jbc.M110.144089	http://dx.doi.org/10.1074/jbc.M110.144089			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21062741	Green Published, hybrid			2022-12-25	WOS:000286464300069
J	Hong, SY; Kim, OK; Kim, SG; Yang, MS; Park, CM				Hong, Shin-Young; Kim, Ok-Kyoung; Kim, Sang-Gyu; Yang, Moon-Sik; Park, Chung-Mo			Nuclear Import and DNA Binding of the ZHD5 Transcription Factor Is Modulated by a Competitive Peptide Inhibitor in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER; SIGNAL-TRANSDUCTION; SUBCELLULAR-LOCALIZATION; HOMEODOMAIN PROTEINS; GENE; LOOP; EXPRESSION; RESPONSES; THALIANA; HELIX	Competitive inhibition of transcription factors by small proteins is an intriguing component of gene regulatory networks in both animals and plants. The small interfering proteins possess limited sequence homologies to specific transcription factors but lack one or more protein motifs required for transcription factor activities. They interfere with the activities of transcription factors, such as DNA binding and transcriptional activation, by forming nonfunctional heterodimers. A potential example is the Arabidopsis MIF1 (mini zinc finger 1) protein consisting of 101 residues. It has a zinc finger domain but lacks other protein motifs normally present in transcription factors. In this work, we show that MIF1 and its functional homologues physically interact with a group of zinc finger homeodomain (ZHD) transcription factors, such as ZHD5, that regulate floral architecture and leaf development. Gel mobility shift assays revealed that MIF1 blocks the DNA binding activity of ZHD5 homodimers by competitively forming MIF1-ZHD5 heterodimers. Accordingly, the transcriptional activation activity of ZHD5 was significantly suppressed by MIF1 coexpressed transiently in Arabidopsis protoplasts. Notably, MIF1 also prevents ZHD5 from nuclear localization. Although ZHD5 was localized exclusively in the nucleus, it was scattered throughout the cytoplasm when MIF1 was coexpressed. Transgenic plants overexpressing the ZHD5 gene (35S:ZHD5) exhibited accelerated growth with larger leaves. Consistent with the negative regulation of ZHD5 by MIF1, the 35S:ZHD5 phenotypes were diminished by MIF1 coexpression. These observations indicate that MIF1 regulates the ZHD5 activities in a dual step manner:nuclear import and DNA binding.	[Hong, Shin-Young; Kim, Ok-Kyoung; Park, Chung-Mo] Seoul Natl Univ, Dept Chem, Seoul 151742, South Korea; [Park, Chung-Mo] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul 151742, South Korea; [Kim, Sang-Gyu] Max Planck Inst Chem Ecol, Dept Mol Ecol, D-07745 Jena, Germany; [Yang, Moon-Sik] Chonbuk Natl Univ, Div Biol Sci, Jeonju 561756, South Korea; [Yang, Moon-Sik] Chonbuk Natl Univ, Res Inst Bioact Mat, Jeonju 561756, South Korea	Seoul National University (SNU); Seoul National University (SNU); Max Planck Society; Jeonbuk National University; Jeonbuk National University	Park, CM (corresponding author), Seoul Natl Univ, Dept Chem, Seoul 151742, South Korea.	cmpark@snu.ac.kr	Park, Chung-Mo/B-6175-2012; Kim, Sang-Gyu/T-5925-2017; Hong, Shin-Young/H-2954-2016	Hong, Shin-Young/0000-0003-3031-2753	Brain Korea 21 Biogreen 21 [20080401034001]; National Research Laboratory; Plant Signaling Network Research Center; National Research Foundation of Korea [2009-0087317, 2007-03415]; Agricultural R & D Promotion Center [309017-5]; Korea Ministry for Food, Agriculture, Forestry, and Fisheries	Brain Korea 21 Biogreen 21(Rural Development Administration (RDA), Republic of Korea); National Research Laboratory(Korea Science and Engineering Foundation); Plant Signaling Network Research Center; National Research Foundation of Korea(National Research Foundation of Korea); Agricultural R & D Promotion Center; Korea Ministry for Food, Agriculture, Forestry, and Fisheries	This work was supported by Brain Korea 21 Biogreen 21 Grant 20080401034001 and National Research Laboratory Programs and by grants from the Plant Signaling Network Research Center, the National Research Foundation of Korea (2009-0087317 and 2007-03415), and the Agricultural R & D Promotion Center (309017-5), Korea Ministry for Food, Agriculture, Forestry, and Fisheries.	BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; Chariot A, 1999, BIOCHEM PHARMACOL, V58, P1851, DOI 10.1016/S0006-2952(99)00234-8; Chen YN, 2008, CURR OPIN PLANT BIOL, V11, P695, DOI 10.1016/j.pbi.2008.10.005; CHRISTIANSON AMK, 1993, NUCLEIC ACIDS RES, V21, P4416, DOI 10.1093/nar/21.18.4416; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; Coego A, 2005, PLANT CELL, V17, P2123, DOI 10.1105/tpc.105.032375; Connolly JP, 1999, NUCLEIC ACIDS RES, V27, P1182, DOI 10.1093/nar/27.4.1182; Crawford KM, 2001, PLANT PHYSIOL, V125, P1802, DOI 10.1104/pp.125.4.1802; Duby A., 1987, CURRENT PROTOCOLS MO, P1; Franklin KA, 2003, PLANT PHYSIOL, V131, P1340, DOI 10.1104/pp.102.015487; Frith MC, 2006, PLOS GENET, V2, P504, DOI 10.1371/journal.pgen.0020023; Furlong EEM, 1996, J BIOL CHEM, V271, P29688, DOI 10.1074/jbc.271.47.29688; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Hanada K, 2007, GENOME RES, V17, P632, DOI 10.1101/gr.5836207; Hashimoto Y, 2008, DEV GROWTH DIFFER, V50, pS269, DOI 10.1111/j.1440-169X.2008.00994.x; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Himmelbach A, 2002, EMBO J, V21, P3029, DOI 10.1093/emboj/cdf316; Hoppe T, 2001, CURR OPIN CELL BIOL, V13, P344, DOI 10.1016/S0955-0674(00)00218-0; Hu W, 2006, PLANT J, V45, P399, DOI 10.1111/j.1365-313X.2005.02626.x; Hu W, 2008, J INTEGR PLANT BIOL, V50, P1031, DOI 10.1111/j.1744-7909.2008.00681.x; Hyun Y, 2006, PLANT MOL BIOL, V61, P283, DOI 10.1007/s11103-006-0010-2; Igarashi D, 2001, PLANT CELL, V13, P2483, DOI 10.1105/tpc.13.11.2483; JEFFERSON RA, 1987, EMBO J, V6, P3901; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim H, 2005, PLANT CELL, V17, P888, DOI 10.1105/tpc.104.028829; Kim K, 2010, BIOCHEM J, V427, P413, DOI 10.1042/BJ20091445; Kim YS, 2008, PLANT CELL, V20, P920, DOI 10.1105/tpc.107.057448; Kim YS, 2006, PLANT CELL, V18, P3132, DOI 10.1105/tpc.106.043018; KLEIN TM, 1988, P NATL ACAD SCI USA, V85, P4305, DOI 10.1073/pnas.85.12.4305; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; LAMB P, 1991, TRENDS BIOCHEM SCI, V16, P417, DOI 10.1016/0968-0004(91)90167-T; LEE KAW, 1992, J CELL SCI, V103, P9; Lee LY, 2008, PLANT PHYSIOL, V146, P325, DOI 10.1104/pp.107.113001; Lee S, 2006, PLANT CELL PHYSIOL, V47, P591, DOI 10.1093/pcp/pcj026; LI XX, 1994, J CELL BIOL, V124, P7, DOI 10.1083/jcb.124.1.7; LUEHRSEN KR, 1992, METHOD ENZYMOL, V216, P397; Miller JH., 1972, EXPT MOL GENETICS; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Park HC, 2007, NUCLEIC ACIDS RES, V35, P3612, DOI 10.1093/nar/gkm273; Park OK, 2000, J BIOL CHEM, V275, P32244, DOI 10.1074/jbc.M005082200; Ponchel F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-18; Remenyi A, 2001, MOL CELL, V8, P569, DOI 10.1016/S1097-2765(01)00336-7; Resnekov O., 1996, NATO ASI SER, P267; Rozen S, 2000, Methods Mol Biol, V132, P365; Seo PJ, 2008, TRENDS PLANT SCI, V13, P550, DOI 10.1016/j.tplants.2008.06.008; Seo PJ, 2010, BIOCHEM J, V427, P359, DOI 10.1042/BJ20091762; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Sicard A, 2008, PLANT J, V55, P415, DOI 10.1111/j.1365-313X.2008.03520.x; Smith GE, 2003, MOL BIOL REP, V30, P199, DOI 10.1023/A:1026330907065; Smith HMS, 2004, CURR BIOL, V14, P812, DOI 10.1016/j.cub.2004.04.032; Sommer P, 2005, CURR OPIN CELL BIOL, V17, P294, DOI 10.1016/j.ceb.2005.04.007; Tan QKG, 2006, PLANT PHYSIOL, V140, P1095, DOI 10.1104/pp.105.070565; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Tootle TL, 2005, BIOESSAYS, V27, P285, DOI 10.1002/bies.20198; Tran LSP, 2007, PLANT J, V49, P46, DOI 10.1111/j.1365-313X.2006.02932.x; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wenkel S, 2007, PLANT CELL, V19, P3379, DOI 10.1105/tpc.107.055772; WHITESIDE ST, 1993, J CELL SCI, V104, P949; Windhovel A, 2001, PLANT MOL BIOL, V45, P201, DOI 10.1023/A:1006450005648; Yun J, 2008, PLANT SIGNAL BEHAV, V3, P615, DOI 10.4161/psb.3.9.6225; Zhang JH, 2001, J BIOL CHEM, V276, P10284, DOI 10.1074/jbc.M009247200; Zhu JH, 2004, P NATL ACAD SCI USA, V101, P9873, DOI 10.1073/pnas.0403166101; Ziegler E. C., 2005, SCI STKE, pre6, DOI DOI 10.1126/STKE.2842005RE6	68	58	78	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1659	1668		10.1074/jbc.M110.167692	http://dx.doi.org/10.1074/jbc.M110.167692			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059647	hybrid, Green Published			2022-12-25	WOS:000286005000078
J	Lejon, S; Thong, SY; Murthy, A; AlQarni, S; Murzina, NV; Blobel, GA; Laue, ED; Mackay, JP				Lejon, Sara; Thong, Sock Yue; Murthy, Andal; AlQarni, Saad; Murzina, Natalia V.; Blobel, Gerd A.; Laue, Ernest D.; Mackay, Joel P.			Insights into Association of the NuRD Complex with FOG-1 from the Crystal Structure of an RbAp48.FOG-1 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELER MI-2-BETA; TRANSCRIPTIONAL REPRESSION; HISTONE H3; MI-2/NURD COMPLEX; GENE-EXPRESSION; RECOGNITION; REGULATOR; PROTEINS; BINDING; RECRUITS	Chromatin-modifying complexes such as the NuRD complex are recruited to particular genomic sites by gene-specific nuclear factors. Overall, however, little is known about the molecular basis for these interactions. Here, we present the 1.9 angstrom resolution crystal structure of the NuRD subunit RbAp48 bound to the 15 N-terminal amino acids of the GATA-1 cofactor FOG-1. The FOG-1 peptide contacts a negatively charged binding pocket on top of the RbAp48 beta-propeller that is distinct from the binding surface used by RpAp48 to contact histone H4. We further show that RbAp48 interacts with the NuRD subunit MTA-1 via a surface that is distinct from its FOG-binding pocket, providing a first glimpse into the way in which NuRD assembly facilitates interactions with cofactors. Our RbAp48 center dot FOG-1 structure provides insight into the molecular determinants of FOG-1-dependent association with the NuRD complex and into the links between transcription regulation and nucleosome remodeling.	[Laue, Ernest D.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Thong, Sock Yue; AlQarni, Saad; Mackay, Joel P.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Blobel, Gerd A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Cambridge; University of Sydney; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Laue, ED (corresponding author), Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England.	e.d.laue@bioc.cam.ac.uk; joel.mackay@sydney.edu.au	Alqarni, Saad/AAH-2502-2020; Mackay, Joel/D-6834-2011	Mackay, Joel/0000-0001-7508-8033; Laue, Ernest/0000-0002-7476-4148	National Institutes of Health [DK058044]; Australian National Health and Medical Research Council; Wellcome Trust, United Kingdom; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058044, R01DK058044] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust, United Kingdom(Wellcome Trust); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant DK058044. This work was also supported by grants from the Australian National Health and Medical Research Council and the Wellcome Trust, United Kingdom.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Dhasarathy A, 2008, MUTAT RES-FUND MOL M, V647, P39, DOI 10.1016/j.mrfmmm.2008.07.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; Gao H, 2009, P NATL ACAD SCI USA, V106, P11258, DOI 10.1073/pnas.0809485106; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Gregory GD, 2010, BLOOD, V115, P2156, DOI 10.1182/blood-2009-10-251280; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Henikoff S, 2003, NATURE, V423, P814, DOI 10.1038/423814a; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Moon HE, 2007, ONCOL REP, V18, P1311; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; PENCIL SD, 1993, BREAST CANCER RES TR, V25, P165, DOI 10.1007/BF00662141; QIAN YW, 1993, NATURE, V364, P648, DOI 10.1038/364648a0; Ramirez J, 2009, EPIGENETICS-US, V4, P532, DOI 10.4161/epi.4.8.10108; Roche AE, 2008, J MOL CELL CARDIOL, V44, P352, DOI 10.1016/j.yjmcc.2007.10.023; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Song JJ, 2008, GENE DEV, V22, P1313, DOI 10.1101/gad.1653308; TOH Y, 1994, J BIOL CHEM, V269, P22958; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808	44	67	70	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1196	1203		10.1074/jbc.M110.195842	http://dx.doi.org/10.1074/jbc.M110.195842			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21047798	Green Published, hybrid			2022-12-25	WOS:000286005000031
J	Mittal, MK; Singh, K; Misra, S; Chaudhuri, G				Mittal, Mukul K.; Singh, Kshipra; Misra, Smita; Chaudhuri, Gautam			SLUG-induced Elevation of D1 Cyclin in Breast Cancer Cells through the Inhibition of Its Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR; TRANSCRIPTION FACTORS; CONJUGATING ENZYMES; GENE-EXPRESSION; IN-VIVO; DEGRADATION; PROTEIN; OVEREXPRESSION; ACTIVATION; TAMOXIFEN	UbcH5c, a member of the UbcH5 family of protein ubiquitin conjugase E2 enzymes, is a critical component of biological processes in human cells, being the initial ubiquitinating enzyme of substrates like I kappa B, TP53, and cyclin D1. We report here that the metastasis regulator protein SLUG inhibits the expression of UbcH5c directly through chromatin remodeling and thus, among other downstream effects, elevates the level of cyclin D1, thus enhancing the growth rates of breast cancer cells. Overexpression of SLUG in the SLUG-deficient breast cancer cells significantly decreased the levels of mRNA and protein of UbcH5c but only elevated the protein levels of cyclin D1. On the contrary, knockdown of SLUG in SLUG-high breast cancer cells elevated the levels of UbcH5c while decreasing the level of cyclin D1 protein. SLUG is recruited at the E2-box sequence at the UbcH5c gene promoter along with the corepressor CtBP1 and the effector HDAC1 to silence the expression of this gene. Knockdown of UbcH5c in the SLUG-deficient human breast cells elevated the level of cyclin D1 as well as the rates of proliferation and invasiveness of these cells. Whereas the growth rates of the cells are enhanced due to overexpression of SLUG or knockdown of UbcH5c in the breast cancer cells tested, ER+ cells also acquire resistance to the anti-estrogen 4 -hydroxytamoxifen due to the rise of cyclin D1 levels in these cells. This study thus implicates high levels of SLUG and low levels of UbcH5c as a determinant in the progression of metastatic breast cancer.	[Mittal, Mukul K.; Misra, Smita; Chaudhuri, Gautam] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Singh, Kshipra] Vanderbilt Univ, Med Ctr, Div Gastroenterol, Nashville, TN 37232 USA	Meharry Medical College; Vanderbilt University	Chaudhuri, G (corresponding author), Meharry Med Coll, Dept Microbiol & Immunol, 1005 DB Todd,Jr Blvd, Nashville, TN 37208 USA.	gchaudhuri@mmc.edu		Mittal, Mukul/0000-0002-9795-7372	Department of Defense [W81XWH-06-1-0466]; Susan G. Komen Breast Cancer Foundation [BCTR0707627]; National Institutes of Health [U54NS041071]; NCRR, National Institutes of Health [UL1 RR024975]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041071] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by Department of Defense Congressionally Directed Medical Research Program IDEA Grant W81XWH-06-1-0466 and Susan G. Komen Breast Cancer Foundation Grant BCTR0707627 (to G.C.). Confocal microscopy was performed through the use of the Meharry Medical College Morphology Core, which is supported in part by National Institutes of Health Grant U54NS041071. Other core facility research was supported in part by Vanderbilt Clinical and Translational Science Award Grant UL1 RR024975 from NCRR, National Institutes of Health.	Ahnstrom M, 2005, BREAST CANCER RES TR, V91, P145, DOI 10.1007/s10549-004-6457-4; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Baek KH, 2006, CURR PROTEIN PEPT SC, V7, P171, DOI 10.2174/138920306776359740; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Butt AJ, 2008, ADV EXP MED BIOL, V630, P189; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Carrano AC, 2001, J CELL BIOL, V153, P1381, DOI 10.1083/jcb.153.7.1381; Conkright MD, 2001, J BIOL CHEM, V276, P29299, DOI 10.1074/jbc.M103670200; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Fang Y, 2010, BBA-REV CANCER, V1806, P1, DOI 10.1016/j.bbcan.2010.03.001; Fournier AK, 2008, J CELL SCI, V121, P226, DOI 10.1242/jcs.017012; Furukawa M, 2002, J BIOL CHEM, V277, P15758, DOI 10.1074/jbc.M108565200; Gallastegui N, 2010, TRENDS BIOCHEM SCI, V35, P634, DOI 10.1016/j.tibs.2010.05.005; Gao F, 2006, NAT CELL BIOL, V8, P1171, DOI 10.1038/ncb1483; Gao M, 2005, MOL CELL, V19, P581, DOI 10.1016/j.molcel.2005.08.017; GILLETT C, 1994, CANCER RES, V54, P1812; Gonen H, 1999, J BIOL CHEM, V274, P14823, DOI 10.1074/jbc.274.21.14823; Hattori H, 2007, BLOOD, V110, P640, DOI 10.1182/blood-2006-11-059048; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Hosokawa Y, 1998, GENE CHROMOSOME CANC, V22, P66, DOI 10.1002/(SICI)1098-2264(199805)22:1<66::AID-GCC9>3.0.CO;2-5; Ishii Y, 2008, CANCER RES, V68, P852, DOI 10.1158/0008-5472.CAN-07-2879; Jensen JP, 1995, J BIOL CHEM, V270, P30408, DOI 10.1074/jbc.270.51.30408; Jirstrom K, 2005, CANCER RES, V65, P8009, DOI 10.1158/0008-5472.CAN-05-0746; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Klein EA, 2007, CELL CYCLE, V6, P1115, DOI 10.4161/cc.6.9.4147; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; Lambertini E, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-13; Li DQ, 2009, P NATL ACAD SCI USA, V106, P17493, DOI 10.1073/pnas.0908027106; Lin DI, 2008, ONCOGENE, V27, P1231, DOI 10.1038/sj.onc.1210738; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Maeda I, 2001, FEBS LETT, V494, P181, DOI 10.1016/S0014-5793(01)02343-2; Masamha CP, 2009, CANCER RES, V69, P6565, DOI 10.1158/0008-5472.CAN-09-0913; Misra S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-50; Mittal MK, 2008, BIOCHEM BIOPH RES CO, V372, P30, DOI 10.1016/j.bbrc.2008.04.187; Mittal MK, 2010, MOL BIOL REP, V37, P1221, DOI 10.1007/s11033-009-9492-8; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Ormandy CJ, 2003, BREAST CANCER RES TR, V78, P323, DOI 10.1023/A:1023033708204; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Piscopo DM, 2008, CANCER RES, V68, P5581, DOI 10.1158/0008-5472.CAN-07-6346; Prasad CP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-325; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Stendahl M, 2004, BRIT J CANCER, V90, P1942, DOI 10.1038/sj.bjc.6601831; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Sutherland RL, 2002, BREAST CANCER RES, V4, P14, DOI 10.1186/bcr411; Sutherland RL, 2004, J MAMMARY GLAND BIOL, V9, P95, DOI 10.1023/B:JOMG.0000023591.45568.77; Tripathi MK, 2005, J BIOL CHEM, V280, P17163, DOI 10.1074/jbc.M501375200; Watanabe H, 1998, P NATL ACAD SCI USA, V95, P1392, DOI 10.1073/pnas.95.4.1392; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Yuan YH, 2007, CANCER RES, V67, P8032, DOI 10.1158/0008-5472.CAN-07-0083; Zhang XD, 2005, NAT CELL BIOL, V7, P12, DOI 10.1038/ncb0105-12; Zwart W, 2009, MOL ENDOCRINOL, V23, P1335, DOI 10.1210/me.2008-0268; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6; Zwijsen RML, 1998, GENE DEV, V12, P3488, DOI 10.1101/gad.12.22.3488	58	43	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					469	479		10.1074/jbc.M110.164384	http://dx.doi.org/10.1074/jbc.M110.164384			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21044962	Green Published, hybrid			2022-12-25	WOS:000285782800050
J	Shang, FF; Rynkiewicz, MJ; McCormack, FX; Wu, HX; Cafarella, TM; Head, JF; Seaton, BA				Shang, Feifei; Rynkiewicz, Michael J.; McCormack, Francis X.; Wu, Huixing; Cafarella, Tanya M.; Head, James F.; Seaton, Barbara A.			Crystallographic Complexes of Surfactant Protein A and Carbohydrates Reveal Ligand-induced Conformational Change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY INNATE IMMUNITY; MANNOSE-BINDING PROTEINS; BACTERIAL LIPOPOLYSACCHARIDES; STRUCTURAL-CHANGES; LUNG COLLECTINS; HOST-DEFENSE; RECOGNITION; DOMAIN; DETERMINANTS; INSIGHTS	Surfactant protein A (SP-A), a C-type lectin, plays an important role in innate lung host defense against inhaled pathogens. Crystallographic SP-A.ligand complexes have not been reported to date, limiting available molecular information about SP-A interactions with microbial surface components. This study describes crystal structures of calcium-dependent complexes of the C-terminal neck and carbohydrate recognition domain of SP-A with D-mannose, D-alpha-methylmannose, and glycerol, which represent subdomains of glycans on pathogen surfaces. Comparison of these complexes with the unliganded SP-A neck and carbohydrate recognition domain revealed an unexpected ligand-associated conformational change in the loop region surrounding the lectin site, one not previously reported for the lectin homologs SP-D and mannan-binding lectin. The net result of the conformational change is that the SP-A lectin site and the surrounding loop region become more compact. The Glu-202 side chain of unliganded SP-A extends out into the solvent and away from the calcium ion; however, in the complexes, the Glu-202 side chain translocates 12.8 angstrom to bind the calcium. The availability of Glu-202, together with positional changes involving water molecules, creates a more favorable hydrogen bonding environment for carbohydrate ligands. The Lys-203 side chain reorients as well, extending outward into the solvent in the complexes, thereby opening up a small cation-friendly cavity occupied by a sodium ion. Binding of this cation brings the large loop, which forms one wall of the lectin site, and the adjacent small loop closer together. The ability to undergo conformational changes may help SP-A adapt to different ligand classes, including microbial glycolipids and surfactant lipids.	[Shang, Feifei; Rynkiewicz, Michael J.; Cafarella, Tanya M.; Head, James F.; Seaton, Barbara A.] Boston Univ, Dept Physiol & Biophys, Sch Med, Boston, MA 02118 USA; [McCormack, Francis X.; Wu, Huixing] Univ Cincinnati, Sch Med, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Cincinnati, OH 45267 USA	Boston University; University System of Ohio; University of Cincinnati	Seaton, BA (corresponding author), Boston Univ, Dept Physiol & Biophys, Sch Med, 72 E Concord St, Boston, MA 02118 USA.	seatonba@bu.edu	shang, feifei/AAH-8592-2019; McCormack, Francis X./ABE-8398-2020	McCormack, Francis X./0000-0001-7168-9464; Seaton, Barbara/0000-0003-4654-7709; Rynkiewicz, Michael/0000-0002-4717-5700; Head, James/0000-0002-6226-4146	National Institutes of Health, NIAID [AI083222]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083222] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI083222 from NIAID (to B. A. S.). This work was also supported by a Department of Veterans Affairs merit award (to F. X. M.).	BENNE CA, 1995, J INFECT DIS, V171, P335, DOI 10.1093/infdis/171.2.335; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cason C., 2005, PERSISTENCE VISION R; Chroneos ZC, 2010, CELL PHYSIOL BIOCHEM, V25, P13, DOI 10.1159/000272047; Crouch E, 2000, IMMUNOL REV, V173, P52, DOI 10.1034/j.1600-065X.2000.917311.x; Crouch E, 2007, BIOCHEMISTRY-US, V46, P5160, DOI 10.1021/bi700037x; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haagsman HP, 2008, NEONATOLOGY, V93, P288, DOI 10.1159/000121454; Hartshorn Kevan L, 2010, Front Biosci (Schol Ed), V2, P527; Hartshorn KL, 2000, BIOCHEM J, V351, P449, DOI 10.1042/0264-6021:3510449; Hartshorn KL, 1997, AM J PHYSIOL-LUNG C, V273, pL1156, DOI 10.1152/ajplung.1997.273.6.L1156; Head JF, 2003, J BIOL CHEM, V278, P43254, DOI 10.1074/jbc.M305628200; Hsin K, 2008, J APPL CRYSTALLOGR, V41, P963, DOI 10.1107/S002188980802476X; Jones T. A., 1992, MANUAL; Kingma PS, 2006, CURR OPIN PHARMACOL, V6, P277, DOI 10.1016/j.coph.2006.02.003; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; KUAN SF, 1992, J CLIN INVEST, V90, P97, DOI 10.1172/JCI115861; MALHOTRA R, 1994, BIOCHEM J, V304, P455, DOI 10.1042/bj3040455; McCormack FX, 1997, BIOCHEMISTRY-US, V36, P13963, DOI 10.1021/bi970745q; McCormack FX, 2002, J CLIN INVEST, V109, P707, DOI 10.1172/JCI200215293; Ng KKS, 1998, BIOCHEMISTRY-US, V37, P17965, DOI 10.1021/bi981972a; Ng KKS, 2002, J BIOL CHEM, V277, P16088, DOI 10.1074/jbc.M200493200; Sano H, 2005, MOL IMMUNOL, V42, P279, DOI 10.1016/j.molimm.2004.07.014; Seaton BA, 2010, INNATE IMMUN-LONDON, V16, P143, DOI 10.1177/1753425910368716; Shrive AK, 2009, J MOL BIOL, V394, P776, DOI 10.1016/j.jmb.2009.09.057; Shrive AK, 2003, J MOL BIOL, V331, P509, DOI 10.1016/S0022-2836(03)00761-7; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; VANIWAARDEN JF, 1994, BIOCHEM J, V303, P407, DOI 10.1042/bj3030407; Wang H, 2008, BIOCHEMISTRY-US, V47, P710, DOI 10.1021/bi7020553; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Whitsett JA, 2005, BIOL NEONATE, V88, P175, DOI 10.1159/000087580; Wright JR, 2004, BIOL NEONATE, V85, P326, DOI 10.1159/000078172; Wurzburg BA, 2006, STRUCTURE, V14, P1049, DOI 10.1016/j.str.2006.03.017; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	37	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					757	765		10.1074/jbc.M110.175265	http://dx.doi.org/10.1074/jbc.M110.175265			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21047777	Green Published, hybrid			2022-12-25	WOS:000285782800075
J	Cui, S; Ho, WK; Kim, ST; Cho, H				Cui, Shanyu; Ho, Won-Kyung; Kim, Seong-Tae; Cho, Hana			Agonist-induced Localization of Gq-coupled Receptors and G Protein-gated Inwardly Rectifying K+ (GIRK) Channels to Caveolae Determines Receptor Specificity of Phosphatidylinositol 4,5-Bisphosphate Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ATRIAL-FIBRILLATION; ADENYLYL-CYCLASE; CARDIAC MYOCYTES; CA2+ CHANNELS; LIPID RAFTS; MODULATION; BRADYKININ; INHIBITION; HEART	G protein-gated inwardly rectifying K+ (GIRK) channels are parasympathetic effectors in cardiac myocytes that act as points of integration of signals from diverse pathways. Neurotransmitters and hormones acting on the Gq protein regulate GIRK channels by phosphatidylinositol 4,5-bisphosphate (PIP2) depletion. In previous studies, we found that endothelin- 1, but not bradykinin, inhibited GIRK channels, even though both of them hydrolyze PIP2 in cardiac myocytes, showing receptor specificity. The present study assessed whether the spatial organization of the PIP2 signal into caveolar microdomains underlies the specificity of PIP2-mediated signaling. Using biochemical analysis, we examined the localization of GIRK and Gq protein-coupled receptors (GqPCRs) in mouse atrial myocytes. Agonist stimulation induced a transient co-localization of GIRK channels with endothelin receptors in the caveolae, excluding bradykinin receptors. Such redistribution was eliminated by caveolar disruption with methyl-beta-cyclodextrin (M beta CD). Patch clamp studies showed that the specific response of GIRK channels to GqPCR agonists was abolished by M beta CD, indicating the functional significance of the caveolae-dependent spatial organization. To assess whether low PIP2 mobility is essential for PIP2-mediated signaling, we blocked the cytoskeletal restriction of PIP2 diffusion by latrunculin B. This abolished the GIRK channel regulation by GqPCRs without affecting their targeting to caveolae. These data suggest that without the hindered diffusion of PIP2 from microdomains, PIP2 loses its signaling efficacy. Taken together, these data suggest that specific targeting combined with restricted diffusion of PIP2 allows the PIP2 signal to be compartmentalized to the targets localized closely to the GqPCRs, enabling cells to discriminate between identical PIP2 signaling that is triggered by different receptors.	[Kim, Seong-Tae] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Cui, Shanyu; Cho, Hana] Sungkyunkwan Univ, Sch Med, Dept Physiol, Suwon 440746, South Korea; [Ho, Won-Kyung] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul 110799, South Korea; [Ho, Won-Kyung] Biomed Plast Res Ctr, Seoul 110799, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Seoul National University (SNU)	Kim, ST (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea.	stkim@med.skku.ac.kr; hanacho@med.skku.ac.kr	Kim, Seong-Tae/A-9917-2013; Ho, Won-Kyung/J-2798-2012		Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A080604]	Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Grant A080604 from the Korea Healthcare area, so that the activation of a given GqPCR affects only Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea.	Bae GU, 2008, J BIOL CHEM, V283, P8301, DOI 10.1074/jbc.M706730200; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Balijepalli RC, 2008, PROG BIOPHYS MOL BIO, V98, P149, DOI 10.1016/j.pbiomolbio.2009.01.012; Calaghan S, 2006, CARDIOVASC RES, V69, P816, DOI 10.1016/j.cardiores.2005.10.006; Chen PS, 2007, HEART RHYTHM, V4, pS61, DOI 10.1016/j.hrthm.2006.12.006; Cho H, 2005, P NATL ACAD SCI USA, V102, P15241, DOI 10.1073/pnas.0408851102; Cho H, 2005, P NATL ACAD SCI USA, V102, P4643, DOI 10.1073/pnas.0408844102; Cho H, 2001, BRIT J PHARMACOL, V134, P1066, DOI 10.1038/sj.bjp.0704347; Cho H, 2001, J BIOL CHEM, V276, P159, DOI 10.1074/jbc.M004826200; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Delmas P, 2005, NEURON, V47, P179, DOI 10.1016/j.neuron.2005.07.001; Dobrzynski H, 2001, J HISTOCHEM CYTOCHEM, V49, P1221, DOI 10.1177/002215540104901004; Feron O, 2006, CARDIOVASC RES, V69, P788, DOI 10.1016/j.cardiores.2005.12.014; Feron O, 1997, J BIOL CHEM, V272, P17744, DOI 10.1074/jbc.272.28.17744; Gamper N, 2004, J NEUROSCI, V24, P10980, DOI 10.1523/JNEUROSCI.3869-04.2004; Gamper N, 2007, J PHYSIOL-LONDON, V582, P967, DOI 10.1113/jphysiol.2007.132787; Garg V, 2009, CARDIOVASC RES, V82, P51, DOI 10.1093/cvr/cvp039; Haasemann M, 1998, J CELL SCI, V111, P917; Horstmeyer A, 1996, J BIOL CHEM, V271, P20811, DOI 10.1074/jbc.271.34.20811; Kitakaze M, 2000, HYPERTENS RES, V23, P253, DOI 10.1291/hypres.23.253; Kolettis TM, 2008, J INTERV CARD ELECTR, V21, P203, DOI 10.1007/s10840-008-9206-5; Lasley RD, 2000, J BIOL CHEM, V275, P4417, DOI 10.1074/jbc.275.6.4417; Lavine N, 2002, J BIOL CHEM, V277, P46010, DOI 10.1074/jbc.M205035200; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Meyer T, 2001, J BIOL CHEM, V276, P5650, DOI 10.1074/jbc.M009179200; MINSHALL RD, 1995, CIRC RES, V76, P773, DOI 10.1161/01.RES.76.5.773; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Ostrom RS, 2004, J BIOL CHEM, V279, P19846, DOI 10.1074/jbc.M313440200; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Sabourin T, 2002, MOL PHARMACOL, V61, P546, DOI 10.1124/mol.61.3.546; SAKMANN B, 1983, NATURE, V303, P250, DOI 10.1038/303250a0; Sbaa E, 2005, TRENDS CARDIOVAS MED, V15, P157, DOI 10.1016/j.tcm.2005.05.006; Schoemaker RG, 2000, AM J PHYSIOL-HEART C, V278, pH1571, DOI 10.1152/ajpheart.2000.278.5.H1571; Sharifov OF, 2004, J AM COLL CARDIOL, V43, P483, DOI 10.1016/j.jacc.2003.09.030; Tsai CT, 2004, CIRCULATION, V109, P1640, DOI 10.1161/01.CIR.0000124487.36586.26; Yamaguchi H, 1997, AM J PHYSIOL-HEART C, V273, pH1745, DOI 10.1152/ajpheart.1997.273.4.H1745	38	16	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41732	41739		10.1074/jbc.M110.153312	http://dx.doi.org/10.1074/jbc.M110.153312			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041306	Green Published, hybrid			2022-12-25	WOS:000285622600060
J	Hagino, Y; Kasai, S; Han, WH; Yamamoto, H; Nabeshima, T; Mishina, M; Ikeda, K				Hagino, Yoko; Kasai, Shinya; Han, Wenhua; Yamamoto, Hideko; Nabeshima, Toshitaka; Mishina, Masayoshi; Ikeda, Kazutaka			Essential Role of NMDA Receptor Channel epsilon 4 Subunit (GluN2D) in the Effects of Phencyclidine, but Not Methamphetamine	PLOS ONE			English	Article							MICE LACKING; IN-VIVO; BEHAVIORAL SENSITIZATION; RAT-BRAIN; NONCOMPETITIVE ANTAGONISTS; EXTRACELLULAR LEVELS; CATECHOLAMINE UPTAKE; TARGETED DISRUPTION; LOCOMOTOR-ACTIVITY; ANESTHETIZED RATS	Phencyclidine (PCP), a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, increases locomotor activity in rodents and causes schizophrenia-like symptoms in humans. Although activation of the dopamine (DA) pathway is hypothesized to mediate these effects of PCP, the precise mechanisms by which PCP induces its effects remain to be elucidated. The present study investigated the effect of PCP on extracellular levels of DA (DA(ex)) in the striatum and prefrontal cortex (PFC) using in vivo microdialysis in mice lacking the NMDA receptor channel epsilon 1 or epsilon 4 subunit (GluR epsilon 1 [GluN2A] or GluR epsilon 4 [GluN2D]) and locomotor activity. PCP significantly increased DA(ex) in wildtype and GluR epsilon 1 knockout mice, but not in GluR epsilon 4 knockout mice, in the striatum and PFC. Acute and repeated administration of PCP did not increase locomotor activity in GluR epsilon 4 knockout mice. The present results suggest that PCP enhances dopaminergic transmission and increases locomotor activity by acting at GluR epsilon 4.	[Hagino, Yoko; Kasai, Shinya; Han, Wenhua; Yamamoto, Hideko; Ikeda, Kazutaka] Tokyo Inst Psychiat, Div Psychobiol, Tokyo, Japan; [Nabeshima, Toshitaka] Meijo Univ, Comparat Cognit Sci Inst, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan; [Nabeshima, Toshitaka] Meijo Univ, Dept Chem Pharmacol, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan; [Mishina, Masayoshi] Univ Tokyo, Dept Mol Neurobiol & Pharmacol, Grad Sch Med, Tokyo, Japan	Tokyo Institute of Psychiatry; Meijo University; Meijo University; University of Tokyo	Hagino, Y (corresponding author), Tokyo Inst Psychiat, Div Psychobiol, Tokyo, Japan.	ikeda-kz@igakuken.or.jp	Ikeda, Kazutaka/I-4694-2013	Ikeda, Kazutaka/0000-0001-8342-0278	Ministry of Health, Labour and Welfare of Japan [H19-Iyaku-023, H22-Iyaku-015]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Naito Foundation; Mitsubishi Foundation	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Mitsubishi Foundation	This work was supported by grants from the Ministry of Health, Labour and Welfare of Japan (H19-Iyaku-023, H22-Iyaku-015), the Ministry of Education, Culture, Sports, Science and Technology of Japan, The Naito Foundation, and The Mitsubishi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 1998, J NEUROSCI, V18, P5545, DOI 10.1523/JNEUROSCI.18-14-05545.1998; ANIS NA, 1983, BRIT J PHARMACOL, V79, P565, DOI 10.1111/j.1476-5381.1983.tb11031.x; BENWELL MEM, 1993, PSYCHOPHARMACOLOGY, V112, P467, DOI 10.1007/BF02244896; Boyce-Rustay JM, 2006, NEUROPSYCHOPHARMACOL, V31, P2405, DOI 10.1038/sj.npp.1301039; Carlsson A, 2000, BRAIN RES REV, V31, P342, DOI 10.1016/S0165-0173(99)00050-8; CASTELLANI S, 1981, EUR J PHARMACOL, V73, P143, DOI 10.1016/0014-2999(81)90086-8; CHAPMAN CD, 1990, NEUROPHARMACOLOGY, V29, P319, DOI 10.1016/0028-3908(90)90089-A; Ebralidze AK, 1996, J NEUROSCI, V16, P5014; FISCHER JF, 1979, J PHARMACOL EXP THER, V208, P203; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; GAREY RE, 1976, LIFE SCI, V18, P1105, DOI 10.1016/0024-3205(76)90145-4; Geyer MA, 2003, PROG NEURO-PSYCHOPH, V27, P1071, DOI 10.1016/j.pnpbp.2003.09.003; GREEN AL, 1978, J PHARM PHARMACOL, V30, P262, DOI 10.1111/j.2042-7158.1978.tb13223.x; GREEN AL, 1971, BIOCHEM J, V121, pP37, DOI 10.1042/bj1210037P; HEIKKILA RE, 1975, BIOCHEM PHARMACOL, V24, P847, DOI 10.1016/0006-2952(75)90152-5; Hertel P, 1996, BEHAV BRAIN RES, V72, P103, DOI 10.1016/0166-4328(96)00138-6; HONDO H, 1994, BRAIN RES, V633, P337, DOI 10.1016/0006-8993(94)91558-X; HORN AS, 1971, MOL PHARMACOL, V7, P66; IKEDA K, 1995, MOL BRAIN RES, V33, P61, DOI 10.1016/0169-328X(95)00107-4; IKEDA K, 1992, FEBS LETT, V313, P34, DOI 10.1016/0014-5793(92)81178-O; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; Jones S, 2005, J PHYSIOL-LONDON, V569, P209, DOI 10.1113/jphysiol.2005.095554; Kadotani H, 1996, J NEUROSCI, V16, P7859; KEMP JA, 1987, TRENDS NEUROSCI, V10, P294, DOI 10.1016/0166-2236(87)90176-7; Kew JNC, 2005, PSYCHOPHARMACOLOGY, V179, P4, DOI 10.1007/s00213-005-2200-z; KURIBARA H, 1992, PSYCHOPHARMACOLOGY, V108, P271, DOI 10.1007/BF02245111; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LILLRANK SM, 1994, ACTA PHYSIOL SCAND, V150, P109, DOI 10.1111/j.1748-1716.1994.tb09667.x; Lindahl JS, 2004, NEUROPSYCHOPHARMACOL, V29, P2065, DOI 10.1038/sj.npp.1300485; LODGE D, 1990, TRENDS PHARMACOL SCI, V11, P81, DOI 10.1016/0165-6147(90)90323-Z; LUBY ED, 1959, ARCH NEURO PSYCHIATR, V81, P363, DOI 10.1001/archneurpsyc.1959.02340150095011; Makins R, 2005, GROWTH HORM IGF RES, V15, P215, DOI 10.1016/j.ghir.2005.02.010; Masuo Y, 1997, BRAIN RES PROTOC, V1, P321, DOI 10.1016/S1385-299X(97)00005-6; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; Millan MJ, 2005, PSYCHOPHARMACOLOGY, V179, P30, DOI 10.1007/s00213-005-2199-1; MILLER HH, 1980, BIOCHEM PHARMACOL, V29, P1347, DOI 10.1016/0006-2952(80)90429-3; Miyamoto Y, 2001, J NEUROSCI, V21, P750, DOI 10.1523/JNEUROSCI.21-02-00750.2001; Miyamoto Y, 2004, EUR J NEUROSCI, V19, P151, DOI 10.1111/j.1460-9568.2004.03086.x; Miyamoto Y, 2002, J NEUROSCI, V22, P2335, DOI 10.1523/JNEUROSCI.22-06-02335.2002; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Mori H, 2003, LIFE SCI, V74, P329, DOI 10.1016/j.lfs.2003.09.020; Mouri A, 2007, NEUROCHEM INT, V51, P173, DOI 10.1016/j.neuint.2007.06.019; NABESHIMA T, 1987, EUR J PHARMACOL, V135, P23, DOI 10.1016/0014-2999(87)90753-9; Nishijima K, 1996, SYNAPSE, V22, P304, DOI 10.1002/(SICI)1098-2396(199604)22:4<304::AID-SYN2>3.0.CO;2-F; OHMORI T, 1994, PHARMACOL BIOCHEM BE, V48, P587, DOI 10.1016/0091-3057(94)90318-2; PARKER EM, 1988, J PHARMACOL EXP THER, V245, P199; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; ROBINSON TE, 1986, BRAIN RES REV, V11, P157, DOI 10.1016/0165-0173(86)90002-0; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Schmitz Y, 2001, J NEUROSCI, V21, P5916, DOI 10.1523/JNEUROSCI.21-16-05916.2001; SEIDEN LS, 1993, ANNU REV PHARMACOL, V33, P639, DOI 10.1146/annurev.pa.33.040193.003231; SMITH RC, 1977, BIOCHEM PHARMACOL, V26, P1435, DOI 10.1016/0006-2952(77)90370-7; SNELL LD, 1988, EUR J PHARMACOL, V145, P223, DOI 10.1016/0014-2999(88)90235-X; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; STANDAERT DG, 1994, J COMP NEUROL, V343, P1, DOI 10.1002/cne.903430102; STURGEON RD, 1979, EUR J PHARMACOL, V59, P169; SULZER D, 1993, J NEUROCHEM, V60, P527, DOI 10.1111/j.1471-4159.1993.tb03181.x; TROUPIN AS, 1986, CURRENT PROBLEMS EPI, V4, P191; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; WOLF ME, 1993, BRAIN RES, V613, P291, DOI 10.1016/0006-8993(93)90913-8; WOLF ME, 1991, BRAIN RES, V562, P164, DOI 10.1016/0006-8993(91)91202-C; XU XJ, 1994, PHARMACOL BIOCHEM BE, V47, P603, DOI 10.1016/0091-3057(94)90165-1; YAMAKURA T, 1993, NEUROREPORT, V4, P687, DOI 10.1097/00001756-199306000-00021	67	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13722	10.1371/journal.pone.0013722	http://dx.doi.org/10.1371/journal.pone.0013722			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060893	Green Submitted, gold, Green Published			2022-12-25	WOS:000283573800017
J	Ayestaran, A; Giurfa, M; de Brito Sanchez, MG				Ayestaran, Ainara; Giurfa, Martin; de Brito Sanchez, Maria Gabriela			Toxic but Drank: Gustatory Aversive Compounds Induce Post-ingestional Malaise in Harnessed Honeybees	PLOS ONE			English	Article							APIS-MELLIFERA; UNCONDITIONED STIMULUS; COLOR DISCRIMINATION; OLFACTORY RECEPTORS; CAFFEINE RESPONSE; LITHIUM-CHLORIDE; FORAGING SPEED; TASTE; INSECT; FOOD	Background: Deterrent substances produced by plants are relevant due to their potential toxicity. The fact that most of these substances have an unpalatable taste for humans and other mammals contrasts with the fact that honeybees do not reject them in the range of concentrations in which these compounds are present in flower nectars. Here we asked whether honeybees detect and ingest deterrent substances and whether these substances are really toxic to them. Results: We show that pairing aversive substances with an odor retards learning of this odor when it is subsequently paired with sucrose. Harnessed honeybees in the laboratory ingest without reluctance a considerable volume (20 mu l) of various aversive substances, even if some of them induce significant post-ingestional mortality. These substances do not seem, therefore, to be unpalatable to harnessed bees but induce a malaise-like state that in some cases results in death. Consistently with this finding, bees learning that one odor is associated with sugar, and experiencing in a subsequent phase that the sugar was paired with 20 mu l of an aversive substance (devaluation phase), respond less than control bees to the odor and the sugar. Such stimulus devaluation can be accounted for by the malaise-like state induced by the aversive substances. Conclusion: Our results indicate that substances that taste bitter to humans as well as concentrated saline solutions base their aversive effect on the physiological consequences that their ingestion generates in harnessed bees rather than on an unpalatable taste. This conclusion is only valid for harnessed bees in the laboratory as freely-moving bees might react differently to aversive compounds could actively reject aversive substances. Our results open a new possibility to study conditioned taste aversion based on post-ingestional malaise and thus broaden the spectrum of aversive learning protocols available in honeybees.	[Ayestaran, Ainara; Giurfa, Martin; de Brito Sanchez, Maria Gabriela] Univ Toulouse UPS, Ctr Rech Cognit Anim, Toulouse, France; [Ayestaran, Ainara; Giurfa, Martin; de Brito Sanchez, Maria Gabriela] CNRS, Ctr Rech Cognit Anim, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Ayestaran, A (corresponding author), Univ Toulouse UPS, Ctr Rech Cognit Anim, Toulouse, France.	debrito@cict.fr	Giurfa, Martin/H-5140-2016; Giurfa, Martin MG/A-7322-2008; Giurfa, Martin/AAS-4945-2020	Giurfa, Martin/0000-0001-7173-769X; Giurfa, Martin/0000-0001-7173-769X; de Brito Sanchez, Maria Gabriela/0000-0001-6940-8088	National Research Agency (ANR) [ANR-BLAN08- 3_337040]; University Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	National Research Agency (ANR)(French National Research Agency (ANR)); University Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	National Research Agency (ANR; Project INSAVEL ANR-BLAN08- 3_337040), the University Paul Sabatier (Project APIGENE) and the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrein H, 2005, CURR BIOL, V15, pR673, DOI 10.1016/j.cub.2005.08.021; AVARGUESWEBER A, 2010, PLOS ONE IN PRESS; BATEMAN DN, 1986, ADVERSE DRUG REACT T, V5, P215; BERNAYS EA, 1988, PHYSIOL ENTOMOL, V13, P131, DOI 10.1111/j.1365-3032.1988.tb00916.x; Bewick V, 2004, CRIT CARE, V8, P389, DOI 10.1186/cc2955; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Chandra S, 1998, J EXP BIOL, V201, P3113; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; COOPER PD, 1994, J INSECT PHYSIOL, V40, P475, DOI 10.1016/0022-1910(94)90120-1; de Brito Sanchez M. G., 2008, J COMP PHYSIOL A, V194, P861, DOI DOI 10.1007/S00359-008-0357-8; de Brito Sanchez MG, 2005, EUR J NEUROSCI, V22, P3161, DOI 10.1111/j.1460-9568.2005.04516.x; Deisig N, 2002, LEARN MEMORY, V9, P112, DOI 10.1101/lm.41002; Detzel Andreas, 1993, Chemoecology, V4, P8, DOI 10.1007/BF01245891; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Dyer AG, 2004, J COMP PHYSIOL A, V190, P759, DOI 10.1007/s00359-004-0547-y; FLANAGAN LM, 1988, NEUROENDOCRINOLOGY, V48, P668, DOI 10.1159/000125080; Freeman KB, 2005, BEHAV PHARMACOL, V16, P591, DOI 10.1097/01.fbp.0000181593.01244.6c; Garcia J, 1966, PSYCHON SCI, V4, P123, DOI [10.3758/BF03342209, DOI 10.3758/BF03342209]; Garcia J, 1966, PSYCHON SCI, V5, P121, DOI DOI 10.3758/BF03328311; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Giurfa M, 2009, LEARN MEMORY, V16, P761, DOI 10.1101/lm.1603009; GLENDINNING JI, 1994, PHYSIOL ENTOMOL, V19, P173, DOI 10.1111/j.1365-3032.1994.tb01040.x; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; HAGLER JR, 1993, J KANSAS ENTOMOL SOC, V66, P223; HELVERSEN OV, 1972, J COMP PHYSIOL, V80, P439, DOI 10.1007/BF00696438; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; HOLLAND PC, 1975, J EXP PSYCHOL ANIM B, V1, P355, DOI 10.1037/0097-7403.1.4.355; Holland PC, 2008, LEARN MOTIV, V39, P265, DOI 10.1016/j.lmot.2008.08.001; Hori S, 2007, J COMP PHYSIOL A, V193, P825, DOI 10.1007/s00359-007-0234-x; Hori S, 2006, J COMP PHYSIOL A, V192, P691, DOI 10.1007/s00359-005-0091-4; Howarth CJ, 2002, J INSECT PHYSIOL, V48, P43, DOI 10.1016/S0022-1910(01)00142-1; Ish-Am G, 1998, J HORTIC SCI BIOTECH, V73, P195, DOI 10.1080/14620316.1998.11510965; Ishimoto H, 2004, CELL MOL LIFE SCI, V61, P10, DOI 10.1007/s00018-003-3182-9; Jorgensen K, 2007, J EXP BIOL, V210, P2563, DOI 10.1242/jeb.004283; Kent LB, 2008, CHEM SENSES, V33, P79, DOI 10.1093/chemse/bjm067; LEE JC, 1990, ANIM BEHAV, V39, P163, DOI 10.1016/S0003-3472(05)80736-5; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Liu F, 2007, FUNCT ECOL, V21, P96, DOI 10.1111/j.1365-2435.2006.01200.x; Liu FL, 2006, BEHAV ECOL SOCIOBIOL, V59, P582, DOI 10.1007/s00265-005-0084-x; Liu FL, 2004, J APICULT RES, V43, P155; London-Shafir I, 2003, PLANT SYST EVOL, V238, P87, DOI 10.1007/s00606-003-0272-y; LORENZO E, 2009, THESIS U P SABATIER, P26; LUFFY D, 1992, J INSECT PHYSIOL, V38, P287, DOI 10.1016/0022-1910(92)90129-2; LUNNEY GH, 1970, J EDUC MEAS, V7, P263, DOI 10.1111/j.1745-3984.1970.tb00727.x; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; MCCANN MJ, 1989, AM J PHYSIOL-REG I, V256, pR436; Mitri C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000147; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; NACHMAN M, 1963, J COMP PHYSIOL PSYCH, V56, P343, DOI 10.1037/h0046484; NEWTON GW, 1981, WESTERN J MED, V134, P97; Niggebrugge C, 2009, J EXP BIOL, V212, P1344, DOI 10.1242/jeb.021881; NUNEZ JA, 1966, Z VERGL PHYSIOL, V53, P142; NUNEZ JA, 1982, J APICULT RES, V21, P139, DOI 10.1080/00218839.1982.11100531; OLDFIELD H, 1982, COMP BIOCH PHYSL C, V73, P303; Olszewski PK, 2000, AM J PHYSIOL-REG I, V279, pR1504, DOI 10.1152/ajpregu.2000.279.4.R1504; Pontoh J, 2002, INSECT BIOCHEM MOLEC, V32, P679, DOI 10.1016/S0965-1748(01)00147-3; Reilly S., 2009, CONDITIONED TASTE AV; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Roussel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004197; SANCHEZ GD, 2007, ARTHROPOD-PLANT INTE, V1, P69; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Scott K, 2004, CURR OPIN NEUROBIOL, V14, P423, DOI 10.1016/j.conb.2004.06.003; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Singaravelan N, 2005, J CHEM ECOL, V31, P2791, DOI 10.1007/s10886-005-8394-z; Smadja C, 2009, MOL BIOL EVOL, V26, P2073, DOI 10.1093/molbev/msp116; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; Teixeira EW, 2005, EVID-BASED COMPL ALT, V2, P85, DOI 10.1093/ecam/neh055; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Unoki S, 2006, EUR J NEUROSCI, V24, P2031, DOI 10.1111/j.1460-9568.2006.05099.x; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Walker LE, 1999, ANN ENTOMOL SOC AM, V92, P902, DOI 10.1093/aesa/92.6.902; Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WINK M, 1988, THEOR APPL GENET, V75, P225, DOI 10.1007/BF00303957; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9; WYKES GR, 1952, J EXP BIOL, V29, P511	79	52	54	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e15000	10.1371/journal.pone.0015000	http://dx.doi.org/10.1371/journal.pone.0015000			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060877	Green Submitted, Green Published, gold			2022-12-25	WOS:000283537000060
J	Johansson, H; Svensson, F; Runnberg, R; Simonsson, T; Simonsson, S				Johansson, Helena; Svensson, Frida; Runnberg, Rikard; Simonsson, Tomas; Simonsson, Stina			Phosphorylated Nucleolin Interacts with Translationally Controlled Tumor Protein during Mitosis and with Oct4 during Interphase in ES Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; BINDING-PROTEIN; SELF-RENEWAL; LR1; DIFFERENTIATION; IDENTIFICATION; MICROTUBULES; REGIONS	Background: Reprogramming of somatic cells for derivation of either embryonic stem (ES) cells, by somatic cell nuclear transfer (SCNT), or ES-like cells, by induced pluripotent stem (iPS) cell procedure, provides potential routes toward non-immunogenic cell replacement therapies. Nucleolar proteins serve as markers for activation of embryonic genes, whose expression is crucial for successful reprogramming. Although Nucleolin (Ncl) is one of the most abundant nucleolar proteins, its interaction partners in ES cells have remained unidentified. Methodology: Here we explored novel Ncl-interacting proteins using in situ proximity ligation assay (PLA), colocalization and immunoprecipitation (IP) in ES cells. Principal Findings: We found that phosphorylated Ncl (Ncl-P) interacted with translationally controlled tumor protein (Tpt1) in murine ES cells. The Ncl-P/Tpt1 complex peaked during mitosis and was reduced upon retinoic acid induced differentiation, signifying a role in cell proliferation. In addition, we showed that Ncl-P interacted with the transcription factor Oct4 during interphase in human as well as murine ES cells, indicating of a role in transcription. The Ncl-P/Oct4 complex peaked during early stages of spontaneous human ES cell differentiation and may thus be involved in the initial differentiation event(s) of mammalian development. Conclusions: Here we described two novel protein-protein interactions in ES cells, which give us further insight into the complex network of interacting proteins in pluripotent cells.	[Johansson, Helena; Svensson, Frida; Runnberg, Rikard; Simonsson, Tomas; Simonsson, Stina] Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden	University of Gothenburg	Johansson, H (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden.	stina.simonsson@gu.se	Simonsson, Stina/R-2699-2016	Simonsson, Stina/0000-0001-9020-3714	Swedish Research Council [K2009-67X-15422-05-2]; Ake Wiberg Stiftelse; Magnus Bergvalls Stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ake Wiberg Stiftelse; Magnus Bergvalls Stiftelse	This work was supported by the Swedish Research Council Grant number K2009-67X-15422-05-2, Ake Wiberg Stiftelse, and Magnus Bergvalls Stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharvand H, 2008, J PROTEOME RES, V7, P412, DOI 10.1021/pr700560t; Bazile F, 2009, CARCINOGENESIS, V30, P555, DOI 10.1093/carcin/bgp022; BELENGUER P, 1989, NUCLEIC ACIDS RES, V17, P6625; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; BRYS A, 1994, P NATL ACAD SCI USA, V91, P4915, DOI 10.1073/pnas.91.11.4915; Byrne JA, 2003, CURR BIOL, V13, P1206, DOI 10.1016/S0960-9822(03)00462-7; CHEN CM, 1991, J BIOL CHEM, V266, P7754; Darnfors C, 2005, STEM CELLS, V23, P483, DOI 10.1634/stemcells.2004-0254; DERENZINI M, 1995, LAB INVEST, V73, P497; Elliott ST, 2004, PROTEOMICS, V4, P3813, DOI 10.1002/pmic.200300820; Gachet Y, 1999, J CELL SCI, V112, P1257; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; Grinstein E, 2007, J BIOL CHEM, V282, P12439, DOI 10.1074/jbc.M608068200; Grinstein E, 2006, J BIOL CHEM, V281, P22223, DOI 10.1074/jbc.M513335200; Hanakahi LA, 1997, P NATL ACAD SCI USA, V94, P3605, DOI 10.1073/pnas.94.8.3605; Hanakahi LA, 2000, NUCLEIC ACIDS RES, V28, P2651, DOI 10.1093/nar/28.14.2651; JOHANSSON H, 2010, CELL CYCLE IN PRESS; Liu HT, 1999, CANCER LETT, V144, P45, DOI 10.1016/S0304-3835(99)00184-6; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Ma N, 2007, J CELL SCI, V120, P2091, DOI 10.1242/jcs.008771; Mahlapuu M, 2001, DEVELOPMENT, V128, P155; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Park IH, 2007, NATURE; PETER M, 1990, CELL, V60, P791, DOI 10.1016/0092-8674(90)90093-T; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Schramm RD, 1999, BIOL REPROD, V60, P721, DOI 10.1095/biolreprod60.3.721; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; WILLIAMS M, 1991, GENE DEV, V5, P2353, DOI 10.1101/gad.5.12a.2353; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	38	22	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13678	10.1371/journal.pone.0013678	http://dx.doi.org/10.1371/journal.pone.0013678			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048921	Green Published, Green Submitted, gold			2022-12-25	WOS:000283537000044
J	Maradeo, ME; Skibbens, RV				Maradeo, Marie E.; Skibbens, Robert V.			Replication Factor C Complexes Play Unique Pro- and Anti-Establishment Roles in Sister Chromatid Cohesion	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; S-PHASE; REMODELING COMPLEX; ESTABLISHMENT; YEAST; PROTEIN; ACETYLATION; ECO1; IDENTIFICATION	Recent studies have lead to a rapid expansion of sister chromatid cohesion pathways. Of particular interest is the growth in classifications of anti-establishment factors-now including those that are cohesin-associated (Rad61/WAPL and Pds5) or DNA replication fork-associated (Elg1-RFC). In this study, we show that the two classes of anti-establishment complexes are indistinguishable when challenged both genetically and functionally. These findings suggest that both classes function in a singular pathway that is centered on Ctf7/Eco1 (herein termed Ctf7) regulation. The anti-establishment activity of Elg1-RFC complex is particular intriguing given that an alternate Ctf18-RFC complex exhibits robust pro-establishment activity. Here, we provide several lines of evidence, including the use of Ctf7 bypass suppressors, indicating that these activities are not simply antagonistic. Moreover, the results suggest that Ctf18-RFC is capable of promoting sister chromatid pairing reactions independent of Ctf7. The combination of these studies suggest a new model of sister chromatid pairing regulation.	[Maradeo, Marie E.; Skibbens, Robert V.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	Lehigh University	Maradeo, ME (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	rvs3@lehigh.edu		Skibbens, Robert/0000-0003-4216-8306	National Institutes of General Medicine [1R15GM083269]; Susan G. Komen for a Cure Foundation [BCTR0707708]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM083269] Funding Source: NIH RePORTER	National Institutes of General Medicine; Susan G. Komen for a Cure Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RVS is supported by award 1R15GM083269 from the National Institutes of General Medicine (http://www.nih.gov) and also by award BCTR0707708 from the Susan G. Komen for a Cure Foundation (http://ww5.komen.org). Any opinions, findings, and conclusions or recommendations expressed in this study are those of the author(s) and do not necessarily reflect the views of the National Institutes of General Medicine nor those of the Susan G. Komen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin NS, 1996, GENETICS, V144, P479; Ansbach AB, 2008, MOL BIOL CELL, V19, P595, DOI 10.1091/mbc.E07-06-0618; Baetz KK, 2004, MOL CELL BIOL, V24, P1232, DOI 10.1128/MCB.24.3.1232-1244.2003; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Dorsett D, 2007, CHROMOSOMA, V116, P1, DOI 10.1007/s00412-006-0072-6; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Heidinger-Pauli JM, 2008, MOL CELL, V31, P47, DOI 10.1016/j.molcel.2008.06.005; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Huang J, 2004, MOL CELL, V13, P739, DOI 10.1016/S1097-2765(04)00103-0; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Kenna MA, 2003, MOL CELL BIOL, V23, P2999, DOI 10.1128/MCB.23.8.2999-3007.2003; KOUPRINA N, 1994, GENETICS, V138, P1067; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Maradeo ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004707; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Ogiwara H, 2007, CELL CYCLE, V6, P1090, DOI 10.4161/cc.6.9.4130; Parnas O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005497; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Rose MD., 1990, METHODS YEAST GENETI; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Skibbens RV, 2008, INT REV CEL MOL BIO, V269, P283, DOI 10.1016/S1937-6448(08)01005-8; Skibbens RV, 2008, CELL CYCLE, V7, P449, DOI 10.4161/cc.7.4.5435; Skibbens RV, 2009, CURR BIOL, V19, pR1126, DOI 10.1016/j.cub.2009.10.067; Skibbens RV, 2000, GENOME RES, V10, P1664, DOI 10.1101/gr.153600; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Skibbens RV, 2004, GENETICS, V166, P33, DOI 10.1534/genetics.166.1.33; SKIBBENS RV, 2010, TRENDS CELL IN PRESS, V9; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	45	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e15381	10.1371/journal.pone.0015381	http://dx.doi.org/10.1371/journal.pone.0015381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060875	gold, Green Published			2022-12-25	WOS:000283537000062
J	Scott, IML; Pound, N; Stephen, ID; Clark, AP; Penton-Voak, IS				Scott, Isabel M. L.; Pound, Nicholas; Stephen, Ian D.; Clark, Andrew P.; Penton-Voak, Ian S.			Does Masculinity Matter? The Contribution of Masculine Face Shape to Male Attractiveness in Humans	PLOS ONE			English	Article							FACIAL ATTRACTIVENESS; SEXUAL-DIMORPHISM; EVOLUTIONARY PSYCHOLOGY; TESTOSTERONE; HEALTH; PERCEPTION; SYMMETRY; IMMUNOCOMPETENCE; PREFERENCES; AGE	Background: In many animals, exaggerated sex-typical male traits are preferred by females, and may be a signal of both past and current disease resistance. The proposal that the same is true in humans - i.e., that masculine men are immunocompetent and attractive - underpins a large literature on facial masculinity preferences. Recently, theoretical models have suggested that current condition may be a better index of mate value than past immunocompetence. This is particularly likely in populations where pathogenic fluctuation is fast relative to host life history. As life history is slow in humans, there is reason to expect that, among humans, condition-dependent traits might contribute more to attractiveness than relatively stable traits such as masculinity. To date, however, there has been little rigorous assessment of whether, in the presence of variation in other cues, masculinity predicts attractiveness or not. Methodology/Principal Findings: The relationship between masculinity and attractiveness was assessed in two samples of male faces. Most previous research has assessed masculinity either with subjective ratings or with simple anatomical measures. Here, we used geometric morphometric techniques to assess facial masculinity, generating a morphological masculinity measure based on a discriminant function that correctly classified >96% faces as male or female. When assessed using this measure, there was no relationship between morphological masculinity and rated attractiveness. In contrast, skin colour - a fluctuating, condition-dependent cue - was a significant predictor of attractiveness. Conclusions/Significance: These findings suggest that facial morphological masculinity may contribute less to men's attractiveness than previously assumed. Our results are consistent with the hypothesis that current condition is more relevant to male mate value than past disease resistance, and hence that temporally fluctuating traits (such as colour) contribute more to male attractiveness than stable cues of sexual dimorphism.	[Scott, Isabel M. L.; Stephen, Ian D.; Penton-Voak, Ian S.] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England; [Pound, Nicholas; Clark, Andrew P.] Brunel Univ, Dept Psychol, Uxbridge UB8 3PH, Middx, England	University of Bristol; Brunel University	Scott, IML (corresponding author), Univ Bristol, Sch Expt Psychol, Bristol, Avon, England.	I.S.Penton-Voak@bristol.ac.uk	Pound, Nicholas/B-5453-2008; Stephen, Ian/ABA-6218-2021	Pound, Nicholas/0000-0003-2170-9943; Stephen, Ian/0000-0001-9714-8295; Penton-Voak, Ian/0000-0003-4232-0953	University of Bristol; Economic and Social Research Council, UK	University of Bristol; Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by the University of Bristol. IDS is supported by the Economic and Social Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2005, BEHAV ECOL, V16, P871, DOI 10.1093/beheco/ari068; Adamo SA, 2009, ANIM BEHAV, V77, P67, DOI 10.1016/j.anbehav.2008.09.011; Angele MK, 2000, SHOCK, V14, P81, DOI 10.1097/00024382-200014020-00001; Booth A, 1999, J BEHAV MED, V22, P1, DOI 10.1023/A:1018705001117; Boothroyd LG, 2005, EVOL HUM BEHAV, V26, P417, DOI 10.1016/j.evolhumbehav.2005.01.001; Brown WM, 2008, P NATL ACAD SCI USA, V105, P12938, DOI 10.1073/pnas.0710420105; CUNNINGHAM MR, 1990, J PERS SOC PSYCHOL, V59, P61, DOI 10.1037/0022-3514.59.1.61; Daly M, 1999, ANIM BEHAV, V57, P509, DOI 10.1006/anbe.1998.1027; DeBruine LM, 2006, P ROY SOC B-BIOL SCI, V273, P1355, DOI 10.1098/rspb.2005.3445; DEBRUINE LM, J EXPT PSYC IN PRESS; Eagly AH, 1999, AM PSYCHOL, V54, P408, DOI 10.1037/0003-066X.54.6.408; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Granger DA, 2000, PSYCHOSOM MED, V62, P583, DOI 10.1097/00006842-200007000-00018; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Henderson JJA, 2003, EVOL HUM BEHAV, V24, P351, DOI 10.1016/S1090-5138(03)00036-9; HILL H, 1995, P ROY SOC B-BIOL SCI, V261, P367, DOI 10.1098/rspb.1995.0161; Jones B., 2008, Animals in transit: the journey ahead. RSPCA Australia Scientific Seminar 2008, 26 February, CSIRO Discovery Centre, Canberra, Australia, P1; Jones BC, 2004, PERCEPTION, V33, P569, DOI 10.1068/p3463; Jones BC, 2001, EVOL HUM BEHAV, V22, P417, DOI 10.1016/S1090-5138(01)00083-6; JONES D, 1993, HUM NATURE-INT BIOS, V4, P271, DOI 10.1007/BF02692202; Kalick SM, 1998, PSYCHOL SCI, V9, P8, DOI 10.1111/1467-9280.00002; Koehler N, 2003, AUST J PSYCHOL, V55, P83; Komori M, 2009, ACTA PSYCHOL, V131, P136, DOI 10.1016/j.actpsy.2009.03.008; Komori M, 2009, VISION RES, V49, P862, DOI 10.1016/j.visres.2009.03.005; Lassek WD, 2009, EVOL HUM BEHAV, V30, P322, DOI 10.1016/j.evolhumbehav.2009.04.002; Lie HC, 2008, EVOLUTION, V62, P2473, DOI 10.1111/j.1558-5646.2008.00478.x; Martinkauppi B, 2002, FACE COLOR VARYING I; Matts PJ, 2007, J AM ACAD DERMATOL, V57, P977, DOI 10.1016/j.jaad.2007.07.040; Messingham KAN, 2001, J ENDOCRINOL, V169, P299, DOI 10.1677/joe.0.1690299; Muehlenbein MP, 2005, AM J HUM BIOL, V17, P527, DOI 10.1002/ajhb.20419; Neave N, 2003, P ROY SOC B-BIOL SCI, V270, P2167, DOI 10.1098/rspb.2003.2502; O'Higgins P, 1998, J ANAT, V193, P251, DOI 10.1046/j.1469-7580.1998.19320251.x; Pawlowski B, 2002, EVOL HUM BEHAV, V23, P139, DOI 10.1016/S1090-5138(01)00092-7; Penton-Voak IS, 2001, P ROY SOC B-BIOL SCI, V268, P1617, DOI 10.1098/rspb.2001.1703; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Peters M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004138; Pound N, 2009, P ROY SOC B-BIOL SCI, V276, P153, DOI 10.1098/rspb.2008.0990; Rennels JL, 2008, J EXP PSYCHOL HUMAN, V34, P884, DOI 10.1037/0096-1523.34.4.884; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; Rhodes G, 2000, BRIT J PSYCHOL, V91, P125, DOI 10.1348/000712600161718; Rhodes G, 2007, PERCEPTION, V36, P1244, DOI 10.1068/p5712; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Russell R, 2006, PERCEPTION, V35, P749, DOI 10.1068/p5490; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; Scott I, 2008, EVOL HUM BEHAV, V29, P289, DOI 10.1016/j.evolhumbehav.2008.02.004; Shackelford TK, 1999, EVOL HUM BEHAV, V20, P71, DOI 10.1016/S1090-5138(98)00036-1; Stephan C. N., 2005, COMPUTER GRAPHIC FAC; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Stephen ID, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005083; Swaddle JP, 2002, P ROY SOC B-BIOL SCI, V269, P2285, DOI 10.1098/rspb.2002.2165; Tarr M. J., 2010, J VISION, V1, P337, DOI [10.1167/1.3.337, DOI 10.1167/1.3.337]; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; van Anders SM, 2010, AM J HUM BIOL, V22, P348, DOI 10.1002/ajhb.20997; Weeden J, 2005, PSYCHOL BULL, V131, P635, DOI 10.1037/0033-2909.131.5.635; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zebrowitz LA, 2004, J NONVERBAL BEHAV, V28, P167, DOI 10.1023/B:JONB.0000039648.30935.1b; ZHANG D, 2010, BENCHMARK GEOMETRIC, P21	65	104	104	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13585	10.1371/journal.pone.0013585	http://dx.doi.org/10.1371/journal.pone.0013585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	671UN	21048972	Green Published, gold			2022-12-25	WOS:000283537000012
J	Villar-Pique, A; Sabate, R; Lopera, O; Gibert, J; Torne, JM; Santos, M; Ventura, S				Villar-Pique, Anna; Sabate, Raimon; Lopera, Oriol; Gibert, Jordi; Maria Torne, Josep; Santos, Mireya; Ventura, Salvador			Amyloid-Like Protein Inclusions in Tobacco Transgenic Plants	PLOS ONE			English	Article							AGGREGATION; BODIES; TRANSGLUTAMINASE; DISEASES; PEPTIDE; RICE; TOXICITY; FIBRILS; MODEL	The formation of insoluble protein deposits in human tissues is linked to the onset of more than 40 different disorders, ranging from dementia to diabetes. In these diseases, the proteins usually self-assemble into ordered beta-sheet enriched aggregates known as amyloid fibrils. Here we study the structure of the inclusions formed by maize transglutaminase (TGZ) in the chloroplasts of tobacco transplastomic plants and demonstrate that they have an amyloid-like nature. Together with the evidence of amyloid structures in bacteria and fungi our data argue that amyloid formation is likely a ubiquitous process occurring across the different kingdoms of life. The discovery of amyloid conformations inside inclusions of genetically modified plants might have implications regarding their use for human applications.	[Villar-Pique, Anna; Sabate, Raimon; Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra, Spain; [Villar-Pique, Anna; Sabate, Raimon; Ventura, Salvador] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Spain; [Lopera, Oriol; Gibert, Jordi; Maria Torne, Josep; Santos, Mireya] UAB, IRTA, CSIC, Mol Genet Lab,CRAG, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona	Villar-Pique, A (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra, Spain.	salvador.ventura@uab.es	Ventura, Salvador/C-7021-2008; Ventura, Salvador/AAY-3170-2021; sabate, raimon/I-7849-2014	Ventura, Salvador/0000-0002-9652-6351; Ventura, Salvador/0000-0002-9652-6351; sabate, raimon/0000-0003-3894-2362	Ministerio de Ciencia e Innovacion (Spain) [BIO2007-68046, BFU2006-15115-CO2-01/BMC, BFU2009-08575]; AGAUR(Agencia de Gestio d'Ajuts Universitaris i de Recerca-Generalitat de Catalunya) [2009-SGR 760]; Universidad Autonoma de Barcelona (UAB); UAB-Generalitat de Catalunya [I3]; Generalitat de Catalunya; ICREA-Institucio Catalana de Recerca i Estudis Avancats	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); AGAUR(Agencia de Gestio d'Ajuts Universitaris i de Recerca-Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Universidad Autonoma de Barcelona (UAB); UAB-Generalitat de Catalunya; Generalitat de Catalunya(Generalitat de Catalunya); ICREA-Institucio Catalana de Recerca i Estudis Avancats(ICREA)	This work was supported by grants BIO2007-68046, BFU2006-15115-CO2-01/BMC and BFU2009-08575 from Ministerio de Ciencia e Innovacion (Spain), by grant 2009-SGR 760 from AGAUR(Agencia de Gestio d'Ajuts Universitaris i de Recerca-Generalitat de Catalunya). AV was beneficiary of a PIF fellowship from Universidad Autonoma de Barcelona (UAB). RS was beneficiary of an I3 contract (UAB-Generalitat de Catalunya). JG was beneficiary of a FPI fellowship awarded by Generalitat de Catalunya. SV has been granted with an ICREA ACADEMIA award (ICREA-Institucio Catalana de Recerca i Estudis Avancats). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Boehm R, 2007, ANN NY ACAD SCI, V1102, P121, DOI 10.1196/annals.1408.009; Bravo R, 2008, J BIOL CHEM, V283, P32471, DOI 10.1074/jbc.M709870200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Carvajal-Vallejos PK, 2007, BIOTECHNOL LETT, V29, P1255, DOI 10.1007/s10529-007-9377-7; Castelli S, 2005, J EXP BOT, V56, P1379, DOI 10.1093/jxb/eri139; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; de Groot NS, 2009, TRENDS BIOCHEM SCI, V34, P408, DOI 10.1016/j.tibs.2009.03.009; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fernandez-Busquets X, 2008, CURR MED CHEM, V15, P1336, DOI 10.2174/092986708784534938; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Gonzalez-Montalban N, 2007, BIOCHEM BIOPH RES CO, V355, P637, DOI 10.1016/j.bbrc.2007.01.192; Ioannidis NE, 2009, BBA-BIOENERGETICS, V1787, P1215, DOI 10.1016/j.bbabio.2009.05.014; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Kisilevsky R, 2000, NAT MED, V6, P633, DOI 10.1038/76203; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lorand L, 1996, P NATL ACAD SCI USA, V93, P14310, DOI 10.1073/pnas.93.25.14310; Meredith SC, 2005, ANN NY ACAD SCI, V1066, P181, DOI 10.1196/annals.1363.030; Millan AFS, 2008, PLANT BIOTECHNOL J, V6, P427, DOI 10.1111/j.1467-7652.2008.00338.x; Morell M, 2008, BBA-MOL CELL RES, V1783, P1815, DOI 10.1016/j.bbamcr.2008.06.007; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Oh J, 2007, J BIOL CHEM, V282, P13601, DOI 10.1074/jbc.M602576200; Oono Y, 2010, PLANT BIOTECHNOL J, V8, P691, DOI 10.1111/j.1467-7652.2010.00502.x; ORTIGOSA S, 2010, PLANTA IN PRESS; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; QUERFURTH HW, NEW ENGLAND J MED, V362, P329; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Sabate R, 2010, CELL MOL LIFE SCI, V67, P2695, DOI 10.1007/s00018-010-0344-4; Saito Y, 2009, J EXP BOT, V60, P615, DOI 10.1093/jxb/ern311; Takaiwa F, 2009, PLANTA, V229, P1147, DOI 10.1007/s00425-009-0905-7; Vendruscolo M, 2008, MOL BIOSYST, V4, P1170, DOI 10.1039/b805710a; Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101; Villalobos E, 2004, GENE, V336, P93, DOI 10.1016/j.gene.2004.03.025; Wang L, 2009, PRION, V3, P139, DOI 10.4161/pri.3.3.9922; Wang L, 2008, PLOS BIOL, V6, P1791, DOI 10.1371/journal.pbio.0060195; Westermark P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006041; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888	40	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13625	10.1371/journal.pone.0013625	http://dx.doi.org/10.1371/journal.pone.0013625			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049018	Green Submitted, Green Published, gold			2022-12-25	WOS:000283487400017
J	Cheng, WX; Li, JS; Huang, CP; Yao, DP; Liu, N; Cui, SX; Jin, Y; Duan, ZJ				Cheng, Wei-xia; Li, Jin-song; Huang, Can-ping; Yao, Dong-ping; Liu, Na; Cui, Shu-xian; Jin, Yu; Duan, Zhao-jun			Identification and Nearly Full-Length Genome Characterization of Novel Porcine Bocaviruses	PLOS ONE			English	Article							HUMAN PARVOVIRUS; BOVINE PARVOVIRUS; CAPSID PROTEIN; MINUTE VIRUS; INFECTIVITY; SAMPLES; VP1; B19; RECOMBINATION; DISEASE	The genus bocavirus includes bovine parvovirus (BPV), minute virus of canines (MVC), and a group of human bocaviruses (HBoV1-4). Using sequence-independent single primer amplification (SISPA), a novel bocavirus group was discovered with high prevalence (12.59%) in piglet stool samples. Two nearly full-length genome sequences were obtained, which were approximately 5,100 nucleotides in length. Multiple alignments revealed that they share 28.7-56.8% DNA sequence identity with other members of Parvovirinae. Phylogenetic analyses indicated their closest neighbors were members of the genus bocavirus. The new viruses had a putative non-structural NP1 protein, which was unique to bocaviruses. They were provisionally named porcine bocavirus 1 and 2 (PBoV1, PBoV2). PBoV1 and PBoV2 shared 94.2% nucleotide identity in NS1 gene sequence, suggesting that they represented two different bocavirus species. Two additional samples (6V, 7V) were amplified for 2,407 bp and 2,434 bp products, respectively, including a partial NP1 gene and the complete VP1 gene; Phylogenetic analysis indicated that 6Vand 7V grouped with PBoV1 and PBoV2 in the genus of bocavirus, but were in the separate clusters. Like other parvoviruses, PBoV1, PBoV2, 6Vand 7V also contained a putative secretory phospholipase A(2) (sPLA(2)) motif in the VP1 unique region, with a conserved HDXXY motif in the catalytic center. The conserved motif YXGXF of the Ca2+-binding loop of sPLA2 identified in human bocavirus was also found in porcine bocavirus, which differs from the YXGXG motif carried by most other parvoviruses. The observation of PBoV and potentially other new bocavirus genus members may aid in molecular and functional characterization of the genus bocavirus.	[Cheng, Wei-xia; Li, Jin-song; Huang, Can-ping; Yao, Dong-ping; Liu, Na; Cui, Shu-xian; Duan, Zhao-jun] China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China; [Cheng, Wei-xia; Jin, Yu] Lanzhou Univ, Sch Basic Med Sci, Lanzhou 730000, Peoples R China; [Jin, Yu] Nanjing Univ, Sch Med, Nanjing 210008, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Lanzhou University; Nanjing University	Cheng, WX (corresponding author), China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China.	jinyuldyy@163.com; zhaojund@126.com			China Mega-Project for Infectious Disease [2009ZX10004-001]; "973" National Key Basic Research Program of China [2007CB310500]	China Mega-Project for Infectious Disease; "973" National Key Basic Research Program of China(National Basic Research Program of China)	This work was partly supported by China Mega-Project for Infectious Disease (2009ZX10004-001) and "973" National Key Basic Research Program of China (Grant No. 2007CB310500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABINANTI FR, 1961, VIROLOGY, V14, P288, DOI 10.1016/0042-6822(61)90206-9; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Bekhit MT, 2009, FETAL DIAGN THER, V25, P153, DOI 10.1159/000209200; Biagini P, 2007, J GEN VIROL, V88, P2696, DOI 10.1099/vir.0.83071-0; BINN L N, 1970, Infection and Immunity, V1, P503; Blomstrom AL, 2009, VIRUS RES, V146, P125, DOI 10.1016/j.virusres.2009.09.006; Blomstrom AL, 2010, VIRUS RES, V152, P59, DOI 10.1016/j.virusres.2010.06.004; Cheng WX, 2008, CLIN INFECT DIS, V47, P161, DOI 10.1086/589244; Fauquet CM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-64; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Finkbeiner SR, 2009, J VIROL, V83, P10836, DOI 10.1128/JVI.00998-09; Girod A, 2002, J GEN VIROL, V83, P973, DOI 10.1099/0022-1317-83-5-973; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; KARALAR L, 2009, CLIN MICROBIOL INFEC; Kirkland PD, 2007, VIRUS RES, V129, P26, DOI 10.1016/j.virusres.2007.05.002; Lau SKP, 2008, J GEN VIROL, V89, P1840, DOI 10.1099/vir.0.2008/000380-0; Li LL, 2009, J VIROL, V83, P12002, DOI 10.1128/JVI.01241-09; Lindner J, 2008, INTERVIROLOGY, V51, P116, DOI 10.1159/000137411; Lopez-Bueno A, 2006, CURR TOP MICROBIOL, V299, P349; Lukashov VV, 2001, J VIROL, V75, P2729, DOI 10.1128/JVI.75.6.2729-2740.2001; Lupescu A, 2006, J VIROL, V80, P11370, DOI 10.1128/JVI.01041-06; Manteufel J, 2008, INTERVIROLOGY, V51, P328, DOI 10.1159/000173734; Qu XW, 2008, BIOCHEM BIOPH RES CO, V365, P158, DOI 10.1016/j.bbrc.2007.10.164; REYES GR, 1991, MOL CELL PROBE, V5, P473, DOI 10.1016/S0890-8508(05)80020-9; Ros C, 2006, J VIROL, V80, P12017, DOI 10.1128/JVI.01435-06; Schroder C, 2006, TRANSPLANTATION, V81, P1165, DOI 10.1097/01.tp.0000203170.77195.e4; Schwartz D, 2002, VIROLOGY, V302, P219, DOI 10.1006/viro.2002.1674; Shackelton LA, 2007, J GEN VIROL, V88, P3294, DOI 10.1099/vir.0.83255-0; Simon MA, 2008, COMPARATIVE MED, V58, P47; Simpson AA, 1998, STRUCT FOLD DES, V6, P1355, DOI 10.1016/S0969-2126(98)00136-1; Suikkanen S, 2003, VIROLOGY, V316, P267, DOI 10.1016/j.virol.2003.08.031; Sun YN, 2009, J VIROL, V83, P3956, DOI 10.1128/JVI.02569-08; Suzuki M, 2009, J VIROL, V83, P10975, DOI 10.1128/JVI.00273-09; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Tolfvenstam T, 2009, SEMIN FETAL NEONAT M, V14, P218, DOI 10.1016/j.siny.2009.01.007; Tozer SJ, 2009, J MED VIROL, V81, P488, DOI 10.1002/jmv.21409; Zadori Z, 2001, DEV CELL, V1, P291, DOI 10.1016/S1534-5807(01)00031-4; Zhai SL, 2010, ARCH VIROL, V155, P1313, DOI 10.1007/s00705-010-0698-9	41	94	113	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13583	10.1371/journal.pone.0013583	http://dx.doi.org/10.1371/journal.pone.0013583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049037	gold, Green Submitted, Green Published			2022-12-25	WOS:000283422100007
J	Chen, R; Davydov, EV; Sirota, M; Butte, AJ				Chen, Rong; Davydov, Eugene V.; Sirota, Marina; Butte, Atul J.			Non-Synonymous and Synonymous Coding SNPs Show Similar Likelihood and Effect Size of Human Disease Association	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; DATABASE; SUSCEPTIBILITY; POLYMORPHISM; TNFSF15; SYSTEM	Many DNA variants have been identified on more than 300 diseases and traits using Genome-Wide Association Studies (GWASs). Some have been validated using deep sequencing, but many fewer have been validated functionally, primarily focused on non-synonymous coding SNPs (nsSNPs). It is an open question whether synonymous coding SNPs (sSNPs) and other non-coding SNPs can lead to as high odds ratios as nsSNPs. We conducted a broad survey across 21,429 disease-SNP associations curated from 2,113 publications studying human genetic association, and found that nsSNPs and sSNPs shared similar likelihood and effect size for disease association. The enrichment of disease-associated SNPs around the 80(th) base in the first introns might provide an effective way to prioritize intronic SNPs for functional studies. We further found that the likelihood of disease association was positively associated with the effect size across different types of SNPs, and SNPs in the 3'untranslated regions, such as the microRNA binding sites, might be under-investigated. Our results suggest that sSNPs are just as likely to be involved in disease mechanisms, so we recommend that sSNPs discovered from GWAS should also be examined with functional studies.	[Chen, Rong; Sirota, Marina; Butte, Atul J.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Chen, Rong; Sirota, Marina; Butte, Atul J.] Lucile Packard Childrens Hosp, Palo Alto, CA USA; [Davydov, Eugene V.] Stanford Univ, Sch Med, Dept Comp Sci, Stanford, CA 94305 USA	Stanford University; Lucile Packard Children's Hospital (LPCH); Stanford University	Chen, R (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.	rchen1@stanford.edu		Sirota, Marina/0000-0002-7246-6083	Lucile Packard Foundation for Children's Health; National Institute of General Medical Sciences [R01 GM079719]; National Library of Medicine [R01 LM009719]; National Cancer Institute [R01 CA138256]; Howard Hughes Medical Institute; Pharmaceutical Research and Manufacturers of America Foundation; Hewlett Packard Foundation; NATIONAL CANCER INSTITUTE [R01CA138256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079719] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009719] Funding Source: NIH RePORTER	Lucile Packard Foundation for Children's Health; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Pharmaceutical Research and Manufacturers of America Foundation; Hewlett Packard Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by Lucile Packard Foundation for Children's Health, National Institute of General Medical Sciences (R01 GM079719), National Library of Medicine (R01 LM009719), National Cancer Institute (R01 CA138256), Howard Hughes Medical Institute, Pharmaceutical Research and Manufacturers of America Foundation, and Hewlett Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; [Anonymous], 2007, NATURE, V447, P661; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hunt R, 2009, METHODS MOL BIOL, V578, P23, DOI 10.1007/978-1-60327-411-1_2; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Li JJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000910; Nakagome S, 2010, ANN HUM GENET, V74, P126, DOI 10.1111/j.1469-1809.2010.00567.x; Nelson SJ, 2004, ST HEAL T, V107, P67; OROZCO G, 2010, HUM MOL GENET; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SIONTIS KC, 2010, EUR J HUM GENET; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yang SK, 2008, AM J GASTROENTEROL, V103, P1437, DOI 10.1111/j.1572-0241.2007.01752.x	24	127	137	8	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13574	10.1371/journal.pone.0013574	http://dx.doi.org/10.1371/journal.pone.0013574			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042586	gold, Green Submitted, Green Published			2022-12-25	WOS:000283419100014
J	Metzele, R; Alt, C; Bai, XW; Yan, YS; Zhang, Z; Pan, ZZ; Coleman, M; Vykoukal, J; Song, YH; Alt, E				Metzele, Roxana; Alt, Christopher; Bai, Xiaowen; Yan, Yasheng; Zhang, Zhi; Pan, Zhizhong; Coleman, Michael; Vykoukal, Jody; Song, Yao-Hua; Alt, Eckhard			Human adipose tissue-derived stem cells exhibit proliferation potential and spontaneous rhythmic contraction after fusion with neonatal rat cardiomyocytes	FASEB JOURNAL			English	Article						differentiation; action potential	MYOCARDIAL-INFARCTION; PROGENITOR CELLS; CARDIAC-FUNCTION; SKELETAL-MUSCLE; DIFFERENTIATION; TRANSPLANTATION; VIRUS	Various types of stem cells have been shown to have beneficial effects on cardiac function. It is still debated whether fusion of injected stem cells with local resident cardiomyocytes is one of the mechanisms. To better understand the role of fusion in stem cell-based myocardial regeneration, the present study was designed to investigate the fate of human adipose tissue-derived stem cells (hASCs) fused with neonatal rat cardiomyocytes in vitro. hASCs labeled with the green fluorescent probe Vybrant DiO were cocultured with neonatal rat cardiomyocytes labeled with the red fluorescent probe Vybrant DiI and then treated with fusion-inducing hemagglutinating virus of Japan (HVJ). Cells that incorporated both red and green fluorescent signals were considered to be hASCs that had fused with rat cardiomyocytes. Fusion efficiency was 19.86 +/- 4.84% at 5 d after treatment with HVJ. Most fused cells displayed cardiomyocyte-like morphology and exhibited spontaneous rhythmic contraction. Both immunofluorescence staining and lentiviral vector labeling showed that fused cells contained separate rat cardiomyocyte and hASC nuclei. Immunofluorescence staining assays demonstrated that human nuclei in fused cells still expressed the proliferation marker Ki67. In addition, hASCs fused with rat cardiomyocytes were positive for troponin I. Whole-cell voltage-clamp analysis demonstrated action potentials in beating fused cells. RT-PCR analysis using rat-or human-specific myosin heavy chain primers revealed that the myosin heavy-chain expression in fused cells was derived from rat cardiomyocytes. Real-time PCR identified expression of human troponin T in fused cells and the presence of rat cardiomyocytes induced a cardiomyogenic protein expression of troponin T in human ASCs. This study illustrates that hASCs exhibit both stem cell (proliferation) and cardiomyocyte properties (action potential and spontaneous rhythmic beating) after fusion with rat cardiomyocytes, supporting the theory that fusion, even if artificially induced in our study, could indeed be a mechanism for cardiomyocyte renewal in the heart.-Metzele, R., Alt, C., Bai, X., Yan, Y., Zhang, Z., Pan, Z., Coleman, M., Vykoukal, J., Song, Y.-H., Alt, E. Human adipose tissue-derived stem cells exhibit proliferation potential and spontaneous rhythmic con-traction after fusion with neonatal rat cardiomyocytes. FASEB J. 25, 830-839 (2011). www.fasebj.org	[Alt, Eckhard] Univ Texas MD Anderson Canc Ctr, Interdisciplinary Stem Cell Lab, Unit 951, Dept Mol Pathol, Houston, TX 77030 USA; [Zhang, Zhi; Pan, Zhizhong] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol, Houston, TX 77030 USA; [Coleman, Michael] InGeneron Inc, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Alt, E (corresponding author), Univ Texas MD Anderson Canc Ctr, Interdisciplinary Stem Cell Lab, Unit 951, Dept Mol Pathol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	ealtmd@aol.com			Alliance of Cardiovascular Researchers [543102]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023069, R01DA027541] Funding Source: NIH RePORTER	Alliance of Cardiovascular Researchers; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Sebastian Gehmert, Sanga Gehmert, Grace Wu, Martha French, and Cynthia Austin for their excellent technical assistance. This work was supported by the Alliance of Cardiovascular Researchers, grant 543102 (to E.A.).	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Bai XW, 2007, AM J PHYSIOL-CELL PH, V293, pC1539, DOI 10.1152/ajpcell.00089.2007; Cai LY, 2009, STEM CELLS, V27, P230, DOI 10.1634/stemcells.2008-0273; Dawn B, 2008, STEM CELLS, V26, P1646, DOI 10.1634/stemcells.2007-0715; Deb A, 2003, CIRCULATION, V107, P1247, DOI 10.1161/01.CIR.0000061910.39145.F0; Farahmand P, 2008, CIRCULATION, V118, pS130, DOI 10.1161/CIRCULATIONAHA.107.757617; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Ishikawa F, 2006, FASEB J, V20, P950, DOI 10.1096/fj.05-4863fje; KIM J, 1987, J MEMBRANE BIOL, V97, P241, DOI 10.1007/BF01869226; Lapidos KA, 2004, J CLIN INVEST, V114, P1577, DOI 10.1172/JCI200423071; Mochizuki H, 1998, J VIROL, V72, P8873, DOI 10.1128/JVI.72.11.8873-8883.1998; Noiseux N, 2006, MOL THER, V14, P840, DOI 10.1016/j.ymthe.2006.05.016; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Oedayrajsingh-Varma MJ, 2006, CYTOTHERAPY, V8, P166, DOI 10.1080/14653240600621125; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Planat-Benard V, 2004, CIRC RES, V94, P223, DOI 10.1161/01.RES.0000109792.43271.47; Reinecke H, 2004, CIRC RES, V94, pE56, DOI 10.1161/01.RES.0000125294.04612.81; Rota M, 2007, P NATL ACAD SCI USA, V104, P17783, DOI 10.1073/pnas.0706406104; Stamm C, 2004, THORAC CARDIOV SURG, V52, P152, DOI 10.1055/s-2004-817981; Valina C, 2007, EUR HEART J, V28, P2667, DOI 10.1093/eurheartj/ehm426; Zhang S, 2007, CIRC RES, V100, P693, DOI 10.1161/01.RES.0000260803.98329.1c	22	32	34	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					830	839		10.1096/fj.09-153221	http://dx.doi.org/10.1096/fj.09-153221			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21059751	Green Published			2022-12-25	WOS:000287806200004
J	Adak, S; DeAndrade, D; Pike, LJ				Adak, Sangeeta; DeAndrade, Diana; Pike, Linda J.			The Tethering Arm of the EGF Receptor Is Required for Negative Cooperativity and Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; LIGAND-BINDING; EXTRACELLULAR DOMAINS; CRYSTAL-STRUCTURE; LIPID RAFTS; PHORBOL ESTERS; ACTIVATION; AFFINITY; ECTODOMAIN; SURFACE	The EGF receptor is a classical receptor-tyrosine kinase. In the absence of ligand, the receptor adopts a closed conformation in which the dimerization arm of subdomain II interacts with the tethering arm in subdomain IV. Following the binding of EGF, the receptor opens to form a symmetric, back-to-back dimer. Although it is clear that the dimerization arm of subdomain II is central to the formation of receptor dimers, the role of the tethering arm of subdomain IV (residues 561-585) in this configuration is not known. Here we use I-125-EGF binding studies to assess the functional role of the tethering arm in the EGF receptor dimer. Mutation of the three major residues that contribute to tethering (D563A, H566A, K585A-EGF receptor) did not significantly alter either the ligand binding properties or the signaling properties of the EGF receptor. By contrast, breaking the Cys(558)-Cys(567) disulfide bond through double alanine replacements or deleting the loop entirely led to a decrease in the negative cooperativity in EGF binding and was associated with small changes in downstream signaling. Deletion of the Cys(571)-Cys(593) disulfide bond abrogated cooperativity, resulting in a high affinity receptor and increased sensitivity of downstream signaling pathways to EGF. Releasing the Cys(571)-Cys(593) disulfide bond resulted in extreme negative cooperativity, ligand-independent kinase activity, and impaired downstream signaling. These data demonstrate that the tethering arm plays an important role in supporting cooperativity in ligand binding. Because cooperativity implies subunit-subunit interactions, these results also suggest that the tethering arm contributes to intersubunit interactions within the EGF receptor dimer.	[Adak, Sangeeta; DeAndrade, Diana; Pike, Linda J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Pike, LJ (corresponding author), 660 S Euclid Ave,Box 8231, St Louis, MO 63110 USA.	pike@biochem.wustl.edu		ADAK, SANGEETA/0000-0003-3855-9099	National Institutes of Health [R01 GM064491]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM064491 (to L.J.P.).	Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; Alvarado D, 2009, NATURE, V461, P287, DOI 10.1038/nature08297; BAJAJ M, 1987, BIOCHIM BIOPHYS ACTA, V916, P220, DOI 10.1016/0167-4838(87)90112-9; BREMER EG, 1986, J BIOL CHEM, V261, P2434; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; DORAN DM, 1980, J IMMUNOL METHODS, V39, P155, DOI 10.1016/0022-1759(80)90304-X; Elleman TC, 2001, BIOCHEMISTRY-US, V40, P8930, DOI 10.1021/bi010037b; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kastner J, 2009, J STRUCT BIOL, V167, P117, DOI 10.1016/j.jsb.2009.04.007; KING AC, 1982, J BIOL CHEM, V257, P3053; LAX I, 1988, MOL CELL BIOL, V8, P1831, DOI 10.1128/MCB.8.4.1831; Liu YH, 2008, GLYCOBIOLOGY, V18, P593, DOI 10.1093/glycob/cwn039; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Macdonald-Obermann JL, 2009, J BIOL CHEM, V284, P13570, DOI 10.1074/jbc.M109.001487; MAGUN BE, 1980, J BIOL CHEM, V255, P6373; Mattoon D, 2004, P NATL ACAD SCI USA, V101, P923, DOI 10.1073/pnas.0307286101; Mi LZ, 2008, BIOCHEMISTRY-US, V47, P10314, DOI 10.1021/bi801006s; Miljan EA, 2002, J BIOL CHEM, V277, P10108, DOI 10.1074/jbc.M111669200; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; REES AR, 1984, EMBO J, V3, P1843, DOI 10.1002/j.1460-2075.1984.tb02057.x; Ringerike T, 2002, J CELL SCI, V115, P1331; Roepstorff K, 2002, J BIOL CHEM, V277, P18954, DOI 10.1074/jbc.M201422200; Saxon ML, 1999, J BIOL CHEM, V274, P28356, DOI 10.1074/jbc.274.40.28356; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; SHOYAB M, 1979, NATURE, V279, P387, DOI 10.1038/279387a0; SOROKIN A, 1995, ONCOGENE, V11, P1531; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Walker F, 2004, J BIOL CHEM, V279, P22387, DOI 10.1074/jbc.M401244200; Wang XQ, 2001, J INVEST DERMATOL, V116, P69, DOI 10.1046/j.1523-1747.2001.00222.x; Wyman J., 1990, BINDING LINKAGE FUNC, P203; Yamabhai M, 2002, J BIOL CHEM, V277, P24843, DOI 10.1074/jbc.C200277200; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411	51	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1545	1555		10.1074/jbc.M110.182899	http://dx.doi.org/10.1074/jbc.M110.182899			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21047778	Green Published, hybrid			2022-12-25	WOS:000286005000067
J	Fernandez, MM; Cho, S; De Marzi, MC; Kerzic, MC; Robinson, H; Mariuzza, RA; Malchiodi, EL				Fernandez, Marisa M.; Cho, Sangwoo; De Marzi, Mauricio C.; Kerzic, Melissa C.; Robinson, Howard; Mariuzza, Roy A.; Malchiodi, Emilio L.			Crystal Structure of Staphylococcal Enterotoxin G (SEG) in Complex with a Mouse T-cell Receptor beta Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIC-SHOCK-SYNDROME; AFFINITY MATURATION; BACTERIAL SUPERANTIGENS; 3-DIMENSIONAL STRUCTURE; BINDING; ZINC; ARCHITECTURE; RECOGNITION; INVOLVEMENT; ACTIVATION	Superantigens (SAgs) are bacterial or viral toxins that bind MHC class II (MHC-II) molecules and T-cell receptor (TCR) in a nonconventional manner, inducing T-cell activation that leads to inflammatory cytokine production, which may result in acute toxic shock. In addition, the emerging threat of purpura fulminans and community-associated meticillin-resistant Staphylococcus aureus emphasizes the importance of a better characterization of SAg binding to their natural ligands that may allow the development of reagents to neutralize their action. The three-dimensional structure of the complex between a mouse TCR beta chain (mV beta 8.2) and staphylococcal enterotoxin G (SEG) at 2.0 angstrom resolution revealed a binding site that does not conserve the "hot spots" present in mV beta 8.2-SEC2, mV beta 8.2-SEC3, mV beta 8.2-SEB, and mV beta 8.2-SPEA complexes. Analysis of the mV beta 8.2-SEG interface allowed us to explain the higher affinity of this complex compared with the others, which may account for the early activation of T-cells bearing mV beta 8.2 by SEG. This mode of interaction between SEG and mV beta 8.2 could be an adaptive advantage to bestow on the pathogen a faster rate of colonization of the host.	[Malchiodi, Emilio L.] Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Catedra Inmunol, RA-1113 Buenos Aires, DF, Argentina; [Malchiodi, Emilio L.] Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Inst Estudios Inmunidad Humoral Prof Ricardo Marg, RA-1113 Buenos Aires, DF, Argentina; [Fernandez, Marisa M.; Cho, Sangwoo; Kerzic, Melissa C.; Mariuzza, Roy A.; Malchiodi, Emilio L.] Univ Maryland, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; [Fernandez, Marisa M.; Cho, Sangwoo; Kerzic, Melissa C.; Mariuzza, Roy A.; Malchiodi, Emilio L.] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [De Marzi, Mauricio C.] Univ Nacl Lujan, Dept Ciencias Basicas, RA-6700 Buenos Aires, DF, Argentina; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidad Nacional de Lujan; United States Department of Energy (DOE); Brookhaven National Laboratory	Mariuzza, RA (corresponding author), 9600 Gudelsky Dr, Rockville, MD 20850 USA.	mariuzza@carb.nist.gov; emalchio@ffyb.uba.ar		Malchiodi, Emilio/0000-0001-7501-3330; Fernandez, Marisa/0000-0002-7480-5907	National Institutes of Health [AI36900, AI073654]; Agencia Nacional de Promocion Cientifica y Tecnica [PICT 38293, 450]; National Multiple Sclerosis Society [RG2747]; Offices of Biological and Environmental Research; Basic Energy Sciences of the U.S. Department of Energy; National Center for Research Resources of the National Institutes of Health; Fogarty International Center [TW007972]; International Centre for Genetic Engineering and Biotechnology [CRP/ARG09-02]; FOGARTY INTERNATIONAL CENTER [R03TW007972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073654, R01AI036900, R37AI036900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Offices of Biological and Environmental Research; Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); International Centre for Genetic Engineering and Biotechnology; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI36900 and AI073654. This work was also supported by Agencia Nacional de Promocion Cientifica y Tecnica Grant PICT 38293 (to E. L. M.) and 450 (to M. M. F.); and National Multiple Sclerosis Society Grant RG2747 (to R. A. M.). Financial support for use of the National Synchrotron Light Source comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the U.S. Department of Energy and from the National Center for Research Resources of the National Institutes of Health.; Supported by the Fogarty International Center (TW007972) and International Centre for Genetic Engineering and Biotechnology (CRP/ARG09-02).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banks MC, 2003, J INFECT DIS, V187, P77, DOI 10.1086/345874; Becker K, 2003, J CLIN MICROBIOL, V41, P1434, DOI 10.1128/JCM.41.4.1434-1439.2003; Brocke S, 1998, SEMIN IMMUNOL, V10, P57, DOI 10.1006/smim.1997.0105; Brouillard JNP, 2007, J MOL BIOL, V367, P925, DOI 10.1016/j.jmb.2007.01.024; Cho SW, 2005, STRUCTURE, V13, P1775, DOI 10.1016/j.str.2005.08.015; De Marzi MC, 2004, EUR J BIOCHEM, V271, P4075, DOI 10.1111/j.1432-1033.2004.04345.x; Fernandez MM, 2007, PROTEINS, V68, P389, DOI 10.1002/prot.21388; Fernandez MM, 2006, J BIOL CHEM, V281, P25356, DOI 10.1074/jbc.M603969200; Fernandez MM, 2006, MOL IMMUNOL, V43, P927, DOI 10.1016/j.molimm.2005.06.029; Fields BA, 1996, NATURE, V384, P188, DOI 10.1038/384188a0; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Jarraud S, 1999, J CLIN MICROBIOL, V37, P2446, DOI 10.1128/JCM.37.8.2446-2449.1999; Jarraud S, 2001, J IMMUNOL, V166, P669, DOI 10.4049/jimmunol.166.1.669; Lappin E, 2009, LANCET INFECT DIS, V9, P281, DOI 10.1016/S1473-3099(09)70066-0; Leder L, 1998, J EXP MED, V187, P823, DOI 10.1084/jem.187.6.823; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; Li YL, 2001, IMMUNITY, V14, P93, DOI 10.1016/S1074-7613(01)00092-9; MACDONALD HR, 1991, EUR J IMMUNOL, V21, P1963, DOI 10.1002/eji.1830210827; Madakamutil LT, 2003, J IMMUNOL, V170, P2985, DOI 10.4049/jimmunol.170.6.2985; MALCHIODI EL, 1995, J EXP MED, V182, P1833, DOI 10.1084/jem.182.6.1833; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Munson SH, 1998, INFECT IMMUN, V66, P3337, DOI 10.1128/IAI.66.7.3337-3348.1998; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papageorgiou AC, 1999, EMBO J, V18, P9, DOI 10.1093/emboj/18.1.9; PAPAGEORGIOU AC, 1995, STRUCTURE, V3, P769, DOI 10.1016/S0969-2126(01)00212-X; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Petersson K, 2001, EMBO J, V20, P3306, DOI 10.1093/emboj/20.13.3306; Renno T, 1999, J IMMUNOL, V162, P6312; Roussel A, 1997, NAT STRUCT BIOL, V4, P635, DOI 10.1038/nsb0897-635; SCHAD EM, 1995, EMBO J, V14, P3292, DOI 10.1002/j.1460-2075.1995.tb07336.x; Sundberg E, 1999, NAT STRUCT BIOL, V6, P123; Sundberg EJ, 2002, CURR OPIN IMMUNOL, V14, P36, DOI 10.1016/S0952-7915(01)00296-5; Sundberg EJ, 2002, STRUCTURE, V10, P687, DOI 10.1016/S0969-2126(02)00759-1; SWAMINATHAN S, 1992, NATURE, V359, P801, DOI 10.1038/359801a0; Yang JY, 2003, J BIOL CHEM, V278, P50412, DOI 10.1074/jbc.M306848200; Yarwood JM, 2000, FEMS MICROBIOL LETT, V192, P1, DOI 10.1016/S0378-1097(00)00400-6	41	11	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1189	1195		10.1074/jbc.M110.142471	http://dx.doi.org/10.1074/jbc.M110.142471			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059660	Green Published, hybrid			2022-12-25	WOS:000286005000030
J	Maity, B; Yang, JQ; Huang, J; Askeland, RW; Bera, S; Fisher, RA				Maity, Biswanath; Yang, Jianqi; Huang, Jie; Askeland, Ryan W.; Bera, Soumen; Fisher, Rory A.			Regulator of G Protein Signaling 6 (RGS6) Induces Apoptosis via a Mitochondrial-dependent Pathway Not Involving Its GTPase-activating Protein Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; CELL-CYCLE PROGRESSION; SACCHAROMYCES-CEREVISIAE; RETINOBLASTOMA PROTEIN; ADENYLYL-CYCLASE; PHOSPHOLIPASE-C; GGL DOMAIN; CANCER; PHOSPHORYLATION; SUBUNIT	Regulator of G protein signaling 6 (RGS6) is a member of a family of proteins called RGS proteins, which function as GTPase-activating proteins (GAPs) for G alpha subunits. Given the role of RGS6 as a G protein GAP, the link between G protein activation and cancer, and a reduction of cancer risk in humans expressing a RGS6 SNP leading to its increased translation, we hypothesized that RGS6 might function to inhibit growth of cancer cells. Here, we show a marked down-regulation of RGS6 in human mammary ductal epithelial cells that correlates with the progression of their transformation. RGS6 exhibited impressive anti-proliferative actions in breast cancer cells, including inhibition of cell growth and colony formation and induction of cell cycle arrest and apoptosis by mechanisms independent of p53. RGS6 activated the intrinsic pathway of apoptosis involving regulation of Bax/Bcl-2, mitochondrial outer membrane permeabilization (MOMP), cytochrome c release, activation of caspases-3 and -9, and poly(ADP-ribose) polymerase cleavage. RGS6 promoted loss of mitochondrial membrane potential (Delta Psi(m)) and increases in reactive oxygen species (ROS). RGS6-induced caspase activation and loss of Delta Psi(m) was mediated by ROS, suggesting an amplification loop in which ROS provided a feed forward signal to induce MOMP, caspase activation, and cell death. Loss of RGS6 in mouse embryonic fibroblasts dramatically impaired doxorubicin-induced growth suppression and apoptosis. Surprisingly, RGS6-induced apoptosis in both breast cancer cells and mouse embryonic fibroblasts does not require its GAP activity toward G proteins. This work demonstrates a novel signaling action of RGS6 in cell death pathways and identifies it as a possible therapeutic target for treatment of breast cancer.	[Maity, Biswanath; Yang, Jianqi; Huang, Jie; Fisher, Rory A.] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA; [Askeland, Ryan W.] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Bera, Soumen] Univ Iowa, Dept Radiat Oncol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Fisher, RA (corresponding author), Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA.	rory-fisher@uiowa.edu	Bera, Soumen/ABG-1233-2021	Fisher, Rory/0000-0003-3108-4836; Maity, Biswanath/0000-0002-3239-3764	National Institutes of Health [GM075033, GM075033-03S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM075033 and GM075033-03S1 (to R.A.F.).	Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Berman DM, 2004, CANCER RES, V64, P6820, DOI 10.1158/0008-5472.CAN-04-1916; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Cabrera JL, 1998, BIOCHEM BIOPH RES CO, V249, P898, DOI 10.1006/bbrc.1998.9218; Chatterjee TK, 2000, J BIOL CHEM, V275, P24013, DOI 10.1074/jbc.M002082200; Chatterjee TK, 2003, J BIOL CHEM, V278, P30272, DOI 10.1074/jbc.M212688200; Chatterjee TK, 2003, J BIOL CHEM, V278, P30261, DOI 10.1074/jbc.M212687200; Chatterjee TK, 1997, J BIOL CHEM, V272, P15481, DOI 10.1074/jbc.272.24.15481; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; DOHLMAN HG, 1995, MOL CELL BIOL, V15, P3635; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Dulin NO, 2000, J BIOL CHEM, V275, P21317, DOI 10.1074/jbc.M910079199; Esposti MD, 1999, J BIOL CHEM, V274, P29831, DOI 10.1074/jbc.274.42.29831; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Gabrielli BG, 1999, J BIOL CHEM, V274, P13961, DOI 10.1074/jbc.274.20.13961; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; James MA, 2009, CANCER RES, V69, P2108, DOI 10.1158/0008-5472.CAN-08-3495; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kato Jun-Ya, 1997, Leukemia (Basingstoke), V11, P347; Kelly BL, 1998, P NATL ACAD SCI USA, V95, P2535, DOI 10.1073/pnas.95.5.2535; Khleif SN, 1996, P NATL ACAD SCI USA, V93, P4350, DOI 10.1073/pnas.93.9.4350; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Liang GQ, 2009, J BIOL CHEM, V284, P21719, DOI 10.1074/jbc.M109.028407; Liu ZY, 2004, J BIOL CHEM, V279, P14120, DOI 10.1074/jbc.M309547200; Liu ZY, 2002, J BIOL CHEM, V277, P37832, DOI 10.1074/jbc.M205908200; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; McCoy KL, 2009, PROG MOL BIOL TRANSL, V86, P49, DOI 10.1016/S1877-1173(09)86003-1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nuydens R, 1999, J NEUROSCI METH, V92, P153, DOI 10.1016/S0165-0270(99)00107-7; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Posner BA, 1999, BIOCHEMISTRY-US, V38, P7773, DOI 10.1021/bi9906367; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Shishodia S, 2003, CANCER RES, V63, P4375; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391	41	41	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1409	1419		10.1074/jbc.M110.186700	http://dx.doi.org/10.1074/jbc.M110.186700			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21041304	hybrid, Green Published			2022-12-25	WOS:000286005000053
J	Xiong, Y; Song, D; Cai, YF; Yu, WF; Yeung, YG; Stanley, ER				Xiong, Ying; Song, Da; Cai, Yunfei; Yu, Wenfeng; Yeung, Yee-Guide; Stanley, E. Richard			A CSF-1 Receptor Phosphotyrosine 559 Signaling Pathway Regulates Receptor Ubiquitination and Tyrosine Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELL FACTOR; C-CBL; GROWTH-FACTOR; MONOCLONAL-ANTIBODIES; JUXTAMEMBRANE DOMAIN; ONCOGENE PRODUCT; STRUCTURAL BASIS; DOWN-REGULATION; PDGF RECEPTOR; BINDING-SITE	Receptor tyrosine kinase (RTK) activation involves ligand-induced receptor dimerization and transphosphorylation on tyrosine residues. Colony-stimulating factor-1 (CSF-1)-induced CSF-1 receptor (CSF-1R) tyrosine phosphorylation and ubiquitination were studied in mouse macrophages. Phosphorylation of CSF-1R Tyr-559, required for the binding of Src family kinases (SFKs), was both necessary and sufficient for these responses and for c-Cbl tyrosine phosphorylation and all three responses were inhibited by SFK inhibitors. In c-Cbl-deficient macrophages, CSF-1R ubiquitination and tyrosine phosphorylation were substantially inhibited. Reconstitution with wild-type, but not ubiquitin ligase-defective C381A c-Cbl rescued these responses, while expression of C381A c-Cbl in wild-type macrophages suppressed them. Analysis of site-directed mutations in the CSF-1R further suggests that activated c-Cbl-mediated CSF-1R ubiquitination is required for a conformational change in the major kinase domain that allows amplification of receptor tyrosine phosphorylation and full receptor activation. Thus the results indicate that CSF-1-mediated receptor dimerization leads to a Tyr-559/SFK/c-Cbl pathway resulting in receptor ubiquitination that permits full receptor tyrosine phosphorylation of this class III RTK in macrophages.	[Xiong, Ying; Song, Da; Cai, Yunfei; Yu, Wenfeng; Yeung, Yee-Guide; Stanley, E. Richard] Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Stanley, ER (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	richard.stanley@aecom.yu.edu	Stanley, Evan R/J-9154-2013	Stanley, Evan R/0000-0002-2910-2065	National Institutes of Health [CA26504, P01 CA 100324]; Albert Einstein College of Medicine Cancer Center [5P30-CA13330]; NATIONAL CANCER INSTITUTE [P30CA013330, R37CA026504, R01CA026504, P01CA100324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA26504, P01 CA 100324 (to E. R. S.), and the Albert Einstein College of Medicine Cancer Center Grant 5P30-CA13330.	ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; Baccarini M, 1991, Receptor, V1, P243; BLAKE TJ, 1991, ONCOGENE, V6, P653; BLECHMAN JM, 1993, J BIOL CHEM, V268, P4399; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bourette RP, 2000, GROWTH FACTORS, V17, P155, DOI 10.3109/08977190009001065; CARLBERG K, 1994, MOL BIOL CELL, V5, P81, DOI 10.1091/mbc.5.1.81; Chang PM, 2003, MOL CELL BIOL, V23, P3067, DOI 10.1128/MCB.23.9.3067-3078.2003; Chen XY, 2008, P NATL ACAD SCI USA, V105, P18267, DOI 10.1073/pnas.0807762105; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Feshchenko EA, 1998, J BIOL CHEM, V273, P8323, DOI 10.1074/jbc.273.14.8323; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Gu TL, 2007, BLOOD, V110, P323, DOI 10.1182/blood-2006-10-052282; Hamilton JA, 1997, J LEUKOCYTE BIOL, V62, P145, DOI 10.1002/jlb.62.2.145; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HAWLEY RG, 1994, GENE THER, V1, P136; Hong L, 2004, MOL CELL BIOL, V24, P1401, DOI 10.1128/MCB.24.3.1401-1410.2004; Hubbard SR, 2002, FRONT BIOSCI, V7, pD330, DOI 10.2741/hubbard; Hunter T, 1998, Harvey Lect, V94, P81; JAT PS, 1989, MOL CELL BIOL, V9, P1672, DOI 10.1128/MCB.9.4.1672; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Joos H, 1996, J BIOL CHEM, V271, P24476, DOI 10.1074/jbc.271.40.24476; Kiyoi H, 2002, LEUKEMIA LYMPHOMA, V43, P1541, DOI 10.1080/1042819021000002866; LANGDON WY, 1989, J VIROL, V63, P5420, DOI 10.1128/JVI.63.12.5420-5424.1989; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Lasota J, 2006, SEMIN DIAGN PATHOL, V23, P91, DOI 10.1053/j.semdp.2006.08.006; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LI W, 1991, MOL CELL BIOL, V11, P3756, DOI 10.1128/MCB.11.7.3756; LI W, 1991, EMBO J, V10, P277, DOI 10.1002/j.1460-2075.1991.tb07948.x; Lokker NA, 1997, J BIOL CHEM, V272, P33037, DOI 10.1074/jbc.272.52.33037; Masson K, 2006, BIOCHEM J, V399, P59, DOI 10.1042/BJ20060464; MEISNER H, 1995, MOL CELL BIOL, V15, P3571; Meng FY, 1998, EMBO J, V17, P4391, DOI 10.1093/emboj/17.15.4391; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Mol CD, 2003, J BACTERIOL, V185, P4152, DOI 10.1128/JB.185.14.4152-4162.2003; MORGAN C, 1987, J CELL PHYSIOL, V130, P420, DOI 10.1002/jcp.1041300316; MULLER AJ, 1991, MOL CELL BIOL, V11, P1785, DOI 10.1128/MCB.11.4.1785; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Pakuts B, 2007, J BIOL CHEM, V282, P17953, DOI 10.1074/jbc.M701182200; Persons DA, 1999, BLOOD, V93, P488, DOI 10.1182/blood.V93.2.488.402k17_488_499; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Rohde CM, 2004, J BIOL CHEM, V279, P43448, DOI 10.1074/jbc.M314170200; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; Stanley E. R., 1998, ANIMAL CELL CULTURE, P301; Stomski FC, 1996, MOL CELL BIOL, V16, P3035; Takeshita S, 2007, J BIOL CHEM, V282, P18980, DOI 10.1074/jbc.M610938200; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Walter M, 2007, J MOL BIOL, V367, P839, DOI 10.1016/j.jmb.2007.01.036; Wang Y, 1999, J CELL BIOCHEM, V72, P119; Wang Y, 1996, J BIOL CHEM, V271, P17, DOI 10.1074/jbc.271.1.17; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Wilhelmsen K, 2002, ONCOGENE, V21, P1079, DOI 10.1038/sj.onc.1205166; Yeung YG, 1998, J BIOL CHEM, V273, P17128, DOI 10.1074/jbc.273.27.17128; Yu WF, 2008, J LEUKOCYTE BIOL, V84, P852, DOI 10.1189/jlb.0308171; ZE W, 1993, MOL CELL BIOL, V13, P5348, DOI 10.1128/MCB.13.9.5348; Zhang Y, 1999, J BIOL CHEM, V274, P33072, DOI 10.1074/jbc.274.46.33072	61	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					952	960		10.1074/jbc.M110.166702	http://dx.doi.org/10.1074/jbc.M110.166702			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21041311	Green Published, hybrid			2022-12-25	WOS:000286005000006
J	Sinnett-Smith, J; Rozengurt, N; Kui, R; Huang, C; Rozengurt, E				Sinnett-Smith, James; Rozengurt, Nora; Kui, Robert; Huang, Carlos; Rozengurt, Enrique			Protein Kinase D1 Mediates Stimulation of DNA Synthesis and Proliferation in Intestinal Epithelial IEC-18 Cells and in Mouse Intestinal Crypts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION LOOP SER(744); SIGNAL-TRANSDUCTION PATHWAY; PLECKSTRIN HOMOLOGY DOMAIN; D PKD ACTIVATION; NF-KAPPA-B; PHORBOL ESTERS; G(Q)-COUPLED RECEPTORS; LYSOPHOSPHATIDIC ACID; SWISS 3T3-CELLS; IN-VIVO	We examined whether protein kinase D1 (PKD1), the founding member of a new protein kinase family, plays a critical role in intestinal epithelial cell proliferation. Our results demonstrate that PKD1 activation is sustained, whereas that of PKD2 is transient in intestinal epithelial IEC-18 stimulated with the G(q)-coupled receptor agonists angiotensin II or vasopressin. PKD1 gene silencing utilizing small interfering RNAs dramatically reduced DNA synthesis and cell proliferation in IEC-18 cells stimulated with G(q)-coupled receptor agonists. To clarify the role of PKD1 in intestinal epithelial cell proliferation in vivo, we generated transgenic mice that express elevated PKD1 protein in the intestinal epithelium. Transgenic PKD1 exhibited constitutive catalytic activity and phosphorylation at the activation loop residues Ser(744) and Ser(748) and on the autophosphorylation site, Ser(916). To examine whether PKD1 expression stimulates intestinal cell proliferation, we determined the rate of crypt cell DNA synthesis by detection of 5-bromo-2-deoxyuridine incorporated into the nuclei of crypt cells of the ileum. Our results demonstrate a significant increase (p < 0.005) in DNA-synthesizing cells in the crypts of two independent lines of PKD1 transgenic mice as compared with non-transgenic littermates. Morphometric analysis showed a significant increase in the length and in the total number of cells per crypt in the transgenic PKD1 mice as compared with the non-transgenic littermates (p < 0.01). Thus, transgenic PKD1 signaling increases the number of cells per crypt by stimulating the rate of crypt cell proliferation. Collectively, our results indicate that PKD1 plays a role in promoting cell proliferation in intestinal epithelial cells both in vitro and in vivo.	[Rozengurt, Enrique] Univ Calif Los Angeles, Sch Med, Dept Med, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Div Digest Dis,CURE Digest Dis Res Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Rozengurt, E (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med, Inst Mol Biol, 900 Vet Ave,Warren Hall,Rm 11-124, Los Angeles, CA 90095 USA.	erozengurt@mednet.ucla.edu			National Institutes of Health [R0- 1 DK 55003, R0- 1 DK56930, P30 DK41301]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, R01DK055003, R01DK056930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R0- 1 DK 55003, R0- 1 DK56930, and P30 DK41301 (to E. R.).	Abedi H, 1998, FEBS LETT, V427, P209, DOI 10.1016/S0014-5793(98)00427-X; Bostick RM, 1997, CANCER EPIDEM BIOMAR, V6, P1011; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; BROOKS SF, 1992, J BIOL CHEM, V267, P14212; BROOKS SF, 1991, EMBO J, V10, P2497, DOI 10.1002/j.1460-2075.1991.tb07789.x; Chiu T, 2005, AM J PHYSIOL-GASTR L, V288, pG182, DOI 10.1152/ajpgi.00200.2004; Chiu T, 2003, AM J PHYSIOL-GASTR L, V285, pG1, DOI 10.1152/ajpgi.00419.2002; Chiu T, 2002, AM J PHYSIOL-CELL PH, V282, pC434, DOI 10.1152/ajpcell.00240.2001; Chiu T, 2001, AM J PHYSIOL-CELL PH, V280, pC929, DOI 10.1152/ajpcell.2001.280.4.C929; Chiu T, 2001, FEBS LETT, V489, P101, DOI 10.1016/S0014-5793(01)02076-2; Chiu TT, 2007, AM J PHYSIOL-CELL PH, V292, pC767, DOI 10.1152/ajpcell.00308.2006; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; ERUSALIMSKY JD, 1991, J BIOL CHEM, V266, P7073; Guha S, 2002, CANCER RES, V62, P1632; Iglesias T, 1999, FEBS LETT, V454, P53, DOI 10.1016/S0014-5793(99)00772-3; Iglesias T, 1998, J BIOL CHEM, V273, P410, DOI 10.1074/jbc.273.1.410; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Jiang XH, 2007, CELL SIGNAL, V19, P1000, DOI 10.1016/j.cellsig.2006.11.004; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Matthews SA, 2000, J EXP MED, V191, P2075, DOI 10.1084/jem.191.12.2075; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Mihailovic T, 2004, CANCER RES, V64, P8939, DOI 10.1158/0008-5472.CAN-04-0981; Paolucci L, 2000, AM J PHYSIOL-CELL PH, V278, pC33, DOI 10.1152/ajpcell.2000.278.1.C33; Podolsky DK, 1999, AM J PHYSIOL-GASTR L, V277, pG495, DOI 10.1152/ajpgi.1999.277.3.G495; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Quaroni A, 1980, Methods Cell Biol, V21B, P403; Rey O, 2003, J CELL PHYSIOL, V196, P483, DOI 10.1002/jcp.10323; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P7244, DOI 10.1073/pnas.80.23.7244; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 2007, CURR OPIN PHARMACOL, V7, P557, DOI 10.1016/j.coph.2007.10.002; Santiskulvong C, 2007, CELL SIGNAL, V19, P1348, DOI 10.1016/j.cellsig.2007.01.006; Simon TC, 1997, J BIOL CHEM, V272, P10652; Sinnett-Smith J, 2004, J BIOL CHEM, V279, P16883, DOI 10.1074/jbc.M313225200; Sinnett-Smith J, 2007, J CELL PHYSIOL, V211, P781, DOI 10.1002/jcp.20984; Sinnett-Smith J, 2009, J BIOL CHEM, V284, P13434, DOI 10.1074/jbc.M806554200; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; VANLINT J, 1995, J BIOL CHEM, V270, P1455, DOI 10.1074/jbc.270.3.1455; Waldron RT, 2000, J BIOL CHEM, V275, P17114, DOI 10.1074/jbc.M908959199; Waldron RT, 2004, J BIOL CHEM, V279, P27482, DOI 10.1074/jbc.M402875200; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang Y, 2002, MOL CELL BIOL, V22, P916, DOI 10.1128/MCB.22.3.916-926.2001; Young LH, 2005, CARDIOVASC DRUG REV, V23, P255; Yuan JZ, 2006, CELL SIGNAL, V18, P1051, DOI 10.1016/j.cellsig.2005.08.017; Yuan JZ, 2003, J BIOL CHEM, V278, P4882, DOI 10.1074/jbc.M211175200; Yuan JZ, 2000, J BIOL CHEM, V275, P2157, DOI 10.1074/jbc.275.3.2157; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200; Zhukova E, 2001, J CELL PHYSIOL, V189, P291, DOI 10.1002/jcp.10018; Zhukova E, 2001, J BIOL CHEM, V276, P40298, DOI 10.1074/jbc.M106512200; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	55	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					511	520		10.1074/jbc.M110.167528	http://dx.doi.org/10.1074/jbc.M110.167528			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21051537	Green Published, hybrid			2022-12-25	WOS:000285782800054
J	Christian, J; Vier, J; Paschen, SA; Hacker, G				Christian, Jan; Vier, Juliane; Paschen, Stefan A.; Haecker, Georg			Cleavage of the NF-kappa B Family Protein p65/RelA by the Chlamydial Protease-like Activity Factor (CPAF) Impairs Proinflammatory Signaling in Cells Infected with Chlamydiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAIL-SPECIFIC PROTEASE; SECRETED PROTEASE; DEGRADATION; ACTIVATION; PATHWAY; GENE	Chlamydiae are obligate intracellular bacteria that frequently cause human disease. Chlamydiae replicate in a membranous vacuole in the cytoplasm termed inclusion but have the ability to transport proteins into the host cell cytosol. Chlamydial replication is associated with numerous changes of host cell functions, and these changes are often linked to proteolytic events. It has been shown earlier that the member of the NF-kappa B family of inflammation-associated transcription factors, p65/RelA, is cleaved during chlamydial infection, and a chlamydial protease has been implicated. We here provide evidence that the chlamydial protease chlamydial protease-like activity factor (CPAF) is responsible for degradation of p65/RelA during infection. This degradation was seen in human and in mouse cells infected with either Chlamydia trachomatis or Chlamydia pneumoniae where it correlated with the expression of CPAF and CPAF activity. Isolated expression of active C. trachomatis or C. pneumoniae CPAF in human or mouse cells yielded a p65 fragment of indistinguishable size from the one generated during infection. Expression of active CPAF in human cells caused a mild reduction in I kappa B alpha phosphorylation but a strong reduction in NF-kappa B reporter activity in response to interleukin-1 beta. Infection with C. trachomatis likewise reduced this responsiveness. IL-1 beta-dependent secretion of IL-8 was further reduced by CPAF expression. Secretion of CPAF is, thus, a mechanism that reduces host cell sensitivity to a proinflammatory stimulus, which may facilitate bacterial growth in vivo.	[Christian, Jan; Paschen, Stefan A.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Christian, Jan; Vier, Juliane; Paschen, Stefan A.; Haecker, Georg] Univ Hosp Freiburg, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany	Technical University of Munich; University of Freiburg	Hacker, G (corresponding author), Hermann Herder Str 11, D-79104 Freiburg, Germany.	georg.haecker@uniklinik-freiburg.de			Else-Kromer-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft	Else-Kromer-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Else-Kromer-Fresenius-Stiftung and the Deutsche Forschungsgemeinschaft (to G.H.).	Belland R, 2004, NAT REV MICROBIOL, V2, P530, DOI 10.1038/nrmicro931; Belland RJ, 2004, CELL MICROBIOL, V6, P117, DOI 10.1046/j.1462-5822.2003.00352.x; Byrne GI, 2004, NAT REV MICROBIOL, V2, P802, DOI 10.1038/nrmicro1007; Dong F, 2004, MOL MICROBIOL, V52, P1487, DOI 10.1111/j.1365-2958.2004.04072.x; Dong F, 2004, INFECT IMMUN, V72, P3863, DOI 10.1128/IAI.72.7.3863-3868.2004; Gerbase AC, 1998, LANCET, V351, P2, DOI 10.1016/S0140-6736(98)90001-0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; HARA H, 1991, J BACTERIOL, V173, P4799, DOI 10.1128/jb.173.15.4799-4813.1991; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; Huang ZW, 2008, CELL HOST MICROBE, V4, P529, DOI 10.1016/j.chom.2008.10.005; Kawana K, 2007, J BIOL CHEM, V282, P7368, DOI 10.1074/jbc.M610754200; Kumar Y, 2008, CELL HOST MICROBE, V4, P159, DOI 10.1016/j.chom.2008.05.018; Lad SP, 2007, J BACTERIOL, V189, P6619, DOI 10.1128/JB.00429-07; Lad SP, 2007, P NATL ACAD SCI USA, V104, P2933, DOI 10.1073/pnas.0608393104; Le Negrate G, 2008, CELL MICROBIOL, V10, P1879, DOI 10.1111/j.1462-5822.2008.01178.x; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; Ostberg Y, 2004, J BACTERIOL, V186, P2074, DOI 10.1128/JB.186.7.2074-2084.2004; Paetzel M, 1997, TRENDS BIOCHEM SCI, V22, P28, DOI 10.1016/S0968-0004(96)10065-7; Paschen SA, 2008, J CELL BIOL, V182, P117, DOI 10.1083/jcb.200804023; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; SILBER KR, 1992, P NATL ACAD SCI USA, V89, P295, DOI 10.1073/pnas.89.1.295; Wyrick PB, 2000, CELL MICROBIOL, V2, P275, DOI 10.1046/j.1462-5822.2000.00059.x; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935; Zhong GM, 2009, TRENDS MICROBIOL, V17, P467, DOI 10.1016/j.tim.2009.07.007	29	46	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41320	41327		10.1074/jbc.M110.152280	http://dx.doi.org/10.1074/jbc.M110.152280			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041296	hybrid, Green Published			2022-12-25	WOS:000285622600017
J	Popkie, AP; Zeidner, LC; Albrecht, AM; D'Ippolito, A; Eckardt, S; Newsom, DE; Groden, J; Doble, BW; Aronow, B; McLaughlin, KJ; White, P; Phiel, CJ				Popkie, Anthony P.; Zeidner, Leigh C.; Albrecht, Ashley M.; D'Ippolito, Anthony; Eckardt, Sigrid; Newsom, David E.; Groden, Joanna; Doble, Bradley W.; Aronow, Bruce; McLaughlin, K. John; White, Peter; Phiel, Christopher J.			Phosphatidylinositol 3-Kinase (PI3K) Signaling via Glycogen Synthase Kinase-3 (Gsk-3) Regulates DNA Methylation of Imprinted Loci	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; DE-NOVO METHYLATION; PROTEIN-KINASE; VALPROIC ACID; SELF-RENEWAL; ES CELLS; MOUSE; PHOSPHORYLATION; PLURIPOTENCY; EXPRESSION	Glycogen synthase kinase-3 (Gsk-3) isoforms, Gsk-3 alpha and Gsk-3 beta, are constitutively active, largely inhibitory kinases involved in signal transduction. Underscoring their biological significance, altered Gsk-3 activity has been implicated in diabetes, Alzheimer disease, schizophrenia, and bipolar disorder. Here, we demonstrate that deletion of both Gsk-3 alpha and Gsk-3 beta in mouse embryonic stem cells results in reduced expression of the de novo DNA methyltransferase Dnmt3a2, causing misexpression of the imprinted genes Igf2, H19, and Igf2r and hypomethylation of their corresponding imprinted control regions. Treatment of wild-type embryonic stem cells and neural stem cells with the Gsk-3 inhibitor, lithium, phenocopies the DNA hypomethylation at these imprinted loci. We show that inhibition of Gsk-3 by phosphatidylinositol 3-kinase (PI3K)-mediated activation of Akt also results in reduced DNA methylation at these imprinted loci. Finally, we find that N-Myc is a potent Gsk-3-dependent regulator of Dnmt3a2 expression. In summary, we have identified a signal transduction pathway that is capable of altering the DNA methylation of imprinted loci.	[Zeidner, Leigh C.; Albrecht, Ashley M.; D'Ippolito, Anthony; Eckardt, Sigrid; McLaughlin, K. John; Phiel, Christopher J.] Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH 43205 USA; [Popkie, Anthony P.; Phiel, Christopher J.] Ohio State Univ, Grad Program Mol Cellular & Dev Biol, Columbus, OH 43210 USA; [Newsom, David E.; White, Peter] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA; [Groden, Joanna] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Doble, Bradley W.] McMaster Univ, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada; [Aronow, Bruce] Cincinnati Childrens Hosp, Div Biomed Informat, Cincinnati, OH 45229 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; McMaster University; Cincinnati Children's Hospital Medical Center	Phiel, CJ (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, 700 Childrens Dr,W432, Columbus, OH 43205 USA.	phiel.1@osu.edu	Aronow, Bruce J/F-8438-2012; Doble, Brad/L-7551-2016; Doble, Bradley/V-7848-2019; McLaughlin, Kenneth/E-3648-2011; White, Peter/E-4301-2011	Doble, Brad/0000-0002-0260-2983; Doble, Bradley/0000-0002-0260-2983; White, Peter/0000-0002-5218-5903	National Institutes of Health [P30 DK078392, U54RR025216, R01CA63517, R01AG031833]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 DK078392 and U54RR025216 (to B. A.), R01CA63517 (to J. G.), and R01AG031833 (to C. J. P.).	BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; BUDOWLE B, 1990, Applied and Theoretical Electrophoresis, V1, P181; CADE JFJ, 1949, MED J AUSTRALIA, V2, P349, DOI 10.5694/j.1326-5377.1949.tb36912.x; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dean W, 1998, DEVELOPMENT, V125, P2273; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Force T, 2009, J BIOL CHEM, V284, P9643, DOI 10.1074/jbc.R800077200; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Horsthemke B, 2008, AM J MED GENET A, V146A, P2041, DOI 10.1002/ajmg.a.32364; HOWLETT SK, 1991, DEVELOPMENT, V113, P119; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Jinno Y, 1996, HUM MOL GENET, V5, P1155, DOI 10.1093/hmg/5.8.1155; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Kuratomi G, 2008, MOL PSYCHIATR, V13, P429, DOI 10.1038/sj.mp.4002001; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Ng SS, 2009, J BIOL CHEM, V284, P35308, DOI 10.1074/jbc.M109.078261; Nimura K, 2006, GENES CELLS, V11, P1225, DOI 10.1111/j.1365-2443.2006.01012.x; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sjostrom SK, 2005, DEV CELL, V9, P327, DOI 10.1016/j.devcel.2005.07.014; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Yamasaki Y, 2005, HUM MOL GENET, V14, P2511, DOI 10.1093/hmg/ddi255; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	59	69	72	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41337	41347		10.1074/jbc.M110.170704	http://dx.doi.org/10.1074/jbc.M110.170704			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21047779	Green Published, hybrid			2022-12-25	WOS:000285622600019
J	Hoffmann, TJ; Marini, NJ; Witte, JS				Hoffmann, Thomas J.; Marini, Nicholas J.; Witte, John S.			Comprehensive Approach to Analyzing Rare Genetic Variants	PLOS ONE			English	Article							COMMON DISEASES; SUSCEPTIBILITY; ASSOCIATIONS; MUTATIONS; MODELS	Recent findings suggest that rare variants play an important role in both monogenic and common diseases. Due to their rarity, however, it remains unclear how to appropriately analyze the association between such variants and disease. A common approach entails combining rare variants together based on a priori information and analyzing them as a single group. Here one must make some assumptions about what to aggregate. Instead, we propose two approaches to empirically determine the most efficient grouping of rare variants. The first considers multiple possible groupings using existing information. The second is an agnostic "step-up" approach that determines an optimal grouping of rare variants analytically and does not rely on prior information. To evaluate these approaches, we undertook a simulation study using sequence data from genes in the one-carbon folate metabolic pathway. Our results show that using prior information to group rare variants is advantageous only when information is quite accurate, but the step-up approach works well across a broad range of plausible scenarios. This agnostic approach allows one to efficiently analyze the association between rare variants and disease while avoiding assumptions required by other approaches for grouping such variants.	[Hoffmann, Thomas J.; Witte, John S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Hoffmann, Thomas J.; Witte, John S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Marini, Nicholas J.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Hoffmann, TJ (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	WitteJ@humgen.ucsf.edu			National Institutes of Health (NIH) [R25CA112355, R01GM072859, R01CA88164, U01CA127298]; NATIONAL CANCER INSTITUTE [R25CA112355, R01CA088164, U01CA127298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072859] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	TJH was supported by National Institutes of Health (NIH) R25CA112355 training grant. NJM was supported by NIH grant R01GM072859 (NIGMS). JSW was supported by NIH grants R01CA88164 and U01CA127298. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzopardi D, 2008, CANCER RES, V68, P358, DOI 10.1158/0008-5472.CAN-07-5733; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Capanu M, 2008, STAT MED, V27, P2536, DOI 10.1002/sim.3049; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Ferrer-Costa C, 2004, PROTEINS, V57, P811, DOI 10.1002/prot.20252; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; HERSHBERGER RE, 2010, CIRC CARDIOVASC GENE; Iyengar Sudha K, 2007, Methods Mol Biol, V376, P71; Lewinger JP, 2007, GENET EPIDEMIOL, V31, P871, DOI 10.1002/gepi.20248; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reed MC, 2006, J NUTR, V136, P2653, DOI 10.1093/jn/136.10.2653; Smith DJ, 2002, HUM MOL GENET, V11, P2455, DOI 10.1093/hmg/11.20.2455; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; THOMAS DC, 1985, AM J EPIDEMIOL, V122, P1080, DOI 10.1093/oxfordjournals.aje.a114189; Witte JS, 1997, GENET EPIDEMIOL, V14, P1137, DOI 10.1002/(SICI)1098-2272(1997)14:6<1137::AID-GEPI96>3.0.CO;2-H	25	98	105	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13584	10.1371/journal.pone.0013584	http://dx.doi.org/10.1371/journal.pone.0013584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072163	Green Published, Green Submitted, gold			2022-12-25	WOS:000283780800001
J	Restelli, E; Fioriti, L; Mantovani, S; Airaghi, S; Forloni, G; Chiesa, R				Restelli, Elena; Fioriti, Luana; Mantovani, Susanna; Airaghi, Simona; Forloni, Gianluigi; Chiesa, Roberto			Cell Type-Specific Neuroprotective Activity of Untranslocated Prion Protein	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; MESSENGER-RNA; ER STRESS; TRANSMEMBRANE FORM; COMMON PATHWAY; PRP; TRANSLOCATION; EXPRESSION; APOPTOSIS; GENE	Background: A key pathogenic role in prion diseases was proposed for a cytosolic form of the prion protein (PrP). However, it is not clear how cytosolic PrP localization influences neuronal viability, with either cytotoxic or anti-apoptotic effects reported in different studies. The cellular mechanism by which PrP is delivered to the cytosol of neurons is also debated, and either retrograde transport from the endoplasmic reticulum or inefficient translocation during biosynthesis has been proposed. We investigated cytosolic PrP biogenesis and effect on cell viability in primary neuronal cultures from different mouse brain regions. Principal Findings: Mild proteasome inhibition induced accumulation of an untranslocated form of cytosolic PrP in cortical and hippocampal cells, but not in cerebellar granules. A cyclopeptolide that interferes with the correct insertion of the PrP signal sequence into the translocon increased the amount of untranslocated PrP in cortical and hippocampal cells, and induced its synthesis in cerebellar neurons. Untranslocated PrP boosted the resistance of cortical and hippocampal neurons to apoptotic insults but had no effect on cerebellar cells. Significance: These results indicate cell type-dependent differences in the efficiency of PrP translocation, and argue that cytosolic PrP targeting might serve a physiological neuroprotective function.	[Restelli, Elena; Fioriti, Luana; Mantovani, Susanna; Airaghi, Simona; Chiesa, Roberto] Dulbecco Telethon Inst, Milan, Italy; [Restelli, Elena; Fioriti, Luana; Mantovani, Susanna; Airaghi, Simona; Forloni, Gianluigi; Chiesa, Roberto] Mario Negri Inst Pharmacol Res, Dept Neurosci, I-20157 Milan, Italy	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Restelli, E (corresponding author), Dulbecco Telethon Inst, Milan, Italy.	roberto.chiesa@marionegri.it	Restelli, Elena/J-7449-2018; Forloni, Gianluigi/AAB-2115-2020; Fioriti, Luana/AAN-7207-2021; Chiesa, Roberto/G-1561-2017	Restelli, Elena/0000-0002-6081-5178; Forloni, Gianluigi/0000-0001-5374-3914; Chiesa, Roberto/0000-0002-3842-3733; Mantovani, Susanna/0000-0001-7046-6541; fioriti, luana/0000-0003-2429-8967	Telethon-Italy [TRC08005]; Fondazione Monzino	Telethon-Italy(Fondazione Telethon); Fondazione Monzino	This work was supported by Telethon-Italy to RC (TRC08005). L.F. was supported by a fellowship from the Fondazione Monzino. R.C. is an Associate Telethon Scientist (Dulbecco Telethon Institute, Fondazione Telethon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly Y, 2004, J COMP NEUROL, V473, P244, DOI 10.1002/cne.20117; Barmada S, 2004, NEUROBIOL DIS, V16, P527, DOI 10.1016/j.nbd.2004.05.005; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; Besemer J, 2005, NATURE, V436, P290, DOI 10.1038/nature03670; Bragason BT, 2005, MOL CELL NEUROSCI, V29, P232, DOI 10.1016/j.mcn.2005.02.013; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Campana V, 2005, TRENDS CELL BIOL, V15, P102, DOI 10.1016/j.tcb.2004.12.002; Chakrabarti O, 2009, TRENDS BIOCHEM SCI, V34, P287, DOI 10.1016/j.tibs.2009.03.001; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Chiesa R, 2004, TECHNIQUES PRION RES, P176; CROZET C, 2006, MOL CELL NEUROSCI; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Faas H, 2010, NEUROIMAGE, V49, P2607, DOI 10.1016/j.neuroimage.2009.10.009; Fioriti L, 2005, J BIOL CHEM, V280, P11320, DOI 10.1074/jbc.M412441200; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Grenier C, 2006, J NEUROCHEM, V97, P1456, DOI 10.1111/j.1471-4159.2006.03837.x; Harant H, 2006, J BIOL CHEM, V281, P30492, DOI 10.1074/jbc.M607243200; HARRIS DA, 1993, P NATL ACAD SCI USA, V90, P4309, DOI 10.1073/pnas.90.9.4309; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Juanes ME, 2009, J BIOL CHEM, V284, P2787, DOI 10.1074/jbc.M804051200; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim SJ, 2002, MOL BIOL CELL, V13, P3775, DOI 10.1091/mbc.E02-05-0293; KOH JY, 1995, EXP NEUROL, V135, P153, DOI 10.1006/exnr.1995.1074; Kristiansen M, 2005, J BIOL CHEM, V280, P38851, DOI 10.1074/jbc.M506600200; KURSCHNER C, 1995, MOL BRAIN RES, V30, P165, DOI 10.1016/0169-328X(95)00013-I; Lang-Rollin I, 2004, J NEUROCHEM, V90, P1511, DOI 10.1111/j.1471-4159.2004.02684.x; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; LEHMANN S, 1995, J BIOL CHEM, V270, P24589, DOI 10.1074/jbc.270.41.24589; Levine CG, 2005, MOL BIOL CELL, V16, P279, DOI 10.1091/mbc.E04-06-0508; Lin DTS, 2008, BBA-MOL CELL RES, V1783, P2001, DOI 10.1016/j.bbamcr.2008.05.022; Lund C, 2009, J BIOL CHEM, V284, P19668, DOI 10.1074/jbc.M109.003566; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; MANSON J, 1992, DEVELOPMENT, V115, P117; Massignan T, 2010, MOL CELL PROTEOMICS, V9, P611, DOI 10.1074/mcp.M900271-MCP200; Miller TM, 1996, J NEUROSCI, V16, P7487; Mironov A, 2003, J NEUROSCI, V23, P7183, DOI 10.1523/JNEUROSCI.23-18-07183.2003; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Orsi A, 2006, J BIOL CHEM, V281, P30431, DOI 10.1074/jbc.M605320200; Orsi A, 2007, PRION, V1, P236, DOI 10.4161/pri.1.4.5727; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RAMBOLD AS, 2006, MOL BIOL CELL; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Roucou X, 2003, J BIOL CHEM, V278, P40877, DOI 10.1074/jbc.M306177200; Rutkowski DT, 2001, P NATL ACAD SCI USA, V98, P7823, DOI 10.1073/pnas.141125098; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Stewart RS, 2005, J NEUROSCI, V25, P3469, DOI 10.1523/JNEUROSCI.0105-05.2005; Stewart RS, 2003, J BIOL CHEM, V278, P45960, DOI 10.1074/jbc.M307833200; Stockton JD, 2003, BIOCHEMISTRY-US, V42, P12821, DOI 10.1021/bi035087q; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang X, 2009, BMB REP, V42, P444, DOI 10.5483/BMBRep.2009.42.7.444; Wang XH, 2009, BBA-MOL BASIS DIS, V1792, P555, DOI 10.1016/j.bbadis.2009.02.014; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	60	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13725	10.1371/journal.pone.0013725	http://dx.doi.org/10.1371/journal.pone.0013725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060848	Green Published, Green Submitted, gold			2022-12-25	WOS:000283573800019
J	Simmler, C; Antheaume, C; Lobstein, A				Simmler, Charlotte; Antheaume, Cyril; Lobstein, Annelise			Antioxidant Biomarkers from Vanda coerulea Stems Reduce Irradiated HaCaT PGE-2 Production as a Result of COX-2 Inhibition	PLOS ONE			English	Article							ULTRAVIOLET-IRRADIATION; SCAVENGING ACTIVITY; PROSTAGLANDIN E-2; OXIDATIVE STRESS; NITRIC-OXIDE; HUMAN SKIN; 9,10-DIHYDROPHENANTHRENE; EXPRESSION; DERIVATIVES; FLAVIDIN	Background: In our investigations towards the isolation of potentially biologically active constituents from Orchidaceae, we carried out phytochemical and biological analyses of Vanda species. A preliminary biological screening revealed that Vanda coerulea (Griff. ex. Lindl) crude hydro-alcoholic stem extract displayed the best DPPH/(OH)-O-center dot radical scavenging activity and in vitro inhibition of type 2 prostaglandin (PGE-2) release from UVB (60 mJ/cm(2)) irradiated HaCaT keratinocytes. Principal Findings: Bio-guided fractionation and phytochemical analysis led to the isolation of five stilbenoids: imbricatin (1) methoxycoelonin (2) gigantol (3) flavidin (4) and coelonin (5). Stilbenoids (1-3) were the most concentrated in crude hydroalcoholic stem extract and were considered as Vanda coerulea stem biomarkers. Dihydro-phenanthropyran (1) and dihydrophenanthrene (2) displayed the best DPPH/(OH)-O-center dot radical scavenging activities as well as HaCaT intracellular antioxidant properties (using DCFH-DA probe: IC50 8.8 mu M and 9.4 mu M, respectively) compared to bibenzyle (3) (IC50 20.6 mu M). In turn, the latter showed a constant inhibition of PGE-2 production, stronger than stilbenoids (1) and (2) (IC50 12.2 mu M and 19.3 mu M, respectively). Western blot analysis revealed that stilbenoids (1-3) inhibited COX-2 expression at 23 mu M. Interestingly, stilbenoids (1) and (2) but not (3) were able to inhibit human recombinant COX-2 activity. Conclusions: Major antioxidant stilbenoids (1-3) from Vanda coerulea stems displayed an inhibition of UVB-induced COX-2 expression. Imbricatin (1) and methoxycoelonin (2) were also able to inhibit COX-2 activity in a concentration-dependent manner thereby reducing PGE-2 production from irradiated HaCaT cells. Our studies suggest that stilbenoids (1-3) could be potentially used for skin protection against the damage caused by UVB exposure.	[Simmler, Charlotte; Antheaume, Cyril; Lobstein, Annelise] Univ Strasbourg, Fac Pharm, Illkirch Graffenstaden, France; [Simmler, Charlotte; Lobstein, Annelise] CNRS, Lab Pharmacognosie, UMR 7200, Illkirch Graffenstaden, France; [Antheaume, Cyril] Serv Commun Anal SCA RMN, Illkirch Graffenstaden, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Simmler, C (corresponding author), Univ Strasbourg, Fac Pharm, Illkirch Graffenstaden, France.	charlotte.simmler@pharma.u-strasbg.fr		Simmler, Charlotte/0000-0002-6923-2630	Louis Vuitton Moet Hennessy (LVMH) Recherche; Guerlain Societe Anonyme (SA)	Louis Vuitton Moet Hennessy (LVMH) Recherche; Guerlain Societe Anonyme (SA)	This work was supported by Louis Vuitton Moet Hennessy (LVMH) Recherche and Guerlain Societe Anonyme (SA), www.lvmh.fr/groupe. The funders did not have any role in study design, data collection and analysis. Funders have supplied facilities for all biological analyses and gave their approval for the manuscript to be published.	Ahn SM, 2002, BRIT J PHARMACOL, V137, P497, DOI 10.1038/sj.bjp.0704896; Anuradha V, 1998, PHYTOCHEMISTRY, V48, P181, DOI 10.1016/S0031-9422(97)00610-9; Anuradha V, 1998, PHYTOCHEMISTRY, V48, P185, DOI 10.1016/S0031-9422(97)00612-2; Bae JY, 2010, EXP DERMATOL, V19, pE182, DOI 10.1111/j.1600-0625.2009.01044.x; Baliga MS, 2006, PHOTOCH PHOTOBIO SCI, V5, P243, DOI 10.1039/b505311k; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Buckman SY, 1998, CARCINOGENESIS, V19, P723, DOI 10.1093/carcin/19.5.723; CHASE MW, DNA DATA ORCHIDACEAE; Deciga-Campos M, 2007, J ETHNOPHARMACOL, V114, P161, DOI 10.1016/j.jep.2007.07.021; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Guo XY, 2007, J ASIAN NAT PROD RES, V9, P165, DOI 10.1080/10286020500480522; GUO XY, 2006, ZHONGCAOYAO, V37, P492; Harman D, 2001, ANN NY ACAD SCI, V928, P1, DOI 10.1111/j.1749-6632.2001.tb05631.x; Isoherranen K, 1999, BRIT J DERMATOL, V140, P1017; Jayaprakasha GK, 2004, BIOORGAN MED CHEM, V12, P5141, DOI 10.1016/j.bmc.2004.07.028; JUNEJA RK, 1985, PHYTOCHEMISTRY, V24, P321, DOI 10.1016/S0031-9422(00)83544-X; JUNEJA RK, 1987, PHYTOCHEMISTRY, V26, P1123, DOI 10.1016/S0031-9422(00)82362-6; Kovacs A, 2008, PHYTOCHEMISTRY, V69, P1084, DOI 10.1016/j.phytochem.2007.12.005; LECOUFLE M, 2004, TRAITE ORCHIDEES, P42; MAJUMDER P, 1982, PHYTOCHEMISTRY, V21, P478, DOI 10.1016/S0031-9422(00)95300-7; MAJUMDER PL, 1982, INDIAN J CHEM B, V21, P829; MAJUMDER PL, 1982, J NAT PROD, V45, P730, DOI 10.1021/np50024a016; MAJUMDER PL, 1995, PHYTOCHEMISTRY, V39, P649, DOI 10.1016/0031-9422(95)00942-Z; MILLER CC, 1994, J BIOL CHEM, V269, P3529; Nayak B S, 2005, Int J Low Extrem Wounds, V4, P200, DOI 10.1177/1534734605282994; Nichols JA, 2010, ARCH DERMATOL RES, V302, P71, DOI 10.1007/s00403-009-1001-3; Parejo I, 2003, LIFE SCI, V73, P1667, DOI 10.1016/S0024-3205(03)00488-0; Pinnell SR, 2003, J AM ACAD DERMATOL, V48, P1, DOI 10.1067/mjd.2003.16; Pyo MK, 2004, ARCH PHARM RES, V27, P381, DOI 10.1007/BF02980077; Rhodes LE, 2001, J INVEST DERMATOL, V117, P880, DOI 10.1046/j.0022-202x.2001.01514.x; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; ROSENKRANZ AR, 1992, J IMMUNOL METHODS, V156, P39, DOI 10.1016/0022-1759(92)90008-H; Seo JY, 2003, MECH AGEING DEV, V124, P903, DOI 10.1016/S0047-6374(03)00150-7; Tripp CS, 2003, J INVEST DERMATOL, V121, P853, DOI 10.1046/j.1523-1747.2003.12495.x; VEERRAJU P, 1989, PHYTOCHEMISTRY, V28, P3031, DOI 10.1016/0031-9422(89)80273-0; Wang J, 2007, J NAT MED, V61, P381, DOI 10.1007/s11418-007-0162-7; WILLIAMS CA, 1976, PHYTOCHEMISTRY, V15, P349, DOI 10.1016/S0031-9422(00)89036-6; Won JH, 2006, PLANTA MED, V72, P1181, DOI 10.1055/s-2006-947201; Yang L, 2006, J CHROMATOGR A, V1104, P230, DOI 10.1016/j.chroma.2005.12.012; Zeng XH, 2006, PLANTA MED, V72, P1359, DOI 10.1055/s-2006-951709; Zhang X, 2007, J NAT PROD, V70, P24, DOI 10.1021/np060449r; ZHU H, 1994, ARCH TOXICOL, V68, P582, DOI 10.1007/s002040050118	42	38	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13713	10.1371/journal.pone.0013713	http://dx.doi.org/10.1371/journal.pone.0013713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060890	Green Submitted, gold, Green Published			2022-12-25	WOS:000283573800013
J	Lee, DY; Jeyapalan, Z; Fang, L; Yang, J; Zhang, Y; Yee, AY; Li, MH; Du, WW; Shatseva, T; Yang, BB				Lee, Daniel Y.; Jeyapalan, Zina; Fang, Ling; Yang, Jennifer; Zhang, Yaou; Yee, Albert Y.; Li, Minhui; Du, William W.; Shatseva, Tatiana; Yang, Burton B.			Expression of Versican 3 '-Untranslated Region Modulates Endogenous MicroRNA Functions	PLOS ONE			English	Article							MESSENGER-RNA DEGRADATION; OSTEOBLAST DIFFERENTIATION; CELL-PROLIFERATION; PROFILING REVEALS; MAMMALIAN-CELLS; STEM-CELLS; IN-VIVO; GENE; MIRNA; APOPTOSIS	Background: Mature microRNAs (miRNAs) are single-stranded RNAs that regulate post-transcriptional gene expression. In our previous study, we have shown that versican 3'UTR, a fragment of non-coding transcript, has the ability to antagonize miR-199a-3p function thereby regulating expression of the matrix proteins versican and fibronectin, and thus resulting in enhanced cell-cell adhesion and organ adhesion. However, the impact of this non-coding fragment on tumorigenesis is yet to be determined. Methods and Findings: Using computational prediction confirmed with in vitro and in vivo experiments, we report that the expression of versican 3'UTR not only antagonizes miR-199a-3p but can also lower its steady state expression. We found that expression of versican 3'UTR in a mouse breast carcinoma cell line, 4T1, decreased miR-199a-3p levels. The decrease in miRNA activity consequently translated into differences in tumor growth. Computational analysis indicated that both miR-199a-3p and miR-144 targeted a cell cycle regulator, Rb1. In addition, miR-144 and miR-136, which have also been shown to interact with versican 3'UTR, was found to target PTEN. Expression of Rb1 and PTEN were up-regulated synergistically in vitro and in vivo, suggesting that the 3'UTR binds and modulates miRNA activities, freeing Rb1 and PTEN mRNAs for translation. In tumor formation assays, cells transfected with the 3'UTR formed smaller tumors compared with cells transfected with a control vector. Conclusion: Our results demonstrated that a 3'UTR fragment can be used to modulate miRNA functions. Our study also suggests that miRNAs in the cancer cells are more susceptible to degradation, due to its interaction with a non-coding 3'UTR. This non-coding component of mRNA may be used retrospectively to modulate miRNA activities.	[Lee, Daniel Y.; Jeyapalan, Zina; Fang, Ling; Yang, Jennifer; Yee, Albert Y.; Li, Minhui; Du, William W.; Shatseva, Tatiana; Yang, Burton B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Zhang, Yaou] Tsinghua Univ, Grad Sch Shenzhen, Div Life Sci, Shenzhen 518057, Guangdong, Peoples R China; [Lee, Daniel Y.; Jeyapalan, Zina; Fang, Ling; Li, Minhui; Shatseva, Tatiana; Yang, Burton B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; University of Toronto	Lee, DY (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada.	byang@sri.utoronto.ca			National Sciences and Engineering Research Council of Canada [227937-01]; Canadian Institutes of Health Research; National Natural Science Foundation of China; Heart and Stroke Foundation of Ontario [CI 5958]; Canada Graduate Scholarship	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canada Graduate Scholarship	This work was supported by a grant from National Sciences and Engineering Research Council of Canada (227937-01) to BBY and a China-Canada Joint Health Research Grant (from Canadian Institutes of Health Research and the National Natural Science Foundation of China to BBY and YZ). BBY is the recipient of Career Investigator Award (CI 5958) from the Heart and Stroke Foundation of Ontario. DYL is the recipient of Canada Graduate Scholarship. There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; Cordes KR, 2009, CIRC RES, V104, P724, DOI 10.1161/CIRCRESAHA.108.192872; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; FANG L, 2010, ONCOGENE IN PRESS; Fang L, 2010, FEBS LETT, V584, P2877, DOI 10.1016/j.febslet.2010.04.074; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu YF, 2009, BLOOD, V113, P1340, DOI 10.1182/blood-2008-08-174854; FURUKAWA Y, 1990, P NATL ACAD SCI USA, V87, P2770, DOI 10.1073/pnas.87.7.2770; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kahai S, 2010, FEBS LETT, V584, P233, DOI 10.1016/j.febslet.2009.11.077; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Koga T, 2005, CURR EYE RES, V30, P455, DOI 10.1080/02713680590959376; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; LaPierre DP, 2007, CANCER RES, V67, P4742, DOI 10.1158/0008-5472.CAN-06-3610; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; MURPHREE AL, 1984, SCIENCE, V223, P1028, DOI 10.1126/science.6320372; Orom UA, 2006, GENE, V372, P137, DOI 10.1016/j.gene.2005.12.031; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Schmalfeldt M, 1998, J BIOL CHEM, V273, P15758, DOI 10.1074/jbc.273.25.15758; Schoolmeesters A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005605; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; Takahashi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006677; Tzur G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007511; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wang XB, 2010, J BIOL CHEM, V285, P23239, DOI 10.1074/jbc.M109.084673; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P152, DOI 10.1093/nar/gkl1032	50	120	131	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13599	10.1371/journal.pone.0013599	http://dx.doi.org/10.1371/journal.pone.0013599			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049042	gold, Green Published, Green Submitted			2022-12-25	WOS:000283422100012
J	Nelson, ESD; Harris, S; Soulsbury, CD; Richards, SA; Stephens, PA				Nelson, Eleanor S. Devenish; Harris, Stephen; Soulsbury, Carl D.; Richards, Shane A.; Stephens, Philip A.			Uncertainty in Population Growth Rates: Determining Confidence Intervals from Point Estimates of Parameters	PLOS ONE			English	Article							FOXES VULPES-VULPES; NEW-SOUTH-WALES; RED FOXES; REPRODUCTIVE-PERFORMANCE; MATRIX MODELS; DEMOGRAPHY; DYNAMICS; PATTERNS; MAMMALS; SAMPLE	Background: Demographic models are widely used in conservation and management, and their parameterisation often relies on data collected for other purposes. When underlying data lack clear indications of associated uncertainty, modellers often fail to account for that uncertainty in model outputs, such as estimates of population growth. Methodology/Principal Findings: We applied a likelihood approach to infer uncertainty retrospectively from point estimates of vital rates. Combining this with resampling techniques and projection modelling, we show that confidence intervals for population growth estimates are easy to derive. We used similar techniques to examine the effects of sample size on uncertainty. Our approach is illustrated using data on the red fox, Vulpes vulpes, a predator of ecological and cultural importance, and the most widespread extant terrestrial mammal. We show that uncertainty surrounding estimated population growth rates can be high, even for relatively well-studied populations. Halving that uncertainty typically requires a quadrupling of sampling effort. Conclusions/Significance: Our results compel caution when comparing demographic trends between populations without accounting for uncertainty. Our methods will be widely applicable to demographic studies of many species.	[Nelson, Eleanor S. Devenish; Richards, Shane A.; Stephens, Philip A.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Harris, Stephen; Soulsbury, Carl D.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	Durham University; University of Bristol	Nelson, ESD (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	e.s.nelson@durham.ac.uk	Stephens, Philip/B-8397-2008; Soulsbury, Carl D./F-3137-2010; Soulsbury, Carl/P-1492-2019	Stephens, Philip/0000-0001-5849-788X; Soulsbury, Carl D./0000-0001-8808-5210; Soulsbury, Carl/0000-0001-8808-5210; Richards, Shane/0000-0002-9638-5827; Devenish-Nelson, Eleanor/0000-0002-9029-4772	Durham University; Dulverton Trust	Durham University; Dulverton Trust	This work was funded by a Durham University Doctoral Fellowship (EDN). S. Harris was funded by the Dulverton Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN SH, 1984, J MAMMAL, V65, P246, DOI 10.2307/1381163; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Bischof R, 2008, J WILDLIFE MANAGE, V72, P79, DOI 10.2193/2007-149; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Caughley G., 1977, ANAL VERTEBRATE POPU; COMAN BJ, 1988, AUST WILDLIFE RES, V15, P223, DOI 10.1071/WR9880223; de Valpine P, 2009, ECOLOGY, V90, P2889, DOI 10.1890/08-0703.1; Doak DF, 2005, ECOLOGY, V86, P1154, DOI 10.1890/04-0611; Ezard THG, 2010, J APPL ECOL, V47, P515, DOI 10.1111/j.1365-2664.2010.01801.x; Fiske IJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003080; Gross K, 2002, ECOLOGY, V83, P1762, DOI 10.1890/0012-9658(2002)083[1762:EDCFEG]2.0.CO;2; Hagen CA, 2008, J WILDLIFE MANAGE, V72, P1369, DOI 10.2193/2007-390; HARRIS S, 1987, J APPL ECOL, V24, P75, DOI 10.2307/2403788; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Heydon MJ, 2000, J ZOOL, V251, P265, DOI 10.1111/j.1469-7998.2000.tb00609.x; Hobbs NT, 2006, ECOL APPL, V16, P5, DOI 10.1890/04-0645; Hone J, 1999, J APPL ECOL, V36, P709, DOI 10.1046/j.1365-2664.1999.00439.x; KALISZ S, 1992, ECOLOGY, V73, P1082, DOI 10.2307/1940182; Kendall BE, 2010, AM NAT, V175, P461, DOI 10.1086/650724; Marboutin E, 2003, J APPL ECOL, V40, P580, DOI 10.1046/j.1365-2664.2003.00813.x; Marlow NJ, 2000, WILDLIFE RES, V27, P457, DOI 10.1071/WR99035; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; McIlroy J, 2001, CAN J ZOOL, V79, P545, DOI 10.1139/cjz-79-4-545; McLeod SR, 2001, WILDLIFE RES, V28, P333, DOI 10.1071/WR00104; Mills L. S., 2007, CONSERVATION WILDLIF; Milner-Gulland, 2007, CONSERVATION SUSTAIN; Morris W. F., 2002, QUANTITATIVE CONSERV; NELSON BB, 1982, Z SAUGETIERKD, V47, P296; Oli MK, 2003, AM NAT, V161, P422, DOI 10.1086/367591; Pech R, 1997, REPROD FERT DEVELOP, V9, P41, DOI 10.1071/R96059; Reed DH, 2003, BIOL CONSERV, V113, P23, DOI 10.1016/S0006-3207(02)00346-4; Salguero-Gomez R, 2010, J ECOL, V98, P250, DOI 10.1111/j.1365-2745.2009.01635.x; Saunders G, 2002, MAMMALIA, V66, P247, DOI 10.1515/mamm.2002.66.2.247; Saunders GR, 2010, MAMMAL REV, V40, P181, DOI 10.1111/j.1365-2907.2010.00159.x; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schleuning M, 2009, CONSERV BIOL, V23, P174, DOI 10.1111/j.1523-1739.2008.01054.x; Solberg EJ, 1999, J ANIM ECOL, V68, P186, DOI 10.1046/j.1365-2656.1999.00275.x; Soulsbury CD, 2008, BEHAV ECOL SOCIOBIOL, V62, P1289, DOI 10.1007/s00265-008-0557-9; Storm G.L., 1976, Wildlife Monogr, V49, P3; Tenhumberg B, 2008, J APPL ECOL, V45, P438, DOI 10.1111/j.1365-2664.2007.01427.x; TULLAR BF, 1981, NEW YORK FISH GAME J, V28, P138; TULLAR BF, 1982, NEW YORK FISH GAME J, V29, P127; Vos Ad, 2001, Lutra, V44, P15; Wisdom MJ, 2000, ECOLOGY, V81, P628, DOI 10.1890/0012-9658(2000)081[0628:LSSAEV]2.0.CO;2	44	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13628	10.1371/journal.pone.0013628	http://dx.doi.org/10.1371/journal.pone.0013628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049049	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000283422100023
J	Lewis, TW; Blott, SC; Woolliams, JA				Lewis, Thomas W.; Blott, Sarah C.; Woolliams, John A.			Genetic Evaluation of Hip Score in UK Labrador Retrievers	PLOS ONE			English	Article							MOUNTAIN DOG; DYSPLASIA; HERITABILITY; PEDIGREE; FINLAND	Hip dysplasia is an important and complex genetic disease in dogs with both genetic and environmental influences. Since the osteoarthritis that develops is irreversible the only way to improve welfare, through reducing the prevalence, is through genetic selection. This study aimed to evaluate the progress of selection against hip dysplasia, to quantify potential improvements in the response to selection via use of genetic information and increases in selection intensity, and to prepare for public provision of estimated breeding values (EBV) for hip dysplasia in the UK. Data consisted of 25,243 single records of hip scores of Labrador Retrievers between one and four years old, from radiographs evaluated between 2000 and 2007 as part of the British Veterinary Association (BVA) hip score scheme. A natural logarithm transformation was applied to improve normality and linear mixed models were evaluated using ASREML. Genetic correlations between left and right scores, and total hip scores at one, two and three years of age were found to be close to one, endorsing analysis of total hip score in dogs aged one to three as an appropriate approach. A heritability of 0.35 +/- 0.016 and small but significant litter effect (0.07 +/- 0.009) were estimated. The observed trends in both mean hip score and mean EBV over year of birth indicate that a small genetic improvement has been taking place, approximately equivalent to avoiding those dogs with the worst 15% of scores. Deterministic analysis supported by simulations showed that a 19% greater response could be achieved using EBV compared to phenotype through increases in accuracy alone. This study establishes that consistent but slow genetic improvement in the hip score of UK Labrador Retrievers has been achieved over the previous decade, and demonstrates that progress may be easily enhanced through the use of EBVs and more intense selection.	[Lewis, Thomas W.; Blott, Sarah C.] Anim Hlth Trust, Kennel Club Genet Ctr, Newmarket, Suffolk, England; [Woolliams, John A.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Woolliams, John A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland	Animal Health Trust; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Lewis, TW (corresponding author), Anim Hlth Trust, Kennel Club Genet Ctr, Newmarket, Suffolk, England.	tom.lewis@aht.org.uk		Blott, Sarah/0000-0003-0233-6846; Lewis, Thomas/0000-0003-4166-7955	Kennel Club Charitable Trust; BBSRC through ISPG; BBSRC [BBS/E/D/05191133] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05191133] Funding Source: researchfish	Kennel Club Charitable Trust; BBSRC through ISPG(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Kennel Club Charitable Trust. JAW is grateful to BBSRC for funding through an ISPG. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. Hip score and pedigree data was collated and provided by the UK Kennel Club.	Bateson P., 2010, INDEPENDENT INQUIRY; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BRASS W, 1989, J SMALL ANIM PRACT, V30, P166, DOI 10.1111/j.1748-5827.1989.tb01525.x; Darwash AO, 1997, J DAIRY SCI, V80, P1227, DOI 10.3168/jds.S0022-0302(97)76051-X; Falconer D. S, 1996, INTRO QUANTITATIVE G; Flint APF, 2008, PHILOS T R SOC B, V363, P573, DOI 10.1098/rstb.2007.2171; Fluckiger M., 2007, EUROPEAN J COMPANION, V17, P135; Gibbs C, 1997, VET REC, V141, P275; Gilmour A., 2006, ASREML USER GUIDE RE; HARRIS DL, 1994, J ANIM SCI, V72, P2178, DOI 10.2527/1994.7282178x; Higgins A, 2008, VET J, V178, P157, DOI 10.1016/j.tvjl.2008.10.004; HOU Y, PLOS ONE, V5, pE9410; Leppanen M, 1999, PREV VET MED, V42, P121, DOI 10.1016/S0167-5877(99)00059-8; Leppanen M, 2000, J ANIM BREED GENET, V117, P97, DOI 10.1111/j.1439-0388.2000x.00229.x; LEWIS T, 2010, VET J, DOI DOI 10.1016/J.TVJL.2010.1002.1016; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lohi H, 2009, VET J, V181, P77, DOI 10.1016/j.tvjl.2009.02.007; Lust G, 1997, J AM VET MED ASSOC, V210, P1443; Maki K, 2004, THESIS U HELSINKI; Malm S, 2008, J ANIM BREED GENET, V125, P403, DOI 10.1111/j.1439-0388.2008.00725.x; Ohlerth S, 1998, DEUT TIERARZTL WOCH, V105, P378; Silvestre AM, 2007, J ANIM SCI, V85, P1880, DOI 10.2527/jas.2007-0166; Solberg TR, 2008, J ANIM SCI, V86, P2447, DOI 10.2527/jas.2007-0010; Steinetz BG, 2008, AM J VET RES, V69, P59, DOI 10.2460/ajvr.69.1.59; Todhunter RJ, 2005, MAMM GENOME, V16, P720, DOI 10.1007/s00335-005-0004-4; Willis MB, 1997, J AM VET MED ASSOC, V210, P1480; Wood JLN, 2003, VET REC, V152, P69, DOI 10.1136/vr.152.3.69; Wood JLN, 2002, PREV VET MED, V55, P95, DOI 10.1016/S0167-5877(02)00090-9	28	40	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e12797	10.1371/journal.pone.0012797	http://dx.doi.org/10.1371/journal.pone.0012797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042573	Green Published, Green Submitted, gold			2022-12-25	WOS:000283419100001
J	Preston, RS; Philp, A; Claessens, T; Gijezen, L; Dydensborg, AB; Dunlop, EA; Harper, KT; Brinkhuizen, T; Menko, FH; Davies, DM; Land, SC; Pause, A; Baar, K; van Steensel, MAM; Tee, AR				Preston, R. S.; Philp, A.; Claessens, T.; Gijezen, L.; Dydensborg, A. B.; Dunlop, E. A.; Harper, K. T.; Brinkhuizen, T.; Menko, F. H.; Davies, D. M.; Land, S. C.; Pause, A.; Baar, K.; van Steensel, M. A. M.; Tee, A. R.			Absence of the Birt-Hogg-Dube gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility	ONCOGENE			English	Article						Birt-Hogg-Dube; HIF; folliculin; warburg effect	RENAL-CELL CARCINOMA; MAMMALIAN TARGET; FUMARATE HYDRATASE; CANCER; ACTIVATION; EXPRESSION; AMPK; MTOR; PHOSPHORYLATION; RAPAMYCIN	Under conditions of reduced tissue oxygenation, hypoxia-inducible factor (HIF) controls many processes, including angiogenesis and cellular metabolism, and also influences cell proliferation and survival decisions. HIF is centrally involved in tumour growth in inherited diseases that give rise to renal cell carcinoma (RCC), such as Von Hippel-Lindau syndrome and tuberous sclerosis complex. In this study, we examined whether HIF is involved in tumour formation of RCC in Birt-Hogg-Dube syndrome. For this, we analysed a Birt-Hogg-Dube patient-derived renal tumour cell line (UOK257) that is devoid of the Birt-Hogg-Dube protein (BHD) and observed high levels of HIF activity. Knockdown of BHD expression also caused a threefold activation of HIF, which was not as a consequence of more HIF1 alpha or HIF2 alpha protein. Transcription of HIF target genes VEGF, BNIP3 and CCND1 was also increased. We found nuclear localization of HIF1 alpha and increased expression of VEGF, BNIP3 and GLUT1 in a chromophobe carcinoma from a Birt-Hogg-Dube patient. Our data also reveal that UOK257 cells have high lactate dehydrogenase, pyruvate kinase and 3-hydroxyacyl-CoA dehydrogenase activity. We observed increased expression of pyruvate dehydrogenase kinase 1 (a HIF gene target), which in turn leads to increased phosphorylation and inhibition of pyruvate dehydrogenase. Together with increased protein levels of GLUT1, our data reveal that UOK257 cells favour glycolytic rather than lipid metabolism (a cancer phenomenon termed the 'Warburg effect'). UOK257 cells also possessed a higher expression level of the L-lactate influx monocarboxylate transporter 1 and consequently utilized L-lactate as a metabolic fuel. As a result of their higher dependency on glycolysis, we were able to selectively inhibit the growth of these UOK257 cells by treatment with 2-deoxyglucose. This work suggests that targeting glycolytic metabolism may be used therapeutically to treat Birt-Hogg-Dube-associated renal lesions. Oncogene (2011) 30, 1159-1173; doi:10.1038/onc.2010.497; published online 8 November 2010	[Preston, R. S.; Dunlop, E. A.; Harper, K. T.; Davies, D. M.; Tee, A. R.] Cardiff Univ, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales; [Philp, A.; Baar, K.] Univ Calif Davis, Davis, CA 95616 USA; [Claessens, T.; Gijezen, L.; Brinkhuizen, T.; van Steensel, M. A. M.] Maastricht Univ, Med Ctr, Dept Dermatol, Maastricht, Netherlands; [Claessens, T.; Gijezen, L.; Brinkhuizen, T.; van Steensel, M. A. M.] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [Dydensborg, A. B.; Pause, A.] McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada; [Menko, F. H.] VU Med Ctr Amsterdam, Dept Clin Genet, Amsterdam, Netherlands; [Land, S. C.] Univ Dundee, Ninewells Hosp & Med Sch, Ctr Cardiovasc & Lung Biol, Div Med Sci, Dundee DD1 9SY, Scotland	Cardiff University; University of California System; University of California Davis; Maastricht University; Maastricht University; McGill University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Dundee	Tee, AR (corresponding author), Cardiff Univ, Inst Med Genet, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	teea@cardiff.ac.uk	van Steensel, Maurice A.M./V-3852-2019; /J-6218-2019	/0000-0002-9209-7561; Philp, Andrew/0000-0003-3860-4136; Tee, Andrew/0000-0002-5577-4631; Land, Stephen/0000-0001-9216-5969; van Steensel, Maurice/0000-0002-7507-2442; Baar, Keith/0000-0001-9337-6186; Davies, Mark/0000-0002-0688-3129	Association for International Cancer Research [06-914/915]; Wellcome Trust [088032/Z/08/Z]; Dutch Cancer Society [UM2009-4352, UM2010-4609]; Engineering and Physical Sciences Research Council [EP/E008925/1]; Biotechnology and Biological Sciences Research Council [BB/F002084/1]; BBSRC [BB/F002084/1] Funding Source: UKRI; EPSRC [EP/E008925/1] Funding Source: UKRI; Worldwide Cancer Research [06-0914] Funding Source: researchfish	Association for International Cancer Research; Wellcome Trust(Wellcome TrustEuropean Commission); Dutch Cancer Society(KWF Kankerbestrijding); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Worldwide Cancer Research	This work was supported by The Association for International Cancer Research Career Development Fellowship (No 06-914/915) (to A Tee). The Myrovlytis Trust supports the labs of A Tee, M v Steensel and A Pause and Partnership for Cures supports A Tee and Mv Steensel. Funding was also provided by the Wellcome Trust (No 088032/Z/08/Z) (to S Land) and the Dutch Cancer Society (grants UM2009-4352 to M v Steensel and UM2010-4609 to T Brinkhuizen). M Kamps, A van Marion and V Winnepenninckx (all of the MUMC) provided valuable assistance with immunohistochemistry. Funding was also provided by the Engineering and Physical Sciences Research Council (EP/E008925/1) and the Biotechnology and Biological Sciences Research Council (BB/F002084/1) (to K Baar). We also thank Wales Gene Park.	Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Bratslavsky G, 2007, CLIN CANCER RES, V13, P4667, DOI 10.1158/1078-0432.CCR-06-2510; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x; Deldicque L, 2007, AM J PHYSIOL-CELL PH, V293, pC1263, DOI 10.1152/ajpcell.00162.2007; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; FIRTH JD, 1994, P NATL ACAD SCI USA, V91, P6496, DOI 10.1073/pnas.91.14.6496; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Gao L, 2004, FEBS LETT, V569, P256, DOI 10.1016/j.febslet.2004.06.004; GARCIA CK, 1995, J BIOL CHEM, V270, P1843, DOI 10.1074/jbc.270.4.1843; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Hasumi Y, 2009, P NATL ACAD SCI USA, V106, P18722, DOI 10.1073/pnas.0908853106; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hemminki K, 2002, CARCINOGENESIS, V23, P809, DOI 10.1093/carcin/23.5.809; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Khoo SK, 2002, J MED GENET, V39, P906, DOI 10.1136/jmg.39.12.906; Kiuru M, 2004, CURR MOL MED, V4, P869, DOI 10.2174/1566524043359638; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liu MY, 2003, CANCER RES, V63, P2675; Maxwell PH, 2005, SEMIN CELL DEV BIOL, V16, P523, DOI 10.1016/j.semcdb.2005.03.001; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Rapisarda A, 2002, CANCER RES, V62, P4316; Robey R.B., 2005, DRUG DISCOV TODAY DI, V2, P239, DOI [10.1016/j.ddmec.2005.05.021, DOI 10.1016/J.DDMEC.2005.05.021, DOI 10.1016/j.ddmec.2005.05.021]; Roland I, 2000, EUR J BIOCHEM, V267, P3567, DOI 10.1046/j.1432-1327.2000.01385.x; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; SLEGTENHORST MV, 2007, J BIOL CHEM, V282, P24583; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; SUAREZ RK, 1986, AM J PHYSIOL, V251, pR537, DOI 10.1152/ajpregu.1986.251.3.R537; Sudarshan S, 2009, MOL CELL BIOL, V29, P4080, DOI 10.1128/MCB.00483-09; Treins C, 2006, BIOCHEM BIOPH RES CO, V342, P1197, DOI 10.1016/j.bbrc.2006.02.088; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P319; Wigfield SM, 2008, BRIT J CANCER, V98, P1975, DOI 10.1038/sj.bjc.6604356; Woodward ER, 2008, CLIN CANCER RES, V14, P5925, DOI 10.1158/1078-0432.CCR-08-0608; YANG Y, 2007, CANC GENET CYTOGEN, V96, P336	44	52	52	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	10					1159	1173		10.1038/onc.2010.497	http://dx.doi.org/10.1038/onc.2010.497			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	732QD	21057536	Green Accepted			2022-12-25	WOS:000288202400003
J	Samuel, S; Fan, F; Dang, LH; Xia, L; Gaur, P; Ellis, LM				Samuel, S.; Fan, F.; Dang, L. H.; Xia, L.; Gaur, P.; Ellis, L. M.			Intracrine vascular endothelial growth factor signaling in survival and chemoresistance of human colorectal cancer cells	ONCOGENE			English	Article						VEGF; chemosensitivity; colorectal cancer; autocrine; intracrine; apoptosis	PERMEABILITY FACTOR; TUMOR-CELLS; FACTOR RECEPTOR-1; VEGF; APOPTOSIS; BCL-2; PROLIFERATION; ANGIOGENESIS; EXPRESSION; LETHALITY	Although the effects of vascular endothelial growth factor (VEGF) on angiogenesis and vascular function are well known, the effects of VEGF on tumor cell function remain to be elucidated. We studied phenotypic changes in human colorectal cancer (CRC) cells with homozygous deletion of VEGF alleles to determine the potential direct role of VEGF on tumor cell function. Loss of VEGF expression led to significantly decreased cell growth and increased spontaneous apoptosis in CRC cells (P < 0.01). Loss of VEGF also increased the in vitro sensitivity of cells to the cytotoxic effects of the chemotherapeutic drug 5-fluorouracil, as shown by increased apoptosis (P < 0.05). These effects were mediated via upregulation of the pro-apoptotic mediators caspase-3, cleaved PARP and Bax and downregulation of the pro-survival mediator survivin. Our findings suggest a novel and distinct function of VEGF in mediating autocrine/intracrine CRC cell survival. Oncogene (2011) 30, 1205-1212; doi:10.1038/onc.2010.496; published online 8 November 2010	[Ellis, L. M.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Unit 173, Houston, TX 77230 USA; [Dang, L. H.] Univ Florida, Dept Med, Div Hematol Oncol, Gainesville, FL USA; [Gaur, P.; Ellis, L. M.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77230 USA	University of Texas System; UTMD Anderson Cancer Center; State University System of Florida; University of Florida; University of Texas System; UTMD Anderson Cancer Center	Ellis, LM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Unit 173, 515 Holcombe Blvd,POB 173, Houston, TX 77230 USA.	lellis@mdanderson.org	Khaitan, Puja/AAQ-6413-2020	Khaitan, Puja/0000-0001-8654-062X	NIH Cancer Center [CA016672]; RE 'Bob' Smith Fund for Cancer Research; NIH [CCSG CA016672, T32 CA09599, R01 CA112390]; William C Liedtke Chair in Cancer Research; NATIONAL CANCER INSTITUTE [R21CA159270, P30CA016672, T32CA009599, R01CA112390] Funding Source: NIH RePORTER	NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RE 'Bob' Smith Fund for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William C Liedtke Chair in Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Cytometry and Cellular Imaging Core Facility at M. D. Anderson Cancer Center (funded by NIH Cancer Center Support Grant CA016672) for assistance with data analysis using the flow cytometers. We thank Sunita Patterson (Department of Scientific Publications) for manuscript editing and Rita Hernandez for editorial assistance. This work was supported by the RE 'Bob' Smith Fund for Cancer Research (SS), NIH grants CCSG CA016672, T32 CA09599 (PG), R01 CA112390 (LME), and the William C Liedtke Chair in Cancer Research.	Bachelder RE, 2001, CANCER RES, V61, P5736; Barr MP, 2008, INT J ONCOL, V32, P41; BROWN LF, 1997, EXS, V79, P233; Calvani M, 2008, CANCER RES, V68, P285, DOI 10.1158/0008-5472.CAN-07-5564; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Dang DT, 2006, CANCER RES, V66, P1684, DOI 10.1158/0008-5472.CAN-05-2887; Dias S, 2002, BLOOD, V99, P2532, DOI 10.1182/blood.V99.7.2532; Escudier B, 2009, J CLIN ONCOL, V27, P3312, DOI 10.1200/JCO.2008.19.5511; Fan F, 2005, ONCOGENE, V24, P2647, DOI 10.1038/sj.onc.1208246; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; Hutchings H, 2003, FASEB J, V17, P1520, DOI 10.1096/fj.02-0691fje; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lee TH, 2007, PLOS MED, V4, P1101, DOI 10.1371/journal.pmed.0040186; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Masuda K, 2008, PLOS MED, V5, P805, DOI 10.1371/journal.pmed.0050094; Nor JE, 2001, CANCER RES, V61, P2183; Pidgeon GP, 2001, BRIT J CANCER, V85, P273, DOI 10.1054/bjoc.2001.1876; Rini BI, 2008, J CLIN ONCOL, V26, P5422, DOI 10.1200/JCO.2008.16.9847; Santos SCR, 2004, BLOOD, V103, P3883, DOI 10.1182/BLOOD-2003-05-1634; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; SENGER DR, 1986, CANCER RES, V46, P5629; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Vincent L, 2005, CANCER RES, V65, P3185, DOI 10.1158/0008-5472.CAN-04-3598	31	48	51	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	10					1205	1212		10.1038/onc.2010.496	http://dx.doi.org/10.1038/onc.2010.496			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	732QD	21057529	Green Accepted			2022-12-25	WOS:000288202400007
J	Noda, M; Doi, Y; Liang, JF; Kawanokuchi, J; Sonobe, Y; Takeuchi, H; Mizuno, T; Suzumura, A				Noda, Mariko; Doi, Yukiko; Liang, Jianfeng; Kawanokuchi, Jun; Sonobe, Yoshifumi; Takeuchi, Hideyuki; Mizuno, Tetsuya; Suzumura, Akio			Fractalkine Attenuates Excito-neurotoxicity via Microglial Clearance of Damaged Neurons and Antioxidant Enzyme Heme Oxygenase-1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; ACTIVATED MICROGLIA; MOUSE MODEL; RAT-BRAIN; TRANSCRIPTION FACTORS; SOLUBLE FRACTALKINE; CHEMOKINE RECEPTORS; APOPTOTIC NEURONS; UP-REGULATION; IN-VIVO	Glutamate-induced excito-neurotoxicity likely contributes to non-cell autonomous neuronal death in neurodegenerative diseases. Microglial clearance of dying neurons and associated debris is essential to maintain healthy neural networks in the central nervous system. In fact, the functions of microglia are regulated by various signaling molecules that are produced as neurons degenerate. Here, we show that the soluble CX3C chemokine fractalkine (sFKN), which is secreted from neurons that have been damaged by glutamate, promotes microglial phagocytosis of neuronal debris through release of milk fat globule-EGF factor 8, a mediator of apoptotic cell clearance. In addition, sFKN induces the expression of the antioxidant enzyme heme oxygenase-1 (HO-1) in microglia in the absence of neurotoxic molecule production, including NO, TNF, and glutamate. sFKN treatment of primary neuron-microglia co-cultures significantly attenuated glutamate-induced neuronal cell death. Using several specific MAPK inhibitors, we found that sFKN-induced heme oxygenase-1 expression was primarily mediated by activation of JNK and nuclear factor erythroid 2-related factor 2. These results suggest that sFKN secreted from glutamate-damaged neurons provides both phagocytotic and neuroprotective signals.	[Noda, Mariko; Doi, Yukiko; Liang, Jianfeng; Kawanokuchi, Jun; Sonobe, Yoshifumi; Takeuchi, Hideyuki; Mizuno, Tetsuya; Suzumura, Akio] Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Mizuno, T (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	tmizuno@riem.nagoya-u.ac.jp		Noda, Mariko/0000-0002-6066-1359; Takeuchi, Hideyuki/0000-0001-5912-7581	National Institute of Biomedical Innovation (NIBIO); Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; New Energy and Industrial Technology Development Organization (NEDO)	National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by the Program for Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation (NIBIO), a Grant-in-aid for the global COE program from the Ministry of Education, Culture, Sports, Science and Technology of Japan, grants from the Ministry of Health, Labor and Welfare of Japan, and the New Energy and Industrial Technology Development Organization (NEDO).	Alam J, 2007, AM J RESP CELL MOL, V36, P166, DOI 10.1165/rcmb.2006-0340TR; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; BOCCHINI V, 1988, INT J DEV NEUROSCI, V6, P525, DOI 10.1016/0736-5748(88)90060-3; Boddaert J, 2007, AM J PATHOL, V170, P921, DOI 10.2353/ajpath.2007.060664; Cambien B, 2001, BLOOD, V97, P2031, DOI 10.1182/blood.V97.7.2031; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Clark AK, 2006, J NEUROCHEM, V99, P868, DOI 10.1111/j.1471-4159.2006.04126.x; Denes A, 2008, J CEREBR BLOOD F MET, V28, P1707, DOI 10.1038/jcbfm.2008.64; Doi Y, 2009, AM J PATHOL, V175, P2121, DOI 10.2353/ajpath.2009.090418; Elbirt KK, 1999, P ASSOC AM PHYSICIAN, V111, P438, DOI 10.1111/paa.1999.111.5.438; Farfara D, 2008, J CELL MOL MED, V12, P762, DOI 10.1111/j.1582-4934.2008.00314.x; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Fuller AD, 2008, J NEUROIMMUNE PHARM, V3, P246, DOI 10.1007/s11481-008-9118-2; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Kanninen K, 2009, P NATL ACAD SCI USA, V106, P16505, DOI 10.1073/pnas.0908397106; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim TS, 2008, NEUROSCI LETT, V436, P196, DOI 10.1016/j.neulet.2008.03.019; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Li QB, 2007, LIFE SCI, V80, P1087, DOI 10.1016/j.lfs.2006.11.043; Limatola C, 2005, J NEUROIMMUNOL, V166, P19, DOI 10.1016/j.jneuroim.2005.03.023; Lyons A, 2009, J NEUROCHEM, V110, P1547, DOI 10.1111/j.1471-4159.2009.06253.x; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Miksa M, 2007, MOL MED, V13, P553, DOI 10.2119/2007-00019.Miksa; Milligan ED, 2008, J NEUROIMMUNOL, V198, P113, DOI 10.1016/j.jneuroim.2008.04.011; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Mizuno T, 2004, NEUROPHARMACOLOGY, V46, P404, DOI 10.1016/j.neuropharm.2003.09.009; Naidu S, 2009, J IMMUNOL, V182, P7048, DOI 10.4049/jimmunol.0900006; Napoli I, 2009, GLIA, V57, P1660, DOI 10.1002/glia.20878; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Nishiyori A, 1998, FEBS LETT, V429, P167, DOI 10.1016/S0014-5793(98)00583-3; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Pappolla MA, 1998, AM J PATHOL, V152, P871; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Stolzing A, 2004, FASEB J, V18, P743, DOI 10.1096/fj.03-0374fje; Surh YJ, 2009, ARCH PHARM RES, V32, P1163, DOI 10.1007/s12272-009-1807-8; SUZUMURA A, 1987, J NEUROIMMUNOL, V15, P263, DOI 10.1016/0165-5728(87)90121-4; Syapin PJ, 2008, BRIT J PHARMACOL, V155, P623, DOI 10.1038/bjp.2008.342; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takekawa M, 2005, MOL CELL, V18, P295, DOI 10.1016/j.molcel.2005.04.001; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Takeuchi H., 2010, CLIN EXP NEUROIMMUNO, V1, P12, DOI [10.1111/j.1759-1961.2009.00001.x, DOI 10.1111/J.1759-1961.2009.00001.X]; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Yasui Y, 2007, BIOL PHARM BULL, V30, P443, DOI 10.1248/bpb.30.443	49	108	112	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2308	2319		10.1074/jbc.M110.169839	http://dx.doi.org/10.1074/jbc.M110.169839			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21071446	hybrid, Green Published			2022-12-25	WOS:000286191500070
J	Palmer, MT; Lee, YK; Maynard, CL; Oliver, JR; Bikle, DD; Jetten, AM; Weaver, CT				Palmer, Matthew T.; Lee, Yun Kyung; Maynard, Craig L.; Oliver, James R.; Bikle, Daniel D.; Jetten, Anton M.; Weaver, Casey T.			Lineage-specific Effects of 1,25-Dihydroxyvitamin D-3 on the Development of Effector CD4 T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; INFLAMMATORY-BOWEL-DISEASE; GROWTH-FACTOR-BETA; ROR-GAMMA; TGF-BETA; IN-VITRO; TRANSCRIPTIONAL REGULATION; INTESTINAL INFLAMMATION; MEDIATED PATHOLOGY; SKIN INFLAMMATION	Vitamin D deficiency is implicated in autoimmune disease. We therefore evaluated the effects of 1 alpha,25-dihydroxyvitamin D-3 (1,25-D-3), the active form of vitamin D, on the development of T helper 1 (Th1), Th17, and Th9 cells, which are implicated in the pathogenesis of different types of autoimmunity. 1,25-D-3 compromised the development of Th17 and Th9 cells, including IL-22-expressing cells while simultaneously increasing the frequency of IL-10-competent cells. Relative to Th17 and Th9 cells, the effects of 1,25-D-3 on Th1 cells were modest, reflecting the significantly reduced levels of the receptor for vitamin D in this lineage. The use of cells deficient in IL-10 or antibodies that block IL-10 signaling abolished the inhibitory effect of 1,25-D-3 on Th9 cells but had no effect on inhibition of Th17 cell frequencies. Thus, the induction of IL-10 in cultures of Th9 cells is an important mechanism by which 1,25-D-3 compromises Th9 development but does not explain inhibition of Th17 cells. A survey of select representatives of the Th17 transcriptome revealed that the levels of mRNA that encode ROR gamma t, IL-17A, IL-17F, IL-23R, and IL-22, were reduced by 1,25-D-3, whereas IL-21 and aryl hydrocarbon receptor mRNA remained unchanged. These data suggest that vitamin D deficiency may promote autoimmunity by favoring the inordinate production of Th17 and Th9 cells at the expense of regulatory IL-10-producing T cells.	[Palmer, Matthew T.; Lee, Yun Kyung; Maynard, Craig L.; Oliver, James R.; Weaver, Casey T.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Bikle, Daniel D.] Univ Calif San Francisco, Ctr Vet Med, Dept Med, San Francisco, CA 94121 USA; [Jetten, Anton M.] NIEHS, Cell Biol Sect, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA	University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Weaver, CT (corresponding author), Univ Alabama, Dept Pathol, BBRB 870,845 19th St S, Birmingham, AL 35294 USA.	cweaver@uab.edu	Jetten, Anton/C-3736-2019	Jetten, Anton/0000-0003-0954-4445; Weaver, Casey/0000-0002-2180-1793	National Institutes of Health [AI035783, AI057956, DK064400]; Crohn's and Colitis Foundation of America;  [AR053458]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057956, R21AI035783, R01AI035783, T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR053458, R01AR050023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI035783, AI057956, and DK064400 (to C. T. W.) and Postdoctoral Training Grant AR053458. This work was also supported by a Crohn's and Colitis Foundation of America fellowship (to M. T. P.).	Adams JS, 2007, ANN NY ACAD SCI, V1117, P94, DOI 10.1196/annals.1402.036; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Atkins GB, 1999, MOL ENDOCRINOL, V13, P1550, DOI 10.1210/me.13.9.1550; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Cantorna MT, 2000, J NUTR, V130, P2648, DOI 10.1093/jn/130.11.2648; Cantorna MT, 1998, J NUTR, V128, P68, DOI 10.1093/jn/128.1.68; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Chen Z, 2007, SEMIN IMMUNOL, V19, P400, DOI 10.1016/j.smim.2007.10.015; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Ehrchen J, 2007, FASEB J, V21, P3208, DOI 10.1096/fj.06-7261com; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; FOURNIER C, 1990, CLIN IMMUNOL IMMUNOP, V54, P53, DOI 10.1016/0090-1229(90)90005-B; Froicu M, 2003, MOL ENDOCRINOL, V17, P2386, DOI 10.1210/me.2003-0281; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Heine G, 2008, EUR J IMMUNOL, V38, P2210, DOI 10.1002/eji.200838216; Hernan MA, 1999, NEUROLOGY, V53, P1711, DOI 10.1212/WNL.53.8.1711; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; HOSOMI J, 1983, ENDOCRINOLOGY, V113, P1950, DOI 10.1210/endo-113-6-1950; Hsieh JC, 2003, J BIOL CHEM, V278, P38665, DOI 10.1074/jbc.M304886200; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kreindler JL, 2010, J CLIN INVEST, V120, P3242, DOI 10.1172/JCI42388; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; LEMIRE JM, 1991, J CLIN INVEST, V87, P1103, DOI 10.1172/JCI115072; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lim WC, 2005, NAT CLIN PRACT GASTR, V2, P308, DOI 10.1038/ncpgasthep0215; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; MATHIEU C, 1992, DIABETES, V41, P1491, DOI 10.2337/diabetes.41.11.1491; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Meyer T, 2000, P NATL ACAD SCI USA, V97, P9197, DOI 10.1073/pnas.150246097; Moan J, 2008, P NATL ACAD SCI USA, V105, P668, DOI 10.1073/pnas.0710615105; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; NIEVES J, 1994, NEUROLOGY, V44, P1687, DOI 10.1212/WNL.44.9.1687; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; O'Quinn DB, 2008, ADV IMMUNOL, V99, P115, DOI 10.1016/S0065-2776(08)00605-6; Quigley DA, 2009, NATURE, V458, P505, DOI 10.1038/nature07683; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Staeva-Vieira TP, 2002, J IMMUNOL, V168, P1181, DOI 10.4049/jimmunol.168.3.1181; Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vidal M, 2002, MOL CELL BIOL, V22, P2777, DOI 10.1128/MCB.22.8.2777-2787.2002; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	63	160	172	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					997	1004		10.1074/jbc.M110.163790	http://dx.doi.org/10.1074/jbc.M110.163790			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21047796	Green Published, hybrid			2022-12-25	WOS:000286005000010
J	Tasseva, G; Cole, L; Vance, JE				Tasseva, Guergana; Cole, Laura; Vance, Jean E.			N-Myc and SP Regulate Phosphatidylserine Synthase-1 Expression in Brain and Glial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE-ALPHA; HAMSTER OVARY CELLS; LOOP-HELIX PROTEINS; TRANSCRIPTIONAL ENHANCER FACTOR-4; DNA-BINDING PROTEINS; C-MYC; CYCLE PROGRESSION; GENE-EXPRESSION; NERVOUS-SYSTEM; LIPID RELEASE	Phosphatidylserine (PS) is an essential constituent of biological membranes and plays critical roles in apoptosis and cell signaling. Because no information was available on transcriptional mechanisms that regulate PS biosynthesis in mammalian cells, we investigated the regulation of expression of the mouse PS synthase-1 (Pss1) gene. The Pss1 core promoter was characterized in vitro and in vivo through gel shift and chromatin immunoprecipitation assays. Transcription factor-binding sites, such as a GC-box cluster that binds Sp1/Sp3/Sp4 and N-Myc, and a degenerate E-box motif that interacts with Tal1 and E47, were identified. Pss1 transactivation was higher in brain of neonatal mice than in other tissues, consistent with brain being a major site of expression of Pss1 mRNA and PSS1 activity. Enzymatic assays revealed that PSS1 activity is enriched in primary cortical astrocytes compared with primary cortical neurons. Site-directed mutagenesis of binding sites within the Pss1 promoter demonstrated that Sp and N-Myc synergistically activate Pss1 expression in astrocytes. Chromatin immunoprecipitation indicated that Sp1, Sp3, and Sp4 interact with a common DNA binding site on the promoter. Reduction in levels of Sp1, Sp3, or N-Myc proteins by RNA interference decreased promoter activity. In addition, disruption of Sp/DNA binding with mithramycin significantly reduced Pss1 expression and PSS1 enzymatic activity, underscoring the essential contribution of Sp factors in regulating PSS1 activity. These studies provide the first analysis of mechanisms that regulate expression of a mammalian Pss gene in brain.	[Tasseva, Guergana; Cole, Laura; Vance, Jean E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Tasseva, Guergana; Vance, Jean E.] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada; [Cole, Laura] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta; University of Alberta	Vance, JE (corresponding author), Univ Alberta, Grp Mol & Cell Biol Lipids, 328 HMRC, Edmonton, AB T6G 2S2, Canada.	jean.vance@ualberta.ca			Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes for Health Research.	Abe T, 2003, BIOCHEM J, V375, P673, DOI 10.1042/BJ20031052; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; AMATI B, 1994, CURR OPIN GENET DEV, V4, P102, DOI 10.1016/0959-437X(94)90098-1; AMATI B, 1993, EMBO J, V12, P5083, DOI 10.1002/j.1460-2075.1993.tb06202.x; AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Aoyama C, 2007, BBA-MOL CELL BIOL L, V1771, P1148, DOI 10.1016/j.bbalip.2007.07.003; Arikketh D, 2008, J BIOL CHEM, V283, P12888, DOI 10.1074/jbc.M800714200; Banchio C, 2004, J BIOL CHEM, V279, P40220, DOI 10.1074/jbc.M406468200; Banchio C, 2006, J BIOL CHEM, V281, P10010, DOI 10.1074/jbc.M513503200; Banchio C, 2003, J BIOL CHEM, V278, P32457, DOI 10.1074/jbc.M304810200; Banchio C, 2007, J BIOL CHEM, V282, P14827, DOI 10.1074/jbc.M700527200; Bergo MO, 2002, J BIOL CHEM, V277, P47701, DOI 10.1074/jbc.M207734200; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; Bradley CK, 2006, EUR J NEUROSCI, V23, P1677, DOI 10.1111/j.1460-9568.2006.04712.x; Chadjichristos C, 2002, J BIOL CHEM, V277, P43903, DOI 10.1074/jbc.M206111200; CHENG JT, 1993, ONCOGENE, V8, P677; Cole LK, 2010, J BIOL CHEM, V285, P11880, DOI 10.1074/jbc.M110.109843; DERYCKERE F, 1994, BIOTECHNIQUES, V16, P405; DiNapoli MR, 1997, J IMMUNOL, V158, P1810; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gadella BM, 2000, DEVELOPMENT, V127, P2407; Gagne J, 1996, BRAIN RES, V740, P337, DOI 10.1016/S0006-8993(96)00897-9; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; GHOSH SJ, 1994, J BIOL CHEM, V269, P10000; Gong JS, 2002, J BIOL CHEM, V277, P29919, DOI 10.1074/jbc.M203934200; Goracci G, 1976, Adv Exp Med Biol, V72, P123; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; Hayashi H, 2004, J BIOL CHEM, V279, P14009, DOI 10.1074/jbc.M313828200; HSU HL, 1994, P NATL ACAD SCI USA, V91, P5947, DOI 10.1073/pnas.91.13.5947; HSU HL, 1991, MOL CELL BIOL, V11, P3037, DOI 10.1128/MCB.11.6.3037; HSU HL, 1994, MOL CELL BIOL, V14, P1256, DOI 10.1128/MCB.14.2.1256; Hubscher H. G., 1959, BIOCHIM BIOPHYS ACTA, V36, P518; Johnson SE, 1996, MOL CELL BIOL, V16, P1604; KANFER JN, 1988, FEBS LETT, V240, P101, DOI 10.1016/0014-5793(88)80347-8; Kennett SB, 1997, NUCLEIC ACIDS RES, V25, P3110, DOI 10.1093/nar/25.15.3110; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Kuge O, 1998, P NATL ACAD SCI USA, V95, P4199, DOI 10.1073/pnas.95.8.4199; KUGE O, 1991, J BIOL CHEM, V266, P24184; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; Le Goff W, 2003, J LIPID RES, V44, P1322, DOI 10.1194/jlr.M200425-JLR200; Lee LTO, 2004, MOL ENDOCRINOL, V18, P1740, DOI 10.1210/me.2003-0461; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Lluis F, 2005, EMBO J, V24, P974, DOI 10.1038/sj.emboj.7600528; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Meyer N, 2006, SEMIN CANCER BIOL, V16, P275, DOI 10.1016/j.semcancer.2006.07.011; Michikawa M, 2001, J NEUROSCI, V21, P7226, DOI 10.1523/JNEUROSCI.21-18-07226.2001; MILLER DM, 1987, AM J MED SCI, V294, P388, DOI 10.1097/00000441-198711000-00015; Mozzi R, 2003, NEUROCHEM RES, V28, P195, DOI 10.1023/A:1022412831330; Muroyama Y, 2005, NATURE, V438, P360, DOI 10.1038/nature04139; NISHIJIMA M, 1986, J BIOL CHEM, V261, P5784; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Parisi F, 2007, NUCLEIC ACIDS RES, V35, P1098, DOI 10.1093/nar/gkl1157; Saito K, 1998, J BIOL CHEM, V273, P17199, DOI 10.1074/jbc.273.27.17199; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Secombe J, 2004, CELL, V117, P153, DOI 10.1016/S0092-8674(04)00336-8; Sloan SR, 1996, MOL CELL BIOL, V16, P6900; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Steenbergen R, 2006, BBA-MOL CELL BIOL L, V1761, P313, DOI 10.1016/j.bbalip.2006.03.005; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Stone SJ, 1999, BIOCHEM J, V342, P57, DOI 10.1042/0264-6021:3420057; Stone SJ, 1998, J BIOL CHEM, V273, P7293, DOI 10.1074/jbc.273.13.7293; Sturbois-Balcerzak B, 2001, J BIOL CHEM, V276, P8205, DOI 10.1074/jbc.M009776200; Sugimoto H, 2005, J BIOL CHEM, V280, P40857, DOI 10.1074/jbc.M503578200; Sugimoto H, 2003, J BIOL CHEM, V278, P19716, DOI 10.1074/jbc.M301590200; Sugimoto H, 2001, J BIOL CHEM, V276, P12338, DOI 10.1074/jbc.M100090200; Sugimoto H, 2008, PROG LIPID RES, V47, P204, DOI 10.1016/j.plipres.2008.01.002; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Van Eekelen JAM, 2003, NEUROSCIENCE, V122, P421, DOI 10.1016/S0306-4522(03)00571-2; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; VANCE JE, 1990, J BIOL CHEM, V265, P7248; WATADA H, 1995, GENE, V153, P255, DOI 10.1016/0378-1119(94)00765-K; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zhu L, 2009, GENE, V447, P51, DOI 10.1016/j.gene.2009.07.014; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	82	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1061	1073		10.1074/jbc.M110.158709	http://dx.doi.org/10.1074/jbc.M110.158709			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21068393	hybrid, Green Published			2022-12-25	WOS:000286005000017
J	Kurasin, M; Valjamae, P				Kurasin, Mihhail; Vaeljamaee, Priit			Processivity of Cellobiohydrolases Is Limited by the Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI; SERRATIA-MARCESCENS; HUMICOLA-INSOLENS; PHANEROCHAETE-CHRYSOSPORIUM; 1.9-ANGSTROM RESOLUTION; CRYSTALLINE CELLULOSE; ENZYMATIC-HYDROLYSIS; AROMATIC RESIDUES; STRUCTURAL BASIS; BINDING DOMAIN	Processive cellobiohydrolases (CBHs) are the key components of fungal cellulase systems. Despite the wealth of structural data confirming the processive mode of action, little quantitative information on the processivity of CBHs is available. Here, we developed a method for measuring cellulase processivity. Sensitive fluorescence detection of enzyme-generated insoluble reducing groups on cellulose after labeling with diaminopyridine enabled quantification of the number of reducing-end exo-mode and endo-mode initiations. Both CBHs TrCel7A from Trichoderma reesei and PcCel7D from Phanerochaete chrysosporium employed reducing-end exo- and endo-mode initiation in parallel. Processivity values measured for TrCel7A and PcCel7D on cellulose hydrolysis were more than an order of magnitude lower than the values of intrinsic processivity that were found from the ratio of catalytic constant (k(cat)) and dissociation rate constant (k(off)). We propose that the length of the obstacle-free path available for a processive run on cellulose chain limits the processivity of CBHs on cellulose. TrCel7A and PcCel7D differed in their k(off) values, whereas the k(cat) values were similar. Furthermore, the k(off) values for endoglucanases (EGs) were much higher than the k(off) values for CBHs, whereas the k(cat) values for EGs and CBHs were within the same order of magnitude. These results suggest that the value of k(off) may be the primary target for the selection of cellulases.	[Kurasin, Mihhail; Vaeljamaee, Priit] Univ Tartu, Inst Mol & Cell Biol, EE-51014 Tartu, Estonia	University of Tartu	Valjamae, P (corresponding author), Vanemuise 46-138, EE-51014 Tartu, Estonia.	priit.valjamae@ut.ee	Väljamäe, Priit/O-6468-2018	Väljamäe, Priit/0000-0002-1035-9493	European Commission [213139]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission (FP7/2007-2013, Grant 213139).	ANUMULA KR, 1994, ANAL BIOCHEM, V220, P275, DOI 10.1006/abio.1994.1338; Armand S, 1997, J BIOL CHEM, V272, P2709, DOI 10.1074/jbc.272.5.2709; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; BHIKHABHAI R, 1984, Journal of Applied Biochemistry, V6, P336; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; HAKANSSON U, 1978, BIOCHIM BIOPHYS ACTA, V524, P385; HENRISSAT B, 1998, CELLULOSE COMMUN, V5, P84; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; HOSHINO E, 1993, J BIOCHEM-TOKYO, V114, P230, DOI 10.1093/oxfordjournals.jbchem.a124159; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Imai T, 1998, FEBS LETT, V432, P113, DOI 10.1016/S0014-5793(98)00845-X; IRWIN DC, 1993, BIOTECHNOL BIOENG, V42, P1002, DOI 10.1002/bit.260420811; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; Lemoine M, 2009, BIOCHEM J, V419, P545, DOI 10.1042/BJ20080619; Linder M, 1996, P NATL ACAD SCI USA, V93, P12251, DOI 10.1073/pnas.93.22.12251; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; Nutt A, 1998, EUR J BIOCHEM, V258, P200, DOI 10.1046/j.1432-1327.1998.2580200.x; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; ReverbelLeroy C, 1997, J BACTERIOL, V179, P46, DOI 10.1128/jb.179.1.46-52.1997; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; SALOHEIMO M, 1988, GENE, V63, P11, DOI 10.1016/0378-1119(88)90541-0; Sandgren M, 2001, J MOL BIOL, V308, P295, DOI 10.1006/jmbi.2001.4583; Schwarzer D, 2009, J BIOL CHEM, V284, P9465, DOI 10.1074/jbc.M808475200; Sikorski P, 2006, BIOCHEMISTRY-US, V45, P9566, DOI 10.1021/bi060370l; STAHLBERG J, 1993, BIOCHIM BIOPHYS ACTA, V1157, P107, DOI 10.1016/0304-4165(93)90085-M; Stern R, 2008, CHEM REV, V108, P5061, DOI 10.1021/cr078240l; Teeri TT, 1997, TRENDS BIOTECHNOL, V15, P160, DOI 10.1016/S0167-7799(97)01032-9; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; UZCATEGUI E, 1991, J BIOTECHNOL, V19, P271, DOI 10.1016/0168-1656(91)90064-3; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; Varrot A, 1999, BIOCHEMISTRY-US, V38, P8884, DOI 10.1021/bi9903998; Varrot A, 2003, STRUCTURE, V11, P855, DOI 10.1016/S0969-2126(03)00124-2; Velleste R, 2010, CELLULOSE, V17, P125, DOI 10.1007/s10570-009-9356-3; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Vuong TV, 2009, APPL ENVIRON MICROB, V75, P6655, DOI 10.1128/AEM.01260-09; Watson BJ, 2009, J BACTERIOL, V191, P5697, DOI 10.1128/JB.00481-09; Wei H, 2009, CURR OPIN BIOTECH, V20, P330, DOI 10.1016/j.copbio.2009.05.008; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200; Zhang S, 2000, EUR J BIOCHEM, V267, P3101, DOI 10.1046/j.1432-1327.2000.01315.x; Zhang YHP, 2005, BIOMACROMOLECULES, V6, P1510, DOI 10.1021/bm049235j; Zhou WL, 2004, BIOCHEMISTRY-US, V43, P9655, DOI 10.1021/bi049394n	55	193	197	3	74	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					169	177		10.1074/jbc.M110.161059	http://dx.doi.org/10.1074/jbc.M110.161059			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21051539	Green Published, hybrid			2022-12-25	WOS:000285782800018
J	Ouyang, JY; Parakhia, RA; Ochs, RS				Ouyang, Jiangyong; Parakhia, Rahulkumar A.; Ochs, Raymond S.			Metformin Activates AMP Kinase through Inhibition of AMP Deaminase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; SKELETAL-MUSCLE; GLUCOSE-UPTAKE; GLYCOGEN-SYNTHESIS; COMPLEX I; INSULIN; LKB1; METABOLISM; TRANSPORT; PHOSPHORYLATION	The mechanism for how metformin activates AMPK (AMP-activated kinase) was investigated in isolated skeletal muscle L6 cells. A widely held notion is that inhibition of the mitochondrial respiratory chain is central to the mechanism. We also considered other proposals for metformin action. As metabolic pathway markers, we focused on glucose transport and fatty acid oxidation. We also confirmed metformin actions on other metabolic processes in L6 cells. Metformin stimulated both glucose transport and fatty acid oxidation. The mitochondrial Complex I inhibitor rotenone also stimulated glucose transport but it inhibited fatty acid oxidation, independently of metformin. The peroxynitrite generator 3-morpholinosydnonimine stimulated glucose transport, but inhibited fatty acid oxidation. Addition of the nitric oxide precursor arginine to cells did not affect glucose transport. These studies differentiate metformin from inhibition of mitochondrial respiration and from active nitrogen species. Knockdown of adenylate kinase also failed to affect metformin stimulation of glucose transport. Hence, any means of increase in ADP appears not to be involved in the metformin mechanism. Knockdown of LKB1, an upstream kinase and AMPK activator, did not affect metformin action. Having ruled out existing proposals, we suggest a new one: metformin might increase AMP through inhibition of AMP deaminase (AMPD). We found that metformin inhibited purified AMP deaminase activity. Furthermore, a known inhibitor of AMPD stimulated glucose uptake and fatty acid oxidation. Both metformin and the AMPD inhibitor suppressed ammonia accumulation by the cells. Knockdown of AMPD obviated metformin stimulation of glucose transport. We conclude that AMPD inhibition is the mechanism of metformin action.	[Parakhia, Rahulkumar A.; Ochs, Raymond S.] St Johns Univ, Dept Pharmaceut Sci, Sch Pharm, Queens, NY 11439 USA; [Ouyang, Jiangyong] NYU, Sch Med, Dept Pathol, New York, NY 10010 USA	Saint John's University; New York University	Ochs, RS (corresponding author), St Johns Univ, Dept Pharmaceut Sci, Sch Pharm, Queens, NY 11439 USA.	ochsr@stjohns.edu	Nili, Mona/P-5570-2016					ASHBY B, 1978, J BIOL CHEM, V253, P8728; Batandier C, 2006, J BIOENERG BIOMEMBR, V38, P33, DOI 10.1007/s10863-006-9003-8; Bergmeyer HU, 1974, METHODS ENZYMATIC AN; Bertrand L., 2006, AM J PHYSL HEART CIR; Blair AS, 1999, J BIOL CHEM, V274, P36293, DOI 10.1074/jbc.274.51.36293; Borkowski T, 2008, NUCLEOS NUCLEOT NUCL, V27, P867, DOI 10.1080/15257770802146536; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Ceddia RB, 2005, DIABETOLOGIA, V48, P132, DOI 10.1007/s00125-004-1609-y; Collier CA, 2006, AM J PHYSIOL-ENDOC M, V291, pE182, DOI 10.1152/ajpendo.00272.2005; CUENDET GS, 1976, J CLIN INVEST, V58, P1078, DOI 10.1172/JCI108559; Daiber A, 2009, FREE RADICAL BIO MED, V47, P458, DOI 10.1016/j.freeradbiomed.2009.05.019; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Davis BJ, 2006, DIABETES, V55, P496, DOI 10.2337/diabetes.55.02.06.db05-1064; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Erion MD, 1999, J AM CHEM SOC, V121, P308, DOI 10.1021/ja983153j; Fediuc S, 2008, J CELL PHYSIOL, V215, P392, DOI 10.1002/jcp.21321; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Halimi S, 2006, DIABETES METAB, V32, P555, DOI 10.1016/S1262-3636(07)70309-9; Halse R, 2003, DIABETES, V52, P9, DOI 10.2337/diabetes.52.1.9; Hancock CR, 2005, AM J PHYSIOL-CELL PH, V288, pC1287, DOI 10.1152/ajpcell.00567.2004; Hanisch F, 2008, J NEUROL, V255, P318, DOI 10.1007/s00415-008-0530-6; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Hardie DG, 2006, GASTROENTEROLOGY, V131, P973, DOI 10.1053/j.gastro.2006.07.032; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Hinke SA, 2007, BRIT J PHARMACOL, V150, P1031, DOI 10.1038/sj.bjp.0707189; Hoek JB, 2006, GASTROENTEROLOGY, V131, P974, DOI 10.1053/j.gastro.2006.07.033; IBSEN KH, 1961, CANCER RES, V21, P829; Imai K, 2006, BIOCHEM BIOPH RES CO, V351, P595, DOI 10.1016/j.bbrc.2006.10.056; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Jorgensen SB, 2004, DIABETES, V53, pA63; Kalsi KK, 2003, CARDIOVASC RES, V59, P678, DOI 10.1016/S0008-6363(03)00497-8; Kang J, 2001, AM J PHYSIOL-ENDOC M, V280, pE428, DOI 10.1152/ajpendo.2001.280.3.E428; Kim WH, 2007, CELL SIGNAL, V19, P791, DOI 10.1016/j.cellsig.2006.10.004; Kotel'nikova AV, 2001, BIOCHEMISTRY-MOSCOW+, V66, P816, DOI 10.1023/A:1010229216652; KUN E, 1966, MOL PHARMACOL, V2, P481; Lee W. J., 2009, KOREAN DIABETES J, V33, P198, DOI DOI 10.4093/KDJ.2009.33.3.198; Liu JK, 2009, ADV DRUG DELIVER REV, V61, P1343, DOI 10.1016/j.addr.2009.06.007; LOWENSTEIN JM, 1990, INT J SPORTS MED, V11, pS37, DOI 10.1055/s-2007-1024853; Misra P, 2008, EXPERT OPIN THER TAR, V12, P91, DOI 10.1517/14728222.12.1.91; Misra P, 2007, INDIAN J MED RES, V125, P389; Musi N, 2006, CURR MED CHEM, V13, P583, DOI 10.2174/092986706776055724; Ota S, 2009, BIOCHEM BIOPH RES CO, V388, P311, DOI 10.1016/j.bbrc.2009.07.164; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Parakhia RA, 2009, FASEB J, V23; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; SADDIK M, 1991, J BIOL CHEM, V266, P8162; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Sakoda H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1239, DOI 10.1152/ajpendo.00455.2001; SARABIA V, 1992, J CLIN INVEST, V90, P1386, DOI 10.1172/JCI116005; Schimmack G, 2006, DIABETES OBES METAB, V8, P591, DOI 10.1111/j.1463-1326.2005.00561.x; Segu VBG, 1998, METABOLISM, V47, P824, DOI 10.1016/S0026-0495(98)90120-2; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; SMILEY KL, 1967, J BIOL CHEM, V242, P2502; SUSSMAN I, 1980, BIOCHIM BIOPHYS ACTA, V591, P209, DOI 10.1016/0005-2728(80)90153-X; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Wingertzahn MA, 1999, P SOC EXP BIOL MED, V221, P234, DOI 10.1046/j.1525-1373.1999.d01-81.x; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	62	160	181	0	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					1	11		10.1074/jbc.M110.121806	http://dx.doi.org/10.1074/jbc.M110.121806			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21059655	Green Published, hybrid			2022-12-25	WOS:000285782800001
J	Wang, SS; Zheng, YX				Wang, Shusheng; Zheng, Yixian			Identification of a Novel Dynein Binding Domain in Nudel Essential for Spindle Pole Organization in Xenopus Egg Extract	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL DOMAIN; CYTOPLASMIC DYNEIN; ASPERGILLUS-NIDULANS; LIS1; PROTEIN; COMPLEX; BEHAVIOR; MITOSIS	The nuclear distribution protein E (NudE) and nuclear distribution protein E-like (Nudel or Ndel1) interact with both lissencephaly 1 (Lis1) and dynein. These interactions are thought to be essential for dynein function. Previous studies have shown that the highly conserved N terminus of NudE/Nudel directly binds to Lis1, and such binding is critical for dynein activity. By contrast, although the C terminus of NudE/Nudel was reported to bind to dynein, the functional significance of this binding has remained unclear. Using the sperm-mediated spindle assembly assay in Xenopus egg extracts and extensive mutagenesis studies, we have identified a highly conserved dynein binding domain within the first 80 amino acids of Nudel. We further demonstrate that the dynein intermediate chain in the dynein complex is directly involved in this interaction. Importantly, we show that both the dynein and Lis1 binding domains of Nudel are required for spindle pole organization. Finally, we report that spindle defects caused by immuno-depletion of Nudel could be rescued by a 1-fold increase of Lis1 concentration in Xenopus egg extracts. This suggests that an important function of the N terminus of Nudel is to facilitate the interaction between Lis1 and dynein during spindle assembly. Together, our findings open up new avenues to further decipher the mechanism of dynein regulation by Nudel and Lis1.	Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Zheng, Yixian] Howard Hughes Med Inst, Baltimore, MD 21218 USA	Carnegie Institution for Science; Howard Hughes Medical Institute	Zheng, YX (corresponding author), 3520 San Martin Dr, Baltimore, MD 21218 USA.	zheng@ciwemb.edu			National Institutes of Health [GM56312]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM56312.	Derewenda U, 2007, STRUCTURE, V15, P1467, DOI 10.1016/j.str.2007.09.015; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Efimov VP, 2003, MOL BIOL CELL, V14, P871, DOI 10.1091/mbc.E02-06-0359; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Guo J, 2006, MOL BIOL CELL, V17, P680, DOI 10.1091/mbc.E05-04-0360; Hoogenraad CC, 2003, EMBO J, V22, P6004, DOI 10.1093/emboj/cdg592; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Li J, 2005, NAT CELL BIOL, V7, P686, DOI 10.1038/ncb1273; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Ma LW, 2009, ADV ENG MATER, V11, pB267, DOI 10.1002/adem.200900149; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Shan YL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000116; Shen YD, 2008, DEV CELL, V14, P342, DOI 10.1016/j.devcel.2008.01.001; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Stehman SA, 2007, J CELL BIOL, V178, P583, DOI 10.1083/jcb.200610112; Stuurman N, 1999, EUR J CELL BIOL, V78, P278, DOI 10.1016/S0171-9335(99)80061-2; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771	24	37	37	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					587	593		10.1074/jbc.M110.181578	http://dx.doi.org/10.1074/jbc.M110.181578			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21056974	Green Published, hybrid			2022-12-25	WOS:000285782800061
J	Godet, AN; Guergnon, J; Croset, A; Cayla, X; Falanga, PB; Colle, JH; Garcia, A				Godet, Angelique N.; Guergnon, Julien; Croset, Amelie; Cayla, Xavier; Falanga, Pierre Barthelemy; Colle, Jean-Herve; Garcia, Alphonse			PP2A(1) Binding, Cell Transducing and Apoptotic Properties of Vpr(77-92): A New Functional Domain of HIV-1 Vpr Proteins	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; YEAST SCHIZOSACCHAROMYCES-POMBE; MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; C-TERMINAL DOMAIN; FISSION YEAST; BIOCHEMICAL-MECHANISM; PHOSPHATASE 2A; CYCLE ARREST; G(2) ARREST; EXPRESSION	Background: The hallmark of HIV-1 pathogenesis is the progressive CD4(+) T cell depletion and high propensity of CD4(+) T cells to apoptosis. HIV-1 viral protein R (Vpr) is a major pro-apoptotic gene product. A first Vpr-mediated apoptotic mechanism that requires a physical interaction of HIV-1 Vpr(71-82) mitochondriotoxic domain containing the conserved sequence (71-)HFRIGCRHSRIG(-82) with the Adenine Nucleotide Translocator (ANT) has been characterized. The family of Ser/Thr protein phosphatase PP2A interacts with several viral proteins to regulate cell growth and apoptotic pathways. Previous studies based on yeast two hybrid assays and mutational experiments indicated that PP2A(1) is involved in the induction of G2 arrest by HIV-1 Vpr. Principal Findings: Experiments combining pull-down, cell penetration and apoptosis analyses in distinct human cells indicate that the PP2A(1) binding sequence from Vpr(77-92) is a new cell penetrating apoptotic sequence. We also found that the I84P mutation or the IIQ/VTR83-85 and T89A substitutions in the Vpr(77-92) sequence prevent PP2A(1) binding, cell penetration and apoptosis. In addition the double R77A and R80A mutation known to inactivate the mitochondriotoxic Vpr(71-82) domain, has no effect on the biological properties of the Vpr(77-92) domain. Conclusion: Together our data provide evidence for the first time that the Vpr(77-92) sequence delineates a biological active domain of Vpr with PP2A(1) binding and pro-apopototic capacities and, it is conceivable that this cell penetrating sequence may account for the Vpr internalization in uninfected cells. Finally, our data also implicate the existence of two partially overlapping pro-apoptotic domains in the Vpr C-terminal part, a redundancy that represents a new approach to address the question of biological relevance of HIV-1 Vpr. In this context, future studies will be required to determine the functional relevance of the Vpr(77-92) domain in full length Vpr protein and also in entire HIV provirus.	[Godet, Angelique N.; Guergnon, Julien; Croset, Amelie; Falanga, Pierre Barthelemy; Garcia, Alphonse] Inst Pasteur, Lab Phosphatases E3, Unite Signalisat Mol & Activat Cellulaire, Paris, France; [Cayla, Xavier] Univ Tours, INRA, CNRS, IFR 135,UMR 6175, Nouzilly, France; [Colle, Jean-Herve] CNRS, Inst Pasteur, Unite Biol Populat Lymphocytaires, URA 1961, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Godet, AN (corresponding author), Inst Pasteur, Lab Phosphatases E3, Unite Signalisat Mol & Activat Cellulaire, Paris, France.	agarcia@pasteur.fr			Institut-Pasteur; French Government; Caisse Nationale de Maladie (CANAM)	Institut-Pasteur; French Government; Caisse Nationale de Maladie (CANAM)	This work was supported by the Institut-Pasteur. A.N.G. is a recipient of a Ministere Recherche et Technique (MRT) fellowship from the French Government. A. C. was supported by Institut-Pasteur. J.G. was supported by Caisse Nationale de Maladie (CANAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimonti JB, 2003, J GEN VIROL, V84, P1649, DOI 10.1099/vir.0.19110-0; Andersen JL, 2008, EXP MOL PATHOL, V85, P2, DOI 10.1016/j.yexmp.2008.03.015; Andersen JL, 2006, PLOS PATHOG, V2, P1106, DOI 10.1371/journal.ppat.0020127; Arunagiri C, 1997, APOPTOSIS, V2, P69, DOI 10.1023/A:1026487609215; BOSCH M, 1995, EUR J BIOCHEM, V230, P1037, DOI 10.1111/j.1432-1033.1995.tb20653.x; Bourbigot S, 2005, BIOCHEM J, V387, P333, DOI 10.1042/BJ20041759; Chen MZ, 1999, J VIROL, V73, P3236, DOI 10.1128/JVI.73.4.3236-3245.1999; Coeytaux E, 2003, J BIOL CHEM, V278, P18110, DOI 10.1074/jbc.M300248200; Deniaud A, 2004, MITOCHONDRION, V4, P223, DOI 10.1016/j.mito.2004.06.012; DENORONHA C, 1993, MOL BIOL CELL; Elder RT, 2001, VIROLOGY, V287, P359, DOI 10.1006/viro.2001.1007; EVERALL IP, 1993, J NEUROL NEUROSUR PS, V56, P481, DOI 10.1136/jnnp.56.5.481; Frank R, 1996, Methods Mol Biol, V66, P149; Fuller RA, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-10; Garcia A, 2003, BIOCHIMIE, V85, P721, DOI 10.1016/j.biochi.2003.09.004; Guergnon J, 2006, MOL PHARMACOL, V69, P1115, DOI 10.1124/mol.105.019364; Guergnon J, 2006, APOPTOSIS, V11, P1263, DOI 10.1007/s10495-006-7702-6; Huang MB, 2000, J NEUROVIROL, V6, P202, DOI 10.3109/13550280009015823; Jacotot E, 2001, J EXP MED, V193, P509, DOI 10.1084/jem.193.4.509; Jacotot E, 2000, J EXP MED, V191, P33, DOI 10.1084/jem.191.1.33; Janoo A, 2005, J CELL BIOCHEM, V94, P816, DOI 10.1002/jcb.20347; Jones GJ, 2007, J NEUROSCI, V27, P3703, DOI 10.1523/JNEUROSCI.5522-06.2007; Lamine A, 2007, AIDS, V21, P1043, DOI 10.1097/QAD.0b013e3280d5a7ac; LEVY DN, 1995, J VIROL, V69, P1243, DOI 10.1128/JVI.69.2.1243-1252.1995; LEVY DN, 1994, P NATL ACAD SCI USA, V91, P10873, DOI 10.1073/pnas.91.23.10873; Li G, 2007, J BIOL CHEM, V282, P7287, DOI 10.1074/jbc.M607951200; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Masuda M, 2000, J VIROL, V74, P2636, DOI 10.1128/JVI.74.6.2636-2646.2000; Patel CA, 2002, J NEUROVIROL, V8, P86, DOI 10.1080/13550280290049552; Piller SC, 1999, J VIROL, V73, P4230, DOI 10.1128/JVI.73.5.4230-4238.1999; RE F, 1995, J VIROL, V69, P6859, DOI 10.1128/JVI.69.11.6859-6864.1995; Romani B, 2009, J GEN VIROL, V90, P1795, DOI 10.1099/vir.0.011726-0; Sabbah EN, 2005, J NEUROVIROL, V11, P489, DOI 10.1080/13550280500384941; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Sontag E, 2007, J NEUROSCI, V27, P2751, DOI 10.1523/JNEUROSCI.3316-06.2007; Stewart SA, 1997, J VIROL, V71, P5579, DOI 10.1128/JVI.71.7.5579-5592.1997; Taguchi T, 2004, BIOCHEM BIOPH RES CO, V320, P18, DOI 10.1016/j.bbrc.2004.05.126; TAKADORIKONDO A, 1996, INT C AIDS, V11, P22; TRISTEM M, 1992, EMBO J, V11, P3405, DOI 10.1002/j.1460-2075.1992.tb05419.x; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; WAELKENS E, 1987, J BIOL CHEM, V262, P1049; Wheeler EDA, 2006, J NEUROVIROL, V12, P200, DOI 10.1080/13550280600827377; ZHAO LJ, 1994, J BIOL CHEM, V269, P32131; ZHAO LJ, 1994, J BIOL CHEM, V269, P15577; Zhao YQ, 1996, J VIROL, V70, P5821, DOI 10.1128/JVI.70.9.5821-5826.1996	45	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2010	5	11							e13760	10.1371/journal.pone.0013760	http://dx.doi.org/10.1371/journal.pone.0013760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FY	21072166	gold, Green Published, Green Submitted			2022-12-25	WOS:000283645700001
J	Desiderio, UV; Zhu, XL; Evans, JP				Desiderio, Ulyana V.; Zhu, Xiaoling; Evans, Janice P.			ADAM2 Interactions with Mouse Eggs and Cell Lines Expressing alpha(4)/alpha(9) (ITGA4/ITGA9) Integrins: Implications for Integrin-Based Adhesion and Fertilization	PLOS ONE			English	Article							SEQUENCE-SPECIFIC INTERACTION; DISINTEGRIN-LIKE DOMAIN; HETERODIMERIC DISINTEGRIN; PLATELET-AGGREGATION; NEUTROPHIL MIGRATION; BIOLOGICAL FUNCTION; ALPHA(V) INTEGRINS; REPRODUCTIVE ADAMS; BETA(1) INTEGRIN; N-GLYCOSYLATION	Background: Integrins are heterodimeric cell adhesion molecules, with 18 alpha (ITGA) and eight beta (ITGB) subunits forming 24 heterodimers classified into five families. Certain integrins, especially the alpha(4)/alpha(9) (ITGA4/ITGA9) family, interact with members of the ADAM (a disintegrin and metalloprotease) family. ADAM2 is among the better characterized and also of interest because of its role in sperm function. Having shown that ITGA9 on mouse eggs participates in mouse sperm-egg interactions, we sought to characterize ITGA4/ITGA9-ADAM2 interactions. Methodology/Principal Findings: An anti-beta(1)/ITGB1 function-blocking antibody that reduces sperm-egg binding significantly inhibited ADAM2 binding to mouse eggs. Analysis of integrin subunit expression indicates that mouse eggs could express at least ten different integrins, five in the RGD-binding family, two in the laminin-binding family, two in the collagen-binding family, and ITGA9-ITGB1. Adhesion assays to characterize ADAM2 interactions with ITGA4/ITGA9 family members produced the surprising result that RPMI 8866 cell adhesion to ADAM2 was inhibited by an anti-ITGA9 antibody, noteworthy because ITGA9 has only been reported to dimerize with ITGB1, and RPMI 8866 cells lack detectable ITGB1. Antibody and siRNA studies demonstrate that ITGB7 is the beta subunit contributing to RPMI 8866 adhesion to ADAM2. Conclusions/Significance: These data indicate that a novel integrin alpha-beta combination, ITGA9-ITGB7 (alpha(9)beta(7)), in RPMI 8866 cells functions as a binding partner for ADAM2. ITGA9 had previously only been reported to dimerize with ITGB1. Although ITGA9-ITGB7 is unlikely to be a widely expressed integrin and appears to be the result of "compensatory dimerization" occurring in the context of little/no ITGB1 expression, the data indicate that ITGA9-ITGB7 functions as an ADAM binding partner in certain cellular contexts, with implications for mammalian fertilization and integrin function.	[Desiderio, Ulyana V.; Zhu, Xiaoling; Evans, Janice P.] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Desiderio, UV (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	jpevans@jhsph.edu	Evans, Janice/Q-8483-2019		National Institutes of Health [R01 HD037696]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037696] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by grant # R01 HD037696 from the National Institutes of Health to the corresponding author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA EAC, 1995, CELL, V81, P1095, DOI 10.1016/S0092-8674(05)80014-5; ANDERSON DJ, 1993, P NATL ACAD SCI USA, V90, P10051, DOI 10.1073/pnas.90.21.10051; ANDREW DP, 1994, J IMMUNOL, V153, P3847; Arribas J, 2006, CANCER METAST REV, V25, P57, DOI 10.1007/s10555-006-7889-6; Baessler KA, 2009, ACS CHEM BIOL, V4, P357, DOI 10.1021/cb900013d; Bigler D, 2000, J BIOL CHEM, V275, P11576, DOI 10.1074/jbc.275.16.11576; BJARNASON J, 1995, SNAKE */* REPROLYSIN, V248, P345; Brando C, 2000, BIOCHEM BIOPH RES CO, V267, P413, DOI 10.1006/bbrc.1999.1897; Bridges LC, 2005, BIOCHEM J, V387, P101, DOI 10.1042/BJ20041444; Bridges LC, 2003, BIOCHEMISTRY-US, V42, P3734, DOI 10.1021/bi026871y; CAMPBELL S, 1995, HUM REPROD, V10, P1571, DOI 10.1093/HUMREP/10.6.1571; Chen MS, 1999, P NATL ACAD SCI USA, V96, P11830, DOI 10.1073/pnas.96.21.11830; Cho CH, 2000, DEV BIOL, V222, P289, DOI 10.1006/dbio.2000.9703; Conesa M, 2003, BIOCHEM J, V370, P703, DOI 10.1042/BJ20021301; Danen EHJ, 2003, J PATHOL, V200, P471, DOI 10.1002/path.1416; Danen EHJ, 2007, ENCY LIFE SCI; deNadai C, 1996, ZYGOTE, V4, P31, DOI 10.1017/S0967199400002860; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Duffy MJ, 2009, CLIN CANCER RES, V15, P1140, DOI 10.1158/1078-0432.CCR-08-1585; Duffy MJ, 2003, THROMB HAEMOSTASIS, V89, P622; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; ERLE DJ, 1994, J IMMUNOL, V153, P517; Eto K, 2002, J BIOL CHEM, V277, P17804, DOI 10.1074/jbc.M200086200; Evans JP, 1997, DEV BIOL, V187, P79, DOI 10.1006/dbio.1997.8611; EVANS JP, 1995, MOL REPROD DEV, V40, P211, DOI 10.1002/mrd.1080400210; Evsikov AV, 2006, GENE DEV, V20, P2713, DOI 10.1101/gad.1471006; FITZGERALD LA, 1987, J BIOL CHEM, V262, P3936; Fujihara Y, 2010, J CELL SCI, V123, P1531, DOI 10.1242/jcs.067363; FUSI FM, 1993, MOL REPROD DEV, V36, P212, DOI 10.1002/mrd.1080360212; Glazar AI, 2009, REPROD FERT DEVELOP, V21, P293, DOI 10.1071/RD08158; Han C, 2009, BIOL REPROD, V80, P1001, DOI 10.1095/biolreprod.108.073700; He ZY, 2003, DEV BIOL, V254, P226, DOI 10.1016/S0012-1606(02)00043-X; HEINO J, 1989, J BIOL CHEM, V264, P380; HOLZMANN B, 1989, CELL, V56, P37, DOI 10.1016/0092-8674(89)90981-1; Huang J, 2005, MOL BIOL CELL, V16, P4982, DOI 10.1091/mbc.E05-03-0258; Hughes AL, 2001, J MOL EVOL, V52, P63, DOI 10.1007/s002390010134; Huhtala M, 2005, MATRIX BIOL, V24, P83, DOI 10.1016/j.matbio.2005.01.003; Humphries MJ, 2001, MOL BIOTECHNOL, V18, P57, DOI 10.1385/MB:18:1:57; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ikawa M, 2010, J CLIN INVEST, V120, P984, DOI 10.1172/JCI41585; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; JASPERS M, 1994, FEBS LETT, V353, P239, DOI 10.1016/0014-5793(94)01054-4; Jia LG, 1997, J BIOL CHEM, V272, P13094, DOI 10.1074/jbc.272.20.13094; Kim T, 2006, BIOL REPROD, V74, P744, DOI 10.1095/biolreprod.105.048892; Koistinen P, 2002, J BIOL CHEM, V277, P24835, DOI 10.1074/jbc.M203149200; Li YH, 2004, REPRODUCTION, V127, P151, DOI 10.1530/rep.1.00006; Lin X, 2006, PROTEINS, V65, P274, DOI 10.1002/prot.21072; Linfor J, 2000, J REPROD FERTIL, V120, P65, DOI 10.1530/reprod/120.1.65; Lu X., 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P29; Marcinkiewicz C, 1999, J BIOL CHEM, V274, P12468, DOI 10.1074/jbc.274.18.12468; Marcinkiewicz C, 2000, J BIOL CHEM, V275, P31930, DOI 10.1074/jbc.M003209200; Mariano-Oliveira A, 2003, EUR J BIOCHEM, V270, P4799, DOI 10.1046/j.1432-1033.2003.03867.x; Miller BJ, 2000, J CELL BIOL, V149, P1289, DOI 10.1083/jcb.149.6.1289; MIYAKE K, 1991, J EXP MED, V173, P599, DOI 10.1084/jem.173.3.599; Nishimura H, 2001, DEV BIOL, V233, P204, DOI 10.1006/dbio.2001.0166; NISHIMURA SL, 1994, J BIOL CHEM, V269, P28708; NOTO K, 1995, INT IMMUNOL, V7, P835, DOI 10.1093/intimm/7.5.835; PALMER EL, 1993, J CELL BIOL, V123, P1289, DOI 10.1083/jcb.123.5.1289; PASQUALINI R, 1993, J CELL SCI, V105, P101; Pate BJ, 2007, MOL REPROD DEV, V74, P600, DOI 10.1002/mrd.20649; Paulissen G, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-127; Rao HW, 2006, J BONE MINER RES, V21, P1657, DOI 10.1359/JBMR.060718; Retta SF, 2001, MOL BIOL CELL, V12, P3126, DOI 10.1091/mbc.12.10.3126; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; RUEGG C, 1992, J CELL BIOL, V117, P179, DOI 10.1083/jcb.117.1.179; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Sengoku K, 2004, HUM REPROD, V19, P639, DOI 10.1093/humrep/deh095; Staniszewska I, 2008, J CELL SCI, V121, P504, DOI 10.1242/jcs.000232; Stein KK, 2005, BIOL REPROD, V73, P1032, DOI 10.1095/biolreprod.105.040972; SUZUKI S, 1986, P NATL ACAD SCI USA, V83, P8614, DOI 10.1073/pnas.83.22.8614; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takahashi Y, 2001, MOL BIOL CELL, V12, P809, DOI 10.1091/mbc.12.4.809; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; TARONE G, 1993, DEVELOPMENT, V117, P1369; TEIXIDO J, 1992, J BIOL CHEM, V267, P1786; Tomczuk M, 2003, EXP CELL RES, V290, P68, DOI 10.1016/S0014-4827(03)00307-0; Vjugina U, 2008, FRONT BIOSCI-LANDMRK, V13, P462, DOI 10.2741/2693; Vjugina U, 2009, BIOL REPROD, V80, P833, DOI 10.1095/biolreprod.108.075275; WANG A, 1995, DEV DYNAM, V204, P421, DOI 10.1002/aja.1002040408; Wang A, 1996, AM J RESP CELL MOL, V15, P664, DOI 10.1165/ajrcmb.15.5.8918373; Webb DL, 1996, J CELL BIOCHEM, V61, P127, DOI 10.1002/(SICI)1097-4644(19960401)61:1<127::AID-JCB14>3.0.CO;2-L; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; WILKINS J, 1993, CELL IMMUNOL, V146, P313, DOI 10.1006/cimm.1993.1029; Williams CJ, 1996, MOL REPROD DEV, V44, P315, DOI 10.1002/(SICI)1098-2795(199607)44:3&lt;315::AID-MRD5&gt;3.0.CO;2-P; Wright N, 2002, J IMMUNOL, V168, P5268, DOI 10.4049/jimmunol.168.10.5268; Yang JT, 1996, MOL BIOL CELL, V7, P1737, DOI 10.1091/mbc.7.11.1737; Yang Y, 1998, EUR J IMMUNOL, V28, P995, DOI 10.1002/(SICI)1521-4141(199803)28:03<995::AID-IMMU995>3.0.CO;2-D; YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691; You WK, 2003, BIOCHEM BIOPH RES CO, V309, P637, DOI 10.1016/j.bbrc.2003.08.049; Zeller Y, 1998, J BIOL CHEM, V273, P6786, DOI 10.1074/jbc.273.12.6786; Zhu XL, 2000, J BIOL CHEM, V275, P7677, DOI 10.1074/jbc.275.11.7677; Zhu XL, 2002, BIOL REPROD, V66, P1193, DOI 10.1095/biolreprod66.4.1193; Ziyyat A, 2006, J CELL SCI, V119, P416, DOI 10.1242/jcs.02730	94	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13744	10.1371/journal.pone.0013744	http://dx.doi.org/10.1371/journal.pone.0013744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060781	Green Published, gold, Green Submitted			2022-12-25	WOS:000283645300024
J	Kam, M; Degen, AA; Khokhlova, IS; Krasnov, BR; Geffen, E				Kam, Michael; Degen, A. Allan; Khokhlova, Irina S.; Krasnov, Boris R.; Geffen, Eli			Do Fleas Affect Energy Expenditure of Their Free-Living Hosts?	PLOS ONE			English	Article							LABELED WATER METHOD; IMMUNE-RESPONSE; THERMOREGULATORY RESPONSES; DESERT RODENT; LIFE-HISTORY; PARASITISM; COSTS; ECTOPARASITES; INFESTATION; TITS	Background: Parasites can cause energetically costly behavioural and immunological responses which potentially can reduce host fitness. However, although most laboratory studies indicate that the metabolic rate of the host increases with parasite infestation, this has never been shown in free-living host populations. In fact, studies thus far have shown no effect of parasitism on field metabolic rate (FMR). Methodology and Results: We tested the effect of parasites on the energy expenditure of a host by measuring FMR using doubly-labelled water in free-living Baluchistan gerbils (Gerbillus nanus) infested by naturally occurring fleas during winter, spring and summer. We showed for the first time that FMR of free-living G. nanus was significantly and positively correlated with parasite load in spring when parasite load was highest; this relationship approached significance in summer when parasite load was lowest but was insignificant in winter. Among seasons, winter FMRs were highest and summer FMRs were lowest in G. nanus. Discussion: The lack of parasite effect on FMR in winter could be related to the fact that FMR rates were highest among seasons. In this season, thermoregulatory costs are high which may indicate that less energy could be allocated to defend against parasites or to compensate for other costly activities. The question about the cost of parasitism in nature is now one of the major themes in ecological physiology. Our study supports the hypothesis that parasites can elevate FMR of their hosts, at least under certain conditions. However, the effect is complex and factors such as season and parasite load are involved.	[Kam, Michael; Degen, A. Allan; Khokhlova, Irina S.] Ben Gurion Univ Negev, Wyler Dept Dryland Agr, Jacob Blaustein Inst Desert Res, IL-84105 Beer Sheva, Israel; [Krasnov, Boris R.] Ben Gurion Univ Negev, Mitrani Dept Desert Ecol, Jacob Blaustein Inst Desert Res, Midreshet Ben Gurion, Israel; [Geffen, Eli] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel	Ben Gurion University; Ben Gurion University; Tel Aviv University	Kam, M (corresponding author), Ben Gurion Univ Negev, Wyler Dept Dryland Agr, Jacob Blaustein Inst Desert Res, IL-84105 Beer Sheva, Israel.	mkam@bgu.ac.il	Krasnov, Boris R./ABG-8403-2021; Khokhlova, Irina/F-2235-2012; Krasnov, Boris R./F-2234-2012; Kam, Michael/Q-8764-2019	Krasnov, Boris R./0000-0002-0382-3331; Khokhlova, Irina/0000-0003-0169-7770; Krasnov, Boris R./0000-0002-0382-3331; Kam, Michael/0000-0002-1062-7654	Israel Scientific Foundation (ISF) [1171/07]; Bi-National Science Foundation, USA - Israel	Israel Scientific Foundation (ISF)(Israel Science Foundation); Bi-National Science Foundation, USA - Israel(US-Israel Binational Science Foundation)	This study was funded by the Israel Scientific Foundation (ISF) under grant number 1171/07 and the Bi-National Science Foundation, USA - Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOOTH DT, 1993, P ROY SOC B-BIOL SCI, V253, P125, DOI 10.1098/rspb.1993.0091; Careau V, 2010, OECOLOGIA, V162, P303, DOI 10.1007/s00442-009-1466-y; Charmantier A, 2004, EVOLUTION, V58, P203, DOI 10.1111/j.0014-3820.2004.tb01588.x; COX FEG, 1981, NATURE, V294, P515, DOI 10.1038/294515a0; De Bellocq JG, 2006, FUNCT ECOL, V20, P637, DOI 10.1111/j.1365-2435.2006.01140.x; Degen A. A, 1997, ECOPHYSIOLOGY SMALL, P93; Degen AA, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P371, DOI 10.1007/978-4-431-36025-4_19; DEGEN AA, 1995, ECOSCIENCE, V2, P48, DOI 10.1080/11956860.1995.11682268; Degen AA, 1997, FUNCT ECOL, V11, P53, DOI 10.1046/j.1365-2435.1997.00059.x; DELOPE F, 1993, OECOLOGIA, V95, P234, DOI 10.1007/BF00323495; Demas GE, 1997, AM J PHYSIOL-REG I, V273, pR1631, DOI 10.1152/ajpregu.1997.273.5.R1631; Devevey G, 2008, FUNCT ECOL, V22, P1091, DOI 10.1111/j.1365-2435.2008.01493.x; Faro CJ, 2000, AM J PHYSIOL-REG I, V278, pR118, DOI 10.1152/ajpregu.2000.278.1.R118; Fitze PS, 2004, ECOLOGY, V85, P2018, DOI 10.1890/03-0138; Fitze PS, 2004, J ANIM ECOL, V73, P216, DOI 10.1111/j.0021-8790.2004.00799.x; Gallizzi K, 2008, BEHAV ECOL, V19, P1225, DOI 10.1093/beheco/arn083; Gallizzi K, 2008, AUK, V125, P915, DOI 10.1525/auk.2008.07175; Giorgi MS, 2001, P ROY SOC B-BIOL SCI, V268, P2071, DOI 10.1098/rspb.2001.1686; Haim A, 1998, COMP BIOCHEM PHYS A, V120, P187, DOI 10.1016/S1095-6433(98)10030-2; Hawlena H, 2006, PARASITOLOGY, V133, P187, DOI 10.1017/S0031182006000308; Hawlena H, 2006, FUNCT ECOL, V20, P1028, DOI 10.1111/j.1365-2435.2006.01190.x; HUNTER DM, 1974, CAN J ZOOL, V52, P209, DOI 10.1139/z74-025; KAM M, 1997, AM J PHYSIOL-REG I, V272, pR1336; Khokhlova IS, 2002, J ZOOL, V258, P349, DOI 10.1017/S0952836902001498; Khokhlova IS, 2004, J EXP BIOL, V207, P2725, DOI 10.1242/jeb.01090; Krasnov B, 2002, ECOLOGY, V83, P164, DOI 10.1890/0012-9658(2002)083[0164:TEOHDO]2.0.CO;2; Krasnov B.R., 2008, FUNCTIONAL EVOLUTION; Krasnov BR, 2006, PARASITOL RES, V99, P541, DOI 10.1007/s00436-006-0201-4; Kyriazakis I, 1998, ANIM BEHAV, V56, P265, DOI 10.1006/anbe.1998.0761; LEHMANN T, 1994, J MED ENTOMOL, V31, P257, DOI 10.1093/jmedent/31.2.257; LIFSON N, 1966, J THEOR BIOL, V12, P46, DOI 10.1016/0022-5193(66)90185-8; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lovegrove BG, 2005, J COMP PHYSIOL B, V175, P231, DOI 10.1007/s00360-005-0477-1; MOLLER AP, 1994, OECOLOGIA, V98, P263, DOI 10.1007/BF00324213; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; NAGY KA, 1980, AM J PHYSIOL, V238, pR466; Nagy KA, 1983, UCLA PUBL; Nilsson JA, 2003, BEHAV ECOL, V14, P175, DOI 10.1093/beheco/14.2.175; Raberg L, 2000, ECOL LETT, V3, P382, DOI 10.1046/j.1461-0248.2000.00154.x; Robbins C.T., 1983, WILDLIFE FEEDING NUT; Scantlebury M, 2007, P ROY SOC B-BIOL SCI, V274, P2169, DOI 10.1098/rspb.2007.0690; Stern E., 1986, ATLAS NEGEV; Tripet F, 2002, IBIS, V144, P461, DOI 10.1046/j.1474-919X.2002.00018.x; Tripet F, 2008, TRENDS PARASITOL, V24, P219, DOI 10.1016/j.pt.2008.02.008; Tschirren B, 2006, P ROY SOC B-BIOL SCI, V273, P1773, DOI 10.1098/rspb.2006.3524; UNESCO, 1977, 7 UNESCO MAB	46	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13686	10.1371/journal.pone.0013686	http://dx.doi.org/10.1371/journal.pone.0013686			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060688	Green Submitted, Green Published, gold			2022-12-25	WOS:000283537000051
J	Mejia, JS; Toot-Zimmer, AL; Schultheiss, PC; Beaty, BJ; Titus, RG				Mejia, J. Santiago; Toot-Zimmer, Amanda L.; Schultheiss, Patricia C.; Beaty, Barry J.; Titus, Richard G.			BluePort: A Platform to Study the Eosinophilic Response of Mice to the Bite of a Vector of Leishmania Parasites, Lutzomyia longipalpis Sand Flies	PLOS ONE			English	Article							EXPERIMENTAL CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; IMMUNE-RESPONSE; NATURAL MODEL; FLY SALIVA; INFECTION; NEUTROPHILS; PROTEINS; IDENTIFICATION; TRANSCRIPTOME	Background: Visceral Leishmaniasis is a serious human disease transmitted, in the New World, by Lutzomyia longipalpis sand flies. Natural resistance to Leishmania transmission in residents of endemic areas has been attributed to the acquisition of immunity to sand fly salivary proteins. One theoretical way to accelerate the acquisition of this immunity is to increase the density of antigen-presenting cells at the sand fly bite site. Here we describe a novel tissue platform that can be used for this purpose. Methodology/Principal Findings: BluePort is a well-vascularized and macrophage-rich compartment induced in the subcutaneous tissue of mice via injection of agarose beads covered with Cibacron blue. We describe the sequence of inflammatory events leading to its formation and how it can be used to study the dermal response to the bite of L. longipalpis sand flies. Results presented indicate that a shift in the inflammatory response, from neutrophilic to eosinophilic, is the main histopathological feature associated with the immunity acquired through repeated exposure to the bite of sand flies, and that the BluePort tissue compartment could be used to accelerate this process. In addition, changes observed inside the BluePort parenchyma indicate that it could be used to study complex immunobiological processes, and to develop ectopic secondary lymphoid structures. Conclusions/Significance: Understanding the characteristics of the dermal response to the bite of sand flies is a critical element of strategies to control leishmaniasis using vaccines that target salivary proteins. Finding that dermal eosinophilia is such a prominent component of the anti-salivary immunity induced by repeated exposure to sand fly bites raises one important consideration: how to avoid the immunological conflict derived from a protective Th2-driven immunity directed to sand fly saliva with a protective Th1-driven immunity directed to the parasite. The BluePort platform is an ideal tool to address experimentally this conundrum.	[Mejia, J. Santiago; Toot-Zimmer, Amanda L.; Schultheiss, Patricia C.; Titus, Richard G.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Beaty, Barry J.] Colorado State Univ, MicroRx Infect Dis Supercluster, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Mejia, JS (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	jsmejia@colostate.edu	Mejia, J. Santiago/E-2552-2012		National Institutes of Health [AI 065784]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health (AI 065784). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Andrade BB, 2007, SCAND J IMMUNOL, V66, P122, DOI 10.1111/j.1365-3083.2007.01964.x; BARRALNETTO M, 1987, AM J PATHOL, V127, P271; Belkaid Y, 1998, J EXP MED, V188, P1941, DOI 10.1084/jem.188.10.1941; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Champagne Donald E., 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P375, DOI 10.2174/1568006043335862; Chang KP, 2003, ACTA TROP, V85, P375, DOI 10.1016/S0001-706X(02)00238-3; Charmoy M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/719361; Conlan JW, 1997, INFECT IMMUN, V65, P630, DOI 10.1128/IAI.65.2.630-635.1997; David CV, 2009, DERMATOL THER, V22, P491, DOI 10.1111/j.1529-8019.2009.01272.x; Donnelly KB, 1998, J PARASITOL, V84, P97, DOI 10.2307/3284537; Faria DR, 2009, PARASITE IMMUNOL, V31, P432, DOI 10.1111/j.1365-3024.2009.01125.x; Gomes RB, 2002, J INFECT DIS, V186, P1530, DOI 10.1086/344733; Gramiccia M, 2005, INT J PARASITOL, V35, P1169, DOI 10.1016/j.ijpara.2005.07.001; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; Harn DA, 2009, IMMUNOL REV, V230, P247, DOI 10.1111/j.1600-065X.2009.00799.x; Hokke CH, 2001, GLYCOCONJUGATE J, V18, P573, DOI 10.1023/A:1020634602161; Iskratsch T, 2009, ANAL BIOCHEM, V386, P133, DOI 10.1016/j.ab.2008.12.005; Jmeian Y, 2009, ELECTROPHORESIS, V30, P249, DOI 10.1002/elps.200800639; Jordan SW, 2007, J VASC SURG, V45, p104A, DOI 10.1016/j.jvs.2007.02.048; KILLICKKENDRICK R, 1977, J MED ENTOMOL, V13, P429, DOI 10.1093/jmedent/13.4-5.429; Kumar S, 2009, J CHROMATOGR B, V877, P3610, DOI 10.1016/j.jchromb.2009.08.045; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Laurenti MD, 2009, SCAND J IMMUNOL, V70, P389, DOI 10.1111/j.1365-3083.2009.02310.x; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Liu D, 2009, INFECT IMMUN, V77, P3272, DOI 10.1128/IAI.01447-08; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Martin K, 2009, DEMENT GERIATR COGN, V27, P451, DOI 10.1159/000216840; Mejia JS, 2006, TRENDS PARASITOL, V22, P367, DOI 10.1016/j.pt.2006.06.001; Mejia JS, 2004, TRENDS PARASITOL, V20, P508, DOI 10.1016/j.pt.2004.08.005; MODI GB, 1983, J MED ENTOMOL, V20, P568, DOI 10.1093/jmedent/20.5.568; Monteiro MC, 2007, AM J TROP MED HYG, V76, P88, DOI 10.4269/ajtmh.2007.76.88; Neves JS, 2009, CURR OPIN IMMUNOL, V21, P694, DOI 10.1016/j.coi.2009.07.011; Norsworthy NB, 2004, INFECT IMMUN, V72, P1240, DOI 10.1128/IAI.72.3.1240-1247.2004; Oliveira F, 2006, VACCINE, V24, P374, DOI 10.1016/j.vaccine.2005.07.085; Oliveira F, 2009, PARASITOL INT, V58, P1, DOI 10.1016/j.parint.2008.07.004; Oliveira SHP, 1998, PARASITE IMMUNOL, V20, P405, DOI 10.1046/j.1365-3024.1998.00159.x; PAGE RB, 1982, AM J PHYSIOL, V243, pE427, DOI 10.1152/ajpendo.1982.243.6.E427; Pearce EJ, 2004, IMMUNOL REV, V201, P117, DOI 10.1111/j.0105-2896.2004.00187.x; Pearson RD, 1996, CLIN INFECT DIS, V22, P1, DOI 10.1093/clinids/22.1.1; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; PRENNER C, 1992, BIOCHEM J, V284, P377, DOI 10.1042/bj2840377; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Rogers KA, 2003, PARASITE IMMUNOL, V25, P127, DOI 10.1046/j.1365-3024.2003.00623.x; Rogers KA, 2002, FEMS MICROBIOL LETT, V209, P1, DOI 10.1111/j.1574-6968.2002.tb11101.x; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; Sakthianandeswaren A, 2009, TRENDS PARASITOL, V25, P383, DOI 10.1016/j.pt.2009.05.004; Sharma Umakant, 2008, Journal of Vector Borne Diseases, V45, P255; Silva F, 2005, AM J TROP MED HYG, V72, P94, DOI 10.4269/ajtmh.2005.72.94; Specht S, 2006, INFECT IMMUN, V74, P5236, DOI 10.1128/IAI.00329-06; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; Valenzuela JG, 2004, J EXP BIOL, V207, P3717, DOI 10.1242/jeb.01185; van Ree R, 2002, INT ARCH ALLERGY IMM, V129, P189, DOI 10.1159/000066770; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; VANDAM GJ, 1994, EUR J BIOCHEM, V225, P467, DOI 10.1111/j.1432-1033.1994.00467.x; Vanloubbeeck Y, 2004, ANN NY ACAD SCI, V1026, P267, DOI 10.1196/annals.1307.041; Vinhas V, 2007, EUR J IMMUNOL, V37, P3111, DOI 10.1002/eji.200737431; Volfova V, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000294; Zhang K, 2010, MOL BIOCHEM PARASIT, V170, P55, DOI 10.1016/j.molbiopara.2009.12.004; Zijistra EE, 2003, LANCET INFECT DIS, V3, P87, DOI 10.1016/S1473-3099(03)00517-6; Zuluaga AF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-55	65	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13546	10.1371/journal.pone.0013546	http://dx.doi.org/10.1371/journal.pone.0013546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048957	Green Submitted, Green Published, gold			2022-12-25	WOS:000283537000006
J	Wang, T; Zeng, Z; Li, T; Liu, J; Li, JY; Li, Y; Zhao, QA; Wei, ZY; Wang, Y; Li, BJ; Feng, GY; He, L; Shi, YY				Wang, Ti; Zeng, Zhen; Li, Tao; Liu, Jie; Li, Junyan; Li, You; Zhao, Qian; Wei, Zhiyun; Wang, Yang; Li, Baojie; Feng, Guoyin; He, Lin; Shi, Yongyong			Common SNPs in Myelin Transcription Factor 1-Like (MYT1L): Association with Major Depressive Disorder in the Chinese Han Population	PLOS ONE			English	Article							ZINC-FINGER; GENETICS; NEURONS; GENOME; MEMBER; FAMILY; GENES	Background: Myelin transcription factor 1-like (MYT1L) is a member of the myelin transcription factor 1 (MYT1) gene family, and the neural specific, zinc-finger-containing, DNA-binding protein that it encodes plays a role in the development of the nervous system. On the basis of a recent copy number variation (CNV) study showing that this gene is disrupted in mental disorder patients, we investigated whether MYT1L also plays a role in MDD. Methods: In this study, 8 SNPs were analyzed in 1139 MDD patients and 1140 controls of Chinese Han origin. Results: Statistically significant differences were noted between cases and controls for rs3748989 (allele: permutated p = 0.0079, corrected p = 0.0048, genotype: corrected p = 0.0204). A haplotype of rs1617213 and rs6759709 G-C was also significant (permutated p = 0.00007). Conclusion: Our results indicate that MYT1L may be a potential risk gene for MDD in the Chinese Han population.	[Wang, Ti; Zeng, Zhen; Li, Tao; Liu, Jie; Li, Junyan; Wang, Yang; He, Lin; Shi, Yongyong] Shanghai Jiao Tong Univ, Minist Educ, Bio X Ctr, Shanghai 200030, Peoples R China; [Wang, Ti; Zeng, Zhen; Li, Tao; Liu, Jie; Li, Junyan; Wang, Yang; He, Lin; Shi, Yongyong] Shanghai Jiao Tong Univ, Minist Educ, Affiliated Changning Mental Hlth Ctr, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China; [Wang, Ti; Li, You; Zhao, Qian; Wei, Zhiyun; He, Lin; Shi, Yongyong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Li, Baojie; Feng, Guoyin] Shanghai Inst Mental Hlth, Shanghai, Peoples R China; [He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Wang, T (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Bio X Ctr, Shanghai 200030, Peoples R China.	shiyongyong@gmail.com	Zeng, Zhen/R-6292-2016; Shi, Yongyong/GSO-1627-2022; Li, Junyan/AFV-3987-2022; Wang, Yang/HCG-9543-2022; Wei, Zhiyun/E-2008-2016	Shi, Yongyong/0000-0003-1710-1505; Wei, Zhiyun/0000-0002-3554-4142	863 Program [2006AA02A407]; Shanghai Changning Health Bureau [2008406002]; Shanghai Municipal Health Bureau [2008095]; 973 Program [2010CB529600, 2006CB910601, 2007CB914703, 2007CB947300]; Shanghai Municipal Commission of Science and Technology [09DJ1400601, 07DZ22917]; National Key Project for Investigational New Drug [2008ZX09312-003]; Shanghai Leading Academic Discipline Project [B205]	863 Program(National High Technology Research and Development Program of China); Shanghai Changning Health Bureau; Shanghai Municipal Health Bureau; 973 Program(National Basic Research Program of China); Shanghai Municipal Commission of Science and Technology; National Key Project for Investigational New Drug; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by the 863 Program 2006AA02A407, the Shanghai Changning Health Bureau program 2008406002, the Shanghai Municipal Health Bureau program (2008095), the 973 Program (2010CB529600, 2006CB910601, 2007CB914703, 2007CB947300), the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601, 07DZ22917), the National Key Project for Investigational New Drug 2008ZX09312-003, and the Shanghai Leading Academic Discipline Project (B205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RC, 1995, GLIA, V14, P303, DOI 10.1002/glia.440140407; Bareiss S, 2010, J NEUROSCI RES, V88, P2350, DOI 10.1002/jnr.22414; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; DAVIDBARBEAU, 1994, NEUROBIOLOGY; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Hennah W, 2009, MOL PSYCHIATR, V14, P865, DOI 10.1038/mp.2008.22; KALUS PFP, 2008, STRUCTURAL FUNCTIONA; Kim JG, 1997, J NEUROSCI RES, V50, P272, DOI 10.1002/(SICI)1097-4547(19971015)50:2<272::AID-JNR16>3.0.CO;2-A; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Numata S, 2009, J PSYCHIATR NEUROSCI, V34, P195; O'Donovan MC, 2009, HUM GENET, V126, P3, DOI 10.1007/s00439-009-0703-0; Orr N, 2008, ADV GENET, V62, P1, DOI 10.1016/S0065-2660(08)00601-9; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Wang S, 2007, MECH DEVELOP, V124, P898, DOI 10.1016/j.mod.2007.08.004; Yee KSY, 1998, J BIOL CHEM, V273, P5366, DOI 10.1074/jbc.273.9.5366; 2004, AM J HUM GENET, V74, P5; 1991, BR J PSYCHIAT	20	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13662	10.1371/journal.pone.0013662	http://dx.doi.org/10.1371/journal.pone.0013662			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048971	Green Submitted, Green Published, gold			2022-12-25	WOS:000283537000031
J	Kosubek, A; Klein-Hitpass, L; Rademacher, K; Horsthemke, B; Ryffel, GU				Kosubek, Anna; Klein-Hitpass, Ludger; Rademacher, Katrin; Horsthemke, Bernhard; Ryffel, Gerhart U.			Aging of Xenopus tropicalis Eggs Leads to Deadenylation of a Specific Set of Maternal mRNAs and Loss of Developmental Potential	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSLATIONAL CONTROL; DELAYED FERTILIZATION; OOCYTE MATURATION; MOUSE OOCYTE; EMBRYO; IDENTIFICATION; MICROARRAY; COMPETENCE; SEQUENCES	As first shown more than 100 years ago, fertilization of an aged (overripe) egg increases the rate of malformations and embryonic loss in several vertebrates, including possibly humans as well. Since the molecular events in aging eggs may be similar in these species, we established in the frog Xenopus tropicalis a defined protocol for delayed fertilization of eggs. A three-hour delayed fertilization led to a dramatic increase in malformation and mortality. Gene expression profiling revealed that 14% of the polyadenylated maternal transcripts were downregulated upon aging. These transcripts were not degraded, but rather deadenylated as shown for specific maternal mRNAs. The affected transcripts are characterized by a relatively short 39UTR and a paucity of cytoplasmic polyadenylation elements (CPE) and polyadenylation signals (PAS). Furthermore, maternal mRNAs known to be deadenylated during egg maturation as well as after fertilization were preferentially deadenylated in aged eggs. Taken together our analysis of aging eggs reveals that unfertilized eggs are in a dynamic state that was previously not realized. On the one hand deadenylation of transcripts that are typically deadenylated during egg maturation continues and this implies overripeness of the aged egg in the truest sense of the word. On the other hand transcripts that normally are deadenylated after fertilization loose their poly(A) in the aged egg and this implies that the egg awaiting fertilization starts processes that are normally only observed after fertilization. Based on our novel finding we postulate that the imbalance of the polyadenylated maternal transcripts upon egg aging contributes to the loss of developmental potential. Based on this hypothesis the developmental consequences of downregulation of specific transcripts can be analyzed in future.	[Kosubek, Anna; Klein-Hitpass, Ludger; Ryffel, Gerhart U.] Univ Duisburg Essen, Univ Klinikum Essen, Inst Zellbiol Tumorforsch, Essen, Germany; [Kosubek, Anna; Rademacher, Katrin; Horsthemke, Bernhard] Univ Duisburg Essen, Univ Klinikum Essen, Inst Humangenet, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Kosubek, A (corresponding author), Univ Duisburg Essen, Univ Klinikum Essen, Inst Zellbiol Tumorforsch, Essen, Germany.	gerhart.ryffel@uni-due.de			Deutsche Forschungsgemeinschaft [GRK1431]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (GRK1431). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegerter S, 2005, MOL REPROD DEV, V72, P377, DOI 10.1002/mrd.20361; Aegerter S, 2004, MOL REPROD DEV, V67, P127, DOI 10.1002/mrd.10384; Andersen AN, 2008, HUM REPROD, V23, P756, DOI 10.1093/humrep/den014; Audic Y, 2001, MOL CELL BIOL, V21, P1662, DOI 10.1128/MCB.21.5.1662-1671.2001; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Blandau RJ, 1939, AM J ANAT, V64, P303, DOI 10.1002/aja.1000640204; Blandau RJ, 1941, AM J ANAT, V68, P275, DOI 10.1002/aja.1000680206; Bonnet E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-55; Bowes JB, 2010, NUCLEIC ACIDS RES, V38, pD607, DOI 10.1093/nar/gkp953; Brook M, 2009, REPRODUCTION, V137, P595, DOI 10.1530/REP-08-0524; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Cooke A, 2010, J BIOL CHEM, V285, P28506, DOI 10.1074/jbc.M110.150763; De Ferrari L, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-277; Evsikov AV, 2009, MOL REPROD DEV, V76, P805, DOI 10.1002/mrd.21038; Fair T, 2007, THERIOGENOLOGY, V68, pS91, DOI 10.1016/j.theriogenology.2007.04.018; Graindorge A, 2006, NUCLEIC ACIDS RES, V34, P986, DOI 10.1093/nar/gkj492; Graindorge A, 2008, NUCLEIC ACIDS RES, V36, P1861, DOI 10.1093/nar/gkn031; Grondahl ML, 2010, HUM REPROD, V25, P957, DOI 10.1093/humrep/deq014; Hansen M, 2005, HUM REPROD, V20, P328, DOI 10.1093/humrep/deh593; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hogan B, 1994, MANIPULATING MOUSE E; Huang JC, 2007, BIOL REPROD, V77, P666, DOI 10.1095/biolreprod.107.062703; JONGBLOET PH, 1987, J MED GENET, V24, P616, DOI 10.1136/jmg.24.10.616; Khokha MK, 2002, DEV DYNAM, V225, P499, DOI 10.1002/dvdy.10184; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Lacham-Kaplan O, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-58; Liang XW, 2008, BIOCHEM BIOPH RES CO, V371, P16, DOI 10.1016/j.bbrc.2008.03.105; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; MIKAMO K, 1968, CYTOGENETICS, V7, P212, DOI 10.1159/000129985; Nieuwkoop P. D., 1975, NORMAL TABLE XENOPUS; Paillard L, 1998, EMBO J, V17, P278, DOI 10.1093/emboj/17.1.278; PAYNTON BV, 1988, DEV BIOL, V129, P304, DOI 10.1016/0012-1606(88)90377-6; PFLUGER E, 1882, ARCH GES PHYSL, V29, P76; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Rassa JC, 2000, VIROLOGY, V274, P438, DOI 10.1006/viro.2000.0494; Richter JD, 2008, CELL, V132, P335, DOI 10.1016/j.cell.2008.01.024; Showell C, 2007, GENESIS, V45, P418, DOI 10.1002/dvg.20286; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Vallee M, 2008, REPRODUCTION, V135, P439, DOI 10.1530/REP-07-0342; VARNUM SM, 1990, GENE DEV, V4, P2278, DOI 10.1101/gad.4.12b.2278; Voeltz GK, 1998, MOL CELL BIOL, V18, P7537, DOI 10.1128/MCB.18.12.7537; Wilcox AJ, 1998, HUM REPROD, V13, P394, DOI 10.1093/humrep/13.2.394; WITSCHI E, 1952, CANCER RES, V12, P763; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	46	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13532	10.1371/journal.pone.0013532	http://dx.doi.org/10.1371/journal.pone.0013532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042572	gold, Green Published, Green Submitted			2022-12-25	WOS:000283419100003
J	Rao, X; Di Leva, G; Li, M; Fang, F; Devlin, C; Hartman-Frey, C; Burow, ME; Ivan, M; Croce, CM; Nephew, KP				Rao, X.; Di Leva, G.; Li, M.; Fang, F.; Devlin, C.; Hartman-Frey, C.; Burow, M. E.; Ivan, M.; Croce, C. M.; Nephew, K. P.			MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways	ONCOGENE			English	Article						microRNAs; breast cancer; antiestrogen; drug resistance; fulvestrant	ESTROGEN-RECEPTOR-ALPHA; ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR-BETA; MESSENGER-RNA; ENDOCRINE RESISTANCE; TAMOXIFEN RESISTANCE; TUMOR-SUPPRESSOR; GENE-EXPRESSION; CELLS; MICRORNAS	Fulvestrant is a selective estrogen receptor downregulator (SERD) and highly effective antagonist to hormone-sensitive breast cancers following failure of previous tamoxifen or aromatase inhibitor therapies. However, after prolonged fulvestrant therapy, acquired resistance eventually occurs in the majority of breast cancer patients, due to poorly understood mechanisms. To examine a possible role(s) of aberrantly expressed microRNAs (miRNAs) in acquired fulvestrant resistance, we compared antiestrogen-resistant and -sensitive breast cancer cells, revealing the overexpression of miR-221/222 in the SERD-resistant cell lines. Fulvestrant treatment of estradiol (E2)- and fulvestrant-sensitive MCF7 cells resulted in increased expression of endogenous miR-221/222. Ectopic upregulation of miR-221/222 in estrogen receptor-alpha (ER alpha)-positive cell lines counteracted the effects of E2 depletion or fulvestrant-induced cell death, thus also conferring hormone-independent growth and fulvestrant resistance. In cells with acquired resistance to fulvestrant, miR-221/222 expression was essential for cell growth and cell cycle progression. To identify possible miR-221/222 targets, miR-221- or miR-222-induced alterations in global gene expression profiles and target gene expression at distinct time points were determined, revealing that miR-221/222 overexpression resulted in deregulation of multiple oncogenic signaling pathways previously associated with drug resistance. Activation of beta-catenin by miR-221/222 contributed to estrogen-independent growth and fulvestrant resistance, whereas TGF-beta-mediated growth inhibition was repressed by the two miRNAs. This first in-depth investigation into the role of miR-221/222 in acquired fulvestrant resistance, a clinically important problem, demonstrates that these two 'oncomirs' may represent promising therapeutic targets for treating hormone-independent, SERD-resistant breast cancer. Oncogene (2011) 30, 1082-1097; doi:10.1038/onc.2010.487; published online 8 November 2010	[Rao, X.; Nephew, K. P.] Indiana Univ, Dept Mol & Cellular Biochem, Interdisciplinary Biochem Grad Program, Bloomington, IN USA; [Di Leva, G.; Croce, C. M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Nephew, K. P.] Indiana Univ Sch Med, Med Sci Program, Dept Med Sci, Bloomington, IN 47405 USA; [Devlin, C.; Ivan, M.] Indiana Univ Sch Med, Dept Immunol & Microbiol, Dept Med, Indianapolis, IN USA; [Burow, M. E.] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Devlin, C.; Ivan, M.; Nephew, K. P.] Indiana Univ Sch Med, IU Simon Canc Ctr, Indianapolis, IN USA; [Devlin, C.; Ivan, M.; Nephew, K. P.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Tulane University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Nephew, KP (corresponding author), Indiana Univ Sch Med, Med Sci Program, Dept Med Sci, Jordan Hall 302,1001 E 3rd St, Bloomington, IN 47405 USA.	knephew@indiana.edu	Burow, Matthew/D-6351-2013; Young, Richard A/F-6495-2012; Ivan, Mircea/A-8109-2012	Burow, Matthew/0000-0002-0642-6630; Young, Richard A/0000-0001-8855-8647; Di Leva, Gianpiero/0000-0001-6759-8682; Ivan, Mircea/0000-0003-3424-6642	Indiana Genomics Initiative of Indiana University; Lilly Endowment, Inc.; NIH [CA085289, CA113001, CA125806]; American Cancer Society [09-244-01]; Walther Cancer Foundation (Indianapolis); NATIONAL CANCER INSTITUTE [R01CA085289, R01CA125806, U54CA113001] Funding Source: NIH RePORTER	Indiana Genomics Initiative of Indiana University; Lilly Endowment, Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Walther Cancer Foundation (Indianapolis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Man-Wook Hur for providing the TOPflash and FOPflash plasmids, Jim Powers for assistance with fluorescence microscopy, Dr Meiyun Fan for advice on experiments and Dr Curt Balch for critical comments and paper preparation. The IUB Light Microscopy Imaging Center provided microscopy resources. The microarray studies were carried out using the facilities of the Center for Medical Genomics (Dr H Edenberg, Director and Dr J McClintick) at Indiana University School of Medicine. The Center for Medical Genomics is supported in part by the Indiana Genomics Initiative of Indiana University, which is supported in part by the Lilly Endowment, Inc. This work was supported in part by NIH grants CA085289, CA113001 and CA125806, American Cancer Society Research Scholar Grant 09-244-01, and the Walther Cancer Foundation (Indianapolis).	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P181, DOI 10.2174/156802606776173483; BASOLO F, 1994, INT J CANCER, V56, P736, DOI 10.1002/ijc.2910560521; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Buck MB, 2004, MOL ENDOCRINOL, V18, P1643, DOI 10.1210/me.2003-0278; Buck MB, 2006, ANN NY ACAD SCI, V1089, P119, DOI 10.1196/annals.1386.024; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Chen Y, 2010, MOL CELL BIOL, V30, P3902, DOI 10.1128/MCB.01237-09; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Di Leva G, 2010, JNCI-J NATL CANCER I, V102, P706, DOI 10.1093/jnci/djq102; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Fan MY, 2006, CANCER RES, V66, P11954, DOI 10.1158/0008-5472.CAN-06-1666; Felicetti F, 2008, EXPERT REV ANTICANC, V8, P1759, DOI 10.1586/14737140.8.11.1759; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gillies JK, 2007, CELL CYCLE, V6, P2005, DOI 10.4161/cc.6.16.4526; GORSCH SM, 1992, CANCER RES, V52, P6949; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Heneghan HM, 2010, J ONCOL, V2010, DOI 10.1155/2010/950201; Howell A, 2006, CRIT REV ONCOL HEMAT, V57, P265, DOI 10.1016/j.critrevonc.2005.08.001; Howell A, 2006, ENDOCR-RELAT CANCER, V13, P689, DOI 10.1677/erc.1.00846; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Iorio MV, 2008, EUR J CANCER, V44, P2753, DOI 10.1016/j.ejca.2008.09.037; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Janicke RU, 2008, CELL DEATH DIFFER, V15, P959, DOI 10.1038/cdd.2008.33; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Jordan VC, 2003, NAT REV DRUG DISCOV, V2, P205, DOI 10.1038/nrd1031; KALKHOVEN E, 1995, CELL GROWTH DIFFER, V6, P1151; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim JY, 2006, J BIOL CHEM, V281, P10865, DOI 10.1074/jbc.M513378200; Klinge CM, 2009, CURR GENOMICS, V10, P169, DOI 10.2174/138920209788185289; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; McDonnell DP, 2006, FASEB J, V20, P2432, DOI 10.1096/fj.06-1202ufm; McEarchern JA, 2001, INT J CANCER, V91, P76, DOI 10.1002/1097-0215(20010101)91:1<76::AID-IJC1012>3.0.CO;2-8; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Nam S, 2009, NUCLEIC ACIDS RES, V37, pW356, DOI 10.1093/nar/gkp294; Nicholson RI, 2005, ENDOCR-RELAT CANCER, V12, pS29, DOI 10.1677/erc.1.00991; Nicholson RI, 2005, BREAST CANCER RES TR, V93, pS3, DOI 10.1007/s10549-005-9036-4; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P721, DOI 10.1677/erc.1.00857; O'Brien CS, 2009, J MAMMARY GLAND BIOL, V14, P45, DOI 10.1007/s10911-009-9115-y; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Sagara Y, 2004, BRIT J CANCER, V91, P959, DOI 10.1038/sj.bjc.6602029; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shitashige M, 2008, CANCER SCI, V99, P631, DOI 10.1111/j.1349-7006.2007.00716.x; Smith IE, 2003, NEW ENGL J MED, V348, P2431, DOI 10.1056/NEJMra023246; Sovak MA, 1999, CELL GROWTH DIFFER, V10, P537; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Weldon CB, 2004, INT J ONCOL, V24, P1473; Wijayaratne AL, 1999, ENDOCRINOLOGY, V140, P5828, DOI 10.1210/en.140.12.5828; Xin FX, 2009, BIOINFORMATICS, V25, P430, DOI 10.1093/bioinformatics/btn646; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200; Zhou CH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2210; ZUGMAIER G, 1989, J CELL PHYSIOL, V141, P353, DOI 10.1002/jcp.1041410217	70	281	295	0	26	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	9					1082	1097		10.1038/onc.2010.487	http://dx.doi.org/10.1038/onc.2010.487			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	729PX	21057537	Green Accepted			2022-12-25	WOS:000287964100007
J	Balla, A; Erdelyi, LS; Soltesz-Katona, E; Balla, T; Varnai, P; Hunyady, L				Balla, Andras; Erdelyi, Laszlo Sandor; Soltesz-Katona, Eszter; Balla, Tamas; Varnai, Peter; Hunyady, Laszlo			Demonstration of Angiotensin II-induced Ras Activation in the trans-Golgi Network and Endoplasmic Reticulum Using Bioluminescence Resonance Energy Transfer-based Biosensors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; COUPLED RECEPTOR ENDOCYTOSIS; GTP-BINDING PROTEINS; SMOOTH-MUSCLE-CELLS; SIGNAL-TRANSDUCTION; LIVING CELLS; LIVE CELLS; H-RAS; K-RAS; PLASMA-MEMBRANE	Previous studies have demonstrated that molecules of the Ras signaling pathway are present in intracellular compartments, including early endosomes, the endoplasmic reticulum (ER), and the Golgi, and suggested that mitogens can regulate Ras activity in these endomembranes. In this study, we investigated the effect of angiotensin II (AngII) on intracellular Ras activity in living HEK293 cells expressing angiotensin type 1 receptors (AT(1)-Rs) using newly developed bioluminescence resonance energy transfer biosensors. To investigate the subcellular localization of AngII-induced Ras activation, we targeted our probes to various intracellular compartments, such as the trans-Golgi network (TGN), the ER, and early endosomes. Using these biosensors, we detected AngII-induced Ras activation in the TGN and ER, but not in early endosomes. In cells expressing a cytoplasmic tail deletion AT(1)-R mutant, the AngII-induced response was enhanced, suggesting that receptor internalization and beta-arrestin binding are not required for AngII-induced Ras activation in endomembranes. Although we were able to demonstrate EGF-induced Ras activation in the plasma membrane and TGN, but not in other endomembranes, AG1478, an EGF receptor inhibitor, did not affect the AngII-induced response, suggesting that the latter is independent of EGF receptor transactivation. AngII was unable to stimulate Ras activity in the studied compartments in cells expressing a G protein coupling-deficient AT(1)R mutant ((DRY127)-D-125 to (125)AAY(127)). These data suggest that AngII can stimulate Ras activity in the TGN and ER with a G protein-dependent mechanism, which does not require beta-arrestin-mediated signaling, receptor internalization, and EGF receptor transactivation.	[Balla, Andras; Erdelyi, Laszlo Sandor; Soltesz-Katona, Eszter; Varnai, Peter; Hunyady, Laszlo] Semmelweis Univ, Dept Physiol, Fac Med, H-1444 Budapest, Hungary; [Balla, Tamas] Eunice Kennedy Shriver NICHD, Sect Mol Signal Transduct, Program Dev Neurosci, NIH, Bethesda, MD 20892 USA; [Hunyady, Laszlo] Semmelweis Univ, Lab Neurobiochem & Mol Physiol, H-1444 Budapest, Hungary; [Hunyady, Laszlo] Hungarian Acad Sci, H-1444 Budapest, Hungary	Semmelweis University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Semmelweis University; Hungarian Academy of Sciences	Hunyady, L (corresponding author), Semmelweis Univ, Dept Physiol, Fac Med, POB 259, H-1444 Budapest, Hungary.	hunyady@eok.sote.hu	Soltész-Katona, Eszter/H-1897-2019	Soltész-Katona, Eszter/0000-0002-9054-740X; Balla, Tamas/0000-0002-9077-3335; Balla, Andras/0000-0002-6450-2793	Hungarian Scientific Research Fund OTKA [NK72661]; Hungarian Ministry of Public Health (ETT) [337/2009]; National Development Agency of Hungary (NFU TAMOP) [4.2.2-08/1/KMR]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER	Hungarian Scientific Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Ministry of Public Health (ETT); National Development Agency of Hungary (NFU TAMOP); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by Hungarian Scientific Research Fund (OTKA) Grant NK72661, Hungarian Ministry of Public Health (ETT) Grant 337/2009, and National Development Agency of Hungary (NFU TAMOP) Grant 4.2.2-08/1/KMR.	Arozarena I, 2004, MOL CELL BIOL, V24, P1516, DOI 10.1128/MCB.24.4.1516-1530.2004; Augsten M, 2006, EMBO REP, V7, P46, DOI 10.1038/sj.embor.7400560; BALMFORTH AJ, 1995, EUR J PHARM-MOLEC PH, V291, P135, DOI 10.1016/0014-2999(95)90089-6; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Bivona TG, 2005, METHODS, V37, P138, DOI 10.1016/j.ymeth.2005.05.022; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Bondeva T, 2002, MOL BIOL CELL, V13, P2323, DOI 10.1091/mbc.E02-01-0019; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fukano T, 2007, CELL STRUCT FUNCT, V32, P9, DOI 10.1247/csf.06019; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Gaborik Z, 1998, FEBS LETT, V428, P147, DOI 10.1016/S0014-5793(98)00511-0; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Hunyady L, 1999, J AM SOC NEPHROL, V10, pS47; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Kiyokawa E, 2006, CANCER SCI, V97, P8, DOI 10.1111/j.1349-7006.2006.00141.x; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Nakamura T, 2006, METHOD ENZYMOL, V406, P315, DOI 10.1016/S0076-6879(06)06023-X; Ohba Y, 2003, EMBO J, V22, P859, DOI 10.1093/emboj/cdg087; Ohtsu H, 2006, HYPERTENSION, V48, P534, DOI 10.1161/01.HYP.0000237975.90870.eb; Olivares-Reyes JA, 2001, J BIOL CHEM, V276, P37761; Plowman SJ, 2008, MOL CELL BIOL, V28, P4377, DOI 10.1128/MCB.00050-08; Plowman SJ, 2005, BBA-MOL CELL RES, V1746, P274, DOI 10.1016/j.bbamcr.2005.06.004; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Roy S, 2002, MOL CELL BIOL, V22, P5128, DOI 10.1128/MCB.22.14.5128-5140.2002; Shah BH, 2004, MOL ENDOCRINOL, V18, P2035, DOI 10.1210/me.2003-0476; Smith RD, 1998, MOL ENDOCRINOL, V12, P634, DOI 10.1210/me.12.5.634; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Varnai P, 2005, P NATL ACAD SCI USA, V102, P7859, DOI 10.1073/pnas.0407535102; Varnai P, 2007, PFLUG ARCH EUR J PHY, V455, P69, DOI 10.1007/s00424-007-0270-y; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	46	6	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5319	5327		10.1074/jbc.M110.176933	http://dx.doi.org/10.1074/jbc.M110.176933			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21062747	Green Published, hybrid			2022-12-25	WOS:000287230600040
J	Scarpato, R; Verola, C; Fabiani, B; Bianchi, V; Saggese, G; Federico, G				Scarpato, Roberto; Verola, Carmela; Fabiani, Barbara; Bianchi, Vanessa; Saggese, Giuseppe; Federico, Giovanni			Nuclear damage in peripheral lymphocytes of obese and overweight Italian children as evaluated by the gamma-H2AX focus assay and micronucleus test	FASEB JOURNAL			English	Article						DNA double-strand break; chromosome damage; childhood obesity	DOUBLE-STRAND BREAKS; HISTONE H2AX PHOSPHORYLATION; BODY-MASS INDEX; BLOOD-LYMPHOCYTES; DNA-DAMAGE; CHILDHOOD OBESITY; CYTOGENETIC DAMAGE; CHROMOSOME-DAMAGE; DISEASE PATIENTS; THYROID-CANCER	Childhood obesity, often characterized by a chronic low-grade inflammation, has been associated with an increased risk of developing some types of cancer later in life. Nuclear gamma-H2AX foci represent the first detectable response of cells to DNA tumorigenesis lesions, such as the double-strand breaks (DSBs). An excess of micronucleated peripheral lymphocytes was found in subjects with cancer or inflammatation-based diseases. We set out to investigate the expression of genome damage, from DNA lesions to chromosome mutations (micronuclei), in overweight and obese children. Using the gamma-H2AX focus assay and micronucleus (MN) test, we analyzed peripheral lymphocytes from 119 Italian children classified as normal weight (n=38), overweight (n=20), or obese (n=61). Cultures treated with bleomycin (BLM) were also set up for each child in both assays to check functioning of the apparatus that ensures DNA integrity. We measured serum TNF-alpha, IL-6, and C-reactive protein (CRP) as markers of inflammation. Overweight and obese children had significantly higher levels of H2AX phosphorylation (0.0191 +/- 0.0039 and 0.0274 +/- 0.0029 gamma-H2AXF/n) and increased MN frequencies (2.30 +/- 0.25 and 2.45 +/- 0.22%) than normal-weight children (0.0034 +/- 0.0006 gamma-H2AXF/n, and 0.92 +/- 0.12% MN), while all subjects responded to BLM induction, irrespective of their weight status. The fold increase of spontaneous MN frequencies in overweight and obese subjects was 2.5 and 2.7, respectively, well below the corresponding increase in the gamma-H2AX foci 5.6- and 8.0-fold, respectively). IL-6 and CRP mean values were significantly higher in obese and overweight children than in controls. Here, we demonstrated that peripheral cells of overweight and obese children showed increased levels of DSBs, which were not completely repaired as part of them has been converted into micronuclei. Characterization of childhood obesity inflammation could be implemented using molecular markers of genome damage.-Scarpato, R., Verola, C., Fabiani, B., Bianchi, V., Saggese, G., Federico, G. Nuclear damage in peripheral lymphocytes of obese and overweight Italian children as evaluated by the gamma-H2AX focus assay and micronucleus test. FASEB J. 25, 685-693 (2011). www.fasebj.org	[Scarpato, Roberto; Verola, Carmela; Fabiani, Barbara] Univ Pisa, Dipartimento Biol, Unita Genet Mutagenesi & Epidemiol Ambientale, I-56100 Pisa, Italy; [Bianchi, Vanessa; Saggese, Giuseppe; Federico, Giovanni] Univ Pisana, Azienda Osped, Dipartimento Materno Infantile, Sez Endocrinol & Diabetol Pediat, Pisa, Italy	University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Scarpato, R (corresponding author), Univ Pisa, Dipartimento Biol, Unita Genet Mutagenesi & Epidemiol Ambientale, Via Derna 1, I-56100 Pisa, Italy.	rscarpato@biologia.unipi.it	Scarpato, Roberto/K-8987-2016		Italian Ministry of Education, University and Research	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This work has been partially funded by the Italian Ministry of Education, University and Research (PRIN). The authors acknowledge the technical support of Dr. Lisa Fiore (Laboratorio di Endocrinologia Pediatrica, Sezione di Endocrinologia e Diabetologia Pediatrica, Dipartimento Materno-Infantile, Azienda Ospedaliero-Universitaria Pisana) for blood sample preparation and of Dr. Maria Rita Metelli (Dipartimento di Medicina di Laboratorio e Diagnostica Molecolare, Azienda Ospedaliero-Universitaria Pisana) for TNF-alpha, CRP, and IL-6 assays.	Ahima RS, 2009, NAT MED, V15, P996, DOI 10.1038/nm0909-996; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Beels L, 2009, CIRCULATION, V120, P1903, DOI 10.1161/CIRCULATIONAHA.109.880385; Biro FM, 2010, AM J CLIN NUTR, V91, p1499S, DOI 10.3945/ajcn.2010.28701B; Bonassi S, 2007, CARCINOGENESIS, V28, P625, DOI 10.1093/carcin/bgl177; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Cizmecioglu FM, 2009, EXP CLIN ENDOCR DIAB, V117, P622, DOI 10.1055/s-0028-1112151; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dardano A, 2007, J CLIN ENDOCR METAB, V92, P4286, DOI 10.1210/jc.2007-0597; Emerit I, 1997, DERMATOLOGY, V194, P140, DOI 10.1159/000246083; Emerit I, 1997, MUTAT RES-FUND MOL M, V373, P47, DOI 10.1016/S0027-5107(96)00187-X; Federico G, 2008, EUR J NUCL MED MOL I, V35, P2113, DOI 10.1007/s00259-008-0867-1; Fenech M, 2003, MUTAT RES-GEN TOX EN, V534, P45, DOI 10.1016/S1383-5718(02)00248-6; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Gutierrez S, 1999, EUR J NUCL MED, V26, P1589, DOI 10.1007/s002590050499; Heitmann BL, 2009, NUTR REV, V67, pS89, DOI 10.1111/j.1753-4887.2009.00167.x; Hoelzl C, 2005, J Physiol Pharmacol, V56 Suppl 2, P49; Holland N, 2007, PEDIATR RES, V61, P209, DOI 10.1203/pdr.0b013e31802d77c7; *IT MIN HLTH I SUP, 2008, EP OB SCH CHILDR IT; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; Kapka L, 2007, MUTAGENESIS, V22, P201, DOI 10.1093/mutage/gem004; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kuefner MA, 2009, INVEST RADIOL, V44, P440, DOI 10.1097/RLI.0b013e3181a654a5; Lyon CJ, 2003, ENDOCRINOLOGY, V144, P2195, DOI 10.1210/en.2003-0285; Maffeis C, 2008, J CLIN ENDOCR METAB, V93, P2122, DOI 10.1210/jc.2007-2089; Maffeis C, 2007, NUTR METAB CARDIOVAS, V17, P394, DOI 10.1016/j.numecd.2006.08.006; Martinez-Perez L M, 2007, Prague Med Rep, V108, P248; Mateuca R, 2006, BIOCHIMIE, V88, P1515, DOI 10.1016/j.biochi.2006.07.004; Migliore L, 2002, NEUROLOGY, V58, P1809, DOI 10.1212/WNL.58.12.1809; Moran LJ, 2008, MUTAT RES-FUND MOL M, V639, P55, DOI 10.1016/j.mrfmmm.2007.11.007; Negre-Salvayre A, 2009, ANTIOXID REDOX SIGN, V11, P3071, DOI [10.1089/ars.2009.2484, 10.1089/ARS.2009.2484]; Neri M, 2005, ENVIRON HEALTH PERSP, V113, P1226, DOI 10.1289/ehp.7806; Nuciforo PG, 2007, CARCINOGENESIS, V28, P2082, DOI 10.1093/carcin/bgm108; Park J, 2007, DIABETES RES CLIN PR, V77, pS11, DOI 10.1016/j.diabres.2007.01.037; Pernice F, 2006, EUR J PHARMACOL, V532, P223, DOI 10.1016/j.ejphar.2006.01.003; Porciello G, 2003, J RHEUMATOL, V30, P1244; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Retnakaran R, 2006, DIABETES OBES METAB, V8, P483, DOI 10.1111/j.1463-1326.2005.00533.x; Riches LC, 2008, MUTAGENESIS, V23, P331, DOI 10.1093/mutage/gen039; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sak A, 2007, INT J RADIAT BIOL, V83, P639, DOI 10.1080/09553000701596118; Sander Miriam, 2008, Mol Carcinog, V47, P707, DOI 10.1002/mc.20214; Sbarbati A, 2006, PEDIATRICS, V117, P220, DOI 10.1542/peds.2004-2854; Scarpato R, 2009, EUR J CLIN INVEST, V39, P1091, DOI 10.1111/j.1365-2362.2009.02214.x; Shalitin S, 2009, HORM RES, V72, P287, DOI 10.1159/000245931; Skinner AC, 2010, PEDIATRICS, V125, pE801, DOI 10.1542/peds.2009-2182; Skinner AC, 2009, PEDIATRICS, V124, pE905, DOI 10.1542/peds.2009-0179; Takahashi A, 2005, CANCER LETT, V229, P171, DOI 10.1016/j.canlet.2005.07.016; Tanaka T, 2007, CELL PROLIFERAT, V40, P1; Tucker JD, 2009, MUTAT RES-GEN TOX EN, V677, P53, DOI 10.1016/j.mrgentox.2009.05.005; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Watters GP, 2009, MUTAT RES-GEN TOX EN, V679, P50, DOI 10.1016/j.mrgentox.2009.07.007; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wu XF, 2007, CANCER RES, V67, P3493, DOI 10.1158/0008-5472.CAN-06-4137; Wuttke K, 1996, INT J RADIAT BIOL, V69, P259, DOI 10.1080/095530096146101; Yan B, 2009, METHODS MOL BIOL, V512, P15, DOI 10.1007/978-1-60327-530-9_2	60	67	68	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2011	25	2					685	693		10.1096/fj.10-168427	http://dx.doi.org/10.1096/fj.10-168427			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	21068397				2022-12-25	WOS:000286724800026
J	Whichard, ZL; Motter, AE; Stein, PJ; Corey, SJ				Whichard, Zakary L.; Motter, Adilson E.; Stein, Peter J.; Corey, Seth J.			Slowly Produced MicroRNAs Control Protein Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVITY-ANALYSIS; TRANSFER-RNA; TRANSLATION; RIBOSOME; EXPRESSION; MECHANISM; TARGETS; BINDING; OUTPUT; MODEL	Proteins are the primary agents of function in biological systems, and their levels are critical control elements, reflecting the interplay between transcription, translation, and protein degradation. Here, we consider the role of microRNAs (miRNAs) in the post-transcriptional regulation of protein synthesis. To determine their impact on protein concentration, we constructed a mechanistic model consisting of four state variables and nine kinetic parameters that account for transcript sequestration and degradation via miRNA-mRNA complex formation. Our dynamical model predicts that, even when present in low copy number, miRNAs can exert potent effects on protein concentration. Sensitivity analysis of the steady-state solution indicates that miRNA synthesis commonly acts to fine-tune protein concentrations. However, the same analysis shows that for a small subset of miRNA-mRNA pairs characterized by slowly produced miRNAs, the miRNA synthesis rate is the dominant control element. Our model equations provide a tool to evaluate the importance of particular miRNAs on their target proteins and promote the development of miRNA-based therapies that target proteins associated with cancer, inflammation, and metabolic disorders.	[Whichard, Zakary L.; Stein, Peter J.; Corey, Seth J.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Whichard, Zakary L.; Stein, Peter J.; Corey, Seth J.] Childrens Mem Hosp, Dept Pediat, Chicago, IL 60611 USA; [Whichard, Zakary L.; Stein, Peter J.; Corey, Seth J.] Childrens Mem Hosp, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Motter, Adilson E.] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA; [Motter, Adilson E.] Northwestern Univ, NW Inst Complex Syst, Evanston, IL 60208 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Northwestern University	Corey, SJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Lurie 5-107,303 E Super St, Chicago, IL 60611 USA.	s-corey@northwestern.edu		Motter, Adilson E./0000-0003-1794-4828	National Institutes of Health [R01HL080052, R01CA108922]; National Cancer Institute [1U54CA143869-01]; Children's Memorial Hospital/Northwestern University; J. P. McCarthy Foundation; NATIONAL CANCER INSTITUTE [U54CA143869, R01CA108922] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080052] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Children's Memorial Hospital/Northwestern University; J. P. McCarthy Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01HL080052 and R01CA108922, National Cancer Institute Grant 1U54CA143869-01, Children's Memorial Hospital/Northwestern University, and a J. P. McCarthy Foundation award (to S. J. C.).	Altuvia S, 2000, P NATL ACAD SCI USA, V97, P9824, DOI 10.1073/pnas.97.18.9824; Altuvia S, 2004, J BACTERIOL, V186, P6679, DOI 10.1128/JB.186.20.6679-6680.2004; Altuvia S, 1998, EMBO J, V17, P6069, DOI 10.1093/emboj/17.20.6069; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0; Clancy JL, 2007, METHOD ENZYMOL, V431, P83, DOI 10.1016/S0076-6879(07)31006-9; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Levine E, 2007, BIOPHYS J, V93, pL52, DOI 10.1529/biophysj.107.118448; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Nandi A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-45; Nissan T, 2008, RNA, V14, P1480, DOI 10.1261/rna.1072808; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; OLOFSSON SO, 1987, AM HEART J, V113, P446, DOI 10.1016/0002-8703(87)90612-0; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Saltelli A., 2000, SENSITIVITY ANAL; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Scherer S., 2008, SHORT GUIDE HUMAN GE; SEGEL LA, 1989, SIAM REV, V31, P446, DOI 10.1137/1031091; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Xie ZR, 2007, BIOCHEM BIOPH RES CO, V358, P722, DOI 10.1016/j.bbrc.2007.04.207	36	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4742	4748		10.1074/jbc.M110.166348	http://dx.doi.org/10.1074/jbc.M110.166348			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21051536	Green Published, hybrid			2022-12-25	WOS:000286975700072
J	Merz, A; Long, G; Hiet, MS; Brugger, B; Chlanda, P; Andre, P; Wieland, F; Krijnse-Locker, J; Bartenschlager, R				Merz, Andreas; Long, Gang; Hiet, Marie-Sophie; Bruegger, Britta; Chlanda, Petr; Andre, Patrice; Wieland, Felix; Krijnse-Locker, Jacomine; Bartenschlager, Ralf			Biochemical and Morphological Properties of Hepatitis C Virus Particles and Determination of Their Lipidome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTRUCTURAL PROTEIN 5A; LOW-DENSITY; APOLIPOPROTEIN-E; IN-VIVO; REPLICATION; CULTURE; CHOLESTEROL; SECRETION; INFECTION; RECEPTOR	A hallmark of hepatitis C virus (HCV) particles is their association with host cell lipids, most notably lipoprotein components. It is thought that this property accounts for the low density of virus particles and their large heterogeneity. However, the composition of infectious virions and their biochemical and morphological properties are largely unknown. We developed a system in which the envelope glycoprotein E2 was N-terminally tagged with a FLAG epitope. This virus, designated Jc1E2(FLAG), produced infectivity titers to wild type levels and allowed affinity purification of virus particles that were analyzed for their protein and lipid composition. By using mass spectrometry, we found the lipid composition of Jc1E2FLAG particles to resemble the one very low-and low density-lipoprotein with cholesteryl esters accounting for almost half of the total HCV lipids. Thus, HCV particles possess a unique lipid composition that is very distinct from all other viruses analyzed so far and from the human liver cells in which HCV was produced. By electron microscopy (EM), we found purified Jc1E2FLAG particles to be heterogeneous, mostly spherical structures, with an average diameter of about 73 nm. Importantly, the majority of E2-containing particles also contained apoE on their surface as assessed by immuno-EM. Taken together, we describe a rapid and efficient system for the production of large quantities of affinity-purified HCV allowing a comprehensive analysis of the infectious virion, including the determination of its lipid composition.	[Krijnse-Locker, Jacomine; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, D-69120 Heidelberg, Germany; [Bruegger, Britta; Wieland, Felix] Heidelberg Univ, Heidelberg Univ Biochem Ctr, D-69120 Heidelberg, Germany; [Chlanda, Petr] EMBL Heidelberg, Struct Computat Biol Programme, D-69117 Heidelberg, Germany; [Andre, Patrice] Univ Lyon, INSERM, U851, F-69365 Lyon 07, France	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Institut National de la Sante et de la Recherche Medicale (Inserm)	Bartenschlager, R (corresponding author), Heidelberg Univ, Dept Infect Dis, Neuenheimer Feld 345, D-69120 Heidelberg, Germany.	ralf_bartenschlager@med.uni-heidelberg.de	Chlanda, Petr/AAK-6368-2021; André, Patrice/M-8139-2014; Locker, Jacomine Krijnse/AAX-1185-2020; Locker, Jacomine Krijnse/E-1009-2016; Bartenschlager, Ralf/L-2582-2015	Chlanda, Petr/0000-0002-7782-2139; André, Patrice/0000-0002-5834-7395; Bartenschlager, Ralf/0000-0001-5601-9307	Deutsche Forschungsgemeinschaft Sonderforschungsbereich [638]; Teilprojekt [A5]; European Research Council [233130]; European Union (Marie Curie Training Network EI-HCV) [MRTN-CT-2006-035599 EI-HCV]; Deutsche Forschungsgemeinschaft [SFB TRR83]	Deutsche Forschungsgemeinschaft Sonderforschungsbereich(German Research Foundation (DFG)); Teilprojekt; European Research Council(European Research Council (ERC)European Commission); European Union (Marie Curie Training Network EI-HCV)(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Deutsche Forschungsgemeinschaft Sonderforschungsbereich 638, Teilprojekt A5 (to R. B.).; Supported in part by European Research Council Grant 233130.; Supported by a grant from the European Union (Marie Curie Training Network EI-HCV, Contract MRTN-CT-2006-035599 EI-HCV).; Supported by Grant SFB TRR83 from the Deutsche Forschungsgemeinschaft.	Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Andre P, 2005, SEMIN LIVER DIS, V25, P93, DOI 10.1055/s-2005-864785; Bartenschlager R, 2004, ADV VIRUS RES, V63, P71, DOI 10.1016/S0065-3527(04)63002-8; BARTENSCHLAGER R, 2011, TRENDS MICR IN PRESS; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brugger B, 2000, J CELL BIOL, V151, P507, DOI 10.1083/jcb.151.3.507; Brugger B, 2004, J BIOL CHEM, V279, P7530, DOI 10.1074/jbc.M310207200; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Bruss V, 2004, VIRUS RES, V106, P199, DOI 10.1016/j.virusres.2004.08.016; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Ciesek S, 2010, J INFECT DIS, V201, P1859, DOI 10.1086/652803; Ciesek S, 2009, HEPATOLOGY, V50, P1638, DOI 10.1002/hep.23281; Dreux M, 2007, J BIOL CHEM, V282, P32357, DOI 10.1074/jbc.M705358200; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Felmlee DJ, 2010, GASTROENTEROLOGY, V139, P1774, DOI 10.1053/j.gastro.2010.07.047; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Gastaminza P, 2010, J VIROL, V84, P10999, DOI 10.1128/JVI.00526-10; Gottwein JM, 2008, ADV VIRUS RES, V71, P51, DOI 10.1016/S0065-3527(08)00002-X; Griffin SDC, 2004, J GEN VIROL, V85, P451, DOI 10.1099/vir.0.19634-0; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; HUI DY, 1981, J BIOL CHEM, V256, P5646; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Jirasko V, 2008, J BIOL CHEM, V283, P28546, DOI 10.1074/jbc.M803981200; Johansson DX, 2007, P NATL ACAD SCI USA, V104, P16269, DOI 10.1073/pnas.0705522104; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Kalvodova L, 2009, J VIROL, V83, P7996, DOI 10.1128/JVI.00635-09; Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Koivusalo M, 2001, J LIPID RES, V42, P663; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Maillard P, 2001, J VIROL, V75, P8240, DOI 10.1128/JVI.75.17.8240-8250.2001; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; Masciopinto F, 2004, EUR J IMMUNOL, V34, P2834, DOI 10.1002/eji.200424887; Mensenkamp AR, 1999, J BIOL CHEM, V274, P35711, DOI 10.1074/jbc.274.50.35711; Mensenkamp AR, 2004, J HEPATOL, V40, P599, DOI 10.1016/j.jhep.2003.12.011; Meunier JC, 2005, P NATL ACAD SCI USA, V102, P4560, DOI 10.1073/pnas.0501275102; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Nahmias Y, 2008, HEPATOLOGY, V47, P1437, DOI 10.1002/hep.22197; Nielsen SU, 2008, J GEN VIROL, V89, P2507, DOI 10.1099/vir.0.2008/000083-0; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Parent R, 2009, HEPATOLOGY, V49, P1798, DOI 10.1002/hep.22852; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; SATOH O, 1990, J LIPID RES, V31, P1293; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; SCHLESINGER HR, 1973, J VIROL, V12, P1028, DOI 10.1128/JVI.12.5.1028-1030.1973; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; Takahashi H, 2010, BIOCHEM BIOPH RES CO, V395, P565, DOI 10.1016/j.bbrc.2010.04.081; van den Hoff M J, 1995, Methods Mol Biol, V48, P185; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Voisset C, 2005, J BIOL CHEM, V280, P7793, DOI 10.1074/jbc.M411600200; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Yu XK, 2007, VIROLOGY, V367, P126, DOI 10.1016/j.virol.2007.05.038	76	272	283	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3018	3032		10.1074/jbc.M110.175018	http://dx.doi.org/10.1074/jbc.M110.175018			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21056986	Green Published, hybrid			2022-12-25	WOS:000286464300065
J	Nagai, S; Okazaki, M; Segawa, H; Bergwitz, C; Dean, T; Potts, JT; Mahon, MJ; Gardella, TJ; Juppner, H				Nagai, So; Okazaki, Makoto; Segawa, Hiroko; Bergwitz, Clemens; Dean, Thomas; Potts, John T., Jr.; Mahon, Matthew J.; Gardella, Thomas J.; Jueppner, Harald			Acute Down-regulation of Sodium-dependent Phosphate Transporter NPT2a Involves Predominantly the cAMP/PKA Pathway as Revealed by Signaling-selective Parathyroid Hormone Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY HYPOPHOSPHATEMIC RICKETS; C ACTIVATION DOMAIN; RECEPTOR; COTRANSPORTER; MUTATIONS; HYPERCALCIURIA; BINDING; REGION; SITES; CELLS	The parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor (PTHR1) in cells of the renal proximal tubule mediates the reduction in membrane expression of the sodium-dependent P-i co-transporters, NPT2a and NPT2c, and thus suppresses the re-uptake of P-i from the filtrate. In most cell types, the liganded PTHR1 activates G alpha(S)/adenylyl cyclase/cAMP/PKA (cAMP/PKA) and G alpha(q/11)/phospholipase C/phosphatidylinositol 1,4,5-trisphosphate (IP3)/Ca2+/PKC (IP3/PKC) signaling pathways, but the relative roles of each pathway in mediating renal regulation P-i transport remain uncertain. We therefore explored the signaling mechanisms involved in PTH-dependent regulation of NPT2a function using potent, long-acting PTH analogs, M-PTH(1-28) (where M = Ala(1,12), Aib(3), Gln(10), Har(11), Trp(14), and Arg(19)) and its position 1-modified variant, Trp(1)-M-PTH(1-28), designed to be phospholipase C-deficient. In cell-based assays, both M-PTH(1-28) and Trp(1)-M-PTH(1-28) exhibited potent and prolonged cAMP responses, whereas only M-PTH(1-28) was effective in inducing IP3 and intracellular calcium responses. In opossum kidney cells, a clonal cell line in which the PTHR1 and NPT2a are endogenously expressed, M-PTH(1-28) and Trp(1)-M-PTH( 1-28) each induced reductions in P-32 uptake, and these responses persisted for more than 24 h after ligand wash-out, whereas that of PTH(1-34) was terminated by 4 h. When injected into wild-type mice, both M-modified PTH analogs induced prolonged reductions in blood P-i levels and commensurate reductions in NPT2a expression in the renal brush border membrane. Our findings suggest that the acute down-regulation of NPT2a expression by PTH ligands involves mainly the cAMP/PKA signaling pathway and are thus consistent with the elevated blood P-i levels seen in pseudohypoparathyroid patients, in whom G alpha(s)-mediated signaling in renal proximal tubule cells is defective.	[Nagai, So; Okazaki, Makoto; Segawa, Hiroko; Bergwitz, Clemens; Dean, Thomas; Potts, John T., Jr.; Mahon, Matthew J.; Gardella, Thomas J.; Jueppner, Harald] Massachusetts Gen Hosp, Endocrine Unit, Dept Med, Boston, MA 02114 USA; [Nagai, So; Okazaki, Makoto; Segawa, Hiroko; Bergwitz, Clemens; Dean, Thomas; Potts, John T., Jr.; Mahon, Matthew J.; Gardella, Thomas J.; Jueppner, Harald] Massachusetts Gen Hosp, Endocrine Unit, Dept Pediat, Boston, MA 02114 USA; [Jueppner, Harald] Massachusetts Gen Hosp, Pediat Nephrol Unit, Dept Med, Boston, MA 02114 USA; [Jueppner, Harald] Massachusetts Gen Hosp, Pediat Nephrol Unit, Dept Pediat, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Juppner, H (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Dept Med, Thier 10,50 Blossum St, Boston, MA 02114 USA.	hjueppner@partners.org						Bastepe M, 2005, HORM RES, V63, P65, DOI 10.1159/000083895; BELL NH, 1972, J CLIN INVEST, V51, P816, DOI 10.1172/JCI106876; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Bisello A, 2002, J BIOL CHEM, V277, P38524, DOI 10.1074/jbc.M202544200; COLE JA, 1988, ENDOCRINOLOGY, V122, P2981, DOI 10.1210/endo-122-6-2981; COLE JA, 1987, AM J PHYSIOL, V253, pE221, DOI 10.1152/ajpendo.1987.253.2.E221; Dean T, 2006, MOL ENDOCRINOL, V20, P931, DOI 10.1210/me.2005-0349; Dean T, 2008, MOL ENDOCRINOL, V22, P156, DOI 10.1210/me.2007-0274; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Forster IC, 2006, KIDNEY INT, V70, P1548, DOI 10.1038/sj.ki.5001813; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Ichikawa S, 2006, J CLIN ENDOCR METAB, V91, P4022, DOI 10.1210/jc.2005-2840; Jankowski M, 2001, KIDNEY BLOOD PRESS R, V24, P1, DOI 10.1159/000054198; JOUISHOMME H, 1992, ENDOCRINOLOGY, V130, P53, DOI 10.1210/en.130.1.53; JOUISHOMME H, 1994, J BONE MINER RES, V9, P943; Levine LM., 2001, PARATHYROIDS BASIC C, P807; Lorenz-Depiereux B, 2006, AM J HUM GENET, V78, P193, DOI 10.1086/499410; Lupp A, 2010, EUR J ENDOCRINOL, V162, P979, DOI 10.1530/EJE-09-0821; Mahon MJ, 2003, MOL ENDOCRINOL, V17, P2355, DOI 10.1210/me.2003-0043; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Okazaki M, 2008, P NATL ACAD SCI USA, V105, P16525, DOI 10.1073/pnas.0808750105; Segawa H, 2007, AM J PHYSIOL-RENAL, V292, pF395, DOI 10.1152/ajprenal.00100.2006; Shimizu M, 2002, BIOCHEMISTRY-US, V41, P13224, DOI 10.1021/bi026162k; Shimizu M, 2001, ENDOCRINOLOGY, V142, P3068, DOI 10.1210/en.142.7.3068; Shimizu N, 2004, J BONE MINER RES, V19, P2078, DOI 10.1359/JBMR.040914; Takasu H, 1996, ENDOCRINOLOGY, V137, P5537, DOI 10.1210/en.137.12.5537; Tenenhouse HS, 2007, J STEROID BIOCHEM, V103, P572, DOI 10.1016/j.jsbmb.2006.12.090; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Whitfield JF, 2001, J BONE MINER RES, V16, P441, DOI 10.1359/jbmr.2001.16.3.441	30	42	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1618	1626		10.1074/jbc.M110.198416	http://dx.doi.org/10.1074/jbc.M110.198416			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21047792	Green Published, hybrid			2022-12-25	WOS:000286005000074
J	Sheridan, JT; Worthington, EN; Yu, KA; Gabriel, SE; Hartzell, HC; Tarran, R				Sheridan, John T.; Worthington, Erin N.; Yu, Kuai; Gabriel, Sherif E.; Hartzell, H. Criss; Tarran, Robert			Characterization of the Oligomeric Structure of the Ca2+-activated Cl- Channel Ano1/TMEM16A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; RESONANCE ENERGY-TRANSFER; ACTIVATED CHLORIDE CHANNEL; PDZ BINDING MOTIF; PLASMA-MEMBRANE; SENSORY NEURONS; LIVING CELLS; K+ CHANNELS; CALCIUM; PROTEIN	Members of the Anoctamin (Ano)/TMEM16A family have recently been identified as essential subunits of the Ca2+-activated chloride channel (CaCC). For example, Ano1 is highly expressed in multiple tissues including airway epithelia, where it acts as an apical conduit for transepithelial Cl- secretion and helps regulate lung liquid homeostasis and mucus clearance. However, little is known about the oligomerization of this protein in the plasma membrane. Thus, utilizing mCherry- and eGFP-tagged Ano1 constructs, we conducted biochemical and Forster resonance energy transfer (FRET)-based experiments to determine the quaternary structure of Ano1. FRET and co-immunoprecipitation studies revealed that tagged Ano1 subunits directly associated before they reached the plasma membrane. This association was not altered by changes in cytosolic Ca2+, suggesting that this is a fixed interaction. To determine the oligomeric structure of Ano1, we performed chemical cross-linking, non-denaturing PAGE, and electromobility shift assays, which revealed that Ano1 exists as a dimer. These data are the first to probe the quaternary structure of Ano1. Understanding the oligomeric nature of Ano1 is an essential step in the development of therapeutic drugs that could be useful in the treatment of cystic fibrosis.	Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Worthington, Erin N.; Gabriel, Sherif E.; Tarran, Robert] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Yu, Kuai; Hartzell, H. Criss] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Emory University		tarran@med.unc.edu			National Institutes of Health [HL084934, HL034322, EY0148852, GM60448]; Cystic Fibrosis Foundation; Children's Healthcare of Atlanta Center for Cystic Fibrosis Research; Howard Hughes Medical Institute Med-Into-Grad University; NATIONAL EYE INSTITUTE [R01EY014852] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084934, P01HL034322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Children's Healthcare of Atlanta Center for Cystic Fibrosis Research; Howard Hughes Medical Institute Med-Into-Grad University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL084934, HL034322, EY0148852, and GM60448, the Cystic Fibrosis Foundation, and the Children's Healthcare of Atlanta Center for Cystic Fibrosis Research.; Supported in part by the Howard Hughes Medical Institute Med-Into-Grad University of North Carolina Program in Translational Medicine.	Albertazzi L, 2009, PHOTOCHEM PHOTOBIOL, V85, P287, DOI 10.1111/j.1751-1097.2008.00435.x; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; Berdiev BK, 2007, J BIOL CHEM, V282, P36481, DOI 10.1074/jbc.M708089200; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chen JH, 2002, J MEMBRANE BIOL, V188, P55, DOI 10.1007/s00232-001-0174-2; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; Das S, 2008, CANCER RES, V68, P6306, DOI 10.1158/0008-5472.CAN-08-0870; Duan DY, 2009, J PHYSIOL-LONDON, V587, P2163, DOI 10.1113/jphysiol.2008.165860; Duran C, 2010, ANNU REV PHYSIOL, V72, P95, DOI 10.1146/annurev-physiol-021909-135811; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; Fischer H, 1995, J PHYSIOL-LONDON, V489, P745, DOI 10.1113/jphysiol.1995.sp021088; Fischmeister R, 2005, J PHYSIOL-LONDON, V562, P477, DOI 10.1113/jphysiol.2004.075622; Haggie PM, 2004, J BIOL CHEM, V279, P5494, DOI 10.1074/jbc.M312445200; Hengl T, 2010, P NATL ACAD SCI USA, V107, P6052, DOI 10.1073/pnas.0909032107; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; JOHNSON LG, 1995, J CLIN INVEST, V95, P1377, DOI 10.1172/JCI117789; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kerschensteiner D, 2005, P NATL ACAD SCI USA, V102, P6160, DOI 10.1073/pnas.0500468102; Kuo MMC, 2007, P NATL ACAD SCI USA, V104, P2151, DOI 10.1073/pnas.0609085104; Kuruma A, 2000, J GEN PHYSIOL, V115, P59, DOI 10.1085/jgp.115.1.59; Lamprecht G, 2006, AM J PHYSIOL-GASTR L, V291, pG766, DOI 10.1152/ajpgi.00135.2006; Large WA, 1996, AM J PHYSIOL-CELL PH, V271, pC435; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MILEDI R, 1982, PROC R SOC SER B-BIO, V215, P491, DOI 10.1098/rspb.1982.0056; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Ramjeesingh M, 2003, BIOCHEM J, V374, P793, DOI 10.1042/BJ20030683; Rasche S, 2010, CHEM SENSES, V35, P239, DOI 10.1093/chemse/bjq007; Ribeiro CMP, 2000, CELL CALCIUM, V27, P175, DOI 10.1054/ceca.2000.0108; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Schwappach B, 2008, MOL MEMBR BIOL, V25, P270, DOI 10.1080/09687680801960998; Sromek SM, 1998, MOL PHARMACOL, V54, P485, DOI 10.1124/mol.54.3.485; Staruschenko A, 2004, J BIOL CHEM, V279, P27729, DOI 10.1074/jbc.M404169200; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Tarran R, 2002, J GEN PHYSIOL, V120, P407, DOI 10.1085/jgp.20028599; Tramier M, 2006, MICROSC RES TECHNIQ, V69, P933, DOI 10.1002/jemt.20370; Weatherman RV, 2002, MOL ENDOCRINOL, V16, P487, DOI 10.1210/me.16.3.487; Wei L, 2001, PFLUG ARCH EUR J PHY, V442, P280, DOI 10.1007/s004240100531; Wittig I, 2008, PROTEOMICS, V8, P3974, DOI 10.1002/pmic.200800017; Xiao QH, 2009, J PHYSIOL-LONDON, V587, P4379, DOI 10.1113/jphysiol.2009.176800; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhu MH, 2009, J PHYSIOL-LONDON, V587, P4905, DOI 10.1113/jphysiol.2009.176206	48	94	99	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1381	1388		10.1074/jbc.M110.174847	http://dx.doi.org/10.1074/jbc.M110.174847			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21056985	hybrid, Green Published			2022-12-25	WOS:000286005000050
J	de Lucas-Cerrillo, AM; Maldifassi, MC; Arnalich, F; Renart, J; Atienza, G; Serantes, R; Cruces, J; Sanchez-Pacheco, A; Andres-Mateos, E; Montiel, C				de Lucas-Cerrillo, Ana M.; Constanza Maldifassi, M.; Arnalich, Francisco; Renart, Jaime; Atienza, Gema; Serantes, Rocio; Cruces, Jesus; Sanchez-Pacheco, Aurora; Andres-Mateos, Eva; Montiel, Carmen			Function of Partially Duplicated Human alpha 7 Nicotinic Receptor Subunit CHRFAM7A Gene POTENTIAL IMPLICATIONS FOR THE CHOLINERGIC ANTI-INFLAMMATORY RESPONSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVE ALLOSTERIC MODULATION; PERIPHERAL-BLOOD LYMPHOCYTES; ACETYLCHOLINE-RECEPTOR; MESSENGER-RNA; XENOPUS-OOCYTES; VAGUS NERVE; ALZHEIMERS-DISEASE; PREFRONTAL CORTEX; GABA(A) RECEPTORS; BIPOLAR DISORDER	The neuronal alpha 7 nicotinic receptor subunit gene (CHRNA7) is partially duplicated in the human genome forming a hybrid gene (CHRFAM7A) with the novel FAM7A gene. The hybrid gene transcript, dup alpha 7, has been identified in brain, immune cells, and the HL-60 cell line, although its translation and function are still unknown. In this study, dup alpha 7 cDNA has been cloned and expressed in GH4C1 cells and Xenopus oocytes to study the pattern and functional role of the expressed protein. Our results reveal that dup alpha 7 transcript was natively translated in HL-60 cells and heterologously expressed in GH4C1 cells and oocytes. Injection of dup alpha 7 mRNA into oocytes failed to generate functional receptors, but when co-injected with alpha 7 mRNA at alpha 7/dup alpha 7 ratios of 5:1, 2:1, 1:1, 1:5, and 1: 10, it reduced the nicotine-elicited alpha 7 current generated in control oocytes (alpha 7 alone) by 26, 53, 75, 93, and 94%, respectively. This effect is mainly due to a reduction in the number of functional alpha 7 receptors reaching the oocyte membrane, as deduced from alpha-bungarotoxin binding and fluorescent confocal assays. Two additional findings open the possibility that the dominant negative effect of dup alpha 7 on alpha 7 receptor activity observed in vitro could be extrapolated to in vivo situations. (i) Compared with alpha 7 mRNA, basal dup alpha 7 mRNA levels are substantial in human cerebral cortex and higher in macrophages. (ii) dup alpha 7 mRNA levels in macrophages are down-regulated by IL-1 beta, LPS, and nicotine. Thus, dup alpha 7 could modulate alpha 7 receptor-mediated synaptic transmission and cholinergic anti-inflammatory response.	[de Lucas-Cerrillo, Ana M.; Constanza Maldifassi, M.; Atienza, Gema; Serantes, Rocio; Montiel, Carmen] Univ Autonoma Madrid, Fac Med, Hosp La Paz,IdiPAZ, Dept Farmacol & Terapeut, E-28029 Madrid, Spain; [Arnalich, Francisco; Serantes, Rocio] Univ Autonoma Madrid, Fac Med, Hosp La Paz,IdiPAZ, Dept Med Interna, E-28029 Madrid, Spain; [Cruces, Jesus; Sanchez-Pacheco, Aurora] Univ Autonoma Madrid, Fac Med, Hosp La Paz,IdiPAZ, Dept Bioquim, E-28029 Madrid, Spain; [Renart, Jaime; Cruces, Jesus; Sanchez-Pacheco, Aurora] Inst Invest Biomed Alberto Sols, Consejo Super Invest Cient, Madrid 28029, Spain; [Andres-Mateos, Eva] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Sch Med, Baltimore, MD 21205 USA	Autonomous University of Madrid; Hospital Universitario La Paz; Autonomous University of Madrid; Hospital Universitario La Paz; Autonomous University of Madrid; Hospital Universitario La Paz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Johns Hopkins University	Montiel, C (corresponding author), Univ Autonoma Madrid, Fac Med, Hosp La Paz,IdiPAZ, Dept Farmacol & Terapeut, Arzobispo Morcillo 4, E-28029 Madrid, Spain.	carmen.montiel@uam.es	Arnalich, Francisco/K-7723-2014; Arnalich, Francisco/J-8184-2017; Arnalich, Francisco/AAF-5924-2021; Renart, Jaime/B-7661-2009; Montiel, Carmen/L-1407-2017	Arnalich, Francisco/0000-0003-2943-0373; Renart, Jaime/0000-0001-6620-3706; Montiel, Carmen/0000-0003-4845-0484; Sanchez Pacheco, Aurora/0000-0002-7776-2594	Ministerio de Ciencia y Tecnologia and Fundacion Mutua Madrilena, Spain [SAF2008-05347]; Ministerio de Ciencia e Innovacion, Spain; CONICYT, Ministerio de Educacion, Chile	Ministerio de Ciencia y Tecnologia and Fundacion Mutua Madrilena, Spain; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONICYT, Ministerio de Educacion, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by Grant SAF2008-05347 (to C. M. and F. A.) from the Ministerio de Ciencia y Tecnologia and Fundacion Mutua Madrilena, Spain.; Recipient of fellowship from Programa de Formacion de Personal Investigador (Ministerio de Ciencia e Innovacion, Spain).; Recipient of fellowship from Beca Chile (CONICYT, Ministerio de Educacion, Chile.	Arias HR, 2009, INT J BIOCHEM CELL B, V41, P1441, DOI 10.1016/j.biocel.2009.01.013; Balduzzi R, 2001, BBA-MOL CELL RES, V1539, P93, DOI 10.1016/S0167-4889(01)00097-0; Bertrand D, 2008, MOL PHARMACOL, V74, P1407, DOI 10.1124/mol.107.042820; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Chen DN, 1997, J BIOL CHEM, V272, P24024, DOI 10.1074/jbc.272.38.24024; Court JA, 2000, J CHEM NEUROANAT, V20, P281, DOI 10.1016/S0891-0618(00)00110-1; Dajas-Bailador FA, 2000, NEUROPHARMACOLOGY, V39, P2799, DOI 10.1016/S0028-3908(00)00127-1; de Almeida MC, 2000, MEM I OSWALDO CRUZ, V95, P221, DOI 10.1590/S0074-02762000000200014; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; De Luca V, 2006, ACTA PSYCHIAT SCAND, V114, P211, DOI 10.1111/j.1600-0447.2006.00785.x; Del Prete MJ, 2007, RNA, V13, P414, DOI 10.1261/rna.79407; Dickinson JA, 2008, MOL PHARMACOL, V74, P348, DOI 10.1124/mol.108.046623; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Feher A, 2009, DEMENT GERIATR COGN, V28, P56, DOI 10.1159/000230036; Flomen RH, 2006, AM J MED GENET B, V141B, P571, DOI 10.1002/ajmg.b.30306; FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X; Garcia-Guzman M., 1994, BIOCHEMISTRY-US, V33, P15198; Gault J, 2003, AM J MED GENET B, V123B, P39, DOI 10.1002/ajmg.b.20061; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Groot Kormelink P. J., 1997, FEBS LETT, V400, P309; Guan ZZ, 1999, NEUROREPORT, V10, P1779, DOI 10.1097/00001756-199906030-00028; Herrero CJ, 1999, BRIT J PHARMACOL, V127, P1375, DOI 10.1038/sj.bjp.0702692; Herrero CJ, 2002, J NEUROSCI, V22, P377, DOI 10.1523/JNEUROSCI.22-02-00377.2002; Hong CJ, 2004, NEUROSCI LETT, V355, P69, DOI 10.1016/j.neulet.2003.10.043; Li DP, 2001, BRAIN RES, V920, P151, DOI 10.1016/S0006-8993(01)03055-4; Locke DP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r50; Mechawar N, 2004, P NATL ACAD SCI USA, V101, P9822, DOI 10.1073/pnas.0403361101; Oddo S, 2006, J PHYSIOL-PARIS, V99, P172, DOI 10.1016/j.jphysparis.2005.12.080; Osato N, 2007, GENETICS, V176, P1299, DOI 10.1534/genetics.106.069484; Pavlov VA, 2006, BIOCHEM SOC T, V34, P1037, DOI 10.1042/BST0341037; PENG X, 1994, MOL PHARMACOL, V45, P546; Perl O, 2006, NEUROPSYCHOBIOLOGY, V53, P88, DOI 10.1159/000091725; Pintado AJ, 2000, BRIT J PHARMACOL, V130, P1893, DOI 10.1038/sj.bjp.0703519; Pradet-Balade B, 2001, BIOTECHNIQUES, V30, P1352, DOI 10.2144/01306rr03; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Raux G, 2002, MOL PSYCHIATR, V7, P1006, DOI 10.1038/sj.mp.4001140; Riley B, 2002, GENOMICS, V79, P197, DOI 10.1006/geno.2002.6694; Rosas-Ballina M, 2009, NEURON, V64, P28, DOI 10.1016/j.neuron.2009.09.039; Serantes R, 2006, J BIOL CHEM, V281, P14632, DOI 10.1074/jbc.M512489200; Severance EG, 2008, GENES BRAIN BEHAV, V7, P37, DOI 10.1111/j.1601-183X.2007.00323.x; Severance EG, 2009, J NEURAL TRANSM, V116, P213, DOI 10.1007/s00702-008-0164-y; Sharma G, 2008, CURR MED CHEM, V15, P2921, DOI 10.2174/092986708786848703; Shaw S, 2002, J BIOL CHEM, V277, P44920, DOI 10.1074/jbc.M204610200; Shytle RD, 2002, MOL PSYCHIATR, V7, P525, DOI 10.1038/sj.mp.4001035; Sinkus ML, 2009, BRAIN RES, V1291, P1, DOI 10.1016/j.brainres.2009.07.041; Solis-Garrido LM, 2004, J BIOL CHEM, V279, P52414, DOI 10.1074/jbc.M408872200; Sweileh W, 2000, MOL BRAIN RES, V75, P293, DOI 10.1016/S0169-328X(99)00302-2; van Maanen MA, 2009, ARTHRITIS RHEUM-US, V60, P1272, DOI 10.1002/art.24470; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; Villiger Y, 2002, J NEUROIMMUNOL, V126, P86, DOI 10.1016/S0165-5728(02)00057-7; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zhang JM, 2007, J PHYSIOL-LONDON, V579, P753, DOI 10.1113/jphysiol.2006.124578; Zwart R, 2002, NEUROPHARMACOLOGY, V43, P374, DOI 10.1016/S0028-3908(02)00094-1	58	87	89	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					594	606		10.1074/jbc.M110.180067	http://dx.doi.org/10.1074/jbc.M110.180067			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21047781	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000285782800062
J	Biuw, M; Nost, OA; Stien, A; Zhou, Q; Lydersen, C; Kovacs, KM				Biuw, Martin; Nost, Ole Anders; Stien, Audun; Zhou, Qin; Lydersen, Christian; Kovacs, Kit M.			Effects of Hydrographic Variability on the Spatial, Seasonal and Diel Diving Patterns of Southern Elephant Seals in the Eastern Weddell Sea	PLOS ONE			English	Article							ANTARCTIC FUR SEALS; KING-GEORGE ISLAND; PENGUINS APTENODYTES-FORSTERI; MIROUNGA-LEONINA; EMPEROR PENGUINS; ARCTOCEPHALUS-GAZELLA; VERTICAL-DISTRIBUTION; FORAGING ECOLOGY; ADULT MALE; PLEURAGRAMMA-ANTARCTICUM	Weddell Sea hydrography and circulation is driven by influx of Circumpolar Deep Water (CDW) from the Antarctic Circumpolar Current (ACC) at its eastern margin. Entrainment and upwelling of this high-nutrient, oxygen-depleted water mass within the Weddell Gyre also supports the mesopelagic ecosystem within the gyre and the rich benthic community along the Antarctic shelf. We used Conductivity-Temperature-Depth Satellite Relay Data Loggers (CTD-SRDLs) to examine the importance of hydrographic variability, ice cover and season on the movements and diving behavior of southern elephant seals in the eastern Weddell Sea region during their overwinter feeding trips from Bouvetoya. We developed a model describing diving depth as a function of local time of day to account for diel variation in diving behavior. Seals feeding in pelagic ice-free waters during the summer months displayed clear diel variation, with daytime dives reaching 500-1500 m and night-time targeting of the subsurface temperature and salinity maxima characteristic of CDW around 150-300 meters. This pattern was especially clear in the Weddell Cold and Warm Regimes within the gyre, occurred in the ACC, but was absent at the Dronning Maud Land shelf region where seals fed benthically. Diel variation was almost absent in pelagic feeding areas covered by winter sea ice, where seals targeted deep layers around 500-700 meters. Thus, elephant seals appear to switch between feeding strategies when moving between oceanic regimes or in response to seasonal environmental conditions. While they are on the shelf, they exploit the locally-rich benthic ecosystem, while diel patterns in pelagic waters in summer are probably a response to strong vertical migration patterns within the copepod-based pelagic food web. Behavioral flexibility that permits such switching between different feeding strategies may have important consequences regarding the potential for southern elephant seals to adapt to variability or systematic changes in their environment resulting from climate change.	[Biuw, Martin; Nost, Ole Anders; Zhou, Qin; Lydersen, Christian; Kovacs, Kit M.] Norwegian Polar Res Inst, Polar Environm Ctr, Tromso, Norway; [Stien, Audun] Norwegian Inst Nat Res, Polar Environm Ctr, Tromso, Norway	Norwegian Polar Institute; Norwegian Institute Nature Research	Biuw, M (corresponding author), Norwegian Polar Res Inst, Polar Environm Ctr, Tromso, Norway.	martin.biuw@npolar.no	Biuw, Martin/AAF-9895-2021	Stien, Audun/0000-0001-8046-7337; Nost, Ole Anders/0000-0002-6139-4088; Biuw, Martin/0000-0001-8051-3399	Research Council of Norway; Natural Environment Research Council [NE/E018289/1] Funding Source: researchfish; NERC [NE/E018289/1] Funding Source: UKRI	Research Council of Norway(Research Council of Norway); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study is part of MEOP (Marine Mammals Exploring the Oceans Pole to pole), Norway, an International Polar Year (IPY) programme funded by the Research Council of Norway (Grant number to be provided). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amante C., 2009, ETOPO1 1 ARC MINUTE; Andrews RD, 2008, POLAR BIOL, V31, P1461, DOI 10.1007/s00300-008-0487-z; Atkinson A, 2000, POLAR BIOL, V23, P46, DOI 10.1007/s003000050007; Bailleul F, 2007, PHILOS T R SOC B, V362, P2169, DOI 10.1098/rstb.2007.2109; Bailleul F, 2007, DEEP-SEA RES PT II, V54, P343, DOI 10.1016/j.dsr2.2006.11.005; Bailleul F, 2010, MAR ECOL PROG SER, V408, P251, DOI 10.3354/meps08560; BAKER JR, 1988, VET REC, V123, P287, DOI 10.1136/vr.123.11.287; Bates D., 2010, IME4 LINEAR MIXED EF; Bennett KA, 2001, J EXP BIOL, V204, P649; Bester MN, 2002, ANTARCT SCI, V14, P123, DOI 10.1017/S0954102002000676; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Biuw M, 2009, MAR ECOL PROG SER, V385, P271, DOI 10.3354/meps08025; Boehme L, 2009, OCEAN SCI, V5, P685, DOI 10.5194/os-5-685-2009; Boehme L, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004647; Boehme L, 2008, LIMNOL OCEANOGR, V53, P2350, DOI 10.4319/lo.2008.53.5_part_2.2350; Bornemann H, 2000, ANTARCT SCI, V12, P3, DOI 10.1017/S095410200000002X; Bost CA, 2002, MAR ECOL PROG SER, V227, P51, DOI 10.3354/meps227051; Boyd IL, 1994, BIOMASS ENERGY CONSU, P98; Bradshaw CJA, 2003, P ROY SOC B-BIOL SCI, V270, P1283, DOI 10.1098/rspb.2003.2371; BURNS JM, 1997, DEV CHANGES DIURNAL, P328; CAMPAGNA C, 1995, J ZOOL, V236, P55, DOI 10.1111/j.1469-7998.1995.tb01784.x; Campagna C, 1999, J MAMMAL, V80, P1341, DOI 10.2307/1383185; Campagna C, 2006, DEEP-SEA RES PT I, V53, P1907, DOI 10.1016/j.dsr.2006.08.015; Charrassin JB, 2008, P NATL ACAD SCI USA, V105, P11634, DOI 10.1073/pnas.0800790105; Charrassin JB, 1998, OECOLOGIA, V114, P194, DOI 10.1007/s004420050436; Cherel Y, 1999, MAR BIOL, V134, P375, DOI 10.1007/s002270050554; Cherel Y, 2008, MAR ECOL PROG SER, V370, P239, DOI 10.3354/meps07673; Cisewski B, 2010, DEEP-SEA RES PT I, V57, P78, DOI 10.1016/j.dsr.2009.10.005; CROXALL JP, 1985, J ANIM ECOL, V54, P1, DOI 10.2307/4616; Daneri GA, 2002, POLAR BIOL, V25, P739, DOI 10.1007/s00300-002-0408-5; DEACON GER, 1979, DEEP-SEA RES, V26, P981, DOI 10.1016/0198-0149(79)90044-X; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; EKAU W, 1990, ANTARCT SCI, V2, P129, DOI 10.1017/S0954102090000165; Fauchald P, 2006, OECOLOGIA, V149, P383, DOI 10.1007/s00442-006-0463-7; Fedak M, 2002, INTEGR COMP BIOL, V42, P3, DOI 10.1093/icb/42.1.3; Fedak Mike, 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P133; Field I, 2001, ANTARCT SCI, V13, P371, DOI 10.1017/S0954102001000529; Field IC, 2005, OECOLOGIA, V142, P127, DOI 10.1007/s00442-004-1704-2; Field IC, 2002, VET REC, V151, P235, DOI 10.1136/vr.151.8.235; Flores H, 2008, MAR ECOL PROG SER, V367, P271, DOI 10.3354/meps07530; GERDES D, 1992, POLAR BIOL, V12, P291; GODLEWSKA M, 1987, POLAR BIOL, V8, P17, DOI 10.1007/BF00297159; GOURETSKI VV, 1993, DEEP-SEA RES PT I, V40, P561, DOI 10.1016/0967-0637(93)90146-T; Guinet C, 2001, MAR ECOL PROG SER, V219, P251, DOI 10.3354/meps219251; Hamer KC, 2007, MAR ECOL PROG SER, V338, P295, DOI 10.3354/meps338295; Hays GC, 2003, HYDROBIOLOGIA, V503, P163, DOI 10.1023/B:HYDR.0000008476.23617.b0; HINDELL MA, 1991, AUST J MAR FRESH RES, V42, P115; HINDELL MA, 1991, AUST J ZOOL, V39, P595, DOI 10.1071/ZO9910595; Hindell MA, 1999, CAN J ZOOL, V77, P1807, DOI 10.1139/cjz-77-11-1807; Hoppema M, 2004, DEEP-SEA RES PT I, V51, P1169, DOI 10.1016/j.dsr.2004.02.011; Horning M, 1999, P ROY SOC B-BIOL SCI, V266, P1127, DOI 10.1098/rspb.1999.0753; HUBOLD G, 1984, POLAR BIOL, V3, P231, DOI 10.1007/BF00292628; HUBOLD G, 1985, POLAR BIOL, V5, P43, DOI 10.1007/BF00446044; HUNTLEY M, 1991, DEEP-SEA RES, V38, P1145, DOI 10.1016/0198-0149(91)90100-T; *IFR CERS, 2010, SSMI PSI SSM I SEA I; Jonker FC, 1998, ANTARCT SCI, V10, P21, DOI 10.1017/S0954102098000042; JOUVENTIN P, 1990, NATURE, V343, P746, DOI 10.1038/343746a0; Kirkwood R, 1997, ECOL MONOGR, V67, P155, DOI 10.1890/0012-9615(1997)067[0155:TFEOFE]2.0.CO;2; KOOYMAN GL, 1995, CONDOR, V97, P536, DOI 10.2307/1369039; KOOYMAN GL, 1975, J MAMMAL, V56, P563, DOI 10.2307/1379469; Kozlov A.N., 1995, CCAMLR Science, V2, P71; LAWS RM, 1994, HIST PRESENT STATUS, P49; Lea MA, 2002, POLAR BIOL, V25, P269, DOI 10.1007/s00300-001-0339-6; Lydersen C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015462; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; McMahon CR, 2000, VET REC, V146, P251, DOI 10.1136/vr.146.9.251; MORRIS DJ, 1984, MAR ECOL PROG SER, V20, P203, DOI 10.3354/meps020203; Moteki M, 2009, POLAR BIOL, V32, P1461, DOI 10.1007/s00300-009-0643-0; Nicholls KW, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035742; ORSI AH, 1993, DEEP-SEA RES PT I, V40, P169, DOI 10.1016/0967-0637(93)90060-G; Pakhomov EA, 1996, MAR ECOL PROG SER, V134, P1, DOI 10.3354/meps134001; Pasternak AF, 2001, POLAR BIOL, V24, P771, DOI 10.1007/s003000100283; Piatkowski U, 2002, J MAR BIOL ASSOC UK, V82, P913, DOI 10.1017/S0025315402006343; PIATKOWSKI U, 1994, ANTARCT SCI, V6, P241, DOI 10.1017/S0954102094000374; Pinaud D, 2005, J ANIM ECOL, V74, P852, DOI 10.1111/j.1365-2656.2005.00984.x; PLOTZ J, 1986, POLAR BIOL, V6, P97, DOI 10.1007/BF00258259; Plotz J, 2001, POLAR BIOL, V24, P901, DOI 10.1007/s003000100297; PLOTZ J, 1991, POLAR BIOL, V11, P305; Pusch C, 2004, DEEP-SEA RES PT I, V51, P1685, DOI 10.1016/j.dsr.2004.06.008; R Development Core Team, 2009, R FDN STAT COMP; RODHOUSE PG, 1992, CAN J ZOOL, V70, P1007, DOI 10.1139/z92-143; Roquet F, 2009, J MARINE SYST, V78, P377, DOI 10.1016/j.jmarsys.2008.11.017; RUCKSTUHL A, 2009, ROBUSTBASE BASIC ROB; Schnack-Schiel SB, 2001, HYDROBIOLOGIA, V453, P9, DOI 10.1023/A:1013195329066; Schroder M, 1999, DEEP-SEA RES PT II, V46, P501, DOI 10.1016/S0967-0645(98)00112-X; Shimode S, 2009, AQUAT BIOL, V7, P295, DOI 10.3354/ab00201; Smedsrud LH, 2005, DEEP-SEA RES PT I, V52, P241, DOI 10.1016/j.dsr.2004.10.004; Spiridonov VA, 1996, J MARINE SYST, V9, P211, DOI 10.1016/S0924-7963(95)00049-6; Spiridonov VA, 1997, MAR ECOL PROG SER, V157, P233, DOI 10.3354/meps157233; Straneo F, 2010, NAT GEOSCI, V3, P182, DOI 10.1038/NGEO764; Tosh CA, 2009, ANTARCT SCI, V21, P113, DOI 10.1017/S0954102008001557; Tynan CT, 1998, NATURE, V392, P708, DOI 10.1038/33675; WHITE MG, 1993, POLAR BIOL, V13, P41; WHITWORTH T, 1987, J GEOPHYS RES-OCEANS, V92, P6462, DOI 10.1029/JC092iC06p06462; Wienecke BC, 1997, MAR ECOL PROG SER, V159, P249, DOI 10.3354/meps159249; WILSON RP, 1993, MAR ECOL PROG SER, V94, P101; Wunsch C, 2009, OCEANOGRAPHY, V22, P88, DOI 10.5670/oceanog.2009.41; Zimmer I, 2008, AQUAT BIOL, V3, P217, DOI 10.3354/ab00082; [No title captured]	99	49	50	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13816	10.1371/journal.pone.0013816	http://dx.doi.org/10.1371/journal.pone.0013816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072199	gold, Green Submitted, Green Published			2022-12-25	WOS:000283780800014
J	Shipp, LE; Lee, JV; Yu, CY; Pufall, M; Zhang, PL; Scott, DK; Wang, JC				Shipp, Lauren E.; Lee, Joyce V.; Yu, Chi-Yi; Pufall, Miles; Zhang, Pili; Scott, Donald K.; Wang, Jen-Chywan			Transcriptional Regulation of Human Dual Specificity Protein Phosphatase 1 (DUSP1) Gene by Glucocorticoids	PLOS ONE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; ALPHA-1-ACID GLYCOPROTEIN GENE; CAMP RESPONSE ELEMENT; MAPK PHOSPHATASE-1; ACCESSORY FACTOR; RECEPTOR; BINDING; KINASE; EXPRESSION; TARGET	Background: Glucocorticoids are potent anti-inflammatory agents commonly used to treat inflammatory diseases. They convey signals through the intracellular glucocorticoid receptor (GR), which upon binding to ligands, associates with genomic glucocorticoid response elements (GREs) to regulate transcription of associated genes. One mechanism by which glucocorticoids inhibit inflammation is through induction of the dual specificity phosphatase-1 (DUSP1, a.k.a. mitogen-activated protein kinase phosphatase-1, MKP-1) gene. Methodology/Principal Findings: We found that glucocorticoids rapidly increased transcription of DUSP1 within 10 minutes in A549 human lung adenocarcinoma cells. Using chromatin immunoprecipitation (ChIP) scanning, we located a GR binding region between -1421 and -1118 upstream of the DUSP1 transcription start site. This region is active in a reporter system, and mutagenesis analyses identified a functional GRE located between -1337 and -1323. We found that glucocorticoids increased DNase I hypersensitivity, reduced nucleosome density, and increased histone H3 and H4 acetylation within genomic regions surrounding the GRE. ChIP experiments showed that p300 was recruited to the DUSP1 GRE, and RNA interference experiments demonstrated that reduction of p300 decreased glucocorticoid-stimulated DUSP1 gene expression and histone H3 hyperacetylation. Furthermore, overexpression of p300 potentiated glucocorticoid-stimulated activity of a reporter gene containing the DUSP1 GRE, and this coactivation effect was compromised when the histone acetyltransferase domain was mutated. ChIP-reChIP experiments using GR followed by p300 antibodies showed significant enrichment of the DUSP1 GRE upon glucocorticoid treatment, suggesting that GR and p300 are in the same protein complex recruited to the DUSP1 GRE. Significance: Our studies identified a functional GRE for the DUSP1 gene. Moreover, the transcriptional activation of DUSP1 by glucocorticoids requires p300 and a rapid modification of the chromatin structure surrounding the GRE. Overall, understanding the mechanism of glucocorticoid-induced DUSP1 gene transcription could provide insights into therapeutic approaches against inflammatory diseases.	[Shipp, Lauren E.; Lee, Joyce V.; Yu, Chi-Yi; Wang, Jen-Chywan] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Pufall, Miles] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Zhang, Pili; Scott, Donald K.] Univ Pittsburgh, Div Endocrinol, Dept Med, Pittsburgh, PA USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shipp, LE (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.	walwang@berkeley.edu	Wang, Jen-Chywan/AAX-4445-2020	Wang, Jen-Chywan/0000-0001-6030-6886; Pufall, Miles/0000-0002-7022-6916	University of California [17KT-0028]; NATIONAL CANCER INSTITUTE [K99CA149088, R00CA149088] Funding Source: NIH RePORTER	University of California(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by a New Investigator Award (17KT-0028) from University of California Tobacco-related Diseases Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SM, 2006, BIOCHEM SOC T, V34, P1018, DOI 10.1042/BST0341018; Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; ALAM T, 1993, J BIOL CHEM, V268, P15681; Barnes PJ, 2006, EUR J PHARMACOL, V533, P2, DOI 10.1016/j.ejphar.2005.12.052; Barnes PJ, 2006, EUR RESPIR J, V27, P413, DOI 10.1183/09031936.06.00125404; Bhattacharyya S, 2007, BLOOD, V109, P4313, DOI 10.1182/blood-2006-10-048215; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Chinenov Y, 2007, MOL CELL ENDOCRINOL, V275, P30, DOI 10.1016/j.mce.2007.04.014; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; ESPINAS ML, 1994, MOL CELL BIOL, V14, P4116, DOI 10.1128/MCB.14.6.4116; Furst R, 2007, FASEB J, V21, P74, DOI 10.1096/fj.06-6752com; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Hermoso MA, 2004, MOL CELL BIOL, V24, P4743, DOI 10.1128/MCB.24.11.4743-4756.2004; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; IMAI E, 1993, J BIOL CHEM, V268, P5353; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; Johansson-Haque K, 2008, J MOL ENDOCRINOL, V41, P239, DOI 10.1677/JME-08-0015; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P2736, DOI 10.1093/nar/gkl361; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; LUCAS PC, 1992, ANNU REV BIOCHEM, V61, P1131; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MINER JN, 1991, TRENDS BIOCHEM SCI, V16, P423, DOI 10.1016/0968-0004(91)90168-U; NISHIO Y, 1993, MOL CELL BIOL, V13, P1854, DOI 10.1128/MCB.13.3.1854; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rogatsky I, 2001, EMBO J, V20, P6071, DOI 10.1093/emboj/20.21.6071; ROUX J, 1995, DNA CELL BIOL, V14, P385, DOI 10.1089/dna.1995.14.385; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Sankar N, 2008, ONCOGENE, V27, P5717, DOI 10.1038/onc.2008.181; Scott DK, 1996, J BIOL CHEM, V271, P31909, DOI 10.1074/jbc.271.50.31909; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Tchen CR, 2010, J BIOL CHEM, V285, P2642, DOI 10.1074/jbc.M109.037309; Trotter KW, 2007, MOL CELL ENDOCRINOL, V265, P162, DOI 10.1016/j.mce.2006.12.015; Vander Kooi BT, 2005, MOL ENDOCRINOL, V19, P3001, DOI 10.1210/me.2004-0497; Wang JC, 2006, GENE DEV, V20, P689, DOI 10.1101/gad.1400506; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wang JC, 1999, MOL ENDOCRINOL, V13, P604, DOI 10.1210/me.13.4.604; Wyszomierski SL, 2001, MOL ENDOCRINOL, V15, P228, DOI 10.1210/me.15.2.228; Yamada K, 1999, J BIOL CHEM, V274, P5880, DOI 10.1074/jbc.274.9.5880; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	49	79	80	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13754	10.1371/journal.pone.0013754	http://dx.doi.org/10.1371/journal.pone.0013754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060794	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000283645300033
J	Oliveira, MT; Kaguni, LS				Oliveira, Marcos T.; Kaguni, Laurie S.			Functional Roles of the N- and C-Terminal Regions of the Human Mitochondrial Single-Stranded DNA-Binding Protein	PLOS ONE			English	Article							GENE 2.5 PROTEIN; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; POLYMERASE GAMMA; DROSOPHILA-MELANOGASTER; ACCESSORY SUBUNIT; BACTERIOPHAGE T7; REPLICATION FORK; COOH TERMINUS; IN-VITRO	Biochemical studies of the mitochondrial DNA (mtDNA) replisome demonstrate that the mtDNA polymerase and the mtDNA helicase are stimulated by the mitochondrial single-stranded DNA-binding protein (mtSSB). Unlike Escherichia coli SSB, bacteriophage T7 gp2.5 and bacteriophage T4 gp32, mtSSBs lack a long, negatively charged C-terminal tail. Furthermore, additional residues at the N-terminus (notwithstanding the mitochondrial presequence) are present in the sequence of species across the animal kingdom. We sought to analyze the functional importance of the N- and C-terminal regions of the human mtSSB in the context of mtDNA replication. We produced the mature wild-type human mtSSB and three terminal deletion variants, and examined their physical and biochemical properties. We demonstrate that the recombinant proteins adopt a tetrameric form, and bind single-stranded DNA with similar affinities. They also stimulate similarly the DNA unwinding activity of the human mtDNA helicase (up to 8-fold). Notably, we find that unlike the high level of stimulation that we observed previously in the Drosophila system, stimulation of DNA synthesis catalyzed by human mtDNA polymerase is only moderate, and occurs over a narrow range of salt concentrations. Interestingly, each of the deletion variants of human mtSSB stimulates DNA synthesis at a higher level than the wild-type protein, indicating that the termini modulate negatively functional interactions with the mitochondrial replicase. We discuss our findings in the context of species-specific components of the mtDNA replisome, and in comparison with various prokaryotic DNA replication machineries.	[Oliveira, Marcos T.] Michigan State Univ, Dept Biochem & Mol Biol, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA; Michigan State Univ, Grad Program Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Oliveira, MT (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA.	lskaguni@msu.edu	Oliveira, Marcos Túlio/AAN-2804-2020; Oliveira, Marcos/B-3249-2014	Oliveira, Marcos/0000-0003-4779-5755	National Institutes of Health [GM45295]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM45295. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; BURKE RL, 1980, J BIOL CHEM, V255, P1484; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Curth U, 1996, NUCLEIC ACIDS RES, V24, P2706, DOI 10.1093/nar/24.14.2706; CURTH U, 1994, EUR J BIOCHEM, V221, P435, DOI 10.1111/j.1432-1033.1994.tb18756.x; Fan L, 2001, BIOCHEMISTRY-US, V40, P4780, DOI 10.1021/bi010102h; Farr CL, 1999, J BIOL CHEM, V274, P14779, DOI 10.1074/jbc.274.21.14779; Farr CL, 2004, J BIOL CHEM, V279, P17047, DOI 10.1074/jbc.M400283200; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; HACKENBR.CR, 1968, P NATL ACAD SCI USA, V61, P598, DOI 10.1073/pnas.61.2.598; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; Hollis T, 2001, P NATL ACAD SCI USA, V98, P9557, DOI 10.1073/pnas.171317698; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Hyland EM, 2003, J BIOL CHEM, V278, P7247, DOI 10.1074/jbc.M210605200; KIM YT, 1994, J BIOL CHEM, V269, P5270; KIM YT, 1992, J BIOL CHEM, V267, P15022; KIM YT, 1993, P NATL ACAD SCI USA, V90, P10173, DOI 10.1073/pnas.90.21.10173; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; Kornberg A, 1992, DNA REPLICATION, pxiv; Kozlov AG, 2010, J BIOL CHEM, V285, P17246, DOI 10.1074/jbc.M110.118273; KRASSA KB, 1991, P NATL ACAD SCI USA, V88, P4010, DOI 10.1073/pnas.88.9.4010; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; LEE YS, 2009, J BIOL CHEM; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200; Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821; Marintcheva B, 2008, P NATL ACAD SCI USA, V105, P1855, DOI 10.1073/pnas.0711919105; NAKAI H, 1988, J BIOL CHEM, V263, P9831; Oliveira MT, 2009, METHODS MOL BIOL, V554, P37, DOI 10.1007/978-1-59745-521-3_3; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Ruhanen H, 2010, BBA-MOL CELL RES, V1803, P931, DOI 10.1016/j.bbamcr.2010.04.008; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; Shereda RD, 2009, J MOL BIOL, V386, P612, DOI 10.1016/j.jmb.2008.12.065; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; SRERE PA, 1980, TRENDS BIOCHEM SCI, V5, P120, DOI 10.1016/0968-0004(80)90051-1; THOMMES P, 1995, J BIOL CHEM, V270, P21137, DOI 10.1074/jbc.270.36.21137; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomaska L, 2001, BIOL CHEM, V382, P179, DOI 10.1515/BC.2001.025; VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Wang YX, 1999, J BIOL CHEM, V274, P28972, DOI 10.1074/jbc.274.41.28972; WERNETTE CM, 1986, J BIOL CHEM, V261, P4764; WILLIAMS AJ, 1995, J BIOL CHEM, V270, P860, DOI 10.1074/jbc.270.2.860; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200; Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079	49	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e15379	10.1371/journal.pone.0015379	http://dx.doi.org/10.1371/journal.pone.0015379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060847	Green Published, gold, Green Submitted			2022-12-25	WOS:000283573800024
J	Bishop, JG; O'Hara, NB; Titus, JH; Apple, JL; Gill, RA; Wynn, L				Bishop, John G.; O'Hara, Niamh B.; Titus, Jonathan H.; Apple, Jennifer L.; Gill, Richard A.; Wynn, Louise			N-P Co-Limitation of Primary Production and Response of Arthropods to N and P in Early Primary Succession on Mount St. Helens Volcano	PLOS ONE			English	Article							BOTTOM-UP FORCES; NITROGEN-FIXATION; ECOSYSTEM DEVELOPMENT; FEEDING GRASSHOPPER; INSECT HERBIVORES; PHOSPHORUS; PLANT; QUALITY; GROWTH; PERFORMANCE	Background: The effect of low nutrient availability on plant-consumer interactions during early succession is poorly understood. The low productivity and complexity of primary successional communities are expected to limit diversity and abundance of arthropods, but few studies have examined arthropod responses to enhanced nutrient supply in this context. We investigated the effects of nitrogen (N) and phosphorus (P) addition on plant productivity and arthropod abundance on 24-yr-old soils at Mount St. Helens volcano. Methodology/Principal Findings: We measured the relative abundance of eight arthropod orders and five families in plots that received N, P, or no nutrients for 3-5 years. We also measured plant % cover, leaf % N, and plant diversity. Vegetation responded rapidly to N addition but showed a lagged response to P that, combined with evidence of increased N fixation, suggested P-limitation to N availability. After 3 yrs of fertilization, orthopterans (primarily Anabrus simplex (Tettigoniidae) and Melanoplus spp (Acrididae)) showed a striking attraction to P addition plots, while no other taxa responded to fertilization. After 5 yrs of fertilization, orthopteran density in the same plots increased 80%-130% with P addition and 40% with N. Using structural equation modeling, we show that in year 3 orthopteran abundance was associated with a P-mediated increase in plant cover (or correlated increases in resource quality), whereas in year 5 orthopteran density was not related to cover, diversity or plant % N, but rather to unmeasured effects of P, such as its influence on other aspects of resource quality. Conclusions/Significance: The marked surprising response to P by orthopterans, combined with a previous observation of P-limitation in lepidopteran herbivores at these sites, suggests that P-mediated effects of food quantity or quality are critical to insect herbivores in this N-P co-limited primary successional system. Our results also support a previous suggestion that the availability of N in these soils is P-limited.	[Bishop, John G.; O'Hara, Niamh B.; Apple, Jennifer L.; Wynn, Louise] Washington State Univ, Sch Biol Sci, Vancouver, WA USA; [Titus, Jonathan H.] SUNY Coll Fredonia, Dept Biol, Fredonia, NY USA; [Gill, Richard A.] Brigham Young Univ, Provo, UT 84602 USA	Washington State University; State University of New York (SUNY) System; SUNY Fredonia; Brigham Young University	Bishop, JG (corresponding author), Washington State Univ, Sch Biol Sci, Vancouver, WA USA.	bishopj@vancouver.wsu.edu	Gill, Richard/AAC-8137-2021	Gill, Richard/0000-0001-8981-0621	National Science Foundation (NSF) [DEB-0089843, DEB-0614538]; M.J. Murdock Charitable Trust	National Science Foundation (NSF)(National Science Foundation (NSF)); M.J. Murdock Charitable Trust	This work was supported by National Science Foundation (NSF) awards DEB-0089843 and DEB-0614538 and a grant from the M.J. Murdock Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apple JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007807; Ayres MP, 2000, ECOLOGY, V81, P2198, DOI 10.1890/0012-9658(2000)081[2198:NBOPFB]2.0.CO;2; BEHMER ST, 1993, FUNCT ECOL, V7, P522, DOI 10.2307/2390127; Behmer ST, 2005, FUNCT ECOL, V19, P55, DOI 10.1111/j.0269-8463.2005.00943.x; Behmer ST, 2002, ECOLOGY, V83, P2489, DOI 10.1890/0012-9658(2002)083[2489:HFICHE]2.0.CO;2; BERTRAM SM, J INSECT SC IN PRESS; Bertram SM, 2006, ANIM BEHAV, V72, P899, DOI 10.1016/j.anbehav.2006.02.012; Bishop JG, 2005, ECOLOGICAL RESPONSES TO THE 1980 ERUPTION OF MOUNT ST. HELENS, P151, DOI 10.1007/0-387-28150-9_11; Bishop JG, 2002, ECOLOGY, V83, P191; Bishop JG, 1998, ECOLOGY, V79, P534, DOI 10.1890/0012-9658(1998)079[0534:VIFPAI]2.0.CO;2; Busch JW, 1999, ECOL ENTOMOL, V24, P132, DOI 10.1046/j.1365-2311.1999.00185.x; Campo J, 2003, J TROP ECOL, V19, P525, DOI 10.1017/S0266467403003572; CHAPIN DM, 1991, CAN J BOT, V69, P2744, DOI 10.1139/b91-345; CLANCY KM, 1993, ECOLOGY, V74, P442, DOI 10.2307/1939306; del Moral R, 2005, PLANT ECOL, V181, P203, DOI 10.1007/s11258-005-6627-4; del Moral R, 2009, J VEG SCI, V20, P1145, DOI 10.1111/j.1654-1103.2009.01113.x; Denno RF, 2002, ECOLOGY, V83, P1443, DOI 10.1890/0012-9658(2002)083[1443:BUFMNE]2.0.CO;2; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Fagan WF, 2005, AM NAT, V166, P669, DOI 10.1086/497621; Fagan WF, 2004, ECOL ENTOMOL, V29, P398, DOI 10.1111/j.0307-6946.2004.00616.x; Fagan WF, 2000, AM NAT, V155, P238, DOI 10.1086/303320; Fox J, 2006, STRUCT EQU MODELING, V13, P465, DOI 10.1207/s15328007sem1303_7; Gill RA, 2006, OECOLOGIA, V148, P312, DOI 10.1007/s00442-006-0358-7; Gruner DS, 2004, ECOLOGY, V85, P3010, DOI 10.1890/04-0020; GRUNER DS, 2005, ECOLOGICAL ENTOMOLOG, P428; Haddad NM, 2000, OECOLOGIA, V124, P73, DOI 10.1007/s004420050026; Halvorson JJ, 2005, ECOLOGICAL RESPONSES TO THE 1980 ERUPTION OF MOUNT ST. HELENS, P243, DOI 10.1007/0-387-28150-9_17; HUNTER MD, 1991, OECOLOGIA, V86, P62, DOI 10.1007/BF00317390; Joern A, 1998, ECOL ENTOMOL, V23, P174, DOI 10.1046/j.1365-2311.1998.00112.x; JOHNSTON J, 2001, GRASSHOPPER MO UNPUB; Jonas JL, 2008, ECOL ENTOMOL, V33, P546, DOI 10.1111/j.1365-2311.2008.01004.x; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; LIPMAN PW, 1981, 1980 ERUPTIONS M STH; Loaiza V, 2008, ENVIRON ENTOMOL, V37, P333, DOI 10.1603/0046-225X(2008)37[333:DDPAFA]2.0.CO;2; McNeill S., 1978, BIOCH ASPECTS PLANT, P77; MULKERN GB, 1969, FOOD HABITS PREFEREN; Neumann G, 2002, TRENDS PLANT SCI, V7, P162, DOI 10.1016/S1360-1385(02)02241-0; Oksanen J., 2007, VEGAN COMMUNITY ECOL; ONSAGER JA, 1977, ACRIDA, V6, P231; Perkins MC, 2004, ARCH INSECT BIOCHEM, V55, P153, DOI 10.1002/arch.10133; POPP MP, 1989, ENVIRON ENTOMOL, V18, P795, DOI 10.1093/ee/18.5.795; Raich JW, 1996, BIOGEOCHEMISTRY, V32, P1, DOI 10.1007/BF00001529; Raubenheimer D, 2004, ECOLOGY, V85, P1203, DOI 10.1890/02-0248; Raubenheimer D, 2003, J EXP BIOL, V206, P1669, DOI 10.1242/jeb.00336; Richardson SJ, 2004, OECOLOGIA, V139, P267, DOI 10.1007/s00442-004-1501-y; RITCHIE ME, 1995, ECOLOGY, V76, P2648, DOI 10.2307/2265835; Ritchie ME, 2000, ECOLOGY, V81, P1601, DOI 10.1890/0012-9658(2000)081[1601:NLATVA]2.0.CO;2; Rowe EC, 2006, BIOL CONSERV, V131, P510, DOI 10.1016/j.biocon.2006.02.023; SCHADE JD, 2003, ECOL LETT, V6, P1; SCHOENFELDER A, OECOLOGIA UNPUB; SLANSKY F, 1977, ECOL MONOGR, V47, P209, DOI 10.2307/1942617; Stiling P, 2005, OECOLOGIA, V142, P413, DOI 10.1007/s00442-004-1739-4; Strengbom J, 2005, OECOLOGIA, V143, P241, DOI 10.1007/s00442-004-1799-5; Throop HL, 2004, ECOSYSTEMS, V7, P109, DOI 10.1007/s10021-003-0225-x; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Uliassi DD, 2002, ECOLOGY, V83, P88, DOI 10.1890/0012-9658(2002)083[0088:LTSNFI]2.0.CO;2; VITOUSEK PM, 1987, SCIENCE, V238, P802, DOI 10.1126/science.238.4828.802; Vitousek PM, 1999, ECOSYSTEMS, V2, P505, DOI 10.1007/s100219900098; Vitousek PM, 1987, COLONIZATION SUCCESS, P207; WALKER LR, 1986, ECOLOGY, V67, P1508, DOI 10.2307/1939082; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; White T. C. R., 1993, INADEQUATE ENV NITRO	62	34	34	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13598	10.1371/journal.pone.0013598	http://dx.doi.org/10.1371/journal.pone.0013598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049006	Green Published, gold			2022-12-25	WOS:000283487400007
J	Wainwright, DA; Sengupta, S; Han, Y; Ulasov, IV; Lesniak, MS				Wainwright, Derek A.; Sengupta, Sadhak; Han, Yu; Ulasov, Ilya V.; Lesniak, Maciej S.			The Presence of IL-17A and T Helper 17 Cells in Experimental Mouse Brain Tumors and Human Glioma	PLOS ONE			English	Article							TH17 LYMPHOCYTES; EXPRESSION; MICE; GLIOBLASTOMA; INHIBITION; ACTIVATION; PHENOTYPE; DEPLETION; T(H)17	Background: Recently, CD4(+)IL-17A(+) T helper 17 (Th17) cells were identified and reported in several diseased states, including autoimmunity, infection and various peripheral nervous system tumors. However, the presence of Th17 in glia-derived tumors of the central nervous system has not been studied. Methodology/Principal Findings: In this report, we demonstrate that mRNA expression for the Th17 cell cytokine IL-17A, as well as Th17 cells, are present in human glioma. The mRNA expression for IL-17A in glioma was recapitulated in an immunocompetent mouse model of malignant glioma. Furthermore, the presence of Th17 cells was confirmed in both human and mouse glioma. Interestingly, some Th17 cells present in mouse glioma co-expressed the Th1 and Th2 lineage markers, IFN-gamma and IL-4, respectively, but predominantly co-expressed the Treg lineage marker FoxP3. Conclusions: These data confirm the presence of Th17 cells in glia-derived CNS tumors and provide the rationale for further investigation into the role of Th17 cells in malignant glioma.	[Wainwright, Derek A.; Sengupta, Sadhak; Han, Yu; Ulasov, Ilya V.; Lesniak, Maciej S.] Univ Chicago, Brain Tumor Ctr, Chicago, IL 60637 USA	University of Chicago	Wainwright, DA (corresponding author), Univ Chicago, Brain Tumor Ctr, Chicago, IL 60637 USA.	mlesniak@surgery.bsd.uchicago.edu	Sengupta, Sadhak/D-2526-2009; Han, Yu/GZA-9220-2022; Ulasov, Ilya/A-2352-2014	Ulasov, Ilya/0000-0002-0818-0363; Wainwright, Derek/0000-0001-7232-4264	NIH [R01CA138587]; NATIONAL CANCER INSTITUTE [R01CA138587] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH grant R01CA138587. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Curtin JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001983; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; El Andaloussi A, 2006, NEURO-ONCOLOGY, V8, P234, DOI 10.1215/15228517-2006-006; El Andaloussi A, 2007, J NEURO-ONCOL, V83, P145, DOI 10.1007/s11060-006-9314-y; El Andaloussi A, 2006, J NEUROSURG, V105, P430, DOI 10.3171/jns.2006.105.3.430; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; GEROSA M, 1981, SURG NEUROL, V16, P48, DOI 10.1016/S0090-3019(81)80065-1; Gocke AR, 2007, J IMMUNOL, V178, P1341, DOI 10.4049/jimmunol.178.3.1341; Gounaris E, 2009, CANCER RES, V69, P5490, DOI 10.1158/0008-5472.CAN-09-0304; Kostianovsky AM, 2008, J IMMUNOL, V181, P5425, DOI 10.4049/jimmunol.181.8.5425; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Schwartzbaum JA, 2010, NEURO-ONCOLOGY, V12, P320, DOI 10.1093/neuonc/nop035; Sharma MD, 2009, BLOOD, V113, P6102, DOI 10.1182/blood-2008-12-195354; Siciliano NA, 2006, J IMMUNOL, V177, P7131, DOI 10.4049/jimmunol.177.10.7131; Steinman L, 2010, NAT IMMUNOL, V11, P41, DOI 10.1038/ni.1803; Su XM, 2010, J IMMUNOL, V184, P1630, DOI 10.4049/jimmunol.0902813; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Wainwright DA, 2009, ASN NEURO, V1, DOI 10.1042/AN20090017; Wainwright DA, 2010, NEUROSCI LETT, V471, P10, DOI 10.1016/j.neulet.2009.12.076; Wainwright DA, 2009, J NEUROIMMUNOL, V216, P66, DOI 10.1016/j.jneuroim.2009.09.009; Wong CK, 2009, IMMUNOL INVEST, V38, P652, DOI 10.1080/08820130903062756; YOO ZB, 1995, J IMMUNOL, V155, P5483	23	44	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2010	5	10							e15390	10.1371/journal.pone.0015390	http://dx.doi.org/10.1371/journal.pone.0015390			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KG	21060663	Green Published, gold, Green Submitted			2022-12-25	WOS:000283419700001
J	Henry, LA; Johnson, DA; Sarrio, D; Lee, S; Quinlan, PR; Crook, T; Thompson, AM; Reis, JS; Isacke, CM				Henry, L. A.; Johnson, D. A.; Sarrio, D.; Lee, S.; Quinlan, P. R.; Crook, T.; Thompson, A. M.; Reis-Filho, J. S.; Isacke, C. M.			Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome	ONCOGENE			English	Article						endoglin; CD105; breast cancer; TGF-beta; MCF10A; ErbB2	GROWTH-FACTOR-BETA; MOUSE SKIN CARCINOGENESIS; TGF-BETA; ENDOTHELIAL-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; RECEPTOR; CANCER; MIGRATION; PROLIFERATION; ACTIVATION	Tumor growth factor-beta (TGF-beta) signaling in cancer has been implicated in growth suppression of early lesions and enhancing tumor cell invasion and metastasis. However, the cellular mechanisms that determine this signaling output in individual tumors are still largely unknown. In endothelial cells, TGF-beta signaling is modulated by the TGF-beta co-receptor endoglin (CD105). Here we demonstrate that endoglin is expressed in a subset of invasive breast cancers and cell lines and is subject to epigenetic silencing by gene methylation. Endoglin downregulation in non-tumorigenic MCF10A breast cells leads to the formation of abnormal acini in 3D culture, but does not promote cell migration or transformation. In contrast, in the presence of activated ErbB2, endoglin downregulation in MCF10A cells leads to enhanced invasion into a 3D matrix. Consistent with these data, ectopic expression of endoglin in MDA-MB-231 cells blocks TGF-beta-enhanced cell motility and invasion and reduces lung colonization in an in vivo metastasis model. Unlike endothelial cells, endoglin does not modulate Smad-mediated TGF-beta signaling in breast cells but attenuates the cytoskeletal remodeling to impair cell migration and invasion. Importantly, in a large cohort of invasive breast cancers, lack of endoglin expression in the tumor cell compartment correlates with ENG gene methylation and poor clinical outcome. Oncogene (2011) 30, 1046-1058; doi:10.1038/onc.2010.488; published online 1 November 2010	[Henry, L. A.; Johnson, D. A.; Sarrio, D.; Lee, S.; Crook, T.; Reis-Filho, J. S.; Isacke, C. M.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Quinlan, P. R.; Thompson, A. M.] Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg & Mol Oncol, Dundee DD1 9SY, Scotland	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Dundee	Isacke, CM (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, 237 Fulham Rd, London SW3 6JB, England.	clare.isacke@icr.ac.uk	SARRIO, DAVID/Y-8903-2019	Isacke, Clare/0000-0002-9222-3345; Quinlan, Philip/0000-0002-3012-6646; Sarrio, David/0000-0003-4886-8290	Breakthrough Breast Cancer; NHS; Marie Curie Intra-European Fellowship [PIEF-GA-2008-221083]; Breast Cancer Research Scotland; Tayside Tissue Bank	Breakthrough Breast Cancer; NHS; Marie Curie Intra-European Fellowship(European Commission); Breast Cancer Research Scotland; Tayside Tissue Bank	We thank Kay Savage and Suzanne Parry for immunohistochemical staining, Reshma Shah for help with the methylation analysis, Caterina Marchio for microdissection, Senthil Muthuswamy for the MCF10A.ErbB2 cells and Ariad Pharmaceuticals (www.ariad.com/regulationkits) for the AP1510 reagent. This project was funded by Breakthrough Breast Cancer and from NHS funding to the NIHR Biomedical Research Centre, a Marie Curie Intra-European Fellowship (PIEF-GA-2008-221083) and Breast Cancer Research Scotland with support from the Tayside Tissue Bank.	Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Bernabeu C, 2007, J CELL BIOCHEM, V102, P1375, DOI 10.1002/jcb.21594; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Conley BA, 2004, J BIOL CHEM, V279, P27440, DOI 10.1074/jbc.M312561200; Craft CS, 2007, ONCOGENE, V26, P7240, DOI 10.1038/sj.onc.1210533; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Guerrero-Esteo M, 2002, J BIOL CHEM, V277, P29197, DOI 10.1074/jbc.M111991200; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Ishibashi O, 2010, J CELL PHYSIOL, V222, P465, DOI 10.1002/jcp.21968; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Klingbeil P, 2010, BREAST CANCER RES TR, V120, P95, DOI 10.1007/s10549-009-0380-7; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Mythreye K, 2009, P NATL ACAD SCI USA, V106, P8221, DOI 10.1073/pnas.0812879106; Oxmann D, 2008, ONCOGENE, V27, P3567, DOI 10.1038/sj.onc.1211025; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Perez-Gomez E, 2007, CANCER RES, V67, P10268, DOI 10.1158/0008-5472.CAN-07-1348; Quintanilla M, 2003, ONCOGENE, V22, P5976, DOI 10.1038/sj.onc.1206841; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Rodriguez-Barbero A, 2006, CELL PHYSIOL BIOCHEM, V18, P135, DOI 10.1159/000095181; Romero D, 2010, CARCINOGENESIS, V31, P359, DOI 10.1093/carcin/bgp217; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Scherner O, 2007, J BIOL CHEM, V282, P13934, DOI 10.1074/jbc.M611062200; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wong VCL, 2008, INT J CANCER, V123, P2816, DOI 10.1002/ijc.23882; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	40	45	49	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	9					1046	1058		10.1038/onc.2010.488	http://dx.doi.org/10.1038/onc.2010.488			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	729PX	21042283				2022-12-25	WOS:000287964100004
J	Li, Q; He, Y; Wei, L; Wu, X; Wu, D; Lin, S; Wang, Z; Ye, Z; Lin, SC				Li, Q.; He, Y.; Wei, L.; Wu, X.; Wu, D.; Lin, S.; Wang, Z.; Ye, Z.; Lin, S-C			AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation	ONCOGENE			English	Article						AXIN; PML; p53; PML-nuclear body	TUMOR-SUPPRESSOR; RAR-ALPHA; PML; HIPK2; GENE; PHOSPHORYLATION; IDENTIFICATION; GROWTH; DAXX; TRANSLOCATION	The PML protein is best known for its role as a tumor suppressor for acute promyelocytic leukemia. Both PML and the key Wnt signaling regulator AXIN regulate p53-dependent apoptosis in response to DNA damage. However, how the two major tumor suppressors coordinate with each other is unknown, and the molecular components orchestrating the PML-induced apoptosis remain enigmatic. Here we show that AXIN interacts with PML in vivo, and further that AXIN, PML and p53 form a ternary complex. Exposure to genotoxic signals including UV and doxorubicin induces AXIN to enter into the nucleus where it colocalizes with PML in the nuclear bodies. Domain-mapping experiments revealed that the C-terminal region (aa 597-832) of AXIN is responsible for its interaction with PML. AXIN fails to activate p53 in PML-/- cells, and conversely, PML is unable to activate p53 in AXIN-null SNU475 cells. Consistently, knockdown with respective siRNAs revealed that AXIN and PML depend on each other to elevate p53-Ser-46 phosphorylation and to induce apoptosis after treatment with genotoxins. Moreover, we found that dominant-negative mutants of PML blocked AXIN-induced p53 activation, and that AXIN promotes PML sumoylation, a modification necessary for PML functions. Our finding has thus provided a new avenue for understanding the mechanism by which PML activates p53 and exerts its role as a tumor suppressor. Oncogene (2011) 30, 1194-1204; doi:10.1038/onc.2010.499; published online 8 November 2010	[Li, Q.; He, Y.; Wei, L.; Wu, X.; Wu, D.; Lin, S.; Wang, Z.; Ye, Z.; Lin, S-C] Xiamen Univ, Key Lab, Fujian Lab Canc Biol, Sch Life Sci,Minist Educ Cell Biol & Tumor Cell, Xiamen 361005, Fujian, Peoples R China	Xiamen University	Lin, SC (corresponding author), Xiamen Univ, Key Lab, Fujian Lab Canc Biol, Sch Life Sci,Minist Educ Cell Biol & Tumor Cell, 422 Siming S Rd, Xiamen 361005, Fujian, Peoples R China.	linsc@xmu.edu.cn	Lin, Shu-Yong/B-7726-2012; Wu, Di/D-3595-2017; Lin, SC/G-4666-2010	Lin, Shu-Yong/0000-0002-4419-1713; Wu, Di/0000-0002-5895-2237; 	MOST [2009CB522200, 2006AA02A303, 2007CB914602]; National Natural Science Foundation of China [30730025, 30921005, 30500273, 30770454, 30970613]; Natural Science Foundation of Fujian Province [2008J0109, 2009J06021]; program for NCET	MOST; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); program for NCET(Program for New Century Excellent Talents in University (NCET))	We thank Dr PP Pandolfi for the gift of the wild-type MEF cells and PML <SUP>/</SUP> MEF cells, Dr Qiao Wu for the RARE luciferase reporter. This work was supported by grants from MOST (nos. 2009CB522200 and 2006AA02A303). This work was also supported by grants from National Natural Science Foundation of China (nos. 30730025, 30921005, 30500273, 30770454, 30970613), the National Basic Research Program of MOST (no. 2007CB914602), the Natural Science Foundation of Fujian Province (nos. 2008J0109 and 2009J06021) and the program for NCET.	ASCOLI CA, 1991, J CELL BIOL, V112, P785, DOI 10.1083/jcb.112.5.785; Bernardi R, 2008, ONCOGENE, V27, P6299, DOI 10.1038/onc.2008.305; Bruno S, 2003, BLOOD, V101, P3514, DOI 10.1182/blood-2002-11-3335; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Eskiw CH, 2004, J BIOL CHEM, V279, P9577, DOI 10.1074/jbc.M312580200; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Gresko E, 2009, ONCOGENE, V28, P698, DOI 10.1038/onc.2008.420; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jin LH, 2003, INT J CANCER, V107, P696, DOI 10.1002/ijc.11435; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; Le XF, 1996, J BIOL CHEM, V271, P130, DOI 10.1074/jbc.271.1.130; Li QX, 2007, CANCER RES, V67, P66, DOI 10.1158/0008-5472.CAN-06-1671; Li QX, 2009, NAT CELL BIOL, V11, P1128, DOI 10.1038/ncb1927; Martic TN, 2010, PATHOL ONCOL RES, V16, P75, DOI 10.1007/s12253-009-9190-9; Moller A, 2003, CANCER RES, V63, P4310; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Pearson M, 2001, ONCOGENE, V20, P7250, DOI 10.1038/sj.onc.1204856; Quignon F, 1998, NAT GENET, V20, P259, DOI 10.1038/3068; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Salomoni P, 2008, CELL RES, V18, P620, DOI 10.1038/cr.2008.58; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Shima Y, 2008, MOL CELL BIOL, V28, P7126, DOI 10.1128/MCB.00897-08; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Wu Q, 2009, J BIOL CHEM, V284, P8738, DOI 10.1074/jbc.M807590200; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752	45	11	12	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	10					1194	1204		10.1038/onc.2010.499	http://dx.doi.org/10.1038/onc.2010.499			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	732QD	21057547				2022-12-25	WOS:000288202400006
J	Bonilla, M; Denicola, A; Marino, SM; Gladyshev, VN; Salinas, G				Bonilla, Mariana; Denicola, Ana; Marino, Stefano M.; Gladyshev, Vadim N.; Salinas, Gustavo			Linked Thioredoxin-Glutathione Systems in Platyhelminth Parasites ALTERNATIVE PATHWAYS FOR GLUTATHIONE REDUCTION AND DEGLUTATHIONYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRASSICEPS METACESTODE CYSTICERCI; FUNCTIONALLY RELATED PROTEINS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; S-NITROSOGLUTATHIONE; SCHISTOSOMA-MANSONI; GLUTAREDOXIN 3; NMR STRUCTURE; SELENOCYSTEINE; MITOCHONDRIAL	In most organisms, thioredoxin (Trx) and/or glutathione (GSH) systems are essential for redox homeostasis and deoxyribonucleotide synthesis. Platyhelminth parasites have a unique and simplified thiol-based redox system, in which the selenoprotein thioredoxin-glutathione reductase (TGR), a fusion of a glutaredoxin (Grx) domain to canonical thioredoxin reductase domains, is the sole enzyme supplying electrons to oxidized glutathione (GSSG) and Trx. This enzyme has recently been validated as a key drug target for flatworm infections. In this study, we show that TGR possesses GSH-independent deglutathionylase activity on a glutathionylated peptide. Furthermore, we demonstrate that deglutathionylation and GSSG reduction are mediated by the Grx domain by a monothiolic mechanism and that the glutathionylated TGR intermediate is resolved by selenocysteine. Deglutathionylation and GSSG reduction via Grx domain, but not Trx reduction, are inhibited at high [GSSG]/[GSH] ratios. We found that Trxs (cytosolic and mitochondrial) provide alternative pathways for deglutathionylation and GSSG reduction. These pathways are operative at high [GSSG]/[GSH] and function in a complementary manner to the Grx domain-dependent one. Despite the existence of alternative pathways, the thioredoxin reductase domains of TGR are an obligate electron route for both the Grx domain-and the Trx-dependent pathways. Overall, our results provide an explanation for the unique array of thiol-dependent redox pathways present in parasitic platyhelminths. Finally, we found that TGR is inhibited by 1-hydroxy-2-oxo-3-(N-3-methyl-aminopropyl)-3-methyl-1-triazene (NOC-7), giving further evidence for NO donation as a mechanism of action for oxadiazole N-oxide TGR inhibitors. Thus, NO donors aimed at TGR could disrupt the entire redox homeostasis of parasitic flatworms.	[Bonilla, Mariana; Salinas, Gustavo] Univ Republica, Catedra Inmunol, Fac Quim, Fac Ciencias,Inst Higiene, Montevideo 11600, Uruguay; [Denicola, Ana] Univ Repupl, Lab Fisicoquim Biol, Fac Ciencias, Montevideo 11400, Uruguay; [Marino, Stefano M.; Gladyshev, Vadim N.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Salinas, G (corresponding author), Univ Republica, Catedra Inmunol, Fac Quim, Fac Ciencias,Inst Higiene, Avda Navarro 3051,Piso 2, Montevideo 11600, Uruguay.	gsalin@fq.edu.uy	Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013	Gladyshev, Vadim/0000-0002-0372-7016; Denicola, Ana/0000-0002-5181-9708; Bonilla, Mariana/0000-0002-9206-345X	National Institutes of Health [1R03TW008588-01, GM065204]; Uruguayan Research Council [PDT 63- 105]; PEDECIBA/ANII (Uruguay); Comision Sectorial de Investigacion Cientifica, UdelaR (Uruguay); FOGARTY INTERNATIONAL CENTER [R03TW008588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065204, R01GM065204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uruguayan Research Council; PEDECIBA/ANII (Uruguay); Comision Sectorial de Investigacion Cientifica, UdelaR (Uruguay); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in whole or in part, by National Institutes of Health FIRCA Grant 1R03TW008588-01 (to G. S.) and Grant GM065204 (to V. N. G.). This study was also supported by Grants PDT 63- 105 from the Uruguayan Research Council (to G. S.), and PEDECIBA/ANII (Uruguay) and Comision Sectorial de Investigacion Cientifica, UdelaR (Uruguay) postgraduate fellowships (to M. B.).	Agorio A, 2003, J BIOL CHEM, V278, P12920, DOI 10.1074/jbc.M209266200; Alger HM, 2002, MOL BIOCHEM PARASIT, V121, P129, DOI 10.1016/S0166-6851(02)00031-2; Angelucci F, 2010, J BIOL CHEM, V285, P32557, DOI 10.1074/jbc.M110.141960; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Bao R, 2009, BBA-PROTEINS PROTEOM, V1794, P1218, DOI 10.1016/j.bbapap.2009.04.001; Bar-Noy S, 2001, FREE RADICAL BIO MED, V30, P51, DOI 10.1016/S0891-5849(00)00448-2; Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Bonilla M, 2008, J BIOL CHEM, V283, P17898, DOI 10.1074/jbc.M710609200; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Discola KF, 2009, J MOL BIOL, V385, P889, DOI 10.1016/j.jmb.2008.10.055; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Foloppe N, 2001, J MOL BIOL, V310, P449, DOI 10.1006/jmbi.2001.4767; FORMANKAY JD, 1991, BIOCHEMISTRY-US, V30, P2685, DOI 10.1021/bi00224a017; Giustarini D, 2005, ANTIOXID REDOX SIGN, V7, P930, DOI 10.1089/ars.2005.7.930; Greetham D, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-3; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kanzok SM, 2000, J BIOL CHEM, V275, P40180, DOI 10.1074/jbc.M007633200; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Martinez-Gonzalez JJ, 2010, PARASITOL RES, V107, P227, DOI 10.1007/s00436-010-1867-1; Muller S, 1997, ARCH MICROBIOL, V168, P421, DOI 10.1007/s002030050517; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Nordstrand K, 2000, J MOL BIOL, V303, P423, DOI 10.1006/jmbi.2000.4145; Otero L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-237; Peltoniemi MJ, 2006, J BIOL CHEM, V281, P33107, DOI 10.1074/jbc.M605602200; Rendon JL, 2004, MOL BIOCHEM PARASIT, V133, P61, DOI 10.1016/j.molbiopara.2003.09.003; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; SAMBROOK J, 1989, MOL CLONING LAB MANU, pA1; Sayed AA, 2008, NAT MED, V14, P407, DOI 10.1038/nm1737; Simeonov A, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000127; Sun QA, 2005, BIOCHEMISTRY-US, V44, P14528, DOI 10.1021/bi051321w; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Tan SX, 2010, J BIOL CHEM, V285, P6118, DOI 10.1074/jbc.M109.062844; Xia B, 2001, J MOL BIOL, V310, P907, DOI 10.1006/jmbi.2001.4721; XIA TH, 1992, PROTEIN SCI, V1, P310	39	30	30	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					4959	4967		10.1074/jbc.M110.170761	http://dx.doi.org/10.1074/jbc.M110.170761			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21051543	Green Published, hybrid			2022-12-25	WOS:000287230600004
J	Hancock, CR; Han, DH; Higashida, K; Kim, SH; Holloszy, JO				Hancock, Chad R.; Han, Dong-Ho; Higashida, Kazuhiko; Kim, Sang Hyun; Holloszy, John O.			Does calorie restriction induce mitochondrial biogenesis? A reevaluation	FASEB JOURNAL			English	Article						aging; citrate synthase; cytochrome c; PGC-1 alpha	TRANSCRIPTIONAL COACTIVATOR PGC-1; RAT SKELETAL-MUSCLE; OXIDATIVE DAMAGE; GLUCOSE-TRANSPORT; GENE-EXPRESSION; PPAR-DELTA; AGE; METABOLISM; SARCOPENIA; INCREASE	It has been reported that 30% calorie restriction (CR) for 3 mo results in large increases in mitochondrial biogenesis in heart, brain, liver, and adipose tissue, with concomitant increases in respiration and ATP synthesis. We found these results surprising, and performed this study to determine whether 30% CR does induce an increase in mitochondria in heart, brain, liver, adipose tissue, and/or skeletal muscle. To this end, we measured the levels of a range of mitochondrial proteins, and mRNAs. With the exception of long-chain acyl-CoA dehydrogenase protein level, which was increased similar to 60% in adipose tissue, none of the mitochondrial proteins or mRNAs that we measured were increased in rats subjected to 30% CR for 14 wk. There was also no increase in citrate synthase activity. Because it is not possible to have an increase in mitochondria without any increase in key mitochondrial proteins, we conclude that 30% CR does not induce an increase in mitochondria in heart, brain, liver, adipose tissue, or skeletal muscle in laboratory rodents.-Hancock, C. R., Han, D.-H., Higashida, K., Kim, S. H., Holloszy, J. O. Does calorie restriction induce mitochondrial biogenesis? A reevaluation. FASEB J. 25, 785-791 (2011). www.fasebj.org	[Hancock, Chad R.; Han, Dong-Ho; Higashida, Kazuhiko; Kim, Sang Hyun; Holloszy, John O.] Washington Univ, Sch Med, Div Geriatr & Nutr Sci, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Holloszy, JO (corresponding author), Washington Univ, Sch Med, Div Geriatr & Nutr Sci, Dept Med, 4566 Scott Ave,Campus Box 8113, St Louis, MO 63110 USA.	jhollosz@dom.wustl.edu	Hancock, Chad R./X-4803-2018	Hancock, Chad R./0000-0002-1578-5301	U.S. National Institutes of Health [AG00425]; American Diabetes Association; Individual National Research Service Award [DK076410]; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK076410, P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG000425, R37AG000425, Z01AG000425, R01AG000425] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Individual National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Iheoma Nwaogu and Jamie Votava for their technical assistance. This research was supported by U.S. National Institutes of Health grant AG00425. C. R. H. was supported by an American Diabetes Association-based post-doctoral fellowship initially and then by Individual National Research Service Award DK076410. K. H. was supported by a Research Fellow of the Japan Society for the Promotion of Science grant.	Baar K, 2003, FASEB J, V17, P1666, DOI 10.1096/fj.03-0049com; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Baker DJ, 2006, J GERONTOL A-BIOL, V61, P675, DOI 10.1093/gerona/61.7.675; Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; BOOTH FW, 1997, HDB PHYSL 12, P1075; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; CARTIER LJ, 1986, J BIOL CHEM, V261, P3827; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; CONSTABLE SH, 1987, AM J PHYSIOL, V253, pC316, DOI 10.1152/ajpcell.1987.253.2.C316; Drew B, 2003, AM J PHYSIOL-REG I, V284, pR474, DOI 10.1152/ajpregu.00455.2002; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Huang JH, 2009, IUBMB LIFE, V61, P201, DOI 10.1002/iub.164; Judge S, 2007, AM J PHYSIOL-CELL PH, V292, pC1983, DOI 10.1152/ajpcell.00285.2006; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0; Lee CM, 1998, ANN NY ACAD SCI, V854, P182, DOI 10.1111/j.1749-6632.1998.tb09901.x; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marzetti E, 2010, BBA-GEN SUBJECTS, V1800, P235, DOI 10.1016/j.bbagen.2009.05.007; Marzetti E, 2009, BIOFACTORS, V35, P28, DOI 10.1002/biof.5; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; McKiernan SH, 2007, AM J PHYSIOL-RENAL, V292, pF1751, DOI 10.1152/ajprenal.00307.2006; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Mulligan JD, 2008, EXP GERONTOL, V43, P146, DOI 10.1016/j.exger.2007.10.011; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Otani K, 2004, J BIOL CHEM, V279, P20915, DOI 10.1074/jbc.M400213200; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rabol R, 2009, METABOLISM, V58, P1145, DOI 10.1016/j.metabol.2009.03.014; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001; Taffet GE, 1997, J GERONTOL A-BIOL, V52, pB285, DOI 10.1093/gerona/52A.6.B285; Terada S, 2006, AM J PHYSIOL-ENDOC M, V290, pE607, DOI 10.1152/ajpendo.00430.2005; Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Ward WF, 2005, J GERONTOL A-BIOL, V60, P847, DOI 10.1093/gerona/60.7.847; WINDER WW, 1979, AM J PHYSIOL, V236, pC132, DOI 10.1152/ajpcell.1979.236.3.C132	45	101	104	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					785	791		10.1096/fj.10-170415	http://dx.doi.org/10.1096/fj.10-170415			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	21048043	Green Published			2022-12-25	WOS:000286724800035
J	Gruner, I; Fradrich, C; Bottger, LH; Trautwein, AX; Jahn, D; Hartig, E				Gruner, Ines; Fraedrich, Claudia; Boettger, Lars H.; Trautwein, Alfred X.; Jahn, Dieter; Haertig, Elisabeth			Aspartate 141 Is the Fourth Ligand of the Oxygen-sensing [4Fe-4S](2+) Cluster of Bacillus subtilis Transcriptional Regulator Fnr	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOSSBAUER-SPECTROSCOPY; PYROCOCCUS-FURIOSUS; ESCHERICHIA-COLI; DNA-BINDING; FERREDOXIN; PROTEINS	The Bacillus subtilis redox regulator Fnr controls genes of the anaerobic metabolism in response to low oxygen tension. An unusual structure for the oxygen-sensing [4Fe-4S](2+) cluster was detected by a combination of genetic experiments with UV-visible and Mossbauer spectroscopy. Asp-141 was identified as the fourth iron-sulfur cluster ligand besides three Cys residues. Exchange of Asp-141 with Ala abolished functional in vivo complementation of an fnr knock-out strain by the mutagenized fnr gene and in vitro DNA binding of the recombinant regulator FnrD141A. In contrast, substitution of Asp-141 with Cys preserved [4Fe-4S](2+) structure and regulator function.	[Gruner, Ines; Fraedrich, Claudia; Jahn, Dieter; Haertig, Elisabeth] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Boettger, Lars H.; Trautwein, Alfred X.] Univ Lubeck, Inst Phys, D-23538 Lubeck, Germany	Braunschweig University of Technology; University of Lubeck	Hartig, E (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Spielmannstr 7, D-38106 Braunschweig, Germany.	e.haertig@tu-bs.de	Böttger, Lars/G-3570-2010	Jahn, Dieter/0000-0002-4064-9205	Deutsche Forschungsgemeinschaft [Ha3456-1/3]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant Ha3456-1/3 and the Fonds der Chemischen Industrie.	BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; BRITT RD, 1991, BIOCHEMISTRY-US, V30, P1892, DOI 10.1021/bi00221a023; Brocker MJ, 2010, J BIOL CHEM, V285, P8268, DOI 10.1074/jbc.M109.087874; CALZOLAI L, 1995, BIOCHEMISTRY-US, V34, P11373, DOI 10.1021/bi00036a010; Crack J, 2004, J BIOL CHEM, V279, P9278, DOI 10.1074/jbc.M309878200; Eiting M, 2005, MOL MICROBIOL, V56, P433, DOI 10.1111/j.1365-2958.2005.04561.x; Green J, 2009, CURR OPIN MICROBIOL, V12, P145, DOI 10.1016/j.mib.2009.01.008; Heroven AK, 2004, MOL MICROBIOL, V53, P871, DOI 10.1111/j.1365-2958.2004.04162.x; Imai T, 2001, J BIOCHEM, V130, P649, DOI 10.1093/oxfordjournals.jbchem.a003030; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; LOVENBERG W, 1963, J BIOL CHEM, V238, P3899; MATZANKE BF, 1989, EUR J BIOCHEM, V183, P371, DOI 10.1111/j.1432-1033.1989.tb14938.x; Muraki N, 2010, NATURE, V465, P110, DOI 10.1038/nature08950; Popescu CV, 1998, P NATL ACAD SCI USA, V95, P13431, DOI 10.1073/pnas.95.23.13431; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Reents H, 2006, MOL MICROBIOL, V60, P1432, DOI 10.1111/j.1365-2958.2006.05198.x; Schunemann V, 2000, REP PROG PHYS, V63, P263, DOI 10.1088/0034-4885/63/3/202; Sharma H, 2009, P NATL ACAD SCI USA, V106, P16604, DOI 10.1073/pnas.0908380106; Sutton VR, 2004, J BACTERIOL, V186, P8018, DOI 10.1128/JB.186.23.8018-8025.2004	19	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2017	2021		10.1074/jbc.M110.191940	http://dx.doi.org/10.1074/jbc.M110.191940			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21068385	Green Published, hybrid			2022-12-25	WOS:000286191500043
J	Zhang, XX; Yu, HJ; Lou, JR; Zheng, J; Zhu, H; Popescu, NI; Lupu, F; Lind, SE; Ding, WQ				Zhang, Xiaoxi; Yu, Haijun; Lou, Jessica R.; Zheng, Jie; Zhu, Hua; Popescu, Narcis-Ioan; Lupu, Florea; Lind, Stuart E.; Ding, Wei-Qun			MicroRNA-19 (miR-19) Regulates Tissue Factor Expression in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TUMOR ANGIOGENESIS; MESSENGER-RNA; LUNG CANCERS; METASTASIS; INVASION; RECEPTOR; ACTIVATION; PHENOTYPE; CLUSTER	Tissue factor has been recognized as a regulator of tumor angiogenesis and metastasis. The tissue factor gene is selectively expressed in highly invasive breast cancer cells, and the mechanisms regulating tissue factor expression in these cells remain unclear. This study demonstrates that microRNA-19 (miR-19) regulates tissue factor expression in breast cancer cells, providing a molecular basis for the selective expression of the tissue factor gene. Tissue factor protein was barely detectable in MCF-7, T47D, and ZR-75-1 cells (less invasive breast lines) but was expressed at a significantly higher level in MDA-MB-231 and BT-20 cells (invasive breast lines) as assayed by Western blot. The tissue factor gene promoter was activated, and forced expression of tissue factor cDNA was achieved in MCF-7 cells, implying that the 3'-UTR of the tissue factor transcript is responsible for the suppression of tissue factor expression. Bioinformatics analysis predicted microRNA-binding sites for miR-19, miR-20, and miR-106b in the 3'-UTR of the tissue factor transcript. Reporter gene assay using the TF-3'-UTR luciferase reporter construct confirmed that the 3'-UTR negatively regulates gene expression in MCF-7 cells, an effect reversed by deletion of the miR-19-binding site. Application of the miR-19 inhibitor induces endogenous tissue factor expression in MCF-7 cells, and overexpression of miR-19 down-regulates tissue factor expression in MDA-MB-231 cells. RT-PCR analysis using cDNA made from Ago2-immunoprecipitated RNA samples confirmed that Ago2 binds preferentially to tissue factor 3'-UTR in MCF-7 cells, as compared with MDA-MB-231 cells, consistent with the observation that miR-19 levels are higher in MCF-7 cells.	[Ding, Wei-Qun] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Zhu, Hua; Popescu, Narcis-Ioan; Lupu, Florea] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Lind, Stuart E.] Univ Colorado, Dept Med, Aurora, CO 80045 USA; [Lind, Stuart E.] Univ Colorado, Dept Pathol, Aurora, CO 80045 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Ding, WQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, 975 NE 10th St,BRC 411A, Oklahoma City, OK 73104 USA.	weiqun-ding@ouhsc.edu	Lupu, Florea/C-3162-2009; Lupu, Florea/AAV-3257-2021	Lupu, Florea/0000-0003-1249-9278; Lupu, Florea/0000-0003-1249-9278; Popescu, Narcis/0000-0002-4809-9885	Susan G. Komen for the Cure Foundation [KG081083]; Oklahoma Center for the Advancement of Science and Technology [HR09-025]	Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); Oklahoma Center for the Advancement of Science and Technology	This work was supported by Susan G. Komen for the Cure Foundation Grant KG081083 and Oklahoma Center for the Advancement of Science and Technology Grant HR09-025.	AHERN SM, 1993, J BIOL CHEM, V268, P2154; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bluff JE, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1871; BRAND K, 1991, MOL CELL BIOL, V11, P4732, DOI 10.1128/MCB.11.9.4732; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Camerer E, 1999, J BIOL CHEM, V274, P32225, DOI 10.1074/jbc.274.45.32225; Contrino J, 1996, NAT MED, V2, P209, DOI 10.1038/nm0296-209; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Ding WQ, 2004, MOL CANCER THER, V3, P1109; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Gusev Y, 2008, METHODS, V44, P61, DOI 10.1016/j.ymeth.2007.10.005; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Jiang X, 2004, J THROMB HAEMOST, V2, P93, DOI 10.1111/j.1538-7836.2004.00545.x; Kirschmann DA, 1999, BREAST CANCER RES TR, V55, P127; Koomagi R, 1998, INT J CANCER, V79, P19, DOI 10.1002/(SICI)1097-0215(19980220)79:1<19::AID-IJC4>3.3.CO;2-9; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mackman N, 1997, THROMB HAEMOSTASIS, V78, P747; MACKMAN N, 1995, FASEB J, V9, P883, DOI 10.1096/fasebj.9.10.7615158; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Negrini M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1867; Ngo CV, 2007, INT J CANCER, V120, P1261, DOI 10.1002/ijc.22426; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Perron Marjorie P., 2009, V487, P369, DOI 10.1007/978-1-60327-547-7_18; Sawada M, 1999, BRIT J CANCER, V79, P472, DOI 10.1038/sj.bjc.6690073; Schaffner F, 2009, ARTERIOSCL THROM VAS, V29, P1999, DOI 10.1161/ATVBAHA.108.177428; Shann YJ, 2008, GENOME RES, V18, P791, DOI 10.1101/gr.070961.107; Steitz JA, 2009, BIOCHEM SOC T, V37, P931, DOI 10.1042/BST0370931; Tong D, 1999, BREAST CANCER RES TR, V56, P91, DOI 10.1023/A:1006262501062; Tsopanoglou NE, 2007, SEMIN THROMB HEMOST, V33, P680, DOI 10.1055/s-2007-991535; Tuller ER, 2009, MOL PHARMACOL, V76, P588, DOI 10.1124/mol.109.057430; Ueno T, 2000, BRIT J CANCER, V83, P164; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wojtukiewicz MZ, 2001, NEOPLASIA, V3, P371, DOI 10.1038/sj.neo.7900184; Yu JL, 2004, SEMIN THROMB HEMOST, V30, P21; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhou JN, 1998, MOL CARCINOGEN, V21, P234, DOI 10.1002/(SICI)1098-2744(199804)21:4<234::AID-MC2>3.0.CO;2-K	44	102	117	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1429	1435		10.1074/jbc.M110.146530	http://dx.doi.org/10.1074/jbc.M110.146530			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059650	Green Published, hybrid			2022-12-25	WOS:000286005000055
J	Zienicke, B; Chen, LY; Khawn, H; Hammam, MAS; Kinoshita, H; Reichert, J; Ulrich, AS; Inomata, K; Lamparter, T				Zienicke, Benjamin; Chen, Li-Yi; Khawn, Htoi; Hammam, Mostafa A. S.; Kinoshita, Hideki; Reichert, Johannes; Ulrich, Anne S.; Inomata, Katsuhiko; Lamparter, Tilman			Fluorescence of Phytochrome Adducts with Synthetic Locked Chromophores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOSS CERATODON-PURPUREUS; AGROBACTERIUM-TUMEFACIENS; CYANOBACTERIUM SYNECHOCYSTIS; BILIVERDIN DERIVATIVES; PSEUDOMONAS-AERUGINOSA; CONFORMATIONAL-CHANGES; BACTERIAL PHYTOCHROME; SIGNAL-TRANSDUCTION; SPECTRAL PROPERTIES; CRYSTAL-STRUCTURE	We performed steady state fluorescence measurements with phytochromes Agp1 and Agp2 of Agrobacterium tumefaciens and three mutants in which photoconversion is inhibited. These proteins were assembled with the natural chromophore biliverdin (BV), with phycoerythrobilin (PEB), which lacks a double bond in the ring C-D-connecting methine bridge, and with synthetic bilin derivatives in which the ring C-D-connecting methine bridge is locked. All PEB and locked chromophore adducts are photoinactive. According to fluorescence quantum yields, the adducts may be divided into four different groups: wild type BV adducts exhibiting a weak fluorescence, mutant BV adducts with about 10-fold enhanced fluorescence, adducts with locked chromophores in which the fluorescence quantum yields are around 0.02, and PEB adducts with a high quantum yield of around 0.5. Thus, the strong fluorescence of the PEB adducts is not reached by the locked chromophore adducts, although the photoconversion energy dissipation pathway is blocked. We therefore suggest that ring D of the bilin chromophore, which contributes to the extended pi-electron system of the locked chromophores, provides an energy dissipation pathway that is independent on photoconversion.	[Chen, Li-Yi; Khawn, Htoi; Hammam, Mostafa A. S.; Kinoshita, Hideki; Inomata, Katsuhiko] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Mat Sci, Kanazawa, Ishikawa 9201192, Japan; [Zienicke, Benjamin; Lamparter, Tilman] KIT, Inst Bot, D-76131 Karlsruhe, Germany; [Reichert, Johannes; Ulrich, Anne S.] KIT, Inst Biol Interfaces IBG 2, D-76021 Karlsruhe, Germany	Kanazawa University; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Inomata, K (corresponding author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Mat Sci, Kanazawa, Ishikawa 9201192, Japan.	inomata@se.kanazawa-u.ac.jp; tilman.lamparter@kit.edu	Lamparter, Tilman/E-4421-2013; Hammam, Mostafa/M-6126-2016; Ulrich, Anne S/H-5519-2013	Lamparter, Tilman/0000-0003-4327-9737; Hammam, Mostafa/0000-0003-4299-2231; Ulrich, Anne S/0000-0001-5571-9483	Deutsche Forschungsgemeinschaft [B2, Sfb 498]; Graduiertenforderung des Landes Baden Wurttemberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduiertenforderung des Landes Baden Wurttemberg	This work was supported by Grant B2 from the Deutsche Forschungsgemeinschaft, Sfb 498, and a grant from the Graduiertenforderung des Landes Baden Wurttemberg (to B. Z.).	ALEKABI H, 1986, PHOTOCHEM PHOTOBIOL, V44, P433, DOI 10.1111/j.1751-1097.1986.tb04690.x; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Blumenstein A, 2005, CURR BIOL, V15, P1833, DOI 10.1016/j.cub.2005.08.061; Borucki B, 2003, BIOCHEMISTRY-US, V42, P13684, DOI 10.1021/bi035511n; Bose G, 2004, BIOPHYS J, V87, P2013, DOI 10.1529/biophysj.103.038521; CHAPMAN DJ, 1967, J AM CHEM SOC, V89, P5976, DOI 10.1021/ja00999a058; Chen LY, 2009, CHEM LETT, V38, P602, DOI 10.1246/cl.2009.602; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Falk H., 1989, CHEM LINEAR OLIGOPYR; Fischer AJ, 2004, P NATL ACAD SCI USA, V101, P17334, DOI 10.1073/pnas.0407645101; Giraud E, 2002, NATURE, V417, P202, DOI 10.1038/417202a; Giraud E, 2008, PHOTOSYNTH RES, V97, P141, DOI 10.1007/s11120-008-9323-0; Hammam MAS, 2006, B CHEM SOC JPN, V79, P1561, DOI 10.1246/bcsj.79.1561; Inomata K, 2005, J BIOL CHEM, V280, P24491, DOI 10.1074/jbc.M504710200; Inomata K, 2006, J BIOL CHEM, V281, P28162, DOI 10.1074/jbc.M603983200; Inomata K, 2009, BIOCHEMISTRY-US, V48, P2817, DOI 10.1021/bi802334u; Karniol B, 2003, P NATL ACAD SCI USA, V100, P2807, DOI 10.1073/pnas.0437914100; Khawn H, 2008, CHEM LETT, V37, P198, DOI 10.1246/cl.2008.198; Kinoshita H, 2005, CHEM LETT, V34, P800, DOI 10.1246/cl.2005.800; Krieger A, 2008, J PHOTOCH PHOTOBIO B, V93, P16, DOI 10.1016/j.jphotobiol.2008.07.001; KUFER W, 1983, ISRAEL J CHEM, V23, P233; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lamparter T, 2004, FEBS LETT, V573, P1, DOI 10.1016/j.febslet.2004.07.050; Lamparter T, 2004, BIOCHEMISTRY-US, V43, P3659, DOI 10.1021/bi035693l; Lamparter T, 1997, PLANT CELL PHYSIOL, V38, P51, DOI 10.1093/oxfordjournals.pcp.a029084; Lamparter T, 2003, J BIOL CHEM, V278, P33786, DOI 10.1074/jbc.M305563200; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Lamparter T, 2001, EUR J BIOCHEM, V268, P4720, DOI 10.1046/j.1432-1327.2001.02395.x; Lamparter T, 1997, P NATL ACAD SCI USA, V94, P11792, DOI 10.1073/pnas.94.22.11792; McDonagh AF, 1979, PORPHYRINS; Montgomery BL, 2007, MOL MICROBIOL, V64, P16, DOI 10.1111/j.1365-2958.2007.05622.x; Murphy JT, 1997, CURR BIOL, V7, P870, DOI 10.1016/S0960-9822(06)00375-7; Noack S, 2007, BIOCHEMISTRY-US, V46, P4164, DOI 10.1021/bi602419x; Oberpichler I, 2006, FEBS LETT, V580, P437, DOI 10.1016/j.febslet.2005.12.035; Otto H, 2003, BIOCHEMISTRY-US, V42, P5885, DOI 10.1021/bi026946y; PETRIER C, 1981, TETRAHEDRON LETT, V22, P855, DOI 10.1016/0040-4039(81)80014-7; Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Rockwell NC, 2009, P NATL ACAD SCI USA, V106, P6123, DOI 10.1073/pnas.0902370106; Rottwinkel G, 2010, J BACTERIOL, V192, P5124, DOI 10.1128/JB.00672-10; Sambrook J, 2001, MOL CLONING LAB MANU; Scheerer P, 2006, J STRUCT BIOL, V153, P97, DOI 10.1016/j.jsb.2005.11.002; Scheerer P, 2010, CHEMPHYSCHEM, V11, P1090, DOI 10.1002/cphc.200900913; SCHNEIDER S, 1994, J PHOTOCH PHOTOBIO B, V26, P75, DOI 10.1016/1011-1344(94)85038-0; Seibeck S, 2007, FEBS LETT, V581, P5425, DOI 10.1016/j.febslet.2007.10.043; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Sineshchekov V, 2002, J PHOTOCH PHOTOBIO B, V67, P39, DOI 10.1016/S1011-1344(02)00282-8; SINESHCHEKOV VA, 1995, BBA-BIOENERGETICS, V1228, P125, DOI 10.1016/0005-2728(94)00173-3; Tasler R, 2005, FEBS J, V272, P1927, DOI 10.1111/j.1742-4658.2005.04623.x; Toh KC, 2010, P NATL ACAD SCI USA, V107, P9170, DOI 10.1073/pnas.0911535107; Tooley AJ, 2002, J BACTERIOL, V184, P4666, DOI 10.1128/JB.184.17.4666-4671.2002; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104	57	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1103	1113		10.1074/jbc.M110.155143	http://dx.doi.org/10.1074/jbc.M110.155143			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21071442	Green Published, hybrid			2022-12-25	WOS:000286005000021
J	Kienitz, MC; Bender, K; Dermietzel, R; Pott, L; Zoidl, G				Kienitz, Marie-Cecile; Bender, Kirsten; Dermietzel, Rolf; Pott, Lutz; Zoidl, Georg			Pannexin 1 Constitutes the Large Conductance Cation Channel of Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEINS; VENTRICULAR MYOCYTES; P2X(7) RECEPTOR; PLASMA-MEMBRANE; HEMICHANNELS; ATP; ACTIVATION; INHIBITION; EXPRESSION; RELEASE	A large conductance (similar to 300 picosiemens) channel (LCC) of unknown molecular identity, activated by Ca2+ release from the sarcoplasmic reticulum, particularly when augmented by caffeine, has been described previously in isolated cardiac myocytes. A potential candidate for this channel is pannexin 1 (Panx1), which has been shown to form large ion channels when expressed in Xenopus oocytes and mammalian cells. Panx1 function is implicated in ATP-mediated auto-/paracrine signaling, and a crucial role in several cell death pathways has been suggested. Here, we demonstrate that after culturing for 4 days LCC activity is no longer detected in myocytes but can be rescued by adenoviral gene transfer of Panx1. Endogenous LCCs and those related to expression of Panx1 share key pharmacological properties previously used for identifying and characterizing Panx1 channels. These data demonstrate that Panx1 constitutes the LCC of cardiac myocytes. Sporadic openings of single Panx1 channels in the absence of Ca2+ release can trigger action potentials, suggesting that Panx1 channels potentially promote arrhythmogenic activities.	[Kienitz, Marie-Cecile; Bender, Kirsten; Pott, Lutz] Ruhr Univ Bochum, Dept Cellular Physiol, D-44780 Bochum, Germany; [Dermietzel, Rolf; Zoidl, Georg] Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Kienitz, MC (corresponding author), Ruhr Univ Bochum, Dept Cellular Physiol, D-44780 Bochum, Germany.	cecile-kienitz@rub.de; georg.zoidl@rub.de	Pott, Lutz/E-5304-2011	Pott, Lutz/0000-0002-4000-4132				Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Bargiotas P, 2009, CURR MOL MED, V9, P186, DOI 10.2174/156652409787581646; BECHEM M, 1983, EUR J CELL BIOL, V31, P366; Bhalla-Gehi R, 2010, J BIOL CHEM, V285, P9147, DOI 10.1074/jbc.M109.082008; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Buvinic S, 2009, J BIOL CHEM, V284, P34490, DOI 10.1074/jbc.M109.057315; Celetti SJ, 2010, J CELL SCI, V123, P1363, DOI 10.1242/jcs.056093; Dando R, 2009, J PHYSIOL-LONDON, V587, P5899, DOI 10.1113/jphysiol.2009.180083; FABIATO A, 1975, J PHYSIOL-LONDON, V249, P497, DOI 10.1113/jphysiol.1975.sp011027; Goldberg GS, 1996, EXP CELL RES, V222, P48, DOI 10.1006/excr.1996.0006; Gurung IS, 2009, J MOL CELL CARDIOL, V47, P622, DOI 10.1016/j.yjmcc.2009.08.001; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kondo RP, 2000, PFLUG ARCH EUR J PHY, V440, P125, DOI 10.1007/s004240051029; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; MECHMANN S, 1986, NATURE, V319, P597, DOI 10.1038/319597a0; Musa H, 2009, N-S ARCH PHARMACOL, V379, P541, DOI 10.1007/s00210-009-0403-2; Nishida M, 2008, EMBO J, V27, P3104, DOI 10.1038/emboj.2008.237; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; POTT L, 1990, J MEMBRANE BIOL, V117, P189, DOI 10.1007/BF01868685; Prochnow N, 2009, NEUROSCIENCE, V162, P1039, DOI 10.1016/j.neuroscience.2009.04.064; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Ray A, 2005, EUR J NEUROSCI, V21, P3277, DOI 10.1111/j.1460-9568.2005.04139.x; Shitara Y, 2005, ANNU REV PHARMACOL, V45, P689, DOI 10.1146/annurev.pharmtox.44.101802.121444; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Vessey DA, 2010, J CARDIOVASC PHARM T, V15, P190, DOI 10.1177/1074248409360356; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; Volk T, 2003, CARDIOVASC RES, V58, P76, DOI 10.1016/S0008-6363(02)00858-1; Zhang YA, 2007, AM J PHYSIOL-HEART C, V293, pH2448, DOI 10.1152/ajpheart.00032.2007; Zoidl G, 2007, NEUROSCIENCE, V146, P9, DOI 10.1016/j.neuroscience.2007.01.061	44	57	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					290	298		10.1074/jbc.M110.163477	http://dx.doi.org/10.1074/jbc.M110.163477			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21041301	Green Published, hybrid			2022-12-25	WOS:000285782800032
J	Marland, JRK; Pan, DX; Buttery, PC				Marland, Jamie R. K.; Pan, DingXin; Buttery, Philip C.			Rac GTPase-activating Protein (Rac GAP) alpha 1-Chimaerin Undergoes Proteasomal Degradation and Is Stabilized by Diacylglycerol Signaling in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER RECEPTOR; DENDRITIC SPINES; KINASE-C; UBIQUITIN LIGASE; HIPPOCAMPAL-NEURONS; RHO GTPASES; ALPHA-2-CHIMAERIN; BETA-2-CHIMAERIN; BINDING; MECHANISM	alpha 1-Chimaerin is a neuron-specific member of the Rho GTPase-activating protein family that selectively inactivates the small GTPase Rac. It is known to regulate the structure of dendrites and dendritic spines. We describe here that under basal conditions alpha 1-chimaerin becomes polyubiquitinated and undergoes rapid proteasomal degradation. This degradation is partly dependent on the N-terminal region that is unique to this isoform. Mimicking diacylglycerol (DAG) signaling with a phorbol ester stabilizes endogenous alpha 1-chimaerin against degradation and causes accumulation of the protein. The stabilization requires phorbol ester binding via the C1 domain of the protein and is independent of PKC activity. In addition, overexpression of a constitutively active Rac1 mutant is sufficient to cause an accumulation of alpha 1-chimaerin through a phospholipase C-dependent mechanism, showing that endogenous DAG signaling can also stabilize the protein. These results suggest that signaling via DAG may regulate the abundance of alpha 1-chimaerin under physiological conditions, providing a new model for understanding how its activity could be controlled.	[Marland, Jamie R. K.; Pan, DingXin; Buttery, Philip C.] Univ Cambridge, Ctr Brain Repair, Cambridge CB2 0PY, England	University of Cambridge	Buttery, PC (corresponding author), Cambridge Ctr Brain Repair, ED Adrian Bldg,Forvie Site,Robinson Way, Cambridge CB2 0PY, England.	pcb10@cam.ac.uk	Pan, Dingxin/AAE-1205-2021	Marland, Jamie/0000-0001-6442-082X	Alzheimer's Research Trust; Medical Research Council; Alzheimers Research UK [ART-PPG2007B-1] Funding Source: researchfish	Alzheimer's Research Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was supported by an Alzheimer's Research Trust pilot grant (to P. C. B.) and by a Medical Research Council studentship (to J. R. K. M.).	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Ang XL, 2008, J BIOL CHEM, V283, P29424, DOI 10.1074/jbc.M802475200; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Buttery P, 2006, P NATL ACAD SCI USA, V103, P1924, DOI 10.1073/pnas.0510655103; Caloca MJ, 2003, BIOCHEM J, V375, P313, DOI 10.1042/BJ20030727; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Colon-Gonzalez F, 2008, J BIOL CHEM, V283, P35247, DOI 10.1074/jbc.M806264200; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Graham DRM, 2005, PROTEOMICS, V5, P2309, DOI 10.1002/pmic.200401249; Hall C, 2001, J NEUROSCI, V21, P5191, DOI 10.1523/JNEUROSCI.21-14-05191.2001; Harden TK, 2009, J LIPID RES, V50, pS243, DOI 10.1194/jlr.R800045-JLR200; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hung AY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009842; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kawabe H, 2010, NEURON, V65, P358, DOI 10.1016/j.neuron.2010.01.007; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; MANSER E, 1992, J BIOL CHEM, V267, P16025; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Miyake N, 2008, SCIENCE, V321, P839, DOI 10.1126/science.1156121; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; Sosa MS, 2009, BIOCHEMISTRY-US, V48, P8171, DOI 10.1021/bi9010623; Storm EE, 2003, P NATL ACAD SCI USA, V100, P1757, DOI 10.1073/pnas.0337736100; Takeuchi S, 2009, FEBS LETT, V583, P1237, DOI 10.1016/j.febslet.2009.03.032; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Ven TJV, 2005, J NEUROSCI, V25, P9488, DOI 10.1523/JNEIROSCI.2450-05.2005; Wang HB, 2002, J BIOL CHEM, V277, P4541, DOI 10.1074/jbc.M107150200; Wang HB, 2006, EMBO J, V25, P2062, DOI 10.1038/sj.emboj.7601098; Wang HB, 2010, MOL BIOL CELL, V21, P1398, DOI 10.1091/mbc.E09-08-0735; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038; Yang CF, 2007, BIOCHEM J, V403, P1, DOI 10.1042/bj20061750	46	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					199	207		10.1074/jbc.M110.166728	http://dx.doi.org/10.1074/jbc.M110.166728			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21056981	Green Published, hybrid			2022-12-25	WOS:000285782800022
J	Dore-Savard, L; Otis, V; Belleville, K; Lemire, M; Archambault, M; Tremblay, L; Beaudoin, JF; Beaudet, N; Lecomte, R; Lepage, M; Gendron, L; Sarret, P				Dore-Savard, Louis; Otis, Valerie; Belleville, Karine; Lemire, Myriam; Archambault, Melanie; Tremblay, Luc; Beaudoin, Jean-Francois; Beaudet, Nicolas; Lecomte, Roger; Lepage, Martin; Gendron, Louis; Sarret, Philippe			Behavioral, Medical Imaging and Histopathological Features of a New Rat Model of Bone Cancer Pain	PLOS ONE			English	Article							BREAST-CANCER; METASTASES; BISPHOSPHONATES	Pre-clinical bone cancer pain models mimicking the human condition are required to respond to clinical realities. Breast or prostate cancer patients coping with bone metastases experience intractable pain, which affects their quality of life. Advanced monitoring is thus required to clarify bone cancer pain mechanisms and refine treatments. In our model of rat femoral mammary carcinoma MRMT-1 cell implantation, pain onset and tumor growth were monitored for 21 days. The surgical procedure performed without arthrotomy allowed recording of incidental pain in free-moving rats. Along with the gradual development of mechanical allodynia and hyperalgesia, behavioral signs of ambulatory pain were detected at day 14 by using a dynamic weight-bearing apparatus. Osteopenia was revealed from day 14 concomitantly with disorganization of the trabecular architecture (mu CT). Bone metastases were visualized as early as day 8 by MRI (T-1-Gd-DTPA) before pain detection. PET (Na F-18) co-registration revealed intra-osseous activity, as determined by anatomical superimposition over MRI in accordance with osteoclastic hyperactivity (TRAP staining). Pain and bone destruction were aggravated with time. Bone remodeling was accompanied by c-Fos (spinal) and ATF3 (DRG) neuronal activation, sustained by astrocyte (GFAP) and microglia (Iba1) reactivity in lumbar spinal cord. Our animal model demonstrates the importance of simultaneously recording pain and tumor progression and will allow us to better characterize therapeutic strategies in the future.	[Dore-Savard, Louis; Otis, Valerie; Belleville, Karine; Lemire, Myriam; Beaudet, Nicolas; Gendron, Louis; Sarret, Philippe] Univ Sherbrooke, Dept Physiol & Biophys, Sherbrooke, PQ J1K 2R1, Canada; [Archambault, Melanie; Tremblay, Luc; Beaudoin, Jean-Francois; Lecomte, Roger; Lepage, Martin] Univ Sherbrooke, Dept Med Nucl & Radiobiol, Sherbrooke, PQ J1K 2R1, Canada; [Archambault, Melanie; Tremblay, Luc; Beaudoin, Jean-Francois; Lecomte, Roger; Lepage, Martin] Univ Sherbrooke, Ctr Imagerie Mol Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Dore-Savard, L (corresponding author), Univ Sherbrooke, Dept Physiol & Biophys, Sherbrooke, PQ J1K 2R1, Canada.	Philippe.Sarret@USherbrooke.ca	LECOMTE, Roger/F-2582-2011	LECOMTE, Roger/0000-0002-8541-0783; Beaudet, Nicolas/0000-0003-2349-2362; Sarret, Philippe/0000-0002-7627-701X; Lepage, Martin/0000-0002-5363-9487; Gendron, Louis/0000-0002-2058-8863	Cancer Research Society; Canadian Pain Society; AstraZeneca Inc.; CIHR Institute of Aging; CIHR Institute of Musculoskeletal Health and Arthritis; CIHR Institute of Neurosciences; Mental Health and Addiction; Quebec Bio-Imaging Network; CIHR Frederick Banting; Charles Best, FRSQ; Canadian Arthritis Network and RSBO	Cancer Research Society; Canadian Pain Society; AstraZeneca Inc.(AstraZeneca); CIHR Institute of Aging(Canadian Institutes of Health Research (CIHR)); CIHR Institute of Musculoskeletal Health and Arthritis(Canadian Institutes of Health Research (CIHR)); CIHR Institute of Neurosciences(Canadian Institutes of Health Research (CIHR)); Mental Health and Addiction; Quebec Bio-Imaging Network; CIHR Frederick Banting(Canadian Institutes of Health Research (CIHR)); Charles Best, FRSQ(Fonds de la Recherche en Sante du Quebec); Canadian Arthritis Network and RSBO	This work is supported by grants from the Cancer Research Society (P. S.) and from the CIHR/Rx&D collaborative research program in partnership with the Canadian Pain Society, AstraZeneca Inc., CIHR Institute of Aging, CIHR Institute of Musculoskeletal Health and Arthritis, CIHR Institute of Neurosciences, Mental Health and Addiction (P.S.) and The Quebec Bio-Imaging Network. L.D.-S. holds CIHR Frederick Banting and Charles Best, FRSQ, Canadian Arthritis Network and RSBO scholarships. P.S. is a CIHR new investigator. L.G. is a FRSQ Junior 1-new investigator. P.S., M. L., L.G. and R.L. are members of the FRSQ-funded Centre de Recherche Clinique Etienne-Le Bel. P.S. and L.G are members of the Quebec Pain Research Network, M.L. and R. L. are members of the Quebec Bio-Imaging Network. M.L. is the Canada Research Chair in Magnetic Resonance Imaging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi M, 2003, EUR SPINE J, V12, pS202, DOI 10.1007/s00586-003-0609-9; Aloisi AM, 2006, HORM BEHAV, V50, P1, DOI 10.1016/j.yhbeh.2005.12.002; Armamento-Villareal R, 2009, CALCIFIED TISSUE INT, V85, P37, DOI 10.1007/s00223-009-9263-5; Bauerle T, 2005, INT J CANCER, V115, P177, DOI 10.1002/ijc.20840; Beyreuther BK, 2007, EUR J PHARMACOL, V565, P98, DOI 10.1016/j.ejphar.2007.02.041; Cairns BE, 2009, MATURITAS, V63, P292, DOI 10.1016/j.maturitas.2009.06.004; Canon JR, 2008, CLIN EXP METASTAS, V25, P119, DOI 10.1007/s10585-007-9127-1; Clemons MJ, 2006, J CLIN ONCOL, V24, P4895, DOI 10.1200/JCO.2006.05.9212; COLEMAN RE, 1987, BRIT J CANCER, V55, P61, DOI 10.1038/bjc.1987.13; COLEMAN RE, 1985, CANCER TREAT REV, V12, P251, DOI 10.1016/0305-7372(85)90008-8; Coleman R, 2007, CLIN BREAST CANCER, V7, pS29, DOI 10.3816/CBC.2007.s.004; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Costelloe CM, 2009, LANCET ONCOL, V10, P606, DOI 10.1016/S1470-2045(09)70088-9; Denes A, 2005, NEUROSCIENCE, V134, P947, DOI 10.1016/j.neuroscience.2005.03.060; Donovan-Rodriguez T, 2006, NEUROSCI LETT, V393, P237, DOI 10.1016/j.neulet.2005.09.073; Donovan-Rodriguez T, 2005, ANESTHESIOLOGY, V102, P132, DOI 10.1097/00000542-200501000-00022; Donovan-Rodriguez T, 2004, NEUROSCI LETT, V360, P29, DOI 10.1016/j.neulet.2004.01.048; Donthineni R, 2009, ORTHOP CLIN N AM, V40, P1, DOI 10.1016/j.ocl.2008.10.001; Dworkin RH, 2002, CLIN J PAIN, V18, P343, DOI 10.1097/00002508-200211000-00001; Edoff K, 2000, CELL TISSUE RES, V299, P193, DOI 10.1007/s004410050017; El Mouedden M, 2007, PHARMACOL BIOCHEM BE, V86, P458, DOI 10.1016/j.pbb.2007.01.003; Fox A, 2004, PAIN, V107, P33, DOI 10.1016/j.pain.2003.09.003; Ghilardi JR, 2005, J NEUROSCI, V25, P3126, DOI 10.1523/JNEUROSCI.3815-04.2005; HAHN M, 1992, BONE, V13, P327, DOI 10.1016/8756-3282(92)90078-B; Hald A, 2008, PHARMACOL BIOCHEM BE, V91, P38, DOI 10.1016/j.pbb.2008.04.021; Hald A, 2009, EUR J PAIN, V13, P138, DOI 10.1016/j.ejpain.2008.03.014; Halvorson KG, 2006, CLIN J PAIN, V22, P587, DOI 10.1097/01.ajp.0000210902.67849.e6; HARADA Y, 1975, ACTA PATHOL JAPON, V25, P451; Harvey HA, 2007, CLIN BREAST CANCER, V7, pS7, DOI 10.3816/CBC.2007.s.001; Honore P, 2000, NEUROSCIENCE, V98, P585, DOI 10.1016/S0306-4522(00)00110-X; Honore P, 2000, Prog Brain Res, V129, P389; Honore P, 2000, PAIN MED, V1, P303, DOI 10.1046/j.1526-4637.2000.00047.x; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; King T, 2007, PAIN, V132, P154, DOI 10.1016/j.pain.2007.06.026; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Kirou-Mauro AN, 2009, J PAIN SYMPTOM MANAG, V37, P77, DOI 10.1016/j.jpainsymman.2007.12.014; LEE YTNM, 1983, J SURG ONCOL, V23, P175, DOI 10.1002/jso.2930230311; Lipton A, 2007, CLIN BREAST CANCER, V7, pS14, DOI 10.3816/CBC.2007.s.002; Luger NM, 2001, CANCER RES, V61, P4038; Luger NM, 2002, PAIN, V99, P397, DOI 10.1016/S0304-3959(02)00102-1; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Malden NJ, 2007, BRIT DENT J, V203, P93, DOI 10.1038/bdj.2007.636; Mao-Ying QL, 2006, BIOCHEM BIOPH RES CO, V345, P1292, DOI 10.1016/j.bbrc.2006.04.186; Medhurst SJ, 2002, PAIN, V96, P129, DOI 10.1016/S0304-3959(01)00437-7; Menendez L, 2003, NEUROREPORT, V14, P867, DOI 10.1097/01.wnr.0000069963.11849.af; Mercadante S, 1997, PAIN, V69, P1, DOI 10.1016/S0304-3959(96)03267-8; Mercadante S, 2007, CURR OPIN ONCOL, V19, P308, DOI 10.1097/CCO.0b013e3281214400; Mercadante S, 2009, CLIN J PAIN, V25, P648, DOI 10.1097/AJP.0b013e3181a68a85; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Muller-Horvat C, 2006, EUR J CANCER, V42, P342, DOI 10.1016/j.ejca.2005.10.008; Nagae M, 2007, J BONE MINER METAB, V25, P99, DOI 10.1007/s00774-006-0734-8; Nicholson B, 2003, DRUGS, V63, P17, DOI 10.2165/00003495-200363010-00002; Niiyama Y, 2009, BRIT J ANAESTH, V102, P251, DOI 10.1093/bja/aen347; Niv D, 2003, PAIN, V105, P387, DOI 10.1016/S0304-3959(03)00277-X; Obata K, 2003, PAIN, V101, P65, DOI 10.1016/S0304-3959(02)00296-8; Ogawa K, 2007, J NUCL MED, V48, P122; Omoumi P, 2009, RADIOL CLIN N AM, V47, P595, DOI 10.1016/j.rcl.2009.04.005; Peters CM, 2005, EXP NEUROL, V193, P85, DOI 10.1016/j.expneurol.2004.11.028; Petren-Mallmin M, 1998, SKELETAL RADIOL, V27, P72, DOI 10.1007/s002560050340; Pichler BJ, 2008, SEMIN NUCL MED, V38, P199, DOI 10.1053/j.semnuclmed.2008.02.001; Rauch F, 2009, ENDOCR DEV, V16, P49, DOI 10.1159/000223688; Riccio AI, 2007, AM FAM PHYSICIAN, V76, P1489; Roato I, 2004, FASEB J, V18, P228, DOI 10.1096/fj.04-1823fje; Romero-Sandoval A, 2008, ANESTHESIOLOGY, V108, P722, DOI 10.1097/ALN.0b013e318167af74; Roodman GD, 2008, CANCER TREAT REV, V34, P92, DOI 10.1016/j.ctrv.2007.09.002; Rozel S, 2009, J CELL BIOCHEM, V107, P58, DOI 10.1002/jcb.22056; Sabino MAC, 2003, INT J CANCER, V104, P550, DOI 10.1002/ijc.10999; Schirrmeister H, 1999, J NUCL MED, V40, P1623; Schirrmeister H, 2007, RADIOL CLIN N AM, V45, P669, DOI 10.1016/j.rcl.2007.05.007; Schmidt GP, 2009, SEMIN MUSCULOSKEL R, V13, P120, DOI 10.1055/s-0029-1220883; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Schwei MJ, 1999, J NEUROSCI, V19, P10886, DOI 10.1523/JNEUROSCI.19-24-10886.1999; Sevcik MA, 2005, PAIN, V115, P128, DOI 10.1016/j.pain.2005.02.022; Sevcik MA, 2004, PAIN, V111, P169, DOI 10.1016/j.pain.2004.06.015; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Urch CE, 2005, J PAIN, V6, P837, DOI 10.1016/j.jpain.2005.08.005; Urch CE, 2003, PAIN, V106, P347, DOI 10.1016/j.pain.2003.08.002; Vallabhajosula S, 2007, SEMIN NUCL MED, V37, P400, DOI 10.1053/j.semnuclmed.2007.08.004; Vestergaard P, 2006, J INTERN MED, V260, P76, DOI 10.1111/j.1365-2796.2006.01667.x; Wacnik PW, 2001, J NEUROSCI, V21, P9355, DOI 10.1523/JNEUROSCI.21-23-09355.2001; Walker K, 2002, PAIN, V100, P219, DOI 10.1016/S0304-3959(02)00040-4; Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P1; Zhang RX, 2005, PAIN, V118, P125, DOI 10.1016/j.pain.2005.08.001; Zwolak P, 2008, INT J CANCER, V122, P681, DOI 10.1002/ijc.23157	84	43	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13774	10.1371/journal.pone.0013774	http://dx.doi.org/10.1371/journal.pone.0013774			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048940	Green Published, Green Submitted, gold			2022-12-25	WOS:000283645300048
J	Sulatskaya, AI; Maskevich, AA; Kuznetsova, IM; Uversky, VN; Turoverov, KK				Sulatskaya, Anna I.; Maskevich, Alexander A.; Kuznetsova, Irina M.; Uversky, Vladimir N.; Turoverov, Konstantin K.			Fluorescence Quantum Yield of Thioflavin T in Rigid Isotropic Solution and Incorporated into the Amyloid Fibrils	PLOS ONE			English	Article							TORSIONAL RELAXATION; BINDING-SITES; PROTEIN; DISEASE; AGGREGATION; PEPTIDES; SOLVENTS; KINETICS; INSULIN; DYE	In this work, the fluorescence of thioflavin T (ThT) was studied in a wide range of viscosity and temperature. It was shown that ThT fluorescence quantum yield varies from 0.0001 in water at room temperature to 0.28 in rigid isotropic solution (T/eta -> 0). The deviation of the fluorescence quantum yield from unity in rigid isotropic solution suggests that fluorescence quantum yield depends not only on the ultra-fast oscillation of ThT fragments relative to each other in an excited state as was suggested earlier, but also depends on the molecular configuration in the ground state. This means that the fluorescence quantum yield of the dye incorporated into amyloid fibrils must depend on its conformation, which, in turn, depends on the ThT environment. Therefore, the fluorescence quantum yield of ThT incorporated into amyloid fibrils can differ from that in the rigid isotropic solution. In particular, the fluorescence quantum yield of ThT incorporated into insulin fibrils was determined to be 0.43. Consequently, the ThT fluorescence quantum yield could be used to characterize the peculiarities of the fibrillar structure, which opens some new possibilities in the ThT use for structural characterization of the amyloid fibrils.	[Sulatskaya, Anna I.; Kuznetsova, Irina M.; Turoverov, Konstantin K.] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia; [Maskevich, Alexander A.] Yanka Kupala Grodno State Univ, Grodno, BELARUS; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Russia; [Uversky, Vladimir N.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Yanka Kupala State University of Grodno; Russian Academy of Sciences; Indiana University System; Indiana University Bloomington	Sulatskaya, AI (corresponding author), Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia.	vuversky@iupui.edu; kkt@mail.cytspb.rssi.ru	Sulatskaya, Anna/I-6042-2014; Uversky, Vladimir N./F-4515-2011; Kuznetsova, Irina M./R-9844-2017; Turoverov, Konstantin/S-2079-2016	Sulatskaya, Anna/0000-0002-1207-3384; Uversky, Vladimir N./0000-0002-4037-5857; Kuznetsova, Irina M./0000-0002-3336-4834; Turoverov, Konstantin/0000-0002-6977-1896	Belorussian Foundation of Basic Research [X10P-227]; Russian Foundation of Basic Research [10-04-90038_Bel]; Program Molecular and Cell Biology; Russian Academy of Sciences; Dmitry Zimin's Russian Charitable Foundation	Belorussian Foundation of Basic Research; Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Program Molecular and Cell Biology; Russian Academy of Sciences(Russian Academy of Sciences); Dmitry Zimin's Russian Charitable Foundation	This work was supported in part by the Belorussian Foundation of Basic Research (grant X10P-227), the Russian Foundation of Basic Research (grant 10-04-90038_Bel), Program "Molecular and Cell Biology,'' Russian Academy of Sciences, and Dmitry Zimin's Russian Charitable Foundation "Dynasty.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsop D, 2001, BIOCHEM BIOPH RES CO, V285, P58, DOI 10.1006/bbrc.2001.5123; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; Carrell RW, 1998, CURR OPIN STRUC BIOL, V8, P799, DOI 10.1016/S0959-440X(98)80101-2; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Goers J, 2002, BIOCHEMISTRY-US, V41, P12546, DOI 10.1021/bi0262698; Groenning M., 2009, J CHEM BIOL; Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3; Hashimoto M, 1999, BRAIN PATHOL, V9, P707; Kelly JW, 1997, STRUCTURE, V5, P595, DOI 10.1016/S0969-2126(97)00215-3; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Kumita JR, 2003, BIOCHEMISTRY-US, V42, P4492, DOI 10.1021/bi026856t; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LeVine H, 1997, ARCH BIOCHEM BIOPHYS, V342, P306, DOI 10.1006/abbi.1997.0137; LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881; Lockhart A, 2005, J BIOL CHEM, V280, P7677, DOI 10.1074/jbc.M412056200; Loksztejn A, 2008, J MOL BIOL, V379, P9, DOI 10.1016/j.jmb.2008.03.057; LOUTFY RO, 1982, J PHYS CHEM-US, V86, P4205, DOI 10.1021/j100218a023; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Maskevich AA, 2007, J PROTEOME RES, V6, P1392, DOI 10.1021/pr0605567; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; NAIKI H, 1990, LAB INVEST, V62, P768; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Pertinhez TA, 2001, FEBS LETT, V495, P184, DOI 10.1016/S0014-5793(01)02384-5; Segur J.B., 1953, PHYS PROPERTIES GLYC, P238; Singh PK, 2010, J PHYS CHEM B, V114, P5920, DOI 10.1021/jp100371s; Singh PK, 2009, J PHYS CHEM B, V113, P8532, DOI 10.1021/jp902207k; Stsiapura VI, 2007, J PHYS CHEM A, V111, P4829, DOI 10.1021/jp070590o; Stsiapura VI, 2008, J PHYS CHEM B, V112, P15893, DOI 10.1021/jp805822c; Turoverov K K, 1998, Tsitologiia, V40, P806; TUROVEROV KK, 2007, P SOC PHOTO OPT INS, V6733, pNI198; Uversky V.N., 1999, MED SCI MONITOR, V5, P1001; Uversky V.N., 1999, MED SCI MONITOR, V5, P1238; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Voropai E. S., 2003, Journal of Applied Spectroscopy, V70, P868, DOI 10.1023/B:JAPS.0000016303.37573.7e; Ye L, 2005, J BIOL CHEM, V280, P23599, DOI 10.1074/jbc.M501285200; Yoshiike Y, 2003, J BIOL CHEM, V278, P23648, DOI 10.1074/jbc.M212785200; Zhu L, 2003, J MOL BIOL, V328, P235, DOI 10.1016/S0022-2836(03)00249-3	43	130	134	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e15385	10.1371/journal.pone.0015385	http://dx.doi.org/10.1371/journal.pone.0015385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048945	Green Published, gold, Green Submitted			2022-12-25	WOS:000283645300052
J	Namadurai, S; Jain, D; Kulkarni, DS; Tabib, CR; Friedhoff, P; Rao, DN; Nair, DT				Namadurai, Sivakumar; Jain, Deepti; Kulkarni, Dhananjay S.; Tabib, Chaitanya R.; Friedhoff, Peter; Rao, Desirazu N.; Nair, Deepak T.			The C-Terminal Domain of the MutL Homolog from Neisseria gonorrhoeae Forms an Inverted Homodimer	PLOS ONE			English	Article							DNA MISMATCH REPAIR; SACCHAROMYCES-CEREVISIAE; ENDONUCLEASE ACTIVITY; DIFFRACTION DATA; ALPHA; HETERODIMER; RECOGNITION; MUTATIONS; INTERFACE; PROTEINS	The mismatch repair (MMR) pathway serves to maintain the integrity of the genome by removing mispaired bases from the newly synthesized strand. In E. coli, MutS, MutL and MutH coordinate to discriminate the daughter strand through a mechanism involving lack of methylation on the new strand. This facilitates the creation of a nick by MutH in the daughter strand to initiate mismatch repair. Many bacteria and eukaryotes, including humans, do not possess a homolog of MutH. Although the exact strategy for strand discrimination in these organisms is yet to be ascertained, the required nicking endonuclease activity is resident in the C-terminal domain of MutL. This activity is dependent on the integrity of a conserved metal binding motif. Unlike their eukaryotic counterparts, MutL in bacteria like Neisseria exist in the form of a homodimer. Even though this homodimer would possess two active sites, it still acts a nicking endonuclease. Here, we present the crystal structure of the C-terminal domain (CTD) of the MutL homolog of Neisseria gonorrhoeae (NgoL) determined to a resolution of 2.4 A. The structure shows that the metal binding motif exists in a helical configuration and that four of the six conserved motifs in the MutL family, including the metal binding site, localize together to form a composite active site. NgoL-CTD exists in the form of an elongated inverted homodimer stabilized by a hydrophobic interface rich in leucines. The inverted arrangement places the two composite active sites in each subunit on opposite lateral sides of the homodimer. Such an arrangement raises the possibility that one of the active sites is occluded due to interaction of NgoL with other protein factors involved in MMR. The presentation of only one active site to substrate DNA will ensure that nicking of only one strand occurs to prevent inadvertent and deleterious double stranded cleavage.	[Namadurai, Sivakumar; Jain, Deepti; Nair, Deepak T.] Natl Ctr Biol Sci, Lab 4, Bangalore, Karnataka, India; [Kulkarni, Dhananjay S.; Tabib, Chaitanya R.; Rao, Desirazu N.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Friedhoff, Peter] Univ Giessen, Inst Biochem FB 08, Giessen, Germany	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Indian Institute of Science (IISC) - Bangalore; Justus Liebig University Giessen	Namadurai, S (corresponding author), Natl Ctr Biol Sci, Lab 4, Bangalore, Karnataka, India.	deepaknair@ncbs.res.in	Nair, Deepak T/AAR-5234-2020; Friedhoff, Peter/G-7905-2012; Jain, Deepti/G-6921-2011	Friedhoff, Peter/0000-0003-1946-1117; Jain, Deepti/0000-0002-8631-7230; Kulkarni, Dhananjaya/0000-0002-0417-4468; Nair, Deepak/0000-0002-0677-9444	Department of Science and Technology (DST), Government of India (GOI); Department of Biotechnology (DBT), GOI; National Centre for Biogical Sciences; Department of Biotechnology and Department of Science and Technology, Government of India; MRC [G0500367] Funding Source: UKRI; Medical Research Council [G0500367] Funding Source: researchfish	Department of Science and Technology (DST), Government of India (GOI)(Department of Science & Technology (India)); Department of Biotechnology (DBT), GOI(Department of Biotechnology (DBT) India); National Centre for Biogical Sciences; Department of Biotechnology and Department of Science and Technology, Government of India; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DJ is the recipient of a Young Investigator Grant from the Department of Science and Technology (DST), Government of India (GOI). DSK is the recipient of a Research Associateship from Department of Biotechnology (DBT), GOI. This work was funded in part by a startup grant provided by the National Centre for Biogical Sciences. Funding for travel to the ESRF synchrotron was provided by the DBT, GOI under the BM-14 project. DNR is a recipient of a JC Bose Fellowship from DST, GOI. DTN is a recipient of a Ramanujan Fellowship from DST, GOI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Viswanandham D and Chiranjeevi B for help in the initial part of this work. All members of the DNR laboratory are acknowledged for critical reading of the manuscript and useful discussions. DTN thanks the X-ray diffraction facility located in the Molecular Biophysics Unit of Indian Institute of Science (funded by Department of Biotechnology and Department of Science and Technology, Government of India) for facilitating screening and data collection. DTN acknowledges the help rendered by Dr. Chitra Rajendran (SLS), Dr. Meitian Wang (SLS) and Dr. Hassan Belrahli (ESRF) during data collection at the X06DA and BM-14 beamlines of SLS and ESRF, respectively.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; da Silva FCC, 2009, SAO PAULO MED J, V127, P46, DOI 10.1590/S1516-31802009000100010; Cutalo JM, 2006, BIOCHEMISTRY-US, V45, P15458, DOI 10.1021/bi061392a; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Deschenes SM, 2007, CANCER LETT, V249, P148, DOI 10.1016/j.canlet.2006.08.008; Duppatla V, 2009, BIOCHEM J, V423, P265, DOI 10.1042/BJ20090626; Erdeniz N, 2007, DNA REPAIR, V6, P1463, DOI 10.1016/j.dnarep.2007.04.013; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Fukui K, 2008, J BIOL CHEM, V283, P12136, DOI 10.1074/jbc.M800110200; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; Habraken Y, 1997, CURR BIOL, V7, P790, DOI 10.1016/S0960-9822(06)00337-X; Habraken Y, 1998, J BIOL CHEM, V273, P9837, DOI 10.1074/jbc.273.16.9837; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joseph N, 2006, PROG NUCLEIC ACID RE, V81, P1, DOI 10.1016/S0079-6603(06)81001-9; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Kosinski J, 2005, J MOL BIOL, V351, P895, DOI 10.1016/j.jmb.2005.06.044; Kosinski J, 2008, J MOL BIOL, V382, P610, DOI 10.1016/j.jmb.2008.06.056; Kosinski J, 2010, HUM MUTAT, V31, P975, DOI 10.1002/humu.21301; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larrea AA, 2010, CELL, V141, DOI 10.1016/j.cell.2010.05.002; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JY, 2005, MOL CELL, V20, P155, DOI 10.1016/j.molcel.2005.08.019; de Saro FJL, 2006, J BIOL CHEM, V281, P14340, DOI 10.1074/jbc.M601264200; Mauris J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007175; Mohd AB, 2006, DNA REPAIR, V5, P347, DOI 10.1016/j.dnarep.2005.11.001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishant KT, 2008, GENETICS, V179, P747, DOI 10.1534/genetics.108.086645; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perera S, 2008, HUM MUTAT, V29, P332, DOI 10.1002/humu.9523; Pillon MC, 2010, MOL CELL, V39, P145, DOI 10.1016/j.molcel.2010.06.027; PLUCIENNIK A, 2010, P NATL ACAD SCI 0816, P1; Polosina YY, 2010, BIOESSAYS, V32, P51, DOI 10.1002/bies.200900089; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SHEN P, 1989, MOL GEN GENET, V218, P358, DOI 10.1007/BF00331291; SULLIVAN MA, 1987, NUCLEIC ACIDS RES, V15, P2059, DOI 10.1093/nar/15.5.2059; Yang W, 2007, DNA REPAIR, V6, P135, DOI 10.1016/j.dnarep.2006.10.021	44	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13726	10.1371/journal.pone.0013726	http://dx.doi.org/10.1371/journal.pone.0013726			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060849	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000283573800020
J	Ahmed, A; Singh, J; Khan, Y; Seshan, SV; Girardi, G				Ahmed, Abdulwahab; Singh, Jameel; Khan, Ysodra; Seshan, Surya V.; Girardi, Guillermina			A New Mouse Model to Explore Therapies for Preeclampsia	PLOS ONE			English	Article							PREGNANCY-INDUCED HYPERTENSION; BLOOD-PRESSURE; PLACENTAL ISCHEMIA; ANGIOGENIC FACTORS; MICE; PATHOPHYSIOLOGY; PATHOGENESIS; COMPLEMENT; ACTIVATION; ABORTION	Background: Pre-eclampsia, a pregnancy-specific multisystemic disorder is a leading cause of maternal and perinatal mortality and morbidity. This syndrome has been known to medical science since ancient times. However, despite considerable research, the cause/s of preeclampsia remain unclear, and there is no effective treatment. Development of an animal model that recapitulates this complex pregnancy-related disorder may help to expand our understanding and may hold great potential for the design and implementation of effective treatment. Methodology/Principal Findings: Here we show that the CBA/J x DBA/2 mouse model of recurrent miscarriage is also a model of immunologically-mediated preeclampsia (PE). DBA/J mated CBA/J females spontaneously develop many features of human PE (primigravidity, albuminuria, endotheliosis, increased sensitivity to angiotensin II and increased plasma leptin levels) that correlates with bad pregnancy outcomes. We previously reported that antagonism of vascular endothelial growth factor (VEGF) signaling by soluble VEGF receptor 1 (sFlt-1) is involved in placental and fetal injury in CBA/J x DBA/2 mice. Using this animal model that recapitulates many of the features of preeclampsia in women, we found that pravastatin restores angiogenic balance, ameliorates glomerular injury, diminishes hypersensitivity to angiotensin II and protects pregnancies. Conclusions/Significance: We described a new mouse model of PE, were the relevant key features of human preeclampsia develop spontaneously. The CBA/J x DBA/2 model, that recapitulates this complex disorder, helped us identify pravastatin as a candidate therapy to prevent preeclampsia and its related complications. We recognize that these studies were conducted in mice and that clinical trials are needed to confirm its application to humans.	[Ahmed, Abdulwahab; Singh, Jameel; Khan, Ysodra; Girardi, Guillermina] CUNY, York Coll, Dept Biol, New York, NY 10021 USA; [Seshan, Surya V.] Weill Cornell Med Coll, Dept Pathol, New York, NY USA	City University of New York (CUNY) System; Cornell University	Ahmed, A (corresponding author), CUNY, York Coll, Dept Biol, New York, NY 10021 USA.	guillerminagirardi@gmail.com	Ahmed, Asif/ABE-9544-2020	Ahmed, Asif/0000-0002-8755-8546; Girardi, Guillermina/0000-0002-5797-7731; Singh, Jameel/0000-0003-1868-0377	York College, CUNY	York College, CUNY	This work was funded by an Institutional Grant from York College, CUNY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003; BOBE P, 1986, CELL IMMUNOL, V98, P477, DOI 10.1016/0008-8749(86)90306-0; Bowen JA, 1999, BIOL REPROD, V60, P428, DOI 10.1095/biolreprod60.2.428; BROWN CEL, 1990, AM J OBSTET GYNECOL, V163, P1853, DOI 10.1016/0002-9378(90)90764-X; Burke SD, 2010, HYPERTENSION, V55, P729, DOI 10.1161/HYPERTENSIONAHA.109.144253; Clark DA, 1998, J IMMUNOL, V160, P545; Cudmore M, 2007, CIRCULATION, V115, P1789, DOI 10.1161/CIRCULATIONAHA.106.660134; Davison JM, 2004, J AM SOC NEPHROL, V15, P2440, DOI 10.1097/01.ASN.0000135975.90889.60; Falcao S, 2009, HYPERTENSION, V54, P1401, DOI 10.1161/HYPERTENSIONAHA.109.137356; Feldstein CA, 2010, AM J THER, V17, P255, DOI 10.1097/MJT.0b013e3181c0695e; Feng MJ, 2009, METHODS MOL BIOL, V573, P45, DOI 10.1007/978-1-60761-247-6_3; Gilbert JS, 2008, AM J PHYSIOL-HEART C, V294, pH541, DOI 10.1152/ajpheart.01113.2007; Gilbert JS, 2010, HYPERTENSION, V55, P380, DOI 10.1161/HYPERTENSIONAHA.109.141937; Girardi G, 2006, J EXP MED, V203, P2165, DOI 10.1084/jem.20061022; Granger JP, 2006, METH MOLEC MED, V122, P383; HAEGER M, 1992, OBSTET GYNECOL, V79, P19; Kanasaki K, 2008, NATURE, V453, P1117, DOI 10.1038/nature06951; Lain KY, 2002, JAMA-J AM MED ASSOC, V287, P3183, DOI 10.1001/jama.287.24.3183; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; LI Z, 2001, HYPERTENSION, V50, P686; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mise H, 1998, J CLIN ENDOCR METAB, V83, P3225, DOI 10.1210/jc.83.9.3225; Redecha P, 2009, BLOOD, V113, P4101, DOI 10.1182/blood-2008-12-194258; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; REDMAN CW, 1987, REPROD PERINATAL, P5; REDMAN CW, 1997, LANCET, V2, P1249; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; ROBILLARD PY, 1994, LANCET, V344, P973, DOI 10.1016/S0140-6736(94)91638-1; Robillard PY, 1999, EUR J OBSTET GYN R B, V84, P37, DOI 10.1016/S0301-2115(98)00250-4; SANCHEZRAMOS L, 1994, OBSTET GYNECOL, V84, P349; Stillman IE, 2007, J AM SOC NEPHROL, V18, P2281, DOI 10.1681/ASN.2007020255; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Wong AYH, 2002, AM J PHYSIOL-HEART C, V282, pH918, DOI 10.1152/ajpheart.00641.2001; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856	36	102	104	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13663	10.1371/journal.pone.0013663	http://dx.doi.org/10.1371/journal.pone.0013663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048973	Green Published, gold			2022-12-25	WOS:000283537000032
J	Helm, S; Lehmann, C; Nagel, A; Stanway, RR; Horstmann, S; Llinas, M; Heussler, VT				Helm, Susanne; Lehmann, Christine; Nagel, Andreas; Stanway, Rebecca R.; Horstmann, Sebastian; Llinas, Manuel; Heussler, Volker T.			Identification and Characterization of a Liver Stage-Specific Promoter Region of the Malaria Parasite Plasmodium	PLOS ONE			English	Article							CONDITIONAL MUTAGENESIS; TRANSCRIPTION FACTORS; DNA-BINDING; FALCIPARUM; BERGHEI; PROTEIN; GENE; EXPRESSION; LUCIFERASE; CELLS	During the blood meal of a Plasmodium-infected mosquito, 10 to 100 parasites are inoculated into the skin and a proportion of these migrate via the bloodstream to the liver where they infect hepatocytes. The Plasmodium liver stage, despite its clinical silence, represents a highly promising target for antimalarial drug and vaccine approaches. Successfully invaded parasites undergo a massive proliferation in hepatocytes, producing thousands of merozoites that are transported into a blood vessel to infect red blood cells. To successfully develop from the liver stage into infective merozoites, a tight regulation of gene expression is needed. Although this is a very interesting aspect in the biology of Plasmodium, little is known about gene regulation in Plasmodium parasites in general and in the liver stage in particular. We have functionally analyzed a novel promoter region of the rodent parasite Plasmodium berghei that is exclusively active during the liver stage of the parasite. To prove stage-specific activity of the promoter, GFP and luciferase reporter assays have been successfully established, allowing both qualitative and accurate quantitative analysis. To further characterize the promoter region, the transcription start site was mapped by rapid amplification of cDNA ends (59-RACE). Using promoter truncation experiments and site-directed mutagenesis within potential transcription factor binding sites, we suggest that the minimal promoter contains more than one binding site for the recently identified parasite-specific ApiAP2 transcription factors. The identification of a liver stage-specific promoter in P. berghei confirms that the parasite is able to tightly regulate gene expression during its life cycle. The identified promoter region might now be used to study the biology of the Plasmodium liver stage, which has thus far proven problematic on a molecular level. Stage-specific expression of dominant-negative mutant proteins and overexpression of proteins normally active in other life cycle stages will help to understand the function of the proteins investigated.	[Helm, Susanne; Lehmann, Christine; Nagel, Andreas; Stanway, Rebecca R.; Horstmann, Sebastian; Heussler, Volker T.] Bernhard Nocht Inst Trop Med, Malaria Lab 1, Hamburg, Germany; [Llinas, Manuel] Princeton Univ, Carl Icahn Lab, Princeton, NJ 08544 USA	Bernhard Nocht Institut fur Tropenmedizin; Princeton University	Helm, S (corresponding author), Bernhard Nocht Inst Trop Med, Malaria Lab 1, Hamburg, Germany.	heussler@bni-hamburg.de	Heussler, Volker/H-9322-2019	Heussler, Volker/0000-0001-8028-9825	Deutsche Forschungsgemeinschaft [HE 4497/1-2]; EU	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU(European Commission)	This work was supported by a Deutsche Forschungsgemeinschaft grant to VH (HE 4497/1-2) and the FP7 EU project MALSIG (Signalling in life cycle stages of malaria parasites). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; ATKINSON CT, 1992, AM J TROP MED HYG, V46, P533, DOI 10.4269/ajtmh.1992.46.533; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Cann H, 2004, MOL BIOCHEM PARASIT, V137, P239, DOI 10.1016/j.molbiopara.2004.06.005; Carvalho TG, 2004, P NATL ACAD SCI USA, V101, P14931, DOI 10.1073/pnas.0404416101; Combe A, 2009, CELL HOST MICROBE, V5, P386, DOI 10.1016/j.chom.2009.03.008; de Koning-Ward TF, 1999, MOL BIOCHEM PARASIT, V100, P141, DOI 10.1016/S0166-6851(99)00042-0; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Garcia JE, 2004, J MOL MED, V82, P600, DOI 10.1007/s00109-004-0573-9; GOPALAKRISHNAN AM, 2010, PARASITOL RES; GUERINMARCHAND C, 1987, NATURE, V329, P164, DOI 10.1038/329164a0; Ishino T, 2009, CELL MICROBIOL, V11, P1329, DOI 10.1111/j.1462-5822.2009.01333.x; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; MATTHEWS JC, 1977, BIOCHEMISTRY-US, V16, P85, DOI 10.1021/bi00620a014; MCANDREW MB, 1993, GENE, V124, P165, DOI 10.1016/0378-1119(93)90390-O; MUHLE RA, 2009, INT J PARASITOL; Oguariri RM, 2006, MOL BIOCHEM PARASIT, V146, P163, DOI 10.1016/j.molbiopara.2005.12.004; Ruvalcaba-Salazar OK, 2005, MOL BIOCHEM PARASIT, V140, P183, DOI 10.1016/j.molbiopara.2005.01.002; Sacci JB, 2005, MOL BIOCHEM PARASIT, V142, P177, DOI 10.1016/j.molbiopara.2005.03.018; Schramm G, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e96; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; VANDERBERG JP, 1977, EXP PARASITOL, V42, P169, DOI 10.1016/0014-4894(77)90075-3; Vaughan AM, 2010, HUM VACCINES, V6, P107, DOI 10.4161/hv.6.1.9654; Yu Min, 2008, Cell Host Microbe, V4, P567, DOI 10.1016/j.chom.2008.11.001; Yuda M, 2010, MOL MICROBIOL, V75, P854, DOI 10.1111/j.1365-2958.2009.07005.x; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x	27	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13653	10.1371/journal.pone.0013653	http://dx.doi.org/10.1371/journal.pone.0013653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048918	Green Published, gold, Green Submitted			2022-12-25	WOS:000283537000024
J	Liu, YM; Suckale, J; Masjkur, J; Magro, MG; Steffen, A; Anastassiadis, K; Solimena, M				Liu, Yanmei; Suckale, Jakob; Masjkur, Jimmy; Magro, Maria Grazia; Steffen, Anja; Anastassiadis, Konstantinos; Solimena, Michele			Tamoxifen-Independent Recombination in the RIP-CreER Mouse	PLOS ONE			English	Article								Background: The inducible Cre-lox system is a valuable tool to study gene function in a spatial and time restricted fashion in mouse models. This strategy relies on the limited background activity of the modified Cre recombinase (CreER) in the absence of its inducer, the competitive estrogen receptor ligand, tamoxifen. The RIP-CreER mouse (Tg (Ins2-cre/Esr1) 1Dam) is among the few available beta-cell specific CreER mouse lines and thus it has been often used to manipulate gene expression in the insulin-producing cells of the endocrine pancreas. Principal Findings: Here, we report the detection of tamoxifen-independent Cre activity as early as 2 months of age in RIP-CreER mice crossed with three distinct reporter strains. Significance: Evidence of Cre-mediated recombination of floxed alleles even in the absence of tamoxifen administration should warrant cautious use of this mouse for the study of pancreatic beta-cells.	[Liu, Yanmei; Suckale, Jakob; Masjkur, Jimmy; Magro, Maria Grazia; Steffen, Anja; Solimena, Michele] Tech Univ Dresden, Sch Med, Paul Langerhans Inst Dresden, Mol Diabetol, Dresden, Germany; [Liu, Yanmei; Suckale, Jakob; Masjkur, Jimmy; Magro, Maria Grazia; Steffen, Anja; Solimena, Michele] Tech Univ Dresden, Univ Clin Carl Gustav Carus, Dresden, Germany; [Liu, Yanmei; Magro, Maria Grazia; Solimena, Michele] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Steffen, Anja] Tech Univ Dresden, Univ Clin Carl Gustav Carus, Med Clin 3, Dresden, Germany; [Anastassiadis, Konstantinos] Tech Univ Dresden, BioInnovat Zentrum, Genet Engn Stem Cells, Dresden, Germany; [Anastassiadis, Konstantinos; Solimena, Michele] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Max Planck Society; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Technische Universitat Dresden	Solimena, M (corresponding author), Tech Univ Dresden, Sch Med, Paul Langerhans Inst Dresden, Mol Diabetol, Dresden, Germany.	michele.solimena@tu-dresden.de	Solimena, Michele/E-1275-2011; Solimena, Michele/GVS-5990-2022; Anastassiadis, Konstantinos/A-8944-2010	Anastassiadis, Konstantinos/0000-0002-9814-0559	DFG [SFB 655]; Max Planck Society; BMBF Network of Competence for Diabetes; Center for Regenerative Therapies Dresden; MedDrive Grant from the Medical School of Dresden University of Technology; Dresden International Graduate School for Biomedicine and Bioengineering (DIGS-BB)	DFG(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); BMBF Network of Competence for Diabetes; Center for Regenerative Therapies Dresden; MedDrive Grant from the Medical School of Dresden University of Technology; Dresden International Graduate School for Biomedicine and Bioengineering (DIGS-BB)	These studies have been supported in part with funds from the DFG-SFB 655, the Max Planck Society, and the BMBF Network of Competence for Diabetes to MS and from the Center for Regenerative Therapies Dresden to K.A. Y.L. and J.S. are the recipients of a MedDrive Grant from the Medical School of Dresden University of Technology. M.G.M is supported by a fellowship from the Dresden International Graduate School for Biomedicine and Bioengineering (DIGS-BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buelow B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003264; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Feil R, 2007, Handb Exp Pharmacol, P3; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Joyner AL, 2006, DEV DYNAM, V235, P2376, DOI 10.1002/dvdy.20884; Knoch KP, 2006, CELL METAB, V3, P123, DOI 10.1016/j.cmet.2005.12.008; Knoch KP, 2004, NAT CELL BIOL, V6, P207, DOI 10.1038/ncb1099; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Mziaut H, 2006, NAT CELL BIOL, V8, P435, DOI 10.1038/ncb1395; SAUER B, 1989, NUCLEIC ACIDS RES, V17, P147, DOI 10.1093/nar/17.1.147; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Trajkovski M, 2008, J BIOL CHEM, V283, P33719, DOI 10.1074/jbc.M804928200; Walter T, 2010, NAT METHODS, V7, pS26, DOI [10.1038/nmeth.1431, 10.1038/NMETH.1431]	18	38	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13533	10.1371/journal.pone.0013533	http://dx.doi.org/10.1371/journal.pone.0013533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VI4QE	21063464	Green Submitted, Green Published, gold			2022-12-25	WOS:000488488500001
J	Nourizadeh-Lillabadi, R; Torgersen, JS; Vestrheim, O; Konig, M; Alestrom, P; Syed, M				Nourizadeh-Lillabadi, Rasoul; Torgersen, Jacob Seilo; Vestrheim, Olav; Konig, Melanie; Alestrom, Peter; Syed, Mohasina			Early Embryonic Gene Expression Profiling of Zebrafish Prion Protein (Prp2) Morphants	PLOS ONE			English	Article							SONIC-HEDGEHOG; PARKINSONS-DISEASE; NEURONS; NEUROGENESIS; SCRAPIE; MODELS; GROWTH; DEATH	Background: The Prion protein (PRNP/Prp) plays a crucial role in transmissible spongiform encephalopathies (TSEs) like Creutzfeldt-Jakob disease (CJD), scrapie and mad cow disease. Notwithstanding the importance in human and animal disease, fundamental aspects of PRNP/Prp function and transmission remains unaccounted for. Methodology/Principal Findings: The zebrafish (Danio rerio) genome contains three Prp encoding genes assigned prp1, prp2 and prp3. Currently, the second paralogue is believed to be the most similar to the mammalian PRNP gene in structure and function. Functional studies of the PRNP gene ortholog was addressed by prp2 morpholino (MO) knockdown experiments. Investigation of Prp2 depleted embryos revealed high mortality and apoptosis at 24 hours post fertilization (hpf) as well as impaired brain and neuronal development. In order to elucidate the underlying mechanisms, a genome-wide transcriptome analysis was carried out in viable 24 hpf morphants. The resulting changes in gene expression profiles revealed 249 differently expressed genes linked to biological processes like cell death, neurogenesis and embryonic development. Conclusions/Significance: The current study contributes to the understanding of basic Prp functions and demonstrates that the zebrafish is an excellent model to address the role of Prp in vertebrates. The gene knockdown of prp2 indicates an essential biological function for the zebrafish ortholog with a morphant phenotype that suggests a neurodegenerative action and gene expression effects which are apoptosis related and effects gene networks controlling neurogenesis and embryo development.	[Nourizadeh-Lillabadi, Rasoul; Torgersen, Jacob Seilo; Vestrheim, Olav; Konig, Melanie; Alestrom, Peter; Syed, Mohasina] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway	Norwegian University of Life Sciences	Nourizadeh-Lillabadi, R (corresponding author), Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway.	Mohasina.Syed@nvh.no			Research Council of Norway [159329/S10 KO-ZFISH]; EU [QLK5-2002-0086]	Research Council of Norway(Research Council of Norway); EU(European Commission)	Financial support was provided by The FUGE Program, Research Council of Norway (via Grant 159329/S10 KO-ZFISH), and EU project: TSE IN FISH (nr. QLK5-2002-0086). The funders had no role in study design, data collection and analysis, decision or preparation of the manyscript.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Cotto E, 2005, FEBS J, V272, P500, DOI 10.1111/j.1742-4658.2004.04492.x; da Costa CA, 2003, J BIOL CHEM, V278, P37330, DOI 10.1074/jbc.M306083200; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Herzog W, 2003, DEV BIOL, V254, P36, DOI 10.1016/S0012-1606(02)00124-0; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; JAY P, 1995, GENOMICS, V29, P541, DOI 10.1006/geno.1995.9970; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Lewis KE, 2001, DEVELOPMENT, V128, P3485; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; METCALFE WK, 1990, DEVELOPMENT, V110, P491; Miesbauer M, 2006, BIOCHEM BIOPH RES CO, V341, P218, DOI 10.1016/j.bbrc.2005.12.168; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Newman M, 2007, BBA-MOL BASIS DIS, V1772, P285, DOI 10.1016/j.bbadis.2006.12.001; Nourizadeh-Lillabadi R, 2009, J TOXICOL ENV HEAL A, V72, P112, DOI 10.1080/15287390802537255; Olivera S, 2003, MOL CELL NEUROSCI, V23, P96, DOI 10.1016/S1044-7431(03)00021-6; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rivera-Milla E, 2006, FASEB J, V20, P317, DOI 10.1096/fj.05-4279fje; Salta E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006175; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Scholpp S, 2006, DEVELOPMENT, V133, P855, DOI 10.1242/dev.02248; Shou J, 1999, NAT NEUROSCI, V2, P339, DOI 10.1038/7251; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sorensen G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-114; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Xiang W, 2005, ANN NEUROL, V58, P242, DOI 10.1002/ana.20551	37	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13573	10.1371/journal.pone.0013573	http://dx.doi.org/10.1371/journal.pone.0013573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042590	Green Submitted, gold, Green Published			2022-12-25	WOS:000283419100013
J	Sun, GH; Hasebe, T; Fujimoto, K; Lu, R; Fu, LZ; Matsuda, H; Kajita, M; Ishizuya-Oka, A; Shi, YB				Sun, Guihong; Hasebe, Takashi; Fujimoto, Kenta; Lu, Rosemary; Fu, Liezhen; Matsuda, Hiroki; Kajita, Mitsuko; Ishizuya-Oka, Atsuko; Shi, Yun-Bo			Spatio-Temporal Expression Profile of Stem Cell-Associated Gene LGR5 in the Intestine during Thyroid Hormone-Dependent Metamorphosis in Xenopus laevis	PLOS ONE			English	Article							EPITHELIUM; RECEPTORS; PROTEIN; IDENTIFICATION; PROLIFERATION; RENEWAL	Background: The intestinal epithelium undergoes constant self-renewal throughout adult life across vertebrates. This is accomplished through the proliferation and subsequent differentiation of the adult stem cells. This self-renewal system is established in the so-called postembryonic developmental period in mammals when endogenous thyroid hormone (T3) levels are high. Methodology/Principal Findings: The T3-dependent metamorphosis in anurans like Xenopus laevis resembles the mammalian postembryonic development and offers a unique opportunity to study how the adult stem cells are developed. The tadpole intestine is predominantly a monolayer of larval epithelial cells. During metamorphosis, the larval epithelial cells undergo apoptosis and, concurrently, adult epithelial stem/progenitor cells develop de novo, rapidly proliferate, and then differentiate to establish a trough-crest axis of the epithelial fold, resembling the crypt-villus axis in the adult mammalian intestine. The leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) is a well-established stem cell marker in the adult mouse intestinal crypt. Here we have cloned and analyzed the spatiotemporal expression profile of LGR5 gene during frog metamorphosis. We show that the two duplicated LGR5 genes in Xenopus laevis and the LGR5 gene in Xenopus tropicalis are highly homologous to the LGR5 in other vertebrates. The expression of LGR5 is induced in the limb, tail, and intestine by T3 during metamorphosis. More importantly, LGR5 mRNA is localized to the developing adult epithelial stem cells of the intestine. Conclusions/Significance: These results suggest that LGR5-expressing cells are the stem/progenitor cells of the adult intestine and that LGR5 plays a role in the development and/or maintenance of the adult intestinal stem cells during postembryonic development in vertebrates.	[Sun, Guihong; Fujimoto, Kenta; Lu, Rosemary; Fu, Liezhen; Matsuda, Hiroki; Shi, Yun-Bo] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, Lab Gene Regulat & Dev, PCRM,NIH, Bethesda, MD USA; [Hasebe, Takashi; Ishizuya-Oka, Atsuko] Nippon Med Sch, Dept Biol, Kawasaki Ku, Kanagawa, Japan; [Kajita, Mitsuko; Ishizuya-Oka, Atsuko] Nippon Med Sch, Inst Dev & Aging Sci, Dept Mol Biol, Kawasaki Ku, Kanagawa, Japan	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Nippon Medical School; Nippon Medical School	Sun, GH (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, Lab Gene Regulat & Dev, PCRM,NIH, Bethesda, MD USA.	Shi@helix.nih.gov	Matsuda, Hiroki/K-5055-2019	Shi, Yun-Bo/0000-0002-6330-0639; Hasebe, Takashi/0000-0001-7200-8173	National Institute of Child Health and Human Development, National Institutes of Health; Narishige Zoological Science Award; Grants-in-Aid for Scientific Research [20570060] Funding Source: KAKEN; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008858] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Narishige Zoological Science Award; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported in part by the Intramural Research Program of National Institute of Child Health and Human Development, National Institutes of Health and in part by Narishige Zoological Science Award to T.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 1998, DEV GROWTH DIFFER, V40, P177; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Buchholz DR, 2007, DEV BIOL, V303, P576, DOI 10.1016/j.ydbio.2006.11.037; Buchholz DR, 2004, MOL CELL BIOL, V24, P9026, DOI 10.1128/MCB.24.20.9026-9037.2004; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Gilbert L.I., 1996, METAMORPHOSIS POSTEM; Hasebe T, 2006, CELL TISSUE RES, V324, P105, DOI 10.1007/s00441-005-0099-7; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Ishizuya-Oka A, 1997, DEV BIOL, V192, P149, DOI 10.1006/dbio.1997.8749; Ishizuya-Oka A, 2003, J CELL SCI, V116, P3157, DOI 10.1242/jcs.00616; Ishizuya-Oka A, 2007, DEV DYN; Ishizuya-Oka A, 2009, FASEB J, V23, P2568, DOI 10.1096/fj.08-128124; Ishizuya-Oka A, 2006, DEV DYNAM, V235, P3240, DOI 10.1002/dvdy.20969; ISHIZUYAOKA A, 1991, IN VITRO CELL DEV B, V27, P853; Kong RCK, 2010, MOL CELL ENDOCRINOL, V320, P1, DOI 10.1016/j.mce.2010.02.003; Kumagai J, 2002, J BIOL CHEM, V277, P31283, DOI 10.1074/jbc.C200398200; LELOUP J, 1977, CR ACAD SCI D NAT, V284, P2261; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; MACDONALD WC, 1964, GASTROENTEROLOGY, V46, P405; MCAVOY JW, 1977, J EXP ZOOL, V202, P129, DOI 10.1002/jez.1402020115; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schreiber AM, 2005, P NATL ACAD SCI USA, V102, P3720, DOI 10.1073/pnas.0409868102; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Shi YB, 1996, CURR TOP DEV BIOL, V32, P205, DOI 10.1016/S0070-2153(08)60429-9; SHI YB, 1994, BBA-GENE STRUCT EXPR, V1217, P227, DOI 10.1016/0167-4781(94)90042-6; TATA JR, 1993, BIOESSAYS, V15, P239, DOI 10.1002/bies.950150404; Toner P. G., 1971, DIGESTIVE SYSTEM ULT; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145	35	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13605	10.1371/journal.pone.0013605	http://dx.doi.org/10.1371/journal.pone.0013605			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042589	Green Published, Green Submitted, gold			2022-12-25	WOS:000283419100024
J	Koslowski, M; Luxemburger, U; Tureci, O; Sahin, U				Koslowski, M.; Luxemburger, U.; Tuereci, Oe; Sahin, U.			Tumor-associated CpG demethylation augments hypoxia-induced effects by positive autoregulation of HIF-1 alpha	ONCOGENE			English	Article						cancer; hypoxia-inducible factor; methylation	INDUCIBLE FACTOR-I; DNA METHYLATION; ERYTHROPOIETIN GENE; HIF-ALPHA; EXPRESSION; BINDING; CANCER; INDUCTION; FACTOR-1; CELLS	Hypoxia-inducible factor 1 alpha (HIF-1 alpha) is frequently over-expressed in human cancers and controls the expression of several genes that have been implicated in tumor growth and progression. Activity of HIF-1 alpha in cancer cells is regulated at the transcriptional, translational and post-translational level by multiple inter-and coacting molecular pathways. In this report, we reveal for the first time that tumor-associated CpG demethylation facilitates positive autoregulation of HIF-1 alpha, resulting in amplification of hypoxia-induced transactivation of HIF-1 alpha target genes. The HIF-1 alpha promoter harbors a hypoxia response element that is normally repressed by methylation of a CpG dinucleotide located in the core element. In colon cancer cell lines and in primary colon cancer specimens, however, we found frequent aberrant demethylation of this element, enabling binding of HIF-1 alpha to its own promoter resulting in autotransactivation of HIF-1 alpha expression. Our results provide novel and highly unexpected insights into the complexity of HIF-1 alpha regulation in cancer cells and implicate that tumor-associated CpG demethylation augments HIF-1 alpha-mediated effects on malignant cell growth. Oncogene (2011) 30, 876-882; doi:10.1038/onc.2010.481; published online 1 November 2010	[Koslowski, M.; Luxemburger, U.; Sahin, U.] TRON Ctr Translat Oncol & Immunol GmbH, D-55131 Mainz, Germany; [Tuereci, Oe] Ganymed Pharmaceut AG, Mainz, Germany		Sahin, U (corresponding author), TRON Ctr Translat Oncol & Immunol GmbH, Langenbeckstr 1, D-55131 Mainz, Germany.	sahin@uni-mainz.de	Sahin, Ugur/L-4818-2017	Sahin, Ugur/0000-0003-0363-1564				ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Bilton RL, 2003, EUR J BIOCHEM, V270, P791, DOI 10.1046/j.1432-1033.2003.03446.x; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; CHEN HM, 1995, ONCOGENE, V11, P1549; CHEN RP, 1990, NATURE, V346, P583, DOI 10.1038/346583a0; Conrad PW, 1999, J BIOL CHEM, V274, P33709, DOI 10.1074/jbc.274.47.33709; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg A P, 1988, Prog Clin Biol Res, V279, P309; FEINBERG AP, 1988, CANCER RES, V48, P1159; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JAENISCH R, 1985, P NATL ACAD SCI USA, V82, P1451, DOI 10.1073/pnas.82.5.1451; Kanai M, 2006, CLIN CANCER RES, V12, P6395, DOI 10.1158/1078-0432.CCR-06-1034; Karpf AR, 2002, ONCOGENE, V21, P5496, DOI 10.1038/sj.onc.1205602; Koslowski M, 2004, CANCER RES, V64, P5988, DOI 10.1158/0008-5472.CAN-04-1187; Koslowski M, 2006, HUM MOL GENET, V15, P2392, DOI 10.1093/hmg/ddl163; Koslowski M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-77; Koslowski M, 2009, J BIOL CHEM, V284, P28607, DOI 10.1074/jbc.M109.031120; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazure NM, 1997, BLOOD, V90, P3322, DOI 10.1182/blood.V90.9.3322; MCCORMICK A, 1990, NATURE, V345, P829, DOI 10.1038/345829a0; NICOLAIDES NC, 1991, MOL CELL BIOL, V11, P6166, DOI 10.1128/MCB.11.12.6166; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Sahin U, 2008, CLIN CANCER RES, V14, P7624, DOI 10.1158/1078-0432.CCR-08-1547; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Serfling E, 2006, TRENDS IMMUNOL, V27, P461, DOI 10.1016/j.it.2006.08.005; Siegfried Z, 1997, CURR BIOL, V7, pR305, DOI 10.1016/S0960-9822(06)00144-8; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; WAINFAN E, 1992, CANCER RES, V52, pS2071; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1993, J BIOL CHEM, V268, P21513; Wenger RH, 1998, EUR J BIOCHEM, V253, P771, DOI 10.1046/j.1432-1327.1998.2530771.x; Yin H, 2000, BLOOD, V95, P111, DOI 10.1182/blood.V95.1.111.001k20_111_119; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zundel W, 2000, GENE DEV, V14, P391	44	61	65	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	7					876	882		10.1038/onc.2010.481	http://dx.doi.org/10.1038/onc.2010.481			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	722OT	21042279				2022-12-25	WOS:000287444600011
J	Hu, JH; Mukhopadhyay, A; Craig, AWB				Hu, Jinghui; Mukhopadhyay, Alka; Craig, Andrew W. B.			Transducer of Cdc42-dependent Actin Assembly Promotes Epidermal Growth Factor-induced Cell Motility and Invasiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE INVAGINATION; FORMIN-BINDING PROTEIN-17; WASP-WIP COMPLEX; N-WASP; CARCINOMA-CELLS; CORTACTIN PHOSPHORYLATION; FIBROBLAST MIGRATION; COLLECTIVE INVASION; BAR PROTEINS	Toca-1 (transducer of Cdc42-dependent actin assembly) interacts with the Cdc42.N-WASP and Abi1.Rac.WAVE F-actin branching pathways that function in lamellipodia formation and cell motility. However, the potential role of Toca-1 in these processes has not been reported. Here, we show that epidermal growth factor (EGF) induces Toca-1 localization to lamellipodia, where it co-localizes with F-actin and Arp2/3 complex in A431 epidermoid carcinoma cells. EGF also induces tyrosine phosphorylation of Toca-1 and interactions with N-WASP and Abi1. Stable knockdown of Toca-1 expression by RNA interference has no effect on cell growth, EGF receptor expression, or internalization. However, Toca-1 knockdown cells display defects in EGF-induced filopodia and lamellipodial protrusions compared with control cells. Further analyses reveal a role for Toca-1 in localization of Arp2/3 and Abi1 to lamellipodia. Toca-1 knockdown cells also display a significant defect in EGF-induced motility and invasiveness. Taken together, these results implicate Toca-1 in coordinating actin assembly within filopodia and lamellipodia to promote EGF-induced cell migration and invasion.	[Craig, Andrew W. B.] Queens Univ, Dept Biochem, Canc Res Inst, Kingston, ON K7L 3N6, Canada; Queens Univ, Canc Biol & Genet Div, Canc Res Inst, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Craig, AWB (corresponding author), Queens Univ, Dept Biochem, Canc Res Inst, Kingston, ON K7L 3N6, Canada.	andrew.craig@queensu.ca	Craig, Andrew/G-2312-2017; Craig, Andrew/AAC-6923-2019	Craig, Andrew/0000-0002-2039-2393; Craig, Andrew/0000-0002-2039-2393	Canadian Cancer Society Research Institute; Canadian Institutes for Health Research (CIHR) at Queen's University; Canadian Breast Cancer Foundation-Ontario Chapter	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research (CIHR) at Queen's University(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation-Ontario Chapter	This work was supported by a grant from the Canadian Cancer Society Research Institute (to A. W. B. C.). Salary support was provided by the Canadian Institutes for Health Research (CIHR) training program in cancer research at Queen's University (to J. H.), Canadian Breast Cancer Foundation-Ontario Chapter (to J. H.), and a CIHR New Investigator award (to A. W. B. C.).	Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; Aspenstrom P, 2006, TRENDS BIOCHEM SCI, V31, P670, DOI 10.1016/j.tibs.2006.10.001; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; Brockbank EC, 2005, BRIT J CANCER, V92, P102, DOI 10.1038/sj.bjc.6602255; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; CHINKERS M, 1979, J CELL BIOL, V83, P260, DOI 10.1083/jcb.83.1.260; Chitu V, 2007, TRENDS CELL BIOL, V17, P145, DOI 10.1016/j.tcb.2007.01.003; Craig AWB, 2001, MOL CELL BIOL, V21, P603, DOI 10.1128/MCB.21.2.603-613.2001; Fricke R, 2009, CURR BIOL, V19, P1429, DOI 10.1016/j.cub.2009.07.058; Fuchs U, 2001, P NATL ACAD SCI USA, V98, P8756, DOI 10.1073/pnas.121433898; Funato Y, 2004, CANCER RES, V64, P5237, DOI 10.1158/0008-5472.CAN-04-0327; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Giuliani C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000675; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Hu JH, 2009, CELL SIGNAL, V21, P1686, DOI 10.1016/j.cellsig.2009.07.007; Huang YT, 2002, INT J CANCER, V99, P505, DOI 10.1002/ijc.10373; Huett A, 2009, J IMMUNOL, V182, P4917, DOI 10.4049/jimmunol.0803050; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; Kakimoto T, 2006, J BIOL CHEM, V281, P29042, DOI 10.1074/jbc.M604025200; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Kurokawa K, 2004, MOL BIOL CELL, V15, P1003, DOI 10.1091/mbc.E03-08-0609; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lee K, 2010, SCIENCE, V329, P1341, DOI 10.1126/science.1191710; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Leung Y, 2008, CELL HOST MICROBE, V3, P39, DOI 10.1016/j.chom.2007.10.011; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; Macpherson IR, 2007, ONCOGENE, V26, P5214, DOI 10.1038/sj.onc.1210334; Malliri A, 1998, J CELL BIOL, V143, P1087, DOI 10.1083/jcb.143.4.1087; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053; Monypenny J, 2009, MOL CELL BIOL, V29, P2730, DOI 10.1128/MCB.01285-08; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rodal AA, 2008, J NEUROSCI, V28, P8316, DOI 10.1523/JNEUROSCI.2304-08.2008; Ryu JR, 2009, MOL CELL BIOL, V29, P1735, DOI 10.1128/MCB.01483-08; Sangrar W, 2007, MOL CELL BIOL, V27, P6140, DOI 10.1128/MCB.01744-06; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Stradal T, 2001, CURR BIOL, V11, P891, DOI 10.1016/S0960-9822(01)00239-1; Suetsugu S, 2010, SEMIN CELL DEV BIOL, V21, P340, DOI 10.1016/j.semcdb.2009.12.002; Suetsugu S, 2009, FEBS LETT, V583, P3401, DOI 10.1016/j.febslet.2009.10.019; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; Toguchi M, 2010, BIOL CELL, V102, P215, DOI 10.1042/BC20090033; Wang C, 2007, MOL CANCER RES, V5, P1031, DOI 10.1158/1541-7786.MCR-06-0391; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006; Yu WD, 2008, CARCINOGENESIS, V29, P1717, DOI 10.1093/carcin/bgn098	61	34	35	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2261	2272		10.1074/jbc.M110.157974	http://dx.doi.org/10.1074/jbc.M110.157974			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21062739	Green Published, hybrid			2022-12-25	WOS:000286191500066
J	Bala, S; Marcos, M; Kodys, K; Csak, T; Catalano, D; Mandrekar, P; Szabo, G				Bala, Shashi; Marcos, Miguel; Kodys, Karen; Csak, Timea; Catalano, Donna; Mandrekar, Pranoti; Szabo, Gyongyi			Up-regulation of MicroRNA-155 in Macrophages Contributes to Increased Tumor Necrosis Factor alpha (TNF alpha) Production via Increased mRNA Half-life in Alcoholic Liver Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; LIPOPOLYSACCHARIDE-BINDING PROTEIN; CHRONIC ETHANOL EXPOSURE; RAT KUPFFER CELLS; NONALCOHOLIC STEATOHEPATITIS; 3'-UNTRANSLATED REGION; INFLAMMATORY RESPONSE; CHOLINE-DEFICIENT; CONTROLLED-TRIAL; HUMAN MONOCYTES	Activation of Kupffer cells (KCs) by gut-derived lipopolysaccharide (LPS) and Toll-Like Receptors 4 (TLR4)-LPS-mediated increase in TNF alpha production has a central role in the pathogenesis of alcoholic liver disease. Micro-RNA (miR)-125b, miR-146a, and miR-155 can regulate inflammatory responses to LPS. Here we evaluated the involvement of miRs in alcohol-induced macrophage activation. Chronic alcohol treatment in vitro resulted in a time-dependent increase in miR-155 but not miR-125b or miR-146a levels in RAW 264.7 macrophages. Furthermore, alcohol pretreatment augmented LPS-induced miR-155 expression in macrophages. We found a linear correlation between alcohol-induced increase in miR-155 and TNF alpha induction. In a mouse model of alcoholic liver disease, we found a significant increase in both miR-155 levels and TNF alpha production in isolated KCs when compared with pair-fed controls. The mechanistic role of miR-155 in TNF alpha regulation was indicated by decreased TNF alpha levels in alcohol-treated macrophages after inhibition of miR-155 and by increased TNF alpha production after miR-155 overexpression, respectively. We found that miR-155 affected TNF alpha mRNA stability because miR-155 inhibition decreased whereas miR-155 overexpression increased TNF alpha mRNA half-life. Using the NF-kappa B inhibitors, MG-132 or Bay11-7082, we demonstrated that NF-kappa B activation mediated the up-regulation of miR-155 by alcohol in KCs. In conclusion, our novel data demonstrate that chronic alcohol consumption increases miR-155 in macrophages via NF-kappa B and the increased miR-155 contributes to alcohol-induced elevation in TNF alpha production via increased mRNA stability.	[Bala, Shashi; Marcos, Miguel; Kodys, Karen; Csak, Timea; Catalano, Donna; Mandrekar, Pranoti; Szabo, Gyongyi] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Szabo, G (corresponding author), Univ Massachusetts, Sch Med, Dept Med, 364 Plantat St, Worcester, MA 01605 USA.	gyongyi.szabo@umassmed.edu	Marcos, Miguel/B-3550-2008	Marcos, Miguel/0000-0003-1269-4487	National Institutes of Health [AA011576, AA008577]; Alfonso Martin Escudero Foundation, Spain; Diabetes Endocrinology Research Center [DK32520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011576, R01AA008577, R01AA017986, R29AA008577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfonso Martin Escudero Foundation, Spain; Diabetes Endocrinology Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA011576 and AA008577 (to G.S.). This work was also supported by a scholarship from the Alfonso Martin Escudero Foundation, Spain (to M.M.).; We thank Jan Petrasek and Odette Taha for help in animal work. Core resources supported by the Diabetes Endocrinology Research Center Grant DK32520 were used for this study.	Akriviadis E, 2000, GASTROENTEROLOGY, V119, P1637, DOI 10.1053/gast.2000.20189; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bi YJ, 2009, J CELL PHYSIOL, V218, P467, DOI 10.1002/jcp.21639; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Dolganiuc A, 2009, ALCOHOL CLIN EXP RES, V33, P1704, DOI 10.1111/j.1530-0277.2009.01007.x; Dong ZJ, 2007, CELL MOL IMMUNOL, V4, P241; Gaetke LM, 2003, J AM COLL NUTR, V22, P415, DOI 10.1080/07315724.2003.10719325; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Han J, 1990, Eur Cytokine Netw, V1, P71; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; Hill DB, 2000, J LAB CLIN MED, V135, P387, DOI 10.1067/mlc.2000.106451; Hill DB, 1999, CLIN BIOCHEM, V32, P563, DOI 10.1016/S0009-9120(99)00056-9; Hritz I, 2008, HEPATOLOGY, V48, P1224, DOI 10.1002/hep.22470; Iimuro Y, 1997, HEPATOLOGY, V26, P1530; Kishore R, 2002, AM J PHYSIOL-GASTR L, V282, pG6, DOI 10.1152/ajpgi.00328.2001; Kishore R, 2001, J BIOL CHEM, V276, P41930, DOI 10.1074/jbc.M107181200; Kluiver J, 2007, ONCOGENE, V26, P3769, DOI 10.1038/sj.onc.1210147; Mandrekar P, 2007, J IMMUNOL, V178, P7686, DOI 10.4049/jimmunol.178.12.7686; Mandrekar P, 2009, J IMMUNOL, V183, P1320, DOI 10.4049/jimmunol.0803206; Mandrekar P, 2009, J HEPATOL, V50, P1258, DOI 10.1016/j.jhep.2009.03.007; McClain CJ, 1999, SEMIN LIVER DIS, V19, P205, DOI 10.1055/s-2007-1007110; MCCLAIN CJ, 1989, HEPATOLOGY, V9, P349, DOI 10.1002/hep.1840090302; McMullen MR, 2003, J BIOL CHEM, V278, P38333, DOI 10.1074/jbc.M304566200; Menon KVN, 2004, AM J GASTROENTEROL, V99, P255, DOI 10.1111/j.1572-0241.2004.04034.x; Nagy LE, 2004, ALCOHOL, V33, P229, DOI 10.1016/j.alcohol.2004.09.002; Nagy LE, 2003, EXP BIOL MED, V228, P882, DOI 10.1177/153537020322800803; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Naveau S, 2004, HEPATOLOGY, V39, P1390, DOI 10.1002/hep.20206; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Pedersen IM, 2009, EMBO MOL MED, V1, P288, DOI 10.1002/emmm.200900028; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Qureshi N, 2003, J IMMUNOL, V171, P1515, DOI 10.4049/jimmunol.171.3.1515; Rai D, 2008, CANCER GENET CYTOGEN, V181, P8, DOI 10.1016/j.cancergencyto.2007.10.008; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Romics L, 2005, ALCOHOL CLIN EXP RES, V29, P1018, DOI 10.1097/01.ALC.0000167744.60838.4A; Romics L, 2004, HEPATOLOGY, V40, P376, DOI 10.1002/hep.20304; Ruggiero T, 2009, FASEB J, V23, P2898, DOI 10.1096/fj.09-131342; Szabo G, 2009, ALCOHOL CLIN EXP RES, V33, P220, DOI 10.1111/j.1530-0277.2008.00842.x; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thakur V, 2007, J GASTROEN HEPATOL, V22, pS53, DOI 10.1111/j.1440-1746.2006.04650.x; Thurman RG, 1998, AM J PHYSIOL-GASTR L, V275, pG605, DOI 10.1152/ajpgi.1998.275.4.G605; Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007; Tilg H, 2003, J HEPATOL, V38, P419, DOI 10.1016/S0168-8278(02)00442-7; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Uesugi T, 2002, J IMMUNOL, V168, P2963, DOI 10.4049/jimmunol.168.6.2963; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Wang EH, 1997, CANCER RES, V57, P5426; Yin M, 1999, GASTROENTEROLOGY, V117, P942, DOI 10.1016/S0016-5085(99)70354-9	52	301	318	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1436	1444		10.1074/jbc.M110.145870	http://dx.doi.org/10.1074/jbc.M110.145870			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21062749	Green Published, hybrid			2022-12-25	WOS:000286005000056
J	Groisman, B; Shenkman, M; Ron, E; Lederkremer, GZ				Groisman, Bella; Shenkman, Marina; Ron, Efrat; Lederkremer, Gerardo Z.			Mannose Trimming Is Required for Delivery of a Glycoprotein from EDEM1 to XTP3-B and to Late Endoplasmic Reticulum-associated Degradation Steps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; ASIALOGLYCOPROTEIN RECEPTOR SUBUNITS; UNFOLDED PROTEIN RESPONSE; UBIQUITIN LIGASE COMPLEX; QUALITY-CONTROL; MISFOLDED PROTEINS; SUGAR CHAINS; MRH DOMAIN; N-GLYCANS; MEMBRANE	Although the trimming of alpha 1,2-mannose residues from precursor N-linked oligosaccharides is an essential step in the delivery of misfolded glycoproteins to endoplasmic reticulum (ER)-associated degradation (ERAD), the exact role of this trimming is unclear. EDEM1 was initially suggested to bind N-glycans after mannose trimming, a role presently ascribed to the lectins OS9 and XTP3-B, because of their in vitro affinities for trimmed oligosaccharides. We have shown before that ER mannosidase I (ERManI) is required for the trimming and concentrates together with the ERAD substrate and ERAD machinery in the pericentriolar ER-derived quality control compartment (ERQC). Inhibition of mannose trimming prevents substrate accumulation in the ERQC. Here, we show that the mannosidase inhibitor kifunensine or ERManI knockdown do not affect binding of an ERAD substrate glycoprotein to EDEM1. In contrast, substrate association with XTP3-B and with the E3 ubiquitin ligases HRD1 and SCFFbs2 was inhibited. Consistently, whereas the ERAD substrate partially colocalized upon proteasomal inhibition with EDEM1, HRD1, and Fbs2 at the ERQC, colocalization was repressed by mannosidase inhibition in the case of the E3 ligases but not for EDEM1. Interestingly, association and colocalization of the substrate with Derlin-1 was independent of mannose trimming. The HRD1 adaptor protein SEL1L had been suggested to play a role in N-glycan-dependent substrate delivery to OS9 and XTP3-B. However, substrate association with XTP3-B was still dependent on mannose trimming upon SEL1L knockdown. Our results suggest that mannose trimming enables delivery of a substrate glycoprotein from EDEM1 to late ERAD steps through association with XTP3-B.	[Groisman, Bella; Shenkman, Marina; Ron, Efrat; Lederkremer, Gerardo Z.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Lederkremer, GZ (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	gerardo@post.tau.ac.il		Lederkremer, Gerardo/0000-0002-9857-7152	Israel Science Foundation [1229/07]; German-Israeli Project Cooperation (DIP)	Israel Science Foundation(Israel Science Foundation); German-Israeli Project Cooperation (DIP)	This work was supported by grants from the Israel Science Foundation (1229/07) and German-Israeli Project Cooperation (DIP).	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Alcock F, 2009, J MOL BIOL, V385, P1032, DOI 10.1016/j.jmb.2008.11.045; Avezov E, 2008, MOL BIOL CELL, V19, P216, DOI 10.1091/mbc.E07-05-0505; Ayalon-Soffer M, 1999, J CELL SCI, V112, P3309; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; D'Alessio C, 2010, SEMIN CELL DEV BIOL, V21, P491, DOI 10.1016/j.semcdb.2009.12.014; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Frenkel Z, 2003, J BIOL CHEM, V278, P34119, DOI 10.1074/jbc.M305929200; Frenkel Z, 2004, MOL BIOL CELL, V15, P2133, DOI 10.1091/mbc.E03-12-0899; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Groisman B, 2006, ISRAEL J CHEM, V46, P189, DOI 10.1560/2QPD-9WP9-NCYK-58X3; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Hosokawa N, 2006, GENES CELLS, V11, P465, DOI 10.1111/j.1365-2443.2006.00957.x; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P651, DOI 10.1093/glycob/cwq013; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P567, DOI 10.1093/glycob/cwq001; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Jakob CA, 2001, EMBO REP, V2, P423; Kamhi-Nesher S, 2001, MOL BIOL CELL, V12, P1711, DOI 10.1091/mbc.12.6.1711; Kamiya Y, 2008, J BIOL CHEM, V283, P1857, DOI 10.1074/jbc.M709384200; Katiyar S, 2005, MOL BIOL CELL, V16, P4584, DOI 10.1091/mbc.E05-04-0345; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kondratyev M, 2007, EXP CELL RES, V313, P3395, DOI 10.1016/j.yexcr.2007.07.006; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Lederkremer GZ, 2005, TRENDS BIOCHEM SCI, V30, P297, DOI 10.1016/j.tibs.2005.04.010; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Olivari S, 2007, FEBS LETT, V581, P3658, DOI 10.1016/j.febslet.2007.04.070; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Shenkman M, 1997, P NATL ACAD SCI USA, V94, P11363, DOI 10.1073/pnas.94.21.11363; Shenkman M, 2000, J BIOL CHEM, V275, P2845, DOI 10.1074/jbc.275.4.2845; Tolchinsky S, 1996, J BIOL CHEM, V271, P14496, DOI 10.1074/jbc.271.24.14496; Wakana Y, 2008, MOL BIOL CELL, V19, P1825, DOI 10.1091/mbc.E07-08-0781; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Yamaguchi D, 2010, GLYCOBIOLOGY, V20, P348, DOI 10.1093/glycob/cwp182; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Yoshida Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2623, DOI 10.1271/bbb.70074; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; YUK MH, 1993, J CELL BIOL, V123, P1735, DOI 10.1083/jcb.123.6.1735; Zuber C, 2007, P NATL ACAD SCI USA, V104, P4407, DOI 10.1073/pnas.0700154104	54	46	46	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1292	1300		10.1074/jbc.M110.154849	http://dx.doi.org/10.1074/jbc.M110.154849			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21062743	Green Published, hybrid			2022-12-25	WOS:000286005000041
J	Misra, UK; Payne, S; Pizzo, SV				Misra, Uma K.; Payne, Sturgis; Pizzo, Salvatore V.			Ligation of Prostate Cancer Cell Surface GRP78 Activates a Proproliferative and Antiapoptotic Feedback Loop A ROLE FOR SECRETED PROSTATE-SPECIFIC ANTIGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COOH-TERMINAL DOMAIN; NF-KAPPA-B; SIGNAL-TRANSDUCTION; RECEPTOR; ALPHA(2)-MACROGLOBULIN; EXPRESSION; PROTEIN; PSA; ALPHA-2-MACROGLOBULIN; ANTIBODIES	GRP78, a well characterized chaperone in the endoplasmic reticulum, is critical to the unfolded protein response. More recently, it has been identified on the cell surface, where it has many roles. On cancer cells, it functions as a signaling receptor coupled to proproliferative/antiapoptotic and promigratory mechanisms. In the current study, we demonstrate that ligation of prostate cancer cell surface GRP78 by its natural ligand, activated alpha(2)-macroglobulin (alpha M-2*), results in a 2-3-fold up-regulation in the synthesis of prostate-specific antigen (PSA). The PSA is secreted into the medium as an active proteinase, where it binds to native alpha M-2. The resultant alpha M-2.PSA complexes bind to GRP78, causing a 1.5-2-fold increase in the activation of MEK1/2, ERK1/2, S6K, and Akt, which is coupled with a 2-3-fold increase in DNA and protein synthesis. PSA is a marker for the progression of prostate cancer, but its mechanistic role in the disease is unclear. The present studies suggest that PSA may be involved in a signal transduction-dependent feedback loop, whereby it promotes a more aggressive behavior by human prostate cancer cells.	[Misra, Uma K.; Payne, Sturgis; Pizzo, Salvatore V.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University	Pizzo, SV (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Box 3712, Durham, NC 27710 USA.	Pizzo001@mc.duke.edu			National Institutes of Health [CA 131235]; NATIONAL CANCER INSTITUTE [R01CA131235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA 131235.	Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Asplin IR, 2000, ARCH BIOCHEM BIOPHYS, V383, P135, DOI 10.1006/abbi.2000.2052; Barry MJ, 2009, NEW ENGL J MED, V360, P1351, DOI 10.1056/NEJMe0901166; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen CD, 2002, MOL CELL BIOL, V22, P2862, DOI 10.1128/MCB.22.8.2862-2870.2002; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Gurova KV, 2002, ONCOGENE, V21, P153, DOI 10.1038/sj.onc.1205001; Ito K, 2009, INT J UROL, V16, P458, DOI 10.1111/j.1442-2042.2009.02293.x; Kanoh W, 2001, ANTICANCER RES, V21, P551; Kanoh Y, 2001, ONCOL REP, V8, P515; Kanoh Y, 2008, J CLIN LAB ANAL, V22, P302, DOI 10.1002/jcla.20260; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; LeBeau AM, 2009, BIOCHEMISTRY-US, V48, P3490, DOI 10.1021/bi9001858; Leman ES, 2009, J CELL BIOCHEM, V108, P3, DOI 10.1002/jcb.22227; Lin VK, 2005, PROSTATE, V63, P299, DOI 10.1002/pros.20183; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Misra UK, 2010, BIOCHEM BIOPH RES CO, V392, P538, DOI 10.1016/j.bbrc.2010.01.058; Misra UK, 2010, APOPTOSIS, V15, P173, DOI 10.1007/s10495-009-0430-y; Misra UK, 2010, BIOCHEM BIOPH RES CO, V391, P272, DOI 10.1016/j.bbrc.2009.11.048; Misra UK, 2009, J CELL BIOCHEM, V106, P381, DOI 10.1002/jcb.22016; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Misra UK, 2005, J IMMUNOL, V174, P2092, DOI 10.4049/jimmunol.174.4.2092; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Misra UK, 2004, CELL SIGNAL, V16, P487, DOI 10.1016/j.cellsig.2003.09.010; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Misra UK, 2010, CANCER BIOL THER, V9, P142, DOI 10.4161/cbt.9.2.10422; Misra UK, 2009, MOL CANCER THER, V8, P1350, DOI 10.1158/1535-7163.MCT-08-0990; Nadiminty N, 2006, CLIN CANCER RES, V12, P1420, DOI 10.1158/1078-0432.CCR-05-1849; Nicotera TM, 2009, PROSTATE, V69, P1270, DOI 10.1002/pros.20968; OHTANI H, 1985, ONCOLOGY, V42, P341, DOI 10.1159/000226060; Otto A, 1998, J UROLOGY, V159, P297, DOI 10.1016/S0022-5347(01)64085-0; Payne H., 2010, UROL ONCOL-SEMIN ORI, DOI [10.1016/j.urolone.2009.11.003, DOI 10.1016/J.UROLONE.2009.11.003]; Stamey TA, 1999, JAMA-J AM MED ASSOC, V281, P1395, DOI 10.1001/jama.281.15.1395; Wu S. M., 2000, HEMOSTASIS THROMBOSI, P367	36	57	63	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1248	1259		10.1074/jbc.M110.129767	http://dx.doi.org/10.1074/jbc.M110.129767			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21056970	Green Published, hybrid			2022-12-25	WOS:000286005000036
J	Cheng, SW; Li, LX; He, ST; Liu, J; Sun, YN; He, MC; Grasing, K; Premont, RT; Suo, WZ				Cheng, Shaowu; Li, Longxuan; He, Shuangteng; Liu, Jun; Sun, Yuning; He, Minchao; Grasing, Kenneth; Premont, Richard T.; Suo, William Z.			GRK5 Deficiency Accelerates beta-Amyloid Accumulation in Tg2576 Mice via Impaired Cholinergic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR KINASES; PRECURSOR PROTEIN-METABOLISM; M1 MUSCARINIC AGONISTS; ALZHEIMERS-DISEASE; SIGNALING PATHWAY; HYPOTHESIS; PHOSPHORYLATION; ACTIVATION; DESENSITIZATION; PERSPECTIVE	Membrane G protein-coupled receptor kinase 5 (GRK5) deficiency is linked to Alzheimer disease, yet its precise roles in the disease pathogenesis remain to be delineated. We have previously demonstrated that GRK5 deficiency selectively impairs desensitization of presynaptic M2 autoreceptors, which causes presynaptic M2 hyperactivity and inhibits acetylcholine release. Here we report that inactivation of one copy of Grk5 gene in transgenic mice overexpressing beta-amyloid precursor protein (APP) carrying Swedish mutations (Tg2576 or APPsw) resulted in significantly increased beta-amyloid (A beta) accumulation, including increased A beta(+) plaque burdens and soluble A beta in brain lysates and interstitial fluid (ISF). In addition, secreted beta-APP fragment (sAPP beta) also increased, whereas full-length APP level did not change, suggesting an alteration in favor of beta-amyloidogenic APP processing in these animals. Reversely, perfusion of methoctramine, a selective M2 antagonist, fully corrected the difference between the control and GRK5-deficient APPsw mice for ISF A beta. In contrast, a cholinesterase inhibitor, eserine, although significantly decreasing the ISF A beta in both control and GRK5-deficient APPsw mice, failed to correct the difference between them. However, combining eserine with methoctramine additively reduced the ISF A beta further in both animals. Altogether, these findings indicate that GRK5 deficiency accelerates beta-amyloidogenic APP processing and A beta accumulation in APPsw mice via impaired cholinergic activity and that presynaptic M2 hyperactivity is the specific target for eliminating the pathologic impact of GRK5 deficiency. Moreover, a combination of an M2 antagonist and a cholinesterase inhibitor may reach the maximal disease-modifying effect for both amyloid pathology and cholinergic dysfunction.	[Suo, William Z.] Univ Kansas, Coll Med, Dept Neurol, Kansas City, KS 66170 USA; [Suo, William Z.] Univ Kansas, Coll Med, Dept Physiol, Kansas City, KS 66170 USA; [He, Shuangteng; Grasing, Kenneth] Kansas City Vet Affairs Med Ctr, Subst Abuse Res Lab, Kansas City, MO 64128 USA; [Li, Longxuan] Guangdong Med Coll Affiliated Hosp, Dept Neurol, Zhanjiang 524001, Peoples R China; [Liu, Jun] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Neurol, Guangzhou 510120, Guangdong, Peoples R China; [He, Minchao] Ningxia Med Univ, Dept Biochem & Mol Biol, Ningxia 750004, Peoples R China; [Premont, Richard T.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Cheng, Shaowu; Li, Longxuan; Liu, Jun; Sun, Yuning; He, Minchao; Suo, William Z.] Kansas City Vet Affairs Med Ctr, Lab Alzheimers Dis & Aging Res, Kansas City, MO 64128 USA	University of Kansas; University of Kansas; Guangdong Medical University; Sun Yat Sen University; Ningxia Medical University; Duke University	Suo, WZ (corresponding author), Vet Adm Med Ctr, Lab Alzheimers Dis & Aging Res, 4801 Linwood Blvd, Kansas City, MO 64128 USA.	William.Suo@va.gov	cheng, shaowu/C-1622-2013	cheng, shaowu/0000-0001-6148-9565; Premont, Richard/0000-0002-8053-5026; cheng, shaowu/0000-0001-9059-4727; Grasing, Kenneth/0000-0002-6464-5700	Medical Research and Development Service, Department of Veterans Affairs, the American Federation for Aging Research; Midwest Biomedical Research Foundation	Medical Research and Development Service, Department of Veterans Affairs, the American Federation for Aging Research(US Department of Veterans Affairs); Midwest Biomedical Research Foundation	This work was supported by grants from the Medical Research and Development Service, Department of Veterans Affairs, the American Federation for Aging Research, and the Midwest Biomedical Research Foundation (to W. Z. S.).	BARTUS RT, 1985, ANN NY ACAD SCI, V444, P332, DOI 10.1111/j.1749-6632.1985.tb37600.x; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bartus RT, 1999, JAMA-J AM MED ASSOC, V282, P2208, DOI 10.1001/jama.282.23.2208; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Budd DC, 2003, J BIOL CHEM, V278, P19565, DOI 10.1074/jbc.M211670200; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davis KL, 1999, JAMA-J AM MED ASSOC, V281, P1401, DOI 10.1001/jama.281.15.1401; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; DeLapp N, 1998, BIOCHEM BIOPH RES CO, V244, P156, DOI 10.1006/bbrc.1998.8235; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; FARBER SA, 1995, J NEUROSCI, V15, P7442; Fisher A, 2003, J MOL NEUROSCI, V20, P349, DOI 10.1385/JMN:20:3:349; Fisher A, 2008, NEUROTHERAPEUTICS, V5, P433, DOI 10.1016/j.nurt.2008.05.002; Fisher A, 2008, NEURODEGENER DIS, V5, P237, DOI 10.1159/000113712; Gainetdinov RR, 1999, NEURON, V24, P1029, DOI 10.1016/S0896-6273(00)81048-X; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Houslay MD, 2000, MOL PHARMACOL, V58, P659, DOI 10.1124/mol.58.4.659; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Imahori K, 1997, J BIOCHEM, V121, P179; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; King DL, 1999, BEHAV BRAIN RES, V103, P145, DOI 10.1016/S0166-4328(99)00037-6; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Ladner CJ, 1998, J NEUROPATH EXP NEUR, V57, P719, DOI 10.1097/00005072-199808000-00001; LEE RKK, 1995, P NATL ACAD SCI USA, V92, P8083, DOI 10.1073/pnas.92.17.8083; Levey AI, 1996, P NATL ACAD SCI USA, V93, P13541, DOI 10.1073/pnas.93.24.13541; Li LX, 2009, BRAIN RES BULL, V78, P145, DOI 10.1016/j.brainresbull.2008.09.019; Li L, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-24; Lin L, 1999, P NATL ACAD SCI USA, V96, P12108, DOI 10.1073/pnas.96.21.12108; Liskowsky W, 2006, INT J DEV NEUROSCI, V24, P149, DOI 10.1016/j.ijdevneu.2005.11.010; Liu J, 2009, J BIOL CHEM, V284, P19564, DOI 10.1074/jbc.M109.005959; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Nitsch RM, 1996, J BIOL CHEM, V271, P4188; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Postina R, 2008, CURR ALZHEIMER RES, V5, P179, DOI 10.2174/156720508783954668; Roberson MR, 1997, BRAIN RES REV, V25, P50, DOI 10.1016/S0165-0173(97)00016-7; Rossner S, 1998, PROG NEUROBIOL, V56, P541, DOI 10.1016/S0301-0082(98)00044-6; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; Sadot E, 1996, J NEUROCHEM, V66, P877; Small DH, 2006, J NEUROCHEM, V99, P708, DOI 10.1111/j.1471-4159.2006.04212.x; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Suo WZ, 2010, THESCIENTIFICWORLDJO, V10, P1667, DOI 10.1100/tsw.2010.154; Suo Z, 2007, NEUROBIOL AGING, V28, P1873, DOI 10.1016/j.neurobiolaging.2006.08.013; Suo ZM, 2004, J NEUROSCI, V24, P3444, DOI 10.1523/JNEUROSCI.4856-03.2004; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Thathiah A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293re8; Trojanowski JQ, 1995, FASEB J, V9, P1570, DOI 10.1096/fasebj.9.15.8529836; Uezu K, 2005, BRAIN RES, V1050, P118, DOI 10.1016/j.brainres.2005.05.044; Walker JKL, 2004, AM J PHYSIOL-LUNG C, V286, pL312, DOI 10.1152/ajplung.00255.2003; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Woolf NJ, 1996, NEUROBIOL LEARN MEM, V66, P258, DOI 10.1006/nlme.1996.0068; Zhang WL, 2002, J NEUROSCI, V22, P1709, DOI 10.1523/JNEUROSCI.22-05-01709.2002; Zhang XY, 1999, AM J PHYSIOL-LUNG C, V276, pL769, DOI 10.1152/ajplung.1999.276.5.L769; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07	59	30	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41541	41548		10.1074/jbc.M110.170894	http://dx.doi.org/10.1074/jbc.M110.170894			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041302	hybrid, Green Published			2022-12-25	WOS:000285622600041
J	Delekta, PC; Apel, IJ; Gu, SF; Siu, K; Hattori, Y; McAllister-Lucas, LM; Lucas, PC				Delekta, Phillip C.; Apel, Ingrid J.; Gu, Shufang; Siu, Katy; Hattori, Yoshiyuki; McAllister-Lucas, Linda M.; Lucas, Peter C.			Thrombin-dependent NF-kappa B Activation and Monocyte/Endothelial Adhesion Are Mediated by the CARMA3.Bcl10.MALT1 Signalosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RELA/P65 NUCLEAR TRANSLOCATION; INDUCED ICAM-1 EXPRESSION; ENDOTHELIAL-CELLS; PROTEIN-KINASE; MOLECULE-1 EXPRESSION; CARMA3/BCL10/MALT1 COMPLEX; SIGNALING PATHWAYS; EPITHELIAL-CELLS; GENE-EXPRESSION; CANCER CELLS	Thrombin is a potent modulator of endothelial function and, through stimulation of NF-kappa B, induces endothelial expression of intracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). These cell surface adhesion molecules recruit inflammatory cells to the vessel wall and thereby participate in the development of atherosclerosis, which is increasingly recognized as an inflammatory condition. The principal receptor for thrombin on endothelial cells is protease-activated receptor-1 (PAR-1), a member of the G protein-coupled receptor superfamily. Although it is known that PAR-1 signaling to NF-kappa B depends on initial PKC activation, the subsequent steps leading to stimulation of the canonical NF-kappa B machinery have remained unclear. Here, we demonstrate that a complex of proteins containing CARMA3, Bcl10, and MALT1 links PAR-1 activation to stimulation of the I kappa B kinase complex. I kappa B kinase in turn phosphorylates I kappa B, leading to its degradation and the release of active NF-kappa B. Further, we find that although this CARMA3.Bcl10.MALT1 signalosome shares features with a CARMA1-containing signalosome found in lymphocytes, there are significant differences in how the signalosomes communicate with their cognate receptors. Specifically, whereas the CARMA1-containing lymphocyte complex relies on 3-phosphoinositide-dependent protein kinase 1 for assembly and activation, the CARMA3-containing endothelial signalosome functions completely independent of 3-phosphoinositide-dependent protein kinase 1 and instead relies on beta-arrestin 2 for assembly. Finally, we show that thrombin-dependent adhesion of monocytes to endothelial cells requires an intact endothelial CARMA3.Bcl10.MALT1 signalosome, underscoring the importance of the signalosome in mediating one of the most significant pro-atherogenic effects of thrombin.	[Apel, Ingrid J.; Gu, Shufang; Siu, Katy; Lucas, Peter C.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Delekta, Phillip C.; Lucas, Peter C.] Univ Michigan, Sch Med, Cellular & Mol Biol Grad Program, Ann Arbor, MI 48109 USA; [McAllister-Lucas, Linda M.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Hattori, Yoshiyuki] Dokkyo Univ, Sch Med, Dept Endocrinol & Metab, Mibu, Tochigi 3210293, Japan	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Dokkyo Medical University	Lucas, PC (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 3510 MSRB I,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	plucas@umich.edu		Lucas, Peter/0000-0003-4880-7172	National Institutes of Health [R01-HL082914, R01-DK079973]; Shirley K. Schlafer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shirley K. Schlafer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL082914 and R01-DK079973 (to P.C.L.). This work was also supported by Shirley K. Schlafer Foundation (to L.M.M.-L.).	ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; Anwar KN, 2004, J IMMUNOL, V173, P6965, DOI 10.4049/jimmunol.173.11.6965; Bijli KM, 2008, J BIOL CHEM, V283, P14674, DOI 10.1074/jbc.M802094200; Bijli KM, 2007, AM J PHYSIOL-LUNG C, V292, pL396, DOI 10.1152/ajplung.00163.2006; Blonska M, 2009, IMMUNOL REV, V228, P199, DOI 10.1111/j.1600-065X.2008.00749.x; Borissoff JI, 2009, CARDIOVASC RES, V82, P392, DOI 10.1093/cvr/cvp066; Borthakur A, 2010, INFLAMM BOWEL DIS, V16, P593, DOI 10.1002/ibd.21092; Cahill CM, 2008, J BIOL CHEM, V283, P25900, DOI 10.1074/jbc.M707692200; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Croce K, 2007, CURR OPIN HEMATOL, V14, P55, DOI 10.1097/00062752-200701000-00011; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Fazal F, 2007, J BIOL CHEM, V282, P3940, DOI 10.1074/jbc.M608074200; Fazal F, 2009, J BIOL CHEM, V284, P21047, DOI 10.1074/jbc.M109.016444; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Gustin JA, 2006, J BIOL CHEM, V281, P16473, DOI 10.1074/jbc.M507373200; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hawkins PT, 2007, BIOCHEM SOC SYMP, V74, P59, DOI 10.1042/BSS2007c06; Hendriks-Balk MC, 2008, EUR J PHARMACOL, V585, P278, DOI 10.1016/j.ejphar.2008.02.088; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; Inohara N, 2000, J BIOL CHEM, V275, P27823; Kalmes A, 2001, ANN NY ACAD SCI, V947, P42; Kang KW, 2003, J BIOL CHEM, V278, P17368, DOI 10.1074/jbc.M300471200; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Le Brocq M, 2008, ANTIOXID REDOX SIGN, V10, P1631, DOI 10.1089/ars.2007.2013; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Mahanivong C, 2008, ONCOGENE, V27, P1273, DOI 10.1038/sj.onc.1210746; Major C, 2003, ARTERIOSCL THROM VAS, V23, pA48; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Martorell L, 2008, THROMB HAEMOSTASIS, V99, P305, DOI 10.1160/TH07-08-0481; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Medoff BD, 2009, AM J RESP CELL MOL, V40, P286, DOI 10.1165/rcmb.2008-0129OC; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Miho N, 2005, CARDIOVASC RES, V68, P289, DOI 10.1016/j.cardiores.2005.05.029; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; Minami T, 2003, J BIOL CHEM, V278, P6976, DOI 10.1074/jbc.M208974200; Minami T, 2001, J BIOL CHEM, V276, P47632, DOI 10.1074/jbc.M108363200; Minhajuddin M, 2005, J IMMUNOL, V174, P5823, DOI 10.4049/jimmunol.174.9.5823; Nakano A, 2009, HYPERTENS RES, V32, P765, DOI 10.1038/hr.2009.95; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; OCONNELL KA, 1990, J IMMUNOL, V144, P521; Ozes ON, 1999, NATURE, V401, P82; Pantano C, 2006, ANTIOXID REDOX SIGN, V8, P1791, DOI 10.1089/ars.2006.8.1791; Park SG, 2009, NAT IMMUNOL, V10, P158, DOI 10.1038/ni.1687; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Rahman A, 2002, CIRC RES, V91, P398, DOI 10.1161/01.RES.0000033520.95242.A2; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; Rahman A, 2009, ANTIOXID REDOX SIGN, V11, P823, DOI [10.1089/ars.2008.2204, 10.1089/ARS.2008.2204]; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Rehman AO, 2009, INT J ORAL SCI, V1, P105, DOI 10.4248/IJOS.09059; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Tantivejkul K, 2005, J CELL BIOCHEM, V96, P641, DOI 10.1002/jcb.20533; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; WEGENER E, 2007, SCI STKE, pPE21; Ye RD, 2001, J LEUKOCYTE BIOL, V70, P839	68	60	64	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41432	41442		10.1074/jbc.M110.158949	http://dx.doi.org/10.1074/jbc.M110.158949			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041303	Green Published, hybrid			2022-12-25	WOS:000285622600029
J	Lin, CY; Meng, SX; Zhu, TN; Wang, XZ				Lin, Chengyi; Meng, Shuxia; Zhu, Tina; Wang, Xiaozhong			PDCD10/CCM3 Acts Downstream of gamma-Protocadherins to Regulate Neuronal Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; ACTIVATED PROTEIN-KINASE; APOPTOSIS-RELATED GENE; PROGRAMMED CELL-DEATH; NERVOUS-SYSTEM; HOMOPHILIC INTERACTION; SPINAL INTERNEURONS; MOLECULAR-GENETICS; RECENT INSIGHTS; ENCODING KRIT1	gamma-Protocadherins (PCDH-gamma) regulate neuronal survival in the vertebrate central nervous system. The molecular mechanisms of how PCDH-gamma mediates this function are still not understood. In this study, we show that through their common cytoplasmic domain, different PCDH-gamma isoforms interact with an intracellular adaptor protein named PDCD10 (programmed cell death 10). PDCD10 is also known as CCM3, a causative genetic defect for cerebral cavernous malformations in humans. Using RNAi-mediated knockdown, we demonstrate that PDCD10 is required for the occurrence of apoptosis upon PCDH-gamma depletion in developing chicken spinal neurons. Moreover, overexpression of PDCD10 is sufficient to induce neuronal apoptosis. Taken together, our data reveal a novel function for PDCD10/CCM3, acting as a critical regulator of neuronal survival during development.	[Lin, Chengyi; Meng, Shuxia; Zhu, Tina; Wang, Xiaozhong] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Wang, XZ (corresponding author), Northwestern Univ, Dept Mol Biosci, 2205 Tech Dr,Hogan 2-100, Evanston, IL 60208 USA.	awang@northwestern.edu			National Institutes of Health [5R01NS051253]; 3M Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051253] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 3M Fellowship(3M); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant 5R01NS051253 (to X. W.).; Supported in part by a 3M Fellowship.	Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Boulday G, 2009, DIS MODEL MECH, V2, P168, DOI 10.1242/dmm.001263; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Chan AC, 2010, FEBS J, V277, P1076, DOI 10.1111/j.1742-4658.2009.07536.x; Chen J, 2009, J BIOL CHEM, V284, P2880, DOI 10.1074/jbc.M807417200; Cheng AW, 2001, J BIOL CHEM, V276, P43320, DOI 10.1074/jbc.M107698200; Dan I, 2002, J BIOL CHEM, V277, P5929, DOI 10.1074/jbc.M110882200; Davies AM, 2003, EMBO J, V22, P2537, DOI 10.1093/emboj/cdg254; Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718; Emond MR, 2008, DEV BIOL, V321, P175, DOI 10.1016/j.ydbio.2008.06.011; Esumi S, 2005, NAT GENET, V37, P171, DOI 10.1038/ng1500; Fernandez-Monreal M, 2009, MOL CELL NEUROSCI, V40, P344, DOI 10.1016/j.mcn.2008.12.002; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Fong B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-2; Guclu B, 2005, NEUROSURGERY, V57, P1008, DOI 10.1227/01.NEU.0000180811.56157.E1; Han MH, 2010, MOL CELL PROTEOMICS, V9, P71, DOI 10.1074/mcp.M900343-MCP200; Harada J, 1999, JPN J PHARMACOL, V79, P369, DOI 10.1254/jjp.79.369; Harel L, 2009, NEURON, V63, P585, DOI 10.1016/j.neuron.2009.08.020; Hasegawa S, 2008, MOL CELL NEUROSCI, V38, P66, DOI 10.1016/j.mcn.2008.01.016; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Hilder TL, 2007, J PROTEOME RES, V6, P4343, DOI 10.1021/pr0704276; Hogan BM, 2008, HUM MOL GENET, V17, P2424, DOI 10.1093/hmg/ddn142; Horstmann S, 1998, J NEUROSCI RES, V52, P483, DOI 10.1002/(SICI)1097-4547(19980515)52:4<483::AID-JNR12>3.3.CO;2-Y; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Katori S, 2009, J NEUROSCI, V29, P9137, DOI 10.1523/JNEUROSCI.5478-08.2009; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kummer JL, 1997, J BIOL CHEM, V272, P20490, DOI 10.1074/jbc.272.33.20490; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Lefebvre JL, 2008, DEVELOPMENT, V135, P4141, DOI 10.1242/dev.027912; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Linseman DA, 2001, J BIOL CHEM, V276, P39123, DOI 10.1074/jbc.M103959200; Liquori Christina L, 2006, Hum Mutat, V27, P118, DOI 10.1002/humu.9389; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Lowrie MB, 2000, PROG NEUROBIOL, V61, P543, DOI 10.1016/S0301-0082(99)00065-9; Lu YY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp686; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; Mennerick S, 2000, MOL NEUROBIOL, V22, P41; Nakamura H, 2001, METHODS, V24, P43, DOI 10.1006/meth.2001.1155; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; Nogueira E, 2008, J BIOL CHEM, V283, P16248, DOI 10.1074/jbc.M709724200; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Pagenstecher A, 2009, HUM MOL GENET, V18, P911, DOI 10.1093/hmg/ddn420; Petit N, 2006, GENE EXPR PATTERNS, V6, P495, DOI 10.1016/j.modgep.2005.11.001; Phillips GR, 2003, J NEUROSCI, V23, P5096; Plummer NW, 2006, MAMM GENOME, V17, P119, DOI 10.1007/s00335-005-0098-8; Prasad T, 2008, DEVELOPMENT, V135, P4153, DOI 10.1242/dev.026807; Riant F, 2010, FEBS J, V277, P1070, DOI 10.1111/j.1742-4658.2009.07535.x; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; Silos-Santiago Inmaculada, 1995, Current Opinion in Neurobiology, V5, P42, DOI 10.1016/0959-4388(95)80085-9; Su H, 2010, DEV BIOL, V339, P38, DOI 10.1016/j.ydbio.2009.12.010; Tanriover G, 2008, NEUROSURGERY, V62, P930, DOI 10.1227/01.neu.0000318179.02912.ca; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Vecino E, 2004, INT J DEV BIOL, V48, P965, DOI 10.1387/ijdb.041891ev; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; Voss K, 2009, HUM MUTAT, V30, P1003, DOI 10.1002/humu.20996; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Wang YG, 1999, SCI CHINA SER C, V42, P323, DOI 10.1007/BF03183610; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Wu HY, 2008, APOPTOSIS, V13, P283, DOI 10.1007/s10495-007-0161-x; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yagi T, 2008, DEV GROWTH DIFFER, V50, pS131, DOI 10.1111/j.1440-169X.2008.00991.x; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679	70	27	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41675	41685		10.1074/jbc.M110.179895	http://dx.doi.org/10.1074/jbc.M110.179895			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041308	Green Published, hybrid			2022-12-25	WOS:000285622600055
J	Xu, H; Yan, YP; Williams, MS; Carey, GB; Yang, JX; Li, HM; Zhang, GX; Rostami, A				Xu, Hui; Yan, Yaping; Williams, Mark S.; Carey, Gregory B.; Yang, Jingxian; Li, Hongmei; Zhang, Guang-Xian; Rostami, Abdolmohamad			MS4a4B, a CD20 Homologue in T Cells, Inhibits T Cell Propagation by Modulation of Cell Cycle	PLOS ONE			English	Article							ANTIGEN; BP35; B1	MS4a4B, a CD20 homologue in T cells, is a novel member of the MS4A gene family in mice. The MS4A family includes CD20, Fc epsilon RI beta, HTm4 and at least 26 novel members that are characterized by their structural features: with four membrane-spanning domains, two extracellular domains and two cytoplasmic regions. CD20, Fc epsilon RI beta and HTm4 have been found to function in B cells, mast cells and hematopoietic cells respectively. However, little is known about the function of MS4a4B in T cell regulation. We demonstrate here that MS4a4B negatively regulates mouse T cell proliferation. MS4a4B is highly expressed in primary T cells, natural killer cells (NK) and some T cell lines. But its expression in all malignant T cells, including thymoma and T hybridoma tested, was silenced. Interestingly, its expression was regulated during T cell activation. Viral vector-driven overexpression of MS4a4B in primary T cells and EL4 thymoma cells reduced cell proliferation. In contrast, knockdown of MS4a4B accelerated T cell proliferation. Cell cycle analysis showed that MS4a4B regulated T cell proliferation by inhibiting entry of the cells into S-G2/M phase. MS4a4B-mediated inhibition of cell cycle was correlated with upregulation of Cdk inhibitory proteins and decreased levels of Cdk2 activity, subsequently leading to inhibition of cell cycle progression. Our data indicate that MS4a4B negatively regulates T cell proliferation. MS4a4B, therefore, may serve as a modulator in the negative-feedback regulatory loop of activated T cells	[Xu, Hui; Yan, Yaping; Yang, Jingxian; Li, Hongmei; Zhang, Guang-Xian; Rostami, Abdolmohamad] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Williams, Mark S.; Carey, Gregory B.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	Jefferson University; University System of Maryland; University of Maryland Baltimore	Xu, H (corresponding author), Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA.	hui.xu@jefferson.edu			American Heart Association [0830072N]; National Institutes of Health [NS040085]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040085] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the American Heart Association (0830072N) (H. X.) and from the National Institutes of Health (NS040085) (A.M.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arens R, 2004, J EXP MED, V199, P1595, DOI 10.1084/jem.20031111; Baumann Sven, 2002, Current Molecular Medicine (Hilversum), V2, P257, DOI 10.2174/1566524024605671; BUBIEN JK, 1993, J CELL BIOL, V121, P1121, DOI 10.1083/jcb.121.5.1121; Dayde D, 2009, BLOOD, V113, P3765, DOI 10.1182/blood-2008-08-175125; GOLAY JT, 1985, J IMMUNOL, V135, P3795; Howie D, 2009, J IMMUNOL, V183, P4197, DOI 10.4049/jimmunol.0901070; Riley LK, 2000, SEMIN ONCOL, V27, P17, DOI 10.1053/sonc.2000.20424; STAMENKOVIC I, 1988, J EXP MED, V167, P1975, DOI 10.1084/jem.167.6.1975; TEDDER TF, 1989, J IMMUNOL, V142, P2555; Xu H, 2006, BLOOD, V107, P2400, DOI 10.1182/blood-2005-08-3340	10	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2010	5	11							e13780	10.1371/journal.pone.0013780	http://dx.doi.org/10.1371/journal.pone.0013780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FY	21072172	Green Published, Green Submitted, gold			2022-12-25	WOS:000283645700005
J	Wolfrum, K; Wang, Y; Prigione, A; Sperling, K; Lehrach, H; Adjaye, J				Wolfrum, Katharina; Wang, Ying; Prigione, Alessandro; Sperling, Karl; Lehrach, Hans; Adjaye, James			The LARGE Principle of Cellular Reprogramming: Lost, Acquired and Retained Gene Expression in Foreskin and Amniotic Fluid-Derived Human iPS Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; SOMATIC-CELLS; IN-VITRO; DIFFERENTIATION; SENESCENCE; PATHWAY; TRANSPLANTATION; CARDIOMYOPLASTY; GENERATION	Human amniotic fluid cells (AFCs) are routinely obtained for prenatal diagnostics procedures. Recently, it has been illustrated that these cells may also serve as a valuable model system to study developmental processes and for application in regenerative therapies. Cellular reprogramming is a means of assigning greater value to primary AFCs by inducing self-renewal and pluripotency and, thus, bypassing senescence. Here, we report the generation and characterization of human amniotic fluid-derived induced pluripotent stem cells (AFiPSCs) and demonstrate their ability to differentiate into the trophoblast lineage after stimulation with BMP2/BMP4. We further carried out comparative transcriptome analyses of primary human AFCs, AFiPSCs, fibroblast-derived iPSCs (FiPSCs) and embryonic stem cells (ESCs). This revealed that the expression of key senescence-associated genes are down-regulated upon the induction of pluripotency in primary AFCs (AFiPSCs). By defining distinct and overlapping gene expression patterns and deriving the LARGE (Lost, Acquired and Retained Gene Expression) Principle of Cellular Reprogramming, we could further highlight that AFiPSCs, FiPSCs and ESCs share a core self-renewal gene regulatory network driven by OCT4, SOX2 and NANOG. Nevertheless, these cell types are marked by distinct gene expression signatures. For example, expression of the transcription factors, SIX6, EGR2, PKNOX2, HOXD4, HOXD10, DLX5 and RAXL1, known to regulate developmental processes, are retained in AFiPSCs and FiPSCs. Surprisingly, expression of the self-renewal-associated gene PRDM14 or the developmental processes-regulating genes WNT3A and GSC are restricted to ESCs. Implications of this, with respect to the stability of the undifferentiated state and long-term differentiation potential of iPSCs, warrant further studies.	[Wolfrum, Katharina; Wang, Ying; Prigione, Alessandro; Lehrach, Hans; Adjaye, James] Max Planck Inst Mol Genet, Dept Vertebrate Genom, Mol Embryol & Aging Grp, Berlin, Germany; [Wolfrum, Katharina] Free Univ Berlin, Inst Chem & Biochem, Dept Biol Chem & Pharm, D-1000 Berlin, Germany; [Sperling, Karl] Charite, Inst Human Genet, D-13353 Berlin, Germany; [Adjaye, James] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia	Max Planck Society; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; King Saud University	Wolfrum, K (corresponding author), Max Planck Inst Mol Genet, Dept Vertebrate Genom, Mol Embryol & Aging Grp, Berlin, Germany.	adjaye@molgen.mpg.de	Prigione, Alessandro/ABA-1584-2021; Alessandro, Prigione/B-2959-2013	Alessandro, Prigione/0000-0001-9457-1952	Bundesministerium fur Bildung und Forschung (BMBF, Federal Ministry of Education and Research) [01GN0807, 0315398G]; Max Planck Society; Deutsche Forschungsgemeinschaft (DFG) through the Berlin-Brandenburg School for Regenerative Therapies (BSRT) [GSC 203]; Adjaye lab	Bundesministerium fur Bildung und Forschung (BMBF, Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft (DFG) through the Berlin-Brandenburg School for Regenerative Therapies (BSRT)(German Research Foundation (DFG)); Adjaye lab	The authors acknowledge support from the Bundesministerium fur Bildung und Forschung (BMBF, Federal Ministry of Education and Research, www.bmbf.de; A.P.: 01GN0807; Y.W., J.A.: 0315398G) and the Max Planck Society (www.mpg.de). Contributions of K. W. were also made possible by funding from the Deutsche Forschungsgemeinschaft (DFG, www.dfg.de) through the Berlin-Brandenburg School for Regenerative Therapies (BSRT, www.bsrt.de) GSC 203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the other members of the Adjaye lab for support and fruitful discussion and A. Sabah at the microarray facility. We would also like to thank Prof. Dr. Wegner and PD Dr. Stumm of the prenatal diagnosis clinic (Zentrum fur Pranataldiagnostik, Kudamm-199, Berlin, Germany) for providing AFCs. We further acknowledge Dr. Korinna Johrens (Institute for Pathology, Charite - Universitatsmedizin Berlin, Berlin, Germany) for the interpretation of histological structures.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Carraro G, 2008, STEM CELLS, V26, P2902, DOI 10.1634/stemcells.2008-0090; Carrour TL, 2010, OPEN BIOINFORMATICS, V4, P5, DOI [10.2174/1875036201004010005, DOI 10.2174/1875036201004010005]; CERDAN C, 2007, CURR PROTOC STEM CEL, pCH1; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Chavez L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-314; Chiavegato A, 2007, J MOL CELL CARDIOL, V42, P746, DOI 10.1016/j.yjmcc.2006.12.008; Cipriani S, 2007, CELL BIOL INT, V31, P845, DOI 10.1016/j.cellbi.2007.01.037; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ditadi A, 2009, BLOOD, V113, P3953, DOI 10.1182/blood-2008-10-182105; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Fauza D, 2004, BEST PRACT RES CL OB, V18, P877, DOI 10.1016/j.bpobgyn.2004.07.001; GALENDE E, 2009, CLONING STE IN PRESS; Gekas J, 2010, CLIN EXP MED, V10, P1, DOI 10.1007/s10238-009-0060-2; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Greber B, 2008, STEM CELLS DEV, V17, P1065, DOI 10.1089/scd.2008.0035; Hasegawa T, 2008, CIRC RES, V103, P1410, DOI 10.1161/CIRCRESAHA.108.180059; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huang BY, 2009, AGING-US, V1, P845, DOI 10.18632/aging.100091; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iacovitti L, 2009, STEM CELLS DEV, V18, P1003; Imoto I, 2001, BIOCHEM BIOPH RES CO, V287, P270, DOI 10.1006/bbrc.2001.5578; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Jung M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010709; Karlmark KR, 2005, INT J MOL MED, V16, P987; Li CL, 2009, HUM MOL GENET, V18, P4340, DOI 10.1093/hmg/ddp386; Longhi MP, 2006, TRENDS IMMUNOL, V27, P102, DOI 10.1016/j.it.2005.12.008; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Mosquera A, 1999, J MED GENET, V36, P494; Nandan MO, 2009, HISTOL HISTOPATHOL, V24, P1343, DOI 10.14670/HH-24.1343; Nunes Fabio Daumas, 2003, Pesqui Odontol Bras, V17, P94; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Perin L, 2007, CELL PROLIFERAT, V40, P936, DOI 10.1111/j.1365-2184.2007.00478.x; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Prusa AR, 2004, AM J OBSTET GYNECOL, V191, P309, DOI 10.1016/j.ajog.2003.12.014; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Roubelakis MG, 2007, STEM CELLS DEV, V16, P931, DOI 10.1089/scd.2007.0036; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Sarnat HB, 2005, J CHILD NEUROL, V20, P637, DOI 10.1177/08830738050200080101; Schmitt S, 2009, INVEST OPHTH VIS SCI, V50, P5901, DOI 10.1167/iovs.08-3067; Schulz LC, 2008, PLACENTA, V29, pS10, DOI 10.1016/j.placenta.2007.10.009; Serr D M, 1955, Bull Res Counc Isr, V5B, P137; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Trovato L, 2009, J ENDOCRINOL INVEST, V32, P873, DOI [10.1007/BF03345764, 10.3275/6401]; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Vaziri H, 2010, REGEN MED, V5, P345, DOI 10.2217/RME.10.21; Walther G, 2009, CATHETER CARDIO INTE, V73, P917, DOI 10.1002/ccd.22016; Wang Han, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P1582; Wang QL, 2004, HUM MOL GENET, V13, P1025, DOI 10.1093/hmg/ddh117; Wang Y, 2010, STEM CELL REV REP, V6, P282, DOI 10.1007/s12015-010-9137-2; XURH, 2006, MOL MED */* METHODS, V121, P189; Ye L, 2009, P NATL ACAD SCI USA, V106, P9826, DOI 10.1073/pnas.0904689106; Yeh YC, 2010, TISSUE ENG PT A, V16, P1925, DOI [10.1089/ten.tea.2009.0728, 10.1089/ten.TEA.2009.0728]; You Q, 2009, J INT MED RES, V37, P105, DOI 10.1177/147323000903700112; Young JI, 2001, J BIOL CHEM, V276, P19610, DOI 10.1074/jbc.M009470200; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao R, 2008, J CELL BIOCHEM, V105, P949, DOI 10.1002/jcb.21871; Zheng QH, 2006, J CELL BIOCHEM, V98, P1230, DOI 10.1002/jcb.20838	73	57	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13703	10.1371/journal.pone.0013703	http://dx.doi.org/10.1371/journal.pone.0013703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060825	Green Published, Green Accepted, gold			2022-12-25	WOS:000283645300007
J	Al-Adsani, A; Burke, ZD; Eberhard, D; Lawrence, KL; Shen, CN; Rustgi, AK; Sakaue, H; Farrant, JM; Tosh, D				Al-Adsani, Amani; Burke, Zoe D.; Eberhard, Daniel; Lawrence, Katherine L.; Shen, Chia-Ning; Rustgi, Anil K.; Sakaue, Hiroshi; Farrant, J. Mark; Tosh, David			Dexamethasone Treatment Induces the Reprogramming of Pancreatic Acinar Cells to Hepatocytes and Ductal Cells	PLOS ONE			English	Article							HUMAN EXOCRINE PANCREAS; TRANSGENIC MICE; GROWTH-FACTOR; TRANSDIFFERENTIATED HEPATOCYTES; MOLECULAR-BASIS; MESSENGER-RNA; RAT PANCREAS; IN-VITRO; LIVER; EXPRESSION	Background: The pancreatic exocrine cell line AR42J-B13 can be reprogrammed to hepatocytes following treatment with dexamethasone. The question arises whether dexamethasone also has the capacity to induce ductal cells as well as hepatocytes. Methodology/Principal Findings: AR42J-B13 cells were treated with and without dexamethasone and analyzed for the expression of pancreatic exocrine, hepatocyte and ductal markers. Addition of dexamethasone inhibited pancreatic amylase expression, induced expression of the hepatocyte marker transferrin as well as markers typical of ductal cells: cytokeratin 7 and 19 and the lectin peanut agglutinin. However, the number of ductal cells was low compared to hepatocytes. The proportion of ductal cells was enhanced by culture with dexamethasone and epidermal growth factor (EGF). We established several features of the mechanism underlying the transdifferentiation of pancreatic exocrine cells to ductal cells. Using a CK19 promoter reporter, we show that a proportion of the ductal cells arise from differentiated pancreatic exocrine-like cells. We also examined whether C/EBP beta (a transcription factor important in the conversion of pancreatic cells to hepatocytes) could alter the conversion from acinar cells to a ductal phenotype. Overexpression of an activated form of C/EBP beta in dexamethasone/EGF-treated cells provoked the expression of hepatocyte markers and inhibited the expression of ductal markers. Conversely, ectopic expression of a dominant-negative form of C/EBP beta, liver inhibitory protein, inhibited hepatocyte formation in dexamethasone-treated cultures and enhanced the ductal phenotype. Conclusions/Significance: These results indicate that hepatocytes and ductal cells may be induced from pancreatic exocrine AR42J-B13 cells following treatment with dexamethasone. The conversion from pancreatic to hepatocyte or ductal cells is dependent upon the expression of C/EBP beta.	[Al-Adsani, Amani; Burke, Zoe D.; Eberhard, Daniel; Lawrence, Katherine L.; Tosh, David] Univ Bath, Ctr Regenerat Med, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Shen, Chia-Ning] Acad Sinica, Genom Res Ctr, Stem Cell Program, Taipei 115, Taiwan; [Rustgi, Anil K.] Univ Penn, Abramson Canc Ctr, Dept Med & Genet, Philadelphia, PA 19104 USA; [Sakaue, Hiroshi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Nutr & Metab, Tokushima 770, Japan; [Farrant, J. Mark] Royal United Hosp, Dept Gastroenterol, Bath BA1 3NG, Avon, England	University of Bath; Academia Sinica - Taiwan; University of Pennsylvania; Pennsylvania Medicine; Tokushima University	Al-Adsani, A (corresponding author), Univ Bath, Ctr Regenerat Med, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	d.tosh@bath.ac.uk	Sakaue, Hiroshi/ABE-2337-2021; SHEN, CHIA-NING/C-6878-2011	Sakaue, Hiroshi/0000-0002-2468-2363; SHEN, CHIA-NING/0000-0002-0747-217X	Government of Kuwait; Wellcome Trust [073381]; Grants-in-Aid for Scientific Research [21591151] Funding Source: KAKEN	Government of Kuwait; Wellcome Trust(Wellcome TrustEuropean Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Government of Kuwait and the Wellcome Trust (073381). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIAS AE, 1993, LAB INVEST, V69, P518; Arnush M, 1996, LAB INVEST, V74, P985; Bouwens L, 2004, CELL BIOCHEM BIOPHYS, P81; Bouwens L, 1996, J HISTOCHEM CYTOCHEM, V44, P947, DOI 10.1177/44.9.8773559; Brembeck FH, 2000, J BIOL CHEM, V275, P28230; Brembeck FH, 2001, GASTROENTEROLOGY, V120, P1720, DOI 10.1053/gast.2001.24846; Burke ZD, 2006, J CELL PHYSIOL, V206, P147, DOI 10.1002/jcp.20438; CHRISTOPHE J, 1994, AM J PHYSIOL, V266, pG963, DOI 10.1152/ajpgi.1994.266.6.G963; Cingolani N, 2000, HUM PATHOL, V31, P938, DOI 10.1053/hupa.2000.9075; DABEVA MD, 1995, AM J PATHOL, V147, P1633; DELISLE RC, 1990, EUR J CELL BIOL, V51, P64; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Duncan SA, 2003, MECH DEVELOP, V120, P19, DOI 10.1016/S0925-4773(02)00328-3; HALL PA, 1992, J PATHOL, V166, P97, DOI 10.1002/path.1711660203; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Kurash JK, 2004, EXP CELL RES, V292, P342, DOI 10.1016/j.yexcr.2003.09.002; Li WC, 2005, J CELL MOL MED, V9, P569, DOI 10.1111/j.1582-4934.2005.tb00489.x; Li WC, 2005, MECH DEVELOP, V122, P835, DOI 10.1016/j.mod.2005.01.001; LONGNECKER DS, 1979, CANCER LETT, V7, P197, DOI 10.1016/S0304-3835(79)80080-4; Mashima H, 1996, ENDOCRINOLOGY, V137, P3969, DOI 10.1210/en.137.9.3969; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Miyatsuka T, 2006, GENE DEV, V20, P1435, DOI 10.1101/gad.1412806; Paner GP, 2000, CANCER, V88, P1582, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1582::AID-CNCR12>3.0.CO;2-A; PARSA I, 1985, CANCER RES, V45, P1285; Quintana JM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-24; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; REDDY JK, 1984, J CELL BIOL, V98, P2082, DOI 10.1083/jcb.98.6.2082; Schmid RM, 2002, J CLIN INVEST, V109, P1403, DOI 10.1172/JCI200215889; Schreiber FS, 2004, GASTROENTEROLOGY, V127, P250, DOI 10.1053/j.gastro.2004.03.058; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Tosh D, 2002, BIOCHEM SOC T, V30, P51, DOI 10.1042/BST0300051; Tosh D, 2002, HEPATOLOGY, V36, P534, DOI 10.1053/jhep.2002.35060; VILA MR, 1994, LAB INVEST, V71, P423; Wagner M, 1998, GASTROENTEROLOGY, V115, P1254, DOI 10.1016/S0016-5085(98)70098-8; WANG RN, 1995, DIABETOLOGIA, V38, P1405, DOI 10.1007/BF00400600; Wang X, 2001, AM J PATHOL, V158, P571, DOI 10.1016/S0002-9440(10)63999-5; Wu SY, 2010, GASTROENTEROLOGY, V138, P2519, DOI 10.1053/j.gastro.2010.02.011; ZVIBEL I, 1995, J CELL PHYSIOL, V162, P36, DOI 10.1002/jcp.1041620106	39	22	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13650	10.1371/journal.pone.0013650	http://dx.doi.org/10.1371/journal.pone.0013650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048969	Green Published, Green Submitted, gold			2022-12-25	WOS:000283537000022
J	Penna, F; Costamagna, D; Fanzani, A; Bonelli, G; Baccino, FM; Costelli, P				Penna, Fabio; Costamagna, Domiziana; Fanzani, Alessandro; Bonelli, Gabriella; Baccino, Francesco M.; Costelli, Paola			Muscle Wasting and Impaired Myogenesis in Tumor Bearing Mice Are Prevented by ERK Inhibition	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; EXPERIMENTAL CANCER CACHEXIA; DISTINCT SIGNALING PATHWAYS; SKELETAL-MUSCLE; INDUCED HYPERTROPHY; SELF-RENEWAL; STEM-CELLS; P38 MAPK; DIFFERENTIATION; EXPRESSION	Background: The onset of cachexia is a frequent feature in cancer patients. Prominent characteristic of this syndrome is the loss of body and muscle weight, this latter being mainly supported by increased protein breakdown rates. While the signaling pathways dependent on IGF-1 or myostatin were causally involved in muscle atrophy, the role of the Mitogen-Activated-Protein-Kinases is still largely debated. The present study investigated this point on mice bearing the C26 colon adenocarcinoma. Methodology/Principal Findings: C26-bearing mice display a marked loss of body weight and muscle mass, this latter associated with increased phosphorylated (p)-ERK. Administration of the ERK inhibitor PD98059 to tumor bearers attenuates muscle depletion and weakness, while restoring normal atrogin-1 expression. In C26 hosts, muscle wasting is also associated with increased Pax7 expression and reduced myogenin levels. Such pattern, suggestive of impaired myogenesis, is reversed by PD98059. Increased p-ERK and reduced myosin heavy chain content can be observed in TNF alpha-treated C2C12 myotubes, while decreased myogenin and MyoD levels occur in differentiating myoblasts exposed to the cytokine. All these changes are prevented by PD98059. Conclusions/Significance: These results demonstrate that ERK is involved in the pathogenesis of muscle wasting in cancer cachexia and could thus be proposed as a therapeutic target.	[Penna, Fabio; Costamagna, Domiziana; Bonelli, Gabriella; Baccino, Francesco M.; Costelli, Paola] Univ Turin, Dept Expt Med & Oncol, Turin, Italy; [Fanzani, Alessandro] Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy	University of Turin; University of Brescia	Penna, F (corresponding author), Univ Turin, Dept Expt Med & Oncol, Turin, Italy.	paola.costelli@unito.it	Penna, Fabio/K-5090-2016	Penna, Fabio/0000-0002-2774-6027; FANZANI, Alessandro/0000-0001-7475-2668; Costamagna, Domiziana/0000-0001-7370-9385; Bonelli, Gabriella/0000-0002-5164-8902	Associazione Italiana per la Ricerca sul Cancro (AIRC), Milano [Fabio Penna-MFAG6211, Paola Costelli-IG9153]; Ministero per l'Universita e la Ricerca, Roma; University of Torino; Regione Piemonte; Compagnia di San Paolo, Torino	Associazione Italiana per la Ricerca sul Cancro (AIRC), Milano(Fondazione AIRC per la ricerca sul cancro); Ministero per l'Universita e la Ricerca, Roma; University of Torino; Regione Piemonte(Regione Piemonte); Compagnia di San Paolo, Torino(Compagnia di San Paolo)	Grant support: Fabio Penna-MFAG6211-Associazione Italiana per la Ricerca sul Cancro (AIRC), Milano; Paola Costelli-IG9153 AIRC, Milano, Ministero per l'Universita e la Ricerca, Roma (PRIN projects), University of Torino (ex-60% funds), Regione Piemonte, Compagnia di San Paolo, Torino. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Acharyya S, 2007, CLIN CANCER RES, V13, P1356, DOI 10.1158/1078-0432.CCR-06-2307; Alapat DV, 2009, CELL SIGNAL, V21, P128, DOI 10.1016/j.cellsig.2008.09.020; Berardi E, 2008, NEUROL RES, V30, P160, DOI 10.1179/174313208X281046; Bonetto A, 2009, CURR CANCER DRUG TAR, V9, P608, DOI 10.2174/156800909789057015; BONETTO A, AMINO ACIDS; Bossola M, 2003, ANN SURG, V237, P384, DOI 10.1097/00000658-200303000-00013; Carlson ME, 2009, EMBO MOL MED, V1, P381, DOI 10.1002/emmm.200900045; Coletti D, 2005, GENESIS, V43, P120, DOI 10.1002/gene.20160; Collins CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004475; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Costelli P, 2008, EUR J CLIN INVEST, V38, P531, DOI 10.1111/j.1365-2362.2008.01970.x; Costelli P, 2005, INT J ONCOL, V26, P1663; Crepaldi T, 2007, J BIOL CHEM, V282, P6812, DOI 10.1074/jbc.M610916200; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Haddad F, 2004, J APPL PHYSIOL, V96, P203, DOI 10.1152/japplphysiol.00856.2003; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Hasselgren PO, 2002, BIOCHEM BIOPH RES CO, V290, P1, DOI 10.1006/bbrc.2001.5849; Hemdan DII, 2009, J MED INVESTIG, V56, P26, DOI 10.2152/jmi.56.26; Kato K, 2002, FASEB J, V16, P1432, DOI 10.1096/fj.02-0129fje; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Kornasio R, 2009, BBA-MOL CELL RES, V1793, P755, DOI 10.1016/j.bbamcr.2008.12.017; Kumar A, 2002, J BIOL CHEM, V277, P46493, DOI 10.1074/jbc.M203654200; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lenk K, 2009, EUR J HEART FAIL, V11, P342, DOI 10.1093/eurjhf/hfp020; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; Liu CM, 2008, GENE THER, V15, P155, DOI 10.1038/sj.gt.3303016; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marinovic AC, 2002, J BIOL CHEM, V277, P16673, DOI 10.1074/jbc.M200501200; McFarlane C, 2008, EXP CELL RES, V314, P317, DOI 10.1016/j.yexcr.2007.09.012; Mitchell PO, 2004, AM J PHYSIOL-CELL PH, V287, pC1753, DOI 10.1152/ajpcell.00292.2004; Miyake T, 2009, J BIOL CHEM, V284, P19679, DOI 10.1074/jbc.M109.017319; Moore-Carrasco R, 2006, FEBS LETT, V580, P691, DOI 10.1016/j.febslet.2005.12.084; Moresi V, 2008, STEM CELLS, V26, P997, DOI 10.1634/stemcells.2007-0493; Morissette MR, 2009, AM J PHYSIOL-CELL PH, V297, pC1124, DOI 10.1152/ajpcell.00043.2009; Murgia M, 2000, NAT CELL BIOL, V2, P142, DOI 10.1038/35004013; Nicolas N, 2005, DEV BIOL, V281, P171, DOI 10.1016/j.ydbio.2005.02.022; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; PENNA F, 2009, INT J CANC; Puri PL, 2000, GENE DEV, V14, P574; Ramamoorthy S, 2009, AM J PHYSIOL-ENDOC M, V297, pE392, DOI 10.1152/ajpendo.90529.2008; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Samuel DS, 1999, HORM METAB RES, V31, P55, DOI 10.1055/s-2007-978699; Shi H, 2007, AM J PHYSIOL-CELL PH, V292, pC1681, DOI 10.1152/ajpcell.00466.2006; Shi H, 2008, FASEB J, V22, P2990, DOI 10.1096/fj.07-097600; Shi H, 2009, AM J PHYSIOL-CELL PH, V296, pC1040, DOI 10.1152/ajpcell.00475.2008; STRASSMANN G, 1992, J CLIN INVEST, V89, P1681, DOI 10.1172/JCI115767; Szalay K, 1997, EUR J CELL BIOL, V74, P391; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; YANG SY, LAB INVEST, V90, P391; Yang W, 2006, CANCER RES, V66, P1320, DOI 10.1158/0008-5472.CAN-05-3060; ZHANG L, 2001, J AM SOC NEPHROL, V21, P419	54	118	121	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13604	10.1371/journal.pone.0013604	http://dx.doi.org/10.1371/journal.pone.0013604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048967	Green Submitted, gold, Green Published			2022-12-25	WOS:000283537000015
J	Welsh, M; Sharpe, RM; Moffat, L; Atanassova, N; Saunders, PTK; Kilter, S; Bergh, A; Smith, LB				Welsh, Michelle; Sharpe, Richard M.; Moffat, Lindsey; Atanassova, Nina; Saunders, Philippa T. K.; Kilter, Sigrid; Bergh, Anders; Smith, Lee B.			Androgen Action via Testicular Arteriole Smooth Muscle Cells Is Important for Leydig Cell Function, Vasomotion and Testicular Fluid Dynamics	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; SEMINIFEROUS TUBULE FLUID; ENDOTHELIAL GROWTH-FACTOR; MALE-MICE LACKING; INTERSTITIAL FLUID; HORMONAL-REGULATION; SELECTIVE KNOCKOUT; VENOUS-BLOOD; RECEPTOR; TESTOSTERONE	Regulation of blood flow through the testicular microvasculature by vasomotion is thought to be important for normal testis function as it regulates interstitial fluid (IF) dynamics which is an important intra-testicular transport medium. Androgens control vasomotion, but how they exert these effects remains unclear. One possibility is by signalling via androgen receptors (AR) expressed in testicular arteriole smooth muscle cells. To investigate this and determine the overall importance of this mechanism in testis function, we generated a blood vessel smooth muscle cell-specific AR knockout mouse (SMARKO). Gross reproductive development was normal in SMARKO mice but testis weight was reduced in adulthood compared to control littermates; this reduction was not due to any changes in germ cell volume or to deficits in testosterone, LH or FSH concentrations and did not cause infertility. However, seminiferous tubule lumen volume was reduced in adult SMARKO males while interstitial volume was increased, perhaps indicating altered fluid dynamics; this was associated with compensated Leydig cell failure. Vasomotion was impaired in adult SMARKO males, though overall testis blood flow was normal and there was an increase in the overall blood vessel volume per testis in adult SMARKOs. In conclusion, these results indicate that ablating arteriole smooth muscle AR does not grossly alter spermatogenesis or affect male fertility but does subtly impair Leydig cell function and testicular fluid exchange, possibly by locally regulating microvascular blood flow within the testis.	[Welsh, Michelle; Sharpe, Richard M.; Moffat, Lindsey; Saunders, Philippa T. K.; Smith, Lee B.] Queens Med Res Inst, Ctr Reprod Biol, MRC, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland; [Atanassova, Nina] Bulgarian Acad Sci, Inst Expt Morphol & Anthropol Museum, Sofia, Bulgaria; [Kilter, Sigrid; Bergh, Anders] Umea Univ, Dept Anat & Pathol, Umea, Sweden	University of Edinburgh; Bulgarian Academy of Sciences; Umea University	Welsh, M (corresponding author), Queens Med Res Inst, Ctr Reprod Biol, MRC, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland.	l.smith@hrsu.mrc.ac.uk	Smith, Lee B/J-4861-2013; Atanassova, Nina/AAH-2722-2021; welsh, michelle/G-2261-2010; Sharpe, Richard M/D-2725-2013; Saunders, Philippa TK/C-7489-2013	Atanassova, Nina/0000-0002-9032-3588; Sharpe, Richard M/0000-0003-1686-8085; Saunders, Philippa TK/0000-0001-9051-9380; Smith, Lee/0000-0002-4103-3074	UK Medical Research Council [WBS U.1276.00.002.0003.01]; Tenovus Scotland [E08/6]; Medical Research Council [MC_U127685841, MC_U127684422, MC_U127685844] Funding Source: researchfish; MRC [MC_U127684422, MC_U127685844, MC_U127685841] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tenovus Scotland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the UK Medical Research Council (WBS U.1276.00.002.0003.01) and Tenovus Scotland (Project grant E08/6) for funding these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand RJK, 2003, BIOL REPROD, V68, P1663, DOI 10.1095/biolreprod.102.009795; BERGH A, 1992, INT J ANDROL, V15, P425, DOI 10.1111/j.1365-2605.1992.tb01357.x; BERGH A, 1988, HORM RES, V30, P207, DOI 10.1159/000181061; Bergh A., 1993, MOL BIOL MALE REPROD, P439, DOI [10.1016/B978-0-08-091764-1.50017-9, DOI 10.1016/B978-0-08-091764-1.50017-9]; BREMNER WJ, 1994, ENDOCRINOLOGY, V135, P1227, DOI 10.1210/en.135.3.1227; Brennan J, 2002, DEV BIOL, V244, P418, DOI 10.1006/dbio.2002.0578; Chang CS, 2004, P NATL ACAD SCI USA, V101, P6876, DOI 10.1073/pnas.0307306101; COLLIN O, 1993, J REPROD FERTIL, V97, P115; Collin O, 2000, ASIAN J ANDROL, V2, P297; CORKER CS, 1978, J STEROID BIOCHEM, V9, P373, DOI 10.1016/0022-4731(78)90634-9; Coveney D, 2008, P NATL ACAD SCI USA, V105, P7212, DOI 10.1073/pnas.0707674105; DAMBER JE, 1992, INT J ANDROL, V15, P385, DOI 10.1111/j.1365-2605.1992.tb01353.x; DAMBER JE, 1986, ACTA PHYSIOL SCAND, V126, P371, DOI 10.1111/j.1748-1716.1986.tb07829.x; DAMBER JE, 1978, J REPROD FERTIL, V52, P265; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; Denolet E, 2006, MOL ENDOCRINOL, V20, P321, DOI 10.1210/me.2005-0113; Ergun S, 1997, MOL CELL ENDOCRINOL, V131, P9, DOI 10.1016/S0303-7207(97)00082-8; Ergun S, 1997, ADV EXP MED BIOL, V424, P163; Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273; FREE MJ, 1972, AM J PHYSIOL, V223, P241, DOI 10.1152/ajplegacy.1972.223.1.241; Frutkin AD, 2006, J MOL CELL CARDIOL, V41, P724, DOI 10.1016/j.yjmcc.2006.06.067; George Frederick W., 1994, P3; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; JEGOU B, 1982, BIOL REPROD, V27, P590, DOI 10.1095/biolreprod27.3.590; Johnston DS, 2001, ENDOCRINOLOGY, V142, P2405, DOI 10.1210/en.142.6.2405; Jones RD, 2003, EUR J ENDOCRINOL, V148, P111, DOI 10.1530/eje.0.1480111; KOTITE NJ, 1978, BIOL REPROD, V18, P65, DOI 10.1095/biolreprod18.1.65; Lissbrant E, 1997, J ANDROL, V18, P385; Liu PY, 2003, ENDOCR REV, V24, P313, DOI 10.1210/er.2003-0005; MADDOCKS S, 1989, J ENDOCRINOL, V121, P311, DOI 10.1677/joe.0.1210311; McLachlan RI, 2002, RECENT PROG HORM RES, V57, P149, DOI 10.1210/rp.57.1.149; McNeilly JR, 2000, ENDOCRINOLOGY, V141, P4284, DOI 10.1210/en.141.11.4284; Mordan-McCombs SE, 2009, FASEB J, V23; Paul C, 2009, BIOL REPROD, V80, P913, DOI 10.1095/biolreprod.108.071779; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; SETCHELL BP, 1981, J ENDOCRINOL, V91, P245, DOI 10.1677/joe.0.0910245; SETCHELL BP, 1990, REPROD FERT DEVELOP, V2, P291, DOI 10.1071/RD9900291; SHARPE RM, 1979, J REPROD FERTIL, V55, P365, DOI 10.1530/jrf.0.0550365; SHARPE RM, 1994, J REPROD FERTIL, V101, P193, DOI 10.1530/jrf.0.1010193; SHARPE RM, 1983, J REPROD FERTIL, V69, P125, DOI 10.1530/jrf.0.0690125; Stallone JN, 2001, J APPL PHYSIOL, V91, P2602, DOI 10.1152/jappl.2001.91.6.2602; Tsai MY, 2006, P NATL ACAD SCI USA, V103, P18975, DOI 10.1073/pnas.0608565103; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; Weidemann W, 2002, CARDIOVASC DRUG REV, V20, P175; Welsh M, 2006, ENDOCRINOLOGY, V147, P4820, DOI 10.1210/en.2006-0149; Welsh M, 2009, FASEB J, V23, P4218, DOI 10.1096/fj.09-138347; WIDMARK A, 1986, J ENDOCRINOL, V109, P419, DOI 10.1677/joe.0.1090419; WIDMARK A, 1989, ACTA ENDOCRINOL-COP, V121, P621, DOI 10.1530/acta.0.1210621; Zhang CX, 2006, P NATL ACAD SCI USA, V103, P17718, DOI 10.1073/pnas.0608556103	49	31	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13632	10.1371/journal.pone.0013632	http://dx.doi.org/10.1371/journal.pone.0013632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049031	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000283487400022
J	Zeuner, KE; Knutzen, A; Al-Ali, A; Hallett, M; Deuschl, G; Bergmann, TO; Siebner, HR				Zeuner, Kirsten E.; Knutzen, Arne; Al-Ali, Asmaa; Hallett, Mark; Deuschl, Guenther; Bergmann, Til O.; Siebner, Hartwig R.			Associative Stimulation of the Supraorbital Nerve Fails to Induce Timing-Specific Plasticity in the Human Blink Reflex	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; HOMEOSTATIC PLASTICITY; HAND DYSTONIA; BLEPHAROSPASM; METAPLASTICITY; INTERNEURONS; HIPPOCAMPUS	Background: Associative high-frequency electrical stimulation (HFS) of the supraorbital nerve in five healthy individuals induced long-term potentiation (LTP)-like or depression (LTD)-like changes in the human blink reflex circuit according to the rules of spike timing-dependent plasticity (Mao and Evinger, 2001). HFS given at the onset of the R2 component of the blink reflex (HFSLTP) produced a lasting facilitation of the R2, whereas HFS given shortly before R2 (HFSLTD) caused a lasting suppression of the R2. In patients with benign essential blepharospasm (BEB), a focal dystonia affecting the orbicularis oculi muscles, HFSLTP induced excessive LTP-like associative plasticity relative to healthy controls, which was normalized after botulinum toxin (BTX) injections (Quartarone et al, 2006). Methodology/Principal Findings: We used HFS conditioning of the supraorbital nerve to study homeostatic metaplasticity of the blink reflex circuit in healthy subjects and dystonic patients. On separate days, we tested the conditioning effects on the R2 response and paired-pulse R2 inhibition after (i) HFSLTP, (ii) HFSLTP followed by HFSLTP, and (iii) HFSLTP followed by HFSLTD. Controls also received (iv) HFSLTD alone and (v) a non-intervention protocol. In BEB patients, HFSLTP followed by HFSLTD was given before and after BTX treatment. We were not able to replicate the bidirectional timing-dependent effects of HFSLTP and HFSLTD alone. All HFS protocols produced a non-specific reduction of the R2 response and a relative decrease in paired-pulse inhibition. These R2 changes also occurred in controls when no HFS was applied. There was also no trace of a homeostatic response pattern in BEB patients before or after BTX treatment. Conclusion/Significance: Our data challenge the efficacy of associative HFS to produce bidirectional plasticity in the human blink reflex circuit. The non-specific decrease of the R2 response might indicate habituation of the blink reflex following repeated electrical supraorbital stimulation. The increase of inhibition after paired pulse stimulation might reflect homeostatic behaviour to prevent further down regulation of the R2 response to preserve the protection of this adverse-effects reflex.	[Zeuner, Kirsten E.; Knutzen, Arne; Al-Ali, Asmaa; Deuschl, Guenther; Bergmann, Til O.; Siebner, Hartwig R.] Univ Kiel, Dept Neurol, D-2300 Kiel, Germany; [Hallett, Mark] Natl Inst Neurol Disorders & Stroke, Human Motor Control Sect, Med Neurol Branch, NIH, Bethesda, MD USA; [Siebner, Hartwig R.] Copenhagen Univ Hosp Hvidovre, Danish Res Ctr Magnet Resonance, Hvidovre, Denmark; [Siebner, Hartwig R.] Univ Copenhagen, Inst Neurol Psychiat & Senses, Fac Med, Copenhagen, Denmark	University of Kiel; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Copenhagen; University of Copenhagen	Zeuner, KE (corresponding author), Univ Kiel, Dept Neurol, D-2300 Kiel, Germany.	k.zeuner@neurologie.uni-kiel.de	Siebner, Hartwig R/G-4052-2016; Bergmann, Til Ole/F-9453-2010; Deuschl, Gunther/A-7986-2010	Bergmann, Til Ole/0000-0002-2282-6618; Deuschl, Gunther/0000-0002-4176-9196	Benign Essential Blepharospasm Foundation, USA; Deutsche Forschungsgemeinschaft [DE 438/7-1, 7-2]; National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002669] Funding Source: NIH RePORTER	Benign Essential Blepharospasm Foundation, USA; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work has been supported by Benign Essential Blepharospasm Foundation, USA to K.E.Z., G.D. and H.S. and a grant from the Deutsche Forschungsgemeinschaft to G.D. and H.S. (DE 438/7-1 and 7-2). M.H. is supported by the Intramural Program of the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 1997, PROG NEUROBIOL, V52, P303, DOI 10.1016/S0301-0082(97)00018-X; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Bear MF, 2003, PHILOS T ROY SOC B, V358, P649, DOI 10.1098/rstb.2002.1255; BERARDELLI A, 1985, BRAIN, V108, P593, DOI 10.1093/brain/108.3.593; Berardelli A, 1998, BRAIN, V121, P1195, DOI 10.1093/brain/121.7.1195; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Delvendahl I, 2010, CLIN NEUROPHYSIOL, V121, P594, DOI 10.1016/j.clinph.2009.09.034; Ellrich J, 1998, BRAIN RES, V803, P161, DOI 10.1016/S0006-8993(98)00646-5; Esteban A, 1999, NEUROPHYSIOL CLIN, V29, P7, DOI 10.1016/S0987-7053(99)80039-2; Fahn S., 1989, QUANTIFICATION NEURO; Fathi D, 2010, CLIN NEUROPHYSIOL, V121, P90, DOI 10.1016/j.clinph.2009.07.048; Floel A, 2005, ANN NEUROL, V58, P121, DOI 10.1002/ana.20536; HEBB, 1949, ORG BEHAV NEUROPSYCH; KIMURA J, 1973, BRAIN, V96, P87, DOI 10.1093/brain/96.1.87; Lang N, 2004, BIOL PSYCHIAT, V56, P634, DOI 10.1016/j.biopsych.2004.07.017; Mao JB, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-12-j0002.2001; Muller-Dahlhaus JFM, 2008, J PHYSIOL-LONDON, V586, P495, DOI 10.1113/jphysiol.2007.142059; Quartarone A, 2005, BRAIN, V128, P1943, DOI 10.1093/brain/awh527; Quartarone A, 2006, TRENDS NEUROSCI, V29, P192, DOI 10.1016/j.tins.2006.02.007; Quartarone A, 2006, J NEUROSCI, V26, P716, DOI 10.1523/JNEUROSCI.3948-05.2006; Siebner HR, 2010, CLIN NEUROPHYSIOL, V121, P461, DOI 10.1016/j.clinph.2009.12.009; Siebner HR, 2004, J NEUROSCI, V24, P3379, DOI 10.1523/JNEUROSCI.5316-03.2004; Sommer M, 2001, CLIN NEUROPHYSIOL, V112, P2293, DOI 10.1016/S1388-2457(01)00701-5; STANTON PK, 1989, NATURE, V339, P215, DOI 10.1038/339215a0; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Svendsen F, 1997, NEUROREPORT, V8, P3427, DOI 10.1097/00001756-199711100-00002; Tecchio F, 2008, CLIN NEUROPHYSIOL, V119, P675, DOI 10.1016/j.clinph.2007.10.023; Tolosa E, 1988, Adv Neurol, V50, P517; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; VALLSSOLE J, 1991, J NEUROL NEUROSUR PS, V54, P310, DOI 10.1136/jnnp.54.4.310; Wang HY, 1999, J NEUROPHYSIOL, V82, P2024, DOI 10.1152/jn.1999.82.4.2024; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002	36	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13602	10.1371/journal.pone.0013602	http://dx.doi.org/10.1371/journal.pone.0013602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049057	Green Submitted, gold, Green Published			2022-12-25	WOS:000283487400009
J	Slezak, DF; Suarez, C; Cecchi, GA; Marshall, G; Stolovitzky, G				Fernandez Slezak, Diego; Suarez, Cecilia; Cecchi, Guillermo A.; Marshall, Guillermo; Stolovitzky, Gustavo			When the Optimal Is Not the Best: Parameter Estimation in Complex Biological Models	PLOS ONE			English	Article							MULTICELL TUMOR SPHEROIDS; SYSTEMS BIOLOGY; FUNCTION MINIMIZATION; MATHEMATICAL-MODELS; GROWTH SATURATION; NECROSIS; CELL	Background: The vast computational resources that became available during the past decade enabled the development and simulation of increasingly complex mathematical models of cancer growth. These models typically involve many free parameters whose determination is a substantial obstacle to model development. Direct measurement of biochemical parameters in vivo is often difficult and sometimes impracticable, while fitting them under data-poor conditions may result in biologically implausible values. Results: We discuss different methodological approaches to estimate parameters in complex biological models. We make use of the high computational power of the Blue Gene technology to perform an extensive study of the parameter space in a model of avascular tumor growth. We explicitly show that the landscape of the cost function used to optimize the model to the data has a very rugged surface in parameter space. This cost function has many local minima with unrealistic solutions, including the global minimum corresponding to the best fit. Conclusions: The case studied in this paper shows one example in which model parameters that optimally fit the data are not necessarily the best ones from a biological point of view. To avoid force-fitting a model to a dataset, we propose that the best model parameters should be found by choosing, among suboptimal parameters, those that match criteria other than the ones used to fit the model. We also conclude that the model, data and optimization approach form a new complex system and point to the need of a theory that addresses this problem more generally.	[Fernandez Slezak, Diego; Suarez, Cecilia; Marshall, Guillermo] Univ Buenos Aires, FCEyN, Dept Computac, Lab Sistemas Complejos, Buenos Aires, DF, Argentina; [Cecchi, Guillermo A.; Stolovitzky, Gustavo] IBM Corp, TJ Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY USA	University of Buenos Aires; International Business Machines (IBM)	Slezak, DF (corresponding author), Univ Buenos Aires, FCEyN, Dept Computac, Lab Sistemas Complejos, Buenos Aires, DF, Argentina.	dfslezak@dc.uba.ar; gustavo@us.ibm.com	Slezak, Diego Fernandez/AAD-9543-2019; , Cecilia/I-5244-2016	, Cecilia/0000-0003-0134-8618; Fernandez Slezak, Diego/0000-0001-6348-1559	Buenos Aires University [UBA X132/08, UBACYT M415]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 5756/06]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICTR 184, PAV 127/03]; Fundacion YPF	Buenos Aires University(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Fundacion YPF	This work was partially supported by grants from Buenos Aires University (UBA X132/08 and UBACYT M415), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (PIP 5756/06), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) (PICTR 184 and PAV 127/03). DFS acknowledges support through a Fundacion YPF scholarship and the summer internship program provided by the IBM Computational Biology Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiga N., 2002, P 2002 ACM IEEE C SU, DOI DOI 10.1109/SC.2002.10017; Araujo RP, 2004, B MATH BIOL, V66, P1039, DOI 10.1016/j.bulm.2003.11.002; Ashyraliyev M, 2009, FEBS J, V276, P886, DOI 10.1111/j.1742-4658.2008.06844.x; Bjorck A., 1996, NUMERICAL METHODS LE; Cedersund G, 2009, FEBS J, V276, P903, DOI 10.1111/j.1742-4658.2008.06845.x; Daniels BC, 2008, CURR OPIN BIOTECH, V19, P389, DOI 10.1016/j.copbio.2008.06.008; FLETCHER R, 1970, COMPUT J, V13, P317, DOI 10.1093/comjnl/13.3.317; Fracasso G, 2000, CRIT REV ONCOL HEMAT, V36, P159, DOI 10.1016/S1040-8428(00)00084-6; FREYER JP, 1980, CANCER RES, V40, P3956; FREYER JP, 1983, ADV EXP MED BIOL, V159, P463; FREYER JP, 1986, CANCER RES, V46, P3504; FREYER JP, 1988, CANCER RES, V48, P2432; Gara A, 2005, IBM J RES DEV, V49, P195, DOI 10.1147/rd.492.0195; Gompertz B, 1825, PHILOS T ROY SOC LON, V31, P513, DOI [10.1098/rstl.1825.0026, DOI 10.1098/RSTL.1825.0026]; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; JAMES F, 1975, COMPUT PHYS COMMUN, V10, P343, DOI 10.1016/0010-4655(75)90039-9; Jiang Y, 2005, BIOPHYS J, V89, P3884, DOI 10.1529/biophysj.105.060640; Jolliffe, 2002, PRINCIPAL COMPONENT; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kreutz C, 2009, FEBS J, V276, P923, DOI 10.1111/j.1742-4658.2008.06843.x; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; MARINARI E, 1992, EUROPHYS LETT, V19, P451, DOI 10.1209/0295-5075/19/6/002; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MARUSIC M, 1994, B MATH BIOL, V56, P617, DOI 10.1007/BF02460714; MARUSIC M, 1994, CELL PROLIFERAT, V27, P73, DOI 10.1111/j.1365-2184.1994.tb01407.x; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Pacheco Peter., 1997, PARALLEL PROGRAMMING; Preziosi L., 2003, CANC MODELLING SIMUL; Rodriguez-Fernandez M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-483; Slezaka D. F., 2007, MECANICA COMPUTACION, V26, P1788; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; Ward JP, 1997, IMA J MATH APPL MED, V14, P39; Wise SM, 2008, J THEOR BIOL, V253, P524, DOI 10.1016/j.jtbi.2008.03.027; Zwolak JW, 2005, IEE P SYST BIOL, V152, P81, DOI 10.1049/ip-syb:20045032; Zwolak JW, 2005, J COMPUT BIOL, V12, P48, DOI 10.1089/cmb.2005.12.48	37	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13283	10.1371/journal.pone.0013283	http://dx.doi.org/10.1371/journal.pone.0013283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049094	Green Published, Green Submitted, gold			2022-12-25	WOS:000283422100001
J	Graveel, CR; DeGroot, JD; Sigler, RE; Vande Woude, GF				Graveel, Carrie R.; DeGroot, Jack D.; Sigler, Robert E.; Vande Woude, George F.			Germline Met Mutations in Mice Reveal Mutation- and Background-Associated Differences in Tumor Profiles	PLOS ONE			English	Article							PAPILLARY RENAL-CARCINOMAS; TYROSINE KINASE RECEPTOR; HEPATOCYTE GROWTH-FACTOR; C-MET; LUNG-CANCER; BREAST-CANCER; SOMATIC MUTATIONS; SCATTER FACTOR; PROTOONCOGENE; AMPLIFICATION	Background: The receptor tyrosine kinase Met is involved in the progression and metastasis of numerous human cancers. Although overexpression and autocrine activation of the Met signaling pathway are commonly found in human cancers, mutational activation of Met has been observed in small cell and non-small cell lung cancers, lung adenocarcinomas, renal carcinomas, and mesotheliomas. Methodology/Principal Findings: To investigate the influence of mutationally activated Met in tumorigenesis, we utilized a novel mouse model. Previously, we observed that various Met mutations developed unique mutation-specific tumor spectra on a C57BL/6 background. Here, we assessed the effect of genetic background on the tumorigenic potential of mutationally activated Met. For this purpose, we created congenic knock-in lines of the Met mutations D1226N, M1248T, and Y1228C on the FVB/N background. Consistent with the mutation-specific tumor spectra, several of the mutations were associated with the same tumor types as observed on C57BL/6 background. However, on the FVB/N background most developed a high incidence of mammary carcinomas with diverse histopathologies. Conclusions/Significance: This study demonstrates that on two distinct mouse backgrounds, Met is able to initiate tumorigenesis in multiple cell types, including epithelial, hematopoietic, and endothelial. Furthermore, these observations emphasize that even a modest increase in Met activation can initiate tumorigenesis with both the Met mutational spectra and host background having profound influence on the type of tumor generated. Greater insight into the interaction of genetic modifiers and Met signaling will significantly enhance our ability to tailor combination therapies for Met-driven cancers.	[Graveel, Carrie R.; DeGroot, Jack D.; Vande Woude, George F.] Van Andel Res Inst, Dept Mol Oncol, Grand Rapids, MI USA; [Sigler, Robert E.] Res Essential Serv LLC, Plymouth, MI USA	Van Andel Institute	Graveel, CR (corresponding author), Van Andel Res Inst, Dept Mol Oncol, Grand Rapids, MI USA.	carrie.graveel@vai.org			Breast Cancer Research Foundation; Jay and Betty Van Andel Foundation	Breast Cancer Research Foundation; Jay and Betty Van Andel Foundation	This work was supported by the Breast Cancer Research Foundation and the Jay and Betty Van Andel Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellon SF, 2008, J BIOL CHEM, V283, P2675, DOI 10.1074/jbc.M705774200; Berthou S, 2004, ONCOGENE, V23, P5387, DOI 10.1038/sj.onc.1207691; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Camp RL, 1999, CANCER, V86, P2259, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2259::AID-CNCR13>3.0.CO;2-2; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ghoussoub RAD, 1998, CANCER, V82, P1513, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1513::AID-CNCR13>3.0.CO;2-7; Graveel C, 2004, P NATL ACAD SCI USA, V101, P17198, DOI 10.1073/pnas.0407651101; Graveel CR, 2009, P NATL ACAD SCI USA, V106, P12909, DOI 10.1073/pnas.0810403106; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Jagadeeswaran R, 2006, CANCER RES, V66, P352, DOI 10.1158/0008-5472.CAN-04-4567; Jeffers M, 1998, ONCOGENE, V17, P2691, DOI 10.1038/sj.onc.1202209; Jeffers M, 1998, P NATL ACAD SCI USA, V95, P14417, DOI 10.1073/pnas.95.24.14417; Jeffers M, 1997, P NATL ACAD SCI USA, V94, P11445, DOI 10.1073/pnas.94.21.11445; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Lee JH, 2000, ONCOGENE, V19, P4947, DOI 10.1038/sj.onc.1203874; Lengyel E, 2005, INT J CANCER, V113, P678, DOI 10.1002/ijc.20598; Ma PC, 2008, GENE CHROMOSOME CANC, V47, P1025, DOI 10.1002/gcc.20604; Ma PC, 2003, CANCER RES, V63, P6272; Nieto AI, 2003, COMPARATIVE MED, V53, P433; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Schmidt L, 1999, ONCOGENE, V18, P2343, DOI 10.1038/sj.onc.1202547; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Timofeevski SL, 2009, BIOCHEMISTRY-US, V48, P5339, DOI 10.1021/bi900438w; TURKE AB, CANC CELL, V17, P77; Ward JM, 2000, PATHOLOGY OF GENETICALLY ENGINEERED MICE, P161; Zeng ZS, 2008, CANCER LETT, V265, P258, DOI 10.1016/j.canlet.2008.02.049; Zhuang ZP, 1998, NAT GENET, V20, P66, DOI 10.1038/1727	34	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13586	10.1371/journal.pone.0013586	http://dx.doi.org/10.1371/journal.pone.0013586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049054	Green Published, Green Submitted, gold			2022-12-25	WOS:000283422100008
J	Vuoriluoto, K; Haugen, H; Kiviluoto, S; Mpindi, JP; Nevo, J; Gjerdrum, C; Tiron, C; Lorens, JB; Ivaska, J				Vuoriluoto, K.; Haugen, H.; Kiviluoto, S.; Mpindi, J-P; Nevo, J.; Gjerdrum, C.; Tiron, C.; Lorens, J. B.; Ivaska, J.			Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer	ONCOGENE			English	Article						vimentin; EMT; Axl	EPITHELIAL-MESENCHYMAL TRANSITION; RECEPTOR TYROSINE KINASES; BASAL-LIKE PHENOTYPE; INTERMEDIATE-FILAMENTS; TUMOR PROGRESSION; PROGNOSTIC-SIGNIFICANCE; TRANSCRIPTION FACTORS; POTENTIAL TARGET; CELL-ADHESION; METASTASIS	Epithelial-to-mesenchymal transition (EMT) is a critical event in the progression toward cancer metastasis. The intermediate filament protein vimentin is an important marker of EMT and a requisite regulator of mesenchymal cell migration. However, it is not known how vimentin functionally contributes to cancer cell invasion. Here, we report that ectopic expression of oncogenic H-Ras-V12G and Slug induces vimentin expression and migration in pre-malignant breast epithelial cells. Conversely, vimentin expression is necessary for Slug-or H-Ras-V12G-induced EMT-associated migration. Furthermore, silencing of vimentin in breast epithelial cells results in specific changes in invasiveness-related gene expression including upregulation of RAB25 (small GTPase Rab25) and down-regulation of AXL (receptor tyrosine kinase Axl), PLAU (plasminogen activator, urokinase) and ITGB4 (integrin beta 4-subunit). Importantly, gene expression profiling analyses reveal that vimentin expression correlates positively/negatively with these genes also in multiple breast cancer cell lines and breast cancer patient samples. Focusing on the tyrosine kinase Axl, we show that induction of vimentin by EMT is associated with upregulation of Axl expression and that Axl enhances the migratory activity of pre-malignant breast epithelial cells. Using null and knock-down cells and overexpression models, we also show that regulation of breast cancer cell migration in two-and three-dimensional matrices by vimentin is Axl-dependent and that Axl functionally contributes to lung extravasation of breast cancer cells in mice. In conclusion, our data show that vimentin functionally contributes to EMT and is required for induction of Axl expression. Moreover, these results provide a molecular explanation for vimentin-dependent cancer cell migration during EMT by identifying Axl as a key proximal component in this process. Oncogene (2011) 30, 1436-1448; doi:10.1038/onc.2010.509; published online 8 November 2010	[Ivaska, J.] Univ Turku, Ctr Biotechnol, VTT Med Biotechnol, Dept Biochem & Food Chem, Turku 20520, Finland; [Vuoriluoto, K.; Kiviluoto, S.; Mpindi, J-P; Nevo, J.; Ivaska, J.] VTT Tech Res Ctr Finland, Turku, Finland; [Vuoriluoto, K.; Nevo, J.; Ivaska, J.] Univ Turku, Turku Ctr Biotechnol, Turku 20520, Finland; [Haugen, H.; Gjerdrum, C.; Tiron, C.; Lorens, J. B.] Univ Bergen, Dept Biomed, Bergen, Norway	University of Turku; VTT Technical Research Center Finland; VTT Technical Research Center Finland; University of Turku; University of Bergen	Ivaska, J (corresponding author), Univ Turku, Ctr Biotechnol, VTT Med Biotechnol, Dept Biochem & Food Chem, Itainen Pitkakatu 4C, Turku 20520, Finland.	Johanna.Ivaska@vtt.fi	Tiron, Crina Elena/AAQ-3995-2020; Lorens, James/B-9737-2017; Kiviluoto, Santeri/M-2743-2014	Tiron, Crina Elena/0000-0002-1469-9153; Lorens, James/0000-0002-6782-3349; Kiviluoto, Santeri/0000-0001-5010-5327; Ivaska, Johanna/0000-0002-6295-6556	Academy of Finland; Sigrid Juselius Foundation; Emil Aaltonen Foundation; Finnish Cancer Organisations; EMBO; University of Turku; Turku University Foundation; Finnish Concordia Fund; Finnish Cultural Foundation; Ida Montini Foundation; Orion and Farmos Research Foundation; K Albin Johansson's Foundation; Scientific Foundation of Instrumentarium; Turku Graduate School for Biomedical Sciences	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Emil Aaltonen Foundation; Finnish Cancer Organisations; EMBO(European Molecular Biology Organization (EMBO)); University of Turku; Turku University Foundation; Finnish Concordia Fund; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Ida Montini Foundation; Orion and Farmos Research Foundation; K Albin Johansson's Foundation; Scientific Foundation of Instrumentarium; Turku Graduate School for Biomedical Sciences	We thank H Marttila, J Siivonen, L Lahtinen, J Rantala, P Terho, E Mattila and T Hoiby for their excellent technical assistance, H Sara for the bioinformatic analysis of the cDNA microarray, K Hellstrom, S-K Leivonen and the Finnish DNA Microarray Centre for their help with gene expression analysis and TCDM (Turku) for the animal experiments. M Salmi is acknowledged for the Hb116 antibody and for critically reading and editing the manuscript. This work was supported by grants from the Academy of Finland, the Sigrid Juselius Foundation, Emil Aaltonen Foundation, Finnish Cancer Organisations, EMBO Young Investigator Program, University of Turku, Turku University Foundation, Finnish Concordia Fund, Finnish Cultural Foundation, Ida Montini Foundation, Orion and Farmos Research Foundation, K Albin Johansson's Foundation and Scientific Foundation of Instrumentarium. K Vuoriluoto is financially supported by Turku Graduate School for Biomedical Sciences.	Allen MP, 2002, MOL CELL BIOL, V22, P599, DOI 10.1128/MCB.22.2.599-613.2002; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Burga LN, 2009, CANCER RES, V69, P1273, DOI 10.1158/0008-5472.CAN-08-2954; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Chabottaux V, 2009, J CELL MOL MED, V13, P4002, DOI 10.1111/j.1582-4934.2009.00764.x; Chen DT, 2010, BREAST CANCER RES TR, V119, P335, DOI 10.1007/s10549-009-0344-y; Cheng JM, 2006, INT J CANCER, V118, P2957, DOI 10.1002/ijc.21739; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Eckes B, 1998, J CELL SCI, V111, P1897; Eckes B, 2000, J CELL SCI, V113, P2455; FRANKE WW, 1982, DIFFERENTIATION, V23, P43, DOI 10.1111/j.1432-0436.1982.tb01266.x; Galang CK, 2004, J BIOL CHEM, V279, P11281, DOI 10.1074/jbc.M311887200; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hasanbasic I, 2004, AM J PHYSIOL-HEART C, V287, pH1207, DOI 10.1152/ajpheart.00020.2004; HEDBERG KK, 1986, EXP CELL RES, V163, P509, DOI 10.1016/0014-4827(86)90081-9; Hendrix MJC, 1997, AM J PATHOL, V150, P483; Holland SJ, 2005, CANCER RES, V65, P9294, DOI 10.1158/0008-5472.CAN-05-0993; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Koorstra JBM, 2009, CANCER BIOL THER, V8, P618, DOI 10.4161/cbt.8.7.7923; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Kumar N, 2007, J BIOL CHEM, V282, P9244, DOI 10.1074/jbc.M605571200; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Lu S, 2008, CLIN CANCER RES, V14, P1050, DOI 10.1158/1078-0432.CCR-07-4116; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Marty B, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2204; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Phua DCY, 2009, MOL BIOL CELL, V20, P2841, DOI 10.1091/mbc.E08-02-0199; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rodriguez-Pinilla SM, 2006, CLIN CANCER RES, V12, P1533, DOI 10.1158/1078-0432.CCR-05-2281; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Tuomi S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000135; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; VARNUM BC, 1995, NATURE, V373, P623, DOI 10.1038/373623a0; Vuoriluoto K, 2008, EXP CELL RES, V314, P3369, DOI 10.1016/j.yexcr.2008.07.005; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661	53	463	485	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2011	30	12					1436	1448		10.1038/onc.2010.509	http://dx.doi.org/10.1038/onc.2010.509			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	739UM	21057535				2022-12-25	WOS:000288743800006
J	Kieseritzky, G; Knapp, EW				Kieseritzky, Gernot; Knapp, Ernst-Walter			Charge Transport in the ClC-type Chloride-Proton Anti-porter from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC REACTION CENTERS; /H+ EXCHANGE TRANSPORTER; PROKARYOTIC HOMOLOG; ELECTRON-TRANSFER; PROTEINS; CHANNELS; ANTIPORTER; MECHANISM; DYNAMICS; SYSTEMS	The first chloride transporter identified in the superfamily of ClC chloride channels was from Escherichia coli (EClC) (Accardi, A., and Miller, C. (2004) Nature 427, 803-807). Pathways, energetics, and mechanism of proton and chloride translocation and their coupling are up to now unclear. To bridge the hydrophobic gap of proton transport, we modeled four stable buried waters into both subunits of the WT EClC structure. Together they form a "water wire" connecting Glu-203 with the chloride at the central site, which in turn connects to Glu-148, the hypothetical proton exit site. Assuming the transient production of hydrochloride in the central chloride binding site of EClC, the water wire could establish a transmembrane proton transport pathway starting from Glu-203 all the way downstream onto Glu-148. We demonstrated by electrostatic and quantum chemical computations that protonation of the central chloride is energetically feasible. We characterized all chloride occupancies and protonation states possibly relevant for the proton-chloride transport cycle in EClC and constructed a working model. Accordingly, EClC evolves through states involving up to two excess protons and between one and three chlorides, which was required to fulfill the experimentally observed 2: 1 stoichiometry. We show that the Y445F and E203H mutants of EClC can operate similarly, thus explaining why they exhibit almost WT activity levels. The proposed mechanism of coupled chloride-proton transport in EClC is consistent with available experimental data and allows predictions on the importance of specific amino acids, which may be probed by mutation experiments.	[Kieseritzky, Gernot; Knapp, Ernst-Walter] Free Univ Berlin, Inst Chem, D-14195 Berlin, Germany	Free University of Berlin	Knapp, EW (corresponding author), Free Univ Berlin, Inst Chem, Fabeckstr 36A, D-14195 Berlin, Germany.	knapp@chemie.fu-berlin.de	Knapp, Ernst-Walter/AAH-6720-2021; Knapp, Ernst-Walter/E-4493-2010	Knapp, Ernst-Walter/0000-0002-2858-0460; Knapp, Ernst-Walter/0000-0002-2858-0460	German National Academic Foundation; Volkswagen Foundation	German National Academic Foundation; Volkswagen Foundation(Volkswagen)	This work was supported by the German National Academic Foundation and the Volkswagen Foundation.	Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Accardi A, 2004, J GEN PHYSIOL, V123, P109, DOI 10.1085/jgp.200308935; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Accardi A, 2006, J MOL BIOL, V362, P691, DOI 10.1016/j.jmb.2006.07.081; AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Day TJF, 2002, J CHEM PHYS, V117, P5839, DOI 10.1063/1.1497157; de Grotthuss C, 1806, ANN CHIM, V58, P54; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Faraldo-Gomez JD, 2004, J MOL BIOL, V339, P981, DOI 10.1016/j.jmb.2004.04.023; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; HOLST M, 1993, J COMPUT CHEM, V14, P105, DOI 10.1002/jcc.540140114; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishikita H, 2005, FEBS LETT, V579, P712, DOI 10.1016/j.febslet.2004.12.049; Ishikita H, 2003, J BIOL CHEM, V278, P52002, DOI 10.1074/jbc.M306434200; Ishikita H, 2006, P NATL ACAD SCI USA, V103, P9855, DOI 10.1073/pnas.0601446103; Iyer R, 2002, NATURE, V419, P715, DOI 10.1038/nature01000; Jayaram H, 2008, P NATL ACAD SCI USA, V105, P11194, DOI 10.1073/pnas.0804503105; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Kieseritzky G, 2008, J COMPUT CHEM, V29, P2575, DOI 10.1002/jcc.20999; Kieseritzky G, 2008, PROTEINS, V71, P1335, DOI 10.1002/prot.21820; KNAPP EW, 1980, CHEM PHYS, V46, P215, DOI 10.1016/0301-0104(80)85096-8; Kuang ZF, 2007, PROTEINS, V68, P26, DOI 10.1002/prot.21441; Lim HH, 2009, J GEN PHYSIOL, V133, P131, DOI 10.1085/jgp.200810112; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Miller C, 2006, NATURE, V440, P484, DOI 10.1038/nature04713; Miller C, 2009, PHILOS T R SOC B, V364, P175, DOI 10.1098/rstb.2008.0138; NAGLE JF, 1978, P NATL ACAD SCI USA, V75, P298, DOI 10.1073/pnas.75.1.298; Nguitragool W, 2007, P NATL ACAD SCI USA, V104, P20659, DOI 10.1073/pnas.0708639104; Nguitragool W, 2006, J MOL BIOL, V362, P682, DOI 10.1016/j.jmb.2006.07.006; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Rabenstein B, 2001, BIOPHYS J, V80, P1141, DOI 10.1016/S0006-3495(01)76091-2; ROBERTSON JL, 2010, NATURE IN PRESS; ROBINSON RA, 1971, ANAL CHEM, V43, P969, DOI 10.1021/ac60302a030; Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; SCHRODINGER L, 2009, JAGUAR, V7; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Song YF, 2009, J COMPUT CHEM, V30, P2231, DOI 10.1002/jcc.21222; Ullmann GM, 1999, EUR BIOPHYS J BIOPHY, V28, P533, DOI 10.1007/s002490050236; Voigt P, 2003, J BIOL CHEM, V278, P51993, DOI 10.1074/jbc.M307560200; Voth GA, 2006, ACCOUNTS CHEM RES, V39, P143, DOI 10.1021/ar0402098; Walden M, 2007, J GEN PHYSIOL, V129, P317, DOI 10.1085/jgp.200709756; Wang D, 2009, BIOPHYS J, V97, P121, DOI 10.1016/j.bpj.2009.04.038; WARSHEL A, 1980, J AM CHEM SOC, V102, P6218, DOI 10.1021/ja00540a008; WARSHEL A, 1991, COMPUTER MODELING CH, P46; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F	54	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2976	2986		10.1074/jbc.M110.163246	http://dx.doi.org/10.1074/jbc.M110.163246			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21059656	Green Published, hybrid			2022-12-25	WOS:000286464300061
J	Park, UH; Yoon, SK; Park, T; Kim, EJ; Um, SJ				Park, Ui-Hyun; Yoon, Seung Kew; Park, Taesun; Kim, Eun-Joo; Um, Soo-Jong			Additional Sex Comb-like (ASXL) Proteins 1 and 2 Play Opposite Roles in Adipogenesis via Reciprocal Regulation of Peroxisome Proliferator-activated Receptor gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; RESPONSIVE ELEMENT; TRANSCRIPTIONAL COACTIVATOR; METABOLIC PATHWAYS; GENE-EXPRESSION; TARGET GENES; HISTONE H3; LYSINE 9; IDENTIFICATION	Our previous studies have suggested that the mammalian additional sex comb-like 1 protein functions as a coactivator or repressor of retinoic acid receptors in a cell-specific manner. Here, we investigated the roles of additional sex comb-like 1 proteins in regulating peroxisome proliferator-activated receptors (PPARs). In pulldown assays in vitro and in immuno-precipitation assays in vivo, ASXL1 and its paralog, ASXL2, interacted with PPAR alpha and PPAR gamma. In 3T3-L1 preadipocyte cells, overexpression of ASXL1 inhibited the induction of PPAR gamma activity by rosiglitazone, as shown by transcription assays, and completely suppressed adipogenesis, as shown by Oil Red O staining. In contrast, overexpression of ASXL2 greatly enhanced rosiglitazone-induced PPAR gamma activity and enhanced adipogenesis. Deletion of the heterochromatin protein 1 (HP1)-binding domain from ASXL1 caused the mutant protein to enhance adipogenesis similarly to ASXL2, indicating that HP1 binding is required for the adipogenesis-suppressing activity of ASXL1. Adipocyte differentiation was associated with a gradual decrease in ASXL1 expression but did not affect ASXL2 expression. Knockdown of ASXL1 and ASXL2 had reciprocal effects on adipogenesis. In chromatin immuno-precipitation assays in 3T3-L1 cells, ASXL1 occupied the promoter of the PPAR gamma target gene aP2 together with HP1 alpha and Lys-9-methylated histone H3, whereas ASXL2 occupied the aP2 promoter together with histone-lysine N-methyltransferase MLL1 and Lys-9-acetylated and Lys-4-methylated H3 histones. Finally, microarray analysis demonstrated that ASXL1 represses, whereas ASXL2 increases, the expression of adipogenic genes, most of which are PPAR gamma targets. These results suggest that members of the additional sex comb-like family provide complex regulation of adipogenesis via differential modulation of PPAR gamma activity.	[Kim, Eun-Joo] Dankook Univ, Grad Program BK21, Dept Mol Biol, Yongin 448701, Gyeonggi Do, South Korea; [Park, Ui-Hyun; Um, Soo-Jong] Sejong Univ, Grad Program BK21, Dept Biosci & Biotechnol, Seoul 143747, South Korea; [Yoon, Seung Kew] Catholic Univ Korea, Dept Internal Med, Seoul 137701, South Korea; [Park, Taesun] Yonsei Univ, Dept Food & Nutr, Seoul 120749, South Korea	Dankook University; Sejong University; Catholic University of Korea; Yonsei University	Kim, EJ (corresponding author), Dankook Univ, Grad Program BK21, Dept Mol Biol, 126 Jukjeon Dong, Yongin 448701, Gyeonggi Do, South Korea.	nbrejk@dankook.ac.kr; umsj@sejong.ac.kr		Park, Taesun/0000-0002-9752-9407	MEST [2007-0053438, 2008-0057731, 2009-0079104, 2008-0059055]; Ministry of Health, Welfare, and Family Affairs, Republic of Korea [A090282]	MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported in part by Basic Science Research Program NRF Grants 2007-0053438, 2008-0057731, and 2009-0079104 (to S.-J. U.) and 2008-0059055 (to E.-J. K.) from MEST and in part by Health 21 R & D Project Grant A090282 (to S.-J. U.) from the Ministry of Health, Welfare, and Family Affairs, Republic of Korea.	Armoni M, 2003, J BIOL CHEM, V278, P30614, DOI 10.1074/jbc.M304654200; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Baskind HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004750; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Biscetti F, 2009, NUTR METAB CARDIOVAS, V19, P751, DOI 10.1016/j.numecd.2009.04.011; Chen JG, 2006, BIOCHEM BIOPH RES CO, V347, P821, DOI 10.1016/j.bbrc.2006.06.170; Cho YS, 2006, J BIOL CHEM, V281, P17588, DOI 10.1074/jbc.M512616200; Cho YW, 2009, CELL METAB, V10, P27, DOI 10.1016/j.cmet.2009.05.010; Deng T, 2006, ENDOCRINOLOGY, V147, P875, DOI 10.1210/en.2005-0623; Fajas L, 2002, DEV CELL, V3, P903, DOI 10.1016/S1534-5807(02)00360-X; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Fisher CL, 2006, GENE, V369, P109, DOI 10.1016/j.gene.2005.10.033; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Hallakou S, 1997, DIABETES, V46, P1393, DOI 10.2337/diabetes.46.9.1393; Kageyama H, 2003, BIOCHEM BIOPH RES CO, V305, P22, DOI 10.1016/S0006-291X(03)00663-6; Katoh M, 2004, INT J ONCOL, V24, P1617; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Leader JE, 2006, BIOCHEM PHARMACOL, V72, P1589, DOI 10.1016/j.bcp.2006.05.024; Lee J, 2008, P NATL ACAD SCI USA, V105, P19229, DOI 10.1073/pnas.0810100105; Lee SW, 2010, J BIOL CHEM, V285, P18, DOI 10.1074/jbc.M109.065862; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Louet JF, 2007, CELL CYCLE, V6, P2448, DOI 10.4161/cc.6.20.4777; Miard S, 2005, INT J OBESITY, V29, pS10, DOI 10.1038/sj.ijo.0802906; Miller CW, 1996, P NATL ACAD SCI USA, V93, P9443, DOI 10.1073/pnas.93.18.9443; Milne TA, 1999, MOL GEN GENET, V261, P753, DOI 10.1007/s004380050018; Moraes LA, 2006, PHARMACOL THERAPEUT, V110, P371, DOI 10.1016/j.pharmthera.2005.08.007; Musri MM, 2007, BIOCHEM CELL BIOL, V85, P397, DOI 10.1139/O07-068; Musri MM, 2006, J BIOL CHEM, V281, P17180, DOI 10.1074/jbc.M601295200; Musri MM, 2010, ORGANOGENESIS, V6, P15, DOI 10.4161/org.6.1.10226; Nagai S, 2004, ENDOCRINOLOGY, V145, P2346, DOI 10.1210/en.2003-1180; Nakachi Y, 2008, BIOCHEM BIOPH RES CO, V372, P362, DOI 10.1016/j.bbrc.2008.05.037; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468; Perera RJ, 2006, GENE, V369, P90, DOI 10.1016/j.gene.2005.10.021; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Sears DD, 2007, BIOCHEM BIOPH RES CO, V364, P515, DOI 10.1016/j.bbrc.2007.10.057; Shimizu M, 2006, J BIOCHEM, V139, P563, DOI 10.1093/jb/mvj053; Sinclair DAR, 1998, DEVELOPMENT, V125, P1207; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Takahashi N, 2002, J BIOL CHEM, V277, P16906, DOI 10.1074/jbc.M200585200; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Wang L, 2006, PPAR RES, V2006, DOI 10.1155/PPAR/2006/67297; Yadav N, 2008, EMBO REP, V9, P193, DOI 10.1038/sj.embor.7401151; Yajima H, 2007, BIOCHEM BIOPH RES CO, V352, P526, DOI 10.1016/j.bbrc.2006.11.054; Yoo EJ, 2006, J BIOL CHEM, V281, P6608, DOI 10.1074/jbc.M508982200; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Yu ST, 2007, BBA-MOL CELL BIOL L, V1771, P936, DOI 10.1016/j.bbalip.2007.01.008; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636	53	57	62	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1354	1363		10.1074/jbc.M110.177816	http://dx.doi.org/10.1074/jbc.M110.177816			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21047783	hybrid, Green Published			2022-12-25	WOS:000286005000047
J	Sasaki, CY; Ghosh, P; Longo, DL				Sasaki, Carl Y.; Ghosh, Paritosh; Longo, Dan L.			Recruitment of RelB to the Csf2 Promoter Enhances RelA-mediated Transcription of Granulocyte-Macrophage Colony-stimulating Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; CHROMATIN IMMUNOPRECIPITATION; NF-KAPPA-B2 P100; IKK-ALPHA; ACTIVATION; GENE; PHOSPHORYLATION; KINASE; SERINE-536	Tumor necrosis factor (TNF) induces expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) but lymphotoxin beta (LT beta) does not. Here we report that priming of cells with agonistic LT beta receptor antibody synergistically enhanced TNF-induced GM-CSF expression. The LT beta priming process was not due to an increase in TNF-mediated nuclear translocation of p65, p65 DNA binding, or NF-kappa B transactivational activity. The synergistic effect of LT beta priming was not observed with other TNF-responsive genes such as Ccl2 or RelB, which suggested that this effect was not a general increase in TNF signaling. Furthermore, RelB and p65 were both independently recruited to the GM-CSF promoter when cells were primed with LT beta followed by TNF treatment. As a consequence, an increase in both chromatin accessibility and the recruitment of RNA polymerase II were observed to the GMCSF promoter. Taken together, these findings suggested that LT beta signaling amplified TNF-mediated GM-CSF expression by facilitating chromatin access and the co-recruitment of RNA polymerase II to increase gene transcription. Moreover, the novel priming process described here underscores the complexity of the interactions between the classical and alternative NF-kappa B signaling pathways.	[Sasaki, Carl Y.; Ghosh, Paritosh; Longo, Dan L.] NIA, Immunol Lab, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Sasaki, CY (corresponding author), NIA, Immunol Lab, NIH, 251 Bay View Blvd,Suite 100, Baltimore, MD 21224 USA.	sasakic@grc.nia.nih.gov	Longo, Dan L./F-6022-2011		NIA, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000426] Funding Source: NIH RePORTER	NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the Intramural Research Program of the NIA, National Institutes of Health.	Basak S, 2008, MOL CELL BIOL, V28, P3139, DOI 10.1128/MCB.01469-07; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; Brettingham-Moore KH, 2008, NUCLEIC ACIDS RES, V36, P2639, DOI 10.1093/nar/gkn117; Brettingham-Moore KH, 2005, NUCLEIC ACIDS RES, V33, P225, DOI 10.1093/nar/gki161; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Geisberg JV, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh148; Holloway AF, 2003, J EXP MED, V197, P413, DOI 10.1084/jem.20021039; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lovas A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-606; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; OSBORNE CS, 1995, J IMMUNOL, V155, P226; Qing GL, 2005, J BIOL CHEM, V280, P40578, DOI 10.1074/jbc.M508776200; Rouillard JM, 2004, NUCLEIC ACIDS RES, V32, pW176, DOI 10.1093/nar/gkh401; Rudolph D, 2000, GENE DEV, V14, P854; Saito T, 2010, BIOCHEM BIOPH RES CO, V391, P235, DOI 10.1016/j.bbrc.2009.11.039; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sasaki CY, 2007, CANCER RES, V67, P11218, DOI 10.1158/0008-5472.CAN-07-0922; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sutcliffe EL, 2009, MOL CELL BIOL, V29, P1972, DOI 10.1128/MCB.01590-08; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3	35	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1093	1102		10.1074/jbc.M110.119438	http://dx.doi.org/10.1074/jbc.M110.119438			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21071440	hybrid, Green Published			2022-12-25	WOS:000286005000020
J	Du, H; Wolf, J; Schafer, B; Moldoveanu, T; Chipuk, JE; Kuwana, T				Du, Han; Wolf, Jacob; Schafer, Blanca; Moldoveanu, Tudor; Chipuk, Jerry E.; Kuwana, Tomomi			BH3 Domains other than Bim and Bid Can Directly Activate Bax/Bak	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; APOPTOTIC PROTEIN BAK; BCL-2 FAMILY-MEMBERS; CELL-DEATH; ANTAGONIST ABT-737; BH3-ONLY PROTEINS; MIMETIC ABT-737; MCL-1; OLIGOMERIZATION; SENSITIVITY	Bcl-2 family proteins regulate a critical step in apoptosis referred to as mitochondrial outer membrane permeabilization (MOMP). Members of a subgroup of the Bcl-2 family, known as the BH3-only proteins, activate pro-apoptotic effectors (Bax and Bak) to initiate MOMP. They do so by neutralizing pro-survival Bcl-2 proteins and/or directly activating Bax/Bak. Bim and Bid are reported to be direct activators; however, here we show that BH3 peptides other than Bim and Bid exhibited various degrees of direct activation of the effector Bax or Bak, including Bmf and Noxa BH3s. In the absence of potent direct activators, such as Bim and Bid, we unmasked novel direct activator BH3 ligands capable of inducing effector-mediated cytochrome c release and liposome permeabilization, even when both Bcl-xL- and Mcl-1-type anti-apoptotic proteins were inhibited. The ability of these weaker direct activator BH3 peptides to cause MOMP correlated with that of the corresponding full-length proteins to induce apoptosis in the absence of Bim and Bid. We propose that, in certain contexts, direct activation by BH3-only proteins other than Bim and Bid may significantly contribute to MOMP and apoptosis.	[Moldoveanu, Tudor; Chipuk, Jerry E.] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA; [Du, Han; Wolf, Jacob; Schafer, Blanca; Kuwana, Tomomi] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA	St Jude Children's Research Hospital; University of Iowa	Kuwana, T (corresponding author), Univ Iowa, Dept Pathol, Carver Coll Med, 1161ML, Ia City, IA 52242 USA.	t-kuwana@uiowa.edu	Moldoveanu, Tudor/N-8173-2018	Moldoveanu, Tudor/0000-0003-0791-318X; Chipuk, Jerry Edward/0000-0002-1337-842X; Du, Han/0000-0002-8488-6755	National Institutes of Health; Dept. of Pathology, University of Iowa Carver College of Medicine; NATIONAL CANCER INSTITUTE [R01CA157740, F32CA101444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Pathology, University of Iowa Carver College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by grants from the National Institutes of Health and the start-up funds from the Dept. of Pathology, University of Iowa Carver College of Medicine (to T. K.).	Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chipuk JE, 2005, NAT REV MOL CELL BIO, V6, P268, DOI [10.1038/nrm1573, 10.1038/nrm2239]; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Griffiths GJ, 2001, ONCOGENE, V20, P7668, DOI 10.1038/sj.onc.1204995; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Khaled AR, 1999, P NATL ACAD SCI USA, V96, P14476, DOI 10.1073/pnas.96.25.14476; Kim HA, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1972; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu Q, 2010, J BIOL CHEM, V285, P19615, DOI 10.1074/jbc.M110.105452; Mason KD, 2008, P NATL ACAD SCI USA, V105, P17961, DOI 10.1073/pnas.0809957105; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Sharpe JC, 1999, J MEMBRANE BIOL, V171, P209, DOI 10.1007/s002329900572; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Uren RT, 2007, J CELL BIOL, V177, P277, DOI 10.1083/jcb.200606065; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	44	118	120	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					491	501		10.1074/jbc.M110.167148	http://dx.doi.org/10.1074/jbc.M110.167148			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21041309	Green Published, hybrid			2022-12-25	WOS:000285782800052
J	Sasaki, Y; Milbrandt, J				Sasaki, Yo; Milbrandt, Jeffrey			Axonal Degeneration Is Blocked by Nicotinamide Mononucleotide Adenylyltransferase (Nmnat) Protein Transduction into Transected Axons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR STOMATITIS-VIRUS; WALLERIAN DEGENERATION; ADENINE-DINUCLEOTIDE; LENTIVIRAL VECTORS; SELF-DESTRUCTION; IN-VIVO; GENE; NEURODEGENERATION; GLYCOPROTEIN; EXPRESSION	Axonal degeneration is an early and important component of many neurological disorders. Overexpression of nicotinamide mononucleotide adenylyltransferase (Nmnat), a component of the slow Wallerian degeneration (Wld(s)) protein, protects axons from a variety of insults. We found that transduction of Nmnat protein into severed axons via virus-like particles prevented axonal degeneration. The post-injury efficacy of Nmnat indicates that its protective effects occur locally within the axon and provides an opportunity to develop novel agents to treat axonal damage.	[Sasaki, Yo; Milbrandt, Jeffrey] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Milbrandt, Jeffrey] Washington Univ, Sch Med, HOPE Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Milbrandt, J (corresponding author), 660 S Euclid Ave,Box 8118, St Louis, MO 63110 USA.	jmilbrandt@wustl.edu		Milbrandt, Jeffrey/0000-0002-5477-7689	National Institutes of Health [NS070053, AG13730, NS065053]; Muscular Dystrophy Association [10040]; Craig H. Neilsen Foundation [124030]; National Institutes of Health Neuroscience Blueprint Center [P30 NS057105]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS070053, R01NS065053, P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Craig H. Neilsen Foundation; National Institutes of Health Neuroscience Blueprint Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS070053 (to J.M.), AG13730 (to J.M.), NS065053 (to A. DiAntonio and J.M.). This work was also supported by Muscular Dystrophy Association Grants 10040 (to J.M.) and Craig H. Neilsen Foundation Grant 124030 (to J.M.). The authors and Washington University may derive benefit from a licensing agreement with Sirtris Pharmaceuticals, which did not provide any support for this work.; We thank Kelli Simburger, Amy Strickland, Amber Neilson, and Tim Fahrner for experimental assistance and members of the Milbrandt laboratory and Aaron DiAntonio for comments on the manuscript and helpful discussions. We thank Michael Whitt, University of Tennessee Health Science Center, for the VSV-G antibody. The HOPE Center for Neurological Disorders of Washington University was supported by National Institutes of Health Neuroscience Blueprint Center Core Grant P30 NS057105.	Abe A, 1998, J VIROL, V72, P6159, DOI 10.1128/JVI.72.7.6159-6163.1998; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Greber UF, 2002, CELL MOL LIFE SCI, V59, P608, DOI 10.1007/s00018-002-8453-3; Haas DL, 2000, MOL THER, V2, P71, DOI 10.1006/mthe.2000.0094; Hammarstedt M, 2004, J VIROL, V78, P5686, DOI 10.1128/JVI.78.11.5686-5697.2004; LEFRANCOIS L, 1982, VIROLOGY, V121, P157, DOI 10.1016/0042-6822(82)90125-8; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Miller BR, 2009, NAT NEUROSCI, V12, P387, DOI 10.1038/nn.2290; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sasaki Y, 2009, J NEUROSCI, V29, P6526, DOI 10.1523/JNEUROSCI.1429-09.2009; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Yahata N, 2009, J NEUROSCI, V29, P6276, DOI 10.1523/JNEUROSCI.4304-08.2009; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	18	51	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41211	41215		10.1074/jbc.C110.193904	http://dx.doi.org/10.1074/jbc.C110.193904			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21071441	Green Published, hybrid			2022-12-25	WOS:000285622600006
J	Wang, GH; Wang, YD; Shen, CY; Huang, YW; Huang, K; Huang, THM; Nephew, KP; Li, L; Liu, YL				Wang, Guohua; Wang, Yadong; Shen, Changyu; Huang, Yi-wen; Huang, Kun; Huang, Tim H. M.; Nephew, Kenneth P.; Li, Lang; Liu, Yunlong			RNA Polymerase II Binding Patterns Reveal Genomic Regions Involved in MicroRNA Gene Regulation	PLOS ONE			English	Article							BREAST-CANCER CELLS; CHROMATIN IMMUNOPRECIPITATION; NUCLEAR EXPORT; EXPRESSION; MIRNA; TRANSCRIPTION; BIOGENESIS; PRECURSORS; PROMOTERS; ENHANCERS	MicroRNAs are small non-coding RNAs involved in post-transcriptional regulation of gene expression. Due to the poor annotation of primary microRNA (pri-microRNA) transcripts, the precise location of promoter regions driving expression of many microRNA genes is enigmatic. This deficiency hinders our understanding of microRNA-mediated regulatory networks. In this study, we develop a computational approach to identify the promoter region and transcription start site (TSS) of pri-microRNAs actively transcribed using genome-wide RNA Polymerase II (RPol II) binding patterns derived from ChIP-seq data. Based upon the assumption that the distribution of RPol II binding patterns around the TSS of microRNA and protein coding genes are similar, we designed a statistical model to mimic RPol II binding patterns around the TSS of highly expressed, well-annotated promoter regions of protein coding genes. We used this model to systematically scan the regions upstream of all intergenic microRNAs for RPol II binding patterns similar to those of TSS from protein coding genes. We validated our findings by examining the conservation, CpG content, and activating histone marks in the identified promoter regions. We applied our model to assess changes in microRNA transcription in steroid hormone-treated breast cancer cells. The results demonstrate many microRNA genes have lost hormone-dependent regulation in tamoxifen-resistant breast cancer cells. MicroRNA promoter identification based upon RPol II binding patterns provides important temporal and spatial measurements regarding the initiation of transcription, and therefore allows comparison of transcription activities between different conditions, such as normal and disease states.	[Wang, Guohua; Shen, Changyu; Li, Lang; Liu, Yunlong] Indiana Univ, Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46204 USA; [Wang, Guohua; Wang, Yadong] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Peoples R China; [Wang, Guohua; Shen, Changyu; Li, Lang; Liu, Yunlong] Indiana Univ, Sch Med, Div Biostat, Indianapolis, IN USA; [Huang, Yi-wen; Huang, Tim H. M.] Ohio State Univ, Div Human Canc Genet, Columbus, OH 43210 USA; [Huang, Yi-wen; Huang, Tim H. M.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Huang, Yi-wen; Huang, Kun; Huang, Tim H. M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Huang, Kun] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Nephew, Kenneth P.] Indiana Univ, Sch Med, Bloomington, IN USA; [Nephew, Kenneth P.] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN USA; [Nephew, Kenneth P.; Li, Lang] Indiana Univ, Sch Med, Simon Canc Ctr, Indianapolis, IN USA; [Li, Lang; Liu, Yunlong] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Liu, Yunlong] Indiana Univ, Sch Med, Ctr Med Genom, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Harbin Institute of Technology; Indiana University System; Indiana University-Purdue University Indianapolis; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Wang, GH (corresponding author), Indiana Univ, Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46204 USA.	yunliu@iupui.edu	Huang, Kun/E-3272-2011; Wang, Guohua/GLR-7939-2022		United States National Institutes of Health [AA017941, CA113001, GM088076, GM085121]; China 863 High-Tech Program [2007AA02Z302]; China Natural Science Foundation [60901075]; NATIONAL CANCER INSTITUTE [U54CA113001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085121, R01GM088076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA017941] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China 863 High-Tech Program(National High Technology Research and Development Program of China); China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work is supported by United States National Institutes of Health grants AA017941 (Y.L.), CA113001 (T. H-M. H. and K.P.N), GM088076 (Y.L. and L. L.), GM085121 (Y.L.), China 863 High-Tech Program 2007AA02Z302 (Y.L.), and China Natural Science Foundation 60901075 (G. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Fan MY, 2006, CANCER RES, V66, P11954, DOI 10.1158/0008-5472.CAN-06-1666; Feng WX, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S23; Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gu J, 2006, MAMM GENOME, V17, P1033, DOI 10.1007/s00335-006-0007-9; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; He SM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-236; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee R, 2004, CELL, V116, pS96; Lee Rosalind, 2004, Cell, VS116, pS89, DOI 10.1016/S0092-8674(04)00035-2; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Wang XW, 2009, GENOME RES, V19, P266, DOI 10.1101/gr.081638.108; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhou XF, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100143	43	44	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13798	10.1371/journal.pone.0013798	http://dx.doi.org/10.1371/journal.pone.0013798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072189	Green Published, gold, Green Submitted			2022-12-25	WOS:000283779700010
J	Castellano-Munoz, M; Israel, SH; Hudspeth, AJ				Castellano-Munoz, Manuel; Israel, Samuel H.; Hudspeth, A. J.			Efferent Control of the Electrical and Mechanical Properties of Hair Cells in the Bullfrog's Sacculus	PLOS ONE			English	Article							FROG SACCULUS; POTASSIUM CURRENTS; ALLIGATOR COCHLEA; BASILAR PAPILLA; TURTLE COCHLEA; LATERAL-LINE; INNER-EAR; INHIBITION; SYNAPSE; SYSTEM	Background: Hair cells in the auditory, vestibular, and lateral-line systems respond to mechanical stimulation and transmit information to afferent nerve fibers. The sensitivity of mechanoelectrical transduction is modulated by the efferent pathway, whose activity usually reduces the responsiveness of hair cells. The basis of this effect remains unknown. Methodology and Principal Findings: We employed immunocytological, electrophysiological, and micromechanical approaches to characterize the anatomy of efferent innervation and the effect of efferent activity on the electrical and mechanical properties of hair cells in the bullfrog's sacculus. We found that efferent fibers form extensive synaptic terminals on all macular and extramacular hair cells. Macular hair cells expressing the Ca(2+)-buffering protein calretinin contain half as many synaptic ribbons and are innervated by twice as many efferent terminals as calretinin-negative hair cells. Efferent activity elicits inhibitory postsynaptic potentials in hair cells and thus inhibits their electrical resonance. In hair cells that exhibit spiking activity, efferent stimulation suppresses the generation of action potentials. Finally, efferent activity triggers a displacement of the hair bundle's resting position. Conclusions and Significance: The hair cells of the bullfrog's sacculus receive a rich efferent innervation with the heaviest projection to calretinin-containing cells. Stimulation of efferent axons desensitizes the hair cells and suppresses their spiking activity. Although efferent activation influences mechanoelectrical transduction, the mechanical effects on hair bundles are inconsistent.	[Castellano-Munoz, Manuel] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Sensory Neurosci, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Castellano-Munoz, M (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	hudspaj@rockefeller.edu			National Institutes of Health [DC000241]; Spanish Ministry of Education and Science [EX-2006-1539]; Rockefeller University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000241, F32DC000241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Education and Science(Spanish Government); Rockefeller University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported by National Institutes of Health grant DC000241. M. C.-M. was supported by postdoctoral fellowship EX-2006-1539 from the Spanish Ministry of Education and Science and S. H. I. by the Bard-Rockefeller Semester in Science Program and the Rockefeller University Summer Undergraduate Research Fellowship Program. A.J.H. is an Investigator of Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; ART JJ, 1984, J PHYSIOL-LONDON, V356, P525, DOI 10.1113/jphysiol.1984.sp015481; ART JJ, 1987, J PHYSIOL-LONDON, V385, P207, DOI 10.1113/jphysiol.1987.sp016492; ART JJ, 1982, PROC R SOC SER B-BIO, V216, P377, DOI 10.1098/rspb.1982.0081; ART JJ, 1984, J PHYSIOL-LONDON, V356, P507, DOI 10.1113/jphysiol.1984.sp015480; ASHMORE JF, 1982, J PHYSIOL-LONDON, V329, pP25; ASHMORE JF, 1983, NATURE, V304, P536, DOI 10.1038/304536a0; Chabbert CH, 1997, PFLUG ARCH EUR J PHY, V435, P82, DOI 10.1007/s004240050486; Chiappe ME, 2007, J NEUROSCI, V27, P11978, DOI 10.1523/JNEUROSCI.3679-07.2007; Cooper NP, 2006, J PHYSIOL-LONDON, V576, P49, DOI 10.1113/jphysiol.2006.114991; CORWIN JT, 1985, P NATL ACAD SCI USA, V82, P3911, DOI 10.1073/pnas.82.11.3911; Edmonds B, 2000, NAT NEUROSCI, V3, P786, DOI 10.1038/77687; EVANS MG, 1987, BIOPHYS J, V52, P649, DOI 10.1016/S0006-3495(87)83256-3; FLOCK A, 1973, J PHYSIOL-LONDON, V235, P591, DOI 10.1113/jphysiol.1973.sp010406; FUCHS PA, 1990, P ROY SOC B-BIOL SCI, V241, P122, DOI 10.1098/rspb.1990.0075; FUCHS PA, 1988, J COMP PHYSIOL A, V164, P151, DOI 10.1007/BF00603947; FUCHS PA, 2006, VERTEBRATE HAIR CELL; FURUKAWA T, 1981, J PHYSIOL-LONDON, V315, P203, DOI 10.1113/jphysiol.1981.sp013742; Gale JE, 2000, JARO-J ASSOC RES OTO, V1, P172, DOI 10.1007/s101620010037; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Goutman JD, 2005, J PHYSIOL-LONDON, V566, P49, DOI 10.1113/jphysiol.2005.087460; Habets RLP, 2006, J NEUROPHYSIOL, V96, P2868, DOI 10.1152/jn.00427.2006; Heller S, 2002, JARO, V3, P488, DOI 10.1007/s10162-002-2050-x; Hellmann B, 1996, BRAIN BEHAV EVOLUT, V47, P185, DOI 10.1159/000113238; HIGHSTEIN SM, 1991, NEUROSCI RES, V12, P13, DOI 10.1016/0168-0102(91)90096-H; Holt JC, 2006, J NEUROSCI, V26, P13180, DOI 10.1523/JNEUROSCI.3539-06.2006; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; HUDSPETH AJ, 1978, AM J PHYSIOL, V234, pC56, DOI 10.1152/ajpcell.1978.234.1.C56; JACOBS RA, 1990, COLD SPRING HARB SYM, V55, P547; Kao HT, 1999, J EXP ZOOL, V285, P360, DOI 10.1002/(SICI)1097-010X(19991215)285:4<360::AID-JEZ4>3.3.CO;2-V; Kong JH, 2008, J PHYSIOL-LONDON, V586, P5471, DOI 10.1113/jphysiol.2008.160077; LEWIS ER, 1982, SCIENCE, V215, P1641, DOI 10.1126/science.6978525; Li GL, 2009, J NEUROSCI, V29, P7558, DOI 10.1523/JNEUROSCI.0514-09.2009; Lioudyno M, 2004, J NEUROSCI, V24, P11160, DOI 10.1523/JNEUROSCI.3674-04.2004; LLINAS R, 1969, EXP BRAIN RES, V9, P16; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; Martin P, 2003, J NEUROSCI, V23, P4533; Masetto S, 2003, J NEUROPHYSIOL, V90, P1266, DOI 10.1152/jn.01157.2002; PRIGIONI I, 1983, BRAIN RES, V269, P83, DOI 10.1016/0006-8993(83)90964-2; Ricci AJ, 2002, J NEUROSCI, V22, P44, DOI 10.1523/JNEUROSCI.22-01-00044.2002; Rutherford MA, 2009, J NEUROSCI, V29, P10025, DOI 10.1523/JNEUROSCI.1798-09.2009; Safieddine S, 1999, EUR J NEUROSCI, V11, P803, DOI 10.1046/j.1460-9568.1999.00487.x; STRUTZ J, 1984, BRAIN RES, V299, P174, DOI 10.1016/0006-8993(84)90803-5; SUGAI T, 1991, JPN J PHYSIOL, V41, P217, DOI 10.2170/jjphysiol.41.217; SUGAI T, 1992, HEARING RES, V61, P56, DOI 10.1016/0378-5955(92)90036-M; SUGIHARA I, 1989, J NEUROPHYSIOL, V62, P1330, DOI 10.1152/jn.1989.62.6.1330; Tank DW, 1995, J NEUROSCI, V15, P7940; Tinevez JY, 2007, BIOPHYS J, V93, P4053, DOI 10.1529/biophysj.107.108498; Zidanic M, 1996, AUDIT NEUROSCI, V2, P347	50	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13777	10.1371/journal.pone.0013777	http://dx.doi.org/10.1371/journal.pone.0013777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048944	gold, Green Published, Green Submitted			2022-12-25	WOS:000283645300051
J	Daneman, R; Zhou, L; Agalliu, D; Cahoy, JD; Kaushal, A; Barres, BA				Daneman, Richard; Zhou, Lu; Agalliu, Dritan; Cahoy, John D.; Kaushal, Amit; Barres, Ben A.			The Mouse Blood-Brain Barrier Transcriptome: A New Resource for Understanding the Development and Function of Brain Endothelial Cells	PLOS ONE			English	Article							TIGHT-JUNCTION PROTEIN; VASCULAR DEVELOPMENT; PHENOTYPIC HETEROGENEITY; PROGENITOR CELLS; GLIAL-CELLS; EXPRESSION; MICE; ANGIOGENESIS; PERMEABILITY; GENOMICS	The blood-brain barrier (BBB) maintains brain homeostasis and limits the entry of toxins and pathogens into the brain. Despite its importance, little is known about the molecular mechanisms regulating the development and function of this crucial barrier. In this study we have developed methods to highly purify and gene profile endothelial cells from different tissues, and by comparing the transcriptional profile of brain endothelial cells with those purified from the liver and lung, we have generated a comprehensive resource of transcripts that are enriched in the BBB forming endothelial cells of the brain. Through this comparison we have identified novel tight junction proteins, transporters, metabolic enzymes, signaling components, and unknown transcripts whose expression is enriched in central nervous system (CNS) endothelial cells. This analysis has identified that RXRalpha signaling cascade is specifically enriched at the BBB, implicating this pathway in regulating this vital barrier. This dataset provides a resource for understanding CNS endothelial cells and their interaction with neural and hematogenous cells.	[Daneman, Richard] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Zhou, Lu; Agalliu, Dritan; Barres, Ben A.] Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; [Cahoy, John D.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Kaushal, Amit] Stanford Univ, Sch Med, Dept Biomed Informat, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University; Stanford University; Stanford University	Daneman, R (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	richard.daneman@ucsf.edu		Kaushal, Amit/0000-0003-0831-4365	National Institute of Neurological Disease [R01 NS045621]; Myelin Repair Foundation; National Multiple Sclerosis Society [RG3936A7]; American Heart Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045621] Funding Source: NIH RePORTER	National Institute of Neurological Disease; Myelin Repair Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disease (R01 NS045621; B. A. B.), http://www.ninds.nih.gov/; the Myelin Repair Foundation (B. A. B, R. D.), http://www.myelinrepair.org/; the National Multiple Sclerosis Society RG3936A7 (B. A. B.), http://www.nationalmssociety.org/index.aspx; and the American Heart Association Graduate Fellowship (R. D.), http://www.americanheart.org/presenter.jhtml?identifier = 1200000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Calabria AR, 2006, DRUG DISCOV TODAY, V11, P792, DOI 10.1016/j.drudis.2006.07.006; Cornford Eain M, 2005, NeuroRx, V2, P27, DOI 10.1007/BF03206640; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; ElHafny B, 1997, NEUROSCI LETT, V236, P107, DOI 10.1016/S0304-3940(97)00679-4; Enerson BE, 2006, J CEREBR BLOOD F MET, V26, P959, DOI 10.1038/sj.jcbfm.9600249; Gloor SM, 2001, BRAIN RES REV, V36, P258, DOI 10.1016/S0165-0173(01)00102-3; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Hawkins BT, 2004, BRAIN RES, V1027, P48, DOI 10.1016/j.brainres.2004.08.043; Hirase T, 1997, J CELL SCI, V110, P1603; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; IDA JA, 1993, J NEUROSCI RES, V36, P596, DOI 10.1002/jnr.490360512; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Kioka N, 2002, CELL STRUCT FUNCT, V27, P1, DOI 10.1247/csf.27.1; LECHARDEUR D, 1995, EXP CELL RES, V220, P161, DOI 10.1006/excr.1995.1302; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; Li JY, 2002, J CEREBR BLOOD F MET, V22, P1319, DOI 10.1097/01.WCB.0000040944.89393.0f; Li JY, 2001, J CEREBR BLOOD F MET, V21, P61, DOI 10.1097/00004647-200101000-00008; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lindahl P, 1998, CURR OPIN LIPIDOL, V9, P407, DOI 10.1097/00041433-199810000-00004; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Macara AG, 2004, CURR BIOL, V14, pR160, DOI 10.1016/j.cub.2004.01.048; Macdonald JA, 2010, J NEUROSCI RES, V88, P1457, DOI 10.1002/jnr.22316; Maysami S, 2006, NEUROREPORT, V17, P1187, DOI 10.1097/01.wnr.0000227985.92551.9a; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Noonan Douglas M., 2007, V174, P219; Ohnishi H, 2004, J BIOL CHEM, V279, P46014, DOI 10.1074/jbc.M402616200; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; Proctor JM, 2005, J NEUROSCI, V25, P9940, DOI 10.1523/JNEUROSCI.3467-05.2005; Riazuddin S, 2006, AM J HUM GENET, V79, P1040, DOI 10.1086/510022; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; SAWADA M, 1993, NEUROSCI LETT, V160, P131, DOI 10.1016/0304-3940(93)90396-3; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Ueno M, 2007, CURR MED CHEM, V14, P1199, DOI 10.2174/092986707780597943; Wang YW, 2005, J LIPID RES, V46, P2377, DOI 10.1194/jlr.M500134-JLR200; Weidenfeller C, 2007, J NEUROCHEM, V101, P555, DOI 10.1111/j.1471-4159.2006.04394.x; Zhang M, 2006, EMBO J, V25, P5284, DOI 10.1038/sj.emboj.7601406; Zhang YJ, 2002, J BIOL CHEM, V277, P38328, DOI 10.1074/jbc.M205576200; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	57	375	392	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13741	10.1371/journal.pone.0013741	http://dx.doi.org/10.1371/journal.pone.0013741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060791	Green Published, gold, Green Submitted			2022-12-25	WOS:000283645300021
J	Osanai, M; Tanaka, S; Takeno, Y; Takimoto, S; Yagi, T				Osanai, Makoto; Tanaka, Satoshi; Takeno, Yusuke; Takimoto, Shouta; Yagi, Tetsuya			Spatiotemporal Properties of the Action Potential Propagation in the Mouse Visual Cortical Slice Analyzed by Calcium Imaging	PLOS ONE			English	Article							IN-VITRO; ORIENTATION SELECTIVITY; INTRINSIC CONNECTIONS; SYNAPTIC ACTIVITY; CORTEX; RAT; NEURONS; CAT; EXCITATION; MICROCIRCUITRY	The calcium ion (Ca2+) is an important messenger for signal transduction, and the intracellular Ca2+ concentration ([Ca2+]i) changes in response to an excitation of the cell. To reveal the spatiotemporal properties of the propagation of an excitatory signal with action potentials in the primary visual cortical circuit, we conducted a Ca2+ imaging study on slices of the mouse visual cortex. Electrical stimulation of layer 4 evoked [Ca2+]i transients around the stimulus electrode. Subsequently, the high [Ca2+]i region mainly propagated perpendicular to the cortical layer (vertical propagation), with horizontal propagation being restricted. When the excitatory synaptic transmission was blocked, only weak and concentric [Ca2+]i transients were observed. When the action potential was blocked, the [Ca2+]i transients disappeared almost completely. These results suggested that the action potential contributed to the induction of the [Ca2+]i transients, and that excitatory synaptic connections were involved in the propagation of the high [Ca2+]i region in the primary visual cortical circuit. To elucidate the involvement of inhibitory synaptic connections in signal propagation in the primary visual cortex, the GABA(A) receptor inhibitor bicuculline was applied. In this case, the evoked signal propagated from layer 4 to the entire field of view, and the prolonged [Ca2+]i transients were observed compared with the control condition. Our results suggest that excitatory neurons are widely connected to each other over the entire primary visual cortex with recurrent synapses, and inhibitory neurons play a fundamental role in the organization of functional sub-networks by restricting the propagation of excitation signals.	[Osanai, Makoto; Tanaka, Satoshi; Takeno, Yusuke; Takimoto, Shouta; Yagi, Tetsuya] Osaka Univ, Grad Sch Engn, Div Elect Elect & Informat Engn, Suita, Osaka, Japan	Osaka University	Osanai, M (corresponding author), Tohoku Univ, Dept Radiol Imaging & Informat, Grad Sch Med, Sendai, Miyagi 980, Japan.	yagi@eei.eng.osaka-u.ac.jp	Osanai, Makoto/B-7048-2009	Osanai, Makoto/0000-0002-3572-8195	Japan Society for the Promotion of Science [19300105, 19206041]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research (KAKENHI) (B) (19300105) to MO and KAKENHI (A) (19206041) to TY from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBOWITZ B, 1993, EUR J NEUROSCI, V5, P1349, DOI 10.1111/j.1460-9568.1993.tb00921.x; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BURKHALTER A, 1989, J COMP NEUROL, V279, P171, DOI 10.1002/cne.902790202; Contreras D, 2001, J NEUROSCI, V21, P9403, DOI 10.1523/JNEUROSCI.21-23-09403.2001; Deisz RA, 1997, SYNAPSE, V25, P62, DOI 10.1002/(SICI)1098-2396(199701)25:1<62::AID-SYN8>3.0.CO;2-D; Domenici L, 1995, J NEUROPHYSIOL, V74, P2649, DOI 10.1152/jn.1995.74.6.2649; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; FRIAUF E, 1991, J NEUROPHYSIOL, V66, P2059, DOI 10.1152/jn.1991.66.6.2059; Fukuda M, 1998, NEUROSCI RES, V31, P9, DOI 10.1016/S0168-0102(98)00018-2; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Gordon JA, 1996, J NEUROSCI, V16, P3274; GRINVALD A, 1994, J NEUROSCI, V14, P2545; Hansel C, 1997, EUR J NEUROSCI, V9, P2309, DOI 10.1111/j.1460-9568.1997.tb01648.x; HATA Y, 1988, NATURE, V335, P815, DOI 10.1038/335815a0; Heistek TS, 2010, BRAIN RES, V1321, P31, DOI 10.1016/j.brainres.2010.01.047; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Ikegaya Y, 2005, NEUROSCI RES, V52, P132, DOI 10.1016/j.neures.2005.02.004; Janders M, 1997, P IEEE EMBS, V18, P245, DOI 10.1109/IEMBS.1996.656936; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; KENANVAKNIN G, 1994, BRAIN RES, V635, P37, DOI 10.1016/0006-8993(94)91421-4; Khawaled R, 1999, PFLUG ARCH EUR J PHY, V438, P314, DOI 10.1007/s004240050915; KOMATSU Y, 1994, NEUROSCI RES, V20, P209, DOI 10.1016/0168-0102(94)90089-2; Laaris N, 2000, J NEUROSCI, V20, P1529; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Murayama M, 2005, EUR J NEUROSCI, V21, P3349, DOI 10.1111/j.1460-9568.2005.04167.x; Nicholls J., 2001, NEURON BRAIN; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; Nowak LG, 1997, EXP BRAIN RES, V117, P219, DOI 10.1007/s002210050218; Oka H, 1999, J NEUROSCI METH, V93, P61, DOI 10.1016/S0165-0270(99)00113-2; OSANAI M, 2007, 2007 NEUR M PLANN SA; OSANAI M, 2008, P ISBPE 22 BPES, P153; Osanai M, 2006, NEUROSCI LETT, V402, P81, DOI 10.1016/j.neulet.2006.04.012; Petersen CCH, 2001, J NEUROSCI, V21, P8435, DOI 10.1523/JNEUROSCI.21-21-08435.2001; Sato H, 1996, J PHYSIOL-LONDON, V494, P757, DOI 10.1113/jphysiol.1996.sp021530; Shao ZW, 1999, J NEUROPHYSIOL, V81, P1014, DOI 10.1152/jn.1999.81.3.1014; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; STONE J, 1972, INVEST OPHTH VISUAL, V11, P338; TANAKA S, 2006, 2006 NEUR M PLANN AT; Tanifuji M, 1996, BRAIN RES, V738, P83, DOI 10.1016/0006-8993(96)00767-6; TANIFUJI M, 1994, SCIENCE, V266, P1057, DOI 10.1126/science.7973662; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; TSUMOTO T, 1979, EXP BRAIN RES, V34, P351; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Yuste R, 1997, CEREB CORTEX, V7, P546, DOI 10.1093/cercor/7.6.546; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221	51	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13738	10.1371/journal.pone.0013738	http://dx.doi.org/10.1371/journal.pone.0013738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060776	Green Published, Green Submitted, gold			2022-12-25	WOS:000283645300018
J	Poluch, S; Juliano, SL				Poluch, Sylvie; Juliano, Sharon L.			Populations of Radial Glial Cells Respond Differently to Reelin and Neuregulin1 in a Ferret Model of Cortical Dysplasia	PLOS ONE			English	Article							DEVELOPING CEREBRAL-CORTEX; LIPID-BINDING PROTEIN; APOE RECEPTOR 2; NEURONAL MIGRATION; ERBB RECEPTORS; SOMATOSENSORY CORTEX; NEURAL DEVELOPMENT; PROGENITOR CELLS; VISUAL-CORTEX; VLDL RECEPTOR	Radial glial cells play an essential role during corticogenesis through their function as neural precursors and guides of neuronal migration. Both reelin and neuregulin1 (NRG1) maintain the radial glial scaffold; they also induce expression of Brain Lipid Binding Protein (BLBP), a well known marker of radial glia. Although radial glia in normal ferrets express both vimentin and BLBP, this coexpression diverges at P3; vimentin is expressed in the radial glial processes, while BLBP appears in cells detached from the ventricular zone. Our lab developed a model of cortical dysplasia in the ferret, resulting in impaired migration of neurons into the cortical plate and disordered radial glia. This occurs after exposure to the antimitotic methylazoxymethanol (MAM) on the 24th day of development (E24). Ferrets treated with MAM on E24 result in an overall decrease of BLBP expression; radial glia that continue to express BLBP, however, show only mild disruption compared with the strongly disrupted vimentin expressing radial glia. When E24 MAM-treated organotypic slices are exposed to reelin or NRG1, the severely disrupted vimentin+ radial glial processes are repaired but the slightly disordered BLBP+ processes are not. The realignment of vimentin+ processes was linked with an increase of their BLBP expression. BLBP expressing radial glia are distinguished by being both less affected by MAM treatment and by attempts at repair. We further investigated the effects induced by reelin and found that signaling was mediated via VLDLR/Dab1/Pi3K activation while NRG1 signaling was mediated via erbB3/erbB4/PI3K. We then tested whether radial glial repair correlated with improved neuronal migration. Repairing the radial glial scaffold is not sufficient to restore neuronal migration; although reelin improves migration of neurons toward the cortical plate signaling through ApoER2/Dab1/PI3K activation, NRG1 does not.	[Poluch, Sylvie; Juliano, Sharon L.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Poluch, S (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	sjuliano@usuhs.edu	Juliano, Sharon/AAO-1030-2020		PHS NIH NIMH [RO1 MH62721]; PHS [RO1 NS24014]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024014] Funding Source: NIH RePORTER	PHS NIH NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by PHS NIH NIMH RO1 MH62721 (SLJ) and PHS RO1 NS24014 (SLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen OM, 2003, BIOCHEMISTRY-US, V42, P9355, DOI 10.1021/bi034475p; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Anton ES, 1997, DEVELOPMENT, V124, P3501; Arnaud L, 2003, MOL CELL BIOL, V23, P9293, DOI 10.1128/MCB.23.24.9293-9302.2003; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Birchmeier C, 2009, EXP CELL RES, V315, P611, DOI 10.1016/j.yexcr.2008.10.035; Borrell V, 2006, CEREB CORTEX, V16, P1571, DOI 10.1093/cercor/bhj094; Campbell K, 2002, TRENDS NEUROSCI, V25, P235, DOI 10.1016/S0166-2236(02)02156-2; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; Chen S, 2006, J NEUROSCI, V26, P3079, DOI 10.1523/JNEUROSCI.3785-05.2006; Choi BH, 1996, TOXICOL APPL PHARM, V141, P357, DOI 10.1006/taap.1996.0300; Corbin JG, 2008, J NEUROCHEM, V106, P2272, DOI 10.1111/j.1471-4159.2008.05522.x; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Ferguson KM, 2000, EMBO J, V19, P4632, DOI 10.1093/emboj/19.17.4632; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Frotscher M, 2003, CEREB CORTEX, V13, P634, DOI 10.1093/cercor/13.6.634; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gierdalski M, 2005, J NEUROSCI, V25, P8498, DOI 10.1523/JNEUROSCI.1476-05.2005; Hack I, 2007, DEVELOPMENT, V134, P3883, DOI 10.1242/dev.005447; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hartfuss E, 2003, DEVELOPMENT, V130, P4597, DOI 10.1242/dev.00654; Hasling TA, 2003, EUR J NEUROSCI, V17, P467, DOI 10.1046/j.1460-9568.2003.02468.x; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howard B, 2006, GLIA, V53, P57, DOI 10.1002/glia.20259; Howard BM, 2008, NEUROSCIENTIST, V14, P459, DOI 10.1177/1073858407313512; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; HunterSchaedle KE, 1997, J NEUROBIOL, V33, P459, DOI 10.1002/(SICI)1097-4695(199710)33:4<459::AID-NEU9>3.0.CO;2-9; JACKSON CA, 1989, J NEUROSCI, V9, P1242; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Jossin Y, 2007, MOL CELL BIOL, V27, P7113, DOI 10.1128/MCB.00928-07; Juliano SL, 1996, J COMP NEUROL, V374, P259, DOI 10.1002/(SICI)1096-9861(19961014)374:2<259::AID-CNE8>3.0.CO;2-1; Keilani S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-69; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Luque JM, 2003, DEV BRAIN RES, V140, P195, DOI 10.1016/S0165-3806(02)00604-1; Mart CR, 2006, CARDIOL YOUNG, V16, P152, DOI 10.1017/S1047951106000084; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; MILLER MW, 1993, J COMP NEUROL, V337, P253, DOI 10.1002/cne.903370206; Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Noctor SC, 1997, J COMP NEUROL, V387, P179; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 1999, CEREB CORTEX, V9, P121, DOI 10.1093/cercor/9.2.121; Nomura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001454; Pang T, 2008, NEUROLOGIST, V14, P181, DOI 10.1097/NRL.0b013e31816606b9; Patten BA, 2003, J NEUROSCI, V23, P6132, DOI 10.1523/JNEUROSCI.23-14-06132.2003; PINTOLORD MC, 1982, DEV BRAIN RES, V4, P379, DOI 10.1016/0165-3806(82)90181-X; Poluch S, 2008, CEREB CORTEX, V18, P78, DOI 10.1093/cercor/bhm032; Poluch S, 2007, GLIA, V55, P822, DOI 10.1002/glia.20488; Rahmatullah M, 1998, MOL CELL BIOL, V18, P6245, DOI 10.1128/MCB.18.11.6245; Rakic P, 2007, BRAIN RES REV, V55, P204, DOI 10.1016/j.brainresrev.2007.02.010; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Roper SN, 1997, DEV NEUROSCI-BASEL, V19, P521, DOI 10.1159/000111249; Ross ME, 2002, INT REV NEUROBIOL, V49, P333; Schaefer A, 2008, DEV NEUROBIOL, V68, P590, DOI 10.1002/dneu.20601; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Shibata T, 1997, J NEUROSCI, V17, P9212; Spalice A, 2009, ACTA PAEDIATR, V98, P421, DOI 10.1111/j.1651-2227.2008.01160.x; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; Tabata H, 2003, J NEUROSCI, V23, P9996; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Uchida T, 2009, J NEUROSCI, V29, P10653, DOI 10.1523/JNEUROSCI.0345-09.2009; VERROTTI A, 2009, EUR J PAEDIAT NEUROL; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; Weissman T, 2003, CEREB CORTEX, V13, P550, DOI 10.1093/cercor/13.6.550; Welker W., 1990, Cerebral Cortex, V8B, P3; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; Zecevic N, 2004, GLIA, V48, P27, DOI 10.1002/glia.20044	78	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13709	10.1371/journal.pone.0013709	http://dx.doi.org/10.1371/journal.pone.0013709			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060844	Green Published, gold, Green Submitted			2022-12-25	WOS:000283573800010
J	Yang, AC; Huang, NE; Peng, CK; Tsai, SJ				Yang, Albert C.; Huang, Norden E.; Peng, Chung-Kang; Tsai, Shih-Jen			Do Seasons Have an Influence on the Incidence of Depression? The Use of an Internet Search Engine Query Data as a Proxy of Human Affect	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; PREVALENCE; SEROTONIN; LATITUDE; CLIMATE; HEALTH; SLEEP; MOOD; WEB	Background: Seasonal depression has generated considerable clinical interest in recent years. Despite a common belief that people in higher latitudes are more vulnerable to low mood during the winter, it has never been demonstrated that human's moods are subject to seasonal change on a global scale. The aim of this study was to investigate large-scale seasonal patterns of depression using Internet search query data as a signature and proxy of human affect. Methodology/Principal Findings: Our study was based on a publicly available search engine database, Google Insights for Search, which provides time series data of weekly search trends from January 1, 2004 to June 30, 2009. We applied an empirical mode decomposition method to isolate seasonal components of health-related search trends of depression in 54 geographic areas worldwide. We identified a seasonal trend of depression that was opposite between the northern and southern hemispheres; this trend was significantly correlated with seasonal oscillations of temperature (USA: r = -0.872, p < 0.001; Australia: r = -0.656, p < 0.001). Based on analyses of search trends over 54 geological locations worldwide, we found that the degree of correlation between searching for depression and temperature was latitude-dependent (northern hemisphere: r = -0.686; p < 0.001; southern hemisphere: r = 0.871; p < 0.0001). Conclusions/Significance: Our findings indicate that Internet searches for depression from people in higher latitudes are more vulnerable to seasonal change, whereas this phenomenon is obscured in tropical areas. This phenomenon exists universally across countries, regardless of language. This study provides novel, Internet-based evidence for the epidemiology of seasonal depression.	[Yang, Albert C.] Chu Tung Vet Hosp, Dept Psychiat, Jhudong Township, Taiwan; [Yang, Albert C.; Tsai, Shih-Jen] Natl Yang Ming Univ, Div Psychiat, Sch Med, Taipei 112, Taiwan; [Yang, Albert C.] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Huang, Norden E.] Natl Cent Univ, Res Ctr Adapt Data Anal, Chungli 32054, Taiwan; [Peng, Chung-Kang] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Peng, Chung-Kang] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Margret & HA Rey Inst Nonlinear Dynam Med, Boston, MA 02215 USA; Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02215 USA; [Tsai, Shih-Jen] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Central University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Taipei Veterans General Hospital	Yang, AC (corresponding author), Chu Tung Vet Hosp, Dept Psychiat, Jhudong Township, Taiwan.	ccyang@physionet.org; sjtsai@vghtpe.gov.tw	Peng, Chung-Kang/N-1308-2019; Tsai, Shih-Jen/AAK-7944-2020; Peng, Chung-Kang/E-1489-2011	Peng, Chung-Kang/0000-0003-3666-9833; Tsai, Shih-Jen/0000-0002-9987-022X; Peng, Chung-Kang/0000-0003-3666-9833; Yang, Albert Chih-Chieh/0000-0003-2794-9649	National Science Council of Taiwan [NSC 95-2314-B-075-111, NSC 96-2314-B-075-075]; Taipei Veterans General Hospital [V97A-061]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was supported by the National Science Council of Taiwan (NSC 95-2314-B-075-111; NSC 96-2314-B-075-075) and Taipei Veterans General Hospital (V97A-061). These funders had no role in the design and conduct of the study, collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	ASCHOFF J, 1981, HDB BEHAVIORAL NEURO, P475; BALZER I, 1991, INT J BIOMETEOROL, V34, P231, DOI 10.1007/BF01041834; Bauer M, 2009, J AFFECT DISORDERS, V116, P152, DOI 10.1016/j.jad.2008.11.013; BRAS RL, 1990, HYDROLOGY; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; COHN EG, 1990, BRIT J CRIMINOL, V30, P51, DOI 10.1093/oxfordjournals.bjc.a047980; Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Hippocrates, 1923, WORKS HIPPOCRATES; HONMA KI, 1992, AM J PHYSIOL, V262, pR885, DOI 10.1152/ajpregu.1992.262.5.R885; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Huang NE, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000228; Hulth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004378; JAMES WH, 1990, J BIOSOC SCI, V22, P113, DOI 10.1017/S0021932000018423; KASPER S, 1989, ARCH GEN PSYCHIAT, V46, P823; Kegel M, 2009, NORD J PSYCHIAT, V63, P331, DOI 10.1080/08039480902799040; Levitt AJ, 2002, CAN J PSYCHIAT, V47, P361, DOI 10.1177/070674370204700407; Lo MT, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061924; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Mercer JG, 1998, COMP BIOCHEM PHYS C, V119, P295, DOI 10.1016/S0742-8413(98)00018-8; MOUL DE, 1992, AM J PSYCHIAT, V149, P852; NIKOLAOS A, 2009, APPL EC Q, V55, P107; Novak V, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-39; Partonen T, 1998, LANCET, V352, P1369, DOI 10.1016/S0140-6736(98)01015-0; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; Praschak-Rieder N, 2008, ARCH GEN PSYCHIAT, V65, P1072, DOI 10.1001/archpsyc.65.9.1072; Rajendran PR, 2001, JAMA-J AM MED ASSOC, V285, P804, DOI 10.1001/jama.285.6.804-a; SARRIAS MJ, 1989, BIOL PSYCHIAT, V26, P695, DOI 10.1016/0006-3223(89)90104-2; Spink A., 2009, HDB RES WEB LOG ANAL, P1; Sweeney-Reed CM, 2007, J COMPUT NEUROSCI, V23, P79, DOI 10.1007/s10827-007-0020-3; Tang HW, 2006, BRIT MED J, V333, P1143, DOI 10.1136/bmj.39003.640567.AE; WEHR TA, 1989, AM J PSYCHIAT, V146, P829; WEHR TA, 1991, J CLIN ENDOCR METAB, V73, P1276, DOI 10.1210/jcem-73-6-1276; WILSON K, 2009, CMAJ; WIRZJUSTICE A, 1986, AM J PSYCHIAT, V143, P932; Wu ZH, 2004, P ROY SOC A-MATH PHY, V460, P1597, DOI 10.1098/rspa.2003.1221; Wu ZH, 2007, P NATL ACAD SCI USA, V104, P14889, DOI 10.1073/pnas.0701020104; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Yang AC, 2011, J AFFECT DISORDERS, V129, P275, DOI 10.1016/j.jad.2010.08.010; ZUNG WWK, 1974, ARCH GEN PSYCHIAT, V30, P89	40	88	91	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13728	10.1371/journal.pone.0013728	http://dx.doi.org/10.1371/journal.pone.0013728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	672HN	21060851	Green Published, Green Submitted, gold			2022-12-25	WOS:000283573800022
J	McHardy, I; Keegan, C; Sim, JH; Shi, WY; Lux, R				McHardy, Ian; Keegan, Caroline; Sim, Jee-Hyun; Shi, Wenyuan; Lux, Renate			Transcriptional Profiles of Treponema denticola in Response to Environmental Conditions	PLOS ONE			English	Article							OUTER SHEATH PROTEIN; PORPHYROMONAS-GINGIVALIS; INFECTIVE ENDOCARDITIS; OXYGEN-METABOLISM; OXIDATIVE STRESS; DENTAL PLAQUE; IDENTIFICATION; CHEMOTAXIS; EXPRESSION; GENE	The periodontal pathogen T. denticola resides in a stressful environment rife with challenges, the human oral cavity. Knowledge of the stress response capabilities of this invasive spirochete is currently very limited. Whole genome expression profiles in response to different suspected stresses including heat shock, osmotic downshift, oxygen and blood exposure were examined. Most of the genes predicted to encode conserved heat shock proteins (HSPs) were found to be induced under heat and oxygen stress. Several of these HSPs also seem to be important for survival in hypotonic solutions and blood. In addition to HSPs, differential regulation of many genes encoding metabolic proteins, hypothetical proteins, transcriptional regulators and transporters was observed in patterns that could betoken functional associations. In summary, stress responses in T. denticola exhibit many similarities to the corresponding stress responses in other organisms but also employ unique components including the induction of hypothetical proteins.	[McHardy, Ian; Keegan, Caroline; Shi, Wenyuan] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90024 USA; [Sim, Jee-Hyun; Shi, Wenyuan; Lux, Renate] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	McHardy, I (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90024 USA.	lux@ucla.edu	SHI, wen/GPW-9531-2022	Keegan, Caroline/0000-0002-0852-5077; McHardy, Ian/0000-0002-2121-5460	National Institutes of Health (NIH) [5T32DE007298-12]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	IM was supported by a T32 training grant in oral biology: National Institutes of Health (NIH) T32 #5T32DE007298-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohin JP, 2000, FEMS MICROBIOL LETT, V186, P11, DOI 10.1016/S0378-1097(00)00110-5; Booth IR, 1999, CURR OPIN MICROBIOL, V2, P166, DOI 10.1016/S1369-5274(99)80029-0; Bowden GHW, 1998, CRIT REV ORAL BIOL M, V9, P54, DOI 10.1177/10454411980090010401; Brissette CA, 2004, ORAL MICROBIOL IMMUN, V19, P403, DOI 10.1111/j.1399-302x.2004.00177.x; Brissette CA, 2002, INFECT IMMUN, V70, P3982, DOI 10.1128/IAI.70.7.3982-3984.2002; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; Caldwell CE, 1999, ORAL MICROBIOL IMMUN, V14, P66, DOI 10.1034/j.1399-302X.1999.140109.x; Capone R, 2008, ORAL MICROBIOL IMMUN, V23, P165, DOI 10.1111/j.1399-302X.2007.00404.x; Carmona IT, 2003, ARCH GERONTOL GERIAT, V36, P49, DOI 10.1016/S0167-4943(02)00054-7; Cohen DJ, 2004, ANN THORAC SURG, V77, P537, DOI 10.1016/S0003-4975(03)01454-1; da Silva APB, 2004, CELL MICROBIOL, V6, P485, DOI 10.1111/j.1462-5822.2004.00377.x; Diaz PI, 2006, J BACTERIOL, V188, P2454, DOI 10.1128/JB.188.7.2454-2462.2006; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Goulhen F, 2003, CRIT REV ORAL BIOL M, V14, P399, DOI 10.1177/154411130301400603; Ilbert M, 2006, ANTIOXID REDOX SIGN, V8, P835, DOI 10.1089/ars.2006.8.835; Kaplan Mitchell, 1993, Dysphagia, V8, P225, DOI 10.1007/BF01354542; Lai YL, 2008, APPL ENVIRON MICROB, V74, P73, DOI 10.1128/AEM.01972-07; Lee JY, 2006, J PERIODONTAL RES, V41, P10, DOI 10.1111/j.1600-0765.2005.00832.x; Li H, 1999, INFECT IMMUN, V67, P694, DOI 10.1128/IAI.67.2.694-699.1999; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lopatin DE, 1999, J PERIODONTOL, V70, P1185, DOI 10.1902/jop.1999.70.10.1185; Lux R, 2001, INFECT IMMUN, V69, P6276, DOI 10.1128/IAI.69.10.6276-6283.2001; Magalhaes MAO, 2008, CELL MICROBIOL, V10, P344, DOI 10.1111/j.1462-5822.2007.01045.x; MARQUIS RE, 1995, J IND MICROBIOL, V15, P198, DOI 10.1007/BF01569826; McDowell JV, 2007, INFECT IMMUN, V75, P1050, DOI 10.1128/IAI.01458-06; Meuric V, 2008, ORAL MICROBIOL IMMUN, V23, P308, DOI 10.1111/j.1399-302X.2007.00429.x; Mitchell HL, 2010, MICROBIOL-SGM, V156, P774, DOI 10.1099/mic.0.033654-0; Miyamoto M, 2006, INFECT IMMUN, V74, P2462, DOI 10.1128/IAI.74.4.2462-2467.2006; Nagata E, 2005, EUR J ORAL SCI, V113, P499, DOI 10.1111/j.1600-0722.2005.00258.x; OHTA K, 1986, INFECT IMMUN, V53, P213, DOI 10.1128/IAI.53.1.213-220.1986; Poolman B, 2002, MOL MICROBIOL, V44, P889, DOI 10.1046/j.1365-2958.2002.02894.x; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Schumann W, 2003, CELL STRESS CHAPERON, V8, P207, DOI 10.1379/1466-1268(2003)008<0207:TBSHSS>2.0.CO;2; Seshadri G, 2004, P NATL ACAD SCI USA, V101, P5646, DOI 10.1073/pnas.0307639101; STAMM LV, 1991, INFECT IMMUN, V59, P1572, DOI 10.1128/IAI.59.4.1572-1575.1991; Strom BL, 2000, CIRCULATION, V102, P2842; SYED SA, 1993, RES MICROBIOL, V144, P317, DOI 10.1016/0923-2508(93)90016-U; Thomas BP, 2006, INFECT IMMUN, V74, P1954, DOI 10.1128/IAI.74.3.1954-1957.2006; VAYSSIER C, 1994, FEMS MICROBIOL LETT, V121, P303, DOI 10.1016/0378-1097(94)90308-5; WARAASWAPATI WPN, 2009, ORAL DIS, V9999; Xu QL, 2007, MOL MICROBIOL, V64, P220, DOI 10.1111/j.1365-2958.2007.05636.x; Yoshida A, 2004, ORAL MICROBIOL IMMUN, V19, P196, DOI 10.1111/j.0902-0055.2004.00142.x; Yura T, 2000, BACTERIAL STRESS RESPONSES, P3	44	16	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13655	10.1371/journal.pone.0013655	http://dx.doi.org/10.1371/journal.pone.0013655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048920	Green Published, Green Submitted, gold			2022-12-25	WOS:000283537000026
J	Drescher, J; Bluthgen, N; Schmitt, T; Buhler, J; Feldhaar, H				Drescher, Jochen; Bluethgen, Nico; Schmitt, Thomas; Buehler, Jana; Feldhaar, Heike			Societies Drifting Apart? Behavioural, Genetic and Chemical Differentiation between Supercolonies in the Yellow Crazy Ant Anoplolepis gracilipes	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; NESTMATE RECOGNITION; POPULATION-STRUCTURE; ARGENTINE ANT; CUTICULAR HYDROCARBONS; INTRASPECIFIC AGGRESSION; EVOLUTION; INFERENCE; CUES; HYMENOPTERA	Background: In populations of most social insects, gene flow is maintained through mating between reproductive individuals from different colonies in periodic nuptial flights followed by dispersal of the fertilized foundresses. Some ant species, however, form large polygynous supercolonies, in which mating takes place within the maternal nest (intranidal mating) and fertilized queens disperse within or along the boundary of the supercolony, leading to supercolony growth (colony budding). As a consequence, gene flow is largely confined within supercolonies. Over time, such supercolonies may diverge genetically and, thus, also in recognition cues (cuticular hydrocarbons, CHC's) by a combination of genetic drift and accumulation of colony-specific, neutral mutations. Methodology/Principal Findings: We tested this hypothesis for six supercolonies of the invasive ant Anoplolepis gracilipes in north-east Borneo. Within supercolonies, workers from different nests tolerated each other, were closely related and showed highly similar CHC profiles. Between supercolonies, aggression ranged from tolerance to mortal encounters and was negatively correlated with relatedness and CHC profile similarity. Supercolonies were genetically and chemically distinct, with mutually aggressive supercolony pairs sharing only 33.1%+/- 17.5% (mean +/- SD) of their alleles across six microsatellite loci and 73.8%+/- 11.6% of the compounds in their CHC profile. Moreover, the proportion of alleles that differed between supercolony pairs was positively correlated to the proportion of qualitatively different CHC compounds. These qualitatively differing CHC compounds were found across various substance classes including alkanes, alkenes and mono-, di- and trimethyl-branched alkanes. Conclusions: We conclude that positive feedback between genetic, chemical and behavioural traits may further enhance supercolony differentiation through genetic drift and neutral evolution, and may drive colonies towards different evolutionary pathways, possibly including speciation.	[Drescher, Jochen; Bluethgen, Nico] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Wurzburg, Germany; [Schmitt, Thomas; Buehler, Jana] Univ Freiburg, Fac Biol, Dept Evolutionary Biol & Anim Ecol, Freiburg, Germany; [Feldhaar, Heike] Univ Wurzburg, Dept Behav Physiol & Sociobiol, Wurzburg, Germany; [Feldhaar, Heike] Univ Osnabruck, Dept Behav Biol, Osnabruck, Germany	University of Wurzburg; University of Freiburg; University of Wurzburg; University Osnabruck	Drescher, J (corresponding author), Univ Wurzburg, Dept Anim Ecol & Trop Biol, Wurzburg, Germany.	feldhaar@biologie.uni-osnabrueck.de	Schmitt, Thomas/H-3033-2013; Blüthgen, Nico/F-5983-2010; Feldhaar, Heike/AAB-8678-2020; Drescher, Jochen/AAO-8885-2020	Drescher, Jochen/0000-0002-5162-9779; Feldhaar, Heike/0000-0001-6797-5126	Deutsche Forschungsgemeinschaft DFG [SFB 554, E2]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft DFG (SFB 554 Eolution and mechanisms of arthropod behaviour, project E2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS ES, 1991, P NATL ACAD SCI USA, V88, P2031, DOI 10.1073/pnas.88.5.2031; Akino T, 2004, APPL ENTOMOL ZOOL, V39, P381, DOI 10.1303/aez.2004.381; Blight O, 2010, BIOL INVASIONS, V12, P1491, DOI 10.1007/s10530-009-9561-x; BLIGHT O, BIOL INVASI IN PRESS; Brandstaetter AS, 2008, NATURWISSENSCHAFTEN, V95, P601, DOI 10.1007/s00114-008-0360-5; Brandt M, 2009, MOL ECOL, V18, P997, DOI 10.1111/j.1365-294X.2008.04056.x; Dapporto L, 2009, BIOCHEM SYST ECOL, V37, P341, DOI 10.1016/j.bse.2009.05.018; DRESCHER J, 2010, BIOTROPICA IN PRESS; Drescher J, 2007, MOL ECOL, V16, P1453, DOI 10.1111/j.1365-294X.2007.03260.x; Dronnet S, 2006, J CHEM ECOL, V32, P1027, DOI 10.1007/s10886-006-9043-x; Elmes GW, 2002, OECOLOGIA, V130, P525, DOI 10.1007/s00442-001-0857-5; Errard C, 2005, NATURWISSENSCHAFTEN, V92, P319, DOI 10.1007/s00114-005-0628-y; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Feldhaar H, 2006, MOL ECOL NOTES, V6, P912, DOI 10.1111/j.1471-8286.2006.01397.x; Florane CB, 2004, J CHEM ECOL, V30, P2559, DOI 10.1007/s10886-004-7950-2; Fournier D, 2009, MOL ECOL, V18, P186, DOI 10.1111/j.1365-294X.2008.04018.x; FRANKS N, 1990, J CHEM ECOL, V16, P1431, DOI 10.1007/BF01014079; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Hefetz Abraham, 2007, Myrmecological News, V10, P59; Helantera H, 2009, TRENDS ECOL EVOL, V24, P341, DOI 10.1016/j.tree.2009.01.013; Holldobler B., 2009, SUPERORGANISM; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jaquiery J, 2005, MOL ECOL, V14, P589, DOI 10.1111/j.1365-294X.2005.02433.x; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; Le Breton J, 2004, J INSECT BEHAV, V17, P263, DOI 10.1023/B:JOIR.0000028575.28700.71; Lenoir A, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P219; Liang D, 2000, NATURWISSENSCHAFTEN, V87, P412, DOI 10.1007/s001140050752; Martin SJ, 2009, INSECT SOC, V56, P375, DOI 10.1007/s00040-009-0035-z; Martin S, 2009, J CHEM ECOL, V35, P1151, DOI 10.1007/s10886-009-9695-4; Martin SJ, 2008, BIOL J LINN SOC, V95, P131, DOI 10.1111/j.1095-8312.2008.01038.x; Martin SJ, 2008, J CHEM ECOL, V34, P1072, DOI 10.1007/s10886-008-9482-7; Mayr E., 1942, P1; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; Pedersen JS, 2006, EVOLUTION, V60, P782, DOI 10.1111/j.0014-3820.2006.tb01156.x; Pennanec'h M, 1997, J INSECT PHYSIOL, V43, P1111, DOI 10.1016/S0022-1910(97)00082-6; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Suarez AV, 2002, ANIM BEHAV, V64, P697, DOI 10.1006/anbe.2002.4011; Sunamura E, 2009, INSECT SOC, V56, P143, DOI 10.1007/s00040-009-0001-9; Sunamura E, 2009, BIOL INVASIONS, V11, P2329, DOI 10.1007/s10530-008-9419-7; Takahashi A, 2001, P NATL ACAD SCI USA, V98, P3920, DOI 10.1073/pnas.061465098; Thomas ML, 2006, MOL ECOL, V15, P4303, DOI 10.1111/j.1365-294X.2006.03038.x; Thomas ML, 2010, BIOL INVASIONS, V12, P677, DOI 10.1007/s10530-009-9473-9; Torres CW, 2007, INSECT SOC, V54, P363, DOI 10.1007/s00040-007-0954-5; Ugelvig LV, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-11; van Wilgenburg E, 2010, EVOL APPL, V3, P136, DOI 10.1111/j.1752-4571.2009.00114.x; van Zweden JS, 2010, J EVOLUTION BIOL, V23, P1498, DOI 10.1111/j.1420-9101.2010.02020.x; van Zweden JS, 2009, J INSECT PHYSIOL, V55, P158, DOI 10.1016/j.jinsphys.2008.11.001; Vander Meer Robert K., 1998, P79; Vogel V, 2010, DIVERS DISTRIB, V16, P170, DOI 10.1111/j.1472-4642.2009.00630.x; Vogel V, 2009, EVOLUTION, V63, P1627, DOI 10.1111/j.1558-5646.2009.00628.x	54	31	34	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13581	10.1371/journal.pone.0013581	http://dx.doi.org/10.1371/journal.pone.0013581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042578	Green Published, Green Submitted, gold			2022-12-25	WOS:000283419100018
J	Huang, SJ; Zhang, XF; Jiang, HM; Yan, QA; Ai, X; Wang, YJ; Cai, JP; Jiang, L; Wu, T; Wang, ZZ; Guan, L; Shih, JWK; Ng, MH; Zhu, FC; Zhang, J; Xia, NS				Huang, Shoujie; Zhang, Xuefeng; Jiang, Hanmin; Yan, Qiang; Ai, Xing; Wang, Yijun; Cai, Jiaping; Jiang, Lang; Wu, Ting; Wang, Zhongze; Guan, Li; Shih, J. Wai Kuo; Ng, Mun-Hon; Zhu, Fengcai; Zhang, Jun; Xia, Ningshao			Profile of Acute Infectious Markers in Sporadic Hepatitis E	PLOS ONE			English	Article							E VIRUS-INFECTION; IMMUNOGLOBULIN-M; UNITED-STATES; OUTBREAK; ASSAYS; DISEASE; ANTIBODIES; DIAGNOSIS; ZOONOSIS; NAMIBIA	Laboratory diagnosis of acute infection of hepatitis E virus (HEV) is commonly based on the detection of HEV RNA, IgM and/or rising IgG levels. However, the profile of these markers when the patients present have not been well determined. To clarify the extent of misdiagnosed sporadic hepatitis E in the initial laboratory detection, serial sera of 271 sporadic acute hepatitis cases were collected, detected and the dynamics of each acute marker during the illness course were analyzed. 91 confirmed cases of hepatitis E were identified based on the presentation of HEV RNA, IgM or at least 4 fold rising of IgG levels. 21 (23.1%) hepatitis E cases were false negative for the viral RNA and 40 (44.0%) for rising IgG, because occurrence of these markers were confined to acute phase of infection and viremia had already subsided and antibody level peaked when these patients presented. IgM was detected in 82 (90.1%) cases. It is the most prevalent of the three markers, because the antibody persisted until early convalescence. Nine cases negative for IgM were positive for rising IgG and one was also positive for the viral RNA; all of these nine cases showed high avid IgG in their acute phase sera, which indicated reinfection. In summary, it is not practicable to determine the true occurrence of sporadic hepatitis E. Nevertheless, it could be closely approximated by approach using a combination of all three acute markers.	[Huang, Shoujie; Yan, Qiang; Jiang, Lang; Wu, Ting; Guan, Li; Shih, J. Wai Kuo; Ng, Mun-Hon; Zhang, Jun; Xia, Ningshao] Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China; [Huang, Shoujie] Xiamen Univ, Coll Med, Dept Prevent Med, Xiamen, Peoples R China; [Zhang, Xuefeng; Ai, Xing; Zhu, Fengcai] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Peoples R China; [Jiang, Hanmin; Wang, Yijun; Cai, Jiaping; Wang, Zhongze] Dongtai Ctr Dis Control & Prevent, Dongtai, Peoples R China	Xiamen University; Xiamen University; Jiangsu Provincial Center for Disease Control & Prevention	Huang, SJ (corresponding author), Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China.	zhangj@xmu.edu.cn	Wang, Yijun/GXW-1763-2022; Zhang, Jun/G-4598-2010; Xia, NS/G-4647-2010	Zhang, Jun/0000-0002-6601-9180; Xia, Ningshao/0000-0003-0179-5266; Wu, Ting/0000-0002-1806-3056	National Advanced Technology Research and Development Program [2006AA02A209]; National Science and Technique Major Project [2008ZX10404, 2009ZX10004-704]; National Science Fund for Distinguished Young Scholars [30925030]; Fujian Provincial Science Fund for Distinguished Young Scholars [2009J06020]	National Advanced Technology Research and Development Program; National Science and Technique Major Project; National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Fujian Provincial Science Fund for Distinguished Young Scholars	Work was funded by National Advanced Technology Research and Development Program (No. 2006AA02A209), National Science and Technique Major Project (No. 2008ZX10404, 2009ZX10004-704), National Science Fund for Distinguished Young Scholars (30925030), and Fujian Provincial Science Fund for Distinguished Young Scholars (2009J06020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya SK, 2007, J HEPATOL, V46, P387, DOI 10.1016/j.jhep.2006.09.016; Amon JJ, 2006, J MED VIROL, V78, P741, DOI 10.1002/jmv.20617; Bendall R, 2008, J MED VIROL, V80, P95, DOI 10.1002/jmv.21033; Chen HY, 2005, CLIN DIAGN LAB IMMUN, V12, P593, DOI 10.1128/CDLI.12.5.593-598.2005; Clayson ET, 1998, J MED VIROL, V54, P178, DOI 10.1002/(SICI)1096-9071(199803)54:3&lt;178::AID-JMV6&gt;3.0.CO;2-2; Corwin AL, 1996, AM J TROP MED HYG, V54, P559, DOI 10.4269/ajtmh.1996.54.559; Curry JA, 2009, ANN INTERN MED, V150, P226, DOI 10.7326/0003-4819-150-3-200902030-00028; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Hamid SS, 2002, HEPATOLOGY, V36, P474, DOI 10.1053/jhep.2002.34856; Herremans M, 2007, CLIN VACCINE IMMUNOL, V14, P562, DOI 10.1128/CVI.00231-06; Im SWK, 2001, VACCINE, V19, P3726, DOI 10.1016/S0264-410X(01)00100-1; Isaacson M, 2000, AM J TROP MED HYG, V62, P619, DOI 10.4269/ajtmh.2000.62.619; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P61, DOI 10.1046/j.1365-2893.2003.00398.x; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; Legrand-Abravanel F, 2009, CLIN VACCINE IMMUNOL, V16, P772, DOI 10.1128/CVI.00438-08; Li RC, 2006, EMERG INFECT DIS, V12, P1682, DOI 10.3201/eid1211.060332; Li SW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000537; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Maila HT, 2004, J GEN VIROL, V85, P89, DOI 10.1099/vir.0.19587-0; Myint KSA, 2006, J CLIN MICROBIOL, V44, P1581, DOI 10.1128/JCM.44.4.1581-1583.2006; Myint KSA, 2005, AM J TROP MED HYG, V73, P942, DOI 10.4269/ajtmh.2005.73.942; Pavio N, 2008, FRONT BIOSCI-LANDMRK, V13, P7172, DOI 10.2741/3219; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Rab MA, 1997, AM J TROP MED HYG, V57, P151, DOI 10.4269/ajtmh.1997.57.151; Sailaja B, 2009, EPIDEMIOL INFECT, V137, P234, DOI 10.1017/S0950268808000952; Seriwatana J, 2002, CLIN DIAGN LAB IMMUN, V9, P1072, DOI 10.1128/CDLI.9.5.1072-1078.2002; Takahashi M, 2007, J CLIN MICROBIOL, V45, P3671, DOI 10.1128/JCM.01086-07; Thomas DL, 1997, J CLIN MICROBIOL, V35, P1244, DOI 10.1128/JCM.35.5.1244-1247.1997; Zhang J, 2005, VACCINE, V23, P2881, DOI 10.1016/j.vaccine.2004.11.065; Zhang J, 2003, J MED VIROL, V71, P518, DOI 10.1002/jmv.10523; Zhang J, 2009, VACCINE, V27, P1869, DOI 10.1016/j.vaccine.2008.12.061	31	95	99	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13560	10.1371/journal.pone.0013560	http://dx.doi.org/10.1371/journal.pone.0013560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042408	Green Published, Green Submitted, gold			2022-12-25	WOS:000283293800022
J	Maisonnasse, A; Lenoir, JC; Beslay, D; Crauser, D; Le Conte, Y				Maisonnasse, Alban; Lenoir, Jean-Christophe; Beslay, Dominique; Crauser, Didier; Le Conte, Yves			E-beta-Ocimene, a Volatile Brood Pheromone Involved in Social Regulation in the Honey Bee Colony (Apis mellifera)	PLOS ONE			English	Article							DIVISION-OF-LABOR; HYPOPHARYNGEAL GLAND; QUEEN; AGE; COMMUNICATION; RECOGNITION; HYMENOPTERA; CONFLICT; BEHAVIOR; ESTERS	Background: In honey bee colony, the brood is able to manipulate and chemically control the workers in order to sustain their own development. A brood ester pheromone produced primarily by old larvae (4 and 5 days old larvae) was first identified as acting as a contact pheromone with specific effects on nurses in the colony. More recently a new volatile brood pheromone has been identified: E-beta-ocimene, which partially inhibits ovary development in workers. Methodology and Principal Finding: Our analysis of E-beta-ocimene production revealed that young brood (newly hatched to 3 days old) produce the highest quantity of E-beta-ocimene relative to their body weight. By testing the potential action of this molecule as a non-specific larval signal, due to its high volatility in the colony, we demonstrated that in the presence of E-beta-ocimene nest workers start to forage earlier in life, as seen in the presence of real brood. Conclusions/Significance: In this way, young larvae are able to assign precedence to the task of foraging by workers in order to increase food stores for their own development. Thus, in the complexity of honey bee chemical communication, E-beta-ocimene, a pheromone of young larvae, provides the brood with the means to express their nutritional needs to the workers.	[Maisonnasse, Alban; Lenoir, Jean-Christophe; Beslay, Dominique; Crauser, Didier; Le Conte, Yves] INRA, Lab Biol & Protect & Abeille, UMR 406, Avignon, France	INRAE	Maisonnasse, A (corresponding author), INRA, Lab Biol & Protect & Abeille, UMR 406, Avignon, France.	alban.maisonnasse@avignon.inra.fr	Le Conte, Yves/AAP-2379-2021; Le Conte, Yves M/B-3246-2016; Le Conte, Yves/M-4442-2018	Le Conte, Yves/0000-0002-8466-5370; Le Conte, Yves M/0000-0002-8466-5370; Le Conte, Yves/0000-0002-8466-5370	Human Frontier Science Program [RGP0042/2007C101]	Human Frontier Science Program(Human Frontier Science Program)	Funds were provided by Human Frontier Science Program (RGP0042/2007C101) (http://www.hfsp.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2009, EXP GERONTOL, V44, P467, DOI 10.1016/j.exger.2009.02.013; ARNOLD G, 1994, CR ACAD SCI III-VIE, V317, P511; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Dampney JR, 2004, APIDOLOGIE, V35, P83, DOI 10.1051/apido:2003067; Deseyn J, 2005, APIDOLOGIE, V36, P49, DOI 10.1051/apido:2004068; FREE JB, 1983, ANIM BEHAV, V31, P539, DOI 10.1016/S0003-3472(83)80077-3; GIRAY T, 1994, BEHAV ECOL SOCIOBIOL, V35, P13, DOI 10.1007/BF00167054; Heinze J, 2009, J EXP BIOL, V212, P1775, DOI 10.1242/jeb.015008; Heinze K, 2004, ADV STUD BEHAV, V34, P1, DOI 10.1016/S0065-3454(04)34001-5; Hoover SER, 2005, BEHAV ECOL SOCIOBIOL, V59, P278, DOI 10.1007/s00265-005-0039-2; Hrassnigg N, 1998, J INSECT PHYSIOL, V44, P929, DOI 10.1016/S0022-1910(98)00058-4; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; HUANG ZY, 1989, INSECT SOC, V36, P264, DOI 10.1007/BF02224880; HUANG ZY, 1991, J INSECT BEHAV, V4, P305, DOI 10.1007/BF01048280; Johnson BR, 2010, BEHAV ECOL SOCIOBIOL, V64, P305, DOI 10.1007/s00265-009-0874-7; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; KOENIGER N, 1985, APIMONDIA, P106; Le Conte Y., 1995, Chemoecology, V5/6, P6, DOI 10.1007/BF01259967; LE CONTE Y, 1994, NATURWISSENSCHAFTEN, V81, P462, DOI 10.1007/BF01136651; LE CONTE Y, 1990, NATURWISSENSCHAFTEN, V77, P334, DOI 10.1007/BF01138390; Le Conte Y, 2001, P ROY SOC B-BIOL SCI, V268, P163, DOI 10.1098/rspb.2000.1345; LE CONTE Y, 1995, J ECON ENTOMOL, V88, P798, DOI 10.1093/jee/88.4.798; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; Maisonnasse A, 2009, APIDOLOGIE, V40, P562, DOI 10.1051/apido/2009024; Mohammedi A, 1998, NATURWISSENSCHAFTEN, V85, P455, DOI 10.1007/s001140050531; Mohammedi A, 1996, CR ACAD SCI III-VIE, V319, P769; PAIN JANINE, 1966, ANN ABEILLE [PARIS], V9, P71, DOI 10.1051/apido:19660106; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; Pankiw T, 1998, BEHAV ECOL SOCIOBIOL, V44, P193, DOI 10.1007/s002650050531; Pankiw T, 2004, NATURWISSENSCHAFTEN, V91, P575, DOI 10.1007/s00114-004-0568-y; Pankiw T, 1996, J CHEM ECOL, V22, P605, DOI 10.1007/BF02033573; Pankiw T, 2007, J INSECT BEHAV, V20, P173, DOI 10.1007/s10905-007-9071-6; Pankiw T, 2007, APIDOLOGIE, V38, P156, DOI 10.1051/apido:2006066; Pernal SF, 2000, APIDOLOGIE, V31, P387, DOI 10.1051/apido:2000130; Peters L, 2010, J INSECT PHYSIOL, V56, P132, DOI 10.1016/j.jinsphys.2009.09.014; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; Ratnieks FLW, 2008, TRENDS ECOL EVOL, V23, P45, DOI 10.1016/j.tree.2007.09.013; Schmickl T, 2002, BEHAV ECOL SOCIOBIOL, V51, P415, DOI 10.1007/s00265-002-0457-3; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; Stabentheiner A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008967; TROUILLER J, 1991, NATURWISSENSCHAFTEN, V78, P368, DOI 10.1007/BF01131612; Tsuruda JM, 2009, BEHAV ECOL SOCIOBIOL, V64, P161, DOI 10.1007/s00265-009-0833-3; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Winston M., 1987, The biology of the honey bee.	46	83	90	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13531	10.1371/journal.pone.0013531	http://dx.doi.org/10.1371/journal.pone.0013531			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042405	Green Published, Green Submitted, gold			2022-12-25	WOS:000283293800008
J	Kaur, G; Jans, DA				Kaur, Gurpreet; Jans, David A.			Dual nuclear import mechanisms of sex determining factor SRY: intracellular Ca2+ as a switch	FASEB JOURNAL			English	Article						calmodulin; importin; NLS; nuclear localization; sex reversal	XY-GONADAL-DYSGENESIS; LOCALIZATION SIGNALS; DETERMINING REGION; DNA-BINDING; HMG-BOX; REVERSAL; SOX9; MUTATIONS; TRANSPORT; INHIBITION	The sex-determining region on the Y chromosome (SRY) has 2 nuclear localization signals (NLSs) that flank the DNA binding high mobility group (HMG) domain; the beta-NLS and the CaM-NLS, which mediate nuclear transport through importin beta 1 (Imp beta 1) and the calcium-binding protein calmodulin (CaM), respectively. Here we reconstitute the nuclear import mediated by the 2 NLSs for the first time in vitro, establishing Ran independence of CaM-NLS-dependent transport. The beta- and CaM-NLSs were found to be independently functional out of the context of the SRY HMG domain, dependent on Imp beta 1 and CaM binding, respectively. Intriguingly, direct protein binding assays also indicated competitive binding of Imp beta 1 and CaM to the SRY HMG domain. To assess the potential role of intracellular calcium in modulating SRY nuclear accumulation, Cos-7 cells expressing SRY and control constructs were treated with agents elevating or reducing intracellular Ca2+ levels. The in vivo results, supported by experiments in vitro where transport was assessed with or without 2 mu M Ca2+, indicate a Ca2+-dependent mode of nuclear transport via the CaM-NLS/CaM, with inhibition of beta-NLS/Imp beta 1-mediated nuclear import by intracellular Ca2+. The results imply mutual exclusivity of nuclear transport via the 2 NLSs with intracellular Ca2+ as the switch between the 2.-Kaur, G. Jans, D. A. Dual nuclear import mechanisms of sex determining factor SRY: intracellular Ca2+ as a switch. FASEB J. 25, 665-675 (2011). www.fasebj.org	[Kaur, Gurpreet] Monash Univ, Nucl Signalling Lab, Dept Biochem & Mol Biol, Monash, Vic 3800, Australia	Monash University	Jans, DA (corresponding author), Monash Univ, Nucl Signalling Lab, Dept Biochem & Mol Biol, Bldg 77, Monash, Vic 3800, Australia.	jans@med.monash.edu.au		Jans, David/0000-0001-5115-4745				Argentaro A, 2003, J BIOL CHEM, V278, P33839, DOI 10.1074/jbc.M302078200; Baliga BC, 2003, J BIOL CHEM, V278, P4899, DOI 10.1074/jbc.M211512200; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Efthymiadis A, 1998, J BIOL CHEM, V273, P1623, DOI 10.1074/jbc.273.3.1623; FINLAY DR, 1987, J CELL BIOL, V104, P189, DOI 10.1083/jcb.104.2.189; Forwood Jade K., 2007, V390, P83; Forwood JK, 2002, BIOCHEMISTRY-US, V41, P9333, DOI 10.1021/bi025548s; Forwood JK, 2001, J BIOL CHEM, V276, P46575, DOI 10.1074/jbc.M101668200; Hanover JA, 2007, J BIOL CHEM, V282, P33743, DOI 10.1074/jbc.M705875200; Harley VR, 2003, ENDOCR REV, V24, P466, DOI 10.1210/er.2002-0025; Harley VR, 2003, P NATL ACAD SCI USA, V100, P7045, DOI 10.1073/pnas.1137864100; Harley VR, 1996, FEBS LETT, V391, P24, DOI 10.1016/0014-5793(96)00694-1; Hiramatsu R, 2009, DEVELOPMENT, V136, P129, DOI 10.1242/dev.029587; Kaur G, 2010, BIOCHEM J, V430, P39, DOI 10.1042/BJ20091758; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Mitchell CL, 2002, MOL GENET METAB, V77, P217, DOI 10.1016/S1096-7192(02)00165-8; Preiss S, 2001, J BIOL CHEM, V276, P27864, DOI 10.1074/jbc.M101278200; Sudbeck P, 1997, J BIOL CHEM, V272, P27848, DOI 10.1074/jbc.272.44.27848; Sweitzer TD, 1996, P NATL ACAD SCI USA, V93, P14574, DOI 10.1073/pnas.93.25.14574; Uehara S, 2002, J HUM GENET, V47, P279, DOI 10.1007/s100380200040; Wagstaff KM, 2006, ANAL BIOCHEM, V348, P49, DOI 10.1016/j.ab.2005.10.029; Wagstaff KM, 2005, J FLUORESC, V15, P469, DOI 10.1007/s10895-005-2819-5; Webb SE, 2003, NAT REV MOL CELL BIO, V4, P539, DOI 10.1038/nrm1149; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4	24	19	20	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2011	25	2					665	675		10.1096/fj.10-173351	http://dx.doi.org/10.1096/fj.10-173351			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	21051653				2022-12-25	WOS:000286724800024
J	Zou, CB; Butler, PL; Coon, TA; Smith, RM; Hammen, G; Zhao, YT; Chen, BB; Mallampalli, RK				Zou, Chunbin; Butler, Phillip L.; Coon, Tiffany A.; Smith, Rebecca M.; Hammen, Gary; Zhao, Yutong; Chen, Bill B.; Mallampalli, Rama K.			LPS Impairs Phospholipid Synthesis by Triggering beta-Transducin Repeat-containing Protein (beta-TrCP)-mediated Polyubiquitination and Degradation of the Surfactant Enzyme Acyl-CoA:Lysophosphatidylcholine Acyltransferase I (LPCAT1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; GLYCOGEN-SYNTHASE KINASE-3; ADULT-RAT LUNG; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; REGULATORY ENZYME; CELLS; PHOSPHORYLATION; EXPRESSION; PHOSPHATIDYLCHOLINE; TRANSCRIPTION	Acyl-CoA: lysophosphatidylcholine acyltransferase 1 (LPCAT1) is a relatively newly described and yet indispensable enzyme needed for generation of the bioactive surfactant phospholipid, dipalmitoylphosphatidylcholine (DPPtdCho). Here, we show that lipopolysaccharide (LPS) causes LPCAT1 degradation using the Skp1-Cullin-F-box ubiquitin E3 ligase component, beta-transducin repeat-containing protein (beta-TrCP), that polyubiquitinates LPCAT1, thereby targeting the enzyme for proteasomal degradation. LPCAT1 was identified as a phosphoenzyme as Ser(178) within a phosphodegron was identified as a putative molecular recognition site for glycogen synthase kinase-3 beta (GSK-3 beta) phosphorylation that recruits beta-TrCP docking within the enzyme. beta-TrCP ubiquitinates LPCAT1 at an acceptor site (Lys(221)), as substitution of Lys(221) with Arg abrogated LPCAT1 polyubiquitination. LPS profoundly reduced immunoreactive LPCAT1 levels and impaired lung surfactant mechanics, effects that were overcome by siRNA to beta-TrCP and GSK-3 beta or LPCAT1 gene transfer, respectively. Thus, LPS appears to destabilize the LPCAT1 protein by GSK-3 beta-mediated phosphorylation within a canonical phosphodegron for beta-TrCP docking and site-specific ubiquitination. LPCAT1 is the first lipogenic substrate for beta-TrCP, and the results suggest that modulation of the GSK-3 beta-SCF beta(TrCP) E3 ligase effector pathway might be a unique strategy to optimize dipalmitoylphosphatidylcholine levels in sepsis.	[Mallampalli, Rama K.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Dept Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15240 USA; [Mallampalli, Rama K.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA; [Hammen, Gary] Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL)	Mallampalli, RK (corresponding author), Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Dept Med, Acute Lung Injury Ctr Excellence, 628 NW Montefiore,3459 5th Ave, Pittsburgh, PA 15213 USA.	mallampallirk@upmc.edu	Zou, Chunbin/L-7488-2019	Zou, Chunbin/0000-0003-1355-4726	NHLBI NIH HHS [HL098174, R01 HL091916, R01 HL098174, HL096376, R01 HL096376, R01 HL091916-02, R01 HL097376, HL097376] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096376, R01HL091916, R01HL097376, R01HL098174] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Butler PL, 2010, J BIOL CHEM, V285, P6246, DOI 10.1074/jbc.M109.017350; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen BB, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706472200; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; DENBREEJEN JN, 1989, BIOCHIM BIOPHYS ACTA, V1002, P277, DOI 10.1016/0005-2760(89)90341-X; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; Huang WC, 2009, IMMUNOLOGY, V128, pe275, DOI 10.1111/j.1365-2567.2008.02959.x; Liberman Z, 2008, AM J PHYSIOL-ENDOC M, V294, pE1169, DOI 10.1152/ajpendo.00050.2008; Mallampalli RK, 2000, J BIOL CHEM, V275, P9699, DOI 10.1074/jbc.275.13.9699; MASON RJ, 1980, J BIOL CHEM, V255, P5101; Morimoto R, 2010, J BIOL CHEM, V285, P29857, DOI 10.1074/jbc.M110.147025; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; POST M, 1983, BIOCHIM BIOPHYS ACTA, V750, P68, DOI 10.1016/0005-2760(83)90205-9; Ray NB, 2010, NAT MED, V16, P1120, DOI 10.1038/nm.2213; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Tachado SD, 2008, J BIOL CHEM, V283, P33191, DOI 10.1074/jbc.M805067200; Wang CY, 2009, MOL BIOL CELL, V20, P4153, DOI 10.1091/mbc.E09-02-0174; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	26	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2719	2727		10.1074/jbc.M110.192377	http://dx.doi.org/10.1074/jbc.M110.192377			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21068446	hybrid, Green Published			2022-12-25	WOS:000286464300038
J	Awayda, MS; Awayda, KL; Pochynyuk, O; Bugaj, V; Stockand, JD; Ortiz, RM				Awayda, Mouhamed S.; Awayda, Karen L.; Pochynyuk, Oleh; Bugaj, Vladislav; Stockand, James D.; Ortiz, Rudy M.			Acute Cholesterol-induced Anti-natriuretic Effects ROLE OF EPITHELIAL Na+ CHANNEL ACTIVITY, PROTEIN LEVELS, AND PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; GAMMA-SUBUNIT; LIPID RAFTS; MEMBRANE CHOLESTEROL; SERUM-CHOLESTEROL; PLASMA-MEMBRANE; RAT-KIDNEY; ACTIVATION; ENAC; PROSTASIN	The epithelial Na+ channel (ENaC) is modulated by membrane lipid composition. However, the effect of an in vivo change of membrane composition is unknown. We examined the effect of a 70-day enhanced cholesterol diet (ECD) on ENaC and renal Na+ handling. Rats were fed a standard chow or one supplemented with 1% cholesterol and 0.5% cholic acid (ECD). ECD animals exhibited marked anti-diuresis and anti-natriuresis (40 and 47%), which peaked at 1-3 weeks. Secondary compensation returned urine output and urinary Na+ excretion to control levels by week 10. During these initial changes, there were no accompanying effects on systolic blood pressure, serum creatinine, or urinary creatinine excretion, indicating that the these effects of ECD preceded those which modify renal filtration and blood pressure. The effects of ECD on ENaC were evaluated by measuring the relative protein content of alpha, beta, and gamma subunits. alpha and gamma blots were further examined for subunit cleavage (a process that activates ENaC). No significant changes were observed in alpha and beta levels throughout the study. However, levels of cleaved gamma were elevated, suggesting that ENaC was activated. The changes of gamma persisted at week 10 and were accompanied by additional subunit fragments, indicating potential changes of gamma-cleaving proteases. Enhanced protease activity, and specifically that which could act on the second identified cleavage site in gamma, was verified in a newly developed urinary protease assay. These results predict enhanced ENaC activity, an effect that was confirmed in patch clamp experiments of principal cells of split open collecting ducts, where ENaC open probability was increased by 40% in the ECD group. These data demonstrate a complex series of events and a new regulatory paradigm that is initiated by ECD prior to the onset of elevated blood pressure. These events lead to changes of renal Na+ handling, which occur in part by effects on extracellular gamma-ENaC cleavage.	[Awayda, Mouhamed S.; Awayda, Karen L.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA; [Pochynyuk, Oleh; Bugaj, Vladislav; Stockand, James D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Ortiz, Rudy M.] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Texas System; University of Texas Health San Antonio; University of California System; University of California Merced	Awayda, MS (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, 124 Sherman Hall,3435 Main St, Buffalo, NY 14214 USA.	awayda@buffalo.edu		Stockand, James/0000-0002-3817-4319	National Institutes of Health [DK55626]; John R. Oishei Foundation; University of California; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John R. Oishei Foundation; University of California(University of California System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK55626. This work was also supported by the John R. Oishei Foundation and University of California start-up funds.	Awayda MS, 2004, J GEN PHYSIOL, V123, P709, DOI 10.1085/jgp.200308983; Balut C, 2006, AM J PHYSIOL-CELL PH, V290, pC87, DOI 10.1152/ajpcell.00184.2005; Barbuti A, 2004, CIRC RES, V94, P1325, DOI 10.1161/01.RES.0000127621.54132.AE; Belli S, 2009, J PHARM SCI-US, V98, P1905, DOI 10.1002/jps.21558; Bengrine A, 2007, J BIOL CHEM, V282, P26884, DOI 10.1074/jbc.M611829200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borghi C, 2007, J HYPERTENS, V25, P2051, DOI 10.1097/HJH.0b013e32827759a6; Borroni V, 2007, MOL MEMBR BIOL, V24, P1, DOI 10.1080/09687860600903387; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Christian AE, 1997, J LIPID RES, V38, P2264; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Eshcol JO, 2008, AM J PHYSIOL-CELL PH, V295, pC732, DOI 10.1152/ajpcell.00514.2007; Frindt G, 2009, AM J PHYSIOL-RENAL, V297, pF389, DOI 10.1152/ajprenal.90528.2008; Gosalia DN, 2005, MOL CELL PROTEOMICS, V4, P626, DOI 10.1074/mcp.M500004-MCP200; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Hill WG, 2002, J BIOL CHEM, V277, P33541, DOI 10.1074/jbc.C200309200; Hinzpeter A, 2007, J BIOL CHEM, V282, P2423, DOI 10.1074/jbc.M608251200; Hu JC, 2009, J BIOL CHEM, V284, P36334, DOI 10.1074/jbc.M109.032870; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; JACOB MP, 1982, ARTERY, V10, P310; Koda A, 2009, HYPERTENS RES, V32, P276, DOI 10.1038/hr.2009.6; Kopkan L, 2009, AM J PHYSIOL-RENAL, V297, pF1606, DOI 10.1152/ajprenal.90743.2008; Krueger B, 2009, CELL PHYSIOL BIOCHEM, V24, P605, DOI 10.1159/000257516; Lee IH, 2009, J BIOL CHEM, V284, P12663, DOI 10.1074/jbc.M809737200; Levitan I, 2009, IUBMB LIFE, V61, P781, DOI 10.1002/iub.192; MOLITORIS BA, 1985, AM J PHYSIOL, V249, pF12, DOI 10.1152/ajprenal.1985.249.1.F12; MORRIS MD, 1957, J BIOL CHEM, V224, P1039; Ortiz RM, 2007, AM J PHYSIOL-RENAL, V293, pF139, DOI 10.1152/ajprenal.00504.2006; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Sampson Laura J., 2008, V491, P91, DOI 10.1007/978-1-59745-526-8_7; Singh DK, 2009, J BIOL CHEM, V284, P30727, DOI 10.1074/jbc.M109.011221; Staruschenko A, 2007, J AM SOC NEPHROL, V18, P1652, DOI 10.1681/ASN.2007010020; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; TSAI AC, 1975, J NUTR, V105, P939, DOI 10.1093/jn/105.7.939; Wang J, 2009, AM J PHYSIOL-RENAL, V296, pF284, DOI 10.1152/ajprenal.90647.2008; Wei SP, 2007, J MEMBRANE BIOL, V220, P21, DOI 10.1007/s00232-007-9071-7; West TA, 2005, CELL PHYSIOL BIOCHEM, V16, P263, DOI 10.1159/000089852; YU JX, 1994, J BIOL CHEM, V269, P18843	46	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1683	1695		10.1074/jbc.M110.159194	http://dx.doi.org/10.1074/jbc.M110.159194			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21041305	Green Published, hybrid			2022-12-25	WOS:000286191500008
J	Cheng, HM; Rashid, S; Yu, ZX; Yoshizumi, A; Hwang, EL; Brodsky, B				Cheng, Haiming; Rashid, Shayan; Yu, Zhuoxin; Yoshizumi, Ayumi; Hwang, Eileen; Brodsky, Barbara			Location of Glycine Mutations within a Bacterial Collagen Protein Affects Degree of Disruption of Triple-helix Folding and Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOGENESIS IMPERFECTA; I COLLAGEN; MOLECULAR-STRUCTURE; MUTANT COLLAGEN; MODEL; DOMAIN; ENZYMES; CHAINS	The hereditary bone disorder osteogenesis imperfecta is often caused by missense mutations in type I collagen that change one Gly residue to a larger residue and that break the typical (Gly-Xaa-Yaa)(n) sequence pattern. Site-directed mutagenesis in a recombinant bacterial collagen system was used to explore the effects of the Gly mutation position and of the identity of the residue replacing Gly in a homogeneous collagen molecular population. Homotrimeric bacterial collagen proteins with a Gly-to-Arg or Gly-to-Ser replacement formed stable triple-helix molecules with a reproducible 2 degrees C decrease in stability. All Gly replacements led to a significant delay in triple-helix folding, but a more dramatic delay was observed when the mutation was located near the N terminus of the triple-helix domain. This highly disruptive mutation, close to the globular N-terminal trimerization domain where folding is initiated, is likely to interfere with triple-helix nucleation. A positional effect of mutations was also suggested by trypsin sensitivity for a Gly-to-Arg replacement close to the triple-helix N terminus but not for the same replacement near the center of the molecule. The significant impact of the location of a mutation on triple-helix folding and conformation could relate to the severe consequences of mutations located near the C terminus of type I and type III collagens, where trimerization occurs and triple-helix folding is initiated.	[Cheng, Haiming; Rashid, Shayan; Yu, Zhuoxin; Yoshizumi, Ayumi; Hwang, Eileen; Brodsky, Barbara] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Brodsky, B (corresponding author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.	barbara.brodsky@tufts.edu	Yu, Zhuoxin/L-1512-2013; Cheng, Haiming/AAU-7243-2020	Cheng, Haiming/0000-0002-1686-5354; Hwang, Eileen/0000-0003-0161-6977	National Institutes of Health [GM60048, T32 GM008360]; China Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060048, T32GM008360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60048 (to B. B.) and Training Grant T32 GM008360 (to E. H.). This work was also supported by a China Scholarship Council fellowship (to H. C.).	BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; Baum Jean, 1999, Current Opinion in Structural Biology, V9, P122, DOI 10.1016/S0959-440X(99)80016-5; Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097; Bhate M, 2002, BIOCHEMISTRY-US, V41, P6539, DOI 10.1021/bi020070d; BONADIO J, 1985, NATURE, V316, P363, DOI 10.1038/316363a0; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; BRYAN MA, 2010, BIOPOLYMERS     0318, DOI DOI 10.1002/BIP.21432; Byers P, 2002, CONNECTIVE TISSUE IT, P385, DOI DOI 10.1002/0471221929.CH8; Byers P H, 1995, Connect Tissue Res, V31, P257, DOI 10.3109/03008209509010818; Byers PH, 2001, PHILOS T ROY SOC B, V356, P151, DOI 10.1098/rstb.2000.0760; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; Feng YB, 1997, BIOCHEMISTRY-US, V36, P8716, DOI 10.1021/bi962980z; Forlino A, 2007, MATRIX BIOL, V26, P604, DOI 10.1016/j.matbio.2007.06.005; Gauba V, 2008, J AM CHEM SOC, V130, P7509, DOI 10.1021/ja801670v; Kelly JW, 2001, PHILOS T R SOC B, V356, P157; Lukomski S, 2000, INFECT IMMUN, V68, P6542, DOI 10.1128/IAI.68.12.6542-6553.2000; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199; Ramachandran G N., 1967, TREATISE COLLAGEN; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; Smith LT, 1997, J INVEST DERMATOL, V108, P241, DOI 10.1111/1523-1747.ep12286441; STARMAN BJ, 1989, J CLIN INVEST, V84, P1206, DOI 10.1172/JCI114286; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134; Yu ZX, 2010, PROTEIN SCI, V19, P775, DOI 10.1002/pro.356	30	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2041	2046		10.1074/jbc.M110.153965	http://dx.doi.org/10.1074/jbc.M110.153965			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21071452	Green Published, hybrid			2022-12-25	WOS:000286191500046
J	Lawrence, MC; Naziruddin, B; Levy, MF; Jackson, A; Mcglynn, K				Lawrence, Michael C.; Naziruddin, Bashoo; Levy, Marlon F.; Jackson, Andrew; Mcglynn, Kathleen			Calcineurin/Nuclear Factor of Activated T Cells and MAPK Signaling Induce TNF-alpha Gene Expression in Pancreatic Islet Endocrine Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; RENAL-TRANSPLANT RECIPIENTS; NONOBESE DIABETIC MICE; TRANSCRIPTION FACTOR NFAT; CYTOKINE MESSENGER-RNA; BETA-CELL; DENDRITIC CELLS; NOD MICE; CYCLOSPORINE-A; NUCLEAR FACTOR	Cytokines contribute to pancreatic islet inflammation, leading to impaired glucose homeostasis and diabetic diseases. A plethora of data shows that proinflammatory cytokines are produced in pancreatic islets by infiltrating mononuclear immune cells. Here, we show that pancreatic islet alpha cells and beta cells express tumor necrosis factor-alpha (TNF-alpha) and other cytokines capable of promoting islet inflammation when exposed to interleukin-1 beta (IL-1 beta). Cytokine expression by beta cells was dependent on calcineurin (CN)/nuclear factor of activated T cells (NFAT) and MAPK signaling. NFAT associated with the TNF-alpha promoter in response to stimuli and synergistically activated promoter activity with ATF2 and c-Jun. In contrast, the beta-cell-specific transcriptional activator MafA could repress NFAT-mediated TNF-alpha gene expression whenever C/EBP-beta was bound to the promoter. NFAT differentially regulated the TNF-alpha gene depending upon the expression and MAPK-dependent activation of interacting basic leucine zipper partners in beta cells. Both p38 and JNK were required for induction of TNF-alpha mRNA and protein expression. Collectively, the data show that glucose and IL-1 beta can activate signaling pathways, which control induction and repression of cytokines in pancreatic endocrine cells. Thus, by these mechanisms, pancreatic beta cells themselves may contribute to islet inflammation and their own immunological destruction in the pathogenesis of diabetes.	[Lawrence, Michael C.; Mcglynn, Kathleen] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Naziruddin, Bashoo; Levy, Marlon F.] Baylor Univ, Med Ctr, Baylor Reg Transplant Inst, Dallas, TX 75246 USA; [Jackson, Andrew] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor University; Baylor University Medical Center; Yale University	Lawrence, MC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Michael.Lawrence@UTSouthwestern.edu	Jackson, Andrew M/C-1426-2008	Jackson, Andrew M/0000-0002-8620-8544	National Institutes of Health [DK55310]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK55310 (to Melanie H. Cobb).	Abdullah HI, 2006, AM J PHYSIOL-RENAL, V290, pF1110, DOI 10.1152/ajprenal.00223.2005; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Al-Uzri A, 2001, TRANSPLANTATION, V72, P1020, DOI 10.1097/00007890-200109270-00007; Araujo EP, 2007, ENDOCRINOLOGY, V148, P5991, DOI 10.1210/en.2007-0132; ARGILES JM, 1994, HORM METAB RES, V26, P447, DOI 10.1055/s-2007-1001730; Arnush M, 1998, J CLIN INVEST, V102, P516, DOI 10.1172/JCI844; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Campbell PM, 1996, TRANSPLANTATION, V61, P933, DOI 10.1097/00007890-199603270-00016; Cardozo AK, 2003, J PROTEOME RES, V2, P553, DOI 10.1021/pr034029o; Cardozo AK, 2001, DIABETES, V50, P909, DOI 10.2337/diabetes.50.5.909; Chen MC, 2001, DIABETOLOGIA, V44, P325, DOI 10.1007/s001250051622; Cho Y, 2003, SLEEP, V26, pA362; Chow CW, 1999, MOL CELL BIOL, V19, P2300; Christen U, 2001, J IMMUNOL, V166, P7023, DOI 10.4049/jimmunol.166.12.7023; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Dahlen E, 1998, J IMMUNOL, V160, P3585; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Doyle ME, 2003, PHARMACOL REV, V55, P105, DOI 10.1124/pr.55.1.7; el-Nawawy A, 1998, Indian J Pediatr, V65, P455, DOI 10.1007/BF02761143; El-Sheikh A, 1999, J AUTOIMMUN, V12, P109, DOI 10.1006/jaut.1998.0264; GEPTS W, 1978, DIABETES, V27, P251, DOI 10.2337/diab.27.1.S251; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Gonzalez-Gay MA, 2006, CLIN EXP RHEUMATOL, V24, P83; GRANELLIPIPERNO A, 1990, J EXP MED, V172, P1869, DOI 10.1084/jem.172.6.1869; GRANELLIPIPERNO A, 1990, J EXP MED, V171, P533, DOI 10.1084/jem.171.2.533; Green EA, 2000, IMMUNITY, V12, P459, DOI 10.1016/S1074-7613(00)80198-3; Green EA, 1998, IMMUNITY, V9, P733, DOI 10.1016/S1074-7613(00)80670-6; Grewal IS, 1996, J EXP MED, V184, P1963, DOI 10.1084/jem.184.5.1963; Hanley S, 2006, TRANSPLANTATION, V82, P813, DOI 10.1097/01.tp.0000234787.05789.23; Heit JJ, 2007, BIOESSAYS, V29, P1011, DOI 10.1002/bies.20644; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hohmeier HE, 2003, INT J OBESITY, V27, pS12, DOI 10.1038/sj.ijo.0802493; Ishizuka N, 1999, METABOLISM, V48, P1485, DOI 10.1016/S0026-0495(99)90234-2; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P968, DOI 10.1073/pnas.87.3.968; JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667; Jorns A, 2005, DIABETES, V54, P2041, DOI 10.2337/diabetes.54.7.2041; Kagi D, 1999, J IMMUNOL, V162, P4598; KAYE RE, 1992, P NATL ACAD SCI USA, V89, P8542, DOI 10.1073/pnas.89.18.8542; Krentz AJ, 2001, TRANSPLANTATION, V72, P1593; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Lawrence MC, 2002, DIABETES, V51, P691, DOI 10.2337/diabetes.51.3.691; Lawrence MC, 2001, MOL ENDOCRINOL, V15, P1758, DOI 10.1210/me.15.10.1758; Lawrence MC, 2007, P NATL ACAD SCI USA, V104, P11518, DOI 10.1073/pnas.0704618104; Lawrence MC, 2009, P NATL ACAD SCI USA, V106, P22181, DOI 10.1073/pnas.0912596106; Lee LF, 2005, P NATL ACAD SCI USA, V102, P15995, DOI 10.1073/pnas.0508122102; LeeperWoodford SK, 1997, AM J PHYSIOL-ENDOC M, V273, pE433, DOI 10.1152/ajpendo.1997.273.2.E433; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LIU J, 1993, TRENDS PHARMACOL SCI, V14, P182, DOI 10.1016/0165-6147(93)90206-Y; LIU J, 1992, BIOCHEMISTRY-US, V31, P3896, DOI 10.1021/bi00131a002; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Maes BD, 2001, TRANSPLANTATION, V72, P1655, DOI 10.1097/00007890-200111270-00014; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; MEHTA V, 1993, LYMPHOKINE CYTOK RES, V12, P255; MEHTA VK, 1994, EUR J ENDOCRINOL, V130, P208, DOI 10.1530/eje.0.1300208; Movahedi B, 2004, DIABETOLOGIA, V47, P998, DOI 10.1007/s00125-004-1426-3; Pakala SV, 1999, J EXP MED, V189, P1053, DOI 10.1084/jem.189.7.1053; PICARELLA DE, 1993, J IMMUNOL, V150, P4136; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Rabinovitch A, 1989, Reg Immunol, V2, P77; Rabinovitch A, 1996, DIABETES, V45, P749, DOI 10.2337/diabetes.45.6.749; Rabinovitch A, 2003, REV ENDOCR METAB DIS, V4, P291, DOI 10.1023/A:1025160614313; Rabinovitch A, 2003, ADV EXP MED BIOL, V520, P159; RABINOVITCH A, 1995, J IMMUNOL, V154, P4874; Rajagopalan G, 2003, DIABETES, V52, P342, DOI 10.2337/diabetes.52.2.342; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rieneck K, 2000, APMIS, V108, P855, DOI 10.1111/j.1600-0463.2000.tb00009.x; Roep BO, 2003, DIABETOLOGIA, V46, P305, DOI 10.1007/s00125-003-1089-5; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Sell H, 2010, CURR OPIN CLIN NUTR, V13, P366, DOI 10.1097/MCO.0b013e32833aab7f; Shao CL, 2010, J BIOL CHEM, V285, P19710, DOI 10.1074/jbc.M109.087486; SVENSSON U, 1995, MOL IMMUNOL, V32, P157, DOI 10.1016/0161-5890(94)00107-C; TOCCI MJ, 1989, J IMMUNOL, V143, P718; Tsai EY, 1996, MOL CELL BIOL, V16, P5232; Tsai EY, 1996, MOL CELL BIOL, V16, P459; Tsiotra PC, 2001, INT J OBESITY, V25, P1018, DOI 10.1038/sj.ijo.0801657; Tsytsykova AV, 1996, J BIOL CHEM, V271, P3763; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; Viola JPB, 1997, MEM I OSWALDO CRUZ, V92, P147, DOI 10.1590/S0074-02761997000800020; VOORBIJ HAM, 1989, DIABETES, V38, P1623, DOI 10.2337/diabetes.38.12.1623; Weir M, 2001, TRANSPL P, V33, p23S, DOI 10.1016/S0041-1345(01)02231-X; YANG XD, 1994, J EXP MED, V180, P995, DOI 10.1084/jem.180.3.995; Yazdani-Biuki B, 2004, EUR J CLIN INVEST, V34, P641, DOI 10.1111/j.1365-2362.2004.01390.x; Zagariya A, 1998, MOL CELL BIOL, V18, P2815, DOI 10.1128/MCB.18.5.2815; ZIEGLER AG, 1992, J AUTOIMMUN, V5, P571, DOI 10.1016/0896-8411(92)90154-I	88	48	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1025	1036		10.1074/jbc.M110.158675	http://dx.doi.org/10.1074/jbc.M110.158675			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059644	hybrid, Green Published			2022-12-25	WOS:000286005000013
J	Liu, SH; Hatano, B; Zhao, MH; Yen, CC; Kang, K; Reilly, SM; Gangl, MR; Gorgun, C; Balschi, JA; Ntambi, JM; Lee, CH				Liu, Sihao; Hatano, Ben; Zhao, Minghui; Yen, Chen-Chung; Kang, Kihwa; Reilly, Shannon M.; Gangl, Matthew R.; Gorgun, Cem; Balschi, James A.; Ntambi, James M.; Lee, Chih-Hao			Role of Peroxisome Proliferator-activated Receptor delta/beta in Hepatic Metabolic Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-DELTA; INSULIN-RESISTANCE; SKELETAL-MUSCLE; PROTEIN-KINASE; TRIGLYCERIDE SYNTHESIS; TARGETED DISRUPTION; GLUCOSE-HOMEOSTASIS; FATTY-ACIDS; IKK-BETA; GENE	Pharmacological activation of peroxisome proliferator-activated receptor delta/beta (PPAR delta/beta) improves glucose handling and insulin sensitivity. The target tissues of drug actions remain unclear. We demonstrate here that adenovirus-mediated liver-restricted PPAR delta activation reduces fasting glucose levels in chow-and high fat-fed mice. This effect is accompanied by hepatic glycogen and lipid deposition as well as up-regulation of glucose utilization and de novo lipogenesis pathways. Promoter analyses indicate that PPAR delta regulates hepatic metabolic programs through both direct and indirect transcriptional mechanisms partly mediated by its co-activator, PPAR gamma co-activator-1 beta. Assessment of the lipid composition reveals that PPAR delta increases the production of monounsaturated fatty acids, which are PPAR activators, and reduces that of saturated FAs. Despite the increased lipid accumulation, adeno-PPAR delta-infected livers exhibit less damage and show a reduction in JNK stress signaling, suggesting that PPAR delta-regulated lipogenic program may protect against lipotoxicity. The altered substrate utilization by PPAR delta also results in a secondary effect on AMP-activated protein kinase activation, which likely contributes to the glucose-lowering activity. Collectively, our data suggest that PPAR delta controls hepatic energy substrate homeostasis by coordinated regulation of glucose and fatty acid metabolism, which provide a molecular basis for developing PPAR delta agonists to manage hyperglycemia and insulin resistance.	[Gangl, Matthew R.; Gorgun, Cem; Lee, Chih-Hao] Harvard Univ, Sch Publ Hlth, Dept Nutr, Dept Genet & Complex Dis,Div Biol Sci, Boston, MA 02115 USA; [Zhao, Minghui; Ntambi, James M.] Univ Wisconsin, Dept Nutr Sci, Dept Biochem, Madison, WI 53706 USA; [Yen, Chen-Chung; Balschi, James A.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Physiol NMR Core Lab, Boston, MA 02115 USA; [Yen, Chen-Chung; Balschi, James A.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Lee, CH (corresponding author), 665 Huntington Ave,Bldg 1,Rm 207, Boston, MA 02115 USA.	clee@hsph.harvard.edu	Reilly, Shannon Marie/ABB-6473-2021; liu, sihao/A-8823-2015	Reilly, Shannon Marie/0000-0003-0412-2446; liu, sihao/0000-0002-4188-3693	National Institutes of Health [HL46033, DK062388, DK075046]; Japan Self Defense Forces Central Hospital; National Institutes of Health NIEHS [T32 ES07155]; American Heart Association; American Diabetes Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046033, R29HL046033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062388, R01DK075046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES016645, T32ES007155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Self Defense Forces Central Hospital; National Institutes of Health NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL46033 (to J. A. B.), DK062388 (to J. M. N.), and DK075046 (to C.-H. L.). This work was also supported by funds from the Japan Self Defense Forces Central Hospital (to B. H.), National Institutes of Health NIEHS Training Grant T32 ES07155 (to S. M. R.), and by the American Heart Association and American Diabetes Association (to C.-H. L.).	Akiyama TE, 2004, J BIOL CHEM, V279, P20874, DOI 10.1074/jbc.M312802200; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chawla A, 2003, P NATL ACAD SCI USA, V100, P1268, DOI 10.1073/pnas.0337331100; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Haber EP, 2003, J CELL PHYSIOL, V194, P1, DOI 10.1002/jcp.10187; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; LEE SST, 1995, MOL CELL BIOL, V15, P3012; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Miyazaki M, 2001, J BIOL CHEM, V276, P39455, DOI 10.1074/jbc.M106442200; Miyazaki M, 2001, J LIPID RES, V42, P1018; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Niswender KD, 1997, J BIOL CHEM, V272, P22570, DOI 10.1074/jbc.272.36.22570; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; PAGLIASSOTTI MJ, 1992, ANNU REV PHYSIOL, V54, P847, DOI 10.1146/annurev.physiol.54.1.847; Postic C, 2001, RECENT PROG HORM RES, V56, P195, DOI 10.1210/rp.56.1.195; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Reilly SM, 2008, FEBS LETT, V582, P26, DOI 10.1016/j.febslet.2007.11.040; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; Shiota M, 2001, DIABETES, V50, P622, DOI 10.2337/diabetes.50.3.622; Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170; Staels B, 2006, CURR MED RES OPIN, V22, pS27, DOI 10.1185/030079906X112732; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Wang Y, 2004, PLOS BIOL, V2, P610, DOI 10.1371/journal.pbio.0020128; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wu CD, 2005, CELL METAB, V2, P131, DOI 10.1016/j.cmet.2005.07.003; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zhang L, 2007, AM J PHYSIOL-HEART C, V293, pH457, DOI 10.1152/ajpheart.00002.2007	48	107	110	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1237	1247		10.1074/jbc.M110.138115	http://dx.doi.org/10.1074/jbc.M110.138115			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059653	Green Published, hybrid			2022-12-25	WOS:000286005000035
J	Nicholson, AM; Methner, DNR; Ferreira, A				Nicholson, Alexandra M.; Methner, D. Nicole Riherd; Ferreira, Adriana			Membrane Cholesterol Modulates beta-Amyloid-dependent Tau Cleavage by Inducing Changes in the Membrane Content and Localization of N-Methyl-D-aspartic Acid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATURE HIPPOCAMPAL-NEURONS; COATED VESICLE FORMATION; SUBUNIT MESSENGER-RNAS; ALZHEIMERS-DISEASE; NMDA-RECEPTOR; LIPID RAFTS; RAT-BRAIN; A-BETA; DEVELOPMENTAL-CHANGES; POSTNATAL-DEVELOPMENT	We have previously shown that beta-amyloid (A beta) treatment resulted in an age-dependent calpain activation leading to Tau cleavage into a neurotoxic 17-kDa fragment in a cellular model of Alzheimer disease. This detrimental cellular response was mediated by a developmentally regulated increase in membrane cholesterol levels. In this study, we assessed the molecular mechanisms by which cholesterol modulated A beta-induced Tau cleavage in cultured hippocampal neurons. Our results indicated that these mechanisms did not involve the regulation of the binding of A beta aggregates to the plasma membrane. On the other hand, experiments using N-methyl-D-aspartic acid receptor inhibitors suggested that these receptors played an essential role in cholesterol-mediated A beta-dependent calpain activity and 17-kDa Tau production. Biochemical and immunocytochemical analyses demonstrated that decreasing membrane cholesterol levels in mature neurons resulted in a significant reduction of the NR1 subunit at the membrane as well as an increase in the number of large NR1, NR2A, and NR2B subunit clusters. Moreover, the majority of these larger N-methyl-D-aspartic acid receptor subunit immunoreactive spots was not juxtaposed to presynaptic sites in cholesterol-reduced neurons. These data suggested that changes at the synaptic level underlie the mechanism by which membrane cholesterol modulates developmental changes in the susceptibility of hippocampal neurons to A beta-induced toxicity.	[Nicholson, Alexandra M.; Methner, D. Nicole Riherd; Ferreira, Adriana] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Ferreira, A (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, 303 E Chicago Ave,Ward Bldg,Rm 8-140, Chicago, IL 60611 USA.	a-ferreira@northwestern.edu		Ferreira, Adriana/0000-0003-3705-3918	National Institutes of Health [RO1 NS39080]; Alzheimer's Association [57869]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 NS39080. This work was also supported byAlzheimer's Association Grant 57869 (to A. F.).	Abulrob A, 2005, J NEUROCHEM, V92, P1477, DOI 10.1111/j.1471-4159.2005.03001.x; ARIOKA M, 1993, J NEUROCHEM, V60, P461, DOI 10.1111/j.1471-4159.1993.tb03173.x; Avdulov NA, 1997, J NEUROCHEM, V69, pS102; BENKE D, 1995, J RECEPT SIGNAL TR R, V15, P393, DOI 10.3109/10799899509045229; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Besshoh S, 2007, J NEUROSCI RES, V85, P1876, DOI 10.1002/jnr.21336; Bharadwaj PR, 2009, J CELL MOL MED, V13, P412, DOI 10.1111/j.1582-4934.2009.00609.x; Blurton-Jones Mathew, 2006, Current Alzheimer Research, V3, P437, DOI 10.2174/156720506779025242; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Brewer LD, 2007, BRAIN RES, V1151, P20, DOI 10.1016/j.brainres.2007.03.020; Carpenter-Hyland EP, 2004, J NEUROSCI, V24, P7859, DOI 10.1523/JNEUROSCI.1902-04.2004; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Christian AE, 1997, J LIPID RES, V38, P2264; Crump FT, 2001, J NEUROSCI, V21, P5079, DOI 10.1523/JNEUROSCI.21-14-05079.2001; Curtain CC, 2003, J BIOL CHEM, V278, P2977, DOI 10.1074/jbc.M205455200; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dante S, 2006, EUR BIOPHYS J BIOPHY, V35, P523, DOI 10.1007/s00249-006-0062-x; Dunah AW, 1996, J NEUROCHEM, V67, P2335; Ferreira A, 1997, MOL CELL NEUROSCI, V9, P220, DOI 10.1006/mcne.1997.0615; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Foradori CD, 2007, NEUROSCIENCE, V149, P155, DOI 10.1016/j.neuroscience.2007.06.054; Frank C, 2004, FEBS LETT, V566, P25, DOI 10.1016/j.febslet.2004.03.113; Fritschy JM, 1998, J COMP NEUROL, V390, P194; FYKSE EM, 1993, J NEUROSCI, V13, P4997; Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006; Goslin K., 1998, CULTURING NERVE CELL, P339; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Harkany T, 2000, REV NEUROSCIENCE, V11, P329; Hering H, 2003, J NEUROSCI, V23, P3262; Higuchi M, 2005, BBA-PROTEINS PROTEOM, V1751, P60, DOI 10.1016/j.bbapap.2005.02.013; Hou QM, 2008, MOL CELL NEUROSCI, V38, P213, DOI 10.1016/j.mcn.2008.02.010; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; ISHII T, 1993, J BIOL CHEM, V268, P2836; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert D, 2005, BIOCHEM J, V387, P553, DOI 10.1042/BJ20041377; Law AJ, 2003, EUR J NEUROSCI, V18, P1197, DOI 10.1046/j.1460-9568.2003.02850.x; Lee VMY, 1996, ANN NY ACAD SCI, V777, P107, DOI 10.1111/j.1749-6632.1996.tb34408.x; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; Lipton Stuart A., 2005, Current Alzheimer Research, V2, P155, DOI 10.2174/1567205053585846; Liu P, 2008, SYNAPSE, V62, P834, DOI 10.1002/syn.20563; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magnusson KR, 1997, J GERONTOL A-BIOL, V52, pB291, DOI 10.1093/gerona/52A.6.B291; Magnusson KR, 1998, MECH AGEING DEV, V104, P227, DOI 10.1016/S0047-6374(98)00076-1; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Mitter D, 2003, J NEUROCHEM, V84, P35, DOI 10.1046/j.1471-4159.2003.01258.x; Mizuno T, 1999, J BIOL CHEM, V274, P15110, DOI 10.1074/jbc.274.21.15110; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morishima-Kawashima M, 1998, BIOCHEMISTRY-US, V37, P15247, DOI 10.1021/bi981843u; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MURPHY SN, 1989, MOL PHARMACOL, V35, P671; Nagler K, 2001, J PHYSIOL-LONDON, V533, P665, DOI 10.1111/j.1469-7793.2001.00665.x; Nicholson AM, 2009, J NEUROSCI, V29, P4640, DOI 10.1523/JNEUROSCI.0862-09.2009; Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7; Oshima N, 2001, AM J PATHOL, V158, P2209, DOI 10.1016/S0002-9440(10)64693-7; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; Pevalova M, 2006, Bratisl Lek Listy, V107, P346; QIU WQ, 1995, J NEUROSCI, V15, P2157, DOI 10.1523/JNEUROSCI.15-03-02157.1995; Resende R, 2007, BRAIN RES, V1143, P11, DOI 10.1016/j.brainres.2007.01.071; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; Shah WA, 2006, J GEN VIROL, V87, P673, DOI 10.1099/vir.0.81444-0; Sun DA, 2004, CELL CALCIUM, V35, P155, DOI 10.1016/j.ceca.2003.09.003; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; Torp R, 2000, NEUROSCIENCE, V96, P495, DOI 10.1016/S0306-4522(99)00568-0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsai LH, 2004, BBA-PROTEINS PROTEOM, V1697, P137, DOI 10.1016/j.bbapap.2003.11.019; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; WATANABE M, 1993, ANN NY ACAD SCI, V707, P463, DOI 10.1111/j.1749-6632.1993.tb38099.x; Wenk GL, 2006, J CLIN PSYCHIAT, V67, P3; Wenzel A, 1997, J NEUROCHEM, V68, P469; Wenzel A, 1995, NEUROREPORT, V7, P45, DOI 10.1097/00001756-199512290-00010; Williamson R, 2008, FASEB J, V22, P1552, DOI 10.1096/fj.07-9766com; Yakunin AF, 1998, ANAL BIOCHEM, V258, P146, DOI 10.1006/abio.1998.2571; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yu WD, 2008, J NEUROCHEM, V104, P830, DOI 10.1111/j.1471-4159.2007.05014.x	82	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					976	986		10.1074/jbc.M110.154138	http://dx.doi.org/10.1074/jbc.M110.154138			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21047784	hybrid, Green Published			2022-12-25	WOS:000286005000008
J	Shakya, A; Kang, JS; Chumley, J; Williams, MA; Tantin, D				Shakya, Arvind; Kang, Jinsuk; Chumley, Jeffrey; Williams, Matthew A.; Tantin, Dean			Oct1 Is a Switchable, Bipotential Stabilizer of Repressed and Inducible Transcriptional States	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; HOMEOBOX GENE CDX2; ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; T-CELLS; OCT-1-DEFICIENT MICE; INTERACTION NETWORK; AUTOIMMUNE-DISEASE; PROMOTER ACTIVITY; HUMAN FIBROBLASTS	Little is known regarding how the Oct1 transcription factor regulates target gene expression. Using murine fibroblasts and two target genes, Polr2a and Ahcy, we show that Oct1 recruits the Jmjd1a/KDM3A lysine demethylase to catalyze the removal of the inhibitory histone H3K9 dimethyl mark and block repression. Using purified murine T cells and the Il2 target locus, and a colon cancer cell line and the Cdx2 target locus, we show that Oct1 recruits the NuRD chromatin-remodeling complex to promote a repressed state, but in a regulated manner can switch to a different capacity and mediate Jmjd1a recruitment to block repression. These findings indicate that Oct1 maintains repression through a mechanism involving NuRD and maintains poised gene expression states through an antirepression mechanism involving Jmjd1a. We propose that, rather than acting as a primary trigger of gene activation or repression, Oct1 is a switchable stabilizer of repressed and inducible states.	[Shakya, Arvind; Kang, Jinsuk; Chumley, Jeffrey; Williams, Matthew A.; Tantin, Dean] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Tantin, D (corresponding author), Univ Utah, Sch Med, Dept Pathol, JMRB 5700B, Salt Lake City, UT 84112 USA.	dean.tantin@path.utah.edu		Shakya, Arvind/0000-0001-7993-6159; Williams, Matthew/0000-0002-4721-4482	National Institutes of Health through the NCI [1R21CA141009]; American Cancer Society [GMC-115196.]; NATIONAL CANCER INSTITUTE [R21CA141009] Funding Source: NIH RePORTER	National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21CA141009 through the NCI. This work was also supported by American Cancer Society Grant GMC-115196.	Almeida R, 2005, J PATHOL, V207, P396, DOI 10.1002/path.1861; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bertolino E, 2002, MOL CELL, V10, P397, DOI 10.1016/S1097-2765(02)00597-X; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Collingwood TN, 1999, J MOL ENDOCRINOL, V23, P255, DOI 10.1677/jme.0.0230255; Cron RQ, 2001, GENES IMMUN, V2, P464, DOI 10.1038/sj.gene.6363811; dela Paz NG, 2007, J BIOL CHEM, V282, P8424, DOI 10.1074/jbc.M606923200; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Dienz O, 2007, P NATL ACAD SCI USA, V104, P7175, DOI 10.1073/pnas.0610442104; Duncliffe KN, 1997, IMMUNITY, V6, P175, DOI 10.1016/S1074-7613(00)80424-0; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; GARRITY PA, 1994, MOL CELL BIOL, V14, P2159, DOI 10.1128/MCB.14.3.2159; Gervaziev YV, 2010, INT J IMMUNOGENET, V37, P13, DOI 10.1111/j.1744-313X.2009.00883.x; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guo RJ, 2004, CANCER BIOL THER, V3, P593, DOI 10.4161/cbt.3.7.913; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; Imai S, 1997, MOL BIOL CELL, V8, P2407, DOI 10.1091/mbc.8.12.2407; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Jenuwein T, 2006, FEBS J, V273, P3121, DOI 10.1111/j.1742-4658.2006.05343.x; Jin TR, 2001, J BIOL CHEM, V276, P14752, DOI 10.1074/jbc.M008277200; Kang JS, 2009, TRENDS BIOCHEM SCI, V34, P491, DOI 10.1016/j.tibs.2009.06.003; Kang JS, 2009, GENE DEV, V23, P208, DOI 10.1101/gad.1750709; KAUSHANSKY K, 1994, J IMMUNOL, V152, P1812; Kiesler P, 2009, HUM MOL GENET, V18, P4513, DOI 10.1093/hmg/ddp411; Krueger F, 2009, CELL SIGNAL, V21, P1846, DOI 10.1016/j.cellsig.2009.07.020; LEBOWITZ JH, 1988, GENE DEV, V2, P1227, DOI 10.1101/gad.2.10.1227; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lu XD, 2008, J BIOL CHEM, V283, P13825, DOI 10.1074/jbc.M801275200; Malhas AN, 2009, J CELL BIOL, V184, P45, DOI 10.1083/jcb.200804155; Mattison J, 2010, CANCER RES, V70, P883, DOI 10.1158/0008-5472.CAN-09-1737; Murayama A, 2006, EMBO J, V25, P1081, DOI 10.1038/sj.emboj.7601012; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; PFEUFFER I, 1994, J IMMUNOL, V153, P5572; Rawat VPS, 2008, BLOOD, V111, P309, DOI 10.1182/blood-2007-04-085407; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Reymann S, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-46; Riedt T, 2009, BLOOD, V113, P4049, DOI 10.1182/blood-2008-12-196634; Scholl C, 2007, J CLIN INVEST, V117, P1037, DOI 10.1172/JCI30182; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shakya A, 2009, NAT CELL BIOL, V11, P320, DOI 10.1038/ncb1840; SHEN LY, 1993, MOL CELL BIOL, V13, P3530, DOI 10.1128/MCB.13.6.3530; SMITH KA, 1992, CURR OPIN IMMUNOL, V4, P271, DOI 10.1016/0952-7915(92)90076-Q; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Suh E, 1996, MOL CELL BIOL, V16, P619; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tantin D, 2002, MOL CELL BIOL, V22, P1460, DOI 10.1128/MCB.22.5.1460-1473.2002; THEVENIN C, 1993, J BIOL CHEM, V268, P5949; Thoene S, 2009, LEUKEMIA, V23, P649, DOI 10.1038/leu.2008.355; Thomas RM, 2005, J IMMUNOL, V174, P4639, DOI 10.4049/jimmunol.174.8.4639; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; ULLMAN KS, 1991, SCIENCE, V254, P558, DOI 10.1126/science.1683003; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang PX, 2009, J BIOL CHEM, V284, P26456, DOI 10.1074/jbc.M109.030668; Wang VEH, 2004, P NATL ACAD SCI USA, V101, P2005, DOI 10.1073/pnas.0307304101; Wang VEH, 2004, MOL CELL BIOL, V24, P1022, DOI 10.1128/MCB.24.3.1022-1032.2004; Wu GD, 1997, J BIOL CHEM, V272, P2396; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zabel MD, 2002, J IMMUNOL, V168, P3341, DOI 10.4049/jimmunol.168.7.3341; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhou L, 2007, MOL CELL BIOL, V27, P2698, DOI 10.1128/MCB.00788-06	66	48	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					450	459		10.1074/jbc.M110.174045	http://dx.doi.org/10.1074/jbc.M110.174045			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21051540	hybrid, Green Published			2022-12-25	WOS:000285782800048
J	Chen, YC; Weinreich, M				Chen, Ying-Chou; Weinreich, Michael			Dbf4 Regulates the Cdc5 Polo-like Kinase through a Distinct Non-canonical Binding Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; BOX DOMAIN; DNA-REPLICATION; BUDDING YEAST; PROTEIN-KINASE; MITOTIC EXIT; MEIOTIC RECOMBINATION; CANCER-THERAPY; CELL-DIVISION; S PHASE	Cdc7-Dbf4 is a conserved, two-subunit kinase required for initiating eukaryotic DNA replication. Recent studies have shown that Cdc7-Dbf4 also regulates the mitotic exit network (MEN) and monopolar homolog orientation in meiosis I (Matos, J., Lipp, J. J., Bogdanova, A., Guillot, S., Okaz, E., Junqueira, M., Shevchenko, A., and Zachariae, W. (2008) Cell 135, 662-678 and Miller, C. T., Gabrielse, C., Chen, Y. C., and Weinreich, M. (2009) PLoS Genet. 5, e1000498). Both activities likely involve a Cdc7-Dbf4 interaction with Cdc5, the single Polo-like kinase in budding yeast. We previously showed that Dbf4 binds the Cdc5 polo-box domain (PBD) via an similar to 40-residue N-terminal sequence, which lacks a PBD consensus binding site (S(pS/pT)(P/X)), and that Dbf4 inhibits Cdc5 function during mitosis. Here we identify a non-consensus PBD binding site within Dbf4 and demonstrate that the PBD-Dbf4 interaction occurs via a distinct PBD surface from that used to bind phosphoproteins. Genetic and biochemical analysis of multiple dbf4 mutants indicate that Dbf4 inhibits Cdc5 function through direct binding. Surprisingly, mutation of invariant Cdc5 residues required for binding phosphorylated substrates has little effect on yeast viability or growth rate. Instead, cdc5 mutants defective for binding phosphoproteins exhibit enhanced resistance to microtubule disruption and an increased rate of spindle elongation. This study, therefore, details the molecular nature of a new type of PBD binding and reveals that Cdc5 targeting to phosphorylated substrates likely regulates spindle dynamics.	Van Andel Res Inst, Grand Rapids, MI 49503 USA; [Chen, Ying-Chou] Michigan State Univ, Grad Program Genet, E Lansing, MI 48824 USA	Van Andel Institute; Michigan State University	Weinreich, M (corresponding author), 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	michael.weinreich@vai.org	Weinreich, Michael/D-2310-2014		Van Andel Research Institute; American Cancer Society [RSG-0506301GMC]	Van Andel Research Institute; American Cancer Society(American Cancer Society)	This work was supported by the Van Andel Research Institute and American Cancer Society Grant RSG-0506301GMC.	Archambault V, 2008, GENE DEV, V22, P2707, DOI 10.1101/gad.486808; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Asano S, 2005, EMBO J, V24, P2194, DOI 10.1038/sj.emboj.7600683; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bin OY, 1997, J BIOL CHEM, V272, P28646, DOI 10.1074/jbc.272.45.28646; Blow JJ, 2005, EMBO REP, V6, P1028, DOI 10.1038/sj.embor.7400557; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Cheng L, 1998, MOL CELL BIOL, V18, P7360, DOI 10.1128/MCB.18.12.7360; Crasta K, 2008, NAT CELL BIOL, V10, P665, DOI 10.1038/ncb1729; D'Aquino KE, 2005, MOL CELL, V19, P223, DOI 10.1016/j.molcel.2005.06.005; de Carcer G, 2007, CURR MED CHEM, V14, P969, DOI 10.2174/092986707780362925; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Gabrielse C, 2006, GENETICS, V173, P541, DOI 10.1534/genetics.106.057521; Garcia-Alvarez B, 2007, P NATL ACAD SCI USA, V104, P3107, DOI 10.1073/pnas.0609131104; Geymonat M, 2003, J BIOL CHEM, V278, P14591, DOI 10.1074/jbc.C300059200; Hardy CFJ, 1996, MOL CELL BIOL, V16, P6775; HARTWELL LH, 1970, P NATL ACAD SCI USA, V66, P352, DOI 10.1073/pnas.66.2.352; Hornig NCD, 2004, EMBO J, V23, P3144, DOI 10.1038/sj.emboj.7600303; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; Jares P, 2000, EMBO REP, V1, P319, DOI 10.1093/embo-reports/kvd076; Johnston LH, 1999, TRENDS CELL BIOL, V9, P249, DOI 10.1016/S0962-8924(99)01586-X; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; KITADA K, 1993, MOL CELL BIOL, V13, P4445, DOI 10.1128/MCB.13.7.4445; Lee KS, 2005, ONCOGENE, V24, P217, DOI 10.1038/sj.onc.1208271; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Lee KS, 2008, CELL CYCLE, V7, P141, DOI 10.4161/cc.7.2.5272; Li Y, 2008, NAT STRUCT MOL BIOL, V15, P865, DOI 10.1038/nsmb.1447; Liang FS, 2007, MOL CELL BIOL, V27, P5067, DOI 10.1128/MCB.00095-07; Lo HC, 2008, MOL BIOL CELL, V19, P4956, DOI 10.1091/mbc.E08-07-0755; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Lowery DM, 2004, CELL CYCLE, V3, P128; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Marston AL, 2009, CURR BIOL, V19, pR74, DOI 10.1016/j.cub.2008.12.003; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; Miller CT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000498; Park CJ, 2003, GENETICS, V163, P21; Pereira G, 2005, MOL CELL, V19, P209, DOI 10.1016/j.molcel.2005.05.030; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Pintard L, 2001, MOL CELL, V8, P1155, DOI 10.1016/S1097-2765(01)00422-1; Rahal R, 2008, CELL CYCLE, V7, P3262, DOI 10.4161/cc.7.20.6852; Reindl WG, 2008, CHEM BIOL, V15, P459, DOI 10.1016/j.chembiol.2008.03.013; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Sasanuma H, 2008, GENE DEV, V22, P398, DOI 10.1101/gad.1626608; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Sherman F., 1986, METHODS YEAST GENETI, P523; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Shou WY, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-4; Snead JL, 2007, CHEM BIOL, V14, P1261, DOI 10.1016/j.chembiol.2007.09.011; Soues S, 1998, J CELL SCI, V111, P2809; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Sullivan M, 2008, MOL CELL BIOL, V28, P5328, DOI 10.1128/MCB.00235-08; SUNKEL CE, 1988, J CELL SCI, V89, P25; Takahashi TS, 2008, GENE DEV, V22, P1894, DOI 10.1101/gad.1683308; Trenz K, 2008, EMBO J, V27, P876, DOI 10.1038/emboj.2008.29; ULLMAN EF, 1994, P NATL ACAD SCI USA, V91, P5426, DOI 10.1073/pnas.91.12.5426; Wan L, 2008, GENE DEV, V22, P386, DOI 10.1101/gad.1626408; Watanabe N, 2009, J BIOL CHEM, V284, P2344, DOI 10.1074/jbc.M805308200; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Yaffe MB, 2004, ANNU REV BIOPH BIOM, V33, P225, DOI 10.1146/annurev.biophys.33.110502.133346; Yoshida S, 2006, SCIENCE, V313, P108, DOI 10.1126/science.1126747	66	27	28	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41244	41254		10.1074/jbc.M110.155242	http://dx.doi.org/10.1074/jbc.M110.155242			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21036905	Green Published, hybrid			2022-12-25	WOS:000285622600010
J	Escola, JM; Kuenzi, G; Gaertner, H; Foti, M; Hartley, O				Escola, Jean-Michel; Kuenzi, Gabriel; Gaertner, Hubert; Foti, Michelangelo; Hartley, Oliver			CC Chemokine Receptor 5 (CCR5) Desensitization CYCLING RECEPTORS ACCUMULATE IN THE TRANS-GOLGI NETWORK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGHLY POTENT; HIV; INHIBITION; PROTEIN; TRAFFICKING; RANTES; CELLS; ENDOCYTOSIS; ENDOSOMES; INTERNALIZATION	CC chemokine receptor 5 (CCR5), the major HIV coreceptor, is a G protein-coupled receptor (GPCR) involved in cell activation and migration in response to chemokines. Blockade of CCR5 is an effective anti-HIV strategy, and potent anti-HIV chemokine analogs such as PSC-RANTES have been developed. These inhibitors act by interfering with receptor trafficking, thereby inducing prolonged intracellular sequestration of CCR5. Like many GPCRs, CCR5 is desensitized following agonist activation. The initial steps in this process are well understood, but later stages, including where CCR5 is sequestered during desensitization, and how anti-HIV chemokine analogs intervene to achieve prolonged sequestration, have yet to be elucidated in detail. In this study we demonstrate that CCR5 cycles to and from the cell surface via the endosome recycling compartment and the trans-Golgi network during desensitization, accumulating in the trans-Golgi network following internalization by both PSC-RANTES and CCL5, the native ligand from which it was derived. In addition, we show that unlike CCR5 sequestered by CCL5, CCR5 sequestered by PSC-RANTES cannot be induced to return to the cell surface by addition of the small molecule CCR5 inhibitor, TAK-779, and that association of PSC-RANTES with CCR5 is more durable than that of native CCL5 during desensitization. Our findings reconcile the previously conflicting descriptions of the location of sequestered CCR5 during desensitization, as well as providing more general insights into potential trafficking routes for endocytosed GPCRs and further elucidation of the unusual inhibitory mechanism of chemokine analogs with potent anti-HIV activity.	[Escola, Jean-Michel; Kuenzi, Gabriel; Gaertner, Hubert; Hartley, Oliver] Univ Geneva, Fac Med, Dept Struct Biol & Bioinformat, CH-1211 Geneva 4, Switzerland; [Foti, Michelangelo] Univ Geneva, Fac Med, Dept Cellular Physiol & Metab, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva	Hartley, O (corresponding author), 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	oliver.hartley@unige.ch		Foti, Michelangelo/0000-0001-7199-4135	Swiss National Science Foundation [3100A0-110042, 310000-120280/1]; NIH/NIAID [U19 AI076981]; Swedish International Development Agency [7500037313]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI076981] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swedish International Development Agency; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Swiss National Science Foundation (3100A0-110042 to O. H.; 310000-120280/1 to M. F.), NIH/NIAID (U19 AI076981), and the Swedish International Development Agency (7500037313 to O. H.).	Alkhatib G, 1997, VIROLOGY, V234, P340, DOI 10.1006/viro.1997.8673; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Csaba Z, 2007, TRAFFIC, V8, P820, DOI 10.1111/j.1600-0854.2007.00580.x; GAERTNER HF, 1994, J BIOL CHEM, V269, P7224; Gaertner H, 2008, PROTEIN ENG DES SEL, V21, P65, DOI 10.1093/protein/gzm079; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hartley O, 2004, P NATL ACAD SCI USA, V101, P16460, DOI 10.1073/pnas.0404802101; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Kiss DL, 2009, CELL MOL BIOL LETT, V14, P537, DOI 10.2478/s11658-009-0017-1; Kuhmann SE, 2008, ANNU REV PHARMACOL, V48, P425, DOI 10.1146/annurev.pharmtox.48.113006.094847; LEDERMAN MM, 1995, ANN INTERN MED, V122, P218, DOI 10.7326/0003-4819-122-3-199502010-00010; Lelouvier B, 2008, J NEUROSCI, V28, P4336, DOI 10.1523/JNEUROSCI.4379-07.2008; Longden J, 2008, BRIT J PHARMACOL, V153, P1513, DOI 10.1038/sj.bjp.0707691; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Neubrand VE, 2005, EMBO J, V24, P1122, DOI 10.1038/sj.emboj.7600600; Offord RE, 1997, METHOD ENZYMOL, V287, P348; Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007; Pastore C, 2003, ANTIMICROB AGENTS CH, V47, P509, DOI 10.1128/AAC.47.2.509-517.2003; Pollok-Kopp B, 2003, J BIOL CHEM, V278, P2190, DOI 10.1074/jbc.M209844200; SAKAI T, 1991, J BIOCHEM-TOKYO, V109, P528, DOI 10.1093/oxfordjournals.jbchem.a123415; Signoret N, 2005, MOL BIOL CELL, V16, P902, DOI 10.1091/mbc.e04-08-0687; Signoret N, 2004, TRAFFIC, V5, P529, DOI 10.1111/j.1600-0854.2004.00200.x; Signoret N, 2000, J CELL BIOL, V151, P1281, DOI 10.1083/jcb.151.6.1281; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Trkola A, 1998, J VIROL, V72, P396, DOI 10.1128/JVI.72.1.396-404.1998	31	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41772	41780		10.1074/jbc.M110.153460	http://dx.doi.org/10.1074/jbc.M110.153460			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041313	Green Published, hybrid			2022-12-25	WOS:000285622600065
J	Zhong, SF; Israel, S; Shalev, I; Xue, H; Ebstein, RP; Chew, SH				Zhong, Songfa; Israel, Salomon; Shalev, Idan; Xue, Hong; Ebstein, Richard P.; Chew, Soo Hong			Dopamine D4 Receptor Gene Associated with Fairness Preference in Ultimatum Game	PLOS ONE			English	Article							EXON-III POLYMORPHISM; DRD4 GENE; GLUCOCORTICOID-RECEPTOR; PERSONALITY-TRAITS; ENVIRONMENT INTERACTION; EPIGENETIC REGULATION; BIRTH VARIATIONS; D-4 RECEPTOR; METAANALYSIS; SEASON	In experimental economics, the preference for reciprocal fairness has been observed in the controlled and incentivized laboratory setting of the ultimatum game, in which two individuals decide on how to divide a sum of money, with one proposing the share while the second deciding whether to accept. Should the proposal be accepted, the amount is divided accordingly. Otherwise, both would receive no money. A recent twin study has shown that fairness preference inferred from responder behavior is heritable, yet its neurogenetic basis remains unknown. The D4 receptor (DRD4) exon3 is a well-characterized functional polymorphism, which is known to be associated with attention deficit hyperactivity disorder and personality traits including novelty seeking and self-report altruism. Applying a neurogenetic approach, we find that DRD4 is significantly associated with fairness preference. Additionally, the interaction among this gene, season of birth, and gender is highly significant. This is the first result to link preference for reciprocal fairness to a specific gene and suggests that gene x environment interactions contribute to economic decision making.	[Zhong, Songfa; Chew, Soo Hong] Natl Univ Singapore, Dept Econ, Singapore 117548, Singapore; [Israel, Salomon; Shalev, Idan; Ebstein, Richard P.] Hebrew Univ Jerusalem, Scheinfeld Ctr Human Genet Social Sci, Jerusalem, Israel; [Xue, Hong] Hong Kong Univ Sci & Technol, Appl Genom Ctr, Kowloon, Hong Kong, Peoples R China; [Ebstein, Richard P.] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore; [Zhong, Songfa; Chew, Soo Hong] Hong Kong Univ Sci & Technol, Dept Econ, Kowloon, Hong Kong, Peoples R China; [Chew, Soo Hong] Natl Univ Singapore, Dept Finance, Singapore 117548, Singapore; [Chew, Soo Hong] Hong Kong Univ Sci & Technol, Ctr Expt Business Res, Kowloon, Hong Kong, Peoples R China	National University of Singapore; Hebrew University of Jerusalem; Hong Kong University of Science & Technology; National University of Singapore; Hong Kong University of Science & Technology; National University of Singapore; Hong Kong University of Science & Technology	Zhong, SF (corresponding author), Natl Univ Singapore, Dept Econ, Singapore 117548, Singapore.	rpebstein@gmail.com; chew.soohong@gmail.com	Zhong, Songfa Z/I-4718-2016; Shalev, Idan/H-1943-2011	Israel, Salomon/0000-0003-3629-2466; Xue, Hong/0000-0002-8133-9828; Ebstein, Richard/0000-0002-3626-541X; Chew, Soo Hong/0000-0003-1245-0909	Hong Kong University of Science and Technology [AOE-MG/H-03/06]; National University of Singapore [R-122-000-125-133, HSS-1001-P02]	Hong Kong University of Science and Technology; National University of Singapore(National University of Singapore)	Financial support is from the Hong Kong University of Science and Technology (grant number: AOE-MG/H-03/06; www.ust.hk) and National University of Singapore (grant number: R-122-000-125-133 and HSS-1001-P02; www.nus.edu.sg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASGHARI V, 1994, MOL PHARMACOL, V46, P364; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Bachner-Melman R, 2005, MOL PSYCHIATR, V10, P333, DOI 10.1038/sj.mp.4001635; Bakermans-Kranenburg MJ, 2006, DEV PSYCHOBIOL, V48, P406, DOI 10.1002/dev.20152; Ben Zion IZ, 2006, MOL PSYCHIATR, V11, P782, DOI 10.1038/sj.mp.4001832; Bookman EB, 2002, MOL PSYCHIATR, V7, P786, DOI 10.1038/sj.mp.4001075; Boyd R, 2002, J THEOR BIOL, V215, P287, DOI 10.1006/jtbi.2001.2515; Boyd R., 2005, ORIGIN EVOLUTION CUL; Burnham TC, 2007, P ROY SOC B-BIOL SCI, V274, P2327, DOI 10.1098/rspb.2007.0546; Camerer C, 2005, J ECON LIT, V43, P9, DOI 10.1257/0022051053737843; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Chotai J, 2001, NEUROPSYCHOBIOLOGY, V44, P19, DOI 10.1159/000054909; CRISAN LG, 2009, SOCIAL COGN IN PRESS; Crockett MJ, 2008, SCIENCE, V320, P1739, DOI 10.1126/science.1155577; DAVIDSON R, 1981, ECONOMETRICA, V49, P781, DOI 10.2307/1911522; de Jonge LV, 2002, APPETITE, V38, P181, DOI 10.1006/appe.2002.0477; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Dreber A, 2009, EVOL HUM BEHAV, V30, P85, DOI 10.1016/j.evolhumbehav.2008.11.001; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Eckel C, 2008, NEGOTIATION J, V24, P429, DOI 10.1111/j.1571-9979.2008.00196.x; Eckel CC, 2001, ECON INQ, V39, P171, DOI 10.1093/ei/39.2.171; Eisenberg DTA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001216; Eisenberg DTA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-173; EISENEGGER C, 2009, NATURE; Faraone SV, 2009, PSYCHOL MED, V39, P685, DOI 10.1017/S0033291708003917; Faraone SV, 2001, AM J PSYCHIAT, V158, P1052, DOI 10.1176/appi.ajp.158.7.1052; Gicquel C, 2008, BEST PRACT RES CL EN, V22, P1, DOI 10.1016/j.beem.2007.07.009; Godoy R, 2008, AM J HUM BIOL, V20, P23, DOI 10.1002/ajhb.20679; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; HOFFMAN E, 1994, GAME ECON BEHAV, V7, P346, DOI 10.1006/game.1994.1056; Israel S, 2009, PLOS ONE, V4; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Jongbloet P, 2008, BRIT J PSYCHIAT, V192, P313, DOI 10.1192/bjp.192.4.313a; Jordaan E, 2006, AUST NZ J PSYCHIAT, V40, P698, DOI 10.1111/j.1440-1614.2006.01870.x; Jovanovic V, 1999, PHARMACOGENETICS, V9, P561, DOI 10.1097/00008571-199910000-00003; KAHNEMAN D, 1986, AM ECON REV, V76, P728; Kamakura S, 1997, BIOCHEM BIOPH RES CO, V235, P321, DOI 10.1006/bbrc.1997.6770; Kang JI, 2008, NEUROSCI LETT, V430, P252, DOI 10.1016/j.neulet.2007.11.005; Kazmi MA, 2000, BIOCHEMISTRY-US, V39, P3734, DOI 10.1021/bi992354c; Keltikangas-Jarvinen L, 2004, MOL PSYCHIATR, V9, P308, DOI 10.1038/sj.mp.4001433; Kim B, 2009, PSYCHIAT INVEST, V6, P216, DOI 10.4306/pi.2009.6.3.216; Kirkpatrick B, 2008, SCHIZOPHR RES, V103, P151, DOI 10.1016/j.schres.2007.12.479; Kluger AN, 2002, MOL PSYCHIATR, V7, P712, DOI 10.1038/sj.mp.4001082; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; KNIGHT J, 2008, STAT GENETICS GENE M, P423; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Kuhnen CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004362; LAIRD PW, 2010, NAT REV GENET; Laucht M, 2007, BIOL PSYCHIAT, V61, P87, DOI 10.1016/j.biopsych.2006.05.025; Leung PWL, 2005, AM J MED GENET B, V133B, P54, DOI 10.1002/ajmg.b.30129; Lucock M, 2010, AM J HUM BIOL, V22, P484, DOI 10.1002/ajhb.21022; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; McClernon FJ, 2007, PSYCHOPHARMACOLOGY, V194, P433, DOI 10.1007/s00213-007-0860-6; McDermott R, 2009, P NATL ACAD SCI USA, V106, P2118, DOI 10.1073/pnas.0808376106; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; MCGOWAN PO, 2010, NEUROBIOL DIS; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Munafo MR, 2008, BIOL PSYCHIAT, V63, P197, DOI 10.1016/j.biopsych.2007.04.006; Munafo MR, 2009, AM J MED GENET B, V150B, P271, DOI 10.1002/ajmg.b.30808; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Perez de Castro I, 1997, PHARMACOGENETICS, V7, P345; Pfaff JJ, 2006, PSYCHIAT RES, V144, P217, DOI 10.1016/j.psychres.2006.04.019; Reist C, 2007, AM J MED GENET B, V144B, P453, DOI 10.1002/ajmg.b.30473; Riala K, 2007, NEUROPSYCHOBIOLOGY, V56, P14, DOI 10.1159/000109972; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Rivera A, 2008, NEUROSCIENCE, V155, P997, DOI 10.1016/j.neuroscience.2008.05.060; Roe BE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006704; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schoots O, 2003, PHARMACOGENOMICS J, V3, P343, DOI 10.1038/sj.tpj.6500208; Seeger G, 2004, NEUROSCI LETT, V366, P282, DOI 10.1016/j.neulet.2004.05.049; Shao CH, 2006, PSYCHOPHARMACOLOGY, V186, P185, DOI 10.1007/s00213-006-0375-6; Shaw P, 2007, ARCH GEN PSYCHIAT, V64, P921, DOI 10.1001/archpsyc.64.8.921; SMITH VL, 1982, AM ECON REV, V72, P923; Solnick SJ, 2001, ECON INQ, V39, P189, DOI 10.1093/ei/39.2.189; Tochigi M, 2006, NEUROSCI LETT, V398, P333, DOI 10.1016/j.neulet.2006.01.020; Turner JD, 2008, NUCLEIC ACIDS RES, V36, P7207, DOI 10.1093/nar/gkn897; Uher R, 2008, MOL PSYCHIATR, V13, P131, DOI 10.1038/sj.mp.4002067; Van Craenenbroeck K, 2005, J BIOL CHEM, V280, P19350, DOI 10.1074/jbc.M414043200; Van den Bergh B, 2006, P R SOC B, V273, P2091, DOI 10.1098/rspb.2006.3550; VANTOL HHM, 1992, NATURE, V358, P149; Vogel CIG, 2006, J NEURAL TRANSM, V113, P1935, DOI 10.1007/s00702-006-0497-3; Wallace B, 2007, P NATL ACAD SCI USA, V104, P15631, DOI 10.1073/pnas.0706642104; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; Weaver ICG, 2007, EPIGENETICS, V2, P22, DOI 10.4161/epi.2.1.3881; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zak PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008330; Zethraeus N, 2009, P NATL ACAD SCI USA, V106, P6535, DOI 10.1073/pnas.0812757106; Zhang DD, 2007, P NATL ACAD SCI USA, V104, P19214, DOI 10.1073/pnas.0703073104; Zhang DD, 2006, CLIMATIC CHANGE, V76, P459, DOI 10.1007/s10584-005-9024-z; Zhong SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008516; Zhong SF, 2009, P ROY SOC B-BIOL SCI, V276, P4181, DOI 10.1098/rspb.2009.1312	99	36	41	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13765	10.1371/journal.pone.0013765	http://dx.doi.org/10.1371/journal.pone.0013765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072167	Green Published, Green Submitted, gold			2022-12-25	WOS:000283780800003
J	Kranzer, K; Zeinecker, J; Ginsberg, P; Orrell, C; Kalawe, NN; Lawn, SD; Bekker, LG; Wood, R				Kranzer, Katharina; Zeinecker, Jennifer; Ginsberg, Philip; Orrell, Catherine; Kalawe, Nosindiso N.; Lawn, Stephen D.; Bekker, Linda-Gail; Wood, Robin			Linkage to HIV Care and Antiretroviral Therapy in Cape Town, South Africa	PLOS ONE			English	Article							FOLLOW-UP; RISK-FACTORS; INFECTED PATIENTS; EARLY MORTALITY; SURVIVAL; TUBERCULOSIS; ADULTS; ADHERENCE; COUNTRIES; PROGRAMS	Background: Antiretroviral therapy (ART) has been scaled-up rapidly in Africa. Programme reports typically focus on loss to follow-up and mortality among patients receiving ART. However, little is known about linkage and retention in care of individuals prior to starting ART. Methodology: Data on adult residents from a periurban community in Cape Town were collected at a primary care clinic and hospital. HIV testing registers, CD4 count results provided by the National Health Laboratory System and ART registers were linked. A random sample (n = 885) was drawn from adults testing HIV positive through antenatal care, sexual transmitted disease and voluntary testing and counseling services between January 2004 and March 2009. All adults (n = 103) testing HIV positive through TB services during the same time period were also included in the study. Linkage to HIV care was defined as attending for a CD4 count measurement within 6 months of HIV diagnosis. Linkage to ART care was defined as initiating ART within 6 months of HIV diagnosis in individuals with a CD4 count <= 200 cells/mu l taken within 6 months of HIV diagnosis. Findings: Only 62.6% of individuals attended for a CD4 count measurement within 6 months of testing HIV positive. Individuals testing through sexually transmitted infection services had the best (84.1%) and individuals testing on their own initiative (53.5%) the worst linkage to HIV care. One third of individuals with timely CD4 counts were eligible for ART and 66.7% of those were successfully linked to ART care. Linkage to ART care was highest among antenatal care clients. Among individuals not yet eligible for ART only 46.3% had a repeat CD4 count. Linkage to HIV care improved in patients tested in more recent calendar period. Conclusion: Linkage to HIV and ART care was low in this poor peri-urban community despite free services available within close proximity. More efforts are needed to link VCT scale-up to subsequent care.	[Kranzer, Katharina; Zeinecker, Jennifer; Ginsberg, Philip; Orrell, Catherine; Lawn, Stephen D.; Bekker, Linda-Gail; Wood, Robin] Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, Fac Hlth Sci,Dept Med, ZA-7925 Cape Town, South Africa; [Kranzer, Katharina; Lawn, Stephen D.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Clin Res Unit, London WC1, England; [Kalawe, Nosindiso N.] False Bay Hosp, Cape Town, South Africa	University of Cape Town; University of London; London School of Hygiene & Tropical Medicine	Kranzer, K (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, Fac Hlth Sci,Dept Med, ZA-7925 Cape Town, South Africa.	katharina.kranzer@lshtm.ac.uk	Wood, Robin/G-8509-2011; Orrell, Catherine/AAF-3405-2019; Bekker, Linda-Gail/AAZ-8929-2020; Kranzer, Katharina/O-8845-2014	Orrell, Catherine/0000-0003-1134-7475; Kranzer, Katharina/0000-0001-5691-7270; BEKKER, LINDA-GAIL/0000-0002-0755-4386	Wellcome Trust, London, UK; National Institutes of Health (NIH) through CIPRA [1U19AI53217-01, A1058736-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI053217, R01AI058736] Funding Source: NIH RePORTER	Wellcome Trust, London, UK(Wellcome Trust); National Institutes of Health (NIH) through CIPRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	KK and SDL are funded by the Wellcome Trust, London, UK. RW and LGB are funded in part by the National Institutes of Health (NIH) through a CIPRA grant 1U19AI53217-01 and RO1 grant (A1058736-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MA, 2009, SAMJ S AFR MED J, V99, P661; Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; GHEBREYESUS TA, 1957, LANCET, V375, P1757; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; KARIM SS, 2009, LANCET, V24, P24; Kitahata MM, 2002, BMJ-BRIT MED J, V325, P954, DOI 10.1136/bmj.325.7370.954; LARSON BA, 2010, B WHO; Larson BA, 2010, TROP MED INT HEALTH, V15, P43, DOI 10.1111/j.1365-3156.2010.02511.x; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2009, CLIN CHEST MED, V30, P685, DOI 10.1016/j.ccm.2009.08.010; Losina E, PLOS ONE, V5, pe9538; MacPherson P, 2009, T ROY SOC TROP MED H, V103, P588, DOI 10.1016/j.trstmh.2008.10.001; Manosuthi W, 2007, J INFECTION, V55, P464, DOI 10.1016/j.jinf.2007.07.002; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; MIDDELKOOP K, 2009, WIDESPREAD ART ASS D; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Nacher M, 2006, AM J TROP MED HYG, V74, P915, DOI 10.4269/ajtmh.2006.74.915; Remien RH, 2009, JAIDS-J ACQ IMM DEF, V51, pS106, DOI 10.1097/QAI.0b013e3181aafd66; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; *S AFR AIDS COUNC, 2010, S AFR ANT TREATM GUI; *S AFR GOV, 2003, OP PLAN COMPR HIV AI; Sanguanwongse N, 2008, JAIDS-J ACQ IMM DEF, V48, P181, DOI 10.1097/QAI.0b013e318177594e; Sieleunou I, 2009, TROP MED INT HEALTH, V14, P36, DOI 10.1111/j.1365-3156.2008.02183.x; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; UNAIDS, 2003, HDB ACC HIV AIDS REL; UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, 2008, EP FACT SHEET HIV AI; Velasco M, 2009, JAIDS-J ACQ IMM DEF, V50, P148, DOI 10.1097/QAI.0b013e31819367e7; WHO, 2010, ANT THER HIV INF AD; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; Zachariah R, 2009, TROP MED INT HEALTH, V14, P713, DOI 10.1111/j.1365-3156.2009.02291.x	40	125	126	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13801	10.1371/journal.pone.0013801	http://dx.doi.org/10.1371/journal.pone.0013801			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072191	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000283779700013
J	Lubarsky, HV; Hubas, C; Chocholek, M; Larson, F; Manz, W; Paterson, DM; Gerbersdorf, SU				Lubarsky, Helen V.; Hubas, Cedric; Chocholek, Melanie; Larson, Fredrik; Manz, Werner; Paterson, David M.; Gerbersdorf, Sabine U.			The Stabilisation Potential of Individual and Mixed Assemblages of Natural Bacteria and Microalgae	PLOS ONE			English	Article							EXTRACELLULAR POLYMERIC SUBSTANCES; STRENGTH METER CSM; INTERTIDAL SEDIMENTS; MICROBIAL BIOFILMS; EPIPELIC DIATOMS; GROWTH; ALGAE; POLYSACCHARIDES; STABILITY; ADHESION	It is recognized that microorganisms inhabiting natural sediments significantly mediate the erosive response of the bed ("ecosystem engineers") through the secretion of naturally adhesive organic material (EPS: extracellular polymeric substances). However, little is known about the individual engineering capability of the main biofilm components (heterotrophic bacteria and autotrophic microalgae) in terms of their individual contribution to the EPS pool and their relative functional contribution to substratum stabilisation. This paper investigates the engineering effects on a non-cohesive test bed as the surface was colonised by natural benthic assemblages (prokaryotic, eukaryotic and mixed cultures) of bacteria and microalgae. MagPI (Magnetic Particle Induction) and CSM (Cohesive Strength Meter) respectively determined the adhesive capacity and the cohesive strength of the culture surface. Stabilisation was significantly higher for the bacterial assemblages (up to a factor of 2) than for axenic microalgal assemblages. The EPS concentration and the EPS composition (carbohydrates and proteins) were both important in determining stabilisation. The peak of engineering effect was significantly greater in the mixed assemblage as compared to the bacterial (x 1.2) and axenic diatom (x 1.7) cultures. The possibility of synergistic effects between the bacterial and algal cultures in terms of stability was examined and rejected although the concentration of EPS did show a synergistic elevation in mixed culture. The rapid development and overall stabilisation potential of the various assemblages was impressive (x 7.5 and x9.5, for MagPI and CSM, respectively, as compared to controls). We confirmed the important role of heterotrophic bacteria in "biostabilisation" and highlighted the interactions between autotrophic and heterotrophic biofilm consortia. This information contributes to the conceptual understanding of the microbial sediment engineering that represents an important ecosystem function and service in aquatic habitats.	[Lubarsky, Helen V.; Hubas, Cedric; Chocholek, Melanie; Larson, Fredrik; Paterson, David M.; Gerbersdorf, Sabine U.] Univ St Andrews, Scottish Oceans Inst, Sediment Ecol Res Grp, St Andrews, Fife, Scotland; [Lubarsky, Helen V.; Gerbersdorf, Sabine U.] Univ Stuttgart, Inst Hydraul Engn, Stuttgart, Germany; [Hubas, Cedric] MNHN CNRS UPMC IRD, Museum Natl Hist Nat, UMR BOREA, DMPA, Paris, France; [Larson, Fredrik] Swedish Board Fisheries, Gothenburg, Sweden; [Manz, Werner] Univ Koblenz Landau, Inst Integrated Nat Sci, Koblenz, Germany	University of St Andrews; University of Stuttgart; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); University of Koblenz & Landau	Lubarsky, HV (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sediment Ecol Res Grp, St Andrews, Fife, Scotland.	sabine.gerbersdorf@iws.uni-stuttgart.de	Hubas, Cédric/P-4200-2019; Larson, Fredrik/D-8024-2011; BOREA, UMR BOREA/C-6165-2008; Gerbersdorf, Sabine U/B-7875-2009; Paterson, David/D-5202-2013	Hubas, Cédric/0000-0002-9110-9292; Larson, Fredrik/0000-0002-5751-7997; BOREA, UMR BOREA/0000-0002-9110-9292; Lubarsky, Helen/0000-0001-8247-3618; Paterson, David/0000-0003-1174-6476	European Union [RTN-CT-2006-035695, 25524]; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)	European Union(European Commission); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas)	The European Union has funded the positions of H. V. Lubarsky by Marie Curie Research Training Network (RTN-CT-2006-035695, Project KEYBIOEFFECT), and S. U. Gerbersdorf by Marie Curie Individual Fellowship (FP6, Project 25524, BioMech) as well as the consumables for this experiment (MCIF project 25524, BioMech). The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas), has financed the postdoctoral scholarship for F. Larson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battin TJ, 2003, NATURE, V426, P439, DOI 10.1038/nature02152; *BMEPC, 1988, BALTIC MARINE ENV D, V27, P16; Boivin MEY, 2007, ENVIRON POLLUT, V145, P884, DOI 10.1016/j.envpol.2006.05.003; Boogert NJ, 2006, BIOSCIENCE, V56, P570, DOI 10.1641/0006-3568(2006)56[570:TIONCA]2.0.CO;2; Bowen JL, 2009, LIMNOL OCEANOGR, V54, P713, DOI 10.4319/lo.2009.54.3.0713; Bruckner CG, 2008, APPL ENVIRON MICROB, V74, P7740, DOI 10.1128/AEM.01399-08; Campa-Cordova AI, 2006, AQUACULTURE, V260, P145, DOI 10.1016/j.aquaculture.2006.06.014; CHO BC, 1990, MAR ECOL PROG SER, V63, P253, DOI 10.3354/meps063253; Czaczyk K, 2007, POL J ENVIRON STUD, V16, P799; Dade WB, 1996, J SEDIMENT RES, V66, P39; Defew EC, 2002, HYDROL EARTH SYST SC, V6, P971, DOI 10.5194/hess-6-971-2002; Defew EC, 2002, MAR ECOL PROG SER, V237, P15, DOI 10.3354/meps237015; DUBOIS M, 1956, ANAL CHEM, V28, P380; EDGAR LA, 1983, PROC R SOC SER B-BIO, V218, P331, DOI 10.1098/rspb.1983.0042; Elifantz H, 2005, APPL ENVIRON MICROB, V71, P7799, DOI 10.1128/AEM.71.12.7799-7805.2005; Fang HHP, 2000, J MICROBIOL METH, V40, P89, DOI 10.1016/S0167-7012(99)00137-2; Flemming HC, 2002, CHEM UNSERER ZEIT, V36, P30, DOI 10.1002/1521-3781(200202)36:1<30::AID-CIUZ30>3.0.CO;2-O; Flemming HC, 2001, WATER SCI TECHNOL, V43, pVII; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; Fukami K, 1997, HYDROBIOLOGIA, V358, P185, DOI 10.1023/A:1003139402315; Garet MJ, 1996, J MICROBIOL METH, V25, P1, DOI 10.1016/0167-7012(95)00071-2; Gerbersdorf SU, 2008, FEMS MICROBIOL ECOL, V66, P282, DOI 10.1111/j.1574-6941.2008.00586.x; Gerbersdorf SU, 2009, J SOIL SEDIMENT, V9, P640, DOI 10.1007/s11368-009-0142-5; Goto N, 2001, J EXP MAR BIOL ECOL, V257, P73, DOI 10.1016/S0022-0981(00)00329-4; Grossart HP, 2007, AQUAT MICROB ECOL, V47, P163, DOI 10.3354/ame047163; Guerrini F, 1998, AQUAT MICROB ECOL, V15, P247, DOI 10.3354/ame015247; Haynes K, 2007, APPL ENVIRON MICROB, V73, P6112, DOI 10.1128/AEM.00551-07; Hubas C, 2007, MAR ECOL PROG SER, V344, P39, DOI 10.3354/meps06947; Hubas C, 2007, MAR BIOL, V151, P41, DOI 10.1007/s00227-006-0446-6; Jain A, 2007, BIOFOULING, V23, P171, DOI 10.1080/08927010701269641; Jeffrey SW, 1999, MAR FRESHWATER RES, V50, P879, DOI 10.1071/MF99109; Klug JL, 2005, CAN J FISH AQUAT SCI, V62, P472, DOI 10.1139/F04-229; Krammer K., 1986, SUSSWASSERFLORA MITT; Lai HT, 2009, ECOTOX ENVIRON SAFE, V72, P329, DOI 10.1016/j.ecoenv.2008.03.005; Lange-Bertalot, 1997, LAUTERBORNIA, V31, P117; Larson F, 2009, LIMNOL OCEANOGR-METH, V7, P490, DOI 10.4319/lom.2009.7.490; Le Hir P, 2007, CONT SHELF RES, V27, P1116, DOI 10.1016/j.csr.2005.11.016; LEE S, 1987, APPL ENVIRON MICROB, V53, P1298, DOI 10.1128/AEM.53.6.1298-1303.1987; Leon-Morales CF, 2007, SEDIMENT DYNAMICS PO, P358; Levy JL, 2009, CHEMOSPHERE, V74, P1266, DOI 10.1016/j.chemosphere.2008.10.049; Long RA, 1996, AQUAT MICROB ECOL, V10, P213, DOI 10.3354/ame010213; Lundkvist M, 2007, CONT SHELF RES, V27, P1143, DOI 10.1016/j.csr.2006.01.021; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Manz W, 1999, METHOD ENZYMOL, V310, P79; Mu RM, 2007, J ENVIRON SCI-CHINA, V19, P1336, DOI 10.1016/S1001-0742(07)60218-6; Pankow H., 1990, OSTEE ALGENFLORA; PATERSON DM, 1989, LIMNOL OCEANOGR, V34, P223, DOI 10.4319/lo.1989.34.1.0223; Pennisi E, 2002, SCIENCE, V296, P250, DOI 10.1126/science.296.5566.250; Raszka A, 2006, ACTA HYDROCH HYDROB, V34, P411, DOI 10.1002/aheh.200500640; RAUNKJAER K, 1994, WATER RES, V28, P251, DOI 10.1016/0043-1354(94)90261-5; Ribalet F, 2008, AQUAT TOXICOL, V86, P249, DOI 10.1016/j.aquatox.2007.11.005; Riethmuller R, 2000, CONT SHELF RES, V20, P1351, DOI 10.1016/S0278-4343(00)00027-3; ROLLER C, 1994, MICROBIOL-UK, V140, P2849, DOI 10.1099/00221287-140-10-2849; Schafer H, 2002, FEMS MICROBIOL ECOL, V42, P25, DOI 10.1111/j.1574-6941.2002.tb00992.x; SIMONSEN R, 1962, HYDROBIOLOGIA, V1, P1; Stal LJ, 2000, EUR J PHYCOL, V35, P97, DOI 10.1080/09670260010001735681; Stal LJ, 2003, GEOMICROBIOL J, V20, P463, DOI 10.1080/713851126; Tolhurst TJ, 1999, ESTUAR COAST SHELF S, V49, P281, DOI 10.1006/ecss.1999.0512; Underwood GJC, 1998, EUR J PHYCOL, V33, P173, DOI 10.1017/S0967026298001565; Underwood GJC, 2003, ADV BOT RES, V40, P183, DOI 10.1016/S0065-2296(05)40005-1; Vardy S, 2007, CONT SHELF RES, V27, P1190, DOI 10.1016/j.csr.2006.01.022; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Wichard T, 2005, J CHROMATOGR B, V814, P155, DOI 10.1016/j.jchromb.2004.10.021; Witkowski A, 2000, DIATOM FLORA MARINE; Wotton RS, 2004, SCI MAR, V68, P13, DOI 10.3989/scimar.2004.68s113; Yallop ML, 2000, MICROB ECOL, V39, P116, DOI 10.1007/s002489900186	66	74	77	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13794	10.1371/journal.pone.0013794	http://dx.doi.org/10.1371/journal.pone.0013794			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072186	gold, Green Published, Green Submitted			2022-12-25	WOS:000283779700008
J	Boberek, JM; Stach, J; Good, L				Boberek, Jaroslaw M.; Stach, Jem; Good, Liam			Genetic Evidence for Inhibition of Bacterial Division Protein FtsZ by Berberine	PLOS ONE			English	Article							ESCHERICHIA-COLI; CELL-DIVISION; HYDRASTIS-CANADENSIS; ANTIMICROBIAL ACTIVITY; SMALL-MOLECULE; CANCER-CELLS; IN-VITRO; RING; APOPTOSIS; BINDING	Background: Berberine is a plant alkaloid that is widely used as an anti-infective in traditional medicine. Escherichia coli exposed to berberine form filaments, suggesting an antibacterial mechanism that involves inhibition of cell division. Berberine is a DNA ligand and may induce filamentation through induction of the SOS response. Also, there is biochemical evidence for berberine inhibition of the cell division protein FtsZ. Here we aimed to assess possible berberine mechanism(s) of action in growing bacteria using genetics tools. Methodology/Principal Findings: First, we tested whether berberine inhibits bacterial growth through DNA damage and induction of the SOS response. The SOS response induced by berberine was much lower compared to that induced by mitomycin C in an SOS response reporter strain. Also, cell filamentation was observed in an SOS-negative E. coli strain. To test whether berberine inhibits FtsZ, we assessed its effects on formation of the cell division Z-rings, and observed a dramatic reduction in Z-rings in the presence of berberine. We next used two different strategies for RNA silencing of ftsZ and both resulted in sensitisation of bacteria to berberine, visible as a drop in the Minimum Inhibitory Concentration (MIC). Furthermore, Fractional Inhibitory Concentration Indices (FICIs) showed a high level of synergy between ftsZ silencing and berberine treatment (FICI values of 0.23 and 0.25 for peptide nucleic acid-and expressed antisense RNA-based silencing of ftsZ, respectively). Finally, over-expression of ftsZ led to a mild rescue effect in berberine-treated cells. Conclusions: The results argue against DNA binding as the primary mechanism of action of berberine and support the hypothesis that its antibacterial properties are due to inhibition of the cell division protein FtsZ. In addition, the genetic approach used here provides a means to rapidly test the activity of other putative FtsZ inhibitors.	[Boberek, Jaroslaw M.; Good, Liam] Univ London Royal Vet Coll, Dept Pathol & Infect Dis, London, England; [Stach, Jem] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of London; University of London Royal Veterinary College; Newcastle University - UK	Boberek, JM (corresponding author), Univ London Royal Vet Coll, Dept Pathol & Infect Dis, London, England.	lgood@rvc.ac.uk		Stach, James/0000-0001-8787-2407; Good, Liam/0000-0002-2798-8640	University of London; Bloomsbury Colleges Consortium; Innovation China UK; STFC [ST/H000429/1] Funding Source: UKRI	University of London; Bloomsbury Colleges Consortium; Innovation China UK; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The authors would like to thank the University of London Central Research Fund and Innovation China UK for research support and the Bloomsbury Colleges Consortium for scholarship support to JMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN AH, 1969, CAN J MICROBIOL, V15, P1067, DOI 10.1139/m69-190; Beuria TK, 2005, BIOCHEMISTRY-US, V44, P16584, DOI 10.1021/bi050767+; Bhadra K, 2008, BBA-GEN SUBJECTS, V1780, P1054, DOI 10.1016/j.bbagen.2008.05.005; BI E, 1993, J BACTERIOL, V175, P1118, DOI 10.1128/JB.175.4.1118-1125.1993; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Choi MS, 2008, ANTICANCER RES, V28, P3777; Das S, 2003, J BIOMOL STRUCT DYN, V20, P703, DOI 10.1080/07391102.2003.10506887; Domadia P, 2007, BIOCHEM PHARMACOL, V74, P831, DOI 10.1016/j.bcp.2007.06.029; Domadia PN, 2008, BIOCHEMISTRY-US, V47, P3225, DOI 10.1021/bi7018546; Dryselius R, 2005, J ANTIMICROB CHEMOTH, V56, P97, DOI 10.1093/jac/dki173; Dziadek J, 2002, MICROBIOL-SGM, V148, P961, DOI 10.1099/00221287-148-4-961; ERICKSON HP, 1995, CELL, V80, P367, DOI 10.1016/0092-8674(95)90486-7; Gentry EJ, 1998, J NAT PROD, V61, P1187, DOI 10.1021/np9701889; Giri P, 2010, MOL BIOSYST, V6, P81, DOI 10.1039/b910706a; Goh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006061; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; Ho YT, 2009, ANTICANCER RES, V29, P4063; Honrubia-Marcos MP, 2005, CAN J MICROBIOL, V51, P85, DOI 10.1139/W04-105; Hur JM, 2009, J CELL BIOCHEM, V107, P955, DOI 10.1002/jcb.22198; Hwang BY, 2003, PLANTA MED, V69, P623, DOI 10.1055/s-2003-41115; Islam MM, 2009, DNA CELL BIOL, V28, P637, DOI 10.1089/dna.2009.0930; Jaiswal R, 2007, BIOCHEMISTRY-US, V46, P4211, DOI 10.1021/bi602573e; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Katiyar SK, 2009, MOL CARCINOGEN, V48, P24, DOI 10.1002/mc.20453; KIM JB, 2009, PHYTOMEDICINE; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Li WY, 1998, SPECTROSC LETT, V31, P1287, DOI 10.1080/00387019808003303; Lock RL, 2008, NAT REV DRUG DISCOV, V7, P324, DOI 10.1038/nrd2510; Mahady GB, 2003, PHYTOTHER RES, V17, P217, DOI 10.1002/ptr.1108; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; McCool JD, 2004, MOL MICROBIOL, V53, P1343, DOI 10.1111/j.1365-2958.2004.04225.x; Nakashima N, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl697; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; PASQUAL MS, 1993, MUTAT RES, V286, P243, DOI 10.1016/0027-5107(93)90189-M; Pichoff S, 2001, J BACTERIOL, V183, P6630, DOI 10.1128/JB.183.22.6630-6635.2001; Salimnia H, 2000, ARCH MICROBIOL, V173, P10, DOI 10.1007/s002030050002; Serafim TL, 2008, CANCER CHEMOTH PHARM, V61, P1007, DOI 10.1007/s00280-007-0558-9; Tegos G, 2002, ANTIMICROB AGENTS CH, V46, P3133, DOI 10.1128/AAC.46.10.3133-3141.2002; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Villinski JR, 2003, PHARM BIOL, V41, P551, DOI 10.1080/13880200390500768; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200; Weiss DS, 2004, MOL MICROBIOL, V54, P588, DOI 10.1111/j.1365-2958.2004.04283.x; Yadav RC, 2005, BIOORGAN MED CHEM, V13, P165, DOI 10.1016/j.bmc.2004.09.045; Yin J, 2008, METABOLISM, V57, P712, DOI 10.1016/j.metabol.2008.01.013; Yin J, 2008, AM J PHYSIOL-ENDOC M, V294, pE148, DOI 10.1152/ajpendo.00211.2007; Yu HH, 2005, J MED FOOD, V8, P454, DOI 10.1089/jmf.2005.8.454; Zhang H, 2010, METABOLISM, V59, P285, DOI 10.1016/j.metabol.2009.07.029	51	121	130	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13745	10.1371/journal.pone.0013745	http://dx.doi.org/10.1371/journal.pone.0013745			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060782	Green Published, Green Submitted, gold			2022-12-25	WOS:000283645300025
J	Kile, ML; Baccarelli, A; Tarantini, L; Hoffman, E; Wright, RO; Christiani, DC				Kile, Molly L.; Baccarelli, Andrea; Tarantini, Letizia; Hoffman, Elaine; Wright, Robert O.; Christiani, David C.			Correlation of Global and Gene-Specific DNA Methylation in Maternal-Infant Pairs	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; BLOOD LEUKOCYTE DNA; EPIGENETIC INHERITANCE; GERMLINE EPIMUTATION; PROMOTER METHYLATION; HYPOMETHYLATION; HYPERMETHYLATION; CELLS; ALU; ASSOCIATION	The inheritance of DNA methylation patterns is a popular theory to explain the influence of parental genetic and environmental factors on the phenotype of their offspring but few studies have examined this relationship in humans. Using 120 paired maternal-umbilical cord blood samples randomly selected from a prospective birth cohort in Bangladesh, we quantified DNA methylation by pyrosequencing seven CpG positions in the promoter region of p16, four CpG positions in the promoter region of p53, LINE-1 and Alu. Positive correlations were observed between maternal and umbilical cord blood at p16, LINE-1, and Alu but not p53. Multiple linear regression models observed a significant association between maternal and umbilical cord blood at LINE-1 and Alu (LINE-1: beta = 0.63, p<0.0001; Alu: beta = 0.28, p = 0.009). After adjusting for multiple comparisons, maternal methylation of p16 at position 4 significantly predicted methylation at the same position in umbilical cord blood (beta = 0.43, p = <0.0001). These models explained 48%, 5% and 16% of the observed variability in umbilical cord % 5mC for LINE-1, Alu and p16 at position 4, respectively. These results suggest that DNA methylation in maternal blood was correlated with her offspring at LINE-1, Alu, and p16 but not p53. Additional studies are needed to confirm whether these observed associations were due to the inheritance of epigenetic events or the shared environment between mother and fetus. Future studies should also use a multi-generational family-based design that would quantify both maternal and paternal contributions to DNA methylation in offspring across more than one generation.	[Kile, Molly L.; Baccarelli, Andrea; Hoffman, Elaine; Wright, Robert O.; Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Baccarelli, Andrea; Tarantini, Letizia] Univ Milan, Dept Environm & Occupat Hlth, Ctr Mol & Genet Epidemiol, Ca Granda Osped Maggiore Policlin IRCCS Fdn, Milan, Italy	Harvard University; Harvard T.H. Chan School of Public Health; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Kile, ML (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	mkile@hsph.harvard.edu	Kile, Molly/A-8582-2012	Baccarelli, Andrea/0000-0002-3436-0640	Harvard School of Public Health National Institute of Environmental Health Sciences Center [P30ES00002]; National Institute of Environmental Health Sciences [R01ES015533, K01ES017800]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020268, R01ES015533, P30ES000002, P42ES016454, K01ES017800] Funding Source: NIH RePORTER	Harvard School of Public Health National Institute of Environmental Health Sciences Center; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Harvard School of Public Health National Institute of Environmental Health Sciences Center Pilot Grant P30ES00002, National Institute of Environmental Health Sciences R01ES015533 and K01ES017800. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarelli A, 2009, AM J RESP CRIT CARE, V180, P1030, DOI 10.1164/ajrccm.180.10.1030a; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Bollati V, 2010, HEREDITY, V105, P105, DOI 10.1038/hdy.2010.2; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; BRINK RA, 1968, SCIENCE, V159, P161, DOI 10.1126/science.159.3811.161; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Chan TL, 2006, NAT GENET, V38, P1178, DOI 10.1038/ng1866; Chanda S, 2006, TOXICOL SCI, V89, P431, DOI 10.1093/toxsci/kfj030; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Choi IS, 2007, MODERN PATHOL, V20, P802, DOI 10.1038/modpathol.3800825; Choi JY, 2009, CARCINOGENESIS, V30, P1889, DOI 10.1093/carcin/bgp143; Daskalos A, 2009, INT J CANCER, V124, P81, DOI 10.1002/ijc.23849; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Fryer AA, 2009, EPIGENETICS-US, V4, P292; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Geiman TM, 2010, MOL REPROD DEV, V77, P105, DOI 10.1002/mrd.21118; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; HALL JM, 1995, BLOOD, V86, P2829; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hillemacher T, 2008, EUR NEUROPSYCHOPHARM, V18, P295, DOI 10.1016/j.euroneuro.2007.12.005; Hitchins M, 2005, GASTROENTEROLOGY, V129, P1392, DOI 10.1053/j.gastro.2005.09.003; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Hou LF, 2010, INT J CANCER, V127, P1866, DOI 10.1002/ijc.25190; Ji WZ, 1997, MUTAT RES-FUND MOL M, V379, P33, DOI 10.1016/S0027-5107(97)00088-2; Jintaridth P, 2010, PHYSIOL GENOMICS, V41, P194, DOI 10.1152/physiolgenomics.00146.2009; KOCHANEK S, 1993, EMBO J, V12, P1141, DOI 10.1002/j.1460-2075.1993.tb05755.x; Li TH, 2001, GENE, V276, P135, DOI 10.1016/S0378-1119(01)00637-0; Liu JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010028; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Mirabello L, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-77; Morgan DK, 2008, MAMM GENOME, V19, P394, DOI 10.1007/s00335-008-9124-y; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Moverare-Skrtic S, 2009, ENDOCRINE, V35, P204, DOI 10.1007/s12020-009-9153-7; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; Pilsner JR, 2007, AM J CLIN NUTR, V86, P1179, DOI 10.1093/ajcn/86.4.1179; Pogribny IP, 2009, CELL MOL LIFE SCI, V66, P2249, DOI 10.1007/s00018-009-0015-5; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sandovici I, 2005, HUM MOL GENET, V14, P2135, DOI 10.1093/hmg/ddi218; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Shaw RJ, 2006, BRIT J CANCER, V94, P561, DOI 10.1038/sj.bjc.6602972; Sun YV, 2010, HUM GENET, V127, P651, DOI 10.1007/s00439-010-0810-y; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Tarantini L, 2009, ENVIRON HEALTH PERSP, V117, P217, DOI 10.1289/ehp.11898; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Wright RO, 2010, ENVIRON HEALTH PERSP, V118, P790, DOI 10.1289/ehp.0901429	52	60	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13730	10.1371/journal.pone.0013730	http://dx.doi.org/10.1371/journal.pone.0013730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060777	Green Published, Green Submitted, gold			2022-12-25	WOS:000283645300011
J	Sun, JY; Oma, Y; Harata, M; Kono, K; Shima, H; Kinomura, A; Ikura, T; Suzuki, H; Mizutani, S; Kanaar, R; Tashiro, S				Sun, Jiying; Oma, Yukako; Harata, Masahiko; Kono, Kazuteru; Shima, Hiroki; Kinomura, Aiko; Ikura, Tsuyoshi; Suzuki, Hidekazu; Mizutani, Shuki; Kanaar, Roland; Tashiro, Satoshi			ATM Modulates the Loading of Recombination Proteins onto a Chromosomal Translocation Breakpoint Hotspot	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; DNA-DAMAGE; TOPOISOMERASE-II; MAMMALIAN-CELLS; SACCHAROMYCES-CEREVISIAE; GENOMIC STABILITY; ACUTE-LEUKEMIA; REPAIR; MLL; CHROMATIN	Chromosome translocations induced by DNA damaging agents, such as ionizing radiation and certain chemotherapies, alter genetic information resulting in malignant transformation. Abrogation or loss of the ataxia-telangiectasia mutated (ATM) protein, a DNA damage signaling regulator, increases the incidence of chromosome translocations. However, how ATM protects cells from chromosome translocations is still unclear. Chromosome translocations involving the MLL gene on 11q23 are the most frequent chromosome abnormalities in secondary leukemias associated with chemotherapy employing etoposide, a topoisomerase II poison. Here we show that ATM deficiency results in the excessive binding of the DNA recombination protein RAD51 at the translocation breakpoint hotspot of 11q23 chromosome translocation after etoposide exposure. Binding of Replication protein A (RPA) and the chromatin remodeler INO80, which facilitate RAD51 loading on damaged DNA, to the hotspot were also increased by ATM deficiency. Thus, in addition to activating DNA damage signaling, ATM may avert chromosome translocations by preventing excessive loading of recombinational repair proteins onto translocation breakpoint hotspots.	[Sun, Jiying; Kono, Kazuteru; Shima, Hiroki; Kinomura, Aiko; Suzuki, Hidekazu; Tashiro, Satoshi] Hiroshima Univ, RIRBM, Dept Cellular Biol, Hiroshima, Japan; [Oma, Yukako; Harata, Masahiko] Tohoku Univ, Grad Sch Agr Sci, Mol Biol Lab, Sendai, Miyagi 980, Japan; [Ikura, Tsuyoshi] Kyoto Univ, RBC, Lab Chromatin Regulatory Network, Kyoto, Japan; [Mizutani, Shuki] Tokyo Med & Dent Univ, Grad Sch Med, Dept Pediat & Dev Biol, Tokyo, Japan; [Kanaar, Roland] Erasmus MC, Canc Genom Ctr, Dept Cell Biol & Genet, Dept Radiat Oncol, Rotterdam, Netherlands	Hiroshima University; Tohoku University; Kyoto University; Tokyo Medical & Dental University (TMDU); Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Sun, JY (corresponding author), Hiroshima Univ, RIRBM, Dept Cellular Biol, Hiroshima, Japan.	ktashiro@hiroshima-u.ac.jp	Harata, Masahiko/T-5281-2019		Ministry of Education, Science and Culture of Japan; Japan Society for the Promotion of Science	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by grants-in-aids for Scientific Research from the Ministry of Education, Science and Culture of Japan and Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander FE, 2001, CANCER RES, V61, P2542; Aoyama N, 2008, EXP CELL RES, V314, P859, DOI 10.1016/j.yexcr.2007.11.020; Bishop AJR, 2000, CANCER RES, V60, P395; Broeker PLS, 1996, BLOOD, V87, P1912, DOI 10.1182/blood.V87.5.1912.bloodjournal8751912; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Felix CA, 2001, MED PEDIATR ONCOL, V36, P525, DOI 10.1002/mpo.1125; Felix CA, 2006, DNA REPAIR, V5, P1093, DOI 10.1016/j.dnarep.2006.05.031; Flygare J, 2001, EXP CELL RES, V268, P61, DOI 10.1006/excr.2001.5265; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Frasca D, 1998, MECH AGEING DEV, V100, P197, DOI 10.1016/S0047-6374(97)00137-1; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Harper DP, 2008, CANCER RES, V68, P10024, DOI 10.1158/0008-5472.CAN-08-2208; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Kabotyanski EB, 1998, NUCLEIC ACIDS RES, V26, P5333, DOI 10.1093/nar/26.23.5333; Khanna KK, 2000, JNCI-J NATL CANCER I, V92, P795, DOI 10.1093/jnci/92.10.795; KOMATSU K, 1990, MUTAT RES, V235, P59, DOI 10.1016/0921-8777(90)90058-D; Lee DH, 2010, NAT STRUCT MOL BIOL, V17, P365, DOI 10.1038/nsmb.1769; Lee K, 2008, NATURE, V454, P543, DOI 10.1038/nature07054; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Martin SA, 2008, CURR OPIN GENET DEV, V18, P80, DOI 10.1016/j.gde.2008.01.016; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Nakada S, 2006, J CLIN INVEST, V116, P80, DOI 10.1172/JCI25716; Oguchi K, 2003, BLOOD, V101, P3622, DOI 10.1182/blood-2002-02-0570; Raderschall E, 2002, CANCER RES, V62, P219; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Shcherbakova OG, 2000, MUTAT RES-DNA REPAIR, V459, P65, DOI 10.1016/S0921-8777(99)00059-2; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sung PA, 2006, DNA REPAIR, V5, P1109, DOI 10.1016/j.dnarep.2006.05.018; Tashiro S, 2000, J CELL BIOL, V150, P283, DOI 10.1083/jcb.150.2.283; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Xia SJJ, 1997, MOL CELL BIOL, V17, P7151, DOI 10.1128/MCB.17.12.7151; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Zhang YM, 2006, DNA REPAIR, V5, P1282, DOI 10.1016/j.dnarep.2006.05.020	45	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13554	10.1371/journal.pone.0013554	http://dx.doi.org/10.1371/journal.pone.0013554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048951	Green Published, Green Submitted, gold			2022-12-25	WOS:000283537000008
J	Artzy-Randrup, Y; Alonso, D; Pascual, M				Artzy-Randrup, Yael; Alonso, David; Pascual, Mercedes			Transmission Intensity and Drug Resistance in Malaria Population Dynamics: Implications for Climate Change	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ACQUIRED-IMMUNITY; HOLOENDEMIC AREA; PUZZLING LINKS; RECOVERY RATES; MODEL; SPREAD; INFECTION; CHLOROQUINE; MUTATIONS	Although the spread of drug resistance and the influence of climate change on malaria are most often considered separately, these factors have the potential to interact through altered levels of transmission intensity. The influence of transmission intensity on the evolution of drug resistance has been addressed in theoretical studies from a population genetics' perspective; less is known however on how epidemiological dynamics at the population level modulates this influence. We ask from a theoretical perspective, whether population dynamics can explain non-trivial, non-monotonic, patterns of treatment failure with transmission intensity, and, if so, under what conditions. We then address the implications of warmer temperatures in an East African highland, where, as in other similar regions at the altitudinal edge of malaria's distribution, there has been a pronounced increase of cases from the 1970s to the 1990s. Our theoretical analyses, with a transmission model that includes different levels of immunity, demonstrate that an increase in transmission beyond a threshold can lead to a decrease in drug resistance, as previously shown [1], but that a second threshold may occur and lead to the re-establishment of drug resistance. Estimates of the increase in transmission intensity from the 1970s to the 1990s for the Kenyan time series, obtained by fitting the two-stage version of the model with an explicit representation of vector dynamics, suggest that warmer temperatures are likely to have moved the system towards the first threshold, and in so doing, to have promoted the faster spread of drug resistance. Climate change and drug resistance can interact and need not be considered as alternative explanations for trends in disease incidence in this region. Non-monotonic patterns of treatment failure with transmission intensity similar to those described as the 'valley phenomenon' for Uganda can result from epidemiological dynamics but under poorly understood assumptions.	[Artzy-Randrup, Yael; Pascual, Mercedes] Univ Michigan, Howard Hughes Med Inst, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Alonso, David] Univ Groningen, Ctr Ecol & Evolutionary Studies, Community & Conservat Ecol Grp, Groningen, Netherlands	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Groningen	Artzy-Randrup, Y (corresponding author), Univ Michigan, Howard Hughes Med Inst, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	YArtzy@umich.edu	Alonso, David/A-5406-2008	Alonso, David/0000-0002-8888-1644	Howard Hughes Medical Institute; James S. McDonnell Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); James S. McDonnell Foundation	Howard Hughes Medical Institute (http://www.hhmi.org/) and the James S. McDonnell Foundation (http://www.jsmf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO D, 2010, P R SOC L B IN PRESS; Ariey F, 2003, TRENDS PARASITOL, V19, P158, DOI 10.1016/S1471-4922(03)00054-0; ARON JL, 1983, MATH BIOSCI, V64, P249, DOI 10.1016/0025-5564(83)90007-X; BABIKER H, 2009, TRENDS PARASITOLOGY, V25; Babiker HA, 2005, ACTA TROP, V94, P260, DOI 10.1016/j.actatropica.2005.04.007; BAIRD JK, 1995, PARASITOL TODAY, V11, P105, DOI 10.1016/0169-4758(95)80167-7; Barry AE, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030034; BEKESSY A, 1976, B WORLD HEALTH ORGAN, V54, P685; Bonnet S, 2003, T ROY SOC TROP MED H, V97, P53, DOI 10.1016/S0035-9203(03)90022-8; CURTIS CF, 1986, T ROY SOC TROP MED H, V80, P889, DOI 10.1016/0035-9203(86)90248-8; DIETZ K, 1974, B WORLD HEALTH ORGAN, V50, P347; Dye C, 1997, P ROY SOC B-BIOL SCI, V264, P61, DOI 10.1098/rspb.1997.0009; Escalante AA, 2009, TRENDS PARASITOL, V25, P557, DOI 10.1016/j.pt.2009.09.008; GITHEKO AK, 1992, T ROY SOC TROP MED H, V86, P355, DOI 10.1016/0035-9203(92)90216-Y; Gouagna LC, 2004, PARASITOLOGY, V128, P235, DOI 10.1017/S003118200300444X; GUPTA S, 1994, PARASITE IMMUNOL, V16, P361, DOI 10.1111/j.1365-3024.1994.tb00361.x; GUPTA S, 1994, SCIENCE, V263, P961, DOI 10.1126/science.8310293; HASTINGS I, 2000, PARASITOLOGY TODAY, V16; Hastings IA, 2005, DRUG RESIST UPDATE, V8, P43, DOI 10.1016/j.drup.2005.03.003; Hastings IM, 1997, PARASITOLOGY, V115, P133, DOI 10.1017/S0031182097001261; Hastings IM, 2003, TRENDS PARASITOL, V19, P160, DOI 10.1016/S1471-4922(03)00053-9; Hastings IM, 2003, TRENDS PARASITOL, V19, P70, DOI 10.1016/S1471-4922(02)00017-X; Hastings IM, 2005, ACTA TROP, V94, P218, DOI 10.1016/j.actatropica.2005.04.003; Hastings IM, 1998, PARASITOLOGY, V117, P411, DOI 10.1017/S0031182098003291; HAY S, 2002, EMERGING INFECT DIS, V8; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Hayward R, 2005, MOL MICROBIOL, V55, P1285, DOI 10.1111/j.1365-2958.2004.04470.x; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Klein EY, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-67; Koella JC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-3; Lafferty KD, 2009, ECOLOGY, V90, P932, DOI 10.1890/08-1767.1; Laufer MK, 2004, DRUG RESIST UPDATE, V7, P279, DOI 10.1016/j.drup.2004.08.003; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Maire N, 2006, AM J TROP MED HYG, V75, P19, DOI 10.4269/ajtmh.2006.75.19; MASABA SC, 1985, B WORLD HEALTH ORGAN, V63, P593; Mharakurwa S, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-35; MOLINEAUX L, 1980, GRAMICCIA GARKI PROJ; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Pascual M, 2009, P NATL ACAD SCI USA, V106, P13645, DOI 10.1073/pnas.0906909106; Pascual M, 2009, ECOLOGY, V90, P906, DOI 10.1890/08-0730.1; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a; Pongtavornpinyo W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-229; RAPUODA BA, 1996, MALARIA INFECT DIS A, V8, P25; Read AF, 2009, EVOL APPL, V2, P40, DOI 10.1111/j.1752-4571.2008.00066.x; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; SCHMIDT KF, 1995, SCIENCE, V269, P1670, DOI 10.1126/science.7569890; Shanks GD, 2005, EMERGING INFECT DIS, V11; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Smith T, 2004, AM J TROP MED HYG, V71, P80, DOI 10.4269/ajtmh.2004.71.80; Smith T, 2003, STAT MED, V22, P1709, DOI 10.1002/sim.1274; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Talisuna AO, 2007, AM J TROP MED HYG, V77, P170; Talisuna AO, 2003, INT J PARASITOL, V33, P1051, DOI 10.1016/S0020-7519(03)00156-5; Talisuna AO, 2002, T ROY SOC TROP MED H, V96, P310, DOI 10.1016/S0035-9203(02)90108-2; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; White NJ, 2003, P ROY SOC B-BIOL SCI, V270, P545, DOI 10.1098/rspb.2002.2241; White NJ, 1998, DRUG RESIST UPDATE, V1, P3, DOI 10.1016/S1368-7646(98)80208-2	60	23	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13588	10.1371/journal.pone.0013588	http://dx.doi.org/10.1371/journal.pone.0013588			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21060886	Green Published, Green Submitted, gold			2022-12-25	WOS:000283487400005
J	Field, J; Browning, SR; Johnson, LJ; Danoy, P; Varney, MD; Tait, BD; Gandhi, KS; Charlesworth, JC; Heard, RN; Stewart, GJ; Kilpatrick, TJ; Foote, SJ; Bahlo, M; Butzkueven, H; Wiley, J; Booth, DR; Taylor, BV; Brown, MA; Rubio, JP; Stankovich, J				Field, Judith; Browning, Sharon R.; Johnson, Laura J.; Danoy, Patrick; Varney, Michael D.; Tait, Brian D.; Gandhi, Kaushal S.; Charlesworth, Jac C.; Heard, Robert N.; Stewart, Graeme J.; Kilpatrick, Trevor J.; Foote, Simon J.; Bahlo, Melanie; Butzkueven, Helmut; Wiley, James; Booth, David R.; Taylor, Bruce V.; Brown, Matthew A.; Rubio, Justin P.; Stankovich, Jim		Australia New Zealand Multiple Scl	A Polymorphism in the HLA-DPB1 Gene Is Associated with Susceptibility to Multiple Sclerosis	PLOS ONE			English	Article							CLASS-I REGION; CLINICAL-COURSE; RISK; MHC; HLA-DRB1; ALLELES; LOCI; COMPLEX; HETEROGENEITY; REPLICATION	We conducted an association study across the human leukocyte antigen (HLA) complex to identify loci associated with multiple sclerosis (MS). Comparing 1927 SNPs in 1618 MS cases and 3413 controls of European ancestry, we identified seven SNPs that were independently associated with MS conditional on the others (each P <= 4 x 10(-6)). All associations were significant in an independent replication cohort of 2212 cases and 2251 controls (P <= 0.001) and were highly significant in the combined dataset (P <= 6 x 10(-8)). The associated SNPs included proxies for HLA-DRB1*15:01 and HLA-DRB1*03:01, and SNPs in moderate linkage disequilibrium (LD) with HLA-A*02:01, HLA-DRB1*04:01 and HLA-DRB1*13:03. We also found a strong association with rs9277535 in the class II gene HLA-DPB1 (discovery set P = 9 x 10(-9), replication set P = 7 x 10(-4), combined P = 2 x 10(-10)). HLA-DPB1 is located centromeric of the more commonly typed class II genes HLA-DRB1, -DQA1 and -DQB1. It is separated from these genes by a recombination hotspot, and the association is not affected by conditioning on genotypes at DRB1, DQA1 and DQB1. Hence rs9277535 represents an independent MS-susceptibility locus of genomewide significance. It is correlated with the HLA-DPB1*03:01 allele, which has been implicated previously in MS in smaller studies. Further genotyping in large datasets is required to confirm and resolve this association.	[Field, Judith; Johnson, Laura J.; Kilpatrick, Trevor J.; Butzkueven, Helmut; Wiley, James; Rubio, Justin P.] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic, Australia; [Field, Judith; Johnson, Laura J.; Kilpatrick, Trevor J.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic, Australia; [Browning, Sharon R.] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [Danoy, Patrick; Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Univ Queensland Diamantina Inst, Brisbane, Qld, Australia; [Varney, Michael D.; Tait, Brian D.] Australian Red Cross Blood Serv, Melbourne, Vic, Australia; [Gandhi, Kaushal S.; Heard, Robert N.; Stewart, Graeme J.; Booth, David R.] Univ Sydney, Westmead Millenium Inst, Sydney, NSW 2006, Australia; [Charlesworth, Jac C.] SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA; [Kilpatrick, Trevor J.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Foote, Simon J.; Taylor, Bruce V.; Stankovich, Jim] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia; [Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Butzkueven, Helmut] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Butzkueven, Helmut] Box Hill Hosp, Dept Neurol, Box Hill, Vic, Australia; [Brown, Matthew A.] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Surg, Oxford, England; [Rubio, Justin P.] GlaxoSmithKline, Harlow, Essex, England	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Auckland; University of Queensland; Australian Red Cross Blood Service; University of Sydney; Westmead Institute for Medical Research; Texas Biomedical Research Institute; Royal Melbourne Hospital; University of Tasmania; Menzies Institute for Medical Research; Walter & Eliza Hall Institute; University of Melbourne; Box Hill Hospital; University of Oxford; GlaxoSmithKline	Field, J (corresponding author), Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic, Australia.	J.Stankovich@utas.edu.au	Brown, Matthew A/E-5749-2010; Foote, Simon J/F-2802-2013; Charlesworth, Jac/J-7661-2014; Kermode, Allan/G-3568-2019; Browning, Sharon/B-1530-2008; Scott, Rodney/B-2827-2013; Slee, Mark/J-4731-2015	Brown, Matthew A/0000-0003-0538-8211; Charlesworth, Jac/0000-0001-6201-3518; Kermode, Allan/0000-0002-4476-4016; Browning, Sharon/0000-0001-7251-9715; Wiley, James/0000-0001-9421-4154; Kilpatrick, Trevor/0000-0003-3999-085X; Butzkueven, Helmut/0000-0003-3940-8727; Lechner-Scott, Jeannette/0000-0002-3850-447X; Stankovich, Jim/0000-0001-9344-7749; RUBIO, JUSTIN/0000-0003-3750-917X; Griffiths, Lyn/0000-0002-6774-5475; Foote, Simon/0000-0002-9142-2107; Scott, Rodney/0000-0001-7724-3404; Moscato, Pablo/0000-0003-2570-5966; Slee, Mark/0000-0003-4323-2453; Bahlo, Melanie/0000-0001-5132-0774; Field, Judith/0000-0002-7089-0999	National Health and Medical Research Council of Australia [509184]; Australian Research Council [LP0776744]; Multiple Sclerosis Research Australia; John T. Reid Charitable Trusts; Trish MS Research Foundation; Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02]; MRC [G0000934] Funding Source: UKRI	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Multiple Sclerosis Research Australia; John T. Reid Charitable Trusts; Trish MS Research Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Health and Medical Research Council of Australia (Project Grant number 509184, Career Development Awards to M.B., H.B. and J.P.R., Principal Research Fellowship to M. A. B.), the Australian Research Council (Linkage Project Grant number LP0776744), Multiple Sclerosis Research Australia (Linkage Project Grant, Post-doctoral Fellowship to J.F.), John T. Reid Charitable Trusts, and the Trish MS Research Foundation. J.P.R. is currently employed by GlaxoSmithKline. Genotype data from the British 1958 Birth Cohort DNA collection was funded by the Medical Research Council grant G0000934 and the Wellcome Trust Grant 068545/Z/02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Aulchenko YS, 2008, NAT GENET, V40, P1402, DOI 10.1038/ng.251; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Ban M, 2009, EUR J HUM GENET, V17, P1309, DOI 10.1038/ejhg.2009.41; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Bergamaschi L, 2010, GENES IMMUN, V11, P173, DOI 10.1038/gene.2009.101; Bronson PG, 2010, HUM MOL GENET, V19, P2331, DOI 10.1093/hmg/ddq101; Browning BL, 2007, GENET EPIDEMIOL, V31, P365, DOI 10.1002/gepi.20216; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2006, AM J HUM GENET, V78, P903, DOI 10.1086/503876; Burfoot RK, 2008, TISSUE ANTIGENS, V71, P42, DOI 10.1111/j.1399-0039.2007.00962.x; Cree BAC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011296; D'Alfonso S, 2008, GENES IMMUN, V9, P7, DOI 10.1038/sj.gene.6364437; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; DEKKER JW, 1993, TISSUE ANTIGENS, V41, P31, DOI 10.1111/j.1399-0039.1993.tb01974.x; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Fogdell-Hahn A, 2000, TISSUE ANTIGENS, V55, P140, DOI 10.1034/j.1399-0039.2000.550205.x; Fukazawa T, 2006, MULT SCLER J, V12, P19, DOI 10.1191/135248506ms1252oa; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hafler JP, 2009, GENES IMMUN, V10, P5, DOI 10.1038/gene.2008.82; Handel AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010142; Harbo HF, 2004, TISSUE ANTIGENS, V63, P237, DOI 10.1111/j.0001-2815.2004.00173.x; Hoppenbrouwers IA, 2008, GENES IMMUN, V9, P334, DOI 10.1038/gene.2008.22; Jakkula E, 2010, AM J HUM GENET, V86, P285, DOI 10.1016/j.ajhg.2010.01.017; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; Marrosu M, 2006, J NEUROL, V253, P208, DOI 10.1007/s00415-005-0957-y; Marrosu MG, 2001, HUM MOL GENET, V10, P2907, DOI 10.1093/hmg/10.25.2907; Marrosu MG, 1998, HUM MOL GENET, V7, P1235, DOI 10.1093/hmg/7.8.1235; McCauley JL, 2010, HUM MOL GENET, V19, P953, DOI 10.1093/hmg/ddp542; McDonnell GV, 1999, J NEUROL SCI, V165, P77, DOI 10.1016/S0022-510X(99)00084-2; McElroy JP, 2010, HUM MOL GENET, V19, P3080, DOI 10.1093/hmg/ddq197; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; PAWELEC G, 1990, CELL IMMUNOL, V127, P520, DOI 10.1016/0008-8749(90)90152-H; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Rubio JP, 2008, GENES IMMUN, V9, P624, DOI 10.1038/gene.2008.59; Sawcer S, 2008, LANCET NEUROL, V7, P567, DOI 10.1016/S1474-4422(08)70122-4; Stankovich J, 2009, TISSUE ANTIGENS, V74, P17, DOI 10.1111/j.1399-0039.2009.01262.x; Tiwari J L, 1981, Prog Clin Biol Res, V58, P151; van der Mei IAF, 2010, ANN NEUROL, V67, P261, DOI 10.1002/ana.21849; Wiendl H, 2005, BRAIN, V128, P2689, DOI 10.1093/brain/awh609; Wu JS, 2010, MULT SCLER J, V16, P526, DOI 10.1177/1352458510362997; Wu XM, 2009, MULT SCLER J, V15, P1422, DOI 10.1177/1352458509345905; Yamasaki K, 1999, BRAIN, V122, P1689, DOI 10.1093/brain/122.9.1689; Yeo TW, 2007, ANN NEUROL, V61, P228, DOI 10.1002/ana.21063; Yu M, 1998, HUM IMMUNOL, V59, P15, DOI 10.1016/S0198-8859(97)00252-8; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E	51	42	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13454	10.1371/journal.pone.0013454	http://dx.doi.org/10.1371/journal.pone.0013454			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049023	Green Published, gold, Green Submitted			2022-12-25	WOS:000283487400001
J	Nunez, CMV; Adelman, JS; Rubenstein, DI				Nunez, Cassandra M. V.; Adelman, James S.; Rubenstein, Daniel I.			Immunocontraception in Wild Horses (Equus caballus) Extends Reproductive Cycling Beyond the Normal Breeding Season	PLOS ONE			English	Article							FERAL HORSES; SEXUAL-BEHAVIOR; TIME-BUDGETS; POPULATION; EXPOSURE; SUCCESS; LENGTH; ESTRUS; MICE	Background: Although the physiological effects of immunocontraceptive treatment with porcine zona pellucida (PZP) have been well studied, little is known about PZP's effects on the scheduling of reproductive cycling. Recent behavioral research has suggested that recipients of PZP extend the receptive breeding period into what is normally the non-breeding season. Methodology/Principal Findings: To determine if this is the case, we compiled foaling data from wild horses (Equus caballus) living on Shackleford Banks, North Carolina for 4 years pre- and 8 years post-contraception management with PZP (pre-contraception, n = 65 births from 45 mares; post-contraception, n = 97 births from 46 mares). Gestation lasts approximately 11-12 months in wild horses, placing conception at approximately 11.5 months prior to birth. Since the contraception program began in January 2000, foaling has occurred over a significantly broader range than it had before the contraception program. Foaling in PZP recipients (n = 45 births from 27 mares) has consistently occurred over a broader range than has foaling in non-recipients (n = 52 births from 19 mares). In addition, current recipients of PZP foaled later in the year than did prior recipient and non-recipient mares. Females receiving more consecutive PZP applications gave birth later in the season than did females receiving fewer applications. Finally, the efficacy of PZP declined with increasing consecutive applications before reaching 100% after five consecutive applications. Conclusions/Significance: For a gregarious species such as the horse, the extension of reproductive cycling into the fall months has important social consequences, including decreased group stability and the extension of male reproductive behavior. In addition, reproductive cycling into the fall months could have long-term effects on foal survivorship. Managers should consider these factors before enacting immunocontraceptive programs in new populations. We suggest minor alterations to management strategies to help alleviate such unintended effects in new populations.	[Nunez, Cassandra M. V.; Adelman, James S.; Rubenstein, Daniel I.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University	Nunez, CMV (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	cmvnunez@princeton.edu		Adelman, James/0000-0002-5577-8798; Nunez, Cassandra/0000-0002-6702-0730	National Science Foundation [IIS-0705311]	National Science Foundation(National Science Foundation (NSF))	This research was funded by the National Science Foundation, IIS-0705311 to D.I. Rubenstein, http://www.nsf.gov/ and a National Science Foundation Graduate Research Fellowship to J.S. Adelman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asa Cheryl S., 2002, P113; ASA CS, 1980, HORM BEHAV, V14, P46, DOI 10.1016/0018-506X(80)90014-8; ASA CS, 1979, HORM BEHAV, V13, P49, DOI 10.1016/0018-506X(79)90034-5; Ball Gregory F., 2002, P649; BOS H, 1980, LIVEST PROD SCI, V7, P181, DOI 10.1016/0301-6226(80)90105-0; Cameron EZ, 2003, BEHAV ECOL SOCIOBIOL, V53, P92, DOI 10.1007/s00265-002-0556-1; Churcher C.S., 1993, Mammalian Species, V453, P1; Crawley MJ., 2007, R BOOK; Crowell-Davis SL, 2007, HORM BEHAV, V52, P12, DOI 10.1016/j.yhbeh.2007.03.020; Davies Morel M C G, 2003, EQUINE REPROD PHYSL, V2nd; Delsink AK, 2006, S AFR J SCI, V102, P403; DUNCAN P, 1985, BEHAVIOUR, V92, P188, DOI 10.1163/156853985X00442; EBERHARDT LL, 1982, J WILDLIFE MANAGE, V46, P367, DOI 10.2307/3808648; Feh C, 1999, ANIM BEHAV, V57, P705, DOI 10.1006/anbe.1998.1009; FEIST JD, 1976, Z TIERPSYCHOL, V41, P337; Goldsby RA, 2000, KUBY IMMUNOLOGY; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; GRUBB P, 1981, MAMMALIAN SPECIES, V157, P1; Heilmann TJ, 1998, J WILDLIFE MANAGE, V62, P243, DOI 10.2307/3802284; HORNBUCKLE T, 1995, THERIOGENOLOGY, V43, P411, DOI 10.1016/0093-691X(94)00034-R; KASEDA Y, 1995, EQUINE VET J, V27, P368, DOI 10.1111/j.2042-3306.1995.tb04072.x; KEARNS M, 2009, MALE HARASSMENT INFL; KEIPER R, 1984, AM J VET RES, V45, P991; Kirkpatrick J. F., 1995, NATL PARK SERVICE MO; Kirkpatrick Jay F., 2003, Journal of Applied Animal Welfare Science, V6, P301, DOI 10.1207/s15327604jaws0604_4; Kirkpatrick JF, 1996, J REPROD FERTIL, P183; Kirkpatrick JF, 1997, REPROD FERT DEVELOP, V9, P105, DOI 10.1071/R96052; Kirkpatrick JF, 2002, REPRODUCTION, P197; KIRKPATRICK JF, 1991, J WILDLIFE MANAGE, V55, P649, DOI 10.2307/3809514; KIRKPATRICK JF, 1992, J REPROD FERTIL, V94, P437, DOI 10.1530/jrf.0.0940437; Lane VM, 2007, REPROD FERT DEVELOP, V19, P617, DOI 10.1071/RD06154; Lea J, 2001, ANIM BEHAV, V61, P373, DOI 10.1006/anbe.2000.1604; LINDZEY J, 1988, HORM BEHAV, V22, P279, DOI 10.1016/0018-506X(88)90001-3; LIU IKM, 1989, J REPROD FERTIL, V85, P19, DOI 10.1530/jrf.0.0850019; Lyda RO, 2005, J ZOO WILDLIFE MED, V36, P610, DOI 10.1638/04104.1; MARSDEN HM, 1964, SCIENCE, V144, P1469, DOI 10.1126/science.144.3625.1469; MCCOMB K, 1987, NATURE, V330, P648, DOI 10.1038/330648a0; McShea WJ, 1997, J WILDLIFE MANAGE, V61, P560, DOI 10.2307/3802615; Morel MCGD, 2006, ANIM SCI, V82, P581, DOI 10.1079/ASC200669; Morris J, 2001, IN PRACTICE, V23, P606, DOI 10.1136/inpract.23.10.606; Nunez CMV, 2009, APPL ANIM BEHAV SCI, V117, P74, DOI 10.1016/j.applanim.2008.12.001; NUNEZ CMV, 2000, THESIS PRINCETON U P; NUNEZ CMV, 2009, EQUINC REPROD; Pacheco MA, 1997, J MAMMAL, V78, P15, DOI 10.2307/1382634; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, pXVI; POLLOCK J, 1980, BEHAV ECOLOGY BODY C, P63; Powell D. M., 2001, Journal of Applied Animal Welfare Science, V4, P271, DOI 10.1207/S15327604JAWS0404_04; Powell D M, 1999, J Appl Anim Welf Sci, V2, P321, DOI 10.1207/s15327604jaws0204_6; Ransom JI, 2010, APPL ANIM BEHAV SCI, V124, P51, DOI 10.1016/j.applanim.2010.01.015; Rubenstein D.I., 1986, P282; Rubenstein DI, 2009, REPRODUCTIVE SKEW IN VERTEBRATES: PROXIMATE AND ULTIMATE CAUSES, P196, DOI 10.1017/CBO9780511641954.010; RUBENSTEIN DI, 1981, EQUINE VET J, V13, P27, DOI 10.1111/j.2042-3306.1981.tb03443.x; SACCO AG, 1977, BIOL REPROD, V16, P164, DOI 10.1095/biolreprod16.2.164; Sadleir R.M.F.S., 1969, ECOLOGY REPROD WILD; STEVENS EF, 1990, BEHAVIOUR, V112, P149, DOI 10.1163/156853990X00167; Sundaresan SR, 2007, BEHAV ECOL, V18, P860, DOI 10.1093/beheco/arm055; TORIBIO RE, 1995, ACTA VET SCAND, V36, P343; TURNER A, 2002, EFFECTS IMMUNOCONTRA, P187; TURNER JW, 2005, J WILDLIFE MANAGE, V71, P662; Valera M, 2006, ANIM REPROD SCI, V95, P75, DOI 10.1016/j.anireprosci.2005.09.008; Venables WN, 2002, MODERN APPL STAT S, pxi; WHITTEN WK, 1968, SCIENCE, V161, P584, DOI 10.1126/science.161.3841.584	62	30	31	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13635	10.1371/journal.pone.0013635	http://dx.doi.org/10.1371/journal.pone.0013635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049017	gold, Green Published			2022-12-25	WOS:000283487400025
J	Mercer, AE; Copple, IM; Maggs, JL; O'Neill, PM; Park, BK				Mercer, Amy E.; Copple, Ian M.; Maggs, James L.; O'Neill, Paul M.; Park, B. Kevin			The Role of Heme and the Mitochondrion in the Chemical and Molecular Mechanisms of Mammalian Cell Death Induced by the Artemisinin Antimalarials	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG DIHYDROARTEMISININ DHA; PLASMODIUM-FALCIPARUM; IN-VIVO; IRON-METABOLISM; DEPLETED CELL; CANCER-CELLS; APOPTOSIS; ACTIVATION; DNA; ARTESUNATE	The artemisinin compounds are the frontline drugs for the treatment of drug-resistant malaria. They are selectively cytotoxic to mammalian cancer cell lines and have been implicated as neurotoxic and embryotoxic in animal studies. The endoperoxide functional group is both the pharmacophore and toxicophore, but the proposed chemical mechanisms and targets of cytotoxicity remain unclear. In this study we have used cell models and quantitative drug metabolite analysis to define the role of the mitochondrion and cellular heme in the chemical and molecular mechanisms of cell death induced by artemisinin compounds. HeLa rho(0) cells, which are devoid of a functioning electron transport chain, were used to demonstrate that actively respiring mitochondria play an essential role in endoperoxide-induced cytotoxicity (artesunate IC50 values, 48 h: HeLa cells, 6 +/- 3 mu M; and HeLa rho(0) cells, 34 +/- 5 mu M) via the generation of reactive oxygen species and the induction of mitochondrial dysfunction and apoptosis but do not have any role in the reductive activation of the endoperoxide to cytotoxic carbon-centered radicals. However, using chemical modulators of heme synthesis (succinylacetone and protoporphyrin IX) and cellular iron content (holotransferrin), we have demonstrated definitively that free or protein-bound heme is responsible for intracellular activation of the endoperoxide group and that this is the chemical basis of cytotoxicity (IC50 value and biomarker of bioactivation levels, respectively: 10 beta-(p-fluorophenoxy)dihydroartemisinin alone, 0.36 +/- 0.20 mu M and 11 +/- 5%; and with succinylacetone, > 100 mu M and 2 +/- 5%).	[Mercer, Amy E.; Copple, Ian M.; Maggs, James L.; Park, B. Kevin] Univ Liverpool, MRC Ctr Drug Safety Sci, Liverpool L69 3GE, Merseyside, England; [O'Neill, Paul M.] Univ Liverpool, Dept Chem, Liverpool L69 3GE, Merseyside, England	University of Liverpool; University of Liverpool	Mercer, AE (corresponding author), Univ Liverpool, MRC Ctr Drug Safety Sci, Sherrington Bldgs, Liverpool L69 3GE, Merseyside, England.	aemercer@liv.ac.uk	Chadwick, Amy E/D-8633-2015	Chadwick, Amy E/0000-0002-7399-8655; Copple, Ian/0000-0003-4101-1913	Medical Research Council; European Union; MRC [G0700654] Funding Source: UKRI; Medical Research Council [G0700654] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by funds from the Medical Research Council (to A. E. M.) and the European Union (to I. M. C.) as part of the FP7 framework.	Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Atamna H, 2002, ARCH BIOCHEM BIOPHYS, V397, P345, DOI 10.1006/abbi.2001.2671; Berman PA, 1997, FREE RADICAL BIO MED, V22, P1283, DOI 10.1016/S0891-5849(96)00508-4; Berridge MV, 1998, PROTOPLASMA, V205, P74, DOI 10.1007/BF01279296; Cazelles J, 2002, J ORG CHEM, V67, P609, DOI 10.1021/jo010688d; Clark RL, 2004, BIRTH DEFECTS RES B, V71, P380, DOI 10.1002/bdrb.20027; Clark RL, 2009, REPROD TOXICOL, V28, P285, DOI 10.1016/j.reprotox.2009.05.002; Disbrow GL, 2005, CANCER RES, V65, P10854, DOI 10.1158/0008-5472.CAN-05-1216; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Efferth T, 2004, FREE RADICAL BIO MED, V37, P998, DOI 10.1016/j.freeradbiomed.2004.06.023; Efferth T, 2001, INT J ONCOL, V18, P767; Ferraresi R, 2008, CYTOM PART A, V73A, P528, DOI 10.1002/cyto.a.20544; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; GREENSTOCK CL, 1975, BIOCHIM BIOPHYS ACTA, V396, P11, DOI 10.1016/0005-2728(75)90184-X; Handrick R, 2010, MOL CANCER THER, V9, P2497, DOI 10.1158/1535-7163.MCT-10-0051; Jefford CW, 2007, DRUG DISCOV TODAY, V12, P487, DOI 10.1016/j.drudis.2007.04.009; JIANG JB, 1985, AM J TROP MED HYG, V34, P424, DOI 10.4269/ajtmh.1985.34.424; Jiang SN, 1999, J BIOL CHEM, V274, P29905, DOI 10.1074/jbc.274.42.29905; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kwok JC, 2002, CRIT REV ONCOL HEMAT, V42, P65, DOI 10.1016/S1040-8428(01)00213-X; Laffan SB, 2006, BIRTH DEFECTS RES A, V76, P329; Li PCH, 2008, CANCER RES, V68, P4347, DOI 10.1158/0008-5472.CAN-07-2970; Li W, 2005, PLOS GENET, V1, P329, DOI 10.1371/journal.pgen.0010036; Longo M, 2008, REPROD TOXICOL, V25, P433, DOI 10.1016/j.reprotox.2008.02.004; Longo M, 2006, REPROD TOXICOL, V22, P797, DOI 10.1016/j.reprotox.2006.08.001; Lu JJ, 2008, CANCER BIOL THER, V7, P1017, DOI 10.4161/cbt.7.7.6035; MAENO Y, 1993, AM J TROP MED HYG, V49, P485, DOI 10.4269/ajtmh.1993.49.485; Mercer AE, 2007, J BIOL CHEM, V282, P9372, DOI 10.1074/jbc.M610375200; Mercer AE, 2009, TOXICOL APPL PHARM, V239, P297, DOI 10.1016/j.taap.2009.05.027; Mercer AE, 2009, CURR OPIN DRUG DISC, V12, P125; Miyoshi N, 2008, BBA-MOL BASIS DIS, V1782, P566, DOI 10.1016/j.bbadis.2008.07.002; Muller O, 2009, LANCET, V374, P1419, DOI 10.1016/S0140-6736(09)61857-2; NASS MMK, 1970, P NATL ACAD SCI USA, V67, P1926, DOI 10.1073/pnas.67.4.1926; Nicotera P, 1998, TOXICOL LETT, V103, P139; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; O'Neill PM, 2004, J MED CHEM, V47, P2945, DOI 10.1021/jm030571c; O'Neill PM, 2001, J MED CHEM, V44, P58, DOI 10.1021/jm000987f; Park BK, 1998, BRIT J CLIN PHARMACO, V46, P521, DOI 10.1046/j.1365-2125.1998.00838.x; Park SY, 2004, J BIOL CHEM, V279, P7512, DOI 10.1074/jbc.M307677200; Ponka P, 1997, BLOOD, V89, P1; Posner GH, 2006, EXPERT OPIN THER PAT, V16, P1665, DOI 10.1517/13543776.16.12.1665; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Robert A, 2005, P NATL ACAD SCI USA, V102, P13676, DOI 10.1073/pnas.0500972102; Robert A, 2002, CHEM COMMUN, P414, DOI 10.1039/b110817b; Rodriguez-Enriquez S, 2006, TOXICOL APPL PHARM, V215, P208, DOI 10.1016/j.taap.2006.02.005; SASSA S, 1976, J EXP MED, V143, P305, DOI 10.1084/jem.143.2.305; Singh NP, 2004, ANTICANCER RES, V24, P2277; Stocks PA, 2007, ANGEW CHEM INT EDIT, V46, P6278, DOI 10.1002/anie.200604697; Taylor SM, 2009, NEW ENGL J MED, V361, P1807, DOI 10.1056/NEJMc091737; TENNANT JR, 1964, TRANSPLANTATION, V2, P685, DOI 10.1097/00007890-196411000-00001; Toovey S, 2006, TOXICOL LETT, V166, P95, DOI 10.1016/j.toxlet.2006.06.001; Vergani L, 2004, EUR J BIOCHEM, V271, P3646, DOI 10.1111/j.1432-1033.2004.04298.x; Wang J, 2010, PLOS ONE, V5, pA158, DOI 10.1371/journal.pone.0009582; World Health Organization, 2003, WHOCDSMAL20031094; Zhang SM, 2008, BIOORGAN MED CHEM, V16, P7853, DOI 10.1016/j.bmc.2008.02.034; Zhang SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007472	57	117	126	2	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					987	996		10.1074/jbc.M110.144188	http://dx.doi.org/10.1074/jbc.M110.144188			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059641	Green Published, hybrid			2022-12-25	WOS:000286005000009
J	Pinto, JR; Reynaldo, DP; Parvatiyar, MS; Dweck, D; Liang, J; Jones, MA; Sorenson, MM; Potter, JD				Pinto, Jose Renato; Reynaldo, Daniel P.; Parvatiyar, Michelle S.; Dweck, David; Liang, Jingsheng; Jones, Michelle A.; Sorenson, Martha M.; Potter, James D.			Strong Cross-bridges Potentiate the Ca2+ Affinity Changes Produced by Hypertrophic Cardiomyopathy Cardiac Troponin C Mutants in Myofilaments A FAST KINETIC APPROACH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOFIBRILLAR ADENOSINE-TRIPHOSPHATASE; MAGNESIUM BINDING-SITES; RABBIT PSOAS FIBERS; T I79N MUTATION; SKELETAL-MUSCLE; CALCIUM-BINDING; TRANSGENIC MICE; FUNCTIONAL-CHARACTERIZATION; DILATED CARDIOMYOPATHY; MOUSE MODEL	This spectroscopic study examined the steady-state and kinetic parameters governing the cross-bridge effect on the increased Ca2+ affinity of hypertrophic cardiomyopathy-cardiac troponin C (HCM-cTnC) mutants. Previously, we found that incorporation of the A8V and D145E HCM-cTnC mutants, but not E134D into thin filaments (TFs), increased the apparent Ca2+ affinity relative to TFs containing the WT protein. Here, we show that the addition of myosin subfragment 1 (S1) to TFs reconstituted with these mutants in the absence of MgATP(2-), the condition conducive to rigor cross-bridge formation, further increased the apparent Ca2+ affinity. Stopped-flow fluorescence techniques were used to determine the kinetics of Ca2+ dissociation (k(off)) from the cTnC mutants in the presence of TFs and S1. At a high level of complexity (i.e. TF + S1), an increase in the Ca2+ affinity and decrease in k(off) was achieved for the A8V and D145E mutants when compared with WT. Therefore, it appears that the cTnC Ca2+ off-rate is most likely to be affected rather than the Ca2+ on rate. At all levels of TF complexity, the results obtained with the E134D mutant reproduced those seen with the WT protein. We conclude that strong cross-bridges potentiate the Ca2+-sensitizing effect of HCM-cTnC mutants on the myofilament. Finally, the slower k(off) from the A8V and D145E mutants can be directly correlated with the diastolic dysfunction seen in these patients.	[Pinto, Jose Renato; Reynaldo, Daniel P.; Parvatiyar, Michelle S.; Dweck, David; Liang, Jingsheng; Jones, Michelle A.; Potter, James D.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Reynaldo, Daniel P.; Sorenson, Martha M.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Ciencias Saude, BR-21941902 Rio De Janeiro, Brazil	University of Miami; Universidade Federal do Rio de Janeiro	Potter, JD (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Rm 6083 R-189,1600 NW 10th Ave, Miami, FL 33136 USA.	jdpotter@miami.edu	Pinto, Jose Renato/H-2631-2017; parvatiyar, michelle/ABH-7542-2020	Pinto, Jose Renato/0000-0001-9092-4976; Pereira Reynaldo, Daniel/0000-0003-2531-2097; Parvatiyar, Michelle/0000-0002-9416-0069	National Institutes of Health [AR050199, HL042325, NS064821]; American Heart Association [AHA 0825368E, AHA 09POST2300030]; Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL042325, R01HL042325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064821] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR050199, HL042325, and NS064821 (to J. D. P.). This work was also supported by postdoctoral fellowships from the American Heart Association AHA 0825368E (to J. R. P.) and AHA 09POST2300030 (to M. S. P.) and Brazilian agencies Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ) (to M. M. S.) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (to M. M. S. and D. P. R., both affiliated with the Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem).	Alcalai R, 2008, J CARDIOVASC ELECTR, V19, P104, DOI 10.1111/j.1540-8167.2007.00965.x; CHANDRA M, 1994, J BIOL CHEM, V269, P14988; COOKE R, 1985, BIOPHYS J, V48, P789, DOI 10.1016/S0006-3495(85)83837-6; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Dweck D, 2010, J BIOL CHEM, V285, P17371, DOI 10.1074/jbc.M109.064105; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; Girolami F, 2010, J AM COLL CARDIOL, V55, P1444, DOI 10.1016/j.jacc.2009.11.062; GRABAREK Z, 1986, J BIOL CHEM, V261, P608; GUTH K, 1987, J BIOL CHEM, V262, P13627; Hershberger RE, 2009, CIRC-CARDIOVASC GENE, V2, P306, DOI 10.1161/CIRCGENETICS.108.846733; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; Hoffmann B, 2001, Hum Mutat, V17, P524, DOI 10.1002/humu.1143; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; Iorga B, 2008, CARDIOVASC RES, V77, P676, DOI 10.1093/cvr/cvm113; JOHNSON JD, 1980, J BIOL CHEM, V255, P9635; KAWAI M, 1987, PFLUG ARCH EUR J PHY, V408, P1, DOI 10.1007/BF00581833; Knollmann BC, 2001, TRENDS CARDIOVAS MED, V11, P206, DOI 10.1016/S1050-1738(01)00115-3; Knollmann BC, 2001, J BIOL CHEM, V276, P10039, DOI 10.1074/jbc.M006745200; Landstrom AP, 2008, J MOL CELL CARDIOL, V45, P281, DOI 10.1016/j.yjmcc.2008.05.003; Lang R, 2002, J BIOL CHEM, V277, P11670, DOI 10.1074/jbc.M108912200; Li YJ, 2010, J MOL CELL CARDIOL, V49, P402, DOI 10.1016/j.yjmcc.2010.04.017; Liang B, 2008, PHYSIOL GENOMICS, V33, P257, DOI 10.1152/physiolgenomics.00154.2007; Linari M, 2007, BIOPHYS J, V92, P2476, DOI 10.1529/biophysj.106.099549; Marian AJ, 2008, CURR OPIN CARDIOL, V23, P199, DOI 10.1097/HCO.0b013e3282fc27d9; Maron BJ, 2007, CARDIOL CLIN, V25, P399, DOI 10.1016/j.ccl.2007.07.006; Miller T, 2001, J BIOL CHEM, V276, P3743, DOI 10.1074/jbc.M006746200; Neulen A, 2009, BASIC RES CARDIOL, V104, P751, DOI 10.1007/s00395-009-0038-y; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pinto JR, 2009, J BIOL CHEM, V284, P19090, DOI 10.1074/jbc.M109.007021; POTTER JD, 1982, METHOD ENZYMOL, V85, P241; POTTER JD, 1975, J BIOL CHEM, V250, P4628; Putkey JA, 1997, BIOCHEMISTRY-US, V36, P970, DOI 10.1021/bi9617466; Regnier M, 1995, AM J PHYSIOL-CELL PH, V269, pC1532, DOI 10.1152/ajpcell.1995.269.6.C1532; ROBERTSON SP, 1981, BIOPHYS J, V34, P559, DOI 10.1016/S0006-3495(81)84868-0; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Schmidtmann A, 2005, FEBS J, V272, P6087, DOI 10.1111/j.1742-4658.2005.05001.x; SMITH L, 1994, J BIOL CHEM, V269, P9857; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Stehle R, 2009, PFLUG ARCH EUR J PHY, V458, P337, DOI 10.1007/s00424-008-0630-2; Swindle N, 2010, BIOCHEMISTRY-US, V49, P4813, DOI 10.1021/bi100400h; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tardiff JC, 1999, J CLIN INVEST, V104, P469, DOI 10.1172/JCI6067; Tikunova SB, 2010, BIOCHEMISTRY-US, V49, P1975, DOI 10.1021/bi901867s; Wang Y, 2002, J APPL PHYSIOL, V92, P2409, DOI 10.1152/japplphysiol.00376.2001; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; Wen YH, 2008, J BIOL CHEM, V283, P20484, DOI 10.1074/jbc.M801661200; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; Zhang R, 1995, J BIOL CHEM, V270, P30773, DOI 10.1074/jbc.270.51.30773; ZOT AS, 1989, BIOCHEMISTRY-US, V28, P6751, DOI 10.1021/bi00442a031	50	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1005	1013		10.1074/jbc.M110.168583	http://dx.doi.org/10.1074/jbc.M110.168583			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21056975	hybrid, Green Published			2022-12-25	WOS:000286005000011
J	Akiyama, H; Kamiguchi, H				Akiyama, Hiroki; Kamiguchi, Hiroyuki			Phosphatidylinositol 3-Kinase Facilitates Microtubule-dependent Membrane Transport for Neuronal Growth Cone Guidance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN-HOMOLOGY DOMAINS; ADENOMATOUS POLYPOSIS-COLI; NERVE GROWTH; AXON GUIDANCE; TRPC CHANNELS; PROTEIN; CALCIUM; BINDING; PHOSPHATASE; ACTIVATION	The activity of PI3K is necessary for polarized cell motility. To guide extending axons, environmental cues polarize the growth cone via asymmetric generation of Ca2+ signals and subsequent intracellular mechanical events, including membrane trafficking and cytoskeletal reorganization. However, it remains unclear how PI3K is involved in such events for axon guidance. Here, we demonstrate that PI3K plays a permissive role in growth cone turning by facilitating microtubule (MT)dependent membrane transport. Using embryonic chick dorsal root ganglion neurons in culture, attractive axon turning was induced by Ca2+ elevations on one side of the growth cone by photolyzing caged Ca2+ or caged inositol 1,4,5-trisphosphate. We show that PI3K activity was required downstream of Ca2+ signals for growth cone turning. Attractive Ca2+ signals, generated with caged Ca2+ or caged inositol 1,4,5-trisphosphate, triggered asymmetric transport of membrane vesicles from the center to the periphery of growth cones in a MT-dependent manner. This centrifugal vesicle transport was abolished by PI3K inhibitors, suggesting that PI3K is involved in growth cone attraction at the level of membrane trafficking. Consistent with this observation, immunocytochemistry showed that PI3K inhibitors reduced MTs in the growth cone peripheral domain. Time-lapse imaging of EB1 on the plus-end of MTs revealed that MT advance into the growth cone peripheral domain was dependent on PI3K activity: inhibition of the PI3K signaling pathway attenuated MT advance, whereas exogenous phosphatidylinositol 3,4,5-trisphosphate, the product of PI3K-catalyzed reactions, promoted MT advance. This study demonstrates the importance of PI3K-dependent membrane trafficking in chemotactic cell migration.	[Akiyama, Hiroki; Kamiguchi, Hiroyuki] RIKEN Brain Sci Inst, Lab Neuronal Growth Mech, Wako, Saitama 3510198, Japan	RIKEN	Kamiguchi, H (corresponding author), RIKEN Brain Sci Inst, Lab Neuronal Growth Mech, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kamiguchi@brain.riken.jp	Kamiguchi, Hiroyuki/N-5409-2015	Kamiguchi, Hiroyuki/0000-0003-1802-6324				Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Akiyama H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000196; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bretscher MS, 1998, CURR OPIN CELL BIOL, V10, P537, DOI 10.1016/S0955-0674(98)80070-7; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Charest PG, 2006, CURR OPIN GENET DEV, V16, P339, DOI 10.1016/j.gde.2006.06.016; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dunn GA, 1997, J CELL SCI, V110, P3091; FORCE T, 2007, SCI STKE, pPE41, DOI DOI 10.1126/STKE.3972007PE41; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hines JH, 2010, NAT NEUROSCI, V13, P829, DOI 10.1038/nn.2554; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Koester MP, 2007, J NEUROSCI, V27, P12590, DOI 10.1523/JNEUROSCI.2250-07.2007; Kollins KM, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-26; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; McConnachie G, 2003, BIOCHEM J, V371, P947, DOI 10.1042/BJ20021848; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Nishiyama M, 2008, NAT NEUROSCI, V11, P762, DOI 10.1038/nn.2130; Ooashi N, 2005, J CELL BIOL, V170, P1159, DOI 10.1083/jcb.200503157; Orlova I, 2007, DEV NEUROBIOL, V67, P1843, DOI 10.1002/dneu.20558; Piehl M, 2003, MOL BIOL CELL, V14, P916, DOI 10.1091/mbc.E02-09-0607; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; Takeda K, 2007, J BIOL CHEM, V282, P11874, DOI 10.1074/jbc.M610984200; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Togashi K, 2008, NEURON, V58, P694, DOI 10.1016/j.neuron.2008.03.017; Tojima T, 2007, NAT NEUROSCI, V10, P58, DOI 10.1038/nn1814; Tojima T, 2010, NEURON, V66, P370, DOI 10.1016/j.neuron.2010.04.007; Tojima T, 2009, J NEUROSCI, V29, P7886, DOI 10.1523/JNEUROSCI.0087-09.2009; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Veale EL, 2010, J BIOL CHEM, V285, P29295, DOI 10.1074/jbc.M110.108423; von Philipsborn A, 2007, INT REV CYTOL, V263, P1, DOI 10.1016/S0074-7696(07)63001-0; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Wolf AM, 2008, J NEUROSCI, V28, P3456, DOI 10.1523/JNEUROSCI.0029-08.2008; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	58	34	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41740	41748		10.1074/jbc.M110.156489	http://dx.doi.org/10.1074/jbc.M110.156489			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041312	Green Published, hybrid			2022-12-25	WOS:000285622600061
J	Baas, DC; Despriet, DD; Gorgels, TGMF; Bergeron-Sawitzke, J; Uitterlinden, AG; Hofman, A; van Duijn, CM; Merriam, JE; Smith, RT; Barile, GR; ten Brink, JB; Vingerling, JR; Klaver, CCW; Allikmets, R; Dean, M; Bergen, AAB				Baas, Dominique C.; Despriet, Dominiek D.; Gorgels, Theo G. M. F.; Bergeron-Sawitzke, Julie; Uitterlinden, Andre G.; Hofman, Albert; van Duijn, Cornelia M.; Merriam, Joanna E.; Smith, R. Theodore; Barile, Gaetano R.; ten Brink, Jacoline B.; Vingerling, Johannes R.; Klaver, Caroline C. W.; Allikmets, Rando; Dean, Michael; Bergen, Arthur A. B.			The ERCC6 Gene and Age-Related Macular Degeneration	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; COCKAYNE-SYNDROME; OXIDATIVE STRESS; RISK; REPAIR; POLYMORPHISM; MACULOPATHY; ROTTERDAM; VARIANT; DAMAGE	Background: Age-related macular degeneration (AMD) is the leading cause of irreversible visual loss in the developed countries and is caused by both environmental and genetic factors. A recent study (Tuo et al., PNAS) reported an association between AMD and a single nucleotide polymorphism (SNP) (rs3793784) in the ERCC6 (NM_000124) gene. The risk allele also increased ERCC6 expression. ERCC6 is involved in DNA repair and mutations in ERCC6 cause Cockayne syndrome (CS). Amongst others, photosensitivity and pigmentary retinopathy are hallmarks of CS. Methodology/Principal Findings: Separate and combined data from three large AMD case-control studies and a prospective population-based study (The Rotterdam Study) were used to analyse the genetic association between ERCC6 and AMD (2682 AMD cases and 3152 controls). We also measured ERCC6 mRNA levels in retinal pigment epithelium (RPE) cells of healthy and early AMD affected human donor eyes. Rs3793784 conferred a small increase in risk for late AMD in the Dutch population (The Rotterdam and AMRO-NL study), but this was not replicated in two non-European studies (AREDS, Columbia University). In addition, the AMRO-NL study revealed no significant association for 9 other variants spanning ERCC6. Finally, we determined that ERCC6 expression in the human RPE did not depend on rs3793784 genotype, but, interestingly, on AMD status: Early AMD-affected donor eyes had a 50% lower ERCC6 expression than healthy donor eyes (P = 0.018). Conclusions/Significance: Our meta-analysis of four Caucasian cohorts does not replicate the reported association between SNPs in ERCC6 and AMD. Nevertheless, our findings on ERCC6 expression in the RPE suggest that ERCC6 may be functionally involved in AMD. Combining our data with those of the literature, we hypothesize that the AMD-related reduced transcriptional activity of ERCC6 may be caused by diverse, small and heterogeneous genetic and/or environmental determinants.	[Baas, Dominique C.; Gorgels, Theo G. M. F.; ten Brink, Jacoline B.; Bergen, Arthur A. B.] Royal Netherlands Acad Arts & Sci KNAW, Dept Clin & Mol Ophthalmogenet, Netherlands Inst Neurosci NIN, Amsterdam, Netherlands; [Despriet, Dominiek D.; Uitterlinden, Andre G.; Hofman, Albert; van Duijn, Cornelia M.; Vingerling, Johannes R.; Klaver, Caroline C. W.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Bergeron-Sawitzke, Julie] SAIC Frederick, Basic Sci Program, Human Genet Sect, Frederick, MD USA; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Merriam, Joanna E.; Smith, R. Theodore; Barile, Gaetano R.; Allikmets, Rando] Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA; [Merriam, Joanna E.; Smith, R. Theodore; Barile, Gaetano R.; Allikmets, Rando] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Dean, Michael] NCI, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD 21701 USA; [Bergen, Arthur A. B.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands; [Bergen, Arthur A. B.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Erasmus University Rotterdam; Erasmus MC; Science Applications International Corporation (SAIC); SAIC-Frederick; Erasmus University Rotterdam; Erasmus MC; Columbia University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Baas, DC (corresponding author), Royal Netherlands Acad Arts & Sci KNAW, Dept Clin & Mol Ophthalmogenet, Netherlands Inst Neurosci NIN, Amsterdam, Netherlands.	a.bergen@nin.knaw.nl	Bergen, Arthur/J-3637-2013; Dean, Michael C/G-8172-2012; Dean, Michael/R-7501-2019; Klaver, Caroline C.W./A-2013-2016; Allikmets, Rando/ABD-4533-2021	Dean, Michael C/0000-0003-2234-0631; Sawitzke, Julie/0000-0002-1715-4626; Baas, Dominique C./0000-0003-0989-9828; Klaver, Caroline/0000-0002-2355-5258; smith, theodore/0000-0002-1693-943X; Van Duijn, Cornelia/0000-0002-2374-9204; Bergen, Arthur/0000-0002-6333-9576	Merck & Co, Inc., NJ, USA; Nederlandse Vereniging ter Voorkoming van Blindheid; Dutch Macula Foundation; LSBS; Oogfonds Nederland; de Rotterdamse Vereniging Blindenbelangen; Netherlands Organization of Scientific Research NWO Investments [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [014-93-015, RIDE2]; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) [050-060-810]; Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE),; Ministry for Health, Welfare and Sports; European Commission; Municipality of Rotterdam; National Eye Institute [EY13435, EY017404]; Macula Vision Research Foundation; Kaplen Foundation; Wigdeon Point Charitable Foundation; Research to Prevent Blindness, Inc.; Merck Co; Ministry of Education, Culture and Science; NATIONAL CANCER INSTITUTE [ZIABC011301] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R24EY017404, R01EY013435] Funding Source: NIH RePORTER	Merck & Co, Inc., NJ, USA(Merck & Company); Nederlandse Vereniging ter Voorkoming van Blindheid; Dutch Macula Foundation; LSBS; Oogfonds Nederland; de Rotterdamse Vereniging Blindenbelangen; Netherlands Organization of Scientific Research NWO Investments(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE),; Ministry for Health, Welfare and Sports; European Commission(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Macula Vision Research Foundation; Kaplen Foundation; Wigdeon Point Charitable Foundation; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); Merck Co(Merck & Company); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was in part supported by an unrestricted research grant from Merck & Co, Inc., NJ, USA and the Nederlandse Vereniging ter Voorkoming van Blindheid, The Dutch Macula Foundation, the LSBS, the Oogfonds Nederland, de Rotterdamse Vereniging Blindenbelangen (to A. A. B.). The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organization of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) project nr. 050-060-810, and funding from the Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The Columbia University study population is supported in part by the grants from the National Eye Institute EY13435 and EY017404; the Macula Vision Research Foundation; Kaplen Foundation; Wigdeon Point Charitable Foundation and an unrestricted grant to the Department of Ophthalmology, Columbia University, from Research to Prevent Blindness, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The funding of Merck & Co was an unrestricted grant to A. A. B. and did not, in any way, interfere with the conception and/or design and/or outcome and/or publication of this study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Age related eye disease study research group, 2001, ARCH OPHTHALMOL, V119, P1439; Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668; Assink JJM, 1997, AM J HUM GENET, V61, P934, DOI 10.1086/514884; Baas DC, 2010, OPHTHALMOLOGY, V117, P500, DOI 10.1016/j.ophtha.2009.08.032; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bergeron-Sawitzke J, 2009, EUR J HUM GENET, V17, P1190, DOI 10.1038/ejhg.2009.23; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Booij JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-164; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; de Waard H, 2003, DNA REPAIR, V2, P13, DOI 10.1016/S1568-7864(02)00188-X; Despriet DDG, 2006, JAMA-J AM MED ASSOC, V296, P301, DOI 10.1001/jama.296.3.301; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dianov G, 1999, NUCLEIC ACIDS RES, V27, P1365, DOI 10.1093/nar/27.5.1365; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gorgels TGMF, 2007, MOL CELL BIOL, V27, P1433, DOI 10.1128/MCB.01037-06; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Hu XF, 2004, GENET TEST, V8, P292, DOI 10.1089/gte.2004.8.292; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Mallery DL, 1998, AM J HUM GENET, V62, P77, DOI 10.1086/301686; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Shen JK, 2007, HISTOL HISTOPATHOL, V22, P1301, DOI 10.14670/HH-22.1301; Spivak G, 2006, DNA REPAIR, V5, P13, DOI 10.1016/j.dnarep.2005.06.017; Tuo JS, 2006, P NATL ACAD SCI USA, V103, P9256, DOI 10.1073/pnas.0603485103; Tuo JS, 2003, FASEB J, V17, P668, DOI 10.1096/fj.02-0851com; van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002; van Soest SS, 2007, MOL VIS, V13, P1608; vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Wang GF, 2010, HUM GENET, V127, P595, DOI 10.1007/s00439-010-0805-8; Wozniak K, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/827562; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618	50	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2010	5	11							e13786	10.1371/journal.pone.0013786	http://dx.doi.org/10.1371/journal.pone.0013786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FY	21072178	Green Submitted, Green Published, gold			2022-12-25	WOS:000283645700009
J	Huang, D; Zhou, XB; Lyon, CJ; Hsueh, WA; Wong, STC				Huang, Di; Zhou, Xiaobo; Lyon, Christopher J.; Hsueh, Willa A.; Wong, Stephen T. C.			MicroRNA-Integrated and Network-Embedded Gene Selection with Diffusion Distance	PLOS ONE			English	Article							EXPRESSION DATA; CLASSIFICATION; DIAGNOSIS; MAPS	Gene network information has been used to improve gene selection in microarray-based studies by selecting marker genes based both on their expression and the coordinate expression of genes within their gene network under a given condition. Here we propose a new network-embedded gene selection model. In this model, we first address the limitations of microarray data. Microarray data, although widely used for gene selection, measures only mRNA abundance, which does not always reflect the ultimate gene phenotype, since it does not account for post-transcriptional effects. To overcome this important (critical in certain cases) but ignored-in-almost-all-existing-studies limitation, we design a new strategy to integrate together microarray data with the information of microRNA, the major post-transcriptional regulatory factor. We also handle the challenges led by gene collaboration mechanism. To incorporate the biological facts that genes without direct interactions may work closely due to signal transduction and that two genes may be functionally connected through multi paths, we adopt the concept of diffusion distance. This concept permits us to simulate biological signal propagation and therefore to estimate the collaboration probability for all gene pairs, directly or indirectly-connected, according to multi paths connecting them. We demonstrate, using type 2 diabetes (DM2) as an example, that the proposed strategies can enhance the identification of functional gene partners, which is the key issue in a network-embedded gene selection model. More importantly, we show that our gene selection model outperforms related ones. Genes selected by our model 1) have improved classification capability; 2) agree with biological evidence of DM2-association; and 3) are involved in many well-known DM2-associated pathways.	[Huang, Di; Lyon, Christopher J.; Hsueh, Willa A.] Cornell Univ, Methodist Hosp, Res Inst, Weill Med Coll,Diabet Res Ctr, Houston, TX USA	Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Huang, D (corresponding author), Cornell Univ, Methodist Hosp, Res Inst, Weill Med Coll,Diabet Res Ctr, Houston, TX USA.	STWong@tmhs.org			Methodist Hospital Research Institute; NATIONAL LIBRARY OF MEDICINE [R01LM010185] Funding Source: NIH RePORTER	Methodist Hospital Research Institute; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	2010 Research Scholars Seed Grant, The Methodist Hospital Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7432, DOI 10.1073/pnas.0500896102; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Futcher B, 1999, MOL CELL BIOL, V19, P7357; GOLUB TR, 1999, MOL CLASSIFICATION C, P531; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Helman P, 2004, J COMPUT BIOL, V11, P581, DOI 10.1089/1066527041887294; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Lafon S, 2006, IEEE T PATTERN ANAL, V28, P1393, DOI 10.1109/TPAMI.2006.184; Lajoix AD, 2006, DIABETES, V55, P3279, DOI 10.2337/db06-0257; Lu HF, 2008, MOL CELL PROTEOMICS, V7, P1434, DOI 10.1074/mcp.M700478-MCP200; Ma S, 2008, BRIEF BIOINFORM, V9, P392, DOI 10.1093/bib/bbn027; MOOTHA VK, 2003, NAT GENET, P1; Muhonen P, 2009, NEPHROL DIAL TRANSPL, V24, P1088, DOI 10.1093/ndt/gfn728; NADLER B, 2005, ADV NEURAL INFORM PR, V18, P955; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; RAHNENFUHRER J, 2004, MOLECULAR BIOL */* S, V3, P16; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; ROBIN L, 2007, UTR UTR P Natl Acad, V104, P9667; Samanta MP, 2003, P NATL ACAD SCI USA, V100, P12579, DOI 10.1073/pnas.2132527100; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100; Wei Z, 2007, BIOINFORMATICS, V23, P1537, DOI 10.1093/bioinformatics/btm129; Xu M, 2003, APPL GENOMICS PROTEO, V2, P79; Xu R, 2007, P ANN INT IEEE EMBS, P4613, DOI 10.1109/IEMBS.2007.4353367; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124	34	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13748	10.1371/journal.pone.0013748	http://dx.doi.org/10.1371/journal.pone.0013748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060785	Green Published, Green Submitted, gold			2022-12-25	WOS:000283645300028
J	Jeong, HK; Ji, KM; Kim, B; Kim, J; Jou, I; Joe, EH				Jeong, Hey-Kyeong; Ji, Kyung-min; Kim, Beomsue; Kim, Jun; Jou, Ilo; Joe, Eun-hye			Inflammatory Responses Are Not Sufficient to Cause Delayed Neuronal Death in ATP-Induced Acute Brain Injury	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; IN-VIVO; ALZHEIMERS-DISEASE; MICROGLIAL CELLS; RECEPTOR MODULATION; ACTIVATED MICROGLIA; RAT HIPPOCAMPUS	Background: Brain inflammation is accompanied by brain injury. However, it is controversial whether inflammatory responses are harmful or beneficial to neurons. Because many studies have been performed using cultured microglia and neurons, it has not been possible to assess the influence of multiple cell types and diverse factors that dynamically and continuously change in vivo. Furthermore, behavior of microglia and other inflammatory cells could have been overlooked since most studies have focused on neuronal death. Therefore, it is essential to analyze the precise roles of microglia and brain inflammation in the injured brain, and determine their contribution to neuronal damage in vivo from the onset of injury. Methods and Findings: Acute neuronal damage was induced by stereotaxic injection of ATP into the substantia nigra pars compacta (SNpc) and the cortex of the rat brain. Inflammatory responses and their effects on neuronal damage were investigated by immunohistochemistry, electron microscopy, quantitative RT-PCR, and stereological counting, etc. ATP acutely caused death of microglia as well as neurons in a similar area within 3 h. We defined as the core region the area where both TH(+) and Iba-1(+) cells acutely died, and as the penumbra the area surrounding the core where Iba-1+ cells showed activated morphology. In the penumbra region, morphologically activated microglia arranged around the injury sites. Monocytes filled the damaged core after neurons and microglia died. Interestingly, neither activated microglia nor monocytes expressed iNOS, a major neurotoxic inflammatory mediator. Monocytes rather expressed CD68, a marker of phagocytic activity. Importantly, the total number of dopaminergic neurons in the SNpc at 3 h (similar to 80% of that in the contralateral side) did not decrease further at 7 d. Similarly, in the cortex, ATP-induced neuron-damage area detected at 3 h did not increase for up to 7 d. Conclusions: Different cellular components (microglia, astrocytes, monocytes, and neutrophils) and different factors (proinflammatory and neurotrophic) could be produced in inflammatory processes depending on the nature of the injury. The results in this study suggest that the inflammatory responses of microglia and monocytes in response to ATP-induced acute injury could not be neurotoxic.	[Jeong, Hey-Kyeong; Ji, Kyung-min; Kim, Beomsue; Kim, Jun; Jou, Ilo; Joe, Eun-hye] Ajou Univ, Sch Med, Grad Program Neurosci, Suwon 441749, South Korea; [Jeong, Hey-Kyeong; Ji, Kyung-min; Kim, Beomsue; Kim, Jun; Jou, Ilo; Joe, Eun-hye] Ajou Univ, Sch Med, Dept Pharmacol, Suwon 441749, South Korea; [Jeong, Hey-Kyeong; Ji, Kyung-min; Kim, Beomsue; Kim, Jun; Joe, Eun-hye] Ajou Univ, Sch Med, Brain Dis Res Ctr, Suwon 441749, South Korea; [Jou, Ilo] Ajou Univ, Sch Med, Chron Inflammatory Dis Res Ctr, Suwon 441749, South Korea	Ajou University; Ajou University; Ajou University; Ajou University	Jeong, HK (corresponding author), Ajou Univ, Sch Med, Grad Program Neurosci, Suwon 441749, South Korea.	ehjoe@ajou.ac.kr	Kim, Beomsue/X-3045-2019	Kim, Beomsue/0000-0003-1207-7876	Korean government (MEST) [2-2008025-0]; Ministry of Science and Technology, Republic of Korea [M103KV010011-06K2201-01110]; KOSEF through Chronic Inflammatory Disease Research Center (CIDRC) at Ajou University [R13-2003-019]	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry of Science and Technology, Republic of Korea(Ministry of Science & Technology (MOST), Republic of Korea); KOSEF through Chronic Inflammatory Disease Research Center (CIDRC) at Ajou University	This work was supported by the KOSEF NRL Program grant funded by the Korean government (MEST) (2-2008025-0) and a grant (M103KV010011-06K2201-01110) from the Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Science and Technology, Republic of Korea, and KOSEF through Chronic Inflammatory Disease Research Center (CIDRC) at Ajou University (Grant R13-2003-019) to E Joe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadio S, 2002, NEUROPHARMACOLOGY, V42, P489, DOI 10.1016/S0028-3908(01)00197-6; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Bohatschek M, 2001, EXP NEUROL, V172, P137, DOI 10.1006/exnr.2001.7764; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; Cavaliere F, 2001, NEUROCHEM INT, V38, P199, DOI 10.1016/S0197-0186(00)00087-5; Cavaliere F, 2001, NEUROCHEM INT, V38, P189, DOI 10.1016/S0197-0186(00)00088-7; CHAO CC, 1992, J IMMUNOL, V149, P2736; Choi SH, 2003, J NEUROSCI, V23, P5877; Connolly ES, 1996, J CLIN INVEST, V97, P209, DOI 10.1172/JCI118392; da Silva RP, 1999, BIOCHEM J, V338, P687, DOI 10.1042/bj3380687; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; de Bock F, 1998, EUR J NEUROSCI, V10, P3107, DOI 10.1046/j.1460-9568.1998.00317.x; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Elkabes S, 1996, J NEUROSCI, V16, P2508; FORD AL, 1995, J IMMUNOL, V154, P4309; Gautier S, 2009, BRIT J PHARMACOL, V156, P673, DOI 10.1111/j.1476-5381.2009.00068.x; GIULIAN D, 1993, J NEUROSCI RES, V36, P681, DOI 10.1002/jnr.490360609; HALLENBECK JM, 1986, STROKE, V17, P246, DOI 10.1161/01.STR.17.2.246; Hide I, 2000, J NEUROCHEM, V75, P965, DOI 10.1046/j.1471-4159.2000.0750965.x; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Inoue K, 2003, LIFE SCI, V74, P189, DOI 10.1016/j.lfs.2003.09.006; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Ji KA, 2008, GLIA, V56, P1039, DOI 10.1002/glia.20677; Ji KA, 2007, GLIA, V55, P1577, DOI 10.1002/glia.20571; Kang J, 2007, J CELL BIOL, V179, P1219, DOI 10.1083/jcb.200705046; Kaushal V, 2008, J NEUROSCI, V28, P2221, DOI 10.1523/JNEUROSCI.5643-07.2008; Kharlamov A, 2002, EXP BRAIN RES, V147, P353, DOI 10.1007/s00221-002-1251-1; KIRINO T, 1984, ACTA NEUROPATHOL, V62, P209, DOI 10.1007/BF00691854; Kitamura Y, 1996, GLIA, V18, P233, DOI 10.1002/(SICI)1098-1136(199611)18:3<233::AID-GLIA7>3.0.CO;2-#; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Lehner M, 2002, INT ARCH ALLERGY IMM, V128, P73, DOI 10.1159/000058006; Lehrmann E, 1998, GLIA, V24, P437, DOI 10.1002/(SICI)1098-1136(199812)24:4<437::AID-GLIA9>3.0.CO;2-X; MAJNO G, 1995, AM J PATHOL, V146, P3; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Matsumoto H, 2007, J NEUROSCI RES, V85, P994, DOI 10.1002/jnr.21198; MATSUO Y, 1994, STROKE, V25, P1469, DOI 10.1161/01.STR.25.7.1469; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Melani A, 2006, J CEREBR BLOOD F MET, V26, P974, DOI 10.1038/sj.jcbfm.9600250; Min KJ, 2006, J NEUROSCI, V26, P1880, DOI 10.1523/JNEUROSCI.3696-05.2006; Motyl T, 2006, J PHYSIOL PHARMACOL, V57, P17; Napoli I, 2010, EXP NEUROL, V225, P24, DOI 10.1016/j.expneurol.2009.04.024; Nerlich AG, 2002, SPINE, V27, P2484, DOI 10.1097/00007632-200211150-00012; Parvathenani LK, 2003, J BIOL CHEM, V278, P13309, DOI 10.1074/jbc.M209478200; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; PETERS A, 1991, FINE STRUCTURE NERVO, V494, P10; Pyo H, 2003, NEUROSCI LETT, V346, P141, DOI 10.1016/S0304-3940(03)00505-6; Rezaie P, 2005, NEUROSCI LETT, V377, P189, DOI 10.1016/j.neulet.2004.12.002; Ryu JK, 2007, GLIA, V55, P439, DOI 10.1002/glia.20479; Ryu JK, 2004, GLIA, V48, P85, DOI 10.1002/glia.20051; Sanz JM, 2000, J IMMUNOL, V164, P4893, DOI 10.4049/jimmunol.164.9.4893; Scali C, 2000, EUR J NEUROSCI, V12, P1900, DOI 10.1046/j.1460-9568.2000.00075.x; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Streit WJ, 2005, BRAIN RES REV, V48, P234, DOI 10.1016/j.brainresrev.2004.12.013; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; ZHANG ZG, 1995, BRAIN RES, V698, P79, DOI 10.1016/0006-8993(95)00830-J; Zhao JW, 2009, EUR J NEUROSCI, V29, P1853, DOI 10.1111/j.1460-9568.2009.06736.x	62	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13756	10.1371/journal.pone.0013756	http://dx.doi.org/10.1371/journal.pone.0013756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060796	Green Published, gold, Green Submitted			2022-12-25	WOS:000283645300035
J	Schwarzkopf, DS; Schindler, A; Rees, G				Schwarzkopf, Dietrich Samuel; Schindler, Andreas; Rees, Geraint			Knowing with Which Eye We See: Utrocular Discrimination and Eye-Specific Signals in Human Visual Cortex	PLOS ONE			English	Article							OCULAR DOMINANCE COLUMNS; SURFACE-BASED ANALYSIS; ORIENTATION; DOMAINS; PATTERN; CATS	Neurophysiological and behavioral reports converge to suggest that monocular neurons in the primary visual cortex are biased toward low spatial frequencies, while binocular neurons favor high spatial frequencies. Here we tested this hypothesis with functional magnetic resonance imaging (fMRI). Human participants viewed flickering gratings at one of two spatial frequencies presented to either the left or the right eye, and judged which of the two eyes was being stimulated (utrocular discrimination). Using multivoxel pattern analysis we found that local spatial patterns of signals in primary visual cortex (V1) allowed successful decoding of the eye-of-origin. Decoding was above chance for low but not high spatial frequencies, confirming the presence of a bias reported by animal studies in human visual cortex. Behaviorally, we found that reliable judgment of the eye-of-origin did not depend on spatial frequency. We further analyzed the mean response in visual cortex to our stimuli and revealed a weak difference between left and right eye stimulation. Our results are thus consistent with the interpretation that participants use overall levels of neural activity in visual cortex, perhaps arising due to local luminance differences, to judge the eye-of-origin. Taken together, we show that it is possible to decode eye-specific voxel pattern information in visual cortex but, at least in healthy participants with normal binocular vision, these patterns are unrelated to awareness of which eye is being stimulated.	[Schwarzkopf, Dietrich Samuel; Schindler, Andreas; Rees, Geraint] UCL, Inst Cognit Neurosci, London, England; [Schwarzkopf, Dietrich Samuel; Rees, Geraint] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Schindler, Andreas] Max Planck Inst Biol Cybernet, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany	University of London; University College London; University of London; University College London; Eberhard Karls University of Tubingen; Max Planck Society	Schwarzkopf, DS (corresponding author), UCL, Inst Cognit Neurosci, London, England.	s.schwarzkopf@fil.ion.ucl.ac.uk	Rees, Geraint/C-1493-2008; Schwarzkopf, D. Sam/F-5285-2012	Rees, Geraint/0000-0002-9623-7007; Schwarzkopf, D. Sam/0000-0003-3686-1622	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2007, J NEUROSCI, V27, P10391, DOI 10.1523/JNEUROSCI.2923-07.2007; Adams DL, 2009, NEUROSCIENTIST, V15, P62, DOI 10.1177/1073858408327806; Chaimow D, 2010, NEUROIMAGE; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Durad AC, 1910, J AMER MED ASSOC, V55, P369, DOI 10.1001/jama.1910.04330050007004; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; GARDNER JL, 2008, J VIS, V8; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; HU B, 1997, J NEUROSCI, V17, P9270; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; KAUL C, 2009, J VIS, V9; Kriegeskorte N, 2010, NEUROIMAGE, V49, P1965, DOI 10.1016/j.neuroimage.2009.09.059; Lowel S, 1998, EUR J NEUROSCI, V10, P2629, DOI 10.1046/j.1460-9568.1998.t01-1-00274.x; MISAKI M, 2010, NEUROIMAGE; Op de Beeck HP, 2010, NEUROIMAGE, V50, P567, DOI 10.1016/j.neuroimage.2009.12.072; Op de Beeck HP, 2010, NEUROIMAGE, V49, P1943, DOI 10.1016/j.neuroimage.2009.02.047; Sasaki Y, 2001, P NATL ACAD SCI USA, V98, P2077, DOI 10.1073/pnas.98.4.2077; Schwarzkopf DS, 2010, NEUROIMAGE; Shmuel A, 2010, NEUROIMAGE, V49, P1957, DOI 10.1016/j.neuroimage.2009.08.040; Shoham D, 1997, NATURE, V385, P529, DOI 10.1038/385529a0; SMITH S, 1945, J EXP PSYCHOL, V35, P1, DOI 10.1037/h0059224; Swisher JD, 2010, J NEUROSCI, V30, P325, DOI 10.1523/JNEUROSCI.4811-09.2010; Weiskopf N, 2007, MAGN RESON IMAGING, V25, P989, DOI 10.1016/j.mri.2007.02.007	25	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13775	10.1371/journal.pone.0013775	http://dx.doi.org/10.1371/journal.pone.0013775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048942	Green Published, gold, Green Submitted			2022-12-25	WOS:000283645300049
J	Chen, JR; Lazarenko, OP; Wu, XL; Tong, YD; Blackburn, ML; Shankar, K; Badger, TM; Ronis, MJJ				Chen, Jin-Ran; Lazarenko, Oxana P.; Wu, Xianli; Tong, Yudong; Blackburn, Michael L.; Shankar, Kartik; Badger, Thomas M.; Ronis, Martin J. J.			Obesity Reduces Bone Density Associated with Activation of PPAR gamma and Suppression of Wnt/beta-Catenin in Rapidly Growing Male Rats	PLOS ONE			English	Article							KAPPA-B LIGAND; ADIPOCYTE DIFFERENTIATION; MINERAL DENSITY; FEMALE RATS; FAT; MASS; OSTEOPOROSIS; ETHANOL; DIET; OSTEOBLASTS	Background: It is well established that excessive consumption of a high fat diet (HFD) results in obesity; however, the consequences of obesity on postnatal skeletal development have not been well studied. Methodology and Principal Findings: Total enteral nutrition (TEN) was used to feed postnatal day 27 male rats intragastrically with a high 45% fat diet (HFD) for four weeks to induce obesity. Fat mass was increased compared to rats fed TEN diets containing 25% fat (medium fat diet, MFD) or a chow diet (low fat diet, LFD) fed ad libitum with matched body weight gains. Serum leptin and total non-esterified fatty acids (NEFA) were elevated in HFD rats, which also had reduced bone mass compared to LFD-fed animals. This was accompanied by decreases in bone formation, but increases in the bone resorption. Bone marrow adiposity and expression of adipogenic genes, PPAR gamma and aP2 were increased, whereas osteoblastogenic markers osteocalcin and Runx2 were decreased, in bone in HFD rats compared to LFD controls. The diversion of stromal cell differentiation in response to HFD stemmed from down-regulation of the key canonical Wnt signaling molecule beta-catenin protein and reciprocal up-regulation of nuclear PPAR gamma expression in bone. In a set of in vitro studies using pluripotent ST2 bone marrow mesenchymal stromal cells treated with serum from rats on the different diets or using the free fatty acid composition of NEFA quantified in rat serum from HFD-fed animals by GC-MS, we were able to recapitulate our in vivo findings. Conclusions/Significance: These observations strongly suggest that increased NEFA in serum from rats made obese by HFD-feeding impaired bone formation due to stimulation of bone marrow adipogenesis. These effects of obesity on bone in early life may result in impaired attainment of peak bone mass and therefore increase the prevalence of osteoporosis later on in life.	[Chen, Jin-Ran; Shankar, Kartik; Badger, Thomas M.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Lazarenko, Oxana P.; Wu, Xianli; Blackburn, Michael L.; Badger, Thomas M.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Ronis, Martin J. J.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Chen, Jin-Ran; Lazarenko, Oxana P.; Wu, Xianli; Tong, Yudong; Blackburn, Michael L.; Shankar, Kartik; Badger, Thomas M.; Ronis, Martin J. J.] Arkansas Childrens Nutr Ctr, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Chen, JR (corresponding author), Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA.	chenjinran@uams.edu		Shankar, Kartik/0000-0002-7964-9026	United States Department of Agriculture (USDA)/Agricultural Research Service (ARS) [6251-51000-003]	United States Department of Agriculture (USDA)/Agricultural Research Service (ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by United States Department of Agriculture (USDA)/Agricultural Research Service (ARS) #6251-51000-003 to the Arkansas Children's Nutrition Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akridge M, 2007, AM J ORTHOD DENTOFAC, V132, P185, DOI 10.1016/j.ajodo.2005.12.034; Bielohuby M, 2010, J BONE MINER RES, V25, P275, DOI 10.1359/jbmr.090813; Cao JJ, 2009, BONE, V44, P1097, DOI 10.1016/j.bone.2009.02.017; Chan G, 2009, CURR OPIN PEDIATR, V21, P65, DOI 10.1097/MOP.0b013e328320a914; Chen JR, 2008, EXP BIOL MED, V233, P1348, DOI 10.3181/0802-RM-63; Chen JR, 2008, J PHARMACOL EXP THER, V324, P50, DOI 10.1124/jpet.107.130351; Chen JR, 2006, J PHARMACOL EXP THER, V319, P1182, DOI 10.1124/jpet.106.109454; Chen JR, 2009, J NUTR, V139, P1839, DOI 10.3945/jn.109.109041; Chen JR, 2009, J BONE MINER RES, V24, P221, DOI 10.1359/JBMR.081011; Cui LH, 2005, OSTEOPOROSIS INT, V16, P1975, DOI 10.1007/s00198-005-1977-2; FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Kennedy ET, 1999, J AM COLL NUTR, V18, P207, DOI 10.1080/07315724.1999.10718853; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kyung TW, 2009, J NUTR, V139, P502, DOI 10.3945/jn.108.100032; Leonard MB, 2004, AM J CLIN NUTR, V80, P514, DOI 10.1093/ajcn/80.2.514; MARECKI JC, 2010, J NUTR BIOC IN PRESS; OH SR, 2009, J LIPID RES     0411; Parhami F, 2001, J BONE MINER RES, V16, P182, DOI 10.1359/jbmr.2001.16.1.182; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; SCHELLER LE, 2010, STEM CELLS IN PRESS; Shankar K, 2008, J BONE MINER RES, V23, P338, DOI 10.1359/JBMR.071023; Shankar K, 2010, ENDOCRINOLOGY, V151, P2577, DOI 10.1210/en.2010-0017; Smas CM, 1999, J BIOL CHEM, V274, P12632, DOI 10.1074/jbc.274.18.12632; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tintut Y, 2004, ARTERIOSCL THROM VAS, V24, pE6, DOI 10.1161/01.ATV.0000112023.62695.7f; Tzameli I, 2004, J BIOL CHEM, V279, P36093, DOI 10.1074/jbc.M405346200; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; Weiler HA, 2000, BONE, V27, P203, DOI 10.1016/S8756-3282(00)00314-8; Yajnik CS, 2004, LANCET, V363, P163, DOI 10.1016/S0140-6736(03)15269-5; Yeung DKW, 2005, J MAGN RESON IMAGING, V22, P279, DOI 10.1002/jmri.20367; Zhao LJ, 2008, J BONE MINER RES, V23, P17, DOI 10.1359/JBMR.070813; Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572; Zhou QD, 2009, P NATL ACAD SCI USA, V106, P10740, DOI 10.1073/pnas.0904412106	36	126	133	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13704	10.1371/journal.pone.0013704	http://dx.doi.org/10.1371/journal.pone.0013704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060836	Green Published, gold, Green Submitted			2022-12-25	WOS:000283573800006
J	Piaggi, P; Lippi, C; Fierabracci, P; Maffei, M; Calderone, A; Mauri, M; Anselmino, M; Cassano, GB; Vitti, P; Pinchera, A; Landi, A; Santini, F				Piaggi, Paolo; Lippi, Chita; Fierabracci, Paola; Maffei, Margherita; Calderone, Alba; Mauri, Mauro; Anselmino, Marco; Cassano, Giovanni Battista; Vitti, Paolo; Pinchera, Aldo; Landi, Alberto; Santini, Ferruccio			Artificial Neural Networks in the Outcome Prediction of Adjustable Gastric Banding in Obese Women	PLOS ONE			English	Article							BARIATRIC SURGERY; WEIGHT-LOSS; PSYCHOSOCIAL PREDICTORS; MORBID-OBESITY; DISORDERS	Background: Obesity is unanimously regarded as a global epidemic and a major contributing factor to the development of many common illnesses. Laparoscopic Adjustable Gastric Banding (LAGB) is one of the most popular surgical approaches worldwide. Yet, substantial variability in the results and significant rate of failure can be expected, and it is still debated which categories of patients are better suited to this type of bariatric procedure. The aim of this study was to build a statistical model based on both psychological and physical data to predict weight loss in obese patients treated by LAGB, and to provide a valuable instrument for the selection of patients that may benefit from this procedure. Methodology/Principal Findings: The study population consisted of 172 obese women, with a mean+/-SD presurgical and postsurgical Body Mass Index (BMI) of 42.5+/-5.1 and 32.4+/-4.8 kg/m(2), respectively. Subjects were administered the comprehensive test of psychopathology Minnesota Multiphasic Personality Inventory-2 (MMPI-2). Main goal of the study was to use presurgical data to predict individual therapeutical outcome in terms of Excess Weight Loss (EWL) after 2 years. Multiple linear regression analysis using the MMPI-2 scores, BMI and age was performed to determine the variables that best predicted the EWL. Based on the selected variables including age, and 3 psychometric scales, Artificial Neural Networks (ANNs) were employed to improve the goodness of prediction. Linear and non linear models were compared in their classification and prediction tasks: non linear model resulted to be better at data fitting (36% vs. 10% variance explained, respectively) and provided more reliable parameters for accuracy and mis-classification rates (70% and 30% vs. 66% and 34%, respectively). Conclusions/Significance: ANN models can be successfully applied for prediction of weight loss in obese women treated by LAGB. This approach may constitute a valuable tool for selection of the best candidates for surgery, taking advantage of an integrated multidisciplinary approach.	[Piaggi, Paolo; Landi, Alberto] Univ Pisa, Dept Elect Syst & Automat, Pisa, Italy; [Lippi, Chita; Fierabracci, Paola; Maffei, Margherita; Calderone, Alba; Anselmino, Marco; Vitti, Paolo; Pinchera, Aldo; Santini, Ferruccio] Univ Hosp Pisa, Dept Endocrinol & Metab, Pisa, Italy; [Maffei, Margherita] Univ Hosp Pisa, Dulbecco Telethon Inst, Pisa, Italy; [Mauri, Mauro; Cassano, Giovanni Battista] Univ Pisa, Sch Med, Dept Psychiat Neurobiol Pharmacol & Biotechnol, I-56100 Pisa, Italy	University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Pisa	Piaggi, P (corresponding author), Univ Pisa, Dept Elect Syst & Automat, Pisa, Italy.	paolo.piaggi@gmail.com	Santini, Ferruccio/J-9272-2018; LANDI, ALBERTO/CAE-9552-2022; Piaggi, Paolo/E-2539-2011; Landi, Alberto/A-7466-2016	Santini, Ferruccio/0000-0002-1706-0822; LANDI, ALBERTO/0000-0002-0105-5121; Piaggi, Paolo/0000-0003-2774-9161; Landi, Alberto/0000-0002-0105-5121	Telethon [TCR07007] Funding Source: Medline	Telethon(Fondazione Telethon)		Bessesen DH, 2008, J CLIN ENDOCR METAB, V93, P2027, DOI 10.1210/jc.2008-0520; Bishop C. M., 1995, NEURAL NETWORKS PATT; Bueter M, 2007, OBES SURG, V17, P1608, DOI 10.1007/s11695-007-9263-3; Busetto L, 2002, OBES SURG, V12, P83, DOI 10.1381/096089202321144649; Busetto L, 2008, OBESITY, V16, P334, DOI 10.1038/oby.2007.85; Butcher J. N., 2001, MMPI 2 MINNESOTA MUL, VRev; Cherkassky V, 1998, LEARNING DATA; Chevallier JM, 2007, ANN SURG, V246, P1034, DOI 10.1097/SLA.0b013e31813e8a56; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colles SL, 2008, OBES SURG, V18, P833, DOI 10.1007/s11695-007-9409-3; Cunneen SA, 2008, SURG OBES RELAT DIS, V4, pS47, DOI 10.1016/j.soard.2008.04.007; De Panfilis C, 2006, OBES SURG, V16, P842, DOI 10.1381/096089206777822278; Dixon JB, 2002, AM J SURG, V184, p17S, DOI 10.1016/S0002-9610(02)01174-1; Graham J., 2006, MMPI 2 ASSESSING PER; Hainer V, 2008, DIABETES CARE, V31, pS269, DOI 10.2337/dc08-s265; Haykin S, 1999, P842; Hudson SM, 2002, OBES SURG, V12, P789, DOI 10.1381/096089202320995565; Kinzl JF, 2006, OBES SURG, V16, P1609, DOI 10.1381/096089206779319301; Kral JG, 2001, INT J OBESITY, V25, pS107, DOI 10.1038/sj.ijo.0801712; Landi A, 2007, INT CONF ON CYBERNETICS AND INFORMATION TECHNOLOGIES, SYSTEMS AND APPLICATIONS/INT CONF ON COMPUTING, COMMUNICATIONS AND CONTROL TECHNOLOGIES, VOL 1, P76; Lee YC, 2007, OBES SURG, V17, P1235, DOI 10.1007/BF02802096; Lorentz FH, 1929, KLIN WOCHENSCHR, V16, P734, DOI DOI 10.1007/BF01738018; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Martin LF, 2007, AM J SURG, V194, P333, DOI 10.1016/j.amjsurg.2007.03.002; Mauri M, 2008, OBES METAB-MILAN, V4, P99; Mauri M, 2008, J CLIN PSYCHIAT, V69, P295, DOI 10.4088/JCP.v69n0216; Myers R., 1990, CLASSICAL MODERN REG; Neter J, 1985, APPL LINEAR REGRESSI; PANCHERI P, 1997, MMPI 2 MINNESOTA MUL; Pontiroli AE, 2007, OBES SURG, V17, P1492, DOI 10.1007/s11695-008-9428-8; Provost F, 1998, MACH LEARN, V30, P127, DOI 10.1023/A:1007442505281; Rojas R., 1996, NEURAL NETWORKS SYST, DOI [10.1007/978-3-642-61068-4{\_}7, DOI 10.1007/978-3-642-61068-4]; ROSEN JC, 1992, ADV PSYCHOL ASSESSME; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; Singhal R, 2009, OBES SURG, V19, P418, DOI 10.1007/s11695-008-9617-5; Steffen R, 2008, SURG OBES RELAT DIS, V4, pS7, DOI 10.1016/j.soard.2008.04.002; Tessier DJ, 2008, CURR PROB SURG, V45, P62, DOI [10.1067/j.cpsurg.2007.12.006, 10.1067/j.cpsurg.2007.12.003]; Tsushima WT, 2004, OBES SURG, V14, P528, DOI 10.1381/096089204323013550; van Hout GCM, 2005, OBES SURG, V15, P552, DOI 10.1381/0960892053723484; Wolnerhanssen BK, 2008, SURG OBES RELAT DIS, V4, P500, DOI 10.1016/j.soard.2008.03.252; Zijlstra H, 2009, OBES SURG, V19, P725, DOI 10.1007/s11695-008-9572-1	41	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13624	10.1371/journal.pone.0013624	http://dx.doi.org/10.1371/journal.pone.0013624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048960	gold, Green Submitted, Green Published			2022-12-25	WOS:000283537000017
J	Stein, S; Lohmann, C; Handschin, C; Stenfeldt, E; Boren, J; Luscher, TF; Matter, CM				Stein, Sokrates; Lohmann, Christine; Handschin, Christoph; Stenfeldt, Elin; Boren, Jan; Luescher, Thomas F.; Matter, Christian M.			ApoE-/- PGC-1 alpha-/- Mice Display Reduced IL-18 Levels and Do Not Develop Enhanced Atherosclerosis	PLOS ONE			English	Article							TRANSMEMBRANE CXC-CHEMOKINE; CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; E-DEFICIENT MICE; ADIPOSE-TISSUE; ACCELERATES ATHEROSCLEROSIS; TRANSCRIPTIONAL COACTIVATOR; HEPATIC GLUCONEOGENESIS; SCAVENGER RECEPTOR; CHOLESTEROL EFFLUX	Background: Atherosclerosis is a chronic inflammatory disease that evolves from the interaction of activated endothelial cells, macrophages, lymphocytes and modified lipoproteins (LDLs). In the last years many molecules with crucial metabolic functions have been shown to prevent important steps in the progression of atherogenesis, including peroxisome proliferator activated receptors (PPARs) and the class III histone deacetylase (HDAC) SIRT1. The PPAR gamma coactivator 1 alpha (Ppargc1a or PGC-1 alpha) was identified as an important transcriptional cofactor of PPAR gamma and is activated by SIRT1. The aim of this study was to analyze total PGC-1 alpha deficiency in an atherosclerotic mouse model. Methodology/Principal Findings: To investigate if total PGC-1 alpha deficiency affects atherosclerosis, we compared ApoE(-/-) PGC-1 alpha(-/-) and ApoE(-/-) PGC-1 alpha(+/+) mice kept on a high cholesterol diet. Despite having more macrophages and a higher ICAM-1 expression in plaques, ApoE(-/-) PGC-1 alpha(-/-) did not display more or larger atherosclerotic plaques than their ApoE(-/-) PGC-1 alpha(+/+) littermates. In line with the previously published phenotype of PGC-1 alpha(-/-) mice, ApoE(-/-) PGC-1 alpha(-/-) mice had marked reduced body, liver and epididymal white adipose tissue (WAT) weight. VLDL/LDL-cholesterol and triglyceride contents were also reduced. Aortic expression of PPAR alpha and PPAR gamma, two crucial regulators for adipocyte differentitation and glucose and lipid metabolism, as well as the expression of some PPAR target genes was significantly reduced in ApoE(-/-) PGC-1 alpha(-/-) mice. Importantly, the epididymal WAT and aortic expression of IL-18 and IL-18 plasma levels, a pro-atherosclerotic cytokine, was markedly reduced in ApoE(-/-) PGC-1 alpha(-/-) mice. Conclusions/Significance: ApoE(-/-) PGC-1 alpha(-/-) mice, similar as PGC-1 alpha(-/-) mice exhibit markedly reduced total body and visceral fat weight. Since inflammation of visceral fat is a crucial trigger of atherogenesis, decreased visceral fat in PGC-1 alpha-deficient mice may explain why these mice do not develop enhanced atherosclerosis.	[Stein, Sokrates; Lohmann, Christine; Luescher, Thomas F.; Matter, Christian M.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Stein, Sokrates; Lohmann, Christine; Luescher, Thomas F.; Matter, Christian M.] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Stein, Sokrates; Lohmann, Christine; Luescher, Thomas F.; Matter, Christian M.] Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland; [Handschin, Christoph] Univ Basel, Biozentrum, Basel, Switzerland; [Stenfeldt, Elin; Boren, Jan] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Gothenburg, Sweden	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital; University of Basel; University of Gothenburg	Stein, S (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	christian.matter@access.uzh.ch	Stein, Sokrates/D-4661-2009; Handschin, Christoph/E-6886-2015	Handschin, Christoph/0000-0003-0603-1097; Stein, Sokrates/0000-0001-6984-6934	University of Zurich; Swiss National Science Foundation [31-114094/1, 310030-130626/1, 3100-068118]	University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by the University Research Priority Program 'Integrative Human Physiology' at the University of Zurich and the Swiss National Science Foundation (#31-114094/1, #310030-130626/1, and #3100-068118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; COOK KS, 1987, SCIENCE, V237, P402, DOI 10.1126/science.3299705; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Elhage R, 2003, CARDIOVASC RES, V59, P234, DOI 10.1016/S0008-6363(03)00343-2; FLIER JS, 1987, SCIENCE, V237, P405, DOI 10.1126/science.3299706; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gough PJ, 2004, J IMMUNOL, V172, P3678, DOI 10.4049/jimmunol.172.6.3678; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hulthe J, 2006, ATHEROSCLEROSIS, V188, P450, DOI 10.1016/j.atherosclerosis.2005.11.013; Kim HJ, 2007, ANTIOXID REDOX SIGN, V9, P301, DOI 10.1089/ars.2006.1456; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Lakka HM, 2002, EUR HEART J, V23, P706, DOI 10.1053/euhj.2001.2889; Lehrke M, 2009, EUR J ENDOCRINOL, V161, P339, DOI 10.1530/EJE-09-0380; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lutgens E, 1999, NAT MED, V5, P1313, DOI 10.1038/15271; Mallat Z, 2001, CIRC RES, V89, pE41, DOI 10.1161/hh1901.098735; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; MIN HY, 1986, NUCLEIC ACIDS RES, V14, P8879; Mitsuoka H, 2009, J ATHEROSCLER THROMB, V16, P586, DOI 10.5551/jat.1081; Mussig K, 2009, METABOLISM, V58, P519, DOI 10.1016/j.metabol.2008.11.011; Oberkofler H, 2003, BIOCHEM J, V371, P89, DOI 10.1042/BJ20021665; Ohman MK, 2008, CIRCULATION, V117, P798, DOI 10.1161/CIRCULATIONAHA.107.717595; Ploplis VA, 2001, ANN NY ACAD SCI, V936, P466; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; PURCELLHUYNH DA, 1995, J CLIN INVEST, V95, P2246, DOI 10.1172/JCI117915; Qian H, 2008, GENE THER, V15, P224, DOI 10.1038/sj.gt.3303069; Recinos A, 2004, PHYSIOL GENOMICS, V19, P131, DOI 10.1152/physiolgenomics.00146.2003; See R, 2007, J AM COLL CARDIOL, V50, P752, DOI 10.1016/j.jacc.2007.04.066; Shimaoka T, 2004, J BIOL CHEM, V279, P26807, DOI 10.1074/jbc.C400163200; Shimaoka T, 2000, J BIOL CHEM, V275, P40663, DOI 10.1074/jbc.C000761200; Shimaoka T, 2004, J LEUKOCYTE BIOL, V75, P267, DOI 10.1189/jlb.1003465; Stein S, 2010, EUR HEART J, V31, P2301, DOI 10.1093/eurheartj/ehq107; Suchanek H, 2005, EUR CYTOKINE NETW, V16, P177; Tenger C, 2005, ARTERIOSCL THROM VAS, V25, P791, DOI 10.1161/01.ATV.0000153516.02782.65; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vaughan DE, 2005, J THROMB HAEMOST, V3, P1879, DOI 10.1111/j.1538-7836.2005.01420.x; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; WHITE RT, 1992, J BIOL CHEM, V267, P9210; Whitman SC, 2002, CIRC RES, V90, pE34, DOI 10.1161/hh0202.105292; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Won JC, 2010, ARTERIOSCL THROM VAS, V30, P290, DOI 10.1161/ATVBAHA.109.198721; Xie Gaoqiang, 2007, BMC Cardiovasc Disord, V7, P33, DOI 10.1186/1471-2261-7-33; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang YG, 2008, CLIN EXP PHARM PHYSL	52	26	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13539	10.1371/journal.pone.0013539	http://dx.doi.org/10.1371/journal.pone.0013539			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042583	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000283419100005
J	Verschoor, ML; Wilson, LA; Verschoor, CP; Singh, G				Verschoor, Meghan L.; Wilson, Leigh A.; Verschoor, Chris P.; Singh, Gurmit			Ets-1 Regulates Energy Metabolism in Cancer Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR ETS-1; MESSENGER-RNA EXPRESSION; OXIDATIVE STRESS; MARKER; IMBALANCE; CARCINOMA; ANGIOGENESIS; INHIBITION; ACTIVATION; SURVIVAL	Cancer cells predominantly utilize glycolysis for ATP production even in the presence of abundant oxygen, an environment that would normally result in energy production through oxidative phosphorylation. Although the molecular mechanism for this metabolic switch to aerobic glycolysis has not been fully elucidated, it is likely that mitochondrial damage to the electron transport chain and the resulting increased production of reactive oxygen species are significant driving forces. In this study, we have investigated the role of the transcription factor Ets-1 in the regulation of mitochondrial function and metabolism. Ets-1 was over-expressed using a stably-incorporated tetracycline-inducible expression vector in the ovarian cancer cell line 2008, which does not express detectable basal levels of Ets-1 protein. Microarray analysis of the effects of Ets-1 over-expression in these ovarian cancer cells shows that Ets-1 up-regulates key enzymes involved in glycolysis and associated feeder pathways, fatty acid metabolism, and antioxidant defense. In contrast, Ets-1 down-regulates genes involved in the citric acid cycle, electron transport chain, and mitochondrial proteins. At the functional level, we have found that Ets-1 expression is directly correlated with cellular oxygen consumption whereby increased expression causes decreased oxygen consumption. Ets-1 over-expression also caused increased sensitivity to glycolytic inhibitors, as well as growth inhibition in a glucose-depleted culture environment. Collectively our findings demonstrate that Ets-1 is involved in the regulation of cellular metabolism and response to oxidative stress in ovarian cancer cells.	[Verschoor, Meghan L.; Wilson, Leigh A.; Singh, Gurmit] Juravinski Canc Ctr, Dept Res, Hamilton, ON, Canada; [Verschoor, Meghan L.] McMaster Univ, Dept Med Sci, Hamilton, ON, Canada; [Verschoor, Chris P.; Singh, Gurmit] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Verschoor, ML (corresponding author), Juravinski Canc Ctr, Dept Res, Hamilton, ON, Canada.	gurmit.singh@jcc.hhsc.ca	Singh, Gurmit/C-6744-2014		Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by grant funding from the Canadian Institutes of Health Research (CIHR). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinci M, 2008, ACTA CIR BRAS, V23, P551, DOI 10.1590/S0102-86502008000600013; ANDREWS PA, 1992, CANCER RES, V52, P1895; Arsova-Sarafinovska Z, 2009, CLIN BIOCHEM, V42, P1228, DOI 10.1016/j.clinbiochem.2009.05.009; Avril N, 1996, J CLIN ONCOL, V14, P1848, DOI 10.1200/JCO.1996.14.6.1848; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Chen K, 2003, J BIOL CHEM, V278, P39527, DOI 10.1074/jbc.M304423200; CHUNGMAN HJ, 2001, CANCER RES, V61, P8578; Davidson B, 2001, AM J SURG PATHOL, V25, P1493, DOI 10.1097/00000478-200112000-00004; Davidson B, 2001, CLIN CANCER RES, V7, P551; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Fujimoto J, 2002, ANN ONCOL, V13, P1598, DOI 10.1093/annonc/mdf248; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; GOKUL S, 2009, ORAL DIS; Hackstadt AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-11; Hahne JC, 2008, MINI-REV MED CHEM, V8, P1095, DOI 10.2174/138955708785909934; Hutter E, 2006, EXP GERONTOL, V41, P103, DOI 10.1016/j.exger.2005.09.011; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; KONSTANTINOV AA, 1987, BIOCHIM BIOPHYS ACTA, V894, P1, DOI 10.1016/0005-2728(87)90206-4; Lee HC, 2009, INT J MOL SCI, V10, P674, DOI 10.3390/ijms10020674; Lefter LP, 2009, CANCER GENE THER, V16, P137, DOI 10.1038/cgt.2008.65; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; MEDES G, 1953, CANCER RES, V13, P27; Murie C, 2008, BIOINFORMATICS, V24, P1735, DOI 10.1093/bioinformatics/btn211; Nakayama T, 1996, AM J PATHOL, V149, P1931; Nomura M, 2000, CARCINOGENESIS, V21, P1885, DOI 10.1093/carcin/21.10.1885; Oberley TD, 1997, HISTOL HISTOPATHOL, V12, P525; Oda N, 1999, J CELL PHYSIOL, V178, P121, DOI 10.1002/(SICI)1097-4652(199902)178:2<121::AID-JCP1>3.3.CO;2-6; Okuducu AF, 2006, HISTOPATHOLOGY, V48, P836, DOI 10.1111/j.1365-2559.2006.02432.x; Park YH, 2008, BIOCHEM BIOPH RES CO, V377, P389, DOI 10.1016/j.bbrc.2008.09.135; Pelicano H, 2009, CANCER RES, V69, P2375, DOI 10.1158/0008-5472.CAN-08-3359; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Picardo M, 1996, J INVEST DERMATOL, V107, P322, DOI 10.1111/1523-1747.ep12363163; Policastro L, 2004, MOL CARCINOGEN, V39, P103, DOI 10.1002/mc.20001; R Development Core Team, 2005, R LANG ENV STAT COMP; Rothhammer T, 2004, CELL MOL LIFE SCI, V61, P118, DOI 10.1007/s00018-003-3337-8; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; SCHATZ G, 1995, BBA-MOL BASIS DIS, V1271, P123, DOI 10.1016/0925-4439(95)00018-Y; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SINHA S, 2009, INT J BIOMETEOROL; Span PN, 2002, ONCOGENE, V21, P8506, DOI 10.1038/sj.onc.1206040; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Takai N, 2002, INT J MOL MED, V9, P287; Trojanowska M, 2000, ONCOGENE, V19, P6464, DOI 10.1038/sj.onc.1204043; WAHL RL, 1990, J NUCL MED, V31, P1831; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Watabe T, 1998, INT J CANCER, V77, P128, DOI 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9; Wilson LA, 2005, FASEB J, V19, P2085, DOI 10.1096/fj.05-4401fje; Wilson LA, 2004, MOL CANCER THER, V3, P823; Yecies JL, 2010, CELL, V140, P28, DOI 10.1016/j.cell.2009.12.037	49	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13565	10.1371/journal.pone.0013565	http://dx.doi.org/10.1371/journal.pone.0013565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042593	Green Submitted, gold, Green Published			2022-12-25	WOS:000283419100009
J	Lu, Z; Moraes, C; Ye, G; Simmons, CA; Sun, Y				Lu, Zhe; Moraes, Christopher; Ye, George; Simmons, Craig A.; Sun, Yu			Single Cell Deposition and Patterning with a Robotic System	PLOS ONE			English	Article							CALCIFICATION; PLATFORM; MATRIX	Integrating single-cell manipulation techniques in traditional and emerging biological culture systems is challenging. Microfabricated devices for single cell studies in particular often require cells to be spatially positioned at specific culture sites on the device surface. This paper presents a robotic micromanipulation system for pick-and-place positioning of single cells. By integrating computer vision and motion control algorithms, the system visually tracks a cell in real time and controls multiple positioning devices simultaneously to accurately pick up a single cell, transfer it to a desired substrate, and deposit it at a specified location. A traditional glass micropipette is used, and whole- and partial-cell aspiration techniques are investigated to manipulate single cells. Partially aspirating cells resulted in an operation speed of 15 seconds per cell and a 95% success rate. In contrast, the whole- cell aspiration method required 30 seconds per cell and achieved a success rate of 80%. The broad applicability of this robotic manipulation technique is demonstrated using multiple cell types on traditional substrates and on open-top microfabricated devices, without requiring modifications to device designs. Furthermore, we used this serial deposition process in conjunction with an established parallel cell manipulation technique to improve the efficiency of single cell capture from similar to 80% to 100%. Using a robotic micromanipulation system to position single cells on a substrate is demonstrated as an effective stand-alone or bolstering technology for single-cell studies, eliminating some of the drawbacks associated with standard single-cell handling and manipulation techniques.	[Lu, Zhe; Moraes, Christopher; Simmons, Craig A.; Sun, Yu] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON, Canada; [Moraes, Christopher; Ye, George; Simmons, Craig A.; Sun, Yu] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada	University of Toronto; University of Toronto	Lu, Z (corresponding author), Univ Toronto, Dept Mech & Ind Engn, Toronto, ON, Canada.	sun@mie.utoronto.ca	Simmons, Craig/A-5880-2008; Simmons, Craig/ABA-2015-2020	Simmons, Craig/0000-0001-7729-1772; Simmons, Craig/0000-0001-7729-1772; Sun, Yu/0000-0001-7895-0741; Moraes, Christopher/0000-0002-8950-2212	Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Research and Innovation; Ontario Graduate Scholarship; Canada Research Chairs in Mechanobiology	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canada Research Chairs in Mechanobiology(Canada Research Chairs)	We acknowledge financial support from the Natural Sciences and Engineering Research Council of Canada, the Ontario Ministry of Research and Innovation, the Ontario Graduate Scholarship program to CM, and the Canada Research Chairs in Mechanobiology to CAS, and in Micro and Nano Engineering systems to YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052; ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; Bhola PD, 2009, J CELL SCI, V122, P4296, DOI 10.1242/jcs.055590; Bradski G., 2008, LEARNING OPENCV; Brehm-Stecher BF, 2004, MICROBIOL MOL BIOL R, V68, P538, DOI 10.1128/MMBR.68.3.538-559.2004; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chen JH, 2009, AM J PATHOL, V174, P1109, DOI 10.2353/ajpath.2009.080750; Cheung WY, 2008, J HEART VALVE DIS, V17, P674; Chin VI, 2004, BIOTECHNOL BIOENG, V88, P399, DOI 10.1002/bit.20254; Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024; Faley S, 2008, LAB CHIP, V8, P1700, DOI 10.1039/b719799c; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Flaim CJ, 2008, STEM CELLS DEV, V17, P29, DOI 10.1089/scd.2007.0085; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; Gherardini L, 2005, ULTRASOUND MED BIOL, V31, P261, DOI 10.1016/j.ultrasmedbio.2004.10.010; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; HOROYAN M, 1990, CELL BIOPHYS, V17, P243, DOI 10.1007/BF02990720; Hosokawa M, 2009, ANAL CHEM, V81, P5308, DOI 10.1021/ac900535h; Lu ZG, 2010, IEEE INT C INT ROBOT; Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Mirsaidov U, 2008, LAB CHIP, V8, P2174, DOI 10.1039/b807987k; Moraes C, 2010, LAB CHIP, V10, P227, DOI 10.1039/b914460a; Moraes C, 2010, BIOMATERIALS, V31, P577, DOI 10.1016/j.biomaterials.2009.09.068; Moraes C, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/6/065015; Nickels K, 2002, IMAGE VISION COMPUT, V20, P47, DOI 10.1016/S0262-8856(01)00076-2; Rettig JR, 2005, ANAL CHEM, V77, P5628, DOI 10.1021/ac0505977; Rosenthal A, 2007, BIOMATERIALS, V28, P3208, DOI 10.1016/j.biomaterials.2007.03.023; Sims CE, 2007, LAB CHIP, V7, P423, DOI 10.1039/b615235j; Skelley AM, 2009, NAT METHODS, V6, P147, DOI [10.1038/NMETH.1290, 10.1038/nmeth.1290]; Voldman J, 2006, ANNU REV BIOMED ENG, V8, P425, DOI 10.1146/annurev.bioeng.8.061505.095739; Wang WH, 2007, INT J ROBOT RES, V26, P821, DOI 10.1177/0278364907080254; Yeo WS, 2006, LANGMUIR, V22, P10816, DOI 10.1021/la061212y; Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394	36	46	54	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13542	10.1371/journal.pone.0013542	http://dx.doi.org/10.1371/journal.pone.0013542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042403	Green Published, gold, Green Submitted			2022-12-25	WOS:000283293800012
J	Stratigopoulos, G; LeDuc, CA; Cremona, ML; Chung, WK; Leibel, RL				Stratigopoulos, George; LeDuc, Charles A.; Cremona, Maria L.; Chung, Wendy K.; Leibel, Rudolph L.			Cut-like Homeobox 1 (CUX1) Regulates Expression of the Fat Mass and Obesity-associated and Retinitis Pigmentosa GTPase Regulator-interacting Protein-1-like (RPGRIP1L) Genes and Coordinates Leptin Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARDET-BIEDL-SYNDROME; GENOME-WIDE ASSOCIATION; FTO GENE; PRIMARY CILIA; SYNDROME PROTEINS; RETINAL DEGENERATION; HOMEODOMAIN PROTEIN; ENERGY-INTAKE; DNA-BINDING; FOOD-INTAKE	The first intron of FTO contains common single nucleotide polymorphisms associated with body weight and adiposity in humans. In an effort to identify the molecular basis for this association, we discovered that FTO and RPGRIP1L (a ciliary gene located in close proximity to the transcriptional start site of FTO) are regulated by isoforms P200 and P110 of the transcription factor, CUX1. This regulation occurs via a single AATAAATA regulatory site (conserved in the mouse) within the FTO intronic region associated with adiposity in humans. Single nucleotide polymorphism rs8050136 (located in this regulatory site) affects binding affinities of P200 and P110. Promoter-probe analysis revealed that binding of P200 to this site represses FTO, whereas binding of P110 increases transcriptional activity from the FTO as well as RPGRIP1L minimal promoters. Reduced expression of Fto or Rpgrip1l affects leptin receptor isoform b trafficking and leptin signaling in N41 mouse hypothalamic or N2a neuroblastoma cells in vitro. Leptin receptor clusters in the vicinity of the cilium of arcuate hypothalamic neurons in C57BL/6J mice treated with leptin, but not in fasted mice, suggesting a potentially important role of the cilium in leptin signaling that is, in part, regulated by FTO and RPGRIP1L. Decreased Fto/Rpgrip1l expression in the arcuate hypothalamus coincides with decreased nuclear enzymatic activity of a protease (cathepsin L) that has been shown to cleave full-length CUX1 (P200) to P110. P200 disrupts (whereas P110 promotes) leptin receptor isoform b clustering in the vicinity of the cilium in vitro. Clustering of the receptor coincides with increased leptin signaling as reflected in protein levels of phosphorylated Stat3 (p-Stat3). Association of the FTO locus with adiposity in humans may reflect functional consequences of A/C alleles at rs8050136. The obesity-risk (A) allele shows reduced affinity for the FTO and RPGRIP1L transcriptional activator P110, leading to the following: 1) decreased FTO and RPGRIP1L mRNA levels; 2) reduced LEPR trafficking to the cilium; and, as a consequence, 3) a diminished cellular response to leptin.	Columbia Univ, Div Mol Genet, Dept Pediat, New York, NY 10032 USA; Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10032 USA	Columbia University; Columbia University	Stratigopoulos, G (corresponding author), 1150 St Nicholas Ave,Rm 620, New York, NY 10032 USA.	GS2172@columbia.edu; RL232@columbia.edu	Stratigopoulos, G/D-4159-2015	Stratigopoulos, G/0000-0003-4752-9123; LeDuc, Charles/0000-0002-2073-5050	National Institutes of Health [RO1 DK52431-15, P30 DK26687-30, P30 DK63608-08]; American Diabetes Association; Russell Berrie Foundation; Lasky Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052431, P30DK063608, P30DK026687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Russell Berrie Foundation; Lasky Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants RO1 DK52431-15, P30 DK26687-30, and P30 DK63608-08, an American Diabetes Association-mentored fellowship award, a grant from the Russell Berrie Foundation, and a gift from the Lasky Foundation.	Alcalay NI, 2008, AM J PHYSIOL-RENAL, V295, pF1725, DOI 10.1152/ajprenal.90420.2008; AUFIERO B, 1994, P NATL ACAD SCI USA, V91, P7757, DOI 10.1073/pnas.91.16.7757; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Belouzard S, 2004, J BIOL CHEM, V279, P28499, DOI 10.1074/jbc.M400508200; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Berulava T, 2010, EUR J HUM GENET, V18, P1054, DOI 10.1038/ejhg.2010.71; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Cadieux C, 2008, J BIOL CHEM, V283, P13817, DOI 10.1074/jbc.M709332200; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Collette J, 2004, INT REV CYTOL, V241, P1, DOI 10.1016/S0074-7696(04)41001-8; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Devuyst O, 2008, NEPHROL DIAL TRANSPL, V23, P1500, DOI 10.1093/ndt/gfn033; Diano S, 1998, J NEUROENDOCRINOL, V10, P647, DOI 10.1046/j.1365-2826.1998.00261.x; Einstein EB, 2010, J NEUROSCI, V30, P4306, DOI 10.1523/JNEUROSCI.5295-09.2010; Ellis T, 2001, GENE DEV, V15, P2307, DOI 10.1101/gad.200101; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Goossens GH, 2009, INT J OBESITY, V33, P669, DOI 10.1038/ijo.2009.59; Gorivodsky M, 2009, DEV BIOL, V325, P24, DOI 10.1016/j.ydbio.2008.09.019; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; Grunnet LG, 2009, DIABETES, V58, P2402, DOI 10.2337/db09-0205; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Harada R, 2008, NUCLEIC ACIDS RES, V36, P189, DOI 10.1093/nar/gkm970; Hardie LJ, 1996, BIOCHEM BIOPH RES CO, V223, P660, DOI 10.1006/bbrc.1996.0951; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Herwig A, 2008, OBESITY FACTS, V1, P71, DOI 10.1159/000123428; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; KAMBERI IA, 1970, J NEUROCHEM, V17, P261, DOI 10.1111/j.1471-4159.1970.tb02209.x; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Khanna-Gupta A, 2003, BLOOD, V101, P3460, DOI 10.1182/blood-2002-09-2767; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Kloting N, 2008, DIABETOLOGIA, V51, P641, DOI 10.1007/s00125-008-0928-9; Luong MX, 2002, MOL CELL BIOL, V22, P1424, DOI 10.1128/MCB.22.5.1424-1437.2002; Mailly F, 1996, MOL CELL BIOL, V16, P5346; Marshall WF, 2008, CURR TOP DEV BIOL, V85, P1, DOI 10.1016/S0070-2153(08)00801-6; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Meyre D, 2010, DIABETES, V59, P311, DOI 10.2337/db09-0703; Moon NS, 2000, J BIOL CHEM, V275, P31325, DOI 10.1074/jbc.M002912200; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; Mukhopadhyay S, 2008, DEV CELL, V14, P762, DOI 10.1016/j.devcel.2008.03.002; Overton JM, 2004, PHYSIOL BEHAV, V81, P749, DOI 10.1016/j.physbeh.2004.04.025; PALKOVITS M, 1973, BRAIN RES, V59, P449, DOI 10.1016/0006-8993(73)90290-4; Peelman F, 2006, J BIOL CHEM, V281, P15496, DOI 10.1074/jbc.M512622200; Sansregret L, 2008, GENE, V412, P84, DOI 10.1016/j.gene.2008.01.017; Santos N, 2008, DEV DYNAM, V237, P1972, DOI 10.1002/dvdy.21540; Schwartz MW, 2003, DIABETES, V52, P232, DOI 10.2337/diabetes.52.2.232; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Sinclair AM, 2001, BLOOD, V98, P3658, DOI 10.1182/blood.V98.13.3658; Slotnick B.M., 1975, STEREOTAXIC ATLAS AL; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Truscott M, 2004, J BIOL CHEM, V279, P49787, DOI 10.1074/jbc.M409484200; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Villanueva EC, 2008, INT J OBESITY, V32, pS8, DOI 10.1038/ijo.2008.232; Wang ZS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006979; Wardle J, 2009, INT J OBESITY, V33, P42, DOI 10.1038/ijo.2008.174; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Wheatley DN, 1996, CELL BIOL INT, V20, P73, DOI 10.1006/cbir.1996.0011; Zabeau L, 2004, MOL ENDOCRINOL, V18, P150, DOI 10.1210/me.2003-0078; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100	74	92	97	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2155	2170		10.1074/jbc.M110.188482	http://dx.doi.org/10.1074/jbc.M110.188482			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21037323	hybrid, Green Published			2022-12-25	WOS:000286191500057
J	Brouwers, O; Niessen, PM; Ferreira, I; Miyata, T; Scheffer, PG; Teerlink, T; Schrauwen, P; Brownlee, M; Stehouwer, CD; Schalkwijk, CG				Brouwers, Olaf; Niessen, Petra M.; Ferreira, Isabel; Miyata, Toshio; Scheffer, Peter G.; Teerlink, Tom; Schrauwen, Patrick; Brownlee, Michael; Stehouwer, Coen D.; Schalkwijk, Casper G.			Overexpression of Glyoxalase-I Reduces Hyperglycemia-induced Levels of Advanced Glycation End Products and Oxidative Stress in Diabetic Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PLASMA-PROTEIN; LIPID-PEROXIDATION; MITOCHONDRIAL PROTEINS; CELLS; INHIBITION; KIDNEY; DAMAGE; N-EPSILON-(CARBOXYMETHYL)LYSINE; N-EPSILON-(CARBOXYETHYL)LYSINE; AMINOGUANIDINE	The reactive advanced glycation end product (AGE) precursor methylglyoxal (MGO) and MGO-derived AGEs are associated with diabetic vascular complications and also with an increase in oxidative stress. Glyoxalase-I (GLO-I) transgenic rats were used to explore whether overexpression of this MGO detoxifying enzyme reduces levels of AGEs and oxidative stress in a rat model of diabetes. Rats were made diabetic with streptozotocin, and after 12 weeks, plasma and multiple tissues were isolated for analysis of AGEs, carbonyl stress, and oxidative stress. GLO-I activity was significantly elevated in multiple tissues of all transgenic rats compared with wild-type (WT) littermates. Streptozotocin treatment resulted in a 5-fold increase in blood glucose concentrations irrespective of GLO-I overexpression. Levels of MGO, glyoxal, 3-deoxyglucosone, AGEs, and oxidative stress markers nitrotyrosine, malondialdehyde, and F2-isoprostane were elevated in the diabetic WT rats. In diabetic GLO-I rats, glyoxal and MGO composite scores were significantly decreased by 81%, and plasma AGEs and oxidative stress markers scores were significantly decreased by similar to 50%. Hyperglycemia induced a decrease in protein levels of the mitochondrial oxidative phosphorylation complex in the gastrocnemius muscle, which was accompanied by an increase in the lipid peroxidation product 4-hydroxy-2-nonenal, and this was counteracted by GLO-I overexpression. This study shows for the first time in an in vivo model of diabetes that GLO-I overexpression reduces hyperglycemia-induced levels of carbonyl stress, AGEs, and oxidative stress. The reduction of oxidative stress by GLO-I overexpression directly demonstrates the link between glycation and oxidative stress.	[Brouwers, Olaf; Niessen, Petra M.; Ferreira, Isabel; Stehouwer, Coen D.; Schalkwijk, Casper G.] Maastricht Univ, Med Ctr, Dept Internal Med, Div Gen Internal Med,Lab Metab & Vasc Med, NL-6202 AZ Maastricht, Netherlands; [Miyata, Toshio] Tohoku Univ, Ctr Translat & Adv Res, Sendai, Miyagi 9808575, Japan; [Scheffer, Peter G.; Teerlink, Tom] Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, NL-1007 MB Amsterdam, Netherlands; [Schrauwen, Patrick] Maastricht Univ, Med Ctr, Dept Human Biol, NL-6200 MD Maastricht, Netherlands; [Brownlee, Michael] Albert Einstein Coll Med, Int Ctr Diabet Complicat Res, Bronx, NY 10461 USA	Maastricht University; Tohoku University; Vrije Universiteit Amsterdam; Maastricht University; Yeshiva University; Albert Einstein College of Medicine	Schalkwijk, CG (corresponding author), Maastricht Univ, Med Ctr, Dept Internal Med, Div Gen Internal Med,Lab Metab & Vasc Med, P Debyelaan 25,POB 5800, NL-6202 AZ Maastricht, Netherlands.	C.Schalkwijk@maastrichtuniversity.nl	Ferreira, Isabel/B-6033-2008; Miyata, Toshio/A-4872-2010; Stehouwer, Coen/AAB-3435-2021	Ferreira, Isabel/0000-0003-1434-0607; schrauwen, patrick/0000-0002-0973-847X; Stehouwer, Coen/0000-0001-8752-3223; Schalkwijk, Casper G/0000-0003-0190-2690	Dutch Diabetes Foundation [2005.11.013]; Netherlands Heart Foundation [2006T050]	Dutch Diabetes Foundation; Netherlands Heart Foundation(Netherlands Heart Foundation)	This study was supported in part by Dutch Diabetes Foundation Grant 2005.11.013.; Supported by Netherlands Heart Foundation Post-doctoral Research Grant 2006T050.	Beisswenger PJ, 2003, BIOCHEM SOC T, V31, P1358; Biswas S, 1997, BIOCHEM J, V323, P343, DOI 10.1042/bj3230343; Brouwers O, 2010, DIABETOLOGIA, V53, P989, DOI 10.1007/s00125-010-1677-0; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Ceriello A, 2006, CURR OPIN LIPIDOL, V17, P510, DOI 10.1097/01.mol.0000245256.17764.fb; Chang TJ, 2005, FREE RADICAL BIO MED, V38, P286, DOI 10.1016/j.freeradbiomed.2004.10.034; de Kerkhof JV, 2004, NEPHROL DIAL TRANSPL, V19, P910, DOI 10.1093/ndt/gfh004; Drel VR, 2006, FREE RADICAL BIO MED, V40, P1454, DOI 10.1016/j.freeradbiomed.2005.12.034; Fu MX, 1996, J BIOL CHEM, V271, P9982, DOI 10.1074/jbc.271.17.9982; Hoeks J, 2008, FEBS LETT, V582, P510, DOI 10.1016/j.febslet.2008.01.013; Ihm SH, 1999, METABOLISM, V48, P1141, DOI 10.1016/S0026-0495(99)90128-2; Inagi R, 2002, KIDNEY INT, V62, P679, DOI 10.1046/j.1523-1755.2002.00488.x; Kakkar P, 2007, MOL CELL BIOCHEM, V305, P235, DOI 10.1007/s11010-007-9520-8; Kedziora-Kornatowska K, 1998, BIOCHEM MOL BIOL INT, V46, P577; Marti R, 1997, CLIN CHEM, V43, P1010; MCLELLAN AC, 1993, ANAL BIOCHEM, V211, P37, DOI 10.1006/abio.1993.1229; Miller AG, 2006, J BIOL CHEM, V281, P11864, DOI 10.1074/jbc.M513813200; Miyata T, 2001, KIDNEY INT, V60, P2351, DOI 10.1046/j.1523-1755.2001.00051.x; MONNIER VM, 1981, SCIENCE, V211, P491, DOI 10.1126/science.6779377; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Rabbani N, 2008, BIOCHEM SOC T, V36, P1045, DOI 10.1042/BST0361045; Reddy VP, 2006, DRUG DISCOV TODAY, V11, P646, DOI 10.1016/j.drudis.2006.05.016; Requena JR, 1996, NEPHROL DIAL TRANSPL, V11, P48; Roest M, 2008, J CLIN LIPIDOL, V2, P298, DOI 10.1016/j.jacl.2008.06.004; Rosca MG, 2005, AM J PHYSIOL-RENAL, V289, pF420, DOI 10.1152/ajprenal.00415.2004; Sakamoto H, 2000, BLOOD, V95, P3214, DOI 10.1182/blood.V95.10.3214; Schalkwijk CG, 1999, PERITON DIALYSIS INT, V19, P325; Scheijen JLJM, 2009, J CHROMATOGR B, V877, P610, DOI 10.1016/j.jchromb.2009.01.022; Schindhelm RK, 2007, DIABETES CARE, V30, P1789, DOI 10.2337/dc06-2585; Schlotterer A, 2009, DIABETES, V58, P2450, DOI 10.2337/db09-0567; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; Teerlink T, 2004, CLIN CHEM, V50, P1222, DOI 10.1373/clinchem.2004.031286; Thornalley PJ, 1996, BIOCHEM PHARMACOL, V51, P1365, DOI 10.1016/0006-2952(96)00059-7; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; YAYLAYAN VA, 1994, CRIT REV FOOD SCI, V34, P321, DOI 10.1080/10408399409527667	36	171	176	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1374	1380		10.1074/jbc.M110.144097	http://dx.doi.org/10.1074/jbc.M110.144097			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21056979	Green Published, hybrid			2022-12-25	WOS:000286005000049
J	Faxen, K; Andersen, JL; Gourdon, P; Fedosova, N; Morth, JP; Nissen, P; Moller, JV				Faxen, Kristina; Andersen, Jacob Lauwring; Gourdon, Pontus; Fedosova, Natalya; Morth, Jens Preben; Nissen, Poul; Moller, Jesper Vuust			Characterization of a Listeria monocytogenes Ca2+ Pump A SERCA-TYPE ATPase WITH ONLY ONE Ca2+-BINDING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA-2+-ATPASE; CALCIUM-TRANSPORT; H+ COUNTERTRANSPORT; MEMBRANE-PROTEINS; HIGH-AFFINITY; RECONSTITUTION; ELECTROGENICITY; CA2+-ATPASE; EXPRESSION; STRONTIUM	We have characterized a putative Ca2+-ATPase from the pathogenic bacterium Listeria monocytogenes with the locus tag lmo0841. The purified and detergent-solubilized protein, which we have named Listeria monocytogenes Ca2+-ATPase 1 (LMCA1), performs a Ca2+-dependent ATP hydrolysis and actively transports Ca2+ after reconstitution in dioleoylphosphatidyl-choline vesicles. Despite a high sequence similarity to the sarcoplasmic reticulum Ca2+-ATPase (SERCA1a) and plasma membrane Ca2+-ATPase (PMCA), LMCA1 exhibits important biochemical differences such as a low Ca2+ affinity (K-0.5 similar to 80 mu M) and a high pH optimum (pH similar to 9). Mutational studies indicate that the unusually high pH optimum can be partially ascribed to the presence of an arginine residue (Arg-795), corresponding in sequence alignments to the Glu-908 position at Ca2+ binding site I of rabbit SERCA1a, but probably with an exposed position in LMCA1. The arginine is characteristic of a large group of putative bacterial Ca2+-ATPases. Moreover, we demonstrate that H+ is countertransported with a transport stoichiometry of 1 Ca2+ out and 1 H+ in per ATP hydrolyzed. The ATPase may serve an important function by removing Ca2+ from the microorganism in environmental conditions when e.g. stressed by high Ca2+ and alkaline pH.	[Faxen, Kristina; Andersen, Jacob Lauwring; Gourdon, Pontus; Morth, Jens Preben; Nissen, Poul] Aarhus Univ, Danish Natl Res Fdn, PUMPKIN, Dept Mol Biol, DK-8000 Aarhus, Denmark; [Fedosova, Natalya; Moller, Jesper Vuust] Aarhus Univ, Danish Natl Res Fdn, PUMPKIN, Dept Physiol & Biophys, DK-8000 Aarhus, Denmark	Aarhus University; Danmarks Grundforskningsfond; Aarhus University; Danmarks Grundforskningsfond	Nissen, P (corresponding author), Aarhus Univ, Danish Natl Res Fdn, PUMPKIN, Dept Mol Biol, Gustav Wieds Vej 10C, DK-8000 Aarhus, Denmark.	pn@mb.au.dk; jvm@biophys.au.dk	Johnson, Michael D. L./B-4352-2012; Morth, Jens Preben/AAP-7834-2021; Gourdon, Pontus/E-1076-2014; Nissen, Poul/D-5774-2014; Morth, Jens Preben/G-4450-2013; Gourdon, Pontus/HCI-8898-2022	Morth, Jens Preben/0000-0003-4077-0192; Gourdon, Pontus/0000-0002-8631-3539; Morth, Jens Preben/0000-0003-4077-0192; Nissen, Poul/0000-0003-0948-6628; Andersen, Jacob Lauwring/0000-0002-6062-7740; Fedosova, Natalya U./0000-0002-1706-6108	Danish National Research Foundation; Swedish Research Council; Novo Nordisk Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond); Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by a Center of Excellence grant from the Danish National Research Foundation, a post-doctoral fellowship from The Swedish Research Council (to P.G.), and a Hallas-Moller research stipend from the Novo Nordisk Foundation (to P.N.).	AMBUDKAR SV, 1986, J BIOL CHEM, V261, P5596; Andersen JP, 1995, BIOSCIENCE REP, V15, P243, DOI 10.1007/BF01788358; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; BERKELMAN T, 1994, J BACTERIOL, V176, P4430, DOI 10.1128/jb.176.14.4430-4436.1994; BERMAN MC, 1990, BIOCHIM BIOPHYS ACTA, V1029, P235, DOI 10.1016/0005-2736(90)90159-L; Campbell A.K, 1983, INTRACELLULAR CALCIU; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; CORNELIUS F, 1991, FEBS LETT, V284, P46, DOI 10.1016/0014-5793(91)80758-U; DACOSTA AG, 1986, ARCH BIOCHEM BIOPHYS, V249, P199, DOI 10.1016/0003-9861(86)90575-8; DeSantiago J, 2007, FRONT BIOSCI, V12, P4641, DOI 10.2741/2414; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; GEISLER M, 1993, J MOL BIOL, V234, P1284, DOI 10.1006/jmbi.1993.1684; Geisler Markus, 1998, Biol Proced Online, V1, P70, DOI 10.1251/bpo9; Giotis ES, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-102; GMAJ P, 1983, EUR J BIOCHEM, V136, P71, DOI 10.1111/j.1432-1033.1983.tb07706.x; Guerini D, 1996, BIOCHEMISTRY-US, V35, P3290, DOI 10.1021/bi952572f; Guerini D, 1998, CELL TISSUE RES, V292, P191, DOI 10.1007/s004410051050; HASSELBACH W, 1983, ANNU REV PHYSIOL, V45, P325, DOI 10.1146/annurev.ph.45.030183.001545; HEEGAARD CW, 1990, J BIOL CHEM, V265, P12020; Inesi G, 1978, Ann N Y Acad Sci, V307, P224, DOI 10.1111/j.1749-6632.1978.tb41947.x; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LEIMEISTERWACHTER M, 1989, INFECT IMMUN, V57, P2350; LEVY D, 1990, J BIOL CHEM, V265, P19524; LONDON E, 1978, ANAL BIOCHEM, V88, P203, DOI 10.1016/0003-2697(78)90412-8; LUND S, 1988, J BIOL CHEM, V263, P1654; MACLENNA.DH, 1970, J BIOL CHEM, V245, P4508; MELTZER S, 1984, J BIOL CHEM, V259, P4244; MERMIER P, 1976, EUR J BIOCHEM, V69, P79, DOI 10.1111/j.1432-1033.1976.tb10860.x; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Preiano BS, 1996, BIOCHEMISTRY-US, V35, P7946; Raeymaekers L, 2002, CELL CALCIUM, V32, P93, DOI 10.1016/S0143-4160(02)00125-2; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Rosch JW, 2008, MOL MICROBIOL, V70, P435, DOI 10.1111/j.1365-2958.2008.06425.x; ROSEN BP, 1987, BIOCHIM BIOPHYS ACTA, V906, P101, DOI 10.1016/0304-4157(87)90007-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salvador JM, 1998, J BIOL CHEM, V273, P18230, DOI 10.1074/jbc.273.29.18230; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Thomas RC, 2009, J PHYSIOL-LONDON, V587, P315, DOI 10.1113/jphysiol.2008.162453; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; TSUCHIYA T, 1976, J BIOL CHEM, V251, P962; YU X, 1993, BIOPHYS J, V64, pA334	46	29	30	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1609	1617		10.1074/jbc.M110.176784	http://dx.doi.org/10.1074/jbc.M110.176784			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21047776	hybrid, Green Published			2022-12-25	WOS:000286005000073
J	Gumiero, A; Metcalfe, CL; Pearson, AR; Raven, EL; Moody, PCE				Gumiero, Andrea; Metcalfe, Clive L.; Pearson, Arwen R.; Raven, Emma Lloyd; Moody, Peter C. E.			Nature of the Ferryl Heme in Compounds I and II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C PEROXIDASE; X-RAY-ABSORPTION; HORSERADISH-PEROXIDASE; ASCORBATE PEROXIDASE; CRYSTAL-STRUCTURE; STRUCTURAL-CHARACTERIZATION; AUTOCATALYTIC FORMATION; SUBSTRATE-BINDING; MYOGLOBIN; SPECTROSCOPY	Heme enzymes are ubiquitous in biology and catalyze a vast array of biological redox processes. The formation of high valent ferryl intermediates of the heme iron (known as Compounds I and Compound II) is implicated for a number of catalytic heme enzymes, but these species are formed only transiently and thus have proved somewhat elusive. In consequence, there has been conflicting evidence as to the nature of these ferryl intermediates in a number of different heme enzymes, in particular the precise nature of the bond between the heme iron and the bound oxygen atom. In this work, we present high resolution crystal structures of both Compound I and Compound II intermediates in two different heme peroxidase enzymes, cytochrome c peroxidase and ascorbate peroxidase, allowing direct and accurate comparison of the bonding interactions in the different intermediates. A consistent picture emerges across all structures, showing lengthening of the ferryl oxygen bond (and presumed protonation) on reduction of Compound I to Compound II. These data clarify long standing inconsistencies on the nature of the ferryl heme species in these intermediates.	[Gumiero, Andrea; Metcalfe, Clive L.; Raven, Emma Lloyd] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England; [Pearson, Arwen R.] Univ Leeds, Inst Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Moody, Peter C. E.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Moody, Peter C. E.] Univ Leicester, Henry Wellcome Labs Struct Biol, Leicester LE1 9HN, Leics, England	University of Leicester; University of Leeds; University of Leicester; University of Leicester	Raven, EL (corresponding author), Univ Leicester, Dept Chem, Henry Wellcome Bldg,Univ Rd, Leicester LE1 7RH, Leics, England.	emma.raven@le.ac.uk; peter.moody@le.ac.uk	Moody, Peter/A-6832-2008	Moody, Peter/0000-0003-1762-9238; Pearson, Arwen/0000-0001-8499-7490; Metcalfe, Clive/0000-0002-7856-8574; Raven, Emma/0000-0002-1643-8694	Leverhulme Trust; ESRF [MX1088, MX310]; Biotechnology and Biological Sciences Research Council [BB/H001905/1, BB/C001184/1] Funding Source: researchfish; BBSRC [BB/H001905/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); ESRF; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Leverhulme Trust (to E. L. R./P. C. E. M.) and ESRF Grants MX1088 and Diamond MX310.	Badyal SK, 2008, BIOCHEMISTRY-US, V47, P4403, DOI 10.1021/bi702337n; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Behan RK, 2006, J INORG BIOCHEM, V100, P448, DOI 10.1016/j.jinorgbio.2005.12.019; Behan RK, 2006, J AM CHEM SOC, V128, P11471, DOI 10.1021/ja062428p; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Bonagura CA, 2003, BIOCHEMISTRY-US, V42, P5600, DOI 10.1021/bi034058c; Bursey EH, 2000, BIOCHEMISTRY-US, V39, P7374, DOI 10.1021/bi000446s; CHANCE B, 1984, ARCH BIOCHEM BIOPHYS, V235, P596, DOI 10.1016/0003-9861(84)90234-0; CHANCE M, 1986, BIOCHEMISTRY-US, V25, P1259, DOI 10.1021/bi00354a010; CHANCE M, 1986, BIOCHEMISTRY-US, V25, P1266, DOI 10.1021/bi00354a011; Davydov R, 2008, BIOCHEMISTRY-US, V47, P5147, DOI 10.1021/bi702514d; DAWSON JH, 1988, SCIENCE, V240, P433, DOI 10.1126/science.3358128; Dunford H. B., 2010, PEROXIDASES CATALASE; EDWARDS SL, 1987, BIOCHEMISTRY-US, V26, P1503, DOI 10.1021/bi00380a002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FINZEL BC, 1984, J BIOL CHEM, V259, P3027; FULOP V, 1994, STRUCTURE, V2, P201, DOI 10.1016/S0969-2126(00)00021-6; GOODIN DB, 1991, BIOCHEMISTRY-US, V30, P4953, DOI 10.1021/bi00234a017; Green MT, 2009, CURR OPIN CHEM BIOL, V13, P84, DOI 10.1016/j.cbpa.2009.02.028; Green MT, 2006, J AM CHEM SOC, V128, P1902, DOI 10.1021/ja054074s; Green MT, 2004, SCIENCE, V304, P1653, DOI 10.1126/science.1096897; Hersleth H. P., 2010, BIOCH BIOPH IN PRESS; Hersleth HP, 2002, J BIOL INORG CHEM, V7, P299, DOI 10.1007/s007750100296; Ho R.Y.N., 1995, ACTIVE OXYGEN BIOCH, P1, DOI [10.1007/978-94-011-0609-2_1, DOI 10.1007/978-94-011-0609-2_1]; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karlin KD, 2010, NATURE, V463, P168, DOI 10.1038/463168a; Lad L, 2002, EUR J BIOCHEM, V269, P3182, DOI 10.1046/j.1432-1033.2002.02998.x; Lad L, 2002, BIOCHEMISTRY-US, V41, P13774, DOI 10.1021/bi0261591; Meharenna YT, 2010, BIOCHEMISTRY-US, V49, P2984, DOI 10.1021/bi100238r; Metcalfe CL, 2004, J AM CHEM SOC, V126, P16242, DOI 10.1021/ja048242c; Metcalfe C, 2008, J BIOL CHEM, V283, P6193, DOI 10.1074/jbc.M707412200; Montellano P. R. O. d., 2005, CYTOCHROME P450 STRU; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newcomb M, 2008, P NATL ACAD SCI USA, V105, P8179, DOI 10.1073/pnas.0708299105; Paithankar KS, 2010, ACTA CRYSTALLOGR D, V66, P381, DOI 10.1107/S0907444910006724; PATTERSON WR, 1995, BIOCHEMISTRY-US, V34, P4331, DOI 10.1021/bi00013a023; PENNERHAHN JE, 1983, J BIOL CHEM, V258, P2761; PENNERHAHN JE, 1986, J AM CHEM SOC, V108, P7819, DOI 10.1021/ja00284a054; Pipirou Z, 2007, BIOCHEMISTRY-US, V46, P13269, DOI 10.1021/bi7015316; Pond AE, 1998, INORG CHIM ACTA, V276, P250; Sharp KH, 2003, NAT STRUCT BIOL, V10, P303, DOI 10.1038/nsb913; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; Stone KL, 2006, J AM CHEM SOC, V128, P6147, DOI 10.1021/ja057876w; Stone KL, 2005, P NATL ACAD SCI USA, V102, P16563, DOI 10.1073/pnas.0507069102; Unno M, 2007, J AM CHEM SOC, V129, P13394, DOI 10.1021/ja076108x; Zhu YQ, 2008, BIOCHEMISTRY-US, V47, P2231, DOI 10.1021/bi7023817	48	83	85	1	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1260	1268		10.1074/jbc.M110.183483	http://dx.doi.org/10.1074/jbc.M110.183483			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21062738	Green Published, hybrid			2022-12-25	WOS:000286005000037
J	Karantzali, E; Lekakis, V; Ioannou, M; Hadjimichael, C; Papamatheakis, J; Kretsovali, A				Karantzali, Efthimia; Lekakis, Vassilios; Ioannou, Marilia; Hadjimichael, Christiana; Papamatheakis, Joseph; Kretsovali, Androniki			Sall1 Regulates Embryonic Stem Cell Differentiation in Association with Nanog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOWNES-BROCKS-SYNDROME; KIDNEY DEVELOPMENT; GENE-EXPRESSION; CAUSATIVE GENE; MURINE HOMOLOG; TRANSCRIPTIONAL NETWORK; DEACETYLASE COMPLEX; PLURIPOTENCY; REPRESSION; HETEROCHROMATIN	Sall1 is a multi-zinc finger transcription factor that regulates kidney organogenesis. It is considered to be a transcriptional repressor, preferentially localized on heterochromatin. Mutations or deletions of the human SALL1 gene are associated with the Townes-Brocks syndrome. Despite its high expression, no function was yet assigned for Sall1 in embryonic stem (ES) cells. In the present study, we show that Sall1 is expressed in a differentiation-dependent manner and physically interacts with Nanog and Sox2, two components of the core pluripotency network. Genome-wide mapping of Sall1-binding loci has identified 591 genes, 80% of which are also targeted by Nanog. A large proportion of these genes are related to self-renewal and differentiation. Sall1 positively regulates and synergizes with Nanog for gene transcriptional regulation. In addition, our data show that Sall1 suppresses the ectodermal and mesodermal differentiation. Specifically, the induction of the gastrulation markers T brachyury, Goosecoid, and Dkk1 and the neuroectodermal markers Otx2 and Hand1 was inhibited by Sall1 overexpression during embryoid body differentiation. These data demonstrate a novel role for Sall1 as a member of the transcriptional network that regulates stem cell pluripotency.	[Karantzali, Efthimia; Ioannou, Marilia; Hadjimichael, Christiana; Papamatheakis, Joseph; Kretsovali, Androniki] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 70013, Crete, Greece; [Karantzali, Efthimia; Ioannou, Marilia; Hadjimichael, Christiana; Papamatheakis, Joseph] Univ Crete, Dept Biol, Iraklion 71409, Crete, Greece; [Lekakis, Vassilios] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA	Foundation for Research & Technology - Hellas (FORTH); University of Crete; University System of Maryland; University of Maryland College Park	Kretsovali, A (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 70013, Crete, Greece.	kretsova@imbb.forth.gr		Ioannou, Marilia/0000-0001-7384-902X	European Union [LSHG-CT 2003-503494]; IMBB	European Union(European Commission); IMBB	This work was supported by the European Union FP6 I. P. FunGenES Grant LSHG-CT 2003-503494 and IMBB intramural funding (to A. K.).	Bohm J, 2008, AM J PATHOL, V173, P1455, DOI 10.2353/ajpath.2008.071039; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Buck A, 2001, MECH DEVELOP, V104, P143, DOI 10.1016/S0925-4773(01)00364-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen X, 2008, STEM CELLS, V26, P2759, DOI 10.1634/stemcells.2008-0398; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; de Celis JF, 1999, DEVELOPMENT, V126, P2653; de Celis JF, 2009, INT J DEV BIOL, V53, P1385, DOI 10.1387/ijdb.072408jd; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; Do JT, 2009, TRENDS PHARMACOL SCI, V30, P296, DOI 10.1016/j.tips.2009.03.003; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Inoue S, 2010, GENESIS, V48, P207, DOI 10.1002/dvg.20603; Karantzali E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r65; Khalfallah O, 2009, STEM CELLS, V27, P1529, DOI 10.1002/stem.78; Kiefer SM, 2003, HUM MOL GENET, V12, P2221, DOI 10.1093/hmg/ddg233; Kiefer SM, 2002, J BIOL CHEM, V277, P14869, DOI 10.1074/jbc.M200052200; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kohlhase J, 2003, J MED GENET, V40; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; Kuhnlein RP, 1997, MECH DEVELOP, V66, P107, DOI 10.1016/S0925-4773(97)00103-2; Lauberth SM, 2007, J BIOL CHEM, V282, P34858, DOI 10.1074/jbc.M703702200; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Lim LS, 2010, STEM CELLS, V28, P1961, DOI 10.1002/stem.527; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Netzer C, 2006, BBA-MOL BASIS DIS, V1762, P386, DOI 10.1016/j.bbadis.2005.12.005; Ng JH, 2008, MUTAT RES-FUND MOL M, V647, P52, DOI 10.1016/j.mrfmmm.2008.08.009; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Nishinakamura R, 2006, J PHYSIOL SCI, V56, P131, DOI 10.2170/physiolsci.M95; Nowling TK, 2000, J BIOL CHEM, V275, P3810, DOI 10.1074/jbc.275.6.3810; Ott T, 2001, MECH DEVELOP, V101, P203, DOI 10.1016/S0925-4773(00)00552-9; Pan GJ, 2005, J BIOL CHEM, V280, P1401, DOI 10.1074/jbc.M407847200; Pavesi G, 2001, Bioinformatics, V17 Suppl 1, pS207; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Sato A, 2004, BIOCHEM BIOPH RES CO, V319, P103, DOI 10.1016/j.bbrc.2004.04.156; Schulz H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006804; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Sweetman D, 2006, DEV BIOL, V293, P285, DOI 10.1016/j.ydbio.2006.02.009; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang ZX, 2008, STEM CELLS, V26, P2791, DOI 10.1634/stemcells.2008-0443; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yamamoto C, 2010, HYPERTENS RES, V33, P143, DOI 10.1038/hr.2009.195; Yamashita K, 2007, GENES CELLS, V12, P171, DOI 10.1111/j.1365-2443.2007.01042.x; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Yuri S, 2009, STEM CELLS, V27, P796, DOI 10.1002/stem.14; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958	53	42	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1037	1045		10.1074/jbc.M110.170050	http://dx.doi.org/10.1074/jbc.M110.170050			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21062744	hybrid, Green Published			2022-12-25	WOS:000286005000014
J	Li, Y; Liu, XQ; Wu, YY; Xu, Z; Li, HQ; Griffith, LC; Zhou, Y				Li, Yong; Liu, Xinqiu; Wu, Yuying; Xu, Zhe; Li, Hongqin; Griffith, Leslie C.; Zhou, Yi			Intracellular Regions of the Eag Potassium Channel Play a Critical Role in Generation of Voltage-dependent Currents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; LONG QT SYNDROME; K+ CHANNELS; CRYSTAL-STRUCTURE; ION CHANNELS; DROSOPHILA; TEMPERATURE; ACTIVATION; EXPRESSION; FAMILY	Folding, assembly, and trafficking of ion channels are tightly controlled processes and are important for biological functions relevant to health and disease. Here, we report that functional expression of the Eag channel is temperature-sensitive by a mechanism that is independent of trafficking or surface targeting of the channel protein. Eag channels in cells grown at 37 degrees C exhibit voltage-evoked gating charge movements but fail to conduct K+ ions. By mutagenesis and chimeric channel studies, we show that the N- and C-terminal regions are involved in controlling a step after movement of the voltage sensor, as well as in regulating biophysical properties of the Eag channel. Synthesis and assembly of Eag at high temperature disrupt the ability of these domains to carry out their function. These results suggest an important role of the intracellular regions in the generation of Eag currents.	[Li, Yong; Liu, Xinqiu; Wu, Yuying; Xu, Zhe; Li, Hongqin; Zhou, Yi] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA; [Li, Yong; Liu, Xinqiu] Shanghai Jiao Tong Univ, Dept Neurobiol, Sch Med, Shanghai 200025, Peoples R China; [Griffith, Leslie C.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Griffith, Leslie C.] Brandeis Univ, Ctr Complex Syst, Waltham, MA 02454 USA	State University System of Florida; Florida State University; Shanghai Jiao Tong University; Brandeis University; Brandeis University	Li, Y (corresponding author), Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA.	liyong68@shsmu.edu.cn; yzhou@fsu.edu	Li, Yong/ABB-5588-2021	Griffith, Leslie/0000-0003-3164-9876	National Institutes of Health [NS50355, GM54408]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health grant (to Irwin B. Levitan) and Grants NS50355 (to Y.Z.) and GM54408 (to L.C.G.).	BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; Bannister JPA, 2005, P NATL ACAD SCI USA, V102, P18718, DOI 10.1073/pnas.0505766102; Bauer CK, 2001, J MEMBRANE BIOL, V182, P1; Brown CR, 1997, J BIOENERG BIOMEMBR, V29, P491, DOI 10.1023/A:1022491124939; Brown CR, 1997, J CLIN INVEST, V99, P1432, DOI 10.1172/JCI119302; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Ganetzky B, 1999, ANN NY ACAD SCI, V868, P356, DOI 10.1111/j.1749-6632.1999.tb11297.x; Ganetzky B, 1983, J NEUROGENET, V1, P17, DOI 10.3109/01677068309107069; GRIFFITH LC, 1994, P NATL ACAD SCI USA, V91, P10044, DOI 10.1073/pnas.91.21.10044; Gustina AS, 2009, P NATL ACAD SCI USA, V106, P13082, DOI 10.1073/pnas.0900180106; Hegle AP, 2006, P NATL ACAD SCI USA, V103, P2886, DOI 10.1073/pnas.0505909103; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Ju M, 2006, BIOCHEM BIOPH RES CO, V342, P1088, DOI 10.1016/j.bbrc.2006.02.062; Lansdell SJ, 1997, J NEUROCHEM, V68, P1812; Levitan IB, 2006, NAT NEUROSCI, V9, P305, DOI 10.1038/nn1647; Li Y, 2006, NEURON, V51, P755, DOI 10.1016/j.neuron.2006.08.014; Liu XQ, 2010, CHANNELS, V4, P311, DOI 10.4161/chan.4.4.12329; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Marble DD, 2005, J NEUROSCI, V25, P4898, DOI 10.1523/JNEUROSCI.4566-04.2005; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Perrin MJ, 2008, PROG BIOPHYS MOL BIO, V98, P137, DOI 10.1016/j.pbiomolbio.2008.10.006; Robertson GA, 1996, NEUROPHARMACOLOGY, V35, P841, DOI 10.1016/0028-3908(96)00113-X; Schmeisser H, 2006, J INTERF CYTOK RES, V26, P866, DOI 10.1089/jir.2006.26.866; Stuhmer W, 2006, FEBS LETT, V580, P2850, DOI 10.1016/j.febslet.2006.03.062; Suda N, 1997, J GEN PHYSIOL, V109, P619, DOI 10.1085/jgp.109.5.619; Sun XX, 2009, MOL CELL NEUROSCI, V40, P338, DOI 10.1016/j.mcn.2008.11.005; Sun XX, 2004, J BIOL CHEM, V279, P10206, DOI 10.1074/jbc.M310728200; Szabo I, 2000, BIOCHEM BIOPH RES CO, V274, P130, DOI 10.1006/bbrc.2000.3095; Tang CY, 2000, J GEN PHYSIOL, V115, P319, DOI 10.1085/jgp.115.3.319; Terlau H, 1997, J PHYSIOL-LONDON, V502, P537, DOI 10.1111/j.1469-7793.1997.537bj.x; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Wang Z, 2002, J BIOL CHEM, V277, P24022, DOI 10.1074/jbc.M201949200; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Wilson GF, 1998, J BIOL CHEM, V273, P6389, DOI 10.1074/jbc.273.11.6389; Wray D, 2004, EUR BIOPHYS J BIOPHY, V33, P194, DOI 10.1007/s00249-003-0363-2; Wray D, 2009, EUR BIOPHYS J BIOPHY, V38, P271, DOI 10.1007/s00249-008-0357-1; Yang K, 2005, FEBS LETT, V579, P4113, DOI 10.1016/j.febslet.2005.06.039; Yu SP, 1998, J NEUROSCI RES, V52, P612, DOI 10.1002/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.0.CO;2-3; Zhang JS, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-24; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123	46	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1389	1399		10.1074/jbc.M110.184077	http://dx.doi.org/10.1074/jbc.M110.184077			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059657	Green Published, hybrid			2022-12-25	WOS:000286005000051
J	Mitra, PS; Basu, NK; Basu, M; Chakraborty, S; Saha, T; Owens, IS				Mitra, Partha S.; Basu, Nikhil K.; Basu, Mousumi; Chakraborty, Sunit; Saha, Tapas; Owens, Ida S.			Regulated Phosphorylation of a Major UDP-glucuronosyltransferase Isozyme by Tyrosine Kinases Dictates Endogenous Substrate Selection for Detoxification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER PATIENTS; COMET ASSAY; DNA-DAMAGE; CELLS; SRC; ESTRADIOL; EXPRESSION; METABOLITES; ESTROGENS; ESTRONE	Whereas UDP-glucuronosyltransferase-2B7 is widely distributed in different tissues, it preferentially detoxifies genotoxic 4-OH-estradiol and 4-OH-estrone (4-OHE1) with barely detectable 17 beta-estradiol (E-2) conversion following expression in COS-1 cells. Consistent with the UDP-glucuronosyltransferase requirement for regulated phosphorylation, we discovered that 2B7 requires Src-dependent tyrosine phosphorylation. Y236F-2B7 and Y438F-2B7 mutants were null and 90% inactive, respectively, when expressed in COS-1. We demonstrated that 2B7 incorporated immunoprecipitable [P-33] orthophosphate and that 2B7His, previously expressed in SYF-(Src, Yes, Fyn)(-/-) cells, was Src-supported or phosphorylated under in vitro conditions. Unexpectedly, 2B7 expressed in SYF-/- and SYF+/- cells metabolized 4-OHE1 at 10- and 3-fold higher rates, respectively, than that expressed in COS-1, and similar analysis showed that E-2 metabolism was 16- and 9-fold higher than in COS-1. Because anti-Tyr(P)-438-2B7 detected Tyr(P)-438-2B7 in each cell line, results indicated that unidentified tyrosine kinase(s) (TKs) phosphorylated 2B7 in SYF-/-. 2B7-transfected COS-1 treated with increasing concentrations of the Src-specific inhibitor PP2 down-regulated 4-OHE1 glucuronidation reaching 60% maximum while simultaneously increasing E-2 metabolism linearly. This finding indicated that increasing PP2 inhibition of Src allows increasing E-2 metabolism caused by 2B7 phosphorylation by unidentified TK(s). Importantly, 2B7 expressed in SYF-/- is more competent at metabolizing E-2 in cellulo than 2B7 expressed in COS-1. To confirm Src-controlled 2B7 prevents toxicity, we showed that 2B7-transfected COS-1 efficiently protected against 4-OH-E-1-mediated depurination. Finally, our results indicate that Src-dependent phosphorylation of 2B7 allows metabolism of 4-OHE1, but not E-2, in COS-1, whereas non-Src-phosphorylated 2B7 metabolizes both chemicals. Importantly, we determined that 2B7 substrate selection is not fixed but varies depending upon the TK(s) that carry out its required phosphorylation.	[Mitra, Partha S.; Basu, Nikhil K.; Basu, Mousumi; Chakraborty, Sunit; Owens, Ida S.] NICHHD, Sect Genet Disorders Drug Metab, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Saha, Tapas] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Georgetown University	Basu, M (corresponding author), NICHHD, Sect Genet Disorders Drug Metab, Program Dev Endocrinol & Genet, NIH, Bldg 10,Rm 9D-42, Bethesda, MD 20892 USA.	basun@mail.nih.gov; owens@mail.nih.gov			National Institutes of Health NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008751] Funding Source: NIH RePORTER	National Institutes of Health NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health NICHD Intramural Research Program.	Basu NK, 2008, J BIOL CHEM, V283, P23048, DOI 10.1074/jbc.M800032200; Basu NK, 2007, BIOCHEM BIOPH RES CO, V360, P7, DOI 10.1016/j.bbrc.2007.05.224; Basu NK, 2005, P NATL ACAD SCI USA, V102, P6285, DOI 10.1073/pnas.0407872102; Basu NK, 2004, J BIOL CHEM, V279, P28320, DOI 10.1074/jbc.M401396200; Basu NK, 2004, J BIOL CHEM, V279, P1429, DOI 10.1074/jbc.M306439200; Basu NK, 2003, BIOCHEM BIOPH RES CO, V303, P98, DOI 10.1016/S0006-291X(03)00241-9; Buitrago C, 2000, J CELL BIOCHEM, V79, P274, DOI 10.1002/1097-4644(20001101)79:2<274::AID-JCB100>3.0.CO;2-R; Burger DM, 2008, CLIN PHARMACOL THER, V84, P698, DOI 10.1038/clpt.2008.106; Castagnetta LAM, 2002, CLIN CANCER RES, V8, P3146; Cavalieri E, 2006, BBA-REV CANCER, V1766, P63, DOI 10.1016/j.bbcan.2006.03.001; Dutton G., 1980, GLUCURONIDATION DRUG, P3; Fernandez SV, 2006, INT J CANCER, V118, P1862, DOI 10.1002/ijc.21590; FOTSIS T, 1994, NATURE, V368, P237, DOI 10.1038/368237a0; Gestl SA, 2002, AM J PATHOL, V160, P1467, DOI 10.1016/S0002-9440(10)62572-2; Huang WC, 2003, J BIOL CHEM, V278, P9944, DOI 10.1074/jbc.M208521200; Kerman K, 2007, ANAL CHIM ACTA, V588, P26, DOI 10.1016/j.aca.2007.02.001; Kim H, 2005, ONCOGENE, V24, P5629, DOI 10.1038/sj.onc.1208718; Klaude M, 1996, MUTAT RES-DNA REPAIR, V363, P89, DOI 10.1016/0921-8777(95)00063-1; Lepine J, 2004, J CLIN ENDOCR METAB, V89, P5222, DOI 10.1210/jc.2004-0331; Leu TH, 2003, BIOCHEM PHARMACOL, V66, P2323, DOI 10.1016/j.bcp.2003.08.017; MACKENZIE PI, 1984, ARCH BIOCHEM BIOPHYS, V231, P487, DOI 10.1016/0003-9861(84)90412-0; Mitra PS, 2009, BIOCHEM BIOPH RES CO, V382, P651, DOI 10.1016/j.bbrc.2009.03.054; Nakamura A, 2008, DRUG METAB DISPOS, V36, P1461, DOI 10.1124/dmd.108.021428; Newman DK, 2009, J THROMB HAEMOST, V7, P195, DOI 10.1111/j.1538-7836.2009.03369.x; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Orlow I, 2008, J CLIN ONCOL, V26, P3560, DOI 10.1200/JCO.2007.13.2654; Paquette B, 2005, INT J CANCER, V113, P706, DOI 10.1002/ijc.20647; Pasqualini JR, 1996, J CLIN ENDOCR METAB, V81, P1460, DOI 10.1210/jc.81.4.1460; RITTER JK, 1992, J CLIN INVEST, V90, P150, DOI 10.1172/JCI115829; RITTER JK, 1992, BIOCHEMISTRY-US, V31, P3409, DOI 10.1021/bi00128a015; RITTER JK, 1990, J BIOL CHEM, V265, P7900; Rivera GM, 2009, MOL CELL, V36, P525, DOI 10.1016/j.molcel.2009.10.025; Thibaudeau J, 2006, CANCER RES, V66, P125, DOI 10.1158/0008-5472.CAN-05-2857; Volak LP, 2010, XENOBIOTICA, V40, P306, DOI 10.3109/00498251003596817; Wells PG, 2004, DRUG METAB DISPOS, V32, P281, DOI 10.1124/dmd.32.3.281; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1	36	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1639	1648		10.1074/jbc.M110.165126	http://dx.doi.org/10.1074/jbc.M110.165126			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21056984	Green Published, hybrid			2022-12-25	WOS:000286005000076
J	Rebres, RA; Roach, TIA; Fraser, IDC; Philip, F; Moon, C; Lin, KM; Liu, J; Santat, L; Cheadle, L; Ross, EM; Simon, MI; Seaman, WE				Rebres, Robert A.; Roach, Tamara I. A.; Fraser, Iain D. C.; Philip, Finly; Moon, Christina; Lin, Keng-Mean; Liu, Jamie; Santat, Leah; Cheadle, Lucas; Ross, Elliott M.; Simon, Melvin I.; Seaman, William E.			Synergistic Ca2+ Responses by G alpha(i)- and G alpha(q)-coupled G-protein-coupled Receptors Require a Single PLC beta Isoform That Is Sensitive to Both G beta gamma and G alpha(q)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C-BETA; ADENOSINE A(1) RECEPTORS; ALPHA-SUBUNIT; CROSS-TALK; MEDIATED ACTIVATION; CELLS; CALCIUM; DOMAIN; STIMULATION; IDENTIFICATION	Cross-talk between G alpha(i)- and G alpha(q)-linked G-protein-coupled receptors yields synergistic Ca2+ responses in a variety of cell types. Prior studies have shown that synergistic Ca2+ responses from macrophage G-protein-coupled receptors are primarily dependent on phospholipase C beta 3 (PLC beta 3), with a possible contribution of PLC beta 2, whereas signaling through PLC beta 4 interferes with synergy. We here show that synergy can be induced by the combination of G beta gamma and G alpha(q) activation of a single PLC beta isoform. Synergy was absent in macrophages lacking both PLC beta 2 and PLC beta 3, but it was fully reconstituted following transduction with PLC beta 3 alone. Mechanisms of PLC beta mediated synergy were further explored in NIH-3T3 cells, which express little if any PLC beta 2. RNAi-mediated knockdown of endogenous PLC beta s demonstrated that synergy in these cells was dependent on PLC beta 3, but PLC beta 1 and PLC beta 4 did not contribute, and overexpression of either isoform inhibited Ca2+ synergy. When synergy was blocked by RNAi of endogenous PLC beta 3, it could be reconstituted by expression of either human PLC beta 3 or mouse PLC beta 2. In contrast, it could not be reconstituted by human PLC beta 3 with a mutation of the Y box, which disrupted activation by G beta gamma, and it was only partially restored by human PLC beta 3 with a mutation of the C terminus, which partly disrupted activation by G alpha(q). Thus, both G beta gamma and G alpha(q) contribute to activation of PLC beta 3 in cells for Ca2+ synergy. We conclude that Ca2+ synergy between G alpha(i)-coupled and G alpha(q)-coupled receptors requires the direct action of both G beta gamma and G alpha(q) on PLC beta and is mediated primarily by PLC beta 3, although PLC beta 2 is also competent.	[Rebres, Robert A.; Roach, Tamara I. A.; Moon, Christina; Simon, Melvin I.] Univ Calif San Francisco, Vet Affairs Med Ctr, No Calif Inst Res & Educ, San Francisco, CA 94121 USA; [Seaman, William E.] Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94121 USA; [Fraser, Iain D. C.; Liu, Jamie; Santat, Leah; Cheadle, Lucas] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Philip, Finly; Lin, Keng-Mean; Ross, Elliott M.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	Northern California Institute for Research & Education; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); California Institute of Technology; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rebres, RA (corresponding author), Univ Calif San Francisco, Vet Affairs Med Ctr, No Calif Inst Res & Educ, 111R,4150 Clement St, San Francisco, CA 94121 USA.	rarebres@yahoo.com; tiaroach@gmail.com; bseaman@medicine.ucsf.edu	Fraser, Iain DC/L-4735-2017	Fraser, Iain DC/0000-0003-2272-3907	National Institutes of Health [GM 62114, GM 30355]; Welch Foundation [I-0982]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062114, R37GM030355, R01GM030355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 62114 and GM 30355 (to E. M. R.). This work was also supported by Welch Foundation Grant I-0982 (to E. M. R.).	Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Biddlecome GH, 1996, J BIOL CHEM, V271, P7999, DOI 10.1074/jbc.271.14.7999; Bonacci TM, 2005, J BIOL CHEM, V280, P10174, DOI 10.1074/jbc.M412514200; BOYER JL, 1994, J BIOL CHEM, V269, P2814; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CARROLL RC, 1995, CURR BIOL, V5, P536, DOI 10.1016/S0960-9822(95)00106-0; Cilluffo MC, 2000, AM J PHYSIOL-CELL PH, V279, pC734, DOI 10.1152/ajpcell.2000.279.3.C734; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Delmas P, 2004, TRENDS NEUROSCI, V27, P41, DOI 10.1016/j.tins.2003.10.013; DICKENSON JM, 1994, INT J BIOCHEM, V26, P959, DOI 10.1016/0020-711X(94)90066-3; Dickenson JM, 1996, EUR J PHARMACOL, V302, P141, DOI 10.1016/0014-2999(96)00039-8; DICKENSON JM, 1993, BIOCHEM SOC T, V21, P1124, DOI 10.1042/bst0211124; Fam SR, 2005, P NATL ACAD SCI USA, V102, P8042, DOI 10.1073/pnas.0408818102; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hwang JI, 2005, J BIOL CHEM, V280, P12467, DOI 10.1074/jbc.M410740200; Ilkaeva O, 2002, J BIOL CHEM, V277, P4294, DOI 10.1074/jbc.M109612200; JHON DY, 1993, J BIOL CHEM, V268, P6654; Jiang HP, 1997, P NATL ACAD SCI USA, V94, P7971, DOI 10.1073/pnas.94.15.7971; Jimenez AI, 1999, GLIA, V26, P119, DOI 10.1002/(SICI)1098-1136(199904)26:2<119::AID-GLIA3>3.0.CO;2-D; Kim CG, 1996, J BIOL CHEM, V271, P21187, DOI 10.1074/jbc.271.35.21187; LEE CW, 1994, J BIOL CHEM, V269, P25335; LEE SB, 1993, J BIOL CHEM, V268, P25952; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; OKAJIMA F, 1989, FEBS LETT, V248, P145, DOI 10.1016/0014-5793(89)80450-8; OKAJIMA F, 1993, BIOCHEM J, V290, P241, DOI 10.1042/bj2900241; PARK DG, 1993, J BIOL CHEM, V268, P4573; PARK DG, 1993, J BIOL CHEM, V268, P3710; Philip F, 2010, CURR BIOL, V20, P1327, DOI 10.1016/j.cub.2010.06.013; Quitterer U, 1999, P NATL ACAD SCI USA, V96, P10626, DOI 10.1073/pnas.96.19.10626; Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Roach TIA, 2008, J BIOL CHEM, V283, P17351, DOI 10.1074/jbc.M800907200; Sankaran B, 1998, J BIOL CHEM, V273, P7148, DOI 10.1074/jbc.273.12.7148; Shah BH, 1999, EXP MOL MED, V31, P42, DOI 10.1038/emm.1999.7; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; STERNWEIS PC, 1993, CIBA F SYMP, V176, P96; Suh PG, 2001, BIOCHEM BIOPH RES CO, V288, P1, DOI 10.1006/bbrc.2001.5710; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Toms NJ, 1999, NEUROPHARMACOLOGY, V38, P1511, DOI 10.1016/S0028-3908(99)00090-8; UEDA N, 1994, J BIOL CHEM, V269, P4388; Wang T, 1999, P NATL ACAD SCI USA, V96, P7843, DOI 10.1073/pnas.96.14.7843; Wang TL, 2000, J BIOL CHEM, V275, P7466, DOI 10.1074/jbc.275.11.7466; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Werry TD, 2003, J PHARMACOL EXP THER, V307, P661, DOI 10.1124/jpet.103.055632; Werry TD, 2003, BIOCHEM J, V374, P281, DOI 10.1042/BJ20030312; WU DQ, 1993, P NATL ACAD SCI USA, V90, P5297, DOI 10.1073/pnas.90.11.5297; WU DQ, 1993, J BIOL CHEM, V268, P3704; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059; Xie W, 1999, P NATL ACAD SCI USA, V96, P10385, DOI 10.1073/pnas.96.18.10385; Zavzavadjian JR, 2007, MOL CELL PROTEOMICS, V6, P413, DOI 10.1074/mcp.M600437-MCP200	52	39	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					942	951		10.1074/jbc.M110.198200	http://dx.doi.org/10.1074/jbc.M110.198200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21036901	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000286005000005
J	Ilioaia, C; Johnson, MP; Duffy, CDP; Pascal, AA; van Grondelle, R; Robert, B; Ruban, AV				Ilioaia, Cristian; Johnson, Matthew P.; Duffy, Christopher D. P.; Pascal, Andrew A.; van Grondelle, Rienk; Robert, Bruno; Ruban, Alexander V.			Origin of Absorption Changes Associated with Photoprotective Energy Dissipation in the Absence of Zeaxanthin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; ABSORBED EXCITATION-ENERGY; PH-DEPENDENT DISSIPATION; PHOTOSYSTEM-II; CHLOROPHYLL FLUORESCENCE; XANTHOPHYLL CYCLE; PHOTOSYNTHETIC MEMBRANES; CONFORMATIONAL-CHANGES; SPECTROSCOPIC ANALYSIS; PHOTOOXIDATIVE STRESS	To prevent photo-oxidative damage to the photosynthetic membrane in strong light, plants dissipate excess absorbed light energy as heat in a mechanism known as non-photochemical quenching (NPQ). NPQ is triggered by the transmembrane proton gradient (Delta pH), which causes the protonation of the photosystem II light-harvesting antenna (LHCII) and the PsbS protein, as well as the de-epoxidation of the xanthophyll violaxanthin to zeaxanthin. The combination of these factors brings about formation of dissipative pigment interactions that quench the excess energy. The formation of NPQ is associated with certain absorption changes that have been suggested to reflect a conformational change in LHCII brought about by its protonation. The light-minus-dark recovery absorption difference spectrum is characterized by a series of positive and negative bands, the best known of which is Delta A(535). Light-minus-dark recovery resonance Raman difference spectra performed at the wavelength of the absorption change of interest allows identification of the pigment responsible from its unique vibrational signature. Using this technique, the origin of Delta A(535) was previously shown to be a subpopulation of red-shifted zeaxanthin molecules. In the absence of zeaxanthin (and antheraxanthin), a proportion of NPQ remains, and the Delta A(535) change is blue-shifted to 525 nm (Delta A(525)). Using resonance Raman spectroscopy, it is shown that the Delta A(525) absorption change in Arabidopsis leaves lacking zeaxanthin belongs to a red-shifted subpopulation of violaxanthin molecules formed during NPQ. The presence of the same Delta A(535) and Delta A(525) Raman signatures in vitro in aggregated LHCII, containing zeaxanthin and violaxanthin, respectively, leads to a new proposal for the origin of the xanthophyll red shifts associated with NPQ.	[Ilioaia, Cristian; van Grondelle, Rienk] Vrije Univ Amsterdam, Dept Phys & Astron, Fac Sci, NL-1081 HV Amsterdam, Netherlands; [Robert, Bruno] CEA, Inst Biol & Technol Saclay iBiTecS, F-91191 Gif Sur Yvette, France; [Robert, Bruno] CENS, Lab Leon Brillouin, CNRS, Unite Rech Associee 2096, F-91191 Gif Sur Yvette, France; [Johnson, Matthew P.; Duffy, Christopher D. P.; Ruban, Alexander V.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England	Vrije Universiteit Amsterdam; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of London; Queen Mary University London	Ilioaia, C (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, Fac Sci, Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	cristian.ilioaia@cea.fr; a.ruban@qmul.ac.uk	Robert, Bruno/D-1264-2012; pascal, andrew a/B-6186-2014	Robert, Bruno/0000-0001-5999-4538; pascal, andrew a/0000-0002-1844-6065; Johnson, Matthew/0000-0002-1663-0205; ILIOAIA, Cristian/0000-0001-7505-1900	United Kingdom Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; The Netherlands Organization for Scientific Research via the Foundation of Earth and Life Sciences; European Union (EU) [ERG 224796]; Engineering and Physical Sciences Research Council [EP/H024697/1] Funding Source: researchfish; EPSRC [EP/H024697/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); The Netherlands Organization for Scientific Research via the Foundation of Earth and Life Sciences; European Union (EU)(CGIAREuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by research and equipment grants from the United Kingdom Biotechnology and Biological Sciences Research Council and Engineering and Physical Sciences Research Council, The Netherlands Organization for Scientific Research via the Foundation of Earth and Life Sciences (to C. I. and R. v. G.), the European Union (EU) FP7 Marie Curie Reintegration Grant (ERG 224796) (to C. I.), and an EU FP7 Marie Curie HARVEST Network grant.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Aspinall-O'Dea M, 2002, P NATL ACAD SCI USA, V99, P16331, DOI 10.1073/pnas.252500999; BAYLISS NS, 1950, J CHEM PHYS, V18, P292, DOI 10.1063/1.1747621; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; BILGER W, 1989, PLANT PHYSIOL, V91, P542, DOI 10.1104/pp.91.2.542; BILGER W, 1994, PLANTA, V193, P238, DOI 10.1007/BF00192536; Billsten HH, 2005, J PHYS CHEM A, V109, P1521, DOI 10.1021/jp044847j; Bode S, 2009, P NATL ACAD SCI USA, V106, P12311, DOI 10.1073/pnas.0903536106; Bonente G, 2007, PHOTOSYNTH RES, V91, P292; BRIANTAIS JM, 1979, BIOCHIM BIOPHYS ACTA, V548, P128, DOI 10.1016/0005-2728(79)90193-2; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Crouchman S, 2006, FEBS LETT, V580, P2053, DOI 10.1016/j.febslet.2006.03.005; Davydov A.S., 1962, THEORY MOL EXCITONS; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Dominici P, 2002, J BIOL CHEM, V277, P22750, DOI 10.1074/jbc.M200604200; GILMORE AM, 1995, P NATL ACAD SCI USA, V92, P2273, DOI 10.1073/pnas.92.6.2273; GOTTFRIED DS, 1991, BIOCHIM BIOPHYS ACTA, V1059, P76, DOI 10.1016/S0005-2728(05)80189-6; HEBER U, 1969, BIOCHIM BIOPHYS ACTA, V180, P302, DOI 10.1016/0005-2728(69)90116-9; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Horton P, 2000, PHILOS T R SOC B, V355, P1361, DOI 10.1098/rstb.2000.0698; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; Ilioaia C, 2008, J BIOL CHEM, V283, P29505, DOI 10.1074/jbc.M802438200; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Johnson MP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702831200; Johnson MP, 2010, PLANT J, V61, P283, DOI 10.1111/j.1365-313X.2009.04051.x; Johnson MP, 2009, J BIOL CHEM, V284, P23592, DOI 10.1074/jbc.M109.013557; Johnson MP, 2009, PLANT PHYSIOL, V149, P1061, DOI 10.1104/pp.108.129957; KRAUSE GH, 1973, BIOCHIM BIOPHYS ACTA, V292, P715, DOI 10.1016/0005-2728(73)90019-4; Ledford HK, 2005, PLANT CELL ENVIRON, V28, P1037, DOI 10.1111/j.1365-3040.2005.01374.x; LEROSEN AL, 1952, J CHEM PHYS, V20, P233, DOI 10.1063/1.1700384; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Li ZR, 2009, PLANT CELL, V21, P1798, DOI 10.1105/tpc.109.066571; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Ma YZ, 2003, P NATL ACAD SCI USA, V100, P4377, DOI 10.1073/pnas.0736959100; Muller MG, 2010, CHEMPHYSCHEM, V11, P1289, DOI 10.1002/cphc.200900852; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; MURAKAMI S, 1970, J CELL BIOL, V47, P332, DOI 10.1083/jcb.47.2.332; NOCTOR G, 1993, BIOCHIM BIOPHYS ACTA, V1183, P339, DOI 10.1016/0005-2728(93)90237-A; Polivka T, 2002, BIOCHEMISTRY-US, V41, P439, DOI 10.1021/bi011589x; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; REICH R, 1977, PHOTOCHEM PHOTOBIOL, V26, P11, DOI 10.1111/j.1751-1097.1977.tb07442.x; Robert B, 2004, TRENDS PLANT SCI, V9, P385, DOI 10.1016/j.tplants.2004.06.006; Ruban A. V., 2009, CAROTENOIDS PHYS CHE; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2000, FEBS LETT, V477, P181, DOI 10.1016/S0014-5793(00)01799-3; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Ruban AV, 2002, J BIOL CHEM, V277, P7785, DOI 10.1074/jbc.M110693200; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P39, DOI 10.1016/0167-4838(92)90496-Z; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P30, DOI 10.1016/0005-2728(92)90061-6; Ruban AV, 1997, BIOCHEMISTRY-US, V36, P7855, DOI 10.1021/bi9630725; RUBAN AV, 1993, PLANT PHYSIOL, V102, P741, DOI 10.1104/pp.102.3.741; Ruban AV, 2001, J BIOL CHEM, V276, P24862, DOI 10.1074/jbc.M103263200; RUBAN AV, 1993, J PHOTOCH PHOTOBIO B, V21, P229, DOI 10.1016/1011-1344(93)80188-F; WALTERS RG, 1994, EUR J BIOCHEM, V226, P1063, DOI 10.1111/j.1432-1033.1994.01063.x	59	21	23	1	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					91	98		10.1074/jbc.M110.184887	http://dx.doi.org/10.1074/jbc.M110.184887			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21036900	Green Published, hybrid			2022-12-25	WOS:000285782800010
J	Mosnier, LO				Mosnier, Laurent O.			Platelet Factor 4 Inhibits Thrombomodulin-dependent Activation of Thrombin-activatable Fibrinolysis Inhibitor (TAFI) by Thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-C; FACTOR-XI; ANTICOAGULANT ACTIVITY; CARBOXYPEPTIDASE-U; PLATELET FACTOR-4; PREMATURE LYSIS; PLASMA; COAGULATION; GENERATION; HEPARIN	Thrombomodulin (TM) is a cofactor for thrombin-mediated activation of protein C and thrombin-activatable fibrinolysis inhibitor (TAFI) and thereby helps coordinate coagulation, anticoagulation, fibrinolysis, and inflammation. Platelet factor 4 (PF4), a platelet alpha-granule protein and a soluble cofactor for TM-dependent protein C activation, stimulates protein C activation in vitro and in vivo. In contrast to stimulation of protein C activation, PF4 is shown here to inhibit activation of TAFI by thrombin-TM. Consequences of inhibition of TAFI activation by PF4 included loss of TM-dependent prolongation of clot lysis times in hemophilia A plasma and loss of TM-stimulated conversion of bradykinin (BK) to des-Arg(9)-BK by TAFIa in normal plasma. Thus, PF4 modulates the substrate specificity of the thrombin-TM complex by selectively enhancing protein C activation while inhibiting TAFI activation, thereby preventing the generation of the antifibrinolytic and anti-inflammatory activities of TAFIa. To block the inhibitory effects of PF4 on TAFI activation, heparin derivatives were tested for their ability to retain high affinity binding to PF4 despite having greatly diminished anticoagulant activity. N-acetylated heparin (NAc-Hep) lacked detectable anticoagulant activity in activated partial thromboplastin time clotting assays but retained high affinity binding to PF4 and effectively reversed PF4 binding to immobilized TM. NAc-Hep permitted BK conversion to des-Arg(9)-BK by TAFIa in the presence of PF4. In a clot lysis assay on TM-expressing cells using hemophilia A plasma, NAc-Hep prevented PF4-mediated inhibition of TAFI activation and the antifibrinolytic functions of TAFIa. Accordingly, NAc-Hep or similar heparin derivatives might provide therapeutic benefits by diminishing bleeding complications in hemophilia A via restoration of TAFIa-mediated protection of clots against premature lysis.	[Mosnier, Laurent O.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Mosnier, LO (corresponding author), Scripps Res Inst, Dept Mol & Expt Med MEM 180, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	lmosnier@scripps.edu			National Institutes of Health, NHLBI [HL087618]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104165, R01HL130678, K99HL087618, R00HL087618] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI Grant HL087618.	ALMONDHIRY H, 1987, THROMB HAEMOSTASIS, V57, P294; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; BAJZAR L, 1993, J BIOL CHEM, V268, P8608; Bajzar L, 1998, J BIOL CHEM, V273, P2792, DOI 10.1074/jbc.273.5.2792; Bajzar L, 1996, BLOOD, V88, P2093, DOI 10.1182/blood.V88.6.2093.bloodjournal8862093; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BOCK PE, 1980, BIOCHEM J, V191, P769, DOI 10.1042/bj1910769; Bouma BN, 1999, THROMB HAEMOSTASIS, V82, P1703; Broze GJ, 1996, BLOOD, V88, P3815, DOI 10.1182/blood.V88.10.3815.bloodjournal88103815; Butenas S, 2006, J THROMB HAEMOST, V4, P2411, DOI 10.1111/j.1538-7836.2006.02226.x; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; Casu B, 2007, PATHOPHYSIOL HAEMO T, V36, P195, DOI 10.1159/000175157; Cazenave Jean-Pierre, 2004, Methods Mol Biol, V272, P13; Chan MY, 2008, CIRCULATION, V118, P2286, DOI 10.1161/CIRCULATIONAHA.108.778837; Chesebro BB, 2009, SHOCK, V32, P659, DOI 10.1097/SHK.0b013e3181a5a632; De Nanteuil G, 2006, J MED CHEM, V49, P5047, DOI 10.1021/jm0606950; Dehmer GJ, 1996, CIRCULATION, V94, P347; Dudek AZ, 1997, J BIOL CHEM, V272, P31785, DOI 10.1074/jbc.272.50.31785; ESMON CT, 1981, P NATL ACAD SCI-BIOL, V78, P2249, DOI 10.1073/pnas.78.4.2249; ESMON CT, 1995, FASEB J, V9, P946, DOI 10.1096/fasebj.9.10.7615164; Foley JH, 2009, J THROMB HAEMOST, V7, P453, DOI 10.1111/j.1538-7836.2008.03261.x; FRIEDRICHS GS, 1994, CIRC RES, V75, P701, DOI 10.1161/01.RES.75.4.701; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; KISIEL W, 1979, J CLIN INVEST, V64, P761, DOI 10.1172/JCI109521; Kokame K, 1998, J BIOL CHEM, V273, P12135, DOI 10.1074/jbc.273.20.12135; Kowalska MA, 2007, BLOOD, V110, P1903, DOI 10.1182/blood-2007-03-081901; Leurs J, 2004, J THROMB HAEMOST, V2, P416, DOI 10.1111/j.1538-7836.2004.00605.x; Levi M, 2001, SEMIN THROMB HEMOST, V27, P569, DOI 10.1055/s-2001-18862; Liu TY, 2006, THROMB HAEMOSTASIS, V95, P68, DOI 10.1160/TH05-05-0361; MEDICI I, 1989, THROMB RES, V54, P277, DOI 10.1016/0049-3848(89)90086-8; Mosnier LO, 2007, J BIOL CHEM, V282, P33022, DOI 10.1074/jbc.M705824200; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Mosnier LO, 2006, ARTERIOSCL THROM VAS, V26, P2445, DOI 10.1161/01.ATV.0000244680.14653.9a; Mosnier LO, 2006, FRONT BIOSCI-LANDMRK, V11, P2381, DOI 10.2741/1977; Mosnier LO, 2004, BLOOD, V104, P1740, DOI 10.1182/blood-2004-01-0110; Mosnier LO, 1998, THROMB HAEMOSTASIS, V80, P829; Mosnier LO, 2001, THROMB HAEMOSTASIS, V86, P1035; Mosnier LO, 2001, THROMB HAEMOSTASIS, V85, P5; Nesheim M, 1997, THROMB HAEMOSTASIS, V78, P386; Shetty S, 2007, BRIT J HAEMATOL, V138, P541, DOI 10.1111/j.1365-2141.2007.06693.x; SLUNGAARD A, 1994, J BIOL CHEM, V269, P25549; Slungaard A, 2004, CRIT CARE MED, V32, pS331, DOI 10.1097/01.CCM.0000126359.92825.E9; Slungaard A, 2003, BLOOD, V102, P146, DOI 10.1182/blood-2002-11-3529; STUCKEY JA, 1992, PROTEINS, V14, P277, DOI 10.1002/prot.340140213; Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92; VONDEMBORNE PAK, 1995, BLOOD, V86, P3035; VondemBorne PAK, 1997, J CLIN INVEST, V99, P2323, DOI 10.1172/JCI119412; Walker JB, 2004, J BIOL CHEM, V279, P27896, DOI 10.1074/jbc.M401027200; Wang W, 2000, J BIOL CHEM, V275, P22942, DOI 10.1074/jbc.M001760200; Xu J, 2009, J THROMB HAEMOST, V7, P851, DOI 10.1111/j.1538-7836.2009.03333.x	50	21	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					502	510		10.1074/jbc.M110.147959	http://dx.doi.org/10.1074/jbc.M110.147959			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21041299	Green Published, hybrid			2022-12-25	WOS:000285782800053
J	Stuart, SF; Leatherbarrow, RJ; Willison, KR				Stuart, Sarah F.; Leatherbarrow, Robin J.; Willison, Keith R.			A Two-step Mechanism for the Folding of Actin by the Yeast Cytosolic Chaperonin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC CHAPERONIN; CCT; INTERACTS; PROTEIN; STATE	Actin requires the chaperonin containing TCP1 (CCT), a hexadecameric ATPase essential for cell viability in eukaryotes, to fold to its native state. Following binding of unfolded actin to CCT, the cavity of the chaperone closes and actin is folded and released in an ATP-dependent folding cycle. In yeast, CCT forms a ternary complex with the phosducin-like protein PLP2p to fold actin, and together they can return nascent or chemically denatured actin to its native state in a pure in vitro folding assay. The complexity of the CCT-actin system makes the study of the actin folding mechanism technically challenging. We have established a novel spectroscopic assay through selectively labeling the C terminus of yeast actin with acrylodan and observe significant changes in the acrylodan fluorescence emission spectrum as actin is chemically unfolded and then refolded by the chaperonin. The variation in the polarity of the environment surrounding the fluorescent probe during the unfolding/folding processes has allowed us to monitor actin as it folds on CCT. The rate of actin folding at a range of temperatures and ATP concentrations has been determined for both wild type CCT and a mutant CCT, CCT4anc2, defective in folding actin in vivo. Binding of the non-hydrolysable ATP analog adenosine 5'-(beta,gamma-imino)-triphosphate to the ternary complex leads to 3-fold faster release of actin from CCT following addition of ATP, suggesting a two-step folding process with a conformational change occurring upon closure of the cavity and a subsequent final folding step involving packing of the C terminus to the native-like state.	[Stuart, Sarah F.; Leatherbarrow, Robin J.] Univ London Imperial Coll Sci Technol & Med, Inst Biol Chem, London SW7 2AZ, England; [Stuart, Sarah F.; Willison, Keith R.] Inst Canc Res, Sect Cell & Mol Biol, London SW3 6JB, England	Imperial College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Willison, KR (corresponding author), 237 Fulham Rd, London SW3 6JB, England.	keith.willison@icr.ac.uk	Leatherbarrow, Robin J/H-3070-2014	Leatherbarrow, Robin J/0000-0001-8193-5964	Engineering and Physical Sciences Research Council through the Institute of Chemical Biology	Engineering and Physical Sciences Research Council through the Institute of Chemical Biology(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by the Engineering and Physical Sciences Research Council through the Institute of Chemical Biology.	Altschuler GM, 2009, FEBS LETT, V583, P782, DOI 10.1016/j.febslet.2009.01.031; Altschuler GM, 2008, J R SOC INTERFACE, V5, P1391, DOI 10.1098/rsif.2008.0185; Altschuler GM, 2005, J MOL BIOL, V353, P385, DOI 10.1016/j.jmb.2005.07.062; Dekker C, 2008, EMBO J, V27, P1827, DOI 10.1038/emboj.2008.108; Goode BL, 2002, METHOD ENZYMOL, V351, P433; Grantham J, 2002, CELL STRESS CHAPERON, V7, P235, DOI 10.1379/1466-1268(2002)007<0235:ECCTCP>2.0.CO;2; Larsson C, 1997, J BACTERIOL, V179, P7243, DOI 10.1128/jb.179.23.7243-7250.1997; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; Llorca O, 2001, EMBO J, V20, P4065, DOI 10.1093/emboj/20.15.4065; MARRIOTT G, 1988, BIOCHEMISTRY-US, V27, P6214, DOI 10.1021/bi00417a004; McCormack EA, 2001, J STRUCT BIOL, V135, P198, DOI 10.1006/jsbi.2001.4385; McCormack EA, 2009, J MOL BIOL, V391, P192, DOI 10.1016/j.jmb.2009.06.003; Neirynck K, 2006, J MOL BIOL, V355, P124, DOI 10.1016/j.jmb.2005.10.051; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Pappenberger G, 2006, J MOL BIOL, V360, P484, DOI 10.1016/j.jmb.2006.05.003; Roy P, 2001, J CELL BIOL, V153, P1035, DOI 10.1083/jcb.153.5.1035; Shimon L, 2008, J MOL BIOL, V377, P469, DOI 10.1016/j.jmb.2008.01.011; Stirling PC, 2007, MOL BIOL CELL, V18, P2336, DOI 10.1091/mbc.E07-01-0069; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; Villebeck L, 2007, BIOCHEMISTRY-US, V46, P5083, DOI 10.1021/bi062093o; VINH DBN, 1994, P NATL ACAD SCI USA, V91, P9116, DOI 10.1073/pnas.91.19.9116; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Yasunaga T, 2001, J BIOCHEM-TOKYO, V129, P201, DOI 10.1093/oxfordjournals.jbchem.a002844	24	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					178	184		10.1074/jbc.M110.166256	http://dx.doi.org/10.1074/jbc.M110.166256			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21056978	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000285782800019
J	Weems, J; Olson, AL				Weems, Juston; Olson, Ann Louise			Class II Histone Deacetylases Limit GLUT4 Gene Expression during Adipocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSIVE GLUCOSE-TRANSPORTER; MYOCYTE ENHANCER FACTOR-2; TRANSCRIPTIONAL REPRESSION; BINDING PROTEIN; ADIPOSE-TISSUE; MESSENGER-RNA; DB/DB MICE; PROMOTER; MEF2; ACTIVATION	Insulin-dependent glucose homeostasis is highly sensitive to the levels of insulin-responsive glucose transporter 4 (GLUT4) expression in adipocytes. The level of GLUT4 protein expression is highly dependent on the rate of GLUT4 gene transcription. GLUT4 gene transcription is decreased in a variety of physiologic states of insulin resistance including type 2 diabetes, obesity, and prolonged fasting. GLUT4 gene expression in adipocytes is differentiation-dependent, with full expression delayed until late in the differentiation program. In this paper, we have tested the hypothesis that differentiation-dependent GLUT4 gene expression in 3T3-L1 adipocytes is dependent on the nuclear concentration of a class II histone deacetylase (HDAC) protein, HDAC5. We have tested this hypothesis by reducing the levels of class II HDACs in the nuclear compartment of 3T3-L1 preadipocytes using two experimental approaches. First, preadipocytes were treated with phenylephrine, an alpha-adrenergic receptor agonist, to drive HDACS out of the nuclear compartment. Also, the class II HDAC concentrations were reduced using siRNA knockdown. In each case, reduction of nuclear class II HDAC concentration resulted in increased expression of endogenous GLUT4 mRNA in preadipocytes. Together, our data indicate that class II HDAC expression is the major regulatory mechanism for inhibiting GLUT4 expression in the predifferentiated state.	[Weems, Juston; Olson, Ann Louise] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Olson, AL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, POB 26901,BMSB 964, Oklahoma City, OK 73190 USA.	ann-olson@ouhsc.edu			National Institutes of Health [DK081545]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK081545, R01DK081545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK081545.	Armoni M, 2003, J BIOL CHEM, V278, P30614, DOI 10.1074/jbc.M304654200; Belfield JL, 2006, J BIOL CHEM, V281, P27724, DOI 10.1074/jbc.M601485200; BERGER J, 1989, NATURE, V340, P70, DOI 10.1038/340070a0; Brozinick JT, 2001, DIABETES, V50, P593, DOI 10.2337/diabetes.50.3.593; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Charron MJ, 1999, J BIOL CHEM, V274, P3253, DOI 10.1074/jbc.274.6.3253; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Christ-Roberts CY, 2004, METABOLISM, V53, P1233, DOI 10.1016/j.metabol.2004.03.022; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Davis FJ, 2003, J BIOL CHEM, V278, P20047, DOI 10.1074/jbc.M209998200; Eyster CA, 2005, J BIOL CHEM, V280, P17978, DOI 10.1074/jbc.M409806200; FLORESRIVEROS JR, 1993, BIOCHEM BIOPH RES CO, V194, P1148, DOI 10.1006/bbrc.1993.1942; GARVEY WT, 1989, SCIENCE, V245, P60, DOI 10.1126/science.2662408; GERRITS PM, 1993, J BIOL CHEM, V268, P640; GIBBS EM, 1995, J CLIN INVEST, V95, P1512, DOI 10.1172/JCI117823; Griesel BA, 2010, DIABETES, V59, P800, DOI 10.2337/db09-1542; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; KAHN BB, 1988, J CLIN INVEST, V82, P691, DOI 10.1172/JCI113649; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Karnieli E, 2008, AM J PHYSIOL-ENDOC M, V295, pE38, DOI 10.1152/ajpendo.90306.2008; Knight JB, 2003, P NATL ACAD SCI USA, V100, P14725, DOI 10.1073/pnas.2432756100; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; McGee SL, 2004, DIABETES, V53, P1208, DOI 10.2337/diabetes.53.5.1208; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Oshel KM, 2000, J BIOL CHEM, V275, P23666, DOI 10.1074/jbc.M001452200; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; SANTALUCIA T, 1992, ENDOCRINOLOGY, V130, P837, DOI 10.1210/en.130.2.837; SINHA MK, 1991, DIABETES, V40, P472, DOI 10.2337/diabetes.40.4.472; SIVITZ WI, 1989, NATURE, V340, P72, DOI 10.1038/340072a0; Sparling DP, 2008, J BIOL CHEM, V283, P7429, DOI 10.1074/jbc.M800481200; Sparrow DB, 1999, EMBO J, V18, P5085, DOI 10.1093/emboj/18.18.5085; Thai MV, 1998, J BIOL CHEM, V273, P14285, DOI 10.1074/jbc.273.23.14285; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wu ZD, 1998, J CLIN INVEST, V101, P22, DOI 10.1172/JCI1244; Youn HD, 2000, J BIOL CHEM, V275, P22563, DOI 10.1074/jbc.C000304200; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	39	37	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					460	468		10.1074/jbc.M110.157107	http://dx.doi.org/10.1074/jbc.M110.157107			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21047791	hybrid, Green Published			2022-12-25	WOS:000285782800049
J	Zaika, O; Zhang, J; Shapiro, MS				Zaika, Oleg; Zhang, Jie; Shapiro, Mark S.			Combined Phosphoinositide and Ca2+ Signals Mediating Receptor Specificity toward Neuronal Ca2+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE; RAT SYMPATHETIC NEURONS; PHOSPHOLIPASE-C; K+ CHANNELS; MUSCARINIC-RECEPTOR; CALCIUM CHANNELS; KCNQ CHANNELS; BINDING PROTEIN; SENSORY NEURONS; IP3 RECEPTOR	Phosphatidylinositol 4,5-bisphosphate (PIP2) regulates Ca2+ (I-Ca) and M-type K+ currents in superior cervical ganglion sympathetic neurons. In those cells, M-1 muscarinic and AT(1) angiotensin types do not elicit Ca-i(2+) signals and suppress both currents via depletion of PIP2, whereas the B-2 bradykinin and P2Y purinergic types elicit robust IP3-mediated [Ca2+](i) rises and neither deplete PIP2 nor inhibit I-Ca. We have suggested that this specificity arises from differential Ca-i(2+) signals underlying receptor-specific stimulation of PIP2 synthesis by phosphatidylinositol (PI) 4-kinase. Here, we investigate which PI 4-kinase isoform underlies this signal, whether stimulation of PI 4-phosphate 5-kinase is also required, and the origin of receptor-specific Ca-i(2+) signals. Recordings of I-Ca were used as a PIP2 "biosensor." In control, stimulation of M-1, but not B-2 or P2Y, receptors robustly suppressed I-Ca. However, when PI 4-kinase III beta, diacylglycerol kinase, Rho, or Rho-kinase was blocked, agonists of all three receptors robustly suppressed I-Ca. Overexpression of exogenous M-1 receptors yielded large [Ca2+](i) rises by muscarinic agonist, and transfection of wildtype IRBIT decreased Ca-i(2+) signals, whereas dominant negative IRBIT-S68A had little effect on B-2 or P2Y responses but greatly increased muscarinic responses. We conclude that overlaid on microdomain organization is IRBIT, setting a "threshold" for [IP3], assisting in fidelity of receptor specificity.	[Zaika, Oleg; Zhang, Jie; Shapiro, Mark S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Shapiro, MS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, MS 7756,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	shapirom@uthscsa.edu			National Institutes of Health, NINDS [R01 NS43394, ARRA R01 NS065138]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043394, R01NS065138] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grants R01 NS43394 and ARRA R01 NS065138 (to M. S. S.).	Ando H, 2003, J BIOL CHEM, V278, P10602, DOI 10.1074/jbc.M210119200; Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; Balla Tamas, 2009, Curr Protoc Cell Biol, VChapter 24, DOI 10.1002/0471143030.cb2404s42; BEECH DJ, 1992, NEURON, V8, P97, DOI 10.1016/0896-6273(92)90111-P; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; Bender K, 2002, FEBS LETT, V529, P356, DOI 10.1016/S0014-5793(02)03426-9; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; Bofill-Cardona E, 2000, MOL PHARMACOL, V57, P1165; Brown SA, 2008, BIOPHYS J, V95, P1795, DOI 10.1529/biophysj.108.130195; Calvert JA, 2004, BRIT J PHARMACOL, V143, P525, DOI 10.1038/sj.bjp.0705959; Carvou N, 2010, J CELL SCI, V123, P1262, DOI 10.1242/jcs.061986; Chatah NEH, 2001, J BIOL CHEM, V276, P34059, DOI 10.1074/jbc.M104917200; Cho H, 2005, P NATL ACAD SCI USA, V102, P4643, DOI 10.1073/pnas.0408844102; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; Cockcroft S, 2007, BBA-MOL CELL BIOL L, V1771, P677, DOI 10.1016/j.bbalip.2007.03.009; Cruzblanca H, 1998, P NATL ACAD SCI USA, V95, P7151, DOI 10.1073/pnas.95.12.7151; DECOURCELLES DD, 1989, J BIOL CHEM, V264, P3274; del Rio E, 1999, J PHYSIOL-LONDON, V520, P101, DOI 10.1111/j.1469-7793.1999.00101.x; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Delmas P, 2004, TRENDS NEUROSCI, V27, P41, DOI 10.1016/j.tins.2003.10.013; Delmas P, 2002, NEURON, V36, P787, DOI 10.1016/S0896-6273(02)01097-8; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; Devogelaere B, 2007, BIOCHEM J, V407, P303, DOI 10.1042/BJ20070361; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; Downing GJ, 1996, BIOCHEMISTRY-US, V35, P3587, DOI 10.1021/bi9517493; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; Filippov AK, 2006, J NEUROSCI, V26, P9340, DOI 10.1523/JNEUROSCI.2635-06.2006; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2004, J NEUROSCI, V24, P10980, DOI 10.1523/JNEUROSCI.3869-04.2004; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Gamper N, 2007, J PHYSIOL-LONDON, V582, P967, DOI 10.1113/jphysiol.2007.132787; Gamper Nikita, 2006, V337, P27; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; GRONDIN P, 1991, J BIOL CHEM, V266, P15705; Halaszovich CR, 2009, J BIOL CHEM, V284, P2106, DOI 10.1074/jbc.M803543200; Heneghan JF, 2009, J GEN PHYSIOL, V134, P369, DOI 10.1085/jgp.200910203; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; Hernandez CC, 2009, J GEN PHYSIOL, V134, P437, DOI 10.1085/jgp.200910313; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; Jones DH, 2000, J BIOL CHEM, V275, P13962, DOI 10.1074/jbc.C901019199; LASSING I, 1990, FEBS LETT, V262, P231, DOI 10.1016/0014-5793(90)80197-Q; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Linley JE, 2008, J NEUROSCI, V28, P11240, DOI 10.1523/JNEUROSCI.2297-08.2008; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Liu LW, 2008, J CELL PHYSIOL, V216, P91, DOI 10.1002/jcp.21378; Loew LM, 2007, J PHYSIOL-LONDON, V582, P945, DOI 10.1113/jphysiol.2007.132860; Logothetis DE, 2007, J PHYSIOL-LONDON, V582, P953, DOI 10.1113/jphysiol.2007.133157; Mao YS, 2007, PFLUG ARCH EUR J PHY, V455, P5, DOI 10.1007/s00424-007-0286-3; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Mitra-Ganguli T, 2009, J GEN PHYSIOL, V134, P385, DOI 10.1085/jgp.200910204; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Nasuhoglu C, 2002, AM J PHYSIOL-CELL PH, V283, pC223, DOI 10.1152/ajpcell.00486.2001; Pochynyuk O, 2006, J BIOL CHEM, V281, P26520, DOI 10.1074/jbc.M603716200; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Ren XD, 1996, MOL BIOL CELL, V7, P435, DOI 10.1091/mbc.7.3.435; Roberts-Crowley ML, 2009, CELL CALCIUM, V45, P589, DOI 10.1016/j.ceca.2009.03.015; Santarius M, 2006, BIOCHEM J, V398, P1, DOI 10.1042/BJ20060565; SEKAR MC, 1984, BIOCHEM J, V223, P527, DOI 10.1042/bj2230527; Shapiro MS, 2000, J NEUROSCI, V20, P1710; SHAPIRO MS, 1994, NEURON, V12, P1319, DOI 10.1016/0896-6273(94)90447-2; Sohn JW, 2007, J PHYSIOL-LONDON, V580, P411, DOI 10.1113/jphysiol.2006.125914; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Suh BC, 2004, J GEN PHYSIOL, V123, P663, DOI 10.1085/jgp.200409029; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2007, J PHYSIOL-LONDON, V582, P911, DOI 10.1113/jphysiol.2007.132647; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Suh BC, 2010, NEURON, V67, P224, DOI 10.1016/j.neuron.2010.07.001; Tolias KF, 1998, MOL CELL BIOL, V18, P762, DOI 10.1128/MCB.18.2.762; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200; WANKE E, 1987, P NATL ACAD SCI USA, V84, P4313, DOI 10.1073/pnas.84.12.4313; Weernink PAO, 2000, J BIOL CHEM, V275, P10168, DOI 10.1074/jbc.275.14.10168; Weernink PAO, 2004, J BIOL CHEM, V279, P7840, DOI 10.1074/jbc.M312737200; Weernink PAO, 2007, BBA-BIOMEMBRANES, V1768, P888, DOI 10.1016/j.bbamem.2006.09.012; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Willars GB, 1998, J BIOL CHEM, V273, P5037, DOI 10.1074/jbc.273.9.5037; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Xu C, 2003, J CELL BIOL, V161, P779, DOI 10.1083/jcb.200301070; Zaika O, 2007, J NEUROSCI, V27, P8914, DOI 10.1523/JNEUROSCI.1739-07.2007; Zaika O, 2006, J PHYSIOL-LONDON, V575, P49, DOI 10.1113/jphysiol.2006.114074; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhao XH, 2000, J BIOL CHEM, V275, P14642, DOI 10.1074/jbc.275.19.14642; Zhao XH, 2001, J BIOL CHEM, V276, P40183, DOI 10.1074/jbc.M104048200; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	92	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					830	841		10.1074/jbc.M110.166033	http://dx.doi.org/10.1074/jbc.M110.166033			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21051544	hybrid, Green Published			2022-12-25	WOS:000285782800082
J	Pino-Yanes, M; Corrales, A; Casula, M; Blanco, J; Muriel, A; Espinosa, E; Garcia-Bello, M; Torres, A; Ferrer, M; Zavala, E; Villar, J; Flores, C				Pino-Yanes, Maria; Corrales, Almudena; Casula, Milena; Blanco, Jesus; Muriel, Arturo; Espinosa, Elena; Garcia-Bello, Miguel; Torres, Antoni; Ferrer, Miguel; Zavala, Elizabeth; Villar, Jesus; Flores, Carlos		GRECIA Grp; GEN SEP Grp	Common Variants of TLR1 Associate with Organ Dysfunction and Sustained Pro-Inflammatory Responses during Sepsis	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; INNATE IMMUNITY; POLYMORPHISM; RECEPTOR; HAPLOTYPE; OUTCOMES; DEFINITIONS; LEPROSY; GENE; SET	Background: Toll-like receptors (TLRs) are critical components for host pathogen recognition and variants in genes participating in this response influence susceptibility to infections. Recently, TLR1 gene polymorphisms have been found correlated with whole blood hyper-inflammatory responses to pathogen-associated molecules and associated with sepsis-associated multiorgan dysfunction and acute lung injury (ALI). We examined the association of common variants of TLR1 gene with sepsis-derived complications in an independent study and with serum levels for four inflammatory biomarkers among septic patients. Methodology/Principal Findings: Seven tagging single nucleotide polymorphisms of the TLR1 gene were genotyped in samples from a prospective multicenter case-only study of patients with severe sepsis admitted into a network of intensive care units followed for disease severity. Interleukin (IL)-1 beta, IL-6, IL-10, and C-reactive protein (CRP) serum levels were measured at study entry, at 48 h and at 7(th) day. Alleles-7202G and 248Ser, and the 248Ser-602Ile haplotype were associated with circulatory dysfunction among severe septic patients (0.001 <= p <= 0.022), and with reduced IL-10 (0.012 <= p <= 0.047) and elevated CRP (0.011 <= p <= 0.036) serum levels during the first week of sepsis development. Additionally, the -7202GG genotype was found to be associated with hospital mortality (p = 0.017) and ALI (p = 0.050) in a combined analysis with European Americans, suggesting common risk effects among studies. Conclusions/Significance: These results partially replicate and extend previous findings, supporting that variants of TLR1 gene are determinants of severe complications during sepsis.	[Pino-Yanes, Maria; Corrales, Almudena; Casula, Milena; Blanco, Jesus; Muriel, Arturo; Torres, Antoni; Ferrer, Miguel; Zavala, Elizabeth; Villar, Jesus; Flores, Carlos] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Pino-Yanes, Maria; Corrales, Almudena; Flores, Carlos] Hosp Univ NS de Candelaria, Res Unit, Tenerife, Spain; [Casula, Milena; Garcia-Bello, Miguel; Villar, Jesus] Hosp Univ Dr Negrin, Multidisciplinary Organ Dysfunct Evaluat Res Netw, Res Unit, Las Palmas Gran Canaria, Spain; [Espinosa, Elena] Hosp Univ NS de Candelaria, Dept Anaesthesia, Tenerife, Spain; [Torres, Antoni; Ferrer, Miguel] Hosp Clin Barcelona, Dept Pneumol, Clin Inst Thorax, Barcelona, Spain; [Torres, Antoni; Ferrer, Miguel] Univ Barcelona, IDIBAPS, Barcelona, Spain; [Zavala, Elizabeth] Hosp Clin Barcelona, Dept Anesthesia, Surg Intens Care Unit, Barcelona, Spain; [Villar, Jesus] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Pino-Yanes, M (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain.	jesus.villar54@gmail.com; cflores@ull.es	Flores, Carlos/R-1159-2019; Casula, Milena/AAA-7461-2019; Villar, Jesús/R-4526-2019; Pino-Yanes, Maria/C-8498-2017; Torres, Antoni/H-6128-2017; Corrales, Almudena/G-5391-2017; Garcia-Bello, Miguel-Angel/F-7436-2016	Villar, Jesús/0000-0001-5687-3562; Pino-Yanes, Maria/0000-0003-0332-437X; Torres, Antoni/0000-0002-8643-2167; Corrales, Almudena/0000-0002-2207-5463; Flores, Carlos/0000-0001-5352-069X; Ferrer, Miguel/0000-0001-8171-6673; CASULA, Milena/0000-0002-5079-9864; Garcia-Bello, Miguel-Angel/0000-0001-6913-2552	Ministry of Science of Spain [SAF 2004-06833]; Fundacion Canaria de Investigacion y Salud [53/04]; Instituto de Salud Carlos III and Gobierno de Canarias [EMER07/001]	Ministry of Science of Spain(Spanish Government); Fundacion Canaria de Investigacion y Salud; Instituto de Salud Carlos III and Gobierno de Canarias	This work was supported by grants from Ministry of Science of Spain (SAF 2004-06833), Fundacion Canaria de Investigacion y Salud (53/04), and by a specific agreement between Instituto de Salud Carlos III and Gobierno de Canarias (EMER07/001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi KR, 2005, NAT GENET, V37, P84, DOI 10.1038/ng1488; Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Arcaroli J, 2006, AM J RESP CRIT CARE, V173, P1335, DOI 10.1164/rccm.200603-341OC; Aziz RK, 2007, GENES IMMUN, V8, P404, DOI 10.1038/sj.gene.6364402; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; Clark MF, 2006, INTENS CARE MED, V32, P1706, DOI 10.1007/s00134-006-0327-y; de Craen AJM, 2005, GENES IMMUN, V6, P167, DOI 10.1038/sj.gene.6364162; de Leon AC, 2008, REV ESP SALUD PUBLIC, V82, P519, DOI 10.1590/S1135-57272008000500007; Flores C, 2009, CRIT CARE MED, V37, P2759, DOI 10.1097/CCM.0b013e3181a57b90; Flores C, 2008, CRIT CARE, V12, DOI 10.1186/cc7098; Georgel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007803; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Hamann L, 2010, INFECT GENET EVOL, V10, P785, DOI 10.1016/j.meegid.2010.05.005; Hawn TR, 2007, EUR J IMMUNOL, V37, P2280, DOI 10.1002/eji.200737034; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Misch EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000231; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Schuring RP, 2009, J INFECT DIS, V199, P1816, DOI 10.1086/599121; SHEY MS, GENES IMMUN IN PRESS; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tregouet DA, 2004, ANN HUM GENET, V68, P165, DOI 10.1046/j.1529-8817.2003.00085.x; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Villar J, 2007, CRIT CARE MED, V35, P2292, DOI 10.1097/01.CCM.0000284511.73556.59; Villar J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006818; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Wang K, 2009, GENET EPIDEMIOL, V33, P637, DOI 10.1002/gepi.20415; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wurfel MM, 2008, AM J RESP CRIT CARE, V178, P710, DOI 10.1164/rccm.200803-462OC; Wurfel MM, 2005, J IMMUNOL, V175, P2570, DOI 10.4049/jimmunol.175.4.2570	39	36	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13759	10.1371/journal.pone.0013759	http://dx.doi.org/10.1371/journal.pone.0013759			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048935	Green Published, Green Submitted, gold			2022-12-25	WOS:000283645300038
J	Yoshida, S; Nagumo, H; Yokomine, T; Araki, H; Suzuki, A; Matsuoka, H				Yoshida, Shigeto; Nagumo, Hiroshi; Yokomine, Takashi; Araki, Hitomi; Suzuki, Ayaka; Matsuoka, Hiroyuki			Plasmodium berghei Circumvents Immune Responses Induced by Merozoite Surface Protein 1-and Apical Membrane Antigen 1-Based Vaccines	PLOS ONE			English	Article							CARBOXYL-TERMINAL FRAGMENT; GROWTH-INHIBITORY ANTIBODIES; BLOOD-STAGE INFECTION; MALARIA VACCINE; ERYTHROCYTE INVASION; PARASITE GROWTH; CIRCUMSPOROZOITE PROTEIN; RODENT MALARIA; DOMAIN-III; IN-VITRO	Background: Two current leading malaria blood-stage vaccine candidate antigens for Plasmodium falciparum, the C-terminal region of merozoite surface protein 1 (MSP1(19)) and apical membrane antigen 1 (AMA1), have been prioritized because of outstanding protective efficacies achieved in a rodent malaria Plasmodium yoelii model. However, P. falciparum vaccines based on these antigens have had disappointing outcomes in clinical trials. Discrepancies in the vaccine efficacies observed between the P. yoelii model and human clinical trials still remain problematic. Methodology and Results: In this study, we assessed the protective efficacies of a series of MSP1(19)- and AMA1-based vaccines using the P. berghei rodent malarial parasite and its transgenic models. Immunization of mice with a baculoviral-based vaccine (BBV) expressing P. falciparum MSP1(19) induced high titers of PfMSP1(19)-specific antibodies that strongly reacted with P. falciparum blood-stage parasites. However, no protection was achieved following lethal challenge with transgenic P. berghei expressing PfMSP1(19) in place of native PbMSP1(19). Similarly, neither P. berghei MSP1(19)- nor AMA1-BBV was effective against P. berghei. In contrast, immunization with P. yoelii MSP1(19)- and AMA1-BBVs provided 100% and 40% protection, respectively, against P. yoelii lethal challenge. Mice that naturally acquired sterile immunity against P. berghei became cross-resistant to P. yoelii, but not vice versa. Conclusion: This is the first study to address blood-stage vaccine efficacies using both P. berghei and P. yoelii models at the same time. P. berghei completely circumvents immune responses induced by MSP1(19)- and AMA1-based vaccines, suggesting that P. berghei possesses additional molecules and/or mechanisms that circumvent the host's immune responses to MSP1(19) and AMA1, which are lacking in P. yoelii. Although it is not known whether P. falciparum shares these escape mechanisms with P. berghei, P. berghei and its transgenic models may have potential as useful tools for identifying and evaluating new blood-stage vaccine candidate antigens for P. falciparum.	[Yoshida, Shigeto; Nagumo, Hiroshi; Yokomine, Takashi; Araki, Hitomi; Suzuki, Ayaka; Matsuoka, Hiroyuki] Jichi Med Univ, Div Med Zool, Dept Infect & Immun, Shimotsuke, Tochigi, Japan	Jichi Medical University	Yoshida, S (corresponding author), Kanazawa Univ, Lab Vaccinol & Appl Immunol, Sch Med Sci, Kanazawa, Ishikawa, Japan.	shigeto@p.kanazawa-u.ac.jp		Matsuoka, Hiroyuki/0000-0001-8839-0012	Ministry of Education, Culture, Sports and Science of Japan [21390126]	Ministry of Education, Culture, Sports and Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports and Science of Japan (21390126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlborg N, 2002, INFECT IMMUN, V70, P820, DOI 10.1128/IAI.70.2.820-825.2002; Badell E, 2000, J EXP MED, V192, P1653, DOI 10.1084/jem.192.11.1653; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; BLAGBOROUGH AM, 2010, VACCINE IN PRESS; Cao Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006894; CHANG SP, 1992, J IMMUNOL, V149, P548; DALY TM, 1995, J IMMUNOL, V155, P236; DALY TM, 1993, INFECT IMMUN, V61, P2462, DOI 10.1128/IAI.61.6.2462-2467.1993; de Koning-Ward TF, 2003, J EXP MED, V198, P869, DOI 10.1084/jem.20030085; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; Fraser TS, 2001, MOL BIOCHEM PARASIT, V117, P49, DOI 10.1016/S0166-6851(01)00326-7; Hirunpetcharat C, 1999, J IMMUNOL, V162, P7309; Hodder AN, 1996, J BIOL CHEM, V271, P29446, DOI 10.1074/jbc.271.46.29446; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; HOLDER AA, 1994, BIOCHEM SOC T, V22, P291, DOI 10.1042/bst0220291; HOLDER AA, 1988, PROG ALLERGY, V41, P72; Holder Anthony A., 1996, P77; Jennings VM, 1998, INFECT IMMUN, V66, P5972, DOI 10.1128/IAI.66.12.5972-5979.1998; Kato K, 2005, P NATL ACAD SCI USA, V102, P5552, DOI 10.1073/pnas.0501594102; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Lyon JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002830; Mambo G, 2008, INFECT IMMUN, V76, P2018, DOI 10.1128/IAI.01409-07; MCCOLM AA, 1983, ANN TROP MED PARASIT, V77, P355, DOI 10.1080/00034983.1983.11811724; McIntosh RS, 2007, PLOS PATHOG, V3, P647, DOI 10.1371/journal.ppat.0030072; MILLER LH, 1993, MOL BIOCHEM PARASIT, V59, P1, DOI 10.1016/0166-6851(93)90002-F; MLAMBO G, 2010, VACCINE IN PRESS; Morgan WD, 1999, J MOL BIOL, V289, P113, DOI 10.1006/jmbi.1999.2753; Mueller MS, 2003, INFECT IMMUN, V71, P4749, DOI 10.1128/IAI.71.8.4749-4758.2003; Murhandarwati EEH, 2010, INFECT IMMUN, V78, P680, DOI 10.1128/IAI.00939-09; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; Near KA, 2002, INFECT IMMUN, V70, P692, DOI 10.1128/IAI.70.2.692-701.2002; Persson C, 2002, J IMMUNOL, V169, P6681, DOI 10.4049/jimmunol.169.12.6681; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Ramjanee S, 2007, VACCINE, V25, P886, DOI 10.1016/j.vaccine.2006.09.035; Reed ZH, 2009, VACCINE, V27, P1651, DOI 10.1016/j.vaccine.2008.10.093; Rotman HL, 1998, J IMMUNOL, V161, P1908; Saul A, 2005, VACCINE, V23, P3076, DOI 10.1016/j.vaccine.2004.09.040; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Tanabe K, 2000, GENE, V241, P325, DOI 10.1016/S0378-1119(99)00472-2; Tian JH, 1996, J IMMUNOL, V157, P1176; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Wykes MN, 2005, J IMMUNOL, V175, P2510, DOI 10.4049/jimmunol.175.4.2510; Yoneto T, 2001, J IMMUNOL, V166, P6236, DOI 10.4049/jimmunol.166.10.6236; Yoshida S, 2003, VIROLOGY, V316, P161, DOI 10.1016/j.virol.2003.08.003; Yoshida S, 2003, BLOOD, V101, P2300, DOI 10.1182/blood-2002-03-0831; Yoshida S, 2010, INFECT IMMUN, V78, P595, DOI 10.1128/IAI.00877-09	49	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13727	10.1371/journal.pone.0013727	http://dx.doi.org/10.1371/journal.pone.0013727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060850	Green Published, Green Submitted, gold			2022-12-25	WOS:000283573800021
J	Monk, CE; Hutvagner, G; Arthur, JSC				Monk, Claire E.; Hutvagner, Gyoergy; Arthur, J. Simon C.			Regulation of miRNA Transcription in Macrophages in Response to Candida albicans	PLOS ONE			English	Article							KAPPA-B-KINASE; RECOGNITION; ACTIVATION; EXPRESSION; INHIBITOR; MSK1; AP-1; LIPOPOLYSACCHARIDE; MICRORNA-155; RECEPTORS	Macrophages detect pathogens via pattern recognition receptors (PRRs), which trigger several intracellular signaling cascades including the MAPK and NFkB pathways. These in turn mediate the up-regulation of pro-inflammatory cytokines that are essential to combat the pathogen. However as the over-production of pro-inflammatory cytokines results in tissue damage or septic shock, precise control of these signaling pathways is essential and achieved via the induction of multiple negative feedback mechanisms. miRNAs are small regulatory RNAs that are able to affect protein expression, via the regulation of either mRNA stability or translation. Up-regulation of specific miRNAs could have the potential to modulate PRR signaling, as has been shown for both miR-146 and miR-155. Here we have analysed which miRNAs are up-regulated in mouse macrophages in response to the fungal pathogen heat killed Candida albicans and compared the profile to that obtained with the TLR4 ligand LPS. We found that in addition to miR-146 and miR-155, both Candida albicans and LPS were also able to up-regulate miR-455 and miR-125a. Analysis of the signaling pathways required showed that NFkB was necessary for the transcription of all 4 pri-miRNAs, while the ERK1/2 and p38 MAPK pathways were also required for pri-miR-125a transcription. In addition the anti-inflammatory cytokine IL-10 was found to be able to induce miR-146a and b, but inhibited miR-155 induction. These results suggest that miR-455, miR-125, miR-146 and miR-155 may play important roles in regulating macrophage function following PRR stimulation.	[Monk, Claire E.; Arthur, J. Simon C.] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat Unit, Dundee, Scotland; [Hutvagner, Gyoergy] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee, Scotland	University of Dundee; University of Dundee	Monk, CE (corresponding author), Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat Unit, Sir James Black Complex, Dundee, Scotland.	j.s.c.arthur@dundee.ac.uk	Arthur, J. Simon/B-8058-2010	Arthur, J. Simon/0000-0002-8135-1958; Hutvagner, Gyorgy/0000-0002-7231-9446	United Kingdom Medical Research Council; Wellcome Trust; EU; AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Merck-Serono; Pfizer; MRC [MC_U127081014] Funding Source: UKRI; Medical Research Council [MC_U127081014] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck-Serono(Merck & Company); Pfizer(Pfizer); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by the United Kingdom Medical Research Council, Wellcome Trust, EU FP6 (SIROCCO), AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck-Serono, and Pfizer. GH holds a Wellcome Trust Career Development Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Darragh J, 2010, BIOCHEM J, V425, P595, DOI 10.1042/BJ20091062; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lam LT, 2005, CLIN CANCER RES, V11, P28; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Martinez-Nunez RT, 2009, J BIOL CHEM, V284, P16334, DOI 10.1074/jbc.M109.011601; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Motsch N, 2007, RNA BIOL, V4, P131, DOI 10.4161/rna.4.3.5206; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Underhill DM, 2007, IMMUNOL REV, V219, P75, DOI 10.1111/j.1600-065X.2007.00548.x; Waterfield M, 2004, MOL CELL BIOL, V24, P6040, DOI 10.1128/MCB.24.13.6040-6048.2004; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681; Ziegelbauer K, 2005, BRIT J PHARMACOL, V145, P178, DOI 10.1038/sj.bjp.0706176	35	98	103	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13669	10.1371/journal.pone.0013669	http://dx.doi.org/10.1371/journal.pone.0013669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060679	Green Published, gold			2022-12-25	WOS:000283537000037
J	Pungaliya, PP; Bai, YC; Lipinski, K; Anand, VS; Sen, S; Brown, EL; Bates, B; Reinhart, PH; West, AB; Hirst, WD; Braithwaite, SP				Pungaliya, Pooja P.; Bai, Yuchen; Lipinski, Kerri; Anand, Vasanti S.; Sen, Saurabh; Brown, Eugene L.; Bates, Brian; Reinhart, Peter H.; West, Andrew B.; Hirst, Warren D.; Braithwaite, Steven P.			Identification and Characterization of a Leucine-Rich Repeat Kinase 2 (LRRK2) Consensus Phosphorylation Motif	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; FAMILIAL PARKINSONS-DISEASE; RAS P21 PROTEIN; ALPHA-SYNUCLEIN; LEUCINE-RICH-REPEAT-KINASE-2 LRRK2; NEURONAL TOXICITY; UBIQUITIN LIGASE; CELLULAR-MODEL; GTP-BINDING; GENE	Mutations in LRRK2 (leucine-rich repeat kinase 2) have been identified as major genetic determinants of Parkinson's disease (PD). The most prevalent mutation, G2019S, increases LRRK2's kinase activity, therefore understanding the sites and substrates that LRRK2 phosphorylates is critical to understanding its role in disease aetiology. Since the physiological substrates of this kinase are unknown, we set out to reveal potential targets of LRRK2 G2019S by identifying its favored phosphorylation motif. A non-biased screen of an oriented peptide library elucidated F/Y-x-T-x-R/K as the core dependent substrate sequence. Bioinformatic analysis of the consensus phosphorylation motif identified several novel candidate substrates that potentially function in neuronal pathophysiology. Peptides corresponding to the most PD relevant proteins were efficiently phosphorylated by LRRK2 in vitro. Interestingly, the phosphomotif was also identified within LRRK2 itself. Autophosphorylation was detected by mass spectrometry and biochemical means at the only F-x-T-x-R site (Thr 1410) within LRRK2. The relevance of this site was assessed by measuring effects of mutations on autophosphorylation, kinase activity, GTP binding, GTP hydrolysis, and LRRK2 multimerization. These studies indicate that modification of Thr1410 subtly regulates GTP hydrolysis by LRRK2, but with minimal effects on other parameters measured. Together the identification of LRRK2's phosphorylation consensus motif, and the functional consequences of its phosphorylation, provide insights into downstream LRRK2-signaling pathways.	[Pungaliya, Pooja P.; Bai, Yuchen; Brown, Eugene L.; Bates, Brian] Pfizer Inc, Global Biotherapeut Technol, Cambridge, MA USA; [Lipinski, Kerri; Anand, Vasanti S.; Reinhart, Peter H.; Hirst, Warren D.; Braithwaite, Steven P.] Pfizer Inc, Neurosci Res Unit, Princeton, NJ USA; [Sen, Saurabh; West, Andrew B.] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA	Pfizer; Pfizer; University of Alabama System; University of Alabama Birmingham	Pungaliya, PP (corresponding author), Pfizer Inc, Global Biotherapeut Technol, Cambridge, MA USA.	pooja.pungaliya@pfizer.com		West, Andrew/0000-0002-3034-4061; Hirst, Warren/0000-0003-0389-8891; Reinhart, Peter/0000-0003-0123-7846	Michael J. Fox Foundation; Pfizer, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064934] Funding Source: NIH RePORTER	Michael J. Fox Foundation; Pfizer, Inc.(Pfizer); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful for grant support from the Michael J. Fox Foundation. The Michael J. Fox Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was funded by Pfizer, Inc. The company had a role in this study due to employment of one or more authors of this study.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Alegre-Abarrategui J, 2009, HUM MOL GENET, V18, P4022, DOI 10.1093/hmg/ddp346; Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; Bembom O, 2007, STAT APPL GENET MOL, V6; Biskup S, 2008, J NEUROL, V255, P8, DOI 10.1007/s00415-008-5005-2; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dehmelt L, 2005, GENOME BIOL, V6; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dorsey FC, 2009, J PROTEOME RES, V8, P5253, DOI 10.1021/pr900583m; Fujii K, 2004, P NATL ACAD SCI USA, V101, P13744, DOI 10.1073/pnas.0401881101; Garcia-Regalado A, 2008, MOL BIOL CELL, V19, P4188, DOI 10.1091/mbc.E07-10-1089; Giasson BI, 2008, NEUROSIGNALS, V16, P99, DOI 10.1159/000109764; Gloeckner CJ, 2010, J PROTEOME RES, V9, P1738, DOI 10.1021/pr9008578; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Ho CCY, 2009, J NEUROSCI, V29, P1011, DOI 10.1523/JNEUROSCI.5175-08.2009; HUANG Q, APOPTOSIS; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Klein CL, 2009, J NEUROCHEM, V111, P703, DOI 10.1111/j.1471-4159.2009.06358.x; KUMAR A, PLOS ONE, V5, pE8730; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; LIU M, BIOCHEMISTRY, V49, P2008; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Lower BH, 2000, J BACTERIOL, V182, P3452, DOI 10.1128/JB.182.12.3452-3459.2000; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; MCGRATH JP, 1984, NATURE, V310, P644, DOI 10.1038/310644a0; Mishra L, 1997, ONCOGENE, V15, P2361, DOI 10.1038/sj.onc.1201405; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Quan A, 2005, METHOD ENZYMOL, V404, P556, DOI 10.1016/S0076-6879(05)04049-8; Richter K, 2009, J BIOL CHEM, V284, P30652, DOI 10.1074/jbc.M109.014506; Roach ES, 2007, ARCH NEUROL-CHICAGO, V64, P143, DOI 10.1001/archneur.64.1.143; Roger B, 2004, CURR BIOL, V14, P363, DOI 10.1016/j.cub.2004.01.058; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sasaki A, 2002, J BIOL CHEM, V277, P22541, DOI 10.1074/jbc.M109728200; Schaefer EM, 1998, ANAL BIOCHEM, V261, P100, DOI 10.1006/abio.1998.2716; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schulz JB, 1999, CURR OPIN NEUROL, V12, P433, DOI 10.1097/00019052-199908000-00010; Schulz JB, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-5011-4; SEN S, 2009, J BIOL CHEM; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; TRAHEY M, 1987, MOL CELL BIOL, V7, P541, DOI 10.1128/MCB.7.1.541; Tu C, 2009, P NATL ACAD SCI USA, V106, P14843, DOI 10.1073/pnas.0904032106; Turk BE, 2006, NAT PROTOC, V1, P375, DOI 10.1038/nprot.2006.57; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; XIONG Y, PLOS GENET, V6; Yang DQ, 2000, NAT CELL BIOL, V2, P893, DOI 10.1038/35046542; Yu P, 2002, GENOMICS, V79, P869, DOI 10.1006/geno.2002.6770; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9; Zimprich A, 2004, AM J HUM GENET, V74, P11, DOI 10.1086/380647	75	55	56	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13672	10.1371/journal.pone.0013672	http://dx.doi.org/10.1371/journal.pone.0013672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060682	gold, Green Published, Green Submitted			2022-12-25	WOS:000283537000039
J	Vanneste, S; Plazier, M; van der Loo, E; Van de Heyning, P; De Ridder, D				Vanneste, Sven; Plazier, Mark; van der Loo, Elsa; Van de Heyning, Paul; De Ridder, Dirk			The Differences in Brain Activity between Narrow Band Noise and Pure Tone Tinnitus	PLOS ONE			English	Article							AUDITORY-CORTEX; ELECTROMAGNETIC TOMOGRAPHY; ANTERIOR THALAMUS; RHESUS-MONKEY; PARAHIPPOCAMPAL REGION; CORTICAL AFFERENTS; NEURAL MECHANISMS; CINGULATE CORTEX; STIMULATION; PET	Background: Tinnitus is an auditory sensation characterized by the perception of sound or noise in the absence of any external sound source. Based on neurobiological research, it is generally accepted that most forms of tinnitus are attributable to maladaptive plasticity due to damage to auditory system. Changes have been observed in auditory structures such as the inferior colliculus, the thalamus and the auditory cortex as well as in non-auditory brain areas. However, the observed changes show great variability, hence lacking a conclusive picture. One of the reasons might be the selection of inhomogeneous groups in data analysis. Methodology: The aim of the present study was to delineate the differences between the neural networks involved in narrow band noise and pure tone tinnitus conducting LORETA based source analysis of resting state EEG. Conclusions: Results demonstrated that narrow band noise tinnitus patients differ from pure tone tinnitus patients in the lateral frontopolar (BA 10), PCC and the parahippocampal area for delta, beta and gamma frequency bands, respectively. The parahippocampal-PCC current density differences might be load dependent, as noise-like tinnitus constitutes multiple frequencies in contrast to pure tone tinnitus. The lateral frontopolar differences might be related to pitch specific memory retrieval.	[Vanneste, Sven; Plazier, Mark; van der Loo, Elsa; Van de Heyning, Paul; De Ridder, Dirk] Univ Antwerp Hosp, TRI, Edegem, Belgium; [Vanneste, Sven; Plazier, Mark; van der Loo, Elsa; De Ridder, Dirk] Univ Antwerp Hosp, Dept Neurosurg, Edegem, Belgium; [Van de Heyning, Paul] Univ Antwerp Hosp, ENT, Edegem, Belgium	University of Antwerp; University of Antwerp; University of Antwerp	Vanneste, S (corresponding author), Univ Antwerp Hosp, TRI, Edegem, Belgium.	sven.vanneste@ua.ac.be	Heyning, Paul H Vande/I-8278-2017	Heyning, Paul H Vande/0000-0002-8424-3717; Vanneste, Sven/0000-0003-1513-5752	Tinnitus Research Initiative (TRI)	Tinnitus Research Initiative (TRI)	This research was supported by a grant of the Tinnitus Research Initiative (TRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Andersson G, 2000, ACTA OTO-LARYNGOL, V120, P967, DOI 10.1080/00016480050218717; Arnold W, 1996, ORL J OTO-RHINO-LARY, V58, P195, DOI 10.1159/000276835; Ashton H, 2007, NEUROSCI LETT, V426, P23, DOI 10.1016/j.neulet.2007.08.034; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Babiloni C, 2006, HUM BRAIN MAPP, V27, P162, DOI 10.1002/hbm.20175; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Boutros NN, 2008, HIPPOCAMPUS, V18, P310, DOI 10.1002/hipo.20388; BUNSEY M, 1993, BEHAV NEUROSCI, V107, P740, DOI 10.1037/0735-7044.107.5.740; Cacace AT, 1999, AUDIOL NEURO-OTOL, V4, P258, DOI 10.1159/000013849; Congedo M., 2002, EUREKA VERSION 3 0 C; De Ridder D., 2009, J NEUROSURG; De Ridder Dirk, 2007, Int J Med Sci, V4, P242; De Ridder Dirk, 2007, Int J Med Sci, V4, P237; Dierks T, 2000, CLIN NEUROPHYSIOL, V111, P1817, DOI 10.1016/S1388-2457(00)00427-2; Eichhammer P, 2003, BIOL PSYCHIAT, V54, P862, DOI 10.1016/S0006-3223(02)01896-6; Engelien A, 2000, ANN NY ACAD SCI, V911, P477; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Goycoolea M, 2005, ACTA OTO-LARYNGOL, V125, P513, DOI 10.1080/00016480510026250; Hall NM, 2008, BEHAV BRAIN RES, V186, P261, DOI 10.1016/j.bbr.2007.08.026; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kobayashi Y, 2003, J COMP NEUROL, V466, P48, DOI 10.1002/cne.10883; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Lockwood AH, 1999, SCAND AUDIOL, V28, P47; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; MEEUS O, 2009, OTOL NEUROTOL; Mirz F, 1999, HEARING RES, V134, P133, DOI 10.1016/S0378-5955(99)00075-1; Mirz F, 2000, NEUROREPORT, V11, P633, DOI 10.1097/00001756-200002280-00039; Moazami-Goudarzi M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-40; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Mulert C, 2004, NEUROIMAGE, V22, P83, DOI 10.1016/j.neuroimage.2003.10.051; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Pizzagalli DA, 2004, MOL PSYCHIATR, V9, P393, DOI 10.1038/sj.mp.4001469; Rauschecker JP, 2004, J NEUROPHYSIOL, V91, P2578, DOI 10.1152/jn.00834.2003; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; ROUILLER EM, 1990, EXP BRAIN RES, V80, P501, DOI 10.1007/BF00227991; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; Smits M, 2007, NEURORADIOLOGY, V49, P669, DOI 10.1007/s00234-007-0231-3; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; van der Loo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007396; VANNESTE S, 2010, EUR J NEUROL; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Vitacco D, 2002, HUM BRAIN MAPP, V17, P4, DOI 10.1002/hbm.10038; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208; Volpe U, 2007, BRAIN RES BULL, V73, P220, DOI 10.1016/j.brainresbull.2007.03.003; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; Weisz N, 2007, PROG BRAIN RES, V166, P61, DOI 10.1016/S0079-6123(07)66006-3; Worrell GA, 2000, BRAIN TOPOGR, V12, P273, DOI 10.1023/A:1023407521772; Zatorre RJ, 2001, ANN NY ACAD SCI, V930, P193, DOI 10.1111/j.1749-6632.2001.tb05734.x; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P4355; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P192, DOI 10.1016/j.clinph.2005.09.015; Zumsteg D, 2005, NEUROLOGY, V65, P1657, DOI 10.1212/01.wnl.0000184516.32369.1a; Zumsteg D, 2006, EPILEPSIA, V47, P1958, DOI 10.1111/j.1528-1167.2006.00824.x; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P1602, DOI 10.1016/j.clinph.2006.04.008	61	51	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13618	10.1371/journal.pone.0013618	http://dx.doi.org/10.1371/journal.pone.0013618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048975	Green Published, gold, Green Submitted			2022-12-25	WOS:000283537000016
J	Otero, JM; Papadakis, MA; Udatha, DBRKG; Nielsen, J; Panagiotou, G				Otero, Jose M.; Papadakis, Manos A.; Udatha, D. B. R. K. Gupta; Nielsen, Jens; Panagiotou, Gianni			Yeast Biological Networks Unfold the Interplay of Antioxidants, Genome and Phenotype, and Reveal a Novel Regulator of the Oxidative Stress Response	PLOS ONE			English	Article							FERULIC ACID; SACCHAROMYCES-CEREVISIAE; FUNGICIDE MANCOZEB; BINDING-SITES; PROTEIN; DOCKING; IDENTIFICATION; GROWTH; MECHANISMS; PREDICTION	Background: Identifying causative biological networks associated with relevant phenotypes is essential in the field of systems biology. We used ferulic acid (FA) as a model antioxidant to characterize the global expression programs triggered by this small molecule and decipher the transcriptional network controlling the phenotypic adaptation of the yeast Saccharomyces cerevisiae. Methodology/Principal Findings: By employing a strict cut off value during gene expression data analysis, 106 genes were found to be involved in the cell response to FA, independent of aerobic or anaerobic conditions. Network analysis of the system guided us to a key target node, the FMP43 protein, that when deleted resulted in marked acceleration of cellular growth (similar to 15% in both minimal and rich media). To extend our findings to human cells and identify proteins that could serve as drug targets, we replaced the yeast FMP43 protein with its human ortholog BRP44 in the genetic background of the yeast strain Delta fmp43. The conservation of the two proteins was phenotypically evident, with BRP44 restoring the normal specific growth rate of the wild type. We also applied homology modeling to predict the 3D structure of the FMP43 and BRP44 proteins. The binding sites in the homology models of FMP43 and BRP44 were computationally predicted, and further docking studies were performed using FA as the ligand. The docking studies demonstrated the affinity of FA towards both FMP43 and BRP44. Conclusions: This study proposes a hypothesis on the mechanisms yeast employs to respond to antioxidant molecules, while demonstrating how phenome and metabolome yeast data can serve as biomarkers for nutraceutical discovery and development. Additionally, we provide evidence for a putative therapeutic target, revealed by replacing the FMP43 protein with its human ortholog BRP44, a brain protein, and functionally characterizing the relevant mutant strain.	[Otero, Jose M.; Panagiotou, Gianni] Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Papadakis, Manos A.; Panagiotou, Gianni] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Otero, Jose M.; Udatha, D. B. R. K. Gupta; Nielsen, Jens] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden	Technical University of Denmark; Technical University of Denmark; Chalmers University of Technology	Otero, JM (corresponding author), Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark.	gpa@bio.dtu.dk	Panagiotou, Ioannis/B-7083-2013; Udatha, D.B.R.K. Gupta/B-1544-2012; Nielsen, Jens/Q-1347-2017	Udatha, D.B.R.K. Gupta/0000-0003-0163-9407; Nielsen, Jens/0000-0002-9955-6003	Danish Research Agency for Technology and Production Sciences; Merck Research Labs, Merck Co., Inc	Danish Research Agency for Technology and Production Sciences; Merck Research Labs, Merck Co., Inc(Merck & Company)	This study was financed by the Danish Research Agency for Technology and Production Sciences (GPA). This work was in part supported by Merck Research Labs, Merck & Co., Inc, through the awarding of a Merck Doctoral Fellowship to J.M.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFF, 2007, 702232 PN AFF; Almqvist J, 2007, PROTEIN SCI, V16, P1819, DOI 10.1110/ps.072944707; Balasubashini MS, 2004, PHYTOTHER RES, V18, P310, DOI 10.1002/ptr.1440; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Cook M, 2007, CURR OPIN BIOTECH, V18, P341, DOI 10.1016/j.copbio.2007.07.006; Domico LM, 2007, NEUROTOXICOLOGY, V28, P1079, DOI 10.1016/j.neuro.2007.04.008; Duverna R, 2010, CURR CANCER DRUG TAR, V10, P634, DOI 10.2174/156800910791859443; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Fay LB, 2008, CURR OPIN BIOTECH, V19, P121, DOI 10.1016/j.copbio.2008.02.010; Ferguson LR, 2001, MUTAT RES-FUND MOL M, V475, P89, DOI 10.1016/S0027-5107(01)00073-2; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gietz RD, 1997, MOL CELL BIOCHEM, V172, P67, DOI 10.1023/A:1006859319926; Goranov AI, 2009, GENE DEV, V23, P1408, DOI 10.1101/gad.1777309; Henrich S, 2010, J MOL RECOGNIT, V23, P209, DOI 10.1002/jmr.984; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hirashima A, 2008, COMPUT BIOL CHEM, V32, P185, DOI 10.1016/j.compbiolchem.2008.03.001; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; HUANG ZX, 1993, APPL ENVIRON MICROB, V59, P2244, DOI 10.1128/AEM.59.7.2244-2250.1993; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; JONES G, 1995, CURR OPIN BIOTECH, V6, P652, DOI 10.1016/0958-1669(95)80107-3; Ju DH, 2004, J BIOL CHEM, V279, P23851, DOI 10.1074/jbc.C400111200; Kann MG, 2007, BRIEF BIOINFORM, V8, P333, DOI 10.1093/bib/bbm031; KATHERINE EM, 2004, ACTA CRYSTALLOGR D, V60, P878; Khanduja KL, 2006, BBA-GEN SUBJECTS, V1760, P283, DOI 10.1016/j.bbagen.2005.12.017; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Larsson S, 2000, APPL BIOCHEM BIOTECH, V84-6, P617, DOI 10.1385/ABAB:84-86:1-9:617; Laurie ATR, 2006, CURR PROTEIN PEPT SC, V7, P395; Legrain P, 2001, TRENDS GENET, V17, P346, DOI 10.1016/S0168-9525(01)02323-X; Lin SS, 2003, J BIOL CHEM, V278, P13390, DOI 10.1074/jbc.M212818200; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Martinez-Azorin F, 2008, BIOCHEM J, V413, P527, DOI 10.1042/BJ20080049; McRobb FM, 2010, J CHEM INF MODEL, V50, P626, DOI 10.1021/ci900444q; Middleton E, 2000, PHARMACOL REV, V52, P673; MORGENSEN J, 1999, J CLIN INVEST, V103, P39; Niu W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000120; Oda A., 2009, CHEM-BIO INFORM J, V9, P52, DOI [10.1273/cbij.9.52, DOI 10.1273/CBIJ.9.52]; Oliveira AP, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-17; Ou SY, 2004, J SCI FOOD AGR, V84, P1261, DOI 10.1002/jsfa.1873; Panagiotou G, 2007, J BIOTECHNOL, V130, P219, DOI 10.1016/j.jbiotec.2007.04.011; Panagiotou G, 2006, METAB ENG, V8, P474, DOI 10.1016/j.ymben.2006.04.004; Pold M, 1999, GENOMICS, V59, P161, DOI 10.1006/geno.1999.5870; Prates JAM, 2001, STRUCTURE, V9, P1183, DOI 10.1016/S0969-2126(01)00684-0; Rist MJ, 2006, TRENDS BIOTECHNOL, V24, P172, DOI 10.1016/j.tibtech.2006.02.001; Santos PM, 2009, PROTEOMICS, V9, P657, DOI 10.1002/pmic.200800452; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shoichet BK, 2002, CURR OPIN CHEM BIOL, V6, P439, DOI 10.1016/S1367-5931(02)00339-3; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Srinivasan M, 2007, J CLIN BIOCHEM NUTR, V40, P92, DOI 10.3164/jcbn.40.92; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stover PJ, 2006, NUTR REV, V64, pS60, DOI 10.1301/nr.2006.may.S60-S71; Subbiah MTR, 2007, TRANSL RES, V149, P55, DOI 10.1016/j.trsl.2006.09.003; TAN K, 2007, PNAS, V105, P2934; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Valencia A, 2002, CURR OPIN STRUC BIOL, V12, P368, DOI 10.1016/S0959-440X(02)00333-0; van der Greef J, 2007, J PROTEOME RES, V6, P1540, DOI 10.1021/pr0606530; Van Slyke C, 2003, NUCLEIC ACIDS RES, V31, P4597, DOI 10.1093/nar/gkg638; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Villas-Boas SG, 2003, ANAL BIOCHEM, V322, P134, DOI 10.1016/j.ab.2003.07.018; Villas-Boas SG, 2005, BIOCHEM J, V388, P669, DOI 10.1042/BJ20041162; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Wang XG, 2008, GENETICS, V180, P1945, DOI 10.1534/genetics.108.094524; Yabe T, 2010, NEUROSCIENCE, V165, P515, DOI 10.1016/j.neuroscience.2009.10.023	68	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13606	10.1371/journal.pone.0013606	http://dx.doi.org/10.1371/journal.pone.0013606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049050	gold, Green Submitted, Green Published			2022-12-25	WOS:000283422100014
J	Prosperi, MCF; De Luca, A; Di Giambenedetto, S; Bracciale, L; Fabbiani, M; Cauda, R; Salemi, M				Prosperi, Mattia C. F.; De Luca, Andrea; Di Giambenedetto, Simona; Bracciale, Laura; Fabbiani, Massimiliano; Cauda, Roberto; Salemi, Marco			The Threshold Bootstrap Clustering: A New Approach to Find Families or Transmission Clusters within Molecular Quasispecies	PLOS ONE			English	Article							PHYLOGENETIC TREES; MAXIMUM-LIKELIHOOD; RECONSTRUCTION; SEQUENCES; ALGORITHM; INFECTION; MATRIX	Background: Phylogenetic methods produce hierarchies of molecular species, inferring knowledge about taxonomy and evolution. However, there is not yet a consensus methodology that provides a crisp partition of taxa, desirable when considering the problem of intra/inter-patient quasispecies classification or infection transmission event identification. We introduce the threshold bootstrap clustering (TBC), a new methodology for partitioning molecular sequences, that does not require a phylogenetic tree estimation. Methodology/Principal Findings: The TBC is an incremental partition algorithm, inspired by the stochastic Chinese restaurant process, and takes advantage of resampling techniques and models of sequence evolution. TBC uses as input a multiple alignment of molecular sequences and its output is a crisp partition of the taxa into an automatically determined number of clusters. By varying initial conditions, the algorithm can produce different partitions. We describe a procedure that selects a prime partition among a set of candidate ones and calculates a measure of cluster reliability. TBC was successfully tested for the identification of type-1 human immunodeficiency and hepatitis C virus subtypes, and compared with previously established methodologies. It was also evaluated in the problem of HIV-1 intra-patient quasispecies clustering, and for transmission cluster identification, using a set of sequences from patients with known transmission event histories. Conclusion: TBC has been shown to be effective for the subtyping of HIV and HCV, and for identifying intra-patient quasispecies. To some extent, the algorithm was able also to infer clusters corresponding to events of infection transmission. The computational complexity of TBC is quadratic in the number of taxa, lower than other established methods; in addition, TBC has been enhanced with a measure of cluster reliability. The TBC can be useful to characterise molecular quasipecies in a broad context.	[Prosperi, Mattia C. F.; De Luca, Andrea; Di Giambenedetto, Simona; Bracciale, Laura; Fabbiani, Massimiliano; Cauda, Roberto] Univ Cattolica Sacro Cuore, Infect Dis Clin, I-00168 Rome, Italy; [Prosperi, Mattia C. F.; Salemi, Marco] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Prosperi, Mattia C. F.; Salemi, Marco] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [De Luca, Andrea] Univ Hosp Siena, Infect Dis Unit 2, Siena, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Siena; University Hospital of Siena	Prosperi, MCF (corresponding author), Univ Cattolica Sacro Cuore, Infect Dis Clin, I-00168 Rome, Italy.	ahnven@yahoo.it	De Luca, Andrea/G-8810-2011; Fabbiani, Massimiliano/K-8842-2016; digiambenedetto, simona/AAL-4429-2020	De Luca, Andrea/0000-0002-9561-9193; Fabbiani, Massimiliano/0000-0002-1343-812X; CAUDA, Roberto/0000-0002-1498-4229	DynaNets [233847]; Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN); Seventh Framework Programme [FP7 2007-2013, 223131]; NIH, NINDS [GRANTR01 NS063897-01A2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063897] Funding Source: NIH RePORTER	DynaNets; Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN); Seventh Framework Programme(European Commission); NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was funded by DynaNets project (www.dynanets.org), a Future and Emerging Technologies (FET)-Open grant # 233847; Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN) project (http://ec.europa.eu/research/health/infectious-diseases/poverty-diseases/projects/185_en.htm), Seventh Framework Programme (FP7 2007-2013), grant # 223131; NIH, NINDS GRANTR01 NS063897-01A2 (Feb 2009-Jan 2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous D., 1985, LECT NOTES MATH, V1117; Archer J, 2007, BIOINFORMATICS, V23, P2952, DOI 10.1093/bioinformatics/btm410; Brown AE, 2009, J INFECT DIS, V199, P427, DOI 10.1086/596049; Chiu S., 1994, J INTELL FUZZY SYST, V2, P267, DOI DOI 10.3233/IFS-1994-2306; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunn JC, 1974, J CYBERNETICS, V4, P95, DOI [DOI 10.1080/01969727408546059, 10.1080/01969727408546059]; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; FERGUSON TS, 1973, ANN STAT, V1, P209, DOI 10.1214/aos/1176342360; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Hendy M. D., 1982, MATH BIOSCI, V60, P133, DOI DOI 10.1016/0025-5564(82)90027-X; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kuncheva LI, 2006, IEEE T PATTERN ANAL, V28, P1798, DOI 10.1109/TPAMI.2006.226; Lemey P, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P1; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Massingham T, 2007, MOL BIOL EVOL, V24, P2277, DOI 10.1093/molbev/msm160; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Pol D, 2004, SYST BIOL, V53, P949, DOI 10.1080/10635150490888868; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Qin ZS, 2006, BIOINFORMATICS, V22, P1988, DOI 10.1093/bioinformatics/btl284; R Core Team, 2022, R LANG ENV STAT COMP; Resik S, 2007, AIDS RES HUM RETROV, V23, P347, DOI 10.1089/aid.2006.0158; RUSMUSSEN C, 2000, ADV NEURAL INFORM PR, V12, P554; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Spath H., 1980, CLUSTER ANAL ALGORIT; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; Zagordi O, 2010, J COMPUT BIOL, V17, P417, DOI 10.1089/cmb.2009.0164; 2010, LOS ALAMOS HIV RESP; 2010, HIV 1 SUBTYPE CIRCUL	40	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13619	10.1371/journal.pone.0013619	http://dx.doi.org/10.1371/journal.pone.0013619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049051	Green Published, gold			2022-12-25	WOS:000283422100021
J	Gandhi, G; Londono, D; Whetstine, CR; Sethi, N; Kim, KS; Zuckert, WR; Cadavid, D				Gandhi, Gaurav; Londono, Diana; Whetstine, Christine R.; Sethi, Nilay; Kim, Kwang S.; Zueckert, Wolfram R.; Cadavid, Diego			Interaction of Variable Bacterial Outer Membrane Lipoproteins with Brain Endothelium	PLOS ONE			English	Article							RELAPSING FEVER SPIROCHETE; BORRELIA-BURGDORFERI; TRANSENDOTHELIAL MIGRATION; PERSISTENT INFECTION; NEUROTROPIC STRAIN; CRYSTAL-STRUCTURE; SURFACE PROTEIN; BLOOD; CELLS; INTERLEUKIN-10	Background: Previously we reported that the variable outer membrane lipoprotein Vsp1 from the relapsing fever spirochete Borrelia turicatae disseminates from blood to brain better than the closely related Vsp2 [1]. Here we studied the interaction between Vsp1 and Vsp2 with brain endothelium in more detail. Methodology/Principal Findings: We compared Vsp1 to Vsp2 using human brain microvascular endothelial cell (HBMEC) association assays with aminoacid radiolabeled Vsp-expressing clones of recombinant Borrelia burgdorferi and lanthanide-labeled purified lipidated Vsp1 (LVsp1) and Vsp2 (LVsp2) and inoculations of the lanthanide-labeled proteins into mice. The results showed that heterologous expression of LVsp1 or LVsp2 in B. burgdorferi increased its association with HBMEC to a similar degree. Purified lanthanide- labeled lipidated Vsp1 (LVsp1) and LVsp2 by themselves were capable of associating with HBMEC. The association of LVsp1 with brain endothelium was time-dependent, saturable, and required the lipidation. The association of Vsp1 with HBMEC was inhibited by incubation at lower temperature or with excess unlabeled LVsp1 or LVsp2 but not with excess rVsp1 or mouse albumin or an anti Vsp1 monoclonal antibody. The association of LVsp2 with HBMEC and its movement from blood to brain parenchyma significantly increased in the presence of LVsp1. Conclusions/Significance: Variable bacterial outer membrane lipoproteins interact with brain endothelium differently; the lipidation and variable features at the protein dome region are key modulators of this interaction.	[Gandhi, Gaurav; Londono, Diana; Sethi, Nilay; Cadavid, Diego] UMDNJ New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ USA; [Gandhi, Gaurav; Londono, Diana; Sethi, Nilay; Cadavid, Diego] UMDNJ New Jersey Med Sch, Ctr Study Emerging Pathogens, Newark, NJ USA; [Londono, Diana; Cadavid, Diego] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Whetstine, Christine R.; Zueckert, Wolfram R.] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA; [Kim, Kwang S.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Harvard University; Massachusetts General Hospital; University of Kansas; University of Kansas Medical Center; Johns Hopkins University	Gandhi, G (corresponding author), UMDNJ New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ USA.	dcadavid@partners.org			National Institutes of Health [NS053997, 7R21NS057545-02, AI059468, AI063261]; Foundation of UMDNJ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053997, R21NS057545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation of UMDNJ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were supported by National Institutes of Health grants NS053997 and 7R21NS057545-02 to D. C. and AI059468 and AI063261 to W. R. Z. The support of the Foundation of UMDNJ to D. C. is also greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonara S, 2007, MOL MICROBIOL, V66, P262, DOI 10.1111/j.1365-2958.2007.05924.x; BARBOUR AG, 1986, ZBL BAKT-INT J MED M, V263, P83; Baron C, 1997, J BACTERIOL, V179, P1211, DOI 10.1128/jb.179.4.1211-1218.1997; Bunikis J, 2001, MOL MICROBIOL, V40, P387, DOI 10.1046/j.1365-2958.2001.02382.x; Burns MJ, 1997, INFECT IMMUN, V65, P1217, DOI 10.1128/IAI.65.4.1217-1222.1997; Cadavid D, 2006, J INFECT DIS, V193, P1451, DOI 10.1086/503367; Cadavid D, 1998, CLIN INFECT DIS, V26, P151, DOI 10.1086/516276; CADAVID D, 1994, J EXP MED, V179, P631, DOI 10.1084/jem.179.2.631; Cadavid D, 1997, INFECT IMMUN, V65, P3352, DOI 10.1128/IAI.65.8.3352-3360.1997; Cadavid D, 2009, CLIN MICROBIOL INFEC, V15, P415, DOI 10.1111/j.1469-0691.2009.02785.x; Cadavid D, 2001, INFECT IMMUN, V69, P3389, DOI 10.1128/IAI.69.5.3389-3397.2001; Cadavid D, 2007, J INFECT DIS, V195, P1686, DOI 10.1086/516783; Cadavid D, 2006, WIEN KLIN WOCHENSCHR, V118, P653, DOI 10.1007/s00508-006-0692-0; Cadavid Diego, 2010, Handb Clin Neurol, V96, P179, DOI 10.1016/S0072-9752(09)96012-2; CARTER CJ, 1994, INFECT IMMUN, V62, P2792, DOI 10.1128/IAI.62.7.2792-2799.1994; COBURN J, 1993, P NATL ACAD SCI USA, V90, P7059, DOI 10.1073/pnas.90.15.7059; COMSTOCK LE, 1991, MICROB PATHOGENESIS, V10, P137, DOI 10.1016/0882-4010(91)90074-K; COMSTOCK LE, 1989, INFECT IMMUN, V57, P1626, DOI 10.1128/IAI.57.5.1626-1628.1989; Dame TM, 2007, J IMMUNOL, V178, P1172, DOI 10.4049/jimmunol.178.2.1172; DIAMANDIS EP, 1990, ANAL CHEM, V62, pA1149, DOI 10.1021/ac00221a001; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Gelderblom H, 2007, J NEUROPATH EXP NEUR, V66, P208, DOI 10.1097/01.jnen.0000248556.30209.6d; Gelderblom H, 2007, AM J PATHOL, V170, P251, DOI 10.2353/ajpath.2007.060407; Gergel EI, 2001, INFECT IMMUN, V69, P2190, DOI 10.1128/IAI.69.4.2190-2197.2001; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Grab DJ, 2005, INFECT IMMUN, V73, P1014, DOI 10.1128/IAI.73.2.1014-1022.2005; Guo BP, 1998, MOL MICROBIOL, V30, P711, DOI 10.1046/j.1365-2958.1998.01103.x; GUO BP, 1995, INFECT IMMUN, V63, P3467, DOI 10.1128/IAI.63.9.3467-3472.1995; HARA H, 1981, BIOCHIM BIOPHYS ACTA, V673, P37, DOI 10.1016/0304-4165(81)90308-1; Ivey NS, 2005, J NEUROSCI METH, V142, P91, DOI 10.1016/j.jneumeth.2004.07.015; Kawabata H, 2004, INFECT IMMUN, V72, P7147, DOI 10.1128/IAI.72.12.7147-7154.2004; Kumaran D, 2001, EMBO J, V20, P971, DOI 10.1093/emboj/20.5.971; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Lawson CL, 2006, J BACTERIOL, V188, P4522, DOI 10.1128/JB.00028-06; Leong JM, 1998, INFECT IMMUN, V66, P994, DOI 10.1128/IAI.66.3.994-999.1998; Lisinski TJ, 2002, J LEUKOCYTE BIOL, V72, P503; Londono D, 2005, INFECT IMMUN, V73, P7669, DOI 10.1128/IAI.73.11.7669-7676.2005; Londono D, 2008, J NEUROPATH EXP NEUR, V67, P976, DOI 10.1097/NEN.0b013e318187a279; Londono D, 2008, J IMMUNOL, V181, P2076, DOI 10.4049/jimmunol.181.3.2076; Londono D, 2010, AM J PATHOL, V176, P2848, DOI 10.2353/ajpath.2010.091235; MA Y, 1991, INFECT IMMUN, V59, P671, DOI 10.1128/IAI.59.2.671-678.1991; Magoun L, 2000, MOL MICROBIOL, V36, P886, DOI 10.1046/j.1365-2958.2000.01906.x; Mehra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007597; MONCO JCG, 1992, NEUROLOGY, V42, P1341, DOI 10.1212/WNL.42.7.1341; Nassif X, 2002, TRENDS MICROBIOL, V10, P227, DOI 10.1016/S0966-842X(02)02349-1; Norman MU, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000169; Pennington PM, 1999, MOL MICROBIOL, V34, P1120, DOI 10.1046/j.1365-2958.1999.01675.x; Pennington PM, 1999, INFECT IMMUN, V67, P4637, DOI 10.1128/IAI.67.9.4637-4645.1999; Prasadarao NV, 1999, INFECT IMMUN, V67, P5775, DOI 10.1128/IAI.67.11.5775-5783.1999; Prasadarao NV, 1999, INFECT IMMUN, V67, P1131, DOI 10.1128/IAI.67.3.1131-1138.1999; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; SADZIENE A, 1995, INFECT IMMUN, V63, P1573, DOI 10.1128/IAI.63.4.1573-1580.1995; Salazar JC, 2005, CLIN DIAGN LAB IMMUN, V12, P949, DOI 10.1128/CDLI.12.8.949-958.2005; Samuels D S, 1995, Methods Mol Biol, V47, P253; Schlachetzki F, 2002, J NEUROCHEM, V81, P203, DOI 10.1046/j.1471-4159.2002.00840.x; SELLATI TJ, 1995, INFECT IMMUN, V63, P4439, DOI 10.1128/IAI.63.11.4439-4447.1995; Sellati TJ, 1996, INFECT IMMUN, V64, P3180, DOI 10.1128/IAI.64.8.3180-3187.1996; Sethi N, 2006, INFECT IMMUN, V74, P6408, DOI 10.1128/IAI.00538-06; Shamaei-Tousi A, 2000, CELL MICROBIOL, V2, P591, DOI 10.1046/j.1462-5822.2000.00083.x; Stewart PE, 2001, MOL MICROBIOL, V39, P714, DOI 10.1046/j.1365-2958.2001.02256.x; SZCZEPANSKI A, 1990, J CLIN INVEST, V85, P1637, DOI 10.1172/JCI114615; THOMAS DD, 1989, INFECT IMMUN, V57, P1324, DOI 10.1128/IAI.57.4.1324-1326.1989; THOMAS DD, 1994, J INFECT DIS, V169, P445, DOI 10.1093/infdis/169.2.445; YAZAKI T, 1995, CANCER RES, V55, P4752; Zambrano MC, 2004, INFECT IMMUN, V72, P3138, DOI 10.1128/IAI.72.6.3138-3146.2004; Zucker WR, 2001, J BIOL CHEM, V276, P457, DOI 10.1074/jbc.M008449200; Zuckert WR, 2004, INFECT IMMUN, V72, P1463, DOI 10.1128/IAI.72.3.1463-1469.2004	67	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13257	10.1371/journal.pone.0013257	http://dx.doi.org/10.1371/journal.pone.0013257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21063459	Green Published, Green Submitted, gold			2022-12-25	WOS:000283419100002
J	Boissinot, M; Cleyrat, C; Vilaine, M; Jacques, Y; Corre, I; Hermouet, S				Boissinot, M.; Cleyrat, C.; Vilaine, M.; Jacques, Y.; Corre, I.; Hermouet, S.			Anti-inflammatory cytokines hepatocyte growth factor and interleukin-11 are over-expressed in Polycythemia vera and contribute to the growth of clonal erythroblasts independently of JAK2V617F	ONCOGENE			English	Article						Polycythemia vera; JAK2V617F; hepatocyte growth factor (HGF); interleukin 11 (IL-11); interleukin 6 (IL-6); inflammation	MARROW STROMAL CELLS; INDUCIBLE FACTOR-I; MYELOPROLIFERATIVE NEOPLASMS; MULTIPLE-MYELOMA; INTERFERON-ALPHA; COLONY FORMATION; TYROSINE KINASE; JAK2 HAPLOTYPE; MUTATION; MET	The V617F activating mutation of janus kinase 2 (JAK2), a kinase essential for cytokine signalling, characterizes Polycythemia vera (PV), one of the myeloproliferative neoplasms (MPN). However, not all MPNs carry mutations of JAK2, and in JAK2-mutated patients, expression of JAK2V617F does not always result in clone expansion. In the present study, we provide evidence that inflammation-linked cytokines are required for the growth of JAK2V617F-mutated erythroid progenitors. In a first series of experiments, we searched for cytokines over-expressed in PV using cytokine antibody (Ab) arrays, and enzyme-linked immunosorbent assays for analyses of serum and bone marrow (BM) plasma, and quantitative reverse transcription-PCRs for analyses of cells purified from PV patients and controls. We found that PV patients over-expressed anti-inflammatory hepatocyte growth factor (HGF) and interleukin-11 (IL-11), BM mesenchymal stromal cells (BMMSCs) and erythroblasts being the main producers. In a second series of experiments, autocrine/paracrine cytokine stimulation of erythroblasts was blocked using neutralizing Abs specific for IL-11 or c-MET, the HGF receptor. The growth of JAK2V617F-mutated HEL cells and PV erythroblasts was inhibited, indicating that JAK2-mutated cells depend on HGF and IL-11 for their growth. Additional experiments showed that transient expression of JAK2V617F in BaF-3/erythropoietin receptor cells, and invalidation of JAK2V617F in HEL cells using anti-JAK2 small interfering RNA, did not affect HGF and IL-11 expression. Thus, anti-inflammatory HGF and IL-11 are upregulated in PV and their overproduction is not a consequence of JAK2V617F. As both cytokines contribute to the proliferation of PV erythroblasts, blocking the c-MET/HGF/IL-11 pathways could be of interest as an additional therapeutic option in PV. Oncogene (2011) 30, 990-1001; doi:10.1038/onc.2010.479; published online 1 November 2010	[Boissinot, M.; Cleyrat, C.; Vilaine, M.; Jacques, Y.; Corre, I.; Hermouet, S.] CHU Nantes, Inst Biol, INSERM, UMR 892, F-44093 Nantes, France; [Hermouet, S.] CHU Nantes, Inst Biol, Hematol Lab, F-44093 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Hermouet, S (corresponding author), CHU Nantes, Inst Biol, INSERM, UMR 892, F-44093 Nantes, France.	sylvie.hermouet@chu-nantes.fr	Vilaine, Mathias/L-3054-2015; Jacques, Yannick/K-9294-2015; Corre, Isabelle/L-2583-2015; Cleyrat, Cedric/F-1824-2016	Cleyrat, Cedric/0000-0002-1928-6497; CORRE, Isabelle/0000-0001-6444-1145; Boissinot, Marjorie/0000-0002-5241-2520	Ligue Nationale contre le Cancer (Comite de Loire-Atlantique); Association pour la Recherche contre le Cancer; French Ministry of Research [MB: 2004-2007, CC: 2007-2010, MV: 2009-2010]	Ligue Nationale contre le Cancer (Comite de Loire-Atlantique); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	We are indebted to Mrs Danielle Pineau for excellent technical help and to colleagues of the Clinical Hematology Departments of the hospitals of Nantes, La Roche-sur-Yon and Lorient for providing patient samples. The study was supported by grants from the Ligue Nationale contre le Cancer (Comite de Loire-Atlantique) and the Association pour la Recherche contre le Cancer. MB, CC and MV have been recipients of scholarships from the French Ministry of Research (MB: 2004-2007; CC: 2007-2010; MV: 2009-2010) and from the Association pour la Recherche contre le Cancer (MB, 2008).	Aman MJ, 1996, EXP HEMATOL, V24, P863; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bernet Agnes, 2007, Bull Cancer, V94, pE12; Cleyrat C, 2010, LEUKEMIA, V24, P1069, DOI 10.1038/leu.2010.23; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Coppo P, 2009, CELL SIGNAL, V21, P52, DOI 10.1016/j.cellsig.2008.09.006; Corre-Buscail I, 2005, EXP HEMATOL, V33, P1299, DOI 10.1016/j.exphem.2005.07.002; Derksen PWB, 2003, LEUKEMIA, V17, P764, DOI 10.1038/sj.leu.2402875; Dobo L, 2004, HEMATOL J, V5, P161, DOI 10.1038/sj.thj.6200344; Du WL, 2007, BLOOD, V109, P3042, DOI 10.1182/blood-2006-02-003103; Ferguson LR, 2010, MUTAT RES-FUND MOL M, V690, P108, DOI 10.1016/j.mrfmmm.2010.01.017; Geissler K, 1998, BLOOD, V92, P1967, DOI 10.1182/blood.V92.6.1967.418k27_1967_1972; Girodon F, 2008, HAEMATOL-HEMATOL J, V93, P1723, DOI 10.3324/haematol.13081; Giuliani N, 2004, HAEMATOLOGICA, V89, P1118; Hermouet S, 2002, CYTOKINE, V20, P178, DOI 10.1006/cyto.2002.1994; Hitoshi Y, 2010, INT J HEMATOL, V91, P189, DOI 10.1007/s12185-010-0531-y; Ho CL, 2007, LEUKEMIA RES, V31, P1389, DOI 10.1016/j.leukres.2006.12.024; Ishii T, 2007, LEUKEMIA, V21, P2433, DOI 10.1038/sj.leu.2404899; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jenkins BJ, 2005, BLOOD, V105, P3512, DOI 10.1182/blood-2004-09-3751; Jenkins BJ, 2007, BLOOD, V109, P2380, DOI 10.1182/blood-2006-08-040352; Jones AV, 2009, NAT GENET, V41, P446, DOI 10.1038/ng.334; Kiladjian JJ, 2006, BLOOD, V108, P2037, DOI 10.1182/blood-2006-03-009860; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Kitajima Y, 2008, CANCER SCI, V99, P1341, DOI 10.1111/j.1349-7006.2008.00828.x; Kopitz C, 2007, CANCER RES, V67, P8615, DOI 10.1158/0008-5472.CAN-07-0232; Kralovics R, 2008, LEUKEMIA, V22, P1841, DOI 10.1038/leu.2008.233; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Lambert JR, 2009, BLOOD, V114, P3018, DOI 10.1182/blood-2009-03-209916; Le Bousse-Kerdiles MC, 1999, ANN HEMATOL, V78, P437, DOI 10.1007/s002770050595; Lippert E, 2006, BLOOD, V108, P1865, DOI 10.1182/blood-2006-01-013540; Lippert E, 2009, HAEMATOL-HEMATOL J, V94, P38, DOI 10.3324/haematol.13486; Matsuda-Hashii Y, 2004, EXP HEMATOL, V32, P955, DOI 10.1016/j.exphem.2004.06.012; Musolino C, 2002, AM J HEMATOL, V69, P159, DOI 10.1002/ajh.10020; Naifeld V, 2007, EXP HEMATOL, V35, P1668, DOI 10.1016/j.exphem.2007.08.025; Nussenzveig RH, 2007, EXP HEMATOL, V35, P32, DOI 10.1016/j.exphem.2006.11.012; Olcaydu D, 2009, NAT GENET, V41, P450, DOI 10.1038/ng.341; Panteli KE, 2005, BRIT J HAEMATOL, V130, P709, DOI 10.1111/j.1365-2141.2005.05674.x; QUESNIAUX VFJ, 1992, BLOOD, V80, P1218; Radaeva S, 2002, GASTROENTEROLOGY, V122, P1020, DOI 10.1053/gast.2002.32388; Sattler Martin, 2007, Curr Oncol Rep, V9, P102, DOI 10.1007/s11912-007-0005-4; Schaub FX, 2009, BLOOD, V113, P2022, DOI 10.1182/blood-2008-07-167056; Schwertschlag US, 1999, LEUKEMIA, V13, P1307, DOI 10.1038/sj.leu.2401514; Shinomiya N, 2004, CANCER RES, V64, P7962, DOI 10.1158/0008-5472.CAN-04-1043; Stellrecht CM, 2007, CANCER RES, V67, P9913, DOI 10.1158/0008-5472.CAN-07-0770; Tacchini L, 2001, CARCINOGENESIS, V22, P1363, DOI 10.1093/carcin/22.9.1363; TEFFERI A, 2010, HEMATOLOGIST, V7, P5; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; UCHIYAMA H, 1993, BLOOD, V82, P3712; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Verstovsek S, 2010, CLIN CANCER RES, V16, P1988, DOI 10.1158/1078-0432.CCR-09-2836; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Wickenhauser C, 1999, LEUKEMIA, V13, P327, DOI 10.1038/sj.leu.2401314; Zdzisinska B, 2008, ARCH IMMUNOL THER EX, V56, P207, DOI 10.1007/s00005-008-0022-5	55	43	46	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	8					990	1001		10.1038/onc.2010.479	http://dx.doi.org/10.1038/onc.2010.479			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	726CJ	21042281				2022-12-25	WOS:000287695900010
J	Chang, WP; Huang, XP; Downs, D; Cirrito, JR; Koelsch, G; Holtzman, DM; Ghosh, AK; Tang, J				Chang, Wan-Pin; Huang, Xiangping; Downs, Deborah; Cirrito, John R.; Koelsch, Gerald; Holtzman, David M.; Ghosh, Arun K.; Tang, Jordan			beta-Secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic mice	FASEB JOURNAL			English	Article						Alzheimer's disease; Tg2576; memapsin 2	AMYLOID PRECURSOR PROTEIN; TG2576 MOUSE MODEL; ALZHEIMERS-DISEASE; A-BETA; MEMORY DEFICITS; KNOCKOUT MICE; BRAIN; BACE1; IDENTIFICATION; THERAPEUTICS	Alzheimer disease is intimately linked to an excess amount of amyloid-beta (A beta) in the brain. Thus, therapeutic inhibition of A beta production is an attractive clinical approach to treat this disease. Here we provide the first direct experimental evidence that the treatment of Tg2576 transgenic mice with an inhibitor of beta-secretase, GRL-8234, rescues the age-related cognitive decline. We demonstrated that the injected GRL-8234 effectively enters the brain and rapidly decreases soluble A beta in the brain of Tg2576 mice. The rescue of cognition, which was observed only after long-term inhibitor treatment ranging from 5 to 7.5 mo, was associated with a decrease of brain amyloid-beta plaque load. We also found no accumulation of amyloid-beta precursor protein after several months of inhibitor treatment. These observations substantiate the idea that A beta accumulation plays a major role in the cognitive decline of Tg2576 mice and support the concept of A beta reduction therapy as a treatment of AD.-Chang, W.-P., Huang, X., Downs, D., Cirrito, J. R., Koelsch, G., Holtzman, D. M. Ghosh, A. K., Tang, J. beta-Secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic mice. FASEB J. 25, 775-784 (2011). www.fasebj.org	[Chang, Wan-Pin; Huang, Xiangping; Downs, Deborah; Tang, Jordan] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Med Res Fdn, Prot Studies Program, Oklahoma City, OK 73104 USA; [Tang, Jordan] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Cirrito, John R.; Holtzman, David M.] Washington Univ, Sch Med, Microdialysis Core Facil, Dept Neurol, St Louis, MO USA; [Koelsch, Gerald] CoMentis Inc, Oklahoma City, OK USA; [Ghosh, Arun K.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Washington University (WUSTL); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Tang, J (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma Med Res Fdn, Prot Studies Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	jordan-tang@omrf.org			U.S. National Institutes of Health (NIH) [AG-18933]; Alzheimer Association; NIH [P20 RR 15577-07]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018933] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Michelle Nicolle for comments and suggestions; Dr. J. Donald Capra for critical reading of the manuscript; Dr. Geoffrey Bilcer for arranging the synthesis of the inhibitor; Dr. William Sonntag, Dr. Matthew Mitschelen, and Julie Farley for the use of facility and advice; and Huining Da and Darby Kinsey for excellent technical assistance. This work was supported in part by U.S. National Institutes of Health (NIH) grant AG-18933 and an Alzheimer Association Pioneer Award (to J. T.) and NIH COBRE/IDeA grant P20 RR 15577-07 (to W.-P. C.). J. T. is holder of the J. G. Puterbaugh Chair in Biomedical Research at the Oklahoma Medical Research Foundation.	Barten Donna M, 2006, Drugs R D, V7, P87, DOI 10.2165/00126839-200607020-00003; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Chang WP, 2004, J NEUROCHEM, V89, P1409, DOI 10.1111/j.1471-4159.2004.02452.x; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Garcia MF, 2004, NEUROREPORT, V15, P73, DOI 10.1097/00001756-200401190-00015; Ghosh AK, 2008, NEUROTHERAPEUTICS, V5, P399, DOI 10.1016/j.nurt.2008.05.007; Ghosh AK, 2008, CURR ALZHEIMER RES, V5, P121, DOI 10.2174/156720508783954730; Ghosh AK, 2008, BIOORG MED CHEM LETT, V18, P1031, DOI 10.1016/j.bmcl.2007.12.028; Han BH, 2008, J NEUROSCI, V28, P13542, DOI 10.1523/JNEUROSCI.4686-08.2008; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P646, DOI 10.1016/S1044-7431(03)00227-6; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hu XY, 2010, J NEUROSCI, V30, P8819, DOI 10.1523/JNEUROSCI.1334-10.2010; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; REMY C, 2000, P INT SOC MAG RESON, V8, P100; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-4; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Whitehouse PJ, 1998, ALZ DIS ASSOC DIS, V12, P281, DOI 10.1097/00002093-199812000-00007; Wolfe MS, 2008, CURR ALZHEIMER RES, V5, P158, DOI 10.2174/156720508783954767; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107	36	88	95	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					775	784		10.1096/fj.10-167213	http://dx.doi.org/10.1096/fj.10-167213			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	21059748	Green Published, Bronze			2022-12-25	WOS:000286724800034
J	Iftikhar, M; Hurtado, P; Bais, MV; Wigner, N; Stephens, DN; Gerstenfeld, LC; Trackman, PC				Iftikhar, Mussadiq; Hurtado, Paola; Bais, Manish V.; Wigner, Nate; Stephens, Danielle N.; Gerstenfeld, Louis C.; Trackman, Philip C.			Lysyl Oxidase-like-2 (LOXL2) Is a Major Isoform in Chondrocytes and Is Critically Required for Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATIVE CARTILAGE REPAIR; TUMOR-SUPPRESSOR ACTIVITY; CHONDROGENIC CELL-LINE; ARTICULAR-CARTILAGE; COLLAGEN NETWORK; GROWTH-FACTOR; MECHANICAL-PROPERTIES; PROPEPTIDE DOMAIN; FRACTURE CALLUS; BONE-FORMATION	The lysyl oxidase family is made up of five members: lysyl oxidase (LOX) and lysyl oxidase-like 1-4 (LOXL1-LOXL4). All members share conserved C-terminal catalytic domains that provide for lysyl oxidase or lysyl oxidase-like enzyme activity; and more divergent propeptide regions. LOX family enzyme activities catalyze the final enzymatic conversion required for the formation of normal biosynthetic collagen and elastin cross-links. The importance of lysyl oxidase enzyme activity to normal bone development has long been appreciated, but regulation and roles for specific LOX isoforms in bone formation in vivo is largely unexplored. Fracture healing recapitulates aspects of endochondral bone development. The present study first investigated the expression of all LOX isoforms in fracture healing. A remarkable coincidence of LOXL2 expression with the chondrogenic phase of fracture healing was found, prompting more detailed analyses of LOXL2 expression in normal growth plates, and LOXL2 expression and function in developing ATDC5 chondrogenic cells. Data show that LOXL2 is expressed by pre-hypertrophic and hypertrophic chondrocytes in vivo, and that LOXL2 expression is regulated in vitro as a function of chondrocyte differentiation. Moreover, LOXL2 knockdown studies in vitro show that LOXL2 expression is required for ATDC5 chondrocyte cell line differentiation through regulation of SNAIL and SOX9, important transcription factors that control chondrocyte differentiation. Taken together, data provide evidence that LOXL2, like LOX, is a multifunctional protein. LOXL2 promotes chondrocyte differentiation by mechanisms that are likely to include roles as both a regulator and an effector of chondrocyte differentiation.	[Iftikhar, Mussadiq; Hurtado, Paola; Bais, Manish V.; Stephens, Danielle N.; Trackman, Philip C.] Boston Univ, Henry M Goldman Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02118 USA; [Bais, Manish V.; Wigner, Nate; Gerstenfeld, Louis C.] Boston Univ, Sch Med, Dept Orthoped Surg, Boston, MA 02118 USA	Boston University; Boston University	Trackman, PC (corresponding author), Boston Univ, Henry M Goldman Sch Dent Med, Dept Periodontol & Oral Biol, 700 Albany St,W-201, Boston, MA 02118 USA.	trackman@bu.edu	Trackman, Philip C/AAX-9280-2021	Trackman, Philip C/0000-0001-5064-614X; Bais, Manish/0000-0003-4198-7377; /0000-0002-0477-1211; Buckley, Paola/0000-0002-7501-8753	National Institutes of Health, NIDCR [R01 DE 14066]; National Institutes of Health, NIAMS [P01AR049920, AR044927]; Dept. of Defense [DAMD17-03-1-0576]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044927, R29AR044927, R56AR044927, P01AR049920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014066] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Dept. of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants NIDCR R01 DE 14066 (to P. C. T.) and NIAMS P01AR049920 and AR044927 (to L. C. G.), and the Dept. of Defense Grant DAMD17-03-1-0576 (to L. C. G.).	Ahsan T, 1999, J ORTHOPAED RES, V17, P850, DOI 10.1002/jor.1100170610; Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215; Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x; Atsawasuwan P, 2008, J BIOL CHEM, V283, P34229, DOI 10.1074/jbc.M803142200; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Bais MV, 2009, BONE, V45, P254, DOI 10.1016/j.bone.2009.04.239; Bais M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005393; Bank RA, 2000, ARTHRITIS RHEUM-US, V43, P2202, DOI 10.1002/1529-0131(200010)43:10<2202::AID-ANR7>3.0.CO;2-E; Basser PJ, 1998, ARCH BIOCHEM BIOPHYS, V351, P207, DOI 10.1006/abbi.1997.0507; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; de Frutos CA, 2007, DEV CELL, V13, P872, DOI 10.1016/j.devcel.2007.09.016; DiMicco MA, 2001, J ORTHOPAED RES, V19, P1105, DOI 10.1016/S0736-0266(01)00037-7; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2; Ford JL, 2004, J ORTHOP RES, V22, P368, DOI 10.1016/j.orthres.2003.08.010; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gerstenfeld LC, 2006, J HISTOCHEM CYTOCHEM, V54, P1215, DOI 10.1369/jhc.6A6959.2006; Hollosi P, 2009, INT J CANCER, V125, P318, DOI 10.1002/ijc.24308; Hong HH, 2004, J CELL PHYSIOL, V200, P53, DOI 10.1002/jcp.10476; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Hurtado PA, 2008, BIOCHEM BIOPH RES CO, V366, P156, DOI 10.1016/j.bbrc.2007.11.116; Ito H, 2001, J BIOL CHEM, V276, P24023, DOI 10.1074/jbc.M100861200; Jepsen KJ, 2008, J BONE MINER RES, V23, P1204, DOI 10.1359/JBMR.080317; KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206; Kagan HM, 1986, REGULATION MATRIX AC, P321; Kayal RA, 2007, J BONE MINER RES, V22, P560, DOI 10.1359/JBMR.070115; LEES S, 1990, CONNECT TISSUE RES, V24, P95, DOI 10.3109/03008209009152426; Li WD, 2003, J CELL BIOCHEM, V88, P152, DOI 10.1002/jcb.10304; Lucero HA, 2008, J BIOL CHEM, V283, P24103, DOI 10.1074/jbc.M709897200; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; McGowan KB, 2005, J ORTHOP RES, V23, P594, DOI 10.1016/j.orthres.2004.02.015; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Min CY, 2009, CANCER RES, V69, P6685, DOI 10.1158/0008-5472.CAN-08-4818; Nakatani S, 2007, BIOL PHARM BULL, V30, P433, DOI 10.1248/bpb.30.433; OXLUND H, 1995, BONE, V17, pS365, DOI 10.1016/8756-3282(95)00328-B; Palamakumbura AH, 2009, ONCOGENE, V28, P3390, DOI 10.1038/onc.2009.203; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2008, CANCER RES, V68, P4541, DOI 10.1158/0008-5472.CAN-07-6345; Rodriguez HM, 2010, J BIOL CHEM, V285, P20964, DOI 10.1074/jbc.M109.094136; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seki K, 2003, J BIOL CHEM, V278, P41862, DOI 10.1074/jbc.M308336200; SELYE H., 1957, REV CANADIENNE BIOL, V16, P1; TANG SS, 1983, J BIOL CHEM, V258, P4331; Uzel MI, 2001, J PERIODONTOL, V72, P921, DOI 10.1902/jop.2001.72.7.921; Vora SR, 2010, BIOCHEMISTRY-US, V49, P2962, DOI 10.1021/bi902218p; Vora SR, 2010, J BIOL CHEM, V285, P7384, DOI 10.1074/jbc.M109.033597; Williamson AK, 2003, J ORTHOPAED RES, V21, P872, DOI 10.1016/S0736-0266(03)00030-5; Williamson AK, 2003, TISSUE ENG, V9, P625, DOI 10.1089/107632703768247322; Wu M, 2007, CANCER RES, V67, P6278, DOI 10.1158/0008-5472.CAN-07-0776	51	35	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					909	918		10.1074/jbc.M110.155622	http://dx.doi.org/10.1074/jbc.M110.155622			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21071451	hybrid, Green Published			2022-12-25	WOS:000286005000002
J	Alvarez, C; Lozano-Juste, J; Romero, LC; Garcia, I; Gotor, C; Leon, J				Alvarez, Consolacion; Lozano-Juste, Jorge; Romero, Luis C.; Garcia, Irene; Gotor, Cecilia; Leon, Jose			Inhibition of Arabidopsis O-Acetylserine(thiol)lyase A1 by Tyrosine Nitration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; NITRIC-OXIDE; SERINE ACETYLTRANSFERASE; GENE FAMILY; CYSTEINE BIOSYNTHESIS; ABSCISIC-ACID; FUNCTIONAL-ANALYSIS; CADMIUM TOLERANCE; PROTEIN OXIDATION; THALIANA	The last step of sulfur assimilation is catalyzed by O-acetyl-serine(thiol) lyase (OASTL) enzymes. OASTLs are encoded by a multigene family in the model plant Arabidopsis thaliana. Cytosolic OASA1 enzyme is the main source of OASTL activity and thus crucial for cysteine homeostasis. We found that nitrating conditions after exposure to peroxynitrite strongly inhibited OASTL activity. Among OASTLs, OASA1 was markedly sensitive to nitration as demonstrated by the comparative analysis of OASTL activity in nitrated crude protein extracts from wild type and different oastl mutants. Furthermore, nitration assays on purified recombinant OASA1 protein led to 90% reduction of the activity due to inhibition of the enzyme, as no degradation of the protein occurred under these conditions. The reduced activity was due to nitration of the protein because selective scavenging of peroxynitrite with epicatechin impaired OASA1 nitration and the concomitant inhibition of OASTL activity. Inhibition of OASA1 activity upon nitration correlated with the identification of a modified OASA1 protein containing 3-nitroTyr(302) residue. The essential role of the Tyr(302) residue for the catalytic activity was further demonstrated by the loss of OASTL activity of a Y302A-mutated version of OASA1. Inhibition caused by Tyr(302) nitration on OASA1 activity seems to be due to a drastically reduced O-acetylserine substrate binding to the nitrated protein, and also to reduced stabilization of the pyridoxal-5'-phosphate cofactor through hydrogen bonds. This is the first report identifying a Tyr nitration site of a plant protein with functional effect and the first post-translational modification identified in OASA1 enzyme.	[Lozano-Juste, Jorge; Leon, Jose] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain; [Alvarez, Consolacion; Romero, Luis C.; Garcia, Irene; Gotor, Cecilia] Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis, Seville 41092, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF)	Leon, J (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, CPI Ed 8E,Camino Vera S-N, Valencia 46022, Spain.	jleon@ibmcp.upv.es	León, José/C-4756-2016; García, Irene/C-8334-2011; Romero, Luis C./B-7138-2012; Gotor, Cecilia/B-7173-2012; Lozano-Juste, Jorge/K-3066-2017; Alvarez Nunez, Consolacion/I-3342-2018	León, José/0000-0002-7332-1572; García, Irene/0000-0001-7586-5664; Romero, Luis C./0000-0002-2414-4813; Gotor, Cecilia/0000-0003-4272-7446; Lozano-Juste, Jorge/0000-0001-7034-566X; Alvarez Nunez, Consolacion/0000-0002-2893-3545	CONSOLIDER TRANSPLANTA [CSD2007-00057];  [BIO2008-00839];  [BIO2010- 15201]	CONSOLIDER TRANSPLANTA; ; 	This work was supported by Grants BIO2008-00839 and CONSOLIDER TRANSPLANTA CSD2007-00057 (to J. L.) and BIO2010- 15201 (to C. G.).	Abello N, 2009, J PROTEOME RES, V8, P3222, DOI 10.1021/pr900039c; Atanassov II, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-14; Barroso C, 1999, PLANT MOL BIOL, V40, P729, DOI 10.1023/A:1006285016296; BARROSO C, 1995, FEBS LETT, V363, P1, DOI 10.1016/0014-5793(95)00255-8; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Corpas FJ, 2009, PLANT SIGNAL BEHAV, V4, P920, DOI 10.4161/psb.4.10.9466; De Michele R, 2009, PLANT PHYSIOL, V150, P217, DOI 10.1104/pp.108.133397; Dominguez-Solis JR, 2001, J BIOL CHEM, V276, P9297, DOI 10.1074/jbc.M009574200; Dominguez-Solis JR, 2004, PLANT BIOTECHNOL J, V2, P469, DOI 10.1111/j.1467-7652.2004.00092.x; Droux M, 2004, PHOTOSYNTH RES, V79, P331, DOI 10.1023/B:PRES.0000017196.95499.11; Durzan DJ, 2002, BIOTECHNOL GENET ENG, V19, P293, DOI 10.1080/02648725.2002.10648032; Francois JA, 2006, PLANT CELL, V18, P3647, DOI 10.1105/tpc.106.047316; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Ghelis T, 2008, PLANT PHYSIOL, V148, P1668, DOI 10.1104/pp.108.124594; Haas FH, 2008, PLANT PHYSIOL, V148, P1055, DOI 10.1104/pp.108.125237; Heeg C, 2008, PLANT CELL, V20, P168, DOI 10.1105/tpc.107.056747; Ischiropoulos H, 2003, BIOCHEM BIOPH RES CO, V305, P776, DOI 10.1016/S0006-291X(03)00814-3; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Koprivova A, 2008, PLANT PHYSIOL, V146, P1408, DOI 10.1104/pp.107.113175; Krueger S, 2009, PLANT CELL ENVIRON, V32, P349, DOI [10.1111/j.1365-3040.2009.01928.x, 10.1111/j.1365-3040.2008.01928.x]; Leustek T, 2000, ANNU REV PLANT PHYS, V51, P141, DOI 10.1146/annurev.arplant.51.1.141; Lindermayr C, 2009, J PROTEOMICS, V73, P1, DOI 10.1016/j.jprot.2009.07.002; Lopez-Martin MC, 2008, PLANT PHYSIOL, V147, P562, DOI 10.1104/pp.108.117408; Lozano-Juste J, 2010, PLANT PHYSIOL, V152, P891, DOI 10.1104/pp.109.148023; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Rinalducci S, 2008, J EXP BOT, V59, P3781, DOI 10.1093/jxb/ern252; Schroeder P, 2001, BIOCHEM BIOPH RES CO, V285, P782, DOI 10.1006/bbrc.2001.5210; Souza JM, 1999, ARCH BIOCHEM BIOPHYS, V371, P169, DOI 10.1006/abbi.1999.1480; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Tai CH, 2001, ACCOUNTS CHEM RES, V34, P49, DOI 10.1021/ar990169l; Thomas DD, 2002, P NATL ACAD SCI USA, V99, P12691, DOI 10.1073/pnas.202312699; van Bentem SD, 2009, TRENDS PLANT SCI, V14, P71, DOI 10.1016/j.tplants.2008.11.003; Watanabe M, 2008, PLANT CELL, V20, P2484, DOI 10.1105/tpc.108.060335; Watanabe M, 2008, PLANT PHYSIOL, V146, P310, DOI 10.1104/pp.107.106831; Wirtz M, 2006, J PLANT PHYSIOL, V163, P273, DOI 10.1016/j.jplph.2005.11.013; Wirtz M, 2004, J EXP BOT, V55, P1785, DOI 10.1093/jxb/erh201; Yi H, 2010, MOL PLANT, V3, P269, DOI 10.1093/mp/ssp112; Zhang LP, 2008, PLANT CELL PHYSIOL, V49, P411, DOI 10.1093/pcp/pcn017; Zhang Y, 2009, INT J BIOCHEM CELL B, V41, P907, DOI 10.1016/j.biocel.2008.08.040	41	40	40	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					578	586		10.1074/jbc.M110.147678	http://dx.doi.org/10.1074/jbc.M110.147678			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21047785	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-25	WOS:000285782800060
J	Muradrasoli, S; Balint, A; Wahlgren, J; Waldenstrom, J; Belak, S; Blomberg, J; Olsen, B				Muradrasoli, Shaman; Balint, Adam; Wahlgren, John; Waldenstrom, Jonas; Belak, Sandor; Blomberg, Jonas; Olsen, Bjorn			Prevalence and Phylogeny of Coronaviruses in Wild Birds from the Bering Strait Area (Beringia)	PLOS ONE			English	Article							INFECTIOUS-BRONCHITIS VIRUS; SEQUENCE; IDENTIFICATION; RESERVOIRS; REVEALS; HKU1	Coronaviruses (CoVs) can cause mild to severe disease in humans and animals, their host range and environmental spread seem to have been largely underestimated, and they are currently being investigated for their potential medical relevance. Infectious bronchitis virus (IBV) belongs to gamma-coronaviruses and causes a costly respiratory viral disease in chickens. The role of wild birds in the epidemiology of IBV is poorly understood. In the present study, we examined 1,002 cloacal and faecal samples collected from 26 wild bird species in the Beringia area for the presence of CoVs, and then we performed statistical and phylogenetic analyses. We detected diverse CoVs by RT-PCR in wild birds in the Beringia area. Sequence analysis showed that the detected viruses are gamma-coronaviruses related to IBV. These findings suggest that wild birds are able to carry gamma-coronaviruses asymptomatically. We concluded that CoVs are widespread among wild birds in Beringia, and their geographic spread and frequency is higher than previously realised. Thus, Avian CoV can be efficiently disseminated over large distances and could be a genetic reservoir for future emerging pathogenic CoVs. Considering the great animal health and economic impact of IBV as well as the recent emergence of novel coronaviruses such as SARS-coronavirus, it is important to investigate the role of wildlife reservoirs in CoV infection biology and epidemiology.	[Muradrasoli, Shaman; Blomberg, Jonas] Uppsala Univ, Dept Med Sci, Sect Clin Virol, Uppsala, Sweden; [Muradrasoli, Shaman] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Sect Bacteriol & Food Safety, Uppsala, Sweden; [Balint, Adam; Belak, Sandor] Swedish Univ Agr Sci, Dept Virol, Joint Res & Dev Div, Uppsala, Sweden; [Balint, Adam; Belak, Sandor] Swedish Univ Agr Sci, Dept Parasitol, Joint Res & Dev Div, Uppsala, Sweden; [Balint, Adam; Belak, Sandor] Natl Vet Inst, S-75007 Uppsala, Sweden; [Wahlgren, John] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Wahlgren, John; Waldenstrom, Jonas] Swedish Inst Infect Dis Control, Solna, Sweden; [Olsen, Bjorn] Linneaus Univ, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden; [Olsen, Bjorn] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; National Veterinary Institute SVA; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Linnaeus University; Uppsala University	Muradrasoli, S (corresponding author), Uppsala Univ, Dept Med Sci, Sect Clin Virol, Uppsala, Sweden.	shaman.muradrasoli@bvf.slu.se	Waldenström, Jonas/E-4460-2013; Belak, Sandor/AAP-4759-2021	Waldenström, Jonas/0000-0002-1152-4235; Olsen, Bjorn/0000-0002-4646-691X; Blomberg, Jonas/0000-0001-6492-2491	Swedish Research Council [2004-5489, 2008-6892]; Research Council FORMAS [2005-51]; Swedish University of Agriculture	Swedish Research Council(Swedish Research CouncilEuropean Commission); Research Council FORMAS(Swedish Research Council Formas); Swedish University of Agriculture	This work was financially supported by the Swedish Research Council VR (2004-5489, 2008-6892) (http://www.vr.se), and the Research Council FORMAS (2005-51) (http://www.formas.se/). This work was also supported by the Award of Excellence of the Swedish University of Agriculture (2007) granted to Prof. Sandor Belak. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao J, 2008, VIRUS RES, V136, P43, DOI 10.1016/j.virusres.2008.04.015; Cavanagh D, 2005, AVIAN PATHOL, V34, P439, DOI 10.1080/03079450500367682; Cavanagh D, 2005, AVIAN PATHOL, V34, P20, DOI 10.1080/03079450400025414; Cavanagh D, 1997, ARCH VIROL, V142, P629; Cavanagh D, 2002, AVIAN PATHOL, V31, P81, DOI 10.1080/03079450120106651; Cavanagh D, 2001, AVIAN PATHOL, V30, P355, DOI 10.1080/03079450120066368; Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Dong BQ, 2007, J VIROL, V81, P6920, DOI 10.1128/JVI.00299-07; Escutenaire S, 2007, ARCH VIROL, V152, P41, DOI 10.1007/s00705-006-0840-x; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Gomaa MH, 2008, VIRUS RES, V135, P237, DOI 10.1016/j.virusres.2008.03.020; Gonzaalez JM, 2003, ARCH VIROL, V148, P2207, DOI 10.1007/s00705-003-0162-1; GORMAN OT, 1992, CURR TOP MICROBIOL, V176, P75; GUYJS, 2000, AVIAN PATHOL, V29, P207; HALL TA, 1999, Windows Nucl Acids S, V41, P95; HANKS J, 1976, 33 TISS CULT ASS; Hughes LA, 2009, EMERG INFECT DIS, V15, P1091, DOI 10.3201/eid1507.090067; Jonassen CM, 2005, J GEN VIROL, V86, P1597, DOI 10.1099/vir.0.80927-0; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Lindstrom Ake, 2005, Wader Study Group Bulletin, V107, P50; Liu SW, 2005, J GEN VIROL, V86, P719, DOI 10.1099/vir.0.80546-0; Mihindukulasuriya KA, 2008, J VIROL, V82, P5084, DOI 10.1128/JVI.02722-07; MURADRASOLI S, 2009, J VIROL METHODS; Pedersen NC, 2009, J FELINE MED SURG, V11, P225, DOI 10.1016/j.jfms.2008.09.008; Saif LJ, 2004, REV SCI TECH OIE, V23, P643, DOI 10.20506/rst.23.2.1513; Saif Y. M., 2008, DIS POULTRY; Stavrinides J, 2004, J VIROL, V78, P76, DOI 10.1128/JVI.78.1.76-82.2004; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Sun L, 2007, VIRUS RES, V130, P121, DOI 10.1016/j.virusres.2007.06.003; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van der Hoek L, 2006, FEMS MICROBIOL REV, V30, P760, DOI 10.1111/j.1574-6976.2006.00032.x; Vijgen L, 2006, J VIROL, V80, P7270, DOI 10.1128/JVI.02675-05; Wahlgren J, 2008, VECTOR-BORNE ZOONOT, V8, P783, DOI 10.1089/vbz.2007.0274; Woo PCY, 2006, J VIROL, V80, P7136, DOI 10.1128/JVI.00509-06; Woo PCY, 2009, J VIROL, V83, P908, DOI 10.1128/JVI.01977-08; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005	38	49	52	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13640	10.1371/journal.pone.0013640	http://dx.doi.org/10.1371/journal.pone.0013640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060827	Green Submitted, gold, Green Published			2022-12-25	WOS:000283645300002
J	Song, YQ; Willer, JR; Scherer, PC; Panzer, JA; Kugath, A; Skordalakes, E; Gregg, RG; Willer, GB; Balice-Gordon, RJ				Song, Yuanquan; Willer, Jason R.; Scherer, Paul C.; Panzer, Jessica A.; Kugath, Amy; Skordalakes, Emmanuel; Gregg, Ronald G.; Willer, Gregory B.; Balice-Gordon, Rita J.			Neural and Synaptic Defects in slytherin, a Zebrafish Model for Human Congenital Disorders of Glycosylation	PLOS ONE			English	Article							GDP-FUCOSE TRANSPORTER; ADHESION DEFICIENCY-II; O-LINKED FUCOSE; UBIQUITIN LIGASE; NOTCH; DELTA; IDENTIFICATION; FRINGE; GENES; EXPRESSION	Congenital disorder of glycosylation type IIc (CDG IIc) is characterized by mental retardation, slowed growth and severe immunodeficiency, attributed to the lack of fucosylated glycoproteins. While impaired Notch signaling has been implicated in some aspects of CDG IIc pathogenesis, the molecular and cellular mechanisms remain poorly understood. We have identified a zebrafish mutant slytherin (srn), which harbors a missense point mutation in GDP-mannose 4,6 dehydratase (GMDS), the rate-limiting enzyme in protein fucosylation, including that of Notch. Here we report that some of the mechanisms underlying the neural phenotypes in srn and in CGD IIc are Notch-dependent, while others are Notch-independent. We show, for the first time in a vertebrate in vivo, that defects in protein fucosylation leads to defects in neuronal differentiation, maintenance, axon branching, and synapse formation. Srn is thus a useful and important vertebrate model for human CDG IIc that has provided new insights into the neural phenotypes that are hallmarks of the human disorder and has also highlighted the role of protein fucosylation in neural development.	[Song, Yuanquan; Scherer, Paul C.; Panzer, Jessica A.; Kugath, Amy; Balice-Gordon, Rita J.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Skordalakes, Emmanuel] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Willer, Jason R.; Gregg, Ronald G.; Willer, Gregory B.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA	University of Pennsylvania; The Wistar Institute; University of Louisville	Song, YQ (corresponding author), Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.	rbaliceg@mail.med.upenn.edu	Song, Yuanquan/E-2603-2012; Skordalakes, Emmanuel/H-7071-2019	Gregg, Ronald/0000-0001-5805-224X; Skordalakes, Emmanuel/0000-0002-7600-2833; Balice-Gordon, Rita/0000-0002-9950-7965; Willer, Jason/0000-0002-5869-3992	National Institutes of Health [NS050524]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health grant NS050524 to R.B.-G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Appel B, 2001, BMC Dev Biol, V1, P13, DOI 10.1186/1471-213X-1-13; Appel B, 1998, DEVELOPMENT, V125, P371; Bae YK, 2005, DEVELOPMENT, V132, P1375, DOI 10.1242/dev.01710; Becker DJ, 1999, BBA-MOL BASIS DIS, V1455, P193, DOI 10.1016/S0925-4439(99)00071-X; Bernardos RL, 2005, DEV BIOL, V278, P381, DOI 10.1016/j.ydbio.2004.11.018; Choe EA, 2007, J NEUROSCI, V27, P9503, DOI 10.1523/JNEUROSCI.1408-07.2007; Cornell RA, 2000, DEVELOPMENT, V127, P2873; Etzioni A, 2002, AM J MED GENET, V110, P131, DOI 10.1002/ajmg.10423; FRYDMAN M, 1992, AM J MED GENET, V44, P297, DOI 10.1002/ajmg.1320440307; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Gray M, 2001, DEV BIOL, V237, P306, DOI 10.1006/dbio.2001.0381; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; HARRIS RJ, 1993, BIOCHEMISTRY-US, V32, P6539, DOI 10.1021/bi00077a007; Hegde A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001479; Hellbusch CC, 2007, J BIOL CHEM, V282, P10762, DOI 10.1074/jbc.M700314200; Hutchinson SA, 2006, DEVELOPMENT, V133, P2137, DOI 10.1242/dev.02355; Ishikawa HO, 2005, P NATL ACAD SCI USA, V102, P18532, DOI 10.1073/pnas.0504115102; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; KOCHIBE N, 1980, BIOCHEMISTRY-US, V19, P2841, DOI 10.1021/bi00554a004; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/ng0501-73; Luhn K, 2004, EXP CELL RES, V301, P242, DOI 10.1016/j.yexcr.2004.08.043; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; Moloney DJ, 1999, GLYCOBIOLOGY, V9, P679, DOI 10.1093/glycob/9.7.679; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Nikolaou N, 2009, DEVELOPMENT, V136, P2523, DOI 10.1242/dev.034736; NONA SN, 1989, GLIA, V2, P189, DOI 10.1002/glia.440020308; Ohata S, 2009, DEVELOPMENT, V136, P1653, DOI 10.1242/dev.033290; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Panzer JA, 2005, DEV BIOL, V285, P340, DOI 10.1016/j.ydbio.2005.06.027; Park HC, 2003, DEVELOPMENT, V130, P3747, DOI 10.1242/dev.00576; Rauskolb C, 1999, NATURE, V401, P476, DOI 10.1038/46786; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Salama-Cohen P, 2006, J NEUROCHEM, V97, P1269, DOI 10.1111/j.1471-4159.2006.03783.x; Scheer N, 2002, MECH DEVELOP, V112, P9, DOI 10.1016/S0925-4773(01)00621-9; Shin J, 2007, DEVELOPMENT, V134, P1911, DOI 10.1242/dev.001602; Smith PL, 2002, J CELL BIOL, V158, P801, DOI 10.1083/jcb.200203125; Sturla L, 2003, J BIOL CHEM, V278, P26727, DOI 10.1074/jbc.M304068200; Thisse B, 2005, HIGH THROUGHPUT EXPR; Thisse B., 2001, EXPRESSION ZEBRAFISH; Thisse B, 2004, ZFIN DIRECT DATA SUB; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Willer GB, 2005, GENETICS, V170, P1827, DOI 10.1534/genetics.105.041608; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zecchin E, 2007, DEV BIOL, V301, P192, DOI 10.1016/j.ydbio.2006.09.041	51	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13743	10.1371/journal.pone.0013743	http://dx.doi.org/10.1371/journal.pone.0013743			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060795	Green Published, Green Submitted, gold			2022-12-25	WOS:000283645300023
J	Viswanathan, K; Koh, X; Chandrasekaran, A; Pappas, C; Raman, R; Srinivasan, A; Shriver, Z; Tumpey, TM; Sasisekharan, R				Viswanathan, Karthik; Koh, Xiaoying; Chandrasekaran, Aarthi; Pappas, Claudia; Raman, Rahul; Srinivasan, Aravind; Shriver, Zachary; Tumpey, Terrence M.; Sasisekharan, Ram			Determinants of Glycan Receptor Specificity of H2N2 Influenza A Virus Hemagglutinin	PLOS ONE			English	Article							PANDEMIC INFLUENZA; NORTH-AMERICA; TRANSMISSION; BINDING; ORIGIN; SWINE; MICROARRAY; TOPOLOGY; CHICKEN; CELLS	The H2N2 subtype of influenza A virus was responsible for the Asian pandemic of 1957-58. However, unlike other subtypes that have caused pandemics such as H1N1 and H3N2, which continue to circulate among humans, H2N2 stopped circulating in the human population in 1968. Strains of H2 subtype still continue to circulate in birds and occasionally pigs and could be reintroduced into the human population through antigenic drift or shift. Such an event is a potential global health concern because of the waning population immunity to H2 hemagglutinin (HA). The first step in such a cross-species transmission and human adaptation of influenza A virus is the ability for its surface glycoprotein HA to bind to glycan receptors expressed in the human upper respiratory epithelia. Recent structural and biochemical studies have focused on understanding the glycan receptor binding specificity of the 1957-58 pandemic H2N2 HA. However, there has been considerable HA sequence divergence in the recent avian-adapted H2 strains from the pandemic H2N2 strain. Using a combination of structural modeling, quantitative glycan binding and human respiratory tissue binding methods, we systematically identify mutations in the HA from a recent avian-adapted H2N2 strain (A/Chicken/PA/2004) that make its quantitative glycan receptor binding affinity (defined using an apparent binding constant) comparable to that of a prototypic pandemic H2N2 (A/Albany/6/58) HA.	[Viswanathan, Karthik; Koh, Xiaoying; Chandrasekaran, Aarthi; Raman, Rahul; Srinivasan, Aravind; Shriver, Zachary; Sasisekharan, Ram] MIT, Koch Inst Integrat Canc Res, Singapore MIT Alliance Res & Technol, Harvard MIT Div Hlth Sci & Technol,Dept Biol Engn, Cambridge, MA 02139 USA; [Pappas, Claudia; Tumpey, Terrence M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Harvard University; Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART); Centers for Disease Control & Prevention - USA	Viswanathan, K (corresponding author), MIT, Koch Inst Integrat Canc Res, Singapore MIT Alliance Res & Technol, Harvard MIT Div Hlth Sci & Technol,Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rams@mit.edu		Koh-Stenta, Carol Xiaoying/0000-0001-9888-0488	National Institute of General Medical Sciences of the NIH [GM57073, U54 GM62116]; Singapore-MIT Alliance for Research and Technology; Agency for Science, Technology and Research (A*STAR) in Singapore; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057073, U54GM062116, R37GM057073] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Singapore-MIT Alliance for Research and Technology(Singapore-MIT Alliance for Research & Technology Centre (SMART)); Agency for Science, Technology and Research (A*STAR) in Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Institute of General Medical Sciences of the NIH (GM57073 and U54 GM62116) and the Singapore-MIT Alliance for Research and Technology. X.K. is supported by Agency for Science, Technology and Research (A*STAR) in Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASLER C, 2002, ENCY MOL MED, P1741; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Gambaryan AS, 2003, AVIAN DIS, V47, P1154, DOI 10.1637/0005-2086-47.s3.1154; Glaser L, 2006, GLYCOCONJUGATE J, V23, P93, DOI 10.1007/s10719-006-5441-0; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Ma W, 2007, P NATL ACAD SCI USA, V104, P20949, DOI 10.1073/pnas.0710286104; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Makarova NA, 1999, J GEN VIROL, V80, P3167, DOI 10.1099/0022-1317-80-12-3167; PAPPAS C, 2010, PLOS ONE IN PRESS; Russell CJ, 2005, CELL, V123, P368, DOI 10.1016/j.cell.2005.10.019; SCHAFER JR, 1993, VIROLOGY, V194, P781, DOI 10.1006/viro.1993.1319; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Shriver Z, 2009, CHEM BIOL, V16, P803, DOI 10.1016/j.chembiol.2009.08.002; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Stevens J, 2006, NAT REV MICROBIOL, V4, P857, DOI 10.1038/nrmicro1530; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; Xu D, 2009, J MOL BIOL, V387, P465, DOI 10.1016/j.jmb.2009.01.040; XU R, 2009, J VIROL; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1	31	30	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13768	10.1371/journal.pone.0013768	http://dx.doi.org/10.1371/journal.pone.0013768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060797	Green Submitted, Green Published, gold			2022-12-25	WOS:000283645300043
J	Merchan, JR; Kovacs, K; Railsback, JW; Kurtoglu, M; Jing, YQ; Pina, Y; Gao, NG; Murray, TG; Lehrman, MA; Lampidis, TJ				Merchan, Jaime R.; Kovacs, Krisztina; Railsback, Jaclyn W.; Kurtoglu, Metin; Jing, Yuqi; Pina, Yolanda; Gao, Ningguo; Murray, Timothy G.; Lehrman, Mark A.; Lampidis, Theodore J.			Antiangiogenic Activity of 2-Deoxy-D-Glucose	PLOS ONE			English	Article							ENDOTHELIAL-CELL PROLIFERATION; GLUCOSE-TRANSPORTER EXPRESSION; IN-VITRO; CLINICAL-TRIALS; F-18-FDG UPTAKE; GROWTH-FACTOR; ANGIOGENESIS; CANCER; RETINOBLASTOMA; INHIBITION	Background: During tumor angiogenesis, endothelial cells (ECs) are engaged in a number of energy consuming biological processes, such as proliferation, migration, and capillary formation. Since glucose uptake and metabolism are increased to meet this energy need, the effects of the glycolytic inhibitor 2-deoxy-D-glucose (2-DG) on in vitro and in vivo angiogenesis were investigated. Methodology/Principal Findings: In cell culture, 2-DG inhibited EC growth, induced cytotoxicity, blocked migration, and inhibited actively forming but not established endothelial capillaries. Surprisingly, 2-DG was a better inhibitor of these EC properties than two more efficacious glycolytic inhibitors, 2-fluorodeoxy-D-glucose and oxamate. As an alternative to a glycolytic inhibitory mechanism, we considered 2-DG's ability to interfere with endothelial N-linked glycosylation. 2-DG's effects were reversed by mannose, an N-linked glycosylation precursor, and at relevant concentrations 2-DG also inhibited synthesis of the lipid linked oligosaccharide (LLO) N-glycosylation donor in a mannose-reversible manner. Inhibition of LLO synthesis activated the unfolded protein response (UPR), which resulted in induction of GADD153/CHOP and EC apoptosis (TUNEL assay). Thus, 2-DG's effects on ECs appeared primarily due to inhibition of LLOs synthesis, not glycolysis. 2-DG was then evaluated in two mouse models, inhibiting angiogenesis in both the matrigel plug assay and the LH(BETA)T(AG) transgenic retinoblastoma model. Conclusions/Significance: In conclusion, 2-DG inhibits endothelial cell angiogenesis in vitro and in vivo, at concentrations below those affecting tumor cells directly, most likely by interfering with N-linked glycosylation rather than glycolysis. Our data underscore the importance of glucose metabolism on neovascularization, and demonstrate a novel approach for anti-angiogenic strategies.	[Merchan, Jaime R.; Kovacs, Krisztina; Railsback, Jaclyn W.; Kurtoglu, Metin; Jing, Yuqi] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; [Merchan, Jaime R.; Kovacs, Krisztina; Railsback, Jaclyn W.; Kurtoglu, Metin; Jing, Yuqi; Lampidis, Theodore J.] Sylvester Comprehens Canc Ctr, Miami, FL USA; [Lampidis, Theodore J.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA; [Pina, Yolanda; Murray, Timothy G.] Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Gao, Ningguo; Lehrman, Mark A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Miami; University of Miami; Bascom Palmer Eye Institute; University of Miami; University of Texas System; University of Texas Southwestern Medical Center Dallas	Merchan, JR (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA.	jmerchan2@med.miami.edu			National Institutes of Health [CA 119545-02, CA 37109, GM 38545, R01 EY013629, P30 EY014801]; University of Miami/Sylvester Comprehensive Cancer Center; PAP Corps; Welch Foundation [I-1168]; Research to prevent blindness, INC; NATIONAL CANCER INSTITUTE [R21CA119545, R01CA037109] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013629, P30EY014801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM038545, R01GM038545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Miami/Sylvester Comprehensive Cancer Center; PAP Corps; Welch Foundation(The Welch Foundation); Research to prevent blindness, INC(Research to Prevent Blindness (RPB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (CA 119545-02 to J.R.M.; CA 37109 to T.J.L.; GM 38545 to M. A. L.; R01 EY013629, P30 EY014801 to T. G. M.); the University of Miami/Sylvester Comprehensive Cancer Center and the PAP Corps (to J.R.M., T.J.L., and T. G. M.); the Welch Foundation (I-1168 to M. A. L.); and an unrestricted grant to the University of Miami from Research to prevent blindness, INC (to T. G. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci HE, 2010, AM J PHYSIOL-CELL PH, V298, pC1527, DOI 10.1152/ajpcell.00484.2009; Aft RL, 2002, BRIT J CANCER, V87, P805, DOI 10.1038/sj.bjc.6600547; Belhocine T, 2003, EUR J NUCL MED MOL I, V30, P1305, DOI 10.1007/s00259-003-1209-y; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bocci G, 2003, P NATL ACAD SCI USA, V100, P12917, DOI 10.1073/pnas.2135406100; Bos R, 2002, J CLIN ONCOL, V20, P379, DOI 10.1200/JCO.20.2.379; BOURKE CA, 1993, AUST VET J, V70, P188, DOI 10.1111/j.1751-0813.1993.tb06131.x; BOUTRID H, 2008, INVEST OPHTHALMOL VI; Buck AK, 2004, J NUCL MED, V45, P461; Cao Y, 2010, EXP CELL RES, V316, P1304, DOI 10.1016/j.yexcr.2010.02.031; Chan B, 2003, MICROVASC RES, V66, P1, DOI 10.1016/S0026-2862(03)00037-2; Chander SK, 2007, BRIT J CANCER, V96, P1368, DOI 10.1038/sj.bjc.6603727; DATEMA R, 1979, BIOCHEM J, V184, P113, DOI 10.1042/bj1840113; Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jockovich ME, 2007, INVEST OPHTH VIS SCI, V48, P2476, DOI 10.1167/iovs.06-1397; Jockovich ME, 2006, INVEST OPHTH VIS SCI, V47, P1264, DOI 10.1167/iovs.05-1194; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; KRUTZFELDT A, 1990, J MOL CELL CARDIOL, V22, P1393, DOI 10.1016/0022-2828(90)90984-A; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Kurtoglu M, 2007, ANTIOXID REDOX SIGN, V9, P1383, DOI 10.1089/ars.2007.1714; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin TY, 1999, J CELL BIOCHEM, V74, P638, DOI 10.1002/(SICI)1097-4644(19990915)74:4<638::AID-JCB13>3.0.CO;2-C; LOIKE JD, 1992, AM J PHYSIOL, V263, pC326, DOI 10.1152/ajpcell.1992.263.2.C326; Maeshima Y, 2000, J BIOL CHEM, V275, P21340, DOI 10.1074/jbc.M001956200; Maeshima Y, 2001, J BIOL CHEM, V276, P31959, DOI 10.1074/jbc.M103024200; Maher JC, 2005, PANCREAS, V30, pE34, DOI 10.1097/01.mpa.0000153327.46945.26; Maher JC, 2007, MOL CANCER THER, V6, P732, DOI 10.1158/1535-7163.MCT-06-0407; Mann GE, 2003, PHYSIOL REV, V83, P183, DOI 10.1152/physrev.00022.2002; Marback EF, 2003, BRIT J OPHTHALMOL, V87, P1224, DOI 10.1136/bjo.87.10.1224; Martinez JA, 1999, CELL MOL BIOL, V45, P137; Martinez JA, 2000, ADV EXP MED BIOL, V476, P197; Martinez JA, 2006, GLYCOCONJUGATE J, V23, P209, DOI 10.1007/s10719-006-7926-2; Maschauer S, 2004, J NUCL MED, V45, P455; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Merchan JR, 2003, J NATL CANCER I, V95, P388, DOI 10.1093/jnci/95.5.388; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; PILI R, 1995, CANCER RES, V55, P2920; Rossler J, 2004, AM J PATHOL, V164, P391, DOI 10.1016/S0002-9440(10)63129-X; RUPRECHT RM, 1989, J ACQ IMMUN DEF SYND, V2, P149; SAUL R, 1985, P NATL ACAD SCI USA, V82, P93, DOI 10.1073/pnas.82.1.93; Sone H, 2000, INVEST OPHTH VIS SCI, V41, P1876; Stein M, 2010, PROSTATE, V70, P1388, DOI 10.1002/pros.21172; WINDLE JJ, 1990, NATURE, V343, P665, DOI 10.1038/343665a0; Yeh WL, 2008, MOL PHARMACOL, V73, P170, DOI 10.1124/mol.107.038851; Yun MJ, 2002, SEMIN NUCL MED, V32, P70, DOI 10.1053/snuc.2002.29279	52	88	93	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13699	10.1371/journal.pone.0013699	http://dx.doi.org/10.1371/journal.pone.0013699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060881	Green Published, gold, Green Submitted			2022-12-25	WOS:000283537000058
J	Bonnefond, A; Durand, E; Sand, O; De Graeve, F; Gallina, S; Busiah, K; Lobbens, S; Simon, A; Bellanne-Chantelot, C; Letourneau, L; Scharfmann, R; Delplanque, J; Sladek, R; Polak, M; Vaxillaire, M; Froguel, P				Bonnefond, Amelie; Durand, Emmanuelle; Sand, Olivier; De Graeve, Franck; Gallina, Sophie; Busiah, Kanetee; Lobbens, Stephane; Simon, Albane; Bellanne-Chantelot, Christine; Letourneau, Louis; Scharfmann, Raphael; Delplanque, Jerome; Sladek, Robert; Polak, Michel; Vaxillaire, Martine; Froguel, Philippe			Molecular Diagnosis of Neonatal Diabetes Mellitus Using Next-Generation Sequencing of the Whole Exome	PLOS ONE			English	Article							ACTIVATING MUTATIONS; GENE; INSULIN; KIR6.2	Background: Accurate molecular diagnosis of monogenic non-autoimmune neonatal diabetes mellitus (NDM) is critical for patient care, as patients carrying a mutation in KCNJ11 or ABCC8 can be treated by oral sulfonylurea drugs instead of insulin therapy. This diagnosis is currently based on Sanger sequencing of at least 42 PCR fragments from the KCNJ11, ABCC8, and INS genes. Here, we assessed the feasibility of using the next-generation whole exome sequencing (WES) for the NDM molecular diagnosis. Methodology/Principal Findings: We carried out WES for a patient presenting with permanent NDM, for whom mutations in KCNJ11, ABCC8 and INS and abnormalities in chromosome 6q24 had been previously excluded. A solution hybridization selection was performed to generate WES in 76 bp paired-end reads, by using two channels of the sequencing instrument. WES quality was assessed using a high-resolution oligonucleotide whole-genome genotyping array. From our WES with high-quality reads, we identified a novel non-synonymous mutation in ABCC8 (c.1455G>C/p.Q485H), despite a previous negative sequencing of this gene. This mutation, confirmed by Sanger sequencing, was not present in 348 controls and in the patient's mother, father and young brother, all of whom are normoglycemic. Conclusions/Significance: WES identified a novel de novo ABCC8 mutation in a NDM patient. Compared to the current Sanger protocol, WES is a comprehensive, cost-efficient and rapid method to identify mutations in NDM patients. We suggest WES as a near future tool of choice for further molecular diagnosis of NDM cases, negative for chr6q24, KCNJ11 and INS abnormalities.	[Bonnefond, Amelie; Durand, Emmanuelle; Sand, Olivier; De Graeve, Franck; Gallina, Sophie; Lobbens, Stephane; Delplanque, Jerome; Vaxillaire, Martine; Froguel, Philippe] Univ Lille Nord France, UDSL, CNRS, UMR 8199, Lille, France; [Busiah, Kanetee; Simon, Albane; Scharfmann, Raphael; Polak, Michel] Univ Paris 05, Hop Necker Enfants Malad, Dept Pediat Endocrinol, Inserm U845, Paris, France; [Bellanne-Chantelot, Christine] Hop La Pitie Salpetriere, Dept Genet, Paris, France; [Letourneau, Louis; Sladek, Robert] McGill Univ, Dept Human Genet, Fac Med, Montreal, PQ, Canada; [Letourneau, Louis; Sladek, Robert] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Hammersmith Hosp, Dept Genom Common Dis, London, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; McGill University; Imperial College London	Bonnefond, A (corresponding author), Univ Lille Nord France, UDSL, CNRS, UMR 8199, Lille, France.	p.froguel@imperial.ac.uk	Kanetee, BUSIAH/AAP-8292-2020; scharfmann, raphael/L-3296-2017; Bonnefond, Amélie/O-2784-2017; FROGUEL, Philippe/O-6799-2017; Sladek, Robert/R-2391-2019	Kanetee, BUSIAH/0000-0002-1059-0791; Bonnefond, Amélie/0000-0001-9976-3005; FROGUEL, Philippe/0000-0003-2972-0784; Sladek, Robert/0000-0002-2730-1204; Scharfmann, Raphael/0000-0001-7619-337X; Gallina, Sophie/0000-0002-6194-3649; Sand, Olivier/0000-0003-1465-1640	Conseil Regional du Nord Pas de Calais (France); Centre National de la Recherche Scientifique (CNRS); ANR [ANR-07-MRAR-000, ERANET 09 RARE 005]; European Union [LSHM-CT-2006-518153]; Medical Research Council [G0600331] Funding Source: researchfish; MRC [G0600331] Funding Source: UKRI	Conseil Regional du Nord Pas de Calais (France)(Region Hauts-de-FranceRegion Ile-de-France); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AB is funded by a research fellowship from the Conseil Regional du Nord Pas de Calais (France) and the Centre National de la Recherche Scientifique (CNRS). This study was supported by the ANR-MRAR research program ("Programme Pluriannuel National de Recherche sur les Maladies Rares'', ANR-07-MRAR-000, to MP), a transnational European research grant on Rare Diseases (ERANET 09 RARE 005, to MV and MP) and the European Union (Integrated Project EuroDia LSHM-CT-2006-518153 in the Framework Programme 6 [FP6] of the European-Community, to PF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aguilar-Bryan L, 2008, ENDOCR REV, V29, P265, DOI 10.1210/er.2007-0029; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; EDGHILL EL, JOP, V11, P14; Ellard S, 2007, AM J HUM GENET, V81, P375, DOI 10.1086/519174; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Hattersley A, 2009, PEDIATR DIABETES, V10, P33, DOI 10.1111/j.1399-5448.2009.00571.x; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Polak M, 2008, DIABETES, V57, P1115, DOI 10.2337/db07-1358; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Vaxillaire M, 2007, DIABETES, V56, P1737, DOI 10.2337/db06-1540; Vaxillaire Martine, 2009, Pediatr Endocrinol Rev, V6, P405	14	83	90	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13630	10.1371/journal.pone.0013630	http://dx.doi.org/10.1371/journal.pone.0013630			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049026	Green Published, gold, Green Submitted			2022-12-25	WOS:000283487400020
J	Zhang, Y; Hu, YB; Yang, BY; Ma, F; Lu, P; Li, LM; Wan, CS; Rayner, S; Chen, SY				Zhang, Yong; Hu, Yangbo; Yang, Baoyu; Ma, Fang; Lu, Pei; Li, Lamei; Wan, Chengsong; Rayner, Simon; Chen, Shiyun			Duckweed (Lemna minor) as a Model Plant System for the Study of Human Microbial Pathogenesis	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA VIRULENCE; RESISTANT STAPHYLOCOCCUS-AUREUS; CAENORHABDITIS-ELEGANS; ARABIDOPSIS-THALIANA; BIOFILM FORMATION; INFECTION MODEL; INNATE IMMUNITY; PATHOGENICITY; HOST; ANIMALS	Background: Plant infection models provide certain advantages over animal models in the study of pathogenesis. However, current plant models face some limitations, e. g., plant and pathogen cannot co-culture in a contained environment. Development of such a plant model is needed to better illustrate host-pathogen interactions. Methodology/Principal Findings: We describe a novel model plant system for the study of human pathogenic bacterial infection on a large scale. This system was initiated by co-cultivation of axenic duckweed (Lemna minor) plants with pathogenic bacteria in 24-well polystyrene cell culture plate. Pathogenesis of bacteria to duckweed was demonstrated with Pseudomonas aeruginosa and Staphylococcus aureus as two model pathogens. P. aeruginosa PAO1 caused severe detriment to duckweed as judged from inhibition to frond multiplication and chlorophyll formation. Using a GFP-marked PAO1 strain, we demonstrated that bacteria colonized on both fronds and roots and formed biofilms. Virulence of PAO1 to duckweed was attenuated in its quorum sensing (QS) mutants and in recombinant strains overexpressing the QS quenching enzymes. RN4220, a virulent strain of S. aureus, caused severe toxicity to duckweed while an avirulent strain showed little effect. Using this system for antimicrobial chemical selection, green tea polyphenols exhibited inhibitory activity against S. aureus virulence. This system was further confirmed to be effective as a pathogenesis model using a number of pathogenic bacterial species. Conclusions/Significance: Our results demonstrate that duckweed can be used as a fast, inexpensive and reproducible model plant system for the study of host-pathogen interactions, could serve as an alternative choice for the study of some virulence factors, and could also potentially be used in large-scale screening for the discovery of antimicrobial chemicals.	[Zhang, Yong; Hu, Yangbo; Yang, Baoyu; Ma, Fang; Lu, Pei; Li, Lamei; Rayner, Simon; Chen, Shiyun] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Wan, Chengsong] So Med Univ, Sch Publ Hlth & Trop Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China; [Hu, Yangbo; Ma, Fang; Lu, Pei; Li, Lamei] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Southern Medical University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, Y (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	sychen@wh.iov.cn	rayner, simon/N-7715-2013	rayner, simon/0000-0001-8703-9140; chen, shi yun/0000-0002-6224-2975; Zhang, Yong/0000-0003-0510-1655	National Science Foundation of China [30771239]; China National Science and Technology Specific Projects [2008ZX08009-003]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Science and Technology Specific Projects	National Science Foundation of China (30771239) and China National Science and Technology Specific Projects (2008ZX08009-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adonizio A, 2008, J MED MICROBIOL, V57, P809, DOI 10.1099/jmm.0.47802-0; Attila C, 2008, MICROB BIOTECHNOL, V1, P17, DOI 10.1111/j.1751-7915.2007.00002.x; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Bernier SP, 2003, INFECT IMMUN, V71, P5306, DOI 10.1128/IAI.71.9.5306-5313.2003; Brain RA, 2007, NAT PROTOC, V2, P979, DOI 10.1038/nprot.2007.146; Cox KM, 2006, NAT BIOTECHNOL, V24, P1591, DOI 10.1038/nbt1260; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Filiatrault MJ, 2006, INFECT IMMUN, V74, P4237, DOI 10.1128/IAI.02014-05; Gopalan S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003891; Guttman DS, 2004, BIOTECHNOL ADV, V22, P363, DOI 10.1016/j.biotechadv.2003.11.001; Hu YB, 2009, MICROBIOL-SGM, V155, P2522, DOI 10.1099/mic.0.028381-0; Hu ZQ, 2002, ANTIMICROB AGENTS CH, V46, P558, DOI 10.1128/AAC.46.2.558-560.2002; Hu ZQ, 2001, J ANTIMICROB CHEMOTH, V48, P361, DOI 10.1093/jac/48.3.361; Irie Y, 2008, CURR TOP MICROBIOL, V322, P67; Jha AK, 2005, INFECT IMMUN, V73, P464, DOI 10.1128/IAI.73.1.464-475.2005; Lugtenberg BJJ, 2002, ANTON LEEUW INT J G, V81, P373, DOI 10.1023/A:1020596903142; Ma F, 2009, APPL MICROBIOL BIOT, V83, P135, DOI 10.1007/s00253-009-1890-2; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Peleg AY, 2008, P NATL ACAD SCI USA, V105, P14585, DOI 10.1073/pnas.0805048105; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225; Prithiviraj B, 2005, PLANT J, V42, P417, DOI 10.1111/j.1365-313X.2005.02385.x; Prithiviraj B, 2005, CELL MICROBIOL, V7, P315, DOI 10.1111/j.1462-5822.2005.00494.x; Prouty MG, 2003, FEMS MICROBIOL LETT, V225, P177, DOI 10.1016/S0378-1097(03)00446-4; QUESSY S, 1995, INFECT IMMUN, V63, P1975, DOI 10.1128/IAI.63.5.1975-1979.1995; Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 1997, P NATL ACAD SCI USA, V94, P13245, DOI 10.1073/pnas.94.24.13245; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; SCHENK RU, 1972, CAN J BOTANY, V50, P199, DOI 10.1139/b72-026; Scherr C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003133; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Silo-Suh L, 2002, P NATL ACAD SCI USA, V99, P15699, DOI 10.1073/pnas.242343999; Starkey M, 2009, NAT PROTOC, V4, P117, DOI 10.1038/nprot.2008.224; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tekstra J, 1999, CLIN EXP IMMUNOL, V117, P489; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; van Baarlen P, 2007, FEMS MICROBIOL REV, V31, P239, DOI 10.1111/j.1574-6976.2007.00065.x; van Baarlen P, 2007, DRUG DISCOV TODAY, V12, P167, DOI 10.1016/j.drudis.2006.12.007; Vunsh R, 2007, PLANT CELL REP, V26, P1511, DOI 10.1007/s00299-007-0361-4; Walker TS, 2004, PLANT PHYSIOL, V134, P320, DOI 10.1104/pp.103.027888; Wang Y, 2007, SCI CHINA SER C, V50, P385, DOI 10.1007/s11427-007-0044-y; Wu H, 2001, MICROBIOL-SGM, V147, P1105, DOI 10.1099/00221287-147-5-1105; Xiong N, 2009, ARCH MICROBIOL, V191, P879, DOI 10.1007/s00203-009-0520-9; Xu J, 2008, ANTIVIR RES, V78, P242, DOI 10.1016/j.antiviral.2007.11.011	47	11	12	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13527	10.1371/journal.pone.0013527	http://dx.doi.org/10.1371/journal.pone.0013527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049039	Green Submitted, gold, Green Published			2022-12-25	WOS:000283422100005
J	Lewis, TW; Woolliams, JA; Blott, SC				Lewis, Thomas W.; Woolliams, John A.; Blott, Sarah C.			Genetic Evaluation of the Nine Component Features of Hip Score in UK Labrador Retrievers	PLOS ONE			English	Article							MOUNTAIN DOG; DYSPLASIA	The aim of this study was to explore the genetic relationship between the nine component traits comprising the British Veterinary Association (BVA) total hip score in UK registered Labrador Retrievers. Data consisted of 11,928 single records of trait scores of dogs aged between one and four years (365-1459 days) old, from radiographs evaluated between 2000 and 2007. Pedigree information was provided by the UK Kennel Club. The distribution of trait scores showed only small numbers of dogs with visible malformation in the six traits that were scored according to the severity of osteoarthritis. Linear mixed models were fitted using ASREML. Estimates of heritability ranged from 0.15 to 0.38, and litter effects from 0.04 to 0.10. Genetic correlations between all nine traits were extremely high ranging from 0.71 to 1.0, implying considerable genetic similarity. The decomposition demonstrated that aggregate scores of only the 3 traits indicative of laxity in one year old dogs was predictive of the phenotype of the remaining six scored on osteoarthritic severity in dogs at 4+ years old. The application of selection index methodology in selecting against hip dysplasia using the trait scores was explored and potential improvements in accuracy (directly related to response to selection) of over 10% are reported compared to the current total hip score. This study demonstrates that traits descriptive of joint laxity are valuable early-age predictors of osteoarthritis and shows that there is scope for improvement in the way data from the UK hip score scheme are used for selection against hip dysplasia in Labradors. This was verified via use of selection indices, which identified substantial increases in accuracy, not only via optimum coefficients, but also through an easily applicable aggregate of scores of just two or three traits only compared with the current total hip score.	[Lewis, Thomas W.; Blott, Sarah C.] Anim Hlth Trust, Kennel Club Genet Ctr, Newmarket, Suffolk, England; [Woolliams, John A.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Woolliams, John A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland	Animal Health Trust; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Lewis, TW (corresponding author), Anim Hlth Trust, Kennel Club Genet Ctr, Newmarket, Suffolk, England.	tom.lewis@aht.org.uk		Blott, Sarah/0000-0003-0233-6846; Lewis, Thomas/0000-0003-4166-7955	Kennel Club Charitable Trust; BBSRC through ISPG; BBSRC [BBS/E/D/05191133] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05191133] Funding Source: researchfish	Kennel Club Charitable Trust; BBSRC through ISPG(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Kennel Club Charitable Trust. JAW is grateful to BBSRC for funding through an ISPG. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. Hip score and pedigree data is collated and provided by the Kennel Club.	BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BRASS W, 1989, J SMALL ANIM PRACT, V30, P166, DOI 10.1111/j.1748-5827.1989.tb01525.x; Cameron N.D., 1997, SELECTION INDICES PR; Gibbs C, 1997, VET REC, V141, P275; Gilmour A., 2006, ASREML USER GUIDE RE; Hou YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009410; Leppanen M, 1999, PREV VET MED, V42, P121, DOI 10.1016/S0167-5877(99)00059-8; LEWIS TW, 2010, PLOS ONE IN PRESS; Maki K, 2004, THESIS U HELSINKI; Malm S, 2008, J ANIM BREED GENET, V125, P403, DOI 10.1111/j.1439-0388.2008.00725.x; Ohlerth S, 1998, DEUT TIERARZTL WOCH, V105, P378; Silvestre AM, 2007, J ANIM SCI, V85, P1880, DOI 10.2527/jas.2007-0166; Willis MB, 1997, J AM VET MED ASSOC, V210, P1480; Wood JLN, 2002, PREV VET MED, V55, P95, DOI 10.1016/S0167-5877(02)00090-9	14	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13610	10.1371/journal.pone.0013610	http://dx.doi.org/10.1371/journal.pone.0013610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042594	gold, Green Published, Green Submitted			2022-12-25	WOS:000283419100026
J	Pagani, L; Semenova, EA; Moriggi, E; Revell, VL; Hack, LM; Lockley, SW; Arendt, J; Skene, DJ; Meier, F; Izakovic, J; Wirz-Justice, A; Cajochen, C; Sergeeva, OJ; Cheresiz, SV; Danilenko, KV; Eckert, A; Brown, SA				Pagani, Lucia; Semenova, Ekaterina A.; Moriggi, Ermanno; Revell, Victoria L.; Hack, Lisa M.; Lockley, Steven W.; Arendt, Josephine; Skene, Debra J.; Meier, Fides; Izakovic, Jan; Wirz-Justice, Anna; Cajochen, Christian; Sergeeva, Oksana J.; Cheresiz, Sergei V.; Danilenko, Konstantin V.; Eckert, Anne; Brown, Steven A.			The Physiological Period Length of the Human Circadian Clock In Vivo Is Directly Proportional to Period in Human Fibroblasts	PLOS ONE			English	Article							GENE-EXPRESSION; MELATONIN RHYTHMS; INTRINSIC PERIOD; ENTRAINMENT; PACEMAKER; SLEEP; TEMPERATURE; INSIGHTS; SYSTEM; TIME	Background: Diurnal behavior in humans is governed by the period length of a circadian clock in the suprachiasmatic nuclei of the brain hypothalamus. Nevertheless, the cell-intrinsic mechanism of this clock is present in most cells of the body. We have shown previously that for individuals of extreme chronotype ("larks" and "owls"), clock properties measured in human fibroblasts correlated with extreme diurnal behavior. Methodology/Principal Findings: In this study, we have measured circadian period in human primary fibroblasts taken from normal individuals and, for the first time, compared it directly with physiological period measured in vivo in the same subjects. Human physiological period length was estimated via the secretion pattern of the hormone melatonin in two different groups of sighted subjects and one group of totally blind subjects, each using different methods. Fibroblast period length was measured via cyclical expression of a lentivirally delivered circadian reporter. Within each group, a positive linear correlation was observed between circadian period length in physiology and in fibroblast gene expression. Interestingly, although blind individuals showed on average the same fibroblast clock properties as sighted ones, their physiological periods were significantly longer. Conclusions/Significance: We conclude that the period of human circadian behaviour is mostly driven by cellular clock properties in normal individuals and can be approximated by measurement in peripheral cells such as fibroblasts. Based upon differences among sighted and blind subjects, we also speculate that period can be modified by prolonged unusual conditions such as the total light deprivation of blindness.	[Pagani, Lucia; Meier, Fides; Eckert, Anne] Psychiat Univ Clin Basel, Neurobiol Lab Brain Aging & Mental Hlth, Basel, Switzerland; [Semenova, Ekaterina A.; Sergeeva, Oksana J.; Danilenko, Konstantin V.] Russian Acad Med Sci, Siberian Branch, Inst Internal Med, Novosibirsk, Russia; [Moriggi, Ermanno; Brown, Steven A.] Univ Zurich, Dept Pharmacol & Toxicol, Zurich, Switzerland; [Revell, Victoria L.; Hack, Lisa M.; Arendt, Josephine; Skene, Debra J.] Univ Surrey, Fac Hlth & Med Sci, Ctr Chronobiol, Guildford GU2 5XH, Surrey, England; [Lockley, Steven W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Circadian Physiol Program,Div Sleep Med, Boston, MA 02115 USA; [Izakovic, Jan] Univ Basel Hosp, Dept Dermatol, CH-4031 Basel, Switzerland; [Wirz-Justice, Anna; Cajochen, Christian] Psychiat Univ Clin Basel, Ctr Chronobiol, Basel, Switzerland; [Cheresiz, Sergei V.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia	University of Basel; Russian Academy of Medical Sciences; Russian Academy of Sciences; University of Zurich; University of Surrey; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Basel; University of Basel; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Pagani, L (corresponding author), Psychiat Univ Clin Basel, Neurobiol Lab Brain Aging & Mental Hlth, Basel, Switzerland.	anne.eckert@upkbs.ch; steven.brown@pharma.uzh.ch	Cajochen, Christian/N-6748-2014; Semenova, Ekaterina/R-9152-2016; Danilenko, Konstantin V./E-1250-2015	Danilenko, Konstantin V./0000-0002-2096-4216; Eckert, Anne/0000-0002-9341-3669; Skene, Debra/0000-0001-8202-6180; Lockley, Steven/0000-0001-5209-2881	Swiss National Science Foundation; Velux Foundation; 6th European Framework Project EUCLOCK [018741]; E.U. [LSHM-CT-2006-018741]; Desiree & Niels Yde Foundation; Fonds der Freiwilligen Akademischen Gesellschaft Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Foundation(Velux Fonden); 6th European Framework Project EUCLOCK(European Commission); E.U.(European Commission); Desiree & Niels Yde Foundation; Fonds der Freiwilligen Akademischen Gesellschaft Basel	This work was supported by grants from the Swiss National Science Foundation, the Velux Foundation, and the 6th European Framework Project EUCLOCK (#018741), from E.U. #LSHM-CT-2006-018741, from the Desiree & Niels Yde Foundation, and from the Fonds der Freiwilligen Akademischen Gesellschaft Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDHOUS ME, 1988, ANN CLIN BIOCHEM, V25, P298, DOI 10.1177/000456328802500319; Blatter K, 2007, PHYSIOL BEHAV, V90, P196, DOI 10.1016/j.physbeh.2006.09.009; Brown SA, 2005, PLOS BIOL, V3, P1813, DOI 10.1371/journal.pbio.0030338; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Carskadon MA, 1999, NEUROSCI LETT, V260, P129, DOI 10.1016/S0304-3940(98)00971-9; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; Dibner C, 2009, EMBO J, V28, P123, DOI 10.1038/emboj.2008.262; Dijk DJ, 2000, CHRONOBIOL INT, V17, P285, DOI 10.1081/CBI-100101049; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; Gachon F, 2004, CHROMOSOMA, V113, P103, DOI 10.1007/s00412-004-0296-2; Gronfier C, 2007, P NATL ACAD SCI USA, V104, P9081, DOI 10.1073/pnas.0702835104; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; Izumo M, 2003, P NATL ACAD SCI USA, V100, P16089, DOI 10.1073/pnas.2536313100; Koorengevel KM, 2002, J BIOL RHYTHM, V17, P463, DOI 10.1177/074873002237140; Kowalska E, 2007, COLD SPRING HARB SYM, V72, P301, DOI 10.1101/sqb.2007.72.014; Lockley SW, 1997, J CLIN ENDOCR METAB, V82, P3763, DOI 10.1210/jc.82.11.3763; Middleton B, 1997, J BIOL RHYTHM, V12, P467, DOI 10.1177/074873049701200508; Mistlberger RE, 2005, J BIOL RHYTHM, V20, P339, DOI 10.1177/0748730405277982; Nakamura Kouji, 1996, Hokkaido Journal of Medical Science, V71, P403; Ptacek LJ, 2007, COLD SPRING HARB SYM, V72, P273; REME CE, 1991, J BIOL RHYTHM, V6, P5, DOI 10.1177/074873049100600104; Scheer FAJL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000721; VANREETH O, 1994, P SOC EXP BIOL MED, V206, P138; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Wright KP, 2005, J BIOL RHYTHM, V20, P168, DOI 10.1177/0748730404274265; Wright KP, 2001, P NATL ACAD SCI USA, V98, P14027, DOI 10.1073/pnas.201530198; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542	29	66	76	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13376	10.1371/journal.pone.0013376	http://dx.doi.org/10.1371/journal.pone.0013376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	21042402	Green Published, Green Accepted, gold			2022-12-25	WOS:000283043700003
J	Brown, BL; Wood, TK; Peti, W; Page, R				Brown, Breann L.; Wood, Thomas K.; Peti, Wolfgang; Page, Rebecca			Structure of the Escherichia coli Antitoxin MqsA (YgiT/b3021) Bound to Its Gene Promoter Reveals Extensive Domain Rearrangements and the Specificity of Transcriptional Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MULTIDRUG TOLERANCE; NUCLEIC-ACID; TOXIN; COMPLEX; MECHANISMS; PROTEIN; RECOGNITION; RESISTANCE; OPERON	Bacterial cultures, especially biofilms, produce a small number of persister cells, a genetically identical subpopulation of wild type cells that are metabolically dormant, exhibit multidrug tolerance, and are highly enriched in bacterial toxins. The gene most highly up-regulated in Escherichia coli persisters is mqsR, a ribonuclease toxin that, along with mqsA, forms a novel toxin.antitoxin (TA) system. Like all known TA systems, both the MqsR.MqsA complex and MqsA alone regulate their own transcription. Despite the importance of TA systems in persistence and biofilms, very little is known about how TA modules, and antitoxins in particular, bind and recognize DNA at a molecular level. Here, we report the crystal structure of MqsA bound to a 26-bp fragment from the mqsRA promoter. We show that MqsA binds DNA predominantly via its C-terminal helix-turn-helix domain, with direct binding of recognition helix residues Asn(97) and Arg(101) to the DNA major groove. Unexpectedly, the structure also revealed that the MqsA N-terminal domain interacts with the DNA phosphate backbone. This results in a more than 105 degrees rotation of the N-terminal domains between the free and complexed states, an unprecedented rearrangement for an antitoxin. The structure also shows that MqsA bends the DNA by more than 55 degrees in order to achieve symmetrical binding. Finally, using a combination of biochemical and NMR studies, we show that the DNA sequence specificity of MqsA is mediated by direct readout.	[Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Brown, Breann L.; Peti, Wolfgang] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Wood, Thomas K.] Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA	Brown University; Brown University; Texas A&M University System; Texas A&M University College Station	Page, R (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Box GE-4, Providence, RI 02912 USA.	rebecca_page@brown.edu	Wood, Thomas/GWZ-2481-2022; Peti, Wolfgang/L-3492-2014	Wood, Thomas/0000-0001-8962-8571; Wood, Thomas/0000-0002-6258-529X	National Institutes of Health [F31 NS062630]; National Science Foundation [MCB-0952550]; Offices of Biological and Environmental Research; Offices of Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of the National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS062630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Offices of Biological and Environmental Research; Offices of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant F31 NS062630 (to B. L. B.). This work was also supported by National Science Foundation CAREER Award MCB-0952550 (to R. P.).; Data for this study were measured at beamline X25 of the National Synchrotron Light Source (supported principally by the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and by the National Center for Research Resources of the National Institutes of Health).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allers J, 2001, J MOL BIOL, V311, P75, DOI 10.1006/jmbi.2001.4857; Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; Arbing MA, 2010, STRUCTURE, V18, P996, DOI 10.1016/j.str.2010.04.018; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Bigger JW, 1944, LANCET, V2, P497; BLACK DS, 1991, J BACTERIOL, V173, P5732, DOI 10.1128/jb.173.18.5732-5739.1991; Brown BL, 2010, ACTA CRYSTALLOGR F, V66, P1060, DOI 10.1107/S1744309110028617; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Button JE, 2007, J BACTERIOL, V189, P1523, DOI 10.1128/JB.01534-06; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Cos P, 2010, CURR PHARM DESIGN, V16, P2279, DOI 10.2174/138161210791792868; Dalton KM, 2010, BIOCHEMISTRY-US, V49, P2205, DOI 10.1021/bi902133s; DEFEYTER R, 1989, MOL GEN GENET, V218, P481, DOI 10.1007/BF00332413; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Haran TE, 2009, Q REV BIOPHYS, V42, P41, DOI 10.1017/S0033583509004752; HIRAGA S, 1986, J BACTERIOL, V166, P100, DOI 10.1128/jb.166.1.100-104.1986; Jiang Y, 2002, MOL MICROBIOL, V44, P971, DOI 10.1046/j.1365-2958.2002.02921.x; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kasari V, 2010, J BACTERIOL, V192, P2908, DOI 10.1128/JB.01266-09; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Kumar P, 2008, J MOL BIOL, V383, P482, DOI 10.1016/j.jmb.2008.08.067; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Lawson CL, 2008, RSC BIOMOL SCI, P66; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; Little EJ, 2008, STRUCTURE, V16, P1828, DOI 10.1016/j.str.2008.09.009; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Madl T, 2006, J MOL BIOL, V364, P170, DOI 10.1016/j.jmb.2006.08.082; Magnuson R, 1998, J BACTERIOL, V180, P6342; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papadopoulos E, 2007, BIOMOL NMR ASSIGM, V1, P217, DOI 10.1007/s12104-007-9060-x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Privalov PL, 2009, TRENDS BIOCHEM SCI, V34, P464, DOI 10.1016/j.tibs.2009.05.005; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Sevin EW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r155; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; TAM JE, 1989, MOL GEN GENET, V219, P26, DOI 10.1007/BF00261153; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006; Watkins D, 2008, BIOCHEMISTRY-US, V47, P2325, DOI 10.1021/bi701826f; Yamaguchi Y, 2009, J BIOL CHEM, V284, P28746, DOI 10.1074/jbc.M109.032904	58	50	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2285	2296		10.1074/jbc.M110.172643	http://dx.doi.org/10.1074/jbc.M110.172643			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21068382	hybrid, Green Published			2022-12-25	WOS:000286191500068
J	Park, SH; Jiang, R; Piao, SF; Zhang, B; Kim, EH; Kwon, HM; Jin, XL; Lee, BL; Ha, NC				Park, Sun Hee; Jiang, Rui; Piao, Shunfu; Zhang, Bing; Kim, Eun-Hye; Kwon, Hyun-Mi; Jin, Xiao Ling; Lee, Bok Luel; Ha, Nam-Chul			Structural and Functional Characterization of a Highly Specific Serpin in the Insect Innate Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY CRYSTALLOGRAPHIC ANALYSIS; CRYSTAL-STRUCTURE; HEPARIN PENTASACCHARIDE; SERINE-PROTEASE; HOST-DEFENSE; FACTOR IXA; ANTITHROMBIN; ACTIVATION; MECHANISM; RECOGNITION	The Toll signaling pathway, an essential innate immune response in invertebrates, is mediated via the serine protease cascade. Once activated, the serine proteases are irreversibly inactivated by serine protease inhibitors (serpins). Recently, we identified three serpin-serine protease pairs that are directly involved in the regulation of Toll signaling cascade in a large beetle, Tenebrio molitor. Of these, the serpin SPN48 was cleaved by its target serine protease, Spatzle-processing enzyme, at a noncanonical P1 residue of the serpin's reactive center loop. To address this unique cleavage, we report the crystal structure of SPN48, revealing that SPN48 exhibits a native conformation of human antithrombin, where the reactive center loop is partially inserted into the center of the largest beta-sheet of SPN48. The crystal structure also shows that SPN48 has a putative heparin-binding site that is distinct from those of the mammalian serpins. Ensuing biochemical studies demonstrate that heparin accelerates the inhibition of Spatzle-processing enzyme by a proximity effect in targeting the SPN48. Our finding provides the molecular mechanism of how serpins tightly regulate innate immune responses in invertebrates.	[Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea; Pusan Natl Univ, Res Inst Drug Dev, Pusan 609735, South Korea	Pusan National University; Pusan National University	Lee, BL (corresponding author), Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea.	brlee@pusan.ac.kr; hnc@pusan.ac.kr	Jiang, Rui/F-9248-2011	Jiang, Rui/0000-0002-5580-9822	Pusan National University [PNU-2008-0596-000]	Pusan National University(Pusan National University)	This work was supported by Bio-Scientific Research Grant PNU-2008-0596-000 from Pusan National University (to N.C.H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARRELL RW, 1985, NATURE, V317, P730, DOI 10.1038/317730a0; CARRELL RW, 1994, STRUCTURE, V2, P257, DOI 10.1016/S0969-2126(00)00028-9; Chai KX, 1997, BBA-GENE STRUCT EXPR, V1353, P277, DOI 10.1016/S0167-4781(97)00100-0; Chen VC, 2000, J BIOL CHEM, V275, P38457, DOI 10.1074/jbc.M005605200; Chuang YJ, 2001, BIOCHEMISTRY-US, V40, P6670, DOI 10.1021/bi002933d; DeLano WL, 2002, PYMOL USERS MANUAL; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Izaguirre G, 2006, J BIOL CHEM, V281, P13424, DOI 10.1074/jbc.M600415200; Jiang R, 2009, J BIOL CHEM, V284, P35652, DOI 10.1074/jbc.M109.071001; Johnson DJD, 2006, J BIOL CHEM, V281, P35478, DOI 10.1074/jbc.M607204200; Johnson DJD, 2010, P NATL ACAD SCI USA, V107, P645, DOI 10.1073/pnas.0910144107; Khush RS, 2001, TRENDS IMMUNOL, V22, P260, DOI 10.1016/S1471-4906(01)01887-7; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Li JP, 1999, STRUCTURE, V7, P103, DOI 10.1016/S0969-2126(99)80013-6; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; MACFARLANE RG, 1964, NATURE, V202, P498, DOI 10.1038/202498a0; OLSON ST, 1992, J BIOL CHEM, V267, P12528; Park SH, 2010, ACTA CRYSTALLOGR F, V66, P198, DOI 10.1107/S1744309109053147; Pearce MC, 2008, PROTEIN SCI, V17, P2127, DOI 10.1110/ps.037234.108; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Piao S, 2005, BBA-PROTEINS PROTEOM, V1752, P103, DOI 10.1016/j.bbapap.2005.05.008; Piao SF, 2007, J BIOL CHEM, V282, P10783, DOI 10.1074/jbc.M611556200; PRATT CW, 1993, BLOOD COAGUL FIBRIN, V4, P479, DOI 10.1097/00001721-199306000-00013; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; Robertson AS, 2006, J BIOL CHEM, V281, P26437, DOI 10.1074/jbc.M606085200; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; VANBOECKEL CAA, 1994, NAT STRUCT BIOL, V1, P423, DOI 10.1038/nsb0794-423; Walenga JM, 2002, EXPERT OPIN INV DRUG, V11, P397, DOI 10.1517/13543784.11.3.397; WALENGA JM, 1988, THROMB RES, V52, P553, DOI 10.1016/0049-3848(88)90128-4; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Whisstock JC, 2000, J MOL BIOL, V301, P1287, DOI 10.1006/jmbi.2000.3982; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979; Yum S, 2009, BIOCHEM BIOPH RES CO, V378, P244, DOI 10.1016/j.bbrc.2008.11.039	44	24	24	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1567	1575		10.1074/jbc.M110.144006	http://dx.doi.org/10.1074/jbc.M110.144006			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21047786	hybrid, Green Published			2022-12-25	WOS:000286005000069
J	Boukalova, S; Marsakova, L; Teisinger, J; Vlachova, V				Boukalova, Stepana; Marsakova, Lenka; Teisinger, Jan; Vlachova, Viktorie			Conserved Residues within the Putative S4-S5 Region Serve Distinct Functions among Thermosensitive Vanilloid Transient Receptor Potential (TRPV) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNEL; 2-AMINOETHOXYDIPHENYL BORATE; CAPSAICIN RECEPTOR; SUBTYPE-1 CHANNEL; VOLTAGE SENSOR; PORE REGION; SENSITIVITY; ACTIVATION; DETERMINANTS; MUTATION	The vanilloid transient receptor potential channel TRPV1 is a tetrameric six-transmembrane segment (S1-S6) channel that can be synergistically activated by various proalgesic agents such as capsaicin, protons, heat, or highly depolarizing voltages, and also by 2-aminoethoxydiphenyl borate (2-APB), a common activator of the related thermally gated vanilloid TRP channels TRPV1, TRPV2, and TRPV3. In these channels, the conserved charged residues in the intracellular S4-S5 region have been proposed to constitute part of a voltage sensor that acts in concert with other stimuli to regulate channel activation. The molecular basis of this gating event is poorly understood. We mutated charged residues all along the S4 and the S4-S5 linker of TRPV1 and identified four potential voltage-sensing residues (Arg(557), Glu(570), Asp(576), and Arg(579)) that, when specifically mutated, altered the functionality of the channel with respect to voltage, capsaicin, heat, 2-APB, and/or their interactions in different ways. The nonfunctional charge-reversing mutations R557E and R579E were partially rescued by the charge-swapping mutations R557E/E570R and D576R/R579E, indicating that electrostatic interactions contribute to allosteric coupling between the voltage-, temperature- and capsaicin-dependent activation mechanisms. The mutant K571E was normal in all aspects of TRPV1 activation except for 2-APB, revealing the specific role of Lys(571) in chemical sensitivity. Surprisingly, substitutions at homologous residues in TRPV2 or TRPV3 had no effect on temperature- and 2-APB-induced activity. Thus, the charged residues in S4 and the S4-S5 linker contribute to voltage sensing in TRPV1 and, despite their highly conserved nature, regulate the temperature and chemical gating in the various TRPV channels in different ways.	[Boukalova, Stepana; Marsakova, Lenka; Teisinger, Jan; Vlachova, Viktorie] Acad Sci Czech Republic, Inst Physiol, Dept Cellular Neurophysiol, CR-14220 Prague 4, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Vlachova, V (corresponding author), Acad Sci Czech Republic, Inst Physiol, Dept Cellular Neurophysiol, Videnska 1083, CR-14220 Prague 4, Czech Republic.	vlachova@biomed.cas.cz	Vlachova, Viktorie/Q-2040-2019; Boukalova, Stepana/AAM-3541-2020; Marsakova, Lenka/F-8637-2014; Teisinger, Jan/B-7122-2012; Vlachova, Viktorie/A-4380-2012; Boukalova, Stepana/H-2610-2014	Vlachova, Viktorie/0000-0002-8621-0935; Boukalova, Stepana/0000-0002-6478-4604; Vlachova, Viktorie/0000-0002-8621-0935; Boukalova, Stepana/0000-0002-6478-4604; Vyklicka, Lenka/0000-0003-4108-5701	Czech Science Foundation [305/09/0081, 301/10/1159]; Academy of Science of the Czech Republic [AV0Z50110509, GAAV IAA600110701]; Ministry of Education, Youth and Sports of the Czech Republic [1M0517, LC554, GAUK 26110]	Czech Science Foundation(Grant Agency of the Czech Republic); Academy of Science of the Czech Republic(Czech Academy of Sciences); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by Czech Science Foundation Grants 305/09/0081 and 301/10/1159, Research Project Fund of the Academy of Science of the Czech Republic Grants AV0Z50110509 and GAAV IAA600110701, and by the Ministry of Education, Youth and Sports of the Czech Republic Grants 1M0517, LC554, and GAUK 26110.	Asakawa M, 2006, J INVEST DERMATOL, V126, P2664, DOI 10.1038/sj.jid.5700468; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Dittert I, 2006, J NEUROSCI METH, V151, P178, DOI 10.1016/j.jneumeth.2005.07.005; Fernandez-Ballester G, 2008, J MEMBRANE BIOL, V223, P161, DOI 10.1007/s00232-008-9123-7; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Hu HZ, 2009, P NATL ACAD SCI USA, V106, P1626, DOI 10.1073/pnas.0812209106; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Neeper MP, 2007, J BIOL CHEM, V282, P15894, DOI 10.1074/jbc.M608287200; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Novakova-Tousova K, 2007, NEUROSCIENCE, V149, P144, DOI 10.1016/j.neuroscience.2007.07.039; Susankova K, 2007, J NEUROSCI, V27, P7578, DOI 10.1523/JNEUROSCI.1956-07.2007; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Vriens J, 2007, J BIOL CHEM, V282, P12796, DOI 10.1074/jbc.M610485200; Xiao R, 2008, CELL CALCIUM, V43, P334, DOI 10.1016/j.ceca.2007.06.004; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yao J, 2010, BIOPHYS J, V99, P1743, DOI 10.1016/j.bpj.2010.07.022; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046	32	53	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41455	41462		10.1074/jbc.M110.145466	http://dx.doi.org/10.1074/jbc.M110.145466			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21044960	Green Published, hybrid			2022-12-25	WOS:000285622600031
J	Lee, SH; Park, Y; Yoon, SK; Yoon, JB				Lee, Seung-Hoon; Park, Yoon; Yoon, Sungjoo Kim; Yoon, Jong-Bok			Osmotic Stress Inhibits Proteasome by p38 MAPK-dependent Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOMES; 26S PROTEASOME; MASS-SPECTROMETRY; SUBSTRATE ENTRY; CORE PARTICLE; S PROTEASOME; ATPASE; ACTIVATION; PROTEINS; COMPLEXES	Osmotic stress causes profound perturbations of cell functions. Although the adaptive responses required for cell survival upon osmotic stress are being unraveled, little is known about the effects of osmotic stress on ubiquitin-dependent proteolysis. We now report that hyperosmotic stress inhibits proteasome activity by activating p38 MAPK. Osmotic stress increased the level of polyubiquitinated proteins in the cell. The selective p38 inhibitor SB202190 decreased osmotic stress-associated accumulation of polyubiquitinated proteins, indicating that p38 MAPK plays an inhibitory role in the ubiquitin proteasome system. Activated p38 MAPK stabilized various substrates of the proteasome and increased polyubiquitinated proteins. Proteasome preparations purified from cells expressing activated p38 MAPK had substantially lower peptidase activities than control proteasome samples. Proteasome phosphorylation sites dependent on p38 were identified by measuring changes in the extent of proteasome phosphorylation in response to p38 MAPK activation. The residue Thr-273 of Rpn2 is the major phosphorylation site affected by p38 MAPK. The mutation T273A in Rpn2 blocked the proteasome inhibition that is mediated by p38 MAPK. These results suggest that p38 MAPK negatively regulates the proteasome activity by phosphorylating Thr-273 of Rpn2.	[Lee, Seung-Hoon] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; Yonsei Univ, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea; [Yoon, Sungjoo Kim] Catholic Univ Korea, Dept Biomed Sci, Seoul 137040, South Korea	Yonsei University; Yonsei University; Catholic University of Korea	Yoon, JB (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, 262 Seongsanno, Seoul 120749, South Korea.	yoonj@yonsei.ac.kr		Yoon, Jong-Bok/0000-0002-3563-0702	MEST [2009-0081317]; Korean Ministry of Science and Technology; Translational Research Center for Protein Function Control, National Research Foundation of Korea [2009-0081489]	MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); Translational Research Center for Protein Function Control, National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported in part by the Mid-Career Researcher Program supported by National Research Foundation of Korea Grant 2009-0081317 funded by the MEST and grants from the Korean Ministry of Science and Technology supporting the Studies on Ubiquitome Functions Project and from the Translational Research Center for Protein Function Control, National Research Foundation of Korea Grant 2009-0081489.	Bode JG, 1999, J BIOL CHEM, V274, P30222, DOI 10.1074/jbc.274.42.30222; Borissenko L, 2007, CHEM REV, V107, P687, DOI 10.1021/cr0502504; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Djakovic SN, 2009, J BIOL CHEM, V284, P26655, DOI 10.1074/jbc.M109.021956; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Gomes AV, 2006, CIRC RES, V99, P362, DOI 10.1161/01.RES.0000237386.98506.f7; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Hartmann-Petersen R, 2001, ARCH BIOCHEM BIOPHYS, V386, P89, DOI 10.1006/abbi.2000.2178; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lu HJ, 2008, MOL CELL PROTEOMICS, V7, P2073, DOI 10.1074/mcp.M800064-MCP200; Min KW, 2003, J BIOL CHEM, V278, P15905, DOI 10.1074/jbc.M213070200; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nickell S, 2007, FEBS LETT, V581, P2751, DOI 10.1016/j.febslet.2007.05.028; Richmond C, 1997, J BIOL CHEM, V272, P13403, DOI 10.1074/jbc.272.20.13403; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Sachon E, 2006, RAPID COMMUN MASS SP, V20, P1127, DOI 10.1002/rcm.2427; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Shibatani T, 2006, MOL BIOL CELL, V17, P4962, DOI 10.1091/mbc.E06-04-0311; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382; Zhang FX, 2007, J BIOL CHEM, V282, P22460, DOI 10.1074/jbc.M702439200; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zong C, 2006, CIRC RES, V99, P372, DOI 10.1161/01.RES.0000237389.40000.02	39	51	52	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41280	41289		10.1074/jbc.M110.182188	http://dx.doi.org/10.1074/jbc.M110.182188			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21044959	hybrid, Green Published			2022-12-25	WOS:000285622600013
J	Oh, YT; Liu, XG; Yue, P; Kang, SM; Chen, J; Taunton, J; Khuri, FR; Sun, SY				Oh, You-Take; Liu, Xiangguo; Yue, Ping; Kang, Sumin; Chen, Jing; Taunton, Jack; Khuri, Fadlo R.; Sun, Shi-Yong			ERK/Ribosomal S6 Kinase (RSK) Signaling Positively Regulates Death Receptor 5 Expression through Co-activation of CHOP and Elk1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; LUNG-CANCER CELLS; CCAAT/ENHANCER-BINDING-PROTEIN; CELECOXIB-INDUCED APOPTOSIS; DEPENDENT DEATH-RECEPTOR-5 INDUCTION; LIGAND-INDUCED APOPTOSIS; TRAIL-INDUCED APOPTOSIS; DRUG-INDUCED APOPTOSIS; NF-KAPPA-B; UP-REGULATION	Death receptor 5 (DR5) is a death domain-containing transmembrane receptor that triggers apoptosis upon binding to its ligand or when overexpressed. Its expression is induced by certain small molecule drugs, including celecoxib, through mechanisms that have not been fully elucidated. The current study has revealed a novel ERK/ribosomal S6 kinase (RSK)-dependent mechanism that regulates DR5 expression primarily using celecoxib as a DR5 inducer. Both C/EBP homologous protein (CHOP) and Elk1 are required for celecoxib-induced DR5 expression based on promoter deletion and mutation analysis and siRNA-mediated gene silencing results. Co-expression of both CHOP and Elk1 exhibited enhanced effects on increasing DR5 promoter activity and DR5 expression, indicating that CHOP and Elk1 co-operatively regulate DR5 expression. Because Elk1 is an ERK-regulated protein, we accordingly found that celecoxib increased the levels of phosphorylated ERK1/2, RSK2, and Elk1. Inhibition of either ERK signaling with a MEK inhibitor or ERK1/2 siRNA, or RSK2 signaling with an RSK2 inhibitor or RSK2 siRNA abrogated DR5 up-regulation by celecoxib as well as other agents. Moreover, these inhibitions suppressed celecoxib-induced CHOP up-regulation. Thus, ERK/RSK-dependent, CHOP and Elk1-mediated mechanisms are critical for DR5 induction. Additionally, celecoxib increased CHOP promoter activity in an ATF4-dependent manner, and siRNA-mediated blockade of ATF4 abrogated both CHOP induction and DR5 up-regulation, indicating that ATF4 is involved in celecoxib-induced CHOP and DR5 expression. Collectively, we conclude that small molecules such as celecoxib induce DR5 expression through activating ERK/RSK signaling and subsequent Elk1 activation and ATF4-dependent CHOP induction.	[Oh, You-Take; Liu, Xiangguo; Yue, Ping; Kang, Sumin; Chen, Jing; Khuri, Fadlo R.; Sun, Shi-Yong] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Oh, You-Take; Liu, Xiangguo; Yue, Ping; Kang, Sumin; Chen, Jing; Khuri, Fadlo R.; Sun, Shi-Yong] Winship Canc Inst, Atlanta, GA 30322 USA; [Liu, Xiangguo] Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China; [Taunton, Jack] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94117 USA	Emory University; Shandong University; University of California System; University of California San Francisco	Sun, SY (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, 1365-C Clifton Rd NE,Suite C3088, Atlanta, GA 30322 USA.	ssun@emory.edu	Liu, Xiangguo/G-1091-2010; Khuri, Fadlo R./AAU-4942-2020	Khuri, Fadlo R./0000-0002-8638-7618; Liu, Xiangguo/0000-0002-1879-3817	National Institutes of Health/NCI [SPORE P50, CA128613]; Georgia Cancer Coalition Distinguished Cancer Scholar award; Department of Defense [W81XWH-04-1-0142]; NATIONAL CANCER INSTITUTE [P50CA128613] Funding Source: NIH RePORTER	National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Coalition Distinguished Cancer Scholar award; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health/NCI SPORE P50 Grant CA128613 (to S.-Y. S. for Project 2). This work was also supported by a Georgia Cancer Coalition Distinguished Cancer Scholar award (to S.-Y. S.) and Department of Defense VITAL Grant W81XWH-04-1-0142 (to S.-Y. S. for Project 4).	Anjum R, 2005, CURR BIOL, V15, P1762, DOI 10.1016/j.cub.2005.08.050; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Arai K, 2004, J NEUROCHEM, V89, P232, DOI 10.1111/j.1471-4159.2004.02317.x; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Baritaki S, 2007, J IMMUNOL, V179, P5441, DOI 10.4049/jimmunol.179.8.5441; Bruhat A, 2000, MOL CELL BIOL, V20, P7192, DOI 10.1128/MCB.20.19.7192-7204.2000; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chen SZ, 2007, MOL PHARMACOL, V72, P1269, DOI 10.1124/mol.107.037465; Chen ST, 2010, LEUKEMIA RES, V34, P250, DOI 10.1016/j.leukres.2009.09.028; Cherasse Y, 2007, NUCLEIC ACIDS RES, V35, P5954, DOI 10.1093/nar/gkm642; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Drosopoulos KG, 2005, J BIOL CHEM, V280, P22856, DOI 10.1074/jbc.M412483200; Elrod HA, 2008, CANCER BIOL THER, V7, P163, DOI 10.4161/cbt.7.2.5335; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; He Q, 2008, ONCOGENE, V27, P2656, DOI 10.1038/sj.onc.1210894; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Jiang CC, 2007, CANCER RES, V67, P9750, DOI 10.1158/0008-5472.CAN-07-2047; Kim Su-Hyeong, 2007, Carcinogenesis, V28, P223, DOI 10.1093/carcin/bgl227; Kurnaz IA, 2004, BIOTECHNOL BIOENG, V88, P890, DOI 10.1002/bit.20322; Lawrence MC, 2007, P NATL ACAD SCI USA, V104, P11518, DOI 10.1073/pnas.0704618104; Lin YD, 2008, CANCER RES, V68, P5335, DOI 10.1158/0008-5472.CAN-07-6209; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Liu X, 2006, CANCER RES, V66, P11115, DOI 10.1158/0008-5472.CAN-06-2471; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Nesterov A, 2004, CANCER RES, V64, P3922, DOI 10.1158/0008-5472.CAN-03-2219; PRICE MA, 1995, EMBO J, V14, P2589, DOI 10.1002/j.1460-2075.1995.tb07257.x; Pyrko P, 2008, BIOCHEM PHARMACOL, V75, P395, DOI 10.1016/j.bcp.2007.08.029; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schonthal Axel H, 2006, Neurosurg Focus, V20, pE21, DOI 10.3171/foc.2006.20.4.14; Scott DW, 2008, DNA CELL BIOL, V27, P607, DOI 10.1089/dna.2008.0773; Shetty S, 2005, MOL CELL BIOL, V25, P5404, DOI 10.1128/MCB.25.13.5404-5416.2005; Suganuma M, 2006, INT J CANCER, V119, P33, DOI 10.1002/ijc.21809; Sun SY, 2007, J BIOL CHEM, V282, P18800, DOI 10.1074/jbc.M611438200; Sun SY, 1999, ONCOGENE, V18, P2357, DOI 10.1038/sj.onc.1202543; Sun SY, 2005, APOPTOSIS, V10, P1203, DOI 10.1007/s10495-005-2274-4; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Tanaka K, 2005, J BIOL CHEM, V280, P31059, DOI 10.1074/jbc.M502956200; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; van der Sanden MHM, 2004, J BIOL CHEM, V279, P52007, DOI 10.1074/jbc.M405577200; Wang AB, 2009, J IMMUNOL, V183, P3268, DOI 10.4049/jimmunol.0900894; Woo KJ, 2007, BIOCHEM PHARMACOL, V73, P68, DOI 10.1016/j.bcp.2006.09.015; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Zhang LJ, 2009, CANCER LETT, V274, P40, DOI 10.1016/j.canlet.2008.08.030; Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238; Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318	62	54	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41310	41319		10.1074/jbc.M110.153775	http://dx.doi.org/10.1074/jbc.M110.153775			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21044953	Green Published, hybrid			2022-12-25	WOS:000285622600016
J	Yamano, K; Tanaka-Yamano, S; Endo, T				Yamano, Koji; Tanaka-Yamano, Sachiko; Endo, Toshiya			Tom7 Regulates Mdm10-mediated Assembly of the Mitochondrial Import Channel Protein Tom40	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARREL MEMBRANE-PROTEINS; OUTER-MEMBRANE; BIOGENESIS; COMPLEX; MACHINERY; MDM10; TRANSLOCASE	beta-Barrel membrane proteins in the mitochondrial outer membrane use the TOM40 complex to enter mitochondria and then the TOB/SAM complex to be assembled into the outer membrane. Tom7, a subunit of the TOM40 complex, regulates association of Mdm10 with the TOB complex. Here, we analyzed the role of Tom7 in assembly of beta-barrel proteins, including Tom40, a central channel subunit of the TOM40 complex, and porin. Depletion of Tom7 decreased transient accumulation of Tom40 at the level of the TOB complex and retarded assembly of porin in vitro. On the other hand, overexpression of Tom7 resulted in enhanced accumulation of in vitro imported Tom40 in the TOB complex, yet it did not affect the in vitro assembly of porin. Site-specific photocross-linking in vivo revealed that Tom7 directly interacts with Tom40 through its transmembrane segment and with Mdm10. These results collectively show that Tom7 recruits Mdm10, enhancing its association with the MMM1 complex, to regulate timing of the release of Tom40 from the TOB complex for subsequent assembly into the TOM40 complex.	[Yamano, Koji; Tanaka-Yamano, Sachiko; Endo, Toshiya] Nagoya Univ, Dept Chem, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University	Endo, T (corresponding author), Nagoya Univ, Dept Chem, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	endo@biochem.chem.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Endo T, 2010, BBA-MOL CELL RES, V1803, P706, DOI 10.1016/j.bbamcr.2009.11.007; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Esaki M, 2004, J BIOL CHEM, V279, P45701, DOI 10.1074/jbc.M404591200; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; GRATZER S, 1995, J CELL BIOL, V129, P25, DOI 10.1083/jcb.129.1.25; Honlinger A, 1996, EMBO J, V15, P2125, DOI 10.1002/j.1460-2075.1996.tb00566.x; Ishikawa D, 2004, J CELL BIOL, V166, P621, DOI 10.1083/jcb.200405138; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Maaev D, 2004, MOL BIOL EVOL, V21, P1557, DOI 10.1093/molbev/msh166; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Meisinger C, 2006, J BIOL CHEM, V281, P22819, DOI 10.1074/jbc.M602679200; Milenkovic D, 2004, J BIOL CHEM, V279, P22781, DOI 10.1074/jbc.C400120200; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Nakai M, 1995, J BIOL CHEM, V270, P30571, DOI 10.1074/jbc.270.51.30571; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Paschen SA, 2005, TRENDS BIOCHEM SCI, V30, P575, DOI 10.1016/j.tibs.2005.08.009; Pfanner N, 2004, NAT STRUCT MOL BIOL, V11, P1044, DOI 10.1038/nsmb852; Tamura Y, 2009, J CELL BIOL, V184, P129, DOI 10.1083/jcb.200808068; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Waizenegger T, 2004, EMBO REP, V5, P704, DOI 10.1038/sj.embor.7400183; Wideman JG, 2010, MOL BIOL CELL, V21, P1725, DOI 10.1091/mbc.E09-10-0844; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wittig I, 2007, METHOD CELL BIOL, V80, P723, DOI 10.1016/S0091-679X(06)80033-6; Yamano K, 2010, EMBO REP, V11, P187, DOI 10.1038/embor.2009.283	32	79	80	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41222	41231		10.1074/jbc.M110.163238	http://dx.doi.org/10.1074/jbc.M110.163238			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21036907	Green Published, hybrid			2022-12-25	WOS:000285622600008
J	Barron, DA; Strand, DW; Ressler, SJ; Dang, TD; Hayward, SW; Yang, F; Ayala, GE; Ittmann, M; Rowley, DR				Barron, David A.; Strand, Douglas W.; Ressler, Steven J.; Dang, Truong D.; Hayward, Simon W.; Yang, Feng; Ayala, Gustavo E.; Ittmann, Michael; Rowley, David R.			TGF-beta 1 Induces an Age-Dependent Inflammation of Nerve Ganglia and Fibroplasia in the Prostate Gland Stroma of a Novel Transgenic Mouse	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CANCER-REACTIVE STROMA; XENOGRAFT MODEL; TRANSFORMING GROWTH-FACTOR-BETA-1; MESENCHYMAL TRANSITION; IN-VIVO; EXPRESSION; MYOFIBROBLAST; ANGIOGENESIS; HYPERPLASIA	TGF-beta 1 is overexpressed in wound repair and in most proliferative disorders including benign prostatic hyperplasia and prostate cancer. The stromal microenvironment at these sites is reactive and typified by altered phenotype, matrix deposition, inflammatory responses, and alterations in nerve density and biology. TGF-beta 1 is known to modulate several stromal responses; however there are few transgenic models to study its integrated biology. To address the actions of TGF-beta 1 in prostate disorders, we targeted expression of an epitope tagged and constitutively active TGF-beta 1 via the enhanced probasin promoter to the murine prostate gland epithelium. Transgenic mice developed age-dependent lesions leading to severe, yet focal attenuation of epithelium, and a discontinuous basal lamina. These changes were associated with elevated fibroplasia and frequency of collagenous micronodules in collapsed acini, along with an induced inflammation in nerve ganglia and small vessels. Elevated recruitment of CD115+ myeloid cells but not mature macrophages was observed in nerve ganglia, also in an age-dependent manner. Similar phenotypic changes were observed using a human prostate epithelium tissue recombination xenograft model, where epithelial cells engineered to overexpress TGF-beta 1 induced fibrosis and altered matrix deposition concurrent with inflammation in the stromal compartment. Together, these data suggest that elevated TGF-beta 1 expression induces a fibroplasia stromal response associated with breach of epithelial wall structure and inflammatory involvement of nerve ganglia and vessels. The novel findings of ganglia and vessel inflammation associated with formation of collagenous micronodules in collapsed acini is important as each of these are observed in human prostate carcinoma and may play a role in disease progression.	[Barron, David A.; Ressler, Steven J.; Dang, Truong D.; Yang, Feng; Rowley, David R.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Strand, Douglas W.; Hayward, Simon W.] Vanderbilt Univ, Med Ctr, Dept Urol Surg, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Ayala, Gustavo E.; Ittmann, Michael] Baylor Coll Med, Dept Pathol, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Vanderbilt University; Baylor College of Medicine	Barron, DA (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	drowley@bcm.tmc.edu	Strand, Douglas/K-4003-2019; Strand, Douglas/A-1702-2011; Ayala, Gustavo/ABC-6625-2020	Strand, Douglas/0000-0002-0746-927X; Hayward, Simon/0000-0002-6059-6550	National Institutes of Health [R01 CA58093]; Diana Helis Henry Medical Research Foundation; Tumor Microenvironment Network of National Cancer Institute [U54 CA126568]; U.S. Department of Defens [W81XWH-08-10059, W81XWH-08-07-0479]; NATIONAL CANCER INSTITUTE [U54CA126568, R01CA058093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083293] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diana Helis Henry Medical Research Foundation; Tumor Microenvironment Network of National Cancer Institute; U.S. Department of Defens; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support for David R. Rowley was made possible via U54 CA126568 through the Tumor Microenvironment Network of National Cancer Institute (http://tmen.nci.nih.gov/), via R01 CA58093 through the National Institutes of Health (http://grants.nih.gov/grants/funding/r01.htm), and from the Diana Helis Henry Medical Research Foundation through its direct engagement in the continuous active conduct of medical research in conjunction with Baylor College of Medicine. Support for Simon W. Hayward was made possible via U54 CA126568 through the Tumor Microenvironment Network of National Cancer Institute (http://tmen.nci.nih.gov/). Support for David Barron was made possible via the Predoctoral Prostate Cancer Training Grant W81XWH-08-10059 through the U.S. Department of Defense (http://cdmrp.army.mil/pcrp/). Support for Douglas Strand was made possible via the Postdoctoral Prostate Cancer Training Grant W81XWH-08-07-0479 through the U.S. Department of Defense (http://cdmrp.army.mil/pcrp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Alonso-Magdalena P, 2009, P NATL ACAD SCI USA, V106, P2859, DOI 10.1073/pnas.0812666106; Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Ayala G, 2003, CLIN CANCER RES, V9, P4792; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Epstein JI, 2004, MODERN PATHOL, V17, P307, DOI 10.1038/modpathol.3800050; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gann PH, 1999, PROSTATE, V40, P248, DOI 10.1002/(SICI)1097-0045(19990901)40:4<248::AID-PROS6>3.0.CO;2-M; Hall BE, 2010, LAB INVEST, V90, P543, DOI 10.1038/labinvest.2010.5; Jiang M, 2010, STEM CELLS, V28, P344, DOI 10.1002/stem.284; Kopp JB, 1996, LAB INVEST, V74, P991; Massague J, 1999, NAT CELL BIOL, V1, pE117, DOI 10.1038/12944; McAlhany SJ, 2003, CANCER RES, V63, P5859; PIERCE DF, 1995, P NATL ACAD SCI USA, V92, P4254, DOI 10.1073/pnas.92.10.4254; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; Sanvito F, 1995, BIOCHEM BIOPH RES CO, V217, P1279, DOI 10.1006/bbrc.1995.2906; Schauer IG, 2008, UROLOGY, V72, P205, DOI 10.1016/j.urology.2007.11.083; Schauer IG, 2009, PROSTATE, V69, P373, DOI 10.1002/pros.20886; Shoskes DA, 2002, J UROLOGY, V168, P331, DOI 10.1016/S0022-5347(05)64916-6; Tuxhorn JA, 2002, CANCER RES, V62, P6021; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Tuxhorn JA, 2001, J UROLOGY, V166, P2472, DOI 10.1016/S0022-5347(05)65620-0; Tuxhorn JA, 2002, CANCER RES, V62, P3298; Wolfraim LA, 2002, J IMMUNOL METHODS, V266, P7, DOI 10.1016/S0022-1759(02)00090-X; Yang F, 2008, ONCOGENE, V27, P450, DOI 10.1038/sj.onc.1210663; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702; Yang G, 1997, PROSTATE, V33, P151, DOI 10.1002/(SICI)1097-0045(19971101)33:3<151::AID-PROS1>3.0.CO;2-M; Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698	28	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13751	10.1371/journal.pone.0013751	http://dx.doi.org/10.1371/journal.pone.0013751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060787	gold, Green Published, Green Submitted			2022-12-25	WOS:000283645300030
J	Nolan, ST; Lamichhane, G				Nolan, Scott T.; Lamichhane, Gyanu			Protective Efficacy of BCG Overexpressing an L, D-Transpeptidase against M. tuberculosis Infection	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; ENHANCED PROTECTION; HYPOXIC RESPONSE; VACCINE EFFICACY; INTERFERON-GAMMA; IMMUNITY; MODEL; EXPRESSION; ANTIGENS; GENE	Background: M. bovis Bacille Calmette-Guerin (BCG), currently the only available vaccine against tuberculosis (TB), fails to adequately protect individuals from active and latent TB infection. New vaccines are desperately needed to decrease the worldwide burden of TB. Methods and Findings: We created a recombinant strain of BCG that overproduces an L, D-transpeptidase in order to alter the bacterial peptidoglycan layer and consequently increase the ability of this immunogen to protect against virulent M. tuberculosis (Mtb). We demonstrate that this novel recombinant BCG protects mice against virulent Mtb at least as well as control BCG, as measured by its ability to reduce bacterial burden in lungs and spleen, reduce lung histopathology, and prolong survival. A nutrient starved recombinant BCG preparation, while offering comparable protection, elicited a response characterized by elevated levels of select Th1 cytokines. Conclusions: Recombinant BCG overexpressing a L, D-transpeptidase that is nutrient starved elicits a stronger Th1 type response and is at least as protective as parent BCG. Results from this study suggest that nutrient starvation treatment of live BCG vaccines should be further investigated as a way to increase host induction of Th-1 related cytokines in the development of experimental anti-TB vaccines.	[Nolan, Scott T.; Lamichhane, Gyanu] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University	Nolan, ST (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	lamichhane@jhu.edu		Lamichhane, Gyanu/0000-0002-2214-0114	Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI087749] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Bill and Melinda Gates Foundation Grand Challenges grant to GL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBERSON JB, 1938, NEW ENGL J MED, V219, P4; Barker LF, 2009, CURR OPIN IMMUNOL, V21, P331, DOI 10.1016/j.coi.2009.05.017; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bhatt K, 2007, J CLIN IMMUNOL, V27, P347, DOI 10.1007/s10875-007-9084-0; Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Dannenberg AM, 2006, PATHOGENESIS OF HUMAN PULMONARY TUBERCULOSIS: INSIGHTS FROM THE RABBIT MODEL, P1; Davis SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006297; Demissie A, 2006, CLIN VACCINE IMMUNOL, V13, P179, DOI 10.1128/CVI.13.2.179-186.2006; DING AH, 1988, J IMMUNOL, V141, P2407; DUBOS R J, 1956, Am Rev Tuberc, V74, P683; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Girardi E, 2000, AIDS, V14, pS47; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Gupta R, 2010, NAT MED, V16, P466, DOI 10.1038/nm.2120; Hatfull GF, 2000, MOL GENETICS MYCOBAC; Hoft DF, 2008, J INFECT DIS, V198, P1491, DOI 10.1086/592450; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Kavanagh H, 2010, CLIN EXP ALLERGY, V40, P933, DOI 10.1111/j.1365-2222.2010.03459.x; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; Maniatis T., 1982, MOL CLONING LAB MANU; Marks GB, 2003, J ALLERGY CLIN IMMUN, V111, P541, DOI 10.1067/mai.2003.171; Orme IM, 2006, VACCINE, V24, P2, DOI 10.1016/j.vaccine.2005.07.078; Orme IM, 2003, TUBERCULOSIS, V83, P112, DOI 10.1016/S1472-9792(02)00069-0; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Qie YQ, 2009, SCAND J IMMUNOL, V69, P342, DOI 10.1111/j.1365-3083.2009.02231.x; Sambandamurthy VK, 2005, INFECT IMMUN, V73, P1196, DOI 10.1128/IAI.73.2.1196-1203.2005; Saviola B, 2003, INFECT IMMUN, V71, P1379, DOI 10.1128/IAI.71.3.1379-1388.2003; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Shafferman A.N.Z., 2010, RECOMBINANT BCG TUBE; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; STEAD WW, 1967, AM REV RESPIR DIS, V95, P729; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Sun R, 2009, VACCINE, V27, P4412, DOI 10.1016/j.vaccine.2009.05.048; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Wedlock DN, 2008, CLIN VACCINE IMMUNOL, V15, P765, DOI 10.1128/CVI.00034-08; World Health Organization, 2009, GLOB TUB CONTR EP ST; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	48	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13773	10.1371/journal.pone.0013773	http://dx.doi.org/10.1371/journal.pone.0013773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048936	Green Submitted, Green Published, gold			2022-12-25	WOS:000283645300047
J	Torras-Llort, M; Medina-Giro, S; Moreno-Moreno, O; Azorin, F				Torras-Llort, Monica; Medina-Giro, Sonia; Moreno-Moreno, Olga; Azorin, Fernando			A Conserved Arginine-Rich Motif within the Hypervariable N-Domain of Drosophila Centromeric Histone H3 (CenH3(CID)) Mediates BubR1 Recruitment	PLOS ONE			English	Article							ACCURATE CHROMOSOME SEGREGATION; SPINDLE CHECKPOINT PROTEINS; CENP-A NUCLEOSOMES; ROUGH-DEAL; PHOSPHORYLATION; RECOGNITION; MUTATIONS; EVOLUTION; COMPONENT; COMPLEX	Background: Centromere identity is determined epigenetically by deposition of CenH3, a centromere-specific histone H3 variant that dictates kinetochore assembly. The molecular basis of the contribution of CenH3 to centromere/kinetochore functions is, however, incompletely understood, as its interactions with the rest of centromere/kinetochore components remain largely uncharacterised at the molecular/structural level. Principal Findings: Here, we report on the contribution of Drosophila CenH3(CID) to recruitment of BubR1, a conserved kinetochore protein that is a core component of the spindle attachment checkpoint (SAC). This interaction is mediated by the N-terminal domain of CenH3(CID) (NCenH3(CID)), as tethering NCenH3(CID) to an ectopic reporter construct results in BubR1 recruitment and BubR1-dependent silencing of the reporter gene. Here, we also show that this interaction depends on a short arginine (R)-rich motif and that, most remarkably, it appears to be evolutionarily conserved, as tethering constructs carrying the highly divergent NCenH3 of budding yeast and human also induce silencing of the reporter. Interestingly, though NCenH3 shows an exceedingly low degree of conservation, the presence of R-rich motives is a common feature of NCenH3 from distant species. Finally, our results also indicate that two other conserved sequence motives within NCenH3(CID) might also be involved in interactions with kinetochore components. Conclusions: These results unveil an unexpected contribution of the hypervariable N-domain of CenH3 to recruitment of kinetochore components, identifying simple R-rich motives within it as evolutionary conserved structural determinants involved in BubR1 recruitment.	[Torras-Llort, Monica] CSIC, Inst Mol Biol Barcelona, Barcelona, Spain; IRB Barcelona, Inst Res Biomed, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Torras-Llort, M (corresponding author), CSIC, Inst Mol Biol Barcelona, Barcelona, Spain.	fambmc@ibmb.csic.es	Azorin, Fernando/N-4388-2014; Torras, Monica/ABE-8392-2021	Azorin, Fernando/0000-0002-8426-7858; Torras-Llort, Monica/0000-0003-1208-905X	MCINN; Ministerio de Ciencia e Innovacion [BFU2009-07111, CSD2006-00049]; Comissio 'Interdepartamental de Recerca i Innovacio Tecnologica [2009SGR1023]	MCINN(European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comissio 'Interdepartamental de Recerca i Innovacio Tecnologica	SMG acknowledges receipt of a FPU fellowship from MCINN. This work was financed by grants from "Ministerio de Ciencia e Innovacion'' (BFU2009-07111; CSD2006-00049) and "Comissio 'Interdepartamental de Recerca i Innovacio Tecnologica'' (2009SGR1023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Basto R, 2000, NAT CELL BIOL, V2, P939, DOI 10.1038/35046592; Basu J, 1999, J CELL BIOL, V146, P13, DOI 10.1083/jcb.146.1.13; Bloom K, 2007, CURR OPIN GENET DEV, V17, P151, DOI 10.1016/j.gde.2007.02.009; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Blower MD, 2006, PLOS GENET, V2, P1025, DOI 10.1371/journal.pgen.0020110; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Chen YH, 2000, MOL CELL BIOL, V20, P7037, DOI 10.1128/MCB.20.18.7037-7048.2000; Ekwall K, 2007, ANNU REV GENET, V41, P63, DOI 10.1146/annurev.genet.41.110306.130127; Ephrussi B, 1944, GENETICS, V29, P148; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Font-Burgada J, 2008, GENE DEV, V22, P3007, DOI 10.1101/gad.481408; GATTI M, 1994, METHOD CELL BIOL, V44, P371, DOI 10.1016/S0091-679X(08)60924-3; Heeger S, 2005, GENE DEV, V19, P2041, DOI 10.1101/gad.347805; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Keith KC, 1999, MOL CELL BIOL, V19, P6130; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Li YH, 2003, DEVELOPMENT, V130, P1817, DOI 10.1242/dev.00405; LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153; Logarinho E, 2004, J CELL SCI, V117, P1757, DOI 10.1242/jcs.01033; Logarinho E, 1998, J CELL SCI, V111, P2897; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Malik HS, 2002, P NATL ACAD SCI USA, V99, P1449, DOI 10.1073/pnas.032664299; Malik HS, 2001, GENETICS, V157, P1293; Malmanche N, 2007, CURR BIOL, V17, P1489, DOI 10.1016/j.cub.2007.07.042; Morris CA, 2007, CELL, V128, P647, DOI 10.1016/j.cell.2007.02.002; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nagao T, 1998, P NATL ACAD SCI USA, V95, P3737, DOI 10.1073/pnas.95.7.3737; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Rahmani Z, 2009, J CELL BIOL, V187, P597, DOI 10.1083/jcb.200905026; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; Scaerou F, 1999, J CELL SCI, V112, P3757; Smith MM, 2002, CURR OPIN CELL BIOL, V14, P279, DOI 10.1016/S0955-0674(02)00331-9; Straight AF, 1997, CURR BIOL, V7, pR613, DOI 10.1016/S0960-9822(06)00315-0; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; Tang TTL, 1998, GENE DEV, V12, P3843, DOI 10.1101/gad.12.24.3843; Torras-Llort M, 2009, EMBO J, V28, P2337, DOI 10.1038/emboj.2009.174; Williams BC, 2003, MOL BIOL CELL, V14, P1379, DOI 10.1091/mbc.E02-09-0624	41	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13747	10.1371/journal.pone.0013747	http://dx.doi.org/10.1371/journal.pone.0013747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060784	Green Published, Green Submitted, gold			2022-12-25	WOS:000283645300027
J	Xi, SC; Yang, MC; Tao, YG; Xu, H; Shan, JG; Inchauste, S; Zhang, M; Mercedes, L; Hong, JA; Rao, M; Schrump, DS				Xi, Sichuan; Yang, Maocheng; Tao, Yongguang; Xu, Hong; Shan, Jigui; Inchauste, Suzanne; Zhang, Mary; Mercedes, Leandro; Hong, Julie A.; Rao, Mahadev; Schrump, David S.			Cigarette Smoke Induces C/EBP-beta-Mediated Activation of miR-31 in Normal Human Respiratory Epithelia and Lung Cancer Cells	PLOS ONE			English	Article							GENE-EXPRESSION; MICRORNA EXPRESSION; LET-7; TRANSFORMATION; WNT; PROLIFERATION; PROFILES; PATHWAYS; TARGETS; BINDING	Background: Limited information is available regarding mechanisms by which miRNAs contribute to pulmonary carcinogenesis. The present study was undertaken to examine expression and function of miRNAs induced by cigarette smoke condensate (CSC) in normal human respiratory epithelia and lung cancer cells. Methodology: Micro-array and quantitative RT-PCR (qRT-PCR) techniques were used to assess miRNA and host gene expression in cultured cells, and surgical specimens. Software-guided analysis, RNA cross-link immunoprecipitation (CLIP), 39 UTR luciferase reporter assays, qRT-PCR, focused super-arrays and western blot techniques were used to identify and confirm targets of miR-31. Chromatin immunoprecipitation (ChIP) techniques were used to evaluate histone marks and transcription factors within the LOC554202 promoter. Cell count and xenograft experiments were used to assess effects of miR-31 on proliferation and tumorigenicity of lung cancer cells. Results: CSC significantly increased miR-31 expression and activated LOC554202 in normal respiratory epithelia and lung cancer cells; miR-31 and LOC554202 expression persisted following discontinuation of CSC exposure. miR-31 and LOC554202 expression levels were significantly elevated in lung cancer specimens relative to adjacent normal lung tissues. CLIP and reporter assays demonstrated direct interaction of miR-31 with Dickkopf-1 (Dkk-1) and DACT-3. Over-expression of miR-31 markedly diminished Dkk-1 and DACT3 expression levels in normal respiratory epithelia and lung cancer cells. Knock-down of miR-31 increased Dkk-1 and DACT3 levels, and abrogated CSC-mediated decreases in Dkk-1 and DACT-3 expression. Furthermore, over-expression of miR-31 diminished SFRP1, SFRP4, and WIF-1, and increased Wnt-5a expression. CSC increased H3K4Me3, H3K9/14Ac and C/EBP-beta levels within the LOC554202 promoter. Knock-down of C/EBP-beta abrogated CSC-mediated activation of LOC554202. Over-expression of miR-31 significantly enhanced proliferation and tumorigenicity of lung cancer cells; knock-down of miR-31 inhibited growth of these cells. Conclusions: Cigarette smoke induces expression of miR-31 targeting several antagonists of cancer stem cell signaling in normal respiratory epithelia and lung cancer cells. miR-31 functions as an oncomir during human pulmonary carcinogenesis.	[Xi, Sichuan; Yang, Maocheng; Inchauste, Suzanne; Zhang, Mary; Mercedes, Leandro; Hong, Julie A.; Rao, Mahadev; Schrump, David S.] NCI, Thorac Oncol Sect, Surg Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Tao, Yongguang; Xu, Hong] NCI, Lab Canc Prevent, Frederick, MD 21701 USA; [Shan, Jigui] NCI, Adv Biomed Comp Ctr, SAIC Frederick, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Xi, SC (corresponding author), NCI, Thorac Oncol Sect, Surg Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	David_Schrump@nih.gov			National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health intramural funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Barh D, 2010, CURR ONCOL, V17, P70; Bishop JA, 2010, CLIN CANCER RES, V16, P610, DOI 10.1158/1078-0432.CCR-09-2638; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Connors SK, 2009, ONCOGENE, V28, P921, DOI 10.1038/onc.2008.429; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Davalos V, 2010, CURR OPIN ONCOL, V22, P35, DOI 10.1097/CCO.0b013e328333dcbb; Deng WG, 2008, CANCER GENE THER, V15, P29, DOI 10.1038/sj.cgt.7701094; Droge P, 2008, CELL STEM CELL, V2, P8, DOI 10.1016/j.stem.2007.12.003; Du LQ, 2010, CANCER METAST REV, V29, P109, DOI 10.1007/s10555-010-9204-9; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Espada J, 2009, CLIN TRANSL ONCOL, V11, P411, DOI 10.1007/s12094-009-0380-4; Gluschnaider U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009060; Glynn T, 2010, CA-CANCER J CLIN, V60, P50, DOI 10.3322/caac.20052; He XY, 2010, J CANCER RES CLIN, V136, P1023, DOI 10.1007/s00432-009-0747-5; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Ivanov SV, 2010, J BIOL CHEM, V285, P22807, DOI 10.1074/jbc.M110.100354; Izzotti A, 2010, CARCINOGENESIS, V31, P894, DOI 10.1093/carcin/bgq037; Jensen Kirk B., 2008, V488, P85, DOI 10.1007/978-1-60327-475-3_6; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kim MH, 2009, PROSTATE, V69, P1435, DOI 10.1002/pros.20993; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Liu F, 2010, ONCOGENE, V29, P3650, DOI 10.1038/onc.2010.129; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174; Melkamu T, 2010, CARCINOGENESIS, V31, P252, DOI 10.1093/carcin/bgp208; Miko E, 2009, EXP LUNG RES, V35, P646, DOI 10.3109/01902140902822312; Narayan S, 2004, ONCOGENE, V23, P5880, DOI 10.1038/sj.onc.1207792; Navarro A, 2009, ONCOLOGY-BASEL, V76, P162, DOI 10.1159/000201569; Pal R, 2009, BLOOD, V114, P3890, DOI 10.1182/blood-2009-01-201111; Patnaik SK, 2010, CANCER RES, V70, P36, DOI 10.1158/0008-5472.CAN-09-3153; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Samet JM, 2009, CLIN CANCER RES, V15, P5626, DOI 10.1158/1078-0432.CCR-09-0376; Schrump D, 2008, CANC PRINCIPLES PRAC, P896; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Sioud M, 2010, METHODS MOL BIOL, V629, P255, DOI 10.1007/978-1-60761-657-3_16; Staiger J, 2009, CARCINOGENESIS, V30, P832, DOI 10.1093/carcin/bgn273; Suzuki M, 2007, CLIN CANCER RES, V13, P6087, DOI 10.1158/1078-0432.CCR-07-0591; Taulli R, 2010, CELL CYCLE, V9, P918, DOI 10.4161/cc.9.5.10864; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wang CJ, 2009, DIS MARKERS, V26, P27, DOI [10.3233/DMA-2009-0601, 10.1155/2009/921907]; WESTFALL T, 1993, RESAMPLING BASED MUL; Xi SC, 2007, P NATL ACAD SCI USA, V104, P14366, DOI 10.1073/pnas.0703669104; Xi SC, 2009, STEM CELLS, V27, P2691, DOI 10.1002/stem.183; Yang HS, 2009, CLIN CANCER RES, V15, P5744, DOI 10.1158/1078-0432.CCR-09-0385; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang JG, 2010, CLIN CHIM ACTA, V411, P846, DOI 10.1016/j.cca.2010.02.074; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	61	95	105	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13764	10.1371/journal.pone.0013764	http://dx.doi.org/10.1371/journal.pone.0013764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048943	gold, Green Published, Green Submitted			2022-12-25	WOS:000283645300042
J	Ertel, KA; Koenen, KC; Rich-Edwards, JW; Gillman, MW				Ertel, Karen A.; Koenen, Karestan C.; Rich-Edwards, Janet W.; Gillman, Matthew W.			Maternal Depressive Symptoms Not Associated with Reduced Height in Young Children in a US Prospective Cohort Study	PLOS ONE			English	Article							FAILURE-TO-THRIVE; CORTICOTROPIN-RELEASING HORMONE; BRITISH WOMENS HEART; POSTNATAL DEPRESSION; ADULT HEIGHT; INFANT GROWTH; RISK-FACTORS; LEG LENGTH; NUTRITIONAL-STATUS; FEEDING PRACTICES	Background: Shorter stature is associated with greater all cause and heart disease mortality, but taller stature with increased risk of cancer mortality. Though childhood environment is important in determining height, limited data address how maternal depression affects linear growth in children. We examined the relationships between antenatal and postpartum depressive symptoms and child height and linear growth from birth to age 3 years in a U. S. sample. Methods: Subjects were 872 mother-child pairs in Project Viva, a prospective pre-birth cohort study. The study population is relatively advantaged with high levels of income and education and low risk of food insecurity. We assessed maternal depression at mid-pregnancy (mean 28 weeks' gestation) and 6 months postpartum with the Edinburgh Postnatal Depression Scale (score >= 13 on 0-30 scale indicating probable depression). Child outcomes at age 3 were height-for-age z-score (HAZ) and leg length. HAZ was also available at birth and ages 6 months, 1, 2, and 3 years. Findings: Seventy (8.0%) women experienced antenatal depression and 64 (7.3%) experienced postpartum depression. The mean (SD) height for children age 3 was 97.2 cm (4.2), with leg length of 41.6 cm (2.6). In multivariable linear regression models, exposure to postpartum depression was associated with greater HAZ (0.37 [95% confidence interval: 0.16, 0.58]) and longer leg length (0.88 cm [0.35, 1.41]). The relationship between postpartum depression and greater HAZ was evident starting at 6 months and continued to age 3. We found minimal relationships between antenatal depression and child height outcomes. Conclusion: Our findings do not support the hypothesis that maternal depression is associated with reduced height in children in this relatively advantaged sample in a high-income country.	[Ertel, Karen A.; Koenen, Karestan C.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Ertel, Karen A.; Koenen, Karestan C.] Harvard Univ, Sch Publ Hlth, Kellogg Hlth Scholars Program, Boston, MA 02115 USA; [Koenen, Karestan C.; Rich-Edwards, Janet W.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Koenen, Karestan C.] Harvard Univ, Ctr Developing Child, Cambridge, MA 02138 USA; [Rich-Edwards, Janet W.] Brigham & Womens Hosp, Ctr Womens Hlth & Gender Biol, Boston, MA 02115 USA; [Gillman, Matthew W.] Harvard Univ, Sch Med, Dept Populat Med, Obes Prevent Program, Boston, MA USA; [Gillman, Matthew W.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Gillman, Matthew W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Harvard T.H. Chan School of Public Health	Ertel, KA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	kertel@hsph.harvard.edu	Koenen, Karestan/K-5402-2014	Koenen, Karestan/0000-0003-3293-4281	National Institutes of Health [HD 34568, HL 64925, HL 68041]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034568] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL068041, R01HL064925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Project Viva is supported by grants from the National Institutes of Health (HD 34568, HL 64925, HL 68041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuya AO, 2008, J AFFECT DISORDERS, V108, P191, DOI 10.1016/j.jad.2007.09.013; ALBANES D, 1988, CANCER RES, V48, P1658; Anoop S, 2004, ARCH DIS CHILD, V89, P325, DOI 10.1136/adc.2002.009738; Azar R, 2007, BIOL PSYCHIAT, V62, P573, DOI 10.1016/j.biopsych.2006.11.009; BINKIN NJ, 1988, PEDIATRICS, V82, P828; Black MM, 2009, AM J CLIN NUTR, V89, p951S, DOI 10.3945/ajcn.2008.26692E; BREUNLIN DC, 1983, INT J EAT DISORDER, V2, P25, DOI 10.1002/1098-108X(198321)2:3<25::AID-EAT2260020304>3.0.CO;2-V; Bugental DB, 2003, HORM BEHAV, V43, P237, DOI 10.1016/S0018-506X(02)00008-9; Burke L, 2003, INT REV PSYCHIATR, V15, P243, DOI 10.1080/0954026031000136866; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dawson G, 1999, CHILD DEV, V70, P1058, DOI 10.1111/1467-8624.00078; De Stavola BL, 2004, AM J EPIDEMIOL, V159, P671, DOI 10.1093/aje/kwh097; Drewett R, 2004, J CHILD PSYCHOL PSYC, V45, P359, DOI 10.1111/j.1469-7610.2004.00226.x; Ertel KA, 2010, PAEDIATR PERINAT EP, V24, P179, DOI 10.1111/j.1365-3016.2010.01098.x; EVANS SL, 1972, J AMER ACAD CHILD PS, V11, P440, DOI 10.1016/S0002-7138(09)61202-4; Farrow CV, 2005, OBES RES, V13, P1999, DOI 10.1038/oby.2005.245; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Gillman MW, 2006, OBESITY, V14, P1647, DOI 10.1038/oby.2006.189; Gunnell D, 2003, J EPIDEMIOL COMMUN H, V57, P141, DOI 10.1136/jech.57.2.141; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; Gunnell DJ, 1998, J EPIDEMIOL COMMUN H, V52, P142, DOI 10.1136/jech.52.3.142; Hall Judith G., 2007, HDB PHYS MEASUREMENT; Halligan SL, 2004, BIOL PSYCHIAT, V55, P376, DOI 10.1016/j.biopsych.2003.09.013; Harpham T, 2005, J EPIDEMIOL COMMUN H, V59, P1060, DOI 10.1136/jech.2005.039180; Hebert PR, 1997, CANCER CAUSE CONTROL, V8, P591, DOI 10.1023/A:1018442329319; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; Hilakivi-Clarke L, 2001, BRIT J CANCER, V85, P1680, DOI 10.1054/bjoc.2001.2109; Hurley KM, 2008, J NUTR, V138, P799, DOI 10.1093/jn/138.4.799; Institute of Medicine, 1990, NUTR PREGN; Jousilahti P, 2000, AM J EPIDEMIOL, V151, P1112, DOI 10.1093/oxfordjournals.aje.a010155; Kaltiala-Heino R, 2003, J ADOLESCENCE, V26, P531, DOI 10.1016/S0140-1971(03)00053-8; Lawlor DA, 2002, DIABETOLOGIA, V45, P1097, DOI 10.1007/s00125-002-0887-5; Lawlor DA, 2004, HEART, V90, P745, DOI 10.1136/hrt.2003.019950; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Martins C, 2000, J CHILD PSYCHOL PSYC, V41, P737, DOI 10.1111/1469-7610.00661; Matthey S, 2006, ARCH WOMEN MENT HLTH, V9, P309, DOI 10.1007/s00737-006-0152-x; McLearn KT, 2006, PEDIATRICS, V118, pE174, DOI 10.1542/peds.2005-1551; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; Murray L, 2003, Arch Womens Ment Health, V6 Suppl 2, pS71, DOI 10.1007/s00737-003-0007-7; National Center for Health Statistics, 2000, CDC GROWTH CHARTS; O'Brien LM, 2004, PEDIATRICS, V113, P1242, DOI 10.1542/peds.113.5.1242; OCALLAGHAN MJ, 1978, ARCH DIS CHILD, V53, P788, DOI 10.1136/adc.53.10.788; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; Overpeck MD, 2000, J PEDIATR-US, V137, P205, DOI 10.1067/mpd.2000.107163; Patel V, 2003, ARCH DIS CHILD, V88, P34, DOI 10.1136/adc.88.1.34; PECK AMN, 1989, J EPIDEMIOL COMMUN H, V43, P380, DOI 10.1136/jech.43.4.380; Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946; Ramsay M, 2002, DEV MED CHILD NEUROL, V44, P405, DOI 10.1017/S0012162201002286; Reck C, 2004, PSYCHOPATHOLOGY, V37, P272, DOI 10.1159/000081983; Remsberg KE, 2005, J CLIN ENDOCR METAB, V90, P2718, DOI 10.1210/jc.2004-1991; Rich-Edwards JW, 2008, J CLIN ENDOCR METAB, V93, P1946, DOI 10.1210/jc.2007-2535; Rich-Edwards JW, 2006, J EPIDEMIOL COMMUN H, V60, P221, DOI 10.1136/jech.2005.039370; RIFASSHIMAN S, 2005, MEDSCAPE GEN MED, V7, P55; Salsberry PJ, 2009, NURS RES, V58, P382, DOI 10.1097/NNR.0b013e3181b4b921; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; SINGER LT, 1990, J PEDIATR PSYCHOL, V15, P711, DOI 10.1093/jpepsy/15.6.711; Smith GD, 2000, J EPIDEMIOL COMMUN H, V54, P97, DOI 10.1136/jech.54.2.97; Song YM, 2008, AM J EPIDEMIOL, V168, P497, DOI 10.1093/aje/kwn187; Stewart RC, 2007, MATERN CHILD NUTR, V3, P94, DOI 10.1111/j.1740-8709.2007.00088.x; Stratakis Constantine A, 2006, Pediatr Endocrinol Rev, V3 Suppl 2, P333; Surkan PJ, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.065664; Surkan PJ, 2008, AM J PUBLIC HEALTH, V98, P125, DOI 10.2105/AJPH.2006.108332; Surkan PJ, 2007, SOC SCI MED, V64, P375, DOI 10.1016/j.socscimed.2006.09.021; Tanner J., 1990, FETUS MAN PHYS GROWT; Tomlinson M, 2006, CHILD CARE HLTH DEV, V32, P81, DOI 10.1111/j.1365-2214.2006.00598.x; WAALER HT, 1984, ACTA MED SCAND, P1; Waynforth D, 2007, DEV PSYCHOBIOL, V49, P640, DOI 10.1002/dev.20248; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Wright CM, 2006, ARCH DIS CHILD, V91, P312, DOI 10.1136/adc.2005.077750	70	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13656	10.1371/journal.pone.0013656	http://dx.doi.org/10.1371/journal.pone.0013656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	671UN	21048958	Green Published, gold			2022-12-25	WOS:000283537000027
J	Lewis-Tuffin, LJ; Rodriguez, F; Giannini, C; Scheithauer, B; Necela, BM; Sarkaria, JN; Anastasiadis, PZ				Lewis-Tuffin, Laura J.; Rodriguez, Fausto; Giannini, Caterina; Scheithauer, Bernd; Necela, Brian M.; Sarkaria, Jann N.; Anastasiadis, Panos Z.			Misregulated E-Cadherin Expression Associated with an Aggressive Brain Tumor Phenotype	PLOS ONE			English	Article							CELL-CELL ADHESION; EPITHELIAL-MESENCHYMAL TRANSITIONS; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR RECEPTOR; XENOGRAFT TEST PANEL; N-CADHERIN; DIFFERENTIAL EXPRESSION; GLIOBLASTOMA-MULTIFORME; BETA-CATENIN; P120 CATENIN	Background: Cadherins are essential components of the adherens junction complexes that mediate cell-cell adhesion and regulate cell motility. During tissue morphogenesis, changes in cadherin expression (known as cadherin switching) are a common mechanism for altering cell fate. Cadherin switching is also common during epithelial tumor progression, where it is thought to promote tumor invasion and metastasis. E-cadherin is the predominant cadherin expressed in epithelial tissues, but its expression is very limited in normal brain. Methodology/Principal Findings: We identified E-cadherin expression in a retrospective series of glioblastomas exhibiting epithelial or pseudoepithelial differentiation. Unlike in epithelial tissues, E-cadherin expression in gliomas correlated with an unfavorable clinical outcome. Western blotting of two panels of human GBM cell lines propagated either as xenografts in nude mice or grown under conventional cell culture conditions confirmed that E-cadherin expression is rare. However, a small number of xenograft lines did express E-cadherin, its expression correlating with increased invasiveness when the cells were implanted orthotopically in mouse brain. In the conventionally cultured SF767 glioma cell line, E-cadherin expression was localized throughout the plasma membrane rather than being restricted to areas of cell-cell contact. ShRNA knockdown of E-cadherin in these cells resulted in decreased proliferation and migration in vitro. Conclusions/Significance: Our data shows an unexpected correlation between the abnormal expression of E-cadherin in a subset of GBM tumor cells and the growth and migration of this aggressive brain tumor subtype.	[Lewis-Tuffin, Laura J.; Necela, Brian M.; Anastasiadis, Panos Z.] Mayo Clin Jacksonville, Dept Canc Cell Biol, Jacksonville, FL 32224 USA; [Rodriguez, Fausto; Giannini, Caterina; Scheithauer, Bernd] Mayo Clin, Dept Pathol, Rochester, MN USA; [Sarkaria, Jann N.] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Lewis-Tuffin, LJ (corresponding author), Mayo Clin Jacksonville, Dept Canc Cell Biol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	panos@mayo.edu	Giannini, Caterina/AAB-7551-2022		National Institutes of Health [R01 CA100467, R01 NS069753, R21 NS070117, P50 CA108961]; Mayo Clinic SPORE in Brain Cancer; Research Training in Neuro-Oncology [T32NS07494]; NATIONAL CANCER INSTITUTE [R01CA100467, P50CA108961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069753, R21NS070117, T32NS007494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic SPORE in Brain Cancer; Research Training in Neuro-Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by National Institutes of Health R01 CA100467, R01 NS069753, and R21 NS070117 (PZ Anastasiadis), P50 CA108961 Mayo Clinic SPORE in Brain Cancer (C Giannini and JN Sarkaria), and T32NS07494 "Research Training in Neuro-Oncology" (PI/PD: BP O'Neill). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Asano K, 2000, NEUROSURG REV, V23, P39, DOI 10.1007/s101430050030; Asano K, 2004, J NEURO-ONCOL, V70, P3, DOI 10.1023/B:NEON.0000040811.14908.f2; Asano K, 1997, Brain Tumor Pathol, V14, P27, DOI 10.1007/BF02478865; Barami Kaveh, 2006, Neurosurg Focus, V21, pE13; Bible KC, 1999, ANAL BIOCHEM, V267, P217, DOI 10.1006/abio.1998.2980; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; DeLeeuw WJF, 1997, J PATHOL, V183, P404, DOI 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9; Demuth T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-54; du Plessis DG, 2004, CLIN NEUROPATHOL, V23, P141; FIGARELLABRANGER D, 1994, MODERN PATHOL, V7, P752; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Howng SL, 2002, CANCER LETT, V183, P95, DOI 10.1016/S0304-3835(02)00085-X; Karpowicz P, 2009, J NEUROSCI, V29, P3885, DOI 10.1523/JNEUROSCI.0037-09.2009; Kislin KL, 2009, NEOPLASIA, V11, P377, DOI 10.1593/neo.81572; Leuraud P, 2003, BRIT J CANCER, V89, P2327, DOI 10.1038/sj.bjc.6601466; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis DN, 2007, ACTA NEUROPATHOL, V114, P547, DOI 10.1007/s00401-007-0278-6; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Motta FJN, 2008, GENET MOL RES, V7, P295, DOI 10.4238/vol7-2gmr424; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ordonez NG, 2003, HUM PATHOL, V34, P749, DOI 10.1016/S0046-8177(03)00285-5; Ozawa T, 1998, IN VIVO, V12, P369; Ozolek JA, 2004, MODERN PATHOL, V17, P739, DOI 10.1038/modpathol.3800109; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Perego C, 2002, J CELL SCI, V115, P3331; Perez TD, 2008, J BIOL CHEM, V283, P5014, DOI 10.1074/jbc.M705209200; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Reddy P, 2005, MOL ENDOCRINOL, V19, P2564, DOI 10.1210/me.2004-0342; Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2; Rodriguez FJ, 2008, CANCER, V113, P2779, DOI 10.1002/cncr.23899; Sarkaria JN, 2007, MOL CANCER THER, V6, P1167, DOI 10.1158/1535-7163.MCT-06-0691; Sarkaria JN, 2006, CLIN CANCER RES, V12, P2264, DOI 10.1158/1078-0432.CCR-05-2510; Schwechheimer K, 1998, VIRCHOWS ARCH, V432, P163, DOI 10.1007/s004280050151; SHINOURA N, 1995, BRIT J CANCER, V72, P627, DOI 10.1038/bjc.1995.384; Soto E, 2008, J CELL BIOL, V183, P737, DOI 10.1083/jcb.200805113; Steinberg MS, 1999, CURR OPIN CELL BIOL, V11, P554, DOI 10.1016/S0955-0674(99)00027-7; Sundfeldt K, 2003, MOL CELL ENDOCRINOL, V202, P89, DOI 10.1016/S0303-7207(03)00068-6; Suzuki SC, 2008, DEV GROWTH DIFFER, V50, pS119, DOI 10.1111/j.1440-169X.2008.01002.x; Takeichi M, 2000, PHILOS T ROY SOC B, V355, P885, DOI 10.1098/rstb.2000.0624; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; The WHO, 2020, CLASSIFICATION TUMOU; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; TOHMA Y, 1992, CANCER RES, V52, P1981; Troyanovsky SM, 1999, CURR OPIN CELL BIOL, V11, P561, DOI 10.1016/S0955-0674(99)00021-6; Utsuki S, 2002, J NEURO-ONCOL, V57, P187, DOI 10.1023/A:1015720220602; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wijnhoven BPL, 2000, BRIT J SURG, V87, P992, DOI 10.1046/j.1365-2168.2000.01513.x; Xia M, 2010, J NEURO-ONCOL, V97, P225, DOI 10.1007/s11060-009-0015-1; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022; Yang L, 2008, CLIN CANCER RES, V14, P3993, DOI 10.1158/1078-0432.CCR-07-4152	61	119	124	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13665	10.1371/journal.pone.0013665	http://dx.doi.org/10.1371/journal.pone.0013665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060868	gold, Green Published, Green Submitted			2022-12-25	WOS:000283537000034
J	Liangos, O; Domhan, S; Schwager, C; Zeier, M; Huber, PE; Addabbo, F; Goligorsky, MS; Hlatky, L; Jaber, BL; Abdollahi, A				Liangos, Orfeas; Domhan, Sophie; Schwager, Christian; Zeier, Martin; Huber, Peter E.; Addabbo, Francesco; Goligorsky, Michael S.; Hlatky, Lynn; Jaber, Bertrand L.; Abdollahi, Amir			Whole Blood Transcriptomics in Cardiac Surgery Identifies a Gene Regulatory Network Connecting Ischemia Reperfusion with Systemic Inflammation	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ARTERY-BYPASS-SURGERY; OFF-PUMP; ON-PUMP; CARDIOPULMONARY BYPASS; NATIONAL DATABASE; LONG PENTRAXIN; RESISTIN; EXPRESSION; INJURY	Background: Cardiac surgery with cardiopulmonary bypass (CS/CPB) is associated with increased risk for postoperative complications causing substantial morbidity and mortality. To identify the molecular mechanisms underlying CS/CPB-induced pathophysiology we employed an integrative systems biology approach using the whole blood transcriptome as the sentinel organ. Methodology/Principal Findings: Total RNA was isolated and globin mRNA depleted from whole blood samples prospectively collected from 10 patients at time points prior (0), 2 and 24 hours following CS/CPB. Genome-wide transcriptional analysis revealed differential expression of 610 genes after CS/CPB (p<0.01). Among the 375 CS/CPB-upregulated genes, we found a gene-regulatory network consisting of 50 genes, reminiscent of activation of a coordinated genetic program triggered by CS/CPB. Intriguingly, the highly connected hub nodes of the identified network included key sensors of ischemia-reperfusion (HIF-1alpha and C/EBPbeta). Activation of this network initiated a concerted inflammatory response via upregulation of TLR-4/5, IL1R2/IL1RAP, IL6, IL18/IL18R1/IL18RAP, MMP9, HGF/HGFR, CalgranulinA/B, and coagulation factors F5/F12 among others. Differential regulation of 13 candidate genes including novel, not hitherto CS/CBP-associated genes, such as PTX3, PGK1 and Resistin, was confirmed using real-time quantitative RT-PCR. In support of the mRNA data, differential expression of MMP9, MIP1alpha and MIP1beta plasma proteins was further confirmed in 34 additional patients. Conclusions: Analysis of blood transcriptome uncovered critical signaling pathways governing the CS/CPB-induced pathophysiology. The molecular signaling underlying ischemia reperfusion and inflammatory response is highly intertwined and includes pro-inflammatory as well as cardioprotective elements. The herein identified candidate genes and pathways may provide promising prognostic biomarker and therapeutic targets.	[Liangos, Orfeas; Jaber, Bertrand L.] Tufts Univ, Sch Med, Caritas St Elizabeths Med Ctr, Kidney & Dialysis Res Lab,Div Nephrol, Boston, MA 02111 USA; [Domhan, Sophie; Hlatky, Lynn; Abdollahi, Amir] Tufts Univ, Sch Med, Caritas St Elizabeths Med Ctr, Ctr Canc Syst Biol, Boston, MA 02111 USA; [Domhan, Sophie; Zeier, Martin] Univ Med Sch, Dept Nephrol, Heidelberg, Germany; [Domhan, Sophie; Schwager, Christian; Zeier, Martin; Huber, Peter E.; Abdollahi, Amir] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Schwager, Christian; Huber, Peter E.; Abdollahi, Amir] Univ Med Sch, Dept Radiat Oncol, Heidelberg, Germany; [Addabbo, Francesco; Goligorsky, Michael S.] New York Med Coll, Div Nephrol, Valhalla, NY 10595 USA	St. Elizabeth's Medical Center; Tufts University; St. Elizabeth's Medical Center; Tufts University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; New York Medical College	Liangos, O (corresponding author), Tufts Univ, Sch Med, Caritas St Elizabeths Med Ctr, Kidney & Dialysis Res Lab,Div Nephrol, Boston, MA 02111 USA.	liangos_o@hotmail.com; amir.abdollahi@tufts.edu			American Heart Association (AHA) [0535367N]; National Institutes of Health [DK065102, DK077751, DK084394]; NASA Specialized Center of Research (NSCOR) [NNJ04HJ12G]; Westchester Artificial Kidney Foundation; German Krebshilfe [107691, 107689, Max-Eder 108876]; BMBF [03NUK004A/C]; DFG (German Research Foundation) [SPP1190]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084394, R03DK077751, K23DK065102] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA Specialized Center of Research (NSCOR); Westchester Artificial Kidney Foundation; German Krebshilfe(Deutsche Krebshilfe); BMBF(Federal Ministry of Education & Research (BMBF)); DFG (German Research Foundation)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the following agencies: 1) American Heart Association (AHA #0535367N, to OL), which funded the principal author (OL) as well as the parent study that provided the samples and clinical data for this manuscript. 2) National Institutes of Health (DK065102 and DK077751, to BLJ), funded the co-author (BLJ). 3) NASA Specialized Center of Research (NSCOR, NNJ04HJ12G, to LH and AA), which provides funding for the infrastructure and major equipment used for the manuscript. 4) DK084394 and Westchester Artificial Kidney Foundation (to MSG), which funded the plasma protein measurement experiments. 5) German Krebshilfe (107691 & 107689, to PH and AA), German Krebshilfe (Max-Eder 108876, to AA), BMBF (03NUK004A/C, to PH and AA), DFG (German Research Foundation) SPP1190 (to PH and AA), which funded the respective authors as listed with their initials. 6) Institutional research funds (to OL), which funded the supplies and consumables for the analytic tests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2005, J EXP MED, V201, P925, DOI 10.1084/jem.20041393; Abdollahi A, 2004, MOL CELL, V13, P649, DOI 10.1016/S1097-2765(04)00102-9; Abdollahi A, 2007, P NATL ACAD SCI USA, V104, P12890, DOI 10.1073/pnas.0705505104; Almog N, 2009, CANCER RES, V69, P836, DOI 10.1158/0008-5472.CAN-08-2590; Castellheim A, 2008, ANN THORAC SURG, V85, P1994, DOI 10.1016/j.athoracsur.2008.03.012; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chandrasekar B, 1999, CIRCULATION, V99, P427, DOI 10.1161/01.CIR.99.3.427; Christenson J T, 1996, Cardiovasc Surg, V4, P15, DOI 10.1016/0967-2109(96)83778-1; Clark SC, 2006, PERFUSION-UK, V21, P225, DOI 10.1191/0267659106pf872oa; Cohen G, 2008, J IMMUNOL, V181, P3761, DOI 10.4049/jimmunol.181.6.3761; Croome KP, 2009, CAN J SURG, V52, P125; Daly Richard C, 2005, Mayo Clin Proc, V80, P636; DAVIES SW, 1993, J THORAC CARDIOV SUR, V105, P979, DOI 10.1016/S0022-5223(19)33769-9; Domhan S, 2008, MOL CANCER THER, V7, P1656, DOI 10.1158/1535-7163.MCT-08-0193; Emani S, 2009, J THORAC CARDIOV SUR, V138, P185, DOI 10.1016/j.jtcvs.2008.12.024; Fransen E, 1998, CHEST, V113, P1290, DOI 10.1378/chest.113.5.1290; Grover FL, 1999, ANN THORAC SURG, V68, P367, DOI 10.1016/S0003-4975(99)00599-8; Grover FW, 1999, ANN THORAC SURG, V68, P374; Hall RI, 1997, ANESTH ANALG, V85, P766, DOI 10.1097/00000539-199710000-00011; Harmoinen A, 2006, SCAND CARDIOVASC J, V40, P110, DOI 10.1080/14017430500401220; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Hung HF, 2008, J HYPERTENS, V26, P2349, DOI 10.1097/HJH.0b013e328311fa30; Jain U, 1997, ANESTHESIOLOGY, V86, P576, DOI 10.1097/00000542-199703000-00009; JANSEN NJG, 1991, EUR J CARDIO-THORAC, V5, P211, DOI 10.1016/1010-7940(91)90032-F; Kielstein JT, 2003, AM J KIDNEY DIS, V42, P62, DOI 10.1016/S0272-6386(03)00409-8; KOLLEF MH, 1995, CHEST, V107, P1395, DOI 10.1378/chest.107.5.1395; Laffey JG, 2002, ANESTHESIOLOGY, V97, P215; Lee SH, 2009, CORONARY ARTERY DIS, V20, P33, DOI 10.1097/MCA.0b013e328318ecb0; Li H, 1996, J BIOL CHEM, V271, P21262, DOI 10.1074/jbc.271.35.21262; Mangano CM, 1998, ANN INTERN MED, V128, P194, DOI 10.7326/0003-4819-128-3-199802010-00005; Mangano DT, 1997, JAMA-J AM MED ASSOC, V277, P325, DOI 10.1001/jama.277.4.325; Meldrum DR, 1999, J SURG RES, V85, P185, DOI 10.1006/jsre.1999.5660; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Ramlawi B, 2007, ANN THORAC SURG, V84, P1166, DOI 10.1016/j.athoracsur.2007.04.126; Ramlawi B, 2007, J THORAC CARDIOV SUR, V134, P996, DOI 10.1016/j.jtcvs.2007.01.096; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; Rothwell SE, 2006, BIOCHEM BIOPH RES CO, V349, P400, DOI 10.1016/j.bbrc.2006.08.052; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Seeburger J, 2005, CIRCULATION, V112, pI224, DOI 10.1161/CIRCULATIONAHA.104.525378; Stallwood MI, 2004, ANN THORAC SURG, V77, P968, DOI 10.1016/j.athoracsur.2003.09.063; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; STOKMAN G, NEPHROL DIAL TRANSPL; Suzuki S, 2008, AM HEART J, V155, P75, DOI 10.1016/j.ahj.2007.08.013; Tomic V, 2005, CIRCULATION, V112, P2912, DOI 10.1161/CIRCULATIONAHA.104.531152; Vartanian K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-2; Wan S, 1997, CHEST, V112, P676, DOI 10.1378/chest.112.3.676; Westhuyzen J, 1997, J THORAC CARDIOV SUR, V113, P942, DOI 10.1016/S0022-5223(97)70268-X; Yamashita Chojiro, 1998, Kobe Journal of Medical Sciences, V44, P199; Zhang M, 2007, FASEB J, V21, P3197, DOI 10.1096/fj.06-6558com	51	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13658	10.1371/journal.pone.0013658	http://dx.doi.org/10.1371/journal.pone.0013658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048961	gold, Green Submitted, Green Published			2022-12-25	WOS:000283537000029
J	Bertola, A; Bonnafous, S; Anty, R; Patouraux, S; Saint-Paul, MC; Iannelli, A; Gugenheim, J; Barr, J; Mato, JM; Le Marchand-Brustel, Y; Tran, A; Gual, P				Bertola, Adeline; Bonnafous, Stephanie; Anty, Rodolphe; Patouraux, Stephanie; Saint-Paul, Marie-Christine; Iannelli, Antonio; Gugenheim, Jean; Barr, Jonathan; Mato, Jose M.; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe			Hepatic Expression Patterns of Inflammatory and Immune Response Genes Associated with Obesity and NASH in Morbidly Obese Patients	PLOS ONE			English	Article							FATTY LIVER-DISEASE; OMENTAL ADIPOSE-TISSUE; TOLL-LIKE RECEPTOR-4; NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; MACROPHAGE ACCUMULATION; MICE; OSTEOPONTIN; CELLS; SYSTEM	Background: Obesity modulates inflammation and activation of immune pathways which can lead to liver complications. We aimed at identifying expression patterns of inflammatory and immune response genes specifically associated with obesity and NASH in the liver of morbidly obese patients. Methodology/Principal Findings: Expression of 222 genes was evaluated by quantitative RT-PCR in the liver of morbidly obese patients with histologically normal liver (n = 6), or with severe steatosis without (n = 6) or with NASH (n = 6), and in lean controls (n = 5). Hepatic expression of 58 out of 222 inflammatory and immune response genes was upregulated in NASH patients. The most notable changes occurred in genes encoding chemokines and chemokine receptors involved in leukocyte recruitment, CD and cytokines involved in the T cell activation towards a Th1 phenotype, and immune semaphorins. This regulation seems to be specific for the liver since visceral adipose tissue expression and serum levels of MCP1, IP10, TNF alpha and IL6 were not modified. Importantly, 47 other genes were already upregulated in histologically normal liver (e.g. CRP, Toll-like receptor (TLR) pathway). Interestingly, serum palmitate, known to activate the TLR pathway, was increased with steatosis. Conclusion/Significance: The liver of obese patients without histological abnormalities already displayed a low-grade inflammation and could be more responsive to activators of the TLR pathway. NASH was then characterized by a specific gene signature. These findings help to identify new potential actors of the pathogenesis of NAFLD.	[Bertola, Adeline; Bonnafous, Stephanie; Anty, Rodolphe; Saint-Paul, Marie-Christine; Gugenheim, Jean; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe] INSERM, U895, Team Hepat Complicat Obes 8, Nice, France; [Bertola, Adeline; Bonnafous, Stephanie; Anty, Rodolphe; Saint-Paul, Marie-Christine; Gugenheim, Jean; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe] Univ Nice Sophia Antipolis, Fac Med, Nice, France; [Bonnafous, Stephanie; Anty, Rodolphe; Iannelli, Antonio; Gugenheim, Jean; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe] Ctr Hosp Univ Nice, Digest Unit, Nice, France; [Patouraux, Stephanie; Saint-Paul, Marie-Christine] Ctr Hosp Univ Nice, Biol Unit, Nice, France; [Barr, Jonathan] OWL Genom, Bizkaia, Spain; [Mato, Jose M.] Ciberehd, CIC BioGUNE, Bizkaia, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CHU Nice; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE	Bertola, A (corresponding author), INSERM, U895, Team Hepat Complicat Obes 8, Nice, France.	gual@unice.fr	Gual, Philippe/M-8787-2017; Gual, Philippe/P-9833-2019; Iannelli, Antonio/E-6521-2012; MATO, JOSE/A-5187-2011	Gual, Philippe/0000-0001-7393-8356; Gual, Philippe/0000-0001-7393-8356; MATO, JOSE/0000-0003-1264-3153; Iannelli, Antonio/0000-0002-1611-071X; GUGENHEIM, Jean/0000-0002-2624-3014; Anty, Rodolphe/0000-0001-8194-9805; Anty, Rodolphe/0000-0002-8053-1957; Bertola, Adeline/0000-0002-4885-8423; patouraux, stephanie/0000-0001-6004-7685	Institut National de la Sante et de la Recherche Medicale (France) [ANR-05-PCOD-025-02]; University of Nice; Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire of Nice); Societe Francophone du Diabete/Association de Langue Francaise pour l'Etude du Diabete et des Maladie Metaboliques (SFD/ALFEDIAM); Association Francaise pour l'Etude du Foie (AFEF)/Schering-Plough; European Commission [LSHM-CT-2005-018734]; Association pour la Recherche sur le Cancer (France); CHU of Nice	Institut National de la Sante et de la Recherche Medicale (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Nice; Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire of Nice); Societe Francophone du Diabete/Association de Langue Francaise pour l'Etude du Diabete et des Maladie Metaboliques (SFD/ALFEDIAM); Association Francaise pour l'Etude du Foie (AFEF)/Schering-Plough(Merck & CompanySchering Plough Corporation); European Commission(European CommissionEuropean Commission Joint Research Centre); Association pour la Recherche sur le Cancer (France)(Fondation ARC pour la Recherche sur le Cancer); CHU of Nice	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale (France) (ANR-05-PCOD-025-02 and PNRHGE to PG), the University of Nice, the Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire of Nice), and charities (Societe Francophone du Diabete/Association de Langue Francaise pour l'Etude du Diabete et des Maladie Metaboliques (SFD/ALFEDIAM) and Association Francaise pour l'Etude du Foie (AFEF)/Schering-Plough to PG). This work is part of the project "Hepatic and adipose tissue and functions in the metabolic syndrome" (HEPADIP, see http://www.hepadip.org/), which is supported by the European Commission as an Integrated Project under the 6th Framework Programme (Contract LSHM-CT-2005-018734). AB was successively supported by the Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire of Nice) and the Association pour la Recherche sur le Cancer (France). SB was supported by ANR-05-PCOD-025-02. YLMB and PG are the recipients of an Interface Grant from CHU of Nice. Jonathan Barr belongs to the OWL Genomics Company, Bizkaia Technology Park, Spain, who did have a role in study design, data collection and analysis. Indeed, JB has determined the palmitate level in the serum samples from the patients and has analyzed the values (Figure 5). The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albano E, 2005, GUT, V54, P987, DOI 10.1136/gut.2004.057968; Anty R, 2008, OBES SURG, V18, P709, DOI 10.1007/s11695-007-9276-y; Anty R, 2006, AM J GASTROENTEROL, V101, P1824, DOI 10.1111/j.1572-0241.2006.00724.x; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Baranova A, 2007, OBES SURG, V17, P1111, DOI 10.1007/s11695-007-9187-y; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Bigorgne AE, 2008, GASTROENTEROLOGY, V134, P1459, DOI 10.1053/j.gastro.2008.02.055; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cayon A, 2008, REV ESP ENFERM DIG, V100, P212, DOI 10.4321/s1130-01082008000400004; Cortez-Pinto H, 2006, J HEPATOL, V44, P197, DOI 10.1016/j.jhep.2005.09.002; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Elinav E, 2006, J PATHOL, V208, P74, DOI 10.1002/path.1869; Estep JM, 2009, OBES SURG, V19, P617, DOI 10.1007/s11695-009-9814-x; Guebre-Xabier M, 2000, HEPATOLOGY, V31, P633, DOI 10.1002/hep.510310313; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Ito S, 2007, ALCOHOL CLIN EXP RES, V31, p83S, DOI 10.1111/j.1530-0277.2006.00292.x; Joshi-Barve S, 2007, HEPATOLOGY, V46, P823, DOI 10.1002/hep.21752; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; LANTHIER N, 2009, AM J PHYSL GASTROINT; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Li ZP, 2002, GASTROENTEROLOGY, V123, P1304, DOI 10.1053/gast.2002.35997; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Maher JJ, 2008, HEPATOLOGY, V48, P670, DOI 10.1002/hep.22399; McCullough AJ, 2006, J CLIN GASTROENTEROL, V40, pS17; Mimura S, 2004, J GASTROENTEROL, V39, P867, DOI 10.1007/s00535-004-1403-0; Mizui M, 2009, J CLIN IMMUNOL, V29, P1, DOI 10.1007/s10875-008-9263-7; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Pacifico L, 2006, EUR J ENDOCRINOL, V154, P691, DOI 10.1530/eje.1.02138; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Solga SF, 2003, J HEPATOL, V38, P681, DOI 10.1016/S0168-8278(03)00097-7; Suzuki A, 2009, WOMENS HEALTH, V5, P191, DOI 10.2217/17455057.5.2.191; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Szabo G, 2005, ALCOHOL CLIN EXP RES, V29, p140S, DOI 10.1097/01.alc.0000189287.83544.33; Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007; Tilg H, 2009, GASTROENTEROLOGY, V136, P1476, DOI 10.1053/j.gastro.2009.03.030; Tordjman J, 2009, J HEPATOL, V51, P354, DOI 10.1016/j.jhep.2009.02.031; VALENTI L, 2009, SEMIN IMMUNOPATHOL; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x; Xu CF, 2007, WORLD J GASTROENTERO, V13, P4504; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang SQ, 1997, P NATL ACAD SCI USA, V94, P2557, DOI 10.1073/pnas.94.6.2557; Yokoyama Y, 2005, J SURG RES, V128, P147, DOI 10.1016/j.jss.2005.04.017	56	169	175	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13577	10.1371/journal.pone.0013577	http://dx.doi.org/10.1371/journal.pone.0013577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042596	Green Submitted, gold, Green Published			2022-12-25	WOS:000283419100016
J	Hult, M; Tornhammar, P; Ueda, P; Chima, C; Bonamy, AKE; Ozumba, B; Norman, M				Hult, Martin; Tornhammar, Per; Ueda, Peter; Chima, Charles; Bonamy, Anna-Karin Edstedt; Ozumba, Benjamin; Norman, Mikael			Hypertension, Diabetes and Overweight: Looming Legacies of the Biafran Famine	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; SYSTOLIC BLOOD-PRESSURE; BODY-MASS INDEX; BIRTH-WEIGHT; FETAL ORIGINS; LATER LIFE; IN-UTERO; CHILD UNDERNUTRITION; PRENATAL EXPOSURE; ADULT DISEASE	Background: Sub-Saharan Africa is facing rapidly increasing prevalences of cardiovascular disease, obesity, diabetes and hypertension. Previous and ongoing undernutrition among pregnant women may contribute to this development as suggested by epidemiological studies from high income countries linking undernutrition in fetal life with increased burden of non-communicable diseases in later life. We undertook to study the risks for hypertension, glucose intolerance and overweight forty years after fetal exposure to famine afflicted Biafra during the Nigerian civil war (1967-1970). Methods and Findings: Cohort study performed in June 27-July 31, 2009 in Enugu, Nigeria. Adults (n = 1,339) born before (1965-67), during (1968-January 1970), or after (1971-73) the years of famine were included. Blood pressure (BP), random plasma glucose (p-glucose) and anthropometrics, as well as prevalence of hypertension (BP>140/90 mmHg), impaired glucose tolerance (IGT; p-glucose 7.8-11.0 mmol/l), diabetes (DM; p-glucose >= 11.1 mmol/l), or overweight (BMI>25 kg/m(2)) were compared between the three groups. Fetal-infant exposure to famine was associated with elevated systolic (+7 mmHg; p<0.001) and diastolic (+5 mmHg; p<0.001) BP, increased p-glucose (+0.3 mmol/L; p<0.05) and waist circumference (+3cm, p<0.001), increased risk of systolic hypertension (adjusted OR 2.87; 95% CI 1.90-4.34), IGT (OR 1.65; 95% CI 1.02-2.69) and overweight (OR 1.41; 95% CI 1.03-1.93) as compared to people born after the famine. Limitations of this study include the lack of birth weight data and the inability to separate effects of fetal and infant famine. Conclusions: Fetal and infant undernutrition is associated with significantly increased risk of hypertension and impaired glucose tolerance in 40-year-old Nigerians. Prevention of undernutrition during pregnancy and in infancy should therefore be given high priority in health, education, and economic agendas.	[Hult, Martin; Tornhammar, Per; Ueda, Peter; Norman, Mikael] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Bonamy, Anna-Karin Edstedt] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Chima, Charles; Ozumba, Benjamin] Univ Nigeria Teaching Hosp, Enugu, Nigeria	Karolinska Institutet; Karolinska Institutet; University of Nigeria	Hult, M (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	mikael.norman@ki.se	Ueda, Peter/AGH-9915-2022; Ueda, Peter/AAB-8961-2020; Bonamy, Anna-Karin E/B-7106-2012	Ueda, Peter/0000-0002-3275-8743; Ueda, Peter/0000-0002-3275-8743; Bonamy, Anna-Karin E/0000-0003-4552-9912; Norman, Mikael/0000-0003-4191-3781	Karolinska Institute; Swedish International Development Cooperation Agency; Carl-Eriks Levins Foundation	Karolinska Institute(Karolinska Institutet); Swedish International Development Cooperation Agency; Carl-Eriks Levins Foundation	Funding was received from the Karolinska Institute, Swedish International Development Cooperation Agency and Carl-Eriks Levins Foundation. Funding was unrestricted and the funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	Aall C, 1970, J Trop Pediatr (1967), V16, P70; Adair LS, 2003, HYPERTENSION, V41, P451, DOI 10.1161/01.HYP.0000054212.23528.B2; [Anonymous], 2010, BMC RES NOTES; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Barker DJP, 1998, MOTHERS BABIES HLTH; Bergvall N, 2007, CIRCULATION, V115, P2931, DOI 10.1161/CIRCULATIONAHA.106.674812; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; BLUM JD, 1969, HARVARD CRIMSON 0225; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; Eriksson J, 2000, HYPERTENSION, V36, P790, DOI 10.1161/01.HYP.36.5.790; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gluckman PD, 2009, LANCET, V373, P1654, DOI 10.1016/S0140-6736(09)60234-8; Grajeda Ruben, 2005, Food and Nutrition Bulletin, V26, pS15; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Holmes MD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000244; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Ike S O, 2009, Niger J Med, V18, P68; Johansson S, 2007, J INTERN MED, V261, P480, DOI 10.1111/j.1365-2796.2007.01776.x; Kaijser M, 2009, DIABETES, V58, P523, DOI 10.2337/db08-0558; Koupil I, 2007, EUR J EPIDEMIOL, V22, P223, DOI 10.1007/s10654-007-9113-6; Lawlor DA, 2002, AM J EPIDEMIOL, V156, P1100, DOI 10.1093/aje/kwf154; Leon DA, 1996, BRIT MED J, V312, P401, DOI 10.1136/bmj.312.7028.401; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; Miller J P, 1970, Lancet, V760, P1330; Moore SE, 2001, DIABETIC MED, V18, P646, DOI 10.1046/j.1464-5491.2001.00565.x; Nwagwu MO, 2000, BRIT J NUTR, V83, P79, DOI 10.1017/S0007114500000118; Oladapo OO, 2010, CARDIOVASC J AFR, V21, P26; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Richter LM, 2004, PAEDIATR PERINAT EP, V18, P290, DOI 10.1111/j.1365-3016.2004.00572.x; Roseboom TJ, 2001, J HYPERTENS, V19, P29, DOI 10.1097/00004872-200101000-00004; Roseboom TJ, 1999, J HYPERTENS, V17, P325, DOI 10.1097/00004872-199917030-00004; Sachdev HS, 2005, AM J CLIN NUTR, V82, P456, DOI 10.1093/ajcn/82.2.456; Shepherd PR, 1997, BRIT J NUTR, V78, P121, DOI 10.1079/BJN19970124; Stanner SA, 1997, BMJ-BRIT MED J, V315, P1342, DOI 10.1136/bmj.315.7119.1342; Stein AD, 2006, EUR J EPIDEMIOL, V21, P759, DOI 10.1007/s10654-006-9065-2; Topouchian JA, 2006, BLOOD PRESS MONIT, V11, P165, DOI 10.1097/01.mbp.0000209078.17246.34; Unwin N, 2001, HEALTH POLICY PLANN, V16, P351, DOI 10.1093/heapol/16.4.351; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora Cesar G., 2003, Cad. Saúde Pública, V19, P1241, DOI 10.1590/S0102-311X2003000500003; World Health Organization/International Diabetes Federation, 2006, DEF DIAGN DIAB MELL; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616; Yusuf S, 2000, NEW ENGL J MED, V342, P145; 1991, AM J EPIDEMIOL, V133, P185	48	189	194	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13582	10.1371/journal.pone.0013582	http://dx.doi.org/10.1371/journal.pone.0013582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042579	Green Published, Green Submitted, gold			2022-12-25	WOS:000283419100019
J	Mazur, PK; Gruner, BM; Nakhai, H; Sipos, B; Zimber-Strobl, U; Strobl, LJ; Radtke, F; Schmid, RM; Siveke, JT				Mazur, Pawel K.; Gruener, Barbara M.; Nakhai, Hassan; Sipos, Bence; Zimber-Strobl, Ursula; Strobl, Lothar J.; Radtke, Freddy; Schmid, Roland M.; Siveke, Jens T.			Identification of Epidermal Pdx1 Expression Discloses Different Roles of Notch1 and Notch2 in Murine Kras(G12D)-Induced Skin Carcinogenesis In Vivo	PLOS ONE			English	Article							TRANSCRIPTION FACTOR PDX-1; BETA-CATENIN; KERATINOCYTE GROWTH; TUMOR-SUPPRESSOR; STEM-CELLS; MOUSE; ACTIVATION; MICE; GENE; RAS	Background: The Ras and Notch signaling pathways are frequently activated during development to control many diverse cellular processes and are often dysregulated during tumorigenesis. To study the role of Notch and oncogenic Kras signaling in a progenitor cell population, Pdx1-Cre mice were utilized to generate conditional oncogenic Kras(G12D) mice with ablation of Notch1 and/or Notch2. Methodology/Principal Findings: Surprisingly, mice with activated Kras(G12D) and Notch1 but not Notch2 ablation developed skin papillomas progressing to squamous cell carcinoma providing evidence for Pdx1 expression in the skin. Immunostaining and lineage tracing experiments indicate that PDX1 is present predominantly in the suprabasal layers of the epidermis and rarely in the basal layer. Further analysis of keratinocytes in vitro revealed differentiation-dependent expression of PDX1 in terminally differentiated keratinocytes. PDX1 expression was also increased during wound healing. Further analysis revealed that loss of Notch1 but not Notch2 is critical for skin tumor development. Reasons for this include distinct Notch expression with Notch1 in all layers and Notch2 in the suprabasal layer as well as distinctive p21 and beta-catenin signaling inhibition capabilities. Conclusions/Significance: Our results provide strong evidence for epidermal expression of Pdx1 as of yet not identified function. In addition, this finding may be relevant for research using Pdx1-Cre transgenic strains. Additionally, our study confirms distinctive expression and functions of Notch1 and Notch2 in the skin supporting the importance of careful dissection of the contribution of individual Notch receptors.	[Mazur, Pawel K.; Gruener, Barbara M.; Schmid, Roland M.; Siveke, Jens T.] Tech Univ Munich, Klinikum Rechts Isar Univ Hosp, Dept Internal Med 2, Munich, Germany; [Nakhai, Hassan] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Sipos, Bence] Univ Tubingen, Univ Hosp, Inst Pathol, Tubingen, Germany; [Zimber-Strobl, Ursula; Strobl, Lothar J.] German Res Ctr Environm Hlth, Helmholtz Zentrum, Dept Gene Vectors, Munich, Germany; [Radtke, Freddy] Ecole Polytech Fed Lausanne EPFL SV ISREC, ISREC, Lausanne, Switzerland	Technical University of Munich; University of Warwick; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Mazur, PK (corresponding author), Tech Univ Munich, Klinikum Rechts Isar Univ Hosp, Dept Internal Med 2, Munich, Germany.	jens.siveke@lrz.tum.de	Zimber-Strobl, Ursula/M-4618-2014; Grüner, Barbara/AAB-9246-2020; Grüner, Barbara M/T-1298-2018; Radtke, Freddy/Q-3198-2017; Strobl, Lothar J/M-7357-2014; Siveke, Jens/AAQ-6170-2021; Mazur, Pawel K./AAU-6343-2021	Zimber-Strobl, Ursula/0000-0002-9765-5251; Grüner, Barbara/0000-0003-0974-4826; Grüner, Barbara M/0000-0003-0974-4826; Radtke, Freddy/0000-0003-4315-4045; Strobl, Lothar J/0000-0001-8389-1862; Mazur, Pawel K./0000-0002-5820-8344	German Cancer Aid [107195]; The Lustgarten Foundation [RFP05-14, 06-12]; German Research Foundation [SI 1549/1-1]	German Cancer Aid(Deutsche Krebshilfe); The Lustgarten Foundation; German Research Foundation(German Research Foundation (DFG))	This work was supported by grants from the German Cancer Aid (#107195), The Lustgarten Foundation (RFP05-14 and 06-12) and the German Research Foundation (SI 1549/1-1; all to J.T.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagheri MM, 2001, CLIN DERMATOL, V19, P244, DOI 10.1016/S0738-081X(01)00179-1; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Buettner M, 2004, MODERN PATHOL, V17, P56, DOI 10.1038/modpathol.3800015; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Chigurupati S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001167; Demehri S, 2009, CANCER CELL, V16, P55, DOI 10.1016/j.ccr.2009.05.016; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Gannon M, 2000, GENESIS, V26, P143, DOI 10.1002/(SICI)1526-968X(200002)26:2<143::AID-GENE13>3.0.CO;2-L; Gannon M, 2001, DEV BIOL, V238, P185, DOI 10.1006/dbio.2001.0359; Geisler F, 2008, HEPATOLOGY, V48, P607, DOI 10.1002/hep.22381; GREENHALGH DA, 1993, MOL CARCINOGEN, V7, P99, DOI 10.1002/mc.2940070208; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hakkinen Lari, 2001, Methods in Cell Science, V23, P189, DOI 10.1023/A:1016385109922; Hamada Y, 1999, DEVELOPMENT, V126, P3415; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kawamori D, 2003, DIABETES, V52, P2896, DOI 10.2337/diabetes.52.12.2896; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Larsson LI, 1996, MECH DEVELOP, V60, P175, DOI 10.1016/S0925-4773(96)00609-0; Lefort K, 2004, SEMIN CANCER BIOL, V14, P374, DOI 10.1016/j.semcancer.2004.04.017; Lewis AK, 1998, MECH DEVELOP, V78, P159, DOI 10.1016/S0925-4773(98)00165-8; Lin MH, 2000, DEVELOPMENT, V127, P2421; Lowell S, 2000, CURR BIOL, V10, P491, DOI 10.1016/S0960-9822(00)00451-6; Macfarlane WM, 1999, J BIOL CHEM, V274, P1011, DOI 10.1074/jbc.274.2.1011; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; MAZUR PK, 2010, P NATL ACAD IN PRESS; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Nakhai H, 2008, DEVELOPMENT, V135, P2757, DOI 10.1242/dev.013722; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Offield MF, 1996, DEVELOPMENT, V122, P983; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Siveke JT, 2007, CANCER CELL, V12, P266, DOI 10.1016/j.ccr.2007.08.002; Sivere JT, 2008, GASTROENTEROLOGY, V134, P544, DOI 10.1053/j.gastro.2007.11.003; Oskarsson T, 2006, GENE DEV, V20, P2024, DOI 10.1101/gad.381206; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Tarutani M, 2003, CANCER RES, V63, P319; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Uyttendaele H, 2004, DIFFERENTIATION, V72, P396, DOI 10.1111/j.1432-0436.2004.07208006.x; Vauclair S, 2005, DEV BIOL, V284, P184, DOI 10.1016/j.ydbio.2005.05.018; Vitale-Cross L, 2004, CANCER RES, V64, P8804, DOI 10.1158/0008-5472.CAN-04-2623; Wescott MP, 2009, MOL BIOL CELL, V20, P4838, DOI 10.1091/mbc.E09-03-0203; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198	58	32	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13578	10.1371/journal.pone.0013578	http://dx.doi.org/10.1371/journal.pone.0013578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042537	Green Published, gold, Green Submitted			2022-12-25	WOS:000283419100017
J	Accordi, B; Espina, V; Giordan, M; VanMeter, A; Milani, G; Galla, L; Ruzzene, M; Sciro, M; Trentin, L; De Maria, R; Kronnie, GT; Petricoin, E; Liotta, L; Basso, G				Accordi, Benedetta; Espina, Virginia; Giordan, Marco; VanMeter, Amy; Milani, Gloria; Galla, Luisa; Ruzzene, Maria; Sciro, Manuela; Trentin, Luca; De Maria, Ruggero; Kronnie, Geertruy Te; Petricoin, Emanuel; Liotta, Lance; Basso, Giuseppe			Functional Protein Network Activation Mapping Reveals New Potential Molecular Drug Targets for Poor Prognosis Pediatric BCP-ALL	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; NITRIC-OXIDE; SYNTHASE ACTIVITY; KINASE; PATHWAY; APOPTOSIS; ASSOCIATION; MECHANISMS; CANCER; BCL-2	Background: In spite of leukemia therapy improvements obtained over the last decades, therapy is not yet effective in all cases. Current approaches in Acute Lymphoblastic Leukemia (ALL) research focus on identifying new molecular targets to improve outcome for patients with a dismal prognosis. In this light phosphoproteomics seems to hold great promise for the identification of proteins suitable for targeted therapy. Methodology/Principal Findings: We employed Reverse Phase Protein Microarrays to identify aberrantly activated proteins in 118 pediatric B-cell precursor (BCP)-ALL patients. Signal transduction pathways were assayed for activation/expression status of 92 key signalling proteins. We observed an increased activation/expression of several pathways involved in cell proliferation in poor clinical prognosis patients. MLL-rearranged tumours revealed BCL-2 hyperphosphorylation through AMPK activation, which indicates that AMPK could provide a functional role in inhibiting apoptosis in MLL-rearranged patients, and could be considered as a new potential therapeutic target. Second, in patients with poor clinical response to prednisone we observed the up-modulation of LCK activity with respect to patients with good response. This tyrosine-kinase can be down-modulated with clinically used inhibitors, thus modulating LCK activity could be considered for further studies as a new additional therapy for prednisone-resistant patients. Further we also found an association between high levels of CYCLIN E and relapse incidence. Moreover, CYCLIN E is more expressed in early relapsed patients, who usually show an unfavourable prognosis. Conclusions/Significance: We conclude that functional protein pathway activation mapping revealed specific deranged signalling networks in BCP-ALL that could be potentially modulated to produce a better clinical outcome for patients resistant to standard-of-care therapies.	[Accordi, Benedetta; Giordan, Marco; Milani, Gloria; Galla, Luisa; Sciro, Manuela; Trentin, Luca; Kronnie, Geertruy Te; Basso, Giuseppe] Univ Padua, Dept Pediat, Oncohematol Lab, Padua, Italy; [Espina, Virginia; VanMeter, Amy; Petricoin, Emanuel; Liotta, Lance] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA; [Ruzzene, Maria] Univ Padua, Dept Biol Chem, Padua, Italy; [Ruzzene, Maria] Univ Padua, VIMM, Padua, Italy; [De Maria, Ruggero] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy	University of Padua; George Mason University; University of Padua; University of Padua; Veneto Institute Molecular Medicine; Istituto Superiore di Sanita (ISS)	Accordi, B (corresponding author), Univ Padua, Dept Pediat, Oncohematol Lab, Padua, Italy.	benedetta.accordi@unipd.it	Kronnie, Geertruy te/L-1014-2016; Giordan, Marco/A-3301-2012; De Maria, Ruggero/S-6385-2019	De Maria, Ruggero/0000-0003-2255-0583; Espina, Virginia/0000-0001-5080-5972; BASSO, GIUSEPPE/0000-0002-2634-9302; /0000-0001-5636-1006; Galla, Luisa/0000-0001-8160-6052; Ruzzene, Maria/0000-0001-8712-8151; te Kronnie, Geertruy/0000-0001-7143-4795; TRENTIN, LUCA/0000-0002-7447-2946	Italian Istituto Superiore di Sanita in the framework of the Italy/USA cooperation agreement between the U.S. Department of Health and Human Services, George Mason University; Italian Ministry of Public Health; Fondazione Citta' della Speranza; Ministero della Salute; Associazione Italiana Ricerca sul Cancro; PRIN MIUR	Italian Istituto Superiore di Sanita in the framework of the Italy/USA cooperation agreement between the U.S. Department of Health and Human Services, George Mason University; Italian Ministry of Public Health(Ministry of Health, Italy); Fondazione Citta' della Speranza; Ministero della Salute(Ministry of Health, Italy); Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); PRIN MIUR(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by grants from the Italian Istituto Superiore di Sanita in the framework of the Italy/USA cooperation agreement between the U.S. Department of Health and Human Services, George Mason University, and the Italian Ministry of Public Health; the Fondazione Citta' della Speranza; the Ministero della Salute (Ricerca Finalizzata 2006- Programma Integrato Oncologia); the Associazione Italiana Ricerca sul Cancro; the PRIN MIUR EX 40%, and the EX 60%. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir LT, 1998, ONCOGENE, V16, P737, DOI 10.1038/sj.onc.1201829; Bachmann PS, 2007, CANCER RES, V67, P4482, DOI 10.1158/0008-5472.CAN-06-4244; Basso G, 2001, HAEMATOLOGICA, V86, P675; Baumann P, 2007, ANTI-CANCER DRUG, V18, P405, DOI 10.1097/CAD.0b013e32801416b6; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; Blake S, 2008, CLIN IMMUNOL, V127, P330, DOI 10.1016/j.clim.2008.02.006; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choi BM, 2002, J BIOCHEM MOL BIOL, V35, P116; Drew BG, 2004, P NATL ACAD SCI USA, V101, P6999, DOI 10.1073/pnas.0306266101; GENARO AM, 1995, J CLIN INVEST, V95, P1884, DOI 10.1172/JCI117869; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; HENZE G, 1991, BLOOD, V78, P1166; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kornblau SM, 2009, BLOOD, V113, P154, DOI 10.1182/blood-2007-10-119438; Lauten M, 2001, KLIN PADIATR, V213, P169, DOI 10.1055/s-2001-16848; Liotta LA, 2003, CANCER CELL, V3, P317, DOI 10.1016/S1535-6108(03)00086-2; MANNICK JB, 1994, CELL, V79, P1137, DOI 10.1016/0092-8674(94)90005-1; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; Petricoin EF, 2005, J CLIN ONCOL, V23, P3614, DOI 10.1200/JCO.2005.02.509; Petricoin EF, 2007, CANCER RES, V67, P3431, DOI 10.1158/0008-5472.CAN-06-1344; Pierobon M, 2009, CLIN COLORECTAL CANC, V8, P110, DOI 10.3816/CCC.2009.n.018; Pollard K. S., 2008, MULTTEST RESAMPLING; Pui CH, 2003, LEUKEMIA, V17, P700, DOI 10.1038/sj.leu.2402883; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Redaelli A, 2005, EUR J CANCER CARE, V14, P53, DOI 10.1111/j.1365-2354.2005.00513.x; REITER A, 1994, BLOOD, V84, P3122, DOI 10.1182/blood.V84.9.3122.3122; Robinson BW, 2008, BRIT J HAEMATOL, V141, P827, DOI 10.1111/j.1365-2141.2008.07100.x; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; Schneider A, 2008, NEOPLASIA, V10, P1295, DOI 10.1593/neo.08586; Schrappe M, 2000, BLOOD, V95, P3310; Scuderi R, 1996, BLOOD, V87, P3360, DOI 10.1182/blood.V87.8.3360.bloodjournal8783360; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; THOMSEN LL, 1995, BRIT J CANCER, V72, P41, DOI 10.1038/bjc.1995.274; van Rhenen A, 2005, CLIN CANCER RES, V11, P6520, DOI 10.1158/1078-0432.CCR-05-0468; Wulfkuhle JD, 2003, PROTEOMICS, V3, P2085, DOI 10.1002/pmic.200300591; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133	38	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13552	10.1371/journal.pone.0013552	http://dx.doi.org/10.1371/journal.pone.0013552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042412	Green Submitted, Green Published, gold			2022-12-25	WOS:000283293800018
J	Iscla, I; Wray, R; Blount, P				Iscla, Irene; Wray, Robin; Blount, Paul			An in vivo screen reveals protein-lipid interactions crucial for gating a mechanosensitive channel	FASEB JOURNAL			English	Article						methanethiosulfonate modification; osmoregulation; MscL	LARGE-CONDUCTANCE MSCL; MEMBRANE-PROTEIN; FLUORESCENCE; RESIDUES; IDENTIFICATION; TENSION; DOMAIN	The bacterial mechanosensitive channel MscL is the best-studied mechanosensor, thus serving as a paradigm of how a protein senses and responds to mechanical force. Models for the transition of Escherichia coli MscL from closed to open states propose a tilting of the transmembrane domains in the plane of the membrane, suggesting dynamic protein-lipid interactions. Here, we used a rapid in vivo assay to assess the function of channels that were post-translationally modified at several different sites in a region just distal to the cytoplasmic end of the second transmembrane helix. We utilized multiple probes with various affinities for the membrane environment. The in vivo functional data, combined with site-directed mutagenesis, single-channel analyses, and tryptophan fluorescence measurements, confirmed that lipid interactions within this region are critical for MscL gating. The data suggest a model in which this region acts as an anchor for the transmembrane domain tilting during gating. Furthermore, the conservation of analogous motifs among many other channels suggests a conserved protein-lipid dynamic mechanism.-Iscla, I., Wray, R., Blount, P. An in vivo screen reveals protein-lipid interactions crucial for gating a mechanosensitive channel. FASEB J. 25, 694-702 (2011). www.fasebj.org	[Iscla, Irene; Wray, Robin; Blount, Paul] UT SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75235 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Blount, P (corresponding author), UT SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.	paul.blount@utsouthwestern.edu	Iscla, Irene/B-8594-2013	Iscla, Irene/0000-0001-8936-430X	Welch Foundation [I-1420]; U.S. National Aeronautics and Space Administration [NNH08ZTT003N NRA]; Cancer Prevention and Research Institute of Texas, (CPRIT) [RP100146]; U.S. National Institutes of Health [GM61028]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061028] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); U.S. National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Cancer Prevention and Research Institute of Texas, (CPRIT); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Christina Eaton for technical support and Michael Dorwart for helpful discussions. This work was supported by the Welch Foundation (grant I-1420), the U.S. National Aeronautics and Space Administration (grant NNH08ZTT003N NRA), the Cancer Prevention and Research Institute of Texas, (CPRIT; grant RP100146), and the U.S. National Institutes of Health (grant GM61028 and its supplement). R. W. generated all MscL mutants and performed and analyzed the in vivo screening with MTS probes. I. I. performed and analyzed the in vivo experiments for the single mutants and designed, performed, and analyzed patch-clamp experiments, tryptophan fluorescence measurements, and the calcein flux experiments. P. B. and I. I. wrote the manuscript. P. B. coordinated and oversaw the project.	Bartlett JL, 2004, P NATL ACAD SCI USA, V101, P10161, DOI 10.1073/pnas.0402040101; Batiza AF, 2002, P NATL ACAD SCI USA, V99, P5643, DOI 10.1073/pnas.082092599; Betanzos M, 2002, NAT STRUCT BIOL, V9, P704, DOI 10.1038/nsb828; Blount P, 1999, Methods Enzymol, V294, P458; Blount P, 1996, BIOL CELL, V87, P1, DOI 10.1016/S0248-4900(97)89832-2; Blount P, 1999, TRENDS MICROBIOL, V7, P420, DOI 10.1016/S0966-842X(99)01594-2; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Blount P, 1996, EMBO J, V15, P4798, DOI 10.1002/j.1460-2075.1996.tb00860.x; Blount P, 2007, CURR TOP MEMBR, V58, P201, DOI 10.1016/S1063-5823(06)58008-1; Blount Paul, 2008, V11, P25; Blount Paul, 2008, V1, P71; BOLEN EJ, 1990, BIOCHEMISTRY-US, V29, P9638, DOI 10.1021/bi00493a019; CARNEY J, 2006, CURR PROTOC PROTEIN, P12; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chiang CS, 2005, BIOCHEMISTRY-US, V44, P12589, DOI 10.1021/bi050750r; Clark EH, 2003, BIOCHEMISTRY-US, V42, P11065, DOI 10.1021/bi034607e; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; EAST JM, 1982, BIOCHEMISTRY-US, V21, P4144, DOI 10.1021/bi00260a035; Elmore DE, 2003, BIOPHYS J, V85, P1512, DOI 10.1016/S0006-3495(03)74584-6; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Iscla I, 2008, BIOPHYS J, V95, P2283, DOI 10.1529/biophysj.107.127423; Jeon J, 2008, BIOPHYS J, V94, P3497, DOI 10.1529/biophysj.107.109850; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kloda A, 2006, BIOPHYS J, V90, P1992, DOI 10.1529/biophysj.105.075481; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Levin G, 2004, BIOPHYS J, V86, P2862, DOI 10.1016/S0006-3495(04)74338-6; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Li YZ, 2009, FASEB J, V23, P2197, DOI 10.1096/fj.09-129296; MCINTOSH TJ, 1987, BIOCHEMISTRY-US, V26, P1783, DOI 10.1021/bi00380a042; Moe P, 2005, BIOCHEMISTRY-US, V44, P12239, DOI 10.1021/bi0509649; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Perozo E, 2001, J GEN PHYSIOL, V118, P193, DOI 10.1085/jgp.118.2.193; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Powl AM, 2005, BIOCHEMISTRY-US, V44, P5873, DOI 10.1021/bi047439e; Powl AM, 2005, BIOCHEMISTRY-US, V44, P5713, DOI 10.1021/bi047338g; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Sukharev S, 2001, BIOPHYS J, V81, P917, DOI 10.1016/S0006-3495(01)75751-7; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319	40	20	21	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					694	702		10.1096/fj.10-170878	http://dx.doi.org/10.1096/fj.10-170878			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	21068398	Green Published			2022-12-25	WOS:000286724800027
J	Peeters, MC; van Westen, GJP; Guo, D; Wisse, LE; Muller, CE; Beukers, MW; IJzerman, AP				Peeters, Miriam C.; van Westen, Gerard J. P.; Guo, Dong; Wisse, Lisanne E.; Mueller, Christa E.; Beukers, Margot W.; IJzerman, Adriaan P.			GPCR structure and activation: an essential role for the first extracellular loop in activating the adenosine A(2B) receptor	FASEB JOURNAL			English	Article						mutagenesis; G protein-coupled receptors; S. cerevisiae; receptor activation; constitutive activity	DOMINANT RETINITIS-PIGMENTOSA; PROTEIN-COUPLED RECEPTORS; LIGAND-BINDING; C5A RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; THYROTROPIN RECEPTOR; RANDOM MUTAGENESIS; RHODOPSIN GENE; YEAST; IDENTIFICATION	The highly variable extracellular loops in G protein-coupled receptors (GPCRs) have been implicated in receptor activation, the mechanism of which is poorly understood. In a random mutagenesis screen on the human adenosine A(2B) receptor (A(2B)R) using the MMY24 Saccharomyces cerevisiae strain as a read-out system, we found that two residues in the first extracellular loop, a phenylalanine and an aspartic acid at positions 71 and 74, respectively, are involved in receptor activation. We subsequently performed further site-directed and site-saturation mutagenesis. These experiments revealed that the introduction of mutations at either of the identified positions results in a wide variety of receptor activation profiles, with changes in agonist potency, constitutive activity, and intrinsic activity. Radioligand binding studies showed that the changes in activation were not due to changes in receptor expression. We interpret these data in the light of the recently revealed structure of the adenosine A(2A)R, the closest homologue of the A(2B)R. The two residues are suggested to be vital in maintaining the tertiary structure of a beta sheet in the extracellular domain of the A(2B)R. We hypothesize that deterioration of structure in the extracellular domains of GPCRs compromises overall receptor structure with profound consequences for receptor activation and constitutive activity.-Peeters, M. C., van Westen, G. J. P., Guo, D., Wisse, L. E., Muller, C. E., Beukers, M. W., IJzerman, A. P. GPCR structure and activation: an essential role for the first extracellular loop in activating the adenosine A(2B) receptor. FASEB J. 25, 632-643 (2011). www.fasebj.org	[Peeters, Miriam C.; van Westen, Gerard J. P.; Guo, Dong; Wisse, Lisanne E.; Beukers, Margot W.; IJzerman, Adriaan P.] Ctr Biopharmaceut Sci, Div Med Chem, Leiden Amsterdam Ctr Drug Res, NL-2300 RA Leiden, Netherlands; [Mueller, Christa E.] Univ Bonn, Inst Pharmazeut, PharmaCtr Bonn, D-5300 Bonn, Germany	Leiden University; Leiden University - Excl LUMC; University of Bonn	IJzerman, AP (corresponding author), Ctr Biopharmaceut Sci, Div Med Chem, Leiden Amsterdam Ctr Drug Res, POB 9502, NL-2300 RA Leiden, Netherlands.	ijzerman@lacdr.leidenuniv.nl	van Westen, Gerard JP/D-7432-2011; Müller, Christa Elisabeth/C-7748-2014; Guo, Dong/T-6126-2019; van Westen, Gerard/HHZ-3762-2022; IJzerman, Ad/ABG-1353-2020	van Westen, Gerard JP/0000-0003-0717-1817; Müller, Christa Elisabeth/0000-0002-0013-6624; Guo, Dong/0000-0001-6142-4825; IJzerman, Ad/0000-0002-1182-2259	Dutch Top Institute Pharma [D1-105]	Dutch Top Institute Pharma	This research was performed under the auspices of the GPCR Forum, a program funded by the Dutch Top Institute Pharma (project D1-105).	Archer-Lahlou E, 2005, J MED CHEM, V48, P180, DOI 10.1021/jm049886y; Bajaj A, 2007, BBA-MOL CELL RES, V1773, P707, DOI 10.1016/j.bbamcr.2007.02.002; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Beukers MW, 2005, TRENDS PHARMACOL SCI, V26, P533, DOI 10.1016/j.tips.2005.08.005; Beukers MW, 2004, MOL PHARMACOL, V65, P702, DOI 10.1124/mol.65.3.702; Borrmann T, 2009, J MED CHEM, V52, P3994, DOI 10.1021/jm900413e; BrõndÚn CI., 1991, INTRO PROTEIN STRUCT; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; Cain SA, 2001, BIOCHEM PHARMACOL, V61, P1571, DOI 10.1016/S0006-2952(01)00608-6; *CHEM COMP GROUP I, 2008, 200810 CHEM COMP GRO; DOHLMAN HG, 1990, BIOCHEMISTRY-US, V29, P2335, DOI 10.1021/bi00461a018; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; FISHMAN GA, 1992, ARCH OPHTHALMOL-CHIC, V110, P646, DOI 10.1001/archopht.1992.01080170068026; Fredholm BB, 2000, N-S ARCH PHARMACOL, V362, P364, DOI 10.1007/s002100000313; Fredholm BB, 2001, PHARMACOL REV, V53, P527; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; Genoud S, 1999, J VIROL, V73, P1645, DOI 10.1128/JVI.73.2.1645-1648.1999; Harterich S, 2008, BIOORGAN MED CHEM, V16, P9359, DOI 10.1016/j.bmc.2008.08.051; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; HAUSER M, 2007, J BIOL CHEM; Hawtin SR, 2006, J BIOL CHEM, V281, P38478, DOI 10.1074/jbc.M607639200; HJORTH SA, 1994, J BIOL CHEM, V269, P30953; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Klco JM, 2006, J BIOL CHEM, V281, P12010, DOI 10.1074/jbc.M600548200; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kleinau G, 2008, FASEB J, V22, P2798, DOI 10.1096/fj.07-104711; Labrou NE, 2001, J BIOL CHEM, V276, P37944; Langer I, 2005, J BIOL CHEM, V280, P22198, DOI 10.1074/jbc.M501786200; Langer I, 2003, NEUROPHARMACOLOGY, V44, P125, DOI 10.1016/S0028-3908(02)00233-2; Li QL, 2007, J PHARMACOL EXP THER, V320, P637, DOI 10.1124/jpet.106.111203; Massotte D, 2005, NAT STRUCT MOL BIOL, V12, P287, DOI 10.1038/nsmb0405-287; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Moro S, 1999, BIOCHEMISTRY-US, V38, P3498, DOI 10.1021/bi982369v; NODA K, 1994, J BIOL CHEM, V269, P6743; Nurwakagari P, 2007, J MOL ENDOCRINOL, V38, P259, DOI 10.1677/jme.1.02160; OLAH ME, 1994, J BIOL CHEM, V269, P24692; Olesnicky NS, 1999, EMBO J, V18, P2756, DOI 10.1093/emboj/18.10.2756; PARMA J, 1995, MOL ENDOCRINOL, V9, P725, DOI 10.1210/me.9.6.725; Pasel K, 2000, J CLIN ENDOCR METAB, V85, P1703, DOI 10.1210/jc.85.4.1703; Spicuzza L, 2006, EUR J PHARMACOL, V533, P77, DOI 10.1016/j.ejphar.2005.12.056; Stewart GD, 2009, J PHARMACOL EXP THER, V331, P277, DOI 10.1124/jpet.109.158667; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; Sura-Trueba S, 2009, ENDOCRINOLOGY, V150, P1043, DOI 10.1210/en.2008-1145; Tenenbaum-Rakover Y, 2007, J CLIN ENDOCR METAB, V92, P1137, DOI 10.1210/jc.2006-2147; VAITHINATHAN R, 1994, GENOMICS, V21, P461, DOI 10.1006/geno.1994.1301; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wilson CN, 2008, BRIT J PHARMACOL, V155, P475, DOI 10.1038/bjp.2008.361	48	38	38	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2011	25	2					632	643		10.1096/fj.10-164319	http://dx.doi.org/10.1096/fj.10-164319			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	21030693				2022-12-25	WOS:000286724800021
J	Mittal, R; Krishnan, S; Gonzalez-Gomez, I; Prasadarao, NV				Mittal, Rahul; Krishnan, Subramanian; Gonzalez-Gomez, Ignacio; Prasadarao, Nemani V.			Deciphering the Roles of Outer Membrane Protein A Extracellular Loops in the Pathogenesis of Escherichia coli K1 Meningitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; BACTERIAL-MENINGITIS; NEONATAL MENINGITIS; TRANSMEMBRANE DOMAIN; DENDRITIC CELLS; STRAIN RS218; OMPA; EXPRESSION; INVASION; BETA	Outer membrane protein A (OmpA) has been implicated as an important virulence factor in several Gram-negative bacterial infections such as Escherichia coli K1, a leading cause of neonatal meningitis associated with significant mortality and morbidity. In this study, we generated E. coli K1 mutants that express OmpA in which three or four amino acids from various extracellular loops were changed to alanines, and we examined their ability to survive in several immune cells. We observed that loop regions 1 and 2 play an important role in the survival of E. coli K1 inside neutrophils and dendritic cells, and loop regions 1 and 3 are needed for survival in macrophages. Concomitantly, E. coli K1 mutants expressing loop 1 and 2 mutations were unable to cause meningitis in a newborn mouse model. Of note, mutations in loop 4 of OmpA enhance the severity of the pathogenesis by allowing the pathogen to survive better in circulation and to produce high bacteremia levels. These results demonstrate, for the first time, the roles played by different regions of extracellular loops of OmpA of E. coli K1 in the pathogenesis of meningitis and may help in designing effective preventive strategies against this deadly disease.	[Mittal, Rahul; Krishnan, Subramanian; Prasadarao, Nemani V.] Childrens Hosp Los Angeles, Div Infect Dis, Dept Pediat, Los Angeles, CA 90027 USA; [Gonzalez-Gomez, Ignacio] Childrens Hosp Los Angeles, Dept Pathol, Los Angeles, CA 90027 USA; [Prasadarao, Nemani V.] Childrens Hosp Los Angeles, Dept Surg, Los Angeles, CA 90027 USA; [Prasadarao, Nemani V.] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; Univ So Calif, Keck Sch Med, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California	Prasadarao, NV (corresponding author), Childrens Hosp Los Angeles, Div Infect Dis, Dept Pediat, MS 51,4650 Sunset Blvd, Los Angeles, CA 90027 USA.	pnemani@chla.usc.edu	Krishnan, Subramanian/K-5032-2019	Krishnan, Subramanian/0000-0001-5780-7452	National Institutes of Health [AI40567, NS73115]; Saban Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040567, R29AI040567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saban Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI40567 and NS73115 (to N. V. P.). This work was also supported by Saban Research Institute research career development fellowship (to R. M.).	Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214; BEHER MG, 1980, J BACTERIOL, V143, P906, DOI 10.1128/JB.143.2.906-913.1980; Boyer-Mariotte S, 2008, J ANTIMICROB CHEMOTH, V62, P1472, DOI 10.1093/jac/dkn362; BRAUN V, 1972, EUR J BIOCHEM, V28, P51, DOI 10.1111/j.1432-1033.1972.tb01883.x; Criss AK, 2008, CELL MICROBIOL, V10, P2257, DOI 10.1111/j.1462-5822.2008.01205.x; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Datta D, 2003, PROTEINS, V50, P213, DOI 10.1002/prot.10257; Dubois D, 2009, EMERG INFECT DIS, V15, P1988, DOI 10.3201/eid1512.090928; Fagan RP, 2008, INFECT IMMUN, V76, P1135, DOI 10.1128/IAI.01327-07; Houdouin V, 2008, CLIN MICROBIOL INFEC, V14, P685, DOI 10.1111/j.1469-0691.2008.02019.x; HUANG SH, 1995, INFECT IMMUN, V63, P4470, DOI 10.1128/IAI.63.11.4470-4475.1995; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kim K S, 2000, Subcell Biochem, V33, P47; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Kleinschmidt JH, 2003, CELL MOL LIFE SCI, V60, P1547, DOI 10.1007/s00018-003-3170-0; Kleinschmidt JH, 2006, CHEM PHYS LIPIDS, V141, P30, DOI 10.1016/j.chemphyslip.2006.02.004; Koebnik R, 1999, J MOL BIOL, V285, P1801, DOI 10.1006/jmbi.1998.2405; Koebnik R, 1999, J BACTERIOL, V181, P3688, DOI 10.1128/JB.181.12.3688-3694.1999; Ling M, 1998, BLOOD, V92, P4764, DOI 10.1182/blood.V92.12.4764.424k03_4764_4770; LUO Y, 2001, CURR PROTOC IMMUNOL, V3; Maruvada R, 2008, IMMUNOLOGY, V124, P265, DOI 10.1111/j.1365-2567.2007.02764.x; Mittal R, 2008, J IMMUNOL, V181, P2672, DOI 10.4049/jimmunol.181.4.2672; Mittal R, 2010, J IMMUNOL, V185, P2998, DOI 10.4049/jimmunol.1001296; Mittal R, 2010, J EXP MED, V207, P1307, DOI 10.1084/jem.20092265; Mittal R, 2010, AM J PATHOL, V176, P1292, DOI 10.2353/ajpath.2010.090851; Mittal R, 2009, FEMS IMMUNOL MED MIC, V57, P156, DOI 10.1111/j.1574-695X.2009.00591.x; MORONA R, 1984, J BACTERIOL, V159, P570, DOI 10.1128/JB.159.2.570-578.1984; Nudelman Y, 2009, DRUGS, V69, P2577, DOI 10.2165/11530590-000000000-00000; Pascal TA, 2010, J BIOL CHEM, V285, P37753, DOI 10.1074/jbc.M110.122804; Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983; Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671; Power ML, 2006, APPL ENVIRON MICROB, V72, P7930, DOI 10.1128/AEM.01040-06; Prasadarao NV, 1996, INFECT IMMUN, V64, P154, DOI 10.1128/IAI.64.1.154-160.1996; Prasadarao NV, 2002, J IMMUNOL, V169, P6352, DOI 10.4049/jimmunol.169.11.6352; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; Prasadarao NV, 2002, INFECT IMMUN, V70, P4556, DOI 10.1128/IAI.70.8.4556-4563.2002; Sidjabat HE, 2010, J ANTIMICROB CHEMOTH, V65, P1301, DOI 10.1093/jac/dkq098; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; SOKURENKO EV, 1994, J BACTERIOL, V176, P748, DOI 10.1128/jb.176.3.748-755.1994; Subramanian K, 2008, J APPL MICROBIOL, V105, P715, DOI 10.1111/j.1365-2672.2008.03800.x; Sukumaran SK, 2003, INFECT IMMUN, V71, P5951, DOI 10.1128/IAI.71.10.5951-5961.2003; Teng CH, 2006, INFECT IMMUN, V74, P5609, DOI 10.1128/IAI.00321-06; Torres AG, 2005, APPL ENVIRON MICROB, V71, P8008, DOI 10.1128/AEM.71.12.8008-8015.2005; Torres AG, 2003, INFECT IMMUN, V71, P4985, DOI 10.1128/IAI.71.9.4985-4995.2003; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573; VOGEL H, 1986, J MOL BIOL, V190, P191, DOI 10.1016/0022-2836(86)90292-5; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; Wooster DG, 2006, IMMUNOLOGY, V117, P482, DOI 10.1111/j.1365-2567.2006.02323.x	49	40	42	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2183	2193		10.1074/jbc.M110.178236	http://dx.doi.org/10.1074/jbc.M110.178236			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21071448	hybrid, Green Published			2022-12-25	WOS:000286191500059
J	Oommen, S; Gupta, SK; Vlahakis, NE				Oommen, Saji; Gupta, Shiv K.; Vlahakis, Nicholas E.			Vascular Endothelial Growth Factor A (VEGF-A) Induces Endothelial and Cancer Cell Migration through Direct Binding to Integrin alpha 9 beta 1 IDENTIFICATION OF A SPECIFIC alpha 9 beta 1 BINDING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RECEPTOR-BINDING; TYROSINE KINASE; MICE LACKING; ANGIOGENESIS; INTEGRIN-ALPHA-9-BETA-1; ACTIVATION; DOMAIN; ALPHA(4)BETA(1); ALPHA(9)BETA(1)	Integrin alpha 9 beta 1 mediates accelerated cell adhesion and migration through interactions with a number of diverse extracellular ligands. We have shown previously that it directly binds the vascular endothelial growth factors (VEGF) A, C, and D and contributes to VEGF-induced angiogenesis and lymphangiogenesis. Until now, the alpha 9 beta 1 binding site in VEGF has not been identified. Here, we report that the three-amino acid sequence, EYP, encoded by exon 3 of VEGF-A is essential for binding of VEGF to integrin alpha 9 beta 1 and induces adhesion and migration of endothelial and cancer cells. EYP is specific for alpha 9 beta 1 binding and neither requires nor activates VEGFR-2, the cognate receptor for VEGF-A. Following binding to EYP, integrin alpha 9 beta 1 transduces cell migration through direct activation of the integrin signaling intermediates Src and focal adhesion kinase. This interaction is biologically important because it mediates in vitro endothelial cell tube formation, wound healing, and cancer cell invasion. These novel findings identify EYP as a potential site for directed pharmacotherapy.	[Oommen, Saji; Gupta, Shiv K.; Vlahakis, Nicholas E.] Mayo Clin, Thorac Dis Res Unit, Div Pulm & Crit Care Med, Rochester, MN 55905 USA	Mayo Clinic	Vlahakis, NE (corresponding author), Mayo Clin, Thorac Dis Res Unit, Div Pulm & Crit Care Med, 200 1st St SW, Rochester, MN 55905 USA.	Vlahakis.nicholas@mayo.edu			National Institutes of Health [K08HL076455-05]; Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL076455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI Research Grant K08HL076455-05 from the National Institutes of Health (to N. E. V.). This work was also supported by a Mayo Foundation Research grant (to N. E. V.).	Angelo LS, 2007, CLIN CANCER RES, V13, P2825, DOI 10.1158/1078-0432.CCR-06-2416; Bagri A, 2010, TRENDS MOL MED, V16, P122, DOI 10.1016/j.molmed.2010.01.004; Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Bhattacharya R, 2005, J BIOL CHEM, V280, P28848, DOI 10.1074/jbc.C500200200; Bruns AF, 2009, BIOCHEM SOC T, V37, P1193, DOI 10.1042/BST0371193; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Chen C, 2006, IMMUNITY, V25, P895, DOI 10.1016/j.immuni.2006.10.013; Choi S, 2009, BLOOD, V113, P1845, DOI 10.1182/blood-2008-05-160671; De S, 2005, P NATL ACAD SCI USA, V102, P7589, DOI 10.1073/pnas.0502935102; De S, 2003, J BIOL CHEM, V278, P39044, DOI 10.1074/jbc.M304494200; Eto B, 2000, J BIOL CHEM, V275, P34922, DOI 10.1074/jbc.M001953200; Farrara N, 2000, CURR OPIN BIOTECH, V11, P617, DOI 10.1016/S0958-1669(00)00153-1; Garmy-Susini B, 2010, CANCER RES, V70, P3042, DOI 10.1158/0008-5472.CAN-09-3761; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Gupta SK, 2010, CELL ADHES MIGR, V4, P194, DOI 10.4161/cam.4.2.10900; Gupta SK, 2009, J CELL SCI, V122, P2043, DOI 10.1242/jcs.041632; Huang XZ, 2000, MOL CELL BIOL, V20, P5208, DOI 10.1128/MCB.20.14.5208-5215.2000; Hutchings H, 2003, FASEB J, V17, P1520, DOI 10.1096/fj.02-0691fje; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivaska J, 2010, CELL TISSUE RES, V339, P111, DOI 10.1007/s00441-009-0857-z; Kajiya K, 2005, EMBO J, V24, P2885, DOI 10.1038/sj.emboj.7600763; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Medford ARL, 2006, THORAX, V61, P621, DOI 10.1136/thx.2005.040204; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Muller YA, 1997, STRUCTURE, V5, P1325, DOI 10.1016/S0969-2126(97)00284-0; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; PRIETO AL, 1993, P NATL ACAD SCI USA, V90, P10154, DOI 10.1073/pnas.90.21.10154; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Smyth SS, 2002, J CELL BIOL, V158, P17, DOI 10.1083/jcb.200202100; Staniszewska I, 2008, J CELL SCI, V121, P504, DOI 10.1242/jcs.000232; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takahashi H, 2000, J BIOL CHEM, V275, P23589, DOI 10.1074/jbc.M003526200; Vlahakis NE, 2005, J BIOL CHEM, V280, P4544, DOI 10.1074/jbc.M412816200; Vlahakis NE, 2007, J BIOL CHEM, V282, P15187, DOI 10.1074/jbc.M609323200; Yokosaki Y, 1996, J BIOL CHEM, V271, P24144, DOI 10.1074/jbc.271.39.24144; Young BA, 2001, MOL BIOL CELL, V12, P3214, DOI 10.1091/mbc.12.10.3214	42	52	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1083	1092		10.1074/jbc.M110.175158	http://dx.doi.org/10.1074/jbc.M110.175158			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21071450	hybrid, Green Published			2022-12-25	WOS:000286005000019
J	Kelso, JK; Halder, N; Milne, GJ				Kelso, Joel K.; Halder, Nilimesh; Milne, George J.			The Impact of Case Diagnosis Coverage and Diagnosis Delays on the Effectiveness of Antiviral Strategies in Mitigating Pandemic Influenza A/H1N1 2009	PLOS ONE			English	Article							NEURAMINIDASE INHIBITOR OSELTAMIVIR; INFECTION; DISEASE; DESIGN; TIME	Background: Neuraminidase inhibitors were used to reduce the transmission of pandemic influenza A/H1N1 2009 at the early stages of the 2009/2010 pandemic. Policies for diagnosis of influenza for the purposes of antiviral intervention differed markedly between and within countries, leading to differences in the timing and scale of antiviral usage. Methodology/Principal Findings: The impact of the percentage of symptomatic infected individuals who were diagnosed, and of delays to diagnosis, for three antiviral intervention strategies (each with and without school closure) were determined using a simulation model of an Australian community. Epidemic characteristics were based on actual data from the A/H1N1 2009 pandemic including reproduction number, serial interval and age-specific infection rate profile. In the absence of intervention an illness attack rate (AR) of 24.5% was determined from an estimated R-o of 1.5; this was reduced to 21%, 16.5% or 13% by treatment-only, treatment plus household prophylaxis, or treatment plus household plus extended prophylaxis antiviral interventions respectively, assuming that diagnosis occurred 24 hours after symptoms arose and that 50% of symptomatic cases were diagnosed. If diagnosis occurred without delay, ARs decreased to 17%, 12.2% or 8.8% respectively. If 90% of symptomatic cases were diagnosed (with a 24 hour delay), ARs decreased to 17.8%, 11.1% and 7.6%, respectively. Conclusion: The ability to rapidly diagnose symptomatic cases and to diagnose a high proportion of cases was shown to improve the effectiveness of all three antiviral strategies. For epidemics with R-o<=1.5 our results suggest that when the case diagnosis coverage exceeds similar to 70% the size of the antiviral stockpile required to implement the extended prophylactic strategy decreases. The addition of at least four weeks of school closure was found to further reduce cumulative and peak attack rates and the size of the required antiviral stockpile.	[Kelso, Joel K.; Halder, Nilimesh; Milne, George J.] Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA, Australia	University of Western Australia	Kelso, JK (corresponding author), Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA, Australia.	joel@csse.uwa.edu.au	Kelso, Joel/C-2433-2013; Milne, George/C-6839-2013	Kelso, Joel/0000-0001-9814-6435; Milne, George/0000-0002-9796-0600				Arinaminpathy N, 2008, J R SOC INTERFACE, V5, P545, DOI 10.1098/rsif.2007.1152; Australian Commonwealth Department of Health and Ageing, 2009, AUSTR HLTH MAN PLAN; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; CHIN J, 2009, J R SOC INT IN PRESS; De Serres G, 2010, EMERG INFECT DIS, V16, P783, DOI 10.3201/eid1605.091894; degli Atti MLC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001790; ECDC, 2009, ECDC RISK ASS 2009 I; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Halder N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-168; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Kelso JK, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-117; Kramarz P, 2009, EUROSURVEILLANCE, V14; Lee VJ, 2007, EMERG INFECT DIS, V13, P449, DOI 10.3201/eid1303.060309; Lee VJ, 2006, EMERG INFECT DIS, V12, P95; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; MCBRYDE E, 2009, EUR SURVEILL, V14; Mccaw JM, 2007, MATH BIOSCI, V209, P336, DOI 10.1016/j.mbs.2007.02.003; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Milne G, 2010, J R SOC INTERFACE, V7, P573, DOI 10.1098/rsif.2009.0312; Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Munayco CV, 2009, EUROSURVEILLANCE, V14, P6; Nishiura H, 2009, EUROSURVEILLANCE, V14; Nishiura H, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-1; Nishiura H, 2009, NEW ZEAL MED J, V122, P73; Smith DW, 2010, MED J AUSTRALIA, V192, P541, DOI 10.5694/j.1326-5377.2010.tb03625.x; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; *UK DEP HLTH, 2007, PAND FLU NAT FRAM RE; *US DEP HHS, 2009, PAND INFL PLAN; Wilson N, 2009, EUROSURVEILLANCE, V14; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361; Wu JT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000085; Yang Y, 2006, J ROY STAT SOC C-APP, V55, P317, DOI 10.1111/j.1467-9876.2006.00539.x	40	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13797	10.1371/journal.pone.0013797	http://dx.doi.org/10.1371/journal.pone.0013797			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072188	gold, Green Published, Green Submitted			2022-12-25	WOS:000283780800007
J	Kitsios, GD; Tangri, N; Castaldi, PJ; Ioannidis, JPA				Kitsios, Georgios D.; Tangri, Navdeep; Castaldi, Peter J.; Ioannidis, John P. A.			Laboratory Mouse Models for the Human Genome-Wide Associations	PLOS ONE			English	Article							PHENOTYPE ONTOLOGY; COMMON DISEASES; LOCI; VARIANTS; INSIGHTS; SH2-B; TOOL	The agnostic screening performed by genome-wide association studies (GWAS) has uncovered associations for previously unsuspected genes. Knowledge about the functional role of these genes is crucial and laboratory mouse models can provide such information. Here, we describe a systematic juxtaposition of human GWAS-discovered loci versus mouse models in order to appreciate the availability of mouse models data, to gain biological insights for the role of these genes and to explore the extent of concordance between these two lines of evidence. We perused publicly available data (NHGRI database for human associations and Mouse Genome Informatics database for mouse models) and employed two alternative approaches for cross-species comparisons, phenotype-and gene-centric. A total of 293 single gene-phenotype human associations (262 unique genes and 69 unique phenotypes) were evaluated. In the phenotype-centric approach, we identified all mouse models and related ortholog genes for the 51 human phenotypes with a comparable phenotype in mice. A total of 27 ortholog genes were found to be associated with the same phenotype in humans and mice, a concordance that was significantly larger than expected by chance (p<0.001). In the gene-centric approach, we were able to locate at least 1 knockout model for 60% of the 262 genes. The knockouts for 35% of these orthologs displayed pre- or post-natal lethality. For the remaining non-lethal orthologs, the same organ system was involved in mice and humans in 71% of the cases (p<0.001). Our project highlights the wealth of available information from mouse models for human GWAS, catalogues extensive information on plausible physiologic implications for many genes, provides hypothesis-generating findings for additional GWAS analyses and documents that the concordance between human and mouse genetic association is larger than expected by chance and can be informative.	[Kitsios, Georgios D.; Tangri, Navdeep; Castaldi, Peter J.; Ioannidis, John P. A.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Castaldi, Peter J.; Ioannidis, John P. A.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Fdn Res & Technol Hellas, Biomed Res Inst, Ioannina, Greece; [Kitsios, Georgios D.; Castaldi, Peter J.; Ioannidis, John P. A.] Tufts Med Ctr, Tufts Clin & Translat Sci Inst, Boston, MA USA; [Castaldi, Peter J.; Ioannidis, John P. A.] Tufts Univ, Sch Med, Dept Med, Ctr Genet Epidemiol & Modeling,Tufts Med Ctr, Boston, MA 02111 USA; [Tangri, Navdeep] Tufts Med Ctr, Div Nephrol, Boston, MA USA; [Ioannidis, John P. A.] Harvard Univ, Dept Epidemiol, Harvard Sch Publ Hlth, Boston, MA 02115 USA; [Ioannidis, John P. A.] Stanford Univ, Stanford Prevent Res Ctr, Sch Med, Stanford, CA 94305 USA	Tufts Medical Center; Tufts University; University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); Tufts Medical Center; Tufts Medical Center; Tufts University; Tufts Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Stanford University	Kitsios, GD (corresponding author), Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011	Kitsios, Georgios/0000-0002-1018-948X; Tangri, Navdeep/0000-0002-5075-6370	Pfizer/Tufts Medical Center; National Center for Research Resources [UL1RR025752]; KRESCENT; Kidney Foundation of Canada; Canadian Institute of Health Research; Canadian Society of Nephrology; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER	Pfizer/Tufts Medical Center(Pfizer); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); KRESCENT; Kidney Foundation of Canada; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Society of Nephrology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Georgios D. Kitsios was a recipient of a Pfizer/Tufts Medical Center career development award. The project described was partially supported by Award Number UL1RR025752 from the National Center for Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. Navdeep Tangri is a recipient of the KRESCENT Post-Doctoral Fellowship award, a joint initiative of the Kidney Foundation of Canada, the Canadian Institute of Health Research and the Canadian Society of Nephrology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Bezerra JA, 1998, J CLIN INVEST, V101, P1175, DOI 10.1172/JCI1744; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Duan CJ, 2004, MOL CELL BIOL, V24, P7435, DOI 10.1128/MCB.24.17.7435-7443.2004; Duan WM, 2005, ONCOGENE, V24, P1510, DOI 10.1038/sj.onc.1208229; Edmondson AC, 2009, J CLIN INVEST, V119, P1042, DOI 10.1172/JCI37176; Hindorff LA, 2009, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Kitsios GD, 2009, ANN HUM GENET, V73, P514, DOI 10.1111/j.1469-1809.2009.00533.x; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; Mungall CJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r2; Ohtsuka S, 2002, MOL CELL BIOL, V22, P3066, DOI 10.1128/MCB.22.9.3066-3077.2002; Panagiotou OA, 2010, AM J EPIDEMIOL, V172, P869, DOI 10.1093/aje/kwq234; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Siontis KCM, 2010, EUR J HUM GENET, V18, P832, DOI 10.1038/ejhg.2010.26; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; Smith CL, 2009, WIRES SYST BIOL MED, V1, P390, DOI 10.1002/wsbm.44; Stefansson H, 2009, NAT GENET, V41, P277, DOI 10.1038/ng.299; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007; Washington NL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000247; Zhang YQ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-1	28	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2010	5	11							e13782	10.1371/journal.pone.0013782	http://dx.doi.org/10.1371/journal.pone.0013782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FY	21072174	Green Submitted, gold, Green Published			2022-12-25	WOS:000283645700007
J	Palidwor, GA; Perkins, TJ; Xia, XH				Palidwor, Gareth A.; Perkins, Theodore J.; Xia, Xuhua			A General Model of Codon Bias Due to GC Mutational Bias	PLOS ONE			English	Article							ESCHERICHIA-COLI; RESPECTIVE CODONS; PROTEIN GENES; TRANSFER-RNAS; USAGE; ISOCHORES; ABUNDANCE; PRESSURE; PATTERNS; HUMANS	Background: In spite of extensive research on the effect of mutation and selection on codon usage, a general model of codon usage bias due to mutational bias has been lacking. Because most amino acids allow synonymous GC content changing substitutions in the third codon position, the overall GC bias of a genome or genomic region is highly correlated with GC3, a measure of third position GC content. For individual amino acids as well, G/C ending codons usage generally increases with increasing GC bias and decreases with increasing AT bias. Arginine and leucine, amino acids that allow GC-changing synonymous substitutions in the first and third codon positions, have codons which may be expected to show different usage patterns. Principal Findings: In analyzing codon usage bias in hundreds of prokaryotic and plant genomes and in human genes, we find that two G-ending codons, AGG (arginine) and TTG (leucine), unlike all other G/C-ending codons, show overall usage that decreases with increasing GC bias, contrary to the usual expectation that G/C-ending codon usage should increase with increasing genomic GC bias. Moreover, the usage of some codons appears nonlinear, even nonmonotone, as a function of GC bias. To explain these observations, we propose a continuous-time Markov chain model of GC-biased synonymous substitution. This model correctly predicts the qualitative usage patterns of all codons, including nonlinear codon usage in isoleucine, arginine and leucine. The model accounts for 72%, 64% and 52% of the observed variability of codon usage in prokaryotes, plants and human respectively. When codons are grouped based on common GC content, 87%, 80% and 68% of the variation in usage is explained for prokaryotes, plants and human respectively. Conclusions: The model clarifies the sometimes-counterintuitive effects that GC mutational bias can have on codon usage, quantifies the influence of GC mutational bias and provides a natural null model relative to which other influences on codon bias may be measured.	[Palidwor, Gareth A.; Perkins, Theodore J.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Xia, Xuhua] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Xia, Xuhua] Univ Ottawa, CAREG, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Palidwor, GA (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.	gpalidwor@ohri.ca	Xia, Xuhua/E-5264-2010	Xia, Xuhua/0000-0002-3092-7566; Palidwor, Gareth/0000-0001-5317-319X; Perkins, Theodore J./0000-0002-6622-8003	Canadian Natural Sciences and Engineering Research Council; Ontario Research Fund; Ottawa Hospital Research Institute	Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Research Fund; Ottawa Hospital Research Institute	This work was supported by Discovery and Response to Intervention (RTI) grants from the Canadian Natural Sciences and Engineering Research Council, the Ontario Research Fund, and the Ottawa Hospital Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; BERNARDI G, 1993, MOL BIOL EVOL, V10, P186; BULMER M, 1991, GENETICS, V129, P897; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Comeron JM, 2004, GENETICS, V167, P1293, DOI 10.1534/genetics.104.026351; Faith JJ, 2003, GENETICS, V165, P735; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Harvey A.C., 1977, J ECONOMETRICS, V6, P103, DOI DOI 10.1016/0304-4076(77)90057-4; Hershberg R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000556; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; IKEMURA T, 1982, J MOL BIOL, V158, P573, DOI 10.1016/0022-2836(82)90250-9; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Jia WL, 2008, MOL BIOL EVOL, V25, P339, DOI 10.1093/molbev/msm259; Kliman RM, 2005, GENE, V352, P92, DOI 10.1016/j.gene.2005.04.001; KNIGHT RD, 2001, GENOME BIOL, V2; Marin A, 2008, J THEOR BIOL, V253, P508, DOI 10.1016/j.jtbi.2008.04.004; MUTO A, 1987, P NATL ACAD SCI USA, V84, P166, DOI 10.1073/pnas.84.1.166; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Semon M, 2006, MOL BIOL EVOL, V23, P523, DOI 10.1093/molbev/msj053; Stabenau A, 2004, GENOME RES, V14, P929, DOI 10.1101/gr.1857204; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; Tatarinova T, 2003, BIOINFORMATICS, V19, pi313, DOI 10.1093/bioinformatics/btg1043; Urbina D, 2006, J MOL EVOL, V62, P340, DOI 10.1007/s00239-005-0051-1; Xia XH, 1998, GENETICS, V149, P37; Xie G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r14; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	28	105	114	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13431	10.1371/journal.pone.0013431	http://dx.doi.org/10.1371/journal.pone.0013431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048949	gold, Green Submitted, Green Published			2022-12-25	WOS:000283537000001
J	Wang, CZ; Peyron, P; Mestre, O; Kaplan, G; van Soolingen, D; Gao, QA; Gicquel, B; Neyrolles, O				Wang, Chongzhen; Peyron, Pascale; Mestre, Olga; Kaplan, Gilla; van Soolingen, Dick; Gao, Qian; Gicquel, Brigitte; Neyrolles, Olivier			Innate Immune Response to Mycobacterium tuberculosis Beijing and Other Genotypes	PLOS ONE			English	Article							GENOMIC DELETIONS; IN-VITRO; STRAINS; INSIGHTS; LINEAGE; PATHOGENESIS; MACROPHAGES; EXPRESSION; PHYLOGENY; INDUCTION	Background: As a species, Mycobacterium tuberculosis is more diverse than previously thought. In particular, the Beijing family of M. tuberculosis strains is spreading and evoluating throughout the world and this is giving rise to public health concerns. Genetic diversity within this family has recently been delineated further and a specific genotype, called Bmyc10, has been shown to represent over 60% of all Beijing clinical isolates in several parts of the world. How the host immune system senses and responds to various M. tuberculosis strains may profoundly influence clinical outcome and the relative epidemiological success of the different mycobacterial lineages. We hypothesised that the success of the Bmyc10 group may, at least in part, rely upon its ability to alter innate immune responses and the secretion of cytokines and chemokines by host phagocytes. Methodology/Principal Findings: We infected human macrophages and dendritic cells with a collection of genetically well-defined M. tuberculosis clinical isolates belonging to various mycobacterial families, including Beijing. We analyzed cytokine and chemokine secretion on a semi-global level using antibody arrays allowing the detection of sixty-five immunity-related soluble molecules. Our data indicate that Beijing strains induce significantly less interleukin (IL)-6, tumor necrosis factor (TNF), IL-10 and GRO-alpha than the H37Rv reference strain, a feature that is variously shared by other modern and ancient M. tuberculosis families and which constitutes a signature of the Beijing family as a whole. However, Beijing strains did not differ relative to each other in their ability to modulate cytokine secretion. Conclusions/Significance: Our results confirm and expand upon previous reports showing that M. tuberculosis Beijing strains in general are poor in vitro cytokine inducers in human phagocytes. The results suggest that the epidemiological success of the Beijing Bmyc10 is unlikely to rely upon any specific ability of this group of strains to impair anti-mycobacterial innate immunity.	[Wang, Chongzhen; Peyron, Pascale; Neyrolles, Olivier] Inst Pharmacol & Biol Struct, CNRS, Toulouse, France; [Wang, Chongzhen; Peyron, Pascale; Neyrolles, Olivier] Univ Toulouse 3, Inst Pharmacol & Biol Struct, F-31062 Toulouse, France; [Mestre, Olga; Gicquel, Brigitte] Inst Pasteur, Unit Mycobacterial Genet, Paris, France; [Kaplan, Gilla] Univ Med & Dent New Jersey, Publ Hlth Res Inst Ctr, Lab Mycobacterial Immun & Pathogenesis, Newark, NJ 07103 USA; [van Soolingen, Dick] Natl Inst Publ Hlth & Environm, TB Reference Lab, NL-3720 BA Bilthoven, Netherlands; [van Soolingen, Dick] Radboud Univ Nijmegen, Dept Pulm Dis, NL-6525 ED Nijmegen, Netherlands; [van Soolingen, Dick] Radboud Univ Nijmegen, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Gao, Qian] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Rutgers State University New Brunswick; Rutgers State University Medical Center; Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; Radboud University Nijmegen; Fudan University	Wang, CZ (corresponding author), Inst Pharmacol & Biol Struct, CNRS, Toulouse, France.	olivier.neyrolles@ipbs.fr	Neyrolles, Olivier B/A-3184-2011; Neyrolles, Olivier/AAG-3692-2019; Wang, Chongzhen/GMX-1772-2022; Mestre, Olga/D-7418-2013	Neyrolles, Olivier/0000-0003-0047-5885; Wang, Chongzhen/0000-0001-9368-6029; Mestre, Olga/0000-0002-0993-2248	Centre de la Recherche Scientifique (CNRS); Institut Pasteur; European Community [200973, LSHP-CT-2006-037919]; CNRS-ATIP	Centre de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); European Community(European Commission); CNRS-ATIP(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Centre de la Recherche Scientifique (CNRS), the Institut Pasteur, and the European Community (FP7 project TB-VIR, Grant no 200973, and FP6 project TB-ADAPT, Grant no LSHP-CT-2006-037919). ON is a fellow of a CNRS-ATIP grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chacon-Salinas R, 2005, CLIN EXP IMMUNOL, V140, P443, DOI 10.1111/j.1365-2249.2005.02797.x; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Huet G, 2009, J BIOL CHEM, V284, P27101, DOI 10.1074/jbc.M109.041939; Kong Y, 2007, J CLIN MICROBIOL, V45, P409, DOI 10.1128/JCM.01459-06; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; MESTRE O, PHYLOGENY MYCO UNPUB; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mostowy S, 2002, J INFECT DIS, V186, P74, DOI 10.1086/341068; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Parwati I, 2010, J INFECT DIS, V201, P553, DOI 10.1086/650311; Puissegur MP, 2004, CELL MICROBIOL, V6, P423, DOI 10.1111/j.1462-5822.2004.00371.x; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Sinsimer D, 2008, INFECT IMMUN, V76, P3027, DOI 10.1128/IAI.01663-07; Sohn H, 2009, SCAND J IMMUNOL, V69, P43, DOI 10.1111/j.1365-3083.2008.02188.x; Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939; Tanveer M, 2009, T ROY SOC TROP MED H, V103, P581, DOI 10.1016/j.trstmh.2009.03.014; Thwaites G, 2008, J CLIN MICROBIOL, V46, P1363, DOI 10.1128/JCM.02180-07; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; van Crevel R, 2009, J INFECT DIS, V200, P1671, DOI 10.1086/648477; van der Spuy GD, 2009, TUBERCULOSIS, V89, P120, DOI 10.1016/j.tube.2008.09.003; WHO, 2009, GLOB TUB CONTR 2009; 2006, EMERG INFECT DIS, V12, P736	40	63	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13594	10.1371/journal.pone.0013594	http://dx.doi.org/10.1371/journal.pone.0013594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049036	Green Submitted, Green Published, gold			2022-12-25	WOS:000283422100011
J	Bunce, D; Anstey, KJ; Cherbuin, N; Burns, R; Christensen, H; Wen, W; Sachdev, PS				Bunce, David; Anstey, Kaarin J.; Cherbuin, Nicolas; Burns, Richard; Christensen, Helen; Wen, Wei; Sachdev, Perminder S.			Cognitive Deficits Are Associated with Frontal and Temporal Lobe White Matter Lesions in Middle-Aged Adults Living in the Community	PLOS ONE			English	Article							WITHIN-PERSON VARIABILITY; HYPERINTENSITIES; HEALTH; MEMORY; BRAIN; ABNORMALITIES; RECOGNITION; PERFORMANCE; TOPOGRAPHY; MRI	Background: The association between brain white matter lesions and cognitive impairment in old age is well established. However, little is known about this association in midlife. As this information will inform policy for early preventative healthcare initiatives, we investigated non-periventricular frontal, temporal, parietal and occipital lobe white matter hyperintensities (WMH) in relation to cognitive function in 428 (232 women) community-dwelling adults aged 44 to 48 years. Results: Frontal white matter lesions were significantly associated with greater intraindividual RT variability in women, while temporal WMH were associated with face recognition deficits in men. Parietal and occipital lobe lesions were unrelated to cognitive performance. These findings did not differ when education and a range of health variables, including vascular risk factors, were taken into account. Conclusion: Gender differences in WMH-cognition associations are discussed, and we conclude that small vessel disease is present in midlife and has functional consequences which are generally not recognized. Preventative strategies should, therefore, begin early in life.	[Bunce, David; Anstey, Kaarin J.; Cherbuin, Nicolas; Burns, Richard; Christensen, Helen] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia; [Bunce, David] Brunel Univ, Dept Psychol, London, England; [Wen, Wei; Sachdev, Perminder S.] Prince Wales Hosp, Inst Neuropsychiat, Randwick, NSW 2031, Australia; [Wen, Wei; Sachdev, Perminder S.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia	Australian National University; Brunel University; University of New South Wales Sydney	Bunce, D (corresponding author), Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia.	david.bunce@brunel.ac.uk	Anstey, Kaarin/A-3852-2008; Sachdev, Perminder/ABC-1137-2020; Cherbuin, Nicolas/A-8515-2008; Burns, Richard A/C-4231-2011; Christensen, Helen/F-5053-2012	Anstey, Kaarin/0000-0002-9706-9316; Sachdev, Perminder/0000-0002-9595-3220; Cherbuin, Nicolas/0000-0001-6481-0748; Burns, Richard A/0000-0002-7750-4341; Christensen, Helen/0000-0003-0435-2065; Wen, Wei/0000-0003-2753-3870; Bunce, David/0000-0003-3265-2700	Leverhulme Trust; British Academy; NHMRC of Australia [973302, 179805]; NHMRC [471501, 366756]; Australian Brewers Foundation; Australian Rotary Health	Leverhulme Trust(Leverhulme Trust); British Academy; NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Brewers Foundation; Australian Rotary Health	David Bunce's collaboration in this work was supported by the Leverhulme Trust and the British Academy. The study was funded by NHMRC of Australia Unit Grant No. 973302, Program Grant No. 179805, NHMRC project grant No. 157125, grants from the Australian Rotary Health Research Fund and the Australian Brewers Foundation. Nicolas Cherbuin is funded by NHMRC Research Fellowship No. 471501. Kaarin Anstey is funded by NHMRC Research Fellowship No. 366756. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; Anstey KJ, 2005, Q J EXP PSYCHOL-A, V58, P5, DOI 10.1080/02724980443000232; Ashburner J, 1997, NEUROIMAGE, V6, P209, DOI 10.1006/nimg.1997.0290; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Baddeley A, 1992, SPOT WORD TEST; Bellgrove MA, 2004, NEUROPSYCHOLOGIA, V42, P1910, DOI 10.1016/j.neuropsychologia.2004.05.007; Bunce D, 2004, BRAIN COGNITION, V56, P320, DOI 10.1016/j.bandc.2004.08.006; Bunce D, 2008, J GERONTOL B-PSYCHOL, V63, pP67, DOI 10.1093/geronb/63.2.P67; Bunce D, 2007, NEUROPSYCHOLOGIA, V45, P2009, DOI 10.1016/j.neuropsychologia.2007.02.006; Bunce D, 2008, PSYCHOL AGING, V23, P848, DOI 10.1037/a0013678; BUNCE DJ, 1993, PSYCHOL AGING, V8, P26, DOI 10.1037/0882-7974.8.1.26; CHERBUIN N, AM J GERIAT IN PRESS; Crane J, 2002, NEUROPSYCHOLOGIA, V40, P530, DOI 10.1016/S0028-3932(01)00131-2; Delis DC., 2000, CALIFORNIA VERBAL LE; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Gunning-Dixon FM, 2009, INT J GERIATR PSYCH, V24, P109, DOI 10.1002/gps.2087; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Hultsch D. F., 2008, HDB AGING COGNITION, V3rd, P491, DOI DOI 10.1017/CB09781107415324.004; Kennedy KM, 2009, NEUROPSYCHOLOGIA, V47, P916, DOI 10.1016/j.neuropsychologia.2009.01.001; Madden DJ, 2009, J COGNITIVE NEUROSCI, V21, P289, DOI 10.1162/jocn.2009.21047; Perani D, 1999, BRAIN, V122, P2337, DOI 10.1093/brain/122.12.2337; Raz N, 2007, NEUROPSYCHOLOGY, V21, P149, DOI 10.1037/0894-4105.21.2.149; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Sullivan EV, 2006, NEUROSCI BIOBEHAV R, V30, P749, DOI 10.1016/j.neubiorev.2006.06.002; Wechsler D., 1991, WECHSLER MEMORY SCAL; Wegesin DJ, 2004, NEUROPSYCHOLOGY, V18, P646, DOI 10.1037/0894-4105.18.4.646; Wells W M 3rd, 1996, Med Image Anal, V1, P35; Wen W, 2004, STROKE, V35, P2813, DOI 10.1161/01.STR.0000147034.25760.3d; Wen W, 2004, NEUROIMAGE, V22, P144, DOI 10.1016/j.neuroimage.2003.12.027; Wen W, 2009, HUM BRAIN MAPP, V30, P1155, DOI 10.1002/hbm.20586; West R, 2002, BRAIN COGNITION, V49, P402, DOI 10.1006/brcg.2001.1507	35	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13567	10.1371/journal.pone.0013567	http://dx.doi.org/10.1371/journal.pone.0013567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	668TQ	21042415	Green Published, gold			2022-12-25	WOS:000283293800025
J	He, Y; Northey, JJ; Primeau, M; Machado, RD; Trembath, R; Siegel, PM; Lamarche-Vane, N				He, Y.; Northey, J. J.; Primeau, M.; Machado, R. D.; Trembath, R.; Siegel, P. M.; Lamarche-Vane, N.			CdGAP is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion	ONCOGENE			English	Article						Rho GTPases; RhoGAPs; TGF beta; breast cancer; cell migration and invasion	GTPASE-ACTIVATING PROTEIN; MAMMARY EPITHELIAL-CELLS; RHO-GTPASES; MESENCHYMAL TRANSITION; PHOSPHORYLATES CDGAP; TUMOR-SUPPRESSOR; FOCAL ADHESION; FAMILY; TUMORIGENESIS; INDUCTION	RhoA, Rac1 and Cdc42, the best-characterized members of the Rho family of small GTPases, are critical regulators of many cellular activities. Cdc42 GTPase-activating protein (CdGAP) is a serine-and proline-rich RhoGAP protein showing GAP activity against both Cdc42 and Rac1 but not RhoA. CdGAP is phosphorylated downstream of the MEK-ERK (extracellular signal-regulated kinase) pathway in response to serum and is required for normal cell spreading and polarized lamellipodia formation. In this study, we found that CdGAP protein and mRNA levels are highly increased in mammary tumor explants expressing an activated Neu/ErbB-2 (Neu-NT) receptor. In response to transforming growth factor-beta (TGF beta) stimulation, Neu-NT-expressing mammary tumor explants demonstrate a clear induction in cell motility and invasion. We show that downregulation of CdGAP expression by small interfering RNA abrogates the ability of TGF beta to induce cell motility and invasion of Neu-NT-expressing mammary tumor explants. However, it has no effect on TGF beta-mediated cell adhesion on type 1 collagen and fibronectin. Interestingly, protein expression of E-Cadherin is highly increased in Neu-NT-expressing mammary tumor explants depleted of CdGAP. In addition, complete loss of E-Cadherin expression is not observed in CdGAP-depleted cells during TGF beta-mediated epithelial to mesenchymal transition. Downregulation of the CdGAP expression also decreases cell proliferation of Neu-NT-expressing mammary tumor explants independently of TGF beta. Rescue analysis using re-expression of various CdGAP deletion-mutant proteins revealed that the proline-rich domain (PRD) but not the GAP domain of CdGAP is essential to mediate TGF beta-induced cell motility and invasion. Finally, we found that TGF beta induces the expression and phosphorylation of CdGAP in mammary epithelial NMuMG cells. Taken together, these studies identify CdGAP as a novel molecular target in TGF beta signaling and implicate CdGAP as an essential component in the synergistic interaction between TGF beta and Neu/ErbB-2 signaling pathways in breast cancer cells. Oncogene (2011) 30, 1032-1045; doi:10.1038/onc.2010.477; published online 1 November 2010	[He, Y.; Primeau, M.; Lamarche-Vane, N.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; [Northey, J. J.; Siegel, P. M.] McGill Univ, Dept Biochem, Montreal, PQ H3A 2B2, Canada; [Northey, J. J.; Siegel, P. M.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 2B2, Canada; [Machado, R. D.; Trembath, R.] Kings Coll London, Dept Med & Mol Genet, Sch Med, London WC2R 2LS, England; [Trembath, R.] Guys Hosp, Dept Clin Studies, London SE1 9RT, England	McGill University; McGill University; McGill University; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Lamarche-Vane, N (corresponding author), McGill Univ, Dept Anat & Cell Biol, 3460 Univ St, Montreal, PQ H3A 2B2, Canada.	nathalie.lamarche@mcgill.ca	Northey, Jason/AAX-6365-2021; Machado, Rajiv D./AAD-7813-2019	Machado, Rajiv D./0000-0001-9247-0744; Northey, Jason/0000-0003-3115-2560; Trembath, Richard/0000-0003-0550-3400	Canadian Institute of Health Research (CIHR) [MOP-84449]; Cancer Research Society; Research Institute of the McGill University Health Centre; National Institute for Health Research [NF-SI-0507-10379] Funding Source: researchfish	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cancer Research Society; Research Institute of the McGill University Health Centre; National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported by grants from Canadian Institute of Health Research (CIHR) MOP-84449 to NL-V and the Cancer Research Society to PMS. JJN is supported by a studentship from the Research Institute of the McGill University Health Centre. MP was a recipient of a CIHR Canada Graduate scholarship. NL-V is a recipient of a FRSQ chercheur-boursier senior. PMS is a research scientist of the Canadian Cancer Society. RDM is a British Heart Foundation Intermediate Research Fellow (BHF-FS/07/036).	Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Danek EI, 2007, J BIOL CHEM, V282, P3624, DOI 10.1074/jbc.M610073200; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; GUPTA SK, 1992, MOL BIOL CELL, V3, P123, DOI 10.1091/mbc.3.1.123; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jenna S, 2002, J BIOL CHEM, V277, P6366, DOI 10.1074/jbc.M105516200; Jiang W, 2008, J BIOL CHEM, V283, P20978, DOI 10.1074/jbc.M802588200; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kim T, 2009, CANCER METAST REV, V28, P77, DOI 10.1007/s10555-008-9167-2; LALONDE D, 2006, CURR BIOL, V16, P1; Lamarche-Vane N, 1998, J BIOL CHEM, V273, P29172, DOI 10.1074/jbc.273.44.29172; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Muraoka RS, 2003, MOL CELL BIOL, V23, P8691, DOI 10.1128/MCB.23.23.8691-8703.2003; Muraoka-Cook RS, 2006, ONCOGENE, V25, P3408, DOI 10.1038/sj.onc.1208964; Muraoka-Cook RS, 2005, CLIN CANCER RES, V11, p937S; Nagaraj NS, 2010, EXPERT OPIN INV DRUG, V19, P77, DOI 10.1517/13543780903382609; Northey JJ, 2008, MOL CELL BIOL, V28, P3162, DOI 10.1128/MCB.01734-07; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Pardali E, 2009, FRONT BIOSCI-LANDMRK, V14, P4848, DOI 10.2741/3573; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; SIEGEL PM, 1994, MOL CELL BIOL, V14, P7068, DOI 10.1128/MCB.14.11.7068; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOUTHGATE L, N ENGL J MED UNPUB; Tcherkezian J, 2005, MOL CELL BIOL, V25, P6314, DOI 10.1128/MCB.25.15.6314-6329.2005; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Tcherkezian J, 2006, BIOL CELL, V98, P445, DOI 10.1042/BC20050101; Titus B, 2005, CRIT REV EUKAR GENE, V15, P103, DOI 10.1615/CritRevEukaryotGeneExpr.v15.i2.20; Tomar A, 2009, J CELL SCI, V122, P1852, DOI 10.1242/jcs.046870; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; Ursini-Siegel J, 2007, NAT REV CANCER, V7, P389, DOI 10.1038/nrc2127; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Wang SE, 2005, MOL CELL BIOL, V25, P4703, DOI 10.1128/MCB.25.11.4703-4715.2005; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yang YA, 2002, J CLIN INVEST, V109, P1607, DOI 10.1172/JCI200215333	45	23	23	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	9					1032	1045		10.1038/onc.2010.477	http://dx.doi.org/10.1038/onc.2010.477			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	729PX	21042277				2022-12-25	WOS:000287964100003
J	Jahani-Asl, A; Pilon-Larose, K; Xu, W; MacLaurin, JG; Park, DS; McBride, HM; Slack, RS				Jahani-Asl, Arezu; Pilon-Larose, Karine; Xu, William; MacLaurin, Jason G.; Park, David S.; McBride, Heidi M.; Slack, Ruth S.			The Mitochondrial Inner Membrane GTPase, Optic Atrophy 1 (Opa1), Restores Mitochondrial Morphology and Promotes Neuronal Survival following Excitotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; CELL-DEATH; ENDOPLASMIC-RETICULUM; RHO-GTPASES; MOLECULAR-MECHANISMS; THERAPEUTIC TARGET; CYTOCHROME-C; FISSION; KINASE; BAX	Mitochondrial dynamics have been extensively studied in the context of classical cell death models involving Bax-mediated cytochrome c release. Excitotoxic neuronal loss is a nonclassical death signaling pathway that occurs following overactivation of glutamate receptors independent of Bax activation. Presently, the role of mitochondrial dynamics in the regulation of excitotoxicity remains largely unknown. Here, we report that NMDA-induced excitotoxicity results in defects in mitochondrial morphology as evident by the presence of excessive fragmented mitochondria, cessation of mitochondrial fusion, and cristae dilation. Up-regulation of the mitochondrial inner membrane GTPase, Opa1, is able to restore mitochondrial morphology and protect neurons against excitotoxic injury. Opa1 functions downstream of the calcium-dependent protease, calpain. Inhibition of calpain activity by calpastatin, an endogenous calpain inhibitor, significantly rescued mitochondrial defects and maintained neuronal survival. Opa1 was required for calpastatin-mediated neuroprotection because the enhanced survival found following NMDA-induced toxicity was significantly reduced upon loss of Opa1. Our results define a mechanism whereby breakdown of the mitochondrial network mediated through loss of Opa1 function contributes to neuronal death following excitotoxic neuronal injury. These studies suggest Opa1 as a potential therapeutic target to promote neuronal survival following acute brain damage and neurodegenerative diseases.	[Jahani-Asl, Arezu; Pilon-Larose, Karine; Xu, William; MacLaurin, Jason G.; Park, David S.; Slack, Ruth S.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [McBride, Heidi M.] Univ Ottawa, Dept Biochem, Ottawa, ON K1H 8M5, Canada; [McBride, Heidi M.] Univ Ottawa, Inst Heart, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa Heart Institute	Slack, RS (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	rslack@uottawa.ca	McBride, Heidi M/C-1162-2008; McBride, Heidi M./ABD-5774-2021	McBride, Heidi M/0000-0003-4666-2280; McBride, Heidi M./0000-0003-4666-2280; Park, David/0000-0002-4490-3784; Jahani-Asl, Arezu/0000-0003-4002-3381; Slack, Ruth/0000-0002-1552-2835	Heart and Stroke Foundation of Canada [NA6030]; Canadian Institutes of Health Research (CIHR)	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Heart and Stroke Foundation of Canada Grant NA6030 and a grant from the Canadian Institutes of Health Research (CIHR) (to R. S. S.).	Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Aznar S, 2004, CANCER LETT, V206, P181, DOI 10.1016/j.canlet.2003.08.035; Badugu R, 2008, J BIOL CHEM, V283, P3409, DOI 10.1074/jbc.M706851200; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chan DC, 2006, DEV CELL, V11, P592, DOI 10.1016/j.devcel.2006.10.009; Cheung ECC, 2005, J NEUROSCI, V25, P1324, DOI 10.1523/JNEUROSCI.4261-04.2005; Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Cregan SP, 1999, J NEUROSCI, V19, P7860; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Dargusch R, 2001, J NEUROCHEM, V76, P295, DOI 10.1046/j.1471-4159.2001.00035.x; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Forder JP, 2009, NEUROSCIENCE, V158, P293, DOI 10.1016/j.neuroscience.2008.10.021; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Hom JR, 2007, J CELL PHYSIOL, V212, P498, DOI 10.1002/jcp.21051; Jahani-Asl A, 2007, J BIOL CHEM, V282, P23788, DOI 10.1074/jbc.M703812200; Jahani-Asl A, 2010, BBA-MOL BASIS DIS, V1802, P162, DOI 10.1016/j.bbadis.2009.09.006; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kloog Y, 2000, MOL MED TODAY, V6, P398, DOI 10.1016/S1357-4310(00)01789-5; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Kume H, 2008, CURR MED CHEM, V15, P2876, DOI 10.2174/092986708786242831; Marchioni F, 2009, CURR PHARM DESIGN, V15, P2481, DOI 10.2174/138161209788682334; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Rashidian J, 2005, P NATL ACAD SCI USA, V102, P14080, DOI 10.1073/pnas.0500099102; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Seo SY, 1999, J NEUROSCI, V19, P8849, DOI 10.1523/JNEUROSCI.19-20-08849.1999; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Wakino S, 2005, DRUG NEWS PERSPECT, V18, P639, DOI 10.1358/dnp.2005.18.10.959578; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Xing XQ, 2006, DRUG NEWS PERSPECT, V19, P517, DOI 10.1358/dnp.2006.19.9.1050426; Zhao DZ, 2003, EXPERT OPIN THER TAR, V7, P583, DOI 10.1517/eott.7.5.583.22527; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	43	88	90	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4772	4782		10.1074/jbc.M110.167155	http://dx.doi.org/10.1074/jbc.M110.167155			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21041314	Green Published, hybrid			2022-12-25	WOS:000286975700075
J	Miethke, M; Pierik, AJ; Peuckert, F; Seubert, A; Marahiel, MA				Miethke, Marcus; Pierik, Antonio J.; Peuckert, Florian; Seubert, Andreas; Marahiel, Mohamed A.			Identification and Characterization of a Novel-type Ferric Siderophore Reductase from a Gram-positive Extremophile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO CHARACTERIZATION; ESCHERICHIA-COLI; IRON-TRANSPORT; FERRIOXAMINE-B; SACCHAROMYCES-CEREVISIAE; STAPHYLOCOCCUS-AUREUS; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; PROTEIN	Iron limitation is one major constraint of microbial life, and a plethora of microbes use siderophores for high affinity iron acquisition. Because specific enzymes for reductive iron release in Gram-positives are not known, we searched Firmicute genomes and found a novel association pattern of putative ferric siderophore reductases and uptake genes. The reductase from the schizokinen-producing alkaliphile Bacillus halodurans was found to cluster with a ferric citrate-hydroxamate uptake system and to catalyze iron release efficiently from Fe[III]-dicitrate, Fe[III]-schizokinen, Fe[III]-aerobactin, and ferrichrome. The gene was hence named fchR for ferric citrate and hydroxamate reductase. The tightly bound [2Fe-2S] cofactor of FchR was identified by UV-visible, EPR, CD spectroscopy, and mass spectrometry. Iron release kinetics were determined with several substrates by using ferredoxin as electron donor. Catalytic efficiencies were strongly enhanced in the presence of an iron-sulfur scaffold protein scavenging the released ferrous iron. Competitive inhibition of FchR was observed with Ga(III)-charged siderophores with K-i values in the micromolar range. The principal catalytic mechanism was found to couple increasing K-m and K-D values of substrate binding with increasing k(cat) values, resulting in high catalytic efficiencies over a wide redox range. Physiologically, a chromosomal fchR deletion led to strongly impaired growth during iron limitation even in the presence of ferric siderophores. Inductively coupled plasma-MS analysis of Delta fchR revealed intracellular iron accumulation, indicating that the ferric substrates were not efficiently metabolized. We further show that FchR can be efficiently inhibited by redox-inert siderophore mimics in vivo, suggesting that substrate-specific ferric siderophore reductases may present future targets for microbial pathogen control.	Univ Marburg, Fachbereich Chem Biochem, D-35032 Marburg, Germany; [Pierik, Antonio J.] Univ Marburg, Inst Zytobiol & Zytopathol, D-35037 Marburg, Germany	Philipps University Marburg; Philipps University Marburg		miethke@staff.uni-marburg.de	Pierik, Antonio J/G-1108-2010	Pierik, Antonio J/0000-0002-1509-6370	Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft and Fonds der Chemischen Industrie.	Abergel RJ, 2009, J AM CHEM SOC, V131, P12682, DOI 10.1021/ja903051q; Adjimani JP, 1997, J INORG BIOCHEM, V66, P247, DOI 10.1016/S0162-0134(96)00221-8; Albrecht AG, 2010, J BACTERIOL, V192, P1643, DOI 10.1128/JB.01536-09; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Arnow LE, 1937, J BIOL CHEM, V118, P531; Banin E, 2008, P NATL ACAD SCI USA, V105, P16761, DOI 10.1073/pnas.0808608105; BATIE CJ, 1981, J BIOL CHEM, V256, P7756; Bernstein LR, 1998, PHARMACOL REV, V50, P665; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BYERS BR, 1967, J BACTERIOL, V93, P286, DOI 10.1128/JB.93.1.286-294.1967; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Chillappagari S, 2010, J BACTERIOL, V192, P2512, DOI 10.1128/JB.00058-10; Clarke TE, 2000, NAT STRUCT BIOL, V7, P287; Clarke TE, 2002, J BIOL CHEM, V277, P13966, DOI 10.1074/jbc.M109385200; COVES J, 1993, BIOCHEM BIOPH RES CO, V192, P1403, DOI 10.1006/bbrc.1993.1572; Cowart RE, 2002, ARCH BIOCHEM BIOPHYS, V400, P273, DOI 10.1016/S0003-9861(02)00012-7; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Dale SE, 2004, INFECT IMMUN, V72, P29, DOI 10.1128/IAI.72.1.29-37.2004; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; DYKES J, 1982, ARCH BIOCHEM BIOPHYS, V218, P46, DOI 10.1016/0003-9861(82)90319-8; EMERY T, 1986, BIOCHEMISTRY-US, V25, P4629, DOI 10.1021/bi00364a026; Fischbach MA, 2005, P NATL ACAD SCI USA, V102, P571, DOI 10.1073/pnas.0408463102; Froissard M, 2007, TRAFFIC, V8, P1601, DOI 10.1111/j.1600-0854.2007.00627.x; GILLAM AH, 1981, ANAL CHEM, V53, P841, DOI 10.1021/ac00229a023; Gilmour R, 1997, J BACTERIOL, V179, P863, DOI 10.1128/jb.179.3.863-870.1997; Grigg JC, 2010, J BIOL CHEM, V285, P11162, DOI 10.1074/jbc.M109.097865; HANTKE K, 1987, MOL GEN GENET, V210, P135, DOI 10.1007/BF00337769; Harrington JM, 2009, BIOMETALS, V22, P679, DOI 10.1007/s10534-009-9233-4; HARRIS WR, 1979, J AM CHEM SOC, V101, P2722, DOI 10.1021/ja00504a038; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Horikoshi K, 1999, MICROBIOL MOL BIOL R, V63, P735, DOI 10.1128/MMBR.63.4.735-750.1999; Hotta K, 2010, MICROBIOL-SGM, V156, P1918, DOI 10.1099/mic.0.039404-0; Ingelman M, 1999, BIOCHEMISTRY-US, V38, P7040, DOI 10.1021/bi982849m; Kaneko Y, 2007, J CLIN INVEST, V117, P877, DOI 10.1172/JCI30783; Kim L, 1996, GENE, V181, P71, DOI 10.1016/S0378-1119(96)00466-0; Kragl C, 2007, EUKARYOT CELL, V6, P1278, DOI 10.1128/EC.00066-07; LESUISSE E, 1995, ANAL BIOCHEM, V226, P375, DOI 10.1006/abio.1995.1239; Lin H, 2005, J AM CHEM SOC, V127, P11075, DOI 10.1021/ja0522027; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; LOOMIS LD, 1991, INORG CHEM, V30, P906, DOI 10.1021/ic00005a008; Matzanke BF, 2004, BIOCHEMISTRY-US, V43, P1386, DOI 10.1021/bi0357661; McMillan DGG, 2010, APPL ENVIRON MICROB, V76, P6955, DOI 10.1128/AEM.01393-10; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Miethke M, 2006, MOL MICROBIOL, V61, P1413, DOI 10.1111/j.1365-2958.2006.05321.x; Miethke M, 2010, ANTIMICROB AGENTS CH, V54, P1580, DOI 10.1128/AAC.01158-09; Mossialos D, 2002, MOL MICROBIOL, V45, P1673, DOI 10.1046/j.1365-2958.2002.03120.x; Muller A, 2006, ANGEW CHEM INT EDIT, V45, P5132, DOI 10.1002/anie.200601198; Muller K, 1998, EUR J BIOCHEM, V258, P1001, DOI 10.1046/j.1432-1327.1998.2581001.x; MULLIS KB, 1971, BIOCHEMISTRY-US, V10, P4894, DOI 10.1021/bi00802a010; Namba K, 2010, CHEM REC, V10, P140, DOI 10.1002/tcr.200900028; NELSON M, 1992, BIOMETALS, V5, P37, DOI 10.1007/BF01079696; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Olakanmi O, 2010, ANTIMICROB AGENTS CH, V54, P244, DOI 10.1128/AAC.00655-09; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; Patzer SI, 1999, J BACTERIOL, V181, P3307, DOI 10.1128/JB.181.10.3307-3309.1999; Peuckert F, 2009, ANGEW CHEM INT EDIT, V48, P7924, DOI 10.1002/anie.200902495; Pierre JL, 2002, BIOMETALS, V15, P341, DOI 10.1023/A:1020259021641; Poole RK, 1997, MICROBIOL-SGM, V143, P1557, DOI 10.1099/00221287-143-5-1557; RAYMOND KN, 1984, TOP CURR CHEM, V123, P49; Riboldi GP, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-3; Ryndak MB, 2010, J BACTERIOL, V192, P861, DOI 10.1128/JB.00223-09; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schroder I, 2003, FEMS MICROBIOL REV, V27, P427, DOI 10.1016/S0168-6445(03)00043-3; Spasojevic I, 1999, INORG CHEM, V38, P449, DOI 10.1021/ic980635n; Storey EP, 2006, BIOMETALS, V19, P637, DOI 10.1007/s10534-006-9001-7; STULKE J, 1993, J GEN MICROBIOL, V139, P2041, DOI 10.1099/00221287-139-9-2041; TAGAWA K, 1968, BIOCHIM BIOPHYS ACTA, V153, P602, DOI 10.1016/0005-2728(68)90188-6; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Takeda K, 2010, BIOMETALS, V23, P727, DOI 10.1007/s10534-010-9339-8; TUFANO TP, 1981, BIOCHIM BIOPHYS ACTA, V668, P420, DOI 10.1016/0005-2795(81)90176-8; USAMI R, 1990, STARCH-STARKE, V42, P230, DOI 10.1002/star.19900420607; Valdebenito M, 2006, INT J MED MICROBIOL, V296, P513, DOI 10.1016/j.ijmm.2006.06.003; Vecerek B, 2007, EMBO J, V26, P965, DOI 10.1038/sj.emboj.7601553; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; WAWROUSEK EF, 1982, J INORG BIOCHEM, V17, P169, DOI 10.1016/S0162-0134(00)80097-5; Xia M, 2007, CURR MICROBIOL, V55, P71, DOI 10.1007/s00284-007-0023-3; Yun CW, 2001, J BIOL CHEM, V276, P10218, DOI 10.1074/jbc.M010065200; Zhu MG, 2005, MICROBIOL-SGM, V151, P2363, DOI 10.1099/mic.0.27888-0	79	20	21	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2245	2260		10.1074/jbc.M110.192468	http://dx.doi.org/10.1074/jbc.M110.192468			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21051545	Green Published, hybrid			2022-12-25	WOS:000286191500065
J	Oyama, M; Nagashima, T; Suzuki, T; Kozuka-Hata, H; Yumoto, N; Shiraishi, Y; Ikeda, K; Kuroki, Y; Gotoh, N; Ishida, T; Inoue, S; Kitano, H; Okada-Hatakeyama, M				Oyama, Masaaki; Nagashima, Takeshi; Suzuki, Takashi; Kozuka-Hata, Hiroko; Yumoto, Noriko; Shiraishi, Yuichi; Ikeda, Kazuhiro; Kuroki, Yoko; Gotoh, Noriko; Ishida, Takanori; Inoue, Satoshi; Kitano, Hiroaki; Okada-Hatakeyama, Mariko			Integrated Quantitative Analysis of the Phosphoproteome and Transcriptome in Tamoxifen-resistant Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR-ALPHA; GROWTH-FACTOR RECEPTOR; GLYCOGEN-SYNTHASE KINASE-3; DNA-BINDING ACTIVITY; ENDOCRINE RESISTANCE; ELEVATED LEVELS; CROSS-TALK; C-JUN; CELLS; PHOSPHORYLATION	Quantitative phosphoproteome and transcriptome analysis of ligand-stimulated MCF-7 human breast cancer cells was performed to understand the mechanisms of tamoxifen resistance at a system level. Phosphoproteome data revealed that WT cells were more enriched with phospho-proteins than tamoxifen-resistant cells after stimulation with ligands. Surprisingly, decreased phosphorylation after ligand perturbation was more common than increased phosphorylation. In particular, 17 beta-estradiol induced down-regulation in WT cells at a very high rate. 17 beta-Estradiol and the ErbB ligand heregulin induced almost equal numbers of up-regulated phospho-proteins in WT cells. Pathway and motif activity analyses using transcriptome data additionally suggested that deregulated activation of GSK3 beta (glycogen-synthase kinase 3 beta) and MAPK1/3 signaling might be associated with altered activation of cAMP-responsive element-binding protein and AP-1 transcription factors in tamoxifen-resistant cells, and this hypothesis was validated by reporter assays. An examination of clinical samples revealed that inhibitory phosphorylation of GSK3 beta at serine 9 was significantly lower in tamoxifen-treated breast cancer patients that eventually had relapses, implying that activation of GSK3 beta may be associated with the tamoxifen-resistant phenotype. Thus, the combined phosphoproteome and transcriptome data set analyses revealed distinct signal transcription programs in tumor cells and provided a novel molecular target to understand tamoxifen resistance.	[Oyama, Masaaki; Kozuka-Hata, Hiroko] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo 1088639, Japan; [Nagashima, Takeshi; Yumoto, Noriko; Shiraishi, Yuichi; Okada-Hatakeyama, Mariko] RIKEN Res Ctr Allergy & Immunol, Lab Cellular Syst Modeling, Tsurumi Ku, Kanagawa 2300045, Japan; [Suzuki, Takashi] Tohoku Univ, Grad Sch Med, Dept Pathol, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Suzuki, Takashi] Tohoku Univ, Grad Sch Med, Dept Histotechnol, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Ikeda, Kazuhiro; Inoue, Satoshi] Saitama Med Univ, Res Ctr Genom Med, Div Gene Regulat & Signal Transduct, Hidaka, Saitama 3501241, Japan; [Kuroki, Yoko] RIKEN Adv Sci Inst, Computat Syst Biol Res Grp, Tsurumi Ku, Kanagawa 2300045, Japan; [Gotoh, Noriko] Univ Tokyo, Inst Med Sci, Div Syst Biomed Technol, Minato Ku, Tokyo 1088639, Japan; [Ishida, Takanori] Tohoku Univ, Grad Sch Med, Dept Surg Oncol, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Bunkyo Ku, Tokyo 1130033, Japan; [Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo 1130033, Japan; [Kitano, Hiroaki] Syst Biol Inst, Minato Ku, Tokyo 1080071, Japan	University of Tokyo; RIKEN; Tohoku University; Tohoku University; Saitama Medical University; RIKEN; University of Tokyo; Tohoku University; University of Tokyo; University of Tokyo	Oyama, M (corresponding author), 4-6-1 Shirokanedai,Minato Ku, Tokyo 1088639, Japan.	moyama@ims.u-tokyo.ac.jp; marikoh@rcai.riken.jp	GOTOH, Noriko/D-8430-2015; Okada, Mariko/N-6933-2015	Kozuka-Hata, Hiroko/0000-0002-9286-6594; Oyama, Masaaki/0000-0001-6478-3735	Ministry of Education, Culture, Sports, Science and Technology, Japan; National Institute of Biomedical Innovation, Japan; Grants-in-Aid for Scientific Research [22591016] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation, Japan(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Genome Network Project and Cell Innovation Program, Ministry of Education, Culture, Sports, Science and Technology, Japan and the Program for Promotion of Fundamental Studies in Health Sciences, National Institute of Biomedical Innovation, Japan.	Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; DOUCAS V, 1991, EMBO J, V10, P2237, DOI 10.1002/j.1460-2075.1991.tb07760.x; Dumont JA, 1996, CELL GROWTH DIFFER, V7, P351; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gee JMW, 2001, INT J CANCER, V95, P247, DOI 10.1002/1097-0215(20010720)95:4<247::AID-IJC1042>3.0.CO;2-S; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Johnston SRD, 1999, CLIN CANCER RES, V5, P251; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Kousidou OC, 2008, MOL ONCOL, V2, P223, DOI 10.1016/j.molonc.2008.06.002; Lewis JS, 2005, MUTAT RES-FUND MOL M, V591, P247, DOI 10.1016/j.mrfmmm.2005.02.028; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Mai L, 2002, J NEUROCHEM, V82, P75, DOI 10.1046/j.1471-4159.2002.00939.x; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; Mendez P, 2006, ENDOCRINOLOGY, V147, P3027, DOI 10.1210/en.2005-1224; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nagashima T, 2009, FEBS J, V276, P5239, DOI 10.1111/j.1742-4658.2009.07220.x; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; NIKOLAKAKI E, 1993, ONCOGENE, V8, P833; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Oyama M, 2009, MOL CELL PROTEOMICS, V8, P226, DOI 10.1074/mcp.M800186-MCP200; Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Sanchez M, 2007, J BIOL CHEM, V282, P4830, DOI 10.1074/jbc.M607908200; Schiff R, 2004, CLIN CANCER RES, V10, p331S, DOI 10.1158/1078-0432.CCR-031212; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SHEMSHEDINI L, 1991, EMBO J, V10, P3839, DOI 10.1002/j.1460-2075.1991.tb04953.x; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Sithanandam G, 2003, CARCINOGENESIS, V24, P1581, DOI 10.1093/carcin/bgg125; Speirs V, 1999, CANCER RES, V59, P5421; STEWART AJ, 1990, J BIOL CHEM, V265, P21172; Teyssier C, 2001, J BIOL CHEM, V276, P36361, DOI 10.1074/jbc.M101806200; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; TZUKERMAN M, 1991, MOL ENDOCRINOL, V5, P1983, DOI 10.1210/mend-5-12-1983; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; [No title captured], DOI DOI 10.1126/STKE.2882005PE27	51	33	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					818	829		10.1074/jbc.M110.156877	http://dx.doi.org/10.1074/jbc.M110.156877			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21044952	Green Published, hybrid			2022-12-25	WOS:000285782800081
J	Goodall, MH; Wardlow, RD; Goldblum, RR; Ziman, A; Lederer, WJ; Randall, W; Rogers, TB				Goodall, Mariah H.; Wardlow, Robert D., II; Goldblum, Rebecca R.; Ziman, Andrew; Lederer, W. Jonathan; Randall, William; Rogers, Terry B.			Novel Function of Cardiac Protein Kinase D1 as a Dynamic Regulator of Ca2+ Sensitivity of Contraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; ELEMENT-BINDING PROTEIN; TROPONIN-I; C-MU; HEART-FAILURE; G(Q)-COUPLED RECEPTORS; HISTONE DEACETYLASE-5; MEDIATED REGULATION; D ACTIVATION; D PKD	Although the function of protein kinase D1 (PKD) in cardiac cells has remained enigmatic, recent work has shown that PKD phosphorylates the nuclear regulators HDAC5/7 (histone deacetylase 5/7) and CREB, implicating this kinase in the development of dysfunction seen in heart failure. Additional studies have shown that PKD also phosphorylates multiple sarcomeric substrates to regulate myofilament function. Initial studies examined PKD through adenoviral vector expression of wild type PKD, constitutively active PKD (caPKD), or dominant negative PKD in cultured adult rat ventricular myocytes. Confocal immunofluorescent images of these cells reveal a predominant distribution of all PKD forms in a non-nuclear, Z-line localized, striated reticular pattern, suggesting the importance of PKD in Ca2+ signaling in heart. Consistent with an established role of PKD in targeting cardiac troponin I (cTnI), caPKD expression led to a marked decrease in contractile myofilament Ca2+ sensitivity with an unexpected electrical stimulus dependence to this response. This desensitization was accompanied by stimulus-dependent increases in cTnI phosphorylation in control and caPKD cells with a more pronounced effect in the latter. Electrical stimulation also provoked phosphorylation of regulatory site Ser(916) on PKD. The functional importance of this phospho-Ser(916) event is demonstrated in experiments with a phosphorylation-defective mutant, caPKD-S916A, which is functionally inactive and blocks stimulus-dependent increases in cTnI phosphorylation. Dominant negative PKD expression resulted in sensitization of the myofilaments to Ca2+ and blocked stimulus-dependent increases in cTnI phosphorylation. Taken together, these data reveal that localized PKD may play a role as a dynamic regulator of Ca2+ sensitivity of contraction in cardiac myocytes.	[Rogers, Terry B.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Randall, William] Univ Maryland, Sch Med, Dept Pharmacol, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Ziman, Andrew; Lederer, W. Jonathan] Univ Maryland, Sch Med, Dept Physiol, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Rogers, TB (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Ctr Biomed Engn & Technol, 108 N Greene St, Baltimore, MD 21201 USA.	trogers@som.umaryland.edu		Wardlow, Robert D/0000-0002-0309-9769	National Institutes of Health [P01 HL070709, T32-GM-008181, T32-AR-07592]; MARC U*STAR [T34-08663, T32-HL-072751]; Economic Development Corporation of Maryland; Leducq Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072751, P01HL070709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008181, T34GM008663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MARC U*STAR; Economic Development Corporation of Maryland; Leducq Foundation(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL070709 (to T. B. R.), T32-GM-008181 (to M. H. G. and A. Z.), T32-AR-07592 (to M. H. G.), MARC U*STAR T34-08663 (to R. D. W.), and T32-HL-072751 (to A. Z.). This work was also supported by an Economic Development Corporation of Maryland stem cell grant (to T. B. R. and W. J. L.) and the Leducq Foundation (to W. J. L.).	Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; Avner BS, 2010, AM J PHYSIOL-HEART C, V299, pH723, DOI 10.1152/ajpheart.00050.2010; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bardswell SC, 2010, J BIOL CHEM, V285, P5674, DOI 10.1074/jbc.M109.066456; Belin RJ, 2006, AM J PHYSIOL-HEART C, V291, pH2344, DOI 10.1152/ajpheart.00541.2006; Bossuyt J, 2008, CIRC RES, V102, P695, DOI 10.1161/CIRCRESAHA.107.169755; Bowman AL, 2007, FEBS LETT, V581, P1549, DOI 10.1016/j.febslet.2007.03.011; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Cuello F, 2007, CIRC RES, V100, P864, DOI 10.1161/01.RES.0000260809.15393.fa; DuBell WH, 2000, AM J PHYSIOL-HEART C, V278, pH886, DOI 10.1152/ajpheart.2000.278.3.H886; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Goodall M. H., 2009, J MOL CELL CARDIOL, V46, pS29; Goodall MH, 2009, BIOPHYS J, V96, p622A, DOI 10.1016/j.bpj.2008.12.3290; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Haworth RS, 2007, J MOL CELL CARDIOL, V43, P686, DOI 10.1016/j.yjmcc.2007.09.013; Haworth RS, 2000, J MOL CELL CARDIOL, V32, P1013, DOI 10.1006/jmcc.2000.1143; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Iwata M, 2005, BIOCHEM BIOPH RES CO, V327, P1105, DOI 10.1016/j.bbrc.2004.12.128; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Johannessen M, 2007, J BIOL CHEM, V282, P14777, DOI 10.1074/jbc.M610669200; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Kim MS, 2008, CIRC RES, V103, P252, DOI 10.1161/CIRCRESAHA.108.178681; Kirk JA, 2009, CIRC RES, V105, P1232, DOI 10.1161/CIRCRESAHA.109.205427; Kunkel MT, 2010, J BIOL CHEM, V285, P22746, DOI 10.1074/jbc.C110.123133; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Liu YW, 2009, J PHYSIOL-LONDON, V587, P1101, DOI 10.1113/jphysiol.2008.164566; Liu YW, 2001, J CELL BIOL, V155, P27, DOI 10.1083/jcb.200103020; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Luiken JJFP, 2008, CELL SIGNAL, V20, P543, DOI 10.1016/j.cellsig.2007.11.007; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; McKinsey TA, 2007, CARDIOVASC RES, V73, P667, DOI 10.1016/j.cardiores.2006.11.036; Metzger JM, 2004, CIRC RES, V94, P146, DOI 10.1161/01.RES.0000110083.17024.60; Oancea E, 2003, DEV CELL, V4, P561, DOI 10.1016/S1534-5807(03)00087-X; Ozgen N, 2008, J BIOL CHEM, V283, P17009, DOI 10.1074/jbc.M709851200; Pi YQ, 2003, J PHYSIOL-LONDON, V552, P845, DOI 10.1113/jphysiol.2003.045260; Prestle J, 1996, J CELL BIOL, V134, P1401, DOI 10.1083/jcb.134.6.1401; Rey O, 2001, J BIOL CHEM, V276, P32616, DOI 10.1074/jbc.M101649200; Rey O, 2001, BIOCHEM BIOPH RES CO, V287, P21, DOI 10.1006/bbrc.2001.5530; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rybin VO, 2009, J BIOL CHEM, V284, P2332, DOI 10.1074/jbc.M806381200; Rybin VO, 2003, J BIOL CHEM, V278, P14555, DOI 10.1074/jbc.M212644200; Sanchez-Ruiloba L, 2006, J BIOL CHEM, V281, P18888, DOI 10.1074/jbc.M603044200; Sinnett-Smith J, 2009, J BIOL CHEM, V284, P13434, DOI 10.1074/jbc.M806554200; Soeller C, 1999, CIRC RES, V84, P266, DOI 10.1161/01.RES.84.3.266; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Spitaler M, 2006, IMMUNITY, V24, P535, DOI 10.1016/j.immuni.2006.02.013; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Sumandea MP, 2008, J BIOL CHEM, V283, P22680, DOI 10.1074/jbc.M802396200; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Wood CD, 2005, J BIOL CHEM, V280, P6245, DOI 10.1074/jbc.M411564200; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	58	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41686	41700		10.1074/jbc.M110.179648	http://dx.doi.org/10.1074/jbc.M110.179648			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041300	Green Published, hybrid			2022-12-25	WOS:000285622600056
J	Kumar, B; LeCompte, KG; Klein, JM; Haas, AL				Kumar, Brajesh; LeCompte, Kimberly G.; Klein, Jennifer M.; Haas, Arthur L.			Ser(120) of Ubc2/Rad6 Regulates Ubiquitin-dependent N-end Rule Targeting by E3 alpha/Ubr1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIUBIQUITIN CHAIN; CONJUGATING ENZYMES; H2B UBIQUITYLATION; ACTIVATING ENZYME; HISTONE H2B; PROTEIN; PATHWAY; DEGRADATION; PROTEOLYSIS; MECHANISM	In CHO cells, CDK1/2-dependent phosphorylation of Ubc2/Rad6 at Ser(120) stimulates its ubiquitin conjugating activity and can be replicated by a S120D point mutant (Sarcevic, B., Mawson, A., Baker, R. T., and Sutherland, R. L. (2002) EMBO J. 21, 2009-2018). In contrast, we find that ectopic expression of wild type Ubc2b but not Ubc2bS120D or Ubc2bS120A in T47D human breast cancer cells specifically stimulates N-end rule-dependent degradation but not the Ubc2-independent unfolded protein response pathway, indicating that the former is E2 limiting in vivo and likely down-regulated by Ser(120) phosphorylation, as modeled by the S120D point mutation. In vitro kinetic analysis shows the in vivo phenotype of Ubc2bS120D and Ubc2bS120A is not due to differences in activating enzyme-catalyzed E2 transthiolation. However, the Ser(120) mutants possess marked differences in their abilities to support in vitro conjugation by the N-end rule-specific E3 alpha/Ubr1 ligase that presumably accounts for their in vivo effects. Initial rate kinetics of human E3 alpha-catalyzed conjugation of the human alpha-lactalbumin N-end rule substrate shows Ubc2bS120D is 20-fold less active than wild type E2, resulting from an 8-fold increase in K-m and a 2.5-fold decrease in V-max, the latter reflecting a decreased ability to support the initial step in target protein conjugation; Ubc2bS120A is 8-fold less active than wild type E2 due almost exclusively to a decrease in V-max, reflecting a defect in polyubiquitin chain elongation. These studies suggest a mechanism for the integrated regulation of diverse ubiquitin-dependent signaling pathways through E2 phosphorylation that yields differential effects on its cognate ligases.	[Haas, Arthur L.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Haas, AL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1901 Perdido St, New Orleans, LA 70112 USA.	ahaas@lsuhsc.edu			National Institutes of Health (NIGMS) [R01GM034009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034009] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM034009 (NIGMS; to A. L. H.).	Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Baboshina OV, 2001, J BIOL CHEM, V276, P39428, DOI 10.1074/jbc.M106967200; Block K, 2001, J BIOL CHEM, V276, P41049, DOI 10.1074/jbc.M106453200; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Calvo F, 2010, BIOESSAYS, V32, P412, DOI 10.1002/bies.200900155; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Froese N, 2006, MOL CELL BIOL, V26, P293, DOI 10.1128/MCB.26.1.293-302.2006; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1981, P NATL ACAD SCI-BIOL, V78, P6845, DOI 10.1073/pnas.78.11.6845; HAAS AL, 1985, J BIOL CHEM, V260, P2464; HAAS AL, 1991, ADV EXP MED BIOL, V307, P191; HAAS AL, 1991, J BIOL CHEM, V266, P5104; HAAS AL, 1995, J BIOL CHEM, V270, P9407, DOI 10.1074/jbc.270.16.9407; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Haas Arthur L., 2005, V301, P23; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kume K, 2010, GENES CELLS, V15, P339, DOI 10.1111/j.1365-2443.2010.01385.x; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; MENENDEZBENI, 2005, METHODS, V399, P490; Monaco EA, 2004, CURR ALZHEIMER RES, V1, P33, DOI 10.2174/1567205043480519; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; OGUNJOBI O, 1990, BIOCHEM SOC T, V18, P1322, DOI 10.1042/bst0181322; Osley MA, 2004, BBA-GENE STRUCT EXPR, V1677, P74, DOI 10.1016/j.bbaexp.2003.10.013; PICKART CM, 1985, J BIOL CHEM, V260, P1573; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; REISS Y, 1988, J BIOL CHEM, V263, P2693; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Salomons FA, 2005, ESSAYS BIOCHEM, V41, P113, DOI 10.1042/EB0410113; Sarcevic B, 2002, EMBO J, V21, P2009, DOI 10.1093/emboj/21.8.2009; SCHWARTZ LM, 1990, NEURON, V5, P411, DOI 10.1016/0896-6273(90)90080-Y; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Streich FC, 2010, SUBCELL BIOCHEM, V54, P1, DOI 10.1007/978-1-4419-6676-6_1; Tokgoz Z, 2006, J BIOL CHEM, V281, P14729, DOI 10.1074/jbc.M513562200; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Varshavsky A, 2003, NAT CELL BIOL, V5, P373, DOI 10.1038/ncb0503-373; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; WIEBEL FF, 1992, NATURE, V359, P73, DOI 10.1038/359073a0; WING SS, 1995, BIOCHEM J, V307, P639, DOI 10.1042/bj3070639; Yamashita K, 2004, P NATL ACAD SCI USA, V101, P11380, DOI 10.1073/pnas.0400078101; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	54	13	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41300	41309		10.1074/jbc.M110.169136	http://dx.doi.org/10.1074/jbc.M110.169136			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041297	Green Published, hybrid			2022-12-25	WOS:000285622600015
J	Spessott, W; Uliana, A; Maccioni, HJF				Spessott, Waldo; Uliana, Andrea; Maccioni, Hugo J. F.			Cog2 Null Mutant CHO Cells Show Defective Sphingomyelin Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; RECEPTOR-MEDIATED ENDOCYTOSIS; NORMAL GOLGI FUNCTION; CONGENITAL DISORDER; GLYCOSPHINGOLIPID SYNTHESIS; RETROGRADE TRANSPORT; HELA-CELLS; COMPLEX; GLYCOSYLATION; PROTEIN	The COG (conserved oligomeric Golgi complex) is a Golgi-associated tethering complex involved in retrograde trafficking of multiple Golgi enzymes. COG deficiencies lead to misorganization of the Golgi, defective trafficking of glycosylation enzymes, and abnormal N-, O- and ceramide-linked oligosaccharides. Here, we show that in Cog2 null mutant ldlC cells, the content of sphingomyelin (SM) is reduced to similar to 25% of WT cells. Sphingomyelin synthase (SMS) activity is essentially normal in ldlC cells, but in contrast with the typical Golgi localization in WT cells, in ldlC cells, transfected SMS1 localizes to vesicular structures scattered throughout the cytoplasm, which show almost no signal of co-transfected ceramide transfer protein (CERT). Cog2 transfection restores SM formation and the typical SMS1 Golgi localization phenotype. Adding exogenous N-6-[(7-nitrobenzo-2-oxa-1,3-diazol-4-yl) amino]hexanoyl-4-d-erythro-sphingosine (C-6-NBD-ceramide) to ldlC cell cultures results in normal SM formation. Endogenous ceramide levels were 3-fold higher in ldlC cells than in WT cells, indicating that Golgi misorganization caused by Cog2 deficiency affects the delivery of ceramide to sites of SM synthesis by SMS1. Considering the importance of SM as a structural component of membranes, this finding is also worth of consideration in relation to a possible contribution to the clinical phenotype of patients suffering congenital disorders of glycosylation type II.	[Spessott, Waldo; Uliana, Andrea; Maccioni, Hugo J. F.] Univ Nacl Cordoba, CONICET, Fac Ciencias Quim, Dept Quim Biol,CIQUIBIC, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Maccioni, HJF (corresponding author), Haya Torre S-N, RA-5000 Cordoba, Argentina.	maccioni@dqb.fcq.unc.edu.ar			Agencia Nacional de Promocion Cientifica y Tecnologica, Universidad Nacional de Cordoba, y MinCyT Cordoba [PICT 2006-01239]; Consejo Nacional de Investigaciones Cientificas y Tecnicas	Agencia Nacional de Promocion Cientifica y Tecnologica, Universidad Nacional de Cordoba, y MinCyT Cordoba(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported in part by Grant PICT 2006-01239 from Agencia Nacional de Promocion Cientifica y Tecnologica, Universidad Nacional de Cordoba, y MinCyT Cordoba.; Recipients of Consejo Nacional de Investigaciones Cientificas y Tecnicas fellowships.	Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bruinsma P, 2004, J BIOL CHEM, V279, P39814, DOI 10.1074/jbc.M405500200; Chandran S, 2008, TRAFFIC, V9, P1894, DOI 10.1111/j.1600-0854.2008.00810.x; Chatterton JE, 1999, P NATL ACAD SCI USA, V96, P915, DOI 10.1073/pnas.96.3.915; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; DANIOTTI JL, 1991, J NEUROCHEM, V57, P2054, DOI 10.1111/j.1471-4159.1991.tb06421.x; DANIOTTI JL, 1994, J NEUROCHEM, V62, P1131; Foulquier F, 2006, P NATL ACAD SCI USA, V103, P3764, DOI 10.1073/pnas.0507685103; Foulquier F, 2009, BBA-MOL BASIS DIS, V1792, P896, DOI 10.1016/j.bbadis.2008.10.020; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; KINGSLEY DM, 1984, P NATL ACAD SCI-BIOL, V81, P5454, DOI 10.1073/pnas.81.17.5454; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; Kranz C, 2007, HUM MOL GENET, V16, P731, DOI 10.1093/hmg/ddm028; KRIEGER M, 1981, J MOL BIOL, V150, P167, DOI 10.1016/0022-2836(81)90447-2; KRIEGER M, 1989, METHOD CELL BIOL, V32, P57; LIPSKY NG, 1985, J CELL BIOL, V100, P27, DOI 10.1083/jcb.100.1.27; Oka T, 2005, J BIOL CHEM, V280, P32736, DOI 10.1074/jbc.M505558200; Oka T, 2004, MOL BIOL CELL, V15, P2423, DOI 10.1091/mbc.E03-09-0699; Paesold-Burda P, 2009, HUM MOL GENET, V18, P4350, DOI 10.1093/hmg/ddp389; PODOS SD, 1994, J CELL BIOL, V127, P679, DOI 10.1083/jcb.127.3.679; Reynders E, 2009, HUM MOL GENET, V18, P3244, DOI 10.1093/hmg/ddp262; Richardson BC, 2009, P NATL ACAD SCI USA, V106, P13329, DOI 10.1073/pnas.0901966106; Ridgway ND, 2000, BBA-MOL CELL BIOL L, V1484, P129, DOI 10.1016/S1388-1981(00)00006-8; Shestakova A, 2006, TRAFFIC, V7, P191, DOI 10.1111/j.1600-0854.2005.00376.x; Spessott W., 2010, J NEUROCHEM IN PRESS; Steet R, 2006, MOL BIOL CELL, V17, P2312, DOI 10.1091/mbc.E05-08-0822; Sztul E, 2009, FEBS LETT, V583, P3770, DOI 10.1016/j.febslet.2009.10.083; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Ungar D, 2006, TRENDS CELL BIOL, V16, P113, DOI 10.1016/j.tcb.2005.12.004; Ungar D, 2002, J CELL BIOL, V157, P405, DOI 10.1083/jcb.200202016; van der Luit AH, 2007, BIOCHEM J, V401, P541, DOI 10.1042/BJ20061178; Vasile E, 2006, EXP CELL RES, V312, P3132, DOI 10.1016/j.yexcr.2006.06.005; Veldman RJ, 2003, FASEB J, V17, P1144, DOI 10.1096/fj.02-1053fje; Weixel KM, 2005, J BIOL CHEM, V280, P10501, DOI 10.1074/jbc.M414304200; Whyte JRC, 2002, J CELL SCI, V115, P2627; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; Yamaji-Hasegawa A, 2003, J BIOL CHEM, V278, P22762, DOI 10.1074/jbc.M213209200; Zolov SN, 2005, J CELL BIOL, V168, P747, DOI 10.1083/jcb.200412003	46	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41472	41482		10.1074/jbc.M110.150011	http://dx.doi.org/10.1074/jbc.M110.150011			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21047787	Green Published, hybrid			2022-12-25	WOS:000285622600033
J	Brideau, CM; Kauppinen, KP; Holmes, R; Soloway, PD				Brideau, Chelsea M.; Kauppinen, Krista P.; Holmes, Rebecca; Soloway, Paul D.			A Non-Coding RNA Within the Rasgrf1 Locus in Mouse Is Imprinted and Regulated by Its Homologous Chromosome in Trans	PLOS ONE			English	Article							H19 GENE; DNA METHYLATION; X-INACTIVATION; CTCF; EXPRESSION; IGF2; CIS; RECEPTOR; ELEMENT; ALLELE	Background: Rasgrf1 is imprinted in mouse, displaying paternal allele specific expression in neonatal brain. Paternal expression is accompanied by paternal-specific DNA methylation at a differentially methylated domain (DMD) within the locus. The cis-acting elements necessary for Rasgrf1 imprinting are known. A series of tandem DNA repeats control methylation of the adjacent DMD, which is a methylation sensitive enhancer-blocking element. These two sequences constitute a binary switch that controls imprinting and represents the Imprinting Control Region (ICR). One paternally transmitted mutation, which helped define the ICR, induced paramutation, in trans, on the maternal allele. Like many imprinted genes, Rasgrf1 lies within an imprinted cluster. One of four noncoding transcripts in the cluster, AK015891, is known to be imprinted. Methodology/Principal Findings: Here we demonstrate that an additional noncoding RNA, AK029869, is imprinted and paternally expressed in brain throughout development. Intriguingly, any of several maternally inherited ICR mutations affected expression of the paternal AK029869 transcript in trans. Furthermore, we found that the ICR mutations exert different trans effects on AK029869 at different developmental times. Conclusions/Significance: Few trans effects have been defined in mammals and, those that exist, do not show the great variation seen at the Rasgrf1 imprinted domain, either in terms of the large number of mutations that produce the effects or the range of phenotypes that emerge when they are seen. These results suggest that trans regulation of gene expression may be more common than originally appreciated and that where trans regulation occurs it can change dynamically during development.	[Brideau, Chelsea M.; Kauppinen, Krista P.; Holmes, Rebecca; Soloway, Paul D.] Cornell Univ, Coll Agr & Life Sci, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University	Brideau, CM (corresponding author), Cornell Univ, Coll Agr & Life Sci, Div Nutr Sci, Ithaca, NY 14853 USA.	soloway@cornell.edu	Soloway, Paul/T-8243-2019	Soloway, Paul/0000-0003-1967-0437; McLean, Chelsea/0000-0002-3548-3482	National Institutes of Health (NIH) [CA098597, T32GM007617]; NATIONAL CANCER INSTITUTE [R01CA098597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007617] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was from the National Institutes of Health (NIH) to PDS (CA098597). CMB was supported in part by NIH Training Grant T32GM007617. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN WR, 1969, NATURE, V223, P64, DOI 10.1038/223064a0; Augui S, 2007, SCIENCE, V318, P1632, DOI 10.1126/science.1149420; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Birger Y, 1999, NATURE, V397, P84, DOI 10.1038/16291; de la Puente A, 2002, GENE, V291, P287, DOI 10.1016/S0378-1119(02)00601-7; Delaval K, 2007, EMBO J, V26, P720, DOI 10.1038/sj.emboj.7601513; Drake NM, 2009, MAMM GENOME, V20, P654, DOI 10.1007/s00335-009-9192-7; Duvillie B, 1998, GENOMICS, V47, P52, DOI 10.1006/geno.1997.5070; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; Forne T, 1997, P NATL ACAD SCI USA, V94, P10243, DOI 10.1073/pnas.94.19.10243; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Herman H, 2003, NAT GENET, V34, P199, DOI 10.1038/ng1162; Hikichi T, 2003, NUCLEIC ACIDS RES, V31, P1398, DOI 10.1093/nar/gkg232; Holmes R, 2006, MOL CELL BIOL, V26, P9564, DOI 10.1128/MCB.00058-06; Hu JF, 1997, J BIOL CHEM, V272, P20715, DOI 10.1074/jbc.272.33.20715; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kato Y, 2005, BIOESSAYS, V27, P1, DOI 10.1002/bies.20171; Landers M, 2005, NUCLEIC ACIDS RES, V33, P3976, DOI 10.1093/nar/gki705; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lindroth AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000145; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Peters J, 2008, MAMM GENOME, V19, P493, DOI 10.1007/s00335-008-9139-4; Plass C, 1996, NAT GENET, V14, P106, DOI 10.1038/ng0996-106; Qiu XW, 2008, MOL ENDOCRINOL, V22, P1476, DOI 10.1210/me.2007-0474; Shemer R, 2000, NAT GENET, V26, P440, DOI 10.1038/82571; Shykind BM, 2005, HUM MOL GENET, V14, pR33, DOI 10.1093/hmg/ddi105; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Srivastava M, 2003, J BIOL CHEM, V278, P5977, DOI 10.1074/jbc.M208437200; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Tsai TF, 2003, GENESIS, V37, P151, DOI 10.1002/gene.10237; Wu MY, 2006, GENE DEV, V20, P2859, DOI 10.1101/gad.1452206; Wutz A, 2007, CURR OPIN GENET DEV, V17, P387, DOI 10.1016/j.gde.2007.08.001; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Yoon B, 2005, MOL CELL BIOL, V25, P11184, DOI 10.1128/MCB.25.24.11184-11190.2005; Yoon BJ, 2002, NAT GENET, V30, P92, DOI 10.1038/ng795; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	54	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13784	10.1371/journal.pone.0013784	http://dx.doi.org/10.1371/journal.pone.0013784			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072176	Green Published, Green Submitted, gold			2022-12-25	WOS:000283779700004
J	Oda-Ishii, I; Ishii, Y; Mikawa, T				Oda-Ishii, Izumi; Ishii, Yasuo; Mikawa, Takashi			Eph Regulates Dorsoventral Asymmetry of the Notochord Plate and Convergent Extension-Mediated Notochord Formation	PLOS ONE			English	Article							PLANAR CELL POLARITY; CIONA-INTESTINALIS; BOUNDARY FORMATION; GENE; EXPRESSION; APKC; DIFFERENTIATION; GASTRULATION; PRICKLE; EPHRINS	Background: The notochord is a signaling center required for the patterning of the vertebrate embryic midline, however, the molecular and cellular mechanisms involved in the formation of this essential embryonic tissue remain unclear. The urochordate Ciona intestinalis develops a simple notochord from 40 specific postmitotic mesodermal cells. The precursors intercalate mediolaterally and establish a single array of disk-shaped notochord cells along the midline. However, the role that notochord precursor polarization, particularly along the dorsoventral axis, plays in this morphogenetic process remains poorly understood. Methodology/Principal Findings: Here we show that the notochord preferentially accumulates an apical cell polarity marker, aPKC, ventrally and a basement membrane marker, laminin, dorsally. This asymmetric accumulation of apicobasal cell polarity markers along the embryonic dorsoventral axis was sustained in notochord precursors during convergence and extension. Further, of several members of the Eph gene family implicated in cellular and tissue morphogenesis, only Ci-Eph4 was predominantly expressed in the notochord throughout cell intercalation. Introduction of a dominant-negative Ci-Eph4 to notochord precursors diminished asymmetric accumulation of apicobasal cell polarity markers, leading to defective intercalation. In contrast, misexpression of a dominant-negative mutant of a planar cell polarity gene Dishevelled preserved asymmetric accumulation of aPKC and laminin in notochord precursors, although their intercalation was incomplete. Conclusions/Significance: Our data support a model in which in ascidian embryos Eph-dependent dorsoventral polarity of notochord precursors plays a crucial role in mediolateral cell intercalation and is required for proper notochord morphogenesis.	[Oda-Ishii, Izumi; Ishii, Yasuo; Mikawa, Takashi] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Oda-Ishii, I (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	takashi.mikawa@ucsf.edu			National Institutes of Health-National Heart, Lung and Blood Institute [R01092429]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092429, R01HL078921] Funding Source: NIH RePORTER	National Institutes of Health-National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health-National Heart, Lung and Blood Institute R01092429. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DS, 1990, DEVELOPMENT, V110, P115; BANCROFT M, 1976, J EMBRYOL EXP MORPH, V35, P383; Bertrand V, 2003, CELL, V115, P615, DOI 10.1016/S0092-8674(03)00928-0; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; Chan J, 2001, DEV BIOL, V234, P470, DOI 10.1006/dbio.2001.0281; Cleaver O, 2001, DEV BIOL, V234, P1, DOI 10.1006/dbio.2001.0214; Cooke JE, 2005, CURR BIOL, V15, P536, DOI 10.1016/j.cub.2005.02.019; Corbo JC, 1997, DEVELOPMENT, V124, P589; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; Coulthard MG, 2002, INT J DEV BIOL, V46, P375; Darken RS, 2002, EMBO J, V21, P976, DOI 10.1093/emboj/21.5.976; Dearborn R, 2002, J NEUROSCI, V22, P1338, DOI 10.1523/JNEUROSCI.22-04-01338.2002; Djiane A, 2005, CELL, V121, P621, DOI 10.1016/j.cell.2005.03.014; Dodd J, 1998, SCIENCE, V282, P1654, DOI 10.1126/science.282.5394.1654; Durbin L, 1998, GENE DEV, V12, P3096, DOI 10.1101/gad.12.19.3096; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Fitsialos G, 2008, J CELL SCI, V121, P2992, DOI 10.1242/jcs.029256; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Glaser V, 2005, ZEBRAFISH, V1, P319; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Hotta K, 2007, DEV DYNAM, V236, P1790, DOI 10.1002/dvdy.21188; Huot J, 2004, PROG NEURO-PSYCHOPH, V28, P813, DOI 10.1016/j.pnpbp.2004.05.025; Ikuta T, 2004, P NATL ACAD SCI USA, V101, P15118, DOI 10.1073/pnas.0401389101; IMOH H, 1988, J EXP ZOOL, V246, P258, DOI 10.1002/jez.1402460306; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Jiang D, 2005, CURR BIOL, V15, P79; Jiang D, 2007, DEV DYNAM, V236, P1748, DOI 10.1002/dvdy.21184; Jones C, 2007, BIOESSAYS, V29, P120, DOI 10.1002/bies.20526; JURAND A, 1962, J EMBRYOL EXP MORPH, V10, P602; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Keys DN, 2002, DEV BIOL, V246, P329, DOI 10.1006/dbio.2002.0656; Kida YS, 2007, P NATL ACAD SCI USA, V104, P6708, DOI 10.1073/pnas.0608946104; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; Mikawa T, 2004, DEV DYNAM, V229, P422, DOI 10.1002/dvdy.10458; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Munro EM, 2002, DEVELOPMENT, V129, P13; Munro EM, 2002, DEVELOPMENT, V129, P1; Naruse-Nakajima C, 2001, MECH DEVELOP, V102, P95, DOI 10.1016/S0925-4773(01)00290-8; Oda-Ishii I, 2007, DEV DYNAM, V236, P1806, DOI 10.1002/dvdy.21213; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Parsons MJ, 2002, DEVELOPMENT, V129, P3137; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Patalano S, 2006, J CELL SCI, V119, P1592, DOI 10.1242/jcs.02873; Picco V, 2007, DEVELOPMENT, V134, P1491, DOI 10.1242/dev.003939; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Reese DE, 2004, DEV CELL, V6, P699, DOI 10.1016/S1534-5807(04)00127-3; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Satoh N, 2003, NAT REV GENET, V4, P285, DOI 10.1038/nrg1042; Satoh N., 1994, DEV BIOL ASCIDIANS; Satou Y, 2003, DEV GENES EVOL, V213, P213, DOI 10.1007/s00427-003-0319-7; Shi WY, 2009, DEVELOPMENT, V136, P23, DOI 10.1242/dev.029157; Smith A, 1997, CURR BIOL, V7, P561, DOI 10.1016/S0960-9822(06)00255-7; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Stemple DL, 2005, DEVELOPMENT, V132, P2503, DOI 10.1242/dev.01812; Suzuki A, 2002, J CELL SCI, V115, P3565, DOI 10.1242/jcs.00032; Suzuki AS, 2002, DEV GROWTH DIFFER, V44, P127; Takahashi Y, 2005, INT J DEV BIOL, V49, P221, DOI 10.1387/ijdb.041960yt; Takeuchi M, 2003, CURR BIOL, V13, P674, DOI 10.1016/S0960-9822(03)00245-8; Veeman MT, 2008, DEVELOPMENT, V135, P33, DOI 10.1242/dev.010892; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Vihanto MM, 2005, FASEB J, V19, P1689, DOI 10.1096/fj.04-3647fje; Xu QL, 1996, NATURE, V381, P319, DOI 10.1038/381319a0; Xu QL, 1995, DEVELOPMENT, V121, P4005	66	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13689	10.1371/journal.pone.0013689	http://dx.doi.org/10.1371/journal.pone.0013689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060822	Green Submitted, Green Published, gold			2022-12-25	WOS:000283645300006
J	Chang, AS; Bennett, SM; Noor, MAF				Chang, Audrey S.; Bennett, Sarah M.; Noor, Mohamed A. F.			Epistasis among Drosophila persimilis Factors Conferring Hybrid Male Sterility with D-pseudoobscura bogotana	PLOS ONE			English	Article							REPRODUCTIVE ISOLATION; GENETIC DISSECTION; SEGREGATION DISTORTION; COMPLEX EPISTASIS; NATURAL-SELECTION; SPECIATION GENE; MAURITIANA; SIMULANS; INCOMPATIBILITIES; LOCI	The Bateson-Dobzhansky-Muller model posits that hybrid incompatibilities result from genetic changes that accumulate during population divergence. Indeed, much effort in recent years has been devoted to identifying genes associated with hybrid incompatibilities, often with limited success, suggesting that hybrid sterility and inviability are frequently caused by complex interactions between multiple loci and not by single or a small number of gene pairs. Our previous study showed that the nature of epistasis between sterility-conferring QTL in the Drosophila persimilis-D. pseudoobscura bogotana species pair is highly specific. Here, we further dissect one of the three QTL underlying hybrid male sterility between these species and provide evidence for multiple factors within this QTL. This result indicates that the number of loci thought to contribute to hybrid dysfunction may have been underestimated, and we discuss how linkage and complex epistasis may be characteristic of the genetics of hybrid incompatibilities. We further pinpoint the location of one locus that confers hybrid male sterility when homozygous, dubbed "mule-like", to roughly 250 kilobases.	[Chang, Audrey S.; Bennett, Sarah M.; Noor, Mohamed A. F.] Duke Univ, Dept Biol, Durham, NC 27706 USA; [Chang, Audrey S.] NYU, Dept Biol, New York, NY 10003 USA	Duke University; New York University	Chang, AS (corresponding author), Duke Univ, Dept Biol, Durham, NC 27706 USA.	noor@duke.edu		Noor, Mohamed/0000-0002-5400-4408	National Science Foundation [0715484]; National Institutes of Health [GM076051, GM086445]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086445, R01GM076051] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Science Foundation award 0715484 and National Institutes of Health awards GM076051 and GM086445. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateson W., 1909, DARWIN MODERN SCI; CABOT EL, 1994, GENETICS, V137, P175; Chang AS, 2007, GENETICS, V176, P343, DOI 10.1534/genetics.106.067314; Chang AS, 2010, EVOLUTION, V64, P253, DOI 10.1111/j.1558-5646.2009.00823.x; COYNE JA, 1984, P NATL ACAD SCI-BIOL, V81, P4444, DOI 10.1073/pnas.81.14.4444; Davis AW, 1996, GENETICS, V143, P1287; Dobzhansky T, 1936, GENETICS, V21, P113; Gadau J, 1999, GENETICS, V153, P1731; Kao KC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001038; Kyoichi S, 2004, GENETICS, V166, P789, DOI 10.1534/genetics.166.2.789; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; Leman SC, 2005, GENETICS, V171, P1419, DOI 10.1534/genetics.104.040402; Long YM, 2008, P NATL ACAD SCI USA, V105, P18871, DOI 10.1073/pnas.0810108105; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Muller HJ, 1942, BIOL S, V6, P71; NOOR MA, 1995, NATURE, V375, P674, DOI 10.1038/375674a0; Orr HA, 2001, GENETICS, V158, P1089; PALOPOLI MF, 1994, GENETICS, V138, P329; PEREZ DE, 1995, GENETICS, V140, P201; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Reed LK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003076; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Sawamura K, 2000, P NATL ACAD SCI USA, V97, P2652, DOI 10.1073/pnas.050558597; Sun S, 2004, SCIENCE, V305, P81, DOI 10.1126/science.1093904; Tao Y, 2003, EVOLUTION, V57, P2580; Tao Y, 2003, GENETICS, V164, P1383; Tao Y, 2003, GENETICS, V164, P1399; Tao Y, 2001, P NATL ACAD SCI USA, V98, P13183, DOI 10.1073/pnas.231478798; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; True JR, 1996, GENETICS, V142, P819; Wang RL, 1997, GENETICS, V147, P1091	32	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e15377	10.1371/journal.pone.0015377	http://dx.doi.org/10.1371/journal.pone.0015377			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060872	Green Published, Green Submitted, gold			2022-12-25	WOS:000283537000061
J	Nyirenda, TS; Seeley, AE; Mandala, WL; Drayson, MT; MacLennan, CA				Nyirenda, Tonney S.; Seeley, Anna E.; Mandala, Wilson L.; Drayson, Mark T.; MacLennan, Calman A.			Early Interferon-gamma Production in Human Lymphocyte Subsets in Response to Nontyphoidal Salmonella Demonstrates Inherent Capacity in Innate Cells	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; NATURAL-KILLER-CELLS; DELTA-T-CELLS; CHRONIC GRANULOMATOUS-DISEASE; NECROSIS-FACTOR-ALPHA; INHERITED INTERLEUKIN-12 DEFICIENCY; NON-TYPHOIDAL SALMONELLA; IFN-GAMMA; IMMUNE-RESPONSE; MURINE SALMONELLOSIS	Background: Nontyphoidal Salmonellae frequently cause life-threatening bacteremia in sub-Saharan Africa. Young children and HIV-infected adults are particularly susceptible. High case-fatality rates and increasing antibiotic resistance require new approaches to the management of this disease. Impaired cellular immunity caused by defects in the T helper 1 pathway lead to intracellular disease with Salmonella that can be countered by IFN gamma administration. This report identifies the lymphocyte subsets that produce IFN gamma early in Salmonella infection. Methodology: Intracellular cytokine staining was used to identify IFN gamma production in blood lymphocyte subsets of ten healthy adults with antibodies to Salmonella (as evidence of immunity to Salmonella), in response to stimulation with live and heat-killed preparations of the D23580 invasive African isolate of Salmonella Typhimurium. The absolute number of IFN gamma-producing cells in innate, innate-like and adaptive lymphocyte subpopulations was determined. Principal Findings: Early IFN gamma production was found in the innate/innate-like lymphocyte subsets: gamma delta-T cells, NK cells and NK-like T cells. Significantly higher percentages of such cells produced IFN gamma compared to adaptive alpha beta-T cells (Student's t test, P < 0.001 and <= 0.02 for each innate subset compared, respectively, with CD4(+)- and CD8(+)-T cells). The absolute numbers of IFN gamma-producing cells showed similar differences. The proportion of IFN gamma-producing gamma delta-T cells, but not other lymphocytes, was significantly higher when stimulated with live compared with heat-killed bacteria (P<0.0001). Conclusion/Significance: Our findings indicate an inherent capacity of innate/innate-like lymphocyte subsets to produce IFN gamma early in the response to Salmonella infection. This may serve to control intracellular infection and reduce the threat of extracellular spread of disease with bacteremia which becomes life-threatening in the absence of protective antibody. These innate cells may also help mitigate against the effect on IFN gamma production of depletion of Salmonella-specific CD4(+)-T lymphocytes in HIV infection.	[Nyirenda, Tonney S.; Seeley, Anna E.; Drayson, Mark T.; MacLennan, Calman A.] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Med Res Council Ctr Immune Regulat & Clin Immunol, Birmingham, W Midlands, England; [Nyirenda, Tonney S.; Seeley, Anna E.; Drayson, Mark T.; MacLennan, Calman A.] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Clin Immunol Serv, Birmingham, W Midlands, England; [Nyirenda, Tonney S.; Mandala, Wilson L.] Univ Malawi, Malawi Liverpool Wellcome Trust Clin Res Programm, Coll Med, Blantyre, Malawi; [Mandala, Wilson L.] Univ Malawi, Coll Med, Dept Biochem, Blantyre, Malawi; [MacLennan, Calman A.] Univ Liverpool, Sch Infect & Host Def, Div Med Microbiol, Liverpool L69 3BX, Merseyside, England	University of Birmingham; University of Birmingham; University of Malawi; University of Malawi; University of Liverpool	Nyirenda, TS (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Med Res Council Ctr Immune Regulat & Clin Immunol, Birmingham, W Midlands, England.	c.maclennan@bham.ac.uk	MacLennan, Calman A/L-9343-2014	MacLennan, Calman A/0000-0001-9694-0846; Seeley, Anna Elizabeth/0000-0001-5354-5889; Mandala, Wilson/0000-0001-9386-9239; Drayson, Mark/0000-0002-1528-7564	Wellcome Trust [085836/Z/08/Z]; GlaxoSmithKline; GlaxoSmithKline through the University of Birmingham; Medical Research Council [G9818340B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline(GlaxoSmithKline); GlaxoSmithKline through the University of Birmingham; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Master's Training Fellowship in Public Health and Tropical Medicine from the Wellcome Trust (Grant Number 085836/Z/08/Z) to TS Nyirenda and a Clinical Research Fellowship from GlaxoSmithKline to CA MacLennan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CA MacLennan is a recipient of a Clinical Research Fellowship from GlaxoSmithKline, awarded through the University of Birmingham. This award is part of the charitable giving of GlaxoSmithKline and involves no employment, consultancy, patents, products in development or marketed products with GlaxoSmithKline. The award does not alter the adherence of CA MacLennan to all the PLoS ONE policies on sharing data and materials.	al-Ramadi BK, 2001, INFECT IMMUN, V69, P3980, DOI 10.1128/IAI.69.6.3980-3988.2001; Altare F, 1998, J CLIN INVEST, V102, P2035, DOI 10.1172/JCI4950; Bailer RT, 1999, J IMMUNOL, V162, P7534; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; Bustarnante J, 2008, CURR OPIN IMMUNOL, V20, P39, DOI 10.1016/j.coi.2007.10.005; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; Cunningham AF, 2007, J IMMUNOL, V178, P6200, DOI 10.4049/jimmunol.178.10.6200; de Jong R, 1998, SCIENCE, V280, P1435; Eckmann L, 1996, J IMMUNOL, V156, P2894; EMOTO M, 1992, J EXP MED, V176, P363, DOI 10.1084/jem.176.2.363; EZEKOWITZ RAB, 1988, NEW ENGL J MED, V319, P146, DOI 10.1056/NEJM198807213190305; Fan J, 1997, ARCH VIROL, V142, P1035, DOI 10.1007/s007050050139; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Foster N, 2003, INFECT IMMUN, V71, P4733, DOI 10.1128/IAI.71.8.4733-4741.2003; GILKS CF, 1990, LANCET, V336, P545, DOI 10.1016/0140-6736(90)92096-Z; GONDWE EN, 2010, P NATL ACAD IN PRESS; Gordon MA, 2005, INFECT IMMUN, V73, P3445, DOI 10.1128/IAI.73.6.3445-3452.2005; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Graham SM, 2000, PEDIATR INFECT DIS J, V19, P1189, DOI 10.1097/00006454-200012000-00016; Gulig PA, 1997, INFECT IMMUN, V65, P5191, DOI 10.1128/IAI.65.12.5191-5197.1997; HARA T, 1992, J CLIN INVEST, V90, P204, DOI 10.1172/JCI115837; Harrington L, 2007, FEMS IMMUNOL MED MIC, V51, P372, DOI 10.1111/j.1574-695X.2007.00313.x; Harrison JA, 1997, IMMUNOLOGY, V90, P618, DOI 10.1046/j.1365-2567.1997.00158.x; Hess J, 1996, J IMMUNOL, V156, P3321; Hirose K, 1999, J LEUKOCYTE BIOL, V66, P382, DOI 10.1002/jlb.66.3.382; HORMAECHE CE, 1990, IMMUNOLOGY, V70, P247; Imami N, 1999, AIDS RES HUM RETROV, V15, P1499, DOI 10.1089/088922299309784; Janssen R, 2002, J IMMUNOL, V169, P3900, DOI 10.4049/jimmunol.169.7.3900; Jason J, 2000, J INFECT DIS, V182, P474, DOI 10.1086/315740; John B, 2002, J IMMUNOL, V169, P2545, DOI 10.4049/jimmunol.169.5.2545; Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7; KAGAYA K, 1989, INFECT IMMUN, V57, P609, DOI 10.1128/IAI.57.2.609-615.1989; Kariuki S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-101; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; Kelleher AD, 1999, CLIN EXP IMMUNOL, V115, P147; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Lapaque N, 2009, J IMMUNOL, V182, P4339, DOI 10.4049/jimmunol.0803329; LAZARUS GM, 1975, J PEDIATR-US, V86, P415, DOI 10.1016/S0022-3476(75)80975-9; MacLennan C, 2004, J INFECT DIS, V190, P1755, DOI 10.1086/425021; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; MacLennan CA, 2010, SCIENCE, V328, P508, DOI 10.1126/science.1180346; Mandala WL, 2010, J ALLERGY CLIN IMMUN, V125, P203, DOI 10.1016/j.jaci.2009.10.010; MASTROENI P, 1992, MICROB PATHOGENESIS, V13, P477, DOI 10.1016/0882-4010(92)90014-F; Mastroeni P, 1998, INFECT IMMUN, V66, P4767, DOI 10.1128/IAI.66.10.4767-4776.1998; Mastroeni P, 1999, INFECT IMMUN, V67, P478, DOI 10.1128/IAI.67.2.478-483.1999; MATSUI K, 1992, MICROBIOL IMMUNOL, V36, P269, DOI 10.1111/j.1348-0421.1992.tb01664.x; Mittrucker HW, 1999, J IMMUNOL, V163, P6769; Mittrucker HW, 2002, INFECT IMMUN, V70, P199, DOI 10.1128/IAI.70.1.199-203.2002; MIXTER PF, 1994, INFECT IMMUN, V62, P4618, DOI 10.1128/IAI.62.10.4618-4621.1994; Mizuno Y, 2003, CLIN EXP IMMUNOL, V131, P111, DOI 10.1046/j.1365-2249.2003.02060.x; Morpeth SC, 2009, CLIN INFECT DIS, V49, P606, DOI 10.1086/603553; MOUY R, 1989, J PEDIATR-US, V114, P555, DOI 10.1016/S0022-3476(89)80693-6; Mtove G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009244; MUOTIALA A, 1990, MICROB PATHOGENESIS, V8, P135, DOI 10.1016/0882-4010(90)90077-4; MUOTIALA A, 1993, INFECT IMMUN, V61, P4248, DOI 10.1128/IAI.61.10.4248-4253.1993; Musso T, 2001, J LEUKOCYTE BIOL, V69, P605; Nadjm B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1350; NAUCIEL C, 1990, J IMMUNOL, V145, P1265; NAUCIEL C, 1992, INFECT IMMUN, V60, P450, DOI 10.1128/IAI.60.2.450-454.1992; Nishimura H, 1996, J IMMUNOL, V156, P663; OBRIEN AD, 1982, J IMMUNOL, V129, P1349; Pashine A, 1999, INT IMMUNOL, V11, P481, DOI 10.1093/intimm/11.4.481; Picard C, 2002, AM J HUM GENET, V70, P336, DOI 10.1086/338625; Pie S, 1997, INFECT IMMUN, V65, P4509, DOI 10.1128/IAI.65.11.4509-4514.1997; RAMARATHINAM L, 1991, MICROB PATHOGENESIS, V11, P347, DOI 10.1016/0882-4010(91)90020-B; RAMARATHINAM L, 1993, J IMMUNOL, V150, P3973; SCHAFER R, 1992, INFECT IMMUN, V60, P791, DOI 10.1128/IAI.60.3.791-797.1992; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Sinha K, 1997, INFECT IMMUN, V65, P1566, DOI 10.1128/IAI.65.4.1566-1569.1997; SKEEN MJ, 1993, J EXP MED, V178, P971, DOI 10.1084/jem.178.3.971; Srinivasan A, 2004, J IMMUNOL, V172, P6884, DOI 10.4049/jimmunol.172.11.6884; THATTE J, 1993, INT IMMUNOL, V5, P1431, DOI 10.1093/intimm/5.11.1431; Ugrinovic S, 2003, INFECT IMMUN, V71, P6808, DOI 10.1128/IAI.71.12.6808-6819.2003; van de Vosse E, 2009, LANCET INFECT DIS, V9, P688, DOI 10.1016/S1473-3099(09)70255-5; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Weintraub BC, 1997, INFECT IMMUN, V65, P2306, DOI 10.1128/IAI.65.6.2306-2312.1997	77	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13667	10.1371/journal.pone.0013667	http://dx.doi.org/10.1371/journal.pone.0013667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048923	gold, Green Submitted, Green Published			2022-12-25	WOS:000283537000036
J	Pinnock, SB; Blake, AM; Platt, NJ; Herbert, J				Pinnock, Scarlett B.; Blake, Alastair M.; Platt, Nicola J.; Herbert, Joe			The Roles of BDNF, pCREB and Wnt3a in the Latent Period Preceding Activation of Progenitor Cell Mitosis in The Adult Dentate Gyrus by Fluoxetine	PLOS ONE			English	Article							HIPPOCAMPAL NEUROGENESIS; NEUROTROPHIC FACTOR; ANTIDEPRESSANT DRUGS; TREATMENT INCREASES; BALB/CJ MICE; RAT-BRAIN; DEPRESSION; CORTICOSTERONE; SURVIVAL; PROLIFERATION	The formation of new neurons continues into adult life in the dentate gyrus of the rat hippocampus, as in many other species. Neurogenesis itself turns out to be highly labile, and is regulated by a number of factors. One of these is the serotoninergic system: treatment with drugs (such as the SSRI fluoxetine) markedly stimulates mitosis in the progenitor cells of the dentate gyrus. But this process has one remarkable feature: it takes at least 14 days of continuous treatment to be effective. This is despite the fact that the pharmacological action of fluoxetine occurs within an hour or so of first administration. This paper explores the role of BDNF in this process, using the effect of a Trk antagonist (K252a) on the labelling of progenitor cells with the mitosis marker Ki67 and the associated expression of pCREB and Wnt3a. These experiments show that (i) Fluoxetine increased Ki67 counts, as well as pCREB and Wnt3a expression in the dentate gyrus. The action of fluoxetine on the progenitor cells and on pCREB (but not Wnt3a) depends upon Trk receptor activation, since it was prevented by icv infusion of K252a. (ii) These receptors are required for both the first 7 days of fluoxetine action, during which no apparent change in progenitor mitosis occurs, as well as the second 7 days. Increased pCREB was always associated with progenitor cell mitosis, but Wnt3a expression may be necessary but not sufficient for increased progenitor cell proliferation. These results shed new light on the action of fluoxetine on neurogenesis in the adult dentate gyrus, and have both clinical and experimental interest.	[Pinnock, Scarlett B.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England	University of Cambridge; University of Cambridge	Pinnock, SB (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	jh24@cam.ac.uk	Herbert, Joe/K-5877-2013		Wellcome Trust [RG 45642]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust, grant number RG 45642. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. wellcome.ac.uk	Al-Majed AA, 2000, EUR J NEUROSCI, V12, P4381, DOI 10.1046/j.1460-9568.2000.01341.x; Balu DT, 2009, NEUROPSYCHOPHARMACOL, V34, P1764, DOI 10.1038/npp.2008.234; Benmansour S, 2008, EUR J PHARMACOL, V587, P90, DOI 10.1016/j.ejphar.2008.03.048; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Bradley J, 1999, BRAIN RES, V815, P140, DOI 10.1016/S0006-8993(98)01112-3; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Cuppini R, 2006, HIPPOCAMPUS, V16, P141, DOI 10.1002/hipo.20140; Davidson KC, 2007, MOL CELL NEUROSCI, V36, P408, DOI 10.1016/j.mcn.2007.07.013; De Foubert G, 2004, NEUROSCIENCE, V128, P597, DOI 10.1016/j.neuroscience.2004.06.054; Deltheil T, 2008, NEUROPHARMACOLOGY, V55, P1006, DOI 10.1016/j.neuropharm.2008.08.001; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Gass P, 2007, BIOESSAYS, V29, P957, DOI 10.1002/bies.20658; Holick KA, 2008, NEUROPSYCHOPHARMACOL, V33, P406, DOI 10.1038/sj.npp.1301399; Huang GJ, 2008, MOL PSYCHIATR, V13, P119, DOI 10.1038/sj.mp.4002104; Huang GJ, 2006, BIOL PSYCHIAT, V59, P619, DOI 10.1016/j.biopsych.2005.09.016; Huang GJ, 2005, NEUROSCIENCE, V135, P803, DOI 10.1016/j.neuroscience.2005.05.056; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Jessberger S, 2009, TRENDS PHARMACOL SCI, V30, P61, DOI 10.1016/j.tips.2008.11.003; Lazarovici P, 1996, ADV EXP MED BIOL, V391, P367; Li GN, 2005, DEV NEUROSCI-BASEL, V27, P93, DOI 10.1159/000085980; Liang FQ, 2000, J NEUROSCI, V20, P2978; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Malberg JE, 2005, CURR PHARM DESIGN, V11, P145, DOI 10.2174/1381612053382223; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Muller MB, 2001, EUR J NEUROSCI, V14, P1603, DOI 10.1046/j.0953-816x.2001.01784.x; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Paxinos G, 1998, RAT BRAIN STEROTAXIC; Pinnock SB, 2008, EUR J NEUROSCI, V27, P2493, DOI 10.1111/j.1460-9568.2008.06250.x; Pinnock SB, 2007, NEUROPSYCHOPHARMACOL, V32, P493, DOI 10.1038/sj.npp.1301245; ROSS AH, 1995, J NEUROCHEM, V65, P2748; Russo-Neustadt AA, 2005, CURR PHARM DESIGN, V11, P1495, DOI 10.2174/1381612053764788; Saarelainen T, 2003, J NEUROSCI, V23, P349; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Solberg N, 2008, DEV DYNAM, V237, P1799, DOI 10.1002/dvdy.21586; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Varea E, 2007, NEUROPSYCHOPHARMACOL, V32, P803, DOI 10.1038/sj.npp.1301183; Wong EYH, 2006, NEUROSCIENCE, V137, P83, DOI 10.1016/j.neuroscience.2005.08.073; Wong EYH, 2005, EUR J NEUROSCI, V22, P785, DOI 10.1111/j.1460-9568.2005.04277.x; Wong EYH, 2004, EUR J NEUROSCI, V20, P2491, DOI 10.1111/j.1460-9568.2004.03717.x; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	47	62	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13652	10.1371/journal.pone.0013652	http://dx.doi.org/10.1371/journal.pone.0013652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048974	Green Published, Green Submitted, gold			2022-12-25	WOS:000283537000023
J	Danalache, BA; Gutkowska, J; Slusarz, MJ; Berezowska, I; Jankowski, M				Danalache, Bogdan A.; Gutkowska, Jolanta; Slusarz, Magdalena J.; Berezowska, Irena; Jankowski, Marek			Oxytocin-Gly-Lys-Arg: A Novel Cardiomyogenic Peptide	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ATRIAL-NATRIURETIC-PEPTIDE; NITRIC-OXIDE SYNTHASE; CARDIAC DIFFERENTIATION; ENDOTHELIAL-CELLS; RAT-HEART; IN-VITRO; VASOPRESSIN; RECEPTORS; CARDIOMYOCYTES	Background: Oxytocin (OT), synthesized in the heart, has the ability to heal injured hearts and to promote cardiomyogenesis from stem cells. Recently, we reported that the OT-GKR molecule, a processing intermediate of OT, potently increased the spontaneous formation of cardiomyocytes (CM) in embryonic stem D3 cells and augmented glucose uptake in newborn rat CM above the level stimulated by OT. In the present experiments, we investigated whether OT-GKR exists in fetal and newborn rodent hearts, interacts with the OT receptors (OTR) and primes the generation of contracting cells expressing CM markers in P19 cells, a model for the study of early heart differentiation. Methodology/Principal Findings: High performance liquid chromatography of newborn rat heart extracts indicated that OT-GKR was a dominant form of OT. Immunocytochemistry of mouse embryos (embryonic day 15) showed cardiac OT-GKR accumulation and OTR expression. Computerized molecular modeling revealed OT-GKR docking to active OTR sites and to V1a receptor of vasopressin. In embryonic P19 cells, OT-GKR induced contracting cell colonies and ventricular CM markers more potently than OT, an effect being suppressed by OT antagonists and OTR-specific small interfering (si) RNA. The V1a receptor antagonist and specific si-RNA also significantly reduced OT-GKR-stimulated P19 contracting cells. In comparison to OT, OT-GKR induced in P19 cells less a-actinin, myogenin and MyoD mRNA, skeletal muscle markers. Conclusions/Significance: These results raise the possibility that C-terminally extended OT molecules stimulate CM differentiation and contribute to heart growth during fetal life.	[Danalache, Bogdan A.; Gutkowska, Jolanta; Jankowski, Marek] Univ Montreal CRCHUM Hotel Dieu, Ctr Hosp, Res Ctr, Montreal, PQ, Canada; [Gutkowska, Jolanta; Jankowski, Marek] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Slusarz, Magdalena J.] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland; [Berezowska, Irena] Clin Res Inst Montreal, Lab Chem Biol & Peptide Res, Montreal, PQ H2W 1R7, Canada	Universite de Montreal; Fahrenheit Universities; University of Gdansk; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Danalache, BA (corresponding author), Univ Montreal CRCHUM Hotel Dieu, Ctr Hosp, Res Ctr, Montreal, PQ, Canada.	marek.jankowski@umontreal.ca	Jankowski, Marek/AAF-7643-2019; Danalache, Bogdan Alexandru 1/B-3958-2010	Jankowski, Marek/0000-0002-1245-0733; Slusarz, Magdalena J./0000-0002-9411-4679	Canadian Institutes of Health Research [MOP-97992, MOP-62901]; Canadian Heart and Stroke Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This research was supported by the Canadian Institutes of Health Research (MOP-97992, MOP-62901 to JG and MJ) and the Canadian Heart and Stroke Foundation (to JG and MJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelalim EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005341; ALTSTEIN M, 1988, PEPTIDES, V9, P87, DOI 10.1016/0196-9781(88)90014-9; ALTSTEIN M, 1988, J NEUROSCI, V8, P3967; Barberis C, 1998, J ENDOCRINOL, V156, P223, DOI 10.1677/joe.0.1560223; Bloch W, 1999, CARDIOVASC RES, V43, P675, DOI 10.1016/S0008-6363(99)00160-1; BROWNSTEIN MJ, 1980, SCIENCE, V207, P373, DOI 10.1126/science.6153132; Burbach JPH, 2001, PHYSIOL REV, V81, P1197, DOI 10.1152/physrev.2001.81.3.1197; Cattaneo MG, 2008, BRIT J PHARMACOL, V153, P728, DOI 10.1038/sj.bjp.0707609; Danalache BA, 2007, STEM CELLS, V25, P679, DOI 10.1634/stemcells.2005-0610; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Elabd C, 2008, STEM CELLS, V26, P2399, DOI 10.1634/stemcells.2008-0127; Fanelli F, 1999, MOL PHARMACOL, V56, P214, DOI 10.1124/mol.56.1.214; Fathi F, 2009, INT J CARDIOL, V134, P75, DOI 10.1016/j.ijcard.2008.01.046; Favaretto AIV, 1997, PEPTIDES, V18, P1377, DOI 10.1016/S0196-9781(97)00209-X; Florian M, 2010, ENDOCRINOLOGY, V151, P482, DOI 10.1210/en.2009-0624; Gassanov N, 2008, STEM CELLS, V26, P45, DOI 10.1634/stemcells.2007-0289; Gassanov N, 2007, J BIOL CHEM, V282, P11255, DOI 10.1074/jbc.M610769200; Gimpl G, 2008, PROG BRAIN RES, V170, P193, DOI 10.1016/S0079-6123(08)00417-2; Gutkowska J, 1997, P NATL ACAD SCI USA, V94, P11704, DOI 10.1073/pnas.94.21.11704; Hatami L, 2007, INT J CARDIOL, V117, P80, DOI 10.1016/j.ijcard.2006.04.054; Holmes CL, 2003, CRIT CARE, V7, P427, DOI 10.1186/cc2337; Hopkins WE, 2004, CIRCULATION, V109, P2872, DOI 10.1161/01.CIR.0000129305.25115.80; Iseri SO, 2005, J SURG RES, V126, P73, DOI 10.1016/j.jss.2005.01.021; Jankowski M, 1998, P NATL ACAD SCI USA, V95, P14558, DOI 10.1073/pnas.95.24.14558; Jankowski M, 2004, P NATL ACAD SCI USA, V101, P13074, DOI 10.1073/pnas.0405324101; Jankowski M, 2010, BASIC RES CARDIOL, V105, P205, DOI 10.1007/s00395-009-0076-5; Kanno S, 2004, P NATL ACAD SCI USA, V101, P12277, DOI 10.1073/pnas.0401557101; Kobayashi H, 2009, J CARDIOVASC PHARM, V54, P510, DOI 10.1097/FJC.0b013e3181bfac02; Loichot C, 2001, N-S ARCH PHARMACOL, V363, P369, DOI 10.1007/s002100000372; Mitchell BF, 1998, BIOL REPROD, V59, P1321, DOI 10.1095/biolreprod59.6.1321; Moore JC, 2004, INT J DEV BIOL, V48, P47, DOI 10.1387/ijdb.15005574; Mora-Castilla S, 2010, CELL DEATH DIFFER, V17, P1025, DOI 10.1038/cdd.2009.204; MORRIS M, 1992, AM J PHYSIOL, V263, pR738, DOI 10.1152/ajpregu.1992.263.3.R738; Mujoo K, 2008, P NATL ACAD SCI USA, V105, P18924, DOI 10.1073/pnas.0810230105; Nakamura Y, 2000, EUR J PHARMACOL, V391, P39, DOI 10.1016/S0014-2999(99)00775-X; Ondrejcakova M, 2009, CAN J PHYSIOL PHARM, V87, P137, DOI 10.1139/Y08-108; Paquin J, 2002, P NATL ACAD SCI USA, V99, P9550, DOI 10.1073/pnas.152302499; Postina R, 1996, J BIOL CHEM, V271, P31593, DOI 10.1074/jbc.271.49.31593; SKERJANC IS, 1994, DEV BIOL, V163, P125, DOI 10.1006/dbio.1994.1128; Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1; Slusarz MJ, 2006, J PEPT SCI, V12, P171, DOI 10.1002/psc.713; Szeto A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1495, DOI 10.1152/ajpendo.90718.2008; Tamma R, 2009, P NATL ACAD SCI USA, V106, P7149, DOI 10.1073/pnas.0901890106; Thibonnier M, 1999, ENDOCRINOLOGY, V140, P1301, DOI 10.1210/en.140.3.1301; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; VIERO C, 2010, CNS NEUROSCI THER; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Yamamoto K, 1997, HYPERTENSION, V30, P1112, DOI 10.1161/01.HYP.30.5.1112	48	19	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13643	10.1371/journal.pone.0013643	http://dx.doi.org/10.1371/journal.pone.0013643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21048978	Green Submitted, gold, Green Published			2022-12-25	WOS:000283487400030
J	Isamah, N; Faison, W; Payne, ME; MacFall, J; Steffens, DC; Beyer, JL; Krishnan, KR; Taylor, WD				Isamah, Nneka; Faison, Warachal; Payne, Martha E.; MacFall, James; Steffens, David C.; Beyer, John L.; Krishnan, K. Ranga; Taylor, Warren D.			Variability in Frontotemporal Brain Structure: The Importance of Recruitment of African Americans in Neuroscience Research	PLOS ONE			English	Article							OLDER-ADULTS; VOLUME MEASUREMENT; ETHNIC-DIFFERENCES; EUROPEAN-AMERICAN; AMYGDALA ACTIVITY; SEX-DIFFERENCES; RACE; PARTICIPATION; POLYMORPHISM; DEPRESSION	Background: Variation in brain structure is both genetically and environmentally influenced. The question about potential differences in brain anatomy across populations of differing race and ethnicity remains a controversial issue. There are few studies specifically examining racial or ethnic differences and also few studies that test for race-related differences in context of other neuropsychiatric research, possibly due to the underrepresentation of ethnic minorities in clinical research. It is within this context that we conducted a secondary data analysis examining volumetric MRI data from healthy participants and compared the volumes of the amygdala, hippocampus, lateral ventricles, caudate nucleus, orbitofrontal cortex (OFC) and total cerebral volume between Caucasian and African-American participants. We discuss the importance of this finding in context of neuroimaging methodology, but also the need for improved recruitment of African Americans in clinical research and its broader implications for a better understanding of the neural basis of neuropsychiatric disorders. Methodology/Principal Findings: This was a case control study in the setting of an academic medical center outpatient service. Participants consisted of 44 Caucasians and 33 ethnic minorities. The following volumetric data were obtained: amygdala, hippocampus, lateral ventricles, caudate nucleus, orbitofrontal cortex (OFC) and total cerebrum. Each participant completed a 1.5 T magnetic resonance imaging (MRI). Our primary finding in analyses of brain subregions was that when compared to Caucasians, African Americans exhibited larger left OFC volumes (F (1,68) = 7.50, p = 0.008). Conclusions: The biological implications of our findings are unclear as we do not know what factors may be contributing to these observed differences. However, this study raises several questions that have important implications for the future of neuropsychiatric research.	[Isamah, Nneka; Payne, Martha E.; MacFall, James; Beyer, John L.; Taylor, Warren D.] Duke Univ, Med Ctr, Duke Neuropsychiat Imaging Res Lab, Durham, NC 27706 USA; [Isamah, Nneka] Duke Univ, Med Ctr, Sch Med, Durham, NC USA; [Payne, Martha E.; Steffens, David C.; Beyer, John L.; Krishnan, K. Ranga; Taylor, Warren D.] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA; [MacFall, James] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Faison, Warachal] Med Univ S Carolina, Alzheimers Res & Clin Programs, Dept Neurosci, Charleston, SC 29425 USA; [Krishnan, K. Ranga] Duke NUS Grad Med Sch, Singapore, Singapore	Duke University; Duke University; Duke University; Duke University; Medical University of South Carolina; National University of Singapore	Isamah, N (corresponding author), Duke Univ, Med Ctr, Duke Neuropsychiat Imaging Res Lab, Durham, NC 27706 USA.	Taylo066@mc.duke.edu	Taylor, Warren D/J-3687-2014		NIH [5R01MH057027-10, 5R01MH077745-03]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057027, R01MH077745] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Work was supported by NIH grants 5R01MH057027-10 and 5R01MH077745-03. The funding source had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGIER N, 2000, NY TIMES, pR1; Apostolova LG, 2006, BRAIN, V129, P2867, DOI 10.1093/brain/awl274; Arean PA, 1996, J CONSULT CLIN PSYCH, V64, P875, DOI 10.1037/0022-006X.64.5.875; BECKERDEA, 1992, NIH PUBL; Beyer JL, 2004, AM J GERIAT PSYCHIAT, V12, P613, DOI 10.1176/appi.ajgp.12.6.613; Beyer JL, 2004, INT J GERIATR PSYCH, V19, P109, DOI 10.1002/gps.1030; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Carmichael OT, 2007, NEUROBIOL AGING, V28, P1316, DOI 10.1016/j.neurobiolaging.2006.06.016; CARTER WB, 1991, GERONTOLOGIST, V31, P584, DOI 10.1093/geront/31.5.584; Coleman EA, 1997, AM J PREV MED, V13, P51, DOI 10.1016/S0749-3797(18)30094-1; Corbie-Smith G, 2004, AM J MED, V116, P249, DOI 10.1016/j.amjmed.2003.09.032; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Cunningham WA, 2004, PSYCHOL SCI, V15, P806, DOI 10.1111/j.0956-7976.2004.00760.x; Dannlowski U, 2007, GENES BRAIN BEHAV, V6, P672, DOI 10.1111/j.1601-183X.2006.00297.x; Doty TJ, 2008, PSYCHIAT RES-NEUROIM, V163, P84, DOI 10.1016/j.pscychresns.2007.08.003; Faison WE, 2007, INT PSYCHOGERIATR, V19, P539, DOI 10.1017/S104161020700511X; Gelernter J, 1997, HUM GENET, V101, P243, DOI 10.1007/s004390050624; Gelernter J, 1998, AM J PSYCHIAT, V155, P1332, DOI 10.1176/ajp.155.10.1332; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Gore S, 2003, J HEALTH SOC BEHAV, V44, P370, DOI 10.2307/1519785; Greenberg DL, 2008, NEUROBIOL AGING, V29, P290, DOI 10.1016/j.neurobiolaging.2006.09.016; GUOZEA, 2000, J MENTAL HLTH AGING, V6, P91; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004; Kim JS, 2006, NEUROSCI LETT, V397, P279, DOI 10.1016/j.neulet.2005.12.061; Knutson B, 2001, BIOL PSYCHIAT, V50, P685, DOI 10.1016/S0006-3223(01)01220-3; Kochunov P, 2003, NEUROREPORT, V14, P961, DOI 10.1097/01.wnr.0000075417.59944.00; Lai TJ, 2000, BIOL PSYCHIAT, V48, P971, DOI 10.1016/S0006-3223(00)01042-8; Leonard CM, 2008, CEREB CORTEX, V18, P2920, DOI 10.1093/cercor/bhn052; Lieberman MD, 2005, NAT NEUROSCI, V8, P720, DOI 10.1038/nn1465; Lovato LC, 1997, CONTROL CLIN TRIALS, V18, P328, DOI 10.1016/S0197-2456(96)00236-X; McNeilly M, 2000, RECRUITMENT AND RETENTION IN MINORITY POPULATIONS, P91; Moody L E, 1995, J Am Acad Nurse Pract, V7, P483, DOI 10.1111/j.1745-7599.1995.tb01116.x; MORSE EV, 1995, APPL NURS RES, V8, P8, DOI 10.1016/S0897-1897(95)80240-1; Mouton CP, 1997, J NATL MED ASSOC, V89, P721; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Olin JT, 2002, ALZ DIS ASSOC DIS, V16, pS82, DOI 10.1097/00002093-200200002-00009; Paskett ED, 2008, CONTEMP CLIN TRIALS, V29, P847, DOI 10.1016/j.cct.2008.07.006; Payne ME, 2002, PSYCHIAT RES-NEUROIM, V115, P63, DOI 10.1016/S0925-4927(02)00009-4; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; Petrella JR, 2008, RADIOLOGY, V246, P20, DOI 10.1148/radiol.2461061994; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Plant EA, 2004, J CONSULT CLIN PSYCH, V72, P41, DOI 10.1037/0022-006X.72.1.41; Rimol LM, 2010, BIOL PSYCHIAT, V67, P493, DOI 10.1016/j.biopsych.2009.09.032; Risch Neil, 2002, GENOME BIO, V3, P1, DOI DOI 10.1186/GB-2002-3-7-COMMENT2007; Sen Bisakha, 2004, J Ment Health Policy Econ, V7, P133; Shen JJ, 2010, ETHNIC DIS, V20, P35; Sinclair S, 2000, RECRUITMENT AND RETENTION IN MINORITY POPULATIONS, P39; Smolka MN, 2007, MOL PSYCHIATR, V12, P307, DOI 10.1038/sj.mp.4001946; STOY DB, 1995, J NATL MED ASSOC, V87, P280; Sullivan EV, 2007, BRIT J RADIOL, V80, pS99, DOI 10.1259/bjr/22893432; Tang YC, 2010, NEUROIMAGE, V51, P33, DOI 10.1016/j.neuroimage.2010.01.111; Vadakkumpadan F, 2006, INT J NEUROSCI, V116, P407, DOI 10.1080/00207450500505662; Wendler D, 2006, PLOS MED, V3, P201, DOI 10.1371/journal.pmed.0030019; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118	56	32	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13642	10.1371/journal.pone.0013642	http://dx.doi.org/10.1371/journal.pone.0013642			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	671GB	21049028	Green Published, gold			2022-12-25	WOS:000283487400029
J	Zhou, Q; Snider, NT; Liao, JA; Li, DH; Hong, A; Ku, NO; Cartwright, CA; Omary, MB				Zhou, Qin; Snider, Natasha T.; Liao, Jian; Li, Daniel H.; Hong, Anita; Ku, Nam-On; Cartwright, Christine A.; Omary, M. Bishr			Characterization of In Vivo Keratin 19 Phosphorylation on Tyrosine-391	PLOS ONE			English	Article							SIMPLE EPITHELIAL KERATINS; INTERMEDIATE-FILAMENTS; DISEASE; PROTEIN; CELLS; ORGANIZATION; VIMENTIN; DYNAMICS; SEQUENCE; HEALTH	Background: Keratin polypeptide 19 (K19) is a type I intermediate filament protein that is expressed in stratified and simple-type epithelia. Although K19 is known to be phosphorylated on tyrosine residue(s), conclusive site-specific characterization of these residue(s) and identification potential kinases that may be involved has not been reported. Methodology/Principal Findings: In this study, biochemical, molecular and immunological approaches were undertaken in order to identify and characterize K19 tyrosine phosphorylation. Upon treatment with pervanadate, a tyrosine phosphatase inhibitor, human K19 (hK19) was phosphorylated on tyrosine 391, located in the 'tail' domain of the protein. K19 Y391 phosphorylation was confirmed using site-directed mutagenesis and cell transfection coupled with the generation of a K19 phospho (p)-Y391-specific rabbit antibody. The antibody also recognized mouse phospho-K19 (K19 pY394). This tyrosine residue is not phosphorylated under basal conditions, but becomes phosphorylated in the presence of Src kinase in vitro and in cells expressing constitutively-active Src. Pervanadate treatment in vivo resulted in phosphorylation of K19 Y394 and Y391 in colonic epithelial cells of non-transgenic mice and hK19-overexpressing mice, respectively. Conclusions/Significance: Human K19 tyrosine 391 is phosphorylated, potentially by Src kinase, and is the first well-defined tyrosine phosphorylation site of any keratin protein. The lack of detection of K19 pY391 in the absence of tyrosine phosphatase inhibition suggests that its phosphorylation is highly dynamic.	[Zhou, Qin; Cartwright, Christine A.] Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA; [Snider, Natasha T.; Omary, M. Bishr] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Liao, Jian] Appl Biom Inc, Hayward, CA USA; [Li, Daniel H.; Hong, Anita] Anaspec Inc, Fremont, CA USA; [Ku, Nam-On] Yonsei Univ, Dept Biomed Sci, Seoul 120749, South Korea	Stanford University; University of Michigan System; University of Michigan; Yonsei University	Zhou, Q (corresponding author), Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA.	mbishr@umich.edu		Omary, Bishr/0000-0002-8624-2347	National Institutes of Health [DK47918]; Department of Veterans Affairs; University of Michigan [UL1RR024986]; Korean Research WCU [R31-2008-000-10086-0 N-OK]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); University of Michigan(University of Michigan System); Korean Research WCU; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant DK47918 and the Department of Veterans Affairs (MBO); a University of Michigan Postdoctoral Translational Scholars Program Award UL1RR024986 (NTS); and Korean Research WCU grant R31-2008-000-10086-0 N-OK). DHL and AH are paid employees of Anaspec, Inc., which produced and supplied the anti-phosphotyrosine antibody (K19 pY391) that was used in this study. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelastro JM, 1998, J NEUROCHEM, V70, P540; BADER BL, 1986, EMBO J, V5, P1865, DOI 10.1002/j.1460-2075.1986.tb04438.x; Barberis L, 2009, EUR J IMMUNOL, V39, P1136, DOI 10.1002/eji.200838884; Boyer B, 2002, ONCOGENE, V21, P2347, DOI 10.1038/sj.onc.1205298; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CHOU CF, 1992, J BIOL CHEM, V267, P3901; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; ECKERT RL, 1988, P NATL ACAD SCI USA, V85, P1114, DOI 10.1073/pnas.85.4.1114; Feng L, 1999, J CELL SCI, V112, P2081; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Goldman RD, 2008, CURR OPIN CELL BIOL, V20, P28, DOI 10.1016/j.ceb.2007.11.003; Inagaki M, 1996, BIOESSAYS, V18, P481, DOI 10.1002/bies.950180610; Kim HT, 2009, INT J APPL CERAM TEC, V6, P587, DOI 10.1111/j.1744-7402.2009.02381.x; Ku NO, 2004, METHOD CELL BIOL, V78, P489; Ku NO, 2000, J CELL BIOL, V149, P547, DOI 10.1083/jcb.149.3.547; Ku NO, 1999, AM J PHYSIOL-GASTR L, V277, pG1108, DOI 10.1152/ajpgi.1999.277.6.G1108; Marceau N, 2007, EXP CELL RES, V313, P2265, DOI 10.1016/j.yexcr.2007.03.038; Omary M B, 1998, Subcell Biochem, V31, P105; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Omary MB, 2002, HEPATOLOGY, V35, P251, DOI 10.1053/jhep.2002.31165; Porter RM, 2003, TRENDS GENET, V19, P278, DOI 10.1016/S0168-9525(03)00071-4; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; STEINERT PM, 1982, BIOCHEMISTRY-US, V21, P177, DOI 10.1021/bi00530a030; Strnad P, 2002, J CELL SCI, V115, P4133, DOI 10.1242/jcs.00096; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Uitto J, 2007, EXP CELL RES, V313, P1995, DOI 10.1016/j.yexcr.2007.03.029; Valgeirsdottir S, 1998, J CELL SCI, V111, P1973; Vijayaraj Preethi, 2007, Methods Mol Biol, V360, P203; Zhou XJ, 1999, J BIOL CHEM, V274, P12861, DOI 10.1074/jbc.274.18.12861	35	13	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13538	10.1371/journal.pone.0013538	http://dx.doi.org/10.1371/journal.pone.0013538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049038	Green Published, gold, Green Submitted			2022-12-25	WOS:000283422100006
J	Daniels, SI; Davis, DA; Soule, EE; Stahl, SJ; Tebbs, IR; Wingfield, P; Yarchoan, R				Daniels, Sarah I.; Davis, David A.; Soule, Erin E.; Stahl, Stephen J.; Tebbs, Irene R.; Wingfield, Paul; Yarchoan, Robert			The Initial Step in Human Immunodeficiency Virus Type 1 GagProPol Processing Can Be Regulated by Reversible Oxidation	PLOS ONE			English	Article							NF-KAPPA-B; HIV-1 PROTEASE; VIRAL INFECTIVITY; SEQUENTIAL STEPS; GAGPOL PRECURSOR; CLEAVAGE SITES; IN-VITRO; ACTIVATION; DIMERIZATION; INHIBITION	Background: Maturation of human immunodeficiency virus type 1 (HIV-1) occurs upon activation of HIV-1 protease embedded within GagProPol precursors and cleavage of Gag and GagProPol polyproteins. Although reversible oxidation can regulate mature protease activity as well as retrovirus maturation, it is possible that the effects of oxidation on viral maturation are mediated in whole, or part, through effects on the initial intramolecular cleavage event of GagProPol. In order assess the effect of reversible oxidation on this event, we developed a system to isolate the first step in protease activation involving GagProPol. Methodology/Principal Findings: To determine if oxidation influences this step, we created a GagProPol plasmid construct (pGPfs-1C) that encoded mutations at all cleavage sites except p2/NC, the initial cleavage site in GagProPol. pGPfs-1C was used in an in vitro translation assay to observe the behavior of this initial step without interference from subsequent processing events. Diamide, a sulfhydral oxidizing agent, inhibited processing at p2/NC by >60% for pGPfs-1C and was readily reversed with the reductant, dithiothreitol. The ability to regulate processing by reversible oxidation was lost when the cysteines of the embedded protease were mutated to alanine. Unlike mature protease, which requires only oxidation of cys95 for inhibition, both cysteines of the embedded protease contributed to this inhibition. Conclusions/Significance: We developed a system that can be used to study the first step in the cascade of HIV-1 GagProPol processing and show that reversible oxidation of cysteines of HIV-1 protease embedded in GagProPol can block this initial GagProPol autoprocessing. This type of regulation may be broadly applied to the majority of retroviruses.	[Daniels, Sarah I.; Davis, David A.; Soule, Erin E.; Tebbs, Irene R.; Yarchoan, Robert] NCI, HIV & AIDS Malignancy Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Stahl, Stephen J.; Wingfield, Paul] NIAMSD, Prot Express Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Daniels, SI (corresponding author), NCI, HIV & AIDS Malignancy Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	dadavis@helix.nih.gov		Wingfield, Paul/0000-0002-9515-4752	NATIONAL CANCER INSTITUTE [ZIASC006737] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AUKRUST P, 1995, BLOOD, V86, P258, DOI 10.1182/blood.V86.1.258.bloodjournal861258; BURSTEIN H, 1991, J VIROL, V65, P6165, DOI 10.1128/JVI.65.11.6165-6172.1991; Ciriolo MR, 1997, J BIOL CHEM, V272, P2700, DOI 10.1074/jbc.272.5.2700; Coffin J, 1997, RETROVIRUSES; DARKE PL, 1994, BIOCHEMISTRY-US, V33, P98, DOI 10.1021/bi00167a013; Davis DA, 1996, BIOCHEMISTRY-US, V35, P2482, DOI 10.1021/bi951525k; Davis DA, 2003, J VIROL, V77, P3319, DOI 10.1128/JVI.77.5.3319-3325.2003; Davis DA, 1999, J VIROL, V73, P1156, DOI 10.1128/JVI.73.2.1156-1164.1999; Davis DA, 2002, METHOD ENZYMOL, V348, P249, DOI 10.1016/S0076-6879(02)48643-0; Davis DA, 1997, J BIOL CHEM, V272, P25935, DOI 10.1074/jbc.272.41.25935; Davis DA, 2000, BIOCHEM J, V346, P305, DOI 10.1042/0264-6021:3460305; Davis DA, 2006, ANTIVIR RES, V72, P89, DOI 10.1016/j.antiviral.2006.03.015; Davis DA, 2009, BIOCHEM J, V419, P497, DOI 10.1042/BJ20082068; GOTTLINGER HG, 1989, P NATL ACAD SCI USA, V86, P5781, DOI 10.1073/pnas.86.15.5781; KARACOSTAS V, 1993, VIROLOGY, V193, P661, DOI 10.1006/viro.1993.1174; Koh Y, 2007, J BIOL CHEM, V282, P28709, DOI 10.1074/jbc.M703938200; KOSOWER EM, 1969, NATURE, V224, P117, DOI 10.1038/224117a0; KRAUSSLICH HG, 1991, P NATL ACAD SCI USA, V88, P3213, DOI 10.1073/pnas.88.8.3213; KUIKEN CL, 2004, HIV SEQUENCE COMPEND; Kurata SI, 1996, J BIOL CHEM, V271, P21798, DOI 10.1074/jbc.271.36.21798; Mascolini M, 2008, ANTIVIR THER, V13, P319; Parker SD, 2001, P NATL ACAD SCI USA, V98, P14631, DOI 10.1073/pnas.251460998; PENG C, 1989, J VIROL, V63, P2550, DOI 10.1128/JVI.63.6.2550-2556.1989; PETTIT SC, 1991, J BIOL CHEM, V266, P14539; PETTIT SC, 1994, J VIROL, V68, P8017, DOI 10.1128/JVI.68.12.8017-8027.1994; Pettit SC, 2005, J VIROL, V79, P10601, DOI 10.1128/JVI.79.16.10601-10607.2005; Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004; Pettit SC, 2003, J VIROL, V77, P366, DOI 10.1128/JVI.77.1.366-374.2003; RICHARDS AD, 1990, J BIOL CHEM, V265, P7733; SAPPEY C, 1995, AIDS RES HUM RETROV, V11, P1049, DOI 10.1089/aid.1995.11.1049; SCHARF SJ, 1986, SCIENCE, V233, P1076, DOI 10.1126/science.3461561; SCHUPPE I, 1992, BIOCHEM PHARMACOL, V44, P1757, DOI 10.1016/0006-2952(92)90069-U; Turpin JA, 1996, J VIROL, V70, P6180, DOI 10.1128/JVI.70.9.6180-6189.1996; WESTENDORP MO, 1995, EMBO J, V14, P546, DOI 10.1002/j.1460-2075.1995.tb07030.x; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998	35	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13595	10.1371/journal.pone.0013595	http://dx.doi.org/10.1371/journal.pone.0013595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042582	Green Published, Green Submitted, gold			2022-12-25	WOS:000283419100021
J	Sasaki, D; Fujihashi, M; Okuyama, N; Kobayashi, Y; Noike, M; Koyama, T; Miki, K				Sasaki, Daisuke; Fujihashi, Masahiro; Okuyama, Naomi; Kobayashi, Yukiko; Noike, Motoyoshi; Koyama, Tanetoshi; Miki, Kunio			Crystal Structure of Heterodimeric Hexaprenyl Diphosphate Synthase from Micrococcus luteus B-P 26 Reveals That the Small Subunit Is Directly Involved in the Product Chain Length Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERANYLGERANYL PYROPHOSPHATE SYNTHASE; CATALYTICALLY ACTIVE COMPLEX; BACILLUS-SUBTILIS; SACCHAROMYCES-CEREVISIAE; SULFOLOBUS-SOLFATARICUS; DETERMINATION MECHANISM; ESSENTIAL COMPONENTS; STRUCTURE VALIDATION; CONSERVED ASPARTATE; ELONGATING ENZYMES	Hexaprenyl diphosphate synthase from Micrococcus luteus B-P 26 (Ml-HexPPs) is a heterooligomeric type trans-prenyltransferase catalyzing consecutive head-to-tail condensations of three molecules of isopentenyl diphosphates (C-5) on a farnesyl diphosphate (FPP; C-15) to form an (all-E) hexaprenyl diphosphate (HexPP; C-30). Ml-HexPPs is known to function as a heterodimer of two different subunits, small and large subunits called HexA and HexB, respectively. Compared with homooligomeric trans-prenyltransferases, the molecular mechanism of heterooligomeric trans-prenyltransferases is not yet clearly understood, particularly with respect to the role of the small subunits lacking the catalytic motifs conserved in most known trans-prenyltransferases. We have determined the crystal structure of Ml-HexPPs both in the substrate-free form and in complex with 7,11-dimethyl-2,6,10-dodecatrien-1-yl diphosphate ammonium salt (3-DesMe-FPP), an analog of FPP. The structure of HexB is composed of mostly antiparallel alpha-helices joined by connecting loops. Two aspartate-rich motifs (designated the first and second aspartate-rich motifs) and the other characteristic motifs in HexB are located around the diphosphate part of 3-DesMe-FPP. Despite the very low amino acid sequence identity and the distinct polypeptide chain lengths between HexA and HexB, the structure of HexA is quite similar to that of HexB. The aliphatic tail of 3-DesMe-FPP is accommodated in a large hydrophobic cleft starting from HexB and penetrating to the inside of HexA. These structural features suggest that HexB catalyzes the condensation reactions and that HexA is directly involved in the product chain length control in cooperation with HexB.	[Sasaki, Daisuke; Fujihashi, Masahiro; Okuyama, Naomi; Kobayashi, Yukiko; Miki, Kunio] Kyoto Univ, Dept Chem, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; [Noike, Motoyoshi; Koyama, Tanetoshi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Kyoto University; Tohoku University	Miki, K (corresponding author), Kyoto Univ, Dept Chem, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan.	miki@kuchem.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [B-024]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by Global Centers of Excellence program "International Center for Integrated Research and Advanced Education in Materials Science" of the Ministry of Education, Culture, Sports, Science and Technology of Japan Grant B-024.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Artz JD, 2008, CHEM BIOL, V15, P1296, DOI 10.1016/j.chembiol.2008.10.017; BLANCHARD L, 1993, GENE, V125, P185, DOI 10.1016/0378-1119(93)90326-X; Burke C, 2004, ARCH BIOCHEM BIOPHYS, V422, P52, DOI 10.1016/j.abb.2003.12.003; Burke C, 2002, J BIOL CHEM, V277, P3141, DOI 10.1074/jbc.M105900200; Burke CC, 1999, P NATL ACAD SCI USA, V96, P13062, DOI 10.1073/pnas.96.23.13062; Cao R, 2008, PROTEINS, V73, P431, DOI 10.1002/prot.22066; Chang TH, 2006, J BIOL CHEM, V281, P14991, DOI 10.1074/jbc.M512886200; Chang TH, 2010, PLANT CELL, V22, P454, DOI 10.1105/tpc.109.071738; Christianson DW, 2007, SCIENCE, V316, P60, DOI 10.1126/science.1141630; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fujihashi M, 2001, P NATL ACAD SCI USA, V98, P4337, DOI 10.1073/pnas.071514398; FUJII H, 1982, BIOCHIM BIOPHYS ACTA, V712, P716; FUJII H, 1983, FEBS LETT, V161, P257, DOI 10.1016/0014-5793(83)81020-5; FUJII H, 1982, J BIOL CHEM, V257, P4610; Fujikura K, 2008, BIOSCI BIOTECH BIOCH, V72, P851, DOI 10.1271/bbb.70723; Gabelli SB, 2006, PROTEINS, V62, P80, DOI 10.1002/prot.20754; Guo RT, 2007, P NATL ACAD SCI USA, V104, P10022, DOI 10.1073/pnas.0702254104; Guo RT, 2005, J BIOL CHEM, V280, P20762, DOI 10.1074/jbc.M502121200; Guo RT, 2004, J BIOL CHEM, V279, P4903, DOI 10.1074/jbc.M310161200; Guo RT, 2004, BIOCHEMISTRY-US, V43, P7678, DOI 10.1021/bi036336d; Hemmi H, 2003, EUR J BIOCHEM, V270, P2186, DOI 10.1046/j.1432-1033.2003.03583.x; Hemmi H, 2002, BIOCHEM BIOPH RES CO, V297, P1096, DOI 10.1016/S0006-291X(02)02348-3; Hirooka K, 2000, EUR J BIOCHEM, V267, P4520, DOI 10.1046/j.1432-1327.2000.01502.x; Hosfield DJ, 2004, J BIOL CHEM, V279, P8526, DOI 10.1074/jbc.C300511200; ITO M, 1987, BIOCHEMISTRY-US, V26, P4745, DOI 10.1021/bi00389a022; JOLY A, 1993, J BIOL CHEM, V268, P26983; Kavanagh KL, 2006, P NATL ACAD SCI USA, V103, P7829, DOI 10.1073/pnas.0601643103; Kavanagh KL, 2006, J BIOL CHEM, V281, P22004, DOI 10.1074/jbc.M602603200; Kloer DP, 2006, BIOCHEMISTRY-US, V45, P15197, DOI 10.1021/bi061572k; KOIKETAKESHITA A, 1995, J BIOL CHEM, V270, P18396, DOI 10.1074/jbc.270.31.18396; KOYAMA T, 1995, BIOCHEM BIOPH RES CO, V212, P681, DOI 10.1006/bbrc.1995.2022; Koyama T, 1996, BIOCHEMISTRY-US, V35, P9533, DOI 10.1021/bi960137v; Koyama T, 1999, BIOSCI BIOTECH BIOCH, V63, P1671, DOI 10.1271/bbb.63.1671; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Liang J, 1998, PROTEINS, V33, P18, DOI 10.1002/(SICI)1097-0134(19981001)33:1<18::AID-PROT2>3.3.CO;2-X; Liang J, 1998, PROTEINS, V33, P1; Long SB, 1998, BIOCHEMISTRY-US, V37, P9612, DOI 10.1021/bi980708e; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mao JH, 2006, J AM CHEM SOC, V128, P14485, DOI 10.1021/ja061737c; MARRERO PF, 1992, J BIOL CHEM, V267, P21873; Miyagi Y, 2007, J BIOCHEM, V142, P377, DOI 10.1093/jb/mvm144; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagaki M, 2001, BIOORG MED CHEM LETT, V11, P2157, DOI 10.1016/S0960-894X(01)00391-2; Noike M, 2008, FEBS J, V275, P3921, DOI 10.1111/j.1742-4658.2008.06538.x; Ogura K, 1998, CHEM REV, V98, P1263, DOI 10.1021/cr9600464; Ohnuma S, 1996, J BIOL CHEM, V271, P18831, DOI 10.1074/jbc.271.31.18831; Ohnuma S, 1996, J BIOL CHEM, V271, P30748, DOI 10.1074/jbc.271.48.30748; Ohnuma S, 1998, J BIOL CHEM, V273, P26705, DOI 10.1074/jbc.273.41.26705; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; Rodan Gideon A., 2002, Current Molecular Medicine (Hilversum), V2, P571, DOI 10.2174/1566524023362104; Rogers Michael J., 2003, Current Pharmaceutical Design, V9, P2643, DOI 10.2174/1381612033453640; Rondeau JM, 2006, CHEMMEDCHEM, V1, P267, DOI 10.1002/cmdc.200500059; Russell RGG, 1999, BONE, V25, P97, DOI 10.1016/S8756-3282(99)00116-7; SAGAMI H, 1992, ARCH BIOCHEM BIOPHYS, V297, P314, DOI 10.1016/0003-9861(92)90678-P; SAGAMI H, 1994, J BIOL CHEM, V269, P20561; SAGAMI H, 1981, BIOCHEM INT, V3, P669; Saiki R, 2005, FEBS J, V272, P5606, DOI 10.1111/j.1742-4658.2005.04956.x; Saiki R, 2003, EUR J BIOCHEM, V270, P4113, DOI 10.1046/j.1432-1033.2003.03804.x; Shimizu N, 1998, J BACTERIOL, V180, P1578, DOI 10.1128/JB.180.6.1578-1581.1998; SONG LS, 1994, P NATL ACAD SCI USA, V91, P3044, DOI 10.1073/pnas.91.8.3044; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Sun HY, 2005, J BACTERIOL, V187, P8137, DOI 10.1128/JB.187.23.8137-8148.2005; TAKAHASHI I, 1980, J BIOL CHEM, V255, P4539; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Tarshis LC, 1996, P NATL ACAD SCI USA, V93, P15018, DOI 10.1073/pnas.93.26.15018; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Wang K, 1999, TRENDS BIOCHEM SCI, V24, P445, DOI 10.1016/S0968-0004(99)01464-4; Wang W, 2008, J MOL BIOL, V381, P129, DOI 10.1016/j.jmb.2008.05.060; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; YOSHIDA I, 1987, BIOCHEMISTRY-US, V26, P6840, DOI 10.1021/bi00395a038; YOSHIDA I, 1989, BIOCHEM BIOPH RES CO, V160, P448, DOI 10.1016/0006-291X(89)92453-4; YOSHIDA I, 1989, BIOCHIM BIOPHYS ACTA, V995, P138, DOI 10.1016/0167-4838(89)90072-1; ZHANG DL, 1993, ANAL BIOCHEM, V213, P356, DOI 10.1006/abio.1993.1432; Zhang H, 2000, STRUCTURE, V8, P241, DOI 10.1016/S0969-2126(00)00102-7; Zhang YW, 2000, BIOCHEMISTRY-US, V39, P12717, DOI 10.1021/bi001311p; Zhang YW, 1998, BIOCHEMISTRY-US, V37, P13411, DOI 10.1021/bi972926y; Zhang YW, 1999, BIOCHEMISTRY-US, V38, P14638, DOI 10.1021/bi9913653; Zhang YW, 1997, J BACTERIOL, V179, P1417, DOI 10.1128/jb.179.4.1417-1419.1997	87	16	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3729	3740		10.1074/jbc.M110.147991	http://dx.doi.org/10.1074/jbc.M110.147991			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21068379	Green Published, hybrid			2022-12-25	WOS:000286653200055
J	Shen, XA; Ying, HY; Qiu, Y; Park, JS; Shyam, R; Chi, ZL; Iwata, T; Yue, BYJT				Shen, Xiang; Ying, Hongyu; Qiu, Ye; Park, Jeong-Seok; Shyam, Rajalekshmy; Chi, Zai-Long; Iwata, Takeshi; Yue, Beatrice Y. J. T.			Processing of Optineurin in Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; OPEN-ANGLE GLAUCOMA; AUTOPHAGY-LYSOSOME PATHWAY; NEURODEGENERATIVE DISEASES; PARKINSONS-DISEASE; TRABECULAR MESHWORK; HUNTINGTONS-DISEASE; MAMMALIAN-CELLS; ALPHA-SYNUCLEIN; PAGETS-DISEASE	Optineurin is a gene linked to amyotrophic lateral sclerosis, Paget disease of bone, and glaucoma, a major blinding disease. Mutations such as E50K were identified in glaucoma patients. We investigated herein the involvement of ubiquitin-proteasome pathway (UPP) and autophagy, two major routes for protein clearance, in processing of optineurin in a retinal ganglion cell model line RGC5 and neuronal PC12 cells. It was found that the endogenous optineurin level in neuronal cells was increased by treatment of proteasomal inhibitor but not by autophagic and lysosomal inhibitors. Multiple bands immunoreactive to anti-ubiquitin were seen in the optineurin pulldown, indicating that optineurin was ubiquitinated. In cells overexpressing wild type and E50K optineurin, the level of the proteasome regulatory beta 5 subunit (PSMB5, indicative of proteasome activity) was reduced, whereas that for autophagy marker microtubule-associated protein 1 light chain 3 was enhanced compared with controls. Autophagosome formation was detected by electron microscopy. The foci formed after optineurin transfection were increased upon treatment of an autophagic inhibitor but were decreased by treatment of an inducer, rapamycin. Moreover, the level of optineurin-triggered apoptosis was reduced by rapamycin. This study thus provides compelling evidence that in a normal homeostatic situation, the turnover of endogenous optineurin involves mainly UPP. When optineurin is up-regulated or mutated, the UPP function is compromised, and autophagy comes into play. A decreased PSMB5 level and an induced autophagy were also demonstrated in vivo in retinal ganglion cells of E50K transgenic mice, validating and making relevant the in vitro findings.	[Shen, Xiang; Ying, Hongyu; Qiu, Ye; Park, Jeong-Seok; Shyam, Rajalekshmy; Yue, Beatrice Y. J. T.] Univ Illinois, Dept Ophthalmol & Visual Sci, Coll Med, Chicago, IL 60612 USA; [Chi, Zai-Long; Iwata, Takeshi] Natl Hosp Org Tokyo Med Ctr, Natl Inst Sensory Organs, Tokyo 1528902, Japan	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yue, BYJT (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Coll Med, 1855 W Taylor St, Chicago, IL 60612 USA.	beatyue@uic.edu	Chi, Zai-Long/L-1523-2019	Shyam, Rajalekshmy/0000-0003-2154-4173	National Institutes of Health, NEI [EY018828, EY005628, EY003890]; Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology of Japan;  [EY01792]; NATIONAL EYE INSTITUTE [R01EY003890, R01EY005628, R01EY018828, P30EY001792] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY018828, EY005628, and EY003890 from NEI (to B. Y. J. T. Y.) and Core Grant EY01792. This work was also supported by Ministry of Health, Labor, and Welfare and Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. I.).	Albagha OME, 2010, NAT GENET, V42, P520, DOI 10.1038/ng.562; Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Aung T, 2005, INVEST OPHTH VIS SCI, V46, P2816, DOI 10.1167/iovs.04-1133; Bao XH, 2010, INT J MOL MED, V25, P493, DOI 10.3892/ijmm_00000369; Bence NF, 2005, METHOD ENZYMOL, V399, P481, DOI 10.1016/S0076-6879(05)99033-2; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Caballero M, 2004, BIOCHEM BIOPH RES CO, V323, P1048, DOI 10.1016/j.bbrc.2004.08.195; Cherra SJ, 2010, NEUROPATH APPL NEURO, V36, P125, DOI [10.1111/j.1365-2990.2009.01062.x, 10.1111/j.1365-2990.2010.01062.x]; Chi ZL, 2010, HUM MOL GENET, V19, P2606, DOI 10.1093/hmg/ddq146; Choi J, 2005, INVEST OPHTH VIS SCI, V46, P214, DOI 10.1167/iovs.04-0765; De Marco N, 2006, J BIOL CHEM, V281, P16147, DOI 10.1074/jbc.M601467200; Eskelinen EL, 2008, AUTOPHAGY, V4, P257, DOI 10.4161/auto.5179; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Garcia-Arencibia M, 2010, SEMIN CELL DEV BIOL, V21, P691, DOI 10.1016/j.semcdb.2010.02.008; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hauser MA, 2006, J GLAUCOMA, V15, P358, DOI 10.1097/01.ijg.0000212255.17950.42; Huang Y, 2007, EXP EYE RES, V85, P659, DOI 10.1016/j.exer.2007.07.020; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Knoferle J, 2010, P NATL ACAD SCI USA, V107, P6064, DOI 10.1073/pnas.0909794107; Koga T, 2010, AM J PATHOL, V176, P343, DOI 10.2353/ajpath.2010.090194; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Kroeber M, 2006, EXP EYE RES, V82, P1075, DOI 10.1016/j.exer.2005.11.004; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li YG, 1998, MOL CELL BIOL, V18, P1601, DOI 10.1128/MCB.18.3.1601; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Matsuda N, 2010, J ALZHEIMERS DIS, V19, P1, DOI 10.3233/JAD-2010-1231; Mayer RJ, 2003, DRUG NEWS PERSPECT, V16, P103, DOI 10.1358/dnp.2003.16.2.829327; McCray BA, 2008, NEUROSIGNALS, V16, P75, DOI 10.1159/000109761; McKinnon SJ, 2003, FRONT BIOSCI-LANDMRK, V8, pS1140, DOI 10.2741/1172; Meijer AJ, 2009, CRIT REV CL LAB SCI, V46, P210, DOI 10.1080/10408360903044068; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Normando EM, 2009, EXP EYE RES, V89, P446, DOI 10.1016/j.exer.2009.05.004; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Park BC, 2007, GENES CELLS, V12, P969, DOI 10.1111/j.1365-2443.2007.01102.x; Park BC, 2006, AM J PATHOL, V169, P1976, DOI 10.2353/ajpath.2006.060400; Park B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011547; Ralston SH, 2008, BONE, V43, P819, DOI 10.1016/j.bone.2008.06.015; Renna M, 2010, J BIOL CHEM, V285, P11061, DOI 10.1074/jbc.R109.072181; Rezaie T, 2005, GENOMICS, V85, P131, DOI 10.1016/j.ygeno.2004.10.011; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Schwamborn K, 2000, J BIOL CHEM, V275, P22780, DOI 10.1074/jbc.M001500200; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; Tezel G, 2008, PROG BRAIN RES, V173, P409, DOI 10.1016/S0079-6123(08)01128-X; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Vittitow JL, 2002, BIOCHEM BIOPH RES CO, V298, P67, DOI 10.1016/S0006-291X(02)02395-1; Wang N, 2001, NAT MED, V7, P304, DOI 10.1038/85446; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wiggs JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P30, DOI 10.1001/archopht.125.1.30; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Ying HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009168; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	67	67	70	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3618	3629		10.1074/jbc.M110.175810	http://dx.doi.org/10.1074/jbc.M110.175810			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21059646	hybrid, Green Published			2022-12-25	WOS:000286653200046
J	Torisawa, T; Nakayama, A; Furuta, K; Yamada, M; Hirotsune, S; Toyoshima, YY				Torisawa, Takayuki; Nakayama, Akiko; Furuta, Ken'ya; Yamada, Masami; Hirotsune, Shinji; Toyoshima, Yoko Y.			Functional Dissection of LIS1 and NDEL1 Towards Understanding the Molecular Mechanisms of Cytoplasmic Dynein Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL MIGRATION DEFECTS; EARLY EMBRYONIC LETHALITY; MOTILE PROPERTIES; BRAIN-TISSUE; PROTEIN; PURIFICATION; DIMERIZATION; TRANSPORT; DYNACTIN; COMPLEX	LIS1 and NDEL1 are known to be essential for the activity of cytoplasmic dynein in living cells. We previously reported that LIS1 and NDEL1 directly regulated the motility of cytoplasmic dynein in an in vitro motility assay. LIS1 suppressed dynein motility and inhibited the translocation of microtubules (MTs), while NDEL1 dissociated dynein from MTs and restored dynein motility following suppression by LIS1. However, the molecular mechanisms and detailed interactions of dynein, LIS1, and NDEL1 remain unknown. In this study, we dissected the regulatory effects of LIS1 and NDEL1 on dynein motility using full-length or truncated recombinant fragments of LIS1 or NDEL1. The C-terminal fragment of NDEL1 dissociated dynein from MTs, whereas its N-terminal fragment restored dynein motility following suppression by LIS1, demonstrating that the two functions of NDEL1 localize to different parts of the NDEL1 molecule, and that restoration from LIS1 suppression is caused by the binding of NDEL1 to LIS1, rather than to dynein. The truncated monomeric form of LIS1 had little effect on dynein motility, but an artificial dimer of truncated LIS1 suppressed dynein motility, which was restored by the N-terminal fragment of NDEL1. This suggests that LIS1 dimerization is essential for its regulatory function. These results shed light on the molecular interactions between dynein, LIS1, and NDEL1, and the mechanisms of cytoplasmic dynein regulation.	[Toyoshima, Yoko Y.] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Yamada, Masami; Hirotsune, Shinji] Osaka City Univ, Grad Sch Med, Dept Genet Dis Res, Osaka 5588585, Japan	University of Tokyo; Osaka Metropolitan University	Toyoshima, YY (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	cyytoyo@mail.ecc.u-tokyo.ac.jp						AMOS LA, 1989, J CELL SCI, V93, P19; Bingham JB, 1998, METHOD ENZYMOL, V298, P171, DOI 10.1016/S0076-6879(98)98017-X; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Derewenda U, 2007, STRUCTURE, V15, P1467, DOI 10.1016/j.str.2007.09.015; Furuta K, 2008, J BIOL CHEM, V283, P36465, DOI 10.1074/jbc.M803730200; Gerlitz G, 2005, CELL CYCLE, V4, P1632, DOI 10.4161/cc.4.11.2151; Hebbar S, 2008, J CELL BIOL, V182, P1063, DOI 10.1083/jcb.200803071; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Mateja A, 2006, J MOL BIOL, V357, P621, DOI 10.1016/j.jmb.2006.01.002; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; READ SM, 1981, ANAL BIOCHEM, V116, P53, DOI 10.1016/0003-2697(81)90321-3; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Sasaki S, 2005, MOL CELL BIOL, V25, P7812, DOI 10.1128/MCB.25.17.7812-7827.2005; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; SLOBODA RD, 1982, METHOD ENZYMOL, V85, P409; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; Toba S, 2004, CELL MOTIL CYTOSKEL, V58, P281, DOI 10.1002/cm.20018; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; Wynshaw-Boris A, 2007, CLIN GENET, V72, P296, DOI 10.1111/j.1399-0004.2007.00888.x; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182	26	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1959	1965		10.1074/jbc.M110.169847	http://dx.doi.org/10.1074/jbc.M110.169847			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21036906	Green Published, hybrid			2022-12-25	WOS:000286191500037
J	Hu, YL; Jiang, F; Guo, Y; Shen, XH; Zhang, Y; Zhang, R; Guo, G; Mao, XH; Zou, QM; Wang, DC				Hu, Yonglin; Jiang, Fan; Guo, Ying; Shen, Xihui; Zhang, Ying; Zhang, Rui; Guo, Gang; Mao, Xuhu; Zou, Quanming; Wang, Da-Cheng			Crystal Structure of HugZ, a Novel Heme Oxygenase from Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE IRON LIGAND; PROXIMAL HISTIDINE; CORYNEBACTERIUM-DIPHTHERIAE; STAPHYLOCOCCUS-AUREUS; HMU O; REPLACEMENT; REFINEMENT; COMPLEX	The crystal structure of a heme oxygenase (HO) HugZ from Helicobacter pylori complexed with heme has been solved and refined at 1.8 angstrom resolution. HugZ is part of the iron acquisition mechanism of H. pylori, a major pathogen of human gastroenteric diseases. It is required for the adaptive colonization of H. pylori in hosts. Here, we report that HugZ is distinct from all other characterized HOs. It exists as a dimer in solution and in crystals, and the dimer adopts a split-barrel fold that is often found in FMN-binding proteins but has not been observed in hemoproteins. The heme is located at the intermonomer interface and is bound by both monomers. The heme iron is coordinated by the side chain of His(245) and an azide molecule when it is present in crystallization conditions. Experiments show that Arg(166), which is involved in azide binding, is essential for HugZ enzymatic activity, whereas His(245), surprisingly, is not, implying that HugZ has an enzymatic mechanism distinct from other HOs. The placement of the azide corroborates the observed gamma-meso specificity for the heme degradation reaction, in contrast to most known HOs that have alpha-meso specificity. We demonstrate through sequence and structural comparisons that HugZ belongs to a new heme-binding protein family with a split-barrel fold. Members of this family are widespread in pathogenic bacteria and may play important roles in the iron acquisition of these bacteria.	[Guo, Ying; Zhang, Rui; Guo, Gang; Mao, Xuhu; Zou, Quanming] Third Mil Med Univ, Coll Med Lab, Dept Clin Microbiol & Immunol, Chongqing 400038, Peoples R China; [Wang, Da-Cheng] Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, Beijing 100101, Peoples R China	Army Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zou, QM (corresponding author), Third Mil Med Univ, Coll Med Lab, Dept Clin Microbiol & Immunol, Chongqing 400038, Peoples R China.	qmzou@mail.tmmu.com.cn; dcwang@ibp.ac.cn			Minister of Science and Technology of China [2006CB806502, 2006CB910901, 2006AA02A322, 2009CB522606]; National Natural Science Foundation of China [30400019]; Natural Science Foundation Project of Chongqing [CSTC 2009BB5166]	Minister of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing(Natural Science Foundation of Chongqing)	This work was supported by funding from Minister of Science and Technology of China Grants 2006CB806502, 2006CB910901, 2006AA02A322, and 2009CB522606, National Natural Science Foundation of China Grant 30400019, and Natural Science Foundation Project of Chongqing Grant CSTC 2009BB5166.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chu GC, 2000, J BIOL CHEM, V275, P17494, DOI 10.1074/jbc.M000830200; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dhaenens L, 1999, RES MICROBIOL, V150, P475, DOI 10.1016/S0923-2508(99)00109-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frankenberg-Dinkel N, 2004, ANTIOXID REDOX SIGN, V6, P825, DOI 10.1089/ars.2004.6.825; Friedman J, 2004, BIOCHEMISTRY-US, V43, P5239, DOI 10.1021/bi049687g; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; Guo Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-226; Jiang F, 2009, ACTA CRYSTALLOGR F, V65, P376, DOI 10.1107/S1744309109008094; Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200; Liu Y, 1999, BIOCHEMISTRY-US, V38, P3733, DOI 10.1021/bi982707s; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Oldham AL, 2008, CAN J MICROBIOL, V54, P97, DOI [10.1139/W07-122, 10.1139/w07-122]; OTTO BR, 1992, CRIT REV MICROBIOL, V18, P217, DOI 10.3109/10408419209114559; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ridley KA, 2006, J BACTERIOL, V188, P7862, DOI 10.1128/JB.00994-06; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Sugishima M, 2002, J BIOL CHEM, V277, P45086, DOI 10.1074/jbc.M207267200; TAKAHASHI S, 1995, J AM CHEM SOC, V117, P6002, DOI 10.1021/ja00127a013; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Unno M, 2007, NAT PROD REP, V24, P553, DOI 10.1039/b604180a; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wilks A, 2000, J BIOL CHEM, V275, P11686, DOI 10.1074/jbc.275.16.11686; WILKS A, 1995, J AM CHEM SOC, V117, P2925, DOI 10.1021/ja00115a027; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Wyckoff EE, 2004, J BACTERIOL, V186, P4142, DOI 10.1128/JB.186.13.4142-4151.2004	29	32	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1537	1544		10.1074/jbc.M110.172007	http://dx.doi.org/10.1074/jbc.M110.172007			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21030596	Green Published, hybrid			2022-12-25	WOS:000286005000066
J	Resseguie, ME; da Costa, KA; Galanko, JA; Patel, M; Davis, IJ; Zeisel, SH				Resseguie, Mary E.; da Costa, Kerry-Ann; Galanko, Joseph A.; Patel, Mukund; Davis, Ian J.; Zeisel, Steven H.			Aberrant Estrogen Regulation of PEMT Results in Choline Deficiency-associated Liver Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-METHYLTRANSFERASE GENE; NEURAL-TUBE DEFECTS; DIETARY REQUIREMENTS; CHIP-CHIP; TRANSCRIPTION; NUTRIENT; PHOSPHATIDYLCHOLINE; SUSCEPTIBILITY; POLYMORPHISM; EXPRESSION	When dietary choline is restricted, most men and postmenopausal women develop multiorgan dysfunction marked by hepatic steatosis (choline deficiency syndrome (CDS)). However, a significant subset of premenopausal women is protected from CDS. Because hepatic PEMT (phosphatidylethanolamine N-methyltransferase) catalyzes de novo biosynthesis of choline and this gene is under estrogenic control, we hypothesized that there are SNPs in PEMT that disrupt the hormonal regulation of PEMT and thereby put women at risk for CDS. In this study, we performed transcript-specific gene expression analysis, which revealed that estrogen regulates PEMT in an isoform-specific fashion. Locus-wide SNP analysis identified a risk-associated haplotype that was selectively associated with loss of hormonal activation. Chromatin immunoprecipitation, analyzed by locus-wide microarray studies, comprehensively identified regions of estrogen receptor binding in PEMT. The polymorphism (rs12325817) most highly linked with the development of CDS (p < 0.00006) was located within 1 kb of the critical estrogen response element. The risk allele failed to bind either the estrogen receptor or the pioneer factor FOXA1. These data demonstrate that allele-specific ablation of estrogen receptor-DNA interaction in the PEMT locus prevents hormone-inducible PEMT expression, conferring risk of CDS in women.	[Zeisel, Steven H.] Inst Nutr Res, Sch Publ Hlth, Kannapolis, NC 28081 USA; [Resseguie, Mary E.; da Costa, Kerry-Ann; Zeisel, Steven H.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Galanko, Joseph A.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Patel, Mukund; Davis, Ian J.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Davis, Ian J.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [Patel, Mukund; Davis, Ian J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zeisel, SH (corresponding author), Inst Nutr Res, Sch Publ Hlth, 500 Laureate Way, Kannapolis, NC 28081 USA.	steven_zeisel@unc.edu		Davis, Ian/0000-0002-1552-0960	National Institutes of Health [DK55865, AG09525, DK56350, DK 034987]; V Foundation for Cancer Research; Rita Allen Foundation; Corn-Hammond Fund for Pediatric Oncology; Mead Johnson Nutritionals; Balchem; Egg Nutrition Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350, R01DK055865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation for Cancer Research; Rita Allen Foundation; Corn-Hammond Fund for Pediatric Oncology; Mead Johnson Nutritionals; Balchem; Egg Nutrition Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK55865 and AG09525 (to S. Z.) and DK56350 (to the University of North Carolina at Chapel Hill Nutrition Obesity Research Center).; Supported by National Institutes of Health Grants DK 034987 and DK 056350.; Supported by the V Foundation for Cancer Research, the Rita Allen Foundation, and Corn-Hammond Fund for Pediatric Oncology.; Supported by Mead Johnson Nutritionals, Balchem, and the Egg Nutrition Research Center and serves on advisory boards for Dupont and Solae. To whom correspondence should be addressed: Nutrition Research Institute, 500 Laureate Way, Kannapolis, NC 28081. Fax: 704-250-5001; E-mail: steven_zeisel@unc.edu.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barkhem T, 1997, J STEROID BIOCHEM, V62, P53, DOI 10.1016/S0960-0760(97)00017-4; BREMER J, 1961, BIOCHIM BIOPHYS ACTA, V46, P205, DOI 10.1016/0006-3002(61)90745-4; Buchman AL, 2001, JPEN-PARENTER ENTER, V25, P260, DOI 10.1177/0148607101025005260; Busby MG, 2004, J AM DIET ASSOC, V104, P1836, DOI 10.1016/j.jada.2004.09.027; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; da Costa KA, 2006, FASEB J, V20, pA606; Dong H, 2007, J HEPATOL, V46, P915, DOI 10.1016/j.jhep.2006.12.012; Eeckhoute J, 2009, GENOME RES, V19, P372, DOI 10.1101/gr.084582.108; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gao H, 2008, MOL ENDOCRINOL, V22, P10, DOI 10.1210/me.2007-0121; Jensen LJ, 2007, FASEB J, V21, pA519; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Li ZY, 2005, J BIOL CHEM, V280, P37798, DOI 10.1074/jbc.M508575200; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Mattick S, 1997, J STEROID BIOCHEM, V60, P285, DOI 10.1016/S0960-0760(96)00198-7; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; MCMAHON KE, 1985, CLIN CHIM ACTA, V149, P1, DOI 10.1016/0009-8981(85)90267-0; *NAT AC SCI US I M, 1998, CHOL DIET REF INT FO, V1, P390; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Resseguie ME, 2007, FASEB J, V21, pA61; RIDGWAY ND, 1992, METHOD ENZYMOL, V209, P366; Rozen S, 2000, Methods Mol Biol, V132, P365; SAS Institute Inc, 1996, SAS STATSOFTWARE CHA; Shaw GM, 2009, EPIDEMIOLOGY, V20, P714, DOI 10.1097/EDE.0b013e3181ac9fe7; Shaw GM, 2006, EPIDEMIOLOGY, V17, P285, DOI 10.1097/01.ede.0000208348.30012.35; Shaw GM, 2004, AM J EPIDEMIOL, V160, P102, DOI 10.1093/aje/kwh187; Song JN, 2005, FASEB J, V19, P1266, DOI 10.1096/fj.04-3580com; Waite KA, 2002, J NUTR, V132, P68, DOI 10.1093/jn/132.1.68; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; ZEISEL SH, 1995, J NUTR, V125, P3049; ZEISEL SH, 1991, FASEB J, V5, P2093, DOI 10.1096/fasebj.5.7.2010061; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zheng M, 2007, BIOMETRICS, V63, P787, DOI 10.1111/j.1541-0420.2007.00768.x; Zhu XN, 2003, BIOCHEM J, V370, P987, DOI 10.1042/BJ20021523	41	67	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1649	1658		10.1074/jbc.M110.106922	http://dx.doi.org/10.1074/jbc.M110.106922			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21059658	Green Published, hybrid			2022-12-25	WOS:000286005000077
J	Walseng, E; Furuta, K; Goldszmid, RS; Weih, KA; Sher, A; Roche, PA				Walseng, Even; Furuta, Kazuyuki; Goldszmid, Romina S.; Weih, Karis A.; Sher, Alan; Roche, Paul A.			Dendritic Cell Activation Prevents MHC Class II Ubiquitination and Promotes MHC Class II Survival Regardless of the Activation Stimulus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXOPLASMA-GONDII; PLASMA-MEMBRANE; COMPLEXES; SURFACE; EXPRESSION; MATURATION; INFECTION; TRANSPORT; PARASITES; FUSION	The expression of MHC class II (MHC-II) on the surface of antigen-presenting cells, such as dendritic cells (DCs), is tightly regulated during cellular activation. Many cells, including DCs, are activated following stimulation of innate Toll-like receptors (TLRs) by products of microorganisms. In the resting (immature) state, MHC-II is ubiquitinated in immature DCs and is rapidly degraded; however, after activation of these cells with MyD88-dependent TLR ligands, MHC-II ubiquitination is blocked, and MHC-II survival is prolonged. We now show that DC activation using MyD88-dependent TLR ligands, MyD88-independent TLR ligands, and even infection with the intracellular parasite Toxoplasma gondii leads to identical changes in MHC-II expression, ubiquitination, and surface stability, revealing a conserved role for enhanced MHC-II stability after DC activation by different stimuli.	[Walseng, Even; Furuta, Kazuyuki; Weih, Karis A.; Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Goldszmid, Romina S.; Sher, Alan] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Goldszmid, Romina S.] NCI, Expt Immunol Lab, Canc & Inflammat Program, Ctr Canc Res,NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Roche, PA (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10,Rm 4B36, Bethesda, MD 20892 USA.	paul.roche@nih.gov		Roche, Paul/0000-0002-8949-9172	National Institutes of Health of NCI and NIAID; NATIONAL CANCER INSTITUTE [ZIABC009404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000579] Funding Source: NIH RePORTER	National Institutes of Health of NCI and NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Programs of NCI and NIAID.	Aliberti J, 2004, IMMUNOL REV, V201, P26, DOI 10.1111/j.0105-2896.2004.00179.x; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Hemmi Hiroaki, 2005, V86, P120, DOI 10.1159/000086657; JOINER KA, 1990, SCIENCE, V249, P641, DOI 10.1126/science.2200126; Kang HK, 2004, BIOCHEM BIOPH RES CO, V322, P899, DOI 10.1016/j.bbrc.2004.07.205; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; McGettrick AF, 2004, MOL IMMUNOL, V41, P577, DOI 10.1016/j.molimm.2004.04.006; Mordue DG, 1999, EXP PARASITOL, V92, P87, DOI 10.1006/expr.1999.4412; Mordue DG, 1999, J EXP MED, V190, P1783, DOI 10.1084/jem.190.12.1783; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Poloso NJ, 2004, J IMMUNOL, V173, P4539, DOI 10.4049/jimmunol.173.7.4539; ROCHE PA, 1993, P NATL ACAD SCI USA, V90, P8581, DOI 10.1073/pnas.90.18.8581; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Subauste CS, 2000, J IMMUNOL, V165, P1498, DOI 10.4049/jimmunol.165.3.1498; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Walseng E, 2008, J BIOL CHEM, V283, P14717, DOI 10.1074/jbc.M801070200; Walseng E, 2010, P NATL ACAD SCI USA, V107, P20465, DOI 10.1073/pnas.1010990107; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665	23	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41749	41754		10.1074/jbc.M110.157586	http://dx.doi.org/10.1074/jbc.M110.157586			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21047782	Green Published, hybrid			2022-12-25	WOS:000285622600062
J	Borrelli, S; Fanoni, D; Dolfini, D; Alotto, D; Ravo, M; Grober, OMV; Weisz, A; Castagnoli, C; Berti, E; Vigano, MA; Mantovani, R				Borrelli, Serena; Fanoni, Daniele; Dolfini, Diletta; Alotto, Daniela; Ravo, Maria; Grober, Oli Maria Victoria; Weisz, Alessandro; Castagnoli, Carlotta; Berti, Emilio; Vigano, M. Alessandra; Mantovani, Roberto			C/EBP delta Gene Targets in Human Keratinocytes	PLOS ONE			English	Article							BINDING-PROTEIN-DELTA; MAMMARY EPITHELIAL-CELLS; BREAST-CANCER; 1,25-DIHYDROXYVITAMIN D-3; TRANSCRIPTION FACTORS; SKIN TUMORIGENESIS; NETHERTON-SYNDROME; HUMAN EPIDERMIS; DEFICIENT MICE; HAIR FOLLICLE	C/EBPs are a family of B-Zip transcription factors -TFs-involved in the regulation of differentiation in several tissues. The two most studied members -C/EBP alpha and C/EBP beta- play important roles in skin homeostasis and their ablation reveals cells with stem cells signatures. Much less is known about C/EBP delta which is highly expressed in the granular layer of interfollicular epidermis and is a direct target of p63, the master regular of multilayered epithelia. We identified C/EBP delta target genes in human primary keratinocytes by ChIP on chip and profiling of cells functionally inactivated with siRNA. Categorization suggests a role in differentiation and control of cell-cycle, particularly of G2/M genes. Among positively controlled targets are numerous genes involved in barrier function. Functional inactivation of C/EBP delta as well as overexpressions of two TF targets -MafB and SOX2- affect expression of markers of keratinocyte differentiation. We performed IHC on skin tumor tissue arrays: expression of C/EBP delta is lost in Basal Cell Carcinomas, but a majority of Squamous Cell Carcinomas showed elevated levels of the protein. Our data indicate that C/EBP delta plays a role in late stages of keratinocyte differentiation.	[Borrelli, Serena; Dolfini, Diletta; Vigano, M. Alessandra; Mantovani, Roberto] Univ Milan, Dipartimento Sci Biomol & Biotecnol, Milan, Italy; [Fanoni, Daniele; Berti, Emilio] Univ Milan, IRCCS Fdn Osped Maggiore Policlin, Ist Sci Dermatol, Milan, Italy; [Alotto, Daniela; Castagnoli, Carlotta] Osped CTO, Dipartimento Chirurg Plast Banca Cute, Turin, Italy; [Ravo, Maria; Grober, Oli Maria Victoria; Weisz, Alessandro] Univ Naples 2, Dipartimento Patol Gen, Naples, Italy; [Ravo, Maria; Grober, Oli Maria Victoria; Weisz, Alessandro] Univ Naples 2, Ctr Grandi Apparecchiature, Naples, Italy; [Weisz, Alessandro] CEINGE Biotecnol Avanzate, AIRC Naples Oncogenom Ctr, Naples, Italy; [Berti, Emilio] Univ Milano Bicocca, Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; CEINGE Biotecnologie Avanzate; University of Milano-Bicocca	Borrelli, S (corresponding author), Univ Milan, Dipartimento Sci Biomol & Biotecnol, Milan, Italy.	mantor@unimi.it	DOLFINI, DILETTA/D-8286-2017; Berti, Emilio/F-5256-2012; Weisz, Alessandro/A-1317-2014	Weisz, Alessandro/0000-0003-0455-2083; vigano, maria alessandra/0000-0003-2009-0384; Berti, Emilio/0000-0001-6753-4910; Ravo, Maria/0000-0003-1003-2922; DOLFINI, DILETTA/0000-0002-5346-6096	European Union [LSHB-CT-2005-019067, LSHM-CT-2005-018652]; Fondazione CARIPLO (Cassa di Risparmio delle Provincie Lombarde) Nobel,; MIUR (Ministero dell'Universitae della Ricerca Scientifica); Associazione Italiana per la Ricerca sul Cancro	European Union; Fondazione CARIPLO (Cassa di Risparmio delle Provincie Lombarde) Nobel,; MIUR (Ministero dell'Universitae della Ricerca Scientifica); Associazione Italiana per la Ricerca sul Cancro	This work was supported by European Union Integrated Projects EPISTEM LSHB-CT-2005-019067 and CRESCENDO LSHM-CT-2005-018652, Fondazione CARIPLO (Cassa di Risparmio delle Provincie Lombarde) Nobel, MIUR (Ministero dell'Universitae della Ricerca Scientifica) PRIN; Associazione Italiana per la Ricerca sul Cancro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; BORRELLI S, 2010, CELL DEATH IN PRESS; Borrelli S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-85; Bull JJ, 2002, J INVEST DERMATOL, V118, P17, DOI 10.1046/j.0022-202x.2001.01629.x; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chikh A, 2007, BIOCHEM BIOPH RES CO, V361, P1, DOI 10.1016/j.bbrc.2007.06.069; CORDANI N, 2010, ONCOGENE IN PRESS; Dai X, 2004, CURR OPIN GENET DEV, V14, P485, DOI 10.1016/j.gde.2004.07.002; Della Gatta G, 2008, GENOME RES, V18, P939, DOI 10.1101/gr.073601.107; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Eckert RL, 2009, AMINO ACIDS, V36, P739, DOI 10.1007/s00726-008-0123-9; Ewing SJ, 2008, CELL DEATH DIFFER, V15, P1734, DOI 10.1038/cdd.2008.105; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Famulski JK, 2007, CURR BIOL, V17, P2143, DOI 10.1016/j.cub.2007.11.037; Fan ZP, 2009, NAT CELL BIOL, V11, P1002, DOI 10.1038/ncb1913; Gigliotti AP, 2003, EXP BIOL MED, V228, P278, DOI 10.1177/153537020322800306; Gosselet FP, 2007, CELL SIGNAL, V19, P731, DOI 10.1016/j.cellsig.2006.09.006; Grimm SL, 2003, J MAMMARY GLAND BIOL, V8, P191, DOI 10.1023/A:1025900908026; Hewett DR, 2005, HUM MOL GENET, V14, P335, DOI 10.1093/hmg/ddi030; Huang AM, 2004, ONCOGENE, V23, P1549, DOI 10.1038/sj.onc.1207285; Hutt JA, 2000, J BIOL CHEM, V275, P29123, DOI 10.1074/jbc.M004476200; Hutt JA, 2002, MOL CANCER THER, V1, P601; Ikezoe T, 2005, CANCER RES, V65, P4762, DOI 10.1158/0008-5472.CAN-03-3619; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Jackson B, 2005, J INVEST DERMATOL, V124, P1062, DOI 10.1111/j.0022-202X.2005.23699.x; Koizumi H, 1996, BRIT J DERMATOL, V134, P686, DOI 10.1111/j.1365-2133.1996.tb06971.x; Komatsu N, 2003, J INVEST DERMATOL, V121, P542, DOI 10.1046/j.1523-1747.2003.12363.x; Komuves LG, 2002, DEV DYNAM, V224, P58, DOI 10.1002/dvdy.10085; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Leong J, 1996, EXP CELL RES, V224, P79, DOI 10.1006/excr.1996.0113; Loomis KD, 2007, CANCER RES, V67, P6768, DOI 10.1158/0008-5472.CAN-07-0139; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Lopez RG, 2009, NAT CELL BIOL, V11, P1181, DOI 10.1038/ncb1960; Magert HJ, 2002, EUR J MED RES, V7, P49; Martin N, 2004, GENOME RES, V14, P2430, DOI 10.1101/gr.2709404; Maytin EV, 1998, J INVEST DERMATOL, V110, P238, DOI 10.1046/j.1523-1747.1998.00123.x; Motohashi H, 2004, P NATL ACAD SCI USA, V101, P6379, DOI 10.1073/pnas.0305902101; Ness SL, 1998, J BIOL CHEM, V273, P23904, DOI 10.1074/jbc.273.37.23904; Neufang G, 2001, P NATL ACAD SCI USA, V98, P7629, DOI 10.1073/pnas.121574098; Nishio H, 2001, J ANAT, V198, P581, DOI 10.1046/j.1469-7580.2001.19850581.x; Ogata A, 2004, ACTA HISTOCHEM, V106, P65, DOI 10.1016/j.acthis.2003.10.001; Oh HS, 1998, J INVEST DERMATOL, V110, P939, DOI 10.1046/j.1523-1747.1998.00199.x; Oh WJ, 2007, CANCER RES, V67, P1867, DOI 10.1158/0008-5472.CAN-06-2746; ORourke J, 1997, J BIOL CHEM, V272, P6291, DOI 10.1074/jbc.272.10.6291; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pabst T, 2009, CLIN CANCER RES, V15, P5303, DOI 10.1158/1078-0432.CCR-08-2941; Patel M, 2010, STEM CELL REV REP, V6, P367, DOI 10.1007/s12015-010-9123-8; Pozzi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005008; Pusapati RV, 2010, MOL CARCINOGEN, V49, P152, DOI 10.1002/mc.20584; Raghunath M, 1998, J INVEST DERMATOL, V111, P559, DOI 10.1046/j.1523-1747.1998.00339.x; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Romeo G, 2002, J INTERF CYTOK RES, V22, P39, DOI 10.1089/107999002753452647; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sanford DC, 2005, PROSTATE, V63, P143, DOI 10.1002/pros.20159; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Sivko GS, 2004, J CELL BIOCHEM, V93, P830, DOI 10.1002/jcb.20223; Smith C, 2004, BIOCHEM J, V380, P757, DOI 10.1042/BJ20040077; Sterneck E, 2006, ONCOGENE, V25, P1272, DOI 10.1038/sj.onc.1209144; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Strong CD, 2006, J CELL BIOL, V175, P661, DOI 10.1083/jcb.200605057; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang D, 2006, BREAST CANCER RES TR, V95, P161, DOI 10.1007/s10549-005-9061-3; Testa A, 2005, J BIOL CHEM, V280, P13606, DOI 10.1074/jbc.M414039200; Testoni B, 2006, CELL CYCLE, V5, P2805, DOI 10.4161/cc.5.23.3525; Thangaraju M, 2005, DEVELOPMENT, V132, P4675, DOI 10.1242/dev.02050; Tong YG, 2009, J MOL ENDOCRINOL, V43, P179, DOI 10.1677/JME-08-0176; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; van der Fits L, 2003, J PATHOL, V199, P107, DOI 10.1002/path.1263; Verlinden L, 2005, J BIOL CHEM, V280, P37319, DOI 10.1074/jbc.M503587200; Vigano MA, 2006, EMBO J, V25, P5105, DOI 10.1038/sj.emboj.7601375; Vogler R, 2003, J INVEST DERMATOL, V120, P693, DOI 10.1046/j.1523-1747.2003.12096.x; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wenzel J, 2008, INT J CANCER, V123, P2605, DOI 10.1002/ijc.23799; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Yang JC, 2008, BLOOD, V112, P805, DOI 10.1182/blood-2007-11-126326; Yang T, 2004, GENE DEV, V18, P2354, DOI 10.1101/gad.1232104; Yoon K, 2007, ONCOGENE, V26, P360, DOI 10.1038/sj.onc.1209797; Zhang YX, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-69; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299; Zhu SY, 1999, MOL CELL BIOL, V19, P7181	89	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13789	10.1371/journal.pone.0013789	http://dx.doi.org/10.1371/journal.pone.0013789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072181	Green Published, Green Submitted, gold			2022-12-25	WOS:000283779700006
J	Sayagues, JM; Fontanillo, C; Abad, MD; Gonzalez-Gonzalez, M; Sarasquete, ME; Chillon, MD; Garcia, E; Bengoechea, O; Fonseca, E; Gonzalez-Diaz, M; De Las Rivas, J; Munoz-Bellvis, L; Orfao, A				Maria Sayagues, Jose; Fontanillo, Celia; del Mar Abad, Maria; Gonzalez-Gonzalez, Maria; Eugenia Sarasquete, Maria; del Carmen Chillon, Maria; Garcia, Eva; Bengoechea, Oscar; Fonseca, Emilio; Gonzalez-Diaz, Marcos; De Las Rivas, Javier; Munoz-Bellvis, Luis; Orfao, Alberto			Mapping of Genetic Abnormalities of Primary Tumours from Metastatic CRC by High-Resolution SNP Arrays	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; IN-SITU HYBRIDIZATION; COPY NUMBER CHANGES; COLORECTAL-CANCER PROGRESSION; CHROMOSOME 18Q DELETION; LYMPH-NODE METASTASIS; LIVER METASTASIS; GASTRIC-CANCER; ALLELIC LOSSES; MESSENGER-RNA	Background: For years, the genetics of metastatic colorectal cancer (CRC) have been studied using a variety of techniques. However, most of the approaches employed so far have a relatively limited resolution which hampers detailed characterization of the common recurrent chromosomal breakpoints as well as the identification of small regions carrying genetic changes and the genes involved in them. Methodology/Principal Findings: Here we applied 500K SNP arrays to map the most common chromosomal lesions present at diagnosis in a series of 23 primary tumours from sporadic CRC patients who had developed liver metastasis. Overall our results confirm that the genetic profile of metastatic CRC is defined by imbalanced gains of chromosomes 7, 8q, 11q, 13q, 20q and X together with losses of the 1p, 8p, 17p and 18q chromosome regions. In addition, SNP-array studies allowed the identification of small (< 1.3 Mb) and extensive/large (> 1.5 Mb) altered DNA sequences, many of which contain cancer genes known to be involved in CRC and the metastatic process. Detailed characterization of the breakpoint regions for the altered chromosomes showed four recurrent breakpoints at chromosomes 1p12, 8p12, 17p11.2 and 20p12.1; interestingly, the most frequently observed recurrent chromosomal breakpoint was localized at 17p11.2 and systematically targeted the FAM27L gene, whose role in CRC deserves further investigations. Conclusions/Significance: In summary, in the present study we provide a detailed map of the genetic abnormalities of primary tumours from metastatic CRC patients, which confirm and extend on previous observations as regards the identification of genes potentially involved in development of CRC and the metastatic process.	[Maria Sayagues, Jose; Gonzalez-Gonzalez, Maria; Orfao, Alberto] Univ Salamanca, Dept Med, Serv Gen Citometria, E-37008 Salamanca, Spain; [Fontanillo, Celia; De Las Rivas, Javier] Univ Salamanca, Ctr Invest Canc IBMCC CSIC USAL, Grp Invest Bioinformat & Genom Func, E-37008 Salamanca, Spain; [del Mar Abad, Maria; Bengoechea, Oscar] Hosp Univ Salamanca, Dept Patol, Salamanca, Spain; [del Carmen Chillon, Maria; Gonzalez-Diaz, Marcos] Univ Hosp, Serv Hematol, Ctr Invest Canc IBMCC CSIC USAL, Salamanca, Spain; [Garcia, Eva] Univ Salamanca, Unidad Genom & Prote, Ctr Invest Canc IBMCC CSIC USAL, E-37008 Salamanca, Spain; [Fonseca, Emilio] Hosp Univ Salamanca, Med Oncol Serv, Dept Cirugia, Salamanca, Spain; [Munoz-Bellvis, Luis] Hosp Univ Salamanca, Unidad Cirugia Hepatobiliopancreat, Dept Cirugia, Salamanca, Spain	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; University of Salamanca	Sayagues, JM (corresponding author), Univ Salamanca, Dept Med, Serv Gen Citometria, E-37008 Salamanca, Spain.	orfao@usal.es	IBSAL, Secretaría/H-3719-2011; Muñoz-Bellvis, Luis/A-2245-2016; Muñoz-Bellvis, Luis/AAU-7364-2021; Orfao, Alberto/B-5801-2017; sarasquete, Maria E/U-8063-2018; Garcia-Sanz, Ramon/B-7986-2017; Chillón, M. Carmen/E-1339-2018; De Las Rivas, Javier/G-5936-2014	Muñoz-Bellvis, Luis/0000-0002-7809-5201; Muñoz-Bellvis, Luis/0000-0002-7809-5201; sarasquete, Maria E/0000-0001-7335-3657; Garcia-Sanz, Ramon/0000-0003-4120-2787; Chillón, M. Carmen/0000-0003-1624-6059; De Las Rivas, Javier/0000-0002-0984-9946; , Maria Gonzalez-Gonzalez/0000-0001-8115-1086; Gonzalez Diaz, Marcos/0000-0001-6637-1072; Fontanillo, Celia/0000-0002-3631-7881	Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain [SAN191/SA09/06, SAN673/SA39/08]; Fundacion Memoria de Don Samuel Solorzano Barruso, Salamanca, Spain; Caja de Burgos (Obra Social), Burgos, Spain; Grupo Excelencia de Castilla y Leon [GR37]; Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia e Innovacion, Madrid, Spain [RD06/0020/0035-FEDER]; ISCIII, Ministerio de Ciencia e Innovacion, Madrid, Spain [CP05/00321, FI08/00721, CA08/00212, CA/07/00077]	Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain(Junta de Castilla y Leon); Fundacion Memoria de Don Samuel Solorzano Barruso, Salamanca, Spain; Caja de Burgos (Obra Social), Burgos, Spain; Grupo Excelencia de Castilla y Leon; Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia e Innovacion, Madrid, Spain(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); ISCIII, Ministerio de Ciencia e Innovacion, Madrid, Spain(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been partially supported by grants from the Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain (SAN191/SA09/06 and SAN673/SA39/08), Fundacion Memoria de Don Samuel Solorzano Barruso, Salamanca, Spain, Caja de Burgos (Obra Social), Burgos, Spain, Grupo Excelencia de Castilla y Leon (GR37) and the RTICC from the Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia e Innovacion, Madrid, Spain (RD06/0020/0035-FEDER). JM Sayagues, M Gonzalez, ME Sarasquete and MC Chillon are supported by grants (CP05/00321, FI08/00721, CA08/00212 and CA/07/00077, respectively) from the ISCIII, Ministerio de Ciencia e Innovacion, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mulla F, 2006, J CLIN PATHOL, V59, P624, DOI 10.1136/jcp.2005.033167; Bai C, 2000, P NATL ACAD SCI USA, V97, P1230, DOI 10.1073/pnas.97.3.1230; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Buffart TE, 2005, CELL ONCOL, V27, P57; Camps J, 2008, CANCER RES, V68, P1284, DOI 10.1158/0008-5472.CAN-07-2864; Camps J, 2009, GENE CHROMOSOME CANC, V48, P1002, DOI 10.1002/gcc.20699; Carvalho B, 2009, GUT, V58, P79, DOI 10.1136/gut.2007.143065; Chen LH, 2007, CANCER BIOL THER, V6, P965, DOI 10.4161/cbt.6.6.4193; Chu D, 2009, ANN SURG ONCOL, V16, P3259, DOI 10.1245/s10434-009-0655-6; De Angelis PM, 1999, BRIT J CANCER, V80, P526; Diep CB, 2006, GENE CHROMOSOME CANC, V45, P31, DOI 10.1002/gcc.20261; Diep CB, 2003, GENE CHROMOSOME CANC, V36, P189, DOI 10.1002/gcc.10162; Fijneman RJA, 2007, CANCER LETT, V258, P223, DOI 10.1016/j.canlet.2007.09.013; Garcia J, 2003, CYTOM PART B-CLIN CY, V51B, P14, DOI 10.1002/cyto.b.10006; Gemignani F, 2004, ONCOGENE, V23, P1954, DOI 10.1038/sj.onc.1207305; Ghadimi BM, 2006, CELL ONCOL, V28, P273; Greene FL, 2007, LANCET ONCOL, V8, P572, DOI 10.1016/S1470-2045(07)70185-7; Gui XY, 2008, PEPTIDES, V29, P1609, DOI 10.1016/j.peptides.2008.04.014; Habermann JK, 2007, GENE CHROMOSOME CANC, V46, P10, DOI 10.1002/gcc.20382; Hoglund M, 2002, CANCER RES, V62, P5939; Hu XT, 2008, ONCOL REP, V19, P441; Junnila S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-73; Knutsen T, 2010, GENE CHROMOSOME CANC, V49, P204, DOI 10.1002/gcc.20730; Korn WM, 1999, GENE CHROMOSOME CANC, V25, P82, DOI 10.1002/(SICI)1098-2264(199906)25:2<82::AID-GCC2>3.0.CO;2-6; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Lehner F, 2007, FASEB J, V21, P1445, DOI 10.1096/fj.06-6575com; Macartney-Coxson DP, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-187; Sayagues JM, 2010, J PATHOL, V221, P308, DOI 10.1002/path.2712; Mild G, 2002, INT J CANCER, V102, P254, DOI 10.1002/ijc.10711; Miotto E, 2004, CANCER RES, V64, P8156, DOI 10.1158/0008-5472.CAN-04-3000; Miyoshi N, 2010, ANN SURG ONCOL, V17, P967, DOI 10.1245/s10434-009-0865-y; Ooi A, 1996, VIRCHOWS ARCH, V428, P243; OOKAWA K, 1993, INT J CANCER, V53, P382, DOI 10.1002/ijc.2910530307; Oue N, 2007, ONCOLOGY-BASEL, V72, P371, DOI 10.1159/000113147; Pang J, 2010, J PROTEOME RES, V9, P216, DOI 10.1021/pr900953s; Paredes-Zaglul A, 1998, CLIN CANCER RES, V4, P879; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; Provenzani A, 2006, CARCINOGENESIS, V27, P1323, DOI 10.1093/carcin/bgi377; Rigola MA, 2002, CANCER GENET CYTOGEN, V137, P49, DOI 10.1016/S0165-4608(02)00544-7; Sato T, 2009, ONCOL REP, V21, P211, DOI 10.3892/or_00000210; Sayagues JM, 2004, J MOL DIAGN, V6, P316, DOI 10.1016/S1525-1578(10)60527-2; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Spillman MA, 2007, GYNECOL ONCOL, V105, P312, DOI 10.1016/j.ygyno.2006.12.017; Tanaka T, 2006, BRIT J CANCER, V95, P1562, DOI 10.1038/sj.bjc.6603460; Tanaka T, 2008, J SURG ONCOL, V97, P69, DOI 10.1002/jso.20896; Tanaka T, 2009, DIAGN MOL PATHOL, V18, P219, DOI 10.1097/PDM.0b013e3181910f17; Thean LF, 2010, GENE CHROMOSOME CANC, V49, P99, DOI 10.1002/gcc.20724; Tsai MS, 2007, ANN SURG ONCOL, V14, P786, DOI 10.1245/s10434-006-9215-5; Tsuruga T, 2007, ONCOL RES, V16, P431, DOI 10.3727/000000007783980855; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Walker BA, 2006, CLIN LYMPHOMA MYELOM, V7, P186, DOI 10.3816/CLM.2006.n.057; World Health Organization, 1988, WHO INT HIST CLASS T, V1-25; World Health Organization, 1967, WHO INT HIST CLASS T, V1-25; Wu CW, 2006, CANCER LETT, V242, P95, DOI 10.1016/j.canlet.2005.10.046; Yang HY, 2004, CLIN EXP METASTAS, V21, P719, DOI 10.1007/s10585-004-8251-4; Zagon IS, 2009, AM J PHYSIOL-REG I, V297, pR1154, DOI 10.1152/ajpregu.00414.2009	58	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13752	10.1371/journal.pone.0013752	http://dx.doi.org/10.1371/journal.pone.0013752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060790	Green Published, gold			2022-12-25	WOS:000283645300031
J	Echaubard, P; Little, K; Pauli, B; Lesbarreres, D				Echaubard, Pierre; Little, Kevin; Pauli, Bruce; Lesbarreres, David			Context-Dependent Effects of Ranaviral Infection on Northern Leopard Frog Life History Traits	PLOS ONE			English	Article							IMMUNE-SYSTEM; RANA-PIPIENS; MOLECULAR CHARACTERIZATION; VIRULENCE; VIRUS; TRANSMISSION; IRIDOVIRUS; MORTALITY; POPULATION; RESISTANCE	Pathogens have important effects on host life-history traits, but the magnitude of these effects is often strongly context-dependent. The outcome of an interaction between a host and an infectious agent is often associated with the level of stress experienced by the host. Ranavirus causes disease and mortality in amphibian populations in various locations around the world, but most known cases of ranaviral infection have occurred in North America and the United Kingdom. While Ranavirus virulence has been investigated, the outcome of Ranavirus infection has seldom been related to the host environment. In a factorial experiment, we exposed Northern leopard frog (Lithobates pipiens, formerly Rana pipiens) tadpoles to different concentrations of Ranavirus and investigated the effect of host density on certain life-history traits, namely survival, growth rate, developmental stage and number of days from virus exposure to death. Our results suggest a prominent role of density in driving the direction of the interaction between L. pipiens tadpoles and Ranavirus. We showed that increasing animal holding density is detrimental for host fitness as mortality rate is higher, day of death earlier, development longer and growth rate significantly lower in high-density tanks. We observed a linear increase of detrimental effects when Ranavirus doses increased in low-density conditions, with control tadpoles having a significantly higher overall relative fitness. However, this pattern was no longer observed in high-density conditions, where the effects of increasing Ranavirus dose were limited. Infected and control animals fitness were consequently similar. We speculate that the host may eventually diverts the energy required for a metabolic/immune response triggered by the infection (i.e., direct costs of the infection) to better cope with the increase in environmental "stress" associated with high density (i.e., indirect benefits of the infection). Our results illustrate how the net fitness of organisms may be shaped by ecological context and emphasize the necessity of examining the direct/indirect costs and benefits balance to fully understand host-pathogen interactions.	[Echaubard, Pierre; Little, Kevin; Lesbarreres, David] Laurentian Univ, Dept Biol, Genet & Ecol Amphibians Res Grp, Sudbury, ON P3E 2C6, Canada; [Pauli, Bruce] Carleton Univ, Environm Canada, Sci & Technol Branch, Natl Wildlife Res Ctr, Ottawa, ON K1S 5B6, Canada	Laurentian University; Carleton University; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada	Echaubard, P (corresponding author), Laurentian Univ, Dept Biol, Genet & Ecol Amphibians Res Grp, Sudbury, ON P3E 2C6, Canada.	dlesbarreres@laurentian.ca	Echaubard, Pierre/H-3500-2019	Echaubard, Pierre/0000-0001-6213-1346; Lesbarreres, David/0000-0002-5505-1935	Natural Science and Engineering Research Council [20-61094]; Innovation/Ontario Innovation Trust [20-61679]	Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Innovation/Ontario Innovation Trust	This work was supported by the Natural Science and Engineering Research Council (grant #20-61094) and the Canadian Fund for Innovation/Ontario Innovation Trust (grant #20-61679) to DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneberg P, 1998, P ROY SOC B-BIOL SCI, V265, P1283, DOI 10.1098/rspb.1998.0431; Arneberg P, 2002, ECOGRAPHY, V25, P88, DOI 10.1034/j.1600-0587.2002.250110.x; Bedhomme S, 2005, ECOL ENTOMOL, V30, P1, DOI 10.1111/j.0307-6946.2005.00665.x; Bensadia F, 2006, J INSECT PHYSIOL, V52, P146, DOI 10.1016/j.jinsphys.2005.09.011; Bollinger TK, 1999, J WILDLIFE DIS, V35, P413, DOI 10.7589/0090-3558-35.3.413; Brown MJF, 2000, OIKOS, V91, P421, DOI 10.1034/j.1600-0706.2000.910302.x; Brunner JL, 2007, DIS AQUAT ORGAN, V77, P87, DOI 10.3354/dao01845; Brunner JL, 2005, OECOLOGIA, V144, P399, DOI 10.1007/s00442-005-0093-5; Burgett AA, 2007, HERPETOL CONSERV BIO, V2, P29; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; Chinchar VG, 2002, ARCH VIROL, V147, P447, DOI 10.1007/s007050200000; Christin MS, 2003, ENVIRON TOXICOL CHEM, V22, P1127, DOI [10.1897/1551-5028(2003)022&lt;1127:EOAPOT&gt;2.0.CO;2, 10.1002/etc.5620220522]; Coors A, 2008, OIKOS, V117, P1840, DOI 10.1111/j.1600-0706.2008.17028.x; Cunningham AA, 1996, PHILOS T ROY SOC B, V351, P1539, DOI 10.1098/rstb.1996.0140; CUNNINGHAM AA, 2001, THESIS U LONDON LOND; CUNNINGHAM AA, 1998, CONSERV BIOL, V12, P1428; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; DASZAK P, 1999, TRENDS ECOL EVOL, V14, P5347; Docherty DE, 2003, J WILDLIFE DIS, V39, P556, DOI 10.7589/0090-3558-39.3.556; DRURY SEN, 1995, VET REC, V137, P72, DOI 10.1136/vr.137.3.72; Duffus ALJ, 2008, J WILDLIFE DIS, V44, P109, DOI 10.7589/0090-3558-44.1.109; DUPASQUIER L, 1989, ANNU REV IMMUNOL, V7, P251, DOI 10.1146/annurev.immunol.7.1.251; Flajnik MF, 1996, VET IMMUNOL IMMUNOP, V54, P145, DOI 10.1016/S0165-2427(96)05685-1; Gantress J, 2003, VIROLOGY, V311, P254, DOI 10.1016/S0042-6822(03)00151-X; Gosner K. L., 1960, Herpetologica, V16, P183; GRANOFF A, 1965, ANN NY ACAD SCI, V126, P237, DOI 10.1111/j.1749-6632.1965.tb14278.x; Greer AL, 2005, DIS AQUAT ORGAN, V67, P9, DOI 10.3354/dao067009; Guay JF, 2009, J INSECT PHYSIOL, V55, P919, DOI 10.1016/j.jinsphys.2009.06.006; Harp EM, 2006, J WILDLIFE DIS, V42, P307, DOI 10.7589/0090-3558-42.2.307; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hyatt AD, 2002, J WILDLIFE DIS, V38, P239, DOI 10.7589/0090-3558-38.2.239; Jancovich JK, 1997, DIS AQUAT ORGAN, V31, P161, DOI 10.3354/dao031161; Jancovich JK, 2001, DIS AQUAT ORGAN, V46, P159, DOI 10.3354/dao046159; Jofre MB, 1999, ENVIRON TOXICOL CHEM, V18, P1806, DOI 10.1002/etc.5620180829; Joshi A, 1996, EVOL ECOL, V10, P463, DOI 10.1007/BF01237879; KHAN RA, 1990, B ENVIRON CONTAM TOX, V44, P759, DOI 10.1007/BF01701799; Kiesecker JM, 2001, ECOLOGY, V82, P1956, DOI 10.1890/0012-9658(2001)082[1956:EODAPD]2.0.CO;2; Koprivnikar J, 2006, CAN J ZOOL, V84, P1623, DOI 10.1139/Z06-158; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Lafferty Kevin D., 2005, P113; Lebarbenchon C, 2008, MOL ECOL, V17, P475, DOI 10.1111/j.1365-294X.2007.03375.x; Lipsitch M, 1996, EVOLUTION, V50, P1729, DOI [10.2307/2410731, 10.1111/j.1558-5646.1996.tb03560.x]; Loreau Michel, 2005, P13; Mao JH, 1997, VIROLOGY, V229, P212, DOI 10.1006/viro.1996.8435; MICHALAKIS Y, 2007, ECOLOGY EVOLUTION PA, P19; Mussmann R, 1998, EUR J IMMUNOL, V28, P2947, DOI 10.1002/(SICI)1521-4141(199809)28:09<2947::AID-IMMU2947>3.0.CO;2-A; Pagan I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000531; Pearman PB, 2004, J WILDLIFE DIS, V40, P660, DOI 10.7589/0090-3558-40.4.660; Poulin R, 1999, PARASITOL TODAY, V15, P474, DOI 10.1016/S0169-4758(99)01554-9; Poulin R., 2007, EVOLUTIONARY ECOLOGY, DOI [10.1515/9781400840809, DOI 10.1515/9781400840809]; RENSHAW M, 1993, ECOL ENTOMOL, V18, P223, DOI 10.1111/j.1365-2311.1993.tb01094.x; Robert J, 2009, DEV DYNAM, V238, P1249, DOI 10.1002/dvdy.21891; Schmid-Hempel P, 2009, PHILOS T R SOC B, V364, P85, DOI 10.1098/rstb.2008.0157; Schock DM, 2008, COPEIA, P133, DOI 10.1643/CP-06-134; Seppala O, 2008, OIKOS, V117, P749, DOI 10.1111/j.0030-1299.2008.16396.x; Sokal R.R., 1995, BIOMETRY PRINCIPLES, Vthird; St-Amour V, 2008, EMERG INFECT DIS, V14, P1175, DOI 10.3201/eid1407.070602; STAMOUR V, 2007, CONSERV GENET, V3, P1247; Su M, 2009, ECOL RES, V24, P889, DOI 10.1007/s11284-008-0568-z; TEACHER AG, 2010, ANIMAL CONSERVATION, P1; WAKELIN D, 1989, PARASITOLOGY, V99, pS21, DOI 10.1017/S0031182000083396; Werner J. Kirwin, 2003, Northwestern Naturalist, V84, P24, DOI 10.2307/3536719; Wilson GA, 2008, CAN J ZOOL, V86, P863, DOI 10.1139/Z08-062; WRIGHT PA, 1995, J EXP BIOL, V198, P273; Yang EV, 2002, INT IMMUNOPHARMACOL, V2, P315, DOI 10.1016/S1567-5769(01)00182-5	65	21	22	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13723	10.1371/journal.pone.0013723	http://dx.doi.org/10.1371/journal.pone.0013723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060894	Green Submitted, Green Published, gold			2022-12-25	WOS:000283573800018
J	Harrer, A; Lang, R; Grims, R; Braitsch, M; Hawranek, T; Aberer, W; Vogel, L; Schmid, W; Ferreira, F; Himly, M				Harrer, Andrea; Lang, Roland; Grims, Robert; Braitsch, Michaela; Hawranek, Thomas; Aberer, Werner; Vogel, Lothar; Schmid, Walther; Ferreira, Fatima; Himly, Martin			Diclofenac Hypersensitivity: Antibody Responses to the Parent Drug and Relevant Metabolites	PLOS ONE			English	Article							ACYL GLUCURONIDES; IMMUNOGLOBULIN-E; DIAGNOSIS; STANDARDIZATION; BIOACTIVATION; ASPIRIN; BINDING; ROLES	Background: Hypersensitivity reactions against nonsteroidal antiinflammatory drugs (NSAIDs) like diclofenac (DF) can manifest as Type I-like allergic reactions including systemic anaphylaxis. However, except for isolated case studies experimental evidence for an IgE-mediated pathomechanism of DF hypersensitivity is lacking. In this study we aimed to investigate the possible involvement of drug-and/or metabolite-specific antibodies in selective DF hypersensitivity. Methodology/Principal Findings: DF, an organochemically synthesized linkage variant, and five major Phase I metabolites were covalently coupled to carrier proteins. Drug conjugates were analyzed for coupling degree and capacity to crosslink receptor-bound IgE antibodies from drug-sensitized mice. With these conjugates, the presence of hapten-specific IgE antibodies was investigated in patients' samples by ELISA, mediator release assay, and basophil activation test. Production of sulfidoleukotrienes by drug conjugates was determined in PBMCs from DF-hypersensitive patients. All conjugates were shown to carry more than two haptens per carrier molecule. Immunization of mice with drug conjugates induced drug-specific IgE antibodies capable of triggering mediator release. Therefore, the conjugates are suitable tools for detection of drug-specific antibodies and for determination of their anaphylactic activity. Fifty-nine patients were enrolled and categorized as hypersensitive either selectively to DF or to multiple NSAIDs. In none of the patients' samples evidence for drug/metabolite-specific IgE in serum or bound to allergic effector cells was found. In contrast, a small group of patients (8/59, 14%) displayed drug/metabolite-specific IgG. Conclusions/Significance: We found no evidence for an IgE-mediated effector mechanism based on haptenation of protein carriers in DF-hypersensitive patients. Furthermore, a potential involvement of the most relevant metabolites in DF hypersensitivity reactions could be excluded.	[Harrer, Andrea; Ferreira, Fatima; Himly, Martin] Salzburg Univ, Div Allergy & Immunol, Dept Mol Biol, A-5020 Salzburg, Austria; [Lang, Roland; Hawranek, Thomas] Paracelsus Med Univ Salzburg, Dept Dermatol, Salzburg, Austria; [Grims, Robert; Aberer, Werner] Med Univ Graz, Dept Dermatol, Graz, Austria; [Braitsch, Michaela; Schmid, Walther] Univ Vienna, Inst Organ Chem, A-1090 Vienna, Austria; [Vogel, Lothar] Paul Ehrlich Inst, Div Allergol, D-6070 Langen, Germany	Salzburg University; Paracelsus Private Medical University; Medical University of Graz; University of Vienna; Paul Ehrlich Institute	Harrer, A (corresponding author), Salzburg Univ, Div Allergy & Immunol, Dept Mol Biol, A-5020 Salzburg, Austria.	martin.himly@sbg.ac.at	Ferreira, Fatima/E-4889-2011; Ferreira, Fatima/AAB-4321-2019; Himly, Martin/D-1568-2015	Ferreira, Fatima/0000-0003-0989-2335; Ferreira, Fatima/0000-0003-0989-2335; Harrer, Andrea/0000-0001-7717-6125; Himly, Martin/0000-0001-5416-085X	Austrian Science Fund (FWF) [P18820-B13]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported financially by grant P18820-B13 of the Austrian Science Fund (FWF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberer W, 2003, ALLERGY, V58, P854, DOI 10.1034/j.1398-9995.2003.00279.x; ASERO R, 2010, 4 HYP M ROM IT APR 2; Bircher Andreas J., 2007, P352, DOI 10.1159/000104212; Bluth MH, 2007, ANN CLIN LAB SCI, V37, P362; BORT R, BIOCH PHARM, V58, P787; Bougie D, 1997, BLOOD, V90, P407; de Weck AL, 2006, CURR PHARM DESIGN, V12, P3347, DOI 10.2174/138161206778193971; DING A, 1993, P NATL ACAD SCI USA, V90, P3797, DOI 10.1073/pnas.90.9.3797; GUZMAN M, 2005, ALLERGY CLIN IMMUN S, V1, P151; Hartl A, 2004, METHODS, V32, P328, DOI 10.1016/j.ymeth.2003.08.014; Himly M, 2003, J ALLERGY CLIN IMMUN, V111, P882, DOI 10.1067/mai.2003.163; Himly M, 2009, ALLERGY, V64, P1038, DOI 10.1111/j.1398-9995.2009.01957.x; Karasuyama H, 2009, NAT REV IMMUNOL, V9, P9, DOI 10.1038/nri2458; Kaul S, 2007, CLIN EXP ALLERGY, V37, P141, DOI 10.1111/j.1365-2222.2006.02618.x; Kenny JR, 2004, J MED CHEM, V47, P2816, DOI 10.1021/jm030891w; Kvedariene V, 2006, ALLERGY, V61, P311, DOI 10.1111/j.1398-9995.2006.00978.x; MULDER GJ, 1992, ANNU REV PHARMACOL, V32, P25; Naisbitt DJ, 2007, TOXICOL LETT, V168, P45, DOI 10.1016/j.toxlet.2006.10.014; PUMFORD NR, 1993, CHEM RES TOXICOL, V6, P147, DOI 10.1021/tx00032a002; Riemer AB, 2010, CLIN EXP ALLERGY, V40, P486, DOI 10.1111/j.1365-2222.2009.03363.x; RING J, 1977, LANCET, V1, P466; Roberts L.J., 2001, GOODMAN GILMANS PHAR, V10th, P687; Salama A, 1996, BRIT J HAEMATOL, V95, P640, DOI 10.1046/j.1365-2141.1996.d01-1947.x; Sirichaiwat C, 2004, J MED CHEM, V47, P345, DOI 10.1021/jm0303352; SPAHNLANGGUTH H, 1992, DRUG METAB REV, V24, P5; Szczeklik A, 2003, J ALLERGY CLIN IMMUN, V111, P913, DOI 10.1067/mai.2003.1487; Tang W, 2003, CURR DRUG METAB, V4, P319, DOI 10.2174/1389200033489398; Tang W, 1999, DRUG METAB DISPOS, V27, P365; Tang W, 1999, CHEM RES TOXICOL, V12, P192, DOI 10.1021/tx9802217; Tojo G, 2006, BASIC REACT ORG SYNT, P1; Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; WILKINSON GR, 2001, GOODMAN GILMANS PHAR, P3; Yan ZY, 2005, DRUG METAB DISPOS, V33, P706, DOI 10.1124/dmd.104.003095; ZIAAMIRHOSSEINI P, 1995, NAT MED, V1, P2, DOI 10.1038/nm0195-2b	35	50	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13707	10.1371/journal.pone.0013707	http://dx.doi.org/10.1371/journal.pone.0013707			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060839	Green Published, gold			2022-12-25	WOS:000283573800008
J	Coler, RN; Baldwin, SL; Shaverdian, N; Bertholet, S; Reed, SJ; Raman, VS; Lu, XH; DeVos, J; Hancock, K; Katz, JM; Vedvick, TS; Duthie, MS; Clegg, CH; Van Hoeven, N; Reed, SG				Coler, Rhea N.; Baldwin, Susan L.; Shaverdian, Narek; Bertholet, Sylvie; Reed, Steven J.; Raman, Vanitha S.; Lu, Xiuhua; DeVos, Joshua; Hancock, Kathy; Katz, Jacqueline M.; Vedvick, Thomas S.; Duthie, Malcolm S.; Clegg, Christopher H.; Van Hoeven, Neal; Reed, Steven G.			A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines	PLOS ONE			English	Article							T-CELL RESPONSES; IN-VIVO; ANTIBODY; AGE; VACCINATION; INFECTION; EMULSION; ADULTS; TRIAL; MICE	Safe, effective adjuvants that enhance vaccine potency, including induction of neutralizing Abs against a broad range of variant strains, is an important strategy for the development of seasonal influenza vaccines which can provide optimal protection, even during seasons when available vaccines are not well matched to circulating viruses. We investigated the safety and ability of Glucopyranosyl Lipid Adjuvant-Stable Emulsion (GLA-SE), a synthetic Toll-like receptor (TLR) 4 agonist formulation, to adjuvant Fluzone(R) in mice and non-human primates. The GLA-SE adjuvanted Fluzone vaccine caused no adverse reactions, increased the induction of T helper type 1 (TH1)-biased cytokines such as IFN gamma, TNF and IL-2, and broadened serological responses against drifted A/H1N1 and A/H3N2 influenza variants. These results suggest that synthetic TLR4 adjuvants can enhance the magnitude and quality of protective immunity induced by influenza vaccines.	[Coler, Rhea N.; Baldwin, Susan L.; Shaverdian, Narek; Bertholet, Sylvie; Reed, Steven J.; Raman, Vanitha S.; Vedvick, Thomas S.; Duthie, Malcolm S.; Reed, Steven G.] Infect Dis Res Inst, Seattle, WA USA; [Lu, Xiuhua; DeVos, Joshua; Hancock, Kathy; Katz, Jacqueline M.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Clegg, Christopher H.; Van Hoeven, Neal; Reed, Steven G.] Immune Design Corp, Seattle, WA USA	Centers for Disease Control & Prevention - USA	Coler, RN (corresponding author), Infect Dis Res Inst, Seattle, WA USA.	sreed@idri.org		Shaverdian, Narek/0000-0002-0294-8749; Duthie, Malcolm/0000-0002-8515-5516; Reed, Jim/0000-0002-3348-123X	National Institutes of Health [AI-044373, AI-25479]; Bill and Melinda Gates Foundation [42387]; Immune Design Corporation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Immune Design Corporation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grant AI-044373 and contract AI-25479, by grant 42387 from the Bill and Melinda Gates Foundation, and by Immune Design Corporation. Immune Design Corporation had a role in study design and data collection and review of the manuscript.	Alderson MR, 2006, J ENDOTOXIN RES, V12, P313, DOI 10.1179/096805106X118753; Anderson RC, 2010, COLLOID SURFACE B, V75, P123, DOI 10.1016/j.colsurfb.2009.08.022; Baldwin SL, 2009, VACCINE, V27, P5956, DOI 10.1016/j.vaccine.2009.07.081; Baldwin SL, 2009, VACCINE, V27, P3063, DOI 10.1016/j.vaccine.2009.03.018; Banzhoff A, 2003, GERONTOLOGY, V49, P177, DOI 10.1159/000069172; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Baudner BC, 2009, PHARM RES-DORDR, V26, P1477, DOI 10.1007/s11095-009-9859-5; Baumgarth N, 1996, J VIROL, V70, P4411, DOI 10.1128/JVI.70.7.4411-4418.1996; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Brown DM, 2004, SEMIN IMMUNOL, V16, P171, DOI 10.1016/j.smim.2004.02.004; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; de Jong J C, 2003, Dev Biol (Basel), V115, P63; de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;94::AID-JMV15&gt;3.0.CO;2-C; Deng YP, 2004, J IMMUNOL, V172, P3437, DOI 10.4049/jimmunol.172.6.3437; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Draize, 1959, APPRAISAL SAFETY CHE; Katz JM, 2009, POULTRY SCI, V88, P872, DOI 10.3382/ps.2008-00465; KENDAL AP, 1982, CONCEPTS PROCEDURES, pB17; Lu XH, 2002, VACCINE, V20, P1019, DOI 10.1016/S0264-410X(01)00452-2; Mbawuike IN, 1996, CELL IMMUNOL, V173, P64, DOI 10.1006/cimm.1996.0252; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Singh M, 1998, VACCINE, V16, P1822, DOI 10.1016/S0264-410X(98)00179-0; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Stoute JA, 2006, AM J TROP MED HYG, V75, P166, DOI 10.4269/ajtmh.2006.75.166; Vogel FR, 2009, EXPERT REV VACCINES, V8, P483, DOI [10.1586/erv.09.5, 10.1586/ERV.09.5]; Wack A, 2008, VACCINE, V26, P552, DOI 10.1016/j.vaccine.2007.11.054; Weksler ME, 2000, J CLIN IMMUNOL, V20, P240, DOI 10.1023/A:1006659401385; *WHO, 2009, 211 WHO; WONG GHW, 1986, NATURE, V323, P819, DOI 10.1038/323819a0	31	112	125	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13677	10.1371/journal.pone.0013677	http://dx.doi.org/10.1371/journal.pone.0013677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060869	Green Submitted, gold, Green Published			2022-12-25	WOS:000283537000043
J	Pirih, FQ; Michalski, MN; Cho, SW; Koh, AJ; Berry, JE; Ghaname, E; Kamarajan, P; Bonnelye, E; Ross, CW; Kapila, YL; Jurdic, P; McCauley, LK				Pirih, Flavia Q.; Michalski, Megan N.; Cho, Sun W.; Koh, Amy J.; Berry, Janice E.; Ghaname, Eduardo; Kamarajan, Pachiyappan; Bonnelye, Edith; Ross, Charles W.; Kapila, Yvonne L.; Jurdic, Pierre; McCauley, Laurie K.			Parathyroid Hormone Mediates Hematopoietic Cell Expansion through Interleukin-6	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; COLONY-STIMULATING FACTOR; BONE-MARROW; FLT3 LIGAND; STEM-CELLS; IN-VIVO; PROGENITOR CELLS; ANABOLIC ACTIONS; STROMAL CELLS; MICE	Parathyroid hormone (PTH) stimulates hematopoietic cells through mechanisms of action that remain elusive. Interleukin-6 (IL-6) is upregulated by PTH and stimulates hematopoiesis. The purpose of this investigation was to identify actions of PTH and IL-6 in hematopoietic cell expansion. Bone marrow cultures from C57B6 mice were treated with fms-like tyrosine kinase-3 ligand (Flt-3L), PTH, Flt-3L plus PTH, or vehicle control. Flt-3L alone increased adherent and non-adherent cells. PTH did not directly impact hematopoietic or osteoclastic cells but acted in concert with Flt-3L to further increase cell numbers. Flt-3L alone stimulated proliferation, while PTH combined with Flt-3L decreased apoptosis. Flt-3L increased blasts early in culture, and later increased CD45(+) and CD11b(+) cells. In parallel experiments, IL-6 acted additively with Flt-3L to increase cell numbers and IL-6-deficient bone marrow cultures (compared to wildtype controls) but failed to amplify in response to Flt-3L and PTH, suggesting that IL-6 mediated the PTH effect. In vivo, PTH increased Lin(-)Sca-1(+)c-Kit(+) (LSK) hematopoietic progenitor cells after PTH treatment in wildtype mice, but failed to increase LSKs in IL-6-deficient mice. In conclusion, PTH acts with Flt-3L to maintain hematopoietic cells by limiting apoptosis. IL-6 is a critical mediator of bone marrow cell expansion and is responsible for PTH actions in hematopoietic cell expansion.	[Pirih, Flavia Q.; Michalski, Megan N.; Cho, Sun W.; Koh, Amy J.; Berry, Janice E.; Ghaname, Eduardo; Kamarajan, Pachiyappan; Kapila, Yvonne L.; McCauley, Laurie K.] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA; [Jurdic, Pierre] Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, INRA,Ecole Normale Super Lyon, F-69365 Lyon, France; [Ross, Charles W.; McCauley, Laurie K.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Bonnelye, Edith] Fac Med RTH Laennec, Lyon, France	University of Michigan System; University of Michigan; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); University of Michigan System; University of Michigan	Pirih, FQ (corresponding author), Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA.	mccauley@umich.edu	McCauley, Laurie/G-4041-2012; Bonnelye, Edith/AAT-9134-2021; Kapila, Yvonne/AAG-5418-2021		National Institutes of Health (NIH) [DK53904, T-90 DK70071-03]; American Academy of Periodontology Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T90DK070071, R01DK053904] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Academy of Periodontology Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) DK53904 (L. K. M.), NIH Institutional grant T-90 DK70071-03 (F. Q. P.) and the American Academy of Periodontology Foundation (F. Q. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Ballen KK, 2007, BIOL BLOOD MARROW TR, V13, P838, DOI 10.1016/j.bbmt.2007.03.007; BERNAD A, 1994, IMMUNITY, V1, P725, DOI 10.1016/S1074-7613(94)80014-6; Blaskovich MA, 2003, CANCER RES, V63, P1270; Brasel K, 1996, BLOOD, V88, P2004, DOI 10.1182/blood.V88.6.2004.bloodjournal8862004; Brunner S, 2007, AM J PHYSIOL-ENDOC M, V293, pE1670, DOI 10.1152/ajpendo.00287.2007; Bryden AAG, 2002, BRIT J CANCER, V86, P322, DOI 10.1038/sj/bjc/6600115; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232; Chauhan D, 1997, BLOOD, V89, P227, DOI 10.1182/blood.V89.1.227.227_227_234; Chen HL, 2002, J BIOL CHEM, V277, P19374, DOI 10.1074/jbc.M108913200; Demiralp B, 2002, ENDOCRINOLOGY, V143, P4038, DOI 10.1210/en.2002-220221; Dempster DW, 2005, J CELL BIOCHEM, V95, P139, DOI 10.1002/jcb.20388; Drexler HG, 2004, GROWTH FACTORS, V22, P71, DOI 10.1080/08977190410001700989; Erices A, 2002, EXP CELL RES, V280, P24, DOI 10.1006/excr.2002.5627; Gay CV, 2003, J CELL BIOCHEM, V89, P902, DOI 10.1002/jcb.10579; GAY CV, 1991, CALCIFIED TISSUE INT, V49, P153, DOI 10.1007/BF02556108; GREENFIELD EM, 1993, J BONE MINER RES, V8, P1163; HIRAYAMA F, 1995, BLOOD, V85, P1762, DOI 10.1182/blood.V85.7.1762.bloodjournal8571762; Hory BG, 2000, J ENDOCRINOL INVEST, V23, P273, DOI 10.1007/BF03343723; IKEBUCHI K, 1987, P NATL ACAD SCI USA, V84, P9035, DOI 10.1073/pnas.84.24.9035; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jung YG, 2008, STEM CELLS, V26, P2042, DOI 10.1634/stemcells.2008-0149; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; KAWANO MM, 1995, BLOOD, V85, P487; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; Koh AJ, 2005, ENDOCRINOLOGY, V146, P4584, DOI 10.1210/en.2005-0333; Komarova SV, 2005, ENDOCRINOLOGY, V146, P3589, DOI 10.1210/en.2004-1642; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Lean JM, 2001, BLOOD, V98, P2707, DOI 10.1182/blood.V98.9.2707; Lee SK, 1999, ENDOCRINOLOGY, V140, P3552, DOI 10.1210/en.140.8.3552; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCCAULEY LK, 1992, ENDOCRINOLOGY, V130, P300, DOI 10.1210/en.130.1.300; MICHALEVICZ R, 1989, SCANNING MICROSCOPY, V3, P1143; O'Brien CA, 2005, AM J PHYSIOL-ENDOC M, V289, pE784, DOI 10.1152/ajpendo.00029.2005; Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353; Peters M, 2001, EXP HEMATOL, V29, P146, DOI 10.1016/S0301-472X(00)00650-0; Pettway GJ, 2008, BONE, V42, P806, DOI 10.1016/j.bone.2007.11.017; Philbrick WM, 1998, P NATL ACAD SCI USA, V95, P11846, DOI 10.1073/pnas.95.20.11846; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; POLI V, 1994, EMBO J, V13, P1189, DOI 10.1002/j.1460-2075.1994.tb06368.x; Rodriguez MDC, 2004, BLOOD, V103, P3349, DOI 10.1182/blood-2003-10-3438; Rusten LS, 1996, BLOOD, V87, P1317, DOI 10.1182/blood.V87.4.1317.bloodjournal8741317; Saltel F, 2006, J BONE MINER RES, V21, P1913, DOI 10.1359/JBMR.060821; Schirmacher P, 1998, AM J PATHOL, V153, P639, DOI 10.1016/S0002-9440(10)65605-2; Servet-Delprat Christine, 2002, BMC Immunol, V3, P15, DOI 10.1186/1471-2172-3-15; Shibutani T, 2000, J BIOMED MATER RES, V50, P153, DOI 10.1002/(SICI)1097-4636(200005)50:2<153::AID-JBM9>3.0.CO;2-R; TAICHMAN RS, 1994, J EXP MED, V179, P1677, DOI 10.1084/jem.179.5.1677; Terauchi M, 2009, CELL METAB, V10, P229, DOI 10.1016/j.cmet.2009.07.010; Way KJ, 2009, J LEUKOCYTE BIOL, V85, P766, DOI 10.1189/jlb.1108689; Wysolmerski JJ, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P713, DOI 10.1016/B978-0-12-373884-4.00051-3; Zaruba MM, 2008, CARDIOVASC RES, V77, P722, DOI 10.1093/cvr/cvm080	52	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13657	10.1371/journal.pone.0013657	http://dx.doi.org/10.1371/journal.pone.0013657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048959	gold, Green Published, Green Submitted			2022-12-25	WOS:000283537000028
J	Wyatt, ASJ; Waite, AM; Humphries, S				Wyatt, Alex S. J.; Waite, Anya M.; Humphries, Stuart			Variability in Isotope Discrimination Factors in Coral Reef Fishes: Implications for Diet and Food Web Reconstruction	PLOS ONE			English	Article							TROPHIC-STEP FRACTIONATION; STABLE-ISOTOPES; LIPID EXTRACTION; GUT-CONTENT; BODY-SIZE; CARBON; NITROGEN; DELTA-N-15; DELTA-C-13; TISSUES	Interpretation of stable isotope ratios of carbon and nitrogen (delta C-13 and delta N-15) is generally based on the assumption that with each trophic level there is a constant enrichment in the heavier isotope, leading to diet-tissue discrimination factors of 3.4% for N-15 (Delta N) and similar to 0.5 parts per thousand for C-13 (Delta C). Diet-tissue discrimination factors determined from paired tissue and gut samples taken from 152 individuals from 26 fish species at Ningaloo Reef, Western Australia demonstrate a large amount of variability around constant values. While caution is necessary in using gut contents to represent diet due to the potential for high temporal variability, there were significant effects of trophic position and season that may also lead to variability in Delta N under natural conditions. Nitrogen enrichment increased significantly at higher trophic levels (higher tissue delta N-15), with significantly higher Delta N in carnivorous species. Changes in diet led to significant changes in Delta N, but not tissue delta N-15, between seasons for several species: Acanthurus triostegus, Chromis viridis, Parupeneus signatus and Pomacentrus moluccensis. These results confirm that the use of meta-analysis averages for Delta N is likely to be inappropriate for accurately determining diets and trophic relationships using tissue stable isotope ratios. Where feasible, discrimination factors should be directly quantified for each species and trophic link in question, acknowledging the potential for significant variation away from meta-analysis averages and, perhaps, controlled laboratory diets and conditions.	[Wyatt, Alex S. J.; Waite, Anya M.] Univ Western Australia, Oceans Inst, Crawley, Australia; [Wyatt, Alex S. J.; Waite, Anya M.] Univ Western Australia, Sch Environm Syst Engn, Crawley, Australia; [Humphries, Stuart] Univ Hull, Dept Biol Sci, Kingston Upon Hull, Yorks, England	University of Western Australia; University of Western Australia; University of Hull	Wyatt, ASJ (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	awyatt@graduate.uwa.edu.au	Waite, Anya M/A-5492-2015; Wyatt, Alex S.J./A-9402-2008; Humphries, Stuart/A-5664-2008	Waite, Anya M/0000-0003-2965-0296; Wyatt, Alex S.J./0000-0002-1339-9546; Humphries, Stuart/0000-0001-9766-6404	Natural Environment Research Council; British Ecological Society; University of Western Australia; Faculty of Engineering, Computing and Mathematical Sciences; Western Australian Marine Science Institution; Australian Research Council (ARC) [DP0663670]; Australian Coral Reef Society; CSIRO Wealth from Oceans; NERC [NE/B500690/3] Funding Source: UKRI; Natural Environment Research Council [NE/B500690/3] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); British Ecological Society; University of Western Australia; Faculty of Engineering, Computing and Mathematical Sciences; Western Australian Marine Science Institution; Australian Research Council (ARC)(Australian Research Council); Australian Coral Reef Society; CSIRO Wealth from Oceans; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by a Natural Environment Research Council Advanced Fellowship and a grant from the British Ecological Society to SH, grants from The University of Western Australia, the Faculty of Engineering, Computing and Mathematical Sciences, and the Western Australian Marine Science Institution (Node 3) to AMW, an Australian Research Council (ARC) Discovery Grant #DP0663670 to AMW et al., an Australian Coral Reef Society Fellowship to ASJW and CSIRO Wealth from Oceans funding to ASJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes C, 2007, FUNCT ECOL, V21, P356, DOI 10.1111/j.1365-2435.2006.01224.x; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Carassou L, 2008, AQUAT LIVING RESOUR, V21, P1, DOI 10.1051/alr:2008017; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; de la Moriniere EC, 2003, MAR ECOL PROG SER, V246, P279; Deb D, 1997, OIKOS, V78, P191, DOI 10.2307/3545816; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Elsdon TS, 2010, MAR ECOL PROG SER, V408, P195, DOI 10.3354/meps08518; Froese R., 2018, FISHBASE WORLD WIDE; FRY B, 1984, CONTRIB MAR SCI, V27, P13; FRY B, 1982, OECOLOGIA, V54, P200, DOI 10.1007/BF00378393; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Granek EF, 2009, ECOSYSTEMS, V12, P462, DOI 10.1007/s10021-009-9235-7; Grey J, 2002, FRESHWATER BIOL, V47, P1235, DOI 10.1046/j.1365-2427.2002.00838.x; Guelinckx J, 2008, J FISH BIOL, V72, P301, DOI 10.1111/j.1095-8649.2007.01692.x; Hill JM, 2009, HYDROBIOLOGIA, V635, P81, DOI 10.1007/s10750-009-9865-y; Ho CT, 2009, ZOOL STUD, V48, P649; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hussey NE, 2010, COMP BIOCHEM PHYS A, V155, P445, DOI 10.1016/j.cbpa.2009.09.023; Kolasinski J, 2009, MAR ECOL PROG SER, V386, P181, DOI 10.3354/meps08081; Logan JM, 2008, RAPID COMMUN MASS SP, V22, P1081, DOI 10.1002/rcm.3471; MacNeil MA, 2006, CAN J FISH AQUAT SCI, V63, P345, DOI 10.1139/F05-219; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Mill AC, 2007, FUNCT ECOL, V21, P1137, DOI 10.1111/j.1365-2435.2007.01330.x; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Nagelkerken I, 2009, J FISH BIOL, V75, P1123, DOI 10.1111/j.1095-8649.2009.02303.x; Olive PJW, 2003, J ANIM ECOL, V72, P608, DOI 10.1046/j.1365-2656.2003.00730.x; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Ponsard S, 1999, RAPID COMMUN MASS SP, V13, P1305; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Robbins CT, 2010, OECOLOGIA, V162, P571, DOI 10.1007/s00442-009-1485-8; Sotiropoulos MA, 2004, ECOL FRESHW FISH, V13, P155, DOI 10.1111/j.1600-0633.2004.00056.x; Sweeting CJ, 2007, J EXP MAR BIOL ECOL, V352, P165, DOI 10.1016/j.jembe.2007.07.007; Sweeting CJ, 2007, J EXP MAR BIOL ECOL, V340, P1, DOI 10.1016/j.jembe.2006.07.023; Sweeting CJ, 2006, RAPID COMMUN MASS SP, V20, P595, DOI 10.1002/rcm.2347; Sweeting CJ, 2005, FUNCT ECOL, V19, P777, DOI 10.1111/j.1365-2435.2005.01019.x; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Wyatt ASJ, 2010, MAR ECOL PROG SER, V405, P113, DOI 10.3354/meps08508	39	50	51	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13682	10.1371/journal.pone.0013682	http://dx.doi.org/10.1371/journal.pone.0013682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060681	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000283537000048
J	Reside, AE; VanDerWal, JJ; Kutt, AS; Perkins, GC				Reside, April E.; VanDerWal, Jeremy J.; Kutt, Alex S.; Perkins, Genevieve C.			Weather, Not Climate, Defines Distributions of Vagile Bird Species	PLOS ONE			English	Article							DISTRIBUTION MODELS; COMMUNITY STRUCTURE; BIOTIC INTERACTIONS; IMPROVE PREDICTION; NORTHERN-TERRITORY; TEMPORAL VARIATION; MOVEMENT PATTERNS; ENVELOPE MODELS; CHANGE IMPACTS; RAIN-FORESTS	Background: Accurate predictions of species distributions are essential for climate change impact assessments. However the standard practice of using long-term climate averages to train species distribution models might mute important temporal patterns of species distribution. The benefit of using temporally explicit weather and distribution data has not been assessed. We hypothesized that short-term weather associated with the time a species was recorded should be superior to long-term climate measures for predicting distributions of mobile species. Methodology: We tested our hypothesis by generating distribution models for 157 bird species found in Australian tropical savannas (ATS) using modelling algorithm Maxent. The variable weather of the ATS supports a bird assemblage with variable movement patterns and a high incidence of nomadism. We developed "weather" models by relating climatic variables (mean temperature, rainfall, rainfall seasonality and temperature seasonality) from the three month, six month and one year period preceding each bird record over a 58 year period (1950-2008). These weather models were compared against models built using long-term (30 year) averages of the same climatic variables. Conclusions: Weather models consistently achieved higher model scores than climate models, particularly for wide-ranging, nomadic and desert species. Climate models predicted larger range areas for species, whereas weather models quantified fluctuations in habitat suitability across months, seasons and years. Models based on long-term climate averages overestimate availability of suitable habitat and species' climatic tolerances, masking species potential vulnerability to climate change. Our results demonstrate that dynamic approaches to distribution modelling, such as incorporating organism-appropriate temporal scales, improves understanding of species distributions.	[Reside, April E.; Kutt, Alex S.; Perkins, Genevieve C.] Commonwealth Sci & Ind Res Org, Climate Adaptat Flagship & Ecosyst Sci, Townsville, Qld, Australia; [Reside, April E.; VanDerWal, Jeremy J.] James Cook Univ, Sch Marine & Trop Biol, Ctr Trop Biodivers & Climate Change, Townsville, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University	Reside, AE (corresponding author), Commonwealth Sci & Ind Res Org, Climate Adaptat Flagship & Ecosyst Sci, Townsville, Qld, Australia.	april.reside@gmail.com	VanDerWal, Jeremy/C-7457-2009; Perkins, Genevieve/D-3338-2011; Kutt, Alex S/B-2020-2008; Reside, April/H-4940-2011	Kutt, Alex S/0000-0001-9679-2206; Reside, April/0000-0002-0760-9527; VanDerWal, Jeremy/0000-0001-7439-8953	CSIRO	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This work was funded by the CSIRO Climate Adaptation Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CR, 2002, ECOSYSTEMS, V5, P348, DOI 10.1007/s10021-001-0079-2; [Anonymous], P 21 INT C MACH LEAR; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Austin GE, 2005, GLOBAL CHANGE BIOL, V11, P31, DOI 10.1111/j.1529-8817.2003.00876.x; Barrett G.W., 2003, NEW ATLAS AUSTR BIRD; Beaumont LJ, 2002, GLOBAL CHANGE BIOL, V8, P954, DOI 10.1046/j.1365-2486.2002.00490.x; Blakers M., 1984, ATLAS AUSTR BIRDS; Brotons L, 2007, DIVERS DISTRIB, V13, P276, DOI 10.1111/j.1472-4642.2007.00339.x; CAI W, 2004, CLIMATE CHANGE QUEEN; Carr MH, 2003, ECOL APPL, V13, pS90; Chan K, 2001, EMU, V101, P281, DOI 10.1071/MU00034; Chan Ken, 1999, Tropical Ecology, V40, P63; Collins DA, 2000, AUST METEOROL MAG, V49, P277; DAVIES SJJF, 1984, J ARID ENVIRON, V7, P183; Dingle H, 2008, EMU, V108, P341, DOI 10.1071/MU08010; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Environmental Protection Agency, 2004, WILDNET DAT; Fensham RJ, 2009, GLOBAL CHANGE BIOL, V15, P380, DOI 10.1111/j.1365-2486.2008.01718.x; Foody GM, 2008, ECOL INFORM, V3, P228, DOI 10.1016/j.ecoinf.2008.02.002; FRANKLIN DC, 1989, EMU, V89, P140, DOI 10.1071/MU9890140; Garnett ST, 2010, RANGELAND J, V32, P215, DOI 10.1071/RJ09083; Grant I, 2008, METEOROLOGICAL REMOT; Green K, 2008, ARCT ANTARCT ALP RES, V40, P74, DOI 10.1657/1523-0430(06-100)[GREEN]2.0.CO;2; Griffioen PA, 2002, EMU, V102, P99, DOI 10.1071/MU01024; Heikkinen RK, 2006, DIVERS DISTRIB, V12, P502, DOI 10.1111/j.1366-9516.2006.00284.x; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; Higgins P. J., 2002, HDB AUSTR NZ ANTARCT, V6; Higgins P.J., 2006, VOLUME 7 BOATBILL ST; Higgins P.J., 1999, HDB AUSTR NZ ANTARCT, V4; Higgins P. J., 2001, HDB AUSTR NZ ANTARCT, V5; Hilbert DW, 2004, BIOL CONSERV, V116, P367, DOI 10.1016/S0006-3207(03)00230-1; HOBBS J, 1988, IMPACT CLIMATE VARIA; Huston MA, 1999, OIKOS, V86, P393, DOI 10.2307/3546645; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jiguet F, 2006, ECOL LETT, V9, P1321, DOI 10.1111/j.1461-0248.2006.00986.x; Jones D.A., 2007, CLIMATE DATA AUSTR W; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Keast A., 1961, Bulletin of the Museum of Comparative Zoology, V123, P305; LING CX, 2003, ADV ARTIFICIAL INTEL; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lowry H, 2007, WILDLIFE RES, V34, P624, DOI 10.1071/WR07025; Mac Nally R, 2000, BIOL CONSERV, V92, P335, DOI 10.1016/S0006-3207(99)00100-7; Mac Nally R, 1996, AUST J ECOL, V21, P280, DOI 10.1111/j.1442-9993.1996.tb00610.x; Marchant S., 1990, HDB AUSTR NZ ANTARCT, V1; Marchant S., 1993, HDB AUSTR NZ ANTARCT, V2; MARGULES CR, 1994, CONSERV BIOL, V8, P398, DOI 10.1046/j.1523-1739.1994.08020398.x; Marini MA, 2009, CONSERV BIOL, V23, P1558, DOI 10.1111/j.1523-1739.2009.01258.x; Maron M, 2005, AUSTRAL ECOL, V30, P383, DOI 10.1111/j.1442-9993.2005.01480.x; Nebel S, 2008, BIOL CONSERV, V141, P971, DOI 10.1016/j.biocon.2008.01.017; Nicholls A. O., 1998, CONSERVATION CHANGIN; NIX H, 1976, P 16 INT ORN C AUSTR; Ogutu JO, 2008, J ANIM ECOL, V77, P814, DOI 10.1111/j.1365-2656.2008.01392.x; Osborne PE, 2007, DIVERS DISTRIB, V13, P313, DOI 10.1111/j.1472-4642.2007.00344.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Petrie SA, 2004, CAN J ZOOL, V82, P1082, DOI 10.1139/Z04-085; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Porter WP, 2000, AM ZOOL, V40, P597, DOI 10.1668/0003-1569(2000)040[0597:CCEOBA]2.0.CO;2; Prates-Clark CD, 2008, ECOL MODEL, V211, P309, DOI 10.1016/j.ecolmodel.2007.09.024; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Price B, 2009, ECOGRAPHY, V32, P745, DOI 10.1111/j.1600-0587.2009.05670.x; Price OF, 1999, BIOL CONSERV, V91, P169, DOI 10.1016/S0006-3207(99)00081-6; Roshier D, 2008, IBIS, V150, P474, DOI 10.1111/j.1474-919X.2008.00806.x; Rowley I., 1975, BIRD LIFE; SCHODDE R, 1982, EVOLUTION FLORA FAUN; Schwinning S, 2004, OECOLOGIA, V141, P191, DOI 10.1007/s00442-004-1683-3; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Watterson I, 2007, REGIONAL CLIMATE CHA; WEAVER CM, 1982, EMU, V82, P2, DOI 10.1071/MU9820002; WIENS JA, 1976, ANNU REV ECOL SYST, V7, P81, DOI 10.1146/annurev.es.07.110176.000501; WIENS JA, 1974, CONDOR, V76, P385, DOI 10.2307/1365813; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Woinarski JCZ, 2006, ECOSYSTEMS, V9, P689, DOI 10.1007/s10021-006-0077-2; WOINARSKI JCZ, 1992, GLOBAL ECOL BIOGEOGR, V2, P1, DOI 10.2307/2997325; Woinarski John C. Z., 2000, Pacific Conservation Biology, V6, P61; Ziembicki Mark, 2007, Pacific Conservation Biology, V13, P128; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106	79	101	105	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13569	10.1371/journal.pone.0013569	http://dx.doi.org/10.1371/journal.pone.0013569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042575	Green Published, Green Accepted, gold			2022-12-25	WOS:000283419100010
J	Ghigo, E; Barry, AO; Pretat, L; Al Moussawi, K; Desnues, B; Capo, C; Kornfeld, H; Mege, JL				Ghigo, Eric; Barry, Abdoulaye Oury; Pretat, Lionel; Al Moussawi, Khatoun; Desnues, Benoit; Capo, Christian; Kornfeld, Hardy; Mege, Jean-Louis			IL-16 Promotes T. whipplei Replication by Inhibiting Phagosome Conversion and Modulating Macrophage Activation	PLOS ONE			English	Article							TROPHERYMA-WHIPPLEI; HUMAN EOSINOPHILS; LYMPHOCYTE; EXPRESSION; MATURATION; MONOCYTES; CYTOKINES; SURVIVAL; DISEASE; CELLS	The replication of Tropheryma whipplei (the agent of Whipple's disease) within human macrophages is associated with the expression of IL-16, a cytokine known for its chemotactic and inflammatory properties. In this study, we asked whether IL-16 acts on T. whipplei replication by interfering with the endocytic pathway. We observed that in macrophages, T. whipplei was located within late phagosomes that were unable to fuse with lysosomes; in monocytes, T. whipplei was eliminated in phagolysosomes. Moreover, adding IL-16 to monocytes induced bacterial replication and inhibited phagolysosome formation. On the other hand, blocking IL-16 activity, either with anti-IL-16 antibodies in human macrophages or by using murine IL-16(-/-) bone marrow-derived macrophages, inhibited T. whipplei replication and rescued phagolysosome biogenesis. Furthermore, we propose that IL-16-mediated interference with the endocytic pathway is likely related to macrophage activation. First, IFN gamma induced T. whipplei elimination and phagolysosome formation and inhibited IL-16 production by macrophages. Second, the full transcriptional response of murine macrophages to T. whipplei showed that T. whipplei specifically modulated the expression of 231 probes in IL-16(-/-) macrophages. Gene Ontology analysis revealed that 10 of 13 over-represented terms were linked to immune responses, including proinflammatory transcriptional factors of the NF-kappa B family. Our results demonstrated a previously unreported function for IL-16 in promoting bacterial replication through inhibited phagolysosome biogenesis and modulated macrophage activation program.	[Ghigo, Eric; Barry, Abdoulaye Oury; Pretat, Lionel; Al Moussawi, Khatoun; Desnues, Benoit; Capo, Christian; Mege, Jean-Louis] Univ Mediterranee, URMITE, CNRS UMR 6236, IRD 3R198, Marseille, France; [Kornfeld, Hardy] Univ Massachusetts, Sch Med, Dept Med, Div Pulm & Crit Care Med, Worcester, MA USA	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); University of Massachusetts System; University of Massachusetts Worcester	Ghigo, E (corresponding author), Univ Mediterranee, URMITE, CNRS UMR 6236, IRD 3R198, Marseille, France.	jean-louis.mege@univmed.fr	Eric, Ghigo/N-9427-2016; MEGE, JEAN-LOUIS/O-6063-2016; Desnues, Benoit/P-4725-2016; Kornfeld, Hardy/AAS-2903-2021	Desnues, Benoit/0000-0003-1422-4294; 	Agence National de la Recherche (ANR) [05-MIIM-043-01]; Fondation pour la Recherche Medicale	Agence National de la Recherche (ANR)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Agence National de la Recherche (ANR, ANR-Microbiology 05-MIIM-043-01). Lionel Pretat is funded as a research assistant by the Fondation pour la Recherche Medicale. Khatoun Al Moussawi and Abdoulaye Oury Barry are fellows of the Scientific Cooperation Foundation "Infectiopole Sud". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the paper.	Al Moussawi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000722; Al-Shahrour F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-114; Alvarez-Dominguez C, 1998, J BIOL CHEM, V273, P33901, DOI 10.1074/jbc.273.51.33901; Baier M, 1997, P NATL ACAD SCI USA, V94, P5273, DOI 10.1073/pnas.94.10.5273; BELLINI A, 1993, J ALLERGY CLIN IMMUN, V92, P412, DOI 10.1016/0091-6749(93)90120-5; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; BERMAN JS, 1985, CELL IMMUNOL, V95, P105, DOI 10.1016/0008-8749(85)90299-0; Bhattacharya M, 2006, EMBO J, V25, P2878, DOI 10.1038/sj.emboj.7601170; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004; Clemens DL, 1996, J EXP MED, V184, P1349, DOI 10.1084/jem.184.4.1349; Cook P, 2007, IMMUNOLOGY, V122, P222, DOI 10.1111/j.1365-2567.2007.02631.x; Cruikshank W, 2008, CRIT REV IMMUNOL, V28, P467; CRUIKSHANK WW, 1987, J IMMUNOL, V138, P3817; Desnues B, 2005, J INFECT DIS, V192, P1642, DOI 10.1086/491745; Desnues B, 2005, J IMMUNOL, V175, P4575, DOI 10.4049/jimmunol.175.7.4575; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; Elssner A, 2004, J IMMUNOL, V172, P7721, DOI 10.4049/jimmunol.172.12.7721; Fenollar F, 2002, J CLIN MICROBIOL, V40, P1119, DOI 10.1128/JCM.40.3.1119-1120.2002; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Ghigo E, 2004, J INFECT DIS, V190, P1767, DOI 10.1086/425041; Ghigo E, 2002, J IMMUNOL, V169, P4488, DOI 10.4049/jimmunol.169.8.4488; Ghigo E, 2001, INFECT IMMUN, V69, P2345, DOI 10.1128/IAI.69.4.2345-2352.2001; Ghigo E, 2002, INFECT IMMUN, V70, P1501, DOI 10.1128/IAI.70.3.1501-1506.2002; Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Haas A, 2007, TRAFFIC, V8, P311, DOI 10.1111/j.1600-0854.2006.00531.x; Kaser A, 2000, J IMMUNOL, V165, P2474, DOI 10.4049/jimmunol.165.5.2474; LIM KG, 1995, INT ARCH ALLERGY IMM, V107, P342, DOI 10.1159/000237023; Liu C, 2007, CYTOKINE, V38, P145, DOI 10.1016/j.cyto.2007.05.016; Marth T, 2003, LANCET, V361, P239, DOI 10.1016/S0140-6736(03)12274-X; Marth T, 2002, GASTROENTEROLOGY, V123, P1468, DOI 10.1053/gast.2002.36583; Mathy NL, 2000, IMMUNOLOGY, V100, P63, DOI 10.1046/j.1365-2567.2000.00997.x; Mege JL, 2006, LANCET INFECT DIS, V6, P557, DOI 10.1016/S1473-3099(06)70577-1; Moos V, 2006, J IMMUNOL, V177, P2015, DOI 10.4049/jimmunol.177.3.2015; Philips JA, 2008, CELL MICROBIOL, V10, P2408, DOI 10.1111/j.1462-5822.2008.01239.x; PITT A, 1992, J CLIN INVEST, V90, P1978, DOI 10.1172/JCI116077; Prada-Delgado A, 2001, J BIOL CHEM, V276, P19059, DOI 10.1074/jbc.M101639200; RAND TH, 1991, J EXP MED, V173, P1521, DOI 10.1084/jem.173.6.1521; Ren FC, 2005, J IMMUNOL, V174, P2738, DOI 10.4049/jimmunol.174.5.2738; Schaible UE, 1998, J IMMUNOL, V160, P1290; Schneider T, 2008, LANCET INFECT DIS, V8, P179, DOI 10.1016/S1473-3099(08)70042-2; Smith AJP, 2009, CYTOKINE GROWTH F R, V20, P43, DOI 10.1016/j.cytogfr.2008.11.006; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; Via LE, 1998, J CELL SCI, V111, P897; Zhang YJ, 1998, J BIOL CHEM, V273, P1144, DOI 10.1074/jbc.273.2.1144	47	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13561	10.1371/journal.pone.0013561	http://dx.doi.org/10.1371/journal.pone.0013561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042409	gold, Green Published, Green Submitted			2022-12-25	WOS:000283293800023
J	Deville, K; Gold, VAM; Robson, A; Whitehouse, S; Sessions, RB; Baldwin, SA; Radford, SE; Collinson, I				Deville, Karine; Gold, Vicki A. M.; Robson, Alice; Whitehouse, Sarah; Sessions, Richard B.; Baldwin, Stephen A.; Radford, Sheena E.; Collinson, Ian			The Oligomeric State and Arrangement of the Active Bacterial Translocon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE CONFORMATIONAL-CHANGE; PROTEIN-CONDUCTING CHANNEL; DIMERIC SECA ATPASE; ESCHERICHIA-COLI; TRANSLATING RIBOSOME; PRECURSOR PROTEINS; COMPLEX SECYEG; MEMBRANE; BINDING; DISSOCIATION	Protein secretion in bacteria is driven through the ubiquitous SecYEG complex by the ATPase SecA. The structure of SecYEG alone or as a complex with SecA in detergent reveal a monomeric heterotrimer enclosing a central protein channel, yet in membranes it is dimeric. We have addressed the functional significance of the oligomeric status of SecYEG in protein translocation using single molecule and ensemble methods. The results show that while monomers are sufficient for the SecA-and ATP-dependent association of SecYEG with pre-protein, active transport requires SecYEG dimers arranged in the back-to-back conformation. Molecular modeling of this dimeric structure, in conjunction with the new functional data, provides a rationale for the presence of both active and passive copies of SecYEG in the functional translocon.	[Gold, Vicki A. M.; Robson, Alice; Whitehouse, Sarah; Sessions, Richard B.; Collinson, Ian] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; [Radford, Sheena E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Deville, Karine; Radford, Sheena E.] Univ Leeds, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Baldwin, Stephen A.] Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England	University of Bristol; University of Leeds; University of Leeds; University of Leeds	Collinson, I (corresponding author), Univ Bristol, Sch Biochem, Univ Walk, Bristol BS8 1TD, Avon, England.	ian.collinson@bristol.ac.uk		Robson, Alice/0000-0003-3338-2626; Collinson, Ian/0000-0002-3931-0503; Sessions, Richard/0000-0003-0320-0895; Gold, Vicki/0000-0002-6908-0745; Radford, Sheena/0000-0002-3079-8039	BBSRC [BB/F002343/1]; Wellcome Trust [080705/Z/06/Z];  [084452];  [082140]; Biotechnology and Biological Sciences Research Council [BB/F002343/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); ; ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the BBSRC (Project Grant BB/F002343/1, to I. C.), Wellcome Trust Studentship Project Grant 080705/Z/06/Z (to K. D.) and Project Grant 084452 (to I. C.), and Equipment Grant 082140 (to I. C.) for the bioreactor.	Bauer BW, 2009, P NATL ACAD SCI USA, V106, P20800, DOI 10.1073/pnas.0910550106; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Bessonneau P, 2002, EMBO J, V21, P995, DOI 10.1093/emboj/21.5.995; Bostina M, 2005, J MOL BIOL, V352, P1035, DOI 10.1016/j.jmb.2005.08.005; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Chen HM, 2010, J AM CHEM SOC, V132, P7244, DOI 10.1021/ja100500k; Collinson I, 2001, EMBO J, V20, P2462, DOI 10.1093/emboj/20.10.2462; de Keyzer J, 2002, J BIOL CHEM, V277, P46059, DOI 10.1074/jbc.M208449200; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; GELL C, 2006, HDB SINGLE MOL FLUOR; Gold VAM, 2007, J BIOL CHEM, V282, P17424, DOI 10.1074/jbc.M702066200; Gold VAM, 2010, P NATL ACAD SCI USA, V107, P10044, DOI 10.1073/pnas.0914680107; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Liang FC, 2009, MOL BIOL CELL, V20, P4256, DOI 10.1091/mbc.E09-01-0075; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; Marme N, 2003, BIOCONJUGATE CHEM, V14, P1133, DOI 10.1021/bc0341324; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Papanikolau Y, 2007, J MOL BIOL, V366, P1545, DOI 10.1016/j.jmb.2006.12.049; Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033; Robson A, 2007, J MOL BIOL, V374, P965, DOI 10.1016/j.jmb.2007.09.086; Robson A, 2009, P NATL ACAD SCI USA, V106, P5111, DOI 10.1073/pnas.0809592106; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Woodbury RL, 2002, PROTEIN SCI, V11, P875, DOI 10.1110/ps.4090102; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	36	48	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4659	4669		10.1074/jbc.M110.175638	http://dx.doi.org/10.1074/jbc.M110.175638			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21056980	Green Published, hybrid			2022-12-25	WOS:000286975700065
J	Giorgetti, S; Raimondi, S; Pagano, K; Relini, A; Bucciantini, M; Corazza, A; Fogolari, F; Codutti, L; Salmona, M; Mangione, P; Colombo, L; De Luigi, A; Porcari, R; Gliozzi, A; Stefani, M; Esposito, G; Bellotti, V; Stoppini, M				Giorgetti, Sofia; Raimondi, Sara; Pagano, Katiuscia; Relini, Annalisa; Bucciantini, Monica; Corazza, Alessandra; Fogolari, Federico; Codutti, Luca; Salmona, Mario; Mangione, Palma; Colombo, Lino; De Luigi, Ada; Porcari, Riccardo; Gliozzi, Alessandra; Stefani, Massimo; Esposito, Gennaro; Bellotti, Vittorio; Stoppini, Monica			Effect of Tetracyclines on the Dynamics of Formation and Destructuration of beta 2-Microglobulin Amyloid Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIALYSIS-RELATED AMYLOIDOSIS; IN-VITRO; BETA(2)-MICROGLOBULIN; SPECTROSCOPY; AGGREGATION; NMR; TOXICITY; SUPPRESSION; DOXYCYCLINE; OLIGOMERS	The discovery of methods suitable for the conversion in vitro of native proteins into amyloid fibrils has shed light on the molecular basis of amyloidosis and has provided fundamental tools for drug discovery. We have studied the capacity of a small library of tetracycline analogues to modulate the formation or destructuration of beta 2-microglobulin fibrils. The inhibition of fibrillogenesis of the wild type protein was first established in the presence of 20% trifluoroethanol and confirmed under a more physiologic environment including heparin and collagen. The latter conditions were also used to study the highly amyloidogenic variant, P32G. The NMR analysis showed that doxycycline inhibits beta 2-microglobulin self-association and stabilizes the native-like species through fast exchange interactions involving specific regions of the protein. Cell viability assays demonstrated that the drug abolishes the natural cytotoxic activity of soluble beta 2-microglobulin, further strengthening a possible in vivo therapeutic exploitation of this drug. Doxycycline can disassemble preformed fibrils, but the IC50 is 5-fold higher than that necessary for the inhibition of fibrillogenesis. Fibril destructuration is a dynamic and time-dependent process characterized by the early formation of cytotoxic protein aggregates that, in a few hours, convert into non-toxic insoluble material. The efficacy of doxycycline as a drug against dialysis-related amyloidosis would benefit from the ability of the drug to accumulate just in the skeletal system where amyloid is formed. In these tissues, the doxycycline concentration reaches values several folds higher than those resulting in inhibition of amyloidogenesis and amyloid destructuration in vitro.	[Mangione, Palma; Bellotti, Vittorio; Stoppini, Monica] Univ Pavia, Dipartimento Biochim, I-27100 Pavia, Italy; [Pagano, Katiuscia; Corazza, Alessandra; Fogolari, Federico; Codutti, Luca; Esposito, Gennaro] Univ Udine, Dept Biomed Sci & Technol, I-33100 Udine, Italy; [Relini, Annalisa; Corazza, Alessandra; Fogolari, Federico; Gliozzi, Alessandra; Esposito, Gennaro; Bellotti, Vittorio; Stoppini, Monica] INBB, I-00136 Rome, Italy; [Relini, Annalisa; Gliozzi, Alessandra] Univ Genoa, Dept Phys, I-16146 Genoa, Italy; [Bucciantini, Monica; Stefani, Massimo] Univ Florence, Dept Biochem Sci, I-50134 Florence, Italy; [Salmona, Mario; De Luigi, Ada] Mario Negri Inst Pharmacol Res, Dept Mol Biochem & Pharmacol, I-20156 Milan, Italy; [Colombo, Lino] Univ Pavia, Dept Pharmaceut Chem, I-27100 Pavia, Italy	University of Pavia; University of Udine; University of Genoa; University of Florence; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Pavia	Bellotti, V (corresponding author), Univ Pavia, Dipartimento Biochim, Via Taramelli 3B, I-27100 Pavia, Italy.	vbellot@unipv.it	De Luigi, Ada/ABF-7913-2020; Relini, Annalisa/AHC-3105-2022; Bellotti, Vittorio/A-6201-2014; Pagano, Katiuscia/AAB-9495-2020; salmona, mario/ABI-4066-2020; Giorgetti, Sofia/AAD-4341-2019; salmona, mario/AAA-7116-2020; Corazza, Alessandra/AGB-1457-2022	De Luigi, Ada/0000-0001-7907-7139; Bellotti, Vittorio/0000-0001-8678-662X; Giorgetti, Sofia/0000-0001-9438-6511; salmona, mario/0000-0002-9098-9873; Corazza, Alessandra/0000-0003-2272-1928; STEFANI, MASSIMO/0000-0002-4490-1922; bucciantini, monica/0000-0002-5243-9301; pagano, katiuscia/0000-0002-0462-2056; Fogolari, Federico/0000-0001-9862-250X; Mangione, Palma/0000-0003-0260-1400; RELINI, ANNALISA/0000-0002-4040-9279	Italian Ministry of University, Research and Instruction (MIUR); European Union (EU) [LSHM-CT-2005-037525]; Fondazione Cariplo [2007.5151, 2009-2543]	Italian Ministry of University, Research and Instruction (MIUR)(Ministry of Education, Universities and Research (MIUR)); European Union (EU)(CGIAREuropean Commission); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by grants from the Italian Ministry of University, Research and Instruction (MIUR) (projects FIRB and PRIN), the European Union (EU) (EURAMY Project LSHM-CT-2005-037525), and the Fondazione Cariplo (2007.5151 and 2009-2543).	Agwuh KN, 2006, J ANTIMICROB CHEMOTH, V58, P256, DOI 10.1093/jac/dkl224; Aitken JF, 2010, DIABETES, V59, P161, DOI 10.2337/db09-0548; Aitken JF, 2003, BIOCHEM J, V374, P779, DOI 10.1042/BJ20030422; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bellotti V, 2007, ANN MED, V39, P200, DOI 10.1080/07853890701206887; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cardoso I, 2006, FASEB J, V20, P234, DOI 10.1096/fj.05-4509com; De Lorenzi E, 2004, CURR MED CHEM, V11, P1065; De Luigi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001888; Diomede L, 2010, NEUROBIOL DIS, V40, P424, DOI 10.1016/j.nbd.2010.07.002; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Esposito G, 2008, J MOL BIOL, V378, P887, DOI 10.1016/j.jmb.2008.03.002; Fogolari F, 2007, BIOPHYS J, V92, P1673, DOI 10.1529/biophysj.106.098483; Forloni G, 2001, FEBS LETT, V487, P404, DOI 10.1016/S0014-5793(00)02380-2; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Giorgetti S, 2007, PROTEIN SCI, V16, P343, DOI 10.1110/ps.062563507; Giorgetti S, 2009, NEPHROL DIAL TRANSPL, V24, P1176, DOI 10.1093/ndt/gfn623; Gordon J, 2003, INT J CANCER, V103, P316, DOI 10.1002/ijc.10828; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; JEENER J, 1979, J CHEM PHYS, V71, P286; Jerschow A, 1998, J MAGN RESON, V132, P13, DOI 10.1006/jmre.1998.1400; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loeb MB, 2004, J AM GERIATR SOC, V52, P381, DOI 10.1111/j.1532-5415.2004.52109.x; Malmo C, 2006, FASEB J, V20, P346, DOI 10.1096/fj.05-4652fje; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Menaa C, 2008, KIDNEY INT, V73, P1275, DOI 10.1038/ki.2008.100; MERLINI G, 1995, P NATL ACAD SCI USA, V92, P2959, DOI 10.1073/pnas.92.7.2959; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; Saikali Zeina, 2003, Anticancer Drugs, V14, P773; Tagliavini F, 2000, J MOL BIOL, V300, P1309, DOI 10.1006/jmbi.2000.3840; Verdone G, 2009, J BIOMOL NMR, V43, P79, DOI 10.1007/s10858-008-9290-y; Yamaguchi K, 2005, J MOL BIOL, V352, P952, DOI 10.1016/j.jmb.2005.07.061; Yamaguchi K, 2006, J MOL BIOL, V363, P279, DOI 10.1016/j.jmb.2006.08.030; Yamamoto S, 2008, CLIN NEPHROL, V70, P496; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7	41	77	81	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2121	2131		10.1074/jbc.M110.178376	http://dx.doi.org/10.1074/jbc.M110.178376			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21068391	hybrid, Green Published			2022-12-25	WOS:000286191500054
J	Haurat, MF; Aduse-Opoku, J; Rangarajan, M; Dorobantu, L; Gray, MR; Curtis, MA; Feldman, MF				Haurat, M. Florencia; Aduse-Opoku, Joseph; Rangarajan, Minnie; Dorobantu, Loredana; Gray, Murray R.; Curtis, Michael A.; Feldman, Mario F.			Selective Sorting of Cargo Proteins into Bacterial Membrane Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORPHYROMONAS-GINGIVALIS W50; GRAM-NEGATIVE BACTERIA; POLYACRYLAMIDE-GELS; STRUCTURAL-ANALYSIS; VIRULENCE FACTORS; STRAIN W50; LIPOPOLYSACCHARIDE; IDENTIFICATION; ANTIGEN; POLYSACCHARIDE	In contrast to the well established multiple cellular roles of membrane vesicles in eukaryotic cell biology, outer membrane vesicles (OMV) produced via blebbing of prokaryotic membranes have frequently been regarded as cell debris or microscopy artifacts. Increasingly, however, bacterial membrane vesicles are thought to play a role in microbial virulence, although it remains to be determined whether OMV result from a directed process or from passive disintegration of the outer membrane. Here we establish that the human oral pathogen Porphyromonas gingivalis has a mechanism to selectively sort proteins into OMV, resulting in the preferential packaging of virulence factors into OMV and the exclusion of abundant outer membrane proteins from the protein cargo. Furthermore, we show a critical role for lipopolysaccharide in directing this sorting mechanism. The existence of a process to package specific virulence factors into OMV may significantly alter our current understanding of host-pathogen interactions.	[Feldman, Mario F.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Dorobantu, Loredana; Gray, Murray R.] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB T6G 2E9, Canada; [Aduse-Opoku, Joseph; Rangarajan, Minnie; Curtis, Michael A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, Ctr Immunol & Infect Dis, London E1 2AT, England	University of Alberta; University of Alberta; University of London; Queen Mary University London	Feldman, MF (corresponding author), Univ Alberta, Dept Biol Sci, Biol Sci Bldg, Edmonton, AB T6G 2E9, Canada.	mfeldman@ualberta.ca	Aduse-Opoku, Joseph/CAF-0056-2022; Haurat, M Florencia/ABA-2634-2020; Feldman, Mario/A-2637-2014	Haurat, M Florencia/0000-0001-7569-2783; Feldman, Mario/0000-0003-4497-0976; opoku, anita/0000-0001-7243-8157; Gray, Murray/0000-0003-2431-7312; Curtis, Mike A/0000-0002-1563-9953	Natural Sciences and Engineering Research Council of Canada; Alberta Ingenuity Centre for Carbohydrate Science; Canada Foundation for Innovation; University of Alberta; Alberta Ingenuity Fund; Alberta Heritage Foundation for Medical Research; Medical Research Council [G0501478]; MRC [G0501478] Funding Source: UKRI	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Ingenuity Centre for Carbohydrate Science; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); University of Alberta(University of Alberta); Alberta Ingenuity Fund; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada, the Alberta Ingenuity Centre for Carbohydrate Science, the Canada Foundation for Innovation, the University of Alberta, the Alberta Ingenuity Fund, the Alberta Heritage Foundation for Medical Research (to M. F. F.), Medical Research Council Grant G0501478 (to M. A. C.), and the Natural Sciences and Engineering Research Council of Canada (to M. R. G.).	Aduse-Opoku J, 2006, INFECT IMMUN, V74, P449, DOI 10.1128/IAI.74.1.449-460.2006; Aldick T, 2009, MOL MICROBIOL, V71, P1496, DOI 10.1111/j.1365-2958.2009.06618.x; Andrade-Navarro MA, 2009, CURR OPIN CELL BIOL, V21, P560, DOI 10.1016/j.ceb.2009.04.005; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Curtis MA, 1999, INFECT IMMUN, V67, P3816, DOI 10.1128/IAI.67.8.3816-3823.1999; CURTIS MA, 1991, ORAL MICROBIOL IMMUN, V6, P321, DOI 10.1111/j.1399-302X.1991.tb00502.x; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Duncan L, 2004, MICROB PATHOGENESIS, V36, P319, DOI 10.1016/j.micpath.2004.02.004; Ellen AF, 2009, EXTREMOPHILES, V13, P67, DOI 10.1007/s00792-008-0199-x; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; Furuta N, 2009, INFECT IMMUN, V77, P4187, DOI 10.1128/IAI.00009-09; Gallagher A, 2003, CURR PROTEIN PEPT SC, V4, P427, DOI 10.2174/1389203033486974; GRENIER D, 1987, INFECT IMMUN, V55, P111, DOI 10.1128/IAI.55.1.111-117.1987; Hanley SA, 1999, INFECT IMMUN, V67, P1157, DOI 10.1128/IAI.67.3.1157-1171.1999; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Jagels MA, 1996, INFECT IMMUN, V64, P1984, DOI 10.1128/IAI.64.6.1984-1991.1996; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; Kato S, 2002, MICROB PATHOGENESIS, V32, P1, DOI 10.1006/mpat.2001.0474; Katz J, 2009, J DENT RES, V88, P575, DOI 10.1177/0022034509338032; Kawai F, 2006, GENES GENET SYST, V81, P69, DOI 10.1266/ggs.81.69; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Marolda CL, 2004, MICROBIOL-SGM, V150, P4095, DOI 10.1099/mic.0.27456-0; Marolda Cristina L., 2006, V347, P237; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x; Matsumoto K, 2006, MOL MICROBIOL, V61, P1110, DOI 10.1111/j.1365-2958.2006.05317.x; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; MILLAR DJ, 1993, FEMS IMMUNOL MED MIC, V7, P211, DOI 10.1111/j.1574-695X.1993.tb00401.x; Murakami Y, 2004, MICROBIOL IMMUNOL, V48, P561, DOI 10.1111/j.1348-0421.2004.tb03552.x; Nagano K, 2005, J BACTERIOL, V187, P902, DOI 10.1128/JB.187.3.902-911.2005; Nagano K, 2007, J MED MICROBIOL, V56, P1536, DOI 10.1099/jmm.0.47289-0; Nishibori A, 2005, J BACTERIOL, V187, P2163, DOI 10.1128/JB.187.6.2163-2174.2005; Paramonov N, 2005, MOL MICROBIOL, V58, P847, DOI 10.1111/j.1365-2958.2005.04871.x; Paramonov N, 2001, EUR J BIOCHEM, V268, P4698, DOI 10.1046/j.1432-1327.2001.02397.x; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rangarajan M, 2008, J BACTERIOL, V190, P2920, DOI 10.1128/JB.01868-07; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shoji M, 2002, MICROBIOL-SGM, V148, P1183, DOI 10.1099/00221287-148-4-1183; Sidhu VK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-87; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Veith PD, 2001, EUR J BIOCHEM, V268, P4748, DOI 10.1046/j.1432-1327.2001.02399.x; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Yi EC, 2000, ANALYST, V125, P651, DOI 10.1039/b000368i	50	193	198	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1269	1276		10.1074/jbc.M110.185744	http://dx.doi.org/10.1074/jbc.M110.185744			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21056982	Green Published, hybrid			2022-12-25	WOS:000286005000038
J	Sileikyte, J; Petronilli, V; Zulian, A; Dabbeni-Sala, F; Tognon, G; Nikolov, P; Bernardi, P; Ricchelli, F				Sileikyte, Justina; Petronilli, Valeria; Zulian, Alessandra; Dabbeni-Sala, Federica; Tognon, Giuseppe; Nikolov, Peter; Bernardi, Paolo; Ricchelli, Fernanda			Regulation of the Inner Membrane Mitochondrial Permeability Transition by the Outer Membrane Translocator Protein (Peripheral Benzodiazepine Receptor)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSLOCASE; RAT-BRAIN MITOCHONDRIA; CYTOCHROME-C RELEASE; AUTORADIOGRAPHIC LOCALIZATION; PHOTODYNAMIC-ACTION; PROTOPORPHYRIN-IX; OXIDATIVE STRESS; PORE COMPLEX; CELL-DEATH; 18 KDA	We studied the properties of the permeability transition pore (PTP) in rat liver mitochondria and in mitoplasts retaining inner membrane ultrastructure and energy-linked functions. Like mitochondria, mitoplasts readily underwent a permeability transition following Ca2+ uptake in a process that maintained sensitivity to cyclosporin A. On the other hand, major differences between mitochondria and mitoplasts emerged in PTP regulation by ligands of the outer membrane translocator protein of 18 kDa, TSPO, formerly known as the peripheral benzodiazepine receptor. Indeed, (i) in mitoplasts, the PTP could not be activated by photo-oxidation after treatment with dicarboxylic porphyrins endowed with protoporphyrin IX configuration, which bind TSPO in intact mitochondria; and (ii) mitoplasts became resistant to the PTP-inducing effects of N,N-dihexyl-2-(4-fluorophenyl)indole-3-acetamide and of other selective ligands of TSPO. Thus, the permeability transition is an inner membrane event that is regulated by the outer membrane through specific interactions with TSPO.	[Sileikyte, Justina; Petronilli, Valeria; Zulian, Alessandra; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Sileikyte, Justina; Petronilli, Valeria; Zulian, Alessandra; Bernardi, Paolo] Univ Padua, Consiglio Nazl Ric Inst Neurosci, I-35121 Padua, Italy; [Dabbeni-Sala, Federica] Univ Padua, Dept Pharmacol & Anesthesiol, I-35121 Padua, Italy; [Tognon, Giuseppe; Ricchelli, Fernanda] Univ Padua, Consiglio Nazl Ric Inst Biomed Technol, I-35121 Padua, Italy; [Tognon, Giuseppe; Ricchelli, Fernanda] Univ Padua, Dept Biol, I-35121 Padua, Italy; [Nikolov, Peter] Bulgarian Acad Sci, Inst Organ Chem, Sofia 1000, Bulgaria	University of Padua; University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Padua; University of Padua; Bulgarian Academy of Sciences	Bernardi, P (corresponding author), Univ Padua, Dept Biomed Sci, Viale Giuseppe Colombo 3, I-35121 Padua, Italy.	bernardi@bio.unipd.it; rchielli@bio.unipd.it	Petronilli, Valeria/C-3558-2015; Bernardi, Paolo/C-3656-2008	Petronilli, Valeria/0000-0003-4026-6404; Bernardi, Paolo/0000-0001-9187-3736; Sileikyte, Justina/0000-0002-6795-6344	Consiglio Nazionale delle Ricerche; Ministry for University and Research (MIUR/FIRB) [CINECA RBAU01YL5R]; Universita di Padova Progetto Strategico; Fondazione Cariparo, Padova, Italy	Consiglio Nazionale delle Ricerche(Consiglio Nazionale delle Ricerche (CNR)); Ministry for University and Research (MIUR/FIRB)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Universita di Padova Progetto Strategico; Fondazione Cariparo, Padova, Italy(Fondazione Cariparo)	This work was supported in part by grants from the Consiglio Nazionale delle Ricerche within the framework of Italy-Bulgaria (BAN) bilateral cooperation, by the Ministry for University and Research (MIUR/FIRB CINECA RBAU01YL5R and PRIN), and the Universita di Padova Progetto Strategico "Models of Mitochondrial Diseases."; Supported by a fellowship from the Fondazione Cariparo, Padova, Italy. Performed this work in partial fulfillment of the requirements for a Ph.D.	ANHOLT RRH, 1985, J PHARMACOL EXP THER, V233, P517; Azarashvili T, 2007, CELL CALCIUM, V42, P27, DOI 10.1016/j.ceca.2006.11.004; Azarashvili T, 2010, BIOL CHEM, V391, P619, DOI 10.1515/BC.2010.070; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Batarseh A, 2010, MOL CELL ENDOCRINOL, V327, P1, DOI 10.1016/j.mce.2010.06.013; BEATRICE MC, 1984, J BIOL CHEM, V259, P1279; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Berson A, 2001, J PHARMACOL EXP THER, V299, P793; Beutner G, 1996, FEBS LETT, V396, P189, DOI 10.1016/0014-5793(96)01092-7; Castedo M, 2002, J EXP MED, V196, P1121, DOI 10.1084/jem.20021758; Chelli B, 2001, BIOCHEM PHARMACOL, V61, P695, DOI 10.1016/S0006-2952(00)00588-8; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; Costantini P, 1998, BBA-BIOENERGETICS, V1365, P385, DOI 10.1016/S0005-2728(98)00090-5; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; DESOUZA EB, 1985, ENDOCRINOLOGY, V116, P567, DOI 10.1210/endo-116-2-567; Galiegue S, 2003, CURR MED CHEM, V10, P1563, DOI 10.2174/0929867033457223; GARNIER M, 1994, MOL PHARMACOL, V45, P201; Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; HIRSCH JD, 1989, MOL PHARMACOL, V35, P164; Hirsch T, 1998, EXP CELL RES, V241, P426, DOI 10.1006/excr.1998.4084; Jayakumar AR, 2002, J NEUROCHEM, V83, P1226, DOI 10.1046/j.1471-4159.2002.01261.x; Kessel D, 1999, CELL DEATH DIFFER, V6, P28, DOI 10.1038/sj.cdd.4400446; KINNALLY KW, 1993, P NATL ACAD SCI USA, V90, P1374, DOI 10.1073/pnas.90.4.1374; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Krestinina OV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P421, DOI 10.1134/S0006297909040105; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Krueger KE, 1995, BBA-REV BIOMEMBRANES, V1241, P453, DOI 10.1016/0304-4157(95)00016-X; Leung AWC, 2008, BBA-BIOENERGETICS, V1777, P946, DOI 10.1016/j.bbabio.2008.03.009; Li JY, 2007, EUR J PHARMACOL, V560, P117, DOI 10.1016/j.ejphar.2006.12.027; Marzo I, 1998, J EXP MED, V187, P1261, DOI 10.1084/jem.187.8.1261; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Moreno G, 2001, ARCH BIOCHEM BIOPHYS, V386, P243, DOI 10.1006/abbi.2000.2200; Papadopoulos V, 1997, STEROIDS, V62, P21, DOI 10.1016/S0039-128X(96)00154-7; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; PASTORINO JG, 1994, J BIOL CHEM, V269, P31041; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; PETRONILLI V, 1993, J BIOL CHEM, V268, P1011; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Petronilli V, 2009, BBA-BIOENERGETICS, V1787, P897, DOI 10.1016/j.bbabio.2009.03.014; Ragan MT, 1987, MITOCHONDRIA PRACTIC, P79; Rao VLR, 1997, EUR J PHARMACOL, V340, P89, DOI 10.1016/S0014-2999(97)01395-2; RICCHELLI F, 1993, PHOTOCHEM PHOTOBIOL, V58, P53, DOI 10.1111/j.1751-1097.1993.tb04903.x; RICCHELLI F, 1995, J PHOTOCH PHOTOBIO B, V29, P109, DOI 10.1016/1011-1344(95)07155-U; Ricchelli F, 1999, BIOCHEMISTRY-US, V38, P9295, DOI 10.1021/bi9900828; Roy SS, 2009, MOL CELL, V33, P377, DOI 10.1016/j.molcel.2009.01.018; Salet C, 1997, J BIOL CHEM, V272, P21938, DOI 10.1074/jbc.272.35.21938; TAKETANI S, 1995, J BIOCHEM-TOKYO, V117, P875, DOI 10.1093/oxfordjournals.jbchem.a124790; TOMOV TC, 1986, J BIOCHEM BIOPH METH, V13, P29, DOI 10.1016/0165-022X(86)90005-9; VERMA A, 1988, MOL PHARMACOL, V34, P800; VERMA A, 1987, P NATL ACAD SCI USA, V84, P2256, DOI 10.1073/pnas.84.8.2256; Wendler G, 2003, BIOCHEM BIOPH RES CO, V311, P847, DOI 10.1016/j.bbrc.2003.10.070	54	87	88	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1046	1053		10.1074/jbc.M110.172486	http://dx.doi.org/10.1074/jbc.M110.172486			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21062740	Green Published, hybrid			2022-12-25	WOS:000286005000015
J	Ariza, ME; Ramakrishnan, R; Singh, NP; Chauhan, A; Nagarkatti, PS; Nagarkatti, M				Ariza, Maria Eugenia; Ramakrishnan, Rupal; Singh, Narendra P.; Chauhan, Ashok; Nagarkatti, Prakash S.; Nagarkatti, Mitzi			Bryostatin-1, a Naturally Occurring Antineoplastic Agent, Acts as a Toll-like Receptor 4 (TLR-4) Ligand and Induces Unique Cytokines and Chemokines in Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; INTERFERON-BETA INDUCTION; RANTES CHEMOKINE; KAPPA-B; SIGNAL-TRANSDUCTION; T-CELLS; CLINICAL DEVELOPMENT; IFN-BETA; PHASE-I; ACTIVATION	Bryostatin-1 (Bryo-1), a natural macrocyclic lactone, is clinically used as an anti-cancer agent. In this study, we demonstrate for the first time that Bryo-1 acts as a Toll-like receptor 4 (TLR4) ligand. Interestingly, activation of bone marrow-derived dendritic cells (in vitro with Bryo-1) led to a TLR4-dependent biphasic activation of nuclear factor-kappa B (NF-kappa B) and the unique induction of cytokines (IL-5, IL-6, and IL-10) and chemokines, including RANTES (regulated on activation normal T cell expressed and secreted) and macrophage inflammatory protein 1 alpha (MIP1-alpha). In addition, EMSA demonstrated that Bryo-1-mediated induction of RANTES was regulated by NF-kappa B and the interferon regulatory factors (IRF)-1, IRF-3, and IRF-7 to the RANTES independently of myeloid differentiation primary response gene-88 (MyD88). Bryo-1 was able to induce the transcriptional activation of IRF-3 through the TLR4/MD2-dependent pathway. In vivo administration of Bryo-1 triggered a TLR-4-dependent T helper cell 2 (Th2) cytokine response and expanded a subset of myeloid dendritic cells that expressed a CD11c(high)CD8 alpha(-)CD11b(+)CD4(+) phenotype. This study demonstrates that Bryo-1 can act as a TLR4 ligand and activate innate immunity. Moreover, the ability of Bryo-1 to trigger RANTES and MIP1-alpha suggests that Bryo-1 could potentially be used to prevent HIV-1 infection. Finally, induction of a Th2 response by Bryo-1 may help treat inflammatory diseases mediated by Th1 cells. Together, our studies have a major impact on the clinical use of Bryo-1 as an anticancer and immunopotentiating agent.	[Ariza, Maria Eugenia; Ramakrishnan, Rupal; Singh, Narendra P.; Chauhan, Ashok; Nagarkatti, Prakash S.; Nagarkatti, Mitzi] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Nagarkatti, M (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	mitzi.nagarkatti@uscmed.sc.edu		Nagarkatti, Prakash/0000-0003-2663-0759	National Institutes of Health [P01AT003961, R01DA016545, R01ES09098, R01AI053703, R01AI058300, R01HL05864]; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058300, R01AI053703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants P01AT003961, R01DA016545, R01ES09098, R01AI053703, R01AI058300, and R01HL05864.	Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bosco MC, 1997, BLOOD, V89, P3402, DOI 10.1182/blood.V89.9.3402; Clamp A, 2002, ANTI-CANCER DRUG, V13, P673, DOI 10.1097/00001813-200208000-00001; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Dearman RJ, 2009, IMMUNOLOGY, V126, P475, DOI 10.1111/j.1365-2567.2008.02922.x; Do Y, 2004, CELL IMMUNOL, V231, P8, DOI 10.1016/j.cellimm.2004.11.003; Do Y, 2004, CANCER RES, V64, P6756, DOI 10.1158/0008-5472.CAN-03-4002; Fiorentino L, 2002, J BIOL CHEM, V277, P35333, DOI 10.1074/jbc.M200446200; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; HESS AD, 1988, TRANSPLANT P, V20, P487; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; KELSO A, 1995, IMMUNOL TODAY, V16, P374, DOI 10.1016/0167-5699(95)80004-2; Kirchhoff S, 1999, EUR J BIOCHEM, V261, P546, DOI 10.1046/j.1432-1327.1999.00308.x; Kortmansky J, 2003, CANCER INVEST, V21, P924, DOI 10.1081/CNV-120025095; Lee AH, 2000, BIOCHEM J, V350, P131, DOI 10.1042/0264-6021:3500131; Lin RT, 1999, MOL CELL BIOL, V19, P959; Lokuta MA, 1996, J BIOL CHEM, V271, P13731, DOI 10.1074/jbc.271.23.13731; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; MARFAINGKOKA A, 1995, J IMMUNOL, V154, P1870; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Montoya CJ, 2006, J IMMUNOL, V177, P1028, DOI 10.4049/jimmunol.177.2.1028; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; NELSON PJ, 1993, J IMMUNOL, V151, P2601; O'Neill LAJ, 2002, TRENDS IMMUNOL, V23, P296, DOI 10.1016/S1471-4906(02)02222-6; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; PHILIP PA, 1993, J NATL CANCER I, V85, P1812, DOI 10.1093/jnci/85.22.1812; Pulendran B, 2008, CURR OPIN IMMUNOL, V20, P61, DOI 10.1016/j.coi.2007.10.009; RAMSDELL JS, 1986, J BIOL CHEM, V261, P7073; Saito T, 1997, J INFECT DIS, V175, P497, DOI 10.1093/infdis/175.3.497; SCHEID C, 1994, CANCER IMMUNOL IMMUN, V39, P223, DOI 10.1007/s002620050118; SHIN HS, 1994, MOL CELL BIOL, V14, P2914, DOI 10.1128/MCB.14.5.2914; Singh NP, 2007, MOL PHARMACOL, V72, P1508, DOI 10.1124/mol.107.038984; STELLATO C, 1995, J IMMUNOL, V155, P410; Sun MK, 2006, CNS DRUG REV, V12, P1, DOI 10.1111/j.1527-3458.2006.00001.x; Tailor P, 2006, CELL RES, V16, P134, DOI 10.1038/sj.cr.7310018; Vangelista L, 2008, VACCINE, V26, P3008, DOI 10.1016/j.vaccine.2007.12.023; Wang ZY, 2006, EXP HEMATOL, V34, P1115, DOI 10.1016/j.exphem.2006.04.025; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yan XY, 2007, LIFE SCI, V80, P307, DOI 10.1016/j.lfs.2006.09.022; Zenke M, 2006, TRENDS IMMUNOL, V27, P140, DOI 10.1016/j.it.2005.12.007	50	25	26	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					24	34		10.1074/jbc.M110.135921	http://dx.doi.org/10.1074/jbc.M110.135921			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21036898	hybrid, Green Published			2022-12-25	WOS:000285782800003
J	Guo, H; Friedman, AD				Guo, Hong; Friedman, Alan D.			Phosphorylation of RUNX1 by Cyclin-dependent Kinase Reduces Direct Interaction with HDAC1 and HDAC3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CBF-BETA-SMMHC; MYOSIN HEAVY-CHAIN; CELL-CYCLE; ADULT HEMATOPOIESIS; ACUTE-LEUKEMIA; PROLIFERATION; BINDING; ONCOPROTEINS; PROGRESSION; EXPRESSION	RUNX1 regulates formation of the definitive hematopoietic stem cell and its subsequent lineage maturation, and mutations of RUNX1 contribute to leukemic transformation. Phosphorylation of Ser-48, Ser-303, and Ser-424 by cyclin-dependent kinases (cdks) increases RUNX1 trans-activation activity without perturbing p300 interaction. We now find that endogenous RUNX1 interacts with endogenous HDAC1 or HDAC3. Mutation of the three RUNX1 serines to aspartic acid reduces co-immunoprecipitation with HDAC1 or HDAC3 when expressed in 293T cells; mutation of these three serines to alanine increases HDAC interaction, and mutation of each serine individually to aspartic acid also reduces these interactions. GST-RUNX1 isolated from bacterial extracts bound in vitro translated HDAC1 or HDAC3, and these interactions were weakened by mutation of Ser-48, Ser-303, and Ser-424 to aspartic acid. The ability of RUNX1 phosphorylation and not only serine to aspartic acid conversion to reduce HDAC1 binding was demonstrated using wild-type GST-RUNX1 phosphorylated in vitro using cdk1/cyclinB and by exposure of 293T cells transduced with RUNX1 and HDAC1 to roscovitine, a cdk inhibitor. Finally, RUNX1 or RUNX1(tripleD), in which Ser-48, Ser-303, and Ser-424 are mutated to aspartic acid, stimulated proliferation of transduced, lineage-negative murine marrow progenitors more potently than did RUNX1(tripleA), in which these serines are mutated to alanine, suggesting that stimulation of RUNX1 trans-activation by cdk-mediated reduction in HDAC interaction increases marrow progenitor cell proliferation.	[Guo, Hong; Friedman, Alan D.] Johns Hopkins Univ, Sch Med, Div Pediat Oncol, Baltimore, MD 21231 USA	Johns Hopkins University	Friedman, AD (corresponding author), CRB 1 Rm 253,1650 Orleans St, Baltimore, MD 21231 USA.	afriedm2@jhmi.edu			National Institutes of Health [R01CA098805, U01HL099775, U01HL100397]; Maryland Stem Cell Research Foundation; NATIONAL CANCER INSTITUTE [R01CA098805] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397, U01HL099775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA098805, U01HL099775, and U01HL100397. This work was also supported by a grant from the Maryland Stem Cell Research Foundation (to A. D. F.).	Bee T, 2009, BLOOD CELL MOL DIS, V43, P35, DOI 10.1016/j.bcmd.2009.03.011; Bernardin F, 2002, CANCER BIOL THER, V1, P492, DOI 10.4161/cbt.1.5.163; Bernardin F, 2002, CANCER RES, V62, P3904; Bernardin-Fried F, 2004, J BIOL CHEM, V279, P15678, DOI 10.1074/jbc.M310023200; Biggs JR, 2006, MOL CELL BIOL, V26, P7420, DOI 10.1128/MCB.00597-06; Burel SA, 2001, MOL CELL BIOL, V21, P5577, DOI 10.1128/MCB.21.16.5577-5590.2001; Burns CE, 2009, BLOOD, V113, P5776, DOI 10.1182/blood-2008-12-193607; Cao WS, 1997, ONCOGENE, V15, P1315, DOI 10.1038/sj.onc.1201305; Cao WS, 1998, J BIOL CHEM, V273, P31534, DOI 10.1074/jbc.273.47.31534; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; D'Costa J, 2005, LEUKEMIA, V19, P921, DOI 10.1038/sj.leu.2403755; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Durst KL, 2003, MOL CELL BIOL, V23, P607, DOI 10.1128/MCB.23.2.607-619.2003; FINER MH, 1994, BLOOD, V83, P43; Friedman AD, 1999, LEUKEMIA, V13, P1932, DOI 10.1038/sj.leu.2401590; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Imai Y, 2004, MOL CELL BIOL, V24, P1033, DOI 10.1128/MCB.24.3.1033-1043.2004; Joshi I, 2009, BLOOD, V113, P1689, DOI 10.1182/blood-2008-03-147967; Kagoshima H, 2007, DEVELOPMENT, V134, P3905, DOI 10.1242/dev.008276; Lou JR, 2000, ONCOGENE, V19, P2695, DOI 10.1038/sj.onc.1203588; Niini T, 2000, HAEMATOLOGICA, V85, P362; Nimmo R, 2005, DEVELOPMENT, V132, P5043, DOI 10.1242/dev.02102; Reed-Inderbitzin E, 2006, ONCOGENE, V25, P5777, DOI 10.1038/sj.onc.1209591; Robertson AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003770; ROUSSEL MF, 1995, P NATL ACAD SCI USA, V92, P6837, DOI 10.1073/pnas.92.15.6837; Strom DK, 2000, J BIOL CHEM, V275, P3438, DOI 10.1074/jbc.275.5.3438; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Tsuzuki S, 2007, PLOS MED, V4, P880, DOI 10.1371/journal.pmed.0040172; Wong CW, 1998, J BIOL CHEM, V273, P27695, DOI 10.1074/jbc.273.42.27695; Yang YD, 2002, CANCER RES, V62, P2232; Zhang LS, 2008, BLOOD, V111, P1193, DOI 10.1182/blood-2007-08-109702; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608	33	41	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					208	215		10.1074/jbc.M110.149013	http://dx.doi.org/10.1074/jbc.M110.149013			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21059642	hybrid, Green Published			2022-12-25	WOS:000285782800023
J	Perez-Cadahia, B; Drobic, B; Espino, PS; He, SH; Mandal, S; Healy, S; Davie, JR				Perez-Cadahia, Beatriz; Drobic, Bojan; Espino, Paula S.; He, Shihua; Mandal, Soma; Healy, Shannon; Davie, James R.			Role of MSK1 in the Malignant Phenotype of Ras-transformed Mouse Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-INDUCED PHOSPHORYLATION; HISTONE H3 PHOSPHORYLATION; CELL-TRANSFORMATION; MITOGEN; CANCER; AP-1; ACTIVATION; KINASE-1; PATHWAY; CYCLOOXYGENASE-2	Activated by the RAS-MAPK signaling pathway, MSK1 is recruited to immediate-early gene (IEG) regulatory regions, where it phosphorylates histone H3 at Ser-10 or Ser-28. Chromatin remodelers and modifiers are then recruited by 14-3-3 proteins, readers of phosphoserine marks, leading to the occupancy of IEG promoters by the initiation-engaged form of RNA polymerase II and the onset of transcription. In this study, we show that this mechanism of IEG induction, initially elucidated in parental 10T1/2 murine fibroblast cells, applies to metastatic Hras1-transformed Ciras-3 cells. As the RAS-MAPK pathway is constitutively activated in Ciras-3 cells, MSK1 activity and phosphorylated H3 steady-state levels are elevated. We found that steady-state levels of the IEG products AP-1 and COX-2 were also elevated in Ciras-3 cells. When MSK1 activity was inhibited or MSK1 expression was knocked down in Ciras-3 cells, the induction of IEG expression and the steady-state levels of COX-2, FRA-1, and JUN were greatly reduced. Furthermore, MSK1 knockdown Ciras-3 cells lost their malignant phenotype, as reflected by the absence of anchorage-independent growth.	[Perez-Cadahia, Beatriz; Drobic, Bojan; Espino, Paula S.; He, Shihua; Mandal, Soma; Healy, Shannon; Davie, James R.] Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada	University of Manitoba	Davie, JR (corresponding author), Univ Manitoba, Manitoba Inst Cell Biol, 675 McDermot Ave, Winnipeg, MB R3E 0V9, Canada.	davie@cc.umanitoba.ca		Davie, James/0000-0002-0420-6888	Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Manitoba Health Research Council; Canada Research Chair; Canadian Cancer Society Research Institute Terry Fox Foundation	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Cancer Society Research Institute Terry Fox Foundation	This work was supported by grants from the Canadian Cancer Society Research Institute, the Canadian Institutes of Health Research, and the Manitoba Health Research Council and by a Canada Research Chair (to J. R. D.), a Canadian Cancer Society Research Institute Terry Fox Foundation studentship (to B. D.), a Manitoba Health Research Council fellowship (to B. P.-C.), and a Canadian Institutes of Health Research Frederick Banting and Charles Best Canada graduate scholarship (to P. S. E.).	Arthur JSC, 2008, FRONT BIOSCI-LANDMRK, V13, P5866, DOI 10.2741/3122; BERGERS G, 1995, MOL CELL BIOL, V15, P3748; BOS JL, 1989, CANCER RES, V49, P4682; Brami-Cherrier K, 2009, J NEUROCHEM, V108, P1323, DOI 10.1111/j.1471-4159.2009.05879.x; Calipel A, 2003, J BIOL CHEM, V278, P42409, DOI 10.1074/jbc.M308709200; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Drobic B, 2004, CANCER RES, V64, P9076, DOI 10.1158/0008-5472.CAN-04-2369; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Dunn KL, 2009, GENE CHROMOSOME CANC, V48, P397, DOI 10.1002/gcc.20649; Dunn KL, 2005, BIOCHEM CELL BIOL, V83, P1, DOI 10.1139/O04-121; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; EGAN SE, 1987, MOL CELL BIOL, V7, P830, DOI 10.1128/MCB.7.2.830; Gesser B, 2007, J INVEST DERMATOL, V127, P2129, DOI 10.1038/sj.jid.5700859; Kim HG, 2008, CANCER RES, V68, P2538, DOI 10.1158/0008-5472.CAN-07-6597; Kustikova O, 1998, MOL CELL BIOL, V18, P7095, DOI 10.1128/MCB.18.12.7095; Mariani O, 2007, CANCER CELL, V11, P361, DOI 10.1016/j.ccr.2007.02.007; Mechta F, 1997, ONCOGENE, V14, P837, DOI 10.1038/sj.onc.1200900; Roze E, 2008, FASEB J, V22, P1083, DOI 10.1096/fj.07-9814; Sahin M, 2009, ANGIOLOGY, V60, P242, DOI 10.1177/0003319708318378; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shen Q, 2008, ONCOGENE, V27, P366, DOI 10.1038/sj.onc.1210643; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Strelkov IS, 2002, CANCER RES, V62, P75; Tange S, 2009, BIOCHEM BIOPH RES CO, V386, P588, DOI 10.1016/j.bbrc.2009.06.082; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Verde P, 2007, CELL CYCLE, V6, P2633, DOI 10.4161/cc.6.21.4850; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002	29	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					42	49		10.1074/jbc.M110.156687	http://dx.doi.org/10.1074/jbc.M110.156687			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21071437	hybrid, Green Published			2022-12-25	WOS:000285782800005
J	Tauber, E; Miller-Fleming, L; Mason, RP; Kwan, W; Clapp, J; Butler, NJ; Outeiro, TF; Muchowski, PJ; Giorgini, F				Tauber, Eran; Miller-Fleming, Leonor; Mason, Robert P.; Kwan, Wanda; Clapp, Jannine; Butler, Nicola J.; Outeiro, Tiago F.; Muchowski, Paul J.; Giorgini, Flaviano			Functional Gene Expression Profiling in Yeast Implicates Translational Dysfunction in Mutant Huntingtin Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE; SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; MODEL; GCN4; BIOINFORMATICS; TRANSCRIPTION; COACTIVATOR; ACTIVATION; EXPANSIONS	Huntington disease (HD) is a neurodegenerative disorder caused by the expansion of a polyglutamine tract in the huntingtin (htt) protein. To uncover candidate therapeutic targets and networks involved in pathogenesis, we integrated gene expression profiling and functional genetic screening to identify genes critical for mutant htt toxicity in yeast. Using mRNA profiling, we have identified genes differentially expressed in wild-type yeast in response to mutant htt toxicity as well as in three toxicity suppressor strains: bna4 Delta, mbf1 Delta, and ume1 Delta. BNA4 encodes the yeast homolog of kynurenine 3-monooxygenase, a promising drug target for HD. Intriguingly, despite playing diverse cellular roles, these three suppressors share common differentially expressed genes involved in stress response, translation elongation, and mitochondrial transport. We then systematically tested the ability of the differentially expressed genes to suppress mutant htt toxicity when overexpressed and have thereby identified 12 novel suppressors, including genes that play a role in stress response, Golgi to endosome transport, and rRNA processing. Integrating the mRNA profiling data and the genetic screening data, we have generated a robust network that shows enrichment in genes involved in rRNA processing and ribosome biogenesis. Strikingly, these observations implicate dysfunction of translation in the pathology of HD. Recent work has shown that regulation of translation is critical for life span extension in Drosophila and that manipulation of this process is protective in Parkinson disease models. In total, these observations suggest that pharmacological manipulation of translation may have therapeutic value in HD.	[Tauber, Eran; Miller-Fleming, Leonor; Mason, Robert P.; Clapp, Jannine; Butler, Nicola J.; Giorgini, Flaviano] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Kwan, Wanda; Muchowski, Paul J.] Univ Calif San Francisco, Gladstone Inst Neurol Dis, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Kwan, Wanda; Muchowski, Paul J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Outeiro, Tiago F.] Univ Lisbon, Fac Med, Inst Fisiol, P-1649028 Lisbon, Portugal; [Miller-Fleming, Leonor; Outeiro, Tiago F.] Univ Lisbon, Fac Med, Inst Mol Med, Cell & Mol Neurosci Unit, P-1649028 Lisbon, Portugal	University of Leicester; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Universidade de Lisboa; Universidade de Lisboa	Giorgini, F (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	fg36@le.ac.uk	Miller-Fleming, Leonor/J-4309-2015; Tauber, Eran/F-9826-2011; Outeiro, Tiago F/C-1067-2008; Tauber, Eran/AAA-1562-2022; Outeiro, Tiago/M-8106-2019; Outeiro, Tiago/L-7351-2019	Miller-Fleming, Leonor/0000-0002-3593-6461; Tauber, Eran/0000-0003-4018-6535; Outeiro, Tiago F/0000-0003-1679-1727; Tauber, Eran/0000-0003-4018-6535; Outeiro, Tiago/0000-0003-1679-1727; Giorgini, Flaviano/0000-0001-7881-9508	Fundacao para a Ciencia e a Tecnologia; CHDI Foundation, Inc.; European Molecular Biology Organization; Marie Curie International Reintegration Grant; NINDS [NS47237]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047237] Funding Source: NIH RePORTER; MRC [G0700090] Funding Source: UKRI; NERC [NE/D012058/1] Funding Source: UKRI; Medical Research Council [G0700090] Funding Source: researchfish; Natural Environment Research Council [NE/D012058/1] Funding Source: researchfish	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); CHDI Foundation, Inc.; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Marie Curie International Reintegration Grant(European Commission); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Supported by the Fundacao para a Ciencia e a Tecnologia.; Supported by the CHDI Foundation, Inc.; Supported by the European Molecular Biology Organization and a Marie Curie International Reintegration Grant.; Supported by National Institutes of Health Grant NS47237 from NINDS.	Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Carrozza MJ, 2005, BBA-GENE STRUCT EXPR, V1731, P77, DOI 10.1016/j.bbaexp.2005.09.005; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Crocker SF, 2006, BRAIN RES, V1088, P176, DOI 10.1016/j.brainres.2006.02.102; Derkatch IL, 1997, GENETICS, V147, P507; Doumanis J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007275; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Giorgini F., 2008, PROTEIN MISFOLDING B, P231; Giorgini F, 2008, J BIOL CHEM, V283, P7390, DOI 10.1074/jbc.M708192200; Giorgini F, 2006, METHOD ENZYMOL, V412, P201, DOI 10.1016/S0076-6879(06)12013-3; Giorgini F, 2009, METHODS MOL BIOL, V548, P161, DOI 10.1007/978-1-59745-540-4_9; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; HINNEBUSCH AG, 1984, P NATL ACAD SCI-BIOL, V81, P6442, DOI 10.1073/pnas.81.20.6442; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kassir Y, 2003, INT REV CYTOL, V224, P111, DOI 10.1016/S0074-7696(05)24004-4; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; King MA, 2008, MOL PHARMACOL, V73, P1052, DOI 10.1124/mol.107.043398; Liang J, 2008, HUM MOL GENET, V17, P3784, DOI 10.1093/hmg/ddn276; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mallory MJ, 2003, J BIOL CHEM, V278, P44727, DOI 10.1074/jbc.M308632200; Manogaran AL, 2010, YEAST, V27, P159, DOI 10.1002/yea.1740; Mascarenhas C, 2008, MOL BIOL CELL, V19, P2995, DOI 10.1091/mbc.E07-11-1173; Matsuo R, 2005, FEBS LETT, V579, P2433, DOI 10.1016/j.febslet.2005.03.043; Mendes ND, 2006, BIOINFORMATICS, V22, P2996, DOI 10.1093/bioinformatics/btl537; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; R Development Core Team, 2009, R FDN STAT COMP; Reimers M, 2006, METHOD ENZYMOL, V411, P119, DOI 10.1016/S0076-6879(06)11008-3; Runne H, 2008, J NEUROSCI, V28, P9723, DOI 10.1523/JNEUROSCI.3044-08.2008; Sipione S, 2002, HUM MOL GENET, V11, P1953, DOI 10.1093/hmg/11.17.1953; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Stevanin G, 2003, BRAIN, V126, P1599, DOI 10.1093/brain/awg155; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Takemaru K, 1997, P NATL ACAD SCI USA, V94, P7251, DOI 10.1073/pnas.94.14.7251; Takemaru K, 1998, MOL CELL BIOL, V18, P4971, DOI 10.1128/MCB.18.9.4971; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	53	35	35	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					410	419		10.1074/jbc.M110.101527	http://dx.doi.org/10.1074/jbc.M110.101527			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21044956	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000285782800044
J	Hoagland, EN; Sherwood, TW; Lee, KG; Walker, CJ; Askwith, CC				Hoagland, Erin N.; Sherwood, Thomas W.; Lee, Kirsten G.; Walker, Christopher J.; Askwith, Candice C.			Identification of a Calcium Permeable Human Acid-sensing Ion Channel 1 Transcript Variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; GATED NA+ CHANNEL; MUTATIONS CAUSING NEURODEGENERATION; TARANTULA TOXIN PSALMOTOXIN-1; MAMMALIAN DEGENERIN MDEG; SENSORY NEURONS; CATION CHANNEL; CAENORHABDITIS-ELEGANS; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING	The acid-sensing ion channels (ASICs) are proton-gated cation channels activated when extracellular pH declines. In rodents, the Accn2 gene encodes transcript variants ASIC1a and ASIC1b, which differ in the first third of the protein and display distinct channel properties. In humans, ACCN2 transcript variant 2 (hVariant 2) is homologous to mouse ASIC1a. In this article, we study two other human ACCN2 transcript variants. Human ACCN2 transcript variant 1 (hVariant 1) is not present in rodents and contains an additional 46 amino acids directly preceding the proposed channel gate. We report that hVariant 1 does not produce proton-gated currents under normal conditions when expressed in heterologous systems. We also describe a third human ACCN2 transcript variant (hVariant 3) that is similar to rodent ASIC1b. hVariant 3 is more abundantly expressed in dorsal root ganglion compared with brain and shows basic channel properties analogous to rodent ASIC1b. Yet, proton-gated currents from hVariant 3 are significantly more permeable to calcium than either hVariant 2 or rodent ASIC1b, which shows negligible calcium permeability. hVariant 3 also displays a small acid-dependent sustained current. Such a sustained current is particularly intriguing as ASIC1b is thought to play a role in sensory transduction in rodents. In human DRG neurons, hVariant 3 could induce sustained calcium influx in response to acidic pH and make a major contribution to acid-dependent sensations, such as pain.	Ohio State Univ, Sch Med, Dept Neurosci, Columbus, OH 43210 USA; [Walker, Christopher J.] Ohio State Univ, Sch Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Askwith, CC (corresponding author), 4197 Graves Hall,333 W 10th Ave, Columbus, OH 43210 USA.	askwith.1@osu.edu			National Institutes of Health [R01 NS062967, T32GM068412]; College of Medicine at The Ohio State University; American Heart Association [09PRE2200005]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Medicine at The Ohio State University; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS062967.; Supported by National Institutes of Health Training Grant T32GM068412 and a fellowship awarded by the College of Medicine at The Ohio State University.; Supported by an American Heart Association Predoctoral Fellowship 09PRE2200005.	Adams CM, 1998, J BIOL CHEM, V273, P30204, DOI 10.1074/jbc.273.46.30204; Akata T, 2007, J ANESTH, V21, P220, DOI 10.1007/s00540-006-0487-5; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Babinski K, 1999, J NEUROCHEM, V72, P51, DOI 10.1046/j.1471-4159.1999.0720051.x; Bashari E, 2009, AM J PHYSIOL-CELL PH, V296, pC372, DOI 10.1152/ajpcell.00200.2008; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Baumann TK, 1996, PAIN, V65, P31, DOI 10.1016/0304-3959(95)00145-X; Baumann TK, 2004, EUR J NEUROSCI, V19, P1343, DOI 10.1111/j.1460-9568.2004.03097.x; Benos DJ, 1999, J PHYSIOL-LONDON, V520, P631, DOI 10.1111/j.1469-7793.1999.00631.x; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Celotto C, 2008, BRAZ J MED BIOL RES, V41, P439, DOI 10.1590/S0100-879X2008005000026; Champigny G, 1998, J BIOL CHEM, V273, P15418, DOI 10.1074/jbc.273.25.15418; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Chen XM, 2006, NEUROPHARMACOLOGY, V50, P964, DOI 10.1016/j.neuropharm.2006.01.007; Cheng JK, 2008, NEUROCHEM RES, V33, P1970, DOI 10.1007/s11064-008-9711-z; Cho JH, 2007, AM J PHYSIOL-CELL PH, V292, pC2161, DOI 10.1152/ajpcell.00598.2006; Chung WS, 2010, AM J PHYSIOL-CELL PH, V298, pC1198, DOI 10.1152/ajpcell.00511.2009; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Coryell MW, 2007, BIOL PSYCHIAT, V62, P1140, DOI 10.1016/j.biopsych.2007.05.008; Coryell MW, 2009, J NEUROSCI, V29, P5381, DOI 10.1523/JNEUROSCI.0360-09.2009; Coscoy S, 1999, J BIOL CHEM, V274, P10129, DOI 10.1074/jbc.274.15.10129; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; de Weille JR, 1998, FEBS LETT, V433, P257, DOI 10.1016/S0014-5793(98)00916-8; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Dib-Hajj SD, 1999, FEBS LETT, V462, P117, DOI 10.1016/S0014-5793(99)01519-7; Dube GR, 2009, CURR PHARM DESIGN, V15, P1750, DOI 10.2174/138161209788186263; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grunder S, 2000, NEUROREPORT, V11, P1607; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Hey JG, 2007, STROKE, V38, P670, DOI 10.1161/01.STR.0000251443.68897.99; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jones NG, 2004, J NEUROSCI, V24, P10974, DOI 10.1523/JNEUROSCI.2619-04.2004; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Salinas M, 2009, J BIOL CHEM, V284, P31851, DOI 10.1074/jbc.M109.043984; Sherwood T, 2009, J BIOL CHEM, V284, P27899, DOI 10.1074/jbc.M109.029009; Sherwood TW, 2008, J BIOL CHEM, V283, P1818, DOI 10.1074/jbc.M705118200; Sherwood TW, 2009, J NEUROSCI, V29, P14371, DOI 10.1523/JNEUROSCI.2186-09.2009; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Springauf A, 2010, J PHYSIOL-LONDON, V588, P809, DOI 10.1113/jphysiol.2009.182931; Tominaga M., 2007, V179, P489; Ugawa S, 2005, MOL BRAIN RES, V136, P125, DOI 10.1016/j.molbrainres.2005.01.010; Ugawa S, 2001, NEUROREPORT, V12, P2865, DOI 10.1097/00001756-200109170-00022; Valeyev AY, 1996, J NEUROPHYSIOL, V76, P3555, DOI 10.1152/jn.1996.76.5.3555; Voilley Nicolas, 2004, Current Drug Targets - Inflammation and Allergy, V3, P71, DOI 10.2174/1568010043483980; Vukicevic M, 2006, J BIOL CHEM, V281, P714, DOI 10.1074/jbc.M510472200; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 2001, ADV EXP MED BIOL, V502, P293; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2006, J MEMBRANE BIOL, V209, P59, DOI 10.1007/s00232-005-0840-x; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xu TL, 2009, PROG NEUROBIOL, V87, P171, DOI 10.1016/j.pneurobio.2009.01.004; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	77	44	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41852	41862		10.1074/jbc.M110.171330	http://dx.doi.org/10.1074/jbc.M110.171330			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21036899	Green Published, hybrid			2022-12-25	WOS:000285622600073
J	Grubb, MS; Burrone, J				Grubb, Matthew S.; Burrone, Juan			Channelrhodopsin-2 Localised to the Axon Initial Segment	PLOS ONE			English	Article							ACTION-POTENTIAL INITIATION; CEREBELLAR PURKINJE-CELLS; PYRAMIDAL NEURONS; NEURAL CIRCUITRY; ANKYRIN-BINDING; SODIUM-CHANNELS; IN-VIVO; PHOTORECEPTOR DEGENERATION; ADHESION MOLECULES; OPTICAL INDUCTION	The light-gated cation channel Channelrhodopsin-2 (ChR2) is a powerful and versatile tool for controlling neuronal activity. Currently available versions of ChR2 either distribute uniformly throughout the plasma membrane or are localised specifically to somatodendritic or synaptic domains. Localising ChR2 instead to the axon initial segment (AIS) could prove an extremely useful addition to the optogenetic repertoire, targeting the channel directly to the site of action potential initiation, and limiting depolarisation and associated calcium entry elsewhere in the neuron. Here, we describe a ChR2 construct that we localised specifically to the AIS by adding the ankyrinG-binding loop of voltage-gated sodium channels (NavII-III) to its intracellular terminus. Expression of ChR2-YFP-NavII-III did not significantly affect the passive or active electrical properties of cultured rat hippocampal neurons. However, the tiny ChR2 currents and small membrane depolarisations resulting from AIS targeting meant that optogenetic control of action potential firing with ChR2-YFP-NavII-III was unsuccessful in baseline conditions. We did succeed in stimulating action potentials with light in some ChR2-YFP-NavII-III-expressing neurons, but only when blocking KCNQ voltage-gated potassium channels. We discuss possible alternative approaches to obtaining precise control of neuronal spiking with AIS-targeted optogenetic constructs and propose potential uses for our ChR2-YFP-NavII-III probe where subthreshold modulation of action potential initiation is desirable.	[Grubb, Matthew S.; Burrone, Juan] Kings Coll London, MRC, Ctr Dev Neurobiol, London WC2R 2LS, England	University of London; King's College London	Grubb, MS (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, London WC2R 2LS, England.	matthew.grubb@kcl.ac.uk	Grubb, Matthew S/B-4939-2008	Grubb, Matthew S/0000-0002-2673-274X; Burrone, Juan/0000-0003-1233-668X	Wellcome Trust; MRC [G0901899] Funding Source: UKRI; Medical Research Council [G0901899] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Alilain WJ, 2008, J NEUROSCI, V28, P11862, DOI 10.1523/JNEUROSCI.3378-08.2008; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Barker AT, 1999, EEG CL N SU, P3; Bellmann D, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00027; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Bender KJ, 2009, NEURON, V61, P259, DOI 10.1016/j.neuron.2008.12.004; Berndt A, 2010, BIOPHYS J, V98, P753, DOI 10.1016/j.bpj.2009.10.052; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brackenbury WJ, 2010, P NATL ACAD SCI USA, V107, P2283, DOI 10.1073/pnas.0909434107; Brechet A, 2008, J CELL BIOL, V183, P1101, DOI 10.1083/jcb.200805169; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Clark BD, 2009, NEUROSCIENTIST, V15, P651, DOI 10.1177/1073858409341973; Colbert CM, 1996, J NEUROSCI, V16, P6676; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P232, DOI 10.1113/jphysiol.1957.sp005888; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; DAVIS JQ, 1993, J CELL BIOL, V121, P121, DOI 10.1083/jcb.121.1.121; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Fache MP, 2004, J CELL BIOL, V166, P571, DOI 10.1083/jcb.200312155; FATT P, 1957, J NEUROPHYSIOL, V20, P61, DOI 10.1152/jn.1957.20.1.61; Fleidervish IA, 2010, NAT NEUROSCI, V13, P852, DOI 10.1038/nn.2574; Foust A, 2010, J NEUROSCI, V30, P6891, DOI 10.1523/JNEUROSCI.0552-10.2010; FUORTES MGF, 1957, J GEN PHYSIOL, V40, P735, DOI 10.1085/jgp.40.5.735; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Garver TD, 1997, J CELL BIOL, V137, P703, DOI 10.1083/jcb.137.3.703; Glickfeld LL, 2009, NAT NEUROSCI, V12, P21, DOI 10.1038/nn.2230; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Grubb MS, 2010, CURR OPIN NEUROBIOL, V20, P481, DOI 10.1016/j.conb.2010.04.012; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hagglund M, 2010, NAT NEUROSCI, V13, P246, DOI 10.1038/nn.2482; Hales Chadwick M, 2010, J Vis Exp, DOI 10.3791/2056; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Khirug S, 2008, J NEUROSCI, V28, P4635, DOI 10.1523/JNEUROSCI.0908-08.2008; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Kramer RH, 2009, CURR OPIN NEUROBIOL, V19, P544, DOI 10.1016/j.conb.2009.09.004; Kuba H, 2010, NATURE, V465, P1075, DOI 10.1038/nature09087; Laezza F, 2007, J NEUROSCI, V27, P12033, DOI 10.1523/JNEUROSCI.2282-07.2007; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Lemaillet G, 2003, J BIOL CHEM, V278, P27333, DOI 10.1074/jbc.M303327200; LETERRIER C, 2010, NEUROSCI LETT; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Meeks JP, 2007, J NEUROPHYSIOL, V97, P3460, DOI 10.1152/jn.01288.2006; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Ogawa Y, 2008, CURR OPIN NEUROBIOL, V18, P307, DOI 10.1016/j.conb.2008.08.008; Ogawa Y, 2008, J NEUROSCI, V28, P5731, DOI 10.1523/JNEUROSCI.4431-07.2008; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Palmer LM, 2010, J PHYSIOL-LONDON, V588, P1709, DOI 10.1113/jphysiol.2010.188300; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Rasmussen HB, 2007, J CELL SCI, V120, P953, DOI 10.1242/jcs.03396; Rush AM, 2005, J PHYSIOL-LONDON, V564, P803, DOI 10.1113/jphysiol.2005.083089; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Schoonheim PJ, 2010, J NEUROSCI, V30, P7111, DOI 10.1523/JNEUROSCI.5193-09.2010; Shah MM, 2008, P NATL ACAD SCI USA, V105, P7869, DOI 10.1073/pnas.0802805105; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; Sobotzik JM, 2009, P NATL ACAD SCI USA, V106, P17564, DOI 10.1073/pnas.0909267106; SOMOGYI P, 1983, BRAIN RES, V259, P137, DOI 10.1016/0006-8993(83)91076-4; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; Tehovnik EJ, 2006, J NEUROPHYSIOL, V96, P512, DOI 10.1152/jn.00126.2006; Thyagarajan S, 2010, J NEUROSCI, V30, P8745, DOI 10.1523/JNEUROSCI.4417-09.2010; Tomita H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007679; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; TOREBJORK HE, 1987, BRAIN, V110, P1509, DOI 10.1093/brain/110.6.1509; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; Tyler WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003511; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wang H, 2009, J NEUROSCI, V29, P13202, DOI 10.1523/JNEUROSCI.3248-09.2009; Wilson BS, 2008, HEARING RES, V242, P3, DOI 10.1016/j.heares.2008.06.005; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Yang Y, 2007, J CELL BIOL, V176, P509, DOI 10.1083/jcb.200610128; Yu YG, 2008, J NEUROSCI, V28, P7260, DOI 10.1523/JNEUROSCI.1613-08.2008; Yu YG, 2010, J NEUROSCI, V30, P11858, DOI 10.1523/JNEUROSCI.2651-10.2010; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhang YP, 2008, P NATL ACAD SCI USA, V105, P12039, DOI 10.1073/pnas.0802940105; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	105	41	41	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13761	10.1371/journal.pone.0013761	http://dx.doi.org/10.1371/journal.pone.0013761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048938	Green Published, gold, Green Submitted			2022-12-25	WOS:000283645300039
J	Ni, H; Huang, L; Chen, N; Zhang, FY; Liu, DB; Ge, M; Guan, SD; Zhu, Y; Wang, JH				Ni, Hong; Huang, Li; Chen, Na; Zhang, Fengyu; Liu, Dongbo; Ge, Ming; Guan, Sudong; Zhu, Yan; Wang, Jin-Hui			Upregulation of Barrel GABAergic Neurons Is Associated with Cross-Modal Plasticity in Olfactory Deficit	PLOS ONE			English	Article							SENSORIMOTOR SYSTEM; CYTOCHROME-OXIDASE; AUDITORY-CORTEX; INTERNEURONS; HIPPOCAMPUS; HOMEOSTASIS; INHIBITION; MECHANISMS; NEOCORTEX; RATS	Background: Loss of a sensory function is often followed by the hypersensitivity of other modalities in mammals, which secures them well-awareness to environmental changes. Cellular and molecular mechanisms underlying cross-modal sensory plasticity remain to be documented. Methodology/Principal Findings: Multidisciplinary approaches, such as electrophysiology, behavioral task and immunohistochemistry, were used to examine the involvement of specific types of neurons in cross-modal plasticity. We have established a mouse model that olfactory deficit leads to a whisking upregulation, and studied how GABAergic neurons are involved in this cross-modal plasticity. In the meantime of inducing whisker tactile hypersensitivity, the olfactory injury recruits more GABAergic neurons and their fine processes in the barrel cortex, as well as upregulates their capacity of encoding action potentials. The hyperpolarization driven by inhibitory inputs strengthens the encoding ability of their target cells. Conclusion/Significance: The upregulation of GABAergic neurons and the functional enhancement of neuronal networks may play an important role in cross-modal sensory plasticity. This finding provides the clues for developing therapeutic approaches to help sensory recovery and substitution.	[Ni, Hong; Huang, Li; Liu, Dongbo; Ge, Ming; Guan, Sudong; Zhu, Yan; Wang, Jin-Hui] Bengbu Med Coll, Dept Physiol, Bengbu, Anhui, Peoples R China; [Chen, Na; Zhang, Fengyu; Wang, Jin-Hui] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China	Bengbu Medical College; Chinese Academy of Sciences; Institute of Biophysics, CAS	Ni, H (corresponding author), Bengbu Med Coll, Dept Physiol, Bengbu, Anhui, Peoples R China.	jhw@ibp.ac.cn			National Award for Outstanding Young Scientist [30325021]; National Basic Research Program [2006CB500804]; Natural Science Foundation China [30621130077, 30870517, 30990261]; Chinese Academy of Sciences [KSCX2-YWR-39]	National Award for Outstanding Young Scientist; National Basic Research Program(National Basic Research Program of China); Natural Science Foundation China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study is supported by the National Award for Outstanding Young Scientist (30325021), National Basic Research Program (2006CB500804), Natural Science Foundation China (30621130077, 30870517 and 30990261), Program in Chinese Academy of Sciences for Knowledge Innovation (KSCX2-YWR-39) to JHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Buck LB, 2000, SMELL TASTE CHEM SEN; Chen N, 2006, BIOCHEM BIOPH RES CO, V340, P151, DOI 10.1016/j.bbrc.2005.11.170; Chen N, 2008, J CELL SCI, V121, P2961, DOI 10.1242/jcs.022368; Chen N, 2006, BIOCHEM BIOPH RES CO, V346, P281, DOI 10.1016/j.bbrc.2006.05.120; Chen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011868; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Collignon O, 2009, EXP BRAIN RES, V192, P343, DOI 10.1007/s00221-008-1553-z; Davis E, 2007, CELL, V130, P593, DOI 10.1016/j.cell.2007.08.007; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Dye MWG, 2008, ANN NY ACAD SCI, V1145, P71, DOI 10.1196/annals.1416.013; Fanselow EE, 2008, J NEUROPHYSIOL, V100, P2640, DOI 10.1152/jn.90691.2008; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Ge RJ, 2009, BIOCHEM BIOPH RES CO, V387, P585, DOI 10.1016/j.bbrc.2009.07.066; Gulyas AI, 2006, EUR J NEUROSCI, V23, P2581, DOI 10.1111/j.1460-9568.2006.04814.x; HEVNER RF, 1989, J NEUROSCI, V9, P3884; Kadosh RC, 2006, CURR BIOL, V16, pR962, DOI 10.1016/j.cub.2006.10.017; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; Maier DL, 1997, EXP NEUROL, V145, P71, DOI 10.1006/exnr.1997.6426; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Neville H, 2002, PROG BRAIN RES, V138, P177, DOI 10.1016/S0079-6123(02)38078-6; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petersen CCH, 2003, PFLUG ARCH EUR J PHY, V447, P126, DOI 10.1007/s00424-003-1167-z; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; Ptito Maurice, 2005, Journal of Integrative Neuroscience, V4, P479, DOI 10.1142/S0219635205000951; Qi YL, 2009, BIOCHEM BIOPH RES CO, V381, P129, DOI 10.1016/j.bbrc.2009.02.058; Sanchez-Vives MV, 2006, PROG BRAIN RES, V155, P287, DOI 10.1016/S0079-6123(06)55017-4; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Towal RB, 2006, J NEUROSCI, V26, P8838, DOI 10.1523/JNEUROSCI.0581-06.2006; Wang JH, 2003, BRAIN RES BULL, V60, P53, DOI 10.1016/S0361-9230(03)00026-1; Wang JH, 2001, J PHYSIOL-LONDON, V533, P407, DOI 10.1111/j.1469-7793.2001.0407a.x; Wang JH, 2008, J CELL SCI, V121, P2951, DOI 10.1242/jcs.025684; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; Yan ZQ, 2008, NEURON, V58, P613, DOI 10.1016/j.neuron.2008.03.012	41	43	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13736	10.1371/journal.pone.0013736	http://dx.doi.org/10.1371/journal.pone.0013736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060832	Green Published, Green Submitted, gold			2022-12-25	WOS:000283645300016
J	Jiang, L; Liu, JF; Sun, DX; Ma, PP; Ding, XD; Yu, Y; Zhang, Q				Jiang, Li; Liu, Jianfeng; Sun, Dongxiao; Ma, Peipei; Ding, Xiangdong; Yu, Ying; Zhang, Qin			Genome Wide Association Studies for Milk Production Traits in Chinese Holstein Population	PLOS ONE			English	Article							SOMATIC-CELL SCORE; TRANSMISSION DISEQUILIBRIUM TEST; GENERALIZED ESTIMATING EQUATIONS; SINGLE-NUCLEOTIDE POLYMORPHISM; ECONOMICALLY IMPORTANT TRAITS; GROWTH-HORMONE RECEPTOR; AYRSHIRE DAIRY-CATTLE; QUANTITATIVE TRAIT; LINKAGE DISEQUILIBRIUM; COMPLEX TRAITS	Genome-wide association studies (GWAS) based on high throughput SNP genotyping technologies open a broad avenue for exploring genes associated with milk production traits in dairy cattle. Motivated by pinpointing novel quantitative trait nucleotide (QTN) across Bos Taurus genome, the present study is to perform GWAS to identify genes affecting milk production traits using current state-of-the-art SNP genotyping technology, i.e., the Illumina BovineSNP50 BeadChip. In the analyses, the five most commonly evaluated milk production traits are involved, including milk yield (MY), milk fat yield (FY), milk protein yield (PY), milk fat percentage (FP) and milk protein percentage (PP). Estimated breeding values (EBVs) of 2,093 daughters from 14 paternal half-sib families are considered as phenotypes within the framework of a daughter design. Association tests between each trait and the 54K SNPs are achieved via two different analysis approaches, a paternal transmission disequilibrium test (TDT)-based approach (L1-TDT) and a mixed model based regression analysis (MMRA). In total, 105 SNPs were detected to be significantly associated genome-wise with one or multiple milk production traits. Of the 105 SNPs, 38 were commonly detected by both methods, while four and 63 were solely detected by L1-TDT and MMRA, respectively. The majority (86 out of 105) of the significant SNPs is located within the reported QTL regions and some are within or close to the reported candidate genes. In particular, two SNPs, ARS-BFGL-NGS-4939 and BFGL-NGS-118998, are located close to the DGAT1 gene (160bp apart) and within the GHR gene, respectively. Our findings herein not only provide confirmatory evidences for previously findings, but also explore a suite of novel SNPs associated with milk production traits, and thus form a solid basis for eventually unraveling the causal mutations for milk production traits in dairy cattle.	[Jiang, Li; Liu, Jianfeng; Sun, Dongxiao; Ma, Peipei; Ding, Xiangdong; Yu, Ying; Zhang, Qin] China Agr Univ, Coll Anim Sci & Technol, Minist Agr, Key Lab Anim Genet & Breeding, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Jiang, L (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Minist Agr, Key Lab Anim Genet & Breeding, Beijing 100094, Peoples R China.	qzhang@cau.edu.cn		Jiang, Li/0000-0002-0648-2173; Liu, Jian-Feng/0000-0002-5766-7864	State High-Tech Development Plan of China [2008AA101002]; National Natural Science Foundations of China [30972092, 30800776]; National Key Basic Research Program of China [2006CB102104]; China Agricultural University	State High-Tech Development Plan of China; National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); China Agricultural University	This work was supported by the State High-Tech Development Plan of China (Grant No. 2008AA101002), the National Natural Science Foundations of China (Grant No. 30972092,30800776), the National Key Basic Research Program of China (Grant No. 2006CB102104), and the Graduate R&D Innovation Project of China Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1998, AM J HUM GENET, V63, P1190, DOI 10.1086/302038; Amills M, 2005, J ANIM SCI, V83, P493; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Ashwell MS, 2001, J DAIRY SCI, V84, P2535, DOI 10.3168/jds.S0022-0302(01)74705-4; Ashwell MS, 2004, J DAIRY SCI, V87, P468, DOI 10.3168/jds.S0022-0302(04)73186-0; Awad A, 2010, ANIM GENET, V41, P1, DOI 10.1111/j.1365-2052.2009.01957.x; Bagnato A, 2008, J DAIRY SCI, V91, P767, DOI 10.3168/jds.2007-0507; Bennewitz J, 2004, J DAIRY SCI, V87, P431, DOI 10.3168/jds.S0022-0302(04)73182-3; Bennewitz J, 2003, GENET SEL EVOL, V35, P319, DOI [10.1051/gse:2003011, 10.1186/1297-9686-35-3-319]; Benyamin B, 2009, PHARMACOGENOMICS, V10, P181, DOI 10.2217/14622416.10.2.181; Blott S, 2003, GENETICS, V163, P253; Boichard D, 2003, GENET SEL EVOL, V35, P77, DOI 10.1051/gse:2002037; Brym Pawel, 2005, Journal of Applied Genetics, V46, P179; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Coppieters W, 1998, MAMM GENOME, V9, P540, DOI 10.1007/s003359900815; Craig DW, 2005, EXPERT REV MOL DIAGN, V5, P159, DOI 10.1586/14737159.5.2.159; Daetwyler HD, 2008, J DAIRY SCI, V91, P3225, DOI 10.3168/jds.2007-0333; Daw EW, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S32; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Farnir F, 2002, GENETICS, V161, P275; Gao H, 2009, HEREDITY, V103, P368, DOI 10.1038/hdy.2009.71; Gauderman W. James, 1999, Journal of the National Cancer Institute Monographs, P31; GEORGES M, 1995, GENETICS, V139, P907; Georges M, 2007, ANNU REV GENOM HUM G, V8, P131, DOI 10.1146/annurev.genom.8.080706.092408; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Grapes L, 2004, GENETICS, V166, P1561, DOI 10.1534/genetics.166.3.1561; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Haegeman A, 2003, ANIM GENET, V34, P349, DOI 10.1046/j.1365-2052.2003.01008.x; Harder B, 2006, J ANIM BREED GENET, V123, P89, DOI 10.1111/j.1439-0388.2006.00577.x; Heyen DW, 1999, PHYSIOL GENOMICS, V1, P165, DOI 10.1152/physiolgenomics.1999.1.3.165; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Horin P, 2008, DEV BIOLOGICALS, V132, P347, DOI 10.1159/000317184; Huang JA, 2003, AM J HUM GENET, V72, P949, DOI 10.1086/374568; Kaminski S, 2008, ANIM BIOTECHNOL, V19, P43, DOI 10.1080/10495390701880946; Kaupe B, 2007, J ANIM SCI, V85, P11, DOI 10.2527/jas.2005-753; Kolbehdari D, 2006, J ANIM BREED GENET, V123, P191, DOI 10.1111/j.1439-0388.2006.00579.x; Kolbehdari D, 2009, J ANIM BREED GENET, V126, P216, DOI 10.1111/j.1439-0388.2008.00793.x; Kuss AW, 2003, J DAIRY SCI, V86, P2213, DOI 10.3168/jds.S0022-0302(03)73811-9; Lange C, 2001, GENETICS, V159, P1325; Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/oxfordjournals.aje.a000179; Liu JF, 2007, AM J HUM GENET, V81, P304, DOI 10.1086/519495; Liu JF, 2009, GENET EPIDEMIOL, V33, P217, DOI 10.1002/gepi.20372; Liu YZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006827; Looft C, 2001, MAMM GENOME, V12, P646, DOI 10.1007/s003350020003; Lund MS, 2008, J DAIRY SCI, V91, P4028, DOI 10.3168/jds.2007-0290; Lund MS, 2008, GENET SEL EVOL, V40, P177, DOI 10.1051/gse:2007043; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Meuwissen THE, 2001, GENET SEL EVOL, V33, P605, DOI 10.1051/gse:2001134; Ng CC, 2009, J HUM GENET, V54, P392, DOI 10.1038/jhg.2009.49; OGOREVC J, 2009, ANIM GENET; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Rodriguez-Zas SL, 2002, J DAIRY SCI, V85, P2681, DOI 10.3168/jds.S0022-0302(02)74354-3; Schaeffer LR, 2000, J DAIRY SCI, V83, P1135, DOI 10.3168/jds.S0022-0302(00)74979-4; Schulman NF, 2008, GENET SEL EVOL, V40, P195, DOI 10.1051/gse:2007044; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sun FZ, 2000, ANN HUM GENET, V64, P555, DOI 10.1017/S000348000000840X; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Thomsen H, 2001, J ANIM BREED GENET, V118, P357, DOI 10.1046/j.1439-0388.2001.00302.x; THOMSEN H, 2006, 8 WORLD C GEN APPL L; Vallet JL, 2005, J ANIM SCI, V83, P1860; Vallet JL, 2005, ANIM GENET, V36, P97, DOI 10.1111/j.1365-2052.2005.01233.x; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Viitala SM, 2003, J DAIRY SCI, V86, P1828, DOI 10.3168/jds.S0022-0302(03)73769-2; Wiener P, 2000, ANIM GENET, V31, P385, DOI 10.1046/j.1365-2052.2000.00689.x; Williams KJ, 2009, ARTERIOSCL THROM VAS, V29, P792, DOI 10.1161/ATVBAHA.109.187823; Zhao HH, 2007, GENETICS, V175, P1975, DOI 10.1534/genetics.106.066480	67	172	190	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13661	10.1371/journal.pone.0013661	http://dx.doi.org/10.1371/journal.pone.0013661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048968	Green Published, Green Submitted, gold			2022-12-25	WOS:000283537000030
J	Schreeg, LA; Kress, WJ; Erickson, DL; Swenson, NG				Schreeg, Laura A.; Kress, W. John; Erickson, David L.; Swenson, Nathan G.			Phylogenetic Analysis of Local-Scale Tree Soil Associations in a Lowland Moist Tropical Forest	PLOS ONE			English	Article							HABITAT ASSOCIATIONS; RAIN-FOREST; MANGANESE TOXICITY; ALUMINUM ACCUMULATION; SPECIES DISTRIBUTION; COMMUNITY STRUCTURE; EDAPHIC FACTORS; BARRO-COLORADO; MYCORRHIZAL; DIVERSITY	Background: Local plant-soil associations are commonly studied at the species-level, while associations at the level of nodes within a phylogeny have been less well explored. Understanding associations within a phylogenetic context, however, can improve our ability to make predictions across systems and can advance our understanding of the role of evolutionary history in structuring communities. Methodology/Principal Findings: Here we quantified evolutionary signal in plant-soil associations using a DNA sequence-based community phylogeny and several soil variables (e. g., extractable phosphorus, aluminum and manganese, pH, and slope as a proxy for soil water). We used published plant distributional data from the 50-ha plot on Barro Colorado Island (BCI), Republic of Panama. Our results suggest some groups of closely related species do share similar soil associations. Most notably, the node shared by Myrtaceae and Vochysiaceae was associated with high levels of aluminum, a potentially toxic element. The node shared by Apocynaceae was associated with high extractable phosphorus, a nutrient that could be limiting on a taxon specific level. The node shared by the large group of Laurales and Magnoliales was associated with both low extractable phosphorus and with steeper slope. Despite significant node-specific associations, this study detected little to no phylogeny-wide signal. We consider the majority of the 'traits' (i.e., soil variables) evaluated to fall within the category of ecological traits. We suggest that, given this category of traits, phylogeny-wide signal might not be expected while node-specific signals can still indicate phylogenetic structure with respect to the variable of interest. Conclusions: Within the BCI forest dynamics plot, distributions of some plant taxa are associated with local-scale differences in soil variables when evaluated at individual nodes within the phylogenetic tree, but they are not detectable by phylogeny-wide signal. Trends highlighted in this analysis suggest how plant-soil associations may drive plant distributions and diversity at the local-scale.	[Schreeg, Laura A.] Univ Florida, Sch Nat Resources & Environm, Dept Biol, Gainesville, FL 32611 USA; [Schreeg, Laura A.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Kress, W. John; Erickson, David L.] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA; [Swenson, Nathan G.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	State University System of Florida; University of Florida; Smithsonian Institution; Smithsonian Tropical Research Institute; Smithsonian Institution; Smithsonian National Museum of Natural History; Michigan State University	Schreeg, LA (corresponding author), Univ Florida, Sch Nat Resources & Environm, Dept Biol, Gainesville, FL 32611 USA.	schreeg@ufl.edu	Swenson, Nathan/A-3514-2012	Swenson, Nathan/0000-0003-3819-9767	National Science Foundation; University of Florida (UF); Smithsonian Tropical Research Institute; NSF [DEB021104, 021115, 0212284, 0212818, OISE 0314581]	National Science Foundation(National Science Foundation (NSF)); University of Florida (UF)(University of Florida); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); NSF(National Science Foundation (NSF))	NGS was supported by a National Science Foundation Post-Doctoral Fellowship in Bioinformatics while this work was being performed. LAS was supported by fellowships from University of Florida (UF) and the Smithsonian Tropical Research Institute during this work. This project was initiated during the Organization for Tropical Studies (OTS) Plant Systematics course. LAS's participation and travel was supported by OTS, UF Department of Botany, UF Office of Research, a Field Research Grant through the UF Tropical Conservation and Development Program and Michelle Mack's Ecosystem Ecology lab. The soil data used in the analysis were collected by STRI Soils Initiative and CTFS, led by Jim Dalling and Kyle Harms with support from NSF DEB021104, 021115, 0212284, 0212818 and OISE 0314581 and the field assistance of Paolo Segre and Juan Di Trani. The plant distribution data used in this work were collected through the Center for Tropical Forest Science and are cited accordingly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba S, 2004, PLANT ECOL, V174, P147, DOI 10.1023/B:VEGE.0000046059.92806.49; BAILLIE I, 2006, SEMIDETAILLED SOIL S; Barthold FK, 2008, FOREST ECOL MANAG, V255, P1135, DOI 10.1016/j.foreco.2007.09.089; BECKER P, 1988, J TROP ECOL, V4, P173, DOI 10.1017/S0266467400002674; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Bohning-Gaese K, 1999, EVOL ECOL RES, V1, P347; Clark DB, 1999, ECOLOGY, V80, P2662, DOI 10.1890/0012-9658(1999)080[2662:EFATLS]2.0.CO;2; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Condit R, 1999, PHILOS T R SOC B, V354, P1739, DOI 10.1098/rstb.1999.0517; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Condit R, 1996, J ECOL, V84, P549, DOI 10.2307/2261477; DALLING J, 2009, SOIL MAPS BARRO COLO; Davies SJ, 2005, ECOL STU AN, V174, P22; Daws MI, 2002, PLANT SOIL, V238, P79, DOI 10.1023/A:1014289930621; Ducic T, 2006, NEW PHYTOL, V170, P11, DOI 10.1111/j.1469-8137.2006.01666.x; El-Jaoual T, 1998, J PLANT NUTR, V21, P353, DOI 10.1080/01904169809365409; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Fine PVA, 2005, EVOLUTION, V59, P1464; Fitter AH, 1996, PHILOS T R SOC B, V351, P1367, DOI 10.1098/rstb.1996.0120; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Gunatilleke CVS, 2006, J TROP ECOL, V22, P371, DOI 10.1017/S0266467406003282; Hall JS, 2004, ECOLOGY, V85, P2171, DOI 10.1890/03-0043; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Harms KE, 2004, FOREST DYNAMICS PLOT; Hubbell S.P., 1986, COMMUNITY ECOLOGY, P314; HUBBELL SP, 1983, BRIT ECOLOGICAL SOC, V2, P25; Hubbell SP, 1986, CONSERVATION BIOL SC, P205; Hue NV, 2001, SOIL SCI SOC AM J, V65, P153, DOI 10.2136/sssaj2001.651153x; Husband R, 2002, MOL ECOL, V11, P2669, DOI 10.1046/j.1365-294X.2002.01647.x; Jansen S, 2002, ANN BOT-LONDON, V90, P53, DOI 10.1093/aob/mcf142; Jansen S, 2002, BOT REV, V68, P235, DOI 10.1663/0006-8101(2002)068[0235:AHIAAR]2.0.CO;2; Jansen S, 2000, ANN BOT-LONDON, V85, P91, DOI 10.1006/anbo.1999.1000; JANSEN S, 2004, EVOLUTION PLANT PHYS, P467; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Kaspari M, 2008, ECOL LETT, V11, P35, DOI 10.1111/j.1461-0248.2007.01124.x; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; KEMBEL SW, BIOINFORMAT IN PRESS; Kiers ET, 2000, ECOL LETT, V3, P106, DOI 10.1046/j.1461-0248.2000.00126.x; Kitao M, 2001, ENVIRON POLLUT, V111, P89, DOI 10.1016/S0269-7491(99)00332-2; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lambers H, 2008, TRENDS ECOL EVOL, V23, P95, DOI 10.1016/j.tree.2007.10.008; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Marschner H., 1986, Mineral nutrition of higher plants.; McQuattie CH, 2000, CAN J FOREST RES, V30, P456, DOI 10.1139/cjfr-30-3-456; MEHLICH A, 1984, COMMUN SOIL SCI PLAN, V15, P1409, DOI 10.1080/00103628409367568; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; MORRIS HD, 1949, AGRON J, V41, P107, DOI 10.2134/agronj1949.00021962004100030003x; Niinemets U, 2006, ECOL MONOGR, V76, P521, DOI 10.1890/0012-9615(2006)076[0521:TTSDAW]2.0.CO;2; PEREZ R, 2005, METODOLOGIA EMPLEADA, P1; Phillips OL, 2003, J ECOL, V91, P757, DOI 10.1046/j.1365-2745.2003.00815.x; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; SANDERS FE, 1971, NATURE, V233, P278, DOI 10.1038/233278c0; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; SMITH SE, 1982, NEW PHYTOL, V90, P293, DOI 10.1111/j.1469-8137.1982.tb03261.x; Sollins P, 1998, ECOLOGY, V79, P23, DOI 10.1890/0012-9658(1998)079[0023:FISCIT]2.0.CO;2; St Clair SB, 2005, TREE PHYSIOL, V25, P85, DOI 10.1093/treephys/25.1.85; Stevens P.F, ANGIOSPERM PHYLOGENY; Svenning JC, 2004, ECOLOGY, V85, P2526, DOI 10.1890/03-0396; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Tateno R, 2003, ECOL RES, V18, P559, DOI 10.1046/j.1440-1703.2003.00578.x; TILMAN D, 1988; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Turner BL, 2008, J ECOL, V96, P698, DOI 10.1111/j.1365-2745.2008.01384.x; van der Heijden MGA, 2007, NEW PHYTOL, V174, P244, DOI 10.1111/j.1469-8137.2007.02041.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vandenkoornhuyse P, 2003, MOL ECOL, V12, P3085, DOI 10.1046/j.1365-294X.2003.01967.x; Vitousek PM, 1997, BIOGEOCHEMISTRY, V37, P63, DOI 10.1023/A:1005757218475; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; WEBB CO, 2008, PHYLOCOM SOFTWARE AN; WEBB L. J., 1954, AUSTRALIAN JOUR BOT, V2, P176, DOI 10.1071/BT9540176; YAVITT JB, 1988, BIOTROPICA, V20, P2, DOI 10.2307/2388420; Zimmerman JK, 2007, J TROP ECOL, V23, P231, DOI 10.1017/S0266467406003890	80	39	41	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13685	10.1371/journal.pone.0013685	http://dx.doi.org/10.1371/journal.pone.0013685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060686	Green Published, gold, Green Submitted			2022-12-25	WOS:000283537000050
J	Dong, BC; Zhang, MX; Alpert, P; Lei, GC; Yu, FH				Dong, Bi-Cheng; Zhang, Ming-Xiang; Alpert, Peter; Lei, Guang-Chun; Yu, Fei-Hai			Effects of Orientation on Survival and Growth of Small Fragments of the Invasive, Clonal Plant Alternanthera philoxeroides	PLOS ONE			English	Article							TRIFOLIUM-REPENS L; NITROGEN RESERVES; REGENERATION; STORAGE; REMOBILIZATION; INTEGRATION; REGROWTH	Background: The ability of small clonal fragments to establish and grow after disturbance is an important ecological advantage of clonal growth in plants and a major factor in the invasiveness of some introduced, clonal species. We hypothesized that orientation in the horizontal position (typical for stoloniferous plants) can increase the survival and growth of dispersed clonal fragments, and that this effect of orientation can be stronger when fragments are smaller and thus have fewer reserves to support initial growth. Methodology/Principal Findings: To test these hypotheses, we compared performance of single-node pieces of stolon fragments of Alternanthera philoxeroides planted at angles of 0, 45 or 90 degrees away from the horizontal position, with either the distal or the proximal end of the fragment up and with either 1 or 3 cm of stolon left attached both distal and proximal to the ramet. As expected, survival and growth were greatest when fragments were positioned horizontally. Contrary to expectations, some of these effects of orientation were stronger when attached stolons were longer. Orientation had smaller effects than stolon length on the performance of fragments; survival of fragments was about 60% with shorter stolons and 90% with longer stolons. Conclusions/Significance: Results supported the hypothesis that orientation can affect establishment of small clonal fragments, suggested that effects of orientation can be stronger in larger rather than smaller fragments, and indicated that orientation may have less effect on establishment than amount of stored resources.	[Dong, Bi-Cheng; Zhang, Ming-Xiang; Lei, Guang-Chun; Yu, Fei-Hai] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Alpert, Peter] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	Beijing Forestry University; University of Massachusetts System; University of Massachusetts Amherst	Dong, BC (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.	zmx1972@126.com; feihaiyu@bjfu.edu.cn	Yu, Fei-Hai/O-9395-2016; Guangchun, Lei/ABC-8081-2021	Yu, Fei-Hai/0000-0001-5007-1745; Dong, Bi-Cheng/0000-0002-9658-9969	Fundamental Research Funds for the Central Universities [BLJ200910]; Forestry Commonwealth Project	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Forestry Commonwealth Project	This work was supported by the Fundamental Research Funds for the Central Universities (BLJ200910) and a Forestry Commonwealth Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrat-Segretain MH, 2000, HYDROBIOLOGIA, V421, P31, DOI 10.1023/A:1003980927853; BAURHOCH B, 1990, J EXP BOT, V41, P573, DOI 10.1093/jxb/41.5.573; Corre N, 1996, J EXP BOT, V47, P1111, DOI 10.1093/jxb/47.8.1111; DANCKWERTS JE, 1989, ANN BOT-LONDON, V64, P533, DOI 10.1093/oxfordjournals.aob.a087875; Decruyenaere JG, 2001, WEED SCI, V49, P760, DOI 10.1614/0043-1745(2001)049[0760:SOCPIG]2.0.CO;2; Dong BC, 2010, EVOL ECOL, V24, P1447, DOI 10.1007/s10682-010-9390-5; Holm L., 1997, NATURAL HIST DISTRIB; Iwasa Y, 1997, EVOL ECOL, V11, P41, DOI 10.1023/A:1018483429029; JULIEN MH, 1995, J AQUAT PLANT MANAGE, V33, P55; Klimes L, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P1; Klimesova J, 2008, WEED RES, V48, P131, DOI 10.1111/j.1365-3180.2007.00608.x; Klimesova J, 2007, PERSPECT PLANT ECOL, V8, P115, DOI 10.1016/j.ppees.2006.10.002; Latzel V, 2009, ACTA OECOL, V35, P541, DOI 10.1016/j.actao.2009.04.003; [马瑞燕 Ma Ruiyan], 2005, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V11, P246; Morris DA, 2004, PLANT HORMONES: BIOSYNTHESIS, SIGNAL TRANSDUCTION, ACTION, P437; Muday GK, 2001, J PLANT GROWTH REGUL, V20, P226, DOI 10.1007/s003440010027; Pan XY, 2007, ACTA PHYTOTAXON SIN, V45, P884, DOI 10.1360/aps06134; Puijalon S, 2008, EVOL ECOL, V22, P493, DOI 10.1007/s10682-007-9177-5; Sainty G., 1997, WETLANDS ECOLOGY MAN, V5, P195, DOI DOI 10.1023/A:1008248921849; Stuefer JF, 1999, ECOL LETT, V2, P135; Suzuki Jun-ichirou, 1999, Plant Species Biology, V14, P11, DOI 10.1046/j.1442-1984.1999.00002.x; Volenec JJ, 1996, PHYSIOL PLANTARUM, V97, P185, DOI 10.1111/j.1399-3054.1996.tb00496.x; Wang N, 2008, ANN BOT-LONDON, V101, P671, DOI 10.1093/aob/mcn005; Wijte AHBM, 2005, INT J PLANT SCI, V166, P507, DOI 10.1086/428915; Xu CY, 2010, J ECOL, V98, P833, DOI 10.1111/j.1365-2745.2010.01668.x; Ye WH, 2003, WEED RES, V43, P297, DOI 10.1046/j.1365-3180.2003.00346.x	26	28	37	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13631	10.1371/journal.pone.0013631	http://dx.doi.org/10.1371/journal.pone.0013631			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049029	Green Published, gold			2022-12-25	WOS:000283487400021
J	Gangolf, M; Czerniecki, J; Radermecker, M; Detry, O; Nisolle, M; Jouan, C; Martin, D; Chantraine, F; Lakaye, B; Wins, P; Grisar, T; Bettendorff, L				Gangolf, Marjorie; Czerniecki, Jan; Radermecker, Marc; Detry, Olivier; Nisolle, Michelle; Jouan, Caroline; Martin, Didier; Chantraine, Frederic; Lakaye, Bernard; Wins, Pierre; Grisar, Thierry; Bettendorff, Lucien			Thiamine Status in Humans and Content of Phosphorylated Thiamine Derivatives in Biopsies and Cultured Cells	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; CYTOSOLIC ADENYLATE KINASE; REDUCED FOLATE CARRIER; PHOSPHATE-ESTERS; RAT-BRAIN; METABOLIZING ENZYMES; ALZHEIMERS-DISEASE; HEART-FAILURE; WHOLE-BLOOD; NUCLEOSIDE-DIPHOSPHATASE	Background: Thiamine (vitamin B1) is an essential molecule for all life forms because thiamine diphosphate (ThDP) is an indispensable cofactor for oxidative energy metabolism. The less abundant thiamine monophosphate (ThMP), thiamine triphosphate (ThTP) and adenosine thiamine triphosphate (AThTP), present in many organisms, may have still unidentified physiological functions. Diseases linked to thiamine deficiency (polyneuritis, Wernicke-Korsakoff syndrome) remain frequent among alcohol abusers and other risk populations. This is the first comprehensive study on the distribution of thiamine derivatives in human biopsies, body fluids and cell lines. Methodology and Principal Findings: Thiamine derivatives were determined by HPLC. In human tissues, the total thiamine content is lower than in other animal species. ThDP is the major thiamine compound and tissue levels decrease at high age. In semen, ThDP content correlates with the concentration of spermatozoa but not with their motility. The proportion of ThTP is higher in humans than in rodents, probably because of a lower 25-kDa ThTPase activity. The expression and activity of this enzyme seems to correlate with the degree of cell differentiation. ThTP was present in nearly all brain and muscle samples and in similar to 60% of other tissue samples, in particular fetal tissue and cultured cells. A low ([ThTP]+[ThMP])/([Thiamine]+[ThMP]) ratio was found in cardiovascular tissues of patients with cardiac insufficiency. AThTP was detected only sporadically in adult tissues but was found more consistently in fetal tissues and cell lines. Conclusions and Significance: The high sensitivity of humans to thiamine deficiency is probably linked to low circulating thiamine concentrations and low ThDP tissue contents. ThTP levels are relatively high in many human tissues, as a result of low expression of the 25-kDa ThTPase. Another novel finding is the presence of ThTP and AThTP in poorly differentiated fast-growing cells, suggesting a hitherto unsuspected link between these compounds and cell division or differentiation.	[Gangolf, Marjorie; Czerniecki, Jan; Lakaye, Bernard; Wins, Pierre; Grisar, Thierry; Bettendorff, Lucien] Univ Liege, GIGA Neurosci, Liege, Belgium; [Radermecker, Marc] Univ Liege, Univ Hosp, Dept Cardiovasc Surg, Liege, Belgium; [Detry, Olivier] Univ Liege, Univ Hosp, Dept Abdominal Surg & Transplantat, Liege, Belgium; [Nisolle, Michelle; Jouan, Caroline; Chantraine, Frederic] Univ Liege, Univ Hosp, Dept Obstet Gynecol, Liege, Belgium; [Martin, Didier] Univ Liege, Univ Hosp, Dept Neurosurg, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege; University of Liege	Gangolf, M (corresponding author), Univ Liege, GIGA Neurosci, Liege, Belgium.	L.Bettendorff@ulg.ac.be	Detry, Olivier/I-9333-2019; Czerniecki, Jan/H-7168-2017	Detry, Olivier/0000-0002-9436-6673; Czerniecki, Jan/0000-0002-8889-8382; MARTIN, Didier Herman/0000-0001-7325-4958				AUGER J, 1989, J ANDROL, V10, P439; BALAGHI M, 1966, J NUTR, V89, P127, DOI 10.1093/jn/89.2.127; BARCHI RL, 1972, J BIOL CHEM, V247, P7668; Benton D, 1997, PSYCHOPHARMACOLOGY, V129, P66, DOI 10.1007/s002130050163; BETTENDORFF L, 1993, J MEMBRANE BIOL, V136, P281; BETTENDORFF L, 1994, BBA-MOL CELL RES, V1222, P1, DOI 10.1016/0167-4889(94)90018-3; BETTENDORFF L, 1991, ANAL BIOCHEM, V198, P52, DOI 10.1016/0003-2697(91)90505-N; BETTENDORFF L, 1988, BIOCHEM BIOPH RES CO, V154, P942, DOI 10.1016/0006-291X(88)90230-6; Bettendorff L, 2003, ANAL BIOCHEM, V322, P190, DOI 10.1016/j.ab.2003.08.013; BETTENDORFF L, 1994, BBA-MOL CELL RES, V1222, P7, DOI 10.1016/0167-4889(94)90019-1; Bettendorff L, 1996, J NEUROCHEM, V66, P250; Bettendorff L, 1997, J NEUROCHEM, V69, P2005; BETTENDORFF L, 1986, J CHROMATOGR, V382, P297, DOI 10.1016/S0378-4347(00)83533-1; BETTENDORFF L, 1989, J NEUROCHEM, V53, P80, DOI 10.1111/j.1471-4159.1989.tb07297.x; BETTENDORFF L, 1987, J NEUROCHEM, V49, P495, DOI 10.1111/j.1471-4159.1987.tb02891.x; Bettendorff L, 2007, NAT CHEM BIOL, V3, P211, DOI 10.1038/nchembio867; Bettendorff L, 2009, FEBS J, V276, P2917, DOI 10.1111/j.1742-4658.2009.07019.x; BRUNNEKREEFT JWI, 1989, J CHROMATOGR-BIOMED, V491, P89, DOI 10.1016/S0378-4347(00)82822-4; BUTTERWORTH RF, 1991, METAB BRAIN DIS, V6, P207, DOI 10.1007/BF00996920; Butterworth RF, 2009, METAB BRAIN DIS, V24, P189, DOI 10.1007/s11011-008-9129-y; Carpenter KJ, 2000, BERIBERI WHITE RICE; CASIROLA D, 1990, J MEMBRANE BIOL, V118, P11, DOI 10.1007/BF01872201; Chaggar PS, 2009, CARDIOVASC THER, V27, P187, DOI 10.1111/j.1755-5922.2009.00094.x; Chen MF, 1996, J AM COLL NUTR, V15, P231; COOPER JR, 1969, SCIENCE, V164, P74, DOI 10.1126/science.164.3875.74; Czerniecki J, 2004, NEUROSCIENCE, V125, P833, DOI 10.1016/j.neuroscience.2004.02.033; DECARO L, 1961, INT Z VITAMINFORSCH, V31, P333; DREYFUS PM, 1961, J NEUROCHEM, V8, P139, DOI 10.1111/j.1471-4159.1961.tb13535.x; EGI Y, 1992, BIOCHIM BIOPHYS ACTA, V1160, P171, DOI 10.1016/0167-4838(92)90004-W; EGI Y, 1986, BIOCHEM INT, V12, P385; Fattal-Valevski A, 2005, PEDIATRICS, V115, pE233, DOI 10.1542/peds.2004-1255; Fayol V, 1997, METHOD ENZYMOL, V279, P57; FLORIDI A, 1984, INT J VITAM NUTR RES, V54, P165; Frederich M, 2009, FEBS J, V276, P3256, DOI 10.1111/j.1742-4658.2009.07040.x; Fukuwatari T, 2010, J NUTR SCI VITAMINOL, V56, P19, DOI 10.3177/jnsv.56.19; Gadau S, 2006, DIABETOLOGIA, V49, P405, DOI 10.1007/s00125-005-0103-5; Gangolf M, 2010, J BIOL CHEM, V285, P583, DOI 10.1074/jbc.M109.054379; GASTALDI G, 1992, BIOCHIM BIOPHYS ACTA, V1105, P271, DOI 10.1016/0005-2736(92)90204-Y; Gigliobianco T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-148; Gigliobianco T, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-16; Gioda CR, 2010, AM J PHYSIOL-HEART C, V298, pH2039, DOI 10.1152/ajpheart.00820.2009; Gioda CR, 2009, EUR J HEART FAIL, V11, P1126, DOI 10.1093/eurjhf/hfp146; GOLD M, 1995, ARCH NEUROL-CHICAGO, V52, P1081, DOI 10.1001/archneur.1995.00540350075019; Gong CL, 2006, RNA, V12, P1468, DOI 10.1261/rna.119806; Harper C, 2006, EUR J NEUROL, V13, P1078, DOI 10.1111/j.1468-1331.2006.01530.x; HARPER CG, 1986, J NEUROL NEUROSUR PS, V49, P341, DOI 10.1136/jnnp.49.4.341; Hazell AS, 2009, ALCOHOL ALCOHOLISM, V44, P141, DOI 10.1093/alcalc/agn120; Heroux M, 1996, METAB BRAIN DIS, V11, P81, DOI 10.1007/BF02080933; HINTING A, 1988, INT J ANDROL, V11, P277, DOI 10.1111/j.1365-2605.1988.tb01001.x; HOORN RKJ, 1975, CLIN CHIM ACTA, V61, P151, DOI 10.1016/0009-8981(75)90309-5; IBER FL, 1982, AM J CLIN NUTR, V36, P1067, DOI 10.1093/ajcn/36.5.1067; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-33; Kawasaki T., 1992, MODERN CHROMATOGRAPH, P319; KIMURA M, 1985, J CHROMATOGR, V332, P181, DOI 10.1016/S0021-9673(01)83295-7; KIMURA M, 1982, CLIN CHEM, V28, P29; Klooster A, 2007, MED HYPOTHESES, V69, P873, DOI 10.1016/j.mehy.2007.01.067; Kopelman MD, 2009, ALCOHOL ALCOHOLISM, V44, P148, DOI 10.1093/alcalc/agn118; KRUGER TF, 1988, FERTIL STERIL, V49, P112; Laforenza U, 1997, AM J CLIN NUTR, V66, P320, DOI 10.1093/ajcn/66.2.320; Lakaye B, 2004, INT J BIOCHEM CELL B, V36, P2032, DOI 10.1016/j.biocel.2004.03.004; Lakaye B, 2004, INT J BIOCHEM CELL B, V36, P1348, DOI 10.1016/j.biocel.2003.11.013; Lakaye B, 2002, J BIOL CHEM, V277, P13771, DOI 10.1074/jbc.M111241200; Lu J, 2008, CLIN CHEM, V54, P901, DOI 10.1373/clinchem.2007.099077; Makarchikov AF, 2003, CELL MOL LIFE SCI, V60, P1477, DOI 10.1007/s00018-003-3098-4; MAKARCHIKOV AF, 1992, BIOCHIM BIOPHYS ACTA, V1117, P326, DOI 10.1016/0304-4165(92)90032-P; Makarchikov Alexander F., 2007, BMC Biochemistry, V8, P17, DOI 10.1186/1471-2091-8-17; Mastrogiacomo F, 1996, ANN NEUROL, V39, P585, DOI 10.1002/ana.410390507; MATSUDA T, 1989, J NEUROCHEM, V52, P842, DOI 10.1111/j.1471-4159.1989.tb02530.x; McCandless D, 2009, THIAMINE DEFICIENCY; MCCANDLESS DW, 1968, J CLIN INVEST, V47, P2268, DOI 10.1172/JCI105912; MIYOSHI K, 1990, J BIOCHEM-TOKYO, V108, P267, DOI 10.1093/oxfordjournals.jbchem.a123192; Molina JA, 2002, J NEURAL TRANSM, V109, P1035, DOI 10.1007/s007020200087; Muri RM, 1999, CLIN NUTR, V18, P375, DOI 10.1016/S0261-5614(99)80019-3; Nascimento JM, 2008, J CELL PHYSIOL, V217, P745, DOI 10.1002/jcp.21549; Nghiem HO, 2000, FASEB J, V14, P543, DOI 10.1096/fasebj.14.3.543; Oishi K, 2004, DEV BIOL, V266, P299, DOI 10.1016/j.ydbio.2003.10.026; Pekovich SR, 1998, J NUTR BIOCHEM, V9, P215, DOI 10.1016/S0955-2863(97)00187-3; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PINCUS JH, 1970, EXP NEUROL, V28, P477, DOI 10.1016/0014-4886(70)90184-6; PINCUS JH, 1976, ARCH NEUROL-CHICAGO, V33, P759, DOI 10.1001/archneur.1976.00500110027005; Reidling JC, 2002, BBA-BIOMEMBRANES, V1561, P180, DOI 10.1016/S0005-2736(02)00341-3; RINDI G, 1981, EXPERIENTIA, V37, P975, DOI 10.1007/BF01971788; Sacca L, 2009, CIRC-HEART FAIL, V2, P151, DOI 10.1161/CIRCHEARTFAILURE.108.821892; SANO S, 1988, EUR J BIOCHEM, V171, P231, DOI 10.1111/j.1432-1033.1988.tb13781.x; SCHRIJVER J, 1978, NEUROCHEM RES, V3, P699, DOI 10.1007/BF00965993; SCILEPPI KP, 1984, J AM GERIATR SOC, V32, P709, DOI 10.1111/j.1532-5415.1984.tb04168.x; SHIKATA H, 1989, BIOCHEM INT, V18, P933; Shimomura T, 1998, ARCH NEUROL-CHICAGO, V55, P1242, DOI 10.1001/archneur.55.9.1242; Shin BH, 2004, MOL CELLS, V18, P133; Siesjo B.K., 1978, BRAIN ENERGY METABOL; SMIDT LJ, 1991, J GERONTOL, V46, pM16, DOI 10.1093/geronj/46.1.M16; Song JK, 2008, J BIOL CHEM, V283, P10939, DOI 10.1074/jbc.M709675200; Szyniarowski P, 2005, BBA-GEN SUBJECTS, V1725, P93, DOI 10.1016/j.bbagen.2005.05.026; TALLAKSEN CME, 1991, J CHROMATOGR-BIOMED, V564, P127, DOI 10.1016/0378-4347(91)80075-N; VANZAANEN HCT, 1992, CANCER, V69, P1710, DOI 10.1002/1097-0142(19920401)69:7<1710::AID-CNCR2820690711>3.0.CO;2-D; Vognar L, 2009, J AM GERIATR SOC, V57, P2166, DOI 10.1111/j.1532-5415.2009.02542.x; Wang YH, 2001, BBA-BIOMEMBRANES, V1513, P49, DOI 10.1016/S0005-2736(01)00340-6; WEBER W, 1985, EUR J CLIN PHARMACOL, V28, P213, DOI 10.1007/BF00609694; Wilkinson TJ, 1997, AM J CLIN NUTR, V66, P925, DOI 10.1093/ajcn/66.4.925; Williams AC, 2004, BIOL REPROD, V71, P1309, DOI 10.1095/biolreprod.104.028407; Williams RD, 1940, ARCH INTERN MED, V66, P785, DOI 10.1001/archinte.1940.00190160002001; YAMAZAKI M, 1968, J BIOL CHEM, V243, P2934; ZEMPLENI J, 1992, INT J VITAM NUTR RES, V62, P165; Zhao RB, 2002, AM J PHYSIOL-CELL PH, V282, pC1512, DOI 10.1152/ajpcell.00547.2001	104	133	138	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13616	10.1371/journal.pone.0013616	http://dx.doi.org/10.1371/journal.pone.0013616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049048	Green Published, gold			2022-12-25	WOS:000283422100020
J	Greenfield, A; Madar, A; Ostrer, H; Bonneau, R				Greenfield, Alex; Madar, Aviv; Ostrer, Harry; Bonneau, Richard			DREAM4: Combining Genetic and Dynamic Information to Identify Biological Networks and Dynamical Models	PLOS ONE			English	Article							REGULATORY NETWORKS; CLUSTER-ANALYSIS; CHIP-SEQ; INFERENCE; RECONSTRUCTION	Background: Current technologies have lead to the availability of multiple genomic data types in sufficient quantity and quality to serve as a basis for automatic global network inference. Accordingly, there are currently a large variety of network inference methods that learn regulatory networks to varying degrees of detail. These methods have different strengths and weaknesses and thus can be complementary. However, combining different methods in a mutually reinforcing manner remains a challenge. Methodology: We investigate how three scalable methods can be combined into a useful network inference pipeline. The first is a novel t-test-based method that relies on a comprehensive steady-state knock-out dataset to rank regulatory interactions. The remaining two are previously published mutual information and ordinary differential equation based methods (tlCLR and Inferelator 1.0, respectively) that use both time-series and steady-state data to rank regulatory interactions; the latter has the added advantage of also inferring dynamic models of gene regulation which can be used to predict the system's response to new perturbations. Conclusion/Significance: Our t-test based method proved powerful at ranking regulatory interactions, tying for first out of 19 methods in the DREAM4 100-gene in-silico network inference challenge. We demonstrate complementarity between this method and the two methods that take advantage of time-series data by combining the three into a pipeline whose ability to rank regulatory interactions is markedly improved compared to either method alone. Moreover, the pipeline is able to accurately predict the response of the system to new conditions (in this case new double knock-out genetic perturbations). Our evaluation of the performance of multiple methods for network inference suggests avenues for future methods development and provides simple considerations for genomic experimental design. Our code is publicly available at http://err.bio.nyu.edu/inferelator/.	[Greenfield, Alex; Bonneau, Richard] NYU, Sackler Sch Med, Computat Biol Program, New York, NY 10012 USA; [Madar, Aviv; Bonneau, Richard] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Ostrer, Harry] NYU, Dept Pediat, Langone Med Ctr, Human Genet Program, New York, NY 10016 USA; [Bonneau, Richard] NYU, Courant Inst Math Sci, Dept Comp Sci, New York, NY 10012 USA	New York University; New York University; New York University; NYU Langone Medical Center; New York University	Greenfield, A (corresponding author), NYU, Sackler Sch Med, Computat Biol Program, New York, NY 10012 USA.	Bonneau@nyu.edu	Bonneau, Richard/ABD-6737-2021; Bonneau, Richard/GZL-2900-2022; Madar, Aviv/D-1023-2013; Madar, Aviv/AAO-1540-2020		National Science Foundation (NSF) [DBI-0820757]; National Institutes of Health (NIH) [I U54CA143907-01]; University of Luxembourg/Luxembourg Centre for Systems Biomedicine; National Institutes of Health through the NIH Roadmap for Medical Research [PN2 EY016586]; NATIONAL CANCER INSTITUTE [U54CA143907] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Luxembourg/Luxembourg Centre for Systems Biomedicine; National Institutes of Health through the NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors were funded by National Science Foundation (NSF) grant DBI-0820757, National Institutes of Health (NIH) PSOC # I U54CA143907-01, the University of Luxembourg/Luxembourg Centre for Systems Biomedicine, and the National Institutes of Health through the NIH Roadmap for Medical Research (PN2 EY016586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ M, 2009, P 12 INT WORKSH ART, V5, P9; Bansal M, 2006, BIOINFORMATICS, V22, P815, DOI 10.1093/bioinformatics/btl003; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bergmann S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031902; Bonneau R, 2008, NAT CHEM BIOL, V4, P658, DOI 10.1038/nchembio.122; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Butte A J, 2000, Pac Symp Biocomput, P418; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Efron B., 1994, INTRO BOOTSTRAP; EFRON B, 2004, LEAST ANGLE REGRESSI, P407; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Facciotti MT, 2007, P NATL ACAD SCI USA, V104, P4630, DOI 10.1073/pnas.0611663104; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman N, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P206; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; GARDNER TS, 2003, INFERRING GENETIC NE, P102; Haynes BC, 2009, BIOINFORMATICS, V25, P801, DOI 10.1093/bioinformatics/btp068; He F, 2009, J BIOTECHNOL, V144, P190, DOI 10.1016/j.jbiotec.2009.07.013; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Horak CE, 2002, METHOD ENZYMOL, V350, P469, DOI 10.1016/S0076-6879(02)50979-4; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kerr MK, 2001, P NATL ACAD SCI USA, V98, P8961, DOI 10.1073/pnas.161273698; Kirk PDW, 2009, BIOINFORMATICS, V25, P1300, DOI 10.1093/bioinformatics/btp139; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Liang KC, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/253894; MADAR A, 2009, C P ANN INT C IEEE E, V1, P5448; Madar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009803; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, ANN NY ACAD SCI, V1158, P102, DOI 10.1111/j.1749-6632.2008.03945.x; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Mardis ER, 2007, NAT METHODS, V4, P613, DOI 10.1038/nmeth0807-613; Margolin A. A., 2006, BMC BIOINFORMATICS, V15, P1; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mazur J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-448; Mendes P, 2003, BIOINFORMATICS, V19, pII122, DOI 10.1093/bioinformatics/btg1069; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; REISS DJ, 2006, BMC BIOINFORMATICS, V7; Schmid CD, 2007, CELL, V131, P831, DOI 10.1016/j.cell.2007.11.017; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHASHA D, 2008, STAT IS EASY, DOI DOI 10.2200/S00142ED1V01Y200807MAS001; Smith V Anne, 2003, Pac Symp Biocomput, P164; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; van Someren EP, 2006, BIOINFORMATICS, V22, P477, DOI 10.1093/bioinformatics/bti816; Yip KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008121	49	152	154	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13397	10.1371/journal.pone.0013397	http://dx.doi.org/10.1371/journal.pone.0013397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049040	Green Published, Green Submitted, gold			2022-12-25	WOS:000283422100003
J	Love, D; Li, FQ; Burke, MC; Cyge, B; Ohmitsu, M; Cabello, J; Larson, JE; Brody, SL; Cohen, JC; Takemaru, KI				Love, Damon; Li, Feng-Qian; Burke, Michael C.; Cyge, Benjamin; Ohmitsu, Masao; Cabello, Jeffrey; Larson, Janet E.; Brody, Steven L.; Cohen, J. Craig; Takemaru, Ken-Ichi			Altered Lung Morphogenesis, Epithelial Cell Differentiation and Mechanics in Mice Deficient in the Wnt/beta-Catenin Antagonist Chibby	PLOS ONE			English	Article							TRANSCRIPTION FACTOR HFH-4; BETA-CATENIN; STEM-CELLS; MOUSE; CILIOGENESIS; EXPRESSION; PATHWAY; CILIARY	The canonical Wnt/beta-catenin pathway plays crucial roles in various aspects of lung morphogenesis and regeneration/repair. Here, we examined the lung phenotype and function in mice lacking the Wnt/b-catenin antagonist Chibby (Cby). In support of its inhibitory role in canonical Wnt signaling, expression of beta-catenin target genes is elevated in the Cby(-/-) lung. Notably, Cby protein is prominently associated with the centrosome/basal body microtubule structures in embryonic lung epithelial progenitor cells, and later enriches as discrete foci at the base of motile cilia in airway ciliated cells. At birth, Cby(-/-) lungs are grossly normal but spontaneously develop alveolar airspace enlargement with reduced proliferation and abnormal differentiation of lung epithelial cells, resulting in altered pulmonary function. Consistent with the Cby expression pattern, airway ciliated cells exhibit a marked paucity of motile cilia with apparent failure of basal body docking. Moreover, we demonstrate that Cby is a direct downstream target for the master ciliogenesis transcription factor Foxj1. Collectively, our results demonstrate that Cby facilitates proper postnatal lung development and function.	[Love, Damon; Li, Feng-Qian; Cyge, Benjamin; Ohmitsu, Masao; Cabello, Jeffrey; Takemaru, Ken-Ichi] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Love, Damon; Li, Feng-Qian; Cyge, Benjamin; Takemaru, Ken-Ichi] SUNY Stony Brook, Grad Program Mol & Cellular Pharmacol, Stony Brook, NY 11794 USA; [Burke, Michael C.] SUNY Stony Brook, Med Scientist Program MSTP, Stony Brook, NY 11794 USA; [Burke, Michael C.; Takemaru, Ken-Ichi] SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; [Larson, Janet E.; Cohen, J. Craig] SUNY Stony Brook, Dept Pediat, Sect Neonatol, Stony Brook, NY 11794 USA; [Brody, Steven L.] Washington Univ, Sch Med, Dept Internal Med, Div Pulm & Crit Care, St Louis, MO 63110 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Washington University (WUSTL)	Love, D (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	takemaru@pharm.stonybrook.edu			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK073191, DK073191-S1]; Brady Russell Fund; New York State Department of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Brady Russell Fund; New York State Department of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant DK073191 to K.-I. Takemaru, an NIDDK research supplemental grant DK073191-S1 to D. Love, and funding from Brady Russell Fund and New York State Department of Health to J.C. Cohen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blatt EN, 1999, AM J RESP CELL MOL, V21, P168, DOI 10.1165/ajrcmb.21.2.3691; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cohen JC, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-21; Cohen JC, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-2; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Feige E, 2002, MECH DEVELOP, V117, P369, DOI 10.1016/S0925-4773(02)00217-4; Fumoto K, 2009, EMBO REP, V10, P606, DOI 10.1038/embor.2009.45; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Hogg C, 2009, PAEDIATR RESPIR REV, V10, P44, DOI 10.1016/j.prrv.2008.10.001; JAIN R, 2010, AM J RESP CELL MOL B; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Larson JE, 2006, AM J PHYSIOL-LUNG C, V291, pL4, DOI 10.1152/ajplung.00372.2005; Leigh MW, 2009, GENET MED, V11, P473, DOI 10.1097/GIM.0b013e3181a53562; Li FQ, 2008, J CELL BIOL, V181, P1141, DOI 10.1083/jcb.200709091; Li FQ, 2010, MOL BIOL CELL, V21, P311, DOI 10.1091/mbc.E09-05-0437; Lim L, 1997, P NATL ACAD SCI USA, V94, P3094, DOI 10.1073/pnas.94.7.3094; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morrisey EE, 2003, AM J PATHOL, V162, P1393, DOI 10.1016/S0002-9440(10)64271-X; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Okubo Tadashi, 2004, J Biol, V3, P11, DOI 10.1186/jbiol3; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Perl AKT, 2009, AM J PHYSIOL-LUNG C, V297, pL299, DOI 10.1152/ajplung.00008.2009; Pinto D, 2005, EXP CELL RES, V306, P357, DOI 10.1016/j.yexcr.2005.02.022; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Reynolds SD, 2008, STEM CELLS, V26, P1337, DOI 10.1634/stemcells.2008-0053; SALAZAR E, 1964, J APPL PHYSIOL, V19, P97, DOI 10.1152/jappl.1964.19.1.97; SCHUESSLER TF, 1995, IEEE T BIO-MED ENG, V42, P860, DOI 10.1109/10.412653; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Singh AM, 2007, CIRCULATION, V115, P617, DOI 10.1161/CIRCULATIONAHA.106.642298; Snyder JC, 2009, J PATHOL, V217, P254, DOI 10.1002/path.2473; Takemaru K. -I., 2008, V186, P261, DOI 10.1007/978-3-540-72843-6_11; Takemaru KI, 2009, CELL CYCLE, V8, P210, DOI 10.4161/cc.8.2.7394; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; TAKEMARU KI, 2006, UCSD NATURE MOL PAGE, DOI DOI 10.1038/MP.A000506.01; Van Scoyk M, 2008, TRANSL RES, V151, P175, DOI 10.1016/j.trsl.2007.12.011; Voronina VA, 2009, J CELL BIOL, V185, P225, DOI 10.1083/jcb.200809144; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; ZHANG Y, 2008, NAT GENET	48	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13600	10.1371/journal.pone.0013600	http://dx.doi.org/10.1371/journal.pone.0013600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049041	gold, Green Submitted, Green Published			2022-12-25	WOS:000283422100013
J	Zilbauer, M; Jenke, A; Wenzel, G; Postberg, J; Heusch, A; Phillips, AD; Noble-Jamieson, G; Torrente, F; Salvestrini, C; Heuschkel, R; Wirth, S				Zilbauer, Matthias; Jenke, Andreas; Wenzel, Gundula; Postberg, Jan; Heusch, Andreas; Phillips, Alan D.; Noble-Jamieson, Gabriele; Torrente, Franco; Salvestrini, Camilla; Heuschkel, Robert; Wirth, Stefan			Expression of Human Beta-Defensins in Children with Chronic Inflammatory Bowel Disease	PLOS ONE			English	Article							INTESTINAL INNATE IMMUNITY; HUMAN BETA-DEFENSIN-2; ULCERATIVE-COLITIS; CROHNS-DISEASE; EPITHELIAL-CELLS	Background: Human beta-defensins (hBDs) are antimicrobial peptides known to play a major role in intestinal innate host defence. Altered mucosal expression of hBDs has been suggested to be implicated in chronic inflammatory bowel disease pathogenesis. However, little is known about expression of these peptides in children. Methods: Intestinal biopsies were obtained from the duodenum (n = 88), terminal ileum (n = 90) and ascending colon (n = 105) of children with Crohn's disease (n = 26), ulcerative colitis (n = 11) and healthy controls (n = 16). Quantitative real-time (RT) PCR was performed and absolute mRNA copy numbers analyzed for hBD1-3 as well as inflammatory cytokines IL-8 and TNF-alpha. Results: Significant induction of hBD2 and hBD3 was observed in the inflamed terminal ileum and ascending colon of IBD children. In the ascending colon induction of hBD2 was found to be significantly lower in children with Crohn's disease compared to ulcerative colitis. A strong correlation was found between inducible defensins hBD2 and 3 and the inflammatory cytokines IL-8 and TNF-alpha, both in the terminal ileum and ascending colon. Conclusion: Our study demonstrates distinct changes in hBD expression throughout the intestinal tract of children with IBD, lending further support for their potential role in disease pathogenesis.	[Zilbauer, Matthias; Jenke, Andreas; Wenzel, Gundula; Postberg, Jan; Heusch, Andreas; Wirth, Stefan] HELIOS Klinikum Wuppertal, Dept Paediat, Wuppertal, Germany; [Zilbauer, Matthias; Noble-Jamieson, Gabriele; Torrente, Franco; Salvestrini, Camilla; Heuschkel, Robert] Addenbrookes Hosp, Dept Paediat Gastroenterol, Cambridge, England; [Phillips, Alan D.] Royal Free Hosp, Ctr Paediat Gastroenterol, London NW3 2QG, England	Helios Kliniken; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Zilbauer, M (corresponding author), HELIOS Klinikum Wuppertal, Dept Paediat, Wuppertal, Germany.	mz304@medschl.cam.ac.uk	Zilbauer, Matthias/AAZ-2740-2020; Jenke, Andreas/AAO-2291-2020	Zilbauer, Matthias/0000-0002-7272-0547; Jenke, Andreas/0000-0002-4008-7185; Postberg, Jan/0000-0002-8562-3316	German society of Paediatric Gastroenterology (GPGE); Witten/Herdecke University; Crohn's in Childhood Research Association (CICRA); Crohn's and Colitis in Childhood (3Cs) charity	German society of Paediatric Gastroenterology (GPGE); Witten/Herdecke University; Crohn's in Childhood Research Association (CICRA); Crohn's and Colitis in Childhood (3Cs) charity	This study was funded by the German society of Paediatric Gastroenterology (GPGE), Witten/Herdecke University, the Crohn's in Childhood Research Association (CICRA) and the Crohn's and Colitis in Childhood (3Cs) charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; Chan M, 2008, ENRICH COMMUN, V2, P1; Dhaliwal W, 2003, MOL IMMUNOL, V40, P469, DOI 10.1016/S0161-5890(03)00156-1; Doss M, 2010, J LEUKOCYTE BIOL, V87, P79, DOI 10.1189/jlb.0609382; Eckmann L, 2005, CURR OPIN GASTROEN, V21, P147, DOI 10.1097/01.mog.0000153311.97832.8c; Fahlgren A, 2004, CLIN EXP IMMUNOL, V137, P379, DOI 10.1111/j.1365-2249.2004.02543.x; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Kocsis AK, 2008, SCAND J GASTROENTERO, V43, P299, DOI 10.1080/00365520701682615; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Otte JM, 2008, J CELL BIOCHEM, V104, P2286, DOI 10.1002/jcb.21787; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wehkamp J, 2003, INFLAMM BOWEL DIS, V9, P215, DOI 10.1097/00054725-200307000-00001; Wehkamp J, 2002, EUR J GASTROEN HEPAT, V14, P745, DOI 10.1097/00042737-200207000-00006; Zilbauer M, 2005, INFECT IMMUN, V73, P7281, DOI 10.1128/IAI.73.11.7281-7289.2005	17	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e15389	10.1371/journal.pone.0015389	http://dx.doi.org/10.1371/journal.pone.0015389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042595	Green Submitted, Green Published, gold			2022-12-25	WOS:000283419100028
J	Haarmann, A; Deiss, A; Prochaska, J; Foerch, C; Weksler, B; Romero, I; Couraud, PO; Stoll, G; Rieckmann, P; Buttmann, M				Haarmann, Axel; Deiss, Annika; Prochaska, Juergen; Foerch, Christian; Weksler, Babette; Romero, Ignacio; Couraud, Pierre-Olivier; Stoll, Guido; Rieckmann, Peter; Buttmann, Mathias			Evaluation of Soluble Junctional Adhesion Molecule-A as a Biomarker of Human Brain Endothelial Barrier Breakdown	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; TUMOR-NECROSIS-FACTOR; TIGHT JUNCTION; MULTIPLE-SCLEROSIS; TRANSENDOTHELIAL MIGRATION; CEREBROSPINAL-FLUID; CELLS; STROKE; INVOLVEMENT; EXPRESSION	Background: An inducible release of soluble junctional adhesion molecule-A (sJAM-A) under pro-inflammatory conditions was described in cultured non-CNS endothelial cells (EC) and increased sJAM-A serum levels were found to indicate inflammation in non-CNS vascular beds. Here we studied the regulation of JAM-A expression in cultured brain EC and evaluated sJAM-A as a serum biomarker of blood-brain barrier (BBB) function. Methodology/Principal Findings: As previously reported in non-CNS EC types, pro-inflammatory stimulation of primary or immortalized (hCMEC/D3) human brain microvascular EC (HBMEC) induced a redistribution of cell-bound JAM-A on the cell surface away from tight junctions, along with a dissociation from the cytoskeleton. This was paralleled by reduced immunocytochemical staining of occludin and zonula occludens-1 as well as by increased paracellular permeability for dextran 3000. Both a self-developed ELISA test and Western blot analysis detected a constitutive sJAM-A release by HBMEC into culture supernatants, which importantly was unaffected by pro-inflammatory or hypoxia/reoxygenation challenge. Accordingly, serum levels of sJAM-A were unaltered in 14 patients with clinically active multiple sclerosis compared to 45 stable patients and remained unchanged in 13 patients with acute ischemic non-small vessel stroke over time. Conclusion: Soluble JAM-A was not suited as a biomarker of BBB breakdown in our hands. The unexpected non-inducibility of sJAM-A release at the human BBB might contribute to a particular resistance of brain EC to inflammatory stimuli, protecting the CNS compartment.	[Haarmann, Axel; Deiss, Annika; Prochaska, Juergen; Stoll, Guido; Rieckmann, Peter; Buttmann, Mathias] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Foerch, Christian] Goethe Univ Frankfurt, Dept Neurol, Frankfurt, Germany; [Weksler, Babette] Cornell Univ, Div Hematol & Med Oncol, Weill Med Coll, New York, NY 10021 USA; [Romero, Ignacio] Open Univ, Dept Biol Sci, Milton Keynes MK7 6AA, Bucks, England; [Couraud, Pierre-Olivier] Univ Paris 05, Inst Cochin, Paris, France	University of Wurzburg; Goethe University Frankfurt; Cornell University; Open University - UK; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Haarmann, A (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-8700 Wurzburg, Germany.	m.buttmann@uni-wuerzburg.de	Buttmann, Mathias/R-7301-2019; Buttmann, Mathias/AAD-7488-2021	Buttmann, Mathias/0000-0001-8309-7685; Buttmann, Mathias/0000-0001-8309-7685; Prochaska, Jurgen/0000-0001-5078-9992; Romero, Ignacio/0000-0002-0322-9180	Teva/Sanofi-Aventis; Deutsche Forschungsgemeinschaft [SFB 688, A6]; State of Bavaria	Teva/Sanofi-Aventis(Sanofi-Aventis); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); State of Bavaria	This study was supported by a research grant from Teva/Sanofi-Aventis, by a grant from the Deutsche Forschungsgemeinschaft (SFB 688, Teilprojekt A6), and by University research funds from the State of Bavaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ JI, BIOCHIM BIOPHYS ACTA; BANKS WA, BIOCHIM BIOPHYS ACTA, V1802, P881; Betz AL, 1996, ADV NEUROL, V71, P301; Bitsch A, 1998, STROKE, V29, P2129, DOI 10.1161/01.STR.29.10.2129; Blann A, 1999, BLOOD COAGUL FIBRIN, V10, P277, DOI 10.1097/00001721-199907000-00009; Buttmann M, 2007, J NEUROCHEM, V102, P1001, DOI 10.1111/j.1471-4159.2007.04563.x; Cavusoglu E, 2007, J AM COLL CARDIOL, V50, P1768, DOI 10.1016/j.jacc.2007.05.051; Corada M, 2005, P NATL ACAD SCI USA, V102, P10634, DOI 10.1073/pnas.0500147102; Del Maschio A, 1999, J EXP MED, V190, P1351, DOI 10.1084/jem.190.9.1351; DOREDUFFY P, 1995, ANN NEUROL, V37, P55, DOI 10.1002/ana.410370111; Dvorak F, 2009, CEREBROVASC DIS, V27, P37, DOI 10.1159/000172632; HARTUNG HP, 1995, ANN NEUROL, V38, P186, DOI 10.1002/ana.410380210; HOU Y, 2009, ANN RHEUM DIS; Huang W, 2009, FASEB J, V23, P1596, DOI 10.1096/fj.08-121624; Hummel V, 2001, J NEUROPATH EXP NEUR, V60, P320, DOI 10.1093/jnen/60.4.320; Kallmann BA, 2002, FASEB J, V16, P589, DOI 10.1096/fj.01-0594fje; Khandoga A, 2005, BLOOD, V106, P725, DOI 10.1182/blood-2004-11-4416; Koenen RR, 2009, BLOOD, V113, P4799, DOI 10.1182/blood-2008-04-152330; KORNECKI E, 1990, J BIOL CHEM, V265, P10042; Liang TW, 2000, AM J PHYSIOL-CELL PH, V279, pC1733, DOI 10.1152/ajpcell.2000.279.6.C1733; Liu Y, 2000, J CELL SCI, V113, P2363; Mandell KJ, 2006, INVEST OPHTH VIS SCI, V47, P2408, DOI 10.1167/iovs.05-0745; Mandell KJ, 2004, J BIOL CHEM, V279, P16254, DOI 10.1074/jbc.M309483200; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Martinez-Estrada OM, 2005, AM J PHYSIOL-LUNG C, V288, pL1081, DOI 10.1152/ajplung.00289.2004; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Ong KL, 2009, AM J HYPERTENS, V22, P500, DOI 10.1038/ajh.2009.23; Ostermann G, 2005, ARTERIOSCL THROM VAS, V25, P729, DOI 10.1161/01.ATV.0000157154.14474.3b; Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755; Ozaki H, 1999, J IMMUNOL, V163, P553; Padden M, 2007, ACTA NEUROPATHOL, V113, P177, DOI 10.1007/s00401-006-0145-x; Salifu MO, 2007, J INVEST MED, V55, P115, DOI 10.2310/6650.2007.06041; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Severson EA, 2009, ANN NY ACAD SCI, V1165, P10, DOI 10.1111/j.1749-6632.2009.04034.x; Shaw SK, 2004, J EXP MED, V200, P1571, DOI 10.1084/jem.20040965; Singh RJR, 2005, CARDIOVASC RES, V67, P39, DOI 10.1016/j.cardiores.2005.02.020; STEED E, TRENDS CELL BIOL, V20, P142; VESTWEBER D, CURR OPIN HEMATOL, V17, P230; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Williams LA, 1999, MOL IMMUNOL, V36, P1175, DOI 10.1016/S0161-5890(99)00122-4; Yeung D, 2008, ACTA NEUROPATHOL, V115, P635, DOI 10.1007/s00401-008-0364-4; Zernecke A, 2006, ARTERIOSCL THROM VAS, V26, pE10, DOI 10.1161/01.ATV.0000197852.24529.4f	43	36	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13568	10.1371/journal.pone.0013568	http://dx.doi.org/10.1371/journal.pone.0013568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21060661	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000283293800026
J	Veitia, RA; Vaiman, D				Veitia, Reiner A.; Vaiman, Daniel			Exploring the mechanistic bases of heterosis from the perspective of macromolecular complexes	FASEB JOURNAL			English	Article						dominant-negative effects; gene dosage	OVERDOMINANT EPISTATIC LOCI; PRIMARY GENETIC-BASIS; INBREEDING DEPRESSION; MOLECULAR-BASIS; HYBRID; RICE; EXPRESSION; AUTOTETRAPLOIDS; DOMINANCE; PATTERNS	Heterosis is defined as greater biomass, fertility or other traits in heterozygotes, polyploids or hybrids compared to their genetically divergent (often homozygous) parents. Heterosis was noticed by various civilizations and scientifically reported by Darwin himself. Despite the importance of heterosis, its molecular bases are still enigmatic. Several genetic models have been proposed but fail to give mechanistic insights. Here we show how dominant negative interactions might give rise to heterotic responses. We also explore a biochemical model of gene dosage effects in macromolecular complexes in a similar context. With the help of heuristic examples and computer simulations we find that heterotic individuals display higher allelic diversity and smaller average multimer concentrations than nonheterotic ones. As intuitively expected, the existence of heterosis involving multimeric complexes arises when the inbred parents have on average smaller genetic values than the maximum possible. Despite its simplicity, the dosage model accounts for the puzzling phenomenon of "progressive heterosis" in which polyploids with increasing genetic diversity exhibit progressively greater heterosis.-Veitia, R. A., Vaiman, D. Exploring the mechanistic bases of heterosis from the perspective of macromolecular complexes. FASEB J. 25, 476-482 (2011). www.fasebj.org	[Veitia, Reiner A.] Inst Jacques Monod, CNRS, UMR 7592, Paris 13, France; [Veitia, Reiner A.] Univ Paris 07, Paris, France; [Vaiman, Daniel] Inst Cochin Genet Mol, Inst Natl Sante & Rech Med INSERM, CNRS, U1016,UMR8104, F-75014 Paris, France; [Vaiman, Daniel] Univ Paris 05, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Veitia, RA (corresponding author), Inst Jacques Monod, CNRS, UMR 7592, Batiment Buffon,15 Rue Helene Brion, Paris 13, France.	veitia.reiner@ijm.univ-paris-diderot.fr	Vaiman, Daniel/O-6030-2015	Vaiman, Daniel/0000-0002-1915-0717	Centre National de la Recherche Scientifique; Universite Paris-Diderot; Association pour la Recherche sur le Cancer, la Fondation pour la Recherche Medicale; Institut Universitaire de France	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Paris-Diderot; Association pour la Recherche sur le Cancer, la Fondation pour la Recherche Medicale(Fondation ARC pour la Recherche sur le CancerFondation pour la Recherche Medicale); Institut Universitaire de France	The research of R.A.V. is funded by the Centre National de la Recherche Scientifique, the Universite Paris-Diderot, the Association pour la Recherche sur le Cancer, la Fondation pour la Recherche Medicale, and the Institut Universitaire de France. The authors gratefuly thank Jim Birchler and Victoria Lebed for sharing helpful thoughts and comments on the manuscript.	Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Alexander D. E., 1961, MAIZE GENET COOP NEW, V35; [Anonymous], 1910, Science, V32, P627; BINGHAM ET, 1994, CROP SCI, V34, P823, DOI 10.2135/cropsci1994.0011183X003400040001x; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; Birchler JA, 2010, PLANT CELL, V22, P2105, DOI 10.1105/tpc.110.076133; BUSBICE TH, 1966, EUPHYTICA, V15, P52; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Chen ZJ, 2010, TRENDS PLANT SCI, V15, P57, DOI 10.1016/j.tplants.2009.12.003; Comai L, 2000, PLANT MOL BIOL, V43, P387, DOI 10.1023/A:1006480722854; CROW JF, 1948, GENETICS, V33, P477; Darwin CR, 1876, EFFECTS CROSS SELF F; Davenport CB, 1908, SCIENCE, V28, P454, DOI 10.1126/science.28.718.454-b; DOBZHANSKY T, 1950, GENETICS, V35, P288; East E. M., 1908, REPORTS CONNECTICUT, P419; East EM, 1936, GENETICS, V21, P375; GROOSE RW, 1989, CROP SCI, V29, P1173, DOI 10.2135/cropsci1989.0011183X002900050015x; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Hochholdinger F, 2007, TRENDS PLANT SCI, V12, P427, DOI 10.1016/j.tplants.2007.08.005; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Jones DF, 1917, GENETICS, V2, P466; LEVINGS CS, 1967, CROP SCI, V7, P72, DOI 10.2135/cropsci1967.0011183X000700010025x; Li XH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-107; Li ZK, 2001, GENETICS, V158, P1737; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Luo LJ, 2001, GENETICS, V158, P1755; Milborrow BV, 1998, J EXP BOT, V49, P1063, DOI 10.1093/jexbot/49.324.1063; MOK DWS, 1975, THEOR APPL GENET, V46, P307, DOI 10.1007/BF00281153; MULLER HJ, 1932, P INT C GENET, V6, P213; Powers L, 1944, AM NAT, V78, P275, DOI 10.1086/281199; RANDOLPH L. F., 1942, GENETICS, V27, P163; REDEI GP, 1962, Z VEREBUNGSL, V93, P164; RICE JS, 1974, CROP SCI, V14, P390, DOI 10.2135/cropsci1974.0011183X001400030015x; Riddle NC, 2010, THEOR APPL GENET, V120, P341, DOI 10.1007/s00122-009-1113-3; Semel Y, 2006, P NATL ACAD SCI USA, V103, P12981, DOI 10.1073/pnas.0604635103; Shull G.H., 1908, J HERED, V4, P296, DOI [10.1093/jhered/os-4.1.296, DOI 10.1093/JHERED/OS-4.1.296]; STUBER CW, 1992, GENETICS, V132, P823; Stupar RM, 2006, GENETICS, V173, P2199, DOI 10.1534/genetics.106.060699; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; TSAFTARIS SA, 1995, PHYSIOL PLANTARUM, V94, P362, DOI 10.1111/j.1399-3054.1995.tb05324.x; van Zanten M, 2009, TRENDS PLANT SCI, V14, P214, DOI 10.1016/j.tplants.2009.01.010; Veitia RA, 2003, BIOL REV, V78, P149, DOI 10.1017/S1464793102006036; Veitia RA, 2010, FASEB J, V24, P994, DOI 10.1096/fj.09-146969; Veitia RA, 2009, J PATHOL, V218, P409, DOI 10.1002/path.2583; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Woolf Charles M., 2003, P99; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226	47	13	14	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					476	482		10.1096/fj.10-170639	http://dx.doi.org/10.1096/fj.10-170639			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	21062972				2022-12-25	WOS:000286724800006
J	Homma, K; Dallos, P				Homma, Kazuaki; Dallos, Peter			Evidence That Prestin Has at Least Two Voltage-dependent Steps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER HAIR CELL; MOTOR PROTEIN PRESTIN; GUINEA-PIG COCHLEA; MEMBRANE CAPACITANCE; ANION-EXCHANGERS; GATING CHARGE; MOTILITY; ELECTROMOTILITY; SALICYLATE; TRANSPORT	Prestin is a voltage-dependent membrane-spanning motor protein that confers electromotility on mammalian cochlear outer hair cells, which is essential for normal hearing of mammals. Voltage-induced charge movement in the prestin molecule is converted into mechanical work; however, little is known about the molecular mechanism of this process. For understanding the electromechanical coupling mechanism of prestin, we simultaneously measured voltage-dependent charge movement and electromotility under conditions in which the magnitudes of both charge movement and electromotility are gradually manipulated by the prestin inhibitor, salicylate. We show that the observed relationships of the charge movement and the physical displacement (q-d relations) are well represented by a three-state Boltzmann model but not by a two-state model or its previously proposed variant. Here, we suggest a molecular mechanism of prestin with at least two voltage-dependent conformational transition steps having distinct electromechanical coupling efficiencies.	Northwestern Univ, Dept Commun Sci & Disorders, Hugh Knowles Ctr, Evanston, IL 60208 USA; [Dallos, Peter] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Homma, K (corresponding author), 2240 Campus Dr, Evanston, IL 60208 USA.	k-homma@northwestern.edu	Dallos, Peter/Q-9360-2019	Dallos, Peter/0000-0002-9731-6591	National Institutes of Health [DC00089]; Hugh Knowles Center; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hugh Knowles Center; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DC00089 (to P. D.). This work was also supported by the Hugh Knowles Center.	Adachi M, 1999, P NATL ACAD SCI USA, V96, P7244, DOI 10.1073/pnas.96.13.7244; Albert JT, 2007, J PHYSIOL-LONDON, V580, P451, DOI 10.1113/jphysiol.2007.127993; ASHMORE JF, 1990, NEUROSCI RES       S, V12, P39; Bai JP, 2006, NEUROSCI LETT, V404, P270, DOI 10.1016/j.neulet.2006.05.062; Bai JP, 2009, BIOPHYS J, V96, P3179, DOI 10.1016/j.bpj.2008.12.3948; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Burnham K.P., 2002, MODEL SELECTION MULT, P60; Canis M, 2008, ACTA OTO-LARYNGOL, V128, P228, DOI 10.1080/00016480701411502; Cheatham MA, 2005, J PHYSIOL-LONDON, V569, P229, DOI 10.1113/jphysiol.2005.093518; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Davis CQ, 1998, OPT ENG, V37, P1299, DOI 10.1117/1.601967; Detro-Dassen S, 2008, J BIOL CHEM, V283, P4177, DOI 10.1074/jbc.M704924200; Dorwart MR, 2008, PHYSIOLOGY, V23, P104, DOI 10.1152/physiol.00037.2007; Frolenkov GI, 2000, J NEUROSCI, V20, P5940, DOI 10.1523/JNEUROSCI.20-16-05940.2000; He DZZ, 2010, CYTOSKELETON, V67, P43, DOI 10.1002/cm.20423; He DZZ, 2003, J PHYSIOL-LONDON, V546, P511, DOI 10.1113/jphysiol.2002.026070; He DZZ, 2000, JARO-J ASSOC RES OTO, V1, P64, DOI 10.1007/s101620010006; Hu XT, 1999, J NEUROPHYSIOL, V82, P2798, DOI 10.1152/jn.1999.82.5.2798; Iwasa KH, 1997, BIOPHYS J, V73, P2965, DOI 10.1016/S0006-3495(97)78325-5; IWASA KH, 1993, BIOPHYS J, V65, P492, DOI 10.1016/S0006-3495(93)81053-1; Kakehata S, 1996, J NEUROSCI, V16, P4881; KAKEHATA S, 1995, BIOPHYS J, V68, P2190, DOI 10.1016/S0006-3495(95)80401-7; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; LINNET K, 1993, CLIN CHEM, V39, P424; Muallem D, 2006, BIOPHYS J, V90, P4035, DOI 10.1529/biophysj.105.073254; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Rybalchenko V, 2003, J PHYSIOL-LONDON, V547, P873, DOI 10.1113/jphysiol.2002.036434; Rybalchenko V, 2008, BIOPHYS J, V95, P4439, DOI 10.1529/biophysj.108.134197; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 2002, PFLUG ARCH EUR J PHY, V444, P99, DOI 10.1007/s00424-002-0804-2; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; Schaechinger TJ, 2007, P NATL ACAD SCI USA, V104, P7693, DOI 10.1073/pnas.0608583104; Scherer MP, 2005, BIOPHYS J, V88, pL27, DOI 10.1529/biophysj.105.059782; SHEHATA WE, 1991, ACTA OTO-LARYNGOL, V111, P707, DOI 10.3109/00016489109138403; Song L, 2010, BIOPHYS J, V98, P371, DOI 10.1016/j.bpj.2009.10.027; Sziklai I, 1996, HEARING RES, V95, P87, DOI 10.1016/0378-5955(96)00026-3; TUNSTALL MJ, 1995, J PHYSIOL-LONDON, V485, P739, DOI 10.1113/jphysiol.1995.sp020765; Wang X, 2010, BRAIN RES, V1333, P28, DOI 10.1016/j.brainres.2010.03.070; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2006, J BIOL CHEM, V281, P19916, DOI 10.1074/jbc.M513854200	41	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2297	2307		10.1074/jbc.M110.185694	http://dx.doi.org/10.1074/jbc.M110.185694			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21071769	Green Published, hybrid			2022-12-25	WOS:000286191500069
J	Walthers, D; Li, Y; Liu, YJ; Anand, G; Yan, J; Kenney, LJ				Walthers, Don; Li, You; Liu, Yingjie; Anand, Ganesh; Yan, Jie; Kenney, Linda J.			Salmonella enterica Response Regulator SsrB Relieves H-NS Silencing by Displacing H-NS Bound in Polymerization Mode and Directly Activates Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGENICITY ISLAND 2; III SECRETION SYSTEM; TYPHIMURIUM TRANSLOCATED EFFECTORS; LYSOSOMAL MEMBRANE-GLYCOPROTEINS; HORIZONTALLY ACQUIRED GENES; SINGLE DNA-MOLECULES; SEROVAR TYPHIMURIUM; YERSINIA-ENTEROCOLITICA; FILAMENTOUS STRUCTURES; VIRULENCE PROTEIN	The response regulator SsrB activates expression of genes encoded within and outside of a pathogenicity island (SPI-2), which is required for systemic infection of Salmonella. SsrB binds upstream of the sifA, sifB, and sseJ effector genes and directly regulates transcription. SsrB also relieves gene silencing by the nucleoid protein H-NS. Single molecule experiments with magnetic tweezers demonstrated that SsrB displaces H-NS from DNA only when it is bound in a polymerization (stiffening) mode and not when H-NS is bound to DNA in the bridging mode. Thus, in contrast to previous views, the polymerization binding mode of H-NS is the relevant form for counter-silencing by SsrB. Our results reveal that response regulators can directly activate transcription and also relieve H-NS silencing. This study adds to the repertoire of mechanisms by which NarL/FixJ subfamily members regulate transcription. Because SsrB-dependent promoters are diversely organized, additional mechanisms of transcriptional activation at other loci are likely.	[Walthers, Don; Kenney, Linda J.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Li, You; Liu, Yingjie; Yan, Jie] Mechanobiol Inst, Dept Phys, Singapore 119007, Singapore; [Anand, Ganesh] Dept Biol, Singapore 119007, Singapore; [Li, You; Liu, Yingjie; Yan, Jie; Kenney, Linda J.] Natl Univ Singapore, Singapore 119007, Singapore	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National University of Singapore	Kenney, LJ (corresponding author), Univ Illinois, Dept Microbiol & Immunol, 835 S Wolcott Ave,MC 790, Chicago, IL 60612 USA.	kenneyl@uic.edu	Yan, Jie/G-2725-2012	Yan, Jie/0000-0002-8555-7291	National Institutes of Health [GM-058746]; Veterans Administration [1IO1BX000372]; Singapore Ministry of Education [R144000192112, R144000251112]; Mechanobiology Biology Institute, National University of Singapore; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058746] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000372] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); Singapore Ministry of Education(Ministry of Education, Singapore); Mechanobiology Biology Institute, National University of Singapore(National University of Singapore); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant GM-058746. This work was also supported by Veterans Administration Grant 1IO1BX000372 (to L. J. K.), Singapore Ministry of Education Grants R144000192112 and R144000251112 (to J. Y.), and the Mechanobiology Biology Institute, National University of Singapore.	Amit R, 2003, BIOPHYS J, V84, P2467, DOI 10.1016/S0006-3495(03)75051-6; Banos RC, 2008, MICROBIOL-SGM, V154, P1281, DOI 10.1099/mic.0.2007/015610-0; Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Brumell JH, 2002, TRAFFIC, V3, P407, DOI 10.1034/j.1600-0854.2002.30604.x; Carroll RK, 2009, J BIOL CHEM, V284, P12008, DOI 10.1074/jbc.M806261200; Cathelyn JS, 2007, MOL MICROBIOL, V66, P189, DOI 10.1111/j.1365-2958.2007.05907.x; Dame RT, 2006, NATURE, V444, P387, DOI 10.1038/nature05283; Fang FC, 2008, CURR OPIN MICROBIOL, V11, P113, DOI 10.1016/j.mib.2008.02.011; Feng XH, 2004, MOL MICROBIOL, V54, P823, DOI 10.1111/j.1365-2958.2004.04317.x; Feng XH, 2003, MOL MICROBIOL, V48, P1131, DOI 10.1046/j.1365-2958.2003.03502.x; Freeman JA, 2003, INFECT IMMUN, V71, P418, DOI 10.1128/IAI.71.1.418-427.2003; GARCIADELPORTILLO F, 1993, P NATL ACAD SCI USA, V90, P10544, DOI 10.1073/pnas.90.22.10544; Hansen-Wester I, 2002, INFECT IMMUN, V70, P1403, DOI 10.1128/IAI.70.3.1403-1409.2002; Jackson LK, 2008, P NATL ACAD SCI USA, V105, P14141, DOI 10.1073/pnas.0801872105; Kato A, 2008, ADV EXP MED BIOL, V631, P7; Kelly A, 2004, MICROBIOL-SGM, V150, P2037, DOI 10.1099/mic.0.27209-0; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; Liu YJ, 2010, GENE DEV, V24, P339, DOI 10.1101/gad.1883510; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845; Martin-Orozco N, 2006, MOL BIOL CELL, V17, P498, DOI 10.1091/mbc.E04-12-1096; MAYER MP, 1995, GENE, V163, P41, DOI 10.1016/0378-1119(95)00389-N; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Miao EA, 2002, J BACTERIOL, V184, P1493, DOI 10.1128/JB.184.5.1493-1497.2002; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Mills SD, 1998, INFECT IMMUN, V66, P1806, DOI 10.1128/IAI.66.4.1806-1811.1998; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Nawabi P, 2008, MOL MICROBIOL, V68, P173, DOI 10.1111/j.1365-2958.2008.06142.x; Nikolaus T, 2001, J BACTERIOL, V183, P6036, DOI 10.1128/JB.183.20.6036-6045.2001; Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012; Ohlson MB, 2005, INFECT IMMUN, V73, P6249, DOI 10.1128/IAI.73.10.6249-6259.2005; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; Perez JC, 2008, J BIOL CHEM, V283, P10773, DOI 10.1074/jbc.M709843200; Rappl C, 2003, FEMS MICROBIOL LETT, V226, P363, DOI 10.1016/S0378-1097(03)00638-4; ROSS W, 1990, EMBO J, V9, P3733, DOI 10.1002/j.1460-2075.1990.tb07586.x; Ross W, 2009, METHODS, V47, P13, DOI 10.1016/j.ymeth.2008.10.018; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Savery N, 1996, PHILOS T ROY SOC B, V351, P543, DOI 10.1098/rstb.1996.0053; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; Tran HJ, 2005, J BIOL CHEM, V280, P42423, DOI 10.1074/jbc.M504464200; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; Worley MJ, 2000, MOL MICROBIOL, V36, P749, DOI 10.1046/j.1365-2958.2000.01902.x; Yan J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011905	47	71	72	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1895	1902		10.1074/jbc.M110.164962	http://dx.doi.org/10.1074/jbc.M110.164962			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21059643	Green Published, hybrid			2022-12-25	WOS:000286191500030
J	Fakas, S; Konstantinou, C; Carman, GM				Fakas, Stylianos; Konstantinou, Chrysanthos; Carman, George M.			DGK1-encoded Diacylglycerol Kinase Activity Is Required for Phospholipid Synthesis during Growth Resumption from Stationary Phase in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID PHOSPHATE PHOSPHATASES; NUCLEAR-MEMBRANE GROWTH; CDP-CHOLINE PATHWAY; SIGNALING FUNCTIONS; YEAST; ACID; PHOSPHATIDYLCHOLINE; PROTEIN; GENE; BIOSYNTHESIS	In the yeast Saccharomyces cerevisiae, triacylglycerol mobilization for phospholipid synthesis occurs during growth resumption from stationary phase, and this metabolism is essential in the absence of de novo fatty acid synthesis. In this work, we provide evidence that DGK1-encoded diacylglycerol kinase activity is required to convert triacylglycerol-derived diacylglycerol to phosphatidate for phospholipid synthesis. Cells lacking diacylglycerol kinase activity (e.g. dgk1 Delta mutation) failed to resume growth in the presence of the fatty acid synthesis inhibitor cerulenin. Lipid analysis data showed that dgk1 Delta mutant cells did not mobilize triacylglycerol for membrane phospholipid synthesis and accumulated diacylglycerol. The dgk1 Delta phenotypes were partially complemented by preventing the formation of diacylglycerol by the PAH1-encoded phosphatidate phosphatase and by channeling diacylglycerol to phosphatidylcholine via the Kennedy pathway. These observations, coupled to an inhibitory effect of dioctanoyl-diacylglycerol on the growth of wild type cells, indicated that diacylglycerol kinase also functions to alleviate diacylglycerol toxicity.	[Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu	Fakas, Stylianos/AAQ-7594-2020; Fakas, Stylianos/R-9908-2019	Fakas, Stylianos/0000-0001-8692-1326; Fakas, Stylianos/0000-0001-8692-1326	National Institutes of Health [GM-28140]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-28140 (to G.M.C.).	[Anonymous], 2003, LIPID ANAL; Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; BISHOP WR, 1986, J BIOL CHEM, V261, P6993; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brachmann CB, 1998, YEAST, V14, P115; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; Fernandez-Murray JP, 2007, BBA-MOL CELL BIOL L, V1771, P331, DOI 10.1016/j.bbalip.2006.04.004; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Goodman JM, 2009, J LIPID RES, V50, P2148, DOI 10.1194/jlr.R001446; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Homan R, 1998, J CHROMATOGR B, V708, P21, DOI 10.1016/S0378-4347(97)00651-8; Howe AG, 2006, CAN J PHYSIOL PHARM, V84, P29, DOI 10.1139/Y05-138; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; INOKOSHI J, 1994, MOL GEN GENET, V244, P90, DOI 10.1007/BF00280191; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JACKSON BJ, 1984, J BACTERIOL, V160, P976, DOI 10.1128/JB.160.3.976-981.1984; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; Kennedy E. P., 1986, LIPIDS MEMBRANES PRE, P171; Kent C, 1999, TRENDS BIOCHEM SCI, V24, P146, DOI 10.1016/S0968-0004(99)01365-1; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; Kosodo Y, 2001, YEAST, V18, pS242; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; MCDONOUGH VM, 1995, J BIOL CHEM, V270, P18774, DOI 10.1074/jbc.270.32.18774; MCMASTER CR, 1994, J BIOL CHEM, V269, P14776; Muller MO, 2000, J BIOL CHEM, V275, P19475, DOI 10.1074/jbc.M002575200; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Omura S, 1981, Methods Enzymol, V72, P520; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; RAETZ CRH, 1978, J BIOL CHEM, V253, P3882; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Rose K, 1995, P NATL ACAD SCI USA, V92, P12151, DOI 10.1073/pnas.92.26.12151; Rose MD., 1990, METHODS YEAST GENETI; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Rudge SA, 2004, MOL BIOL CELL, V15, P207, DOI 10.1091/mbc.e03-04-0245; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; SIKORSKI RS, 1989, GENETICS, V122, P19; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200; Zanghellini J, 2008, FEBS J, V275, P5552, DOI 10.1111/j.1742-4658.2008.06681.x; Zhang Q, 2003, J BIOL CHEM, V278, P47145, DOI 10.1074/jbc.M306998200; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	71	47	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1464	1474		10.1074/jbc.M110.194308	http://dx.doi.org/10.1074/jbc.M110.194308			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21071438	hybrid, Green Published			2022-12-25	WOS:000286005000059
J	Labro, AJ; Boulet, IR; Choveau, FS; Mayeur, E; Bruyns, T; Loussouarn, G; Raes, AL; Snyders, DJ				Labro, Alain J.; Boulet, Inge R.; Choveau, Frank S.; Mayeur, Evy; Bruyns, Tine; Loussouarn, Gildas; Raes, Adam L.; Snyders, Dirk J.			The S4-S5 Linker of KCNQ1 Channels Forms a Structural Scaffold with the S6 Segment Controlling Gate Closure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; SHAKER K+ CHANNEL; KVLQT1 POTASSIUM CHANNELS; C-TYPE INACTIVATION; SELECTIVITY FILTER; ACTIVATION GATE; VOLTAGE SENSOR; PORE; MUTATIONS; PROTEINS	In vivo, KCNQ1 alpha-subunits associate with the beta-subunit KCNE1 to generate the slowly activating cardiac potassium current (I-Ks). Structurally, they share their topology with other Kv channels and consist out of six transmembrane helices (S1-S6) with the S1-S4 segments forming the voltage-sensing domain (VSD). The opening or closure of the intracellular channel gate, which localizes at the bottom of the S6 segment, is directly controlled by the movement of the VSD via an electromechanical coupling. In other Kv channels, this electromechanical coupling is realized by an interaction between the S4-S5 linker (S4S5(L)) and the C-terminal end of S6 (S6(T)). Previously we reported that substitutions for Leu(353) in S6(T) resulted in channels that failed to close completely. Closure could be incomplete because Leu(353) itself is the pore-occluding residue of the channel gate or because of a distorted electromechanical coupling. To resolve this and to address the role of S4S5(L) in KCNQ1 channel gating, we performed an alanine/tryptophan substitution scan of S4S5(L). The residues with a "high impact" on channel gating (when mutated) clustered on one side of the S4S5(L) alpha-helix. Hence, this side of S4S5(L) most likely contributes to the electromechanical coupling and finds its residue counterparts in S6(T). Accordingly, substitutions for Val(254) resulted in channels that were partially constitutively open and the ability to close completely was rescued by combination with substitutions for Leu(353) in S6(T). Double mutant cycle analysis supported this cross-talk indicating that both residues come in close contact and stabilize the closed state of the channel.	[Labro, Alain J.; Boulet, Inge R.; Mayeur, Evy; Bruyns, Tine; Raes, Adam L.; Snyders, Dirk J.] Univ Antwerp, Lab Mol Biophys Physiol & Pharmacol, Dept Biomed Sci, CDE, B-2610 Antwerp, Belgium; [Choveau, Frank S.; Loussouarn, Gildas] INSERM, U915, F-44000 Nantes, France; [Choveau, Frank S.; Loussouarn, Gildas] CNRS, ERL3147, F-44035 Nantes, France; [Choveau, Frank S.; Loussouarn, Gildas] Univ Nantes, Fac Med, Inst Thorax, F-44000 Nantes, France	University of Antwerp; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Nantes Universite; CHU de Nantes	Snyders, DJ (corresponding author), Univ Antwerp, Lab Mol Biophys Physiol & Pharmacol, Dept Biomed Sci, CDE, Univ Pl 1, B-2610 Antwerp, Belgium.	dirk.snyders@ua.ac.be	Choveau, Frank/AAF-3858-2022; Loussouarn, Gildas/D-3590-2015; Snyders, Dirk/A-2713-2013; Choveau, Frank/AFI-6500-2022; Loussouarn, Gildas/ABH-6043-2020	Loussouarn, Gildas/0000-0001-8007-5931; Snyders, Dirk/0000-0001-7142-6672; Loussouarn, Gildas/0000-0001-8007-5931; Labro, Alain J/0000-0002-0871-7511	Research Foundation Flanders (Fonds voor Wetenschappelijk Onderzoek Vlaanderen) [G.0152.06, G.0256.08, 1.5.044.07]; Belgian Federal Science Policy Office [P6/31]; University of Antwerp [GOA/TOP41.3016]; Tournesol [T2010.13]	Research Foundation Flanders (Fonds voor Wetenschappelijk Onderzoek Vlaanderen)(FWO); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); University of Antwerp; Tournesol	This work was supported by Research Foundation Flanders (Fonds voor Wetenschappelijk Onderzoek Vlaanderen) Grants G.0152.06 and G.0256.08 (to D. J. S.) and 1.5.044.07 (to A. J. L.), the Interuniversity Attraction Poles program P6/31 of the Belgian Federal Science Policy Office, GOA/TOP41.3016 (concerted action fund University of Antwerp), and Tournesol T2010.13 (to D. J. S. and G. L.).	Barghaan J, 2009, J GEN PHYSIOL, V133, P205, DOI 10.1085/jgp.200810073; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Batulan Z, 2010, J BIOL CHEM, V285, P14005, DOI 10.1074/jbc.M109.097717; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Boulet IR, 2007, J PHYSIOL-LONDON, V585, P325, DOI 10.1113/jphysiol.2007.145813; Choveau F., 2010, J BIOL CHEM, P707; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; Deschenes D, 2003, CAN J PHYSIOL PHARM, V81, P129, DOI 10.1139/Y02-162; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Franqueza L, 1999, J BIOL CHEM, V274, P21063, DOI 10.1074/jbc.274.30.21063; Gibor G, 2007, BIOPHYS J, V93, P4159, DOI 10.1529/biophysj.107.107987; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Itoh T, 1998, HUM GENET, V103, P290, DOI 10.1007/s004390050819; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Kubota T, 2000, J CARDIOVASC ELECTR, V11, P1048, DOI 10.1111/j.1540-8167.2000.tb00178.x; Kurata HT, 2006, PROG BIOPHYS MOL BIO, V92, P185, DOI 10.1016/j.pbiomolbio.2005.10.001; Labro AJ, 2010, J MOL CELL CARDIOL, V48, P1096, DOI 10.1016/j.yjmcc.2009.10.027; Labro AJ, 2008, J GEN PHYSIOL, V132, P667, DOI 10.1085/jgp.200810048; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Miceli F, 2009, CHANNELS, V3, P274; MILDVAN AS, 1992, ARCH BIOCHEM BIOPHYS, V294, P327, DOI 10.1016/0003-9861(92)90692-P; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Ohlenschlager O, 2002, BIOPHYS J, V82, P2995, DOI 10.1016/S0006-3495(02)75640-3; Olcese R, 1997, J GEN PHYSIOL, V110, P579, DOI 10.1085/jgp.110.5.579; Panaghie G, 2008, BIOPHYS J, V95, P2759, DOI 10.1529/biophysj.108.133678; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Prole DL, 2006, J GEN PHYSIOL, V128, P273, DOI 10.1085/jgp.200609590; Pusch M, 1998, BIOPHYS J, V75, P785, DOI 10.1016/S0006-3495(98)77568-X; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Seebohm G, 2005, J PHYSIOL-LONDON, V563, P359, DOI 10.1113/jphysiol.2004.080887; Shamgar L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001943; Smith JA, 2007, BIOCHEMISTRY-US, V46, P14141, DOI 10.1021/bi701597s; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Wang Z, 1999, J CARDIOVASC ELECTR, V10, P817, DOI 10.1111/j.1540-8167.1999.tb00262.x; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9	45	46	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					717	725		10.1074/jbc.M110.146977	http://dx.doi.org/10.1074/jbc.M110.146977			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21059661	Green Published, hybrid			2022-12-25	WOS:000285782800071
J	Vergnes, L; Chin, R; Young, SG; Reue, K				Vergnes, Laurent; Chin, Robert; Young, Stephen G.; Reue, Karen			Heart-type Fatty Acid-binding Protein Is Essential for Efficient Brown Adipose Tissue Fatty Acid Oxidation and Cold Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL UNCOUPLING PROTEIN; MICE LACKING; GENE DELETION; UP-REGULATION; THERMOGENESIS; EXPRESSION; ADIPOCYTE; DEFICIENCY; OBESITY; IDENTIFICATION	Brown adipose tissue has a central role in thermogenesis to maintain body temperature through energy dissipation in small mammals and has recently been verified to function in adult humans as well. Here, we demonstrate that the heart-type fatty acid-binding protein, FABP3, is essential for cold tolerance and efficient fatty acid oxidation in mouse brown adipose tissue, despite the abundant expression of adiposetype fatty acid-binding protein, FABP4 (also known as aP2). Fabp3(-/-) mice exhibit extreme cold sensitivity despite induction of uncoupling and oxidative genes and hydrolysis of brown adipose tissue lipid stores. However, using FABP3 gain-and loss-of-function approaches in brown adipocytes, we detected a correlation between FABP3 levels and the utilization of exogenous fatty acids. Thus, Fabp3(-/-) brown adipocytes fail to oxidize exogenously supplied fatty acids, whereas enhanced Fabp3 expression promotes more efficient oxidation. These results suggest that FABP3 levels are a determinant of fatty acid oxidation efficiency by brown adipose tissue and that FABP3 represents a potential target for modulation of energy dissipation.	[Vergnes, Laurent; Chin, Robert; Young, Stephen G.; Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Vergnes, Laurent; Chin, Robert; Young, Stephen G.; Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Vergnes, Laurent; Chin, Robert; Reue, Karen] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Reue, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Gonda 6506A,695 Charles E Young Dr S, Los Angeles, CA 90095 USA.	reuek@ucla.edu		vergnes, laurent/0000-0002-8804-589X; Young, Stephen/0000-0001-7270-3176	National Institutes of Health [P01 HL90553, U01 HL66621]; American Heart Association [09BGIA2080363]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553, U01HL066621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL90553 (to K. R. and S. G. Y.) and U01 HL66621 (to S. G. Y.). This work was also supported by American Heart Association Grant 09BGIA2080363 (to L. V.).	Arnyasi M, 2006, J ANIM BREED GENET, V123, P198, DOI 10.1111/j.1439-0388.2006.00588.x; Beigneux AP, 2004, J BIOL CHEM, V279, P9557, DOI 10.1074/jbc.M310512200; Binas B, 2007, MOL CELL BIOCHEM, V299, P75, DOI 10.1007/s11010-005-9043-0; Binas B, 1999, FASEB J, V13, P805, DOI 10.1096/fasebj.13.8.805; Brauch KM, 2005, PHYSIOL GENOMICS, V23, P227, DOI 10.1152/physiolgenomics.00076.2005; Buck MJ, 2002, PHYSIOL GENOMICS, V8, P5, DOI 10.1152/physiolgenomics.00076.2001; Cabrero A, 2001, DIABETES, V50, P1883, DOI 10.2337/diabetes.50.8.1883; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carmona MC, 2005, BIOCHEM J, V389, P47, DOI 10.1042/BJ20050009; Chmurzynska A, 2007, ANIM BIOTECHNOL, V18, P37, DOI 10.1080/10495390600671560; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Cho S, 2008, BMB REP, V41, P29, DOI 10.5483/BMBRep.2008.41.1.029; Coe NR, 1999, J LIPID RES, V40, P967; Coe NR, 1998, BBA-LIPID LIPID MET, V1391, P287, DOI 10.1016/S0005-2760(97)00205-1; Crosson SM, 2003, J CLIN INVEST, V111, P1423, DOI 10.1172/JCI200317975; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Daikoku T, 1997, FEBS LETT, V410, P383, DOI 10.1016/S0014-5793(97)00619-4; de Meis L, 2005, BIOSCIENCE REP, V25, P181, DOI 10.1007/s10540-005-2884-7; de Meis L, 2006, J BIOL CHEM, V281, P16384, DOI 10.1074/jbc.M600678200; Eddy SF, 2004, BBA-GENE STRUCT EXPR, V1676, P63, DOI 10.1016/j.bbaexp.2003.10.008; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Erol E, 2004, AM J PHYSIOL-ENDOC M, V287, pE977, DOI 10.1152/ajpendo.00139.2004; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Guerra C, 1998, J CLIN INVEST, V102, P1724, DOI 10.1172/JCI4532; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; Hittel D, 2001, BBA-GENE STRUCT EXPR, V1522, P238, DOI 10.1016/S0167-4781(01)00338-4; Hittel D, 2002, ARCH BIOCHEM BIOPHYS, V401, P244, DOI 10.1016/S0003-9861(02)00048-6; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Lee SH, 2004, J LIPID RES, V45, P1674, DOI 10.1194/jlr.M400039-JLR200; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Murphy EJ, 2004, J BIOL CHEM, V279, P34481, DOI 10.1074/jbc.M314263200; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; ROSS SR, 1992, P NATL ACAD SCI USA, V89, P7561, DOI 10.1073/pnas.89.16.7561; SADDIK M, 1991, J BIOL CHEM, V266, P8162; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Schaap FG, 1999, CIRC RES, V85, P329, DOI 10.1161/01.RES.85.4.329; Shabalina IG, 2010, BBA-BIOENERGETICS, V1797, P968, DOI 10.1016/j.bbabio.2010.02.033; Shearer J, 2005, DIABETES, V54, P3133, DOI 10.2337/diabetes.54.11.3133; Shin Hyoung Doo, 2003, Hum Mutat, V22, P180; Storch J, 2002, MOL CELL BIOCHEM, V239, P25, DOI 10.1023/A:1020546321508; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Ueno T, 2008, AM J HYPERTENS, V21, P691, DOI 10.1038/ajh.2008.40; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; WOOTAN MG, 1994, J BIOL CHEM, V269, P10517; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xu J, 2006, DIABETES, V55, P3429, DOI 10.2337/db06-0260; Yamashita H, 2008, BIOCHEM BIOPH RES CO, V377, P632, DOI 10.1016/j.bbrc.2008.10.041; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	61	67	70	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					380	390		10.1074/jbc.M110.184754	http://dx.doi.org/10.1074/jbc.M110.184754			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21044951	hybrid, Green Published			2022-12-25	WOS:000285782800041
J	Kretzer, NM; Cherian, MT; Mao, CJ; Aninye, IO; Reynolds, PD; Schiff, R; Hergenrother, PJ; Nordeen, SK; Wilson, EM; Shapiro, DJ				Kretzer, Nicole M.; Cherian, Milu T.; Mao, Chengjian; Aninye, Irene O.; Reynolds, Philip D.; Schiff, Rachel; Hergenrother, Paul J.; Nordeen, Steven K.; Wilson, Elizabeth M.; Shapiro, David J.			A Noncompetitive Small Molecule Inhibitor of Estrogen-regulated Gene Expression and Breast Cancer Cell Growth That Enhances Proteasome-dependent Degradation of Estrogen Receptor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; CYCLIN D1; IN-VIVO; TRANSCRIPTIONAL ACTIVATION; COACTIVATOR INTERACTION; ENDOCRINE RESISTANCE; PEPTIDE ANTAGONISTS; ANDROGEN RECEPTOR; RESPONSE ELEMENTS; NUCLEAR RECEPTORS	The mechanisms responsible for 17 beta-estradiol (E-2)-stimulated breast cancer growth and development of resistance to tamoxifen and other estrogen receptor alpha (ER alpha) antagonists are not fully understood. We describe a new tool for dissecting ER alpha action in breast cancer, p-fluoro-4-(1,2,3,6,-tetrahydro-1,3-dimethyl-2-oxo-6-thionpurin-8-ylthio) (TPSF), a potent small-molecule inhibitor of estrogen receptor alpha that does not compete with estrogen for binding to ER alpha. TPSF noncompetitively inhibits estrogen-dependent ER alpha-mediated gene expression with little inhibition of transcriptional activity by NF-kappa B or the androgen or glucocorticoid receptor. TPSF inhibits E-2-ER alpha-mediated induction of the proteinase inhibitor 9 gene, which is activated by ER alpha binding to estrogen response element DNA, and the cyclin D1 gene, which is induced by tethering ER alpha to other DNA-bound proteins. TPSF inhibits anchorage-dependent and anchorage-independent E-2-ER alpha-stimulated growth of MCF-7 cells but does not inhibit growth of ER-negative MDA-MB-231 breast cancer cells. TPSF also inhibits ER alpha-dependent growth in three cellular models for tamoxifen resistance; that is, 4-hydroxytamoxifen-stimulated MCF7ER alpha HA cells that overexpress ER alpha, fully tamoxifen-resistant BT474 cells that have amplified HER-2 and AIB1, and partially tamoxifen-resistant ZR-75 cells. TPSF reduces ER alpha protein levels in MCF-7 cells and several other cell lines without altering ER alpha mRNA levels. The proteasome inhibitor MG132 abolished down-regulation of ER alpha by TPSF. Thus, TPSF affects receptor levels at least in part due to its ability to enhance proteasome-dependent degradation of ER alpha. TPSF represents a novel class of ER inhibitor with significant clinical potential.	[Cherian, Milu T.; Aninye, Irene O.; Shapiro, David J.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Kretzer, Nicole M.; Mao, Chengjian] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Hergenrother, Paul J.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Reynolds, Philip D.; Wilson, Elizabeth M.] Univ N Carolina, Dept Pediat, Labs Reprod Biol, Chapel Hill, NC 27599 USA; [Reynolds, Philip D.; Wilson, Elizabeth M.] Univ N Carolina, Dept Biochem & Biophys, Labs Reprod Biol, Chapel Hill, NC 27599 USA; [Reynolds, Philip D.; Wilson, Elizabeth M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Schiff, Rachel] Baylor Coll Med, Breast Ctr, Houston, TX 77030 USA; [Nordeen, Steven K.] Univ Colorado, Dept Pathol, Denver, CO 80045 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; University of Colorado System; University of Colorado Denver	Shapiro, DJ (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	djshapir@illinois.edu		Aninye, Irene/0000-0002-1747-9148	National Institutes of Health [RO1 DK 071909, RO1 HD 16910, PO1-CA77739]; Endocrine Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016910] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endocrine Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK 071909 (to D. J. S.) and RO1 HD 16910 and PO1-CA77739 (to E. M. W.). This work was also supported by a Bridge grant from the Endocrine Society (to D. J. S.). The University of Illinois at Urbana-Champaign has filed a novel use patent that claims TPSF. D. J. Shapiro, N. M. Patterson, M. Cherian, and C. Mao are co-inventors on the patent.	Abukhdeir AM, 2008, P NATL ACAD SCI USA, V105, P288, DOI 10.1073/pnas.0710887105; Anderson H, 2007, J STEROID BIOCHEM, V106, P49, DOI 10.1016/j.jsbmb.2007.05.024; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Arteaga CL, 1999, JNCI-J NATL CANCER I, V91, P46, DOI 10.1093/jnci/91.1.46; CANNEY PA, 1987, LANCET, V1, P36; Carlson KE, 1997, BIOCHEMISTRY-US, V36, P14897, DOI 10.1021/bi971746l; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Castro-Rivera E, 2001, J BIOL CHEM, V276, P30853, DOI 10.1074/jbc.M103339200; Chang CY, 2003, METHOD ENZYMOL, V364, P118; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Cheng JW, 2007, ENDOCRINOLOGY, V148, P4634, DOI 10.1210/en.2007-0148; CORADINI D, 1995, CANCER DETECT PREV, V19, P348; Cunningham TD, 2007, CELL IMMUNOL, V245, P32, DOI 10.1016/j.cellimm.2007.03.004; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Fabian CJ, 2005, J CLIN ONCOL, V23, P1644, DOI 10.1200/JCO.2005.11.005; Fowler AM, 2006, MOL ENDOCRINOL, V20, P291, DOI 10.1210/me.2005-0288; Fowler AM, 2004, FASEB J, V18, P81, DOI 10.1096/fj.03-0038com; Glass CK, 2000, GENE DEV, V14, P121; Grillo M, 2006, BREAST CANCER RES TR, V95, P185, DOI 10.1007/s10549-005-9066-y; Grunberg SM, 2006, CANCER INVEST, V24, P727, DOI 10.1080/07357900601062339; Gunther JR, 2008, ACS CHEM BIOL, V3, P282, DOI 10.1021/cb800056r; Henderson BE, 2000, CARCINOGENESIS, V21, P427, DOI 10.1093/carcin/21.3.427; Hoffmann J, 2004, J NATL CANCER I, V96, P210, DOI 10.1093/jnci/djh022; HOWELL A, 1992, ANN ONCOL, V3, P611, DOI 10.1093/oxfordjournals.annonc.a058286; Ishii Y, 2008, CANCER RES, V68, P852, DOI 10.1158/0008-5472.CAN-07-2879; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Jiang X, 2007, ONCOGENE, V26, P4106, DOI 10.1038/sj.onc.1210197; Jiang XG, 2006, ENDOCRINOLOGY, V147, P1419, DOI 10.1210/en.2005-0996; Jiang XG, 2008, ENDOCRINOLOGY, V149, P5366, DOI 10.1210/en.2008-0857; Jones JO, 2009, P NATL ACAD SCI USA, V106, P7233, DOI 10.1073/pnas.0807282106; Jordan VC, 2001, ANN NY ACAD SCI, V949, P72; Katzenellenbogen BS, 1997, BREAST CANCER RES TR, V44, P23, DOI 10.1023/A:1005835428423; KATZENELLENBOGEN JA, 1973, BIOCHEMISTRY-US, V12, P4085, DOI 10.1021/bi00745a010; Kilker RL, 2006, CANCER RES, V66, P11478, DOI 10.1158/0008-5472.CAN-06-1755; Krieg AJ, 2004, J BIOL CHEM, V279, P5025, DOI 10.1074/jbc.M307076200; Krieg SA, 2001, MOL ENDOCRINOL, V15, P1971, DOI 10.1210/me.15.11.1971; Kummer JA, 2007, CELL DEATH DIFFER, V14, P1486, DOI 10.1038/sj.cdd.4402152; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; LaFrate AL, 2008, BIOORGAN MED CHEM, V16, P10075, DOI 10.1016/j.bmc.2008.10.007; Mao C, 2008, J BIOL CHEM, V283, P12819, DOI 10.1074/jbc.M709936200; McKenna NJ, 2002, ENDOCRINOLOGY, V143, P2461, DOI 10.1210/endo.143.7.8892; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; Naughton C, 2007, MOL ENDOCRINOL, V21, P2615, DOI 10.1210/me.2007-0110; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; NORDEEN SK, 1989, MOL ENDOCRINOL, V3, P1270, DOI 10.1210/mend-3-8-1270; Norris JD, 1999, SCIENCE, V285, P744, DOI 10.1126/science.285.5428.744; O'Lone R, 2004, MOL ENDOCRINOL, V18, P1859, DOI 10.1210/me.2003-0044; Pan YF, 2008, J BIOL CHEM, V283, P32977, DOI 10.1074/jbc.M802024200; Powell E, 2010, J BIOL CHEM, V285, P16125, DOI 10.1074/jbc.M110.104356; Qin CH, 1999, ENDOCRINOLOGY, V140, P2501, DOI 10.1210/en.140.6.2501; Ramondetta LM, 2009, CANCER-AM CANCER SOC, V115, P1867, DOI 10.1002/cncr.24197; REESE JC, 1992, MOL CELL BIOL, V12, P4531, DOI 10.1128/MCB.12.10.4531; REESE JC, 1991, NUCLEIC ACIDS RES, V19, P6595, DOI 10.1093/nar/19.23.6595; Robertson JFR, 2007, ONCOLOGIST, V12, P774, DOI 10.1634/theoncologist.12-7-774; ROMAIN S, 1994, INT J CANCER, V59, P17, DOI 10.1002/ijc.2910590105; Sabbah M, 1999, P NATL ACAD SCI USA, V96, P11217, DOI 10.1073/pnas.96.20.11217; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; Schiff R, 2004, CLIN CANCER RES, V10, p331S, DOI 10.1158/1078-0432.CCR-031212; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; ten Berge RL, 2003, HISTOPATHOLOGY, V43, P462, DOI 10.1046/j.1365-2559.2003.01726.x; ten Berge RL, 2003, J PATHOL, V200, P4, DOI 10.1002/path.1331; ten Berge RL, 2002, BLOOD, V99, P4540, DOI 10.1182/blood.V99.12.4540; THORPE SM, 1993, EUR J CANCER, V29A, P971, DOI 10.1016/S0959-8049(05)80204-7; van Houdt IS, 2005, CLIN CANCER RES, V11, P6400, DOI 10.1158/1078-0432.CCR-05-0306; Wang LH, 2006, CANCER CELL, V10, P487, DOI 10.1016/j.ccr.2006.09.015; Wang S, 2007, J BIOL CHEM, V282, P2765, DOI 10.1074/jbc.M607531200; Wang SY, 2004, BIOTECHNIQUES, V37, P807, DOI 10.2144/04375RR01; Wei XL, 2006, MOL CELL, V21, P295, DOI 10.1016/j.molcel.2005.11.030; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180	75	17	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41863	41873		10.1074/jbc.M110.183723	http://dx.doi.org/10.1074/jbc.M110.183723			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041310	hybrid, Green Published			2022-12-25	WOS:000285622600074
J	Liu, QA; Gehring, K				Liu, Qian; Gehring, Kalle			Heterodimerization of BAK and MCL-1 Activated by Detergent Micelles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY-MEMBERS; BH3-ONLY PROTEINS; BH3 DOMAINS; MEMBRANE PERMEABILIZATION; MITOCHONDRIAL APOPTOSIS; OLIGOMERIZES BAK; DOWN-REGULATION; CYTOCHROME-C; DEATH; BCL-X(L)	BAK is a key protein mediating mitochondrial outer membrane permeabilization; however, its behavior in the membrane is poorly understood. Here, we characterize the conformational changes in BAK and MCL-1 using detergents to mimic the membrane environment and study their interaction by in vitro pulldown experiments, size exclusion chromatography, titration calorimetry, and NMR spectroscopy. The nonionic detergent IGEPAL has little impact on the structure of MCL-1 but induces a conformational change in BAK, whereby its BH3 region is able to engage the hydrophobic groove of MCL-1. Although the zwitterionic detergent CHAPS induces only minor conformational changes in both proteins, it is still able to initiate heterodimerization. The complex of MCL-1 and BAK can be disrupted by a BID-BH3 peptide, which acts through binding to MCL-1, but a mutant peptide, BAK-BH3-L78A, with low affinity for MCL-1 failed to dissociate the complex. The mutation L78A in BAK prevented binding to MCL-1, thus demonstrating the essential role of the BH3 region of BAK in its regulation by MCL-1. Our results validate the current models for the activation of BAK and highlight the potential value of small molecule inhibitors that target MCL-1 directly.	McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Liu, Qian; Gehring, Kalle] McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada; [Gehring, Kalle] McGill Univ, Quebec Eastern Canada High Field NMR Facil, Montreal, PQ H3A 2A7, Canada	McGill University; McGill University; McGill University	Gehring, K (corresponding author), 3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019; liu, qian/HDM-2936-2022	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184; 	Canadian Institutes of Health Research [MOP-81277]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-81277.	Alvi AJ, 2005, BLOOD, V105, P4484, DOI 10.1182/blood-2004-07-2713; Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Cavarretta IT, 2007, ONCOGENE, V26, P2822, DOI 10.1038/sj.onc.1210097; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Dai HM, 2009, J BIOL CHEM, V284, P18311, DOI 10.1074/jbc.M109.004770; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denisov AY, 2006, BIOCHEMISTRY-US, V45, P2250, DOI 10.1021/bi052332s; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Fire E, 2010, PROTEIN SCI, V19, P507, DOI 10.1002/pro.329; Gillissen B, 2010, J CELL BIOL, V188, P851, DOI 10.1083/jcb.200912070; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Haker G, 2007, ARCH BIOCHEM BIOPHYS, V462, P150, DOI 10.1016/j.abb.2006.12.022; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Ivashyna O, 2009, J BIOL CHEM, V284, P23935, DOI 10.1074/jbc.M109.023853; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kim HA, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1972; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu Q, 2010, J BIOL CHEM, V285, P19615, DOI 10.1074/jbc.M110.105452; Losonczi JA, 2000, BIOCHEMISTRY-US, V39, P11024, DOI 10.1021/bi000919v; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Mandic A, 2001, MOL CELL BIOL, V21, P3684, DOI 10.1128/MCB.21.11.3684-3691.2001; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sawai H, 2009, BIOCHEM BIOPH RES CO, V378, P529, DOI 10.1016/j.bbrc.2008.11.073; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937; Zhang LL, 2004, J BIOL CHEM, V279, P33865, DOI 10.1074/jbc.M403499200	52	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41202	41210		10.1074/jbc.M110.144857	http://dx.doi.org/10.1074/jbc.M110.144857			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	21036904	hybrid, Green Published			2022-12-25	WOS:000285414400082
J	Prieto, L; Astorga, D; Navarro, G; Ruiz, J				Prieto, Laura; Astorga, Diana; Navarro, Gabriel; Ruiz, Javier			Environmental Control of Phase Transition and Polyp Survival of a Massive-Outbreaker Jellyfish	PLOS ONE			English	Article							LIFE-HISTORY; AURELIA-AURITA; CTENOPHORE MNEMIOPSIS; RHOPILEMA-NOMADICA; NEMOPILEMA-NOMURAI; BLACK-SEA; SCYPHOZOA; STROBILATION; CNIDARIA; TEMPERATURE	A number of causes have been proposed to account for the occurrence of gelatinous zooplankton (both jellyfish and ctenophore) blooms. Jellyfish species have a complex life history involving a benthic asexual phase (polyp) and a pelagic sexual phase (medusa). Strong environmental control of jellyfish life cycles is suspected, but not fully understood. This study presents a comprehensive analysis on the physicochemical conditions that control the survival and phase transition of Cotylorhiza tuberculata; a scyphozoan that generates large outbreaks in the Mediterranean Sea. Laboratory experiments indicated that the influence of temperature on strobilation and polyp survival was the critical factor controlling the capacity of this species to proliferate. Early life stages were less sensitive to other factors such as salinity variations or the competitive advantage provided by zooxanthellae in a context of coastal eutrophication. Coherently with laboratory results, the presence/absence of outbreaks of this jellyfish in a particular year seems to be driven by temperature. This is the first time the environmental forcing of the mechanism driving the life cycle of a jellyfish has been disentangled via laboratory experimentation. Projecting this understanding to a field population under climatological variability results in a pattern coherent with in situ records.	[Prieto, Laura; Astorga, Diana; Navarro, Gabriel; Ruiz, Javier] CSIC, Inst Ciencias Marinas Andalucia, Dept Ecol & Coastal Management, Cadiz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN)	Prieto, L (corresponding author), CSIC, Inst Ciencias Marinas Andalucia, Dept Ecol & Coastal Management, Cadiz, Spain.	laura.prieto@icman.csic.es	Ruiz, Javier/G-3184-2016; Navarro, Gabriel/G-1960-2010; Prieto, Laura/B-3986-2009; Navarro, Gabriel/AAA-9528-2020	Ruiz, Javier/0000-0002-3375-2327; Navarro, Gabriel/0000-0002-8919-0060; Prieto, Laura/0000-0003-4704-7757; Navarro, Gabriel/0000-0002-8919-0060	Consejer-ia de Ciencia, Innovacion y Empresa (Junta de Andaluc-ia) [PO7-RNM-02976]; European Commission [FP6-036949 GOCE]; Spanish MIC; i3P-CSIC; Consejeri-a de Educacion y Ciencia (Junta de Andaluci-a)	Consejer-ia de Ciencia, Innovacion y Empresa (Junta de Andaluc-ia); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish MIC; i3P-CSIC; Consejeri-a de Educacion y Ciencia (Junta de Andaluci-a)(Junta de Andalucia)	The meteorological results of San Javier Station were obtained from the information provided by the Spanish "Agencia Estatal de Meteorologia (Ministerio de Medio Ambiente)", for which contribution is acknowledged. This work was financially supported by Consejer-ia de Ciencia, Innovacion y Empresa (Junta de Andaluc-ia, project PO7-RNM-02976), and European Commission Project SESAME (FP6-036949 GOCE). Two research grants to LP, one by the Consejeri-a de Educacion y Ciencia (Junta de Andaluci-a) and one from Ramon y Cajal Programme of Spanish MIC, and an i3P-CSIC doctoral fellowship to DA, are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai MN, 2001, HYDROBIOLOGIA, V451, P69, DOI 10.1023/A:1011840123140; Barz K, 2007, MAR BIOL, V151, P1021, DOI 10.1007/s00227-006-0545-4; Berking S, 2005, INT J DEV BIOL, V49, P969, DOI 10.1387/ijdb.052024sb; CALDER DR, 1982, BIOL BULL, V162, P149, DOI 10.2307/1540810; CALDER DR, 1973, MAR BIOL, V21, P109, DOI 10.1007/BF00354606; Colin SP, 2002, ESTUARIES, V25, P70, DOI 10.1007/BF02696050; *ECOS, 2004, POBL MED MAR MEN; Gibbons MJ, 2009, HYDROBIOLOGIA, V616, P51, DOI 10.1007/s10750-008-9593-8; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; HENROTH L, 1983, OPHELIA, V22, P189; HOFMANN DK, 1978, MAR BIOL, V47, P161, DOI 10.1007/BF00395637; Holst S, 2007, MAR BIOL, V151, P863, DOI 10.1007/s00227-006-0530-y; Holst S, 2010, HYDROBIOLOGIA, V645, P53, DOI 10.1007/s10750-010-0214-y; Hoover RA, 2009, HYDROBIOLOGIA, V616, P259, DOI 10.1007/s10750-008-9595-6; Kawahara M, 2006, MAR ECOL PROG SER, V307, P161, DOI 10.3354/meps307161; KIKINGER R, 1992, MAR ECOL-P S Z N I, V13, P333, DOI 10.1111/j.1439-0485.1992.tb00359.x; Kogovsek T, 2010, HYDROBIOLOGIA, V645, P81, DOI 10.1007/s10750-010-0217-8; Liu WC, 2009, HYDROBIOLOGIA, V616, P247, DOI 10.1007/s10750-008-9597-4; LOTAN A, 1994, MAR ECOL PROG SER, V109, P59, DOI 10.3354/meps109059; LOTAN A, 1992, MAR BIOL, V112, P237, DOI 10.1007/BF00702467; Lucas CH, 2001, HYDROBIOLOGIA, V451, P229, DOI 10.1023/A:1011836326717; Malej A, 2007, MAR BIOL, V151, P827, DOI 10.1007/s00227-006-0503-1; Malej A, 2004, NATO SCI S SS IV EAR, V35, P273; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; PAGES F, 2001, GELATINOUS ZOOPLANKT, V14, P69; Parsons T. R., 2002, Mer (Tokyo), V40, P111; PASPALEFF BW, 1938, TRUD CHERNOMORSK BIO, V7, P1; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; PELLICIER M, MEDUSAS LLEGAN ESTE; Perez-Ruzafa A, 2002, HYDROBIOLOGIA, V475, P359, DOI 10.1023/A:1020343510060; Pierce J., 2005, International Zoo Yearbook, V39, P62; PITT KA, 2009, HYDROBIOLOGIA, V616, P289; Pitt KA, 2009, HYDROBIOLOGIA, V616, P133, DOI 10.1007/s10750-008-9584-9; Purcell JE, 2001, HYDROBIOLOGIA, V451, P145, DOI 10.1023/A:1011826618539; Purcell JE, 2005, J MAR BIOL ASSOC UK, V85, P461, DOI 10.1017/S0025315405011409; PURCELL JE, 2010, HYDROBIOLOGIA, V645, P234; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2007, MAR ECOL PROG SER, V348, P183, DOI 10.3354/meps07056; SANTOS SR, 1995, ULTRAVIOLET RAD CORA, P165; Schiariti A, 2008, MAR BIOL, V156, P1, DOI 10.1007/s00227-008-1050-8; Shiganova T.A., 2003, BIOL BULL, V2, P225; Shiganova TA, 2001, MAR BIOL, V139, P431; SILVERSTONE M, 1977, GEN COMP ENDOCR, V32, P108, DOI 10.1016/0016-6480(77)90087-9; SPANGENB.DB, 1965, J EXP ZOOL, V160, P1, DOI 10.1002/jez.1401600102; SUGIURA Y, 1965, BIOL BULL, V128, P493, DOI 10.2307/1539908; Sugiura Y., 1963, Annotationes Zoologicae Japonenses, V36, P194; Velasco J, 2006, WATER AIR SOIL POLL, V176, P37, DOI 10.1007/s11270-006-2859-8; Willcox S, 2008, MAR BIOL, V154, P661, DOI 10.1007/s00227-008-0959-2; Yamamoto J, 2008, MAR BIOL, V153, P311, DOI 10.1007/s00227-007-0807-9	49	64	67	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13793	10.1371/journal.pone.0013793	http://dx.doi.org/10.1371/journal.pone.0013793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072185	Green Published, Green Submitted, gold			2022-12-25	WOS:000283780800006
J	Kristjansson, A; Eyjolfsdottir, KO; Jonsdottir, A; Arnkelsson, G				Kristjansson, Arni; Eyjolfsdottir, Katrin Osk; Jonsdottir, Anna; Arnkelsson, Gudmundur			Temporal Consistency Is Currency in Shifts of Transient Visual Attention	PLOS ONE			English	Article							TARGET REPETITION; POP-OUT; SEARCH; MEMORY; TIME; DISCRIMINATION; SPACE; PROBABILITY; FOREPERIOD; COMPONENTS	Background: Observers respond more accurately to targets in visual search tasks that share properties with previously presented items, and transient attention can learn featural consistencies on a precue, irrespective of its absolute location. Methodology/Principal Findings: We investigated whether such attentional benefits also apply to temporal consistencies. Would performance on a precued Vernier acuity discrimination task, followed by a mask, improve if the cue-lead times (CLTs; 50, 100, 150 or 200 ms) remained constant between trials compared to when they changed? The results showed that if CLTs remained constant for a few trials in a row, Vernier acuity performance gradually improved while changes in CLT from one trial to the next led to worse than average discrimination performance. The results show that transient attention can quickly adjust to temporal regularities, similarly to spatial and featural regularities. Further experiments show that this form of learning is not under voluntary control. Conclusions/Significance: The results add to a growing literature showing how consistency in visual presentation improves visual performance, in this case temporal consistency.	[Kristjansson, Arni; Eyjolfsdottir, Katrin Osk; Jonsdottir, Anna; Arnkelsson, Gudmundur] Univ Iceland, Dept Psychol, Reykjavik, Iceland	University of Iceland	Kristjansson, A (corresponding author), Univ Iceland, Dept Psychol, Reykjavik, Iceland.	ak@hi.is			University of Iceland	University of Iceland	The experiments were supported by the research fund of the University of Iceland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker SI, 2008, ACTA PSYCHOL, V127, P324, DOI 10.1016/j.actpsy.2007.07.005; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Coull JT, 1998, J NEUROSCI, V18, P7426; Edelman JA, 2007, J VISION, V7, DOI 10.1167/7.6.12; Efron B., 1994, INTRO BOOTSTRAP; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Fecteau JH, 2007, J VISION, V7, DOI 10.1167/7.6.1; FISCHER B, 1993, BEHAV BRAIN SCI, V16, P553, DOI 10.1017/S0140525X00031575; Fiser J, 2001, PSYCHOL SCI, V12, P499, DOI 10.1111/1467-9280.00392; Fuggetta G, 2007, VIS COGN, V15, P834, DOI 10.1080/13506280600992432; Fuggetta G, 2009, SPATIAL VISION, V22, P147, DOI 10.1163/156856809787465618; Geng JJ, 2005, PERCEPT PSYCHOPHYS, V67, P1252, DOI 10.3758/BF03193557; Geyer T, 2006, PERCEPT PSYCHOPHYS, V68, P736, DOI 10.3758/BF03193697; GIBSON EJ, 1963, ANNU REV PSYCHOL, V14, P29, DOI 10.1146/annurev.ps.14.020163.000333; GRIFFIN IC, 2001, FRONT BIOSCI, V6, P660; Hommel B, 2006, PSYCHOL RES-PSYCH FO, V70, P425, DOI 10.1007/s00426-005-0009-3; JONIDES J, 1981, ATTENTION PERFORM, V9, P1187; KARLIN L, 1959, J EXP PSYCHOL, V58, P185, DOI 10.1037/h0049152; Kristjansson A, 2006, VIS COGN, V13, P324, DOI 10.1080/13506280544000039; Kristjansson A, 2005, PERCEPTION, V34, P40; Kristjansson A, 2003, PERCEPT PSYCHOPHYS, V65, P711, DOI 10.3758/BF03194808; Kristjansson A, 2002, VISION RES, V42, P2039, DOI 10.1016/S0042-6989(02)00129-3; Kristjansson A, 2002, COGNITION, V85, P37, DOI 10.1016/S0010-0277(02)00074-4; Kristjansson A, 2001, PERCEPTION, V30, P1375, DOI 10.1068/p3251; Kristjansson A, 2008, PERCEPTION, V37, P747, DOI 10.1068/p5922; Kristjansson A, 2008, VISION RES, V48, P1217, DOI 10.1016/j.visres.2008.02.007; Kristjansson A, 2008, FRONT BIOSCI-LANDMRK, V13, P1171, DOI 10.2741/2753; Kristjansson A, 2007, SCAND J PSYCHOL, V48, P97, DOI 10.1111/j.1467-9450.2007.00537.x; Kristjansson A, 2006, VISION RES, V46, P2554, DOI 10.1016/j.visres.2006.01.015; Kristjansson A, 2010, ATTEN PERCEPT PSYCHO, V72, P5, DOI 10.3758/APP.72.1.5; Kristjansson A, 2009, J VISION, V9, DOI 10.1167/9.4.21; Lamy D, 2005, PSYCHON B REV, V12, P1112, DOI 10.3758/BF03206452; Lamy D, 2006, PERCEPT PSYCHOPHYS, V68, P919, DOI 10.3758/BF03193355; LASLEY DJ, 1981, J OPT SOC AM, V71, P845, DOI 10.1364/JOSA.71.000845; MALJKOVIC V, 1994, MEM COGNITION, V22, P657, DOI 10.3758/BF03209251; Maljkovic V, 2005, VISION RES, V45, P2831, DOI 10.1016/j.visres.2005.05.019; Martens S, 2005, MEM COGNITION, V33, P234, DOI 10.3758/BF03195312; Meeter M, 2006, VIS COGN, V13, P202, DOI 10.1080/13506280500277488; MILLER J, 1988, J EXP PSYCHOL HUMAN, V14, P453, DOI 10.1037/0096-1523.14.3.453; Milliken B, 2003, PSYCHON B REV, V10, P877, DOI 10.3758/BF03196547; Montagna B, 2009, VISION RES, V49, P735, DOI 10.1016/j.visres.2009.02.001; Mooney CZ, 1993, SAGE U PAPER SERIES; MULLER HJ, 1988, ACTA PSYCHOL, V69, P129, DOI 10.1016/0001-6918(88)90003-0; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Nakayama K, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P397; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Nobre AC, 2001, NEUROSCI BIOBEHAV R, V25, P477, DOI 10.1016/S0149-7634(01)00028-8; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Pashler HE, 1998, PSYCHOL ATTENTION; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Sigurdardottir HM, 2008, VIS COGN, V16, P643, DOI 10.1080/13506280701218364; Solomon JA, 1997, J OPT SOC AM A, V14, P2443, DOI 10.1364/JOSAA.14.002443; TEICHNER WH, 1954, PSYCHOL BULL, V51, P128, DOI 10.1037/h0060900; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V49, P83, DOI 10.3758/BF03211619; Westheimer G, 1996, J OPT SOC AM A, V13, P884, DOI 10.1364/JOSAA.13.000884; Woodrow H, 1914, PSYCHOL MONOGR, V17, P1; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Yeshurun Y, 1999, VISION RES, V39, P293, DOI 10.1016/S0042-6989(98)00114-X	59	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13660	10.1371/journal.pone.0013660	http://dx.doi.org/10.1371/journal.pone.0013660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	672HN	21060888	Green Published, Green Submitted, gold			2022-12-25	WOS:000283573800001
J	Li, Y; Wang, N; Perkins, EJ; Zhang, CY; Gong, P				Li, Ying; Wang, Nan; Perkins, Edward J.; Zhang, Chaoyang; Gong, Ping			Identification and Optimization of Classifier Genes from Multi-Class Earthworm Microarray Dataset	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; CANCER CLASSIFICATION; FEATURE-SELECTION; BINDING-PROTEIN; VARIABLE SELECTION; EXPRESSION; DISCOVERY; RECOGNITION; RESPONSES	Monitoring, assessment and prediction of environmental risks that chemicals pose demand rapid and accurate diagnostic assays. A variety of toxicological effects have been associated with explosive compounds TNT and RDX. One important goal of microarray experiments is to discover novel biomarkers for toxicity evaluation. We have developed an earthworm microarray containing 15,208 unique oligo probes and have used it to profile gene expression in 248 earthworms exposed to TNT, RDX or neither. We assembled a new machine learning pipeline consisting of several well-established feature filtering/selection and classification techniques to analyze the 248-array dataset in order to construct classifier models that can separate earthworm samples into three groups: control, TNT-treated, and RDX-treated. First, a total of 869 genes differentially expressed in response to TNT or RDX exposure were identified using a univariate statistical algorithm of class comparison. Then, decision tree-based algorithms were applied to select a subset of 354 classifier genes, which were ranked by their overall weight of significance. A multiclass support vector machine (MC-SVM) method and an unsupervised K-mean clustering method were applied to independently refine the classifier, producing a smaller subset of 39 and 30 classifier genes, separately, with 11 common genes being potential biomarkers. The combined 58 genes were considered the refined subset and used to build MC-SVM and clustering models with classification accuracy of 83.5% and 56.9%, respectively. This study demonstrates that the machine learning approach can be used to identify and optimize a small subset of classifier/biomarker genes from high dimensional datasets and generate classification models of acceptable precision for multiple classes.	[Li, Ying; Wang, Nan; Zhang, Chaoyang] Univ So Mississippi, Sch Comp, Hattiesburg, MS 39406 USA; [Perkins, Edward J.] USA, Environm Lab, Engn Res & Dev Ctr, Vicksburg, MS USA; [Gong, Ping] SpecPro Inc, Environm Serv, Vicksburg, MS USA	University of Southern Mississippi; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Li, Y (corresponding author), Univ So Mississippi, Sch Comp, Hattiesburg, MS 39406 USA.	ping.gong@usace.army.mil			U.S. Army Environmental Quality Technology Research; ERDC; U.S. Army Chief of Engineers	U.S. Army Environmental Quality Technology Research; ERDC(United States Department of DefenseUnited States Army); U.S. Army Chief of Engineers	This work was supported by the U.S. Army Environmental Quality Technology Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SpecPro Inc. supported Ping Gong through a contract granted by ERDC, and through this employment is considered by PLoS ONE to have played a role in the research. Permission to publish this information was granted by the U.S. Army Chief of Engineers.	Abeel T, 2010, BIOINFORMATICS, V26, P392, DOI 10.1093/bioinformatics/btp630; Anand A, 2009, J THEOR BIOL, V259, P533, DOI 10.1016/j.jtbi.2009.04.013; Ankley GT, 2006, ENVIRON SCI TECHNOL, V40, P4055, DOI 10.1021/es0630184; Antonov AV, 2004, BIOINFORMATICS, V20, P644, DOI 10.1093/bioinformatics/btg462; Arcuri F, 2005, BIOL REPROD, V73, P745, DOI 10.1095/biolreprod.105.042077; Boutros PC, 2005, BRIEF BIOINFORM, V6, P331, DOI 10.1093/bib/6.4.331; Chi JT, 2007, PLOS GENET, V3, P1770, DOI 10.1371/journal.pgen.0030164; Choi JK, 2005, BIOINFORMATICS, V21, P4348, DOI 10.1093/bioinformatics/bti722; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Falciani F, 2008, AQUAT TOXICOL, V90, P92, DOI 10.1016/j.aquatox.2008.07.020; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; GONG P, 2010, PLOS ONE UNPUB; Gong P, 2007, ENVIRON SCI TECHNOL, V41, P8195, DOI 10.1021/es0716352; Gong P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S15; Hawkins DM, 2004, J CHEM INF COMP SCI, V44, P1, DOI 10.1021/ci0342472; Horng JT, 2009, EXPERT SYST APPL, V36, P9072, DOI 10.1016/j.eswa.2008.12.037; Huang LT, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-25; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Jorgensen R, 2006, BIOCHEM SOC T, V34, P1; Kuperman R.G., 2009, ECOTOXICOLOGY EXPLOS, P35, DOI 10.1201/9781420004342; Lu Y, 2003, INFORM SYST, V28, P243, DOI 10.1016/S0306-4379(02)00072-8; MCLACHLAN GJ, 2008, PARAMETRICS INTERDIS, P364; Moens LN, 2006, TOXICOL SCI, V93, P298, DOI 10.1093/toxsci/kfl057; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Nota B, 2010, TOXICOL SCI, V115, P34, DOI 10.1093/toxsci/kfq043; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Powell W, 2007, APPROXIMATE DYNAMIC; Poynton HC, 2008, ENVIRON SCI TECHNOL, V42, P6257, DOI 10.1021/es800262k; Rocke DM, 2009, BIOINFORMATICS, V25, P701, DOI 10.1093/bioinformatics/btp038; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Simon R, 2007, CANCER INFORM, V3, P11; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Southby J, 1999, MOL CELL BIOL, V19, P2699; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Suzuki T, 2005, GENE, V362, P11, DOI 10.1016/j.gene.2005.07.039; Svendsen C, 2008, ENVIRON SCI TECHNOL, V42, P4208, DOI 10.1021/es702745d; Tan PJ, 2007, LECT NOTES COMPUT SC, V4830, P589; Tonevitsky EA, 2009, B EXP BIOL MED+, V147, P733, DOI 10.1007/s10517-009-0593-0; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Trevino V, 2006, BIOINFORMATICS, V22, P1154, DOI 10.1093/bioinformatics/btl074; Wang RL, 2008, ENVIRON TOXICOL CHEM, V27, P664, DOI 10.1897/07-192.1; Wang Y, 2005, COMPUT BIOL CHEM, V29, P37, DOI 10.1016/j.compbiolchem.2004.11.001; Yang YL, 2009, DRUG DISCOV TODAY, V14, P147, DOI 10.1016/j.drudis.2008.12.005; Yu CG, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-52; Yu L, 2004, J MACH LEARN RES, V5, P1205; Zhang CY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S4-S15; [No title captured]	48	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13715	10.1371/journal.pone.0013715	http://dx.doi.org/10.1371/journal.pone.0013715			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060837	Green Published, gold, Green Submitted			2022-12-25	WOS:000283573800014
J	Li, F; Wang, LP; Shen, XM; Tsien, JZ				Li, Fei; Wang, L. Phillip; Shen, Xiaoming; Tsien, Joe Z.			Balanced Dopamine Is Critical for Pattern Completion during Associative Memory Recall	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ANTERIOR CINGULATE CORTEX; RAT PREFRONTAL CORTEX; PARKINSONS-DISEASE; SPATIAL MEMORY; MICE LACKING; ATTENTION; TRANSPORTER; RETRIEVAL; HIPPOCAMPUS	Pattern completion, the ability to retrieve complete memories initiated by partial cues, is a critical feature of the memory process. However, little is known regarding the molecular and cellular mechanisms underlying this process. To study the role of dopamine in memory recall, we have analyzed dopamine transporter heterozygous knockout mice (DAT(+/-)), and found that while these mice possess normal learning, consolidation, and memory recall under full cue conditions, they exhibit specific deficits in pattern completion under partial cue condition. This form of memory recall deficit in the dopamine transporter heterozygous knockout mice can be reversed by a low dose of the dopamine antagonist haloperidol, further confirming that the inability to retrieve memory patterns is a result of dopamine imbalance. Therefore, our results reveal that a delicate control of the brain's dopamine level is critical for pattern completion during associative memory recall.	[Li, Fei; Shen, Xiaoming] Shanghai Jiao Tong Univ, Sch Med, Dept Dev & Behav Pediat, Shanghai Childrens Med Ctr, Shanghai 200030, Peoples R China; [Li, Fei; Shen, Xiaoming] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Childrens Environm Hlth, XinHua Hosp, Shanghai 200030, Peoples R China; [Li, Fei; Wang, L. Phillip; Tsien, Joe Z.] Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30912 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University System of Georgia; Augusta University	Li, F (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Dev & Behav Pediat, Shanghai Childrens Med Ctr, Shanghai 200030, Peoples R China.	xmshen@shsmu.edu.cn; jtsien@mcg.edu			NIMH [MH060236]; NIA [AG024022, AG034663, AG025918]; Georgia Research Alliance, and Science and Technology Commission of Shanghai Municipality [101409005003]; National Science Foundation of China [81000592]; Science and Technology Commission of Shanghai Municipality [10DZ2272200, 09DZ2200900, 10PJ1407500, 10JC1411200]; Shanghai Municipal Education Commission [11ZZ103];  [USAMRA00002]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024022, R01AG034663, R01AG025918] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Georgia Research Alliance, and Science and Technology Commission of Shanghai Municipality; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by funds from NIMH (MH060236), NIA (AG024022, AG034663 & AG025918), USAMRA00002, Georgia Research Alliance, and Science and Technology Commission of Shanghai Municipality (10140900500) (all to JZT). National Science Foundation of China (81000592), Science and Technology Commission of Shanghai Municipality (10DZ2272200, 09DZ2200900, 10PJ1407500 and 10JC1411200), Shanghai Municipal Education Commission (11ZZ103) to FL and XMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit-Marand M, 2000, EUR J NEUROSCI, V12, P2985, DOI 10.1046/j.1460-9568.2000.00155.x; Brennan AR, 2008, ANN NY ACAD SCI, V1129, P236, DOI 10.1196/annals.1417.007; Cao XH, 2008, NEURON, V60, P353, DOI 10.1016/j.neuron.2008.08.027; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Chen GF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008256; Chen X, 2005, NAT NEUROSCI, V8, P925, DOI 10.1038/nn1482; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; CUMMINGS JL, 1988, EUR NEUROL, V28, P15; Dujardin K, 2003, CURR OPIN NEUROL, V16, pS11, DOI 10.1097/00019052-200312002-00003; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Gill M, 1997, MOL PSYCHIATR, V2, P311, DOI 10.1038/sj.mp.4000290; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Granon S, 2000, J NEUROSCI, V20, P1208, DOI 10.1523/JNEUROSCI.20-03-01208.2000; Han CJ, 2003, P NATL ACAD SCI USA, V100, P13087, DOI 10.1073/pnas.2132313100; Ito R, 2002, J NEUROSCI, V22, P6247; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Kirwan CB, 2010, P NATL ACAD SCI USA, V107, P344, DOI 10.1073/pnas.0912543107; Korz V, 2007, LEARN MEMORY, V14, P160, DOI 10.1101/lm.459807; Leon WC, 2010, LEARN MEMORY, V17, P297, DOI 10.1101/lm.1804410; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Matus-Amat P, 2004, J NEUROSCI, V24, P2431, DOI 10.1523/JNEUROSCI.1598-03.2004; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Morice E, 2007, NEUROPSYCHOPHARMACOL, V32, P2108, DOI 10.1038/sj.npp.1301354; Muzzio IA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000140; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Ouyang M, 2008, P NATL ACAD SCI USA, V105, P11993, DOI 10.1073/pnas.0804172105; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; Phillips AG, 2004, J NEUROSCI, V24, P547, DOI 10.1523/JNEUROSCI.4653-03.2004; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Ridley RM, 2006, BEHAV BRAIN RES, V166, P253, DOI 10.1016/j.bbr.2005.08.007; Rodriguiz RM, 2004, BEHAV BRAIN RES, V148, P185, DOI 10.1016/S0166-4328(03)00187-6; ROLLS ET, 1994, PROG BRAIN RES, V102, P335; SARA SJ, 1985, ANN NY ACAD SCI, V444, P178, DOI 10.1111/j.1749-6632.1985.tb37588.x; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Taubenfeld SM, 2010, P NATL ACAD SCI USA, V107, P12345, DOI 10.1073/pnas.1003152107; Thompson RE, 2005, ANNU REV PSYCHOL, V56, P1, DOI 10.1146/annurev.psych.56.091103.070239; Tirapu-Ustarroz J, 2005, REV NEUROLOGIA, V41, P475, DOI 10.33588/rn.4108.2005240; Waldman ID, 1998, AM J HUM GENET, V63, P1767, DOI 10.1086/302132; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Weintraub Daniel, 2004, Cogn Behav Neurol, V17, P195; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	49	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e15401	10.1371/journal.pone.0015401	http://dx.doi.org/10.1371/journal.pone.0015401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060884	Green Published, Green Submitted, gold			2022-12-25	WOS:000283537000064
J	Narayanan, R; Jiang, JM; Gusev, Y; Jones, A; Kearbey, JD; Miller, DD; Schmittgen, TD; Dalton, JT				Narayanan, Ramesh; Jiang, Jinmai; Gusev, Yuriy; Jones, Amanda; Kearbey, Jeffrey D.; Miller, Duane D.; Schmittgen, Thomas D.; Dalton, James T.			MicroRNAs Are Mediators of Androgen Action in Prostate and Muscle	PLOS ONE			English	Article							NUCLEAR RECEPTOR; HORMONE-RECEPTOR; BODY-COMPOSITION; CANCER; MODULATORS; MOUSE; IDENTIFICATION; ORGANOGENESIS; INACTIVATION; COACTIVATOR	Androgen receptor (AR) function is critical for the development of male reproductive organs, muscle, bone and other tissues. Functionally impaired AR results in androgen insensitivity syndrome (AIS). The interaction between AR and microRNA (miR) signaling pathways was examined to understand the role of miRs in AR function. Reduction of androgen levels in Sprague-Dawley rats by castration inhibited the expression of a large set of miRs in prostate and muscle, which was reversed by treatment of castrated rats with 3 mg/day dihydrotestosterone (DHT) or selective androgen receptor modulators. Knockout of the miR processing enzyme, DICER, in LNCaP prostate cancer cells or tissue specifically in mice inhibited AR function leading to AIS. Since the only function of miRs is to bind to 39 UTR and inhibit translation of target genes, androgens might induce miRs to inhibit repressors of AR function. In concordance, knock-down of DICER in LNCaP cells and in tissues in mice induced the expression of corepressors, NCoR and SMRT. These studies demonstrate a feedback loop between miRs, corepressors and AR and the imperative role of miRs in AR function in non-cancerous androgen-responsive tissues.	[Narayanan, Ramesh; Jones, Amanda; Kearbey, Jeffrey D.; Miller, Duane D.; Dalton, James T.] GTx Inc, Preclin Res & Dev, Memphis, TN USA; [Jiang, Jinmai; Schmittgen, Thomas D.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Gusev, Yuriy] Georgetown Univ, Lombardi Canc Ctr, Washington, DC USA	University System of Ohio; Ohio State University; Georgetown University	Narayanan, R (corresponding author), GTx Inc, Preclin Res & Dev, Memphis, TN USA.	rnarayanan@gtxinc.com; jdalton@gtxinc.com		Gusev, Yuriy/0000-0001-7371-4715; Dalton, James T/0000-0002-3915-7326	GTx Inc.	GTx Inc.	No external funding sources for this study. As some of the authors are employees of GTx Inc. (www.gtxinc.com), the studies were funded as part of the preclinical research and development program of GTx Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asli NS, 2008, CURR MOL MED, V8, P698, DOI 10.2174/156652408786733739; Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Bala S, 2009, WORLD J GASTROENTERO, V15, P5633, DOI 10.3748/wjg.15.5633; Bethke A, 2009, SCIENCE, V324, P95, DOI 10.1126/science.1164899; Bohl CE, 2005, J BIOL CHEM, V280, P37747, DOI 10.1074/jbc.M507464200; Catalucci D, 2009, CIRC-CARDIOVASC GENE, V2, P402, DOI 10.1161/CIRCGENETICS.109.857425; Chen TS, 2008, CURR OPIN CHEM BIOL, V12, P418, DOI 10.1016/j.cbpa.2008.07.001; Clarke BL, 2009, CURR OPIN RHEUMATOL, V21, P374, DOI 10.1097/BOR.0b013e32832ca447; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; De Bosscher K, 2010, CURR OPIN PHARMACOL, V10, P497, DOI 10.1016/j.coph.2010.04.007; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Gao WQ, 2005, ENDOCRINOLOGY, V146, P4887, DOI 10.1210/en.2005-0572; Gentile MA, 2010, J MOL ENDOCRINOL, V44, P55, DOI 10.1677/JME-09-0048; Gonzalez G, 2009, MOL REPROD DEV, V76, P678, DOI 10.1002/mrd.21010; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gusev Y, 2008, METHODS, V44, P61, DOI 10.1016/j.ymeth.2007.10.005; Hong XM, 2008, ENDOCRINOLOGY, V149, P6207, DOI 10.1210/en.2008-0294; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Li J, 2009, MATURITAS, V63, P142, DOI 10.1016/j.maturitas.2009.03.008; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; MARTINI L, 1990, ANN NY ACAD SCI, V595, P184, DOI 10.1111/j.1749-6632.1990.tb34292.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mohler ML, 2009, J MED CHEM, V52, P3597, DOI 10.1021/jm900280m; Narayanan R, 2005, MOL CELL BIOL, V25, P264, DOI 10.1128/MCB.25.1.264-277.2005; Narayanan R, 2008, MOL ENDOCRINOL, V22, P2448, DOI 10.1210/me.2008-0160; Narayanan R, 2010, CANCER RES, V70, P842, DOI 10.1158/0008-5472.CAN-09-3206; Narayanan Ramesh, 2008, Nucl Recept Signal, V6, pe010, DOI 10.1621/nrs.06010; Pan W, 2002, BIOINFORMATICS, V18, P546, DOI 10.1093/bioinformatics/18.4.546; Prins G S, 2000, Mayo Clin Proc, V75 Suppl, pS32; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Thomson AA, 2008, DIFFERENTIATION, V76, P587, DOI 10.1111/j.1432-0436.2008.00296.x; TREMBLAY RR, 1977, STEROIDS, V29, P185, DOI 10.1016/0039-128X(77)90038-1; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Vlassov VV, 2010, CURR MOL MED, V10, P142, DOI 10.2174/156652410790963295; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017; Yin DH, 2003, J PHARMACOL EXP THER, V304, P1334, DOI 10.1124/jpet.102.040840; Yoon HG, 2006, MOL ENDOCRINOL, V20, P1048, DOI 10.1210/me.2005-0324	47	44	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13637	10.1371/journal.pone.0013637	http://dx.doi.org/10.1371/journal.pone.0013637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048966	Green Published, Green Submitted, gold			2022-12-25	WOS:000283537000018
J	Krashia, P; Moroni, M; Broadbent, S; Hofmann, G; Kracun, S; Beato, M; Groot-Kormelink, PJ; Sivilotti, LG				Krashia, Paraskevi; Moroni, Mirko; Broadbent, Steven; Hofmann, Giovanna; Kracun, Sebastian; Beato, Marco; Groot-Kormelink, Paul J.; Sivilotti, Lucia G.			Human alpha 3 beta 4 Neuronal Nicotinic Receptors Show Different Stoichiometry if They Are Expressed in Xenopus Oocytes or Mammalian HEK293 Cells	PLOS ONE			English	Article							SINGLE-CHANNEL CONDUCTANCE; RAT SYMPATHETIC NEURONS; ACETYLCHOLINE-RECEPTORS; ALTERNATE STOICHIOMETRIES; KINETIC-PROPERTIES; MICE LACKING; DETERMINANTS; SENSITIVITY; CHAPERONE; EXPOSURE	Background: The neuronal nicotinic receptors that mediate excitatory transmission in autonomic ganglia are thought to be formed mainly by the alpha 3 and beta 4 subunits. Expressing this composition in oocytes fails to reproduce the properties of ganglionic receptors, which may also incorporate the alpha 5 and/or beta 2 subunits. We compared the properties of human alpha 3 beta 4 neuronal nicotinic receptors expressed in Human embryonic kidney cells (HEK293) and in Xenopus oocytes, to examine the effect of the expression system and alpha:beta subunit ratio. Methodology/Principal Findings: Two distinct channel forms were observed: these are likely to correspond to different stoichiometries of the receptor, with two or three copies of the alpha subunit, as reported for alpha 4 beta 2 channels. This interpretation is supported by the pattern of change in acetylcholine (ACh) sensitivity observed when a hydrophilic Leu to Thr mutation was inserted in position 9' of the second transmembrane domain, as the effect of mutating the more abundant subunit is greater. Unlike alpha 4 beta 2 channels, for alpha 3 beta 4 receptors the putative two-alpha form is the predominant one in oocytes (at 1:1 alpha:beta cRNA ratio). This two-alpha form has a slightly higher ACh sensitivity (about 3-fold in oocytes), and displays potentiation by zinc. The putative three-alpha form is the predominant one in HEK cells transfected with a 1:1 alpha:beta DNA ratio or in oocytes at 9:1 alpha:beta RNA ratio, and is more sensitive to dimethylphenylpiperazinium (DMPP) than to ACh. In outside-out single-channel recordings, the putative two-alpha form opened to distinctive long bursts (100 ms or more) with low conductance (26 pS), whereas the three-alpha form gave rise to short bursts (14 ms) of high conductance (39 pS). Conclusions/Significance: Like other neuronal nicotinic receptors, the alpha 3 beta 4 receptor can exist in two different stoichiometries, depending on whether it is expressed in oocytes or in mammalian cell lines and on the ratio of subunits transfected.	[Krashia, Paraskevi; Moroni, Mirko; Hofmann, Giovanna; Beato, Marco; Sivilotti, Lucia G.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Broadbent, Steven] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Kracun, Sebastian] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Groot-Kormelink, Paul J.] Novartis Inst Biomed Res, Novartis Horsham Res Ctr, Horsham, W Sussex, England	University of London; University College London; Newcastle University - UK; University of California System; University of California Los Angeles; Novartis	Krashia, P (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	l.sivilotti@ucl.ac.uk	Krashia, Paraskevi/K-7973-2016; Sivilotti, Lucia/D-8919-2011; Moroni, Mirko/Q-1524-2018; Beato, Marco/C-1713-2008	Krashia, Paraskevi/0000-0002-8476-9233; Sivilotti, Lucia/0000-0003-2510-8424; Broadbent, Steven/0000-0002-7872-3968; Beato, Marco/0000-0002-7283-8318	Wellcome Trust [064652]; MRC [G0400869]; Royal Society; Medical Research Council [G0400869] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (http://www.wellcome.ac.uk/) (project grant 064652, LGS; PhD studentship, SK); the MRC (http://www.mrc.ac.uk/index.htm) (programme grant G0400869, LGS; PhD studentship, SB); and the Royal Society (http://royalsociety.org/) (University Research Fellowship, MB; European Exchange grant, GH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boorman JPB, 2000, J PHYSIOL-LONDON, V529, P565, DOI 10.1111/j.1469-7793.2000.00565.x; Britt JC, 1997, PFLUG ARCH EUR J PHY, V434, P38, DOI 10.1007/s004240050360; Broadbent S, 2006, MOL PHARMACOL, V70, P1350, DOI 10.1124/mol.106.026682; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Colquhoun D., 2003, BURGERS MED CHEM DRU, P357; Colquhoun D, 1971, LECT BIOSTATISTICS; Colquhoun David, 1995, P483; CONROY WG, 1995, J BIOL CHEM, V270, P4424, DOI 10.1074/jbc.270.9.4424; COVERNTON PJO, 1994, J PHYSIOL-LONDON, V481, P27, DOI 10.1113/jphysiol.1994.sp020416; DERKACH VA, 1987, J PHYSIOL-LONDON, V388, P141, DOI 10.1113/jphysiol.1987.sp016606; Drenan RM, 2008, MOL PHARMACOL, V73, P27, DOI 10.1124/mol.107.039180; Exley R, 2006, J NEUROCHEM, V98, P876, DOI 10.1111/j.1471-4159.2006.03915.x; Figl A, 2000, J PHYSIOL-LONDON, V524, P685, DOI 10.1111/j.1469-7793.2000.00685.x; Fischer H, 2005, J PHYSIOL-LONDON, V563, P119, DOI 10.1113/jphysiol.2004.075788; Groot-Kormelink PJ, 2002, J NEUROSCI METH, V113, P207, DOI 10.1016/S0165-0270(01)00500-3; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Hsiao B, 2001, J NEUROSCI, V21, P1848, DOI 10.1523/JNEUROSCI.21-06-01848.2001; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Kristufek D, 1999, J PHYSIOL-LONDON, V516, P739, DOI 10.1111/j.1469-7793.1999.0739u.x; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lewis TM, 1997, J PHYSIOL-LONDON, V505, P299, DOI 10.1111/j.1469-7793.1997.299bb.x; MATHIE A, 1991, J PHYSIOL-LONDON, V439, P717, DOI 10.1113/jphysiol.1991.sp018690; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nelson ME, 1999, J PHYSIOL-LONDON, V516, P657, DOI 10.1111/j.1469-7793.1999.0657u.x; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; PAPKE RL, 1991, J PHYSIOL-LONDON, V440, P95, DOI 10.1113/jphysiol.1991.sp018698; PAPKE RL, 1989, NEURON, V3, P589, DOI 10.1016/0896-6273(89)90269-9; Peters JA, 2005, TRENDS PHARMACOL SCI, V26, P587, DOI 10.1016/j.tips.2005.09.011; RUST G, 1994, EUR J NEUROSCI, V6, P478, DOI 10.1111/j.1460-9568.1994.tb00290.x; Sigel E, 1997, TRENDS PHARMACOL SCI, V18, P425, DOI 10.1016/S0165-6147(97)90675-1; Sivilotti LG, 1997, J PHYSIOL-LONDON, V500, P123, DOI 10.1113/jphysiol.1997.sp022004; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Xu W, 1999, P NATL ACAD SCI USA, V96, P5746, DOI 10.1073/pnas.96.10.5746; Xu W, 1999, J NEUROSCI, V19, P9298; Zhao LK, 2003, J PHARMACOL EXP THER, V305, P1132, DOI 10.1124/jpet.103.048777; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124	39	56	57	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13611	10.1371/journal.pone.0013611	http://dx.doi.org/10.1371/journal.pone.0013611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049012	gold, Green Published, Green Submitted			2022-12-25	WOS:000283487400010
J	Kuczma, M; Kopij, M; Pawlikowska, I; Wang, CY; Rempala, GA; Kraj, P				Kuczma, Michal; Kopij, Magdalena; Pawlikowska, Iwona; Wang, Cong-Yi; Rempala, Grzegorz A.; Kraj, Piotr			Intratumoral Convergence of the TCR Repertoires of Effector and Foxp3(+) CD4(+) T cells	PLOS ONE			English	Article							REGULATORY-CELLS; TUMOR-IMMUNITY; TGF-BETA; TOLERANCE INDUCTION; PANCREATIC-CANCER; ANTIGEN; EXPRESSION; MELANOMA; IMMUNOTHERAPY; PROGRESSION	The presence of Foxp3(+) regulatory CD4(+) T cells in tumor lesions is considered one of the major causes of ineffective immune response in cancer. It is not clear whether intratumoral T-reg cells represent T-reg cells pre-existing in healthy mice, or arise from tumor-specific effector CD4(+) T cells and thus representing adaptive T-reg cells. The generation of T-reg population in tumors could be further complicated by recent evidence showing that both in humans and mice the peripheral population of T-reg cells is heterogenous and consists of subsets which may differentially respond to tumor-derived antigens. We have studied T-reg cells in cancer in experimental mice that express naturally selected, polyclonal repertoire of CD4(+) T cells and which preserve the heterogeneity of the T-reg population. The majority of T-reg cells present in healthy mice maintained a stable suppressor phenotype, expressed high level of Foxp3 and an exclusive set of TCRs not used by naive CD4(+) T cells. A small T-reg subset, utilized TCRs shared with effector T cells and expressed a lower level of Foxp3. We show that response to tumor-derived antigens induced efficient clonal recruitment and expansion of antigen-specific effector and T-reg cells. However, the population of T-reg cells in tumors was dominated by cells expressing TCRs shared with effector CD4(+) T cells. In contrast, T-reg cells expressing an exclusive set of TCRs, that dominate in healthy mice, accounted for only a small fraction of all T-reg cells in tumor lesions. Our results suggest that the T-reg repertoire in tumors is generated by conversion of effector CD4(+) T cells or expansion of a minor subset of T-reg cells. In conclusion, successful cancer immunotherapy may depend on the ability to block upregulation of Foxp3 in effector CD4(+) T cells and/or selectively inhibiting the expansion of a minor T-reg subset.	[Kuczma, Michal; Kopij, Magdalena; Wang, Cong-Yi; Kraj, Piotr] Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Pawlikowska, Iwona; Rempala, Grzegorz A.] Med Coll Georgia, Dept Biostat, Augusta, GA 30912 USA; [Pawlikowska, Iwona; Rempala, Grzegorz A.] Med Coll Georgia, Ctr Canc, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Kuczma, M (corresponding author), Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA.	pkraj@mail.mcg.edu		Wang, Cong-Yi/0000-0001-7914-168X	National Institutes of Health [R01 CA107349-01A1, 1R01DE019243-01, DMS 0840695]; NATIONAL CANCER INSTITUTE [R01CA107349, R01CA152158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019243] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [0840695] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Institutes of Health grants R01 CA107349-01A1 to PK and 1R01DE019243-01 and DMS 0840695 to GAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AJ, 2000, J IMMUNOL, V164, P649, DOI 10.4049/jimmunol.164.2.649; Ahmadzadeh M, 2008, BLOOD, V112, P4953, DOI 10.1182/blood-2008-06-163048; Allan SE, 2008, IMMUNOL REV, V223, P391, DOI 10.1111/j.1600-065X.2008.00634.x; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; CHAO A, 1984, SCAND J STAT, V11, P265; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chikamatsu K, 2009, CANCER IMMUNOL IMMUN, V58, P1441, DOI 10.1007/s00262-009-0661-3; Chmielowski B, 1999, J IMMUNOL, V162, P95; Chmielowski B, 2002, P NATL ACAD SCI USA, V99, P15012, DOI 10.1073/pnas.222463499; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2008, CURR OPIN IMMUNOL, V20, P241, DOI 10.1016/j.coi.2008.04.008; Darrasse-Jeze G, 2009, J CLIN INVEST, V119, P2648, DOI 10.1172/JCI36628; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; GAO XM, 1989, J IMMUNOL, V143, P3007; Getnet D, 2009, J IMMUNOL, V182, P4675, DOI 10.4049/jimmunol.0803400; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; IGNATOWICZ L, 1995, J IMMUNOL, V154, P3852; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Joncker NT, 2006, INT J CANCER, V118, P1205, DOI 10.1002/ijc.21472; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Kraj P, 2001, J IMMUNOL, V166, P2251, DOI 10.4049/jimmunol.166.4.2251; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kubuschok B, 2006, CLIN CANCER RES, V12, P1365, DOI 10.1158/1078-0432.CCR-05-1672; Kuczma M, 2009, J IMMUNOL, V183, P3118, DOI 10.4049/jimmunol.0900514; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lehe C, 2008, CANCER RES, V68, P6350, DOI 10.1158/0008-5472.CAN-08-0050; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; Nishikawa H, 2001, P NATL ACAD SCI USA, V98, P14571, DOI 10.1073/pnas.251547298; Nishikawa H, 2005, J EXP MED, V201, P681, DOI 10.1084/jem.20041959; Nishikawa H, 2005, BLOOD, V106, P1008, DOI 10.1182/blood-2005-02-0607; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Sasada T, 2003, CANCER-AM CANCER SOC, V98, P1089, DOI 10.1002/cncr.11618; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Shimizu J, 1999, J IMMUNOL, V163, P5211; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sotomayor EM, 2001, BLOOD, V98, P1070, DOI 10.1182/blood.V98.4.1070; Srivastava PK, 2000, NAT IMMUNOL, V1, P363, DOI 10.1038/80795; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Strauss L, 2008, J IMMUNOL, V180, P2967, DOI 10.4049/jimmunol.180.5.2967; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Valzasina B, 2006, CANCER RES, V66, P4488, DOI 10.1158/0008-5472.CAN-05-4217; Wang CL, 2010, P NATL ACAD SCI USA, V107, P1518, DOI 10.1073/pnas.0913939107; Welters MJP, 2008, CLIN CANCER RES, V14, P178, DOI 10.1158/1078-0432.CCR-07-1880; Yu P, 2005, J EXP MED, V201, P779, DOI 10.1084/jem.20041684; Zhou G, 2006, BLOOD, V107, P628, DOI 10.1182/blood-2005-07-2737; Zhou G, 2007, J IMMUNOL, V178, P2155, DOI 10.4049/jimmunol.178.4.2155; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	61	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13623	10.1371/journal.pone.0013623	http://dx.doi.org/10.1371/journal.pone.0013623			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049016	gold, Green Published, Green Submitted			2022-12-25	WOS:000283487400016
J	Caglayan, E; Romeo, GR; Kappert, K; Odenthal, M; Sudkamp, M; Body, SC; Shernan, SK; Hackbusch, D; Vantler, M; Kazlauskas, A; Rosenkranz, S				Caglayan, Evren; Romeo, Giulio R.; Kappert, Kai; Odenthal, Margarete; Suedkamp, Michael; Body, Simon C.; Shernan, Stanton K.; Hackbusch, Daniel; Vantler, Marius; Kazlauskas, Andrius; Rosenkranz, Stephan			Profilin-1 Is Expressed in Human Atherosclerotic Plaques and Induces Atherogenic Effects on Vascular Smooth Muscle Cells	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; ACTIN-BINDING PROTEIN; RAT MESANGIAL CELLS; GROWTH-FACTOR; INSULIN-RESISTANCE; DNA-SYNTHESIS; CHEMOTAXIS; INFLAMMATION; DYSFUNCTION; DISEASE	Background: Profilin-1 is an ubiquitous actin binding protein. Under pathological conditions such as diabetes, profilin-1 levels are increased in the vascular endothelium. We recently demonstrated that profilin-1 overexpression triggers indicators of endothelial dysfunction downstream of LDL signaling, and that attenuated expression of profilin-1 confers protection from atherosclerosis in vivo. Methodology: Here we monitored profilin-1 expression in human atherosclerotic plaques by immunofluorescent staining. The effects of recombinant profilin-1 on atherogenic signaling pathways and cellular responses such as DNA synthesis (BrdU-incorporation) and chemotaxis (modified Boyden-chamber) were evaluated in cultured rat aortic and human coronary vascular smooth muscle cells (VSMCs). Furthermore, the correlation between profilin-1 serum levels and the degree of atherosclerosis was assessed in humans. Principal Findings: In coronary arteries from patients with coronary heart disease, we found markedly enhanced profilin expression in atherosclerotic plaques compared to the normal vessel wall. Stimulation of rat aortic and human coronary VSMCs with recombinant profilin-1 (10(-6) M) in vitro led to activation of intracellular signaling cascades such as phosphorylation of Erk1/2, p70(S6) kinase and PI3K/Akt within 10 minutes. Furthermore, profilin-1 concentration-dependently induced DNA-synthesis and migration of both rat and human VSMCs, respectively. Inhibition of PI3K (Wortmannin, LY294002) or Src-family kinases (SU6656, PP2), but not PLC gamma (U73122), completely abolished profilin-induced cell cycle progression, whereas PI3K inhibition partially reduced the chemotactic response. Finally, we found that profilin-1 serum levels were significantly elevated in patients with severe atherosclerosis in humans (p<0.001 vs. no atherosclerosis or control group). Conclusions: Profilin-1 expression is significantly enhanced in human atherosclerotic plaques compared to the normal vessel wall, and the serum levels of profilin-1 correlate with the degree of atherosclerosis in humans. The atherogenic effects exerted by profilin-1 on VSMCs suggest an auto-/paracrine role within the plaque. These data indicate that profilin-1 might critically contribute to atherogenesis and may represent a novel therapeutic target.	[Caglayan, Evren; Vantler, Marius; Rosenkranz, Stephan] Univ Cologne, Innere Med Klin 3, Cologne, Germany; [Caglayan, Evren; Vantler, Marius; Rosenkranz, Stephan] Univ Cologne, CMMC, Cologne, Germany; [Romeo, Giulio R.] Joslin Diabet Ctr, Dept Cellular & Mol Physiol, Boston, MA 02215 USA; [Kappert, Kai; Hackbusch, Daniel] Charite, CCR, Inst Pharmakol, D-13353 Berlin, Germany; [Odenthal, Margarete] Univ Cologne, Inst Pathol, D-5000 Cologne, Germany; [Suedkamp, Michael] Univ Freiburg Klinikum, Freiburg, Germany; [Body, Simon C.; Shernan, Stanton K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Kazlauskas, Andrius] Harvard Univ, Schepens Eye Res Inst, Sch Med, Boston, MA USA	University of Cologne; University of Cologne; Harvard University; Joslin Diabetes Center, Inc.; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; University of Freiburg; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Schepens Eye Research Institute	Caglayan, E (corresponding author), Univ Cologne, Innere Med Klin 3, Cologne, Germany.	stephan.rosenkranz@uk-koeln.de	Body, Simon/AAQ-7572-2020; Kappert, Kai/H-4116-2017; Body, Simon C/O-2605-2013; Caglayan, Evren/ABB-8674-2020	Body, Simon/0000-0001-6721-7050; Kappert, Kai/0000-0001-6976-0428; Body, Simon C/0000-0001-6721-7050; 	Deutsche Forschungsgemeinschaft [Ro 1306/2-1, Ro 1306/2-2]; Center for Molecular Medicine (CMMC) of the University of Cologne [A6]; Maria-Pesch-Stiftung; Medical Faculty; University of Cologne; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL068774, R01HL098601] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Molecular Medicine (CMMC) of the University of Cologne; Maria-Pesch-Stiftung; Medical Faculty; University of Cologne; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the Deutsche Forschungsgemeinschaft (to SR; Ro 1306/2-1 and 2-2), the Center for Molecular Medicine (CMMC) of the University of Cologne (to SR; A6), the Maria-Pesch-Stiftung (to EC), and by the Koeln Fortune Program (Medical Faculty; University of Cologne, to KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Caglayan E, 2008, DIABETES, V57, P2470, DOI 10.2337/db07-0924; CHAMLEYCAMPBELL J, 1979, PHYSIOL REV, V59, P1, DOI 10.1152/physrev.1979.59.1.1; Dandona P, 2003, J CLIN ENDOCR METAB, V88, P2422, DOI 10.1210/jc.2003-030178; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; HAUGWITZ M, 1994, CELL, V79, P303, DOI 10.1016/0092-8674(94)90199-6; Hsueh WA, 2004, HYPERTENSION, V43, P297, DOI 10.1161/01.HYP.0000113626.76571.5b; Hsueh WA, 2003, AM J CARDIOL, V92, p10J, DOI 10.1016/S0002-9149(03)00611-8; KWIATKOWSKI DJ, 1988, J BIOL CHEM, V263, P5910; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Machesky Laura M., 1993, Trends in Cell Biology, V3, P381, DOI 10.1016/0962-8924(93)90087-H; Marx N, 2004, ARTERIOSCL THROM VAS, V24, P540, DOI 10.1161/01.ATV.0000116027.81513.68; Moustafa-Bayoumi M, 2007, J BIOL CHEM, V282, P37632, DOI 10.1074/jbc.M703227200; Paavilainen VO, 2004, TRENDS CELL BIOL, V14, P386, DOI 10.1016/j.tcb.2004.05.002; Romeo G, 2004, FASEB J, V18, P725, DOI 10.1096/fj.03-0841fje; Romeo GR, 2007, CIRC RES, V101, P357, DOI 10.1161/CIRCRESAHA.107.151399; Rosenkranz S, 1999, J BIOL CHEM, V274, P28335, DOI 10.1074/jbc.274.40.28335; Rosenkranz S, 2002, FASEB J, V16, P1958, DOI 10.1096/fj.02-0207fje; Suzuki LA, 2001, DIABETES, V50, P851, DOI 10.2337/diabetes.50.4.851; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Tamura M, 2000, J AM SOC NEPHROL, V11, P423, DOI 10.1681/ASN.V113423; Tamura M, 2000, J AM SOC NEPHROL, V11, P1620, DOI 10.1681/ASN.V1191620; Walcher D, 2006, CIRC RES, V99, P1181, DOI 10.1161/01.RES.0000251231.16993.88; Waltenberger J, 2000, CIRCULATION, V102, P185, DOI 10.1161/01.CIR.102.2.185; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Yarmola EG, 2006, TRENDS BIOCHEM SCI, V31, P197, DOI 10.1016/j.tibs.2006.02.006; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893	28	42	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13608	10.1371/journal.pone.0013608	http://dx.doi.org/10.1371/journal.pone.0013608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049052	Green Published, Green Submitted, gold			2022-12-25	WOS:000283422100015
J	Hasegawa, D; Fujii, R; Yagishita, N; Matsumoto, N; Aratani, S; Izumi, T; Azakami, K; Nakazawa, M; Fujita, H; Sato, T; Araya, N; Koike, J; Tadokoro, M; Suzuki, N; Nagata, K; Senoo, H; Friedman, SL; Nishioka, K; Yamano, Y; Itoh, F; Nakajima, T				Hasegawa, Daisuke; Fujii, Ryoji; Yagishita, Naoko; Matsumoto, Nobuyuki; Aratani, Satoko; Izumi, Toshihiko; Azakami, Kazuko; Nakazawa, Minako; Fujita, Hidetoshi; Sato, Tomoo; Araya, Natsumi; Koike, Junki; Tadokoro, Mamoru; Suzuki, Noboru; Nagata, Kazuhiro; Senoo, Haruki; Friedman, Scott L.; Nishioka, Kusuki; Yamano, Yoshihisa; Itoh, Fumio; Nakajima, Toshihiro			E3 Ubiquitin Ligase Synoviolin Is Involved in Liver Fibrogenesis	PLOS ONE			English	Article							INDUCED CELL-DEATH; ENDOPLASMIC-RETICULUM; HEPATIC-FIBROSIS; ER STRESS; IN-VIVO; MISFOLDED PROCOLLAGEN; RHEUMATOID-ARTHRITIS; STELLATE CELLS; HUMAN HRD1; COLLAGEN	Background and Aim: Chronic hepatic damage leads to liver fibrosis, which is characterized by the accumulation of collagen-rich extracellular matrix. However, the mechanism by which E3 ubiquitin ligase is involved in collagen synthesis in liver fibrosis is incompletely understood. This study aimed to explore the involvement of the E3 ubiquitin ligase synoviolin (Syno) in liver fibrosis. Methods: The expression and localization of synoviolin in the liver were analyzed in CCl(4)-induced hepatic injury models and human cirrhosis tissues. The degree of liver fibrosis and the number of activated hepatic stellate cells (HSCs) was compared between wild type (wt) and Syno(+/-) mice in the chronic hepatic injury model. We compared the ratio of apoptosis in activated HSCs between wt and Syno(+/-) mice. We also analyzed the effect of synoviolin on collagen synthesis in the cell line from HSCs (LX-2) using siRNA-synoviolin and a mutant synoviolin in which E3 ligase activity was abolished. Furthermore, we compared collagen synthesis between wt and Syno(-/-) mice embryonic fibroblasts (MEF) using quantitative RT-PCR, western blotting, and collagen assay; then, we immunohistochemically analyzed the localization of collagen in Syno(-/-) MEF cells. Results: In the hepatic injury model as well as in cirrhosis, synoviolin was upregulated in the activated HSCs, while Syno(+/-) mice developed significantly less liver fibrosis than in wt mice. The number of activated HSCs was decreased in Syno(+/-) mice, and some of these cells showed apoptosis. Furthermore, collagen expression in LX-2 cells was upregulated by synoviolin overexpression, while synoviolin knockdown led to reduced collagen expression. Moreover, in Syno(-/-) MEF cells, the amounts of intracellular and secreted mature collagen were significantly decreased, and procollagen was abnormally accumulated in the endoplasmic reticulum. Conclusion: Our findings demonstrate the importance of the E3 ubiquitin ligase synoviolin in liver fibrosis.	[Hasegawa, Daisuke; Fujii, Ryoji; Yagishita, Naoko; Aratani, Satoko; Izumi, Toshihiko; Azakami, Kazuko; Nakazawa, Minako; Fujita, Hidetoshi; Sato, Tomoo; Araya, Natsumi; Nishioka, Kusuki; Yamano, Yoshihisa; Nakajima, Toshihiro] St Marianna Univ, Sch Med, Inst Med Sci, Kawasaki, Kanagawa, Japan; [Hasegawa, Daisuke; Matsumoto, Nobuyuki; Itoh, Fumio] St Marianna Univ, Sch Med, Div Gastroenterol & Hepatol, Kawasaki, Kanagawa, Japan; [Koike, Junki; Tadokoro, Mamoru] St Marianna Univ, Sch Med, Dept Pathol, Kawasaki, Kanagawa, Japan; [Suzuki, Noboru] St Marianna Univ, Sch Med, Dept Immunol, Kawasaki, Kanagawa, Japan; [Suzuki, Noboru] St Marianna Univ, Sch Med, Dept Med, Kawasaki, Kanagawa, Japan; [Nagata, Kazuhiro] Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto, Japan; [Senoo, Haruki] Akita Univ, Sch Med, Dept Cell Biol & Histol, Hondo, Japan; [Friedman, Scott L.] Mt Sinai Sch Med, Div Liver Dis, New York, NY USA; [Nishioka, Kusuki; Nakajima, Toshihiro] Tokyo Med Univ, Inst Med Sci, Tokyo, Japan; [Nakajima, Toshihiro] Fukushimura Hosp, Choju Med Inst, Toyohasi, Japan; [Nakajima, Toshihiro] Misato Marine Hosp, Kochi, Japan	Saint Marianna University; Saint Marianna University; Saint Marianna University; Saint Marianna University; Saint Marianna University; Kyoto University; Akita University; Icahn School of Medicine at Mount Sinai; Tokyo Medical University	Hasegawa, D (corresponding author), St Marianna Univ, Sch Med, Inst Med Sci, Kawasaki, Kanagawa, Japan.	nakashit@marianna-u.ac.jp	Matsumoto, Nobuyuki/AAK-6459-2020; Sato, Tomoo/E-3262-2010; Yamano, Yoshihisa/AAG-3955-2020	Sato, Tomoo/0000-0001-8439-3128; 	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japanese Ministry of Health, Labour, and Welfare; National Institute of Biomedical Innovation; Uehara Memorial Foundation; Nagao Takeshi Nanbyo Foundation; Kanagawa Nanbyo Foundation; Mishima Kaiun Memorial Foundation; Takeda Science Foundation; ITSUU Laboratory Research Foundation; Kanae Foundation for Life and Socio-Medical Science; Japan Research Foundation for Clinical Pharmacology; Kanagawa Academy of Science and Technology; Japan College of Rheumatology; Nakajima Foundation; Osaka Foundation for Cancer Research; New Energy and Industrial Technology Development Organization; Mochida Pharmaceutical Company, Ltd.; Kanagawa High-Technology Foundation; Kanto Bureau of Economy, Trade and Industry; Mitsui Life Insurance Company, Ltd.; Heiwa Nakajima Foundation; Sagawa Foundation for Promotion of Cancer Research; Tokyo Biochemical Research Foundation; National Institutes of Health [DK56621]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056621, R56DK056621] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [20249052] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japanese Ministry of Health, Labour, and Welfare; National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Uehara Memorial Foundation(Uehara Memorial Foundation); Nagao Takeshi Nanbyo Foundation; Kanagawa Nanbyo Foundation(Kanagawa Nanbyo Foundation); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); ITSUU Laboratory Research Foundation; Kanae Foundation for Life and Socio-Medical Science; Japan Research Foundation for Clinical Pharmacology; Kanagawa Academy of Science and Technology; Japan College of Rheumatology; Nakajima Foundation; Osaka Foundation for Cancer Research; New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Mochida Pharmaceutical Company, Ltd.; Kanagawa High-Technology Foundation; Kanto Bureau of Economy, Trade and Industry; Mitsui Life Insurance Company, Ltd.; Heiwa Nakajima Foundation; Sagawa Foundation for Promotion of Cancer Research; Tokyo Biochemical Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by a Grant-in Aid for Scientific Research from Japan Society for the Promotion of Science; The Ministry of Education, Culture, Sports, Science and Technology, Japanese Ministry of Health, Labour, and Welfare; National Institute of Biomedical Innovation; Uehara Memorial Foundation; Nagao Takeshi Nanbyo Foundation; Kanagawa Nanbyo Foundation; Mishima Kaiun Memorial Foundation; Takeda Science Foundation; ITSUU Laboratory Research Foundation; Kanae Foundation for Life and Socio-Medical Science; Japan Research Foundation for Clinical Pharmacology; Kanagawa Academy of Science and Technology (research grants); Japan College of Rheumatology; Nakajima Foundation; Osaka Foundation for Cancer Research; New Energy and Industrial Technology Development Organization; Mochida Pharmaceutical Company, Ltd.; Kanagawa High-Technology Foundation; Kanto Bureau of Economy, Trade and Industry; Mitsui Life Insurance Company, Ltd.; Heiwa Nakajima Foundation; Sagawa Foundation for Promotion of Cancer Research; Tokyo Biochemical Research Foundation and National Institutes of Health (DK56621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Boot-Handford RP, 2010, CELL TISSUE RES, V339, P197, DOI 10.1007/s00441-009-0877-8; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681; Gao BX, 2008, EMBO REP, V9, P480, DOI 10.1038/embor.2008.37; Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Ishida Y, 2009, AUTOPHAGY, V5, P1217, DOI 10.4161/auto.5.8.10168; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Izumi T, 2009, ARTHRITIS RHEUM-US, V60, P63, DOI 10.1002/art.24178; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kimmelman AC, 2004, ONCOGENE, V23, P5077, DOI 10.1038/sj.onc.1207662; Koide T, 2005, TOP CURR CHEM, V247, P85, DOI 10.1007/b103820; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Lisse TS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040007; Mehtani S, 1998, J BIOL CHEM, V273, P13236, DOI 10.1074/jbc.273.21.13236; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nadav E, 2003, BIOCHEM BIOPH RES CO, V303, P91, DOI 10.1016/S0006-291X(03)00279-1; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; Perez F, 2002, J CELL BIOL, V156, P631, DOI 10.1083/jcb.200111003; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Ratziu V, 1998, P NATL ACAD SCI USA, V95, P9500, DOI 10.1073/pnas.95.16.9500; Sawa T, 1999, INFECT IMMUN, V67, P1450, DOI 10.1128/IAI.67.3.1450-1454.1999; Stefanovic B, 2004, MOL CELL BIOL, V24, P1758, DOI 10.1128/MCB.24.4.1758-1768.2004; Toh ML, 2006, ARTHRITIS RHEUM-US, V54, P2109, DOI 10.1002/art.21926; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yagishita N, 2005, J BIOL CHEM, V280, P7909, DOI 10.1074/jbc.M410863200; Yagishita N, 2008, NAT CLIN PRACT RHEUM, V4, P91, DOI 10.1038/ncprheum0699; Yamano Y, 2010, NAT REV RHEUMATOL, V6, P106, DOI 10.1038/nrrheum.2009.257; Yamasaki S, 2005, ARTHRITIS RES THER, V7, P181, DOI 10.1186/ar1808; Yamasaki S, 2007, EMBO J, V26, P113, DOI 10.1038/sj.emboj.7601490; Yamasaki S, 2006, INT J MOL MED, V18, P113	40	30	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13590	10.1371/journal.pone.0013590	http://dx.doi.org/10.1371/journal.pone.0013590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049091	Green Published, gold, Green Submitted			2022-12-25	WOS:000283422100010
J	Tan, W; Dean, M; Law, AJ				Tan, Wei; Dean, Michael; Law, Amanda J.			Molecular Cloning and Characterization of the Human ErbB4 Gene: Identification of Novel Splice Isoforms in the Developing and Adult Brain	PLOS ONE			English	Article							SCHIZOPHRENIA; EXPRESSION; NEUREGULIN-1; TRANSLATION; VARIANTS; DISEASE; CODE	ErbB4 is a growth factor receptor tyrosine kinase essential for neurodevelopment. Genetic variation in ErbB4 is associated with schizophrenia and risk-associated polymorphisms predict overexpression of ErbB4 CYT-1 isoforms in the brain in the disorder. The molecular mechanism of association is unclear because the polymorphisms flank exon 3 of the gene and reside 700 kb distal to the CYT-1 defining exon. We hypothesized that the polymorphisms are indirectly associated with ErbB4 CYT-1 via splicing of exon 3 on the CYT-1 background. We report via cloning and sequencing of adult and fetal human brain cDNA libraries the identification of novel splice isoforms of ErbB4, whereby exon 3 is skipped (del. 3). ErbB4 del. 3 transcripts exist as CYT-2 isoforms and are predicted to produce truncated proteins. Furthermore, our data refine the structure of the human ErbB4 gene, clarify that juxtamembrane (JM) splice variants of ErbB4, JM-a and JM-b respectively, are characterized by the replacement of a 75 nucleotide (nt) sequence with a 45-nt insertion, and demonstrate that there are four alternative exons in the gene. Our analyses reveal that novel splice variants of ErbB4 exist in the developing and adult human brain and, given the failure to identify ErbB4 del. 3 CYT-1 transcripts, suggest that the association of risk polymorphisms in the ErbB4 gene with CYT-1 transcript levels is not mediated via an exon 3 splicing event.	[Tan, Wei] Natl Canc Inst Frederick, Basic Sci Program, Sci Applicat Int Corp Frederick, Frederick, MD USA; [Dean, Michael] Natl Canc Inst Frederick, Expt Immunol Lab, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD USA; [Law, Amanda J.] NIMH, Clin Brain Disorders Branch, Intramural Res Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Tan, W (corresponding author), Natl Canc Inst Frederick, Basic Sci Program, Sci Applicat Int Corp Frederick, Frederick, MD USA.	lawa@mail.nih.gov	Law, Amanda J/G-6372-2012; Dean, Michael/R-7501-2019; Dean, Michael C/G-8172-2012; Pethe, Kevin/L-1199-2013	Law, Amanda J/0000-0002-2574-1564; Dean, Michael C/0000-0003-2234-0631; Pethe, Kevin/0000-0003-0297-0150; Dick, Thomas/0000-0002-9604-9452; Cliff, Penelope/0000-0001-6558-6039; Pethe, Kevin/0000-0003-0916-8873	National Institute of Mental Health, National Institutes of Health (NIH), Bethesda, MD; National Cancer Institute, National Institutes of Health [HHSN26120080001E]; NIH, National Cancer Institute, Center for Cancer Research; MRC [G120/997] Funding Source: UKRI; Medical Research Council [G120/997] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIABC011301] Funding Source: NIH RePORTER	National Institute of Mental Health, National Institutes of Health (NIH), Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institute of Mental Health, National Institutes of Health (NIH), Bethesda, MD 20892, USA and federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN26120080001E. This research was also supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761; Elenius K, 1999, ONCOGENE, V18, P2607, DOI 10.1038/sj.onc.1202612; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Junttila TT, 2003, CLIN CANCER RES, V9, P5346; Konrad A, 2009, NEUROPSYCHOPHARMACOL, V34, P641, DOI 10.1038/npp.2008.112; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Law AJ, 2007, HUM MOL GENET, V16, P129, DOI 10.1093/hmg/ddl449; LUUKKONEN BGM, 1995, J VIROL, V69, P4086, DOI 10.1128/JVI.69.7.4086-4094.1995; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Rudloff U, 2010, CELL CYCLE, V9, P1487, DOI 10.4161/cc.9.8.11239; Silberberg G, 2006, AM J MED GENET B, V141B, P142, DOI 10.1002/ajmg.b.30275; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164	17	94	95	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12924	10.1371/journal.pone.0012924	http://dx.doi.org/10.1371/journal.pone.0012924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	21048946	gold, Green Published, Green Submitted			2022-12-25	WOS:000282091100028
J	Del Genio, CI; Kim, H; Toroczkai, Z; Bassler, KE				Del Genio, Charo I.; Kim, Hyunju; Toroczkai, Zoltan; Bassler, Kevin E.			Efficient and Exact Sampling of Simple Graphs with Given Arbitrary Degree Sequence	PLOS ONE			English	Article								Uniform sampling from graphical realizations of a given degree sequence is a fundamental component in simulation-based measurements of network observables, with applications ranging from epidemics, through social networks to Internet modeling. Existing graph sampling methods are either link-swap based (Markov-Chain Monte Carlo algorithms) or stub-matching based (the Configuration Model). Both types are ill-controlled, with typically unknown mixing times for link-swap methods and uncontrolled rejections for the Configuration Model. Here we propose an efficient, polynomial time algorithm that generates statistically independent graph samples with a given, arbitrary, degree sequence. The algorithm provides a weight associated with each sample, allowing the observable to be measured either uniformly over the graph ensemble, or, alternatively, with a desired distribution. Unlike other algorithms, this method always produces a sample, without backtracking or rejections. Using a central limit theorem-based reasoning, we argue, that for large N, and for degree sequences admitting many realizations, the sample weights are expected to have a lognormal distribution. As examples, we apply our algorithm to generate networks with degree sequences drawn from power-law distributions and from binomial distributions.	[Del Genio, Charo I.; Bassler, Kevin E.] Univ Houston, Dept Phys, Houston, TX 77004 USA; [Del Genio, Charo I.; Bassler, Kevin E.] Univ Houston, Texas Ctr Superconduct TcSUH, Houston, TX USA; [Kim, Hyunju; Toroczkai, Zoltan] Univ Notre Dame, Interdisciplinary Ctr Network Sci & Applicat ICeN, Notre Dame, IN 46556 USA	University of Houston System; University of Houston; University of Houston System; University of Houston; University of Notre Dame	Del Genio, CI (corresponding author), Univ Houston, Dept Phys, Houston, TX 77004 USA.	Kevin.E.Bassler@mail.uh.edu	Toroczkai, Zoltan/AAC-8446-2019; del Genio, Charo I/F-7249-2010	Toroczkai, Zoltan/0000-0002-6602-2849; del Genio, Charo I/0000-0001-9958-017X	National Science Foundation (NSF) [DMR-0908286]; Norman Hackerman Advanced Research Program [95921]; NSF [BCS-0826958]; Defense Threat Reduction Agency (DTRA) [HDTRA 201473-35045]	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Norman Hackerman Advanced Research Program; NSF(National Science Foundation (NSF)); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	CIDG and KEB are supported by the National Science Foundation (NSF) through grant DMR-0908286 and by the Norman Hackerman Advanced Research Program through grant 95921. HK and ZT are supported in part by the NSF BCS-0826958 and by the Defense Threat Reduction Agency (DTRA) through HDTRA 201473-35045. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; BENDER EA, 1978, J COMB THEORY A, V24, P296, DOI 10.1016/0097-3165(78)90059-6; Bianconi G, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016114; Bianconi G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036114; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boguna M, 2004, EUR PHYS J B, V38, P205, DOI 10.1140/epjb/e2004-00038-8; Bollobas B., 1980, EUROPEAN J COMBIN, V1, P311, DOI [10.1016/S0195-6698(80)80030-8, DOI 10.1016/S0195-6698(80)80030-8]; Burda Z, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.046118; Catanzaro M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.027103; Chung F., 2002, ANN COMB, V6, P125, DOI [10.1007/PL00012580, 10.1007/PL00012580.pdf, DOI 10.1007/PL00012580.PDF]; COCHRAN W. G, 1977, SAMPLING TECHNIQUES, V3rd; Cooper C, 2007, COMB PROBAB COMPUT, V16, P557, DOI 10.1017/S0963548306007978; ERDOS P, 1960, MAT LAPOK, V11, P477; HAKIMI SL, 1962, J SOC IND APPL MATH, V10, P496, DOI 10.1137/0110037; Havel V., 1955, CASOPIS PROPESTOV MA, V80, P477, DOI DOI 10.21136/CPM.1955.108220; Kannan R, 1999, RANDOM STRUCT ALGOR, V14, P293, DOI 10.1002/(SICI)1098-2418(199907)14:4<293::AID-RSA1>3.0.CO;2-G; Kim H, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/39/392001; KOREN M, 1976, J COMB THEORY B, V21, P235, DOI 10.1016/S0095-8956(76)80007-X; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Newman M., 1999, MONTE CARLO METHODS; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Newman MEJ., 2006, STRUCTURE DYNAMICS N; TAYLOR R, 1982, SIAM J ALGEBRA DISCR, V3, P114, DOI 10.1137/0603011; Tripathi A, 2003, DISCRETE MATH, V265, P417, DOI 10.1016/S0012-365X(02)00886-5; Viger F, 2005, LECT NOTES COMPUT SC, V3595, P440, DOI 10.1007/11533719_45	28	113	113	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10012	10.1371/journal.pone.0010012	http://dx.doi.org/10.1371/journal.pone.0010012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386694	Green Submitted, Green Published, gold			2022-12-25	WOS:000276482000005
